PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Carino, A; Marchiano, S; Biagioli, M; Bucci, M; Vellecco, V; Brancaleone, V; Fiorucci, C; Zampella, A; Monti, MC; Distrutti, E; Fiorucci, S				Carino, Adriana; Marchiano, Silvia; Biagioli, Michele; Bucci, Mariarosaria; Vellecco, Valentina; Brancaleone, Vincenzo; Fiorucci, Chiara; Zampella, Angela; Monti, Maria Chiara; Distrutti, Eleonora; Fiorucci, Stefano			Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis	FASEB JOURNAL			English	Article						NASH; TGR5; high fat diet; aortic rings	NONALCOHOLIC FATTY LIVER; BROWN ADIPOSE-TISSUE; FARNESOID-X-RECEPTOR; ACTIVATED RECEPTORS; CARDIOVASCULAR RISK; ENERGY-EXPENDITURE; GENE-EXPRESSION; DISEASE; TGR5; IDENTIFICATION	Nonalcoholic steatohepatitis (NASH) is associated with an increased risk of developing cardiovascular complications and mortality, suggesting that treatment of NASH might benefit from combined approaches that target the liver and the cardiovascular components of NASH. Using genetic and pharmacologic approaches, we show that G protein-coupled bile acid-activated receptor 1 (GPBAR1) agonism reverses liver and vascular damage in mouse models of NASH. NASH is associated with accelerated vascular inflammation representing an independent risk factor for development of cardiovascular diseases and cardiovascular-related mortality. GPBAR1, also known as TGR5, is a G protein-coupled receptor for secondary bile acids that reduces inflammation and promotes energy expenditure. Using genetic and pharmacologic approaches, we investigated whether GPBAR1 agonism by 6-ethyl-3,7-dihydroxy-5-cholan-24-ol (BAR501) reverses liver and vascular damage induced by exposure to a diet enriched in fat and fructose (HFD-F). Treating HFD-F mice with BAR501 reversed liver injury and promoted the browning of white adipose tissue in a Gpbar1-dependent manner. Feeding HFD-F resulted in vascular damage, as shown by the increased aorta intima-media thickness and increased expression of inflammatory genes (IL-6,TNF-, iNOS, and F4/80) and adhesion molecules (VCAM, intercellular adhesion molecule-1, and endothelial selectin) in the aorta, while reducing the expression of genes involved in NO and hydrogen sulfide generation, severely altering vasomotor activities of aortic rings in an ex vivo assay. BAR501 reversed this pattern in a Gpbar1-dependent manner, highlighting a potential role for GPBAR1 agonism in treating the liver and vascular component of NASH.Carino, A., Marchian, S., Biagioli, M., Bucci, M., Vellecco, V., Brancaleone, V., Fiorucci, C., Zampella, A., Monti, M. C., Distrutti, E., Fiorucci, S. Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis.	[Carino, Adriana; Marchiano, Silvia; Biagioli, Michele; Fiorucci, Chiara; Fiorucci, Stefano] Univ Perugia, Dept Surg & Biomed Sci, Piazza Lucio Severi 1, I-06122 Perugia, Italy; [Bucci, Mariarosaria; Vellecco, Valentina; Zampella, Angela] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Brancaleone, Vincenzo] Univ Basilicata, Dept Sci, Potenza, Italy; [Monti, Maria Chiara] Univ Salerno, Dept Pharm, Salerno, Italy; [Distrutti, Eleonora] Azienda Osped Perugia, Perugia, Italy	University of Perugia; University of Naples Federico II; Italfarmaco; University of Basilicata; University of Salerno; University of Perugia; Azienda Ospedaliera di Perugia	Carino, A (corresponding author), Univ Perugia, Dept Surg & Biomed Sci, Piazza Lucio Severi 1, I-06122 Perugia, Italy.	adriana.carino@unipg.it	Fiorucci, Stefano/I-1251-2012; Biagioli, Michele/AAF-6419-2019	Biagioli, Michele/0000-0002-2995-6896; Vellecco, Valentina/0000-0002-5674-9112				Arulanandan A, 2015, CLIN GASTROENTEROL H, V13, P1513, DOI 10.1016/j.cgh.2015.01.027; Bertholet AM, 2017, BIOCHIMIE, V134, P28, DOI 10.1016/j.biochi.2016.10.013; Betz MJ, 2015, DIABETES, V64, P2352, DOI 10.2337/db15-0146; Biagioli M, 2017, J IMMUNOL, V199, P718, DOI 10.4049/jimmunol.1700183; Bishop-Bailey D, 2004, P NATL ACAD SCI USA, V101, P3668, DOI 10.1073/pnas.0400046101; Calligaris SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060931; Carino A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13102-y; Carino A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42801; Castro RE, 2018, J HEPATOL, V69, P272, DOI 10.1016/j.jhep.2018.05.002; Chaar LJ, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12811; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chatterjee A, 2008, VASC PHARMACOL, V49, P134, DOI 10.1016/j.vph.2008.06.008; Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399; Cipriani S, 2013, CIRCULATION, V127, P2114, DOI 10.1161/CIRCULATIONAHA.113.001278; Cipriani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025637; Cuspidi C, 2018, PHARMACOL RES, V129, P20, DOI 10.1016/j.phrs.2018.01.007; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de Chantemele EJB, 2011, HYPERTENSION, V58, P271, DOI 10.1161/HYPERTENSIONAHA.110.168427; Donepudi AC, 2017, HEPATOLOGY, V65, P813, DOI 10.1002/hep.28707; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Fiorucci S, 2017, AM J PHYSIOL-HEART C, V312, pH21, DOI 10.1152/ajpheart.00577.2016; Fiorucci S, 2016, PHARMACOL RES, V111, P749, DOI 10.1016/j.phrs.2016.07.040; Fiorucci S, 2015, TRENDS MOL MED, V21, P702, DOI 10.1016/j.molmed.2015.09.001; Francque SM, 2016, J HEPATOL, V65, P425, DOI 10.1016/j.jhep.2016.04.005; Freed JK, 2017, J CARDIOVASC PHARM, V69, P264, DOI 10.1097/FJC.0000000000000463; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Keitel V, 2010, GLIA, V58, P1794, DOI 10.1002/glia.21049; Kida T, 2014, J PHARMACOL EXP THER, V348, P125, DOI 10.1124/jpet.113.209288; Kida T, 2013, ARTERIOSCL THROM VAS, V33, P1663, DOI 10.1161/ATVBAHA.113.301565; Kim D, 2012, HEPATOLOGY, V56, P605, DOI 10.1002/hep.25593; Li YTY, 2007, ARTERIOSCL THROM VAS, V27, P2606, DOI 10.1161/ATVBAHA.107.152694; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Oni ET, 2013, ATHEROSCLEROSIS, V230, P258, DOI 10.1016/j.atherosclerosis.2013.07.052; Perino A, 2014, J CLIN INVEST, V124, P5424, DOI 10.1172/JCI76289; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Rathouska J, 2015, HEART VESSELS, V30, P241, DOI 10.1007/s00380-014-0493-8; Reddy DS, 2016, TRENDS PHARMACOL SCI, V37, P543, DOI 10.1016/j.tips.2016.04.003; Renga B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141082; Renga B, 2015, AM J PHYSIOL-HEART C, V309, pH114, DOI 10.1152/ajpheart.00087.2015; Rossiello MR, 2005, J THROMB HAEMOST, V3, P2554, DOI 10.1111/j.1538-7836.2005.01605.x; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; Sepe V, 2014, J MED CHEM, V57, P7687, DOI 10.1021/jm500889f; Simas BB, 2018, STRESS, V21, P247, DOI 10.1080/10253890.2018.1437413; Sinn DH, 2016, GASTROENTEROLOGY, V151, P481, DOI 10.1053/j.gastro.2016.06.001; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Song C, 2007, INT J CANCER, V121, P1055, DOI 10.1002/ijc.22808; Tabas I, 2017, IMMUNITY, V47, P621, DOI 10.1016/j.immuni.2017.09.008; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Teufel A, 2016, GASTROENTEROLOGY, V151, P513, DOI 10.1053/j.gastro.2016.05.051; Townsend KL, 2008, ENDOCRINE, V33, P176, DOI 10.1007/s12020-008-9070-1; Vassileva G, 2010, J ENDOCRINOL, V205, P225, DOI 10.1677/JOE-10-0009; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Zeb I, 2016, J AM COLL CARDIOL, V67, P1965, DOI 10.1016/j.jacc.2016.01.070	58	31	32	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2809	2822		10.1096/fj.201801373RR	http://dx.doi.org/10.1096/fj.201801373RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303744				2022-12-26	WOS:000457296600102
J	Wang, LY; Wang, WS; Wang, YW; Lu, JW; Lu, Y; Zhang, CY; Li, WJ; Sun, K; Ying, H				Wang, Lu-Yao; Wang, Wang-Sheng; Wang, Ya-Wei; Lu, Jiang-Wen; Lu, Yi; Zhang, Chu-Yue; Li, Wen-Jiao; Sun, Kang; Ying, Hao			Drastic induction of MMP-7 by cortisol in the human amnion: implications for membrane rupture at parturition	FASEB JOURNAL			English	Article						matrix metalloproteinase-7; fetal membranes; collagen; extracellular matrix; glucocorticoids	HUMAN FETAL MEMBRANES; DEHYDROGENASE TYPE-1 EXPRESSION; PREMATURE RUPTURE; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; PLACENTAL TROPHOBLAST; BASEMENT-MEMBRANE; CELL-DEATH; PRETERM	Preterm premature rupture of fetal membranes precedes 30-40% of preterm births. Activation of matrix metalloproteases (MMPs) is the one of the major causes of extracellular matrix (ECM) degradation in membrane rupture. Increased cortisol, regenerated by 11-hydroxysteroid dehydrogenase 1 in the amnion at parturition, is known to participate in a number of parturition-pertinent events. However, whether cortisol has a role in the regulation of MMPs in the membranes is not known. Here, we addressed this issue using human amnion tissue, the most tensile layer of the membranes. RNA-sequencing revealed that cortisol induced MMP7 expression dramatically in amnion fibroblasts, which was confirmed by real-time quantitative RT-PCR and Western blotting analysis in cortisol-treated amnion explants and fibroblasts. Measurement of collagen IV 5 chain (COL4A5), a substrate for MMP-7, showed that cortisol reduced its extracellular abundance, which was blocked by an antibody against MMP-7. Moreover, increased MMP-7 but decreased COL4A5 abundance was observed in the amnion tissue following labor-initiated spontaneous rupture of membranes. Mechanistic studies showed that cortisol increased the phosphorylation of c-Jun and the expression of c-Fos, the 2 major components of activated protein 1 (AP-1), respectively. The knocking down of c-Fos or c-Jun significantly attenuated the induction of MMP7 expression by cortisol. Chromatin immunoprecipitation assays showed that cortisol stimulated the enrichment of c-Fos and c-Jun at the AP-1 binding site in the MMP7 promoter. The data suggest that induction of MMP7 by cortisol via AP-1 may be a contributing factor to ECM degradation in membrane rupture at parturition.Wang, L.-Y., Wang, W.-S., Wang, Y.-W., Lu, J.-W., Lu, Y., Zhang, C.-Y., Li, W.-J., Sun, K., Ying, H. Drastic induction of MMP-7 by cortisol in the human amnion: implications for membrane rupture at parturition.	[Wang, Lu-Yao; Wang, Ya-Wei; Ying, Hao] Tongji Univ, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 201204, Peoples R China; [Wang, Wang-Sheng; Lu, Jiang-Wen; Lu, Yi; Zhang, Chu-Yue; Sun, Kang] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, 845 Lingshan Rd, Shanghai 200135, Peoples R China; [Wang, Wang-Sheng; Lu, Jiang-Wen; Lu, Yi; Zhang, Chu-Yue; Sun, Kang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China; [Li, Wen-Jiao] Matern & Infant Hosp Changning Dist, Shanghai, Peoples R China	Tongji University; Shanghai Jiao Tong University	Ying, H (corresponding author), Tongji Univ, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 201204, Peoples R China.; Sun, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, 845 Lingshan Rd, Shanghai 200135, Peoples R China.	sungangrenji@hotmail.com; stephenying_2011@163.com	Wang, Wang-sheng/E-9811-2017	Wang, Wang-sheng/0000-0003-1429-9237; Sun, Kang/0000-0003-2727-141X	National Natural Science Foundation of China [81330018, 81601320, 31671566, 81771600]; National Key R&D Program of China [2017YFC1001403]; National Key Basic Research Projects [2014CB943302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; National Key Basic Research Projects(National Basic Research Program of China)	The authors thank Dr. Dev Sooranna (Imperial College London, London, United Kingdom) for editing the manuscript. This work was supported by the National Natural Science Foundation of China (Grants 81330018, 81601320, 31671566, and 81771600), National Key R&D Program of China (2017YFC1001403), and National Key Basic Research Projects (2014CB943302). The authors declare no conflicts of interest.	Alfaidy N, 2003, J CLIN ENDOCR METAB, V88, P5033, DOI 10.1210/jc.2002-021915; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baraniuk JN, 1998, THORAX, V53, P577, DOI 10.1136/thx.53.7.577; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bryant-Greenwood GD, 1998, PLACENTA, V19, P1, DOI 10.1016/S0143-4004(98)90092-3; Challis JRG, 1997, ANN NY ACAD SCI, V828, P254, DOI 10.1111/j.1749-6632.1997.tb48546.x; Cosgrove D, 2017, MATRIX BIOL, V57-58, P45, DOI 10.1016/j.matbio.2016.08.005; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fortunato SJ, 2000, AM J OBSTET GYNECOL, V182, P1468, DOI 10.1067/mob.2000.107330; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Goldman S, 2003, EUR J OBSTET GYN R B, V111, P109, DOI 10.1016/S0301-2115(03)00341-5; Gomez-Lopez N, 2010, BIOL REPROD, V82, P809, DOI 10.1095/biolreprod.109.080432; GULLER S, 1995, J CLIN ENDOCR METAB, V80, P2244, DOI 10.1210/jc.80.7.2244; Kaden JJ, 2003, ATHEROSCLEROSIS, V170, P205, DOI 10.1016/S0021-9150(03)00284-3; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kossakowska AE, 1999, BLOOD, V94, P2080, DOI 10.1182/blood.V94.6.2080.418k30_2080_2089; Kwon MJ, 2014, BIOCHEM BIOPH RES CO, V446, P487, DOI 10.1016/j.bbrc.2014.02.142; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Lei HQ, 1996, J CLIN INVEST, V98, P1971, DOI 10.1172/JCI119001; LIBRACH CL, 1994, J BIOL CHEM, V269, P17125; Liu C, 2016, ENDOCRINOLOGY, V157, P4055, DOI 10.1210/en.2016-1406; Luo LG, 1998, BRAIN RES, V791, P56, DOI 10.1016/S0006-8993(97)01550-3; MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6; Maymon E, 2000, AM J OBSTET GYNECOL, V182, P1545, DOI 10.1067/mob.2000.107652; Menon R, 2004, J SOC GYNECOL INVEST, V11, P427, DOI 10.1016/j.jsgi.2004.04.001; Mi YB, 2018, J MOL ENDOCRINOL, V60, P45, DOI 10.1530/JME-17-0215; Mi YB, 2017, ENDOCRINOLOGY, V158, P1005, DOI 10.1210/en.2016-1829; MURPHY BEP, 1977, NATURE, V266, P179; MURPHY BEP, 1981, J STEROID BIOCHEM, V14, P811; Nishihara S, 2008, REPROD SCI, V15, P156, DOI 10.1177/1933719107310308; OCKLEFORD C, 1993, J ANAT, V183, P483; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Oyen ML, 2006, AM J OBSTET GYNECOL, V195, P510, DOI 10.1016/j.ajog.2006.02.010; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Patel FA, 1999, J CLIN ENDOCR METAB, V84, P395, DOI 10.1210/jc.84.2.395; POTESTIO FA, 1988, J CLIN ENDOCR METAB, V67, P1205, DOI 10.1210/jcem-67-6-1205; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Sado Y, 1998, J BIOCHEM-TOKYO, V123, P767; Schroen DJ, 1996, GENE EXPRESSION, V6, P197; Shi M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-269; Strauss JF, 2013, REPROD SCI, V20, P140, DOI 10.1177/1933719111424454; Sun K, 2003, ENDOCRINOLOGY, V144, P5568, DOI 10.1210/en.2003-0780; Sun K, 1997, J CLIN ENDOCR METAB, V82, P300, DOI 10.1210/jc.82.1.300; Sun K, 1997, ENDOCRINOLOGY, V138, P4912, DOI 10.1210/en.138.11.4912; TANSWELL AK, 1977, J CLIN ENDOCR METAB, V45, P721, DOI 10.1210/jcem-45-4-721; von Bredow DC, 1998, BIOCHEM J, V331, P965, DOI 10.1042/bj3310965; Wang WS, 2014, PLACENTA, V35, P30, DOI 10.1016/j.placenta.2013.10.018; Wang WS, 2018, ENDOCR REV, V39, P241, DOI 10.1210/er.2017-00188; Wang WS, 2016, ENDOCRINOLOGY, V157, P4487, DOI 10.1210/en.2016-1464; Wang WS, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac6151; Wang WS, 2012, ENDOCRINOLOGY, V153, P2012, DOI 10.1210/en.2011-1626; Xu P, 2002, J CLIN ENDOCR METAB, V87, P1353, DOI 10.1210/jc.87.3.1353; Yang Z, 2007, J ENDOCRINOL, V195, P241, DOI 10.1677/JOE-07-0303; Yin Z, 2017, NUCLEIC ACIDS RES, V45, P11425, DOI 10.1093/nar/gkx795; Yonemoto H, 2006, PLACENTA, V27, P669, DOI 10.1016/j.placenta.2005.05.014	57	8	9	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2770	2781		10.1096/fj.201801216R	http://dx.doi.org/10.1096/fj.201801216R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303742				2022-12-26	WOS:000457296600099
J	Zheng, HM; Zhang, YF; Chen, YC; Guo, PF; Wang, XX; Yuan, X; Ge, WZ; Yang, R; Yan, QF; Yang, XH; Xi, YM				Zheng, Huimei; Zhang, Yafei; Chen, Yuchen; Guo, Pengfei; Wang, Xuexiang; Yuan, Xin; Ge, Wanzhong; Yang, Ru; Yan, Qingfeng; Yang, Xiaohang; Xi, Yongmei			Prominin-like, a homolog of mammalian CD133, suppresses dilp6 and TOR signaling to maintain body size and weight in Drosophila	FASEB JOURNAL			English	Article						AC133; prominin-1; ecdysone; fat body	INSULIN-LIKE PEPTIDE; FAT-BODY; EPITHELIAL-CELLS; CELLULAR GROWTH; STEM-CELLS; RECEPTOR; METABOLISM; STARVATION; IDENTIFICATION; MOBILIZATION	CD133 (AC133/prominin-1) has been identified as a stem cell marker and a putative cancer stem cell marker in many solid tumors. Its biologic function and molecular mechanisms remain largely elusive. Here, we show that a fly mutant for prominin-like, a homolog of mammalian CD133, shows a larger body size and excess weight accompanied with higher fat deposits as compared with the wild type. The expression levels of prominin-like are mediated by ecdysone signaling where its protein levels increase dramatically in the fat body during metamorphosis. Prominin-like mutants exhibit higher Drosophila insulin-like peptide 6 (dilp6) levels during nonfeeding stages and increased Akt/Drosophila target of rapamycin (dTOR) signaling. On an amino acid-restricted diet, prominin-like mutants exhibit a significantly larger body size than the wild type does, similar to that which occurs upon the activation of the dTOR pathway in the fat body. Our data suggest that prominin-like functions by suppressing TOR and dilp6 signaling to control body size and weight. The identification of the physiologic function of prominin-like in Drosophila may provide valuable insight into the understanding of the metabolic function of CD133 in mammals.Zheng, H., Zhang, Y., Chen, Y., Guo, P., Wang, X., Yuan, X., Ge, W., Yang, R., Yan, Q., Yang, X., Xi, Y. Prominin-like, a homolog of mammalian CD133, suppresses dilp6 and TOR signaling to maintain body size and weight in Drosophila.	[Zheng, Huimei; Chen, Yuchen; Guo, Pengfei; Yuan, Xin; Ge, Wanzhong; Yang, Xiaohang; Xi, Yongmei] Zhejiang Univ, Womens Hosp, Sch Med, Div Human Reprod & Dev Genet, Hangzhou, Zhejiang, Peoples R China; [Zheng, Huimei; Chen, Yuchen; Guo, Pengfei; Yuan, Xin; Ge, Wanzhong; Yang, Xiaohang; Xi, Yongmei] Zhejiang Univ, Sch Med, Dept Genet, Hangzhou, Zhejiang, Peoples R China; [Zheng, Huimei; Chen, Yuchen; Guo, Pengfei; Yuan, Xin; Ge, Wanzhong; Yang, Xiaohang; Xi, Yongmei] Zhejiang Univ, Inst Genet, Hangzhou, Zhejiang, Peoples R China; [Zheng, Huimei; Zhang, Yafei; Guo, Pengfei; Wang, Xuexiang; Yan, Qingfeng] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Yang, Xiaohang] Zhejiang Univ, Zhejiang Univ Univ Toronto Joint Inst Genet & Gen, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yafei] Beijing Genom Inst, Shanghai, Peoples R China; [Yang, Ru] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China; [Yang, Ru] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Beijing Genomics Institute (BGI); Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, XH; Xi, YM (corresponding author), Zhejiang Univ, Sch Med, Yuhangtang Rd 866, Hangzhou 310012, Zhejiang, Peoples R China.	xhyang@zju.edu.cn; xyyongm@zju.edu.cn	guo, peng/AAG-4052-2019; 席, 咏梅/AAE-1909-2022; yan, qing/GZN-2287-2022; Guo, Peng/GWC-0572-2022	ZHENG, HUIMEI/0000-0001-7129-8412; Ge, Wanzhong/0000-0003-1334-2723	National Key Basic Research Program of China (973 Program) [2012CB966804]; National Natural Science Foundation of China [31371319, 31801230]; China Postdoctoral Science Foundation [2018M632452]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors acknowledge the Bloomington Drosophila Stock Center, the Exelixis Collection at the Harvard Medical School, and the Tsinghua Fly Center for providing the fly stocks, and L. M. Wang (Zhejiang University) for providing the Drosophila Activity Monitoring System. This study was supported by grants from the National Key Basic Research Program of China (973 Program) (Grant 2012CB966804), the National Natural Science Foundation of China (Grants 31371319 and 31801230), and the China Postdoctoral Science Foundation (Grant 2018M632452). The authors declare no conflicts of interest.	Alves-Bezerra M, 2016, INSECT BIOCHEM MOLEC, V69, P51, DOI 10.1016/j.ibmb.2015.06.013; Asha H, 2003, GENETICS, V163, P203; Ballard JWO, 2008, J INSECT PHYSIOL, V54, P1371, DOI 10.1016/j.jinsphys.2008.07.009; Bassett A, 2014, METHODS, V69, P128, DOI 10.1016/j.ymeth.2014.02.019; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Bruno S, 2006, AM J PATHOL, V169, P2223, DOI 10.2353/ajpath.2006.060498; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Corbeil D, 2001, BIOCHEM BIOPH RES CO, V285, P939, DOI 10.1006/bbrc.2001.5271; Corbeil D, 2013, PROMININ 1 CD133 NEW; Demontis F, 2007, DEV DYNAM, V236, P3408, DOI 10.1002/dvdy.21324; Fossett N, 2013, BBA-GEN SUBJECTS, V1830, P2375, DOI 10.1016/j.bbagen.2012.06.005; Glatter T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.79; Grewal SS, 2009, INT J BIOCHEM CELL B, V41, P1006, DOI 10.1016/j.biocel.2008.10.010; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Han Z, 2012, INVEST OPHTH VIS SCI, V53, P361, DOI 10.1167/iovs.11-8635; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hennig KM, 2002, GENESIS, V34, P107, DOI 10.1002/gene.10139; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Klambt T. H. C., 2008, METHODS PROTOCOLS, P108; Lan X, 2013, INT J MOL MED, V31, P315, DOI 10.3892/ijmm.2012.1208; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Nassel DR, 2015, GEN COMP ENDOCR, V221, P255, DOI 10.1016/j.ygcen.2014.11.021; Nie J, 2012, DEV BIOL, V371, P312, DOI 10.1016/j.ydbio.2012.08.024; Okamoto N, 2015, DEV CELL, V35, P295, DOI 10.1016/j.devcel.2015.10.003; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Oldham S, 2011, TRENDS ENDOCRIN MET, V22, P45, DOI 10.1016/j.tem.2010.11.002; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Parisi F, 2013, DEV BIOL, V379, P64, DOI 10.1016/j.ydbio.2013.04.008; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; Shingleton AW, 2005, CURR BIOL, V15, pR825, DOI 10.1016/j.cub.2005.10.006; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Slack C, 2007, DEVELOPMENT, V134, P3781, DOI 10.1242/dev.010900; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Slocumb ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131275; Song W, 2010, CELL METAB, V11, P427, DOI 10.1016/j.cmet.2010.04.002; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Tiebe M, 2015, DEV CELL, V33, P272, DOI 10.1016/j.devcel.2015.03.013; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028405; Yang Z, 2015, P NATL ACAD SCI USA, V112, P5219, DOI 10.1073/pnas.1417838112; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zheng HM, 2017, FASEB J, V31, P1964, DOI 10.1096/fj.201601127R; Zheng HM, 2016, LIFE SCI, V167, P22, DOI 10.1016/j.lfs.2016.10.019; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	65	5	5	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2646	2658		10.1096/fj.201800123R	http://dx.doi.org/10.1096/fj.201800123R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307770				2022-12-26	WOS:000457296600089
J	Wang, L; Wang, QM; Wang, YR; Xi, XG; Hou, XM				Wang, Lei; Wang, Qing-Man; Wang, Yi-Ran; Xi, Xu-Guang; Hou, Xi-Miao			DNA-unwinding activity of Saccharomyces cerevisiae Pif1 is modulated by thermal stability, folding conformation, and loop lengths of G-quadruplex DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICASE; INSTABILITY; MECHANISM; LONG	G-quadruplexes (G4s) are four-stranded DNA structures formed by Hoogsteen base pairing between stacked sets of four guanines. Pif1 helicase plays critical roles in suppressing genomic instability in the yeast Saccharomyces cerevisiae by resolving G4s. However, the structural properties of G4s in S. cerevisiae and the substrate preference of Pif1 for different G4s remain unknown. Here, using CD spectroscopy and 83 G4 motifs from S. cerevisiae ranging in length from 30 to 60 nucleotides, we first show that G4 structures can be formed with a broad range of loop sizes in vitro and that a parallel conformation is favored. Using single-molecule FRET analysis, we then systematically addressed Pif1-mediated unwinding of various G4s and found that Pif1 is sensitive to G4 stability. Moreover, Pif1 preferentially unfolded antiparallel G4s rather than parallel G4s having similar stability. Furthermore, our results indicate that most G4 structures in S. cerevisiae sequences have long loops and can be efficiently unfolded by Pif1 because of their low stability. However, we also found that G4 structures with short loops can be barely unfolded. This study highlights the formidable capability of Pif1 to resolve the majority of G4s in S. cerevisiae sequences, narrows the fractions of G4s that may be challenging for genomic stability, and provides a framework for understanding the influence of different G4s on genomic stability via their processing by Pif1.	[Wang, Lei; Wang, Qing-Man; Wang, Yi-Ran; Xi, Xu-Guang; Hou, Xi-Miao] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Wang, Lei; Wang, Qing-Man; Wang, Yi-Ran; Xi, Xu-Guang; Hou, Xi-Miao] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Xi, Xu-Guang] Ecole Normale Super, CNRS, Lab Biol & Pharmacol Appl, 61 Ave President Wilson, F-94235 Cachan, France	Northwest A&F University - China; Northwest A&F University - China; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Hou, XM (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Hou, XM (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	houximiao@nwsuaf.edu.cn	wang, yi/GVT-8516-2022; Wang, Yijun/GXW-1763-2022; Hou, Ximiao/P-2542-2017; Wang, Yixuan/GZK-6559-2022; Hou, Xi-Miao/AAA-7919-2021; Xi, Xu Guang/AAK-4511-2020; wang, yixuan/GXW-2866-2022; Wang, Yin/HCI-9352-2022	Hou, Ximiao/0000-0003-3499-443X	Chinese Universities Scientific Fund Grant [Z109021718]; National Natural Science Foundation of China [11574252]	Chinese Universities Scientific Fund Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Universities Scientific Fund Grant Z109021718 and National Natural Science Foundation of China Grant 11574252. The authors declare that they have no conflicts of interest with the contents of this article.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Barranco-Medina S, 2010, BIOCHEMISTRY-US, V49, P8445, DOI 10.1021/bi100984j; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Bugaut A, 2008, BIOCHEMISTRY-US, V47, P689, DOI 10.1021/bi701873c; Byrd AK, 2017, BIOCHEM SOC T, V45, P1159, DOI 10.1042/BST20170096; Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Cheng X, 2007, MITOCHONDRION, V7, P211, DOI 10.1016/j.mito.2006.11.023; Chung WH, 2014, J MICROBIOL, V52, P89, DOI 10.1007/s12275-014-3524-3; De Cian A, 2007, METHODS, V42, P183, DOI 10.1016/j.ymeth.2006.10.004; del Villar-Guerra R, 2018, ANGEW CHEM INT EDIT, V57, P7171, DOI 10.1002/anie.201709184; Dou SX, 2004, J BIOL CHEM, V279, P6354, DOI 10.1074/jbc.M311272200; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hou XM, 2017, NUCLEIC ACIDS RES, V45, P11401, DOI 10.1093/nar/gkx766; Hou XM, 2015, BIOCHEM J, V466, P189, DOI 10.1042/BJ20140997; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; Lu KY, 2018, NUCLEIC ACIDS RES, V46, P1486, DOI 10.1093/nar/gkx1217; Masiero S, 2010, ORG BIOMOL CHEM, V8, P2683, DOI 10.1039/c003428b; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Mendoza O, 2015, NUCLEIC ACIDS RES, V43, pE71, DOI 10.1093/nar/gkv193; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Piazza A, 2015, EMBO J, V34, P1718, DOI 10.15252/embj.201490702; Piazza A, 2010, NUCLEIC ACIDS RES, V38, P4337, DOI 10.1093/nar/gkq136; Rachwal PA, 2007, NUCLEIC ACIDS RES, V35, P4214, DOI 10.1093/nar/gkm316; Ramanagoudr-Bhojappa R, 2013, J BIOL CHEM, V288, P16185, DOI 10.1074/jbc.M113.470013; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sauer M, 2017, BIOCHEM SOC T, V45, P1173, DOI 10.1042/BST20170097; Tippana R, 2016, P NATL ACAD SCI USA, V113, P8448, DOI 10.1073/pnas.1603724113; Ying LM, 2003, P NATL ACAD SCI USA, V100, P14629, DOI 10.1073/pnas.2433350100; Zhang B, 2016, NUCLEIC ACIDS RES, V44, P8385, DOI 10.1093/nar/gkw669; Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190	42	22	23	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18504	18513		10.1074/jbc.RA118.005071	http://dx.doi.org/10.1074/jbc.RA118.005071			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30305390	hybrid, Green Published			2022-12-26	WOS:000458467300008
J	Singh, A; Azad, M; Shymko, MD; Henson, ES; Katyal, S; Eisenstat, DD; Gibson, SB				Singh, Amandeep; Azad, Meghan; Shymko, Miriam D.; Henson, Elizabeth S.; Katyal, Sachin; Eisenstat, David D.; Gibson, Spencer B.			The BH3 only Bcl-2 family member BNIP3 regulates cellular proliferation	PLOS ONE			English	Article							DEATH; MITOCHONDRIAL; AUTOPHAGY; INHIBITION; EXPRESSION; APOPTOSIS; DIFFERENTIATION; PROTEINS; CELLS; NIX	The BH3-only family member BNIP3 has been described as either promoting cell survival or cell death. This depends upon the level of BNIP3 expression and its cellular localization. Increased BNIP3 expression under hypoxia contributes to cell death through increased mitochondrial dysfunction. Furthermore, mice lacking BNIP3 show inhibition of ischemic cardiomyocyte apoptosis. In contrast, nuclear localization of BNIP3 contributes to blockage of apoptosis in glioma cells through repression of pro-apoptotic genes. We have discovered that mouse embryonic fibroblasts (MEFs) lacking BNIP3 expression show increased proliferation and cell number compared to wild-type cells. Furthermore, the cells lacking BNIP3 showed increased MAPK activation. Increased proliferation was not due to decreased cell death as oxidative stress induced cell death in BNIP3 null MEFs. In addition, we isolated astrocytes from wild-type or embryonic mice lacking expression of BNIP3. There was increased density and cell number in the astrocytes lacking BNIP3 expression. To confirm these results in human cells, we inducibly expressed BNIP3 in human embryonic kidney (HEK293) cells and found that induced BNIP3 reduced cell proliferation and failed to change background cell death levels. Transient over-expression of BNIP3 in the nucleus of HEK293 cells also reduced DNA synthesis. Finally, to determine whether this increased proliferation occurs in mice lacking BNIP3, we isolated brains from wild-type mice or those lacking BNIP3 expression. The mice lacking BNIP3 had increased cellularity in the brain of embryonic and adult mice. Taken together, our study describes a new function for BNIP3 in the regulation of cellular proliferation.	[Singh, Amandeep; Shymko, Miriam D.; Henson, Elizabeth S.; Katyal, Sachin; Gibson, Spencer B.] Univ Manitoba, Res Inst Oncol & Hematol, CancerCare Manitoba, Winnipeg, MB, Canada; [Singh, Amandeep; Shymko, Miriam D.; Henson, Elizabeth S.; Gibson, Spencer B.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Azad, Meghan] Children Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Katyal, Sachin] Univ Manitoba, Dept Pharmacol, Winnipeg, MB, Canada; [Katyal, Sachin] Univ Manitoba, Dept Therapeut, Winnipeg, MB, Canada; [Eisenstat, David D.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Eisenstat, David D.] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Eisenstat, David D.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	CancerCare Manitoba Foundation; University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Manitoba; University of Alberta; University of Alberta; University of Alberta	Gibson, SB (corresponding author), Univ Manitoba, Res Inst Oncol & Hematol, CancerCare Manitoba, Winnipeg, MB, Canada.; Gibson, SB (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada.	spencer.gibson@umanitoba.ca	Azad, Meghan/H-7226-2019; Eisenstat, David/AAA-4653-2020	Azad, Meghan/0000-0002-5942-4444; Gibson, Spencer/0000-0003-0119-732X	NSERC Discovery Grant	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a NSERC Discovery Grant to Dr. S. Gibson, Operating grant, Title: Role of BH3 only protein BNIP3 in regulating cell survival in the brain, Amount: $38,000/yr, 2015-2020.	Azad MB, 2008, AUTOPHAGY, V4, P195, DOI 10.4161/auto.5278; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Brayer S, 2017, CELL CYCLE, V16, P2108, DOI 10.1080/15384101.2017.1371882; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Burton TR, 2009, J NEUROSCI, V29, P4189, DOI 10.1523/JNEUROSCI.5747-08.2009; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Diwan A, 2007, J CLIN INVEST, V117, P2825, DOI 10.1172/JCI32490; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; Giatromanolaki A, 2004, CLIN CANCER RES, V10, P5566, DOI 10.1158/1078-0432.CCR-04-0076; Glick D, 2012, MOL CELL BIOL, V32, P2570, DOI 10.1128/MCB.00167-12; Gross A, 2017, CELL DEATH DIFFER, V24, P1348, DOI 10.1038/cdd.2017.22; Itoh T, 2003, J NEUROCHEM, V85, P1500, DOI 10.1046/j.1471-4159.2003.01795.x; Kale J, 2018, CELL DEATH DIFFER, V25, P65, DOI 10.1038/cdd.2017.186; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Li SQ, 2014, J NEUROSCI, V34, P2169, DOI 10.1523/JNEUROSCI.4077-13.2014; Li Y, 2007, J BIOL CHEM, V282, P35803, DOI 10.1074/jbc.M705231200; Moriyama M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.4; Ney PA, 2015, BBA-MOL CELL RES, V1853, P2775, DOI 10.1016/j.bbamcr.2015.02.022; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Sandau US, 2006, BRAIN RES, V1100, P55, DOI 10.1016/j.brainres.2006.05.006; Shi RY, 2014, CNS NEUROSCI THER, V20, P1045, DOI 10.1111/cns.12325; Tolcher AW, 2018, MOL CANCER THER, V17, P3, DOI 10.1158/1535-7163.MCT-17-0349; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Wolpin BM, 2014, ONCOLOGIST, V19, P637, DOI 10.1634/theoncologist.2014-0086; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	25	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204792	10.1371/journal.pone.0204792	http://dx.doi.org/10.1371/journal.pone.0204792			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307949	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500025
J	Briani, RV; Silva, DD; Floride, CS; Aragao, FA; de Albuquerque, CE; Magalhaes, FH; de Azevedo, FM				Briani, Ronaldo Valdir; Silva, Danilo De Oliveira; Floride, Carolina Silva; Aragao, Fernando Amancio; de Albuquerque, Carlos Eduardo; Magalhaes, Fernando Henrique; de Azevedo, Fabio Micolis			Quadriceps neuromuscular function in women with patellofemoral pain: Influences of the type of the task and the level of pain	PLOS ONE			English	Article							ANTERIOR KNEE PAIN; ISOMETRIC CONTRACTIONS; SURFACE ELECTROMYOGRAPHY; PHYSICAL-ACTIVITY; OUTCOME MEASURES; HOFFMANN REFLEX; MUSCLE PAIN; KINEMATICS; EMG; ACTIVATION	The present study aimed at investigating whether the neuromuscular system behaves differently (in terms of force and muscle activity generation) as a function of the task being performed (i.e. maximal voluntary efforts vs stair negotiation) and the presence of patellofemoral pain (PFP) and possible influences of pain intensity. Thirty-eight women with (n = 19) and without PFP (n = 19) had their knee strength (extension joint torque) measured during maximal voluntary isometric contractions (MVIC) and electromyography (EMG) data recorded during both MVIC and stair ascent tasks, which were performed before and after a loading protocol designed to exacerbate pain symptoms. Women with PFP displayed lower levels of vastus medialis (p = 0.002) and vastus lateralis (p = 0.032) EMG activation during MVIC assessments. Conversely, the PFP group showed higher levels of vastus medialis muscle activity during stair climbing (p = 0.007), which happened exclusively after the loading protocol. Similarly, women with PFP displayed lower knee extensor torque only during the MVIC tests performed after the loading protocol, which was moderately correlated with the increase in self-reported pain (p = 0.041, r = 0.37), whereas the changes in EMG activity during stair ascent were not correlated with changes in pain intensity (p = 0.215, r = 0.12). These results suggest that, in comparison to pain-free controls, women with PFP display lower levels of quadriceps EMG activation during maximal contractions, but higher activation during dynamic tasks (stair ascent). In addition, the moderate association between the decrease in knee extensor torque and increase in self-reported pain indicates that care should be taken by clinicians during quadriceps strength evaluation in women with PFP, as misleading outcomes may emerge if the intensity of knee pain is not considered during screening. Additionally, rehabilitation strategies should focus on both restoring neuromuscular control and increasing muscle strength.	[Briani, Ronaldo Valdir; Silva, Danilo De Oliveira; de Azevedo, Fabio Micolis] Sao Paulo State Univ, Sch Sci & Technol, Phys Therapy Dept, Presidente Prudente, SP, Brazil; [Floride, Carolina Silva; Aragao, Fernando Amancio; de Albuquerque, Carlos Eduardo] State Univ West Parana, Dept Phys Therapy, Res Lab Human Movement, Cascavel, Parana, Brazil; [Magalhaes, Fernando Henrique] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual do Oeste do Parana; Universidade de Sao Paulo	Briani, RV (corresponding author), Sao Paulo State Univ, Sch Sci & Technol, Phys Therapy Dept, Presidente Prudente, SP, Brazil.	ronaldobriani@hotmail.com	Azevedo, Fábio M/B-9369-2008; Briani, Ronaldo/L-1534-2016; Magalhães, Fernando Henrique/A-1894-2013; De Oliveira Silva, Danilo/D-2783-2015	Azevedo, Fábio M/0000-0002-4187-7058; Briani, Ronaldo/0000-0002-0452-7753; Magalhães, Fernando Henrique/0000-0003-0783-6102; De Oliveira Silva, Danilo/0000-0003-0753-2432	Sao Paulo Research Foundation	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The Sao Paulo Research Foundation is acknowledged for the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldon RD, 2014, J ORTHOP SPORT PHYS, V44, P240, DOI 10.2519/jospt.2014.4940; Bolgla LA, 2011, INT J SPORTS PHYS TH, V6, P285; Boling M, 2010, SCAND J MED SCI SPOR, V20, P725, DOI 10.1111/j.1600-0838.2009.00996.x; Briani RV, 2017, BRAZ J PHYS THER, V21, P138, DOI 10.1016/j.bjpt.2017.03.009; Briani RV, 2018, KNEE, V25, P398, DOI 10.1016/j.knee.2018.03.009; Briani RV, 2016, J ELECTROMYOGR KINES, V26, P137, DOI 10.1016/j.jelekin.2015.10.012; Chapman T, 2015, SURG RADIOL ANAT, V37, P1169, DOI 10.1007/s00276-015-1495-7; Citaker S, 2011, SPORTS HEALTH, V3, P524, DOI 10.1177/1941738111420803; Cohen J., 1988, STAT POWER ANAL BEHA; Crossley KM, 2016, BRIT J SPORT MED, V50, P839, DOI 10.1136/bjsports-2016-096384; Crossley KM, 2004, ARCH PHYS MED REHAB, V85, P815, DOI 10.1016/S0003-9993(03)00613-0; da Silva CR, 2016, KINESIOLOGY, V48, P174; Denning WM, 2014, OSTEOARTHR CARTILAGE, V22, P1111, DOI 10.1016/j.joca.2014.05.006; Dey P, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1097-5; Eren OT, 2003, ARTHROSCOPY, V19, P850, DOI 10.1016/S0749-8063(03)00736-9; Ervilha UF, 2004, EUR J APPL PHYSIOL, V92, P168, DOI 10.1007/s00421-004-1083-8; Farina D, 2004, J NEUROPHYSIOL, V91, P1250, DOI 10.1152/jn.00620.2003; Fauth ML, 2010, J STRENGTH COND RES, V24, P1131, DOI 10.1519/JSC.0b013e3181cc2353; Ferrari D, 2018, GAIT POSTURE, V60, P268, DOI 10.1016/j.gaitpost.2017.07.034; Grenholm A, 2009, CLIN BIOMECH, V24, P88, DOI 10.1016/j.clinbiomech.2008.09.004; Henriksen M, 2011, J PAIN, V12, P460, DOI 10.1016/j.jpain.2010.10.004; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Kaya D, 2011, KNEE SURG SPORT TR A, V19, P242, DOI 10.1007/s00167-010-1290-2; Keenan KG, 2008, BIOMED SIGNAL PROCES, V3, P154, DOI 10.1016/j.bspc.2008.01.002; Kooiker L, 2014, J ORTHOP SPORT PHYS, V44, P391, DOI 10.2519/jospt.2014.4127; Lack S, 2018, PHYS THER SPORT, V32, P155, DOI 10.1016/j.ptsp.2018.04.010; Lehman GJ, 1999, J MANIP PHYSIOL THER, V22, P444, DOI 10.1016/S0161-4754(99)70032-1; Lin F, 2010, J BIOMECH, V43, P235, DOI 10.1016/j.jbiomech.2009.08.043; MOLLER BN, 1986, ARCH ORTHOP TRAUM SU, V105, P24, DOI 10.1007/BF00625655; Morton JP, 2005, EUR J APPL PHYSIOL, V94, P541, DOI 10.1007/s00421-005-1373-9; Park J, 2013, CLIN J SPORT MED, V23, P19, DOI 10.1097/JSM.0b013e3182717b7b; Pazzinatto MF, 2016, PAIN MED, V17, P1953, DOI 10.1093/pm/pnw068; Pincivero DM, 2003, J ELECTROMYOGR KINES, V13, P159, DOI 10.1016/S1050-6411(02)00096-2; Powers CM, 2014, J ORTHOP SPORT PHYS, V44, P320, DOI 10.2519/jospt.2014.4936; Powers CM, 1997, PHYS THER, V77, P1063, DOI 10.1093/ptj/77.10.1063; Rathleff CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079153; Rathleff MS, 2013, MED SCI SPORT EXER, V45, P1730, DOI 10.1249/MSS.0b013e318292be30; Reaz MBI, 2006, BIOL PROCED ONLINE, V8, P11, DOI [10.1251/bpo115, 10.1251/bpo124]; Sacco IDN, 2006, J ELECTROMYOGR KINES, V16, P167, DOI 10.1016/j.jelekin.2004.06.010; Seeley MK, 2013, J ATHL TRAINING, V48, P337, DOI 10.4085/1062-6050-48.2.02; Sheehan FT, 2012, CLIN BIOMECH, V27, P525, DOI 10.1016/j.clinbiomech.2011.12.012; Sheehan FT, 2009, J ORTHOP RES, V27, P561, DOI 10.1002/jor.20783; Silva DD, 2017, ARCH PHYS MED REHAB, V98, P114, DOI 10.1016/j.apmr.2016.06.011; Silva DD, 2016, KNEE, V23, P376, DOI 10.1016/j.knee.2016.01.014; Silva DD, 2016, ARCH PHYS MED REHAB, V97, P1115, DOI 10.1016/j.apmr.2015.12.017; Silva DD, 2015, J APPL BIOMECH, V31, P409, DOI 10.1123/jab.2015-0048; Smith BE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190892; Toumi H, 2013, CLIN BIOMECH, V28, P544, DOI 10.1016/j.clinbiomech.2013.04.005; Willy RW, 2012, MED SCI SPORT EXER, V44, P2165, DOI 10.1249/MSS.0b013e3182629215	49	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205553	10.1371/journal.pone.0205553	http://dx.doi.org/10.1371/journal.pone.0205553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304030	Green Published, Green Submitted, gold			2022-12-26	WOS:000446921100106
J	Latif, T; McKnight, M; Dickey, MD; Bozkurt, A				Latif, Tahmid; McKnight, Michael; Dickey, Michael D.; Bozkurt, Alper			In vitro electrochemical assessment of electrodes for neurostimulation in roach biobots	PLOS ONE			English	Article							NEURAL STIMULATION	Biobotics investigates the use of live insects as biological robots whose locomotion can be controlled by neurostimulation through implanted electrodes. Inactivity in the biobots (biological robots) can sometimes be noticed following extended neurostimulation, partly owing to incompatibility of implanted electrodes with the biobotic application or gradual degradation of the tissue-electrode interface. Implanted electrodes need to sufficiently exhibit consistent, reliable, and stable performance during stimulation experiments, have low tissueelectrode impedance, facilitate good charge injection capacity, and be compact in size or shape. Towards the goal of finding such electrodes suitable for biobotic applications, we compare electrochemical performances of five different types of electrodes in vitro with a saline based electrolytic medium. These include stainless steel wire electrodes, microfabricated flexible gold electrodes coated with PEDOT:PSS conductive polymer, eutectic gallium indium (EGaln) in a tube, and "hybrid" stainless steel electrodes coated with EGaln. We also performed accelerated aging of the electrodes to help estimate their longitudinal performance. Based on our experimentation, microfabricated electrodes with PEDOT:PSS and stainless steel electrodes coated with EGaln performed remarkably well. This is the first time conductive polymer and liquid metal electrodes were studied comparatively for neurostimulation applications. These in vitro comparison results will be used in the future to provide a benchmark for subsequent in vivo tests with implanted electrodes in cockroach biobots.	[Latif, Tahmid; McKnight, Michael; Bozkurt, Alper] North Carolina State Univ, Dept Elect & Comp Engn, Raleigh, NC 27695 USA; [Dickey, Michael D.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Bozkurt, A (corresponding author), North Carolina State Univ, Dept Elect & Comp Engn, Raleigh, NC 27695 USA.	aybozkur@ncsu.edu	Dickey, Michael/AAY-1894-2021; Latif, Tahmid/AFR-4955-2022	Dickey, Michael/0000-0003-1251-1871; Latif, Tahmid/0000-0002-8342-3513	National Science Foundation (NSF) under the Cyber-physical Systems Program [1239243]; NSF Graduate Research Fellowship [DGE-1252376]; NSF as part of the National Nanotechnology Coordinated Infrastructure (NNCI) [ECCS-1542015]; State of North Carolina; NSF [ECCS-1542015]	National Science Foundation (NSF) under the Cyber-physical Systems Program; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSF as part of the National Nanotechnology Coordinated Infrastructure (NNCI)(National Science Foundation (NSF)NSF - Office of the Director (OD)); State of North Carolina; NSF(National Science Foundation (NSF))	This research was fully funded by the National Science Foundation (NSF) under the Cyber-physical Systems Program (Award Number 1239243). M.M. acknowledges support from the NSF Graduate Research Fellowship (DGE-1252376). Any opinion, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the NSF.; The authors thank Drs. Edward Grant, Edgar Lobaton, and Mihail Sichitiu for helpful feedback, Peter Sotory and Chuck Mooney for technical help with SEM imaging, Bryan Fennell, Ahmet Hatip, Ian Taylor, John Fitzpatrick, and Ahmed Samara for their assistance in running some of the tests. The work was performed in part at the NCSU Nanofabrication Facility (NNF), a member of the NC Research Triangle Nanotechnology Network (RTNN), which is supported by the NSF (Grant ECCS-1542015) as part of the National Nanotechnology Coordinated Infrastructure (NNCI), and at the Analytical Instrumentation Facility (AIF) at NCSU, which is supported by the State of North Carolina and the NSF (award number ECCS-1542015).	[Anonymous], 1998, MED PLAST BIOMATER; Bierwagen G, 2003, PROG ORG COAT, V46, P148, DOI 10.1016/S0300-9440(02)00222-9; Bihar E, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201601167; Bozkurt A, 2011, IEEE ENG MED BIO, P5420, DOI 10.1109/IEMBS.2011.6091340; Bozkurt A, 2011, SENSOR ACTUAT A-PHYS, V169, P89, DOI 10.1016/j.sna.2011.05.015; Bozkurt A, 2009, IEEE T BIO-MED ENG, V56, P2304, DOI 10.1109/TBME.2009.2022551; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; Cui XY, 2003, SENSOR ACTUAT B-CHEM, V89, P92, DOI 10.1016/S0925-4005(02)00448-3; Dickey MD, 2017, ADV MATER, V29, DOI 10.1002/adma.201606425; Erickson JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134348; Hallfors N, 2013, LAB CHIP, V13, P522, DOI 10.1039/c2lc40954b; Hukins DWL, 2008, MED ENG PHYS, V30, P1270, DOI 10.1016/j.medengphy.2008.06.001; Khan MR, 2014, ACS APPL MATER INTER, V6, P22467, DOI 10.1021/am506496u; Khan MR, 2015, RECAPILLARITY ELECTR, P671; Latif T, 2017, IEEE PULSE, V8, P27, DOI 10.1109/MPUL.2017.2729413; Latif T, 2016, IEEE ENG MED BIO, P2141, DOI 10.1109/EMBC.2016.7591152; Latif T, 2016, IEEE SENS J, V16, P3444, DOI 10.1109/JSEN.2015.2477443; Latif T, 2014, IEEE ENG MED BIO, P1670, DOI 10.1109/EMBC.2014.6943927; Latif T, 2012, IEEE ENG MED BIO, P972, DOI 10.1109/EMBC.2012.6346095; Lide DR, 2004, CRC HDB CHEM PHYS, V84; Liu X, 1999, IEEE Trans Rehabil Eng, V7, P315, DOI 10.1109/86.788468; Ludwig KA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/1/014001; Merrill DR, 2005, IEEE T BIO-MED ENG, V52, P1960, DOI 10.1109/TBME.2005.856245; Mortimer JT, 1981, TRAUMA, VII, P155; Sanchez CJ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1363; Sato H, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00199; Serwar RA, 1997, PRINCIPLES PHYS; So JH, 2011, LAB CHIP, V11, P905, DOI 10.1039/c0lc00501k; Wei XF, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046008	29	5	5	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0203880	10.1371/journal.pone.0203880	http://dx.doi.org/10.1371/journal.pone.0203880			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303994	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100021
J	Philipp, N; Weichert, H; Bohra, U; Weschke, W; Schulthess, AW; Weber, H				Philipp, Norman; Weichert, Heiko; Bohra, Utkarsh; Weschke, Winfriede; Schulthess, Albert Wilhelm; Weber, Hans			Grain number and grain yield distribution along the spike remain stable despite breeding for high yield in winter wheat	PLOS ONE			English	Article							TRITICUM-AESTIVUM; DEVELOPMENTAL PHASES; GENETIC-IMPROVEMENT; BREAD WHEAT; WEIGHT; SIZE; EAR; DURATION; TRAITS; ASSOCIATION	Two winter wheat (Triticum aestivum L.) populations, i.e. 180 genetic resources and 210 elite varieties, were compared in a field trial to analyse how grain number and grain yield distribution along the spike changed during the breeding process and how this associates to yield-related traits. Elites showed in average 38% more yield compared to resources. This breeding improvement mainly derived from an increase in grains and yield per spike in addition to grains and yield per spikelet. These increments corresponded to 19, 23, 21 and 25%, respectively. Not much gain in thousand grain weight (4%) was observed in elites as compared to resources. The number of spikelets per spike was not, or even negatively, correlated with most traits, except of grains per spike, which suggests that this trait was not favoured during breeding. The grain number and grain yield distributions along the spike (GDAS and GYDAS) were measured and compared by using a novel mathematical tool. GDAS and GYDAS measure the deviation of a spike of interest from the architecture of a model spike with even grain and yield distribution along all spikelets, respectively. Both traits were positively correlated. Elites showed in average only a 1% improvement in GDAS and GYDAS values compared to resources. This comparison revealed that breeding increased grain number and yield uniformly along the spike without changing relative yield input of individual spikelets, thereby, maintaining the general spike architecture.	[Philipp, Norman; Schulthess, Albert Wilhelm] Leibniz Inst Plant Genet & Crop Plant Res, Dept Breeding Res, Corrensstr 3, Gatersleben, Germany; [Weichert, Heiko; Bohra, Utkarsh; Weschke, Winfriede; Weber, Hans] Leibniz Inst Plant Genet & Crop Plant Res, Dept Mol Genet, Corrensstr 3, Gatersleben, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Philipp, N (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res, Dept Breeding Res, Corrensstr 3, Gatersleben, Germany.	philipp@ipk-gatersleben.de		Philipp, Norman/0000-0002-9735-9946; Schulthess Borgel, Albert Wilhelm/0000-0002-9365-0939	Federal Ministry of Education and Research of Germany within the GeneBank2.0 Project [FKZ031B0184A]	Federal Ministry of Education and Research of Germany within the GeneBank2.0 Project	AWS was supported by the Federal Ministry of Education and Research of Germany within the GeneBank2.0 Project (Grant FKZ031B0184A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acreche MM, 2009, FIELD CROP RES, V110, P98, DOI 10.1016/j.fcr.2008.07.006; ANSCOMBE FJ, 1963, TECHNOMETRICS, V5, P141, DOI 10.2307/1266059; Asli D. E., 2011, Advances in Environmental Biology, V5, P1433; Austin R, 1989, GENETIC IMPROVEMENT, P295; Bernardo R., 2010, BREEDING QUANTITATIV, V2; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Boz H, 2012, TURK J AGRIC FOR, V36, P309, DOI 10.3906/tar-1102-41; Brancourt-Hulmel M, 2003, CROP SCI, V43, P37, DOI 10.2135/cropsci2003.0037; BREMNER PM, 1978, AUST J PLANT PHYSIOL, V5, P61, DOI 10.1071/PP9780061; BROCKLEHURST PA, 1977, NATURE, V266, P348, DOI 10.1038/266348a0; Butler DG, 2018, ASREML R REFERENCE M; Calderini DF., 2014, WHEAT YIELD CONSORT, P114; Lizana XC, 2010, J EXP BOT, V61, P1147, DOI 10.1093/jxb/erp380; Charmet G, 2011, CR BIOL, V334, P212, DOI 10.1016/j.crvi.2010.12.013; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; DONALD CM, 1968, EUPHYTICA, V17, P385, DOI 10.1007/BF00056241; Donmez E, 2001, CROP SCI, V41, P1412, DOI 10.2135/cropsci2001.4151412x; Falconer D. S., 1996, INTRO QUANTITATIVE G; FEIL B, 1992, PLANT BREEDING, V108, P1, DOI 10.1111/j.1439-0523.1992.tb00093.x; Feng F, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00129; Fischer S, 2010, CROP SCI, V50, P584, DOI 10.2135/cropsci2009.04.0225; Foulkes MJ, 2011, J EXP BOT, V62, P469, DOI 10.1093/jxb/erq300; FRIEND DJC, 1965, CAN J BOTANY, V43, P345, DOI 10.1139/b65-037; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Isidro J, 2011, ANN BOT-LONDON, V107, P1355, DOI 10.1093/aob/mcr063; Jiang Y, 2017, THEOR APPL GENET, V130, P471, DOI 10.1007/s00122-016-2827-7; Kollers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057500; Kuchel H, 2007, THEOR APPL GENET, V115, P1029, DOI 10.1007/s00122-007-0629-7; Langer R, 2016, BOTANY; Lewis S, 2008, J EXP BOT, V59, P3595, DOI 10.1093/jxb/ern209; Li Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155351; Longin CFH, 2014, TRENDS PLANT SCI, V19, P631, DOI 10.1016/j.tplants.2014.06.012; Lopez-Garrido E, 2001, INT J DEV BIOL, V45, pS47; MARTINEZCARRASCO R, 1979, J EXP BOT, V30, P669, DOI 10.1093/jxb/30.4.669; MATSUO RR, 1980, CAN J PLANT SCI, V60, P49, DOI 10.4141/cjps80-007; Pielot R, 2015, J EXP BOT, V66, P6927, DOI 10.1093/jxb/erv397; Piepho HP, 2006, HORTSCIENCE, V41, P446, DOI 10.21273/HORTSCI.41.2.446; PUCKRIDGE DW, 1968, AUST J AGR RES, V19, P191, DOI 10.1071/AR9680191; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAWSON HM, 1971, AUST J AGR RES, V22, P537, DOI 10.1071/AR9710537; RAWSON HM, 1970, AUST J BIOL SCI, V23, P1, DOI 10.1071/BI9700001; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Reynolds M, 2011, J EXP BOT, V62, P439, DOI 10.1093/jxb/erq311; Reynolds M, 2009, J EXP BOT, V60, P1899, DOI 10.1093/jxb/erp016; Saalbach I, 2014, J CEREAL SCI, V60, P75, DOI 10.1016/j.jcs.2014.01.017; SCHULER SF, 1995, CROP SCI, V35, P949, DOI 10.2135/cropsci1995.0011183X003500040001x; Schulthess AW, 2017, J EXP BOT, V68, P4089, DOI 10.1093/jxb/erx214; Shearman VJ, 2005, CROP SCI, V45, P175; Slafer G.A., 1996, INCREASING YIELD POT, P101; SLAFER GA, 1991, EUPHYTICA, V58, P37, DOI 10.1007/BF00035338; Slafer GA, 2014, FIELD CROP RES, V157, P71, DOI 10.1016/j.fcr.2013.12.004; SOFIELD I, 1977, AUST J PLANT PHYSIOL, V4, P785, DOI 10.1071/PP9770785; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Wang M, 2018, TRENDS BIOTECHNOL, V36, P160, DOI 10.1016/j.tibtech.2017.10.002; Weichert H, 2017, J EXP BOT, V68, P5511, DOI 10.1093/jxb/erx366; Westreich D, 2012, EPIDEMIOLOGY, V23, P159, DOI 10.1097/EDE.0b013e31823b6296; Xie Q, 2018, PLANTA, V247, P1089, DOI 10.1007/s00425-018-2847-4; Xie Q, 2015, J EXP BOT, V66, P6715, DOI 10.1093/jxb/erv378; Yang JC, 2006, NEW PHYTOL, V171, P293, DOI 10.1111/j.1469-8137.2006.01753.x	59	49	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205452	10.1371/journal.pone.0205452	http://dx.doi.org/10.1371/journal.pone.0205452			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304020	gold, Green Published, Green Submitted			2022-12-26	WOS:000446921100094
J	Ishimura, ME; Teixeira, D; Silveira, GD; Gambero, M; Gama, GAC; Pimenta, BSO; Rodrigues, EG; Longo-Maugeri, IM				Ishimura, Mayari E.; Teixeira, Daniela; Silveira, Gabriela da P.; Gambero, Monica; Gama, Gabriel A. C.; Pimenta, Bruna S. O.; Rodrigues, Elaine G.; Longo-Maugeri, Ieda M.			Killed Propionibacterium acnes enhances immunogenicity and tumor growth control of a dendritic-tumor cell hybrid vaccine in a murine melanoma model	PLOS ONE			English	Article							PURIFIED SOLUBLE POLYSACCHARIDE; PERITONEAL-EXUDATE CELLS; PHASE-I TRIAL; CORYNEBACTERIUM-PARVUM; MALIGNANT-MELANOMA; CYTOKINE RESPONSES; ANTITUMOR IMMUNITY; INTERFERON-GAMMA; IL-18 PRODUCTION; IFN-GAMMA	Hybrid vaccines have been investigated in clinical and experimental studies once expresses total antigens of a tumor cell combined with the ability of a dendritic cell (DC) to stimulate immune responses. However, the response triggered by these vaccines is often weak, requiring the use of adjuvants to increase vaccine immunogenicity. Killed Propionibacterium acnes (P. acnes) exerts immunomodulatory effects by increasing the phagocytic and tumoricidal activities of macrophages, promoting DC maturation, inducing pro-inflammatory cytokines production and increasing the humoral response to different antigens. Here, we evaluated the effect of P. acnes on a specific antitumor immune response elicited by a hybrid vaccine in a mouse melanoma model. Hybrid vaccine associated with P. acnes increased the absolute number of memory T cells, the IFN-Y secretion by these cells and the IgG-specific titers to B16F10 antigens, polarizing the immune response to a T helper 1 pattern. Furthermore, the addition of P. acnes to a hybrid vaccine increased the cytotoxic activity of splenocytes toward B16F10 in vitro and avoided late tumor progression in a pulmonary colonization model. These results revealed the adjuvant effect of a killed P. acnes suspension, as it improved specific humoral and cellular immune responses elicited by DC-tumor cell hybrid vaccines.	[Ishimura, Mayari E.; Teixeira, Daniela; Silveira, Gabriela da P.; Gambero, Monica; Gama, Gabriel A. C.; Pimenta, Bruna S. O.; Longo-Maugeri, Ieda M.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Disciplina Imunol, Sao Paulo, Brazil; [Rodrigues, Elaine G.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Lab Imunobiol Canc,Disciplina Biol Celular, Sao Paulo, Brazil		Longo-Maugeri, IM (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Disciplina Imunol, Sao Paulo, Brazil.	imaugeri@unifesp.br	Rodrigues, Elaine G/H-3688-2014; Longo-Maugeri, Ieda M/B-9764-2012; Teixeira, Daniela/A-6600-2019; Rodrigues, Elaine Guadelupe/ABB-6632-2021	Longo-Maugeri, Ieda M/0000-0003-4184-8414; Teixeira, Daniela/0000-0001-7092-2009; Rodrigues, Elaine Guadelupe/0000-0002-3248-3081	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/09885-2]; Conselho nacional de desenvolvimento cientofico e tecnologico; Coordenacao de aperfeicoamento de pessoal de novel superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho nacional de desenvolvimento cientofico e tecnologico; Coordenacao de aperfeicoamento de pessoal de novel superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/)(Grant number 2012/09885-2 to MEI). Conselho nacional de desenvolvimento cientofico e tecnologico (http:// cnpq.br/) e Coordenacao de aperfeicoamento de pessoal de novel superior (http://www.capes.gov. br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananias RZ, 2007, SCAND J IMMUNOL, V65, P538, DOI 10.1111/j.1365-3083.2007.01939.x; Asavaroengchai W, 2002, P NATL ACAD SCI USA, V99, P931, DOI 10.1073/pnas.022634999; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braga EG, 2003, IMMUNOL LETT, V88, P163, DOI 10.1016/S0165-2478(03)00079-8; BRENER Z, 1976, J PARASITOL, V62, P645, DOI 10.2307/3279437; Chang AE, 2002, CLIN CANCER RES, V8, P1021; DeMatos P, 1998, J SURG ONCOL, V68, P79, DOI 10.1002/(SICI)1096-9098(199806)68:2<79::AID-JSO3>3.0.CO;2-H; Duran-Aniotz C, 2013, CANCER IMMUNOL IMMUN, V62, P761, DOI 10.1007/s00262-012-1377-3; FISHER B, 1990, CANCER-AM CANCER SOC, V66, P220, DOI 10.1002/1097-0142(19900715)66:2<220::AID-CNCR2820660205>3.0.CO;2-6; Gambero M, 2016, IMMUNOBIOLOGY, V221, P1001, DOI 10.1016/j.imbio.2016.03.003; GHAFFAR A, 1975, BRIT J CANCER, V31, P15, DOI 10.1038/bjc.1975.3; Gong JL, 1997, NAT MED, V3, P558, DOI 10.1038/nm0597-558; HA DKK, 1986, J COMP PATHOL, V96, P565, DOI 10.1016/0021-9975(86)90077-0; HALPERN BN, 1966, NATURE, V212, P853, DOI 10.1038/212853a0; HALPERN BN, 1964, J RETICULOENDOTH SOC, V1, P77; HILL JO, 1987, J LEUKOCYTE BIOL, V41, P165, DOI 10.1002/jlb.41.2.165; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Kalis C, 2005, J IMMUNOL, V174, P4295, DOI 10.4049/jimmunol.174.7.4295; KELLER R, 1991, INT J CANCER, V49, P796, DOI 10.1002/ijc.2910490526; KENNEDY JD, 1989, NEUROSURGERY, V25, P709, DOI 10.1227/00006123-198911000-00004; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; KLIGMAN AM, 1976, J INVEST DERMATOL, V67, P160, DOI 10.1111/1523-1747.ep12513007; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Kursunel MA, 2016, CYTOKINE GROWTH F R, V31, P73, DOI 10.1016/j.cytogfr.2016.07.005; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lau R, 2001, J IMMUNOTHER, V24, P66, DOI 10.1097/00002371-200101000-00008; Lespagnard L, 1998, INT J CANCER, V76, P250, DOI 10.1002/(SICI)1097-0215(19980413)76:2<250::AID-IJC13>3.3.CO;2-D; Leyden JJ, 1998, DERMATOLOGY, V196, P55, DOI 10.1159/000017868; LEYDEN JJ, 1975, J INVEST DERMATOL, V65, P379, DOI 10.1111/1523-1747.ep12607630; LIPTON A, 1983, CANCER, V51, P57, DOI 10.1002/1097-0142(19830101)51:1<57::AID-CNCR2820510114>3.0.CO;2-V; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; Marchi LHL, 2011, CANCER GENE THER, V18, P110, DOI 10.1038/cgt.2010.58; Matsui K, 1997, J IMMUNOL, V159, P97; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Mussalem JS, 2006, MICROBIOL IMMUNOL, V50, P253, DOI 10.1111/j.1348-0421.2006.tb03791.x; Mussalem JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033955; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Pecher G, 2002, CANCER IMMUNOL IMMUN, V51, P669, DOI 10.1007/s00262-002-0317-z; Schneble EJ, 2014, HUM VACC IMMUNOTHER, V10, p[11, 3132], DOI [10.4161/hv.26319, DOI 10.4161/HV.26319]; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shi MQ, 2005, TUMORI J, V91, P531, DOI 10.1177/030089160509100614; SMITH SR, 1993, J LEUKOCYTE BIOL, V54, P23, DOI 10.1002/jlb.54.1.23; Squaiella CC, 2008, IMMUNOL LETT, V121, P157, DOI 10.1016/j.imlet.2008.10.005; Squaiella CC, 2006, IMMUNOBIOLOGY, V211, P105, DOI 10.1016/j.imbio.2005.10.013; Squaiella-Baptistao CC, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/132083; Tan CR, 2013, J SURG RES, V185, P904, DOI 10.1016/j.jss.2013.06.045; Teixeira D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00177; Trefzer U, 2005, VACCINE, V23, P2367, DOI 10.1016/j.vaccine.2005.01.081; Tsuda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029020; Tsuji H, 1999, J IMMUNOL, V162, P1049; WARR GW, 1975, IMMUNOLOGY, V28, P431; WOODRUFF MF, 1974, CLIN EXP IMMUNOL, V17, P509; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	56	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205148	10.1371/journal.pone.0205148	http://dx.doi.org/10.1371/journal.pone.0205148			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300366	gold, Green Submitted, Green Published			2022-12-26	WOS:000446897200041
J	Kalyebi, A; Macfadyen, S; Parry, H; Tay, WT; De Barro, P; Colvin, J				Kalyebi, Andrew; Macfadyen, Sarina; Parry, Hazel; Tay, Wee Tek; De Barro, Paul; Colvin, John			African cassava whitefly, Bemisia tabaci, cassava colonization preferences and control implications	PLOS ONE			English	Article							PARASITE-HOST RELATIONSHIP; MOSAIC DISEASE; POPULATION-DYNAMICS; COMMERCIAL GLASSHOUSE; GENETIC DIVERSITY; YIELD LOSSES; ALEYRODIDAE; VECTOR; VAPORARIORUM; GENNADIUS	Cassava is a staple food for people across sub-Saharan Africa. Over the last 20 years, there has been an increased frequency of outbreaks and crop damage in this region caused by the cassava-adapted Bemisia tabaci putative species. Little is known about when and why B. tabaci adults move and colonize new cassava crops, especially in farming systems that contain a mixture of cultivar types and plant ages. Here, we assessed experimentally whether the age and variety of cassava affected the density of B. tabaci. We also tested whether the age and variety of the source cassava field affected the variety preference of B. tabaci when they colonized new cassava plants. We placed uninfested potted "sentinel" plants of three cassava varieties (Nam 130, Nase 14, and Njule Red) in source fields containing one of two varieties (Nam 130 or Nase 14) and one of three age classes (young, medium, or old). After two weeks, the numbers of nymphs on the sentinel plants were used as a measure of colonization. Molecular identification revealed that the B. tabaci species was sub-Saharan Africa 1 (SSA1). We found a positive correlation between the density of nymphs on sentinel plants and the density of adults in the source field. The density of nymphs on the sentinels was not significantly related to the age of the source field. Bemisia tabaci adults did not preferentially colonize the sentinel plant of the same variety as the source field. There was a significant interactive effect, however, between the source and sentinel variety that may indicate variability in colonization. We conclude that managing cassava source fields to reduce B. tabaci abundance will be more effective than manipulating nearby varieties. We also suggest that planting a "whitefly sink" variety is unlikely to reduce B. tabaci SSA1 populations unless fields are managed to reduce B. tabaci densities using other integrative approaches.	[Kalyebi, Andrew] Natl Crops Resources Res Inst, Kampala, Uganda; [Kalyebi, Andrew] Mikocheni Agr Res Inst, Dar Es Salaam, Tanzania; [Macfadyen, Sarina; Tay, Wee Tek] CSIRO, Clunies Ross St, Acton, ACT, Australia; [Parry, Hazel; De Barro, Paul] CSIRO Ecosci Precinct, Brisbane, Qld, Australia; [Colvin, John] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Greenwich	Kalyebi, A (corresponding author), Natl Crops Resources Res Inst, Kampala, Uganda.; Kalyebi, A (corresponding author), Mikocheni Agr Res Inst, Dar Es Salaam, Tanzania.	akalyebi@yahoo.com	Kalyebi, Andrew/AAI-1462-2020; Macfadyen, Sarina/C-1511-2008; De Barro, Paul J/C-1724-2008; Tay, Wee Tek/GPF-6142-2022; Tay, Wee Tek/C-1818-2008; Parry, Hazel/C-3643-2009	Macfadyen, Sarina/0000-0003-3553-4910; Tay, Wee Tek/0000-0002-8451-0811; Tay, Wee Tek/0000-0002-8451-0811; Parry, Hazel/0000-0002-6747-3182	Bill and Melinda gates foundation through the Natural Resources Institute, University of Greenwich [OPP1058938]	Bill and Melinda gates foundation through the Natural Resources Institute, University of Greenwich	This study was funded by the Bill and Melinda gates foundation (OPP1058938) through the Natural Resources Institute, University of Greenwich, to JC.	Abele S., 2007, AAAE C P, P479; AKORODA MO, 1987, AGR SYST, V24, P305, DOI 10.1016/0308-521X(87)90029-1; Akoroda MO, 1985, IMPACT IITA CASSAVA; Alaux JP, 1990, INT SEM AFR CASS MOS; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2009, WHY CASS; Bates D, 2015, R PACKAGE, P1; Bellotti AC, 2004, 15 INT PLANT PROT C; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; BLACKMER TM, 1994, AGRON J, V86, P934, DOI 10.2134/agronj1994.00021962008600060002x; Boykin LM, 2018, SYST ENTOMOL, V43, P427, DOI 10.1111/syen.12294; Boykin Laura M, 2017, F1000Res, V6, P1835, DOI 10.12688/f1000research.12858.1; Boykin LM, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00045; Bruno JF, 2008, FRONT ECOL ENVIRON, V6, P539, DOI 10.1890/070136; Burns A, SUSTAINABILITY, V2, P3572; Butler C. G., 1938, Transactions of the Royal Entomological Society of London, V87, P291; Colvin J, 2004, PLANT PATHOL, V53, P577, DOI 10.1111/j.0032-0862.2004.01062.x; COSTA HS, 1991, J APPL ENTOMOL, V112, P146, DOI 10.1111/j.1439-0418.1991.tb01040.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Leite GL, 2006, PESQUI AGROPECU BRAS, V41, P1241, DOI 10.1590/S0100-204X2006000800005; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Elfekih S, 2018, PEST MANAG SCI, V74, P170, DOI 10.1002/ps.4676; FARGETTE D, 1988, TROP PEST MANAGE, V34, P89; Fargette D., 1988, ASPECTS APPL BIOL, V17, P195; GOLD CS, 1989, B ENTOMOL RES, V79, P115, DOI 10.1017/S0007485300018629; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HUSAIN M. A., 1940, INDIAN JOUR AGRIC SCI, V10, P101; Ikpi A, 1986, CASSAVA CROP HOUSEHO; Isaacs R, 1998, J ANIM ECOL, V67, P741, DOI 10.1046/j.1365-2656.1998.00236.x; JOYCE R J V, 1983, Bulletin OEPP, V13, P111; Kawuki RS, 2013, PLANT GENET RESOUR-C, V11, P170, DOI 10.1017/S1479262113000014; Legg JP, 2014, VIRUS RES, V186, P61, DOI 10.1016/j.virusres.2013.11.018; LEGG JP, 1995, ECOLOGY BEMISIA TABA; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Lloyd LL, 1922, ANN APPL BIOL, V9, P1, DOI 10.1111/j.1744-7348.1922.tb05933.x; Macfadyen S, 2018, B ENTOMOL RES, V108, P565, DOI [10.1017/S0007485318000032, 10.1017/s0007485318000032]; Macfadyen S, 2009, ECOL LETT, V12, P229, DOI 10.1111/j.1461-0248.2008.01279.x; MADDEN LV, 1987, PHYTOPATHOLOGY, V77, P1409, DOI 10.1094/Phyto-77-1409; MANSVELD MHE, 1982, Z ANGEW ENTOMOL, V93, P113; MANSVELD MHE, 1982, Z ANGEW ENTOMOL, V93, P258; Maruthi MN, 2007, VIRUS GENES, V34, P373, DOI 10.1007/s11262-006-0027-2; Maruthi MN, 2002, VIRUS RES, V86, P71, DOI 10.1016/S0168-1702(02)00051-5; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Neiva IP, 2013, CIENC AGROTEC, V37, P61, DOI 10.1590/S1413-70542013000100007; Omongo CA, 2001, P 7 TRIENN S INT SOC, P608; Omongo CA, 2012, J INTEGR AGR, V11, P327, DOI 10.1016/S2095-3119(12)60017-3; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; PERRIN RM, 1977, AGRO-ECOSYSTEMS, V3, P93; PERRIN RM, 1978, ENTOMOL EXP APPL, V24, P585, DOI 10.1007/BF02385112; Philpott SA, 2013, ENCY BIODIVERSITY, P373, DOI [10.1016/B978-0-12-384719-5.00344-0, DOI 10.1016/B978-0-12-384719-5.00344-0]; Pinheiro J., 2017, PACKAGE NLME LINEAR; ROBERTSON IAD, 1987, INSECT SCI APPL, V8, P797, DOI 10.1017/S1742758400022943; Salvador E. M., 2014, Journal of Agricultural Biotechnology and Sustainable Development, V6, P29; Souissi R, 1997, ENTOMOL EXPT APPL, V90, P215; Srinivas T, 2005, CENTRAL TUBER CROPS, V43, P1; Sseruwagi P, 2006, ENTOMOL EXP APPL, V119, P145, DOI 10.1111/j.1570-7458.2006.00402.x; Sseruwagi P, 2005, ANN APPL BIOL, V147, P253, DOI 10.1111/j.1744-7348.2005.00026.x; Sseruwagi P., 2003, African Crop Science Journal, V11, P171; Sseruwagi P, 2004, VIRUS RES, V100, P129, DOI 10.1016/j.virusres.2003.12.021; Staden R, 2000, Methods Mol Biol, V132, P115; Tajebe LS, 2015, J APPL ENTOMOL, V139, P627, DOI 10.1111/jen.12197; Thresh J. M., 1994, Tropical Science, V34, P3; Tumwegamire S, 2018, FOOD SECUR, V10, P351, DOI 10.1007/s12571-018-0779-2; Uzokwe VNE, 2016, CROP PROT, V84, P69, DOI 10.1016/j.cropro.2016.02.013; Zundel C, 2009, AGR FOREST ENTOMOL, V11, P321, DOI 10.1111/j.1461-9563.2009.00429.x	65	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0204862	10.1371/journal.pone.0204862	http://dx.doi.org/10.1371/journal.pone.0204862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300388	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000446897200022
J	Neumann, W; Bichert, A; Fleischhauer, J; Stern, A; Figuli, R; Wilhelm, M; Schad, LR; Zollner, FG				Neumann, Wiebke; Bichert, Andreas; Fleischhauer, Jonas; Stern, Antonia; Figuli, Roxana; Wilhelm, Manfred; Schad, Lothar R.; Zoellner, Frank G.			A novel 3D printed mechanical actuator using centrifugal force for magnetic resonance elastography: Initial results in an anthropomorphic prostate phantom	PLOS ONE			English	Article							MR ELASTOGRAPHY; IN-VIVO; MYOCARDIAL STIFFNESS; VISCOELASTIC PROPERTIES; NONINVASIVE ASSESSMENT; LIVER; QUANTIFICATION; FEASIBILITY; FIBROSIS; MUSCLE	This work demonstrates a new method for the generation of mechanical shear wave during magnetic resonance elastography (MRE) that creates greater forces at higher vibrational frequencies as opposed to conventionally used pneumatic transducers. We developed an MR-compatible pneumatic turbine with an eccentric mass that creates a sinusoidal centrifugal force. The turbine was assessed with respect to its technical parameters and evaluated for MRE on a custom-made anthropomorphic prostate phantom. The silicone-based tissue-mimicking materials of the phantom were selected with regard to their complex shear moduli examined by rheometric testing. The tissue-mimicking materials closely matched human soft tissue elasticity values with a complex shear modulus ranging from 3.21 kPa to 7.29 kPa. We acquired MRE images on this phantom at 3 T with actuation frequencies of 50, 60 Hz, 70 Hz, and 80 Hz. The turbine generated vibrational wave amplitudes sufficiently large to entirely penetrate the phantoms during the feasibility study. Increased wave length in the stiffer inclusions compared to softer background material were detected. Our initial results suggest that silicone-based phantoms are useful for the evaluation of elasticities during MRE. Furthermore, our turbine seems suitable for the mechanical assessment of soft tissue during MRE.	[Neumann, Wiebke; Bichert, Andreas; Fleischhauer, Jonas; Stern, Antonia; Schad, Lothar R.; Zoellner, Frank G.] Heidelberg Univ, Med Fac Mannheim, Dept Comp Assisted Clin Med, Mannheim, Germany; [Figuli, Roxana; Wilhelm, Manfred] Karlsruhe Inst Technol, Inst Chem Technol & Polymer Chem, Karlsruhe, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology	Neumann, W (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Comp Assisted Clin Med, Mannheim, Germany.	wiebke.Neumann@medma.uni-heidelberg.de	Zöllner, Frank G/A-2725-2012	Zöllner, Frank G/0000-0003-3405-1394	German Federal Ministry of Education and Research (BMBF) within the Framework Forschungscampus: public-private partnership for Innovations [13GW0092D]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-UniversitaEt Heidelberg	German Federal Ministry of Education and Research (BMBF) within the Framework Forschungscampus: public-private partnership for Innovations; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-UniversitaEt Heidelberg	This research project is part of the Research Campus M2OLIE and funded by the German Federal Ministry of Education and Research (BMBF) within the Framework Forschungscampus: public-private partnership for Innovations under the funding code 13GW0092D. The authors acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-UniversitaEt Heidelberg within the funding programme Open Access Publishing.	Ahn BM, 2010, UROLOGY, V76, P1007, DOI 10.1016/j.urology.2010.02.025; Arani A, 2017, MAGN RESON MED, V77, P351, DOI 10.1002/mrm.26101; Bosboom EMH, 2003, J APPL PHYSIOL, V95, P2235, DOI 10.1152/japplphysiol.01023.2001; Bosboom EMH, 2001, J BIOMECH, V34, P1365, DOI 10.1016/S0021-9290(01)00083-5; Cao R, 2013, MED PHYS, V40, DOI 10.1118/1.4773315; Chamarthi SK, 2014, MAGN RESON IMAGING, V32, P679, DOI 10.1016/j.mri.2014.02.013; Chopra R, 2009, MAGN RESON MED, V62, P665, DOI 10.1002/mrm.22038; da Silveira JS, 2016, MAGN RESON IMAGING, V34, P26, DOI 10.1016/j.mri.2015.10.001; Glaser KJ, 2012, J MAGN RESON IMAGING, V36, P757, DOI 10.1002/jmri.23597; Hawley J, 2016, J MAGN RESON IMAGING; Hungr N, 2012, MED PHYS, V39, P2031, DOI 10.1118/1.3692179; Huwart L, 2006, NMR BIOMED, V19, P173, DOI 10.1002/nbm.1030; Ipek-Ugay S, 2015, J MAGN RESON, V251, P13, DOI 10.1016/j.jmr.2014.11.009; Kashif AS, 2013, MED PHYS, V40, DOI 10.1118/1.4805096; Kemper J, 2004, ROFO-FORTSCHR RONTG, V176, P1094, DOI 10.1055/s-2004-813279; Klatt D, 2007, PHYS MED BIOL, V52, P7281, DOI 10.1088/0031-9155/52/24/006; Klatt D, 2010, BIORHEOLOGY, V47, P133, DOI 10.3233/BIR-2010-0565; Kolipaka A, 2012, J MAGN RESON IMAGING, V36, P120, DOI 10.1002/jmri.23616; Kolipaka A, 2009, MAGN RESON MED, V62, P691, DOI 10.1002/mrm.22048; Latta P, 2011, MAGN RESON IMAGING, V29, P147, DOI 10.1016/j.mri.2010.07.014; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006; Mazumder R, 2017, J MAGN RESON IMAGING, V45, P813, DOI 10.1002/jmri.25423; Morisaka H, 2017, J MAGN RESON IMAGING, V45, P1163, DOI 10.1002/jmri.25425; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Nenadic IZ, 2013, PHYS MED BIOL, V58, P2675, DOI 10.1088/0031-9155/58/8/2675; Neumann W, 2017, Z MED PHYS; Neumann W, 2017, IEEE ENG MED BIO, P3541, DOI 10.1109/EMBC.2017.8037621; Patil AV, 2007, PHYS MED BIOL, V52, P3643, DOI 10.1088/0031-9155/52/12/019; Qin EC, 2014, RADIOLOGY, V273, P726, DOI 10.1148/radiol.14132661; Qin EC, 2013, J MAGN RESON IMAGING, V37, P217, DOI 10.1002/jmri.23797; Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606; Runge JH, 2017, P INT SOC MAGN RESON, V25, P1369; Sahebjavaher RS, 2015, NMR BIOMED, V28, P124, DOI 10.1002/nbm.3218; Sahebjavaher RS, 2013, MAGN RESON MED, V69, P411, DOI 10.1002/mrm.24268; Serai SD, 2015, ABDOM IMAGING, V40, P789, DOI 10.1007/s00261-014-0282-y; Uffmann K, 2002, CONCEPT MAGNETIC RES, V15, P239, DOI 10.1002/cmr.10045; Uffmann K, 2008, IEEE ENG MED BIOL, V27, P28, DOI 10.1109/EMB.2007.910268; Venkatesh SK, 2008, AM J ROENTGENOL, V190, P1534, DOI 10.2214/AJR.07.3123; Venkatesh SK, 2013, J COMPUT ASSIST TOMO, V37, P887, DOI 10.1097/RCT.0000000000000032; Venkatesh SK, 2015, ABDOM IMAGING, V40, P745, DOI 10.1007/s00261-014-0315-6; Wassenaar PA, 2016, MAGN RESON MED, V75, P1586, DOI 10.1002/mrm.25760; Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; Yin Meng, 2009, Top Magn Reson Imaging, V20, P79, DOI 10.1097/RMR.0b013e3181c4737e; Zhang M, 2008, ULTRASOUND MED BIOL, V34, P1033, DOI 10.1016/j.ultrasmedbio.2007.11.024	45	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205442	10.1371/journal.pone.0205442	http://dx.doi.org/10.1371/journal.pone.0205442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296308	Green Submitted, Green Published, gold			2022-12-26	WOS:000446632700038
J	Bosak, A; Ramic, A; Smidlehner, T; Hrenar, T; Primozic, I; Kovarik, Z				Bosak, Anita; Ramic, Alma; Smidlehner, Tamara; Hrenar, Tomica; Primozic, Ines; Kovarik, Zrinka			Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffold	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ACETYLCHOLINESTERASE INHIBITORS; HUMAN CHOLINESTERASES; ENANTIOMERS; RESOLUTION; BINDING; POTENT; ETHOPROPAZINE; DERIVATIVES; BAMBUTEROL	This paper describes the synthesis and anticholinesterase potency of Cinchona-based alkaloids; ten quaternary derivatives of cinchonines and their corresponding pseudo-enantiomeric cinchonidines. The quaternization of quinuclidine moiety of each compound was carried out with groups diverse in their size: methyl, benzyl and differently meta-and para-substituted benzyl groups. All of the prepared compounds reversibly inhibited human butyrylcholinesterase and acetylcholinesterase with K-i constants within nanomolar to micromolar range. Five cinchonidine derivatives displayed 95-510 times higher inhibition selectivity to butyrylcholinesterase over acetylcholinesterase and four were potent butyrylcholinesterase inhibitors with K-i constants up to 100 nM, of which N-para-bromobenzyl cinchonidinium bromide can be considered a lead for further modifications and optimizations for possible use in the treatment of neurodegenerative diseases.	[Bosak, Anita; Kovarik, Zrinka] Inst Med Res & Occupat Hlth, Ksaverska Cesta 2, Zagreb, Croatia; [Ramic, Alma; Smidlehner, Tamara; Hrenar, Tomica; Primozic, Ines] Univ Zagreb, Fac Sci, Horvatovac 102A, Zagreb, Croatia	Institute for Medical Research & Occupational Health (IMROH); University of Zagreb	Bosak, A (corresponding author), Inst Med Res & Occupat Hlth, Ksaverska Cesta 2, Zagreb, Croatia.; Primozic, I (corresponding author), Univ Zagreb, Fac Sci, Horvatovac 102A, Zagreb, Croatia.	abosak@imi.hr; ines.primozic@chem.pmf.hr	Smidlehner, Tamara/AAA-9006-2021	Smidlehner, Tamara/0000-0001-5097-9606; Hrenar, Tomica/0000-0002-4570-0524; Primozic, Ines/0000-0003-1154-4735	Croatian Science Foundation [IP-2016-06-3775 ADESIRE, IP-2013-11-4307 CHOLINESTERASE]	Croatian Science Foundation	This work was supported by the Croatian Science Foundation, Projects No: IP-2016-06-3775 ADESIRE (TH) and IP-2013-11-4307 CHOLINESTERASE (ZK), URL: https://www.hrzz.hr/	BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bosak A, 2005, CROAT CHEM ACTA, V78, P121; Bosak A, 2013, ARCH BIOCHEM BIOPHYS, V529, P140, DOI 10.1016/j.abb.2012.11.012; Bosak A, 2012, J MED CHEM, V55, P6716, DOI 10.1021/jm300289k; Eagleson M, 1994, CONCISE ENCY CHEM; Edwards A, 2014, TETRAHEDRON-ASYMMETR, V25, P1537, DOI 10.1016/j.tetasy.2014.10.017; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Frisch M.J., 2016, GAUSSIAN 16 REV C 01; Galdeano C, 2018, MOLECULES, V23, DOI 10.3390/molecules23030634; Gazic I, 2006, ANAL BIOANAL CHEM, V385, P1513, DOI 10.1007/s00216-006-0566-3; Giacobini E., 2003, BUTYRYLCHOLINESTERAS, V1st; Giacobini E., 2006, BRAIN CHOLINERGIC SY, P235, DOI [10.1201/b14486-19, DOI 10.1201/B14486-19]; Greig NH, 2001, CURR MED RES OPIN, V17, P159; Gurung P., 2017, J PHARMACOGN PHOTOCH, V6, P162, DOI 10.22271/phyto; Hrenar T., 2017, QUANTUM CHEM CODE, P682; Hrenar T., 2017, PROGRAM MANIPULATION; Kamal MA, 2008, J NEURAL TRANSM, V115, P889, DOI 10.1007/s00702-008-0022-y; Karlsson D, 2014, NAT PROD COMMUN, V9, P455; Karlsson D, 2012, EUR J PHARM SCI, V47, P190, DOI 10.1016/j.ejps.2012.05.014; Katalinic M, 2017, MOLECULES, V22, DOI 10.3390/molecules22071234; Kosak U, 2016, SCI REP-UK, V6, DOI 10.1038/srep39495; Kovarik Z, 2003, BIOCHEM J, V373, P33, DOI 10.1042/BJ20021862; Kovarik Z, 2003, CROAT CHEM ACTA, V76, P63; Lan JS, 2017, EUR J MED CHEM, V133, P184, DOI 10.1016/j.ejmech.2017.02.045; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li Q, 2017, EUR J MED CHEM, V132, P294, DOI 10.1016/j.ejmech.2017.03.062; Lian MM, 2010, EUR J ORG CHEM, V2010, P6525, DOI 10.1002/ejoc.201001175; Lockridge O, 2016, CHEM RES TOXICOL, V29, P1381, DOI 10.1021/acs.chemrestox.6b00228; Marakovic N, 2016, CHEM-BIOL INTERACT, V259, P122, DOI 10.1016/j.cbi.2016.05.035; Mohammad D, 2017, EXPERT OPIN DRUG SAF, V16, P1009, DOI 10.1080/14740338.2017.1351540; Musilek K, 2011, EUR J MED CHEM, V46, P811, DOI 10.1016/j.ejmech.2010.12.011; Nawaz SA, 2011, BIOCHEM BIOPH RES CO, V404, P935, DOI 10.1016/j.bbrc.2010.12.084; Ng YP, 2015, NEUROCHEM INT, V89, P260, DOI 10.1016/j.neuint.2015.07.018; Ngamelue MN, 2007, ACTA CRYSTALLOGR F, V63, P723, DOI 10.1107/S1744309107037335; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; Palm K, 1999, J PHARMACOL EXP THER, V291, P435; Primozic I, 2012, MOLECULES, V17, P786, DOI 10.3390/molecules17010786; Reiner E., 2000, CHOLINESTERASES CHOL, V3rd, P103; Savini L, 2001, BIOORG MED CHEM LETT, V11, P1779, DOI 10.1016/S0960-894X(01)00294-3; Saxena A, 2003, EUR J BIOCHEM, V270, P4447, DOI 10.1046/j.1432-1033.2003.03837.x; Simeon-Rudolf V, 2001, CROAT CHEM ACTA, V74, P173; Sinko G, 2011, BIOCHIMIE, V93, P1797, DOI 10.1016/j.biochi.2011.06.023; Song C. E., 2009, CINCHONA ALKALOIDS S, DOI DOI 10.1002/9783527628179; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Tasker Andrea, 2005, Expert Rev Neurother, V5, P101, DOI 10.1586/14737175.5.1.101	46	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205193	10.1371/journal.pone.0205193	http://dx.doi.org/10.1371/journal.pone.0205193			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289893	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500056
J	Fruci, M; Poole, K				Fruci, Michael; Poole, Keith			Aminoglycoside-inducible expression of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: Involvement of the envelope stress-responsive AmgRS two-component system	PLOS ONE			English	Article							OXIDATION-SENSING MECHANISM; CYSTIC-FIBROSIS PATIENTS; MEXCD-OPRJ; ANTIBIOTIC-RESISTANCE; PROTEIN AGGREGATION; BIOFILM TOLERANCE; ESCHERICHIA-COLI; CROSS-RESISTANCE; PUMP EXPRESSION; REGULATOR MEXR	Exposure of P. aeruginosa to the aminoglycoside (AG) paromomycin (PAR) induced expression of the PA3720-armR locus and the mexAB-oprM multidrug efflux operon that AmgR controls, although PAR induction of mexAB-oprM was independent of armR. Multiple AGs promoted mexAB-oprM expression and this was lost in the absence of the amgRS locus encoding an aminoglycoside-activated envelope stress-responsive 2-component system (TCS). Purified AmgR bound to the mexAB-oprM promoter region consistent with this response regulator directly regulating expression of the efflux operon. The thiol-active reagent, diamide, which, like AGs, promotes protein aggregation and cytoplasmic membrane damage also promoted AmgRS-dependent mexAB-oprM expression, a clear indication that the MexAB-OprM efflux system is recruited in response to membrane perturbation and/or circumstances that lead to this. Despite the AG and diamide induction of mexAB-oprM, however, MexAB-OprM does not appear to contribute to resistance to these agents.	[Fruci, Michael; Poole, Keith] Queens Univ, Dept Biomed & Mol Sci, Botterell Hall, Kingston, ON, Canada	Queens University - Canada	Poole, K (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall, Kingston, ON, Canada.	poolek@queensu.ca			Canadian Institutes of Health Research [MOP - 102740]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research to KP (MOP - 102740; http://www.cihr-irsc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2013, J ANTIMICROB CHEMOTH, V68, pi31, DOI 10.1093/jac/dkt024; Adewoye L, 2002, J BACTERIOL, V184, P4308, DOI 10.1128/JB.184.15.4308-4312.2002; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; Bordes P, 2011, J BACTERIOL, V193, P246, DOI 10.1128/JB.00884-10; Braz VS, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw166; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Cao L, 2004, MOL MICROBIOL, V53, P1423, DOI 10.1111/j.1365-2958.2004.04210.x; Caughlan RE, 2012, ANTIMICROB AGENTS CH, V56, P17, DOI 10.1128/AAC.05417-11; Chalhoub H, 2017, SCI REP-UK, V7, DOI 10.1038/srep40208; Chen H, 2008, P NATL ACAD SCI USA, V105, P13586, DOI 10.1073/pnas.0803391105; Chen H, 2010, EMBO REP, V11, P685, DOI 10.1038/embor.2010.96; Chen WZ, 2016, MOL MICROBIOL, V100, P749, DOI 10.1111/mmi.13346; Choudhury D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149156; Chuanchuen R, 2001, ANTIMICROB AGENTS CH, V45, P428, DOI 10.1128/AAC.45.2.428-432.2001; Daigle DM, 2007, J BACTERIOL, V189, P5441, DOI 10.1128/JB.00543-07; Engman J, 2015, MOL MICROBIOL, V95, P51, DOI 10.1111/mmi.12842; Evans K, 2001, J BACTERIOL, V183, P807, DOI 10.1128/JB.183.3.807-812.2001; Evans K, 1998, J BACTERIOL, V180, P5443, DOI 10.1128/JB.180.20.5443-5447.1998; Fetar H, 2011, ANTIMICROB AGENTS CH, V55, P508, DOI 10.1128/AAC.00830-10; Fraud S, 2008, ANTIMICROB AGENTS CH, V52, P4478, DOI 10.1128/AAC.01072-08; Ghosh S, 2011, MOL MICROBIOL, V79, P1547, DOI 10.1111/j.1365-2958.2011.07544.x; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hirakata Y, 2002, J EXP MED, V196, P109, DOI 10.1084/jem.20020005; Jalal S, 2000, ANTIMICROB AGENTS CH, V44, P710, DOI 10.1128/AAC.44.3.710-712.2000; Jeannot K, 2005, J BACTERIOL, V187, P5341, DOI 10.1128/JB.187.15.5341-5346.2005; Jo JTH, 2003, ANTIMICROB AGENTS CH, V47, P1101, DOI 10.1128/AAC.47.3.1101-1111.2003; Jorth P, 2017, MBIO, V8, DOI 10.1128/mBio.00517-17; Ketelboeter LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178084; Khanam S, 2017, CELL CALCIUM, V61, P32, DOI 10.1016/j.ceca.2016.11.004; Krahn T, 2012, ANTIMICROB AGENTS CH, V56, P5591, DOI 10.1128/AAC.01446-12; Lamour V, 2002, J BIOL CHEM, V277, P18947, DOI 10.1074/jbc.M111740200; Lau CHF, 2015, MICROBIOLOGYOPEN, V4, P121, DOI 10.1002/mbo3.226; Lau CHF, 2013, ANTIMICROB AGENTS CH, V57, P2243, DOI 10.1128/AAC.00170-13; Lau CHF, 2012, ANTIMICROB AGENTS CH, V56, P5171, DOI 10.1128/AAC.00846-12; Lee S, 2009, P NATL ACAD SCI USA, V106, P14570, DOI 10.1073/pnas.0903619106; Li XZ, 1998, J BACTERIOL, V180, P2987, DOI 10.1128/JB.180.11.2987-2991.1998; Li XZ, 2000, J ANTIMICROB CHEMOTH, V46, P885, DOI 10.1093/jac/46.6.885; Liao J, 2013, J BACTERIOL, V195, P3352, DOI 10.1128/JB.00318-13; Liao JL, 2012, J BACTERIOL, V194, P4823, DOI 10.1128/JB.00765-12; Ling JQ, 2012, MOL CELL, V48, P713, DOI 10.1016/j.molcel.2012.10.001; Llanes C, 2004, ANTIMICROB AGENTS CH, V48, P1797, DOI 10.1128/AAC.48.5.1797-1802.2004; Lopez-Causape C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00685; Maseda H, 2004, ANTIMICROB AGENTS CH, V48, P1320, DOI 10.1128/AAC.48.4.1320-1328.2004; MASUDA N, 1992, ANTIMICROB AGENTS CH, V36, P1847, DOI 10.1128/AAC.36.9.1847; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Morita Y, 2006, J BACTERIOL, V188, P1847, DOI 10.1128/JB.188.5.1847-1855.2006; Morita Y, 2006, J BACTERIOL, V188, P8649, DOI 10.1128/JB.01342-06; Muller A, 2013, J BACTERIOL, V195, P2807, DOI 10.1128/JB.00127-13; Nehme D, 2004, J BACTERIOL, V186, P2973, DOI 10.1128/JB.186.10.2973-2983.2004; Olivares J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00103; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Poole K, 2013, MICROBIAL EFFLUX PUMPS: CURRENT RESEARCH, P175; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Purssell A, 2013, MICROBIOL-SGM, V159, P2058, DOI 10.1099/mic.0.069286-0; Runde S, 2014, MOL MICROBIOL, V91, P1036, DOI 10.1111/mmi.12521; Saito K, 1999, FEMS MICROBIOL LETT, V179, P67, DOI 10.1016/S0378-1097(99)00394-8; Sambrook J., 2001, MOL CLONING LAB MANU; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sobel ML, 2005, ANTIMICROB AGENTS CH, V49, P1782, DOI 10.1128/AAC.49.5.1782-1786.2005; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Srikumar R, 1998, ANTIMICROB AGENTS CH, V42, P65, DOI 10.1128/AAC.42.1.65; Srikumar R, 2000, J BACTERIOL, V182, P1410, DOI 10.1128/JB.182.5.1410-1414.2000; Srikumar R., 1999, CLIN MICROBIOL INFEC, V5; Starr LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032684; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sugimura M, 2008, ANTIMICROB AGENTS CH, V52, P4141, DOI 10.1128/AAC.00511-08; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; Tian ZX, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005932; Vestergaard M, 2016, INT J ANTIMICROB AG, V47, P48, DOI 10.1016/j.ijantimicag.2015.09.014; WEINBACH EC, 1969, NATURE, V221, P1016, DOI 10.1038/2211016a0; Wieland K, 2018, AM J INFECT CONTROL, V46, P643, DOI 10.1016/j.ajic.2017.12.014; Wilson DN, 2011, ANN NY ACAD SCI, V1241, P1, DOI 10.1111/j.1749-6632.2011.06192.x; Zhao QX, 1998, ANTIMICROB AGENTS CH, V42, P1682, DOI 10.1128/AAC.42.7.1682; Ziha-Zarifi I, 1999, ANTIMICROB AGENTS CH, V43, P287, DOI 10.1128/AAC.43.2.287	74	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205036	10.1371/journal.pone.0205036	http://dx.doi.org/10.1371/journal.pone.0205036			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289929	gold, Green Submitted, Green Published			2022-12-26	WOS:000446545500040
J	Choi, CH; Park, SY; Park, JM; Wu, HG; Kim, JH; Kim, JI				Choi, Chang Heon; Park, So-Yeon; Park, Jong Min; Wu, Hong-Gyun; Kim, Jin-Ho; Kim, Jung-in			Comparison of the IPSA and HIPO algorithms for interstitial tongue high-dose-rate brachytherapy	PLOS ONE			English	Article							RATE PROSTATE BRACHYTHERAPY; OPTIMIZATION ALGORITHMS; AMERICAN BRACHYTHERAPY; HDR BRACHYTHERAPY; CANCER; RADIOTHERAPY; PERFORMANCE	Purpose This study aimed to compare the inverse planning simulated annealing (IPSA) stochastic algorithm with the hybrid inverse planning and optimization (HIPO) algorithm for interstitial tongue high-dose-rate (HDR) brachytherapy. Methods Twenty patients who received radiotherapy for tongue cancer using interstitial HDR brachy-therapy were retrospectively selected for this study. Oncentra Brachy v. 4.3 was used for IPSA and HIPO planning. Four to eight fixed catheter configurations were determined according to the target shape. During the optimization process, predetermined constrain values were used for each IPSA and HIPO plan. The dosimetric parameters and dwell time were analyzed to evaluate the performances of the plans. Results The total dwell time using IPSA was 4 seconds longer than that of HIPO. The number of active positions per catheter for the IPSA plans were approximately 2.5 fewer than those of the HIPO plans. The dose-volumetric parameters related to the clinical target volume with IPSA were lower than those with HIPO. In terms of the dose-volumetric parameters related to normal tissue, HIPO tended to associate with slightly higher values than IPSA, without statistical significance. After GrO, the target coverages were satisfied to clinical goal for all patients. The total dwell times was approximately increased by 10%. Conclusions The IPSA and HIPO dose optimization algorithms generate similar dosimetric results. In terms of the dwell time, HIPO appears to be more beneficial.	[Choi, Chang Heon; Park, So-Yeon; Park, Jong Min; Wu, Hong-Gyun; Kim, Jin-Ho; Kim, Jung-in] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Choi, Chang Heon; Park, So-Yeon; Park, Jong Min; Wu, Hong-Gyun; Kim, Jin-Ho; Kim, Jung-in] Seoul Natl Univ, Coll Med, Biomed Res Inst, Seoul, South Korea; [Choi, Chang Heon; Park, So-Yeon; Park, Jong Min; Wu, Hong-Gyun; Kim, Jin-Ho; Kim, Jung-in] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Park, Jong Min] Adv Inst Convergence Technol, Ctr Convergence Res Robot, Suwon, South Korea; [Wu, Hong-Gyun] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, JH; Kim, JI (corresponding author), Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea.; Kim, JH; Kim, JI (corresponding author), Seoul Natl Univ, Coll Med, Biomed Res Inst, Seoul, South Korea.; Kim, JH; Kim, JI (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.	jinho.kim.md@gmail.com; madangin@gmail.com		Kim, Jung-in/0000-0002-0305-5969	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1631200]; National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2017R1C1B1006636]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (No. 1631200) to JK and by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2017R1C1B1006636) to CHC.	Balvert M, 2015, PHYS MED BIOL, V60, P537, DOI 10.1088/0031-9155/60/2/537; Bansal A, 2016, J CONTEMP BRACHYTHER, V8, P56, DOI 10.5114/jcb.2016.58082; Choi Chang Heon, 2017, [PROGRESS in MEDICAL PHYSICS, 의학물리], V28, P39, DOI 10.14316/pmp.2017.28.2.39; Choi CH, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160652; Dinkla AM, 2015, BRACHYTHERAPY, V14, P279, DOI 10.1016/j.brachy.2014.09.006; Erickson BA, 2017, BRACHYTHERAPY, V16, P75, DOI 10.1016/j.brachy.2016.05.006; Farrus B, 1996, RADIOTHER ONCOL, V38, P145, DOI 10.1016/0167-8140(95)01685-6; FRIEDRICH RE, 1995, J CRANIO MAXILL SURG, V23, P238, DOI 10.1016/S1010-5182(05)80214-8; Hsu I-Chow J, 2004, Brachytherapy, V3, P147, DOI 10.1016/j.brachy.2004.05.007; Inoue T, 2001, INT J RADIAT ONCOL, V51, P171, DOI 10.1016/S0360-3016(01)01561-9; Jacob D, 2008, INT J RADIAT ONCOL, V72, P820, DOI 10.1016/j.ijrobp.2008.02.009; Jamema SV, 2011, BRACHYTHERAPY, V10, P306, DOI 10.1016/j.brachy.2010.08.011; Katimoto N, 2003, RADIOTHER ONCOL, V68, P123, DOI 10.1016/S0167-8140(03)00055-0; Leung TW, 2002, HEAD NECK-J SCI SPEC, V24, P274, DOI 10.1002/hed.10021; Mavroidis Panayiotis, 2010, J Contemp Brachytherapy, V2, P117; Morton GC, 2008, BRACHYTHERAPY, V7, P12, DOI 10.1016/j.brachy.2007.10.001; Panettieri V, 2014, J APPL CLIN MED PHYS, V15, P256, DOI 10.1120/jacmp.v15i6.5055; Peppa V, 2017, PHYS MED; Poder J, 2016, J CONTEMP BRACHYTHER, V8, P203, DOI 10.5114/jcb.2016.60499; Pokharel S, 2013, J APPL CLIN MED PHYS, V14, P96, DOI 10.1120/jacmp.v14i4.4198; Poulin E, 2016, BRACHYTHERAPY, V15, P102, DOI 10.1016/j.brachy.2015.09.010; Pouliot J, 2004, INT J RADIAT ONCOL, V59, P1196, DOI 10.1016/j.ijrobp.2004.02.055; Takacsi-Nagy Z, 2017, BRACHYTHERAPY, V16, P44, DOI 10.1016/j.brachy.2016.07.005; Trnkova Petra, 2010, J Contemp Brachytherapy, V2, P163; Trnkova P, 2009, RADIOTHER ONCOL, V93, P331, DOI 10.1016/j.radonc.2009.10.004; Umeda M, 2000, ORAL SURG ORAL MED O, V90, P667, DOI 10.1067/moe.2000.110087; Vargo JA, 2014, WORLD J CLIN ONCOL, V5, P921, DOI 10.5306/wjco.v5.i5.921; Yamazaki H, 2004, INT J RADIAT ONCOL, V58, P139, DOI 10.1016/S0360-3016(03)01459-7; Yamazaki H, 2013, J RADIAT RES, V54, P1, DOI 10.1093/jrr/rrs103; Yoshida K, 2017, J CONTEMP BRACHYTHER, V9, P66, DOI 10.5114/jcb.2017.65163	30	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205229	10.1371/journal.pone.0205229	http://dx.doi.org/10.1371/journal.pone.0205229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286187	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500100
J	Diem, AK; Carare, RO; Weller, RO; Bressloff, NW				Diem, Alexandra K.; Carare, Roxana O.; Weller, Roy O.; Bressloff, Neil W.			A control mechanism for intra-mural peri-arterial drainage via astrocytes: How neuronal activity could improve waste clearance from the brain	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; ALZHEIMERS-DISEASE; PERIVASCULAR DRAINAGE; LIFE-STYLE; DEMENTIA; MODEL; DYSFUNCTION; EXERCISE; SOLUTES; FLUID	The mechanisms behind the clearance of soluble waste from deep within the parenchyma of the brain remain unclear. Experimental evidence reveals that one pathway for clearance of waste, termed intra-mural peri-arterial drainage (IPAD), is the rapid drainage of interstitial fluid along basement membranes (BM) of the smooth muscle cells of cerebral arteries; failure of IPAD is closely associated with the pathology of Alzheimer's disease (AD), but its driving mechanism remains unclear. We have previously shown that arterial pulsations generated by the heart beat are not strong enough to drive IPAD. Here we present computational evidence for a mechanism for clearance of waste from the brain that is driven by functional hyperaemia, that is, the dilatation of cerebral arterioles as a consequence of increased nutrient demand from neurons. This mechanism is based on our model for the flow of fluid through the vascular BM. It accounts for clearance rates observed in mouse experiments, and aligns with pathological observations and recommendations to lower the individual risk of AD, such as mental and physical activity. Thus, our neurovascular hypothesis should act as the new working hypothesis for the driving force behind IPAD.	[Diem, Alexandra K.] Simula Res Lab, Dept Computat Physiol, N-1364 Fornebu, Norway; [Diem, Alexandra K.; Bressloff, Neil W.] Univ Southampton, Fac Engn & Environm, Computat Engn & Design, Southampton Boldrewood Innovat Campus, Southampton SO16 7QF, Hants, England; [Carare, Roxana O.] Univ Southampton, Southampton Gen Hosp, Fac Med, Clin Neurosci, Southampton SO16 6YD, Hants, England; [Weller, Roy O.] Southampton Gen Hosp, Neuropathol, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton; University of Southampton	Diem, AK (corresponding author), Simula Res Lab, Dept Computat Physiol, N-1364 Fornebu, Norway.; Diem, AK (corresponding author), Univ Southampton, Fac Engn & Environm, Computat Engn & Design, Southampton Boldrewood Innovat Campus, Southampton SO16 7QF, Hants, England.	alexandra@simula.no		Diem, Alexandra K./0000-0003-1719-1942	UK Engineering and Physical Sciences Research Council (EPSRC) [EP/N509747/1]	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was funded by the UK Engineering and Physical Sciences Research Council (EPSRC) grant number EP/N509747/1 (AKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Albargothy NJ, 2018, ACTA NEUROPATHOL, V136, P139, DOI 10.1007/s00401-018-1862-7; Alnaes MS, 2015, ARCH NUMBERICAL SOFT, V3; Alzheimer's Society, 2016, FACTSH RISK FACT DEM; Arbel-Ornath M, 2013, ACTA NEUROPATHOL, V126, P353, DOI 10.1007/s00401-013-1145-2; Asgari M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15024; BLACK JA, 1985, NEUROSCI LETT, V55, P371, DOI 10.1016/0304-3940(85)90464-1; Carare RO, 2008, NEUROPATH APPL NEURO, V34, P131, DOI 10.1111/j.1365-2990.2007.00926.x; Diem AK, 2017, RESCIENCE, V3, P11; Diem AK, 2016, THESIS; Diem AK, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00475; Farr H, 2011, J THEOR BIOL, V286, P13, DOI 10.1016/j.jtbi.2011.07.006; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Gomez-Pinilla F, 2013, COMPR PHYSIOL, V3, P403, DOI 10.1002/cphy.c110063; Haglund MM, 2014, J NEUROSURG, V4, P654; Hannocks MJ, 2018, J CEREBR BLOOD F MET, V38, P669, DOI 10.1177/0271678X17749689; Hawkes CA, 2014, BRAIN PATHOL, V24, P396, DOI 10.1111/bpa.12159; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heppell C, 2015, B MATH BIOL, V77, P1101, DOI 10.1007/s11538-015-0078-4; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Horsburgh K, 2018, CLIN SCI, V132, P851, DOI 10.1042/CS20171620; Kotliar K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13349-5; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Morris AWJ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00251; Nelson AR, 2016, BBA-MOL BASIS DIS, V1862, P887, DOI 10.1016/j.bbadis.2015.12.016; Ostergaard L, 2013, NEUROBIOL AGING, V34, P1018, DOI 10.1016/j.neurobiolaging.2012.09.011; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Schley D, 2006, J THEOR BIOL, V238, P962, DOI 10.1016/j.jtbi.2005.07.005; Sharp MK, 2016, ANN BIOMED ENG, V44, P1553, DOI 10.1007/s10439-015-1457-6; Smith JC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00061; Weller RO, 2018, ACTA NEUROPATHOL, V135, P363, DOI 10.1007/s00401-018-1809-z; Weller RO, 2009, ACTA NEUROPATHOL, V118, P87, DOI 10.1007/s00401-009-0498-z; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Witthoft A, 2012, J THEOR BIOL, V311, P80, DOI 10.1016/j.jtbi.2012.07.014; Woodard JL, 2012, CURR ALZHEIMER RES, V9, P436, DOI 10.2174/156720512800492477; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	37	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205276	10.1371/journal.pone.0205276	http://dx.doi.org/10.1371/journal.pone.0205276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286191	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000446383500104
J	Mahrholz, G; Belin, P; McAleer, P				Mahrholz, Gaby; Belin, Pascal; McAleer, Phil			Judgements of a speaker's personality are correlated across differing content and stimulus type	PLOS ONE			English	Article							PREDICTS INDIVIDUAL-DIFFERENCES; 1ST IMPRESSIONS; VOICE PITCH; VOCAL ATTRACTIVENESS; JUDGING PERSONALITY; WOMENS PREFERENCES; PHYSICAL STRENGTH; ZERO ACQUAINTANCE; SOCIAL JUDGMENTS; TRAIT INFERENCES	It has previously been shown that first impressions of a speaker's personality, whether accurate or not, can be judged from short utterances of vowels and greetings, as well as from prolonged sentences and readings of complex paragraphs. From these studies, it is established that listeners' judgements are highly consistent with one another, suggesting that different people judge personality traits in a similar fashion, with three key personality traits being related to measures of valence (associated with trustworthiness), dominance, and attractiveness. Yet, particularly in voice perception, limited research has established the reliability of such personality judgements across stimulus types of varying lengths. Here we investigate whether first impressions of trustworthiness, dominance, and attractiveness of novel speakers are related when a judgement is made on hearing both one word and one sentence from the same speaker. Secondly, we test whether what is said, thus adjusting content, influences the stability of personality ratings. 60 Scottish voices (30 females) were recorded reading two texts: one of ambiguous content and one with socially-relevant content. One word (similar to 500 ms) and one sentence (similar to 3000 ms) were extracted from each recording for each speaker. 181 participants (138 females) rated either male or female voices across both content conditions (ambiguous, socially-relevant) and both stimulus types (word, sentence) for one of the three personality traits (trustworthiness, dominance, attractiveness). Pearson correlations showed personality ratings between words and sentences were strongly correlated, with no significant influence of content. In short, when establishing an impression of a novel speaker, judgments of three key personality traits are highly related whether you hear one word or one sentence, irrespective of what they are saying. This finding is consistent with initial personality judgments serving as elucidators of approach or avoidance behaviour, without modulation by time or content. All data and sounds are available on OSF (osf.io/s3cxy).	[Mahrholz, Gaby; McAleer, Phil] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland; [Belin, Pascal] CNRS, UMR 7289, Inst Neurosci Timone, Marseille, France; [Belin, Pascal] Univ Aix Marseille, Marseille, France	University of Glasgow; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Mahrholz, G; McAleer, P (corresponding author), Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland.	g.mahrholz.1@research.gla.ac.uk; philip.mcaleer@glasgow.ac.uk	; McAleer, Phil/A-8178-2011	Mahrholz, Gaby/0000-0002-2135-6888; McAleer, Phil/0000-0002-4523-2097	1+3 Economic and Social Research Council (ESRC) award from the Scottish Graduate School of Social Science (SGSSS)	1+3 Economic and Social Research Council (ESRC) award from the Scottish Graduate School of Social Science (SGSSS)	Gaby Mahrholz is a recipient of a 1+3 Economic and Social Research Council (ESRC) award from the Scottish Graduate School of Social Science (SGSSS).	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; ALBRIGHT L, 1988, J PERS SOC PSYCHOL, V55, P387, DOI 10.1037/0022-3514.55.3.387; Allport GW, 1934, J SOC PSYCHOL, V5, P37, DOI 10.1080/00224545.1934.9921582; Ames DR, 2010, PERS SOC PSYCHOL B, V36, P264, DOI 10.1177/0146167209354519; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; ARONOVITCH CD, 1976, J SOC PSYCHOL, V99, P207, DOI 10.1080/00224545.1976.9924774; Bar M, 2006, EMOTION, V6, P269, DOI 10.1037/1528-3542.6.2.269; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; Belin P, 2011, BRIT J PSYCHOL, V102, P711, DOI 10.1111/j.2044-8295.2011.02041.x; BERRY DS, 1990, J NONVERBAL BEHAV, V14, P141, DOI 10.1007/BF00996223; Biesanz JC, 2011, SOC PSYCHOL PERS SCI, V2, P452, DOI 10.1177/1948550610397211; BORKENAU P, 1993, J PERS, V61, P477, DOI 10.1111/j.1467-6494.1993.tb00779.x; Borkowska B, 2011, ANIM BEHAV, V82, P55, DOI 10.1016/j.anbehav.2011.03.024; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; Carney DR, 2007, J RES PERS, V41, P1054, DOI 10.1016/j.jrp.2007.01.004; Cowan ML, 2016, EVOL HUM BEHAV, V37, P97, DOI 10.1016/j.evolhumbehav.2015.09.002; Dickinson ER, 2012, ARCH SEX BEHAV, V41, P325, DOI 10.1007/s10508-011-9887-1; Dunbar NE, 2005, J SOC PERS RELAT, V22, P207, DOI 10.1177/0265407505050944; Ekstrom C., 2020, PWR BASIC FUNCTIONS; Fairbanks G., 1960, VOICE ARTICULATION D, V2; Ferdenzi C, 2013, BEHAV RES METHODS, V45, P405, DOI 10.3758/s13428-012-0275-0; Fischer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024490; Funder DC, 2012, CURR DIR PSYCHOL SCI, V21, P177, DOI 10.1177/0963721412445309; Gorn GJ, 2008, J CONSUM RES, V35, P36, DOI 10.1086/529533; GROSJEAN F, 1980, PERCEPT PSYCHOPHYS, V28, P267, DOI 10.3758/BF03204386; Harrison XA, 2018, PEERJ, V6, DOI 10.7717/peerj.4794; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Herzog H, 1933, Z PSYCHOL PHYSIOL SI, V130, P300; Hodges-Simeon CR, 2011, ARCH SEX BEHAV, V40, P551, DOI 10.1007/s10508-010-9625-0; Hughes SM, 2010, J SOC EVOL CULT PSYC, V4, P290, DOI DOI 10.1037/H0099282; Hughes SM, 2008, J NONVERBAL BEHAV, V32, P93, DOI 10.1007/s10919-007-0042-6; Hughes SM, 2013, PERCEPTION, V42, P941, DOI 10.1068/p7526; Imhof M., 2010, INT J LISTENING, V24, P19, DOI [10.1080/10904010903466295, DOI 10.1080/10904010903466295]; Jack RE, 2018, TRENDS COGN SCI, V22, P1, DOI 10.1016/j.tics.2017.10.002; Jiang XM, 2015, CORTEX, V66, P9, DOI 10.1016/j.cortex.2015.02.002; Jones BC, 2010, ANIM BEHAV, V79, P57, DOI 10.1016/j.anbehav.2009.10.003; Kahneman D., 2011, THINKING FAST SLOW; Kennedy Q, 2004, PSYCHOL SCI, V15, P208, DOI 10.1111/j.0956-7976.2004.01503011.x; KENNY DA, 1992, J PERS SOC PSYCHOL, V62, P88, DOI 10.1037/0022-3514.62.1.88; Klofstad CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133779; Klofstad CA, 2012, P ROY SOC B-BIOL SCI, V279, P2698, DOI 10.1098/rspb.2012.0311; Knight S, 2018, P NATL ACAD SCI USA, V115, pE6103, DOI 10.1073/pnas.1806345115; KRAMER E, 1970, J PERS ASSESS, V34, P426, DOI 10.1080/0091651X.1970.10380278; Kramer RSS, 2010, Q J EXP PSYCHOL, V63, P2273, DOI 10.1080/17470211003770912; Krauss RM, 2002, J EXP SOC PSYCHOL, V38, P618, DOI 10.1016/S0022-1031(02)00510-3; Lander K, 2008, ANIM BEHAV, V75, P817, DOI 10.1016/j.anbehav.2007.07.001; Latinus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041384; Latinus M, 2011, CURR BIOL, V21, pR143, DOI 10.1016/j.cub.2010.12.033; Lavan N, 2018, BREAKING VOICE IDENT; Lavan N, 2019, PSYCHON B REV, V26, P90, DOI 10.3758/s13423-018-1497-7; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; McAleer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090779; Mehl MR, 2006, J PERS SOC PSYCHOL, V90, P862, DOI 10.1037/0022-3514.90.5.862; MEHRABIAN A, 1967, J CONSULT PSYCHOL, V31, P248, DOI 10.1037/h0024648; Mileva M, 2017, J EXPT PSYCHOL HUMAN; MONTEPARE JM, 1987, J EXP SOC PSYCHOL, V23, P331, DOI 10.1016/0022-1031(87)90045-X; Moyse E, 2014, EUR J AGEING, V11, P241, DOI 10.1007/s10433-014-0305-0; Nesse RM, 2005, EVOL HUM BEHAV, V26, P88, DOI 10.1016/j.evolhumbehav.2004.08.002; O'Connor JJM, 2017, EVOL HUM BEHAV, V38, P506, DOI 10.1016/j.evolhumbehav.2017.03.001; O'Connor JJM, 2014, EVOL HUM BEHAV, V35, P368, DOI 10.1016/j.evolhumbehav.2014.05.001; O'Connor JJM, 2018, BRIT J PSYCHOL; Olivola CY, 2010, J NONVERBAL BEHAV, V34, P83, DOI 10.1007/s10919-009-0082-1; Olivola CY, 2010, J EXP SOC PSYCHOL, V46, P315, DOI 10.1016/j.jesp.2009.12.002; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; PASSINI FT, 1966, J PERS SOC PSYCHOL, V4, P44, DOI 10.1037/h0023519; Pear T. H., 1931, VOICE PERSONALITY; Pisanski K, 2016, ANIM BEHAV, V112, P13, DOI 10.1016/j.anbehav.2015.11.008; Pisanski K, 2014, ANIM BEHAV, V95, P89, DOI 10.1016/j.anbehav.2014.06.011; Ponsot E, 2018, P NATL ACAD SCI USA, V115, pE6104, DOI 10.1073/pnas.1806857115; Ponsot E, 2018, P NATL ACAD SCI USA, V115, P3972, DOI 10.1073/pnas.1716090115; Puts DA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2830; Puts DA, 2012, P ROY SOC B-BIOL SCI, V279, P601, DOI 10.1098/rspb.2011.0829; Rendall D, 2007, J EXP PSYCHOL HUMAN, V33, P1208, DOI 10.1037/0096-1523.33.5.1208; Rezlescu C, 2015, J NONVERBAL BEHAV, V39, P355, DOI 10.1007/s10919-015-0214-8; Rule NO, 2011, PERS SOC PSYCHOL B, V37, P1499, DOI 10.1177/0146167211415630; Satchell L., 2018, PHOTOGRAPH FACE TO F; SCHERER KR, 1972, J PERS, V40, P191, DOI 10.1111/j.1467-6494.1972.tb00998.x; Schroeder J, 2015, PSYCHOL SCI, V26, P877, DOI 10.1177/0956797615572906; Scott SK, 2014, TRENDS COGN SCI, V18, P618, DOI 10.1016/j.tics.2014.09.002; Sell A, 2010, P ROY SOC B-BIOL SCI, V277, P3509, DOI 10.1098/rspb.2010.0769; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Simons DJ, 2017, PERSPECT PSYCHOL SCI, V12, P1123, DOI 10.1177/1745691617708630; STARKWEATHER JA, 1956, J ABNORM SOC PSYCH, V52, P394, DOI 10.1037/h0041133; Sutherland CAM, 2017, BRIT J PSYCHOL, V108, P397, DOI 10.1111/bjop.12206; Sutherland CAM, 2013, COGNITION, V127, P105, DOI 10.1016/j.cognition.2012.12.001; Tigue CC, 2012, EVOL HUM BEHAV, V33, P210, DOI 10.1016/j.evolhumbehav.2011.09.004; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813; Tomlinson JM, 2011, COGNITION, V119, P58, DOI 10.1016/j.cognition.2010.12.005; Toscano H, 2016, PERS SOC PSYCHOL B, V42, P1603, DOI 10.1177/0146167216666266; Toscano H, 2014, EVOL PSYCHOL-US, V12, P1; Tsantani MS, 2016, PERCEPTION, V45, P946, DOI 10.1177/0301006616643675; Tyler JC, 2015, J ENGL LINGUIST, V43, P284, DOI 10.1177/0075424215607061; Vernon RJW, 2014, P NATL ACAD SCI USA, V111, pE3353, DOI 10.1073/pnas.1409860111; Vukovic J, 2008, PERS INDIV DIFFER, V45, P451, DOI 10.1016/j.paid.2008.05.013; Vukovic J, 2011, BRIT J PSYCHOL, V102, P37, DOI 10.1348/000712610X498750; Wang HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161114; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Willis ML, 2011, SOC COGNITION, V29, P415, DOI 10.1521/soco.2011.29.4.415; Wood TJ, 2014, ADV HEALTH SCI EDUC, V19, P409, DOI 10.1007/s10459-013-9453-9; Yovel G, 2013, TRENDS COGN SCI, V17, P263, DOI 10.1016/j.tics.2013.04.004; Zacks JM, 2007, CURR DIR PSYCHOL SCI, V16, P80, DOI 10.1111/j.1467-8721.2007.00480.x; Zebrowitz L A, 1997, Pers Soc Psychol Rev, V1, P204, DOI 10.1207/s15327957pspr0103_2; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x; Zebrowitz LA, 2014, EXP AGING RES, V40, P375, DOI 10.1080/0361073X.2014.897151; Zebrowitz LA, 2013, PSYCHOL AGING, V28, P202, DOI 10.1037/a0030927; ZUCKERMAN M, 1989, J NONVERBAL BEHAV, V13, P67	109	16	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204991	10.1371/journal.pone.0204991	http://dx.doi.org/10.1371/journal.pone.0204991			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286148	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000446383500071
J	Nagamani, S; Muthusamy, K				Nagamani, Selvaraman; Muthusamy, Karthikeyan			A theoretical insight to understand the molecular mechanism of dual target ligand CTA-018 in the chronic kidney disease pathogenesis	PLOS ONE			English	Article							GROWTH-FACTOR 23; D-RECEPTOR ACTIVATION; HOMOLOGY MODEL; A-RING; VITAMIN; ANALOGS; DOCKING; BINDING; CYP24A1; CYTOCHROME-P450	The level of the vitamin D in the bloodstream is regulated by cytochrome P450 enzyme 24-hydroxylase A1 (CYP24A1). Over expression of CYP24A1 enzyme is correlated with vitamin D deficiency and resistance to vitamin D therapy. Chronic kidney disease (CKD) patients are commonly reported with the above said expression variations. This deregulation could be solved by ligands that act as a vitamin D receptor (VDR) agonists and CYP24A1 antagonists. Posner et al., (2010) first time reported two new vitamin D analogues namely CTA-091 and CTA-018 to inhibit CYP24A1. The CTA-018 inhibited CYP24A1 with an IC50 27 +/- 6 nM (10 times more potent than the ketoconazole (253 +/- 20 nM)). CTA-018 induced VDR expression (15-fold lower than 1 alpha,25(OH)(2)D-3) and is under phase II clinical trial, whereas CTA-091 was not able to efficiently induce the VDR expression (>2000 nM). To explore the molecular mechanism, binding specificity of these two vitamin D analogues along with native ligand was extensively studied through in silico approaches. Through molecular dynamics simulations studies, we shown that the sulfonic group (0 = S = 0) in the side chain of CTA-018 plays an important role in the regulation of VDR agonistic activity. The electron lone pairs of the sulfonic group that interacted with His393 lead to be a factor for agonistic mechanism of VDR activity. Compared to azol-based compounds, CTA-018 binds the different sites in the CYP24A1 binding cavity and thus it could be a potent antagonistic for CYP24A1enzyme.	[Nagamani, Selvaraman; Muthusamy, Karthikeyan] Alagappa Univ, Dept Bioinformat, Karaikkudi, Tamil Nadu, India	Alagappa University	Muthusamy, K (corresponding author), Alagappa Univ, Dept Bioinformat, Karaikkudi, Tamil Nadu, India.	mkbioinformatics@gmail.com		Muthusamy, Karthikeyan/0000-0001-7755-3381	Indian Council of Medical Research (ICMR), Govt. of. India Senior Research Fellowship [BIC/11(09)/14]	Indian Council of Medical Research (ICMR), Govt. of. India Senior Research Fellowship	Authors gratefully acknowledge financial support provided by Indian Council of Medical Research (ICMR), Govt. of. India Senior Research Fellowship to S. Nagamani (F. No.: BIC/11(09)/14).	Alam A, 2009, J COMPUT AID MOL DES, V23, P209, DOI 10.1007/s10822-008-9252-1; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amadei A, 1996, J BIOMOL STRUCT DYN, V13, P615, DOI 10.1080/07391102.1996.10508874; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; [Anonymous], 2015, PRIM VERS 3 9; [Anonymous], 2015, LIGPREP VERS 2 8; [Anonymous], 2013, JAG VERS 8 2; Beckman MJ, 1996, BIOCHEMISTRY-US, V35, P8465, DOI 10.1021/bi960658i; Belorusova AY, 2014, J MED CHEM, V57, P4710, DOI 10.1021/jm5002524; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; BOUILLON R, 1993, J BONE MINER RES, V8, P1009; Cozzolino M, 2010, HIPPOKRATIA, V14, P7; Damasiewicz MJ, 2011, NEPHROLOGY, V16, P261, DOI 10.1111/j.1440-1797.2011.01443.x; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Das D, 2009, J CHEM INF MODEL, V49, P2851, DOI 10.1021/ci900320p; Gomaa MS, 2007, J STEROID BIOCHEM, V104, P53, DOI 10.1016/j.jsbmb.2006.09.041; Goodman WG, 2003, NEPHROL DIAL TRANSPL, V18, P2, DOI 10.1093/ndt/gfg1002; Jones G, 2013, ANNU REV NUTR, V33, P23, DOI 10.1146/annurev-nutr-071812-161203; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kakuda S, 2010, ACTA CRYSTALLOGR D, V66, P918, DOI 10.1107/S0907444910020810; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; LLC. Schrodinger, PYMOL MOL GRAPH SYST; Loh ZY, 2012, CLIN KIDNEY J, V5, P303, DOI 10.1093/ckj/sfs074; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Masuda S, 2007, ARCH BIOCHEM BIOPHYS, V460, P177, DOI 10.1016/j.abb.2006.11.030; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; OKAMURA WH, 1989, J ORG CHEM, V54, P4072, DOI 10.1021/jo00278a018; OSTREM VK, 1987, J BIOL CHEM, V262, P14164; Perlstein J., 2001, INT UNION CRYSTALLOG, V123, P191, DOI [DOI 10.1021/JA0047368, 10.1021/ja0047368]; Perwad F, 2007, AM J PHYSIOL-RENAL, V293, pF1577, DOI 10.1152/ajprenal.00463.2006; Petkovich M, 2011, CURR OPIN NEPHROL HY, V20, P337, DOI 10.1097/MNH.0b013e3283477a7b; Posner GH, 2010, J STEROID BIOCHEM, V121, P13, DOI 10.1016/j.jsbmb.2010.03.065; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shen XL, 2012, J MOL MODEL, V18, P203, DOI 10.1007/s00894-011-1066-8; Sicinski RR, 2007, J MED CHEM, V50, P6154, DOI 10.1021/jm070635+; Singh KD, 2011, J MOL GRAPH MODEL, V30, P186, DOI 10.1016/j.jmgm.2011.07.004; Singh KD, 2013, ACTA PHARMACOL SIN, V34, P1592, DOI 10.1038/aps.2013.129; TEETER MM, 1990, J PHYS CHEM-US, V94, P8091, DOI 10.1021/j100384a021; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wan M, 2013, NEPHROL DIAL TRANSPL, V28, P153, DOI 10.1093/ndt/gfs411; Yamamoto K, 2000, P NATL ACAD SCI USA, V97, P1467, DOI 10.1073/pnas.020522697	42	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203194	10.1371/journal.pone.0203194	http://dx.doi.org/10.1371/journal.pone.0203194			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286109	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500006
J	Oliveira, KM; Binda, NS; Lavor, MSL; Silva, CMO; Rosado, IR; Gabellini, ELA; Da Silva, JF; Oliveira, CM; Melo, MM; Gomez, MV; Melo, EG				Oliveira, Karen M.; Binda, Nancy S.; Lavor, Mario Sergio L.; Silva, Carla M. O.; Rosado, Isabel R.; Gabellini, Endrigo L. A.; Da Silva, Juliana F.; Oliveira, Camila M.; Melo, Marilia M.; Gomez, Marcus Vinicius; Melo, Eliane G.			Conotoxin MVIIA improves cell viability and antioxidant system after spinal cord injury in rats	PLOS ONE			English	Article							CALCIUM-CHANNEL ANTAGONIST; TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; N-TYPE; OXIDATIVE STRESS; NITRIC-OXIDE; MITOCHONDRIAL DYSFUNCTION; OMEGA-CONOTOXIN; INTRATHECAL ZICONOTIDE; BLOCKER ZICONOTIDE	This study evaluates whether intrathecal MVIIA injection after spinal cord injury (SCI) elicits neuroprotective effects. The test rats were randomly distributed into six groups- sham, placebo, MVIIA 2.5 mu M, MVIIA 5 mu M, MVIIA 10 mu M, and MVIIA 20 mu M-and were administered the treatment four hours after SCI. After the optimal MVIIA dose (MVIIA 10 mu M) was defined, the best time for application, one or four hours, was analyzed. Locomotor hind limb function and side effects were assessed. Forty-eight hours after the injury and immediately after euthanasia, spinal cord segments were removed from the test rats. Cell viability, reactive oxygen species, lipid peroxidation, and glutamate release were investigated. To examine the MVIIA mechanism of action, the gene expressions of pro-apoptotic (Bax, nNOS, and caspase-3, -8, -9, -12) and anti-apoptotic (Bcl-xl) factors in the spinal cord tissue samples were determined by real-time PCR, and the activities of antioxidant enzymes were also investigated. Application of intrathecal MVIIA 10 mu M four hours after SCI prompted a neuroprotective effect: neuronal death decreased (22.46%), oxidative stress diminished, pro-apoptotic factors (Bax, nNOS, and caspase-3, -8) were expressed to a lesser extent, and mitochondrial viability as well as anti-apoptotic factor (Bcl-xl) expression increased. These results suggested that MVIIA provided neuroprotection through antioxidant effects. Indeed, superoxide dismutase (188.41%), and glutathione peroxidase (199.96%), reductase (193.86%), and transferase (175.93%) expressions increased. Therefore, intrathecal MVIIA (MVIIA 10 mu M, 4 h) application has neuroprotective potential, and the possible mechanisms are related to antioxidant agent modulation and to intrinsic and extrinsic apoptotic pathways.	[Oliveira, Karen M.; Silva, Carla M. O.; Melo, Marilia M.; Melo, Eliane G.] Minas Gerais Fed Univ, Clin & Surg Dept, Sch Vet, Campus Pampulha, Belo Horizonte, MG, Brazil; [Binda, Nancy S.; Da Silva, Juliana F.; Gomez, Marcus Vinicius] Inst Educ & Res, Lab Toxins, Belo Horizonte, MG, Brazil; [Lavor, Mario Sergio L.] Univ Estadual Santa Cruz, Dept Agr & Environm Sci, Ilheus, BA, Brazil; [Rosado, Isabel R.; Gabellini, Endrigo L. A.] Univ Uberaba, Dept Vet Med, Uberaba, MG, Brazil; [Oliveira, Camila M.] Univ Fed Parana, Sch Med, Curitiba, Parana, Brazil	Insper; Universidade Estadual de Santa Cruz; Universidade de Uberaba (Uniube); Universidade Federal do Parana	Oliveira, KM (corresponding author), Minas Gerais Fed Univ, Clin & Surg Dept, Sch Vet, Campus Pampulha, Belo Horizonte, MG, Brazil.	kamoliveira@yahoo.com.br	DE LAVOR, MARIO SERGIO LIMA/Y-4138-2019; da Silva, Juliana/AAN-4275-2021	DE LAVOR, MARIO SERGIO LIMA/0000-0003-0795-5320; da Silva, Juliana/0000-0002-2906-517X; Binda, Nancy/0000-0003-0603-0342	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [140633/2012-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq): http://cnpq.br/ grant number: 140633/2012-0 (KMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Bingham JP, 2010, CHEM-BIOL INTERACT, V183, P1, DOI 10.1016/j.cbi.2009.09.021; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BOWERSOX SS, 1995, J PHARMACOL EXP THER, V273, P248; Bowersox SS, 1998, TOXICON, V36, P1651, DOI 10.1016/S0041-0101(98)00158-5; Bowersox SS, 1997, BRAIN RES, V747, P343; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHAN AM, 1994, J CEREBR BLOOD F MET, V14, P903, DOI 10.1038/jcbfm.1994.121; Burns LH, 1999, J VASC SURG, V30, P334, DOI 10.1016/S0741-5214(99)70145-X; Carlson Gregory D, 2002, Spine J, V2, P116, DOI 10.1016/S1529-9430(01)00029-8; Chatzipanteli K, 2002, J NEUROTRAUM, V19, P639, DOI 10.1089/089771502753754109; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Colbourne F, 1999, STROKE, V30, P662, DOI 10.1161/01.STR.30.3.662; Dasuri K, 2013, FREE RADICAL BIO MED, V62, P170, DOI 10.1016/j.freeradbiomed.2012.09.016; Oliveira KM, 2016, CIENC RURAL, V46, P150, DOI 10.1590/0103-8478cr20141203; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Eckert MJ, 2017, SURG CLIN N AM, V97, P1031, DOI 10.1016/j.suc.2017.06.008; Fang MR, 2011, TOXICOL LETT, V206, P325, DOI 10.1016/j.toxlet.2011.07.022; Galang N, 2000, TOXICOLOGY, V148, P111, DOI 10.1016/S0300-483X(00)00201-8; GAUR S, 1994, NEUROPHARMACOLOGY, V33, P1211, DOI 10.1016/S0028-3908(05)80012-7; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GOHIL K, 1994, BRAIN RES, V653, P258, DOI 10.1016/0006-8993(94)90398-0; Goncaves JM, 2011, CELL MOL NEUROBIOL, V31, P277, DOI 10.1007/s10571-010-9618-5; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Greenberg DA, 1997, ANN NEUROL, V42, P275, DOI 10.1002/ana.410420302; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hall ED, 2016, J BIOENERG BIOMEMBR, V48, P169, DOI 10.1007/s10863-015-9600-5; Hama A, 2009, NEUROPHARMACOLOGY, V56, P556, DOI 10.1016/j.neuropharm.2008.10.008; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Horvath G, 2002, N-S ARCH PHARMACOL, V366, P270, DOI 10.1007/s00210-002-0591-5; HOVDA DA, 1994, ACTA NEUROCHIR, P521; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Igelmund P, 1996, EXP BRAIN RES, V109, P22; ISAAC L, 1995, SURG NEUROL, V43, P484, DOI 10.1016/0090-3019(95)80094-W; Ishikawa T, 1996, No To Shinkei, V48, P259; Jia XF, 2013, J INTENSIVE CARE MED, V28, P12, DOI 10.1177/0885066611403270; Johnson Simon, 2012, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0939s61; Torres BBJ, 2010, INT J EXP PATHOL, V91, P530, DOI 10.1111/j.1365-2613.2010.00738.x; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kubli DA, 2008, AM J PHYSIOL-HEART C, V295, pH2025, DOI 10.1152/ajpheart.00552.2008; Lanz O, 2000, VET MED-US, V95, P851; Lee S, 2010, MOL PAIN, V6, P1, DOI [10.1186/1744-8069-6-1, DOI 10.1186/1744-8069-6-1]; Leo M, 2017, EXP NEUROL, V288, P62, DOI 10.1016/j.expneurol.2016.11.003; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; LIU DX, 1993, BRAIN RES, V609, P293, DOI 10.1016/0006-8993(93)90885-Q; Liu WM, 2011, J NEUROSCI RES, V89, P791, DOI 10.1002/jnr.22602; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Luo HX, 2014, BIOMED REP, V2, P207, DOI 10.3892/br.2013.212; MALMBERG AB, 1994, J NEUROSCI, V14, P4882; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Martins BD, 2018, SPINE J, V18, P532, DOI 10.1016/j.spinee.2017.10.067; Maulik N, 1998, FREE RADICAL BIO MED, V24, P869, DOI 10.1016/S0891-5849(97)00388-2; McDowell GC, 2016, NEUROMODULATION, V19, P522, DOI 10.1111/ner.12392; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Minami K, 2001, FEBS LETT, V491, P127, DOI 10.1016/S0014-5793(01)02183-4; Montazeri F, 2013, J SPINAL CORD MED, V36, P231, DOI 10.1179/2045772312Y.0000000077; NADASDI L, 1995, BIOCHEMISTRY-US, V34, P8076, DOI 10.1021/bi00025a013; Naderi A, 2014, METAB BRAIN DIS, V29, P763, DOI 10.1007/s11011-014-9570-z; Nagai T, 2001, FOOD CHEM, V75, P237, DOI 10.1016/S0308-8146(01)00193-5; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; NEWCOMB R, 1994, BRAIN RES, V638, P95, DOI 10.1016/0006-8993(94)90637-8; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oliveira KM, 2014, INT J CLIN EXP PATHO, V7, P3524; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Patel SP, 2012, NEUROSCIENCE, V210, P296, DOI 10.1016/j.neuroscience.2012.03.006; Patel SP, 2010, J NEUROCHEM, V114, P291, DOI 10.1111/j.1471-4159.2010.06764.x; Perez-Pinzon MA, 1997, J NEUROL SCI, V153, P25, DOI 10.1016/S0022-510X(97)00196-2; Pitkanen A., 2005, DRUG DISCOV TODAY DI, V2, P409, DOI DOI 10.1016/J.DDMEC.2005.11.011; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Priestley John V, 2012, Handb Clin Neurol, V109, P463, DOI 10.1016/B978-0-444-52137-8.00029-2; Qian ZJ, 2008, BIORESOURCE TECHNOL, V99, P3365, DOI 10.1016/j.biortech.2007.08.018; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rosado IR, 2014, INT J CLIN EXP PATHO, V7, P4617; Samraj AK, 2007, MOL BIOL CELL, V18, P84, DOI 10.1091/mbc.E06-04-0263; Sanford M, 2013, CNS DRUGS, V27, P989, DOI 10.1007/s40263-013-0107-5; Scott DA, 2002, EUR J PHARMACOL, V451, P279, DOI 10.1016/S0014-2999(02)02247-1; SELIGMAN ML, 1977, LIPIDS, V12, P945, DOI 10.1007/BF02533316; Siniscalco D, 2007, PHARMACOL RES, V55, P158, DOI 10.1016/j.phrs.2006.11.009; Siqueira IR, 2004, BRAIN RES, V1025, P226, DOI 10.1016/j.brainres.2004.08.005; Skov MJ, 2007, INT J TOXICOL, V26, P411, DOI 10.1080/10915810701582970; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; Snutch Terrance P, 2005, NeuroRx, V2, P662, DOI 10.1602/neurorx.2.4.662; Song YX, 2013, LIFE SCI, V92, P1215, DOI 10.1016/j.lfs.2013.05.007; SOUZA A. H., 2011, TOXICON, V58, P626, DOI [10.1016/j.toxicon.2011.09.008, DOI 10.1016/J.TOXICON.2011.09.008]; Souza AH, 2013, CELL MOL NEUROBIOL, V33, P59, DOI [10.1007/s10571-012-9871-x, DOI 10.1007/S10571-012-9871-X]; Souza AH, 2008, PAIN, V140, P115, DOI 10.1016/j.pain.2008.07.014; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; TAKIZAWA S, 1995, J CEREBR BLOOD F MET, V15, P611, DOI 10.1038/jcbfm.1995.75; Twede VD, 2009, IDRUGS, V12, P231; Uchitel OD, 1997, TOXICON, V35, P1161, DOI 10.1016/S0041-0101(96)00210-3; VALENTINO K, 1993, P NATL ACAD SCI USA, V90, P7894, DOI 10.1073/pnas.90.16.7894; Verweij BH, 2000, J NEUROSURG, V93, P829, DOI 10.3171/jns.2000.93.5.0829; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Visavadiya NP, 2016, REDOX BIOL, V8, P59, DOI 10.1016/j.redox.2015.12.011; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wang F, 2016, NEUROPHARMACOLOGY, V101, P137, DOI 10.1016/j.neuropharm.2015.08.047; Wang LY, 2008, J IMMUNOL, V180, P3072, DOI 10.4049/jimmunol.180.5.3072; Wermeling D, 2003, J CLIN PHARMACOL, V43, P624, DOI 10.1177/0091270003253349; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Wu KLH, 2009, J NEUROTRAUM, V26, P965, DOI 10.1089/neu.2008.0692; Xia YZ, 2017, EXP THER MED, V14, P1589, DOI 10.3892/etm.2017.4674; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xu GY, 2004, EXP NEUROL, V187, P329, DOI 10.1016/j.expneurol.2004.01.029; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Yamamoto T, 1998, BRAIN RES, V794, P329, DOI 10.1016/S0006-8993(98)00306-0; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002; Zhang H, 2014, J TRANSL MED, V12, P1, DOI [10.1186/1479-5876-12-1, DOI 10.1186/1479-5876-12-1]	121	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204948	10.1371/journal.pone.0204948	http://dx.doi.org/10.1371/journal.pone.0204948			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286181	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500066
J	Playe, B; Azencott, CA; Stoven, V				Playe, Benoit; Azencott, Chloe-Agathe; Stoven, Veronique			Efficient multi-task chemogenomics for drug specificity prediction	PLOS ONE			English	Article							TARGET INTERACTION PREDICTION; HOSPITALIZED-PATIENTS; HOMOLOGY DETECTION; CHEMICAL GENOMICS; CROSS-VALIDATION; KERNELS; SUPPORT; INFORMATION; DISCOVERY	Adverse drug reactions, also called side effects, range from mild to fatal clinical events and significantly affect the quality of care. Among other causes, side effects occur when drugs bind to proteins other than their intended target. As experimentally testing drug specificity against the entire proteome is out of reach, we investigate the application of chemogenomics approaches. We formulate the study of drug specificity as a problem of predicting interactions between drugs and proteins at the proteome scale. We build several benchmark datasets, and propose NN-MT, a multi-task Support Vector Machine (SVM) algorithm that is trained on a limited number of data points, in order to solve the computational issues or proteome-wide SVM for chemogenomics. We compare NN-MTto different state-of-the-art methods, and show that its prediction performances are similar or better, at an efficient calculation cost. Compared to its competitors, the proposed method is particularly efficient to predict (protein, ligand) interactions in the difficult double-orphan case, i.e. when no interactions are previously known for the protein nor for the ligand. The NN-MTalgorithm appears to be a good default method providing state-of-the-art or better performances, in a wide range of prediction scenario that are considered in the present study: proteome-wide prediction, protein family prediction, test (protein, ligand) pairs dissimilar to pairs in the train set, and orphan cases.	[Playe, Benoit; Azencott, Chloe-Agathe; Stoven, Veronique] PSL Res Univ, Mines ParisTech, Ctr Computat Biol, Paris, France; [Playe, Benoit; Azencott, Chloe-Agathe; Stoven, Veronique] Inst Curie, F-75248 Paris, France; [Playe, Benoit; Azencott, Chloe-Agathe; Stoven, Veronique] INSERM, U900, F-75248 Paris, France	UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Playe, B (corresponding author), PSL Res Univ, Mines ParisTech, Ctr Computat Biol, Paris, France.; Playe, B (corresponding author), Inst Curie, F-75248 Paris, France.; Playe, B (corresponding author), INSERM, U900, F-75248 Paris, France.	benoit.playe@mines-paristech.fr		Playe, Benoit/0000-0003-3836-2683; Azencott, Chloe-Agathe/0000-0003-1003-301X				Allenby GM, 1999, J ECONOMETRICS, V89, P57; Arora N, 1998, MARKET SCI, V17, P29, DOI 10.1287/mksc.17.1.29; Azencott CA, 2007, J CHEM INF MODEL, V47, P965, DOI 10.1021/ci600397p; Bakker B, 2003, J MACHINE LEARNING R, V4, P83; Bleakley K, 2009, BIOINFORMATICS, V25, P2397, DOI 10.1093/bioinformatics/btp433; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Caruana R, 1998, LEARNING TO LEARN, P95, DOI 10.1007/978-1-4615-5529-2_5; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Erhan D, 2006, J CHEM INF MODEL, V46, P626, DOI 10.1021/ci050367t; Eskin E, 2002, NIPS, P1417; Faulon JL, 2008, BIOINFORMATICS, V24, P225, DOI 10.1093/bioinformatics/btm580; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; GOLUB GH, 1979, TECHNOMETRICS, V21, P215, DOI 10.1080/00401706.1979.10489751; Gonen M, 2012, BIOINFORMATICS, V28, P2304, DOI 10.1093/bioinformatics/bts360; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Hizukuri Y, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0158-1; Hue M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-144; Jaakkola T, 2000, J COMPUT BIOL, V7, P95, DOI 10.1089/10665270050081405; Jacob L, 2008, BIOINFORMATICS, V24, P2149, DOI 10.1093/bioinformatics/btn409; Jacob L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-363; Johnson C. C., 2014, P ADV NEUR INF PROC, V27, P1; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kashima H., 2003, P 20 INT C MACHINE L, P321; Kellenberger E, 2008, J CHEM INF MODEL, V48, P1014, DOI 10.1021/ci800023x; Kramer C, 2010, J CHEM INF MODEL, V50, P1961, DOI 10.1021/ci100264e; Kuang Rui, 2005, Journal of Bioinformatics and Computational Biology, V3, P527, DOI 10.1142/S021972000500120X; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LESLIE C, 2002, P PSB, V7, P566; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu Y, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004760; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martinez-Lopez Y, 2017, CURR TOP MED CHEM, V17, P2957, DOI 10.2174/1568026617666170821123856; Mei JP, 2013, BIOINFORMATICS, V29, P238, DOI 10.1093/bioinformatics/bts670; Miguel A, 2012, PHARMACOEPIDEM DR S, V21, P1139, DOI 10.1002/pds.3309; Napolitano F, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-30; Nascimento AC RB, 2016, BMC BIOINFORMATICS, V17, P1, DOI [10.1186/s12859-016-0890-3, DOI 10.1186/S12859-016-0890-3]; Okuno Y, 2008, NUCLEIC ACIDS RES, V36, pD907, DOI 10.1093/nar/gkm948; Onakpoya IJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0553-2; Pahikkala T, 2015, BRIEF BIOINFORM, V16, P325, DOI 10.1093/bib/bbu010; Paul N, 2004, PROTEINS, V54, P671, DOI 10.1002/prot.10625; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; RAGHAVAN VV, 1989, ACM T INFORM SYST, V7, P205, DOI 10.1145/65943.65945; Rakotomamonjy A, 2008, J MACH LEARN RES, V9, P2491; Saigo H, 2004, BIOINFORMATICS, V20, P1682, DOI 10.1093/bioinformatics/bth141; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Swamidass SJ, 2005, BIOINFORMATICS, V21, pI359, DOI 10.1093/bioinformatics/bti1055; Takarabe M, 2012, BIOINFORMATICS, V28, pI611, DOI 10.1093/bioinformatics/bts413; van Laarhoven T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066952; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; Vert JP, 2008, COMB CHEM HIGH T SCR, V11, P677, DOI 10.2174/138620708785739899; Warmuth MK, 2003, J CHEM INF COMP SCI, V43, P667, DOI 10.1021/ci025620t; Xia Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S6; Xu Xianjin, 2018, Biophys Rep, V4, P1, DOI 10.1007/s41048-017-0045-8; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yamanishi Y, 2013, MOL INFORM, V32, P991, DOI 10.1002/minf.201300079; Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176; Yuan QJ, 2016, BIOINFORMATICS, V32, P18, DOI 10.1093/bioinformatics/btw244; Zheng XD, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P1025	67	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204999	10.1371/journal.pone.0204999	http://dx.doi.org/10.1371/journal.pone.0204999			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286165	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500072
J	Rahm, J; Johansson, M				Rahm, Johan; Johansson, Maria			Assessing the pedestrian response to urban outdoor lighting: A full-scale laboratory study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OBSTACLE DETECTION; PERCEPTION; RECOGNITION; WALKING; EXPERIENCES; SIMULATION; LUMINANCE; DESIGN; IMPACT	This study identifies and applies methods for evaluating the human response to pedestrian lighting applications intended for future use by the municipality of Malmo, Sweden. The methods employed provide a supplementary perspective to that given by the photometric properties of the lighting applications. The study involved 89 participants from two age groups (Young: N: 43, 19-31 yrs.; Elderly: N: 46, 62-77 yrs.). Data were collected in a full-scale laboratory using a mock-up pedestrian pathway. Three lighting applications (one ceramic metal halide and two LED) were presented and the participants' behavior (walking speed), perception (ability to perform visual tasks-recognize facial expressions, detect obstacles, read street signpost), affective response, and evaluation of the lighting quality were assessed. The three lighting applications significantly differed with regard to the human response. The facial expression recognition distance, sign reading distance and the obstacle detection task, along with the evaluation of lighting quality and level of arousal, distinguished one of the LEDs (Correlated Color Temperature: 3810, Color Rendering Index: 75, Scotopic/Photopic ratio: 1.48) from the other two lighting applications-the participants performed better on the visual tasks, and the lighting was perceived as brighter, more arousing and less pleasant. Methods to capture human perception, evaluation and behavior in relation to outdoor lighting, provide a valuable perspective that should be systematically applied when municipalities consider different pedestrian lighting applications.	[Rahm, Johan; Johansson, Maria] Lund Univ, Dept Architecture & Built Environm, Environm Psychol, Lund, Sweden	Lund University	Rahm, J (corresponding author), Lund Univ, Dept Architecture & Built Environm, Environm Psychol, Lund, Sweden.	johan.rahm@arkitektur.lth.se		Rahm, Johan/0000-0002-7331-1286	Swedish energy agency [2012-00-3180]; INTERREG-project Lighting Metropolis - European Regional Development Fund [NYPS 20200430]	Swedish energy agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); INTERREG-project Lighting Metropolis - European Regional Development Fund	This research was funded by the Swedish energy agency, dnr: 2012-00-3180 (www.energimyndigheten.se), and by the INTERREG-project Lighting Metropolis, funded by the European Regional Development Fund, NYPS 20200430 (www.lightingmetropolis.com).	Addy CL, 2004, AM J PUBLIC HEALTH, V94, P440, DOI 10.2105/AJPH.94.3.440; Boyce P. R., 2000, International Journal of Lighting Research and Technology, V32, P79, DOI 10.1177/096032710003200205; Boyce PR, 2009, LIGHTING RES TECHNOL, V41, P245, DOI 10.1177/1477153509338887; British Standards Institution (BSI), 2013, 548912013 BSI; Caminada J. F., 1980, INT LIGHTING REV, V3, P69; Choi JS, 2014, ACTA BIOENG BIOMECH, V16, P3, DOI 10.5277/abb140101; Corseuil MW, 2011, PREV MED, V53, P289, DOI 10.1016/j.ypmed.2011.07.016; Corseuil MW, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/641010; Davoudian N, 2012, LIGHTING RES TECHNOL, V44, P438, DOI 10.1177/1477153512437157; de lEclairage C.I., 2010, 1152010 CIE; Dong M, 2015, LIGHTING RES TECHNOL, V47, P693, DOI 10.1177/1477153514539781; Ekman P., 2007, EMOTIONS REVEALED RE; Ewing R, 2010, J AM PLANN ASSOC, V76, P265, DOI 10.1080/01944361003766766; Eyler AA, 2002, WOMEN HEALTH, V36, P1, DOI 10.1300/J013v36n02_01; Fotios S, 2017, LIGHTING RES TECHNOL, V49, P243, DOI 10.1177/1477153515616166; Fotios S, 2020, LIGHTING RES TECHNOL, V52, P607, DOI 10.1177/1477153519876972; Fotios S, 2018, LIGHTING RES TECHNOL, V50, P390, DOI 10.1177/1477153516659783; Fotios S, 2015, LIGHTING RES TECHNOL, V47, P548, DOI 10.1177/1477153514529299; Fotios S, 2015, LIGHTING RES TECHNOL, V47, P301, DOI 10.1177/1477153513510311; Fotios S, 2015, LIGHTING RES TECHNOL, V47, P149, DOI 10.1177/1477153514522473; Fotios S, 2015, LIGHTING RES TECHNOL, V47, P133, DOI 10.1177/1477153514522472; Fotios S, 2013, LIGHTING RES TECHNOL, V45, P362, DOI 10.1177/1477153512444112; Fotios S, 2009, LIGHTING RES TECHNOL, V41, P321, DOI 10.1177/1477153509102343; Fotios S, 2017, LIGHTING RES TECHNOL; Gustafsson B, 2011, 32011 SWED RES COUNC; Hanyu K, 1997, J ENVIRON PSYCHOL, V17, P301, DOI 10.1006/jevp.1997.0067; International Energy Agency, 2006, LIGHTS LAB LOST POL; Itoh N, 2006, GERONTECHNOLOGY, V5, P246, DOI DOI 10.4017/GT.2006.05.04.010.00; Iwata M., 2011, J LIGHT VISUAL ENV, V35, P42; IZARD CE, 1993, J PERS SOC PSYCHOL, V64, P847, DOI 10.1037/0022-3514.64.5.847; Jackson GR, 1999, VISION RES, V39, P3975, DOI 10.1016/S0042-6989(99)00092-9; Jagerbrand A, 2013, 786 VTI SWED NAT ROA; Jago R, 2005, AM J PREV MED, V29, P98, DOI 10.1016/j.amepre.2005.04.002; Johansson M, 2014, J ENVIRON PSYCHOL, V39, P14, DOI 10.1016/j.jenvp.2013.12.002; Johansson M, 2011, LIGHTING RES TECHNOL, V43, P31, DOI 10.1177/1477153510370757; Johansson M, 2016, J URBAN DES, V21, P256, DOI 10.1080/13574809.2015.1133225; Kim S, 2014, TRANSPORT RES D-TR E, V30, P10, DOI 10.1016/j.trd.2014.05.005; Knight C, 2010, LIGHTING RES TECHNOL, V42, P313, DOI 10.1177/1477153510376794; Kohko S, 2008, J LIGHT VISUAL ENV, V32, P315; Kuhn L, 2013, LIGHTING RES TECHNOL, V45, P568, DOI 10.1177/1477153512464968; Kuller R, 1996, ENVIRON INT, V22, P33, DOI 10.1016/0160-4120(95)00101-8; Kuller R., 1993, Lighting Research and Technology, V25, P71; Lee C, 2008, BUILD RES INF, V36, P395, DOI 10.1080/09613210802045547; Lin Y, 2015, LIGHTING RES TECHNOL, V47, P221, DOI 10.1177/1477153513505306; Lin YD, 2015, INVEST OPHTH VIS SCI, V56, P1649, DOI 10.1167/iovs.14-15963; Park N. K., 2007, J INT DESIGN, V33, P17, DOI DOI 10.1111/j.1939-1668.2007.tb00419.x; Park S, 2014, TRANSPORT RES REC, P126, DOI 10.3141/2464-16; Park S, 2015, INT J SUSTAIN TRANSP, V9, P529, DOI 10.1080/15568318.2013.825036; Pedersen E, 2018, LIGHTING RES TECHNOL, V50, P522, DOI 10.1177/1477153516684544; Quartier K, 2014, J ENVIRON PSYCHOL, V39, P32, DOI 10.1016/j.jenvp.2014.04.005; Rahm J, 2016, 26 DEP ARCH BUILT EN; Raynham P, 2011, LIGHTING RES TECHNOL, V43, P129; Rea MS, 2009, LIGHTING RES TECHNOL, V41, P297, DOI 10.1177/1477153509102342; Rosenberg DE, 2013, GERONTOLOGIST, V53, P268, DOI 10.1093/geront/gns119; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; Shikakura T., 1992, J ILLUM ENG I JPN, V74, P648, DOI [10.2150/jieij1980.74.10_648, DOI 10.2150/JIEIJ1980.74.10_648]; Swedish Transport Administration, 2015, 2015086 SWED TRANSP; Uttley J, 2017, LIGHTING RES TECHNOL, V49, P211, DOI 10.1177/1477153515602954; van den Berg T.J.T.P., 2009, J OPTOM, V2, P112, DOI 10.3921/joptom.2009.112; Viliunas V, 2014, LIGHTING RES TECHNOL, V46, P421, DOI 10.1177/1477153513491760; Yang B, 2015, LIGHTING RES TECHNOL, V47, P964, DOI 10.1177/1477153514547753; Yang Chunyu, 2013, ING ILLUM, VV15, P19; Yao Q, 2009, LEUKOS, V6, P169, DOI 10.1582/LEUKOS.2009.06.02006; Zeng WL, 2017, TRANSPORT RES C-EMER, V80, P37, DOI 10.1016/j.trc.2017.04.009; Zeng WL, 2014, PROCD SOC BEHV, V138, P521, DOI 10.1016/j.sbspro.2014.07.233	65	13	13	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204638	10.1371/journal.pone.0204638	http://dx.doi.org/10.1371/journal.pone.0204638			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286094	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500029
J	Hauer, R; Tessitore, A; Binder, N; Tschan, H				Hauer, Richard; Tessitore, Antonio; Binder, Nicole; Tschan, Harald			Physiological, perceptual, and technical responses to continuous and intermittent small-sided games in lacrosse players	PLOS ONE			English	Article							YOUTH SOCCER PLAYERS; HEART-RATE RESPONSES; VIDEO INCIDENT ANALYSIS; RECOVERY TEST; PHYSICAL PERFORMANCE; EXERCISE INTENSITY; BASKETBALL PLAYERS; WOMENS LACROSSE; RELIABILITY; VALIDITY	Purpose The present study was designed to investigate the influence of two distinct small-sided game (SSG) regimes on physiological, perceptual, and technical parameters in male elite lacrosse players. Method Data were collected in twelve elite male Austrian lacrosse players (25.8 +/- 5.5 years; 80.1 +/- 7.7 kg; 178.5 +/- 6.2 cm). Players' were assigned to an intermittent (SSG-I) or a continuous (SSG-C) SSG regime, respectively. Regimes were equated for total practice time, but not active playing time. SSG data from eight sessions of 3 vs. 3 self-regulated match-play were collected along a 4-week pre-season period. Players' YoYo-Level 1 (YYL1) performance before and after the training intervention was recorded. Further, heart-rate (HR), rating of perceived exertion (RPE), physical activity enjoyment scale (PACES), and technical actions during and after SSG sessions were analyzed. Results Both SSG regimes showed improvement with medium to very large effect sizes (ES) in YYL1 total distance covered pre- to post-intervention (SSG-C mean-difference +/- SD: 840 +/- 299 m; p = 0.003; d = 1.08; CI = 0.60 to 1.56 and SSG-I: 607 +/- 274 m; p = 0.003; d = 1.25; CI = 0.66 to 1.85 respectively). Higher %HRmax values with very large ES (92 +/- 0.6%; p = 0.002; d = 5.33; CI = 2.78 to 7.88) and time spent in HR zone 4 (1248.0 +/- 122.7 s; p = 0.000; d = 3.43; CI = 2.31 to 4.55) were observed for SSG-C. No differences between regimes were found for any of the assessed technical actions, global RPE, and PACES scores. Conclusions Both SSG regimes investigated in this study were effective in improving YYL1 performance. Further, findings indicate that the regime does not influence players' subjective feelings and technical actions in SSG play. However, SSG-I in lacrosse specific training could have additional benefits such as lower signs of fatigue. Further, breaks can be used to give technical and tactical inputs by coaches.	[Hauer, Richard; Binder, Nicole; Tschan, Harald] Univ Vienna, Ctr Sport Sci & Univ Sports, Vienna, Austria; [Tessitore, Antonio] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy	University of Vienna; Foro Italico University of Rome	Hauer, R (corresponding author), Univ Vienna, Ctr Sport Sci & Univ Sports, Vienna, Austria.	richard.hauer@univie.ac.at	Tessitore, Antonio/H-9922-2014	Tessitore, Antonio/0000-0002-3542-0991; Hauer, Richard/0000-0001-6835-4030	University of Vienna	University of Vienna	Open access funding was provided by University of Vienna. The authors received no other specific funding for this work.	Atl H, 2013, J STRENGTH COND RES, V27, P352, DOI 10.1519/JSC.0b013e3182542674; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Borg G., 1998, BORGS PERCEIVED EXER, V8; Brandes M, 2012, J STRENGTH COND RES, V26, P1353, DOI 10.1519/JSC.0b013e318231ab99; Carter EA, 2010, INT J INJ CONTROL SA, V17, P111, DOI 10.1080/17457300903524888; Castagna C, 2008, J SCI MED SPORT, V11, P202, DOI 10.1016/j.jsams.2007.02.013; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Chamari K, 2005, BRIT J SPORT MED, V39, P24, DOI 10.1136/bjsm.2003.009985; Christopher J, 2016, HUM MOVEMENT SCI, V48, P1, DOI 10.1016/j.humov.2016.03.013; Clemente FM, 2017, J HUM KINET, V58, P141, DOI 10.1515/hukin-2017-0080; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Collins SM, 2014, J STRENGTH COND RES, V28, P2673, DOI 10.1519/JSC.0000000000000454; Delextrat A, 2018, J STRENGTH COND RES, V32, P1882, DOI 10.1519/JSC.0000000000002570; Dellal A, 2011, INT J SPORT PHYSIOL, V6, P322, DOI 10.1123/ijspp.6.3.322; Dellal A, 2008, J STRENGTH COND RES, V22, P1449, DOI 10.1519/JSC.0b013e31817398c6; Deprez D, 2014, J SPORT SCI, V32, P903, DOI 10.1080/02640414.2013.876088; Dolan P, 2017, J STRENGTH COND RES, V31, P2473, DOI 10.1519/JSC.0000000000001819; Enemark-Miller EA, 2009, J STRENGTH COND RES, V23, P39, DOI 10.1519/JSC.0b013e318185f07c; Fanchini M, 2011, J STRENGTH COND RES, V25, P453, DOI 10.1519/JSC.0b013e3181c1f8a2; Federation-of-International-Lacrosse, 2013, 2013 WOM LACR WORLD; Federation-of-International-Lacrosse, 2017, FIL MEMB MEMB TYP; Federation-of-International-Lacrosse, 2014 WORLD CHAMP 201; Fleay B, 2018, J STRENGTH COND RES, V32, P2039, DOI 10.1519/JSC.0000000000002423; Foster CD, 2010, J STRENGTH COND RES, V24, P906, DOI 10.1519/JSC.0b013e3181aeb11a; Gaudino P, 2014, HUM MOVEMENT SCI, V36, P123, DOI 10.1016/j.humov.2014.05.006; Gutowski AE, 2011, STRENGTH COND, V33, P7; Halouani J, 2014, J STRENGTH COND RES, V28, P3594, DOI 10.1519/JSC.0000000000000564; Hauer R, 2017, KINESIOLOGIA SLOVENI, V23, P14; Helgerud J, 2001, MED SCI SPORT EXER, V33, P1925, DOI 10.1097/00005768-200111000-00019; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hill-Haas SV, 2009, J STRENGTH COND RES, V23, P111, DOI 10.1519/JSC.0b013e31818efc1a; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hoff J, 2002, BRIT J SPORT MED, V36, P218, DOI 10.1136/bjsm.36.3.218; Hoffman JR, 2009, J STRENGTH COND RES, V23, P1524, DOI 10.1519/JSC.0b013e3181b3391d; Hughes M., 2004, NOTATIONAL ANAL SPOR; Impellizzeri FM, 2006, INT J SPORTS MED, V27, P483, DOI 10.1055/s-2005-865839; Kelly DA, 2009, J SCI MED SPORT, V12, P475, DOI 10.1016/j.jsams.2008.01.010; Kennett DC, 2012, J STRENGTH COND RES, V26, P2037, DOI 10.1519/JSC.0b013e31823a3b26; Koklu Y, 2017, INT J SPORT PHYSIOL, V12, P1370, DOI 10.1123/ijspp.2016-0584; Koklu Y, 2012, J HUM KINET, V31, P89, DOI 10.2478/v10078-012-0009-5; Krustrup P, 2003, MED SCI SPORT EXER, V35, P697, DOI 10.1249/01.MSS.0000058441.94520.32; Roman PAL, 2014, J ASTHMA, V51, P633, DOI 10.3109/02770903.2014.898773; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Los Arcos A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137224; Los Arcos A, 2014, J STRENGTH COND RES, V28, P752, DOI 10.1519/JSC.0b013e3182a47f0b; Macaulay CAJ, 2017, J SPORT SCI, V35, P2350, DOI 10.1080/02640414.2016.1267385; Mara JK, 2016, INT J SPORT PHYSIOL, V11, P953, DOI 10.1123/IJSPP.2015-0087; Martone D, 2017, J STRENGTH COND RES, V31, P1486, DOI 10.1519/JSC.0000000000001615; Mullen SP, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-103; O'donoghue P., 2009, RES METHODS SPORTS P; Plisk S. S, 1994, J STRENGTH COND RES, V8, P28; Polley CS, 2015, J STRENGTH COND RES, V29, P126, DOI 10.1519/JSC.0000000000000599; Rampinini E, 2007, J SPORT SCI, V25, P659, DOI 10.1080/02640410600811858; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Tessitore A, 2006, J SPORT MED PHYS FIT, V46, P36; Vennum Thomas, 1994, AM INDIAN LACROSSE L; Vescovi JD, 2007, J SCI MED SPORT, V10, P334, DOI 10.1016/j.jsams.2006.07.010	58	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203832	10.1371/journal.pone.0203832	http://dx.doi.org/10.1371/journal.pone.0203832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281632	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400031
J	Mirzadeh, A; Yoosefy, A; Kazemirad, E; Barati, Z; Golkar, M; Babaie, J; Jafarihaghighi, F; Valadkhani, Z				Mirzadeh, Abolfazl; Yoosefy, Asiyeh; Kazemirad, Elham; Barati, Zahra; Golkar, Majid; Babaie, Jalal; Jafarihaghighi, Farid; Valadkhani, Zarrintaj			Evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; BOLIVIAN ALTIPLANO; LEUCINE AMINOPEPTIDASE; SECRETORY PRODUCTS; ESCHERICHIA-COLI; HEPATICA; DIAGNOSIS; PROTEIN; ELISA; EXPRESSION	Diagnosis of fascioliasis with high sensitivity and specificity antigens play a vital role in the management of the disease. Majority of commercial serological tests use F. hepatica native antigens and indicate wide diversities in test accuracy. Nowadays, recombinant antigens have been introduced as diagnostic reagents offer better test standardization. A combination of highly pure recombinant antigens associated with correct folding will leads to improve specificity and sensitivity of ELISA for diagnosis of Fascioliasis. In this article, Fasciola hepatica saposin-like protein 2 (SAP-2), ferritin protein (Ftn-1) and leucine aminopeptidase (LAP) recombinant antigens were considered as tools for the detection of F. hepatica immunoglobulin G antibodies in persons with chronic human fasciolasis. The recombinant antigens were obtained as fusion proteins, expressed in Escherichia coli and purified by immobilized metal affinity chromatography (IMAC). The refolding processes of denatured recombinant proteins were performed using dialysis method in the presence of chemical additives, and reduced/oxidized glutathione (in vitro). The immunoreactivity of the recombinant antigens was assessed individually and in a combination compared with excretory/secretory antigen (E/S) in an enzyme-linked immunosorbent assay (ELISA) test. The experiments were optimized using 213 serum samples from humans, including patients with chronic fascioliasis, patients with other parasitic diseases, and healthy subjects. The results indicated 95% sensitivity and 98% specificity for rtFhSAP-2, 96% sensitivity and 91% specificity for E/S, 80% and 83.3% for rtFhFtn-1, 84% and 88% for FhLAP, and also, 96% and 95% for combination of recombinant antigens, respectively. In conclusion, the results of this investigation showed that rtFhSAP-2 with the highest specificity and acceptable sensitivity has a considerable superiority compared to mentioned antigens and even in combination with these antigens in serodiagnosis of human fascioliasis.	[Mirzadeh, Abolfazl; Yoosefy, Asiyeh; Barati, Zahra; Golkar, Majid; Babaie, Jalal; Jafarihaghighi, Farid; Valadkhani, Zarrintaj] Pasteur Inst Iran, Dept Med Parasitol, Tehran, Iran; [Kazemirad, Elham] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Parasitol & Mycol, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tehran University of Medical Sciences	Valadkhani, Z (corresponding author), Pasteur Inst Iran, Dept Med Parasitol, Tehran, Iran.	z_valadkhani@pasteur.ac.ir	Kazemirad, Elham/ABA-8391-2020; jafarihaghighi, farid/AAV-4144-2020; Babaie, Jalal/B-2938-2018	Kazemirad, Elham/0000-0001-8634-5584; Babaie, Jalal/0000-0002-4989-5998; Mirzadeh, Abolfazl/0000-0002-0336-3486	Pasteur Institute of Iran, Tehran [836]	Pasteur Institute of Iran, Tehran	Zarrintaj Valadkhani is the project designer no. 836, that granted by Pasteur Institute of Iran, Tehran. http://www.pasteur.ac.ir. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelbaset AE, 2017, EXP PARASITOL, V172, P1, DOI 10.1016/j.exppara.2016.11.003; Acosta D, 2008, MOL BIOCHEM PARASIT, V158, P52, DOI 10.1016/j.molbiopara.2007.11.011; Valero MA, 2012, TROP MED INT HEALTH, V17, P630, DOI 10.1111/j.1365-3156.2012.02964.x; Attallah AM, 2013, CLIN VACCINE IMMUNOL; Caban-Hernandez K, 2012, MOL BIOCHEM PARASIT, V182, P54, DOI 10.1016/j.molbiopara.2011.12.005; Cordova M, 1997, AM J TROP MED HYG, V57, P660, DOI 10.4269/ajtmh.1997.57.660; Espino AM, 2004, J PARASITOL, V90, P876, DOI 10.1645/GE-215R; Espino AM, 2003, J PARASITOL, V89, P545, DOI 10.1645/GE-3113; Espino Ana M, 2010, Ethn Dis, V20, pS1; Figueroa-Santiago O, 2011, DIAGN MICR INFEC DIS, V70, P355, DOI 10.1016/j.diagmicrobio.2011.03.016; Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33; Gottstein B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002860; HILLYER GV, 1992, AM J TROP MED HYG, V46, P603, DOI 10.4269/ajtmh.1992.46.603; Jayaraj R, 2011, DIAGN MICR INFEC DIS, V71, P403, DOI 10.1016/j.diagmicrobio.2011.09.007; Kuerpick B, 2013, VET PARASITOL, V193, P206, DOI 10.1016/j.vetpar.2012.11.021; Marcilla A, 2008, CLIN VACCINE IMMUNOL, V15, P95, DOI 10.1128/CVI.00338-07; Mas-Coma S, 2005, J HELMINTHOL, V79, P207, DOI 10.1079/JOH2005296; Mas-Coma S, 1999, TROP MED INT HEALTH, V4, P454, DOI 10.1046/j.1365-3156.1999.00418.x; Mas-Coma S, 1999, B WORLD HEALTH ORGAN, V77, P340; Mas-Coma S, 1999, FASCIOLOSIS, V411, P434; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Middelberg APJ, 2002, TRENDS BIOTECHNOL, V20, P437, DOI 10.1016/S0167-7799(02)02047-4; Mirzadeh A, 2017, ACTA TROP, V171, P163, DOI 10.1016/j.actatropica.2017.03.002; Mirzadeh A, 2017, PROTEIN EXPRES PURIF, V133, P66, DOI 10.1016/j.pep.2017.03.001; O'Neill SM, 1998, AM J TROP MED HYG, V58, P417, DOI 10.4269/ajtmh.1998.58.417; Okumura M, 2011, FEBS J, V278, P1137, DOI 10.1111/j.1742-4658.2011.08039.x; Organization WH, 2007, WHO INF M US TRICL F, V92; Patil NA, 2015, INT J MOL SCI, V16, P1791, DOI 10.3390/ijms16011791; Perez-Sanchez R, 2006, PROTEOMICS, V6, pS226, DOI 10.1002/pmic.200500420; Ramon A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00056; Rokni MB, 2008, ANN TROP MED PARASIT, V102, P283, DOI 10.1179/136485908X300805; Rokni MB, 2002, DIAGN MICR INFEC DIS, V44, P175, DOI 10.1016/S0732-8893(02)00431-5; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Sahdev S, 2008, MOL CELL BIOCHEM, V307, P249, DOI 10.1007/s11010-007-9603-6; Santana BG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002414; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; Valero MA, 2009, ACTA TROP, V111, P150, DOI 10.1016/j.actatropica.2009.04.005	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203490	10.1371/journal.pone.0203490	http://dx.doi.org/10.1371/journal.pone.0203490			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281608	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400023
J	Davis, RAH; Deemer, SE; Bergeron, JM; Little, JT; Warren, JL; Fisher, G; Smith, DL; Fontaine, KR; Dickinson, SL; Allison, DB; Plaisance, EP				Davis, Rachel A. H.; Deemer, Sarah E.; Bergeron, Jonathan M.; Little, Jason T.; Warren, Jonathan L.; Fisher, Gordon; Smith, Daniel L., Jr.; Fontaine, Kevin R.; Dickinson, Stephanie L.; Allison, David B.; Plaisance, Eric P.			Dietary R,S-1,3-butanediol diacetoacetate reduces body weight and adiposity in obese mice fed a high-fat diet	FASEB JOURNAL			English	Article						ketones; ketogenic diet; energy expenditure; adipose tissue thermogenesis; weight loss	KETOGENIC DIET; FOOD-INTAKE; BETA-HYDROXYBUTYRATE; ACETOACETATE ESTERS; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; KETONE-BODIES; MALONYL-COA; MITOCHONDRIAL; METABOLISM	The dietary R-3-hydroxybutyrate-R-1,3-butanediol monoester increases resting energy expenditure (REE) and markers of brown and white adipose thermogenesis in lean mice. The purpose of this investigation was to determine whether the ketone ester, R,S-1,3-butanediol diacetoacetate (BD-AcAc2), increases energy expenditure and markers of adipose tissue thermogenesis in the context of high-fat diet (HFD)-induced obesity. Thirty-five-week-old male C57BL/6J mice were placed on an ad libitum HFD (45% kcal) for 10 wk. The mice were then randomized to 1 of 3 groups (n = 10 per group) for an additional 12 wk: 1) control (Con), continuous HFD, 2) pair-fed (PF) to ketone ester (KE); and 3) KE: HFD+30% energy from BD-AcAc2. Mean energy intake throughout the study was approximate to 26% lower in the KE compared to the Con group (8.2 +/- 0.5 vs. 11.2 +/- 0.7 kcal/d; P < 0.05). Final body weight (26.8 +/- 3.6 vs. 34.9 +/- 4.8 g; P < 0.001) and fat mass (5.2 +/- 1.2 vs. 11.3 +/- 4.5 g; P < 0.001) of the KE group was significantly lower than PF, despite being matched for energy provisions. Differences in body weight and adiposity were accompanied by higher REE and total energy expenditure in the KE group compared to PF after adjustment for lean body mass and fat-mass (P = 0.001 and 0.007, respectively). Coupled or uncoupled mitochondrial respiratory rates in skeletal muscle were not different among groups, but markers of mitochondrial uncoupling and thermogenesis (uncoupling protein-1, deiodinase-2, and peroxisome proliferator-activated receptor coactivator-1) were higher in interscapular brown adipose tissue (BAT) of mice receiving the KE diet. The absence of mitochondrial uncoupling in skeletal muscle and increased markers of mitochondrial uncoupling in BAT suggest that BD-AcAc2 initiates a transcriptional signature consistent with BAT thermogenesis in the context of HFD-induced obesity.Davis, R. A. H., Deemer, S. E., Bergeron, J. M., Little, J. T., Warren, J. L., Fisher, G., Smith, D. L., Jr., Fontaine, K. R., Dickinson, S. L., Allison, D. B., Plaisance, E. P. Dietary R,S-1,3-butanediol diacetoacetate reduces body weight and adiposity in obese mice fed a high-fat diet.	[Davis, Rachel A. H.; Warren, Jonathan L.; Fisher, Gordon; Smith, Daniel L., Jr.; Plaisance, Eric P.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Davis, Rachel A. H.; Deemer, Sarah E.; Fisher, Gordon; Smith, Daniel L., Jr.; Fontaine, Kevin R.; Plaisance, Eric P.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL USA; [Bergeron, Jonathan M.; Little, Jason T.; Fisher, Gordon; Plaisance, Eric P.] Univ Alabama Birmingham, Dept Human Studies, 901 13th St South,Educ Bldg 201, Birmingham, AL 35294 USA; [Fontaine, Kevin R.; Plaisance, Eric P.] Univ Alabama Birmingham, Dept Hlth Behav, Birmingham, AL USA; [Dickinson, Stephanie L.; Allison, David B.] Indiana Univ, Sch Publ Hlth, Bloomington, IN USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Indiana University System; Indiana University Bloomington	Plaisance, EP (corresponding author), Univ Alabama Birmingham, Dept Human Studies, 901 13th St South,Educ Bldg 201, Birmingham, AL 35294 USA.	plaisep@uab.edu	Deemer, Sarah/S-1647-2019	Deemer, Sarah/0000-0002-4758-6796; Smith Jr, Daniel/0000-0002-1602-2023; Dickinson, Stephanie/0000-0002-2998-4467	Pilot and Feasibility Grant NORC, U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) from the UAB Nutrition Obesity Research Center [P30DK056336]; NIH NIDDK [P30DK079626]; NIH National Institute on Aging [P30AG050886, U24AG056053]; T32 Predoctoral Award from the UAB Pre-Doctoral Training Program in Obesity-Related Research, NIH, National Heart, Lung and Blood institute [T32HL105349]; T32 Postdoctoral Award from the UAB Pre-Doctoral Training Program in Obesity-Related Research, NIH NIDDK [T32DK062710]; UAB NORC, NIH NIDDK [P30DK056336]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD071866] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626, T32DK062710, P30DK056336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG050886, U24AG056053] Funding Source: NIH RePORTER	Pilot and Feasibility Grant NORC, U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) from the UAB Nutrition Obesity Research Center; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); T32 Predoctoral Award from the UAB Pre-Doctoral Training Program in Obesity-Related Research, NIH, National Heart, Lung and Blood institute; T32 Postdoctoral Award from the UAB Pre-Doctoral Training Program in Obesity-Related Research, NIH NIDDK; UAB NORC, NIH NIDDK; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Maria S. Johnson (University of Alabama at Birmingham, Department of Nutrition Sciences) for performing indirect calorimetry and condensing the results for analysis; Dr. Tim R. Nagy (University of Alabama at Birmingham, Department of Nutrition Sciences) for his expertise with interpretation of the indirect calorimetry results; and Michayla B. Brown (University of Alabama at Birmingham, Department of Human Studies) for development and assistance with measurement of BAT lipid content. This work was supported by Pilot and Feasibility Grant NORC, U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant P30DK056336 (to E.P.P.) from the UAB Nutrition Obesity Research Center; the NIH NIDDK Grant P30DK079626 (to the UAB Diabetes Research Center); the NIH National Institute on Aging Grants P30AG050886 and U24AG056053 (to the Nathan Shock Center Excellence in the Basic Biology of Aging); a T32 Predoctoral Award from the UAB Pre-Doctoral Training Program in Obesity-Related Research, NIH, National Heart, Lung and Blood institute Grant T32HL105349 (to R.A.H.D.); a T32 Postdoctoral Award from the UAB Pre-Doctoral Training Program in Obesity-Related Research, NIH NIDDK Grant T32DK062710 (to S.E.D.); and a Named New Investigator Award from the UAB NORC, NIH NIDDK Grant P30DK056336 (to E.P.P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases or NIH. The authors declare no conflicts of interest.	ARASE K, 1988, AM J PHYSIOL, V255, pR974, DOI 10.1152/ajpregu.1988.255.6.R974; Ari C, 2016, FRONT MOL NEUROSCI, V9, DOI [10.3389/fnmal.2016.00137, 10.3389/fnmol.2016.00137]; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Carneiro L, 2016, AM J PHYSIOL-ENDOC M, V310, pE103, DOI 10.1152/ajpendo.00282.2015; Clarke K, 2012, REGUL TOXICOL PHARM, V63, P401, DOI 10.1016/j.yrtph.2012.04.008; D'Agostino DP, 2013, AM J PHYSIOL-REG I, V304, pR829, DOI 10.1152/ajpregu.00506.2012; DAVIS JD, 1981, SCIENCE, V212, P81, DOI 10.1126/science.7193909; DESROCHERS S, 1992, BIOCHEM J, V285, P647, DOI 10.1042/bj2850647; DESROCHERS S, 1995, AM J PHYSIOL-ENDOC M, V268, pE660, DOI 10.1152/ajpendo.1995.268.4.E660; DESROCHERS S, 1995, J NUTR BIOCHEM, V6, P111, DOI 10.1016/0955-2863(94)00011-A; Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109; Hall KD, 2016, AM J CLIN NUTR, V104, P324, DOI 10.3945/ajcn.116.133561; HAWKINS RA, 1979, SCIENCE, V205, P325, DOI 10.1126/science.451608; HAYTER AJ, 1986, J AM STAT ASSOC, V81, P1000; Heymsfield SB, 2007, AM J CLIN NUTR, V85, P346, DOI 10.1093/ajcn/85.2.346; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Kashiwaya Y, 2010, J BIOL CHEM, V285, P25950, DOI 10.1074/jbc.M110.138198; Keipert S, 2017, CELL METAB, V26, P437, DOI 10.1016/j.cmet.2017.07.016; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kesl SL, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0069-y; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Laeger T, 2010, APPETITE, V54, P450, DOI 10.1016/j.appet.2010.04.005; LANGHANS W, 1985, PHYSIOL BEHAV, V34, P579, DOI 10.1016/0031-9384(85)90052-6; LANGHANS W, 1985, J AUTONOM NERV SYST, V13, P255, DOI 10.1016/0165-1838(85)90014-1; LANGHANS W, 1983, PHYSIOL BEHAV, V31, P483, DOI 10.1016/0031-9384(83)90070-7; le Roux CW, 2005, J CLIN ENDOCR METAB, V90, P4521, DOI 10.1210/jc.2004-2537; LINCOLN BC, 1987, ARCH BIOCHEM BIOPHYS, V259, P149, DOI 10.1016/0003-9861(87)90480-2; Martin-Montalvo A, 2013, ANTIOXID REDOX SIGN, V19, P310, DOI 10.1089/ars.2012.4866; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; McCurdy CE, 2005, DIABETES, V54, P1349, DOI 10.2337/diabetes.54.5.1349; Moreno B, 2014, ENDOCRINE, V47, P793, DOI 10.1007/s12020-014-0192-3; Muller TD, 2015, MOL METAB, V4, P437, DOI 10.1016/j.molmet.2015.03.005; Park S, 2011, BRAIN RES, V1401, P95, DOI 10.1016/j.brainres.2011.05.040; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Plaisance EP, 2010, AM J PHYSIOL-REG I, V299, pR740, DOI 10.1152/ajpregu.00838.2009; Poff AM, 2014, INT J CANCER, V135, P1711, DOI 10.1002/ijc.28809; Redman LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004377; Rossi R, 2000, J VET MED A, V47, P9, DOI 10.1046/j.1439-0442.2000.00255.x; Sanchez-Gurmaches J, 2018, CELL METAB, V27, P195, DOI 10.1016/j.cmet.2017.10.008; Srivastava S, 2013, IUBMB LIFE, V65, P58, DOI 10.1002/iub.1102; Srivastava S, 2012, FASEB J, V26, P2351, DOI 10.1096/fj.11-200410; Stubbs BJ, 2018, OBESITY, V26, P269, DOI 10.1002/oby.22051; Stubbs BJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00848; Sun M, 1997, PHYSIOL BEHAV, V61, P433, DOI 10.1016/S0031-9384(9X)00455-8; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; WEBBER RJ, 1977, J BIOL CHEM, V252, P5222; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006	51	24	25	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2409	2421		10.1096/fj.201800821RR	http://dx.doi.org/10.1096/fj.201800821RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303740	Green Published, Bronze			2022-12-26	WOS:000457296600070
J	Qi, H; Shi, XY; Yu, M; Liu, BY; Liu, MH; Song, S; Chen, SY; Zou, JH; Zhu, WG; Luo, JY				Qi, Hao; Shi, Xiaoyan; Yu, Miao; Liu, Boya; Liu, Minghui; Song, Shi; Chen, Shuaiyi; Zou, Junhua; Zhu, Wei-Guo; Luo, Jianyuan			Sirtuin 7-mediated deacetylation of WD repeat domain 77 (WDR77) suppresses cancer cell growth by reducing WDR77/PRMT5 transmethylase complex activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone methylation; cell proliferation; post-translational modification (PTM); colon cancer; epigenetics; H4R3me2; protein acetylation; SIRT7; transmethylase; WDR77	RNA-POLYMERASE-I; DISEASE; PRMT5; OVEREXPRESSION; TRANSCRIPTION; REPRESSION; EXPRESSION; STRESS; ROLES	The histone transmethylase complex comprising WD repeat domain 77 (WDR77) and protein arginine methyltransferase 5 (PRMT5) catalyzes dimethylation of H4R3 (H4R3me2) and drives cancer cell proliferation and migration, but its regulation is not fully understood. Here, we report that sirtuin 7 (SIRT7) directly deacetylates WDR77 and that this deacetylation interferes with the WDR77-PRMT5 interaction and suppresses proliferation of human colon cancer HCT116 cells. Using co-expression in HEK293T cells and co-immunoprecipitation assays, we observed that SIRT7 deacetylates WDR77 at Lys-3 and Lys-243, which reduced of WDR77's interaction with PRMT5. More importantly, this reduction suppressed the transmethylase activity of the WDR77/PRMT5 complex, resulting in a reduction of the H4R3me2 modification. Rescue of the WDR77-KO HCT116 cells with a WDR77-2KR (K3R and K243R) variant yielded cell migration and proliferation rates that were significantly lower than those of WDR77-KO HCT116 cells rescued with WT WDR77. In summary, SIRT7 is a major deacetylase for WDR77, and SIRT7-mediated deacetylation of WDR77 at Lys-3 and Lys-243 weakens the WDR77-PRMT5 interaction and activity and thereby suppresses growth of cancer cells.	[Qi, Hao; Yu, Miao; Liu, Boya; Liu, Minghui; Song, Shi; Chen, Shuaiyi; Zou, Junhua; Luo, Jianyuan] Peking Univ, Hlth Sci Ctr, Ctr Med Genet, Dept Med Genet, Beijing 100191, Peoples R China; [Shi, Xiaoyan] Henan Univ, Coll Pharm, Kaifeng 475001, Henan, Peoples R China; [Zhu, Wei-Guo] Shenzhen Univ, Dept Biochem & Mol Biol, Sch Med, Shenzhen 518060, Peoples R China	Peking University; Henan University; Shenzhen University	Luo, JY (corresponding author), Peking Univ, Hlth Sci Ctr, Ctr Med Genet, Dept Med Genet, Beijing 100191, Peoples R China.	luojianyuan@bjmu.edu.cn	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; Zhu, Wei-Guo/0000-0001-8385-6581	National Natural Science Foundation of China [81270427, 81471405, 81671389, 81621063]; National Research Program of China 973 Program [2013CB530801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Program of China 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 81270427, 81471405, 81671389, and 81621063 and National Research Program of China 973 Program Grant 2013CB530801 (to J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; Bao XX, 2013, J HISTOCHEM CYTOCHEM, V61, P206, DOI 10.1369/0022155413475452; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Chen H, 2017, ONCOGENE, V36, P373, DOI 10.1038/onc.2016.205; Chen SF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10734; Chen SF, 2013, MOL CELL, V52, P303, DOI 10.1016/j.molcel.2013.10.010; de Nigris F, 2002, BRIT J CANCER, V87, P1479, DOI 10.1038/sj.bjc.6600636; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Hirschey MD, 2011, CELL METAB, V14, P718, DOI 10.1016/j.cmet.2011.10.006; Ho MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057008; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Ibrahim R, 2014, HUM PATHOL, V45, P1397, DOI 10.1016/j.humpath.2014.02.013; Kiran S, 2015, CELL SIGNAL, V27, P673, DOI 10.1016/j.cellsig.2014.11.026; Lai CC, 2013, TUMOR BIOL, V34, P1847, DOI 10.1007/s13277-013-0726-y; Malik S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09841; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Nahalkova J, 2015, MOL CELL BIOCHEM, V409, P13, DOI 10.1007/s11010-015-2507-y; Osborne B, 2016, FREE RADICAL BIO MED, V100, P164, DOI 10.1016/j.freeradbiomed.2016.04.197; Ryu D, 2014, CELL METAB, V20, P856, DOI 10.1016/j.cmet.2014.08.001; Stopa N, 2015, CELL MOL LIFE SCI, V72, P2041, DOI 10.1007/s00018-015-1847-9; Tang XL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00396-9; Taylor DM, 2008, CELL MOL LIFE SCI, V65, P4000, DOI 10.1007/s00018-008-8357-y; Yu HY, 2014, CLIN CANCER RES, V20, P3434, DOI 10.1158/1078-0432.CCR-13-2952; Zhang CH, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600395	26	14	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17769	17779		10.1074/jbc.RA118.003629	http://dx.doi.org/10.1074/jbc.RA118.003629			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30282801	hybrid, Green Published			2022-12-26	WOS:000450409500009
J	Knight, AK; Dunlop, AL; Kilaru, V; Cobb, D; Corwin, EJ; Conneely, KN; Smith, AK				Knight, Anna K.; Dunlop, Anne L.; Kilaru, Varun; Cobb, Dawayland; Corwin, Elizabeth J.; Conneely, Karen N.; Smith, Alicia K.			Characterization of gene expression changes over healthy term pregnancies	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; BACTERIAL VAGINOSIS; PRETERM BIRTH; MICROARRAY; ARTHRITIS	During pregnancy, women experience numerous physiological changes but, to date, there is limited published data that characterize accompanying changes in gene expression over pregnancy. This study sought to characterize the complexity of the transcriptome over the course of pregnancy among women with healthy pregnancies. Subjects provided a venous blood sample during early (6-15 weeks) and late (22-33 weeks) pregnancy, which was used to isolate peripheral blood mononuclear cells prior to RNA extraction. Gene expression was examined for 63 women with uncomplicated, term deliveries. We evaluated the association between weeks gestation at sample collection and expression of each transcript. Of the 16,311 transcripts evaluated, 439 changed over pregnancy after a Bonferroni correction to account for multiple comparisons. Genes whose expression increased over pregnancy were associated with oxygen transport, the immune system, and host response to bacteria. Characterization of changes in the transcriptome over the course of healthy term pregnancies may enable the identification of genes whose expression predicts complications or adverse outcomes of pregnancy.	[Knight, Anna K.; Conneely, Karen N.; Smith, Alicia K.] Emory Univ, Genet & Mol Biol Program, Atlanta, GA 30322 USA; [Dunlop, Anne L.; Corwin, Elizabeth J.] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Kilaru, Varun; Cobb, Dawayland; Smith, Alicia K.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA; [Conneely, Karen N.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Smith, Alicia K.] Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University	Smith, AK (corresponding author), Emory Univ, Genet & Mol Biol Program, Atlanta, GA 30322 USA.; Smith, AK (corresponding author), Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA.; Smith, AK (corresponding author), Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA 30322 USA.	alicia.smith@emory.edu	Smith, Alicia/W-6809-2019	Smith, Alicia/0000-0002-8537-5156; Knight, Anna/0000-0002-5809-050X	National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health [R01MD009064]; National Institute of Nursing Research (NINR) of the National Institutes of Health [R01NR014800]; Office of the Director [UG3OD023318]; National Institute of General Medical Sciences [T32 GM 8490-24]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014800] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009064] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023318, UH3OD023318] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health; National Institute of Nursing Research (NINR) of the National Institutes of Health; Office of the Director(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported in part by the National Institute on Minority Health and Health Disparities (NIMHD, https://nimhd.nih.gov) of the National Institutes of Health, award number R01MD009064 to AKS and ALD, and the National Institute of Nursing Research (NINR, https://www.ninr.nih.gov) of the National Institutes of Health, under award number R01NR014800 to ALD and EJC. The study was also supported by the Office of the Director (grant UG3OD023318 to Anne L Dunlop) and the National Institute of General Medical Sciences (grant T32 GM 8490-24 to Ms. Anna K Knight). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardin T, 2003, BEST PRACT RES CL RH, V17, P201, DOI 10.1016/S1521-6942(02)00125-0; Barfield RT, 2012, BIOINFORMATICS, V28, P1280, DOI 10.1093/bioinformatics/bts124; Burke SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119526; Butcher JT, 2014, FREE RADICAL BIO MED, V73, P136, DOI 10.1016/j.freeradbiomed.2014.04.019; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Corwin EJ, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1357-x; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x; Faas MM, 2017, J REPROD IMMUNOL, V119, P91, DOI 10.1016/j.jri.2016.06.009; Gaillard R, 2014, PAEDIATR PERINAT EP, V28, P213, DOI 10.1111/ppe.12112; GELLIN BG, 1991, AM J EPIDEMIOL, V133, P392, DOI 10.1093/oxfordjournals.aje.a115893; Gilli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008962; Han L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114488; Heilmann L, 1987, Baillieres Clin Haematol, V1, P777, DOI 10.1016/S0950-3536(87)80024-0; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Jwa SC, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0516-1; Kuo PL, 1999, OBSTET GYNECOL, V94, P464, DOI 10.1016/S0029-7844(99)00281-1; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Mallone R, 2011, CLIN EXP IMMUNOL, V163, P33, DOI 10.1111/j.1365-2249.2010.04272.x; Mittal A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145204; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Moya J, 2014, J EXPO SCI ENV EPID, V24, P449, DOI 10.1038/jes.2013.92; Piccinni Marie-Pierre, 2016, Clin Mol Allergy, V14, P11, DOI 10.1186/s12948-016-0048-x; Pinheiro J, 2016, LINEAR NONLINEAR MIX; Saha D, 2014, INT J INFLAMM, V2014, DOI 10.1155/2014/803237; Silk BJ, 2013, MMWR-MORBID MORTAL W, V62, P448, DOI 10.1016/j.annemergmed.2013.08.006; Silversides CK, 2007, HEART DISEASE IN PREGNANCY, 2ND EDITION, P6, DOI 10.1002/9780470994955.ch2; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Townsley DM, 2013, SEMIN HEMATOL, V50, P222, DOI 10.1053/j.seminhematol.2013.06.004; van Nieuwenhoven ALV, 2002, FERTIL STERIL, V77, P1032, DOI 10.1016/S0015-0282(02)02976-X; Wegienka G, 2011, J REPROD IMMUNOL, V88, P58, DOI 10.1016/j.jri.2010.06.157; Weix J, 2012, ARTHRITIS RHEUM-US, V64, P2095, DOI 10.1002/art.34375; Yarbrough VL, 2015, HUM REPROD UPDATE, V21, P353, DOI 10.1093/humupd/dmu065	36	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204228	10.1371/journal.pone.0204228	http://dx.doi.org/10.1371/journal.pone.0204228			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303981	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100035
J	Li, FF; Xu, Z				Li, Feifei; Xu, Zhe			A multi-agent system for distributed multi-project scheduling with two-stage decomposition	PLOS ONE			English	Article							AGENT-BASED NEGOTIATION; GENETIC ALGORITHM; SUPPLY CHAINS; OPTIMIZATION; HEURISTICS	A two-stage decomposition approach based on a novel multi-agent system (MAS) is proposed for the distributed resource constrained multi-project scheduling problem (DRCMPSP). In stage one, from the point of view of each local project manager, a forward-backward hybrid genetic algorithm (FBHGA) is developed to generate an initial local schedule with the objective of minimizing individual project makespan. In stage two, from the global perspective of project management office, a sequential game-based negotiation mechanism is employed to eliminate global resource conflicts with the objective of minimizing total tardiness cost (TTC). The proposed approach is tested on 140 benchmark problem instances. According to the computational results, high-quality local project schedules can be obtained by FBHGA in stage one. Furthermore, it is observed that our method is capable of dealing with various complex multi-project instances under different degrees of resource conflicts in reasonable CPU running time. Compared to the existing decentralized methods for DRCMPSP, the proposed approach with sequential game-based negotiation mechanism shows the superiority in producing multi-project schedules with lower TTC, especially for large-size and strong conflicting instances.	[Li, Feifei; Xu, Zhe] Beihang Univ, Sch Econ & Management, Beijing, Peoples R China	Beihang University	Xu, Z (corresponding author), Beihang Univ, Sch Econ & Management, Beijing, Peoples R China.	zhexubuaa@163.com			National Natural Science Foundation of China [71271019, 71571005]; Outstanding Chinese and Foreign Youth Exchange Program of China Association for Science and Technology [2017CASTQNJL003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Chinese and Foreign Youth Exchange Program of China Association for Science and Technology	We gratefully acknowledge the support given by the National Natural Science Foundation of China (Grant No. 71271019, Grant No. 71571005) and the Outstanding Chinese and Foreign Youth Exchange Program of China Association for Science and Technology (Grant No. 2017CASTQNJL003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhau S, 2013, INT J PROD ECON, V146, P646, DOI 10.1016/j.ijpe.2013.08.013; Adhau S, 2012, ENG APPL ARTIF INTEL, V25, P1738, DOI 10.1016/j.engappai.2011.12.003; Arauzo JA, 2010, SIMUL MODEL PRACT TH, V18, P1428, DOI 10.1016/j.simpat.2010.04.008; Alcaraz J, 2001, ANN OPER RES, V102, P83, DOI 10.1023/A:1010949931021; Artto K, 2011, INT J PROJ MANAG, V29, P408, DOI 10.1016/j.ijproman.2011.01.008; Benbouzid-Si Tayeb F, 2018, OPER RES-GER, V18, P221, DOI 10.1007/s12351-016-0261-x; BLAZEWICZ J, 1983, DISCRETE APPL MATH, V5, P11, DOI 10.1016/0166-218X(83)90012-4; Bouleimen K, 2003, EUR J OPER RES, V149, P268, DOI 10.1016/S0377-2217(02)00761-0; Can A, 2014, ANN OPER RES, V217, P95, DOI 10.1007/s10479-014-1555-0; Cohen I, 2005, ANN OPER RES, V134, P183, DOI 10.1007/s10479-005-5730-1; Confessore G, 2007, ANN OPER RES, V150, P115, DOI 10.1007/s10479-006-0158-9; Davis E. W., 1975, AIIE Transactions, V7, P132, DOI 10.1080/05695557508974995; Deblaere F, 2011, COMPUT APPL ENG EDUC, V19, P327, DOI 10.1002/cae.20314; Demeulemeester EL, 1997, OPER RES, V45, P201, DOI 10.1287/opre.45.2.201; Duan RB, 2014, FUTURE GENER COMP SY, V30, P27, DOI 10.1016/j.future.2013.09.001; Fink A., 2004, Proceedings of the 37th Annual Hawaii International Conference on System Sciences; Goncalves JF, 2008, EUR J OPER RES, V189, P1171, DOI 10.1016/j.ejor.2006.06.074; Hartmann S, 1998, NAV RES LOG, V45, P733, DOI 10.1002/(SICI)1520-6750(199810)45:7<733::AID-NAV5>3.0.CO;2-C; Hartmann S, 2000, EUR J OPER RES, V127, P394, DOI 10.1016/S0377-2217(99)00485-3; Hartmann S, 2010, EUR J OPER RES, V207, P1, DOI 10.1016/j.ejor.2009.11.005; Homberger Jorg, 2007, International Transactions in Operational Research, V14, P565, DOI 10.1111/j.1475-3995.2007.00614.x; Homberger J, 2012, OR SPECTRUM, V34, P107, DOI 10.1007/s00291-009-0178-3; JENNINGS NR, 1995, APPL ARTIF INTELL, V9, P357, DOI 10.1080/08839519508945480; Kolisch R., 1996, Journal of Operations Management, V14, P179, DOI 10.1016/0272-6963(95)00032-1; Kolisch R, 1996, EUR J OPER RES, V90, P320, DOI [10.1016/0377-2217(95)00357-6, 10.1016/S0377-2217(96)00170-1]; Kolisch R, 2006, EUR J OPER RES, V174, P23, DOI 10.1016/j.ejor.2005.01.065; Kum-Khiong Yang, 1993, Journal of Operations Management, V11, P207, DOI 10.1016/0272-6963(93)90023-I; Lau JSK, 2005, INT J PROD RES, V43, P4899, DOI 10.1080/00207540500232240; Lau JSK, 2005, INT J PROD RES, V43, P4813, DOI 10.1080/00207540500066796; Lee YH, 2003, J INTELL MANUF, V14, P471, DOI 10.1023/A:1025753309346; Leitao P, 2009, ENG APPL ARTIF INTEL, V22, P979, DOI 10.1016/j.engappai.2008.09.005; LI KY, 1992, EUR J OPER RES, V56, P370, DOI 10.1016/0377-2217(92)90320-9; Li Zhi-Jie, 2006, Journal of Software, V17, P2373, DOI 10.1360/jos172373; Lova A, 2001, ANN OPER RES, V102, P263, DOI 10.1023/A:1010966401888; Mendes JJM, 2009, COMPUT OPER RES, V36, P92, DOI 10.1016/j.cor.2007.07.001; Merkle D, 2002, IEEE T EVOLUT COMPUT, V6, P333, DOI 10.1109/TEVC.2002.802450; Mittal M. L., 2009, International Journal of Operational Research, V4, P159, DOI 10.1504/IJOR.2009.022598; MOHANTY RP, 1989, INT J PROD RES, V27, P261, DOI 10.1080/00207548908942546; Myerson R. B., 2013, GAME THEORY ANAL CON; Payne J. H., 1995, INT J PROJ MANAG, V13, P163, DOI [DOI 10.1016/0263-7863(94)00019-9, 10.1016/0263-7863(94)00019-9]; Rostami M., 2017, OPER RES-GER, DOI [10.1007/s12351-017-0358-x, DOI 10.1007/S12351-017-0358-X]; Song W, 2016, AAMAS'16: PROCEEDINGS OF THE 2016 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS, P836; Sonmez R, 2015, J COMPUT CIVIL ENG, V29, DOI 10.1061/(ASCE)CP.1943-5487.0000382; Stranjak A., 2008, P 7 INT C AUTONOMOUS, P81; Thomas PR, 1998, J HEURISTICS, V4, P123, DOI 10.1023/A:1009673512884; Turner J. R., 2008, HDB PROJECT BASED MA; Vanhoucke M, 2001, ANN OPER RES, V102, P179, DOI 10.1023/A:1010958200070; Villafanez F, 2019, SOFT COMPUT, V23, P3465, DOI 10.1007/s00500-017-3003-y; Wang MH, 2009, ENG APPL ARTIF INTEL, V22, P1046, DOI 10.1016/j.engappai.2008.09.001; Wauters T, 2015, J SCHEDULING, V18, P61, DOI 10.1007/s10951-014-0401-1; Zheng Z, 2014, NEUROCOMPUTING, V143, P282, DOI 10.1016/j.neucom.2014.04.056; Zhou R, 2004, ENG APPL ARTIF INTEL, V17, P623, DOI 10.1016/j.engappai.2004.08.007	52	11	13	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205445	10.1371/journal.pone.0205445	http://dx.doi.org/10.1371/journal.pone.0205445			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300417	Green Submitted, gold, Green Published			2022-12-26	WOS:000446897200067
J	Batista, EPA; Ngowo, H; Opiyo, M; Shubis, GK; Meza, FC; Siria, DJ; Eiras, AE; Okumu, FO				Batista, Elis P. A.; Ngowo, Halfan; Opiyo, Mercy; Shubis, Gasper K.; Meza, Felician C.; Siria, Doreen J.; Eiras, Alvaro E.; Okumu, Fredros O.			Field evaluation of the BG-Malaria trap for monitoring malaria vectors in rural Tanzanian villages	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITOS; GAMBIAE-SENSU-STRICTO; HUMAN-LANDING CATCHES; CARBON-DIOXIDE; ANOPHELES-ARABIENSIS; DIPTERA-CULICIDAE; HUMAN ODORS; COLLECTION; IDENTIFICATION; ATTRACTANTS	BG-Malaria (BGM) trap is a simple adaptation of the widely-used BG-Sentinel trap (BGS). It is proven to be highly effective for trapping the Brazilian malaria vector, Anopheles darlingi, in field conditions, and the African vector, Anopheles arabiensis, under controlled semi-field environments, but has not been field-tested in Africa. Here, we validated the BGM for field sampling of malaria vectors in south-eastern Tanzania. Using a series of Latin-Square experiments conducted nightly (6pm-7am) in rural villages, we compared mosquito catches between BGM, BGS and human landing catches (HLC). We also compared BGMs baited with different attractants (Ifakara-blend, Mbita-blend, BG-Lure and CO2). Lastly, we tested BGMs baited with Ifakara-blend from three odour-dispensing methods (BG-Cartridge, BG-Sachet and Nylon strips). One-tenth of the field-collected female Anopheles gambiae s.l. and Anopheles funestus were dissected to assess parity. BGM captured more An. gambiae s.l. than BGS (p < 0.001), but HLC caught more than either trap (p < 0.001). However, BGM captured more An. funestus than HLC. Proportions of parous An. gambiae s.l. and An. funestus consistently exceeded 50%, with no significant difference between methods. While the dominant species caught by HLC was An. gambiae s.l. (56.0%), followed by Culex spp. (33.1%) and Mansonia spp. (6.0%), the BGM caught mostly Culex (81.6%), followed by An. gambiae s.l. (10.6%) and Mansonia (5.8%). The attractant-baited BGMs were all significantly superior to un-baited controls (p < 0.001), although no difference was found between the specific attractants. The BG-Sachet was the most efficient dispenser for capturing An. gambiae s.l. (14.5(2.75-42.50) mosquitoes/trap/night), followed by BG-Cartridge (7.5(1.75-26.25)). The BGM caught more mosquitoes than BGS in field-settings, but sampled similar species diversity and physiological states as BGS. The physiological states of malaria vectors caught in BGM and BGS were similar to those naturally attempting to bite humans (HLC). The BGM was most efficient when baited with Ifakara blend, dispensed from BG-Sachet. We conclude that though BGM traps have potential for field-sampling of host-seeking African malaria vectors with representative physiological states, both BGM and BGS predominantly caught more culicines than Anopheles, compared to HLC, which caught mostly An. gambiae s.l.	[Batista, Elis P. A.; Eiras, Alvaro E.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Ecol Quim Insetos Vetores, Belo Horizonte, MG, Brazil; [Batista, Elis P. A.; Ngowo, Halfan; Opiyo, Mercy; Shubis, Gasper K.; Meza, Felician C.; Siria, Doreen J.; Okumu, Fredros O.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Ifakara, Tanzania; [Okumu, Fredros O.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Parktown, South Africa; [Okumu, Fredros O.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	Universidade Federal de Minas Gerais; Ifakara Health Institute; University of Witwatersrand; University of Glasgow	Batista, EPA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Ecol Quim Insetos Vetores, Belo Horizonte, MG, Brazil.; Batista, EPA (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Ifakara, Tanzania.	ebatista@ihi.or.tz	Ngowo, Halfan/AFS-8039-2022; Batista, Elis P A/O-7790-2018; Eiras, Alvaro/Z-6023-2019	Ngowo, Halfan/0000-0003-2789-0261; Batista, Elis P A/0000-0002-5545-6633; Eiras, Alvaro/0000-0002-3045-0673	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88881.133584/2016-01]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Ministerio da Ciencia, Tecnologia e Inovacao (CNPq/MCTI) [310205/2014-0]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [PPM-00502-15]; Wellcome Trust Intermediate Research Fellowship [WT102350/Z/13/Z]; CNPq/MCTI [42070/2013-2]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Ministerio da Ciencia, Tecnologia e Inovacao (CNPq/MCTI); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Wellcome Trust Intermediate Research Fellowship(Wellcome Trust); CNPq/MCTI	EPAB was funded by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Grant 88881.133584/2016-01) and AEE funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Ministerio da Ciencia, Tecnologia e Inovacao (CNPq/MCTI) (Grant 310205/2014-0) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (Grant PPM-00502-15). FOO was funded by a Wellcome Trust Intermediate Research Fellowship (Grant WT102350/Z/13/Z) and a Visiting Researcher Fellowship from CNPq/MCTI (Grant 42070/2013-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the community in the villages in Ulanga and Kilombero district for their participation in the study. We thank all our Ifakara Health Institute colleagues for their support during the work. We would like to extend our sincere gratitude to Prof. George Corliss for his constructive comments and English revision of this manuscript. EPAB was funded by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Grant 88881.133584/2016-01) and AEE funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Ministerio da Ciencia, Tecnologia e Inovacao (CNPq/MCTI) (Grant 310205/2014-0) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (Grant PPM-00502-15). FOO was funded by a Wellcome Trust Intermediate Research Fellowship (Grant WT102350/Z/13/Z) and a Visiting Researcher Fellowship from CNPq/MCTI (Grant 42070/2013-2).	[Anonymous], OPEN TROP MED J; Bates D, 2014, ARXIV14065823; Batista EPA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186696; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Busula AO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0635-1; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Dekker T, 1998, MED VET ENTOMOL, V12, P136, DOI 10.1046/j.1365-2915.1998.00073.x; Gama RA, 2013, MEM I OSWALDO CRUZ, V108, P763, DOI 10.1590/0074-0276108062013013; Gama RA, 2012, REV SOC BRAS MED TRO, V45, P125, DOI 10.1590/S0037-86822012000100025; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Govella NJ, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1513-1; Govella NJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-124; Hoel DF, 2014, J MED ENTOMOL, V51, P1268, DOI 10.1603/ME14065; Kaindoa EW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177807; Kaindoa EW, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1268-8; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-19; Killeen GF, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-172; Killeen GF, 2017, BMJ GLOBAL HLTH, V2; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Lwetoijera DW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-331; Maliti DV, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1025-4; Matowo NS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145653; Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020; Mboera L., 2006, TANZAN J HLTH RES, V7, P117; Mendis C, 2000, MED VET ENTOMOL, V14, P171, DOI 10.1046/j.1365-2915.2000.00228.x; Menger DJ, 2014, MED VET ENTOMOL, V28, P407, DOI 10.1111/mve.12061; Mmbando AS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1013-8; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; Mukabana WR, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-202; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Mweresa CK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-376; Mweresa CK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-160; Obermayr U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129878; Okal MN, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0916-0; Okumu F, 2010, J MED ENTOMOL, V47, P274, DOI 10.1603/ME09114; Okumu FO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-12; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Lima JBP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005245; Lima JBP, 2014, MEM I OSWALDO CRUZ, V109, P685, DOI 10.1590/0074-0276140134; Pombi M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0674-7; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Rodrigues MS, 2014, J AM MOSQUITO CONTR, V30, P184, DOI 10.2987/14-6423R.1; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; Saitoh Y, 2004, J AM MOSQUITO CONTR, V20, P261; Salazar FV, 2012, J VECTOR ECOL, V37, P8, DOI 10.1111/j.1948-7134.2012.00195.x; Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Spitzen J, 2008, PHYSIOL ENTOMOL, V33, P116, DOI 10.1111/j.1365-3032.2008.00612.x; Team RC, 2016, R LANG ENV STAT COMP; Tirados I, 2006, MED VET ENTOMOL, V20, P425, DOI 10.1111/j.1365-2915.2006.652.x; Verhulst NO, 2015, J AM MOSQUITO CONTR, V31, P223, DOI 10.2987/moco-31-03-223-232.1; Verhulst NO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-28; WHO, 2014, GLOB BRIEF VECT BOM; WHO, 1975, MAN PRACT ENT MAL ME; World Health Organization, 2017, DEPRESSION; Zhu L, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1920-y	62	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205358	10.1371/journal.pone.0205358	http://dx.doi.org/10.1371/journal.pone.0205358			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296287	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000446632700035
J	Shin, HY; Yang, W; Lee, EJ; Han, GH; Cho, H; Chay, DB; Kim, JH				Shin, Ha-Yeon; Yang, Wookyeom; Lee, Eun-ju; Han, Gwan Hee; Cho, Hanbyoul; Chay, Doo Byung; Kim, Jae-hoon			Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression	PLOS ONE			English	Article							GROWTH-FACTOR; CANCER-CELLS; POOR-PROGNOSIS; PROTEIN-KINASE; PROLIFERATION; APOPTOSIS; ADHESION; OVEREXPRESSION; TRANSITION; RECEPTOR	Background Human ovarian surface epithelial (HOSE) cells are a critical cell source for ovarian cancer research; however, they are difficult to obtain and maintain under standard laboratory conditions in large quantities. The aim of this study was to generate immortalized HOSE (IHOSE) cells with maintained properties to the original cell source, thereby guaranteeing a sufficiently large cell quantity for ovarian cancer research. Methods HOSE cells isolated from four non-cancer patients and five IHOSE cell lines were established by induction of HPV-E6/E7 expression or SV40 large T antigen using a lenti-viral system. Each of IHOSE cells was confirmed to be distinct by STR profiling. RNA-sequencing was used to compare gene expression profiles in HOSE, IHOSE and ovarian cancer cells. Results RNA-sequencing results revealed a stronger linear correlation in gene expression between IHOSE and HOSE cells (R-2 = 0.9288) than between IHOSE or HOSE cells and ovarian cancer cells (R-2 = 0.8562 and R-2 = 0.7982, respectively). The gene expression pattern of 319 differentially expressed genes revealed minimal differences between HOSE and IHOSE cells, while a strong difference between ovarian cancer cells and HOSE or IHOSE cells was observed. Furthermore, the five IHOSE cell lines displayed morphological characteristics typical of epithelial cells but showed a lower level of EpCAM, CD133 and E-cadherin, as cancer stem marker, than ovarian cancer cells. Moreover, unlike cancer cells, IHOSE cells could not form colonies in the anchorage-independent soft agar growth assay. Conclusion These findings demonstrate that five newly established IHOSE cell lines have characteristics of progenitor HOSE cells while exhibiting continuous growth, and thus, should be highly useful as control cells for ovarian cancer research.	[Shin, Ha-Yeon; Yang, Wookyeom; Lee, Eun-ju; Han, Gwan Hee; Cho, Hanbyoul; Chay, Doo Byung; Kim, Jae-hoon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System	Kim, JH (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Seoul, South Korea.	jaehoonkim@yuhs.ac	Yang, Wookyeom/X-3939-2019	Yang, Wookyeom/0000-0002-3970-7973; Jae-Hoon, Kim/0000-0001-6599-7065; Cho, Hanbyoul/0000-0002-6177-1648; Han, Gwan Hee/0000-0001-5263-4855	Basic Science Research program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1D1A1A09000576, NRF-2017R1A2B2008505]	Basic Science Research program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	The study was supported by Basic Science Research program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2017R1D1A1A09000576, NRF-2017R1A2B2008505).	Auersperg N, 1999, P NATL ACAD SCI USA, V96, P6249, DOI 10.1073/pnas.96.11.6249; AUERSPERG N, 1994, LAB INVEST, V71, P510; Balducci L, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt452; Beaufort CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103988; Cho H, 2014, ONCOTARGET, V5, P3482, DOI 10.18632/oncotarget.1947; Cho H, 2014, GENE CHROMOSOME CANC, V53, P277, DOI 10.1002/gcc.22136; Cho H, 2013, CANCER INVEST, V31, P607, DOI 10.3109/07357907.2013.849722; Cho H, 2009, J HISTOCHEM CYTOCHEM, V57, P513, DOI 10.1369/jhc.2009.953257; Choi JH, 2004, J CLIN ENDOCR METAB, V89, P5508, DOI 10.1210/jc.2004-0044; Choi KC, 2003, BIOL REPROD, V68, P309, DOI 10.1095/biolreprod.102.006551; Choi KC, 2001, J CLIN ENDOCR METAB, V86, P2125, DOI 10.1210/jc.86.5.2125; Choi KC, 2001, ENDOCRINOLOGY, V142, P2351, DOI 10.1210/en.142.6.2351; Davies BR, 2003, EXP CELL RES, V288, P390, DOI 10.1016/S0014-4827(03)00218-0; Dixon SC, 2017, BRIT J CANCER, V116, P1223, DOI 10.1038/bjc.2017.68; Dunfield Lesley D., 2002, Biol Proced Online, V4, P55; Erickson BK, 2013, AM J OBSTET GYNECOL, V209, P409, DOI 10.1016/j.ajog.2013.04.019; Gregoire L, 2001, CLIN CANCER RES, V7, P4280; Hsu MMH, 2014, INT J MOL SCI, V15, P17963, DOI 10.3390/ijms151017963; Hu C, 2016, ONCOL REP, V35, P2027, DOI 10.3892/or.2016.4591; Hu YL, 2001, J NATL CANCER I, V93, P762, DOI 10.1093/jnci/93.10.762; Huang HZ, 2015, INT J ONCOL, V47, P1494, DOI 10.3892/ijo.2015.3133; Hurst JH, 2009, CELL MOL BIOL LETT, V14, P153, DOI 10.2478/s11658-008-0040-7; Joshi PS, 2017, TUMOUR BIOL J INT SO, V39, DOI [10.1177/1010428317724283, DOI 10.1177/1010428317724283]; Kim CW, 2017, J PHARMACOL TOX MET, V88, P130, DOI 10.1016/j.vascn.2017.08.005; Kurman RJ, 2016, AM J PATHOL, V186, P733, DOI 10.1016/j.ajpath.2015.11.011; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Li B, 2015, CANCER LETT, V356, P418, DOI 10.1016/j.canlet.2014.09.023; Li J, 2017, ORAL ONCOL, V69, P108, DOI 10.1016/j.oraloncology.2017.04.007; Li NF, 2007, CELL PROLIFERAT, V40, P780, DOI 10.1111/j.1365-2184.2007.00462.x; Li NF, 2009, ONCOGENE, V28, P773, DOI 10.1038/onc.2008.412; Li NFF, 2004, LAB INVEST, V84, P923, DOI 10.1038/labinvest.3700093; Liu W, 2007, ONCOGENE, V26, P2747, DOI 10.1038/sj.onc.1210077; Maqsood MI, 2013, CELL BIOL INT, V37, P1038, DOI 10.1002/cbin.10137; McClellan M, 1999, EXP CELL RES, V246, P471, DOI 10.1006/excr.1998.4328; Moh MC, 2009, CELL ADHES MIGR, V3, P334, DOI 10.4161/cam.3.4.9246; Moh MC, 2009, J CELL PHYSIOL, V219, P382, DOI 10.1002/jcp.21685; Nakamura Kohei, 2018, Oncotarget, V9, P12609, DOI 10.18632/oncotarget.23035; Okegawa T, 2002, J UROLOGY, V167, P1836, DOI 10.1016/S0022-5347(05)65245-7; Rattan R, 2010, ONCOGENE, V29, P1362, DOI 10.1038/onc.2009.431; Romano P, 2009, NUCLEIC ACIDS RES, V37, pD925, DOI 10.1093/nar/gkn730; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; SHERLEY JL, 1995, CELL PROLIFERAT, V28, P137, DOI 10.1111/j.1365-2184.1995.tb00062.x; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; TSAO SW, 1995, EXP CELL RES, V218, P499, DOI 10.1006/excr.1995.1184; Tsao SW, 2001, CANCER GENET CYTOGEN, V130, P141, DOI 10.1016/S0165-4608(01)00473-3; Volchenboum SL, 2009, CANCER RES, V69, P4143, DOI 10.1158/0008-5472.CAN-08-3112; Wang MY, 2010, MED ONCOL, V27, P1329, DOI 10.1007/s12032-009-9384-8; Yang W, 2016, ONCOTARGET, V7, P49481, DOI 10.18632/oncotarget.10373; ZHANG QY, 2017, FRONTIERS ENDOCRINOL, V8, DOI DOI 10.3389/FEND0.2017.00066; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	50	20	22	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205297	10.1371/journal.pone.0205297	http://dx.doi.org/10.1371/journal.pone.0205297			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296284	Green Published, gold, Green Submitted			2022-12-26	WOS:000446632700029
J	de Figueiredo, MN; Krippeit, L; Ihorst, G; Sattel, H; Bylund, CL; Joos, A; Bengel, J; Lahmann, C; Fritzsche, K; Wuensch, A				de Figueiredo, Marcelo Niglio; Krippeit, Lorena; Ihorst, Gabriele; Sattel, Heribert; Bylund, Carma L.; Joos, Andreas; Bengel, Juergen; Lahmann, Claas; Fritzsche, Kurt; Wuensch, Alexander			ComOn-Coaching: The effect of a varied number of coaching sessions on transfer into clinical practice following communication skills training in oncology: Results of a randomized controlled trial	PLOS ONE			English	Article							PATIENT COMMUNICATION; CANCER CARE; PHYSICIANS; PROGRAM; EDUCATION; EFFICACY; BAD; PARADIGM; VALIDITY; NURSES	Objective To investigate the effect of the number of coaching sessions after communication skills training on the medical communicative performance of oncologists in clinical practice. Methods/Design The training, consisting of a workshop and one (control group) vs. four (intervention group) sessions of individual coaching, was evaluated in a randomized controlled trial. Eligible participants included physicians working in any setting where patients with oncological diseases were treated. Real medical consultations were video recorded at three time points: before the workshop (t0), after the workshop (t1) and after completion of coaching (t2). The 1.5-day workshop was based on role-playing in small groups; in the coaching sessions, the videos recorded at t1 were analyzed in detail by both the trainer and the physician. The coaching sessions were manualized and based on the physician's learning goals. The primary hypothesis was that the intervention group would improve to a higher extent than the control group, as assessed by external raters using rating scales specially developed for this project. Physicians were stratified for sex and setting and randomized by an independent statistician. The group assignment was revealed for physicians and trainers at the end of the workshop, while the raters were blinded to group assignments and assessment points. Results A total of 72 physicians participated in one of 8 workshops and could be allocated to either the control or intervention group. The intervention group showed a statistically significant improvement (ES d = 0.41, p<.01) in the All items domain of the rating scales between t1 and t2 and showed a significant advantage compared with the CG (ES = .41, p = .04). The impact on diverse specified skills was heterogeneous; a larger sample is necessary for more detailed analysis. Conclusions The training achieved some observable and significant changes in the communicative behavior of oncologists in clinical practice. The four coaching sessions showed some significant advantages compared to the single coaching session. Considerable effort is necessary to achieve sustained changes in communication in clinical every-day practice. Thus, our coaching concept is a promising method for this purpose.	[de Figueiredo, Marcelo Niglio; Krippeit, Lorena; Joos, Andreas; Lahmann, Claas; Fritzsche, Kurt; Wuensch, Alexander] Univ Freiburg, Fac Med, Med Ctr, Dept Psychosomat Med & Psychotherapy, Freiburg, Germany; [de Figueiredo, Marcelo Niglio] Univ Freiburg, Fac Med, Med Ctr, Clin Dermatol & Venereol, Freiburg, Germany; [Ihorst, Gabriele] Univ Freiburg, Fac Med, Med Ctr, Clin Trials Unit, Freiburg, Germany; [Sattel, Heribert; Wuensch, Alexander] Tech Univ Munich, Klinikum Rechts Isar, Psychosomat Med & Psychotherapy, Munich, Germany; [Bylund, Carma L.] Univ Florida, Coll Med, Coll Journalism & Commun, Gainesville, FL USA; [Bengel, Juergen] Univ Freiburg, Inst Psychol Rehabil Psychol & Psychotherapy, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Technical University of Munich; State University System of Florida; University of Florida; University of Freiburg	de Figueiredo, MN (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Dept Psychosomat Med & Psychotherapy, Freiburg, Germany.; de Figueiredo, MN (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Clin Dermatol & Venereol, Freiburg, Germany.	marcelo.de.figueiredo@uniklinik-freiburg.de	Ihorst, Gabriele/AAA-7445-2021	Lahmann, Claas/0000-0003-0947-116X	German Cancer Aid (Deutsche Krebshilfe) [109980]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	This Study was funded by German Cancer Aid (Deutsche Krebshilfe, https://www.krebshilfe.de), Funding Number 109980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baile W F, 2000, Oncologist, V5, P302, DOI 10.1634/theoncologist.5-4-302; Baile WF, 1999, ONCOLOGY-NY, V13, P1021; Barth J, 2011, ANN ONCOL, V22, P1030, DOI 10.1093/annonc/mdq441; Berkhof M, 2011, PATIENT EDUC COUNS, V84, P152, DOI 10.1016/j.pec.2010.06.010; Boissy A, 2016, J GEN INTERN MED, V31, P755, DOI 10.1007/s11606-016-3597-2; Boon H, 1998, PATIENT EDUC COUNS, V35, P161, DOI 10.1016/S0738-3991(98)00063-9; Brown H, 2015, APPL MIXED MODELS ME; Brown RF, 2008, ACAD MED, V83, P37, DOI 10.1097/ACM.0b013e31815c631e; Brunett PH, 2001, ACAD MED, V76, P390, DOI 10.1097/00001888-200104000-00021; Butow P, 2008, PSYCHO-ONCOLOGY, V17, P209, DOI 10.1002/pon.1217; Butow PN, 2010, HDB COMMUNICATION ON, P707; Bylund CL, 2018, PATIENT EDUC COUNS, V101, P1924, DOI 10.1016/j.pec.2018.05.026; Bylund CL, 2017, PATIENT EDUC COUNS, V100, P1408, DOI 10.1016/j.pec.2017.02.006; Cegala DJ, 2002, MED EDUC, V36, P1004, DOI 10.1046/j.1365-2923.2002.01331.x; Comert M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152717; Curtis JR, 2001, J GEN INTERN MED, V16, P41; de Figueiredo MN, 2019, J CANCER EDUC, V34, P73, DOI 10.1007/s13187-017-1269-5; de Figueiredo MN, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1454-z; Fallowfield L, 1999, EUR J CANCER, V35, P1592, DOI 10.1016/S0959-8049(99)00212-9; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; Fallowfield L, 2004, LANCET, V363, P312, DOI 10.1016/S0140-6736(03)15392-5; Frankel R M, 2001, J Med Pract Manage, V16, P184; Fujimori M, 2014, PALLIAT SUPPORT CARE, V12, P379, DOI 10.1017/S147895151300031X; Gillis AE, 2015, POSTGRAD MED J, V91, P13, DOI 10.1136/postgradmedj-2014-132772; Giroldi E, 2016, FAM PRACT, V33, P100, DOI 10.1093/fampra/cmv094; Goelz T, 2011, J CLIN ONCOL, V29, P3402, DOI 10.1200/JCO.2010.31.6372; Goelz T, 2010, ONKOLOGIE, V33, P65, DOI 10.1159/000264626; Grossman R, 2011, INT J TRAIN DEV, V15, P103, DOI 10.1111/j.1468-2419.2011.00373.x; Gysels M, 2005, SUPPORT CARE CANCER, V13, P356, DOI 10.1007/s00520-004-0732-0; Haidet P, 2016, MED EDUC, V50, P1208, DOI 10.1111/medu.13083; Heaven C, 2006, PATIENT EDUC COUNS, V60, P313, DOI 10.1016/j.pec.2005.08.008; Kanfer F., 2012, SELBSTMANAGEMENT THE, V5; Kissane DW, 2012, J CLIN ONCOL, V30, P1242, DOI 10.1200/JCO.2011.39.6184; Kurtz SM, 1996, MED EDUC, V30, P83, DOI 10.1111/j.1365-2923.1996.tb00724.x; Langewitz W, 2012, BUNDESGESUNDHEITSBLA, V55, P1176, DOI 10.1007/s00103-012-1533-0; Langewitz W, 2010, J ADV NURS, V66, P2266, DOI 10.1111/j.1365-2648.2010.05386.x; Lienard A, 2010, BRIT J CANCER, V103, P171, DOI 10.1038/sj.bjc.6605749; Lipkin M, 2010, HDB COMMUNICATION ON, P3; Lundeby T, 2015, PATIENT EDUC COUNS, V98, P598, DOI 10.1016/j.pec.2015.01.015; Lutz G, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0823-x; Makoul G, 2001, PATIENT EDUC COUNS, V45, P1, DOI 10.1016/S0738-3991(01)00145-8; Moore P, 2009, COCHRANE DB SYST REV, V1, DOI [10.1002/14651858.CD003751.pub3, DOI 10.1002/14651858.CD003751.PUB2]; Moore PM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003751.pub3; O'Callaghan A, 2016, THESIS; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Ramani S, 2008, MED TEACH, V30, P347, DOI 10.1080/01421590802061613; Razavi D, 2003, J CLIN ONCOL, V21, P3141, DOI 10.1200/JCO.2003.08.031; Razavi D, 2002, BRIT J CANCER, V87, P1, DOI 10.1038/sj.bjc.6600412; Rider E. A., 2010, PRACTICAL GUIDE TEAC, V2nd, P1; Rosenbaum ME, 2017, PATIENT EDUC COUNS, V100, P2054, DOI 10.1016/j.pec.2017.05.035; Salmon P, 2005, PATIENT EDUC COUNS, V58, P225, DOI 10.1016/j.pec.2005.05.018; Salmon P, 2017, MED EDUC, V51, P258, DOI 10.1111/medu.13204; Salmon P, 2013, PATIENT EDUC COUNS, V90, P193, DOI 10.1016/j.pec.2012.04.010; Salmon P, 2011, MED EDUC, V45, P217, DOI 10.1111/j.1365-2923.2010.03801.x; Schirmer JM, 2005, FAM MED, V37, P184; Setyonugroho W, 2015, PATIENT EDUC COUNS, V98, P1482, DOI 10.1016/j.pec.2015.06.004; Stiefel F, 2010, ANN ONCOL, V21, P204, DOI 10.1093/annonc/mdp564; Stiefel F, 2010, HDB COMMUNICATION ON, P641; Stiefel F, 2006, COMMUNICATION CANC C; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Tulsky JA, 2011, ANN INTERN MED, V155, P593, DOI 10.7326/0003-4819-155-9-201111010-00007; van den Eertwegh V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125958; Wuensch A, 2011, EUR J CANCER CARE, V20, P570, DOI 10.1111/j.1365-2354.2010.01233.x; Wuensch A, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3238-0; Zill JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112637	65	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205315	10.1371/journal.pone.0205315	http://dx.doi.org/10.1371/journal.pone.0205315			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289905	gold, Green Published, Green Submitted			2022-12-26	WOS:000446545500066
J	Willingham-Lane, JM; Coulson, GB; Hondalus, MK				Willingham-Lane, Jennifer M.; Coulson, Garry B.; Hondalus, Mary K.			Identification of a VapA virulence factor functional homolog in Rhodococcus equi isolates housing the pVAPB plasmid	PLOS ONE			English	Article							17-KILODALTON ANTIGENS; INTRACELLULAR SURVIVAL; PATHOGENICITY ISLAND; CORYNEBACTERIUM-EQUI; LYMPH-NODES; PROTEIN-A; MACROPHAGES; INFECTION; PIGS; 15-KILODALTON	Rhodococcus equi is a facultative intracellular bacterium of macrophages and is an important pathogen of animals and immunocompromised people wherein disease results in abcessation of the lungs and other sites. Prior work has shown that the presence of the major virulence determinant, VapA, encoded on the pVAPA-type plasmid, disrupts normal phagosome development and is essential for bacterial replication within macrophages. pVAPA- type plasmids are typical of R. equi strains derived from foals while strains from pigs carry plasmids of the pVAPB-type, lacking vapA, and those from humans harbor various types of plasmids including pVAPA and pVAPB. Through the creation and analysis of a series of gene deletion mutants, we found that vapK1 or vapK2 is required for optimal intracellular replication of an R. equi isolate carrying a pVAPB plasmid type. Complementation analysis of a Delta vapA R. equi strain with vapK1 or vapK2 showed the VapK proteins of the pVAPB-type plasmid could restore replication capacity to the macrophage growth-attenuated Delta vapA strain. Additionally, in contrast to the intracellular growth capabilities displayed by an equine R. equi transconjugent strain carrying a pVAPB-type plasmid, a transconjugant strain carrying a pVAPB-type plasmid deleted of vapK1 and vapK2 proved incapable of replication in equine macrophages. Cumulatively, these data indicate that VapK1 and K2 are functionally equivalent to VapA.	[Willingham-Lane, Jennifer M.; Coulson, Garry B.; Hondalus, Mary K.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Hondalus, MK (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	hondalus@uga.edu						Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; BARTON MD, 1984, VET MICROBIOL, V9, P65, DOI 10.1016/0378-1135(84)90079-8; Coulson GB, 2015, INFECT IMMUN, V83, P3137, DOI 10.1128/IAI.00230-15; Coulson GB, 2010, INFECT IMMUN, V78, P3323, DOI 10.1128/IAI.00081-10; Fernandez-Mora E, 2005, TRAFFIC, V6, P635, DOI 10.1111/j.1600-0854.2005.00304.x; Flynn O, 2001, VET MICROBIOL, V78, P221, DOI 10.1016/S0378-1135(00)00297-2; Geerds C, 2014, ACTA CRYSTALLOGR F, V70, P866, DOI 10.1107/S2053230X14009911; Giguere S, 1999, INFECT IMMUN, V67, P3548; GOLUB B, 1967, ANN INTERN MED, V66, P1174, DOI 10.7326/0003-4819-66-6-1174; HONDALUS MK, 1994, INFECT IMMUN, V62, P4167, DOI 10.1128/IAI.62.10.4167-4175.1994; Jain S, 2003, MOL MICROBIOL, V50, P115, DOI 10.1046/j.1365-2958.2003.03689.x; JOHNSON JA, 1983, VET PATHOL, V20, P440, DOI 10.1177/030098588302000407; Letek M, 2008, J BACTERIOL, V190, P5797, DOI 10.1128/JB.00468-08; Luhrmann A, 2004, INFECT IMMUN, V72, P853, DOI 10.1128/IAI.72.2.853-862.2004; Madarame H, 1998, FEMS IMMUNOL MED MIC, V22, P329, DOI 10.1111/j.1574-695X.1998.tb01222.x; Okoko T, 2015, VET MICROBIOL, V179, P42, DOI 10.1016/j.vetmic.2015.01.027; PRESCOTT JF, 1991, CLIN MICROBIOL REV, V4, P20, DOI 10.1128/CMR.4.1.20-34.1991; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; TAKAI S, 1992, INFECT IMMUN, V60, P2995, DOI 10.1128/IAI.60.7.2995-2997.1992; Takai S, 1996, J CLIN MICROBIOL, V34, P1034, DOI 10.1128/JCM.34.4.1034-1037.1996; TAKAI S, 1991, J CLIN MICROBIOL, V29, P439, DOI 10.1128/JCM.29.3.439-443.1991; TAKAI S, 1993, J CLIN MICROBIOL, V31, P1726, DOI 10.1128/JCM.31.7.1726-1729.1993; TAKAI S, 1986, JPN J VET SCI, V48, P445; Takai S, 2000, INFECT IMMUN, V68, P6840, DOI 10.1128/IAI.68.12.6840-6847.2000; TAKAI S, 1995, FEMS IMMUNOL MED MIC, V11, P181, DOI 10.1111/j.1574-695X.1995.tb00115.x; TKACHUKSAAD O, 1991, J CLIN MICROBIOL, V29, P2696, DOI 10.1128/JCM.29.12.2696-2700.1991; Toyooka K, 2005, J MED MICROBIOL, V54, P1007, DOI 10.1099/jmm.0.46086-0; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Tripathi VN, 2012, J BACTERIOL, V194, P6790, DOI 10.1128/JB.01210-12; Valero-Rello A, 2015, INFECT IMMUN, V83, P2725, DOI 10.1128/IAI.00376-15; van der Geize R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn811; von Bargen K, 2009, INFECT IMMUN, V77, P5676, DOI 10.1128/IAI.00856-09; Whittingham JL, 2014, ACTA CRYSTALLOGR D, V70, P2139, DOI 10.1107/S1399004714012632; Willingham-Lane JM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00186-16; Wright LM, 2018, MOL MICROBIOL, V107, P428, DOI 10.1111/mmi.13892; YAGER JA, 1987, VET MICROBIOL, V14, P225, DOI 10.1016/0378-1135(87)90109-X	36	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204475	10.1371/journal.pone.0204475	http://dx.doi.org/10.1371/journal.pone.0204475			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286098	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500022
J	Herz, K; Dietz, S; Gorzolka, K; Haider, S; Jandt, U; Scheel, D; Bruelheide, H				Herz, Katharina; Dietz, Sophie; Gorzolka, Karin; Haider, Sylvia; Jandt, Ute; Scheel, Dierk; Bruelheide, Helge			Linking root exudates to functional plant traits	PLOS ONE			English	Article							LEAF-AREA; RHIZOSPHERE; COMMUNICATION; METABOLOMICS; ARABIDOPSIS; DIVERSITY; GRASS	Primary and secondary metabolites exuded by plant roots have mainly been studied under laboratory conditions, while knowledge of root exudate patterns of plants growing in natural communities is very limited. Focusing on ten common European grassland plant species, we asked to which degree exuded metabolite compositions are specific to species or growth forms (forbs and grasses), depend on environments and local neighbourhoods, and reflect traditional plant functional traits. Root exudates were collected under field conditions and analysed using a non-targeted gas chromatography coupled mass spectrometry (GC-MS) approach. In total, we annotated 153 compounds of which 36 were identified by structure and name as metabolites mainly derived from the primary metabolism. Here we show by using variance partitioning, that the composition of exuded polar metabolites was mostly explained by plot identity, followed by plant species identity while plant species composition of the local neighbourhood played no role. Total and root dry biomass explained the largest proportion of variance in exudate composition, with additional variance explained by traditional plant traits. Although the exudate composition was quite similar between the two growth forms, we found some metabolites that occurred only in one of the two growth forms. Our study demonstrated the feasibility of measuring polar exudates under non-sterile field conditions by mass spectrometry, which opens new avenues of research for functional plant ecology.	[Herz, Katharina; Haider, Sylvia; Jandt, Ute; Bruelheide, Helge] Martin Luther Univ Halle Wittenberg, Inst Biol Geobot, Halle, Germany; [Herz, Katharina; Haider, Sylvia; Jandt, Ute; Bruelheide, Helge] Martin Luther Univ Halle Wittenberg, Bot Garden, Halle, Germany; [Dietz, Sophie; Gorzolka, Karin; Scheel, Dierk] Leibniz Inst Plant Biochem, Halle, Germany; [Haider, Sylvia; Jandt, Ute; Scheel, Dierk; Bruelheide, Helge] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzenbiochemie	Herz, K (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Biol Geobot, Halle, Germany.; Herz, K (corresponding author), Martin Luther Univ Halle Wittenberg, Bot Garden, Halle, Germany.	katharina.herz@gmx.net	Haider, Sylvia/M-2990-2014; Bruelheide, Helge/G-3907-2013; Jandt, Ute/S-7886-2016	Haider, Sylvia/0000-0002-2966-0534; Bruelheide, Helge/0000-0003-3135-0356; Jandt, Ute/0000-0002-3177-3669; Scheel, Dierk/0000-0002-2105-6711	DFG Priority Program 1374	DFG Priority Program 1374	The work has been funded by the DFG Priority Program 1374 (http://gepris.dfg.de/gepris/projekt/60761519) "Infrastructure-BiodiversityExploratories" (Project BE LOW, BR 1698/11-3 by HB and SCHE 235/16-3 by DS; http://gepris.dfg.de/gepris/projekt/61580740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger B, 2012, MOL PLANT MICROBE IN, V25, P993, DOI 10.1094/MPMI-01-12-0006-R; Aulakh MS, 2001, PLANT BIOLOGY, V3, P139, DOI 10.1055/s-2001-12905; Badri DV, 2013, J BIOL CHEM, V288, P4502, DOI 10.1074/jbc.M112.433300; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Biedrzycki Meredith L, 2010, Commun Integr Biol, V3, P28; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Bouwmeester HJ, 2007, TRENDS PLANT SCI, V12, P224, DOI 10.1016/j.tplants.2007.03.009; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; De-La-Pena C, 2008, J BIOL CHEM, V283, P25247, DOI 10.1074/jbc.M801967200; De-la-Pena C, 2010, J BIOL CHEM, V285, P30654, DOI 10.1074/jbc.M110.119040; Eisenhauer N, 2017, SCI REP-UK, V7, DOI 10.1038/srep44641; Faure D, 2009, PLANT SOIL, V321, P279, DOI 10.1007/s11104-008-9839-2; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Freschet GT, 2015, NEW PHYTOL, V206, P1247, DOI 10.1111/nph.13352; Gorzolka K, 2012, J BIOTECHNOL, V159, P177, DOI 10.1016/j.jbiotec.2012.03.012; Gubsch M, 2011, ANN BOT-LONDON, V107, P157, DOI 10.1093/aob/mcq220; Herz K, 2017, J VEG SCI, V28, P705, DOI 10.1111/jvs.12534; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Kuijken RCP, 2015, J EXP BOT, V66, P5389, DOI 10.1093/jxb/erv239; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3; Mir-Marques A, 2016, FOOD CHEM, V196, P1023, DOI 10.1016/j.foodchem.2015.10.048; Moles AT, 2014, J VEG SCI, V25, P1167, DOI 10.1111/jvs.12190; Neuweger H, 2008, BIOINFORMATICS, V24, P2726, DOI 10.1093/bioinformatics/btn452; Oburger E, 2018, RHIZOSPHERE-NETH, V6, P116, DOI 10.1016/j.rhisph.2018.06.004; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; R Core Team, 2021, R LANGUAGE ENV STAT; Ravenek JM, 2014, OIKOS, V123, P1528, DOI 10.1111/oik.01502; Siebenkas A, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv029; Strehmel N, 2014, PHYTOCHEMISTRY, V108, P35, DOI 10.1016/j.phytochem.2014.10.003; Valentinuzzi F, 2015, BIOL FERT SOILS, V51, P757, DOI 10.1007/s00374-015-1015-2; van Dam NM, 2016, TRENDS PLANT SCI, V21, P256, DOI 10.1016/j.tplants.2016.01.008; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x	37	42	43	17	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204128	10.1371/journal.pone.0204128	http://dx.doi.org/10.1371/journal.pone.0204128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281675	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400041
J	Lim, SW; Shin, YJ; Luo, K; Quan, Y; Ko, EJ; Chung, BH; Yang, CW				Lim, Sun Woo; Shin, Yoo Jin; Luo, Kang; Quan, Yi; Ko, Eun Jeong; Chung, Byung Ha; Yang, Chul Woo			Effect of Klotho on autophagy clearance in tacrolimus-induced renal injury	FASEB JOURNAL			English	Article						kidney; nephrotoxicity; lysosome; TFEB; bafilomycin A1	CANCER CELLS; INHIBITION; NEPHROTOXICITY; RESISTANCE	Recently, we showed that tacrolimus-induced renal injury was closely associated with impairment of autophagy clearance, and Klotho deficiency aggravated tacrolimus-induced renal injury. In this study, we evaluated the effect of Klotho treatment on autophagy clearance in tacrolimus-induced renal injury. We evaluated the effect of Klotho on tacrolimus-induced renal injury in an experimental mouse model and in vitro by treatment with tacrolimus and/or recombinant mouse Klotho. In vivo and in vitro studies showed that tacrolimus treatment impaired lysosomal acidification and decreased cathepsin B activity, expression of lysosome-associated membrane protein 2, and expression of transcription factor EB (TFEB), a master regulator for lysosomal biogenesis. These results were improved by Klotho treatment. Moreover, addition of bafilomycin A1, an inhibitor of lysosomal function, abolished the protective effect of Klotho, indicating that the protective effect of Klotho was closely associated with lysosome function. Klotho induced nuclear translocation of TFEB through inhibition of phosphorylation of glycogen synthase kinase 3 (GSK3) by confirming using CHIR99021, a GSK3 inhibitor. Collectively, our data suggest that Klotho improves autophagy clearance via activation of lysosomal function in tacrolimus-induced nephrotoxicity.Lim, S. W., Shin, Y. J., Luo, K., Quan, Y., Ko, E. J., Chung, B. H., Yang, C. W. Effect of Klotho on autophagy clearance in tacrolimus-induced renal injury.	[Lim, Sun Woo; Shin, Yoo Jin; Luo, Kang; Quan, Yi; Ko, Eun Jeong; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Lim, Sun Woo; Shin, Yoo Jin; Luo, Kang; Quan, Yi; Ko, Eun Jeong; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Transplant Res Ctr, Seoul, South Korea; [Ko, Eun Jeong; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Nephrol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Yang, CW (corresponding author), Catholic Univ Korea, Sch Med, Seoul St Marys Hosp, Dept Internal Med,Div Nephrol, 222 Banpo Daero, Seoul 06591, South Korea.	yangch@catholic.ac.kr		Ko, Eun Jeong/0000-0002-5604-1296	Korean Health Technology Research and Development Project, Ministry for Health and Welfare [HI14C3417, HI16C1641]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, Information and Computer Technology (ICT) and Future Planning [NRF-2015R1A1A3A04000946, NRF-2018R1D1A1A02043014]	Korean Health Technology Research and Development Project, Ministry for Health and Welfare; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, Information and Computer Technology (ICT) and Future Planning	This work was supported by the Korean Health Technology Research and Development Project, Ministry for Health and Welfare (Grants HI14C3417 and HI16C1641), and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, Information and Computer Technology (ICT) and Future Planning (Grants NRF-2015R1A1A3A04000946 and NRF-2018R1D1A1A02043014). The authors declare no conflicts of interest.	Behera R, 2017, CLIN CANCER RES, V23, P3181, DOI 10.1158/1078-0432.CCR-17-0201; Chen J, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00499; Chen TJ, 2016, DNA CELL BIOL, V35, P751, DOI 10.1089/dna.2016.3437; Cosner D, 2015, J TRANSPLANT, V2015, DOI 10.1155/2015/142521; Guan X, 2014, J PATHOL, V234, P560, DOI 10.1002/path.4420; Han DH, 2010, TRANSPLANTATION, V90, P135, DOI 10.1097/TP.0b013e3181e117b4; Huang CL, 2011, PFLUG ARCH EUR J PHY, V462, P185, DOI 10.1007/s00424-011-0950-5; Isaka Y, 2011, AUTOPHAGY, V7, P1085, DOI 10.4161/auto.7.9.16465; Issa N, 2013, AM J NEPHROL, V37, P602, DOI 10.1159/000351648; Jin J, 2016, AM J NEPHROL, V43, P357, DOI 10.1159/000446447; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuang X, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00353; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Leon J, 2017, CELL REP, V20, P1360, DOI 10.1016/j.celrep.2017.07.024; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li LL, 2017, LUNG, V195, P295, DOI 10.1007/s00408-017-9997-1; Lim SW, 2017, LAB INVEST, V97, P1271, DOI 10.1038/labinvest.2017.75; Lim SW, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.365; Lim SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep29921; Madathil SV, 2014, AM J PATHOL, V184, P827, DOI 10.1016/j.ajpath.2013.11.016; Marchand B, 2015, J BIOL CHEM, V290, P5592, DOI 10.1074/jbc.M114.616714; Marchand B, 2012, CARCINOGENESIS, V33, P529, DOI 10.1093/carcin/bgr309; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Qian YY, 2018, CELL PHYSIOL BIOCHEM, V45, P2268, DOI 10.1159/000488172; Sardiello M, 2009, CELL CYCLE, V8, P4021, DOI 10.4161/cc.8.24.10263; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Song S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082968	33	22	24	4	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2694	2706		10.1096/fj.201800751R	http://dx.doi.org/10.1096/fj.201800751R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307767				2022-12-26	WOS:000457296600093
J	Ryu, I; Park, Y; Seo, JW; Park, OH; Ha, H; Nam, JW; Kim, YK				Ryu, Incheol; Park, Yeonkyoung; Seo, Jwa-Won; Park, Ok Hyun; Ha, Hongseok; Nam, Jin-Wu; Kim, Yoon Ki			HuR stabilizes a polyadenylated form of replication-dependent histone mRNAs under stress conditions	FASEB JOURNAL			English	Article						mRNA stability; 3UTR; polyadenylation signal; UVC	LOOP-BINDING-PROTEIN; ALTERNATIVE POLYADENYLATION; STEM-LOOP; RAPID DEGRADATION; EXPRESSION; GENE; CLEAVAGE; MECHANISM; COMPLEX; INTERACTS	All metazoan mRNAs have a poly(A) tail at the 3 end with the exception of replication-dependent histone (RDH) mRNAs, which end in a highly conserved stem-loop (SL) structure. However, a subset of RDH mRNAs are reported to be polyadenylated under physiologic conditions. The molecular details of the biogenesis of polyadenylated RDH [poly(A)(+) RDH] mRNAs remain unknown. In this study, our genome-wide analyses reveal that puromycin treatment or UVC irradiation stabilizes poly(A)(+) RDH mRNAs, relative to canonical RDH mRNAs, which end in an SL structure. We demonstrate that the stabilization of poly(A)(+) RDH mRNAs occurs in a translation-independent manner and is regulated via human antigen R (HuR) binding to the extended 3 UTR under stress conditions. Our data suggest that HuR regulates the expression of poly(A)(+) RDH mRNAs.Ryu, I., Park, Y., Seo, J.-W., Park, O. H., Ha, H., Nam, J.-W., Kim, Y. K. HuR stabilizes a polyadenylated form of replication-dependent histone mRNAs under stress conditions.	[Ryu, Incheol; Park, Yeonkyoung; Park, Ok Hyun; Ha, Hongseok; Kim, Yoon Ki] Korea Univ, Creat Res Initiat Ctr Mol Biol Translat, Seoul, South Korea; [Ryu, Incheol; Park, Yeonkyoung; Park, Ok Hyun; Ha, Hongseok; Kim, Yoon Ki] Korea Univ, Div Life Sci, Anam Ro 145, Seoul 02841, South Korea; [Seo, Jwa-Won; Nam, Jin-Wu] Hanyang Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea; [Nam, Jin-Wu] Hanyang Univ, Res Inst Nat Sci, Seoul, South Korea	Korea University; Korea University; Hanyang University; Hanyang University	Kim, YK (corresponding author), Korea Univ, Div Life Sci, Anam Ro 145, Seoul 02841, South Korea.	yk-kim@korea.ac.kr	Nam, Jin-Wu/F-7370-2017	Kim, Yoon Ki/0000-0003-1303-072X; Ha, Hongseok/0000-0002-0923-9187	National Research Foundation (NRF) of Korea - Korean government (MSIP) [NRF-2015R1A3A2033665, NRF-2018R1A5A1024261, 2013R1A1A2063273, 2016R1D1A1B3933894]; Korea University	National Research Foundation (NRF) of Korea - Korean government (MSIP); Korea University	The authors thank Dr. Berndt Muller (University of Aberdeen, Aberdeen, United Kingdom) for providing the antibody against human SLBP, Dr. Lynne E. Maquat (University of Rochester, Rochester, NY, USA) for the antibody against human UPF1, and Dr. You-Sub Won (Korea University) for scientific comments. This work was supported by the National Research Foundation (NRF) of Korea funded by the Korean government (MSIP) (Grants NRF-2015R1A3A2033665 and NRF-2018R1A5A1024261 to Y.K.K.; and, in part, 2013R1A1A2063273 and 2016R1D1A1B3933894 to I.R.), and by a Korea University grant (to Y.K.K.). The authors declare no conflicts of interest.	BAUMBACH LL, 1984, BIOCHEMISTRY-US, V23, P1618, DOI 10.1021/bi00303a006; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; Brocato J, 2015, BIOL TRACE ELEM RES, V166, P72, DOI 10.1007/s12011-015-0296-5; Brocato J, 2014, J BIOL CHEM, V289, P31751, DOI 10.1074/jbc.M114.591883; Celik A, 2017, CURR GENET, V63, P1007, DOI 10.1007/s00294-017-0709-4; Cho H, 2015, P NATL ACAD SCI USA, V112, pE1540, DOI 10.1073/pnas.1409612112; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Choe J, 2014, P NATL ACAD SCI USA, V111, pE4577, DOI 10.1073/pnas.1409695111; Choe J, 2014, NUCLEIC ACIDS RES, V42, P9334, DOI 10.1093/nar/gku610; Choe J, 2013, NUCLEIC ACIDS RES, V41, P1307, DOI 10.1093/nar/gks1196; COLLART D, 1991, BIOCHEMISTRY-US, V30, P1610, DOI 10.1021/bi00220a024; Danckwardt S, 2011, MOL CELL, V41, P298, DOI 10.1016/j.molcel.2010.12.032; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Gabler C, 2004, ANN RHEUM DIS, V63, P1135, DOI 10.1136/ard.2003.011452; Gorospe M, 1998, MOL CELL BIOL, V18, P1400, DOI 10.1128/MCB.18.3.1400; Graber JH, 2013, GENOME RES, V23, P1690, DOI 10.1101/gr.144964.112; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gruber JJ, 2012, MOL CELL, V45, P87, DOI 10.1016/j.molcel.2011.12.020; Gupta P, 2018, MOL BIOL REP, V45, P39, DOI 10.1007/s11033-017-4139-7; Hoefig KP, 2014, WIRES RNA, V5, P577, DOI 10.1002/wrna.1232; Hollerer I, 2016, RNA, V22, P1441, DOI 10.1261/rna.055657.115; Hrossova D, 2015, NUCLEIC ACIDS RES, V43, P4236, DOI 10.1093/nar/gkv240; Jaeger S, 2005, BIOCHIMIE, V87, P827, DOI 10.1016/j.biochi.2005.03.012; Kari V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063745; Karousis ED, 2016, WIRES RNA, V7, P661, DOI 10.1002/wrna.1357; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kim HH, 2008, CELL CYCLE, V7, P3371; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kim KM, 2009, GENE DEV, V23, P2033, DOI 10.1101/gad.1823409; Kim M, 2015, METHODS, V83, P111, DOI 10.1016/j.ymeth.2015.04.011; KIRSH AL, 1989, GENE DEV, V3, P2172, DOI 10.1101/gad.3.12b.2172; Kraynik SM, 2015, BBA-GENE REGUL MECH, V1849, P688, DOI 10.1016/j.bbagrm.2015.02.004; Liu YT, 2013, SCI REP-UK, V3, DOI 10.1038/srep02054; Lubas M, 2015, CELL REP, V10, P178, DOI 10.1016/j.celrep.2014.12.026; Lyons SM, 2016, NUCLEIC ACIDS RES, V44, P9190, DOI 10.1093/nar/gkw620; Marzluff WF, 2017, TRENDS GENET, V33, P745, DOI 10.1016/j.tig.2017.07.014; Mayr C, 2017, ANNU REV GENET, V51, P171, DOI 10.1146/annurev-genet-120116-024704; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Nam JW, 2014, MOL CELL, V53, P1031, DOI 10.1016/j.molcel.2014.02.013; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Neve J, 2017, RNA BIOL, V14, P865, DOI 10.1080/15476286.2017.1306171; Park J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15730; Park OH, 2016, GENE DEV, V30, P2093, DOI 10.1101/gad.286484.116; Pirngruber J, 2010, ONCOGENE, V29, P2853, DOI 10.1038/onc.2010.42; Romeo V, 2016, CURR OPIN CELL BIOL, V40, P23, DOI 10.1016/j.ceb.2016.01.015; Romeo V, 2014, MOL CELL BIOL, V34, P4272, DOI 10.1128/MCB.00791-14; Saldi T, 2018, GENE DEV, V32, P297, DOI 10.1101/gad.310896.117; Sullivan KD, 2009, RNA, V15, P459, DOI 10.1261/rna.1205409; Tan DZ, 2013, SCIENCE, V339, P318, DOI 10.1126/science.1228705; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner RE, 2018, SEMIN CELL DEV BIOL, V75, P61, DOI 10.1016/j.semcdb.2017.08.056; von Roretz C, 2013, CELL DEATH DIFFER, V20, P154, DOI 10.1038/cdd.2012.111; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Yang XC, 2009, MOL CELL, V36, P267, DOI 10.1016/j.molcel.2009.08.016; Yu LJ, 2013, NUCLEIC ACIDS RES, V41, P3104, DOI 10.1093/nar/gkt020; Zhao JY, 2004, CELL CYCLE, V3, P695	57	3	3	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2680	2693		10.1096/fj.201800431R	http://dx.doi.org/10.1096/fj.201800431R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303743				2022-12-26	WOS:000457296600092
J	Chen, Y; Gao, J; Xie, J; Liang, J; Zheng, GL; Xie, LP; Zhang, RQ				Chen, Yan; Gao, Jing; Xie, Jun; Liang, Jian; Zheng, Guilan; Xie, Liping; Zhang, Rongqing			Transcriptional regulation of the matrix protein Shematrin-2 during shell formation in pearl oyster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomineralization; extracellular matrix protein; biomaterials; calcium; crystal structure; Pf-C; EBP-A; Pf-C; EBP-B; shell formation; Shematrin-2; transcriptional regulation	CCAAT/ENHANCER-BINDING PROTEINS; MOUSE AMELOGENIN GENE; PINCTADA-FUCATA; PRISMATIC LAYER; C/EBP-BETA; EXTRAPALLIAL FLUID; CALCIUM-CARBONATE; KEY MACROMOLECULE; NACRE FORMATION; GLOBIN GENE	The molluscan shell is a fascinating biomineral consisting of a highly organized calcium carbonate composite. Biomineralization is elaborately controlled and involves several macromolecules, especially matrix proteins, but little is known about the regulatory mechanisms. The matrix protein Shematrin-2, expression of which peaks in the mantle tissues and in the shell components of the pearl oyster Pinctada fucata, has been suggested to be a key participant in biomineralization. Here, we expressed and purified Shematrin-2 from P. fucata and explored its function and transcriptional regulation. An in vitro functional assay revealed that Shematrin-2 binds the calcite, aragonite, and chitin components of the shell, decreases the rate of calcium carbonate deposition, and changes the morphology of the deposited crystal in the calcite crystallization system. Furthermore, we cloned the Shematrin-2 gene promoter, and analysis of its sequence revealed putative binding sites for the transcription factors CCAAT enhancer-binding proteins (Pf-C/EBPs) and nuclear factor-Y (NF-Y). Using transient co-transfection and reporter gene assays, we found that cloned and recombinantly expressed Pf-C/EBP-A and Pf-C/EBP-B greatly and dose-dependently up-regulate the promoter activity of the Shematrin-2 gene. Importantly, Pf-C/EBP-A and Pf-C/EBP-B knockdowns decreased Shematrin-2 gene expression and induced changes in the inner-surface structures in prismatic layers that were similar to those of antibody-based Shematrin-2 inhibition. Altogether, our data reveal that the transcription factors Pf-C/EBP-A and Pf-C/EBP-B up-regulate the expression of the matrix protein Shematrin-2 during shell formation in P. fucata, improving our understanding of the transcriptional regulation of molluscan shell development at the molecular level.	[Chen, Yan; Gao, Jing; Xie, Jun; Liang, Jian; Zheng, Guilan; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China; [Zhang, Rongqing] Tsinghua Univ, Dept Biotechnol & Biomed, Yangtze Delta Reg Inst, Jiaxing 314006, Zhejiang, Peoples R China	Tsinghua University; Tsinghua University	Xie, LP; Zhang, RQ (corresponding author), Tsinghua Univ, Sch Life Sci, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China.; Zhang, RQ (corresponding author), Tsinghua Univ, Dept Biotechnol & Biomed, Yangtze Delta Reg Inst, Jiaxing 314006, Zhejiang, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Natural Science Foundation of China [31572594]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grant 31572594. The authors declare that they have no conflicts of interest with the contents of this article.	Aleksic M, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-2; Arias JL, 2008, CHEM REV, V108, P4475, DOI 10.1021/cr078269p; BARBERIS A, 1987, CELL, V50, P347, DOI 10.1016/0092-8674(87)90489-2; Centrella M, 2004, GENE, V342, P13, DOI 10.1016/j.gene.2004.06.036; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Flausse A, 2013, J BIOMED MATER RES A, V101, P3211, DOI 10.1002/jbm.a.34629; FRITZ M, 1994, NATURE, V371, P49, DOI 10.1038/371049a0; Gao J, 2016, FEBS J, V283, P1962, DOI 10.1111/febs.13716; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Hsu YC, 2010, J BIOL CHEM, V285, P13885, DOI 10.1074/jbc.M109.081463; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Inoue H, 2004, BIOCHEM BIOPH RES CO, V318, P649, DOI 10.1016/j.bbrc.2004.04.075; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Launspach M, 2014, ACTA BIOMATER, V10, P3986, DOI 10.1016/j.actbio.2014.02.050; Li H, 2007, CELL MOL IMMUNOL, V4, P407; Liang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131868; Lin Y, 2014, ACTA BIOCH BIOPH SIN, V46, P709, DOI 10.1093/abbs/gmu054; Liu J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1524-2; Liu Y, 2009, FUTURE MICROBIOL, V4, P299, DOI 10.2217/FMB.09.4; Lowenstam H. A., 1989, ON BLOMINERALIZATION; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; MISCHOULON D, 1992, MOL CELL BIOL, V12, P2553, DOI 10.1128/MCB.12.6.2553; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyashita T, 2000, MAR BIOTECHNOL, V2, P409; Miyazaki Y, 2010, COMP BIOCHEM PHYS B, V155, P241, DOI 10.1016/j.cbpb.2009.11.009; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Nerlov C, 2008, CURR OPIN CELL BIOL, V20, P180, DOI 10.1016/j.ceb.2008.02.002; Nikitin V P, 2004, Ross Fiziol Zh Im I M Sechenova, V90, P455; Osada S, 1996, FEBS LETT, V390, P44, DOI 10.1016/0014-5793(96)00622-9; Osada S, 1996, J BIOL CHEM, V271, P3891; Pan C, 2014, J BIOL CHEM, V289, P2776, DOI 10.1074/jbc.M113.504027; Pulido-Salgado M, 2015, PROG NEUROBIOL, V132, P1, DOI 10.1016/j.pneurobio.2015.06.003; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Sun J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131711; SUPERTIFURGA G, 1988, EMBO J, V7, P3099, DOI 10.1002/j.1460-2075.1988.tb03176.x; Suzuki M, 2007, FEBS J, V274, P5158, DOI 10.1111/j.1742-4658.2007.06036.x; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takeuchi T, 2008, FEBS LETT, V582, P591, DOI 10.1016/j.febslet.2008.01.026; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Wen CL, 2012, PHYTOMEDICINE, V19, P424, DOI 10.1016/j.phymed.2011.11.003; Xie J, 2016, CRYST GROWTH DES, V16, P672, DOI 10.1021/acs.cgd.5b01203; Xu GF, 2001, J AM CHEM SOC, V123, P2196, DOI 10.1021/ja002537i; Xu Y, 2006, J BIOL CHEM, V281, P16090, DOI 10.1074/jbc.M510514200; Yan ZG, 2007, BIOMACROMOLECULES, V8, P3597, DOI 10.1021/bm0701494; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103830; Zheng XN, 2015, SCI REP-UK, V5, DOI 10.1038/srep14408; Zhou YL, 2000, J BIOL CHEM, V275, P12273, DOI 10.1074/jbc.275.16.12273; ZORBAS H, 1992, J BIOL CHEM, V267, P8478	59	7	7	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17803	17816		10.1074/jbc.RA118.005281	http://dx.doi.org/10.1074/jbc.RA118.005281			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30282805	Green Published, hybrid			2022-12-26	WOS:000450409500012
J	Bernardo, K; Jousse, C; Fafournoux, P; Schiphorst, AM; Grand, M; Robins, RJ; Hankard, R; De Luca, A				Bernardo, Karine; Jousse, Celine; Fafournoux, Pierre; Schiphorst, Anne-Marie; Grand, Mathilde; Robins, Richard J.; Hankard, Regis; De Luca, Arnaud			Protein restricted diet during gestation and/or lactation in mice affects( 15)N natural isotopic abundance of organs in the offspring: Effect of diet N-15 content and growth	PLOS ONE			English	Article							AMINO-ACIDS; HAIR PROTEIN; BREAST-MILK; NITROGEN; CARBON; RATIOS; DISCRIMINATION; BIOMARKERS; METABOLISM; TISSUES	Objectives and study This study aimed at measuring the effect in normal to restricted protein diets with specific N-15 natural isotopic abundance (NIA) given during gestation and/or lactation on the N-15 NIA of fur, liver and muscle in dams and their offspring from birth to adulthood. The secondary aim was to study the effect of growth on the same parameters. Methods Female Balb/c mice were fed normal protein diet containing 22% protein or isocaloric low protein diet containing 10% protein throughout gestation. Dam's diets were either maintained or switched to the other diet until weaning at 30 days. All animals were fed standard chow thereafter. Offspring were sacrificed at 1, 11, 30, 60, 480 days and a group of dams at d1. Growth was modeled as an exponential function on the group followed up until 480 days. Fur, liver and muscle were sampled at sacrifice and analyzed for bulk N-15 NIA. Fixed effects and interactions between fixed effects and random elements were tested by three-way ANOVA. Results Higher N-15 NIA in the diet resulted in higher organ N-15 NIA. Switching from one diet to another changed N-15 NIA in each organ. Although dam and offspring shared the same isotopic environment during gestation, N-15 NIA at day 1 was higher in dams. Growth rate did not differ between groups after 10 days and decreased between 1 and 5 months. N-15 NIA differed between organs and was affected by growth and gestation/lactation. Conclusion Dietary N-15 NIA is a major determinant of the N-15 NIA of organs. N-15 NIA depended on organ and age (i.e. growth) suggesting an effect of metabolism and/or dilution space. Postnatal normal-protein diet of lactating dams could reverse the effect of a protein-restricted diet during gestation on the offspring growth. Measuring N-15 NIA in various matrices may open a field of application particularly useful in studying the pre- and post-natal origins of health and disease.	[Bernardo, Karine; Hankard, Regis; De Luca, Arnaud] Inserm UMR 1069, Tours, France; [Bernardo, Karine; Hankard, Regis; De Luca, Arnaud] Univ Hosp Tours, Tours, France; [Bernardo, Karine; Hankard, Regis] F Rabelais Univ, Tours, France; [Jousse, Celine; Fafournoux, Pierre] Clermont Auvergne Univ, INRA, UNH, Clermont Ferrand, France; [Schiphorst, Anne-Marie; Grand, Mathilde; Robins, Richard J.] Univ Nantes, CNRS, Elucidat Biosynth Isotop Spectrometry Grp, CEISAM,UMR 6230, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; INRAE; Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Nantes Universite	De Luca, A (corresponding author), Inserm UMR 1069, Tours, France.; De Luca, A (corresponding author), Univ Hosp Tours, Tours, France.	a.deluca@chu-tours.fr	de Luca, Arnaud/AAC-2039-2022	de Luca, Arnaud/0000-0003-1704-8599; HANKARD, Regis/0000-0001-8450-5839	French-speaking Clinical Nutrition and Metabolism Society (SFNCM); Novalac	French-speaking Clinical Nutrition and Metabolism Society (SFNCM); Novalac	The study was supported by a grant from the French-speaking Clinical Nutrition and Metabolism Society (SFNCM, www.sfncm.org) obtained by A. De Luca. K. Bernardo was supported by a grant from Novalac (www.novalac.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneson LS, 2005, CAN J ZOOL, V83, P989, DOI 10.1139/Z05-083; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Braun A, 2014, J AGR FOOD CHEM, V62, P8008, DOI 10.1021/jf502295f; De Luca A, 2016, NUTRITION, V32, P1295, DOI 10.1016/j.nut.2016.05.013; de Luca A, 2012, PEDIATR RES, V71, P598, DOI 10.1038/pr.2012.3; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Hatch KA, 2006, RAPID COMMUN MASS SP, V20, P3367, DOI 10.1002/rcm.2740; Huelsemann F, 2009, RAPID COMMUN MASS SP, V23, P2448, DOI 10.1002/rcm.4039; Jousse C, 2011, FASEB J, V25, P3271, DOI 10.1096/fj.11-181792; Laugier S, 2014, E SPEN J, V9, pe204; Mantha OL, 2018, BRIT J NUTR, V119, P981, DOI [10.1017/S0007114518000326, 10.1017/s0007114518000326]; O'Brien DM, 2015, ANNU REV NUTR, V35, P565, DOI 10.1146/annurev-nutr-071714-034511; Petzke KJ, 2005, J NUTR, V135, P1515; Petzke KJ, 2006, RAPID COMMUN MASS SP, V20, P2973, DOI 10.1002/rcm.2695; Poupin N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003865; Poupin N, 2013, AM J PHYSIOL-REG I, V304, pR218, DOI 10.1152/ajpregu.00310.2012; Poupin N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028046; Romek KM, 2013, AMINO ACIDS, V45, P1365, DOI 10.1007/s00726-013-1597-7; Schwertl M, 2005, AGR ECOSYST ENVIRON, V109, P153, DOI 10.1016/j.agee.2005.01.015; Sick H, 1997, Z ERNAHRUNGSWISS, V36, P340, DOI 10.1007/BF01617819; Waterlow J. C., 1978, PROTEIN TURNOVER MAM	22	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205271	10.1371/journal.pone.0205271	http://dx.doi.org/10.1371/journal.pone.0205271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304003	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100073
J	Costa, B; Kendall, M; McKagan, S				Costa, Bryan; Kendall, Matthew; McKagan, Steven			Managers, modelers, and measuring the impact of species distribution model uncertainty on marine zoning decisions	PLOS ONE			English	Article							BOOSTED REGRESSION TREES; CONSERVATION MANAGEMENT; HABITAT MODELS; RESERVE DESIGN; PREDICTION; BIODIVERSITY; LAGOON; CLASSIFICATION; ASSEMBLAGES; PROTECTION	Marine managers routinely use spatial data to make decisions about their marine environment. Uncertainty associated with this spatial data can have profound impacts on these management decisions and their projected outcomes. Recent advances in modeling techniques, including species distribution models (SDMs), make it easier to generate continuous maps showing the uncertainty associated with spatial predictions and maps. However, SDM predictions and maps can be complex and nuanced. This complexity makes their use challenging for non-technical managers, preventing them from having the best available information to make decisions. To help bridge these communication and information gaps, we developed maps to illustrate how SDMs and associated uncertainty can be translated into readily usable products for managers. We also explicitly described the potential impacts of uncertainty on marine zoning decisions. This approach was applied to a case study in Saipan Lagoon, Commonwealth of the Northern Mariana Islands (CNMI). Managers in Saipan are interested in minimizing the potential impacts of personal watercraft (e.g., jet skis) on staghorn Acropora (i.e., Acropora aspera, A. formosa, and A. pulchra), which is an important coral assemblage in the lagoon. We used a recently completed SDM for staghorn Acropora to develop maps showing the sensitivity of zoning options to three different prediction and three different uncertainty thresholds (nine combinations total). Our analysis showed that the amount of area and geographic location of predicted staghorn Acropora presence changed based on these nine combinations. These dramatically different spatial patterns would have significant zoning implications when considering where to exclude and/or allow jet skis operations inside the lagoon. They also show that different uncertainty thresholds may lead managers to markedly different conclusions and courses of action. Defining acceptable levels of uncertainty upfront is critical for ensuring that managers can make more informed decisions, meet their marine resource goals and generate favorable outcomes for their stakeholders.	[Costa, Bryan; Kendall, Matthew] NOAA, Natl Ctr Coastal Ocean Sci, Biogeog Branch, Silver Spring, MD 20910 USA; [McKagan, Steven] NOAA, Natl Marine Fisheries Serv, CNMI, Saipan, CM USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Centers for Coastal Ocean Science (NOOCS); National Oceanic Atmospheric Admin (NOAA) - USA	Costa, B (corresponding author), NOAA, Natl Ctr Coastal Ocean Sci, Biogeog Branch, Silver Spring, MD 20910 USA.	bryan.costa@noaa.gov			NOAA's Coral Reef Conservation Program [31100]	NOAA's Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA)	The author(s) received no specific funding for this work. Original data collection and modeling effort was funded by NOAA's Coral Reef Conservation Program under Grant #31100.	Addison PFE, 2013, DIVERS DISTRIB, V19, P490, DOI 10.1111/ddi.12054; [Anonymous], 2010, MAPPING SPECIES DIST; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Battista T. A, 2007, 61 NOAA NOS NCCOS, V61; Battista TA, 2007, 59 NOAA NOS NCCOS; Battista TA, 2005, NCCOS8 NOAA NOS BIOG; Beech T, 2008, ECOL INFORM, V3, P321, DOI 10.1016/j.ecoinf.2008.09.001; Ben-Haim Y., 2006, INFO GAP DECISION TH, V33, P368; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; CNMI and NOAA CRCP (Commonwealth of the Northern Mariana Islands and National Oceanic and Atmospheric Coral Reef Conservation Program), 2010, COMM NO MAR ISL COR; CNMI BECQ (Commonwealth of the Northern Mariana Islands Bureau of Environmental and Coastal Quality), 2017, RFP17BECQDCRM158 CNM; CNMI BECQ (Commonwealth of the Northern Mariana Islands Bureau of Environmental and Coastal Quality), 2016, PAR PER COR BLEACH C; Costa BK, 2017, 241 NOAA NOS NCCOS; Damlamian H, 2010, 439 SOPAC; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Dokulil M. T., 2014, EUTROPHICATION CAUSE; Ehlers P, 2016, WMU J MARIT AFF, V15, P187, DOI 10.1007/s13437-016-0104-x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Erbe C, 2013, J ACOUST SOC AM, V133, pEL326, DOI 10.1121/1.4795220; ESRI, ARCGIS VERS 10 4; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Gregory R., 2012, STRUCTURED DECISION, DOI [DOI 10.1002/9781444398557, 10.1002/9781444398557]; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hartmann AC, 2015, MAR ECOL PROG SER, V536, P163, DOI 10.3354/meps11437; Houk P, 2008, MAR ECOL PROG SER, V356, P39, DOI 10.3354/meps07252; Jupiter S, 2009, FIJI MARINE ECOLOGIC; Jupiter S. D., 2011, J MARINE BIOL, V2011, DOI [10.1155/2011/940765, 940710.941155/942011/940765, DOI 10.1155/2011/940765]; Kendall MS, 2017, 229 NOAA NOS NCCOS; Kendall MS, 2017, SAIPAN LAGOON BIOMAP; Knight AT, 2006, CONSERV BIOL, V20, P739, DOI 10.1111/j.1523-1739.2006.00452.x; Kujala H, 2013, CONSERV LETT, V6, P73, DOI 10.1111/j.1755-263X.2012.00299.x; Lenzi M, 2013, J ENVIRON MANAGE, V123, P8, DOI 10.1016/j.jenvman.2013.03.002; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mariana Visitors Authority, 2016, COMM NO MAR VIS ARR; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; Murdoch TJT, 1999, CORAL REEFS, V18, P341, DOI 10.1007/s003380050210; Negri AP, 2016, SCI REP-UK, V6, DOI 10.1038/srep21153; Nicholson E, 2007, ECOL APPL, V17, P251, DOI 10.1890/1051-0761(2007)017[0251:MCDUUF]2.0.CO;2; NOAA NMFS (National Oceanic and Atmospheric Administration National Marine Fisheries Service), 2014, FED REG, V79; Northern Mariana Islands Tourism Master Plan, 2012, NO MAR ISL TOUR MAST; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Phillips Wayne N., 2015, Environment and Natural Resources Journal, V13, P47; Pittman SJ, 2009, J COASTAL RES, V25, P27, DOI [10.2112/SI53-004.1, 10.2112/S153-004.1]; R Core Team, R LANG ENV STAT COMP; Raymundo LJ, 2017, MAR ECOL PROG SER, V564, P47, DOI 10.3354/meps12005; Regan HM, 2005, ECOL APPL, V15, P1471, DOI 10.1890/03-5419; Schmolke A, 2010, TRENDS ECOL EVOL, V25, P479, DOI 10.1016/j.tree.2010.05.001; Schwartz MW, 2012, BIOL CONSERV, V155, P149, DOI 10.1016/j.biocon.2012.06.011; SLUMP, 2012, 541748 SLUMP COMM NO; SLUMP, 2017, SAIP LAG US MAN PLAN; Tulloch VJ, 2017, J ENVIRON MANAGE, V188, P108, DOI 10.1016/j.jenvman.2016.11.070; Tulloch VJ, 2013, BIOL CONSERV, V162, P41, DOI 10.1016/j.biocon.2013.03.003; van Beukering P., 2006, EC VALUE CORAL REEFS; Villanueva-Dizon FS, 2016, SAIPAN TRIBUNE  0212; Wall LM, 2005, J SHELLFISH RES, V24, P965; Whitfield AK, 2014, MAR POLLUT BULL, V83, P24, DOI 10.1016/j.marpolbul.2014.03.055; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004; Wood LJ, 2007, BIODIVERS CONSERV, V16, P2539, DOI 10.1007/s10531-006-9035-8	71	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204569	10.1371/journal.pone.0204569	http://dx.doi.org/10.1371/journal.pone.0204569			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304038	Green Submitted, gold, Green Published			2022-12-26	WOS:000446921100054
J	Zilio, G; Moesch, L; Bovet, N; Sarr, A; Koella, JC				Zilio, Giacomo; Moesch, Lea; Bovet, Nathalie; Sarr, Anouk; Koella, Jacob C.			The effect of parasite infection on the recombination rate of the mosquito Aedes aegypti	PLOS ONE			English	Article							CONDITION-DEPENDENT SEX; DROSOPHILA-MELANOGASTER; RED QUEEN; COEVOLUTIONARY INTERACTIONS; MEIOTIC RECOMBINATION; DNA REARRANGEMENTS; GENETIC-VARIATION; LINKED FACTORS; CROSSING-OVER; SELECTION	Sexual reproduction and meiotic recombination generate new genetic combinations and may thereby help an individual infected by a parasite to protect its offspring from being infected. While this idea is often used to understand the evolutionary forces underlying the maintenance of sex and recombination, it also suggests that infected individuals should increase plastically their rate of recombination. We tested the latter idea with the mosquito Aedes aegypti and asked whether females infected by the microsporidian Vavraia culicis were more likely to have recombinant offspring than uninfected females. To measure the rate of recombination over a chromosome we analysed combinations of microsatellites on chromosome 3 in infected and uninfected females, in the (uninfected) males they copulated with and in their offspring. As predicted, the infected females were more likely to have recombinant offspring than the uninfected ones. These results show the ability of a female to diversify her offspring in response to parasitic infection by plastically increasing her recombination rate.	[Zilio, Giacomo; Moesch, Lea; Bovet, Nathalie; Sarr, Anouk; Koella, Jacob C.] Univ Neuchatel, Inst Biol, Neuchatel, Switzerland; [Moesch, Lea] ETHZ, Dept Environm Syst Sci, Zurich, Switzerland	University of Neuchatel; ETH Zurich	Zilio, G (corresponding author), Univ Neuchatel, Inst Biol, Neuchatel, Switzerland.	gcm.zilio@gmail.com	Zilio, Giacomo/AAE-7593-2019	Zilio, Giacomo/0000-0002-4448-3118				Abdullah MFF, 2001, P NATL ACAD SCI USA, V98, P14524, DOI 10.1073/pnas.201529598; ABDULLAH NF, 1974, GENETICS, V76, P447; Agrawal AF, 2005, GENETICS, V171, P803, DOI 10.1534/genetics.105.041301; Agrawal AF, 2006, CURR BIOL, V16, pR696, DOI 10.1016/j.cub.2006.07.063; Agrawal AF, 2006, PLOS BIOL, V4, P1364, DOI 10.1371/journal.pbio.0040265; Andreadis TG, 2007, J AM MOSQUITO CONTR, V23, P3, DOI 10.2987/8756-971X(2007)23[3:MPOM]2.0.CO;2; Andronic L, 2012, CAN J PLANT SCI, V92, P1083, DOI [10.4141/CJPS2011-197, 10.4141/cjps2011-197]; Bates D. M., 2014, J STAT SOFTWARE; Bedhomme S, 2004, P ROY SOC B-BIOL SCI, V271, P739, DOI 10.1098/rspb.2003.2657; Bell G, 1996, BASICS SELECTION; BELYAEV DK, 1982, BIOL ZBL, V101, P705; Bridges CB, 1915, J EXP ZOOL, V19, P1, DOI 10.1002/jez.1400190102; Campbell CL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7260; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; CHAN KL, 1971, B WORLD HEALTH ORGAN, V44, P629; CHINNICI JP, 1971, GENETICS, V69, P71; Christopher SR, 1960, AEDES AEGYPTI L YELL; CHURCH K, 1969, CAN J GENET CYTOL, V11, P209, DOI 10.1139/g69-025; Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004; Desjardins CA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8121; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Dumont BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142266; FABRE F, 1977, P NATL ACAD SCI USA, V74, P1667, DOI 10.1073/pnas.74.4.1667; Fischer O, 2005, BIOL LETTERS, V1, P193, DOI 10.1098/rsbl.2005.0296; Fox J., 2019, R COMPANION APPL REG, V.; Gibson AK, 2016, EVOLUTION, V70, P2049, DOI 10.1111/evo.13001; Greeff M, 2010, GENETICA, V138, P737, DOI 10.1007/s10709-010-9454-z; Hadany L, 2007, GENETICS, V176, P1713, DOI 10.1534/genetics.107.074203; Hadany L, 2009, AM NAT, V174, pS71, DOI 10.1086/599086; Haldane JBS, 1919, J GENET, V8, P299; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Heinz E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004547; Huehn M, 2011, GENOME, V54, P196, DOI 10.1139/G10-109; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; Kerstes NAG, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-18; KIDWELL MG, 1972, GENETICS, V70, P419; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Koskela T, 2002, EVOLUTION, V56, P899; Koskella B, 2007, EVOLUTION, V61, P152, DOI 10.1111/j.1558-5646.2007.00012.x; Koskella B, 2009, EVOLUTION, V63, P2213, DOI 10.1111/j.1558-5646.2009.00711.x; Kovalchuk I, 2003, NATURE, V423, P760, DOI 10.1038/nature01683; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Lim JGY, 2008, GENETICS, V180, P715, DOI 10.1534/genetics.108.090142; Lively CM, 2014, J EVOLUTION BIOL, V27, P1292, DOI 10.1111/jeb.12354; Lively CM, 2010, J HERED, V101, pS13, DOI 10.1093/jhered/esq010; Lovin DD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-590; LU BC, 1976, MOL GEN GENET, V147, P121, DOI 10.1007/BF00267563; Lucht JM, 2002, NAT GENET, V30, P311, DOI 10.1038/ng846; MAGUIRE MP, 1968, GENETICS, V60, P353; MARK HFL, 1977, GENETICS, V86, P121; Maze-Guilmo E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2567; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Munstermann LE, MOL BIOL INSECT DIS, P13; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Oliva CF, 2014, ACTA TROP, V132, pS12, DOI 10.1016/j.actatropica.2013.11.021; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Otto SP, 2004, SCIENCE, V304, P1018, DOI 10.1126/science.1094072; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; PARSONS PA, 1988, BIOL J LINN SOC, V35, P49, DOI 10.1111/j.1095-8312.1988.tb00458.x; Peters AD, 2007, J EVOLUTION BIOL, V20, P1206, DOI 10.1111/j.1420-9101.2006.01283.x; Peters AD, 1999, AM NAT, V154, P393, DOI 10.1086/303247; Petersen LR, 2016, NEW ENGLAND J MED; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x; RICE WR, 1983, AM NAT, V121, P187, DOI 10.1086/284050; Salathe M, 2008, EVOLUTION, V62, P295, DOI 10.1111/j.1558-5646.2007.00265.x; Schmid-Hempel P, 2002, AM NAT, V160, P403, DOI 10.1086/341517; Severson DW, 2002, INSECT MOL BIOL, V11, P371, DOI 10.1046/j.1365-2583.2002.00347.x; SHAW DD, 1972, CHROMOSOMA, V37, P297, DOI 10.1007/BF00319872; Singh ND, 2015, SCIENCE, V349, P747, DOI 10.1126/science.aab1768; Slowinski SP, 2016, EVOLUTION, V70, P2632, DOI 10.1111/evo.13048; SMITH JM, 1978, EVOLUTION SEX; Stevison LS, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0459; Sturtevant AH, 1913, J EXP ZOOL, V14, P43, DOI 10.1002/jez.1400140104; Timoshevskiy VA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002052; Tsaousis AD, 2008, NATURE, V453, P553, DOI 10.1038/nature06903; van Kleunen M, 2001, OIKOS, V94, P515, DOI 10.1034/j.1600-0706.2001.940313.x; Vergara D, 2014, AM NAT, V184, pS22, DOI 10.1086/676886; WEISER J, 1972, Folia Parasitologica (Ceske Budejovice), V19, P197; Zuchenko AA, 1986, SOV GENET, V22, P730	83	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0203481	10.1371/journal.pone.0203481	http://dx.doi.org/10.1371/journal.pone.0203481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300349	Green Submitted, gold, Green Published			2022-12-26	WOS:000446897200006
J	Leslie, HH; Zhou, X; Spiegelman, D; Kruk, ME				Leslie, Hannah H.; Zhou, Xin; Spiegelman, Donna; Kruk, Margaret E.			Health system measurement: Harnessing machine learning to advance global health	PLOS ONE			English	Article							EFFECTIVE COVERAGE; QUALITY; CARE; PREDICTION; READINESS; COUNTRIES; MORTALITY; SERVICES	Background Further improvements in population health in low- and middle-income countries demand high-quality care to address an increasingly complex burden of disease. Health facility surveys provide an important but costly source of information on readiness to provide care. To improve the efficiency of health system measurement, we applied unsupervised machine learning methods to assess the performance of the service readiness index (SRI) defined by the World Health Organization and compared it to empirically derived indices. Methods We drew data from nationally representative Service Provision Assessment surveys conducted in 10 countries between 2007 and 2015. We extracted 649 items in domains such as infrastructure, medication, and management to calculate an index using all available information and classified facilities into quintiles. We compared three approaches against the full item set: the SRI, a new index based on sequential backward selection, and an enriched SRI that added empirically selected items to the SRI. We evaluated index performance with a cross-validated kappa statistic comparing classification using the candidate index against the 649-item index. Results 9238 facilities were assessed. The 49-item SRI performed poorly against the index using all 649 items, with a kappa value of 0.35. New empirically derived indices with 50 and 100 items captured much more information, with cross-validated kappa statistics of 0.71 and 0.80, respectively. Items varied across the indices and in sensitivity analyses. A 100-item enriched SRI reliably captured the information from the full index: 83% of the facilities were classified into correct quintiles of service readiness based on the full index. Conclusion A facility readiness measure developed by global health experts performed poorly in capturing the totality of readiness information collected during facility surveys. Using a machine learning approach with sequential selection and cross-validation to identify the most informative items dramatically improved performance. Such approaches can make assessment of health facility readiness more efficient. Further improvements in measurement will require identification of external criteria-such as patient outcomes-to guide and validate measure development.	[Leslie, Hannah H.; Spiegelman, Donna; Kruk, Margaret E.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Zhou, Xin; Spiegelman, Donna] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Zhou, Xin; Spiegelman, Donna] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Spiegelman, Donna] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Spiegelman, Donna] Yale Sch Publ Hlth, Ctr Methods Implementat & Prevent Sci, New Haven, CT USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Yale University	Leslie, HH (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	hleslie@hsph.harvard.edu		Leslie, Hannah Hogan/0000-0002-7464-3645	Bill and Melinda Gates Foundation [OPP1161450]; National Institutes of Health [DP1ES025459]; McLennan Family Fund (MEK); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES025459] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McLennan Family Fund (MEK); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Bill and Melinda Gates Foundation (https://www.gatesfoundation.org/, OPP1161450, MEK), the National Institutes of Health (https://www.niehs.nih.gov/index.cfm, DP1ES025459, DS), and the McLennan Family Fund (MEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akachi Y, 2017, B WORLD HEALTH ORGAN, V95, P465, DOI 10.2471/BLT.16.180190; Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/s0140-6736(17)30818-8, 10.1016/S0140-6736(17)30818-8]; Das J, 2014, ANNU REV ECON, V6, P525, DOI 10.1146/annurev-economics-080213-041350; Demographic and Health Surveys Program, 2017, DHS PROGR SERV PROV; Do M, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020501; Gage AJ, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1097-3; Hastie T., 2009, UNSUPERVISED LEARNIN; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Hubbard A, 2013, J TRAUMA ACUTE CARE, V75, pS53, DOI 10.1097/TA.0b013e3182914553; Kanyangarara M, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.021101; Katende D, 2015, TROP MED INT HEALTH, V20, P1385, DOI 10.1111/tmi.12560; Kruk M, 2018, LANCET GLOBAL HLTH; Leslie HH, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002464; Leslie HH, 2017, BMJ GLOBAL HLTH, V2; Leslie HH, 2017, B WHO, V95; Liu H, 1998, FEATURE EXTRACTION C, DOI 10. 1007/978-1-4615-5725-8; Mbondji PE, 2014, J ROY SOC MED, V107, P34, DOI 10.1177/0141076814531750; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Nguhiu PK, 2017, TROP MED INT HEALTH, V22, P442, DOI 10.1111/tmi.12841; O'Neill K, 2013, B WORLD HEALTH ORGAN, V91, P923, DOI 10.2471/BLT.12.116798; Rose S, 2016, HLTH SERVICES RES, V51; Rose S, 2013, AM J EPIDEMIOL, V177, P443, DOI 10.1093/aje/kws241; Sobel HL, 2016, HEALTH POLICY PLANN, V31, P547, DOI 10.1093/heapol/czv095; The World Health Organization, 2013, SERV AV READ ASS SAR; UN, 2015, SUSTAINABLE DEV GOAL	27	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204958	10.1371/journal.pone.0204958	http://dx.doi.org/10.1371/journal.pone.0204958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289935	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500032
J	Fahmy, AM; Khabir, M; Blanchet, M; Labonte, P				Fahmy, Ahmed M.; Khabir, Marwa; Blanchet, Matthieu; Labonte, Patrick			LC3B is not recruited along with the autophagy elongation complex (ATG5-12/16L1) at HCV replication site and is dispensable for viral replication	PLOS ONE			English	Article							HEPATITIS-C VIRUS; UNFOLDED PROTEIN RESPONSE; ATG12-ATG5 CONJUGATE; MEMBRANE; INFECTION; CELLS; RNA; LIPIDATION; INDUCTION; MACHINERY	Hepatitis C virus (HCV) infection is known to induce autophagosome accumulation as observed by the typical punctate cytoplasmic distribution of LC3B-II in infected cells. Previously, we showed that viral RNA-dependent RNA polymerase (NS5B) interacts with ATG5, a major component of the autophagy elongation complex that is involved in the formation of double-membrane vesicles (DMV), and demonstrated that the autophagy elongation complex (ATG5-12/16L1) but not LC3B is required for proper membranous web formation. In this study, the colocalization and in situ interaction of all HCV replicase components with the constituent of the autophagy elongation complex and LC3B were analyzed. The results clearly show the recruitment of the elongation complex to the site of viral replication. Using in situ proximity ligation assay, we show that ATG5, but not ATG16L1, interacts with several HCV replicase components suggesting that the recruitment is directed via the ATG5-12 conjugate. Interestingly, no E3-like conjugation activity of ATG5-12/16L1 can be detected at the at HCV replication site since LC3B-II is not found along with the elongation complex at the site of viral replication. In agreement with this result, no sign of in situ interaction of LC3B with the replicase components is observed. Finally, using dominant negative forms of ATG proteins, we demonstrate that ATG5-12 conjugate, but not LC3-II formation, is critical for viral replication. Altogether, these findings suggest that although HCV needs the elongation complex for its replication, it has developed a mechanism to avoid canonical LC3-II accumulation at viral replication site.	[Fahmy, Ahmed M.; Khabir, Marwa; Blanchet, Matthieu; Labonte, Patrick] Inst Natl Rech Sci, INRS Inst Armand Frappier, Laval, PQ, Canada; [Fahmy, Ahmed M.] NRC, Div Med Res, Dept Reprod Med, Mol Med Res Grp, Dokki, Egypt	University of Quebec; Institut national de la recherche scientifique (INRS); Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Labonte, P (corresponding author), Inst Natl Rech Sci, INRS Inst Armand Frappier, Laval, PQ, Canada.	patrick.labonte@iaf.inrs.ca	Fahmy, Ahmed/U-4709-2019	Fahmy, Ahmed/0000-0003-0444-383X	NCRTP-HepC; Natural Science and Engineering Research Council of Canada	NCRTP-HepC; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by AMF was supported by a fellowship from NCRTP-HepC. PL was funded by the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Biering SB, 2017, AUTOPHAGY, V13, P2010, DOI 10.1080/15548627.2017.1371396; Biering SB, 2017, CELL HOST MICROBE, V22, P74, DOI 10.1016/j.chom.2017.06.005; Blanchet M, 2012, ANTIVIR RES, V95, P159, DOI 10.1016/j.antiviral.2012.05.006; Chen YJ, 2010, J BIOL CHEM, V285, P28183, DOI 10.1074/jbc.M110.118323; Combs C, 1997, GASTROENTEROLOGY, V112, P1372, DOI 10.1016/S0016-5085(97)70152-5; Doring T, 2018, J VIROL, V92, DOI 10.1128/JVI.01513-17; Dreux M, 2009, AUTOPHAGY, V5, P1224, DOI 10.4161/auto.5.8.10219; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Eyre NS, 2014, J VIROL, V88, P3636, DOI 10.1128/JVI.02490-13; Fahmy AM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40351; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Granato M, 2014, J VIROL, V88, P12715, DOI 10.1128/JVI.02199-14; Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032; Guevin C, 2009, ANTIVIR RES, V84, P14, DOI 10.1016/j.antiviral.2009.07.009; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Huang H, 2013, AUTOPHAGY, V9, P175, DOI 10.4161/auto.22791; Into T, 2012, CELL SIGNAL, V24, P1150, DOI 10.1016/j.cellsig.2012.01.020; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kaufmann A, 2014, CELL, V156, P469, DOI 10.1016/j.cell.2013.12.022; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Kim JH, 2017, J VIROL, V91, DOI 10.1128/JVI.01206-16; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Le QT, 2015, J BIOL CHEM, V290, P23385, DOI 10.1074/jbc.M115.642991; Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001; Liu QH, 2012, VIROLOGY, V429, P136, DOI 10.1016/j.virol.2012.03.022; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500; Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mohl BP, 2016, J GEN VIROL, V97, P680, DOI 10.1099/jgv.0.000387; Mohl BP, 2012, J VIROL, V86, P10724, DOI 10.1128/JVI.01667-12; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Oh JE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00044; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Santana S, 2012, J ALZHEIMERS DIS, V30, P815, DOI 10.3233/JAD-2012-112000; Shrivastava S, 2012, J VIROL, V86, P8705, DOI 10.1128/JVI.00616-12; Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Sir D, 2012, J BIOL CHEM, V287, P18036, DOI 10.1074/jbc.M111.320085; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Su WC, 2011, J VIROL, V85, P10561, DOI 10.1128/JVI.00173-11; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243; Tian L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0271-0; Wang LY, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006609; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; Webster DP, 2009, LANCET INFECT DIS, V9, P108, DOI 10.1016/S1473-3099(09)70020-9; Zhao Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11105-3	57	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205189	10.1371/journal.pone.0205189	http://dx.doi.org/10.1371/journal.pone.0205189			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286180	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500096
J	Matsuoka, K; Hamada, S; Shimizu, M; Nanki, K; Mizuno, S; Kiyohara, H; Arai, M; Sugimoto, S; Iwao, Y; Ogata, H; Hisamatsu, T; Naganuma, M; Kanai, T; Mochizuki, M; Hashiguchi, M				Matsuoka, Katsuyoshi; Hamada, Shunsuke; Shimizu, Mikiko; Nanki, Kosaku; Mizuno, Shinta; Kiyohara, Hiroki; Arai, Mari; Sugimoto, Shinya; Iwao, Yasushi; Ogata, Haruhiko; Hisamatsu, Tadakazu; Naganuma, Makoto; Kanai, Takanori; Mochizuki, Mayumi; Hashiguchi, Masayuki			Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn's disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; ANTI-TNF; GENETIC POLYMORPHISMS; FACTOR-ALPHA; BIOLOGICAL RESPONSE; ASSOCIATION; EFFICACY; METAANALYSIS; INDUCTION	Since anti-tumor necrosis factor (TNF)-alpha agents (TNF-alpha inhibitors) induce both clinical response and remission in patients with moderate to severe inflammatory bowel disease (IBD), the use of anti-TNF therapies has fundamentally changed the approach to treatment for patients with IBD. Infliximab (IFX) is a TNF-alpha inhibitor approved for the induction and remission of Crohn's disease (CD). However, even among patients who initially demonstrate a clinical response to IFX therapy, secondary loss of response occurs, although the reason remains unknown. We therefore investigated predictive factors associated with the response to IFX in long-term maintenance treatment in Japanese CD patients. Eight types of single-nucleotide polymorphisms (SNPs) were investigated using the real-time PCR method, and patient characteristics were collected from the electronic medical records. The Crohn's Disease Activity Index criteria were used as the response to IFX therapy. The observation period was 1 year after IFX had been administered for more than 1 year. Associations between the IFX response and patient characteristics were evaluated using the multivariate logistic regression model. We studied 121 unrelated adult Japanese with CD treated for more than 1 year with IFX as outpatients at Keio University Hospital from November 1, 2014 to November 30, 2015. Among them, 71 were classified as in remisson. In multivariate analysis, patients with the TNF-alpha 857C>T C/C genotype, shorter disease duration, without double dosing, and combination treatment with an immunomodulator had higher remisson rates than those with the C/T or T/T genotype, longer disease duration, with double dosing, and no combination treatment with an immunomodulator. The response to IFX in Japanese CD patients may therefore be predicted by these 4 characteristics in actual clinical practice.	[Matsuoka, Katsuyoshi; Nanki, Kosaku; Mizuno, Shinta; Kiyohara, Hiroki; Arai, Mari; Sugimoto, Shinya; Hisamatsu, Tadakazu; Naganuma, Makoto; Kanai, Takanori] Keio Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Shinjuku Ku, Shinanomachi, Tokyo, Japan; [Hamada, Shunsuke; Mochizuki, Mayumi; Hashiguchi, Masayuki] Keio Univ, Div Evaluat & Anal Drug Informat, Fac Pharm, Minato Ku, Tokyo, Japan; [Shimizu, Mikiko] Keio Univ, Dept Hyg Chem, Fac Pharm, Minato Ku, Tokyo, Japan; [Iwao, Yasushi] Keio Univ, Ctr Prevent Med, Sch Med, Shinjuku Ku, Shinanomachi, Tokyo, Japan; [Ogata, Haruhiko] Keio Univ, Ctr Diagnost & Therapeut Endoscopy, Sch Med, Shinjuku Ku, Shinanomachi, Tokyo, Japan	Keio University; Keio University; Keio University; Keio University; Keio University	Hashiguchi, M (corresponding author), Keio Univ, Div Evaluat & Anal Drug Informat, Fac Pharm, Minato Ku, Tokyo, Japan.	hashiguchi-ms@pha.keio.ac.jp	Matsuoka, Katsuyoshi/AAB-1580-2022; Sugimoto, Shinya/X-6548-2018	Matsuoka, Katsuyoshi/0000-0002-2950-7660; Sugimoto, Shinya/0000-0002-1560-1605; Kanai, Takanori/0000-0002-1466-4532; Nanki, Kosaku/0000-0003-4232-0523				Allez M, 2010, J CROHNS COLITIS, V4, P355, DOI 10.1016/j.crohns.2010.04.004; Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; Ben-Horin S, 2011, ALIMENT PHARM THER, V33, P987, DOI 10.1111/j.1365-2036.2011.04612.x; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Canete JD, 2009, ANN RHEUM DIS, V68, P1547, DOI 10.1136/ard.2008.096982; Cholapranee A, 2017, ALIMENT PHARM THER, V45, P1291, DOI 10.1111/apt.14030; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanauer SB, 2004, CLIN GASTROENTEROL H, V2, P542, DOI 10.1016/S1542-3565(04)00238-1; Hibi T, 2006, J GASTROENTEROL, V41, P10, DOI 10.1007/s00535-005-1744-3; Kimura K, 2016, APMIS, V124, P669, DOI 10.1111/apm.12559; Lopez-Hernandez R, 2014, INT J IMMUNOGENET, V41, P63, DOI 10.1111/iji.12059; Louis E, 2004, ALIMENT PHARM THER, V19, P511, DOI 10.1111/j.1365-2036.2004.01871.x; Matsukura H, 2008, ALIMENT PHARM THERAP, V27, P765, DOI 10.1111/j.1365-2036.2008.03630.x; Medrano LM, 2014, HUM IMMUNOL, V75, P71, DOI 10.1016/j.humimm.2013.09.017; Miligkos M, 2016, CLIN THER, V38, P1342, DOI 10.1016/j.clinthera.2016.03.018; Montes A, 2014, PHARMACOGENET GENOM, V24, P238, DOI 10.1097/FPC.0000000000000042; Moroi R, 2013, IMMUNOGENETICS, V65, P265, DOI 10.1007/s00251-013-0679-8; Papamichael K, 2011, ANN GASTROENTEROL, V24, P35; Papamichael K, 2015, INFLAMM BOWEL DIS, V21, P182, DOI 10.1097/MIB.0000000000000202; Pierik M, 2004, ALIMENT PHARM THER, V20, P303, DOI 10.1111/j.1365-2036.2004.01946.x; Romero-Cara P, 2018, INT J MED SCI, V15, P10, DOI 10.7150/ijms.22812; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P1593, DOI 10.1053/j.gastro.2004.02.070; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Sands BE, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1995-7; Steenholdt C, 2012, ALIMENT PHARM THER, V36, P650, DOI 10.1111/apt.12010; Urabe S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/416838; Vermeire S, 2000, GASTROENTEROLOGY, V118, pA654, DOI 10.1016/S0016-5085(00)84757-5	28	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204632	10.1371/journal.pone.0204632	http://dx.doi.org/10.1371/journal.pone.0204632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286108	Green Submitted, gold, Green Published			2022-12-26	WOS:000446383500028
J	Qin, SL; Clausen, E; Nouraie, SM; Kingsley, L; McMahon, D; Kleerup, E; Huang, L; Ghedin, E; Greenblatt, RM; Morris, A				Qin, Shulin; Clausen, Emily; Nouraie, Seyed Mehdi; Kingsley, Lawrence; McMahon, Deborah; Kleerup, Eric; Huang, Laurence; Ghedin, Elodie; Greenblatt, Ruth M.; Morris, Alison			Tropheryma whipplei colonization in HIV-infected individuals is not associated with lung function or inflammation	PLOS ONE			English	Article							DIFFUSING-CAPACITY; PULMONARY-FUNCTION; STANDARDIZATION; IMPAIRMENT; ACTIVATION; INSIGHTS; DISEASE; SAMPLE	Studies demonstrate that Tropheryma whipplei (T. whipplei) is present in the lungs of healthy individuals without acute respiratory symptoms or acute respiratory infection and is more common in the lungs of HIV-infected individuals and in smokers. The impact of T. whipplei colonization in the lung on local inflammation and pulmonary dysfunction in HIV-infected individuals is currently unknown. In this study, we performed specific polymerase chain reaction (PCR) and sequencing for T. whipplei in bronchoalveolar lavage (BAL) and induced sputum (IS) samples in 76 HIV-infected participants from three clinical sites. Pulmonary function and proinflammatory cytokine and chemokine levels in BAL were measured. Frequency of T. whipplei in either BAL or IS was 43.4%. The sensitivity and specificity of IS compared to BAL for detection of T. whipplei was 92.3% and 84.2%, respectively, and isolates of T. whipplei in the BAL and IS in the same subject shared genetic identity. Pulmonary function measures were not associated with T. whipplei colonization, and proinflammatory cytokine and chemokine levels in BAL and plasma as well as percentages of inflammatory cells in BAL and IS were not higher in colonized individuals. Overall, these results indicate that T. whipplei colonization in the lung is common, but may not be associated with decreased pulmonary function or inflammation in HIV-infected individuals.	[Qin, Shulin; Clausen, Emily; Nouraie, Seyed Mehdi; McMahon, Deborah; Morris, Alison] Univ Pittsburgh, Dept Med, 930 Scaife Hall, Pittsburgh, PA 15260 USA; [Kingsley, Lawrence] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Kleerup, Eric] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Huang, Laurence] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Ghedin, Elodie] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Ghedin, Elodie] NYU, Global Inst Publ Hlth, New York, NY USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; [Morris, Alison] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; New York University; New York University; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Morris, A (corresponding author), Univ Pittsburgh, Dept Med, 930 Scaife Hall, Pittsburgh, PA 15260 USA.; Morris, A (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.	morrisa@upmc.edu	Nouraie, Seyed Mehdi/O-4071-2018; Huang, Laurence/AAZ-7120-2021; Ghedin, Elodie/Y-5654-2019; Qin, Shulin/ABA-3986-2020; Huang, Laurence/AAE-1590-2019	Nouraie, Seyed Mehdi/0000-0001-7465-0581; Huang, Laurence/0000-0003-3888-2195; Ghedin, Elodie/0000-0002-1515-725X; Qin, Shulin/0000-0003-2496-3007; 	NIH [U01 HL098962, R01 HL120398, R01 HL125049, K24 HL023342, K24 HL087713]; University of Pittsburgh CTRC [UL1 TR001857]; MACS [UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041]; WIHS [UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; National Cancer Institute [UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041]; National Institute of Allergy and Infectious Diseases [UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041, UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [UO1-HD-32632]; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Center for Research Resources (UCSF-CTSI) [UL1 RR024131];  [U01-AI-103390]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001857] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, R01HL125049, K24HL123342, R01HL120398] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh CTRC(University of Pittsburgh); MACS; WIHS; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources (UCSF-CTSI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from NIH U01 HL098962, R01 HL120398, R01 HL125049, K24 HL023342 and University of Pittsburgh CTRC UL1 TR001857 (AM). Dr. Huang was partially supported by NIH K24 HL087713 (LH). San Francisco WIHS data used for this study were supported by U01-AI-103390 (RG). MACS (UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041); WIHS (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A subset of subjects in this cohort was recruited from sites of the Multicenter AIDS Cohort Study (MACS) with centers University of California, Los Angeles (Roger Detels) and University of Pittsburgh (Charles R. Rinaldo, Lawrence Kingsley). The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute. UO1-AI-35042, UL1-RR025005 (GCRC), UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041. Website located at http://www.statepi.jhsph.edu/macs/macs.html. A subset of subjects in this cohort was recruited from the Connie Wofsy Study Consortium of Northern California Ruth Greenblatt, Phyllis Tien and Bradley Aouizerat) of the Women's Interagency HIV Study (WIHS) Collaborative Study Group. The WIHS is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, and UO1-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The WIHS is cofunded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131).	Beck JM, 2015, AM J RESP CRIT CARE, V192, P1335, DOI 10.1164/rccm.201501-0128OC; Crothers K, 2013, JAIDS-J ACQ IMM DEF, V64, P271, DOI 10.1097/QAI.0b013e3182a9215a; Cui LJ, 2015, AM J RESP CRIT CARE, V191, P932, DOI 10.1164/rccm.201409-1583OC; Desnues B, 2010, MICROBES INFECT, V12, P1102, DOI 10.1016/j.micinf.2010.08.001; Drummond MB, 2014, LANCET RESP MED, V2, P583, DOI 10.1016/S2213-2600(14)70017-7; Durand DV, 1997, MEDICINE, V76, P170, DOI 10.1097/00005792-199705000-00003; Fitzpatrick ME, 2016, AIDS, V30, P1327, DOI 10.1097/QAD.0000000000001092; Fitzpatrick ME, 2014, AIDS, V28, P2505, DOI 10.1097/QAD.0000000000000471; Fitzpatrick ME, 2013, JAIDS-J ACQ IMM DEF, V64, P284, DOI 10.1097/QAI.0b013e3182a9213a; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Gershman NH, 1996, EUR RESPIR J, V9, P2448, DOI 10.1183/09031936.96.09122448; Gingo MR, 2014, EUR RESPIR J, V43, P195, DOI 10.1183/09031936.00157712; Gingo MR, 2010, AM J RESP CRIT CARE, V182, P790, DOI 10.1164/rccm.200912-1858OC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Iwai S, 2012, J CLIN MICROBIOL, V50, P2995, DOI 10.1128/JCM.00278-12; Lozupone C, 2013, AM J RESP CRIT CARE, V187, P1110, DOI 10.1164/rccm.201211-2145OC; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morgenegg S, 2000, J CLIN MICROBIOL, V38, P2248; Morris A, 2008, J INFECT DIS, V197, P10, DOI 10.1086/523814; Morris A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0183-0; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Morris A, 2012, CLIN MICROBIOL REV, V25, P297, DOI 10.1128/CMR.00013-12; Neas LM, 1996, AM J RESP CRIT CARE, V153, P656, DOI 10.1164/ajrccm.153.2.8564114; Qin SL, 2016, AM J RESP CRIT CARE, V194, P243, DOI 10.1164/rccm.201601-0162LE; Simpson JL, 2016, EUR RESPIR J, V47, P792, DOI 10.1183/13993003.00405-2015; Sze MA, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0303-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsao TCY, 2000, CHEST, V117, P103, DOI 10.1378/chest.117.1.103	29	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205065	10.1371/journal.pone.0205065	http://dx.doi.org/10.1371/journal.pone.0205065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286195	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500081
J	Ryde, GC; Booth, JN; Brooks, NE; Chesham, RA; Moran, CN; Gorely, T				Ryde, Gemma C.; Booth, Josephine N.; Brooks, Naomi E.; Chesham, Ross A.; Moran, Colin N.; Gorely, Trish			The Daily Mile: What factors are associated with its implementation success?	PLOS ONE			English	Article							PROMOTE PHYSICAL-ACTIVITY; INTERVENTIONS; ADOLESCENTS; CHILDREN	Background Despite the known benefits of a physically active lifestyle, there are few examples of interventions that have been successfully implemented at a population level over a long period of time. One such example is The Daily Mile, a school based physical activity initiative, where a teacher takes their class out daily during class time for a short bout of ambulatory activity. At one school, this activity appears has been sustained over a long period (6 years), has the whole school participating and is now incorporated into its daily routine. The aim of this paper was to understand how The Daily Mile was implemented in primary schools and to assess factors associated with its successful implementation. Methods Semi-structured interviews with school staff who had a significant role in implementing The Daily Mile were conducted at four primary schools in central Scotland. Interviews were digitally recorded and transcribed verbatim. Data were analysed using thematic analysis and descriptive analysis and interpretation of data undertaken. Details regarding the school grounds and facilities were also noted during the interviews. Results Having simple core intervention components, flexible delivery that supports teacher autonomy and being adaptable to suit the specific primary school context appear to be key aspects of The Daily Mile that are related to its implementation success. Other factors relating to how The Daily Mile was developed, trialled and rolled out might also have contributed towards its successful implementation. Conclusion The Daily Mile appears to have several factors which may relate to its implementation success. These are important considerations for others looking to implement The Daily Mile effectively in their primary school or in other contexts.	[Ryde, Gemma C.; Brooks, Naomi E.; Chesham, Ross A.; Moran, Colin N.] Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland; [Booth, Josephine N.] Univ Edinburgh, Inst Educ Community & Soc, Edinburgh, Midlothian, Scotland; [Gorely, Trish] Univ Highlands & Isl, Dept Nursing, Inverness, Scotland	University of Stirling; University of Edinburgh; UHI Millennium Institute	Ryde, GC (corresponding author), Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland.	gemma.ryde@stir.ac.uk	Moran, Colin Neil/F-5416-2011	Moran, Colin Neil/0000-0001-6226-8131; Booth, Josephine/0000-0002-2867-9719; Chesham, Ross/0000-0002-2411-4147	University of Stirling; University of Edinburgh; Stirling Council	University of Stirling; University of Edinburgh; Stirling Council	This research project was partially funded from internal sources at the University of Stirling and the University of Edinburgh. Neither of the funders had involvement in the data analysis, data interpretation, data collection, or writing of the paper. The views expressed in this publication are those of the authors and not necessarily of the funding bodies listed here.; We extend sincere thanks to all the teachers who took part in the present study. We would also like to thank Stirling Council for their ongoing support of this research. Additional thanks goes to our colleague Dr Amy Nimegeer from the University of Glasgow, Institute of Health and Wellbeing for her assistance with data analysis and interpretation.	[Anonymous], 2017, THE DAILY MILE; Chalkley AE, 2016, 6 INT SOC PHYS ACT H; Chesham RA, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1049-z; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2; Dudley D, 2011, EUR PHYS EDUC REV, V17, P353, DOI 10.1177/1356336X11416734; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Erwin HE, 2011, J SCHOOL HEALTH, V81, P455, DOI 10.1111/j.1746-1561.2011.00614.x; Fullan M., 2007, NEW MEANING ED CHANG; Glasgow RE, 2007, ANNU REV PUBL HEALTH, V28, P413, DOI 10.1146/annurev.publhealth.28.021406.144145; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hewitt-Taylor J, 2001, Nurs Stand, V15, P39; Holt E, 2013, J PHYS ACT HEALTH, V10, P480, DOI 10.1123/jpah.10.4.480; Jamshed Shazia, 2014, J Basic Clin Pharm, V5, P87, DOI 10.4103/0976-0105.141942; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Naylor PJ, 2006, J SCI MED SPORT, V9, P413, DOI 10.1016/j.jsams.2006.06.013; Naylor PJ, 2015, PREV MED, V72, P95, DOI 10.1016/j.ypmed.2014.12.034; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Phillippi J, 2018, QUAL HEALTH RES, V28, P381, DOI 10.1177/1049732317697102; Rogers RH, 2018, QUAL REP, V23, P889; Scottish National Party, 2016, IS SNP ENC PEOPL BE; The Scottish Government, 2018, SCOTT GOV URB RUR CL; The Scottish Government, 2016, SCOTT IND MULT DEPR; van Sluijs EMF, 2008, BRIT J SPORT MED, V42, P653, DOI 10.1136/bmj.39320.843947.BE; Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024	25	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204988	10.1371/journal.pone.0204988	http://dx.doi.org/10.1371/journal.pone.0204988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286175	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500070
J	Woo, Y; Shin, JS; Shim, CY; Kim, JS; Kim, BK; Park, S; Chang, HJ; Hong, GR; Ko, YG; Kang, SM; Choi, D; Ha, JW; Hong, MK; Jang, Y; Lee, SH				Woo, Yeongmin; Shin, Jeong-soo; Shim, Chi-Young; Kim, Jung-Sun; Kim, Byeong-Keuk; Park, Sungha; Chang, Hyuk-Jae; Hong, Geu-Ru; Ko, Young-Guk; Kang, Seok-Min; Choi, Donghoon; Ha, Jong-Won; Hong, Myeong-Ki; Jang, Yangsoo; Lee, Sang-Hak			Effect of fenofibrate in 1113 patients at low-density lipoprotein cholesterol goal but high triglyceride levels: Real-world results and factors associated with triglyceride reduction	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MIXED DYSLIPIDEMIA; THERAPY; ACID; HYPERTRIGLYCERIDEMIA; PREDICTORS; MANAGEMENT; VARIANTS; EFFICACY; IMPACT	Fibrates are used in patients with dyslipidemia and high cardiovascular risk. However, information regarding drug response to fibrate has been highly limited. We investigated treatment results and factors associated with triglyceride reduction after fenofibrate therapy using large-scale real-world data. Patients with one or more cardiovascular risk factors, at low-density lipoprotein-cholesterol goal but with triglyceride level >= 150 mg/dL, and undergoing treatment with fenofibrate 135-160 mg for the first time were included in this retrospective observational study. The outcome variable was the percentage changes of TG levels. The achievement rate of triglyceride <150 mg/dL was additionally analyzed. Factors associated with treatment results were also analyzed. Among 2546 patients who were initially screened, 1113 patients were enrolled (median age: 61 years; male: 71%). After median follow-up of 4 months, the median change in triglyceride was -60%, and 49% of the patients reached triglyceride <150 mg/dL. After adjusting for confounding variables, female sex, non-diabetic status, coronary artery disease, lower baseline triglyceride, and no statin use were identified to be independently associated with achievement of triglyceride <150 mg/dL. Among them, female sex, non-diabetic status, and coronary artery disease were also related to median or greater percentage reduction of triglyceride. In conclusion, only half of the study patients reached triglyceride levels <150 mg/dL after real-world fenofibrate therapy. This study indicates that more attention is needed on some subgroups to obtain optimal triglyceride levels when treating with fenofibrate.	[Woo, Yeongmin] Univ Ulsan, Gangneung Asan Hosp, Div Cardiol, Dept Internal Med,Coll Med, Kangnung, South Korea; [Shin, Jeong-soo] Yonsei Univ, Dept Biostat & Comp, Coll Med, Seoul, South Korea; [Shim, Chi-Young; Kim, Jung-Sun; Kim, Byeong-Keuk; Park, Sungha; Chang, Hyuk-Jae; Hong, Geu-Ru; Ko, Young-Guk; Kang, Seok-Min; Choi, Donghoon; Ha, Jong-Won; Hong, Myeong-Ki; Jang, Yangsoo; Lee, Sang-Hak] Yonsei Univ, Severance Hosp, Div Cardiol, Dept Internal Med,Coll Med, Seoul, South Korea; [Shim, Chi-Young; Kim, Jung-Sun; Kim, Byeong-Keuk; Park, Sungha; Chang, Hyuk-Jae; Hong, Geu-Ru; Ko, Young-Guk; Kang, Seok-Min; Choi, Donghoon; Ha, Jong-Won; Hong, Myeong-Ki; Jang, Yangsoo; Lee, Sang-Hak] Yonsei Univ, Cardiovasc Res Inst, Coll Med, Seoul, South Korea	University of Ulsan; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, SH (corresponding author), Yonsei Univ, Severance Hosp, Div Cardiol, Dept Internal Med,Coll Med, Seoul, South Korea.; Lee, SH (corresponding author), Yonsei Univ, Cardiovasc Res Inst, Coll Med, Seoul, South Korea.	shl1106@yuhs.ac	Shim, Chi Young/AAK-1057-2021	Shim, Chi Young/0000-0002-6136-0136; Chang, Hyuk-Jae/0000-0002-6139-7545; Ko, Young-Guk/0000-0001-7748-5788; Kim, Byeong-Keuk/0000-0003-2493-066X; Park, Sungha/0000-0001-5362-478X; Hong, Geu-Ru/0000-0003-4981-3304; Ha, Jong-Won/0000-0002-8260-2958; Woo, Yeongmin/0000-0002-4390-2915; Kim, Jung-Sun/0000-0003-2263-3274; Kang, Seok-Min/0000-0001-9856-9227; Hong, Myeong-Ki/0000-0002-2090-2031; Choi, Donghoon/0000-0002-2009-9760; Jang, Yangsoo/0000-0002-2169-3112	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2017R1D1B03029399]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [2015M3A9B6029138]; Ministry of Food and Drug Safety, Korea [18182MFD410]; National Research Council of Science & Technology grant by the Korean government, MSIP [CAP-12-2-KBSI]	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Bio & Medical Technology Development Program of the NRF - Korean government, MSIP(National Research Foundation of Korea); Ministry of Food and Drug Safety, Korea(Ministry of Food & Drug Safety (MFDS), Republic of Korea); National Research Council of Science & Technology grant by the Korean government, MSIP	This research was financially supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2017R1D1B03029399), the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3A9B6029138), the Ministry of Food and Drug Safety, Korea (18182MFD410), and the National Research Council of Science & Technology grant by the Korean government, MSIP (No. CAP-12-2-KBSI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar C, 2015, ATHEROSCLEROSIS SUPP, V19, DOI 10.1016/S1567-5688(15)30001-5; Catapano AL, 2016, EUR HEART J, V37, P2999, DOI 10.1093/eurheartj/ehw272; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Christian JB, 2014, AM J MED, V127, P36, DOI 10.1016/j.amjmed.2013.09.018; d'Emden MC, 2014, DIABETOLOGIA, V57, P2296, DOI 10.1007/s00125-014-3344-3; Davidson MH, 2014, ARTERIOSCL THROM VAS, V34, P1298, DOI 10.1161/ATVBAHA.113.302926; Davis TME, 2011, DIABETOLOGIA, V54, P280, DOI 10.1007/s00125-010-1951-1; Ferrari R, 2016, EUR HEART J SUPPL, V18, pC2, DOI 10.1093/eurheartj/suw009; Filippatos TD, 2012, CARDIOVASC DRUG THER, V26, P245, DOI 10.1007/s10557-012-6394-0; Frank ATH, 2014, CIRCULATION, V129, P570, DOI 10.1161/CIRCULATIONAHA.113.005757; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Ho LT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116513; Irvin MR, 2016, PHARMACOGENET GENOM, V26, P324, DOI 10.1097/FPC.0000000000000219; Ito MK, 2015, ATHEROSCLEROSIS, V242, P647, DOI 10.1016/j.atherosclerosis.2015.06.012; Jacobson TA, 2014, J CLIN LIPIDOL, V8, P473, DOI 10.1016/j.jacl.2014.07.007; Kronish IM, 2013, PROG CARDIOVASC DIS, V55, P590, DOI 10.1016/j.pcad.2013.02.001; Lai CQ, 2007, ARTERIOSCL THROM VAS, V27, P1417, DOI 10.1161/ATVBAHA.107.140103; Lee SH, 2012, ATHEROSCLEROSIS, V221, P169, DOI 10.1016/j.atherosclerosis.2011.12.042; Maki KC, 2016, J CLIN LIPIDOL, V10, P905, DOI 10.1016/j.jacl.2016.03.008; Mann DM, 2010, ANN PHARMACOTHER, V44, P1410, DOI 10.1345/aph.1P150; Oikawa S, 2017, J ATHEROSCLER THROMB, V24, P77, DOI 10.5551/jat.35626; Pepine CJ, 2010, CLIN CARDIOL, V33, P609, DOI 10.1002/clc.20830; Rotroff DM, 2018, CLIN PHARMACOL THER, V103, P712, DOI 10.1002/cpt.798; Smith JA, 2008, EUR J HUM GENET, V16, P603, DOI 10.1038/sj.ejhg.5202003; Sudhop T, 1996, EUR J CLIN PHARMACOL, V50, P365, DOI 10.1007/s002280050124; Wi J, 2010, ATHEROSCLEROSIS, V213, P235, DOI 10.1016/j.atherosclerosis.2010.08.068; Yuan G, 2007, CAN MED ASSOC J, V176, P1113, DOI 10.1503/cmaj.060963; Zhao SP, 2016, INT J CARDIOL, V221, P832, DOI 10.1016/j.ijcard.2016.06.234; Zhao SP, 2014, ATHEROSCLEROSIS, V235, P463, DOI 10.1016/j.atherosclerosis.2014.05.916	30	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205006	10.1371/journal.pone.0205006	http://dx.doi.org/10.1371/journal.pone.0205006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286170	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500075
J	Hojreh, A; Homolka, P; Gamper, J; Unterhumer, S; Kienzl-Palma, D; Balassy, C; Wrba, T; Prosch, H				Hojreh, Azadeh; Homolka, Peter; Gamper, Jutta; Unterhumer, Sylvia; Kienzl-Palma, Daniela; Balassy, Csilla; Wrba, Thomas; Prosch, Helmut			Automated tube voltage selection in pediatric non-contrast chest CT	PLOS ONE			English	Article							EUROPEAN CYSTIC-FIBROSIS; COMPUTED-TOMOGRAPHY; KILOVOLTAGE SELECTION; SOCIETY STANDARDS; IMAGE QUALITY; POTENTIAL SELECTION; CURRENT MODULATION; ANGIOGRAPHY; SCANS; RISK	Background Modern CT scanners provide automatic dose adjustment systems, which are promising options for reducing radiation dose in pediatric CT scans. Their impact on patient dose, however, has not been investigated sufficiently thus far. Objective To evaluate automated tube voltage selection (ATVS) in combination with automated tube current modulation (ATCM) in non-contrast pediatric chest CT, with regard to the diagnostic image quality. Materials and methods There were 160 non-contrast pediatric chest CT scans (8.7 +/- 5.4 years) analyzed retrospectively without and with ATVS. Correlations of volume CT Dose Index (CTDIvol) and effective diameter, with and without ATVS, were compared using Fisher's z-transformation. Image quality was assessed by mean signal-difference-to-noise ratios (SDNR) in the aorta and in the left main bronchus using the independent samples t-test. Two pediatric radiologists and a general radiologist rated overall subjective Image quality. Readers' agreement was assessed using weighted kappa coefficients. A p value <0.05 was considered significant. Results CTDIvol correlation with the effective diameter was r = 0.62 without and r = 0.80 with ATVS (CI: -0.04 to -0.60; p = 0.025). Mean SDNR was 10.88 without and 10.03 with ATVS (p = 0.0089). Readers' agreement improved with ATVS (weighted kappa between pediatric radiologists from 0.1 (0.03-0.16) to 0.27 (0.09-0.45) with ATVS; between general and each pediatric radiologist from 0.1 (0.06-0.14) to 0.12 (0.05-0.20), and from 0.22 (0.11-0.34) to 0.36 (0.24-0.49)). Conclusion ATVS, combined with ATCM, results in a radiation dose reduction for pediatric non-contrast chest CT without a loss of diagnostic image quality and prevents errors in manual tube voltage setting, and thus protecting larger children against an unnecessarily high radiation exposure.	[Hojreh, Azadeh; Unterhumer, Sylvia; Kienzl-Palma, Daniela; Balassy, Csilla; Prosch, Helmut] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Homolka, Peter] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Gamper, Jutta] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Wrba, Thomas] Med Univ Vienna, IT Syst & Commun, IT4Sci, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Hojreh, A (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	azadeh.hojreh@meduniwien.ac.at	Hojreh, Azadeh/X-8161-2019; Homolka, Peter/I-2168-2012; Prosch, Helmut/A-7619-2008	Homolka, Peter/0000-0002-2300-3015; Prosch, Helmut/0000-0002-6119-6364; Wrba, Thomas/0000-0002-4915-4620; Hojreh, Azadeh/0000-0002-4556-1931				AAPM, 2011, 204 AAPM, P204; Austrian Standards Institute, 2010, DIAGN REF LEV XRAY D; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Conway S, 2014, J CYST FIBROS, V13, pS3, DOI 10.1016/j.jcf.2014.03.009; Frellesen C, 2014, EUR RADIOL, V24, P1725, DOI 10.1007/s00330-014-3197-7; Granata C, 2013, EUR J RADIOL, V82, P1098, DOI 10.1016/j.ejrad.2011.12.008; Hojreh A, 2015, EUR J RADIOL, V84, P1574, DOI 10.1016/j.ejrad.2015.04.027; Hough DM, 2012, AM J ROENTGENOL, V199, P1070, DOI 10.2214/AJR.12.8637; Huda W, 2000, RADIOLOGY, V217, P430, DOI 10.1148/radiology.217.2.r00nv35430; International Atomic Ernergy Agency, 2013, IAEA HUM HLTH SER, V24; Krazinski AW, 2014, EUR RADIOL, V24, P2677, DOI 10.1007/s00330-014-3312-9; Kuo WY, 2014, AM J RESP CRIT CARE, V189, P1328, DOI 10.1164/rccm.201311-2099CI; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee CH, 2008, RADIOGRAPHICS, V28, P1451, DOI 10.1148/rg.285075075; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; National Research Council, 2006, HLTH RISKS EXP LOW L, P141; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Peng Y, 2009, ACTA RADIOL, V50, P1175, DOI 10.3109/02841850903241914; Siegel MJ, 2013, RADIOLOGY, V268, P538, DOI 10.1148/radiol.13122438; Siegel MJ, 2013, INVEST RADIOL, V48, P584, DOI 10.1097/RLI.0b013e318289f918; Siemens Healthcare website. Grant K, CARE KV AUTOMATED DO; Smyth AR, 2014, J CYST FIBROS, V13, pS23, DOI 10.1016/j.jcf.2014.03.010; Sorantin E, 2013, EUR J RADIOL, V82, P1043, DOI 10.1016/j.ejrad.2011.11.041; Spearman JV, 2016, RADIOLOGY, V279, P167, DOI 10.1148/radiol.2015141507; Stern M, 2014, J CYST FIBROS, V13, pS43, DOI 10.1016/j.jcf.2014.03.011; Strauss KJ, 2010, AM J ROENTGENOL, V194, P868, DOI 10.2214/AJR.09.4091; Suh YJ, 2013, RADIOLOGY, V269, P722, DOI 10.1148/radiol.13130408; Winklehner A, 2015, EUR RADIOL, V25, P2346, DOI 10.1007/s00330-015-3632-4; Winklehner A, 2011, INVEST RADIOL, V46, P767, DOI 10.1097/RLI.0b013e3182266448; Yu LF, 2011, RADIOGRAPHICS, V31, P835, DOI 10.1148/rg.313105079	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204794	10.1371/journal.pone.0204794	http://dx.doi.org/10.1371/journal.pone.0204794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281614	gold, Green Published, Green Submitted			2022-12-26	WOS:000446342400057
J	Yamada, M; Minoura, K; Mizoguchi, T; Nakamatsu, K; Taguchi, T; Kameda, T; Sekiguchi, M; Suzutani, T; Konno, S				Yamada, Miho; Minoura, Kiyoshi; Mizoguchi, Takashi; Nakamatsu, Kenichiro; Taguchi, Tokio; Kameda, Takuya; Sekiguchi, Miho; Suzutani, Tatsuo; Konno, Shinichi			Antibacterial effects of nano-imprinted moth-eye film in practical settings	PLOS ONE			English	Article							BACTERICIDAL SURFACES; STAPHYLOCOCCUS-AUREUS; NANOPARTICLES; CONTAMINATION	Background Recent studies report that surfaces displaying micrometer- or nanometer-sized undulating structures exhibit antibacterial effects. In previous work, we described the use of an advanced nanofabrication technique to generate an artificial biomimetic Moth-eye film by coating a polyethylene terephthalate (PET) film with nanoscale moth-eye protrusions made from a hydrophilic resin. This moth-eye film exhibited enhanced antibacterial effects in in vitro experiments. The aim of the present study was to verify the antibacterial efficacy of the Moth-eye film in practical environments. Materials and methods The antibacterial effects of three types of film (Moth-eye film, Flat film, and PET film) were compared. Sample films were pasted onto hand washing basins at the testing locations. After several hours, bacteria were collected from the surface of the sample films with one of three kinds of culture media stamper (to permit identification of bacterial species). The stampers were incubated for 48 hours at 35 degrees C, and the numbers of colonies were counted. Results and discussion The number of common bacteria including E. coli and S. aureus obtained from the Moth-eye film was significantly lower than those from the PET film (p<0.05) and Flat film at 1 hour (p<0.05). This study found that the Moth-eye film showed a long-term (6h) antibacterial effect and the Moth-eye structure (PET coated with nanoscale cone-shaped pillars) demonstrated a physical antibacterial effect from earlier time points. Therefore, the Moth-eye film appears to have potential general-purpose applications in practical environments.	[Yamada, Miho; Minoura, Kiyoshi] Sharp Co Ltd, Display Technol Dev Ctr, Dev Grp, Display Device Co, Tenri, Nara, Japan; [Mizoguchi, Takashi; Nakamatsu, Kenichiro; Taguchi, Tokio] Sharp Co Ltd, New Business Promot Ctr, Dev Grp, Display Device Co, Tenri, Nara, Japan; [Kameda, Takuya; Sekiguchi, Miho; Konno, Shinichi] Fukushima Med Univ, Sch Med, Dept Orthopaed Surg, Fukushima, Japan; [Suzutani, Tatsuo] Fukushima Med Univ, Sch Med, Dept Microbiol, Fukushima, Japan	Hisense; Sharp Corporation; Hisense; Sharp Corporation; Fukushima Medical University; Fukushima Medical University	Yamada, M (corresponding author), Sharp Co Ltd, Display Technol Dev Ctr, Dev Grp, Display Device Co, Tenri, Nara, Japan.	yamada.miho@sharp.co.jp		Minoura, Kiyoshi/0000-0002-5236-3087; Kameda, Takuya/0000-0001-8770-4884	Sharp Corporation	Sharp Corporation	The authors received no specific funding for this work. Sharp Corporation provided support in the form of salaries for authors [MY, KM, TM, KN and TT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405; Dickson MN, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4922157; Egusa M, 2015, INT J MOL SCI, V16, P26202, DOI 10.3390/ijms161125947; Gunawan C, 2013, SMALL, V9, P3554, DOI 10.1002/smll.201300761; Hasan J, 2013, APPL MICROBIOL BIOT, V97, P9257, DOI 10.1007/s00253-012-4628-5; Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017; Hoshino Y, 2009, SMALL, V5, P1562, DOI 10.1002/smll.200900186; Ivanova EP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3838; Ivanova EP, 2012, SMALL, V8, P2489, DOI 10.1002/smll.201200528; Kimura S, 2009, JPN J ENV INFECT, V24, P21; Kitada M, 2015, FUJI FILM TECHNICAL, V60, P6; Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003; Minoura K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185366; Muller MP, 2016, J HOSP INFECT, V92, P7, DOI 10.1016/j.jhin.2015.09.008; Ono H, 1998, BIOSCI BIOTECH BIOCH, V62, P363, DOI 10.1271/bbb.62.363; Roe D, 2008, J ANTIMICROB CHEMOTH, V61, P869, DOI 10.1093/jac/dkn034; Tarana Sarwat, 2015, International Journal of Current Microbiology and Applied Sciences, V4, P286; Teramoto T, 2003, JPN J FOOD MICROBIAL, V20, P217; Tokoro M, 1987, J JPN ASS INFECT DIS, V61, P1376; Tripathy A, 2017, ADV COLLOID INTERFAC, V248, P85, DOI 10.1016/j.cis.2017.07.030; Tuladhar E, 2012, APPL ENVIRON MICROB, V78, P7769, DOI 10.1128/AEM.02144-12; Vitiello G, 2018, CURR TOP MED CHEM, V18, P22, DOI 10.2174/1568026618666180206101129; Vitiello G, 2017, MAT SCI ENG C-MATER, V75, P454, DOI 10.1016/j.msec.2016.12.135; Vitiello G, 2015, J MATER CHEM B, V3, P2808, DOI 10.1039/c5tb00039d; WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015	26	12	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0198300	10.1371/journal.pone.0198300	http://dx.doi.org/10.1371/journal.pone.0198300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281619	gold, Green Published, Green Submitted			2022-12-26	WOS:000446342400002
J	David, JP; Lisewski, U; Crump, SM; Jepps, TA; Bocksteins, E; Wilck, N; Lossie, J; Roepke, TK; Schmitt, N; Abbott, GW				David, Jens-Peter; Lisewski, Ulrike; Crump, Shawn M.; Jepps, Thomas A.; Bocksteins, Elke; Wilck, Nicola; Lossie, Janine; Roepke, Torsten K.; Schmitt, Nicole; Abbott, Geoffrey W.			Deletion in mice of X-linked, Brugada syndrome- and atrial fibrillation-associated Kcne5 augments ventricular K-V currents and predisposes to ventricular arrhythmia	FASEB JOURNAL			English	Article						MiRP4; I-Kslow; I-to; potassium channel	POTASSIUM CHANNEL; I-KS; MENTAL-RETARDATION; BETA-SUBUNITS; REPOLARIZATION; MOUSE; MINK; KV2.1; GENE; EXPRESSION	KCNE5 is an X-linked gene encoding KCNE5, an ancillary subunit to voltage-gated potassium (K-V) channels. Human KCNE5 mutations are associated with atrial fibrillation (AF)- and Brugada syndrome (BrS)-induced cardiac arrhythmias that can arise from increased potassium current in cardiomyocytes. Seeking to establish underlying molecular mechanisms, we created and studied Kcne5 knockout (Kcne5(-/0)) mice. Intracardiac ECG revealed that Kcne5 deletion caused ventricular premature beats, increased susceptibility to induction of polymorphic ventricular tachycardia (60 vs. 24% in Kcne5(+/0) mice), and 10% shorter ventricular refractory period. Kcne5 deletion increased mean ventricular myocyte K-V current density in the apex and also in the subpopulation of septal myocytes that lack fast transient outward current (I-to,I-f). The current increases arose from an apex-specific increase in slow transient outward current-1 (I-Kslow,I-1) (conducted by K(V)1.5) and I-to,I-f (conducted by K(V)4) and an increase in I-Kslow,I-2 (conducted by K(V)2.1) in both apex and septum. Kcne5 protein localized to the intercalated discs in ventricular myocytes, where K(V)2.1 was also detected in both Kcne5(-/0) and Kcne5(+/0) mice. In HL-1 cardiac cells and human embryonic kidney cells, KCNE5 and K(V)2.1 colocalized at the cell surface, but predominantly in intracellular vesicles, suggesting that Kcne5 deletion increases I-K,I-slow2 by reducing K(V)2.1 intracellular sequestration. The human AF-associated mutation KCNE5-L65F negative shifted the voltage dependence of K(V)2.1-KCNE5 channels, increasing their maximum current density >2-fold, whereas BrS-associated KCNE5 mutations produced more subtle negative shifts in K(V)2.1 voltage dependence. The findings represent the first reported native role for Kcne5 and the first demonstrated Kcne regulation of K(V)2.1 in mouse heart. Increased K-V current is a manifestation of KCNE5 disruption that is most likely common to both mouse and human hearts, providing a plausible mechanistic basis for human KCNE5-linked AF and BrS.David, J.-P., Lisewski, U., Crump, S. M., Jepps, T. A., Bocksteins, E., Wilck, N., Lossie, J., Roepke, T. K., Schmitt, N., Abbott, G. W. Deletion in mice of X-linked, Brugada syndrome- and atrial fibrillation-associated Kcne5 augments ventricular K-V currents and predisposes to ventricular arrhythmia.	[David, Jens-Peter; Jepps, Thomas A.; Schmitt, Nicole] Univ Copenhagen, Danish Natl Res Fdn, Ctr Cardiac Arrhythmia, Copenhagen, Denmark; [David, Jens-Peter; Jepps, Thomas A.; Schmitt, Nicole] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Lisewski, Ulrike; Wilck, Nicola; Lossie, Janine; Roepke, Torsten K.] Charite Med Univ Berlin, Med Clin & Polyclin Cardiol & Angiol, Berlin, Germany; [Lisewski, Ulrike; Wilck, Nicola; Lossie, Janine; Roepke, Torsten K.] Charite Med Univ Berlin, ECRC, Berlin, Germany; [Crump, Shawn M.; Abbott, Geoffrey W.] Univ Calif Irvine, Dept Physiol & Biophys, Bioelect Lab, Irvine, CA 92717 USA; [Bocksteins, Elke] Univ Antwerp, Lab Mol Biophys Physiol & Pharmacol, Dept Biomed Sci, Antwerp, Belgium; [Bocksteins, Elke] Qual Design NV, Antwerp, Belgium; [Wilck, Nicola] Charite Univ Med Berlin, Med Klin Schwerpunkt Nephrol & Internist Intens M, Berlin, Germany; [Wilck, Nicola] ECRC, Berlin, Germany; [Lossie, Janine] Omeicos Therapeut, Berlin, Germany	Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Irvine; University of Antwerp; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Abbott, GW (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, Bioelect Lab, Med Sci D337, Irvine, CA 92697 USA.	abbottg@uci.edu	Jepps, Thomas/U-3630-2017	Jepps, Thomas/0000-0002-9903-714X; Wilck, Nicola/0000-0003-3189-5364	Danish National Research Foundation; Faculty of Health and Medical Sciences, UCPH; Arvid Nilsson Foundation; European Union [608765]; Lundbeck Foundation; Research Foundation-Flanders (FWO); U.S. National Institutes of Health/National Heart, Lung and Blood Institute [HL079275, HL079275-S1]	Danish National Research Foundation(Danmarks Grundforskningsfond); Faculty of Health and Medical Sciences, UCPH; Arvid Nilsson Foundation; European Union(European Commission); Lundbeck Foundation(Lundbeckfonden); Research Foundation-Flanders (FWO)(FWO); U.S. National Institutes of Health/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Morten Thomsen [University of Copenhagen (UCPH), Copenhagen, Denmark] for advice on mouse ECG analysis and the Core Facility for Integrated Microscopy at UCPH. This work was supported by a framework grant of the Danish National Research Foundation (to N.S.); a Ph.D. stipend from the Faculty of Health and Medical Sciences, UCPH (to J.-P.D.); funding from the Arvid Nilsson Foundation (to J.-P.D.); the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme Grant FP7/2007-2013 (Research Executive Agency Grant Agreement 608765) and a grant from the Lundbeck Foundation (to T.A.J.); a postdoctoral fellowship from the Research Foundation-Flanders (FWO) (to E.B.); and U.S. National Institutes of Health/National Heart, Lung and Blood Institute Grant HL079275 and Postdoctoral Diversity Supplement Grant HL079275-S1 (to G.W.A.). The authors declare no conflicts of interest.	Abbott GW, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00066; Abbott GW, 2016, J VASC RES, V53, P138, DOI 10.1159/000449060; Abbott GW, 2016, GENE, V593, P249, DOI 10.1016/j.gene.2016.07.069; Abbott GW, 2016, GENE, V576, P1, DOI 10.1016/j.gene.2015.09.059; Abbott GW, 2015, GENE, V569, P162, DOI 10.1016/j.gene.2015.06.061; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Bou-Abboud E, 2000, J PHYSIOL-LONDON, V529, P345, DOI 10.1111/j.1469-7793.2000.00345.x; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Crump SM, 2016, FASEB J, V30, P360, DOI 10.1096/fj.15-278754; Crump SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00003; David JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12813; David JP, 2013, TRAFFIC, V14, P399, DOI 10.1111/tra.12042; Drici MD, 1998, CIRC RES, V83, P95, DOI 10.1161/01.RES.83.1.95; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Hu ZY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26599-8; Hu ZY, 2014, CIRC-CARDIOVASC GENE, V7, P33, DOI 10.1161/CIRCGENETICS.113.000315; Jonsson JJ, 1998, J MED GENET, V35, P273, DOI 10.1136/jmg.35.4.273; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Lee SM, 2017, FASEB J, V31, P2674, DOI 10.1096/fj.201601347; Lee SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23118; Lisewski U, 2016, FASEB J, V30, P2476, DOI 10.1096/fj.201600317R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; McCrossan ZA, 2009, J MEMBRANE BIOL, V228, P1, DOI 10.1007/s00232-009-9154-8; O'Connell KMS, 2008, AM J PHYSIOL-HEART C, V294, pH229, DOI 10.1152/ajpheart.01038.2007; Ohno S, 2011, CIRC-ARRHYTHMIA ELEC, V4, P352, DOI 10.1161/CIRCEP.110.959619; Olesen MS, 2014, HEART RHYTHM, V11, P246, DOI 10.1016/j.hrthm.2013.10.034; Piccini M, 1999, GENOMICS, V60, P251, DOI 10.1006/geno.1999.5904; Radicke S, 2006, CARDIOVASC RES, V71, P695, DOI 10.1016/j.cardiores.2006.06.017; Ravn LS, 2008, HEART RHYTHM, V5, P427, DOI 10.1016/j.hrthm.2007.12.019; Ravn LS, 2005, AM J CARDIOL, V96, P405, DOI 10.1016/j.amjcard.2005.03.086; ROBSON WLM, 1994, CLIN GENET, V45, P314; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schmitt N, 2014, PHYSIOL REV, V94, P609, DOI 10.1152/physrev.00022.2013; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanWagoner DR, 1997, CIRC RES, V80, P772; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Warth R, 2002, AM J PHYSIOL-REG I, V282, pR639, DOI 10.1152/ajpregu.00649.2001; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Zhou J, 2003, AM J PHYSIOL-HEART C, V284, pH491, DOI 10.1152/ajpheart.00576.2002	47	15	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2537	2552		10.1096/fj.201800502R	http://dx.doi.org/10.1096/fj.201800502R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30289750	Green Published			2022-12-26	WOS:000457296600080
J	Delhon, L; Mahaut, C; Goudin, N; Gaudas, E; Piquand, K; Le Goff, W; Cormier-Daire, V; Le Goff, C				Delhon, Laure; Mahaut, Clementine; Goudin, Nicolas; Gaudas, Emilie; Piquand, Kevin; Le Goff, Wilfried; Cormier-Daire, Valerie; Le Goff, Carine			Impairment of chondrogenesis and microfibrillar network in Adamtsl2 deficiency	FASEB JOURNAL			English	Article						cartilage; mouse model; geleophysic dysplasia; extracellular matrix	TGF-BETA; GROWTH; FIBRILLIN-1; MUTATIONS; DYSPLASIA; PROTEINS; MATRIX; DIFFERENTIATION; BIOAVAILABILITY; PROLIFERATION	Mutations in the a disintegrin and metalloproteinase with thrombospondin motif-like 2 (ADAMTSL2) gene are responsible for the autosomal recessive form of geleophysic dysplasia, which is characterized by short stature, short extremities, and skeletal abnormalities. However, the exact function of ADAMTSL2 is unknown. To elucidate the role of this protein in skeletal development, we generated complementary knockout (KO) mouse models with either total or chondrocyte Adamtsl2 deficiency. We observed that the Adamtsl2 KO mice displayed skeletal abnormalities reminiscent of the human phenotype. Adamtsl2 deletion affected the growth plate formation with abnormal differentiation and proliferation of chondrocytes. In addition, a TGF- signaling impairment in limbs lacking Adamtsl2 was demonstrated. Further investigations revealed that Adamtsl2 KO chondrocytes failed to establish a microfibrillar network composed by fibrillin1 and latent TGF- binding protein 1 fibrils. Chondrocyte Adamtsl2 KO mice also exhibited dwarfism. These studies uncover the function of Adamtsl2 in the maintenance of the growth plate ECM by modulating the microfibrillar network.Delhon, L., Mahaut, C., Goudin, N., Gaudas, E., Piquand, K., Le Goff, W., Cormier-Daire, V., Le Goff, C. Impairment of chondrogenesis and microfibrillar network in Adamtsl2 deficiency.	[Delhon, Laure; Mahaut, Clementine; Gaudas, Emilie; Piquand, Kevin; Cormier-Daire, Valerie; Le Goff, Carine] Paris Descartes Univ, Sorbonne Paris Cite, INSERM,Imagine Inst, UMR 1163,Lab Mol & Physiopathol Bases Osteochondr, Paris, France; [Goudin, Nicolas] Imaging Platform Necker Enfants Malades Hosp, Struct Federat Rech SFR Necker, Paris, France; [Le Goff, Wilfried] Sorbonne Univ, INSERM, Hop Pitie, UMR S1166,Inst Cardiometab & Nutr ICAN, Paris, France; [Cormier-Daire, Valerie] Necker Enfants Malades Hosp, AP HP, Reference Ctr Skeletal Dysplasia, Dept Med Genet, Paris, France; [Le Goff, Carine] Hop Xavier Bichat, INSERM, UMR 1148, Lab Vasc Translat Sci, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Le Goff, C (corresponding author), Lab Vasc Translat Sci, UMR1148, 46 Rue Henri Huchard, F-75018 Paris, France.	carine.le-goff@inserm.fr	Le Goff, Wilfried/N-6326-2017; Le Goff, Wilfried/N-7593-2019; LE GOFF, Carine/AAG-2390-2020	Le Goff, Wilfried/0000-0002-7611-9644; Le Goff, Wilfried/0000-0002-7611-9644; LE GOFF, Carine/0000-0002-7788-708X	French National Research Agency Grant ANR [R09183KS]; FP7 Sybil Program; FRM Prix Pomaret de Lalande; National Research Agency under the Investments for the Future Program [ANR-A0-IAHU-01]	French National Research Agency Grant ANR; FP7 Sybil Program; FRM Prix Pomaret de Lalande; National Research Agency under the Investments for the Future Program(French National Research Agency (ANR))	The authors thank Dr. L. Legeai-Mallet for critical reading of the manuscript, the animal facilities and histology platform from Imagine Institute, and the mouse clinic at Strasbourg (IGBMC). This work was supported by French National Research Agency Grant ANR R09183KS (to C.L.G. and V.C.-D.), the FP7 Sybil Program (to V.C.-D.), and by FRM Prix Pomaret de Lalande (to L.D. and C.L.G.). This program has received a state subsidy managed by the National Research Agency under the Investments for the Future Program (ANR-A0-IAHU-01). The authors declare no conflicts of interest.	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Bader HL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012817; Ballut L, 2013, J MOL RECOGNIT, V26, P76, DOI 10.1002/jmr.2250; Cain SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048634; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Dubail J, 2015, MATRIX BIOL, V44-46, P24, DOI 10.1016/j.matbio.2015.03.001; Duplan MB, 2016, HUM MOL GENET, V25, P2997, DOI 10.1093/hmg/ddw153; Hubmacher D, 2015, DIS MODEL MECH, V8, P487, DOI 10.1242/dmm.017046; Hubmacher D, 2011, CELL MOL LIFE SCI, V68, P3137, DOI 10.1007/s00018-011-0780-9; Iwata T, 2000, HUM MOL GENET, V9, P1603, DOI 10.1093/hmg/9.11.1603; Jonquoy A, 2012, HUM MOL GENET, V21, P841, DOI 10.1093/hmg/ddr514; Kinsey R, 2008, J CELL SCI, V121, P2696, DOI 10.1242/jcs.029819; Koo BH, 2007, MATRIX BIOL, V26, P431, DOI 10.1016/j.matbio.2007.03.003; Kramerova IA, 2000, DEVELOPMENT, V127, P5475; Larrede S, 2009, ARTERIOSCL THROM VAS, V29, P1930, DOI 10.1161/ATVBAHA.109.194548; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Le Goff C, 2011, AM J HUM GENET, V89, P7, DOI 10.1016/j.ajhg.2011.05.012; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Liu CJ, 2007, FRONT BIOSCI, V12, P3899, DOI 10.2741/2359; McInerney-Leo AM, 2016, J MED GENET, V53, P457, DOI 10.1136/jmedgenet-2015-103647; Melrose J, 2016, MATRIX BIOL, V52-54, P363, DOI 10.1016/j.matbio.2016.01.008; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Nandadasa S, 2014, MATRIX BIOL, V35, P34, DOI 10.1016/j.matbio.2014.01.005; Pannier S, 2010, BONE, V47, P905, DOI 10.1016/j.bone.2010.07.020; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Sengle G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002425; Yadin DA, 2013, STRUCTURE, V21, P1743, DOI 10.1016/j.str.2013.08.004	30	17	17	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2707	2718		10.1096/fj.201800753RR	http://dx.doi.org/10.1096/fj.201800753RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303737				2022-12-26	WOS:000457296600094
J	Chen, CH; Lin, YH; Chen, CH; Wang, YH; Yeh, ML; Cheng, TL; Wang, CZ				Chen, Chia-Hsin; Lin, Yi-Hsiung; Chen, Chung-Hwan; Wang, Yan-Hsiung; Yeh, Ming-Long; Cheng, Tsung-Lin; Wang, Chau-Zen			Transforming growth factor beta 1 mediates the low-frequency vertical vibration enhanced production of tenomodulin and type I collagen in rat Achilles tendon	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; HUMAN PATELLAR TENDON; GENE-EXPRESSION; MECHANICAL-PROPERTIES; HORMONAL RESPONSES; SKELETAL-MUSCLE; EXERCISE; MATRIX; STRENGTH; DECORIN	Vertical vibration (VV) is a whole-body vibration with mechanical loading that commonly used in rehabilitation and sports training to increase athlete muscle strength. Our previous study showed that low-magnitude, low-frequency VV at 8 Hz and 10 Hz increased myoblast myogenesis. Herein, we investigated whether a VV frequency at low-frequency 5-10 Hz has anabolic effects on tenocytes and improves tendon stiffness. In primary tenocytes, 10 Hz VV treatment increased the tenogenic marker gene expression of tenomodulin and extracellular matrix type I collagen but decreased decorin expression. qPCR and Enzyme-Linked Immunosorbent Assay (ELISA) results showed that TGF-beta 1 expression was increased in tenocytes after 3 days of 10 Hz VV treatment in vitro and in Achilles tendons after 3 weeks in vivo. Tenomodulin expression and Achilles tendon stiffness were significantly increased in Achilles tendons after 3 weeks in vivo. We also showed that the TGF-beta 1 receptor inhibitor SB431542 (10 mu M) decreased the expression of tenomodulin and type I collagen but increased the decorin expression in tenocytes. These results indicated that the 10 Hz VV stimulated anabolic effects in tenocytes by increasing TGF-beta 1 expression that subsequently increases the expression of tenomodulin and type I collagen, and increased the Achilles tendon stiffness. This study provides insight into the low-frequency 10 Hz VV treatment improves tendon properties and can minimizes the risk of ligament/tendon reinjure during rehabilitation.	[Chen, Chia-Hsin] Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin; Lin, Yi-Hsiung; Chen, Chung-Hwan; Wang, Yan-Hsiung; Cheng, Tsung-Lin; Wang, Chau-Zen] Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Lin, Yi-Hsiung; Cheng, Tsung-Lin; Wang, Chau-Zen] Kaohsiung Med Univ, Coll Med, Dept Physiol, Kaohsiung, Taiwan; [Lin, Yi-Hsiung; Wang, Chau-Zen] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chen, Chung-Hwan] Kaohsiung Med Univ, Coll Med, Dept Orthopaed, Kaohsiung, Taiwan; [Chen, Chung-Hwan] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Orthoped, Kaohsiung, Taiwan; [Chen, Chung-Hwan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Orthoped, Div Adult Reconstruct Surg, Kaohsiung, Taiwan; [Wang, Yan-Hsiung] Kaohsiung Med Univ, Sch Dent, Kaohsiung, Taiwan; [Wang, Yan-Hsiung; Cheng, Tsung-Lin; Wang, Chau-Zen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Yeh, Ming-Long] Natl Cheng Kung Univ, Dept Biomed Engn, 1 Univ Rd, Tainan, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Cheng Kung University	Wang, CZ (corresponding author), Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan.; Wang, CZ (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Physiol, Kaohsiung, Taiwan.; Wang, CZ (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.; Wang, CZ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.	czwang@kmu.edu.tw	Chen, Chung-Hwan/D-4036-2009; Wang, Yan-Hsiung/ABD-4004-2020	Chen, Chung-Hwan/0000-0001-8941-4792; Wang, Yan-Hsiung/0000-0001-8161-7472; Chen, Chia-Hsin/0000-0002-6557-9848; Cheng, Tsung-Lin/0000-0001-7080-8652	Ministry of Science and Technology [MOST 105-2320-B-037 -017 -MY3, MOST 106-2314-B-037 -050 -MY3]; Ministry of Health and Welfare [MOHW106-TDU-B-212-113006, MOHW107-TDU-B-212-123006]; Orthopaedic Research Center in Kaohsiung Medical University	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Orthopaedic Research Center in Kaohsiung Medical University	This work was supported by a grant from the Ministry of Science and Technology (https://www.most.gov.tw) Grant number: MOST 105-2320-B-037 -017 -MY3 and MOST 106-2314-B-037 -050 -MY3 (C-ZW) and Ministry of Health and Welfare, Grant number: MOHW106-TDU-B-212-113006 and MOHW107-TDU-B-212-123006 (C-HC). This study was supported by Orthopaedic Research Center in Kaohsiung Medical University for the research resource and equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautmans Ivan, 2005, BMC Geriatr, V5, P17, DOI 10.1186/1471-2318-5-17; Bosco C, 2000, EUR J APPL PHYSIOL, V81, P449, DOI 10.1007/s004210050067; Cardinale M, 2005, BRIT J SPORT MED, V39, P585, DOI 10.1136/bjsm.2005.016857; Chan KM, 2008, WOUND REPAIR REGEN, V16, P399, DOI 10.1111/j.1524-475X.2008.00379.x; Chokalingam K, 2009, TISSUE ENG PT A, V15, P2561, DOI [10.1089/ten.tea.2008.0451, 10.1089/ten.TEA.2008.0451]; Clegg PD, 2007, INT J EXP PATHOL, V88, P227, DOI 10.1111/j.1365-2613.2007.00549.x; Dex S, 2017, EBIOMEDICINE, V20, P240, DOI 10.1016/j.ebiom.2017.05.003; Doral MN, 2010, KNEE SURG SPORT TR A, V18, P638, DOI 10.1007/s00167-010-1083-7; Eriksen HA, 2002, J ORTHOPAED RES, V20, P1352, DOI 10.1016/S0736-0266(02)00064-5; Erskine J, 2007, CLIN PHYSIOL FUNCT I, V27, P242, DOI 10.1111/j.1475-097X.2007.00745.x; Fagnani F, 2006, AM J PHYS MED REHAB, V85, P956, DOI 10.1097/01.phm.0000247652.94486.92; Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200; Fu SC, 2005, CLIN ORTHOP RELAT R, P226, DOI 10.1097/01.blo.0000145887.48534.6f; HANSSON HA, 1988, SCAND J PLAST RECONS, V22, P1; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Heinemeier KM, J MUSCULOSKELET NEUR, V11, P115; Ho ML, 2009, EUR J CLIN INVEST, V39, P296, DOI 10.1111/j.1365-2362.2009.02092.x; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jones ER, 2013, BBA-MOL CELL RES, V1833, P2596, DOI 10.1016/j.bbamcr.2013.06.019; Kawanabe Kazuhiro, 2007, Keio Journal of Medicine, V56, P28, DOI 10.2302/kjm.56.28; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Legerlotz K, 2007, J APPL PHYSIOL, V102, P564, DOI 10.1152/japplphysiol.00767.2006; Liang JI, 2014, J MATER SCI-MATER M, V25, P217, DOI 10.1007/s10856-013-5036-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811; Maas H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/575672; Martin D, 2003, J CELL BIOL, V160, P171, DOI 10.1083/jcb.200206109; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Mousavizadeh R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097356; Park DY, 2006, FOOT ANKLE INT, V27, P1086, DOI 10.1177/107110070602701215; Pel JJM, 2009, MED ENG PHYS, V31, P937, DOI 10.1016/j.medengphy.2009.05.005; Reeves ND, 2005, J APPL PHYSIOL, V98, P2278, DOI 10.1152/japplphysiol.01266.2004; Reeves ND, 2003, J PHYSIOL-LONDON, V548, P971, DOI 10.1113/jphysiol.2002.035576; Rieder F, 2016, SCAND J MED SCI SPOR, V26, P902, DOI 10.1111/sms.12522; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Roelants M, 2004, INT J SPORTS MED, V25, P1, DOI 10.1055/s-2003-45238; Sandhu E, 2011, J BIOMECH, V44, P1189, DOI 10.1016/j.jbiomech.2011.02.017; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Stewart JM, 2005, AM J PHYSIOL-REG I, V288, pR623, DOI 10.1152/ajpregu.00513.2004; Sun HB, 2008, CLIN ORTHOP RELAT R, V466, P1555, DOI 10.1007/s11999-008-0278-4; Thompson WR, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115585783; Totosy de Zepetnek JO, 2009, J REHABIL RES DEV, V46, P529, DOI 10.1682/JRRD.2008.09.0136; Uzer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090840; Wang CZ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-115; Wang CK, 2009, BIOMATERIALS, V30, P4178, DOI 10.1016/j.biomaterials.2009.04.029; Yamamoto E, 1999, CLIN BIOMECH, V14, P418, DOI 10.1016/S0268-0033(99)00006-6; Yang GG, 2004, J BIOMECH, V37, P1543, DOI 10.1016/j.jbiomech.2004.01.005; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	51	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205258	10.1371/journal.pone.0205258	http://dx.doi.org/10.1371/journal.pone.0205258			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307981	Green Submitted, Green Published, gold			2022-12-26	WOS:000447173500054
J	Liu, YT; Wang, WX; Xu, JQ; Xue, HY; Stanford, K; McAllister, TA; Xu, WP				Liu, Yuting; Wang, Wenxia; Xu, Jianqiang; Xue, Hongyu; Stanford, Kim; McAllister, Tim A.; Xu, Weiping			Evaluation of compost, vegetable and food waste as amendments to improve the composting of NaOH/NaClO-contaminated poultry manure	PLOS ONE			English	Article							SP-NOV.; GEN. NOV.; MICROBIAL COMMUNITIES; BACTERIAL; BIODEGRADATION; IDENTIFICATION; STABILIZATION; DISINFECTANTS; DIVERSITY; SUBSTRATE	Regular usage of NaOH/NaClO disinfectants results in high sodium salt and alkalinity of poultry manure. This study compared three amendments: vegetable waste (V), food waste (F) and mature compost (C) for their ability to improve the composting of NaOH/NaClO-contaminated poultry manure. C compost resulted in the highest compost temperatures (p<0.001) and greatest reduction in OM, TC, TN and NH4-N (p<0.05). C and V composts were more efficient at lowering extractable-Na (ext-Na) and electrical conductivity (EC) than F (p<0.05). Maturity was primarily indicated by NH4-N, EC and ext-Na. Bacterial dynamics was profoundly influenced by NH4-N, EC and TC, with the decrease leading to discriminate genera shift from Sinibacillus and Thiopseudomonas to Brevbacterium, Brachybacterium, and Microbacterium. These findings suggest that mature compost was more desirable amendment than vegetable and food waste in the composting of NaOH/NaClO-contaminated poultry manure, and the decrease of ext-Na indicated compost maturity but did not influence bacterial dynamics.	[Liu, Yuting; Wang, Wenxia; Xu, Weiping] Dalian Univ Technol, Sch Food & Environm, Panjin Campus, Panjin, Peoples R China; [Xu, Jianqiang; Xue, Hongyu] Dalian Univ Technol, Sch Life Sci & Med, Panjin Campus, Panjin, Peoples R China; [Xu, Jianqiang; Xu, Weiping] Dalian Univ Technol, Panjin Ind Technol Inst, Panjin, Peoples R China; [Stanford, Kim] Alberta Agr & Forestry, Agr Ctr, Lethbridge, AB, Canada; [McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada	Dalian University of Technology; Dalian University of Technology; Dalian University of Technology; Agriculture & Agri Food Canada	Xu, WP (corresponding author), Dalian Univ Technol, Sch Food & Environm, Panjin Campus, Panjin, Peoples R China.; Xu, WP (corresponding author), Dalian Univ Technol, Panjin Ind Technol Inst, Panjin, Peoples R China.	Weiping.Xu@dlut.edu.cn	Xu, Jianqiang/T-7507-2019	Xu, Jianqiang/0000-0002-1289-5943	Research Project Foundation of Dalian University of Technology [DUT15RC(3)052, DUT17JC35]; General Research Project of Liaoning Provincial Education Department [L2015117]; Scientific Research and Development Project of Panjin Industrial Technology Institute of Dalian University of Technology [PJYJY2016A009]; National Natural Science Foundation of China (NSFC) [31670767, 31400307]	Research Project Foundation of Dalian University of Technology; General Research Project of Liaoning Provincial Education Department; Scientific Research and Development Project of Panjin Industrial Technology Institute of Dalian University of Technology; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported financially by the Research Project Foundation of Dalian University of Technology (DUT15RC(3)052 and DUT17JC35), URL: www.dlut.edu.cn; the General Research Project of Liaoning Provincial Education Department (L2015117), URL: http://www.lnen.cn/; the Scientific Research and Development Project of Panjin Industrial Technology Institute of Dalian University of Technology (PJYJY2016A009), URL: http://pjyjy.dlut.edu.cn/index.htm; and the National Natural Science Foundation of China (NSFC No. 31670767 and 31400307), URL: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Awasthi MK, 2017, BIORESOURCE TECHNOL, V237, P156, DOI 10.1016/j.biortech.2017.01.044; Azeez JO, 2012, COMMUN SOIL SCI PLAN, V43, P865, DOI 10.1080/00103624.2012.653022; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; BRINK N, 1994, ACTA AGR SCAND B-S P, V44, P184, DOI 10.1080/09064719409410243; Chen QQ, 2017, ANN MICROBIOL, V67, P491, DOI 10.1007/s13213-017-1278-y; Chowdhury S, 2016, ENVIRON SCI POLLUT R, V23, P7099, DOI 10.1007/s11356-015-5411-9; Cotta MA, 2004, ANAEROBE, V10, P191, DOI 10.1016/j.anaerobe.2004.04.001; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Duan ML, 2016, ENVIRON TECHNOL, V37, P1357, DOI 10.1080/09593330.2015.1115131; Rizzo PF, 2015, J MATER CYCLES WASTE, V17, P42, DOI 10.1007/s10163-013-0221-y; Fox J., 2019, R COMPANION APPL REG, V.; Huhe,, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.518; Ignatowicz K, 2017, ENVIRON RES, V156, P19, DOI 10.1016/j.envres.2017.02.035; Irshad M, 2013, J SOIL SCI PLANT NUT, V13, P115, DOI [10.4067/S0718-95162013005000011, 10.4067/S0718-95162012005000037]; Jang Y, 2014, POULTRY SCI, V93, P70, DOI 10.3382/ps.2013-03452; Jo EY, 2013, MYCOBIOLOGY, V41, P42, DOI 10.5941/MYCO.2013.41.1.42; Lee IB, 2002, SOIL SCI PLANT NUTR, V48, P1, DOI 10.1080/00380768.2002.10409164; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Li-Xian Y, 2007, SCI TOTAL ENVIRON, V383, P106, DOI 10.1016/j.scitotenv.2007.05.027; Liu L, 2018, WASTE MANAGE, V73, P101, DOI 10.1016/j.wasman.2017.12.026; Luyckx K, 2017, POULTRY SCI, V96, P938, DOI 10.3382/ps/pew355; Meng LQ, 2016, BIORESOURCE TECHNOL, V210, P160, DOI 10.1016/j.biortech.2016.01.094; Neher DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079512; Oksanen J., 2019, R PACKAGE VERSION; Onwosi CO, 2017, J ENVIRON MANAGE, V190, P140, DOI 10.1016/j.jenvman.2016.12.051; Ouellette M.-H., 2013, MVPARTWRAP ADDITIONA; Parillo R, 2017, WASTE BIOMASS VALORI, V8, P2711, DOI 10.1007/s12649-016-9761-4; Ren GM, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2059-7; Safdar M, 2014, MEAT SCI, V98, P296, DOI 10.1016/j.meatsci.2014.06.006; Sener A, 2007, ANN MICROBIOL, V57, P101, DOI 10.1007/BF03175057; Seo HS, 2015, INT J SYST EVOL MICR, V65, P3591, DOI 10.1099/ijsem.0.000463; Costa MSSD, 2017, J CLEAN PROD, V142, P2084, DOI 10.1016/j.jclepro.2016.11.075; Tamura M, 2004, BRIT J NUTR, V92, P771, DOI 10.1079/BJN20041267; Tan WB, 2015, INT J SYST EVOL MICR, V65, P225, DOI 10.1099/ijs.0.064634-0; Tiquia SM, 1996, ENVIRON POLLUT, V93, P249, DOI 10.1016/S0269-7491(96)00052-8; Wang J, 2016, J AGR FOOD CHEM, V64, P6838, DOI 10.1021/acs.jafc.6b02442; Wang SG, 2018, BIORESOURCE TECHNOL, V248, P13, DOI 10.1016/j.biortech.2017.07.050; Xi BD, 2015, BIORESOURCE TECHNOL, V196, P399, DOI 10.1016/j.biortech.2015.07.069; Xu WP, 2011, BIORESOURCE TECHNOL, V102, P4800, DOI 10.1016/j.biortech.2011.01.037; Xu WP, 2010, COMPOST SCI UTIL, V18, P32; Xu WP, 2009, ENVIRON SCI TECHNOL, V43, P6248, DOI 10.1021/es900310c; Xu WP, 2009, J ENVIRON QUAL, V38, P437, DOI 10.2134/jeq2008.0168; Yang GQ, 2014, INT J SYST EVOL MICR, V64, P1647, DOI 10.1099/ijs.0.055608-0; Yu YongXiang, 2015, Acta Ecologica Sinica - International Journal, V35, P17; Zhang LL, 2016, BIORESOURCE TECHNOL, V203, P1, DOI 10.1016/j.biortech.2015.12.040; Zhang LL, 2015, BIORESOURCE TECHNOL, V197, P266, DOI 10.1016/j.biortech.2015.08.089; Zhong XZ, 2018, BIORESOURCE TECHNOL, V247, P443, DOI 10.1016/j.biortech.2017.09.116	48	23	23	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205112	10.1371/journal.pone.0205112	http://dx.doi.org/10.1371/journal.pone.0205112			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307982	Green Submitted, gold, Green Published			2022-12-26	WOS:000447173500038
J	Sengupta, M; Wang, BD; Lee, NH; Marx, A; Kusner, LL; Kaminski, HJ				Sengupta, Manjistha; Wang, Bi-Dar; Lee, Norman H.; Marx, Alexander; Kusner, Linda L.; Kaminski, Henry J.			MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis	PLOS ONE			English	Article							B-CELL; MATRIX METALLOPROTEINASES; ALTERED EXPRESSION; FDC-SP; PATHOGENESIS; ACTIVATION; LUPUS; DIFFERENTIATION; RESPONSIVENESS; IDENTIFICATION	Background A characteristic pathology of early onset myasthenia gravis is thymic hyperplasia with ectopic germinal centers (GC). However, the mechanisms that trigger and maintain thymic hyperplasia are poorly characterized. Dysregulation of small, non-coding microRNAs (miRNAs) and their target genes has been identified in the pathology of several autoimmune diseases. We assessed the miRNA and mRNA profiles of the MG thymus and have investigated their role in GC formation and maintenance. Methods MG thymus samples were assessed by histology and grouped based upon the appearance of GC; GC positive and GC negative. A systems biology approach was used to study the differences between the groups. Our study included miRNA and mRNA profiling, quantitative real-time PCR validation, miRNA target identification, pathway analysis, miRNA-mRNA reciprocal expression pairing and interaction. Results Thirty-eight mature miRNAs and forty-six annotated mRNA transcripts were differentially expressed between the two groups (>1.5 fold change, ANOVA p<0.05). The miRNAs were found to be involved in immune response pathways and identified in other autoimmune diseases. The cellular and molecular functions of the mRNAs showed involvement in cell death and cell survival, cellular proliferation, cytokine signaling and extra-cellular matrix reorganization. Eleven miRNA and mRNA pairs were reciprocally regulated. The Regulator of G protein Signalling 13 (RGS13), known to be involved in GC regulation, was identified in specimens with GC and was paired with downregulation of miR-452-5p and miR-139-5p. MiRNA target sites were validated by dual luciferase assay. Transfection of miRNA mimics led to down regulation of RGS13 expression in Raji cells. Conclusion Our study indicates a distinct miRNA and mRNA expression pattern in ectopic GC in MG thymus. These miRNAs and mRNAs are involved in regulatory pathways common to inflammation and immune response, cell cycle regulation and anti-apoptotic pathways suggesting their involvement in support of GC formation in the thymus. We demonstrate for the first time that miR-139-5p and miR-452-5p negatively regulate RGS13 expression.	[Sengupta, Manjistha; Kaminski, Henry J.] George Washington Univ, Dept Neurol, Washington, DC USA; [Wang, Bi-Dar; Lee, Norman H.; Kusner, Linda L.] George Washington Univ, Dept Pharmacol & Physiol, Washington, DC 20052 USA; [Wang, Bi-Dar] Univ Maryland Eastern Shore, Dept Pharmaceut Sci, Princess Anne, MD USA; [Marx, Alexander] Heidelberg Univ, Univ Med Ctr Mannheim, Mannheim, Germany	George Washington University; George Washington University; University System of Maryland; University of Maryland Eastern Shore; Ruprecht Karls University Heidelberg	Kusner, LL (corresponding author), George Washington Univ, Dept Pharmacol & Physiol, Washington, DC 20052 USA.	lkusner@gwu.edu		Kusner, Linda/0000-0002-5530-2140; Wang, Bi-Dar/0000-0002-2530-7020; Kaminski, Henry/0000-0002-8195-0141	Muscular Dystrophy Association [417990]; Myasthenia Gravis Foundation of America; MGTX study group;  [U01 NS 42685]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS042685] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); Myasthenia Gravis Foundation of America; MGTX study group; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was performed with support of a supplemental award to NIH grant U01 NS 42685 (Henry J Kaminski), the Muscular Dystrophy Association (417990, Linda L Kusner), the Myasthenia Gravis Foundation of America (Linda L Kusner).; The work was performed with support of a supplemental award to NIH grant U01 NS 42685 (HJK), the Muscular Dystrophy Association (417990, LLK), the Myasthenia Gravis Foundation of America (LLK) and the MGTX study group.	Al-Alwan M, 2007, J IMMUNOL, V178, P7859, DOI 10.4049/jimmunol.178.12.7859; Avidan N, 2014, J AUTOIMMUN, V52, P146, DOI 10.1016/j.jaut.2013.12.001; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Barzago C, 2016, IMMUNOBIOLOGY, V221, P1227, DOI 10.1016/j.imbio.2016.06.012; Bates EEM, 1998, MOL IMMUNOL, V35, P513, DOI 10.1016/S0161-5890(98)00045-5; Berrih-Aknin S, 1987, ANN NY ACAD SCI, V505, P50; Berrih-Aknin S, 2009, ANN NEUROL, V66, P521, DOI 10.1002/ana.21628; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cao ZX, 2009, J BIOL CHEM, V284, P24914, DOI 10.1074/jbc.M109.000059; Carlsen AL, 2013, ARTHRITIS RHEUM-US, V65, P1324, DOI 10.1002/art.37890; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng ZA, 2013, J CLIN IMMUNOL, V33, P567, DOI 10.1007/s10875-012-9834-5; Cho SL, 2017, J IMMUNOL, V198, P3919, DOI 10.4049/jimmunol.1601404; Cizeron-Clairac G, 2008, J NEUROIMMUNOL, V201, P57, DOI 10.1016/j.jneuroim.2008.06.028; COHENKAMINSKY S, 1989, THYMUS, V14, P187; Cron MA, 2018, ANN NY ACAD SCI, V1412, P137, DOI 10.1111/nyas.13519; Deem TL, 2004, BLOOD, V104, P2385, DOI 10.1182/blood-2004-02-0665; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Fang XY, 2015, AUTOIMMUNITY, V48, P189, DOI 10.3109/08916934.2014.983266; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gabler J, 2013, EUR J IMMUNOL, V43, P3028, DOI 10.1002/eji.201243271; Gao Y, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0362-4; Garo LP, 2016, CELL MOL LIFE SCI, V73, P2041, DOI 10.1007/s00018-016-2167-4; Ge RT, 2016, IMMUNOL RES, V64, P470, DOI 10.1007/s12026-015-8702-9; Ghisi M, 2011, BLOOD, V117, P7053, DOI 10.1182/blood-2010-12-326629; Giraud M, 2007, NATURE, V448, P934, DOI 10.1038/nature06066; Gradolatto A, 2014, J AUTOIMMUN, V52, P53, DOI 10.1016/j.jaut.2013.12.015; Han JI, 2006, J LEUKOCYTE BIOL, V79, P1357, DOI 10.1189/jlb.1105693; Hwang IY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060139; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Jallouli M, 2012, J NEUROL, V259, P1290, DOI 10.1007/s00415-011-6335-z; Jensen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070721; Jiang L, 2012, INT IMMUNOPHARMACOL, V14, P217, DOI 10.1016/j.intimp.2012.07.003; KAMINSKI HJ, 1993, MUSCLE NERVE, V16, P1332, DOI 10.1002/mus.880161210; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; KIRCHNER T, 1988, AM J PATHOL, V130, P268; Klein R, 2013, HUM IMMUNOL, V74, P1184, DOI 10.1016/j.humimm.2013.06.020; Kuo CF, 2015, JAMA INTERN MED, V175, P1518, DOI 10.1001/jamainternmed.2015.3528; Le Panse R, 2006, J IMMUNOL, V177, P7868, DOI 10.4049/jimmunol.177.11.7868; LEPRINCE C, 1990, J IMMUNOL, V145, P2115; Li JP, 2018, J NEUROIMMUNOL, V320, P125, DOI 10.1016/j.jneuroim.2018.03.021; Liu L, 2005, J EXP MED, V202, P1341, DOI 10.1084/jem.20051359; Lu JY, 2013, NEUROSCI LETT, V555, P85, DOI 10.1016/j.neulet.2013.09.014; Marco M, 2013, J LEUKOCYTE BIOL, V94, P237, DOI 10.1189/jlb.0612267; Marshall AJ, 2002, J IMMUNOL, V169, P2381, DOI 10.4049/jimmunol.169.5.2381; Marx A, 2012, ANN NY ACAD SCI, V1275, P92, DOI 10.1111/j.1749-6632.2012.06799.x; Meraouna A, 2006, BLOOD, V108, P432, DOI 10.1182/blood-2005-06-2383; Moratz C, 2000, J IMMUNOL, V164, P1829, DOI 10.4049/jimmunol.164.4.1829; Mueller CGF, 1997, J EXP MED, V186, P655, DOI 10.1084/jem.186.5.655; Nogales-Gadea G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091927; O'Connor MJ, 2011, INT J DATA MIN BIOIN, V5, P321, DOI 10.1504/IJDMB.2011.040387; Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309; Punga T, 2016, J NEUROIMMUNOL, V292, P21, DOI 10.1016/j.jneuroim.2016.01.003; Punga T, 2014, ANN CLIN TRANSL NEUR, V1, P49, DOI 10.1002/acn3.24; Ramagopalan SV, 2007, NEW ENGL J MED, V357, P2199; Sabre L, 2018, J NEUROIMMUNOL, V321, P164, DOI 10.1016/j.jneuroim.2018.05.003; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Sardu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032487; SCHLUEP M, 1987, ANN NEUROL, V22, P212, DOI 10.1002/ana.410220205; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi GX, 2002, J IMMUNOL, V169, P2507, DOI 10.4049/jimmunol.169.5.2507; Shi L, 2015, MED SCI MONITOR, V21, P1774, DOI 10.12659/MSM.893458; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Sun W, 2010, CELL RES, V20, P1158, DOI 10.1038/cr.2010.134; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Te JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010344; Torri A, 2017, J BIOL CHEM, V292, P2903, DOI 10.1074/jbc.M116.769893; Truffault F, 2017, CLIN REV ALLERG IMMU, V52, P108, DOI 10.1007/s12016-016-8558-3; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15921; Wang BD, 2015, CLIN CANCER RES, V21, P4970, DOI 10.1158/1078-0432.CCR-14-1566; Wang BD, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/763569; Wang J, 2013, J NEUROIMMUNE PHARM, V8, P1287, DOI 10.1007/s11481-013-9498-9; Wang JH, 2013, ARTHRITIS RHEUM-US, V65, P2703, DOI 10.1002/art.38059; Wang LL, 2013, J MOL HISTOL, V44, P661, DOI 10.1007/s10735-013-9515-6; Wang ZD, 2017, J ZHEJIANG UNIV-SC B, V18, P27, DOI 10.1631/jzus.B1600205; Weiss JM, 2013, IMMUNOBIOLOGY, V218, P373, DOI 10.1016/j.imbio.2012.05.006; Wolfe GI, 2016, NEW ENGL J MED, V375, P511, DOI 10.1056/NEJMoa1602489; Wu XN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009131; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xu HP, 2015, NAT IMMUNOL, V16, P1274, DOI 10.1038/ni.3287; Yang AX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086306; Ye SB, 2014, ONCOTARGET, V5, P5439, DOI 10.18632/oncotarget.2118; Yeh JH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000835; Zhang Y, 2016, CLIN EXP MED, V16, P413, DOI 10.1007/s10238-015-0358-1; Zhao L, 2015, BIOCHEM BIOPH RES CO, V457, P370, DOI 10.1016/j.bbrc.2014.12.119; Zhernakova A, 2013, NAT REV ENDOCRINOL, V9, P646, DOI 10.1038/nrendo.2013.161	90	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205464	10.1371/journal.pone.0205464	http://dx.doi.org/10.1371/journal.pone.0205464			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308012	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500084
J	Takahashi, T; Nagatoishi, S; Kuroda, D; Tsumoto, K				Takahashi, Tomoya; Nagatoishi, Satoru; Kuroda, Daisuke; Tsumoto, Kouhei			Thermodynamic and computational analyses reveal the functional roles of the galloyl group of tea catechins in molecular recognition	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; BINDING THERMODYNAMICS; RECEPTOR; DOCKING; PROTEIN; POLYPHENOLS; AFFINITY; ASSAY; EGCG	Catechins, biologically active polyphenols in green tea, exhibit various biological activities, such as anticancer and antiviral activities, arising from interactions with functional proteins. However, the molecular details of these interactions remain unclear. In this study, we investigated the interactions between human serum albumin (HSA) and various catechins, including some with a galloyl group, by means of isothermal titration calorimetry (ITC), differential scanning calorimetry (DSC), and docking simulations. Our results indicate that the galloyl group was important for recognition by HSA and was responsible for enthalpic gains derived from a larger buried surface area and more van der Waals contacts. Thus, our thermodynamic and computational analyses suggest that the galloyl group plays important functional roles in the specific binding of catechins to proteins, implying that the biological activities of these compounds may be due in part to the physicochemical characteristics of the galloyl group.	[Takahashi, Tomoya; Nagatoishi, Satoru; Kuroda, Daisuke; Tsumoto, Kouhei] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan; [Takahashi, Tomoya] Kao Corp, Global R&D, Hlth Care Food, Sumida Ku, Tokyo, Japan; [Nagatoishi, Satoru; Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; [Kuroda, Daisuke; Tsumoto, Kouhei] Univ Tokyo, Med Device Dev & Regulat Res Ctr, Sch Engn, Bunkyo Ku, Tokyo, Japan	University of Tokyo; KAO Corporation; University of Tokyo; University of Tokyo	Tsumoto, K (corresponding author), Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Med Device Dev & Regulat Res Ctr, Sch Engn, Bunkyo Ku, Tokyo, Japan.	tsumoto@bioeng.t.u-tokyo.ac.jp	Kuroda, Daisuke/AAZ-5672-2020; Satoru, NAGATOISHI/AAY-8198-2021	Kuroda, Daisuke/0000-0003-2390-4785; Satoru, NAGATOISHI/0000-0002-0794-3963	Kao Corporation	Kao Corporation	The Kao Corporation provided support in the form of salaries for author TT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Additionally, supercomputing resources in this study were provided in part by the ROIS National Institute of Genetics, and by the Human Genome Center at the Institute of Medical Science, The University of Tokyo, Japan.	Ashok P.K., 2012, J PHARMACOGN PHYTOCH, V1, P45, DOI DOI 10.11648/J.IJNFS.20140304.18; Banerjee T, 2006, J PHYS CHEM B, V110, P24147, DOI 10.1021/jp062734p; Bohin MC, 2013, J AGR FOOD CHEM, V61, P10010, DOI 10.1021/jf4030823; Braicu C, 2013, FOOD CHEM, V141, P3282, DOI 10.1016/j.foodchem.2013.05.122; Bulic B, 2013, J MED CHEM, V56, P4135, DOI 10.1021/jm3017317; de Freitas V, 2012, CURR ORG CHEM, V16, P724, DOI 10.2174/138527212799958002; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Hatasa Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153002; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Ishii T, 2011, BIOSCI BIOTECH BIOCH, V75, P100, DOI 10.1271/bbb.100600; Ishii T, 2010, MOL NUTR FOOD RES, V54, P816, DOI 10.1002/mnfr.200900071; Ishino N, 2010, BIOSCI BIOTECH BIOCH, V74, P875, DOI 10.1271/bbb.90884; Karas D, 2017, FOOD CHEM TOXICOL, V105, P223, DOI 10.1016/j.fct.2017.04.021; Kawasaki Y, 2014, CHEM PHARM BULL, V62, P77, DOI 10.1248/cpb.c13-00710; Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011; Kowalinski E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002831; Kuroda D, 2016, BIOINFORMATICS, V32, P2451, DOI 10.1093/bioinformatics/btw197; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Landrum g, 2006, RDKIT OPEN SOURCE CH; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Li M, 2014, J AGR FOOD CHEM, V62, P3768, DOI 10.1021/jf500246m; Li XR, 2015, NEW J CHEM, V39, P386, DOI 10.1039/c4nj01344a; Maiti TK, 2006, PROTEINS, V64, P355, DOI 10.1002/prot.20995; Martin S, 2013, BRIT J CANCER, V109, P433, DOI 10.1038/bjc.2013.325; Mori S, 2008, BIOORG MED CHEM LETT, V18, P4249, DOI 10.1016/j.bmcl.2008.02.020; Murphy KP, 1999, MED RES REV, V19, P333, DOI 10.1002/(SICI)1098-1128(199907)19:4<333::AID-MED6>3.0.CO;2-5; Narukawa M, 2011, BIOCHEM BIOPH RES CO, V405, P620, DOI 10.1016/j.bbrc.2011.01.079; Ohtaka H, 2002, PROTEIN SCI, V11, P1908, DOI 10.1110/ps.0206402; Ozdal T, 2013, FOOD RES INT, V51, P954, DOI 10.1016/j.foodres.2013.02.009; Pal S, 2014, J BIOMOL STRUCT DYN, V32, P1132, DOI 10.1080/07391102.2013.811700; Pal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043321; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Soares S, 2013, J AGR FOOD CHEM, V61, P1525, DOI 10.1021/jf304198k; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SULMAN FG, 1962, LANCET, V2, P616; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tanaka T, 2011, FREE RADICAL BIO MED, V50, P1324, DOI 10.1016/j.freeradbiomed.2011.01.024; Tarcsay A, 2015, DRUG DISCOV TODAY, V20, P86, DOI 10.1016/j.drudis.2014.09.014; Trnkova L, 2011, J MOL STRUCT, V985, P243, DOI 10.1016/j.molstruc.2010.11.001; Wang SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111143; Wang ZM, 2013, BBA-GEN SUBJECTS, V1830, P5356, DOI 10.1016/j.bbagen.2013.06.032; Xiaokaiti Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep11494; Zaidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071422; Zinellu A, 2014, J CHROMATOGR A, V1367, P167, DOI 10.1016/j.chroma.2014.09.053	46	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204856	10.1371/journal.pone.0204856	http://dx.doi.org/10.1371/journal.pone.0204856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307946	gold, Green Published, Green Submitted			2022-12-26	WOS:000447173500029
J	Saeterbakken, AH; Loken, E; Scott, S; Hermans, E; Vereide, VA; Andersen, V				Saeterbakken, Atle Hole; Loken, Einar; Scott, Suzanne; Hermans, Espen; Vereide, Vegard Albert; Andersen, Vidar			Effects of ten weeks dynamic or isometric core training on climbing performance among highly trained climbers	PLOS ONE			English	Article							SCHOOL BASEBALL PLAYERS; STRENGTH; STABILITY; INSTABILITY; HIP; EXERCISES; ENDURANCE; KINETICS; PROGRAM; FITNESS	This is the first study to compare the effects of isometric vs. dynamic core training and characterize core-training adaptations using climbing-specific performance and core strength tests in elite climbers. The aim of the study was to compare the effects of attending a progressive core-training program on climbing performance. 19 advanced and elite climbers (7.3 +/- 5.6 years climbing experience, red point skill grade 19 IRCRA) were randomized into a dynamic (DCT) or isometric (ICT) core training group and trained twice weekly for ten weeks. The climbers were tested using two climbing-specific core tests (body lock-off and body-lift) and four non-specific core strength tests-one dynamic (superman) and three isometric (trunk flexion and trunk rotation left and right). Between group comparisons showed no differences between the groups at post-test (p = 0.328-0.824) and neither group demonstrated greater improvement compared with the other (p = 0.300-0.926). The ICT group demonstrated 10.8% and 29.6% improvement in trunk flexion and body-lift (p = 0.029-0.037 with no improvement in body lock-off and rotation (p = 0.101-0.343). The DCT group demonstrated 5.0-14.9% improvement in the core strength tests (p = 0.012-0.043), a non-significant 33.8% improvement in body-lift (p = 0.100) and no improvement in body lock-off (p = 0.943). In conclusion, none of the training groups demonstrated greater improvement than the other and both dynamic and isometric core training improved climbing-specific test performance. Dynamic training was slightly more favorable although not significantly superior to isometric core training in improving core strength.	[Saeterbakken, Atle Hole; Loken, Einar; Hermans, Espen; Vereide, Vegard Albert; Andersen, Vidar] Western Norway Univ, Fac Educ Arts & Sports, Dept Sport Food & Nat Sci, Campus Sogndal, Sogndal, Norway; [Scott, Suzanne] Univ Exeter, Dept Sport & Hlth Sci, Exeter, Devon, England	University of Exeter	Saeterbakken, AH (corresponding author), Western Norway Univ, Fac Educ Arts & Sports, Dept Sport Food & Nat Sci, Campus Sogndal, Sogndal, Norway.	atle.saeterbakken@hvl.no		Scott, Suzanne/0000-0003-1485-160X				Balas J, 2012, EUR J SPORT SCI, V12, P16, DOI 10.1080/17461391.2010.546431; Balas J, 2009, ISOKINET EXERC SCI, V17, P173, DOI 10.3233/IES-2009-0350; Behm DG, 2010, APPL PHYSIOL NUTR ME, V35, P91, DOI 10.1139/H09-127; Ben Kibler W, 2006, SPORTS MED, V36, P189, DOI 10.2165/00007256-200636030-00001; BENKIBLER W, 1994, AAOS INSTR COURS LEC, V43, P17; Bourne MN, 2016, SCAND J MED SCI SPOR, V26, P666, DOI 10.1111/sms.12494; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Draper N, 2015, SPORTS TECH, V8, P88, DOI [10.1080/19346182.2015.1107081, DOI 10.1080/19346182.2015.1107081]; Drinkwater EJ, 2007, INT J SPORT PHYSIOL, V2, P400, DOI 10.1123/ijspp.2.4.400; Ekstrom RA, 2007, J ORTHOP SPORT PHYS, V37, P754, DOI 10.2519/jospt.2007.2471; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Folland JP, 2005, J SPORT SCI, V23, P817, DOI 10.1080/02640410400021783; Hermans E, 2017, EUR J SPORT SCI, V17, P378, DOI 10.1080/17461391.2016.1248499; Lephart SM, 2007, J STRENGTH COND RES, V21, P860; Lust KR, 2009, J SPORT REHABIL, V18, P407, DOI 10.1123/jsr.18.3.407; Mermier CM, 2000, BRIT J SPORT MED, V34, P359, DOI 10.1136/bjsm.34.5.359; Muehlbauer T, 2012, INT J SPORTS MED, V33, P445, DOI 10.1055/s-0031-1301312; Myer GD, 2008, BRIT J SPORT MED, V42, P614, DOI 10.1136/bjsm.2007.046086; Parkhouse KL, 2011, J BODYW MOV THER, V15, P517, DOI 10.1016/j.jbmt.2010.12.001; Pedersen J., 2006, MED SCI SPORT EXERCI, V38, P243; Phillips KC, 2012, STRENGTH COND J, V34, P1, DOI 10.1519/SSC.0b013e318255f012; Prieske O, 2016, SCAND J MED SCI SPOR, V26, P48, DOI 10.1111/sms.12403; Reed CA, 2012, SPORTS MED, V42, P697, DOI 10.2165/11633450-000000000-00000; Saeterbakken AH, 2011, J STRENGTH COND RES, V25, P712, DOI 10.1519/JSC.0b013e3181cc227e; Saeterbakken AH, 2016, EUR J APPL PHYSIOL, V116, P2247, DOI 10.1007/s00421-016-3470-3; SALE D, 1981, Canadian Journal of Applied Sport Sciences, V6, P87; Sato K, 2009, J STRENGTH COND RES, V23, P133, DOI 10.1519/JSC.0b013e31818eb0c5; Schibek JS, 1999, J ATHL TRAINING, V34, P27; Stanton R, 2004, J STRENGTH COND RES, V18, P522; Szymanski DJ, 2007, J STRENGTH COND RES, V21, P1117; Szymanski DJ, 2007, J STRENGTH COND RES, V21, P894; Thompson CJ, 2007, J STRENGTH COND RES, V21, P131, DOI 10.1519/00124278-200702000-00024; Timmins RG, 2015, MED SCI SPORT EXER, V47, P905, DOI 10.1249/MSS.0000000000000507; Tse MA, 2005, J STRENGTH COND RES, V19, P547; Vera-Garcia FJ, 2011, J ELECTROMYOGR KINES, V21, P893, DOI 10.1016/j.jelekin.2011.08.003; Watts PB, 2004, EUR J APPL PHYSIOL, V91, P361, DOI 10.1007/s00421-003-1036-7; Watts PB, 1993, J SPORT SCI, V11, P113, DOI 10.1080/02640419308729974; Weston M, 2015, INT J SPORT PHYSIOL, V10, P204, DOI 10.1123/ijspp.2013-0488	39	9	9	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0203766	10.1371/journal.pone.0203766	http://dx.doi.org/10.1371/journal.pone.0203766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303973	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100019
J	Oyenuga, AO; Couper, D; Matsushita, K; Boerwinkle, E; Folsom, AR				Oyenuga, Abayomi O.; Couper, David; Matsushita, Kunihiro; Boerwinkle, Eric; Folsom, Aaron R.			Association of monocyte myeloperoxidase with incident cardiovascular disease: The Atherosclerosis Risk in Communities Study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ARIC CAROTID MRI; PLAQUE CHARACTERISTICS; INFLAMMATION; POLYMORPHISM; SURVIVAL; METAANALYSIS; POPULATION; MARKERS; EVENTS	Myeloperoxidase (MPO) is a heme-containing peroxidase found in azurophilic granules of neutrophils and monocytes. Epidemiological studies have reported greater plasma MPO concentration to be associated with increased incidence of several cardiovascular diseases (CVD), but the association of intracellular monocyte MPO (mMPO) with CVD is unclear. The prospective population-based Atherosclerosis Risk in Communities (ARIC) cohort study measured mMPO using flow cytometry in 1,465 participants. The association of mMPO with incident cardiovascular disease (CVD, comprising incident coronary heart disease (CHD), heart failure, stroke, peripheral artery disease, and cardiovascular mortality) was examined over a median 9.6 years of follow-up (n = 290 CVD events). There was no statistically significant association between mMPO and all incident CVD events in either age, sex, and race-adjusted proportional hazards models (HR (95% CI) across tertiles of mMPO: 1, 1.09 (0.76, 1.57), and 0.78 (0.52, 1.15), P-trend = 0.21) or adjusted for other major CVD risk factors (HR (95% CI): 1, 1.17 (0.81, 1.69), and 0.87 (0.58, 1.29), P-trend = 0.50). There also was no association between mMPO tertiles and incident CHD, heart failure, or all-cause mortality, examined separately. In conclusion, intracellular monocyte myeloperoxidase was not associated with incident cardiovascular disease in this prospective population-based study.	[Oyenuga, Abayomi O.; Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Couper, David] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Matsushita, Kunihiro] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Dept Epidemiol, Baltimore, MD USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Human Genet & Environm Sci, Dept Epidemiol, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Folsom, AR (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	folso001@umn.edu	Matsushita, Kunihiro/AAJ-5817-2020	Matsushita, Kunihiro/0000-0002-7179-718X; Couper, David/0000-0002-4313-9235; Oyenuga, Abayomi/0000-0003-4699-6678	Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I, HHSN268201700005I]; ARIC carotid MRI [U01HL075572-01]	Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services; ARIC carotid MRI	The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. (HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I, HHSN268201700005I) with the ARIC carotid MRI examination funded by U01HL075572-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan S, 2017, BIOMED REP, V7, P547, DOI 10.3892/br.2017.995; Asselbergs FW, 2004, AM J MED, V116, P429, DOI 10.1016/j.amjmed.2003.10.025; Biasucci LM, 1996, J AM COLL CARDIOL, V27, P611, DOI 10.1016/0735-1097(95)00524-2; BOS A, 1978, BIOCHIM BIOPHYS ACTA, V525, P37, DOI 10.1016/0005-2744(78)90197-3; Catellier DJ, 2008, CLIN CHEM, V54, P1363, DOI 10.1373/clinchem.2007.102202; Chang CX, 2013, CLIN BIOCHEM, V46, P1644, DOI 10.1016/j.clinbiochem.2013.09.002; Chistiakov DA, 2018, J CELL MOL MED, V22, P1366, DOI 10.1111/jcmm.13462; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hansson M, 2006, ARCH BIOCHEM BIOPHYS, V445, P214, DOI 10.1016/j.abb.2005.08.009; Hazen SL, 2004, ARTERIOSCL THROM VAS, V24, P1143, DOI 10.1161/01.ATV.0000135267.82813.52; Karakas M, 2012, J INTERN MED, V271, P43, DOI 10.1111/j.1365-2796.2011.02397.x; Li YY, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006461, 10.1097/md.0000000000006461]; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Maddhuri S, 2016, FOLIA CARDIOL, V11, P272, DOI [10.5603/FC.2016.0047, DOI 10.5603/FC.2016.0047]; Matijevic N, 2011, ANGIOLOGY, V62, P237, DOI 10.1177/0003319710385336; Meuwese MC, 2007, J AM COLL CARDIOL, V50, P159, DOI 10.1016/j.jacc.2007.03.033; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Nikpoor B, 2001, AM HEART J, V142, P336, DOI 10.1067/mhj.2001.116769; Nussbaum C, 2013, ANTIOXID REDOX SIGN, V18, P692, DOI 10.1089/ars.2012.4783; Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355; Pecoits R, 2003, KIDNEY INT, V63, pS172, DOI 10.1046/j.1523-1755.63.s84.32.x; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Singh U, 2009, CLIN CHEM, V55, P361, DOI 10.1373/clinchem.2008.109207; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Tang NP, 2013, GENE, V523, P152, DOI 10.1016/j.gene.2013.03.131; Tavora FR, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-27; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; Virani SS, 2011, ATHEROSCLEROSIS, V219, P596, DOI 10.1016/j.atherosclerosis.2011.08.001; Virani SS, 2011, EUR HEART J, V32, P459, DOI 10.1093/eurheartj/ehq367; Wagenknecht L, 2009, CIRC-CARDIOVASC IMAG, V2, P314, DOI 10.1161/CIRCIMAGING.108.823922; Wang Y, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009367; WHISNANT JP, 1990, STROKE, V21, P707, DOI 10.1161/01.STR.21.5.707; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong ND, 2009, JACC-CARDIOVASC IMAG, V2, P1093, DOI 10.1016/j.jcmg.2009.05.012; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136	37	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205310	10.1371/journal.pone.0205310	http://dx.doi.org/10.1371/journal.pone.0205310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300402	Green Published, Green Submitted, gold			2022-12-26	WOS:000446897200052
J	Rath, P; Allen, JA; Schneider, DS				Rath, Poonam; Allen, Jessica A.; Schneider, David S.			Predicting position along a looping immune response trajectory	PLOS ONE			English	Article							YELLOW-FEVER VACCINE	When we get sick, we want to be resilient and recover our original health. To measure resilience, we need to quantify a host's position along its disease trajectory. Here we present Looper, a computational method to analyze longitudinally gathered datasets and identify gene pairs that form looping trajectories when plotted in the space described by these phases. These loops enable us to track where patients lie on a typical trajectory back to health. We analyzed two publicly available, longitudinal human microarray datasets that describe self-resolving immune responses. Looper identified looping gene pairs expressed by human donor monocytes stimulated by immune elicitors, and in YF17D-vaccinated individuals. Using loops derived from training data, we found that we could predict the time of perturbation in withheld test samples with accuracies of 94% in the human monocyte data, and 65-83% within the same cohort and in two independent cohorts of YF17D vaccinated individuals. We suggest that Looper will be useful in building maps of resilient immune processes across organisms.	[Rath, Poonam; Allen, Jessica A.; Schneider, David S.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University	Schneider, DS (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	dschneider@stanford.edu		Allen, Jessica/0000-0001-6668-4845; Schneider, David/0000-0002-2391-9963	National Institutes of Health [DP1 AT0007753]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by a National Institutes of Health Director's Pioneer Award DP1 AT0007753.	Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; De Boever P, 2014, GENOMICS, V103, P31, DOI 10.1016/j.ygeno.2013.11.006; Dower K, 2008, J IMMUNOL, V180, P3520, DOI 10.4049/jimmunol.180.5.3520; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Hughey JJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw030; Italiani P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087680; Kim CC, 2008, INFECT IMMUN, V76, P5873, DOI 10.1128/IAI.00640-08; Lin J., 2003, P 8 ACM SIGMOD WORKS, P2, DOI DOI 10.1145/882082.882086; Lough G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2151; Louie A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002435; Lum PY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01236; Power D, 2015, VIROLOGY, V481, P142, DOI 10.1016/j.virol.2015.02.046; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Read AF, 2008, PLOS BIOL, V6, P2638, DOI 10.1371/journal.pbio.1000004; Reid JE, 2016, BIOINFORMATICS, V32, P2973, DOI 10.1093/bioinformatics/btw372; Scicluna BP, 2015, AM J RESP CRIT CARE, V192, P826, DOI 10.1164/rccm.201502-0355OC; Singh G., 2007, TOPOL METHOD NONL AN, P91; Torres BY, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002436; Wullaert A, 2007, J BIOL CHEM, V282, P81, DOI 10.1074/jbc.M607481200	21	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0200147	10.1371/journal.pone.0200147	http://dx.doi.org/10.1371/journal.pone.0200147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296270	Green Submitted, Green Published, gold			2022-12-26	WOS:000446632700004
J	House, R; Majumder, M; Janakiraman, H; Ogretmen, B; Kato, M; Erkul, E; Hill, E; Atkinson, C; Barth, J; Day, TA; Palanisamy, V				House, Reniqua; Majumder, Mrinmoyee; Janakiraman, Harinarayan; Ogretmen, Besim; Kato, Masanari; Erkul, Evren; Hill, Elizabeth; Atkinson, Carl; Barth, Jeremy; Day, Terrence A.; Palanisamy, Viswanathan			Smoking-induced control of miR-133a-3p alters the expression of EGFR and HuR in HPV-infected oropharyngeal cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR; HUMAN-PAPILLOMAVIRUS; P16 IMMUNOHISTOCHEMISTRY; BLADDER-CANCER; LUNG-CANCER; HEAD; NECK; SURVIVAL; PROGNOSIS	Purpose Human papillomavirus (HPV) infected oropharyngeal squamous cell carcinoma (OPSCC) patients have a better prognosis compared to HPV(-) counterparts. However, a subset of HPV(+) patients with a smoking history fail to respond to the standard of care treatments such as radiation and chemotherapy. To understand the underlying mechanism driving HPV (+) OPSCC patient resistance to treatment and recurrence, we sought to identify and characterize the differentially expressed miRNAs and their target genes in HPV(+) smokers and non-smokers. Experimental design MicroRNA expression analysis was performed using Nanostring in tumor tissues isolated from a prospective cohort of HPV(+) smoking (n = 9) and HPV(+) (n = 13) non-smoking OPSCC patients. Identified miRNAs of interest were further validated using qRT-PCR in cigarette smoke extract (CSE) treated HPV(+) and E6/E7 overexpressing HPV(-) cells. Results In comparison to OPSCC HPV(+) non-smokers, 38 miRNAs were significantly altered in the HPV(+) smoker patients cohort and out of that 9 were downregulated. Altered miRNA expression was also detected in the serum and metastatic lymph nodes of HPV(+) smokers versus non-smokers. Expression of miR-133a-3p was significantly downregulated in OPSCC smokers, HPV(+) cells and E6/E7 overexpressing HPV(-) cells treated with CSE. Reduction of miR-133a-3p induced the upregulation of miR-133a-3p target mRNAs EGFR and HuR. Conclusions Our results indicate that miR-133a-3p is a target of smoking-induced changes in HPV(+) patients and alters the expression of EGFR and HuR which may promote HPV associated oropharyngeal cancer. Therefore, future treatment strategies for HPV(+) OPSCC smokers should focus on EGFR inhibition and the development of selective therapies to target HuR.	[House, Reniqua; Majumder, Mrinmoyee; Janakiraman, Harinarayan; Ogretmen, Besim; Palanisamy, Viswanathan] Med Univ South Carolina, Coll Med, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Kato, Masanari; Day, Terrence A.] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA; [Kato, Masanari; Erkul, Evren] Med Univ South Carolina, Coll Med, Dept Otolaryngol & Head & Neck Surg, Charleston, SC 29425 USA; [Erkul, Evren] Univ Hlth Sci, Gulhane Med Sch, Dept Otorhinolaryngol, Istanbul, Turkey; [Hill, Elizabeth] Med Univ South Carolina, Coll Med, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Atkinson, Carl] Med Univ South Carolina, Coll Med, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Barth, Jeremy] Med Univ South Carolina, Coll Med, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [House, Reniqua] Boehringer Ingelheim GmbH & Co KG, Div Canc Immunol & Immune Modulat, Ridgefield, CT USA	Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Medical University of South Carolina; University of Health Sciences Turkey; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Boehringer Ingelheim	Palanisamy, V (corresponding author), Med Univ South Carolina, Coll Med, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	visu@musc.edu	MAJUMDER, MRINMOYEE/G-2627-2018	Janakiraman, Harinarayanan/0000-0002-3043-2352; Erkul, Evren/0000-0002-0360-1309	NIH NIDCR [DE022776, DE025920]; NIH [P30GM103331]; Hollings Cancer Center through the HCC Clinical Scholars Program; NIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001450]; NATIONAL CANCER INSTITUTE [P01CA203628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE025920, R01DE016572, R01DE022776] Funding Source: NIH RePORTER	NIH NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hollings Cancer Center through the HCC Clinical Scholars Program; NIH National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the NIH NIDCR DE022776 and DE025920 to V. Palanisamy. Part of the study is supported by the NIH grant P30GM103331 to T. Day. This study was supported in part by the Hollings Cancer Center through the HCC Clinical Scholars Program. Part of this work was supported by the NIH National Center for Advancing Translational Sciences (NCATS) through Grant Number UL1 TR001450.	Adams BD, 2017, J CLIN INVEST, V127, P761, DOI 10.1172/JCI84424; Anantharaman D, 2016, INT J EPIDEMIOL, V45, P752, DOI 10.1093/ije/dyw069; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chaudhary AK, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-22; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Duncan LD, 2013, J ORAL MAXIL SURG, V71, P1367, DOI 10.1016/j.joms.2013.02.019; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Fakhry C, 2014, J CLIN ONCOL, V32, P3365, DOI 10.1200/JCO.2014.55.1937; Filosto S, 2012, MOL CANCER THER, V11, P795, DOI 10.1158/1535-7163.MCT-11-0698; Gao G, 2013, CANCER-AM CANCER SOC, V119, P72, DOI 10.1002/cncr.27696; Gao L, 2017, ONCOTARGETS THER, V10, P3667, DOI 10.2147/OTT.S137433; Gillison Maurah, 2010, Clin Adv Hematol Oncol, V8, P680; Grandis JR, 1996, CANCER-AM CANCER SOC, V78, P1284, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X; He BX, 2018, J CELL BIOCHEM, V119, P338, DOI 10.1002/jcb.26182; Huang JK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/364316; Kinoshita T, 2012, INT J ONCOL, V40, P1770, DOI 10.3892/ijo.2012.1390; Kong CS, 2009, INT J RADIAT ONCOL, V74, P553, DOI 10.1016/j.ijrobp.2009.02.015; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Kumar B, 2007, INT J RADIAT ONCOL, V69, pS109, DOI 10.1016/j.ijrobp.2007.05.072; Kunchithapautham K, 2014, J BIOL CHEM, V289, P14534, DOI 10.1074/jbc.M114.564674; Lajer CB, 2011, BRIT J CANCER, V104, P830, DOI 10.1038/bjc.2011.29; Lan D, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0139-z; Legnini I, 2014, MOL CELL, V53, P506, DOI 10.1016/j.molcel.2013.12.012; MUNGER K, 1989, J VIROL, V63, P4417; Psyrri A, 2011, ANTI-CANCER DRUG, V22, P586, DOI 10.1097/CAD.0b013e328344ec44; Salazar C, 2014, EXPERT REV MOL DIAGN, V14, P1033, DOI 10.1586/14737159.2014.960519; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Shelton J, 2017, MODERN PATHOL, V30, P1194, DOI 10.1038/modpathol.2017.31; Song XS, 2015, ONCOL REP, V34, P1573, DOI 10.3892/or.2015.4101; Spector ME, 2012, HEAD NECK-J SCI SPEC, V34, P1727, DOI 10.1002/hed.21997; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taberna M, 2017, ANN ONCOL, V28, P2386, DOI 10.1093/annonc/mdx304; TODD R, 1989, CARCINOGENESIS, V10, P1553, DOI 10.1093/carcin/10.8.1553; Viens LJ, 2016, MMWR-MORBID MORTAL W, V65, P661, DOI 10.15585/mmwr.mm6526a1; Vojtechova Z, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2430-y; Vucic EA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-778; Wang H, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw677; Xi LF, 2009, CANCER EPIDEM BIOMAR, V18, P3490, DOI 10.1158/1055-9965.EPI-09-0763; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23	42	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205077	10.1371/journal.pone.0205077	http://dx.doi.org/10.1371/journal.pone.0205077			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289952	Green Published, Green Submitted, gold			2022-12-26	WOS:000446545500046
J	Mendez-Lara, KA; Santos, D; Farre, N; Ruiz-Nogales, S; Leanez, S; Sanchez-Quesada, JL; Zapico, E; Lerma, E; Escola-Gil, JC; Blanco-Vaca, F; Martin-Campos, JM; Julve, J; Pol, O				Alejandra Mendez-Lara, Karen; Santos, David; Farre, Nuria; Ruiz-Nogales, Sheila; Leanez, Sergi; Luis Sanchez-Quesada, Jose; Zapico, Edgar; Lerma, Enrique; Carles Escola-Gil, Joan; Blanco-Vaca, Francisco; Maria Martin-Campos, Jesus; Julve, Josep; Pol, Olga			Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; MONOXIDE-RELEASING MOLECULE; CARBON-MONOXIDE; INSULIN-RESISTANCE; OXIDATIVE STRESS; NADPH OXIDASE; MOUSE MODELS; PAIN; EXPRESSION	antinociceptive effects of the carbon monoxide-releasing molecule tricarbonyldichloror-uthenium (II) dimer (CORM-2) during chronic pain are well documented, but most of its possible side-effects remain poorly understood. In this work, we examine the impact of CORM- 2 treatment on the lipoprotein profile and two main atheroprotective functions attributed to high-density lipoprotein (HDL) in a mouse model of type 1 diabetes while analyzing the effect of this drug on diabetic neuropathy. Streptozotocin (Stz)-induced diabetic mice treated with CORM-2 (Stz-CORM-2) or vehicle (Stz-vehicle) were used to evaluate the effect of this drug on the modulation of painful diabetic neuropathy using nociceptive behavioral tests. Plasma and tissue samples were used for chemical and functional analyses, as appropriate. Two main antiatherogenic properties of HDL, i.e., the ability of HDL to protect low-density lipoprotein (LDL) from oxidation and to promote reverse cholesterol transport from macrophages to the liver and feces in vivo (m-RCT), were also assessed. Stz-induced diabetic mice displayed hyperglycemia, dyslipidemia and pain hypersensitivity. The administration of 10 mg/kg CORM-2 during five consecutive days inhibited allodynia and hyperalgesia and significantly ameliorated spinal cord markers (Cybb and Bdkrb /expression) of neuropathic pain in Stz mice, but it did not reduce the combined dyslipidemia shown in Stz-treated mice. Its administration to Stz-treated mice led to a significant increase in the plasma levels of cholesterol (similar to 1.4-fold vs. Ctrl,similar to 1.3- fold vs. Stz-vehicle; p < 0.05) and was attributed to significant elevations in both non-HDL (similar to 1.8-fold vs. Ctrl;similar to 1.6-fold vs. Stz-vehicle; p < 0.05) and HDL cholesterol (similar to 1.3-fold vs. Ctrl, similar to 1.2-fold vs. Stz-vehicle; p <0.05). The increased HDL in plasma was not accompanied by a commensurate elevation in m-RCT in Stz-CORM-2 compared to Stz-vehicle mice; instead, it was worsened as revealed by decreased [H-3]-tracer trafficking into the feces in vivo. Furthermore, the HDL-mediated protection against LDL oxidation ex vivo shown by the HDL isolated from Stz-CORM-2 mice did not differ from that obtained in Stz-vehicle mice. In conclusion, the antinociceptive effects produced by a high dose of CORM-2 were accompanied by antioxidative effects but were without favorable effects on the dyslipidemia manifested in diabetic mice.	[Alejandra Mendez-Lara, Karen; Farre, Nuria; Ruiz-Nogales, Sheila; Carles Escola-Gil, Joan; Blanco-Vaca, Francisco; Maria Martin-Campos, Jesus; Julve, Josep] Hosp Santa Creu & Sant Pau, Inst Recerca, Grp Bases Metab Risc Cardiovasc, Barcelona, Spain; [Alejandra Mendez-Lara, Karen; Farre, Nuria; Ruiz-Nogales, Sheila; Leanez, Sergi; Luis Sanchez-Quesada, Jose; Carles Escola-Gil, Joan; Blanco-Vaca, Francisco; Maria Martin-Campos, Jesus; Julve, Josep; Pol, Olga] IIB St Pau, Barcelona, Spain; [Alejandra Mendez-Lara, Karen; Luis Sanchez-Quesada, Jose; Carles Escola-Gil, Joan; Blanco-Vaca, Francisco; Maria Martin-Campos, Jesus; Julve, Josep] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain; [Santos, David; Luis Sanchez-Quesada, Jose; Carles Escola-Gil, Joan; Blanco-Vaca, Francisco; Maria Martin-Campos, Jesus; Julve, Josep] CIBERDEM, CIBER Diabet & Enfermedades Metab Asociades, Inst Recerca, Barcelona, Spain; [Leanez, Sergi; Pol, Olga] Hosp Santa Creu & Sant Pau, Grp Neurofarmacol Mol, Barcelona, Spain; [Leanez, Sergi; Pol, Olga] Univ Autonoma Barcelona, Inst Neurociencies, Grp Neurofarmacol Mol, Barcelona, Spain; [Luis Sanchez-Quesada, Jose] Hosp Santa Creu & Sant Pau, Inst Recerca, Grp Bioquim Cardiovasc, Barcelona, Spain; [Zapico, Edgar] Hosp Santa Creu & Sant Pau, Dept Bioquim, Barcelona, Spain; [Lerma, Enrique] Hosp Santa Creu & Sant Pau, Dept Patol, Barcelona, Spain; [Lerma, Enrique] Univ Autonoma Barcelona, Dept Ciencies Morfol, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona	Julve, J (corresponding author), Hosp Santa Creu & Sant Pau, Inst Recerca, Grp Bases Metab Risc Cardiovasc, Barcelona, Spain.; Julve, J; Pol, O (corresponding author), IIB St Pau, Barcelona, Spain.; Julve, J (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain.; Julve, J (corresponding author), CIBERDEM, CIBER Diabet & Enfermedades Metab Asociades, Inst Recerca, Barcelona, Spain.; Pol, O (corresponding author), Hosp Santa Creu & Sant Pau, Grp Neurofarmacol Mol, Barcelona, Spain.; Pol, O (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Grp Neurofarmacol Mol, Barcelona, Spain.	jjulve@santpau.cat; opol@santpau.es	Martín-Campos, Jesús M./AAQ-5478-2021; Escolà, Joan Carles/U-1521-2019; Mendez Lara, Karen/GZH-2511-2022; Julve, Josep/I-1003-2017; Blanco-Vaca, Francisco/AAC-2600-2022; Pol, Olga/O-2146-2019; Escolà-Gil, Joan Carles/H-9522-2014; Mendez Lara, Karen Alejandra/Q-1750-2017	Escolà, Joan Carles/0000-0001-9021-2485; Julve, Josep/0000-0002-6531-2246; Pol, Olga/0000-0002-4621-8457; Santos, David/0000-0003-1157-4969; Blanco-Vaca, Francisco/0000-0001-7380-5385; Mendez Lara, Karen Alejandra/0000-0002-8372-2310	Ministerio de Economia y Competitividad; Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional (FEDER), Union Europea [PI17/00232, PI16/00139, PI16/00471, PI0900968, PI1400927]; FEDER "Una manera de hacer Europa"; Fundacio La Marato de TV3 [201602-31]; Miguel Servet Type 1 contract ISCIII [CP13/00070]; AGAUR [FI-DGR2014]	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER), Union Europea; FEDER "Una manera de hacer Europa"; Fundacio La Marato de TV3; Miguel Servet Type 1 contract ISCIII; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was partly supported by the Ministerio de Economia y Competitividad, Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER), Union Europea grants PI17/00232 (to JJ), PI16/00139 (to JCE-G), PI16/00471 (to JLS-Q), PI0900968 and PI1400927 (to OP), and FEDER "Una manera de hacer Europa"; and Fundacio La Marato de TV3 (grant number 201602-31 to JJ). JJ is recipient of a Miguel Servet Type 1 contract ISCIII (CP13/00070). KAM-L is recipient of an AGAUR grant FI-DGR2014 (Generalitat de Catalunya). CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM) is a project of the Instituto de Salud Carlos III. Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau is accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA).	BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bierhaus A, 2012, EXP CLIN ENDOCR DIAB, V120, P188, DOI 10.1055/s-0032-1304567; Bijjem KRV, 2013, N-S ARCH PHARMACOL, V386, P79, DOI 10.1007/s00210-012-0816-1; Bloks VW, 2004, DIABETOLOGIA, V47, P104, DOI 10.1007/s00125-003-1261-y; Boemi M, 2001, ATHEROSCLEROSIS, V155, P229, DOI 10.1016/S0021-9150(00)00556-6; Boulton AJM, 2013, DIABETES-METAB RES, V29, P327, DOI 10.1002/dmrr.2397; Castany S, 2016, NEUROSCI LETT, V614, P49, DOI 10.1016/j.neulet.2015.12.059; Catanzaro O, 2013, PEPTIDES, V44, P100, DOI 10.1016/j.peptides.2013.01.019; Cedo L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189834; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chi PL, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/279171; Connelly PW, 2004, J LIPID RES, V45, P561, DOI 10.1194/jlr.M300464-JLR200; Cooney SJ, 2014, FREE RADICAL RES, V48, P929, DOI 10.3109/10715762.2014.927578; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; de Boer JF, 2012, J LIPID RES, V53, P348, DOI 10.1194/jlr.M018671; Errico TL, 2017, TRANSL RES, V186, P19, DOI 10.1016/j.trsl.2017.05.004; Escola-Gil JC, 2015, METHODS MOL BIOL, V1339, P211, DOI 10.1007/978-1-4939-2929-0_15; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Farbstein D, 2012, EXPERT REV CARDIOVAS, V10, P353, DOI [10.1586/erc.11.182, 10.1586/ERC.11.182]; Gabra BH, 2005, REGUL PEPTIDES, V127, P245, DOI 10.1016/j.regpep.2004.12.003; Guilford BL, 2011, EXP DIABETES RES, DOI 10.1155/2011/848307; Gylling H, 2004, DIABETES, V53, P2217, DOI 10.2337/diabetes.53.9.2217; Haemmerle G, 2003, CURR OPIN LIPIDOL, V14, P289, DOI 10.1097/00041433-200306000-00009; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hervera A, 2013, PSYCHOPHARMACOLOGY, V228, P463, DOI 10.1007/s00213-013-3053-5; Hervera A, 2013, ANESTHESIOLOGY, V118, P1180, DOI 10.1097/ALN.0b013e318286d085; Hervera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043693; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; Jarvisalo M, 2006, DIABETES CARE, V29, P2300, DOI 10.2337/dc05-2235; Julve J, 2013, MOL NUTR FOOD RES, V57, P1814, DOI 10.1002/mnfr.201300133; Julve J, 2010, ARTERIOSCL THROM VAS, V30, P232, DOI 10.1161/ATVBAHA.109.198226; Kalogerakis G, 2005, CLIN SCI, V108, P497, DOI 10.1042/CS20040312; Karlsson H, 2015, HDB EXPT PHARM, V224, P207, DOI DOI 10.1007/978-3-319-09665-0_5; Kennedy JM, 2005, DIABETES, V54, P830, DOI 10.2337/diabetes.54.3.830; Kim D, 2010, P NATL ACAD SCI USA, V107, P14851, DOI 10.1073/pnas.1009926107; Kontush A, 2008, CURR DIABETES REP, V8, P51, DOI 10.1007/s11892-008-0010-5; Lee-Rueckert M, 2016, BBA-MOL CELL BIOL L, V1861, P566, DOI 10.1016/j.bbalip.2016.03.004; Liu XM, 2016, PAIN MED, V17, P220, DOI 10.1111/pme.12906; Low H, 2012, DIABETOLOGIA, V55, P2513, DOI 10.1007/s00125-012-2570-9; Motterlini R, 2017, AM J PHYSIOL-CELL PH, V312, pC302, DOI 10.1152/ajpcell.00360.2016; Navab M, 2000, J LIPID RES, V41, P1481; Negrete R, 2014, PSYCHOPHARMACOLOGY, V231, P853, DOI 10.1007/s00213-013-3302-7; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; Ory DS, 2010, DIABETES, V59, P2358, DOI 10.2337/db10-1040; Preiss-Landl K, 2002, CURR OPIN LIPIDOL, V13, P471, DOI 10.1097/00041433-200210000-00002; Rochette L, 2013, PHARMACOL THERAPEUT, V137, P133, DOI 10.1016/j.pharmthera.2012.09.007; Rye KA, 2014, J LIPID RES, V55, P168, DOI 10.1194/jlr.R039297; SAID G, 1983, BRAIN, V106, P791, DOI 10.1093/brain/106.4.791; Sampaio E, 2013, DIABETES RES CLIN PR, V99, P321, DOI 10.1016/j.diabres.2012.12.012; Sinnreich M, 2005, NEUROLOGIST, V11, P63, DOI 10.1097/01.nrl.0000156314.24508.ed; Stadler K, 2013, ADV EXP MED BIOL, V771, P272; Tabet F, 2009, CLIN SCI, V116, P87, DOI 10.1042/CS20080106; Tahrani AA, 2010, EXPERT OPIN EMERG DR, V15, P661, DOI 10.1517/14728214.2010.512610; Takada J, 2007, METABOLISM, V56, P977, DOI 10.1016/j.metabol.2006.05.021; Talbot S, 2012, EXP NEUROL, V234, P373, DOI 10.1016/j.expneurol.2011.11.032; Talbot S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-36; Verges B, 2009, DIABETES METAB, V35, P353, DOI 10.1016/j.diabet.2009.04.004; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Wang DM, 2014, EUR J PHARMACOL, V728, P59, DOI 10.1016/j.ejphar.2014.01.057; Zochodne DW, 2007, MUSCLE NERVE, V36, P144, DOI 10.1002/mus.20785	60	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204841	10.1371/journal.pone.0204841	http://dx.doi.org/10.1371/journal.pone.0204841			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286142	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500048
J	Stiles, NRB; Li, M; Levitan, CA; Kamitani, Y; Shimojo, S				Stiles, Noelle R. B.; Li, Monica; Levitan, Carmel A.; Kamitani, Yukiyasu; Shimojo, Shinsuke			What you saw is what you will hear: Two new illusions with audiovisual postdictive effects	PLOS ONE			English	Article							PERCEPTION; SOUND; CONVERGENCE; UNCERTAINTY; MOVEMENT; AUDITION; OBJECTS; HUMANS; MOTION; COLOR	Neuroscience investigations are most often focused on the prediction of future perception or decisions based on prior brain states or stimulus presentations. However, the brain can also process information retroactively, such that later stimuli impact conscious percepts of the stimuli that have already occurred (called "postdiction"). Postdictive effects have thus far been mostly unimodal (such as apparent motion), and the models for postdiction have accordingly been limited to early sensory regions of one modality. We have discovered two related multimodal illusions in which audition instigates postdictive changes in visual perception. In the first illusion (called the "Illusory Audiovisual Rabbit"), the location of an illusory flash is influenced by an auditory beep-flash pair that follows the perceived illusory flash. In the second illusion (called the "Invisible Audiovisual Rabbit"), a beep-flash pair following a real flash suppresses the perception of the earlier flash. Thus, we showed experimentally that these two effects are influenced significantly by postdiction. The audiovisual rabbit illusions indicate that postdiction can bridge the senses, uncovering a relatively-neglected yet critical type of neural processing underlying perceptual awareness. Furthermore, these two new illusions broaden the Double Flash Illusion, in which a single real flash is doubled by two sounds. Whereas the double flash indicated that audition can create an illusory flash, these rabbit illusions expand audition's influence on vision to the suppression of a real flash and the relocation of an illusory flash. These new additions to auditory-visual interactions indicate a spatio-temporally fine-tuned coupling of the senses to generate perception.	[Stiles, Noelle R. B.; Li, Monica; Shimojo, Shinsuke] CALTECH, Biol & Biol Engn, Pasadena, CA 91125 USA; [Levitan, Carmel A.] Occident Coll, Cognit Sci, Los Angeles, CA USA; [Kamitani, Yukiyasu] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Kamitani, Yukiyasu] ATR Computat Neurosci Labs, Kyoto, Japan	California Institute of Technology; Kyoto University	Stiles, NRB (corresponding author), CALTECH, Biol & Biol Engn, Pasadena, CA 91125 USA.	nstiles@caltech.edu			National Institutes of Health; Philanthropic Educational Organization Scholar Award Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philanthropic Educational Organization Scholar Award Program	We are grateful for research grants from the National Institutes of Health, the Philanthropic Educational Organization Scholar Award Program, from the Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), and from JSPS KAKENHI Grant number JP15H05710. ATR Computational Neuroscience Laboratories did not provided support in the form of salaries and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2003, CURR BIOL, V13, P59, DOI 10.1016/S0960-9822(02)01402-1; Bachmann T, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00593; BECK J, 1977, PERCEPT PSYCHOPHYS, V21, P33, DOI 10.3758/BF03199464; COLAVITA FB, 1974, PERCEPT PSYCHOPHYS, V16, P409, DOI 10.3758/BF03203962; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; GELDARD FA, 1972, SCIENCE, V178, P178, DOI 10.1126/science.178.4057.178; Goldreich D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00221; Heron J, 2004, VISION RES, V44, P2875, DOI 10.1016/j.visres.2004.07.001; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Kamitani Y, 1999, NAT NEUROSCI, V2, P767, DOI 10.1038/11245; KOLERS PA, 1976, VISION RES, V16, P329, DOI 10.1016/0042-6989(76)90192-9; KOLERS PA, 1975, SCIENCE, V187, P757, DOI 10.1126/science.1114322; MACDONALD J, 1978, PERCEPT PSYCHOPHYS, V24, P253, DOI 10.3758/BF03206096; MACKAY DM, 1958, NATURE, V181, P507, DOI 10.1038/181507a0; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Sergent C, 2013, CURR BIOL, V23, P150, DOI 10.1016/j.cub.2012.11.047; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Shams L, 2001, NEUROREPORT, V12, P3849, DOI 10.1097/00001756-200112040-00049; Shams L., 2000, NATURE; Sheth BR, 2000, NAT NEUROSCI, V3, P489, DOI 10.1038/74865; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; Shimojo S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00196; SHIPLEY T, 1964, SCIENCE, V145, P1328, DOI 10.1126/science.145.3638.1328; Spence C, 1998, PERCEPT PSYCHOPHYS, V60, P544, DOI 10.3758/BF03206045; Spence C., 2012, NEURAL BASEMULTISE, DOI DOI 10.1201/B11092; Vidal M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172028; Vroomen J, 2004, J EXP PSYCHOL HUMAN, V30, P513, DOI 10.1037/0096-1523.30.3.513; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; Wu CT, 2009, CURR BIOL, V19, P2003, DOI 10.1016/j.cub.2009.10.017; Yamada Y, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00166	33	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204217	10.1371/journal.pone.0204217	http://dx.doi.org/10.1371/journal.pone.0204217			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281629	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000446342400044
J	Wang, VG; Kim, H; Chuang, JH				Wang, Victor G.; Kim, Hyunsoo; Chuang, Jeffrey H.			Whole-exome sequencing capture kit biases yield false negative mutation calls in TCGA cohorts	PLOS ONE			English	Article							NONCODING RNA MALAT1; CELL LUNG-CANCER; METASTASIS; ONCOGENE	The Cancer Genome Atlas (TCGA) provides a genetic characterization of more than ten thousand tumors, enabling the discovery of novel driver mutations, molecular subtypes, and enticing drug targets across many histologies. Here we investigated why some mutations are common in particular cancer types but absent in others. As an example, we observed that the gene CCDC168 has no mutations in the stomach adenocarcinoma (STAD) cohort despite its common presence in other tumor types. Surprisingly, we found that the lack of called mutations was due to a systematic insufficiency in the number of sequencing reads in the STAD and other cohorts, as opposed to differential driver biology. Using strict filtering criteria, we found similar behavior in four other genes across TCGA cohorts, with each gene exhibiting systematic sequencing depth issues affecting the ability to call mutations. We identified the culprit as the choice of exome capture kit, as kit choice was highly associated with the set of genes that have insufficient reads to call a mutation. Overall, we found that thousands of samples across all cohorts are subject to some capture kit problems. For example, for the 6353 samples using the Broad Institute's Custom capture kit there are undercalling biases for at least 4833 genes. False negative mutation calls at these genes may obscure biological similarities between tumor types and other important cancer driver effects in TCGA datasets.	[Wang, Victor G.; Kim, Hyunsoo; Chuang, Jeffrey H.] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Wang, Victor G.; Chuang, Jeffrey H.] Univ Connecticut, Ctr Hlth, Dept Genet & Genome Sci, Farmington, CT 06030 USA	Jackson Laboratory; University of Connecticut	Chuang, JH (corresponding author), Jackson Lab Genom Med, Farmington, CT 06032 USA.; Chuang, JH (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Genome Sci, Farmington, CT 06030 USA.	jeff.chuang@jax.org		Chuang, Jeffrey/0000-0002-3298-2358	National Cancer Institute [P30CA034196, R21CA191848, U24CA224067, R01CA230031]; NATIONAL CANCER INSTITUTE [U24CA224067, P30CA034196, R21CA191848, R01CA230031] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors VW, HK, and JC are supported by the National Cancer Institute grants P30CA034196, R21CA191848, U24CA224067, and R01CA230031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brennana DJ, 2009, EUR J CANCER, V45, P1510, DOI 10.1016/j.ejca.2009.01.028; Buckley AR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3770-y; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; Choi YJ, 2014, HUM PATHOL, V45, P1674, DOI 10.1016/j.humpath.2014.04.013; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cortes-Ciriano I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15180; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fang J, 2016, BIOCHEM BIOPH RES CO, V478, P811, DOI 10.1016/j.bbrc.2016.08.030; Gustavsson E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-187; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Hide T, 2009, CANCER RES, V69, P7953, DOI 10.1158/0008-5472.CAN-09-2006; Huang YS, 2016, ONCOTARGET, V7, P43256, DOI 10.18632/oncotarget.9673; Integrated DNA Technologies, XGEN EX RES PAN; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Ji Q, 2014, BRIT J CANCER, V111, P736, DOI 10.1038/bjc.2014.383; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; McNeil C, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv193; Noorbakhsh J, 2017, NAT GENET, V49, P1288, DOI 10.1038/ng.3876; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Ren SC, 2013, J UROLOGY, V190, P2278, DOI 10.1016/j.juro.2013.07.001; Roche, SEQCAP EZ HGSC VCROM; Sernbo S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-405; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; SureSelect Yi Y., LEADER TARGET ENRICH; The Cancer Genome Atlas, TCGA TISS SAMPL REQ; Wang QY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01005-x; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034	33	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204912	10.1371/journal.pone.0204912	http://dx.doi.org/10.1371/journal.pone.0204912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281678	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400067
J	Zheng, GQ; Yu, HY; Kanerva, A; Forsti, A; Sundquist, K; Hemminki, K				Zheng, Guoqiao; Yu, Hongyao; Kanerva, Anna; Forsti, Asta; Sundquist, Kristina; Hemminki, Kari			Familial risks of ovarian cancer by age at diagnosis, proband type and histology	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MUTATIONS; MORTALITY; CARCINOMA; SUBTYPE; HISTORY; BRCA1; WOMEN; CARRIERS; SWEDEN	Ovarian cancer is a heterogeneous disease. Data regarding familial risks for specific proband, age at diagnosis and histology are limited. Such data can assist genetic counseling and help elucidate etiologic differences among various histologic types of ovarian malignancies. By using the Swedish Family-Cancer Database, we calculated relative risks (RRs) for detailed family histories using a two-way comparison, which implied e.g. estimation of RRs for overall ovarian cancer when family history was histology-specific ovarian cancer, and conversely, RRs for histology-specific ovarian cancer when family history was overall ovarian cancer. In families of only mother, only sisters or both mother and sisters diagnosed with ovarian cancer, cancer risks for ovary were 2.40, 2.59 and 10.40, respectively; and were higher for cases diagnosed before the age of 50 years. All histological types showed a familial risk in two-way analyses, except mucinous and sex cord-stromal tumors. RRs for concordant histology were found for serous (2.47), endometrioid (3.59) and mucinous ovarian cancers (6.91). Concordant familial risks were highest for mucinous cancer; for others, some discordant associations, such as endometrioid-undifferentiated (9.27) and serous-undifferentiated (4.80), showed the highest RRs. Familial risks are high for early-onset patients and for those with multiple affected relatives. Sharing of different histological types of ovarian cancer is likely an indication of the complexity of the underlying mechanisms.	[Zheng, Guoqiao; Yu, Hongyao; Forsti, Asta; Hemminki, Kari] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Kanerva, Anna] Univ Helsinki, Fac Med, Canc Gene Therapy Grp, Helsinki, Finland; [Kanerva, Anna] Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Forsti, Asta; Sundquist, Kristina; Hemminki, Kari] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Lund University	Zheng, GQ (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.	g.zheng@dkfz.de			German Cancer Aid; Swedish Research Council for Health, Working Life and Welfare (in Swedish: FORTE) [2013-1836]; FORTE [2014-0804]; Swedish Research Council [2012-2378, 2014-10134]; Region Skane; China Scholarship Council [201606100057]	German Cancer Aid(Deutsche Krebshilfe); Swedish Research Council for Health, Working Life and Welfare (in Swedish: FORTE); FORTE; Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Skane; China Scholarship Council(China Scholarship Council)	This work was supported by the German Cancer Aid; and the Swedish Research Council for Health, Working Life and Welfare (in Swedish: FORTE; Reg. no. 2013-1836), and FORTE (Reg. no. 2014-0804) and the Swedish Research Council (2012-2378 and 2014-10134); and ALF funding from Region Skane. This research was also supported by the China Scholarship Council (201606100057 to GZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1966, CANC INCIDENCE 5 CON, DOI DOI 10.1001/jamaoncol.2019.2996; Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; Beral V, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001200; Centre for Epidemiology, 2013, CANC INC SWED 2012; Chui MH, 2013, ADV ANAT PATHOL, V20, P378, DOI 10.1097/PAP.0b013e3182a92cf8; Conklin CM, 2013, EXPERT REV OBSTET GY, V8, P67, DOI [10.1586/eog.12.72, DOI 10.1586/EOG.12.72]; Frank C, 2017, INT J CANCER, V140, P1510, DOI 10.1002/ijc.30583; Gates MA, 2010, AM J EPIDEMIOL, V171, P45, DOI 10.1093/aje/kwp314; Geary J, 2008, FAM CANCER, V7, P163, DOI 10.1007/s10689-007-9164-6; Hemminki K, 2004, INT J CANCER, V110, P291, DOI 10.1002/ijc.20107; Hemminki K, 2003, INT J CANCER, V105, P692, DOI 10.1002/ijc.11150; Hemminki K, 2011, CANCER-AM CANCER SOC, V117, P3972, DOI 10.1002/cncr.26016; Hemminki K, 2010, INT J CANCER, V126, P2259, DOI 10.1002/ijc.24795; Jervis S, 2013, J MED GENETICS; Ji JG, 2008, ACTA ONCOL, V47, P1133, DOI 10.1080/02841860701784544; Kari H, 2003, INT J CANCER, V105, P701, DOI 10.1002/ijc.11151; Kim SI, 2016, J GYNECOL ONCOL, V27, DOI 10.3802/jgo.2016.27.e5; Kjaerbye-Thygesen A, 2005, ACTA OBSTET GYN SCAN, V84, P1006, DOI 10.1111/j.0001-6349.2005.00878.x; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lakhani SR, 2004, CLIN CANCER RES, V10, P2473, DOI 10.1158/1078-0432.CCR-1029-3; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Murff HJ, 2004, JAMA-J AM MED ASSOC, V292, P1480, DOI 10.1001/jama.292.12.1480; Norquist BM, 2016, JAMA ONCOL, V2, P482, DOI 10.1001/jamaoncol.2015.5495; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; Pal T, 2012, BRIT J CANCER, V107, P1783, DOI 10.1038/bjc.2012.452; Riman T, 2002, AM J EPIDEMIOL, V156, P363, DOI 10.1093/aje/kwf048; Roett MA, 2009, AM FAM PHYSICIAN, V80, P609; Skirnisdottir I, 2008, INT J CANCER, V123, P1897, DOI 10.1002/ijc.23724; Soegaard M, 2007, CANCER EPIDEM BIOMAR, V16, P1160, DOI 10.1158/1055-9965.EPI-07-0089; Sopik V, 2015, GYNECOL ONCOL, V138, P741, DOI 10.1016/j.ygyno.2015.06.017; Teerlink CC, 2012, GENET MED, V14, P107, DOI 10.1038/gim.2011.2; Torre L.A., 2017, GLOBAL CANC WOMEN BU; Watson P, 2001, GYNECOL ONCOL, V82, P223, DOI 10.1006/gyno.2001.6279; Wentzensen N, 2016, J CLIN ONCOL, V34, P2888, DOI 10.1200/JCO.2016.66.8178	34	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205000	10.1371/journal.pone.0205000	http://dx.doi.org/10.1371/journal.pone.0205000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281663	gold, Green Submitted, Green Published			2022-12-26	WOS:000446342400074
J	Liu, Y; Sumpter, DJT				Liu, Yu; Sumpter, David J. T.			Mathematical modeling reveals spontaneous emergence of self-replication in chemical reaction systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOCATALYTIC SETS; ORIGIN; EVOLUTION; LIFE; EVOLVABILITY; ORGANIZATION; NETWORKS	Explaining the origin of life requires us to elucidate how self-replication arises. To be specific, how can a self-replicating entity develop spontaneously from a chemical reaction system in which no reaction is self-replicating? Previously proposed mathematical models either supply an explicit framework for a minimal living system or consider only catalyzed reactions, and thus fail to provide a comprehensive theory. Here, we set up a general mathematical model for chemical reaction systems that properly accounts for energetics, kinetics, and the conservation law. We found that 1) some systems are collectively catalytic, a mode whereby reactants are transformed into end products with the assistance of intermediates (as in the citric acid cycle), whereas some others are self-replicating, that is, different parts replicate each other and the system self-replicates as a whole (as in the formose reaction, in which sugar is replicated from form-aldehyde); 2) side reactions do not always inhibit such systems; 3) randomly chosen chemical universes (namely random artificial chemistries) often contain one or more such systems; 4) it is possible to construct a self-replicating system in which the entropy of some parts spontaneously decreases, in a manner similar to that discussed by Schrodinger; and 5) complex self-replicating molecules can emerge spontaneously and relatively easily from simple chemical reaction systems through a sequence of transitions. Together, these results start to explain the origins of prebiotic evolution.	[Liu, Yu; Sumpter, David J. T.] Uppsala Univ, Dept Math, S-75105 Uppsala, Sweden	Uppsala University	Liu, Y (corresponding author), Uppsala Univ, Dept Math, S-75105 Uppsala, Sweden.	yu.ernest.liu@hotmail.com	Liu, Yu/AAE-2161-2019	Liu, Yu/0000-0003-2640-6490	Erasmus Mundus Action 2 program (Lotus III Scholarship) - European Commission	Erasmus Mundus Action 2 program (Lotus III Scholarship) - European Commission	Supported by the Erasmus Mundus Action 2 program (Lotus III Scholarship), funded by the European Commission.	Alberty RA, 2004, J BIOL CHEM, V279, P27831, DOI 10.1074/jbc.X400003200; Amend JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0255; Ashkenasy G, 2004, P NATL ACAD SCI USA, V101, P10872, DOI 10.1073/pnas.0402674101; Atkins P, 2014, ATKINS PHYS CHEM, P185; Banzhaf W, 2015, ARTIFICIAL CHEMISTRIES, P111; Branscomb E, 2013, BBA-BIOENERGETICS, V1827, P62, DOI 10.1016/j.bbabio.2012.10.003; Cavicchioli R, 2002, ASTROBIOLOGY, V2, P281, DOI 10.1089/153110702762027862; Czaran T, 2015, J THEOR BIOL, V381, P39, DOI 10.1016/j.jtbi.2015.06.002; Dittrich P, 2001, ARTIF LIFE, V7, P225, DOI 10.1162/106454601753238636; Dittrich P, 2007, B MATH BIOL, V69, P1199, DOI 10.1007/s11538-006-9130-8; England JL, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818538; FARMER JD, 1986, PHYSICA D, V22, P50, DOI 10.1016/0167-2789(86)90233-2; FONTANA W, 1994, B MATH BIOL, V56, P1; Ganti T., 2003, PRINCIPLES LIFE, P4; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Hordijk W, 2004, J THEOR BIOL, V227, P451, DOI 10.1016/j.jtbi.2003.11.020; Hordijk W, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aa9fcd; Hordijk W, 2017, BIOSYSTEMS, V152, P1, DOI 10.1016/j.biosystems.2016.12.002; Hordijk W, 2016, J MATH CHEM, V54, P1997, DOI 10.1007/s10910-016-0666-z; Hordijk W, 2016, ORIGINS LIFE EVOL B, V46, P233, DOI 10.1007/s11084-015-9471-0; Hordijk W, 2013, BIOSCIENCE, V63, P877, DOI 10.1525/bio.2013.63.11.6; Hordijk W, 2012, ACTA BIOTHEOR, V60, P379, DOI 10.1007/s10441-012-9165-1; Jain S, 2001, P NATL ACAD SCI USA, V98, P543, DOI 10.1073/pnas.021545098; KAUFFMAN SA, 1986, J THEOR BIOL, V119, P1, DOI 10.1016/S0022-5193(86)80047-9; Kim HJ, 2011, J AM CHEM SOC, V133, P9457, DOI 10.1021/ja201769f; KOPP LE, 1972, J BIOL CHEM, V247, P3564; Kun A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r51; Levy M, 2003, P NATL ACAD SCI USA, V100, P6416, DOI 10.1073/pnas.1130145100; Li L, 2013, J BIOL CHEM, V288, P26856, DOI 10.1074/jbc.M113.496125; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Martin WF, 2014, SCIENCE, V344, P1092, DOI 10.1126/science.1251653; MAVROVOUNIOTIS ML, 1991, J BIOL CHEM, V266, P14440; Maynard Smith J, 1995, MAJOR TRANSITIONS EV, P41; Mix LJ, 2006, ASTROBIOLOGY, V6, P735; Morowitz HJ, 2000, P NATL ACAD SCI USA, V97, P7704, DOI 10.1073/pnas.110153997; Nghe P, 2015, MOL BIOSYST, V11, P3206, DOI 10.1039/c5mb00593k; Rasmussen S, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0440; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; Robertson M.P., 2012, COLD SPRING HARB PER, V4, P4, DOI DOI 10.1101/CSHPERSPECT.A003608; RUSSELL MJ, 1993, TERRA NOVA, V5, P343, DOI 10.1111/j.1365-3121.1993.tb00267.x; Schmidt M, 2010, BIOESSAYS, V32, P322, DOI 10.1002/bies.200900147; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Segre D, 1998, ORIGINS LIFE EVOL B, V28, P501, DOI 10.1023/A:1006583712886; SIEVERS D, 1994, NATURE, V369, P221, DOI 10.1038/369221a0; Smith Joshua I, 2014, J Syst Chem, V5, P2; Sousa Filipa L, 2015, J Syst Chem, V6, P4; STADLER PF, 1993, PHYSICA D, V63, P378, DOI 10.1016/0167-2789(93)90118-K; Steel M, 2000, APPL MATH LETT, V13, P91, DOI 10.1016/S0893-9659(99)00191-3; Szathmary E, 1999, MG BEH ECOL, P31; Szathmary E, 2005, TOP CURR CHEM, V259, P167, DOI 10.1007/tcc001; SZATHMARY E, 1995, P ROY SOC B-BIOL SCI, V260, P279, DOI 10.1098/rspb.1995.0092; Szathmary E, 2006, PHILOS T R SOC B, V361, P1761, DOI 10.1098/rstb.2006.1912; Szilagyi A, 2017, LIFE-BASEL, V7, DOI 10.3390/life7040048; Vaidya N, 2012, NATURE, V491, P72, DOI 10.1038/nature11549; Vasas V, 2015, J THEOR BIOL, V381, P29, DOI 10.1016/j.jtbi.2015.06.047; Vasas V, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-1; Vasas V, 2010, P NATL ACAD SCI USA, V107, P1470, DOI 10.1073/pnas.0912628107; WACHTERSHAUSER G, 1990, P NATL ACAD SCI USA, V87, P200, DOI 10.1073/pnas.87.1.200; WACHTERSHAUSER G, 1988, MICROBIOL REV, V52, P452; Wills P, 2000, NEW ENGL COMPL SYST, P613	60	11	11	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18854	18863		10.1074/jbc.RA118.003795	http://dx.doi.org/10.1074/jbc.RA118.003795			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30282809	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-26	WOS:000458467400004
J	Betancourt-Solis, MA; Desai, T; McNew, JA				Betancourt-Solis, Miguel A.; Desai, Tanvi; McNew, James A.			The atlastin membrane anchor forms an intramembrane hairpin that does not span the phospholipid bilayer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; HOMOTYPIC FUSION; STRUCTURAL BASIS; COMMON PATHWAY; PROTEINS; REQUIRES; RECONSTITUTION; GENERATION; MECHANISM; SNARE	The endoplasmic reticulum (ER) is composed of flattened sheets and interconnected tubules that extend throughout the cytosol and makes physical contact with all other cytoplasmic organelles. This cytoplasmic distribution requires continuous remodeling. These discrete ER morphologies require specialized proteins that drive and maintain membrane curvature. The GTPase atlastin is required for homotypic fusion of ER tubules. All atlastin homologs possess a conserved domain architecture consisting of a GTPase domain, a three-helix bundle middle domain, a hydrophobic membrane anchor, and a C-terminal cytosolic tail. Here, we examined several Drosophila-human atlastin chimeras to identify functional domains of human atlastin-1 in vitro. Although all chimeras could hydrolyze GTP, only chimeras containing the human C-terminal tail, hydrophobic segments, or both could fuse membranes in vitro. We also determined that co-reconstitution of atlastin with reticulon does not influence GTPase activity or membrane fusion. Finally, we found that both human and Drosophila atlastin hydrophobic membrane anchors do not span the membrane, but rather form two intramembrane hairpin loops. The topology of these hairpins remains static during membrane fusion and does not appear to play an active role in lipid mixing.	[Betancourt-Solis, Miguel A.; Desai, Tanvi; McNew, James A.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Rice University	McNew, JA (corresponding author), Rice Univ, Dept BioSci, 6100 Main St,MS601, Houston, TX 77005 USA.	mcnew@rice.edu	Desai, Tanvi/AAH-7038-2021; McNew, James/ABD-8081-2020; McNew, James/AAV-4911-2020	McNew, James/0000-0001-8459-3664; Desai, Tanvi/0000-0003-2571-5910; Betancourt-Solis, Miguel Alberto/0000-0001-8041-4120	National Institutes of Health [GM101377]; Virginia and L. E. Simmons Family Foundation; Hamill Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and L. E. Simmons Family Foundation; Hamill Foundation	Supported by National Institutes of Health Grant GM101377, the Virginia and L. E. Simmons Family Foundation, and the Hamill Foundation. To whom correspondence should be addressed: Dept. of BioSciences, Rice University, 6100 Main St., Rice University, MS601, Houston, TX 77005. Tel.: 713-348-3133; E-mail: mcnew@rice.edu.	Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Blackstone Craig, 2018, Handb Clin Neurol, V148, P633, DOI 10.1016/B978-0-444-64076-5.00041-7; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Blijleven JS, 2016, SEMIN CELL DEV BIOL, V60, P78, DOI 10.1016/j.semcdb.2016.07.007; Byrnes LJ, 2013, EMBO J, V32, P369, DOI 10.1038/emboj.2012.353; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Chen S, 2015, P NATL ACAD SCI USA, V112, P418, DOI 10.1073/pnas.1423026112; Chen SL, 2012, NAT CELL BIOL, V14, P707, DOI 10.1038/ncb2523; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; English AR, 2009, CURR OPIN CELL BIOL, V21, P596, DOI 10.1016/j.ceb.2009.04.004; Evans K, 2006, P NATL ACAD SCI USA, V103, P10666, DOI 10.1073/pnas.0510863103; Faust JE, 2015, J BIOL CHEM, V290, P4772, DOI 10.1074/jbc.M114.601823; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; Fink JK, 2014, SEMIN NEUROL, V34, P293, DOI 10.1055/s-0034-1386767; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Hu JJ, 2016, SEMIN CELL DEV BIOL, V60, P105, DOI 10.1016/j.semcdb.2016.06.001; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Hubner CA, 2014, BRAIN, V137, P3109, DOI 10.1093/brain/awu287; Klebe S, 2015, REV NEUROL-FRANCE, V171, P505, DOI 10.1016/j.neurol.2015.02.017; Kornak U, 2014, BRAIN, V137, P683, DOI 10.1093/brain/awt357; Kozlov MM, 2014, CURR OPIN CELL BIOL, V29, P53, DOI 10.1016/j.ceb.2014.03.006; Lee Y, 2008, NEUROBIOL AGING, V29, P84, DOI 10.1016/j.neurobiolaging.2006.09.004; Liu TY, 2015, P NATL ACAD SCI USA, V112, pE1851, DOI 10.1073/pnas.1504368112; Liu TY, 2012, P NATL ACAD SCI USA, V109, pE2146, DOI 10.1073/pnas.1208385109; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Mcnew JA, 2008, CHEM REV, V108, P1669, DOI 10.1021/cr0782325; McNew JA, 2013, ANNU REV CELL DEV BI, V29, P529, DOI 10.1146/annurev-cellbio-101512-122328; Montenegro G, 2012, J CLIN INVEST, V122, P538, DOI 10.1172/JCI60560; Morin-Leisk J, 2011, J CELL BIOL, V195, P605, DOI 10.1083/jcb.201105006; Moss B, 2016, SEMIN CELL DEV BIOL, V60, P89, DOI 10.1016/j.semcdb.2016.07.015; Moss TJ, 2011, P NATL ACAD SCI USA, V108, P11133, DOI 10.1073/pnas.1105056108; Moss TJ, 2011, TRENDS CELL BIOL, V21, P416, DOI 10.1016/j.tcb.2011.03.009; Noreau A, 2014, EXP CELL RES, V325, P18, DOI 10.1016/j.yexcr.2014.02.021; O'Donnell JP, 2018, J BIOL CHEM, V293, P687, DOI 10.1074/jbc.RA117.000380; O'Donnell JP, 2017, STRUCTURE, V25, P997, DOI 10.1016/j.str.2017.05.007; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Pendin D, 2011, CURR OPIN CELL BIOL, V23, P435, DOI 10.1016/j.ceb.2011.04.007; Powers RE, 2017, NATURE, V543, P257, DOI 10.1038/nature21387; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Rothman JE, 2014, ANGEW CHEM INT EDIT, V53, P12676, DOI 10.1002/anie.201402380; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Scott BL, 2003, METHOD ENZYMOL, V372, P274; Shemesh T, 2014, P NATL ACAD SCI USA, V111, pE5243, DOI 10.1073/pnas.1419997111; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Summerville JB, 2016, J CELL SCI, V129, P1635, DOI 10.1242/jcs.184929; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wakefield S, 2006, CELL MOL LIFE SCI, V63, P2027, DOI 10.1007/s00018-006-6142-3; Wang S, 2016, ELIFE, V5, DOI 10.7554/eLife.14211; White JM, 1995, COLD SPRING HARB SYM, V60, P581, DOI 10.1101/SQB.1995.060.01.062; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389; Wu FY, 2015, PROTEIN CELL, V6, P139, DOI 10.1007/s13238-014-0118-0; Yalcin B, 2017, ELIFE, V6, DOI 10.7554/eLife.23882; Yang YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-234; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	63	19	20	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18514	18524		10.1074/jbc.RA118.003812	http://dx.doi.org/10.1074/jbc.RA118.003812			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30287684	Green Published, hybrid			2022-12-26	WOS:000458467300009
J	Jeschke, GR; Lou, HJ; Weise, K; Hammond, CI; Demonch, M; Brennwald, P; Turk, BE				Jeschke, Grace R.; Lou, Hua Jane; Weise, Keith; Hammond, Charlotte I.; Demonch, Mallory; Brennwald, Patrick; Turk, Benjamin E.			Substrate priming enhances phosphorylation by the budding yeast kinases Kin1 and Kin2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase; protein phosphorylation; signal transduction; exocytosis; endoplasmic reticulum stress (ER stress); yeast; SNARE proteins; kinase priming; phosphorecognition; Sec9	PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; BINDING DOMAINS; SNARE COMPLEX; CELL-CYCLE; SPECIFICITY; PHOSPHOPROTEINS; INTEGRATION; MECHANISM	Multisite phosphorylation of proteins is a common mechanism for signal integration and amplification in eukaryotic signaling networks. Proteins are commonly phosphorylated at multiple sites in an ordered manner, whereby phosphorylation by one kinase primes the substrate by generating a recognition motif for a second kinase. Here we show that substrate priming promotes phosphorylation by Saccharomyces cerevisiae Kin1 and Kin2, kinases that regulate cell polarity, exocytosis, and the endoplasmic reticulum (ER) stress response. Kin1/Kin2 phosphorylated substrates within the context of a sequence motif distinct from those of their most closely related kinases. In particular, the rate of phosphorylation of a peptide substrate by Kin1/Kin2 increased >30-fold with incorporation of a phosphoserine residue two residues downstream of the phosphorylation site. Recognition of phosphorylated substrates by Kin1/Kin2 was mediated by a patch of basic residues located in the region of the kinase C helix. We identified a set of candidate Kin1/Kin2 substrates reported to be dually phosphorylated at sites conforming to the Kin1/Kin2 consensus sequence. One of these proteins, the t-SNARE protein Sec9, was confirmed to be a Kin1/Kin2 substrate both in vitro and in vivo. Sec9 phosphorylation by Kin1 in vitro was enhanced by prior phosphorylation at the +2 position. Recognition of primed substrates was not required for the ability of Kin2 to suppress the growth defect of secretory pathway mutants but was necessary for optimal growth under conditions of ER stress. These results suggest that at least some endogenous protein substrates of Kin1/Kin2 are phosphorylated in a priming-dependent manner.	[Jeschke, Grace R.; Lou, Hua Jane; Weise, Keith; Turk, Benjamin E.] Yale Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA; [Hammond, Charlotte I.] Quinnipiac Univ, Dept Biol, Hamden, CT 06518 USA; [Demonch, Mallory; Brennwald, Patrick] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	Yale University; Quinnipiac University; University of North Carolina; University of North Carolina Chapel Hill	Turk, BE (corresponding author), Yale Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA.	ben.turk@yale.edu		Jeschke, Grace/0000-0001-6271-7750	National Institutes of Health [R01 GM104047, R01 GM105947, R01 GM054712-21]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054712, R01GM104047, R01GM105947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM104047 and R01 GM105947 (to B. E. T.) and R01 GM054712-21 (to P. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anshu A, 2015, MOL CELL BIOL, V35, P199, DOI 10.1128/MCB.00981-14; Bachmann M, 2004, J BIOL CHEM, V279, P48319, DOI 10.1074/jbc.M404440200; Begley MJ, 2015, NAT STRUCT MOL BIOL, V22, P983, DOI 10.1038/nsmb.3117; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Cadou A, 2010, MOL MICROBIOL, V77, P1186, DOI 10.1111/j.1365-2958.2010.07281.x; Cadou A, 2009, CELL CYCLE, V8, P2451, DOI 10.4161/cc.8.15.9219; Cesaro L, 2015, MOL BIOSYST, V11, P2666, DOI 10.1039/c5mb00337g; Chen S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003936; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; DONOVAN M, 1994, YEAST, V10, P113, DOI 10.1002/yea.320100111; Drewes G, 2003, FEBS LETT, V554, P45, DOI 10.1016/S0014-5793(03)01080-9; Elbert M, 2005, MOL BIOL CELL, V16, P532, DOI 10.1091/mbc.E04-07-0549; Elbing K, 2006, BIOCHEM J, V393, P797, DOI 10.1042/BJ20051213; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Goodwin JM, 2014, MOL CELL, V55, P436, DOI 10.1016/j.molcel.2014.06.021; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Koivomagi M, 2013, NAT STRUCT MOL BIOL, V20, P1415, DOI 10.1038/nsmb.2706; La Carbona S, 2004, BIOL CELL, V96, P169, DOI 10.1016/j.biolcel.2003.12.004; La Carbona S, 2006, CURR GENET, V50, P377, DOI 10.1007/s00294-006-0099-5; LAMB A, 1991, YEAST, V7, P219, DOI 10.1002/yea.320070304; LasaBenito M, 1996, FEBS LETT, V382, P149, DOI 10.1016/0014-5793(96)00136-6; Lee ME, 2018, CURR BIOL, V28, P84, DOI 10.1016/j.cub.2017.11.034; Lee YJ, 2012, MOL CELL BIOL, V32, P4705, DOI 10.1128/MCB.00897-12; LEVIN DE, 1990, P NATL ACAD SCI USA, V87, P8272, DOI 10.1073/pnas.87.21.8272; LEVIN DE, 1987, P NATL ACAD SCI USA, V84, P6035, DOI 10.1073/pnas.84.17.6035; Miller CJ, 2018, TRENDS BIOCHEM SCI, V43, P380, DOI 10.1016/j.tibs.2018.02.009; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Nesic D, 2010, NAT STRUCT MOL BIOL, V17, P130, DOI 10.1038/nsmb.1705; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Rice LM, 1997, FEBS LETT, V415, P49, DOI 10.1016/S0014-5793(97)01091-0; Sarno S, 1997, BIOCHEMISTRY-US, V36, P11717, DOI 10.1021/bi9705772; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Serber Z, 2007, CELL, V128, P441, DOI 10.1016/j.cell.2007.01.018; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; Uboha NV, 2007, J NEUROSCI, V27, P4413, DOI 10.1523/JNEUROSCI.0725-07.2007; Xiao JY, 2013, P NATL ACAD SCI USA, V110, P10574, DOI 10.1073/pnas.1309211110; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Yuan SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153992	51	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18353	18364		10.1074/jbc.RA118.005651	http://dx.doi.org/10.1074/jbc.RA118.005651			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30305396	Green Published, hybrid			2022-12-26	WOS:000451375200026
J	Gworek, B; Baczewska-Dabrowska, AH; Kalinowski, R; Gorska, EB; Rekosz-Burlaga, H; Gozdowski, D; Olejniczak, I; Graniewska, M; Dmuchowski, W				Gworek, Barbara; Baczewska-Dabrowska, Aneta Helena; Kalinowski, Radoslaw; Gorska, Ewa Beata; Rekosz-Burlaga, Hanna; Gozdowski, Dariusz; Olejniczak, Izabella; Graniewska, Magdalena; Dmuchowski, Wojciech			Ecological risk assessment for land contaminated by petrochemical industry	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SOIL ARTHROPOD COMMUNITY; ORGANIC-MATTER; COLLEMBOLA; POLLUTION; AIR; BIODIVERSITY; MANAGEMENT; EMISSIONS; STRESS	Contamination with harmful chemical substances, including organic compounds of the BTEX and PAH groups, constitutes one of the major threats to the functioning of soil habitat. Excessive contents of the above substances can exert adverse effects on soil organisms, reduce biodiversity, and thus deteriorate soil quality. The threat to soil ecosystems within areas particularly exposed to contamination with accumulating chemical compounds was assessed using the Ecological Risk Assessment (ERA) with a multi-stage Triad (triage rapid initial assessment) procedure (taking into account the different lines of evidence). The article presents the results of chemical and ecotoxicological study of soils sampled at sites affected by contamination from petrochemical industry. The study results provided foundations for developing the site specific ERA framework for the area examined.	[Gworek, Barbara; Baczewska-Dabrowska, Aneta Helena; Kalinowski, Radoslaw; Graniewska, Magdalena; Dmuchowski, Wojciech] Natl Res Inst, Inst Environm Protect, Warsaw, Poland; [Gorska, Ewa Beata; Rekosz-Burlaga, Hanna; Gozdowski, Dariusz] Warsaw Univ Life Sci, SGGW, Warsaw, Poland; [Olejniczak, Izabella] Cardinal Stefan Wyszynski Univ, Inst Ecol & Bioeth, Warsaw, Poland	Institute of Environmental Protection - National Research Institute; Warsaw University of Life Sciences; Cardinal Stefan Wyszynski University in Warsaw	Baczewska-Dabrowska, AH (corresponding author), Natl Res Inst, Inst Environm Protect, Warsaw, Poland.	aneta.baczewska@ios.edu.pl	Górska, Ewa/AAB-1808-2021; Olejniczak, Izabella/AEV-8367-2022	Olejniczak, Izabella/0000-0003-4746-7874; Rekosz-Burlaga, Hanna/0000-0002-5412-5365; Gorska, Ewa/0000-0003-0001-2274; Gozdowski, Dariusz/0000-0002-7365-7607; Gworek, Barbara/0000-0002-2368-5888				ADDINK R, 1995, ENVIRON SCI TECHNOL, V29, P1425, DOI 10.1021/es00006a002; Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Antonkiewicz J, 2016, INT J PHYTOREMEDIAT, V18, P245, DOI 10.1080/15226514.2015.1078771; BEHYMER TD, 1988, ENVIRON SCI TECHNOL, V22, P1311, DOI 10.1021/es00176a011; BENGTSSON G, 1984, AMBIO, V13, P29; Bradley L., 1994, J SOIL CONTAM, V4, P1; BROWN SK, 1994, INDOOR AIR, V4, P123, DOI 10.1111/j.1600-0668.1994.t01-2-00007.x; Chapman PM, 2007, ENVIRON INT, V33, P492, DOI 10.1016/j.envint.2006.09.001; CHRISTIANSEN K, 1964, ANNU REV ENTOMOL, V9, P147, DOI 10.1146/annurev.en.09.010164.001051; Dagnino Alessandro, 2008, Integrated Environmental Assessment and Management, V4, P314, DOI 10.1897/IEAM_2007-067.1; Fiera C, 2009, PESQUI AGROPECU BRAS, V44, P868, DOI 10.1590/S0100-204X2009000800010; FJELLBERG A, 2007, FAUNA ENTOMOL SCAD, V42, P1; Fjellberg A., 1998, FAUNA ENTOMOL SCAD, V35, P1; Gillet S, 2003, APPL SOIL ECOL, V22, P127, DOI 10.1016/S0929-1393(02)00134-8; Greenslade P, 2007, AUST J EXP AGR, V47, P424, DOI 10.1071/EA05264; Gworek B, 2016, ENVIRON SCI POLLUT R, V23, P19461, DOI 10.1007/s11356-016-7130-2; Hasegawa M, 2001, EUR J SOIL BIOL, V37, P281, DOI 10.1016/S1164-5563(01)01099-8; Hope BK, 2006, ENVIRON INT, V32, P983, DOI 10.1016/j.envint.2006.06.005; JOHNSON J, 1995, ENVIRON SCI TECHNOL, V29, pA24, DOI 10.1021/es00001a750; KALDOR J, 1984, ENVIRON HEALTH PERSP, V54, P319, DOI 10.2307/3429821; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Kozielska B, 2013, ARCH WASTE MANAGEMEN, V15, P3; Lee HK, 2000, ENV HLTH PERSPECT, V106, P792; Lin MC, 2001, J TOXICOL ENV HEAL A, V63, P565, DOI 10.1080/152873901316857743; Maliszewska-Kordybach B, 2000, ENVIRON TECHNOL, V21, P1099, DOI 10.1080/09593330.2000.9618996; Migliorini M, 2004, ENVIRON POLLUT, V129, P331, DOI 10.1016/j.envpol.2003.09.025; Miguel AH, 1998, ENVIRON SCI TECHNOL, V32, P450, DOI 10.1021/es970566w; Nadal M, 2004, SCI TOTAL ENVIRON, V321, P59, DOI 10.1016/j.scitotenv.2003.08.029; Nam JJ, 2008, CHEMOSPHERE, V70, P1596, DOI 10.1016/j.chemosphere.2007.08.010; Olejniczak Izabella, 2000, Polish Journal of Ecology, V48, P209; Petruzzelli L, 2002, J ENVIRON SCI HEAL B, V37, P187, DOI 10.1081/PFC-120003097; Salminen J, 1996, BIOL FERT SOILS, V23, P182; Schroder JL, 2000, ENVIRON TOXICOL CHEM, V19, P2066, DOI [10.1897/1551-5028(2000)019&lt;2066:SCABOI&gt;2.3.CO;2, 10.1002/etc.5620190815]; SIEPEL H, 1995, BIOL FERT SOILS, V19, P75, DOI 10.1007/BF00336351; Smreczak B, 2003, FRESEN ENVIRON BULL, V12, P946; Stach J, 1995, KLUCZE OZNACZANIA OW; Stewart R, 2014, POSTEPY TECHNIKI JAD, V57, P26; Stewart R., 2009, INTRO SPATIAL ANAL D; Suter II, 2016, ECOLOGICAL RISK ASSE; Swartjes FA, 2008, SCI TOTAL ENVIRON, V406, P523, DOI 10.1016/j.scitotenv.2008.07.034; Traczewska T. M., 2011, BIOL METODY OCENY SK; U.S. EPA, 1992, FRAM EC RISK ASS	42	13	15	7	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204852	10.1371/journal.pone.0204852	http://dx.doi.org/10.1371/journal.pone.0204852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307997	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500028
J	Hayashi, Y; Yoshimura, J; Roff, DA; Kumita, T; Shimizu, A				Hayashi, Yaoko; Yoshimura, Jin; Roff, Derek A.; Kumita, Tetsuro; Shimizu, Akira			Four types of vibration behaviors in a mole cricket	PLOS ONE			English	Article							SOUND PRODUCTION; ACOUSTIC BURROW; COMMUNICATION; GRYLLOTALPIDAE; ORTHOPTERA	Vibrational communication is known in some subterranean insects. Except for their use in sexual signaling, vibration behavior has rarely been reported. We report here four distinct types of substrate-based vibration behaviors in the mole cricket, Gryllotalpa orientalis, which are not associated with sexual signaling because of the occurrence of these behaviors in nymphs: (1) scraping with the forelegs; (2) foreleg taps (tapping with the forelegs); (3) palpal taps (tapping with the maxillary palpi); and (4) tremulation (back-and-forth movement of the whole body). Scraping is hypothesized to be used for the inspection of borrows. Foreleg taps are possibly informing nearby individuals of their presence, because it is never observed in solitary conditions. Palpal taps are rarely observed and its function is unknown. Tremulation is possibly related to avoidance of conspecific individual approaching and touching. The combination of the four vibration behaviors in the mole cricket may be unique among insects.	[Hayashi, Yaoko; Shimizu, Akira] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan; [Yoshimura, Jin] Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka, Japan; [Yoshimura, Jin] Shizuoka Univ, Dept Math & Syst Engn, Hamamatsu, Shizuoka, Japan; [Yoshimura, Jin] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Yoshimura, Jin] Chiba Univ, Marine Biosyst Res Ctr, Kamogawa, Chiba, Japan; [Roff, Derek A.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Kumita, Tetsuro] Tokyo Metropolitan Univ, Dept Phys, Hachioji, Tokyo, Japan	Tokyo Metropolitan University; Shizuoka University; Shizuoka University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Chiba University; University of California System; University of California Riverside; Tokyo Metropolitan University	Shimizu, A (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan.	shimizu-akira@tmu.ac.jp			Japan Society for Promotion of Science (JSPS) [22255004, 22370010, 26257405, 15H04420, 25440217]	Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants-in-aid from the Japan Society for Promotion of Science (JSPS) to JY (nos. 22255004, 22370010, 26257405 and 15H04420) and AS (no. 25440217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennet-Clark H.C., 1989, CRICKET BEHAV NEUROB, V227, P261; BENNETCLARK HC, 1987, J EXP BIOL, V128, P383; BENNETCLARK HC, 1970, J EXP BIOL, V52, P619; BIRCH MC, 1991, J INSECT BEHAV, V4, P257, DOI 10.1007/BF01054618; Claridge M, 2006, CONT T ENT, P3; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Daws A. G., 1996, Bioacoustics, V7, P81; Drosopoulos S., 2005, INSECT SOUNDS COMMUN; Endler JA, 2014, STUDYING VIBRATIONAL, pVII, DOI DOI 10.1007/978-3-662-43607-3; Endo C, 2007, J ZOOL, V273, P414, DOI 10.1111/j.1469-7998.2007.00345.x; Forrest T.G., 1983, P185; Gwynne DT, 2001, CORNELL S ARTHR BIOL; Hill P.S., 2008, VIBRATIONAL COMMUNIC, DOI DOI 10.4159/9780674273825; Hill Peggy S. M., 2006, Journal of Orthoptera Research, V15, P23, DOI 10.1665/1082-6467(2006)15[23:SFACBW]2.0.CO;2; Hill PSM, 2001, AM ZOOL, V41, P1135, DOI 10.1668/0003-1569(2001)041[1135:VAACAR]2.0.CO;2; Hill PSM, 2001, AM ZOOL, V41, P1200, DOI 10.1668/0003-1569(2001)041[1200:TBSSVS]2.0.CO;2; Hill PSM, 1998, BEHAV ECOL, V9, P101, DOI 10.1093/beheco/9.1.101; ISHAY J, 1974, ANIM BEHAV, V22, P741, DOI 10.1016/S0003-3472(74)80026-6; ISHAY J, 1972, NATURE, V237, P286, DOI 10.1038/237286a0; Jafari S, 2015, NORTH-WEST J ZOOL, V11, P58; KAVANAGH MW, 1989, J COMP PHYSIOL A, V166, P43, DOI 10.1007/BF00190208; Loher W., 1989, P43; Mason MJ, 2001, AM ZOOL, V41, P1171, DOI 10.1668/0003-1569(2001)041[1171:SSUBFM]2.0.CO;2; Miyatake Y, 2011, INSECT COMMUNICATION, P285; NICKERSON JC, 1979, ANN ENTOMOL SOC AM, V72, P438, DOI 10.1093/aesa/72.3.438; Randall J. A., 2010, USE VIBRATIONS COMMU, P99; Randall JA, 2001, AM ZOOL, V41, P1143, DOI 10.1668/0003-1569(2001)041[1143:EAFODA]2.0.CO;2; Stewart KW, 2006, CONT T ENT, P179; the Orthopterological Society of Japan, 2006, ORTHOPTERA JAPANESE; ULAGARAJ SM, 1976, ANN ENTOMOL SOC AM, V69, P299, DOI 10.1093/aesa/69.2.299; Virant-Doberlet M, 2004, NEOTROP ENTOMOL, V33, P121, DOI 10.1590/S1519-566X2004000200001; WALKER TJ, 1990, J KANSAS ENTOMOL SOC, V63, P237	32	1	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204628	10.1371/journal.pone.0204628	http://dx.doi.org/10.1371/journal.pone.0204628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304041	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100059
J	Tsuzuki, T; Yoshihara, T; Ichinoseki-Sekine, N; Kakigi, R; Takamine, Y; Kobayashi, H; Naito, H				Tsuzuki, Takamasa; Yoshihara, Toshinori; Ichinoseki-Sekine, Noriko; Kakigi, Ryo; Takamine, Yuri; Kobayashi, Hiroyuki; Naito, Hisashi			Body temperature elevation during exercise is essential for activating the Akt signaling pathway in the skeletal muscle of type 2 diabetic rats	PLOS ONE			English	Article							GLUCOSE-UPTAKE; INSULIN-RESISTANCE; PROTEIN-KINASE; CONTRACTILE ACTIVITY; 3-KINASE ACTIVITY; FATTY-ACID; PHOSPHORYLATION; GLUT4; SENSITIVITY; TRANSPORT	This study examined the effect of changes in body temperature during exercise on signal transduction-related glucose uptake in the skeletal muscle of type 2 diabetic rats. Otsuka Long-Evans Tokushima Fatty rats (25 weeks of age), which have type 2 diabetes, were divided into the following four weight-matched groups; control (CON, n = 6), exercised under warm temperature (WEx, n = 8), exercised under cold temperature (CEx, n = 8), and heat treatment (HT, n = 6). WEx and CEx animals were subjected to running on a treadmill at 20 m/min for 30 min under warm (25 degrees C) or cold (4 degrees C) temperature. HT animals were exposed to single heat treatment (40-41 degrees C for 30 min) in a heat chamber. Rectal and muscle temperatures were measured immediately after exercise and heat treatment, and the gastrocnemius muscle was sampled under anesthesia. Rectal and muscle temperatures increased significantly in rats in the WEx and HT, but not the CEx, groups. The phosphorylation levels of Akt, AS160, and TBC1D1 (Thr590) were significantly higher in the WEx and HT groups than the CON group (p < 0.05). In contrast, the phosphorylation levels of AMP-activated protein kinase, ACC, and TBC1D1 (Ser660) were significantly higher in rats in the WEx and CEx groups than the CON group (p < 0.05) but did not differ significantly between rats in the WEx and CEx groups. Body temperature elevation by heat treatment did not activate the AMPK signaling. Our data suggest that body temperature elevation during exercise is essential for activating the Akt signaling pathway in the skeletal muscle of rats with type 2 diabetic rats.	[Tsuzuki, Takamasa; Yoshihara, Toshinori; Ichinoseki-Sekine, Noriko; Takamine, Yuri; Kobayashi, Hiroyuki; Naito, Hisashi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan; [Tsuzuki, Takamasa] Meijo Univ, Fac Pharm, Nagoya, Aichi, Japan; [Ichinoseki-Sekine, Noriko] Open Univ Japan, Fac Liberal Arts, Chiba, Japan; [Kakigi, Ryo] Juntendo Univ, Fac Med, Tokyo, Japan; [Kobayashi, Hiroyuki] Tsukuba Univ Hosp, Mito Med Ctr, Dept Gen Med, Ibaraki, Japan	Juntendo University; Meijo University; Juntendo University; University of Tsukuba	Naito, H (corresponding author), Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan.	hnaitou@juntendo.ac.jp	Ichinoseki-Sekine, Noriko/F-9075-2011; Naito, Hisashi/F-5655-2011; Yoshihara, Toshinori/M-3374-2019; Tsuzuki, Takamasa/S-3563-2019	Ichinoseki-Sekine, Noriko/0000-0002-0467-3312; Naito, Hisashi/0000-0002-0522-9512; Yoshihara, Toshinori/0000-0002-8465-5439; Tsuzuki, Takamasa/0000-0002-0241-1183	MEXT-Supported program for the Strategic Research Foundation at Private Universities [S1101008];  [13J10819]	MEXT-Supported program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported in part by grants from the MEXT-Supported program for the Strategic Research Foundation at Private Universities (S1101008) to HN and a grant-in-aid for Japan Society for the Promotion of Science Fellows (13J10819) to TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brozinick JT, 1998, J BIOL CHEM, V273, P14679, DOI 10.1074/jbc.273.24.14679; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; DEFRONZO RA, 1981, J CLIN INVEST, V68, P1468, DOI 10.1172/JCI110399; Di Meo S, 2017, J ENDOCRINOL, V234, pR159, DOI 10.1530/JOE-17-0186; Esbjornsson M, 2012, ACTA PHYSIOL, V205, P411, DOI [10.1111/j.1748-1716.2011.02404.x, 10.1111/j.1748-1716.2012.02404.x]; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; GOODYEAR LJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE987, DOI 10.1152/ajpendo.1995.268.5.E987; Goto A, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12601; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Koshinaka K, 2013, J PHYSIOL SCI, V63, P409, DOI 10.1007/s12576-013-0278-3; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; LUND S, 1995, P NATL ACAD SCI USA, V92, P5817, DOI 10.1073/pnas.92.13.5817; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Oehler-Janne C, 2008, BIOCHEM BIOPH RES CO, V375, P399, DOI 10.1016/j.bbrc.2008.08.035; Rasmussen BB, 1997, J APPL PHYSIOL, V83, P1104, DOI 10.1152/jappl.1997.83.4.1104; Rockl KSC, 2008, IUBMB LIFE, V60, P145, DOI 10.1002/iub.21; Sakamoto K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1081, DOI 10.1152/ajpendo.00228.2003; Sakamoto K, 2002, J BIOL CHEM, V277, P11910, DOI 10.1074/jbc.M112410200; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sherwood DJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE870, DOI 10.1152/ajpendo.1999.276.5.E870; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Tsuzuki T, 2017, CELL STRESS CHAPERON, V22, P263, DOI 10.1007/s12192-017-0767-z; Witczak CA, 2007, DIABETES, V56, P1403, DOI 10.2337/db06-1230; Wright DC, 2004, DIABETES, V53, P330, DOI 10.2337/diabetes.53.2.330; Yoshihara T, 2013, ACTA PHYSIOL, V207, P416, DOI 10.1111/apha.12040; Yoshihara T, 2015, J APPL PHYSIOL, V119, P1023, DOI 10.1152/japplphysiol.00438.2015; Zhou Q, 1997, BIOCHEM BIOPH RES CO, V236, P647, DOI 10.1006/bbrc.1997.7028; Zierath JR, 1998, MOL CELL BIOCHEM, V182, P153, DOI 10.1023/A:1006861628496; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	31	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205456	10.1371/journal.pone.0205456	http://dx.doi.org/10.1371/journal.pone.0205456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304029	Green Published, Green Submitted, gold			2022-12-26	WOS:000446921100095
J	Ward, JN; Hinton, JW; Johannsen, KL; Karlin, ML; Miller, KV; Chamberlain, MJ				Ward, Jennifer N.; Hinton, Joseph W.; Johannsen, Kristina L.; Karlin, Melissa L.; Miller, Karl, V; Chamberlain, Michael J.			Home range size, vegetation density, and season influences prey use by coyotes (Canis latrans)	PLOS ONE			English	Article							WHITE-TAILED DEER; SYMPATRIC RED WOLVES; HABITAT SELECTION; EASTERN COYOTES; PREDATION RISK; CARNIVORE DIET; SNOWSHOE HARE; SCAT-ANALYSIS; FOOD-HABITS; GRAY WOLVES	To ensure reproductive success, Canis species establish contiguous mosaics of territories in suitable habitats to partition space and defend limiting resources. Consequently, Canis species can exert strong effects on prey populations locally because of their year-round maintenance of territories. We assessed prey use by coyotes (Canis latrans) by sampling scats from within known territories in southeastern Alabama and the Savannah River area of Georgia and South Carolina. We accounted for the size and habitat composition of coyote home ranges to investigate the influence of space use, vegetation density, and habitat type on coyote diets. Coyote use of prey was influenced by a combination of mean monthly temperature, home range size, vegetation density, and hardwood forests. For example, coyote use of adult white-tailed deer (Odocoileus virginianus) was associated with cooler months and smaller home ranges, whereas use of rabbits (Sylvilagus spp.) was associated with cooler months, larger home ranges, and less vegetation density. Coyotes in our study relied primarily on nutritionally superior mammalian prey and supplemented their diet with fruit when available, as their use of mammalian prey did not appreciably decrease with increasing use of fruit. We suggest that differential use of prey by coyotes is influenced by habitat heterogeneity within their home ranges, and prey-switching behaviors may stabilize local interactions between coyotes and their food resources to permit stable year-round territories. Given that habitat composition affects coyote prey use, future studies should also incorporate effects of habitat composition on coyote distribution and abundance to further identify coyote influences on prey communities.	[Ward, Jennifer N.; Hinton, Joseph W.; Miller, Karl, V; Chamberlain, Michael J.] Univ Georgia, Warne Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Johannsen, Kristina L.] Georgia Dept Nat Resources, Wildlife Resources Div, Social Circle, GA USA; [Karlin, Melissa L.] St Marys Univ, Dept Phys & Environm Sci, San Antonio, TX USA	University System of Georgia; University of Georgia	Hinton, JW (corresponding author), Univ Georgia, Warne Sch Forestry & Nat Resources, Athens, GA 30602 USA.	jhinton@uga.edu		Hinton, Joseph/0000-0002-2602-0400	Alabama Department of Conservation and Natural Resources; Georgia Department of Natural Resources; South Carolina Department of Natural Resources	Alabama Department of Conservation and Natural Resources; Georgia Department of Natural Resources; South Carolina Department of Natural Resources	This work received support from the Alabama Department of Conservation and Natural Resources (http://www.outdooralabama.com/), MJC received funding; the Georgia Department of Natural Resources (https://gadnr.org/), MJC received funding. KLJ of GADNR assisted with editing and approved manuscript; and the South Carolina Department of Natural Resources (http://www.dnr.sc.gov/), MJC received funding. Alabama Department of Conservation and Natural Resources and South Carolina Department of Natural Resources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorjan A. S., 1969, ONTARIO DEP LANDS FO, V90, P1; ANDELT WF, 1987, J WILDLIFE MANAGE, V51, P273, DOI 10.2307/3801002; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], WILD PIGS BIOL DAMAG; Bacon MM, 2011, WILDLIFE SOC B, V35, P409, DOI 10.1002/wsb.85; Ballard WB, 1999, J WILDLIFE MANAGE, V63, P574, DOI 10.2307/3802645; Bartel RA, 2005, CAN J ZOOL, V83, P569, DOI 10.1139/Z05-039; BASSET A, 1995, ECOLOGY, V76, P1027, DOI 10.2307/1940913; Benson JF, 2017, ECOL APPL, V27, P718, DOI 10.1002/eap.1499; Benson JF, 2013, OECOLOGIA, V173, P1539, DOI 10.1007/s00442-013-2730-8; Bevins SN, 2014, BIOSCIENCE, V64, P291, DOI 10.1093/biosci/biu015; Beyer H. L, 2012, GEOSPATIAL MODELLING, V2010, P1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Chamberlain MJ, 1999, PROCEEDINGS OF THE FIFTY-THIRD ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P204; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cherry MJ, 2016, WILDLIFE RES, V43, P662, DOI 10.1071/WR16052; Cherry MJ, 2016, WILDLIFE BIOL, V22, P64, DOI 10.2981/wlb.00144; Cherry MJ, 2015, BEHAV ECOL, V26, P1091, DOI 10.1093/beheco/arv054; Chitwood MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119070; Chitwood MC, 2014, SOUTHEAST NAT, V13, pN30, DOI 10.1656/058.013.0316; Chitwood MC, 2015, J WILDLIFE MANAGE, V79, P211, DOI 10.1002/jwmg.835; Ciucci P, 1996, WILDLIFE BIOL, V2, P37, DOI 10.2981/wlb.1996.006; Cunningham MA, 2011, J WILDLIFE MANAGE, V75, P692, DOI 10.1002/jwmg.85; Cushman SA, 2008, ECOL INDIC, V8, P691, DOI 10.1016/j.ecolind.2007.12.002; Debelica Anica, 2009, Texas Tech University Museum Special Publications, V55, P1; Dellinger JA, 2013, BIOL CONSERV, V157, P324, DOI 10.1016/j.biocon.2012.09.004; Dellinger JA, 2011, SOUTHEAST NAT, V10, P731, DOI 10.1656/058.010.0412; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Ditchkoff SS, 2001, J WILDLIFE MANAGE, V65, P552, DOI 10.2307/3803108; Ditchkoff SS, 2011, BIOLOGY AND MANAGEMENT OF WHITE-TAILED DEER, P43; Dumond M, 2001, ECOSCIENCE, V8, P301, DOI 10.1080/11956860.2001.11682657; ELDER WILLIAM H., 1942, JOUR WILDLIFE MANAGEMENT, V6, P203, DOI 10.2307/3795902; Etter DR, 2002, J WILDLIFE MANAGE, V66, P500, DOI 10.2307/3803183; Foley AM, 2015, J MAMMAL, V96, P279, DOI 10.1093/jmammal/gyv004; Gable TD, 2017, CAN J ZOOL, V95, P843, DOI 10.1139/cjz-2016-0308; Gable TD, 2018, AM MIDL NAT, V179, P15, DOI 10.1674/0003-0031-179.1.15; Geist V., 1998, DEER WORLD THEIR EVO, P255; Gese EM, 1996, CAN J ZOOL, V74, P784, DOI 10.1139/z96-090; Gese EM, 1996, ANIM BEHAV, V52, P1025, DOI 10.1006/anbe.1996.0250; Gipson PS, 2000, J WILDLIFE MANAGE, V64, P752, DOI 10.2307/3802745; Gorini L, 2012, MAMMAL REV, V42, P55, DOI 10.1111/j.1365-2907.2011.00189.x; Gotelli Nicholas J., 2005, PRIMER ECOLOGICAL ST; GRIFFITHS D, 1980, AM NAT, V116, P743, DOI 10.1086/283666; Gulsby WD, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2141; Gulsby WD, 2017, J WILDLIFE MANAGE, V81, P601, DOI 10.1002/jwmg.21240; Hague SM, 1911, BOT GAZ, V52, P0034, DOI 10.1086/330571; HARRISON DJ, 1992, J WILDLIFE MANAGE, V56, P128, DOI 10.2307/3808800; Hebblewhite M, 2005, OIKOS, V111, P101, DOI 10.1111/j.0030-1299.2005.13858.x; Hinton JW, 2017, J MAMMAL, V98, P475, DOI 10.1093/jmammal/gyw233; Hinton JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167603; Hinton JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132203; Hoerath J. David, 1991, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V45, P91; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; Holt Robert D., 1997, P149, DOI 10.1016/B978-012323445-2/50010-9; Jackson AM, 2013, AM MIDL NAT, V170, P184, DOI 10.1674/0003-0031-170.1.184; Kamler JF, 2000, CAN J ZOOL, V78, P2106, DOI 10.1139/cjz-78-12-2106; KAREIVA P, 1987, NATURE, V326, P388, DOI 10.1038/326388a0; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Keiter DA, 2017, NAT AREA J, V37, P6, DOI 10.3375/043.037.0117; Kelly J. D., 2015, J SE ASS FISH WILDLI, V2, P296; Kilgo JC, 2016, WILDLIFE SOC B, V40, P747, DOI 10.1002/wsb.708; Kilgo JC, 2014, J WILDLIFE MANAGE, V78, P1261, DOI 10.1002/jwmg.764; Kilgo JC, 2012, J WILDLIFE MANAGE, V76, P1420, DOI 10.1002/jwmg.393; Kilgo JC, 2010, J WILDLIFE MANAGE, V74, P929, DOI 10.2193/2009-263; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Knowlton FF, 1999, J RANGE MANAGE, V52, P398, DOI 10.2307/4003765; Lance CE, 2006, ORGAN RES METHODS, V9, P202, DOI 10.1177/1094428105284919; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lingle S, 2000, CAN J ZOOL, V78, P85, DOI 10.1139/cjz-78-1-85; Long RA, 1998, WILDLIFE BIOL, V4, P237, DOI 10.2981/wlb.1998.021; Losin N, 2016, ECOL LETT, V19, P260, DOI 10.1111/ele.12561; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Maher CR, 2000, AM MIDL NAT, V143, P1, DOI 10.1674/0003-0031(2000)143[0001:AROEDO]2.0.CO;2; McGarigal K., 2000, MULTIVARIATE STAT WI; MCNAB BK, 1995, J MAMMAL, V76, P206, DOI 10.2307/1382329; McVey JM, 2013, J MAMMAL, V94, P1141, DOI 10.1644/13-MAMM-A-109.1; Mitchell MS, 2004, ECOL MODEL, V177, P209, DOI 10.1016/j.ecolmodel.2004.01.015; Mitchell WA, 2002, OIKOS, V99, P249, DOI 10.1034/j.1600-0706.2002.990205.x; Morin DJ, 2016, WILDLIFE SOC B, V40, P669, DOI 10.1002/wsb.723; NELSON ME, 1986, J WILDLIFE MANAGE, V50, P691, DOI 10.2307/3800983; O'Donoghue M, 1998, ECOLOGY, V79, P1193, DOI 10.1890/0012-9658(1998)079[1193:FROCAL]2.0.CO;2; OKSANEN T, 1992, EVOL ECOL, V6, P383, DOI 10.1007/BF02270699; Patterson BR, 1998, CAN J ZOOL, V76, P1885, DOI 10.1139/cjz-76-10-1885; Petroelje TR, 2014, POPUL ECOL, V56, P349, DOI 10.1007/s10144-013-0413-2; Prugh LR, 2008, WILDLIFE BIOL, V14, P318, DOI 10.2981/0909-6396(2008)14[318:UOFGTD]2.0.CO;2; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Reed JE, 2004, WILDLIFE SOC B, V32, P685, DOI 10.2193/0091-7648(2004)032[0685:DMGWAC]2.0.CO;2; Richer MC, 2002, ECOSCIENCE, V9, P44, DOI 10.1080/11956860.2002.11682689; Robinson KF, 2014, J WILDLIFE MANAGE, V78, P571, DOI 10.1002/jwmg.693; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Saalfeld ST, 2007, J WILDLIFE MANAGE, V71, P940, DOI 10.2193/2006-116; SAUER JR, 1985, J MAMMAL, V66, P316, DOI 10.2307/1381244; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; SCHOENER TW, 1983, AM NAT, V121, P608, DOI 10.1086/284090; Schrecengost JD, 2008, SOUTHEAST NAT, V7, P135, DOI 10.1656/1528-7092(2008)7[135:SFHOTC]2.0.CO;2; Seidler RG, 2014, APPL ANIM BEHAV SCI, V154, P83, DOI 10.1016/j.applanim.2014.02.006; Shuman RM, 2017, J WILDLIFE MANAGE, V81, P834, DOI 10.1002/jwmg.21257; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simoneaux T.N., 2016, J SE ASS FISH WILDLI, V3, P210; Steenweg R, 2015, MAMMAL RES, V60, P207, DOI 10.1007/s13364-015-0222-4; Steiner W, 2014, ACCIDENT ANAL PREV, V66, P168, DOI 10.1016/j.aap.2014.01.020; Stratman MR, 1997, PROCEEDINGS OF THE FIFTY-FIRST ANNUAL CONFERENCE - SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P269; Sudharsan K, 2006, J WILDLIFE MANAGE, V70, P1161, DOI 10.2193/0022-541X(2006)70[1161:ROAHST]2.0.CO;2; SWIHART RK, 1988, ECOLOGY, V69, P393, DOI 10.2307/1940437; Swingen MB, 2015, SOUTHEAST NAT, V14, P397, DOI 10.1656/058.014.0219; Thibault I, 2005, ECOSCIENCE, V12, P466, DOI 10.2980/i1195-6860-12-4-466.1; Thornton DH, 2004, J MAMMAL, V85, P973, DOI 10.1644/BEH-020; Tucker MA, 2014, GLOBAL ECOL BIOGEOGR, V23, P1105, DOI 10.1111/geb.12194; Turner KL, 2017, ECOLOGY, V98, P2413, DOI 10.1002/ecy.1930; USUI M, 1994, CAN J PLANT SCI, V74, P581, DOI 10.4141/cjps94-105; Van Valkenburgh B, 1999, ANNU REV EARTH PL SC, V27, P463, DOI 10.1146/annurev.earth.27.1.463; VANVALKENBURGH B, 1985, PALEOBIOLOGY, V11, P406, DOI 10.1017/S0094837300011702; VERNER J, 1977, AM NAT, V111, P769, DOI 10.1086/283204; Vreeland JK, 2004, WILDLIFE SOC B, V32, P542, DOI 10.2193/0091-7648(2004)32[542:SRMCAH]2.0.CO;2; Ward J.N, 2017, SPACE USE RESOURCE S; Way JG, 2007, NORTHEAST NAT, V14, P111, DOI 10.1656/1092-6194(2007)14[111:ACOBMO]2.0.CO;2; WEAVER JL, 1993, J WILDLIFE MANAGE, V57, P534, DOI 10.2307/3809278; Webb Stephen L., 2010, International Journal of Ecology, V2010, P1; WERNER EE, 1974, ECOLOGY, V55, P1042, DOI 10.2307/1940354; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x; WINDBERG LA, 1988, J WILDLIFE MANAGE, V52, P632, DOI 10.2307/3800922; Wooding J.B., 1984, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V38, P182	125	19	20	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0203703	10.1371/journal.pone.0203703	http://dx.doi.org/10.1371/journal.pone.0203703			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303970	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100018
J	Gunasekar, P; Swier, VJ; Fleegel, JP; Boosani, CS; Radwan, MM; Agrawal, DK				Gunasekar, Palanikumar; Swier, Vicki J.; Fleegel, Jonathan P.; Boosani, Chandra S.; Radwan, Mohamed M.; Agrawal, Devendra K.			Vitamin D and macrophage polarization in epicardial adipose tissue of atherosclerotic swine	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; D DEFICIENCY; CARDIOVASCULAR-DISEASE; FAT TISSUE; D-3; INFLAMMATION; 25-HYDROXYVITAMIN-D3; EXTENT	Vitamin D functions as a potent immunomodulator by interacting with many immune cells however, its role in regulating inflammation in the epicardial adipose tissue (EAT) is unclear. In the EAT of atherosclerotic microswine that were fed with deficient, sufficient or supplemented levels of vitamin D, we evaluated the phenotype of the macrophages. Vitamin D treatment was continued for 12 months and serum 25(OH) D levels were measured regularly. Infiltration of M1/M2 macrophage was investigated by immunostaining for CCR7 and CD206, respectively in conjunction with a pan macrophage marker CD14. Significant difference in the number of CCR7+ cells was observed in the EAT from vitamin D-deficient swine compared to vitamin D-sufficient or -supplemented swine. Expression of CD206 correlated with high levels of serum 25(OH) D indicating a significant increase in M2 macrophages in the EAT of vitamin D-supplemented compared to -deficient swine. These findings suggest that vitamin D-deficiency exacerbates inflammation by increasing pro-inflammatory M1 macrophages, while vitamin D-supplementation attenuates the inflammatory cytokines and promotes M2 macrophages in EAT. This study demonstrates the significance of vitamin D mediated inhibition of macrophage mediated inflammation in the EAT during coronary intervention in addition to its immunomodulatory role. However, additional studies are required to identify the cellular mechanisms that transduce signals between macrophages and smooth muscle cells during restenosis in the presence and absence of vitamin D.	[Gunasekar, Palanikumar; Swier, Vicki J.; Fleegel, Jonathan P.; Boosani, Chandra S.; Radwan, Mohamed M.; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE 68178 USA	Creighton University	Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE 68178 USA.	dkagr@creighton.edu	Gunasekar, Palanikumar/J-6789-2019; Agrawal, Devendra/GLR-3925-2022	Gunasekar, Palanikumar/0000-0001-8540-4386; Agrawal, Devendra/0000-0001-5445-0013; Swier, Vicki/0000-0001-7509-9920; Boosani, Chandra/0000-0001-6904-8203	National Institutes of Health, USA [R01HL116042, R01HL120659]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116042, R01HL120659] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by research grants R01HL116042 and R01HL120659 from the National Institutes of Health, USA to DKA. The content of this review article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blum M, 2008, ENDOCRINE, V33, P90, DOI 10.1007/s12020-008-9051-4; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Didriksen A, 2015, EUR J ENDOCRINOL, V172, P235, DOI 10.1530/EJE-14-0870; Ding C, 2012, BRIT J NUTR, V108, P1915, DOI 10.1017/S0007114512003285; Dozio E, 2015, NUTR METAB CARDIOVAS, V25, P267, DOI 10.1016/j.numecd.2014.08.012; Folias AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102125; Giulietti A, 2007, DIABETES RES CLIN PR, V77, P47, DOI 10.1016/j.diabres.2006.10.007; Gupta GK, 2012, EXP MOL PATHOL, V93, P82, DOI 10.1016/j.yexmp.2012.04.006; Hadjadj L., 2018, DIABETES VASCULAR DI; Hirata Y, 2011, J AM COLL CARDIOL, V58, P248, DOI 10.1016/j.jacc.2011.01.048; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; Iacobellis G, 2015, NAT REV ENDOCRINOL, V11, P363, DOI 10.1038/nrendo.2015.58; Iacobellis G, 2011, TRENDS ENDOCRIN MET, V22, P450, DOI 10.1016/j.tem.2011.07.003; Inoue M, 1998, EUR J DERMATOL, V8, P16; Ku YC, 2013, WORLD J CARDIOL, V5, P337, DOI 10.4330/wjc.v5.i9.337; LAWSON DEM, 1986, CLIN CHIM ACTA, V157, P175, DOI 10.1016/0009-8981(86)90223-8; Lehmann U, 2013, J CLIN ENDOCR METAB, V98, P4339, DOI 10.1210/jc.2012-4287; Levin GP, 2012, JAMA-J AM MED ASSOC, V308, P1898, DOI 10.1001/jama.2012.17304; Looker Anne C, 2011, NCHS Data Brief, P1; MAWER EB, 1972, CLIN SCI, V43, P413, DOI 10.1042/cs0430413; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Mozos I, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/109275; Myszka M, 2014, POSTEP HIG MED DOSW, V68, P865, DOI 10.5604/17322693.1110168; Noor S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-77; Norman AW, 2007, J STEROID BIOCHEM, V103, P204, DOI 10.1016/j.jsbmb.2006.12.071; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; Norman PE, 2005, ARTERIOSCL THROM VAS, V25, P39, DOI 10.1161/01.ATV.0000148450.56697.4a; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; SCRAGG R, 1990, INT J EPIDEMIOL, V19, P559, DOI 10.1093/ije/19.3.559; SCRAGG R, 1995, DIABETES RES CLIN PR, V27, P181, DOI 10.1016/0168-8227(95)01040-K; Seker T, 2014, J CLIN LAB ANAL, V28, P52, DOI 10.1002/jcla.21643; Verdoia M, 2014, EUR J CLIN INVEST, V44, P634, DOI 10.1111/eci.12281; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412	35	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0199411	10.1371/journal.pone.0199411	http://dx.doi.org/10.1371/journal.pone.0199411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296271	Green Published, gold, Green Submitted			2022-12-26	WOS:000446632700002
J	Istomin, A; Masarwah, A; Pitkanen, M; Joukainen, S; Sutela, A; Vanninen, R; Sudah, M				Istomin, Aleksandr; Masarwah, Amro; Pitkanen, Marja; Joukainen, Sarianna; Sutela, Anna; Vanninen, Ritva; Sudah, Mazen			Galactography is not an obsolete investigation in the evaluation of pathological nipple discharge	PLOS ONE			English	Article							UNILATERAL BLOODY; PREDICTIVE-VALUE; BREAST-CANCER; DUCTOGRAPHY; DIAGNOSIS; MRI; PERFORMANCE; MANAGEMENT; SURGERY; WOMEN	Purpose To evaluate the malignancy rate and diagnostic performance of galactography in patients with pathological nipple discharge (PND) after negative clinical breast examination, mammography and ultrasound. Materials and methods We retrospectively evaluated all galactograms obtained between January 2006 and December 2014 in women with PND. Galactographic findings were classified into 6 groups according to a modified Galactogram Image Classification system (GICS) to comply with the breast imaging reporting and data system classification. Observers were blinded to the final histology and clinical outcome at the time of analysis. MRI was performed as a problem solving ancillary examination. Imaging findings, pathological diagnosis and follow-up data were evaluated. The diagnostic performance of MRI and technically successful galactography in the detection of neoplastic or risk lesions were separately calculated. Results A total of 146 patients with PND (mean age, 51.5 years; range, 17-93) were examined. Malignant lesions were detected in only 4 patients (2.7%) and risk-lesions in 5 patients (3.4%). Only one low-grade ductal carcinoma in situ was missed by galactography (GICS 1) and MRI. MRI examinations were performed in 21 (14.4%) patients; one of these patients (4.8%) had a malignant finding (GICS 0), two (9.5%) had risk-lesions (GICS 2 and 5). In the detection of neoplastic or risk lesions the sensitivity and specificity of galactography were 77.4% and 75.7% and of MRI 85.7% and 71.4%, consecutively. Conclusion The malignancy rate is negligible if clinical, mammography, ultrasound and galactography examinations are negative. Galactography remains a practical, valuable and cost-effective examination procedure. If galactography is technically unsuccessful, MRI should be considered as an additional ancillary tool to evaluate the possible etiology of symptoms, but the routine use of MRI in all patients cannot be justified.	[Istomin, Aleksandr; Masarwah, Amro; Pitkanen, Marja; Sutela, Anna; Vanninen, Ritva; Sudah, Mazen] Kuopio Univ Hosp, Diagnost Imaging Ctr, Dept Clin Radiol, Kuopio, Finland; [Istomin, Aleksandr; Joukainen, Sarianna] Kuopio Univ Hosp, Dept Plast Surg, Surg Div, Kuopio, Finland; [Vanninen, Ritva] Univ Eastern Finland, Sch Med, Inst Clin Med, Clin Radiol, Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Istomin, A (corresponding author), Kuopio Univ Hosp, Diagnost Imaging Ctr, Dept Clin Radiol, Kuopio, Finland.; Istomin, A (corresponding author), Kuopio Univ Hosp, Dept Plast Surg, Surg Div, Kuopio, Finland.	Aleksandr.Istomin@kuh.fi		Joukainen, Sarianna/0000-0002-9896-5585	Kuopio University Hospital (Kuopio, Finland) [5063542]	Kuopio University Hospital (Kuopio, Finland)	The author acknowledges the Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (IA) (project 5063542, Kuopio, Finland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author acknowledges the Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (IA) (project 5063542, Kuopio, Finland).	Bahl M, 2015, ANN SURG ONCOL, V22, pS435, DOI 10.1245/s10434-015-4792-9; Berger N, 2017, AM J ROENTGENOL, V209, P465, DOI 10.2214/AJR.16.16682; Berna-Serna JD, 2010, ACTA RADIOL, V51, P128, DOI 10.3109/02841850903436659; Blum KS, 2015, CLIN IMAG, V39, P587, DOI 10.1016/j.clinimag.2015.03.001; CARDENOSA G, 1994, AM J ROENTGENOL, V162, P1081, DOI 10.2214/ajr.162.5.8165986; Chen L, 2012, BREAST CANCER RES TR, V132, P9, DOI 10.1007/s10549-011-1787-5; Dinkel HP, 2000, BRIT J RADIOL, V73, P706, DOI 10.1259/bjr.73.871.11089460; Foulkes RE, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/495315; Gray RJ, 2007, AM J SURG, V194, P850, DOI 10.1016/j.amjsurg.2007.08.027; King TA, 2000, AM SURGEON, V66, P960; Kuhl CK, 2017, RADIOLOGY, V284, P645, DOI 10.1148/radiol.2017161449; Lau S, 2005, ANN SURG ONCOL, V12, P546, DOI 10.1245/ASO.2005.04.013; Lorenzon M, 2011, EUR RADIOL, V21, P899, DOI 10.1007/s00330-010-2009-y; Lubina N, 2015, EUR RADIOL, V25, P1285, DOI 10.1007/s00330-014-3521-2; Manganaro L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/806368; Moriarty AT, 2013, ARCH PATHOL LAB MED, V137, P1039, DOI 10.5858/arpa.2012-0231-CP; Morrogh M, 2007, ANN SURG ONCOL, V14, P3369, DOI 10.1245/s10434-007-9530-5; Orel SG, 2000, RADIOLOGY, V216, P248, DOI 10.1148/radiology.216.1.r00jn28248; Rissanen T, 2007, J ULTRAS MED, V26, P1031, DOI 10.7863/jum.2007.26.8.1031; Sagara Y, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00192; Sanders LM, 2016, BREAST J, V22, P209, DOI 10.1111/tbj.12551; Sardanelli F, 2010, EUR J CANCER, V46, P1296, DOI 10.1016/j.ejca.2010.02.015; Scheurlen K, 2014, RADIOLOGE, V54, P160, DOI 10.1007/s00117-013-2573-7; Sheiman LS, 2016, CURR PROBL DIAGN RAD, V45, P61, DOI 10.1067/j.cpradiol.2015.05.007; Slawson SH, 2001, RADIOGRAPHICS, V21, P133, DOI 10.1148/radiographics.21.1.g01ja15133; TABAR L, 1983, RADIOLOGY, V149, P31, DOI 10.1148/radiology.149.1.6611939; van Gelder L, 2015, WORLD J SURG, V39, P184, DOI 10.1007/s00268-014-2701-1; Van Zee KJ, 1998, CANCER, V82, P1874; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yilmaz R, 2017, BALK MED J, V34, P119, DOI 10.4274/balkanmedj.2016.0184	30	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0204326	10.1371/journal.pone.0204326	http://dx.doi.org/10.1371/journal.pone.0204326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296280	Green Published, Green Submitted, gold			2022-12-26	WOS:000446632700011
J	Deng, JM; Zhang, W; Qin, BQ; Zhang, YL; Paerl, HW; Salmaso, N				Deng, Jianming; Zhang, Wei; Qin, Boqiang; Zhang, Yunlin; Paerl, Hans W.; Salmaso, Nico			Effects of climatically-modulated changes in solar radiation and wind speed on spring phytoplankton community dynamics in Lake Taihu, China	PLOS ONE			English	Article							LARGE SHALLOW LAKE; HARMFUL CYANOBACTERIAL BLOOMS; MICROCYSTIS SPP. BLOOMS; FRESH-WATER ECOSYSTEMS; CLIMATE-CHANGE; GLOBAL EXPANSION; NUTRIENT RELEASE; LIGHT CLIMATE; SEDIMENT; SURFACE	Many studies have focused on the interactive effects of temperature increases due to global warming and nutrient enrichment on phytoplankton communities. Recently, non-temperature effects of climate change (e.g., decreases in wind speed and increases in solar radiation) on large lakes have received increasing attention. To evaluate the relative contributions of both temperature and non-temperature effects on phytoplankton communities in a large eutrophic subtropical shallow lake, we analyzed long-term monitoring data from Lake Taihu, China from 1997 to 2016. Results showed that Lake Taihu's spring phytoplankton biovolume and composition changed dramatically over this time frame, with a change in dominant species. Stepwise multiple linear regression models indicated that spring phytoplankton biovolume was strongly influenced by total phosphorus (TP), light condition, wind speed and total nitrogen (TN) (r(adj)(2) = 0.8, p < 0.01). Partial redundancy analysis (pRDA) showed that light condition accounted for the greatest variation of phytoplankton community composition, followed by TP and wind speed, as well as the interactions between TP and wind speed. Our study points to the additional importance of non-temperature effects of climate change on phytoplankton community dynamics in Lake Taihu.	[Deng, Jianming; Qin, Boqiang; Zhang, Yunlin] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Taihu Lake Lab Ecosyst Res Stn, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Zhang, Wei] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Minist Educ,Ctr Res Environm Ecol & Fish Nutr, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China; [Paerl, Hans W.] Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC USA; [Paerl, Hans W.] Hohai Univ, Coll Environm, Nanjing, Jiangsu, Peoples R China; [Salmaso, Nico] FEM, Res & Innovat Ctr, San Michele All Adige, Italy	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Shanghai Ocean University; University of North Carolina; University of North Carolina Chapel Hill; Hohai University; Fondazione Edmund Mach	Qin, BQ (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, Taihu Lake Lab Ecosyst Res Stn, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China.	qinbq@niglas.ac.cn	Deng, Jianming/F-3822-2011; Deng, Jianming/AAN-2998-2020; Zhang, Yunlin/N-5464-2014	Deng, Jianming/0000-0003-2432-6307; Deng, Jianming/0000-0003-2432-6307; Zhang, Yunlin/0000-0002-3382-4570	Natural Science Foundation of China [41501215, 41621002, 41661134036]; Key Research Program of Frontier Sciences, CAS [QYZDB-SSW-DQC016]; Natural Science Foundation of Jiangsu Province, China [BK20171517]; US National Science Foundation Dimensions of Biodiversity [1240851, 1831096]; CBET Programs [1230543]; China Scholarship Council	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of Frontier Sciences, CAS; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); US National Science Foundation Dimensions of Biodiversity(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); CBET Programs; China Scholarship Council(China Scholarship Council)	The study was jointly supported by the Natural Science Foundation of China (Grant No.: 41501215, 41621002 and 41661134036), the Key Research Program of Frontier Sciences, CAS (Grant No: QYZDB-SSW-DQC016) and the Natural Science Foundation of Jiangsu Province, China (Grant No.: BK20171517). H.W. Paerl was supported by the US National Science Foundation Dimensions of Biodiversity (1240851, https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503446), (1831096) and CBET (1230543) Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was jointly supported by the Natural Science Foundation of China (Grant No.: 41501215, 41621002 and 41661134036), the Key Research Program of Frontier Sciences, CAS (Grant No: QYZDB-SSW-DQC016) and the Natural Science Foundation of Jiangsu Province, China (Grant No.: BK20171517). H.W. Paerl was supported by the US National Science Foundation Dimensions of Biodiversity (1240851, https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503446), (1831096) and CBET (1230543) Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank the Taihu Laboratory for Lake Ecosystem Research (TLLER) for providing long-term monitoring data for Lake Taihu, and Zijuan Chen for helping us drawing Fig 1. The authors also would also like to thank the two anonymous reviewers and editor for their useful comments and constructive suggestions for manuscript. The work was finished while J.M. visited Aarhus University (Silkeborg, Denmark) as a visiting postdoctoral researcher, sponsored by the China Scholarship Council.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 1980, FRESHWATER ALGAE CHI; Barton A. D., 2014, LIMNOL OCEANOGR FLUI, V4, P34, DOI [10.1215/21573689-2651533, DOI 10.1215/21573689-2651533]; Barton AD, 2016, P NATL ACAD SCI USA, V113, P2964, DOI 10.1073/pnas.1519080113; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bleiker W, 1997, AQUAT SCI, V59, P135, DOI 10.1007/s000270050081; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; CARPENTER SR, 1992, ANNU REV ECOL SYST, V23, P119, DOI 10.1146/annurev.es.23.110192.001003; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Deng JM, 2018, SCI TOTAL ENVIRON, V645, P1361, DOI 10.1016/j.scitotenv.2018.07.208; Deng JM, 2015, INT J CLIMATOL, V35, P3385, DOI 10.1002/joc.4212; Deng JM, 2014, FRESHWATER BIOL, V59, P1076, DOI 10.1111/fwb.12330; Diamond SL, 2013, ECOL MODEL, V264, P98, DOI 10.1016/j.ecolmodel.2013.05.001; Dokulil MT, 2000, HYDROBIOLOGIA, V438, P1, DOI 10.1023/A:1004155810302; Elliott JA, 2010, GLOBAL CHANGE BIOL, V16, P864, DOI 10.1111/j.1365-2486.2009.01998.x; Guo WJ, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-6318-3; Hamilton DP, 2016, AQUAT ECOL, V50, P351, DOI 10.1007/s10452-016-9594-z; Izaguirre I, 2012, HYDROBIOLOGIA, V698, P203, DOI 10.1007/s10750-012-1069-1; Jeppesen E, 2011, HYDROBIOLOGIA, V663, P1, DOI 10.1007/s10750-010-0547-6; Jeppesen E, 2009, J ENVIRON QUAL, V38, P1930, DOI 10.2134/jeq2008.0113; Jiang L, 2017, ECOL MODEL, V363, P68, DOI 10.1016/j.ecolmodel.2017.08.026; Jiang X, 2008, WATER RES, V42, P2251, DOI 10.1016/j.watres.2007.12.003; Jin X., 1990, STANDARD METHODS OBS; Korsak MN, 2009, MOSCOW U BIOL SCI B, V64, P37, DOI DOI 10.3103/S0096392509010088; Kosten S, 2012, GLOBAL CHANGE BIOL, V18, P118, DOI 10.1111/j.1365-2486.2011.02488.x; Legendre L., 1998, NUMERICAL ECOLOGY DE; Lepparanta M, 2010, HYDROL RES, V41, P50, DOI 10.2166/nh.2010.122; Li XY, 2014, MAR POLLUT BULL, V81, P210, DOI 10.1016/j.marpolbul.2013.08.006; [刘霞 Liu Xia], 2012, [环境科学学报, Acta Scientiae Circumstantiae], V32, P821; Liu Xia, 2012, Hupo Kexue, V24, P142; Lurling M, 2013, FRESHWATER BIOL, V58, P552, DOI 10.1111/j.1365-2427.2012.02866.x; Mooij WM, 2005, AQUAT ECOL, V39, P381, DOI 10.1007/s10452-005-9008-0; Nathans L.L., 2012, PRACTICAL ASSESSMENT, V17; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Ozkundakci D, 2016, GLOBAL CHANGE BIOL, V22, P284, DOI 10.1111/gcb.13085; Oksanen J, 2017, COMMUNITY ECOLOGY PA, V2; Pacheco J, 2010, HYDROBIOLOGIA, V646, P187, DOI 10.1007/s10750-010-0180-4; Paerl H. W., 2014, J FRESHWATER ECOL, P1; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2017, MICROB BIOTECHNOL, V10, P1106, DOI 10.1111/1751-7915.12725; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Qin B., 2008, LAKE TAIHU CHINA DYN; Qin BQ, 2007, HYDROBIOLOGIA, V581, P3, DOI 10.1007/s10750-006-0521-5; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; Qin BQ, 2004, CHINESE SCI BULL, V49, P54, DOI 10.1360/03wd0174; Reichwaldt ES, 2012, WATER RES, V46, P1372, DOI 10.1016/j.watres.2011.11.052; Salmaso N, 2007, HYDROBIOLOGIA, V578, P97, DOI 10.1007/s10750-006-0437-0; Salmaso N, 2015, FRESHWATER BIOL, V60, P603, DOI 10.1111/fwb.12520; Shatwell T, 2012, LIMNOL OCEANOGR, V57, P541, DOI 10.4319/lo.2012.57.2.0541; Shi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep40326; Sommer U, 2008, GLOBAL CHANGE BIOL, V14, P1199, DOI 10.1111/j.1365-2486.2008.01571.x; Sommer U, 2012, ANNU REV ECOL EVOL S, V43, P429, DOI 10.1146/annurev-ecolsys-110411-160251; Sommer U, 2011, GLOBAL CHANGE BIOL, V17, P154, DOI 10.1111/j.1365-2486.2010.02182.x; Stocker T. F., 2013, CLIMATE CHANGE 2013; Torremorell A, 2009, FRESHWATER BIOL, V54, P437, DOI 10.1111/j.1365-2427.2008.02119.x; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Van Duin EHS, 2001, HYDROBIOLOGIA, V444, P25, DOI 10.1023/A:1017512614680; Vautard R, 2010, NAT GEOSCI, V3, P756, DOI [10.1038/ngeo979, 10.1038/NGEO979]; Wang H, 2016, WATER RES, V98, P280, DOI 10.1016/j.watres.2016.04.037; Wang JJ, 2015, ENVIRON SCI POLLUT R, V22, P10471, DOI 10.1007/s11356-015-4247-7; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Winder M, 2012, MAR BIOL, V159, P2491, DOI 10.1007/s00227-012-1964-z; Winder M, 2012, HYDROBIOLOGIA, V698, P5, DOI 10.1007/s10750-012-1149-2; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woolway RI, 2017, CLIMATIC CHANGE, V141, P759, DOI 10.1007/s10584-017-1909-0; Wu TF, 2015, SCI TOTAL ENVIRON, V518, P24, DOI 10.1016/j.scitotenv.2015.02.090; Xiong Wen, 2012, Hupo Kexue, V24, P698; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Yang JR, 2017, WATER RES, V120, P52, DOI 10.1016/j.watres.2017.04.062; You QL, 2010, THEOR APPL CLIMATOL, V101, P445, DOI 10.1007/s00704-009-0231-9; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219; Zhang M, 2012, WATER RES, V46, P442, DOI 10.1016/j.watres.2011.11.013; Zhang YL, 2004, THEOR APPL CLIMATOL, V78, P217, DOI 10.1007/s00704-003-0030-7; Zhang YL, 2016, ENVIRON SCI POLLUT R, V23, P12811, DOI 10.1007/s11356-016-6856-1; Zhu GW, 2005, CHINESE SCI BULL, V50, P577, DOI 10.1360/04wd0083; Zhu MY, 2014, HARMFUL ALGAE, V39, P310, DOI 10.1016/j.hal.2014.09.003	78	12	13	7	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205260	10.1371/journal.pone.0205260	http://dx.doi.org/10.1371/journal.pone.0205260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289946	Green Published, Green Submitted, gold			2022-12-26	WOS:000446545500061
J	Akpan, GE; Adepoju, KA; Oladosu, OR; Adelabu, SA				Akpan, Godwin E.; Adepoju, Kayode A.; Oladosu, Olakunle R.; Adelabu, Samuel A.			Dominant malaria vector species in Nigeria: Modelling potential distribution of Anopheles gambiae sensu lato and its siblings with MaxEnt	PLOS ONE			English	Article							ECOLOGICAL ZONES; CLIMATE-CHANGE; TRANSMISSION; ARABIENSIS; MOSQUITOS	Malaria is a major infectious disease that still affects nearly half of the world's population. Information on spatial distribution of malaria vector species is needed to improve malaria control efforts. In this study we used Maximum Entropy Model (MaxEnt) to estimate the potential distribution of Anopheles gambiae sensu lato and its siblings: Anopheles gambiae sensu stricto, and Anopheles arabiensis in Nigeria. Species occurrence data collected during the period 1900-2010 was used together with 19 bioclimatic, landuse and terrain variables. Results show that these species are currently widespread across all ecological zones. Temperature fluctuation from mean diurnal temperature range, extreme temperature and precipitation conditions, high humidity in dry season from precipitation during warm months, and land use and land cover dynamics have the greatest influence on the current seasonal distribution of the Anopheles species. MaxEnt performed statistically significantly better than random with AUC approximately 0.7 for estimation of the Anopheles species environmental suitability, distribution and variable importance. This model result can contribute to surveillance efforts and control strategies for malaria eradication.	[Akpan, Godwin E.; Oladosu, Olakunle R.] Obafemi Awolowo Univ, ARCSSTEE, Ife, Osun State, Nigeria; [Adepoju, Kayode A.; Adelabu, Samuel A.] Univ Free State, Dept Geog, Qwaqwa Campus, Qwagwa, Phuthaditjhaba, South Africa	Obafemi Awolowo University; University of the Free State	Akpan, GE (corresponding author), Obafemi Awolowo Univ, ARCSSTEE, Ife, Osun State, Nigeria.	profjedidiah@yahoo.com	Adepoju, Kayode/E-2976-2015; Adelabu, Samuel Adewale SA/M-4938-2015; Akpan, Godwin/AAY-2541-2021; Taylan Ozkan, Aysegul/B-9721-2016	Adepoju, Kayode/0000-0001-7906-3415; Adelabu, Samuel Adewale SA/0000-0001-9362-9948; Akpan, Godwin/0000-0001-8204-9219; Taylan Ozkan, Aysegul/0000-0001-8421-3625				Altamiranda-Saavedra M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179093; Amajoh CN, 1997, REV MALARIA VECTOR B; [Anonymous], 2017, BRIEF TUTORIAL MAXEN; [Anonymous], 1998, REGIONAL IMPACTS CLI; [Anonymous], 2017, MAL LAG STAT REC 1 2; [Anonymous], 1996, FAO SOILS B, V73; Autino B, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.060; Awolola TS, 2005, T ROY SOC TROP MED H, V99, P525, DOI 10.1016/j.trstmh.2004.12.003; Briga M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16600; Bruce-Chwatt L. J., 1951, Bulletin of the World Health Organization, V4, P301; CDC, 2015, AN MOSQ; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Consultative Group on International Agricultural Research Consortium for Spatial Information (CGIAR-CSI), 2017, SRTM 90M DIG EL DAT; Dalitz MK, 2005, THESIS; Dimitrov NB, 2009, OPER RES COMPUT SCI, P167, DOI 10.1007/978-0-387-88843-9_9; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Evangelista P., 2011, MAXENT MODEL V3 3 3E; Ewona, 2014, INT J PURE APPL PHYS, V2, P1; Foley DH, 2009, J MED ENTOMOL, V46, P680, DOI 10.1603/033.046.0336; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gilles MT, 1987, ANOPHELINAE AFRICA S, P55; Gillies M.T., 1968, PUBL S AFRICAN I MED, V54, P3; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; IPCC, 1995, CLIMATE CHANGE 1995; Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041; Kulkarni MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009396; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Metz, 1991, NIGERIA COUNTRY STUD; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; NMEP, 2014, DESCR EP MAL GUID PL; Okorie Patricia N., 2014, Journal of Entomology and Zoology Studies, V2, P164; Okorie PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028347; Okwa OO, 2009, ANN AFR MED, V8, P1, DOI 10.4103/1596-3519.55756; Olayemi IK, 2014, APP SCI REPORT, V5, P110, DOI [10.15192/PSCP.ASR.2014.1.3.110117, DOI 10.15192/PSCP.ASR.2014.1.3.110117]; Onyabe DY, 2003, T ROY SOC TROP MED H, V97, P605, DOI 10.1016/S0035-9203(03)80045-7; Onyabe DY, 2001, MEM I OSWALDO CRUZ, V96, P1081, DOI 10.1590/S0074-02762001000800009; Ostfeld RS, 2009, ECOLOGY, V90, P903, DOI 10.1890/08-0659.1; Owoseye A., 2017, PREMIUM TIMES; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-59; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Siettos CI, 2013, VIRULENCE, V4, P295, DOI 10.4161/viru.24041; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; Siteti MC., 2016, CHRISMED J HEALTH RE, V3, P45; Sunday O, 2006, AEJSR, P31; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Takken W, 2003, WAG UR FRON, V2, P75; Tappan GG, 2016, W AFRICA LAND USE LA, DOI [10.5066/F73N21JF, DOI 10.5066/F73N21JF]; Umar A., 2015, Advanced Studies in Biology, V7, P323; United Nations Department of Economic and Social Affairs Population Division, 2017, ESAPWP248 UNDESA; USAID, 2002, LAG100990001300 USAI; WHO, 2016, WORLD MAL REP 2016; WHO, 2015, WORLD MAL REP 2015; World Guides, 2016, NIG WEATH GO CLIM IN; World Health Organization, 2017, DEPRESSION; WorldClim D, GLOB CLIM DAT FREE C	66	13	13	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204233	10.1371/journal.pone.0204233	http://dx.doi.org/10.1371/journal.pone.0204233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281634	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400045
J	Canfield, J; Arlier, S; Mong, EF; Lockhart, J; VanWye, J; Guzeloglu-Kayisli, O; Schatz, F; Magness, RR; Lockwood, CJ; Tsibris, JCM; Kayisli, UA; Totary-Jain, H				Canfield, John; Arlier, Sefa; Mong, Ezinne F.; Lockhart, John; VanWye, Jeffrey; Guzeloglu-Kayisli, Ozlem; Schatz, Frederick; Magness, Ronald R.; Lockwood, Charles J.; Tsibris, John C. M.; Kayisli, Umit A.; Totary-Jain, Hana			Decreased LIN28B in preeclampsia impairs human trophoblast differentiation and migration	FASEB JOURNAL			English	Article						C19MC; inflammation; cell invasion; DOHaD	NECROSIS-FACTOR-ALPHA; MICRORNA BIOGENESIS; PLACENTAL SYNCYTIN; DOWN-REGULATION; EXPRESSION; LET-7; CELLS; RECEPTOR; CANCER; LIN-28	Preeclampsia (PE) is a common cause of maternal morbidity, characterized by impaired trophoblast invasion and spiral artery transformation resulting in progressive uteroplacental hypoxia. Given the primary role of LIN28A and LIN28B in modulating cell metabolism, differentiation, and invasion, we hypothesized that LIN28A and/or LIN28B regulates trophoblast differentiation and invasion, and that its dysregulation may contribute to PE. Here we show that LIN28B is expressed approximate to 1300-fold higher than LIN28A in human term placenta and is the predominant paralog expressed in primary human trophoblast cultures. The expression of LIN28B mRNA and protein levels are significantly reduced in gestational age-matched preeclamptic vs. normal placentas, whereas LIN28A expression is not different. First trimester human placental sections displayed stronger LIN28B immunoreactivity in extravillous (invasive) cytotrophoblasts and syncytial sprouts vs. villous trophoblasts. LIN28B overexpression increased HTR8 cell proliferation, migration, and invasion, whereas LIN28B knockdown in JEG3 cells reduced cell proliferation. Moreover, LIN28B knockdown in JEG3 cells suppressed syncytin 1 (SYN-1), apelin receptor early endogenous ligand (ELABELA), and the chromosome 19 microRNA cluster, and increased mRNA expression of ITG4 and TNF-. Incubation of BeWo and JEG3 cells under hypoxia significantly decreased expression of LIN28B and LIN28A, SYN-1, and ELABELA, whereas TNF- is increased. These results provide the first evidence that LIN28B is the predominant paralog in human placenta and that decreased LIN28B may play a role in PE by reducing trophoblast invasion and syncytialization, and by promoting inflammation.Canfield, J., Arlier, S., Mong, E. F., Lockhart, J., VanWye, J., Guzeloglu-Kayisli, O., Schatz, F., Magness, R. R., Lockwood, C. J., Tsibris, J. C. M., Kayisli, U. A., Totary-Jain, H. Decreased LIN28B in preeclampsia impairs human trophoblast differentiation and migration.	[Canfield, John; Mong, Ezinne F.; Lockhart, John; VanWye, Jeffrey; Totary-Jain, Hana] Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Arlier, Sefa; Guzeloglu-Kayisli, Ozlem; Schatz, Frederick; Magness, Ronald R.; Lockwood, Charles J.; Tsibris, John C. M.; Kayisli, Umit A.] Morsani Coll Med, Dept Obstet & Gynecol, Tampa, FL USA		Totary-Jain, H (corresponding author), Univ S Florida, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC08,2170, Tampa, FL 33612 USA.	totaryjainh@health.usf.edu	arlıer, sefa/GLS-1518-2022; arlıer, sefa/AAQ-3582-2021; arlıer, sefa/Y-7888-2019; Totary-Jain, Hana/A-6387-2014; arlier, sefa/P-3698-2016; Totary-Jain, Hana/ABC-3469-2021	arlıer, sefa/0000-0002-0019-8403; arlıer, sefa/0000-0002-0019-8403; arlıer, sefa/0000-0002-0019-8403; arlier, sefa/0000-0002-0019-8403; Totary-Jain, Hana/0000-0003-2203-0377; Lockhart, John/0000-0002-2727-6969; Tsibris, John/0000-0002-6725-2734	American Heart Association [15PRE25850019]; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01HL128411]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128411, R01HL117341] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge Dr. Ananth Karumanchi (Beth Israel Deaconess Medical Center, Harvard Medical School) for providing total placental RNA from normal and preeclampsia affected pregnancies. J.C. was supported by the American Heart Association (Grant 15PRE25850019), and H.T.J. was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (Grant R01HL128411). The authors declare no conflicts of interest.	Ali PSS, 2012, FEBS LETT, V586, P3986, DOI 10.1016/j.febslet.2012.09.034; Balzeau J, 2017, FRONT GENET, V8, P1, DOI 10.3389/fgene.2017.00031; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Chen CP, 2006, BJOG-INT J OBSTET GY, V113, P152, DOI 10.1111/j.1471-0528.2005.00843.x; Choudhry H, 2016, BRIEF FUNCT GENOMICS, V15, P174, DOI 10.1093/bfgp/elv050; Degner K, 2017, REPROD SCI, V24, P753, DOI 10.1177/1933719116669056; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Fu JJ, 2009, PLACENTA, V30, P305, DOI 10.1016/j.placenta.2009.01.005; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hafner M, 2013, RNA, V19, P613, DOI 10.1261/rna.036491.112; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hakim J, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/953150; Henderson JT, 2017, JAMA-J AM MED ASSOC, V317, P1668, DOI 10.1001/jama.2016.18315; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Ho LN, 2017, SCIENCE, V357, P707, DOI 10.1126/science.aam6607; Holtan SG, 2009, MAYO CLIN PROC, V84, P985, DOI 10.1016/S0025-6196(11)60669-1; Hromadnikova I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171756; Hromadnikova I, 2015, DNA CELL BIOL, V34, P437, DOI 10.1089/dna.2014.2687; Hutter D, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/401323; Jun-Hao ET, 2016, TRENDS ENDOCRIN MET, V27, P132, DOI 10.1016/j.tem.2015.12.006; Karumanchi SA, 2004, ENDOCRINOLOGY, V145, P4835, DOI 10.1210/en.2004-1028; Knerr I, 2002, AM J OBSTET GYNECOL, V186, P210, DOI 10.1067/mob.2002.119636; Kucera J, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4386947; Kudo Y, 2003, BBA-MOL BASIS DIS, V1638, P63, DOI 10.1016/S0925-4439(03)00043-7; KUPFERMINC MJ, 1994, AM J OBSTET GYNECOL, V170, P1752, DOI 10.1016/S0002-9378(94)70351-5; Lee MJ, 2005, ENDOCRINOLOGY, V146, P4619, DOI 10.1210/en.2005-0235; Lee X, 2001, PLACENTA, V22, P808, DOI 10.1053/plac.2001.0722; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Lockwood CJ, 2009, J CLIN ENDOCR METAB, V94, P2164, DOI 10.1210/jc.2009-0065; Lockwood CJ, 2006, AM J PATHOL, V169, P1294, DOI 10.2353/ajpath.2006.060185; Loughlin FE, 2012, NAT STRUCT MOL BIOL, V19, P84, DOI 10.1038/nsmb.2202; Mayr F, 2013, INT J MOL SCI, V14, P16532, DOI 10.3390/ijms140816532; Mong EF, 2018, ARTERIOSCL THROM VAS, V38, P1321, DOI 10.1161/ATVBAHA.118.310908; Murray MJ, 1999, SEMIN REPROD ENDOCR, V17, P275, DOI 10.1055/s-2007-1016235; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ni XT, 2009, PLACENTA, V30, P1023, DOI 10.1016/j.placenta.2009.10.005; Nwabuobi C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102037; Paauw ND, 2016, CLIN SCI, V130, P239, DOI 10.1042/CS20150567; Park Sung Won, 2012, Korean J Pediatr, V55, P388, DOI 10.3345/kjp.2012.55.10.388; Nguyen PNN, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0326-z; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; ROBERTS JM, 1992, AM J REPROD IMMUNOL, V27, P101, DOI 10.1111/j.1600-0897.1992.tb00735.x; Saito Y, 2009, ONCOGENE, V28, P2738, DOI 10.1038/onc.2009.140; Santulli G, 2014, J CLIN INVEST, V124, P4102, DOI 10.1172/JCI76069; Serin IS, 2002, EUR J OBSTET GYN R B, V104, P86; Shih T, 2016, AM J PERINAT, V33, P329, DOI 10.1055/s-0035-1564881; Shinoda G, 2013, STEM CELLS, V31, P1563, DOI 10.1002/stem.1423; Smyth A, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0714-5; Tang ZH, 2011, AM J REPROD IMMUNOL, V66, P336, DOI 10.1111/j.1600-0897.2011.01006.x; Totary-Jain H, 2013, J BIOL CHEM, V288, P6034, DOI 10.1074/jbc.M112.416446; Totary-Jain H, 2012, CANCER RES, V72, P1836, DOI 10.1158/0008-5472.CAN-11-2195; Tsanov KM, 2017, NAT CELL BIOL, V19, P60, DOI 10.1038/ncb3453; Tsialikas J, 2015, DEVELOPMENT, V142, P2397, DOI 10.1242/dev.117580; Usha K, 2011, J OBSTET GYN INDIA, V61, P505, DOI 10.1007/s13224-011-0092-x; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Widen E, 2010, AM J HUM GENET, V86, P773, DOI 10.1016/j.ajhg.2010.03.010; Wu CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.060; Wu L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0045-0; Yen CF, 2017, REPROD SCI, V24, P1176, DOI 10.1177/1933719116681515; Zeng YX, 2016, MOL CELL, V61, P153, DOI 10.1016/j.molcel.2015.11.020; Zhang J, 2013, MOL CELL ENDOCRINOL, V375, P53, DOI 10.1016/j.mce.2013.04.022; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	68	33	35	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2759	2769		10.1096/fj.201801163R	http://dx.doi.org/10.1096/fj.201801163R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307771	Green Published			2022-12-26	WOS:000457296600098
J	Ge, YH; Borne, E; Stewart, S; Hansen, MR; Arturo, EC; Jaffe, EK; Voelz, VA				Ge, Yunhui; Borne, Elias; Stewart, Shannon; Hansen, Michael R.; Arturo, Emilia C.; Jaffe, Eileen K.; Voelz, Vincent A.			Simulations of the regulatory ACT domain of human phenylalanine hydroxylase (PAH) unveil its mechanism of phenylalanine binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular dynamics; ligand-binding protein; kinetics; allosteric regulation; conformational change; binding pathways; ligand binding kinetics; Markov state models; phenylketonuria; phenylalanine hydroxylase; molecular simulation; conformational selection	STRUCTURAL BASIS; MODEL; IDENTIFICATION; DIMERIZATION; SYSTEM; SITE; JUMP	Phenylalanine hydroxylase (PAH) regulates phenylalanine (Phe) levels in mammals to prevent neurotoxicity resulting from high Phe concentrations as observed in genetic disorders leading to hyperphenylalaninemia and phenylketonuria. PAH senses elevated Phe concentrations by transient allosteric Phe binding to a protein-protein interface between ACT domains of different subunits in a PAH tetramer. This interface is present in an activated PAH (A-PAH) tetramer and absent in a resting-state PAH (RS-PAH) tetramer. To investigate this allosteric sensing mechanism, here we used the GROMACS molecular dynamics simulation suite on the Folding@home computing platform to perform extensive molecular simulations and Markov state model (MSM) analysis of Phe binding to ACT domain dimers. These simulations strongly implicated a conformational selection mechanism for Phe association with ACT domain dimers and revealed protein motions that act as a gating mechanism for Phe binding. The MSMs also illuminate a highly mobile hairpin loop, consistent with experimental findings also presented here that the PAH variant L72W does not shift the PAH structural equilibrium toward the activated state. Finally, simulations of ACT domain monomers are presented, in which spontaneous transitions between resting-state and activated conformations are observed, also consistent with a mechanism of conformational selection. These mechanistic details provide detailed insight into the regulation of PAH activation and provide testable hypotheses for the development of new allosteric effectors to correct structural and functional defects in PAH.	[Ge, Yunhui; Voelz, Vincent A.] Temple Univ, Dept Chem, Philadelphia, PA 19122 USA; [Borne, Elias; Stewart, Shannon; Hansen, Michael R.; Arturo, Emilia C.; Jaffe, Eileen K.] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Arturo, Emilia C.] Drexel Univ, Coll Med, Philadelphia, PA 19129 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Drexel University	Voelz, VA (corresponding author), Temple Univ, Dept Chem, Philadelphia, PA 19122 USA.	voelz@temple.edu	Ge, Yunhui/I-1514-2018; Arturo, Emilia/ABA-8516-2020; Voelz, Vincent/HCI-4181-2022	Ge, Yunhui/0000-0002-3946-1440; Arturo, Emilia/0000-0002-6911-129X; Voelz, Vincent/0000-0002-1054-2124	National Institutes of Health [1R01GM123296-01, 1S10OD020095-01, 1R01NS100081, P30CA006927]; National Science Foundation [CNS-09-58854]; BioMarin Pharmaceuticals; National PKU Alliance; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100081] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020095] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); BioMarin Pharmaceuticals; National PKU Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants 1R01GM123296-01 (to V.A.V.), 1S10OD020095-01, 1R01NS100081 (to E.K.J.), and P30CA006927 (to Fox Chase Cancer Center) and in part by the National Science Foundation through Major Research Instrumentation Grant CNS-09-58854. The in vitro studies were also supported by the National PKU Alliance and BioMarin Pharmaceuticals. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Arturo EC, 2016, P NATL ACAD SCI USA, V113, P2394, DOI 10.1073/pnas.1516967113; Bowman GR, 2015, P NATL ACAD SCI USA, V112, P2734, DOI 10.1073/pnas.1417811112; Carluccio C, 2016, J BIOMOL STRUCT DYN, V34, P497, DOI 10.1080/07391102.2015.1052016; Carluccio C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079482; Case D. A., 2017, AMBER 2017; Daubner SC, 1997, BIOCHEMISTRY-US, V36, P11574, DOI 10.1021/bi9711137; Erlandsen H, 1999, MOL GENET METAB, V68, P103, DOI 10.1006/mgme.1999.2922; Gjetting T, 2001, AM J HUM GENET, V68, P1353, DOI 10.1086/320604; Gu S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003767; GUILLAIN F, 1970, J AM CHEM SOC, V92, P5534, DOI 10.1021/ja00721a051; Harrigan MP, 2017, BIOPHYS J, V112, P10, DOI 10.1016/j.bpj.2016.10.042; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Huang XH, 2014, ADV EXP MED BIOL, V797, P107, DOI 10.1007/978-94-007-7606-7_9; Jaffe EK, 2017, MOL GENET METAB, V121, P289, DOI 10.1016/j.ymgme.2017.06.005; Jaffe EK, 2013, ARCH BIOCHEM BIOPHYS, V530, P73, DOI 10.1016/j.abb.2012.12.017; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; KNAPPSKOG PM, 1995, BIOCHEMISTRY-US, V34, P11790, DOI 10.1021/bi00037a017; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Kokh DB, 2018, J CHEM THEORY COMPUT, V14, P3859, DOI 10.1021/acs.jctc.8b00230; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Leandro J, 2017, FEBS OPEN BIO, V7, P195, DOI 10.1002/2211-5463.12175; Li DW, 2010, ANGEW CHEM INT EDIT, V49, P6778, DOI 10.1002/anie.201001898; Li J, 2011, ARCH BIOCHEM BIOPHYS, V505, P250, DOI 10.1016/j.abb.2010.10.009; Li J, 2010, BIOCHEMISTRY-US, V49, P3327, DOI 10.1021/bi1001294; Malmstrom RD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8588; McGibbon RT, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4916292; Meisburger SP, 2016, J AM CHEM SOC, V138, P6506, DOI 10.1021/jacs.6b01563; Metzner P, 2009, MULTISCALE MODEL SIM, V7, P1192, DOI 10.1137/070699500; Naritomi Y, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4834695; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Noe F, 2009, P NATL ACAD SCI USA, V106, P19011, DOI 10.1073/pnas.0905466106; Oleinikovas V, 2016, J AM CHEM SOC, V138, P14257, DOI 10.1021/jacs.6b05425; Pang XD, 2017, ANNU REV BIOPHYS, V46, P105, DOI 10.1146/annurev-biophys-070816-033639; Patel D, 2016, SCI REP-UK, V6, DOI 10.1038/srep23748; Paul F, 2018, J PHYS CHEM B, V122, P5649, DOI 10.1021/acs.jpcb.7b12146; Perez-Hernandez G, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4811489; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS RS, 1984, BIOCHEMISTRY-US, V23, P3836, DOI 10.1021/bi00312a007; Plattner N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8653; Schwantes CR, 2013, J CHEM THEORY COMPUT, V9, P2000, DOI 10.1021/ct300878a; SHIMAN R, 1979, J BIOL CHEM, V254, P1300; Shirts M, 2000, SCIENCE, V290, P1903, DOI 10.1126/science.290.5498.1903; Shirts MR, 2001, PHYS REV LETT, V86, P4983, DOI 10.1103/PhysRevLett.86.4983; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Stanley N, 2016, SCI REP-UK, V6, DOI 10.1038/srep22639; Voelz VA, 2010, J AM CHEM SOC, V132, P1526, DOI 10.1021/ja9090353; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Zhang SN, 2016, J BIOL CHEM, V291, P7418, DOI 10.1074/jbc.M115.709998; Zhang SN, 2014, BIOCHEMISTRY-US, V53, P6625, DOI 10.1021/bi501109s	52	13	13	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19532	19543		10.1074/jbc.RA118.004909	http://dx.doi.org/10.1074/jbc.RA118.004909			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30287685	Green Published, hybrid			2022-12-26	WOS:000454294900003
J	Lellahi, SM; Rosenlund, IA; Hedberg, A; Kiaer, LT; Mikkola, I; Knutsen, E; Perander, M				Lellahi, S. Mohammad; Rosenlund, Ingrid Arctander; Hedberg, Annica; Kiaer, Liv Torill; Mikkola, Ingvild; Knutsen, Erik; Perander, Maria			The long noncoding RNA NEAT1 and nuclear paraspeckles are up-regulated by the transcription factor HSF1 in the heat shock response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-TRANSCRIPTION; STRESS-RESPONSE; PROTEIN; HSP70; BINDING; TARGET; CANCER; SUBPOPULATION; PROTEOSTASIS; DEGRADATION	The long noncoding RNA (lncRNA) NEAT1 (nuclear enriched abundant transcript 1) is the architectural component of nuclear paraspeckles, and it has recently gained considerable attention as it is abnormally expressed in pathological conditions such as cancer and neurodegenerative diseases. NEAT1 and paraspeckle formation are increased in cells upon exposure to a variety of environmental stressors and believed to play an important role in cell survival. The present study was undertaken to further investigate the role of NEAT1 in cellular stress response pathways. We show that NEAT1 is a novel target gene of heat shock transcription factor 1 (HSF1) and is up-regulated when the heat shock response pathway is activated by sulforaphane (SFN) or elevated temperature. HSF1 binds specifically to a newly identified conserved heat shock element in the NEAT1 promoter. In line with this, SFN induced the formation of NEAT1-containing paraspeckles via an HSF1-dependent mechanism. HSF1 plays a key role in the cellular response to proteotoxic stress by promoting the expression of a series of genes, including those encoding molecular chaperones. We have found that the expression of HSP70, HSP90, and HSP27 is amplified and sustained during heat shock in NEAT1-depleted cells compared with control cells, indicating that NEAT1 feeds back via an unknown mechanism to regulate HSF1 activity. This interrelationship is potentially significant in human diseases such as cancer and neurodegenerative disorders.	[Lellahi, S. Mohammad; Rosenlund, Ingrid Arctander; Hedberg, Annica; Kiaer, Liv Torill; Knutsen, Erik; Perander, Maria] UiT, Fac Hlth Sci, Dept Med Biol, N-9037 Tromso, Norway; [Mikkola, Ingvild] UiT, Fac Hlth Sci, Dept Pharm, N-9037 Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Perander, M (corresponding author), UiT, Fac Hlth Sci, Dept Med Biol, RNA & Mol Pathol Res Grp, N-9037 Tromso, Norway.	maria.perander@uit.no	Knutsen, Erik/ABH-6287-2020	Knutsen, Erik/0000-0002-4903-0150; Lellahi, Seyed Mohammad/0000-0003-3633-8065; Perander, Maria/0000-0002-1177-2407	Helse Nord RHF (Northern Norway Regional Health Authority)	Helse Nord RHF (Northern Norway Regional Health Authority)	This work was supported by Helse Nord RHF (Northern Norway Regional Health Authority). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Adriaens C, 2016, NAT MED, V22, P861, DOI 10.1038/nm.4135; Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Beeharry Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24500-1; Brown JA, 2012, P NATL ACAD SCI USA, V109, P19202, DOI 10.1073/pnas.1217338109; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chen HJ, 2016, BRAIN, V139, P1417, DOI 10.1093/brain/aww028; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Dai C, 2016, TRENDS CELL BIOL, V26, P17, DOI 10.1016/j.tcb.2015.10.011; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Gan NQ, 2010, J BIOL CHEM, V285, P35528, DOI 10.1074/jbc.M110.152686; Gao FB, 2017, EMBO J, V36, P2931, DOI 10.15252/embj.201797568; Gibbs A, 2009, P NATL ACAD SCI USA, V106, P16663, DOI 10.1073/pnas.0908908106; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gomez-Pastor R, 2018, NAT REV MOL CELL BIO, V19, P4, DOI 10.1038/nrm.2017.73; Gomez-Pastor R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14405; Hirose T, 2014, MOL BIOL CELL, V25, P169, DOI 10.1091/mbc.E13-09-0558; Holmberg CI, 2000, CELL STRESS CHAPERON, V5, P219, DOI 10.1379/1466-1268(2000)005<0219:FONHGV>2.0.CO;2; Huang C, 2018, EUR J PHARMACOL, V822, P69, DOI 10.1016/j.ejphar.2018.01.005; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Idogawa M, 2017, INT J CANCER, V140, P2785, DOI 10.1002/ijc.30689; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Kim D, 1999, BIOCHEM BIOPH RES CO, V254, P264, DOI 10.1006/bbrc.1998.9840; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Li J, 2017, TRENDS CELL BIOL, V27, P895, DOI 10.1016/j.tcb.2017.08.002; Li YY, 2012, J NUTR BIOCHEM, V23, P1617, DOI 10.1016/j.jnutbio.2011.11.004; Lin D, 2012, J BIOL CHEM, V287, P4299, DOI 10.1074/jbc.M111.282152; Lu M, 2008, BIOCHEMISTRY-US, V47, P6007, DOI 10.1021/bi702185u; Ma HW, 2017, J VIROL, V91, DOI 10.1128/JVI.02250-16; Mello SS, 2017, GENE DEV, V31, P1095, DOI 10.1101/gad.284661.116; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Naidu SD, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700908; Naidu SD, 2017, FEBS J, V284, P1606, DOI 10.1111/febs.13999; Naidu SD, 2015, TRENDS PHARMACOL SCI, V36, P6, DOI 10.1016/j.tips.2014.10.011; Nakagawa S, 2014, DEVELOPMENT, V141, P4618, DOI 10.1242/dev.110544; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Neef DW, 2014, CELL REP, V9, P955, DOI 10.1016/j.celrep.2014.09.056; Neef DW, 2011, NAT REV DRUG DISCOV, V10, P930, DOI 10.1038/nrd3453; Nishimoto Y, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-31; Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Schonrock N, 2016, CURR GENE THER, V16, P220, DOI 10.2174/1566523216666160524144159; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Shelkovnikova TA, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0263-7; Shelkovnikova TA, 2014, HUM MOL GENET, V23, P2298, DOI 10.1093/hmg/ddt622; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Standaert L, 2014, RNA, V20, P1844, DOI 10.1261/rna.047332.114; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Sunwoo JS, 2017, MOL NEUROBIOL, V54, P1577, DOI 10.1007/s12035-016-9928-9; Trinklein ND, 2004, CELL STRESS CHAPERON, V9, P21, DOI 10.1379/1466-1268(2004)009<0021:TRABOH>2.0.CO;2; Vujanac M, 2005, TRAFFIC, V6, P214, DOI 10.1111/j.1600-0854.2005.00266.x; Wang P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00088-4; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Zhang Q, 2013, MBIO, V4, DOI 10.1128/mBio.00596-12; Zhang Y, 2011, CHEM BIOL, V18, P1355, DOI 10.1016/j.chembiol.2011.09.008; Zhou MY, 1996, J BIOL CHEM, V271, P24769, DOI 10.1074/jbc.271.40.24769; Zhou W, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4461-z; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	66	37	40	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18965	18976		10.1074/jbc.RA118.004473	http://dx.doi.org/10.1074/jbc.RA118.004473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30305397	Green Published, hybrid			2022-12-26	WOS:000458467400012
J	Mihalas, BP; Bromfield, EG; Sutherland, JM; De Iuliis, GN; McLaughlin, EA; Aitken, RJ; Nixon, B				Mihalas, Bettina P.; Bromfield, Elizabeth G.; Sutherland, Jessie M.; De Iuliis, Geoffry N.; McLaughlin, Eileen A.; Aitken, R. John; Nixon, Brett			Oxidative damage in naturally aged mouse oocytes is exacerbated by dysregulation of proteasomal activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; LIPID-PEROXIDATION; FOLLICULAR-FLUID; PROTEIN OXIDATION; OXIDIZED PROTEINS; SPINDLE DISRUPTION; HYDROGEN-PEROXIDE; CELL-DEATH; STRESS; DEGRADATION	An increase in oxidative protein damage is a leading contributor to the age-associated decline in oocyte quality. By removing such damaged proteins, the proteasome plays an essential role in maintaining the fidelity of oocyte meiosis. In this study, we established that decreased proteasome activity in naturally aged, germinal vesicle (GV) mouse oocytes positively correlates with increased protein modification by the lipid aldehyde 4-hydroxynonenal (4-HNE). Furthermore, attenuation of proteasome activity in GV oocytes of young animals was accompanied by an increase in 4-HNE-modified proteins, including alpha-tubulin, thereby contributing to a reduction in tubulin polymerization, microtubule stability, and integrity of oocyte meiosis. A decrease in proteasome activity was also recapitulated in theGV oocytes of young animals following exposure to oxidative insults in the form of either hydrogen peroxide (H2O2) or 4-HNE. We also observed that upon oxidative insult, 4-HNE exhibits elevated adduction to multiple proteasomal subunits. Notably, the inclusion of the antioxidant penicillamine, to limit propagation of oxidative stress cascades, led to a complete recovery of proteasome activity and enhanced clearance of 4-HNE-adducted alpha-tubulin during a 6-h post-treatment recovery period. This strategy also proved effective in reducing the incidence of oxidative stress-induced aneuploidy following in vitro oocyte maturation, but was ineffective for naturally aged oocytes. Taken together, our results implicate proteasome dysfunction as an important factor in the accumulation of oxidatively induced protein damage in the female germline. This discovery holds promise for the design of therapeutic interventions to address the age-dependent decline in oocyte quality.	[Mihalas, Bettina P.; Bromfield, Elizabeth G.; Sutherland, Jessie M.; De Iuliis, Geoffry N.; McLaughlin, Eileen A.; Aitken, R. John; Nixon, Brett] Univ Newcastle, Sch Environm & Life Sci, Prior Res Ctr Reprod Sci, Univ Dr, Callaghan, NSW 2308, Australia; [McLaughlin, Eileen A.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand	University of Newcastle; University of Auckland	Mihalas, BP; Nixon, B (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Prior Res Ctr Reprod Sci, Univ Dr, Callaghan, NSW 2308, Australia.	Bettina.Mihalas@uon.edu.au; Brett.Nixon@newcastle.edu.au	Aitken, Robert John/AAY-8238-2020; McLaughlin, Eileen/AAF-5588-2021; De Iuliis, Geoffry N./G-7042-2013; McLaughlin, Eileen A/G-7620-2013; Nixon, Brett/B-5121-2012; Bromfield, Elizabeth Grace/S-5043-2016	Aitken, Robert John/0000-0002-9152-156X; De Iuliis, Geoffry N./0000-0002-6978-6123; Mihalas, Bettina/0000-0002-6006-8475; Nixon, Brett/0000-0003-2745-8188; McLaughlin, Eileen/0000-0002-5837-3876; Bromfield, Elizabeth Grace/0000-0001-7256-1403; Sutherland, Jessie/0000-0001-9672-2371	University of Newcastle's Priority Research Centre for Reproductive Science; Hunter Medical Research Institute's (HMRI) Pregnancy and Reproduction Program; Research Training Program Scholarship; Emlyn and Jennie Thomas Postgraduate Medical Research Scholarship	University of Newcastle's Priority Research Centre for Reproductive Science; Hunter Medical Research Institute's (HMRI) Pregnancy and Reproduction Program; Research Training Program Scholarship; Emlyn and Jennie Thomas Postgraduate Medical Research Scholarship	This work was supported in part by the University of Newcastle's Priority Research Centre for Reproductive Science and the Hunter Medical Research Institute's (HMRI) Pregnancy and Reproduction Program. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Research Training Program Scholarship and an Emlyn and Jennie Thomas Postgraduate Medical Research Scholarship.	Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Aiken CE, 2015, SCI REP-UK, V5, DOI 10.1038/srep16175; Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Aitken RJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102020; Aitken RJ, 2012, J BIOL CHEM, V287, P33048, DOI 10.1074/jbc.M112.366690; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Babuska V, 2012, Ceska Gynekol, V77, P543; Baker MA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123679; Bardag-Gorce F, 1999, MOL BIOL REP, V26, P89, DOI 10.1023/A:1006968208077; Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759; Bhattacharya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082249; Bromfield EG, 2017, MOL HUM REPROD, V23, P91, DOI 10.1093/molehr/gaw074; Bromfield EG, 2015, HUM REPROD, V30, P2597, DOI 10.1093/humrep/dev214; Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Bulteau AL, 2000, EXP GERONTOL, V35, P767, DOI 10.1016/S0531-5565(00)00136-4; Camlin NJ, 2017, MOL REPROD DEV, V84, P6, DOI 10.1002/mrd.22766; Camlin NJ, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135848; Canu N, 2000, J NEUROSCI, V20, P589, DOI 10.1523/JNEUROSCI.20-02-00589.2000; Carrard G, 2003, INT J BIOCHEM CELL B, V35, P728, DOI 10.1016/S1357-2725(02)00356-4; Casarejos MJ, 2011, NEUROCHEM INT, V58, P512, DOI 10.1016/j.neuint.2011.01.008; Chaube SK, 2005, APOPTOSIS, V10, P863, DOI 10.1007/s10495-005-0367-8; Chavez J, 2010, CHEM RES TOXICOL, V23, P37, DOI 10.1021/tx9002462; Chiang T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094367; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Choi WJ, 2007, FERTIL STERIL, V88, P1220, DOI 10.1016/j.fertnstert.2007.02.067; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Collins JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9553; Compton DA, 2011, CURR OPIN CELL BIOL, V23, P109, DOI 10.1016/j.ceb.2010.08.007; Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; Das S, 2006, HUM REPROD, V21, P2403, DOI 10.1093/humrep/del156; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Devroey P, 1996, HUM REPROD, V11, P1324; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P130, DOI 10.1089/ars.2006.8.130; Ding QX, 2003, FEBS LETT, V546, P228, DOI 10.1016/S0014-5793(03)00582-9; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Doorn JA, 2002, CHEM RES TOXICOL, V15, P1445, DOI 10.1021/tx025590o; Dunmore BJ, 2013, HUM MOL GENET, V22, P3667, DOI 10.1093/hmg/ddt216; Elizur SE, 2014, GYNECOL ENDOCRINOL, V30, P705, DOI 10.3109/09513590.2014.924100; Elofsson M, 1999, CHEM BIOL, V6, P811, DOI 10.1016/S1074-5521(99)80128-8; ESTERBAUER H, 1993, AM J CLIN NUTR, V57, P779, DOI 10.1093/ajcn/57.5.779S; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Farout L, 2006, ARCH BIOCHEM BIOPHYS, V453, P135, DOI 10.1016/j.abb.2006.02.003; Ferrington DA, 2004, FEBS LETT, V578, P217, DOI 10.1016/j.febslet.2004.11.003; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Girotti AW, 1998, J LIPID RES, V39, P1529; Grune T, 2001, J GERONTOL A-BIOL, V56, pB459, DOI 10.1093/gerona/56.11.B459; Grune Tilman, 2003, Molecular Aspects of Medicine, V24, P195, DOI 10.1016/S0098-2997(03)00014-1; Haglund C, 2014, MEDCHEMCOMM, V5, P376, DOI 10.1039/c3md00386h; Halliwell B, 2000, IUBMB LIFE, V50, P251, DOI 10.1080/15216540051080930; Han SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13688-3; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hochrainer K, 2012, STROKE, V43, P2229, DOI 10.1161/STROKEAHA.112.650416; Holt JE, 2012, MOL BIOL CELL, V23, P3970, DOI 10.1091/mbc.E12-05-0352; Huo LJ, 2004, MECH DEVELOP, V121, P1275, DOI 10.1016/j.mod.2004.05.007; Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x; Hyun DH, 2002, J NEUROCHEM, V83, P360, DOI 10.1046/j.1471-4159.2002.01125.x; Jennings PC, 2011, HUM REPROD, V26, P878, DOI 10.1093/humrep/deq393; Josefsberg LBY, 2000, BIOL REPROD, V62, P1270, DOI 10.1095/biolreprod62.5.1270; Jung T, 2014, REDOX BIOL, V2, P388, DOI 10.1016/j.redox.2013.12.029; Just J, 2015, FREE RADICAL BIO MED, V89, P786, DOI 10.1016/j.freeradbiomed.2015.10.405; KANNER J, 1987, CRC CR REV FOOD SCI, V25, P317, DOI 10.1080/10408398709527457; Kerr JB, 2013, REPRODUCTION, V146, pR205, DOI 10.1530/REP-13-0181; Kinnunen PKJ, 2012, BBA-BIOMEMBRANES, V1818, P2446, DOI 10.1016/j.bbamem.2012.04.008; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Kokubo J, 2008, CELL STRUCT FUNCT, V33, P51, DOI 10.1247/csf.07038; Lim J, 2011, BIOL REPROD, V84, P775, DOI 10.1095/biolreprod.110.088583; Lister LM, 2010, CURR BIOL, V20, P1511, DOI 10.1016/j.cub.2010.08.023; Liu L, 2002, HUM REPROD, V17, P2678, DOI 10.1093/humrep/17.10.2678; Lord T, 2015, DEV BIOL, V406, P1, DOI 10.1016/j.ydbio.2015.07.024; Lord T, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.122820; Ma JY, 2013, CELL CYCLE, V12, P1233, DOI 10.4161/cc.24311; Maiti K, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.06.015; Marangos P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9706; McLaughlin EA, 2009, REPRODUCTION, V137, P1, DOI 10.1530/REP-08-0118; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Mihalas BP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06372-z; Mihalas BP, 2015, REPRODUCTION, V150, P485, DOI 10.1530/REP-14-0585; Monroy CA, 2013, CHEM RES TOXICOL, V26, P1832, DOI 10.1021/tx400212q; Nederlof PM, 1995, P NATL ACAD SCI USA, V92, P12060, DOI 10.1073/pnas.92.26.12060; Neely MD, 1999, J NEUROCHEM, V72, P2323, DOI 10.1046/j.1471-4159.1999.0722323.x; Nixon B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135605; Nunez-Calonge R, 2016, REPROD BIOMED ONLINE, V32, P446, DOI 10.1016/j.rbmo.2015.12.010; Okada K, 1999, J BIOL CHEM, V274, P23787, DOI 10.1074/jbc.274.34.23787; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Pizzimenti S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00242; Reeg S, 2015, ANTIOXID REDOX SIGN, V23, P239, DOI 10.1089/ars.2014.6062; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saez I, 2014, CURR GENOMICS, V15, P38, DOI 10.2174/138920291501140306113344; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; SCHWARTZ D, 1982, NEW ENGL J MED, V306, P404, DOI 10.1056/NEJM198202183060706; Selesniemi K, 2011, P NATL ACAD SCI USA, V108, P12319, DOI 10.1073/pnas.1018793108; Shang F, 2001, EXP EYE RES, V73, P229, DOI 10.1006/exer.2001.1029; Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Shringarpure R, 2000, CELL MOL LIFE SCI, V57, P1802, DOI 10.1007/PL00000660; Silber SJ, 2017, FERTIL STERIL, V107, P1232, DOI 10.1016/j.fertnstert.2017.03.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stewart BJ, 2007, CHEM RES TOXICOL, V20, P1111, DOI 10.1021/tx700106v; Taiyeb AM, 2014, CLIN EXP PHARMACOL P, V41, P147, DOI 10.1111/1440-1681.12193; Takeo S, 2017, REPROD FERT DEVELOP, V29, P759, DOI 10.1071/RD15228; Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X; TANAKA K, 1990, FEBS LETT, V271, P41, DOI 10.1016/0014-5793(90)80367-R; Tarin JJ, 2004, MOL REPROD DEV, V69, P402, DOI 10.1002/mrd.20180; TARIN JJ, 1995, HUM REPROD, V10, P1563, DOI 10.1093/HUMREP/10.6.1563; Tarin JJ, 1996, MOL HUM REPROD, V2, P895, DOI 10.1093/molehr/2.12.895; Tarin JJ, 1996, MOL HUM REPROD, V2, P717, DOI 10.1093/molehr/2.10.717; Tomaru U, 2012, AM J PATHOL, V180, P963, DOI 10.1016/j.ajpath.2011.11.012; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; WAGNER BJ, 1995, ARCH BIOCHEM BIOPHYS, V323, P455, DOI 10.1006/abbi.1995.0067; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Wang XM, 2015, GUT, V64, P459, DOI 10.1136/gutjnl-2014-307213; Wiener-Megnazi Z, 2004, FERTIL STERIL, V82, P1171, DOI 10.1016/j.fertnstert.2004.06.013; Wojcik C, 2000, MOL HUM REPROD, V6, P331, DOI 10.1093/molehr/6.4.331; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z; Yun Y, 2014, CELL CYCLE, V13, P1938, DOI 10.4161/cc.28897; Zhang X, 2006, CELL RES, V16, P841, DOI 10.1038/sj.cr.7310095	123	22	22	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18944	18964		10.1074/jbc.RA118.005751	http://dx.doi.org/10.1074/jbc.RA118.005751			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	HL1NY	30305393	hybrid, Green Published			2022-12-26	WOS:000458467400011
J	Ferreira, M; Verbinnen, I; Fardilha, M; Van Eynde, A; Bollen, M				Ferreira, Monica; Verbinnen, Iris; Fardilha, Margarida; Van Eynde, Aleyde; Bollen, Mathieu			The deletion of the protein phosphatase 1 regulator NIPP1 in testis causes hyperphosphorylation and degradation of the histone methyltransferase EZH2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; chromatin; epigenetics; histone methylation; phosphoprotein phosphatase 1 (PP1); protein phosphorylation; protein stability; proteolysis; spermatogenesis; testis; EZH2; germ cells; NIPP1; Polycomb group; protein phosphatase 1; PRC2; RBAP48; SUZ12; enhancer of zeste homolog 2	POLYCOMB GROUP PROTEIN; NUCLEAR INHIBITOR; CELL FATE; PHOSPHORYLATION; METHYLATION; BINDING; SUZ12; PP1; DIFFERENTIATION; REPRESSION	Germ cell proliferation is epigenetically controlled, mainly through DNA methylation and histone modifications. However, the pivotal epigenetic regulators of germ cell self-renewal and differentiation in postnatal testis are still poorly defined. The histone methyltransferase enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of Polycomb repressive complex 2, represses target genes through trimethylation of histone H3 at Lys-27 (H3K27me3), and interacts (in)directly with both protein phosphatase 1 (PP1) and nuclear inhibitor of PP1 (NIPP1). Here, we report that postnatal, testis-specific ablation of NIPP1 in mice results in loss of EZH2 and reduces H3K27me3 levels. Mechanistically, the NIPP1 deletion abrogated PP1-mediated EZH2 dephosphorylation at two cyclin-dependent kinase sites (Thr-345/487), thereby generating hyperphosphorylated EZH2, which is a substrate for proteolytic degradation. Accordingly, alanine mutation of these residues prolonged the half-life of EZH2 in male germ cells. Our study discloses a key role for the PP1:NIPP1 holoenzyme in stabilizing EZH2 and maintaining the H3K27me3 mark on genes that are important for germ cell development and spermatogenesis.	[Ferreira, Monica; Verbinnen, Iris; Van Eynde, Aleyde; Bollen, Mathieu] Univ Leuven, KU Leuven, Dept Cellular & Mol Med, Lab Biosignaling & Therapeut, B-3000 Leuven, Belgium; [Ferreira, Monica; Fardilha, Margarida] Univ Aveiro, Dept Hlth Sci, Inst Res Biomed iBiMED, P-3810 Aveiro, Portugal	KU Leuven; Universidade de Aveiro	Van Eynde, A; Bollen, M (corresponding author), Campus Gasthuisberg,Herestr 49,O&N1,PB901, B-3000 Leuven, Belgium.	Aleyde.VanEynde@kuleuven.be; Mathieu.Bollen@kuleuven.be	Fardilha, Margarida/G-3182-2010	Fardilha, Margarida/0000-0001-7459-9173; Ferreira, Monica/0000-0001-9609-5099	Fonds Wetenschappelijk Onderzoek [G078717N]; Bijzonder Onderzoeksfonds [BOF-GOA 10/18]; FCT/Portuguese Ministry of Science and Technology (MEC Fundacao para a Ciencia e a Tecnologia (FCT))	Fonds Wetenschappelijk Onderzoek(FWO); Bijzonder Onderzoeksfonds; FCT/Portuguese Ministry of Science and Technology (MEC Fundacao para a Ciencia e a Tecnologia (FCT))	This work was supported by the Fonds Wetenschappelijk Onderzoek G078717N and by the Bijzonder Onderzoeksfonds (BOF-GOA 10/18). This work was also supported by a doctoral fellowship from FCT/Portuguese Ministry of Science and Technology (MEC Fundacao para a Ciencia e a Tecnologia (FCT)) (to M.F.). The authors declare that they have no conflicts of interest with the contents of this article.	Aranda S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500737; Ardehali MB, 2017, MOL CELL, V68, P872, DOI 10.1016/j.molcel.2017.10.025; Beullens M, 2000, BIOCHEM J, V352, P651, DOI 10.1042/0264-6021:3520651; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Comet I, 2014, NAT STRUCT MOL BIOL, V21, P573, DOI 10.1038/nsmb.2848; Ferreira M, 2019, BBA-MOL CELL RES, V1866, P16, DOI 10.1016/j.bbamcr.2018.07.019; Ferreira M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13809-y; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Jin QM, 2003, J BIOL CHEM, V278, P30677, DOI 10.1074/jbc.M302273200; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Komai Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06175; Kubo N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1833-5; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Ly L, 2015, SEMIN CELL DEV BIOL, V43, P96, DOI 10.1016/j.semcdb.2015.07.006; Minnebo N, 2013, NUCLEIC ACIDS RES, V41, P842, DOI 10.1093/nar/gks1255; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Mu WP, 2017, DEV BIOL, V424, P198, DOI 10.1016/j.ydbio.2017.02.017; Mu WP, 2014, GENE DEV, V28, P2056, DOI 10.1101/gad.246124.114; Nishioka K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30649-6; Nuytten M, 2008, ONCOGENE, V27, P1449, DOI 10.1038/sj.onc.1210774; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; Roy N, 2007, BBA-GENE STRUCT EXPR, V1769, P541, DOI 10.1016/j.bbaexp.2007.07.004; Sahasrabuddhe AA, 2015, ONCOGENE, V34, P445, DOI 10.1038/onc.2013.571; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Tanuma N, 2008, J BIOL CHEM, V283, P35805, DOI 10.1074/jbc.M805468200; Van Dessel N, 2015, FEBS LETT, V589, P1314, DOI 10.1016/j.febslet.2015.04.017; Van Dessel N, 2010, NUCLEIC ACIDS RES, V38, P7500, DOI 10.1093/nar/gkq643; Vasanthakumar A, 2017, EMBO REP, V18, P619, DOI 10.15252/embr.201643237; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Winkler C, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214932; Winkler C, 2015, J CELL SCI, V128, P4526, DOI 10.1242/jcs.175588; Wu D, 2018, J BIOL CHEM, V293, P15152, DOI 10.1074/jbc.RA118.004132; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yang CC, 2015, AM J TRANSL RES, V7, P1009	41	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18031	18039		10.1074/jbc.AC118.005577	http://dx.doi.org/10.1074/jbc.AC118.005577			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30305391	Green Published, hybrid			2022-12-26	WOS:000451375200002
J	Genievskaya, Y; Almerekova, S; Sariev, B; Chudinov, V; Tokhetova, L; Sereda, G; Ortaev, A; Tsygankov, V; Blake, T; Chao, S; Sato, K; Abugalieva, S; Turuspekov, Y				Genievskaya, Yuliya; Almerekova, Shyryn; Sariev, Burabai; Chudinov, Vladimir; Tokhetova, Laura; Sereda, Grigoriy; Ortaev, Anarbai; Tsygankov, Vladimir; Blake, Thomas; Chao, Shiaoman; Sato, Kazuhiro; Abugalieva, Saule; Turuspekov, Yerlan			Marker-trait associations in two-rowed spring barley accessions from Kazakhstan and the USA	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ENVIRONMENT INTERACTION; STRUCTURED POPULATIONS; ALLELE FREQUENCIES; GRAIN-YIELD; GENOTYPE; LOCI; CULTIVARS; GENES; QTL	In this study, phenotyping and single nucleotide polymorphism (SNP) genotyping data of 272 accessions of two-rowed spring barley from the USA along with 94 accessions from Kazakhstan were assessed in field trials at six breeding organizations in Kazakhstan to evaluate the performance of the USA samples over three years (2009-2011). The average grain yield over the six locations was not significantly higher in Kazakh accessions in comparison to the USA samples. Twenty four samples from Montana, Washington, the USDA station in Aberdeen Idaho, and the Anheuser-Busch breeding programs showed heavier average yield than the local standard cultivar "Ubagan". Principal Coordinate analysis based on two sets of SNP data suggested that Kazakh accessions were closest to the USA accessions among eight groups of samples from different parts of the World, and within five US barley origin groups the samples from Montana and Washington perfectly matched six groups of Kazakh breeding origins. A genome-wide association study (GWAS) using data from eighteen field trials allowed the identification of ninety one marker-trait associations (MTA) in two or more environments for nine traits, including key characters such as heading time (HT), number of kernels per spike (NKS), and thousand grain weight (TGW). Our GWAS allowed the identification of eight MTA for HT and NKS, and sixteen MTA for TGW, when those MTA were linked to mapped SNPs. Based on comparisons of chromosomal positions of MTA identified in this study, and positions of known genes and quantitative trait loci for HT, NKS and TGW, it was suggested that MTA for HT on chromosome 2H (at 158.2 cM, 11_21414), MTA for NKS on 5H (at 118.6 cM, 11_20298), and two MTA for TGW on chromosome 4H (at 94.7 cM, 12_30718, and at 129.3 cM, 11_20013) were potentially new associations in barley. GWAS suggested that six MTA for HT, including two on chromosome 1H, two on chromosome 3H, and one each on chromosomes 4H and 6H, had useful pleio-tropic effects for improving barley spike traits.	[Genievskaya, Yuliya; Almerekova, Shyryn; Abugalieva, Saule; Turuspekov, Yerlan] Inst Plant Biol & Biotechnol, Alma Ata, Kazakhstan; [Almerekova, Shyryn; Abugalieva, Saule; Turuspekov, Yerlan] al Farabi Kazakh Natl Univ, Dept Biodivers & Bioresources, Alma Ata, Kazakhstan; [Sariev, Burabai] Kazakh Res Inst Agr & Plant Ind, Alma Ata, Almaty Region, Kazakhstan; [Chudinov, Vladimir] Karabalyk Breeding Stn, Kostanay, Kostanai Region, Kazakhstan; [Tokhetova, Laura] Kazakh Res Inst Rice, Kyzylorda, Kazakhstan; [Sereda, Grigoriy] Karaganda Breeding Stn, Karaganda, Karaganda Regio, Kazakhstan; [Ortaev, Anarbai] Krasnovodopad Breeding Stn, Alma Ata, South Kazakhsta, Kazakhstan; [Tsygankov, Vladimir] Aktobe Breeding Stn, Aktobe, Aktobe Region, Kazakhstan; [Blake, Thomas] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Chao, Shiaoman] USDA ARS, Biosci Res Lab, Fargo, ND 58105 USA; [Sato, Kazuhiro] Okayama Univ, Res Inst Bioresources, Kurashiki, Okayama, Japan	Institute of Plant Biology & Biotechnology in Kazakhstan; Al-Farabi Kazakh National University; Kazakh Scientific Research Institute of Plant Protection & Quarantine of Zh.Zhienbaev; Montana State University System; Montana State University Bozeman; United States Department of Agriculture (USDA); Okayama University	Turuspekov, Y (corresponding author), Inst Plant Biol & Biotechnol, Alma Ata, Kazakhstan.; Turuspekov, Y (corresponding author), al Farabi Kazakh Natl Univ, Dept Biodivers & Bioresources, Alma Ata, Kazakhstan.	yerlant@yahoo.com	Tokhetova, Laura/AAC-6892-2021; Genievskaya, Yuliya/AAF-2410-2019; Abugalieva, Saule/M-6690-2015; SATO, Kazuhiro/B-2504-2011; Turuspekov, Yerlan/C-3458-2011; Almerekova, Shyryn/AAO-1157-2020	Tokhetova, Laura/0000-0003-2053-6956; Genievskaya, Yuliya/0000-0001-5987-2952; Abugalieva, Saule/0000-0002-9748-507X; SATO, Kazuhiro/0000-0001-8818-5203; Turuspekov, Yerlan/0000-0001-8590-1745; Almerekova, Shyryn/0000-0002-6079-264X	Ministry of Education and Sciences of the Republic of Kazakhstan [010900329, 0109PK00329]	Ministry of Education and Sciences of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	This work was supported by the grant 010900329 funded by the Ministry of Education and Sciences of the Republic of Kazakhstan (2009-2011).; This work was supported by the grant 0109PK00329 funded by the Ministry of Education and Sciences of the Republic of Kazakhstan (2009-2011). The authors are grateful to John Snape (John Innes Centre, Norwich, UK) for critical reading of the manuscript.	Abugalieva AI, 2011, GENETIC RESOURCES CU; Alqudah AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113120; Bayer MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01792; Beheshtizadeh H, 2018, INDIAN J GENET PL BR, V78, P69, DOI 10.5958/0975-6906.2018.00008.1; Bellucci A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173313; Blake VC, 2012, PLANT GENOME-US, V5, P81, DOI 10.3835/plantgenome2012.03.0002; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cai SG, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-35; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Costa JM, 2001, THEOR APPL GENET, V103, P415, DOI 10.1007/s001220100622; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Fan Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00946; Franckowiak J.D., 1997, BARLEY GENET NEWSL, V26, P9; Gryaznov AA, 1996, KARABALYK BARLEY FOR; Guo BJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00542; Gutierrez L, 2015, THEOR APPL GENET, V128, P501, DOI 10.1007/s00122-014-2448-y; Hassan AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182537; Houston K, 2013, P NATL ACAD SCI USA, V110, P16675, DOI 10.1073/pnas.1311681110; Hyland Howard L., 1977, ENVIRON REV, V4, P26, DOI [10.2307/3984262, DOI 10.2307/3984262]; Igartua E, 2013, GENET RESOUR CROP EV, V60, P251, DOI 10.1007/s10722-012-9831-9; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; Lorenz AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014079; Mangini G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190162; Miyagawa T, 2008, J HUM GENET, V53, P886, DOI 10.1007/s10038-008-0322-y; Mohammadi M, 2015, THEOR APPL GENET, V128, P705, DOI 10.1007/s00122-015-2465-5; Munoz-Amatriain M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094688; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Pauli D, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.11.0037; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pswarayi A, 2008, EUPHYTICA, V163, P435, DOI 10.1007/s10681-008-9726-1; Ren XiFeng, 2013, Australian Journal of Crop Science, V7, P878; Reynolds MP, 2002, FIELD CROP RES, V75, P139, DOI 10.1016/S0378-4290(02)00023-0; Rode J, 2012, MOL BREEDING, V30, P831, DOI 10.1007/s11032-011-9667-6; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Saade S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32586; Sameri M, 2006, BREEDING SCI, V56, P243, DOI 10.1270/jsbbs.56.243; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; TAKAHASHI R, 1951, BER OHARA I LANDWIRT, V9, P399; Turuspekov Y, 2005, PLANT BREEDING, V124, P542, DOI 10.1111/j.1439-0523.2005.01161.x; Turuspekov Y, 2013, RUSS J GENET+, V49, P196, DOI 10.1134/S1022795413020129; Turuspekov Y, 2017, PLANT GENET RESOUR-C, V15, P29, DOI 10.1017/S1479262115000325; Turuspekov Y, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-015-0686-z; Turuspekov Y, 2014, BREEDING SCI, V64, P399, DOI 10.1270/jsbbs.64.399; Turuspekov Y, 2009, BREEDING SCI, V59, P657, DOI 10.1270/jsbbs.59.657; Vavilov N. I., 1926, B APPL BOT GEN PB, V14, P1; von Zitzewitz J, 2005, PLANT MOL BIOL, V59, P449, DOI 10.1007/s11103-005-0351-2; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Xu X, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.08.0073; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	57	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205421	10.1371/journal.pone.0205421	http://dx.doi.org/10.1371/journal.pone.0205421			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308008	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500073
J	Mugele, H; Plummer, A; Baritello, O; Towe, M; Brecht, P; Mayer, F				Mugele, Hendrik; Plummer, Ashley; Baritello, Omar; Towe, Maggie; Brecht, Pia; Mayer, Frank			Accuracy of training recommendations based on a treadmill multistage incremental exercise test	PLOS ONE			English	Article							INDIVIDUAL ANAEROBIC THRESHOLD; LACTATE THRESHOLD; PERFORMANCE; RELIABILITY; VALIDITY	Competitive runners will occasionally undergo exercise in a laboratory setting to obtain predictive and prescriptive information regarding their performance. The present research aimed to assess whether the physiological demands of lab-based treadmill running (TM) can simulate that of over-ground (OG) running using a commonly used protocol. Fifteen healthy volunteers with a weekly mileage of >= 20 km over the past 6 months and treadmill experience participated in this cross-sectional study. Two stepwise incremental tests until volitional exhaustion was performed in a fixed order within one week in an Outpatient Clinic research laboratory and outdoor athletic track. Running velocity (IAT(speed)), heart rate (IAT(HR)) and lactate concentration at the individual anaerobic threshold (IAT(bLa)) were primary endpoints. Additionally, distance covered (DIST), maximal heart rate (HRmax), maximal blood lactate concentration (bLa(max)) and rate of perceived exertion (RPE) at IAT(speed) were analyzed. IAT(speed), DIST and HRmax were not statistically significantly different between conditions, whereas bLa(max) and RPE at IAT speed showed statistical significance (p < 0.05). Apart from RPE at IAT(speed), IAT(speed), DIST, HRmax and bLa(max) strongly correlate between conditions (r = 0.815-0.988). High reliability between conditions provides strong evidence to suggest that running on a treadmill are physiologically comparable to that of OG and that training recommendations and be made with assurance.	[Mugele, Hendrik; Plummer, Ashley; Baritello, Omar; Towe, Maggie] Univ Potsdam, Dept Sport & Hlth Sci, Clin Exercise Sci, Potsdam, Germany; [Brecht, Pia; Mayer, Frank] Univ Potsdam, Dept Sport & Hlth Sci, Professorship Sports Med & Orthoped, Univ Outpatient Clin, Potsdam, Germany	University of Potsdam; University of Potsdam	Plummer, A (corresponding author), Univ Potsdam, Dept Sport & Hlth Sci, Clin Exercise Sci, Potsdam, Germany.	plummer@uni-potsdam.de						Barnes KR, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0007-y; Binder RK, 2008, EUR J CARDIOV PREV R, V15, P726, DOI 10.1097/HJR.0b013e328304fed4; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Bosquet L, 2001, EUR J APPL PHYSIOL, V84, P107, DOI 10.1007/s004210000343; Bourdon P., 2013, PHYSL TESTS ELITE AT, V2nd, P77; Brunet J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3130-y; Campbell CSG, 2014, INTERNATIONAL SPORTM, V15; Casa DJ, 2010, J ATHL TRAINING, V45, P147, DOI 10.4085/1062-6050-45.2.147; Cerda-Kohler H, 2016, J STRENGTH COND RES, V30, P2864, DOI 10.1519/JSC.0000000000001368; Clermont CA, 2019, J SPORT HEALTH SCI, V8, P249, DOI 10.1016/j.jshs.2017.08.003; Coen B, 2001, INT J SPORTS MED, V22, P8, DOI 10.1055/s-2001-11332; Da Silva JF, 2011, J SPORT SCI, V29, P1621, DOI 10.1080/02640414.2011.609179; DAVIES CTM, 1980, J APPL PHYSIOL, V48, P702, DOI 10.1152/jappl.1980.48.4.702; Dickhuth HH, 1999, INT J SPORTS MED, V20, P122, DOI 10.1055/s-1999-970277; Faude O, 2009, SPORTS MED, V39, P469, DOI 10.2165/00007256-200939060-00003; Fernandez-Fernandez J, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093152; HECK H, 1985, INT J SPORTS MED, V6, P117, DOI 10.1055/s-2008-1025824; Hecksteden A, 2015, J STRENGTH COND RES, V29, P2497, DOI 10.1519/JSC.0b013e31828a485c; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; Jones AM, 2006, INT J SPORTS SCI COA, V1, P101, DOI [10.1260/174795406777641258, DOI 10.1260/174795406777641258]; Legaz-Arrese A, 2011, ACTA PHYSIOL HUNG, V98, P147, DOI 10.1556/APhysiol.98.2011.2.6; Motoyama Yuri Lopes, 2014, Rev. bras. cineantropom. desempenho hum., V16, P419, DOI 10.5007/1980-0037.2014v16n4p419; NIGG BM, 1995, MED SCI SPORT EXER, V27, P98; Panasci M, 2017, APPL PHYSIOL NUTR ME, V42, P973, DOI 10.1139/apnm-2017-0132; Pfitzinger P, 1998, INT J SPORTS MED, V19, P349, DOI 10.1055/s-2007-971929; Renberg J, 2014, J THERM BIOL, V45, P9, DOI 10.1016/j.jtherbio.2014.06.009; Roecker K, 1998, MED SCI SPORT EXER, V30, P1552, DOI 10.1097/00005768-199810000-00014; Roecker K, 2002, MED SCI SPORT EXER, V34, P881, DOI 10.1097/00005768-200205000-00024; Saunders PU, 2004, SPORTS MED, V34, P465, DOI 10.2165/00007256-200434070-00005; Simoes HG, 1999, EUR J APPL PHYSIOL O, V80, P34, DOI 10.1007/s004210050555; Sinclair J, 2013, SPORT BIOMECH, V12, P272, DOI 10.1080/14763141.2012.759614; Storer, 2001, EXERCISE TESTING INT, DOI [10.1017/CBO9780511545689, DOI 10.1017/CBO9780511545689]; URHAUSEN A, 1993, INT J SPORTS MED, V14, P134, DOI 10.1055/s-2007-1021157; West MA, 2015, BRIT J ANAESTH, V114, P244, DOI 10.1093/bja/aeu318; Zatloukal B, 1995, SPORTS MED TRAINING, V5, P255, DOI [10.1080/15438629509512023, DOI 10.1080/15438629509512023]; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204696	10.1371/journal.pone.0204696	http://dx.doi.org/10.1371/journal.pone.0204696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307961	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500023
J	Vanlangendonck, F; Willems, RM; Hagoort, P				Vanlangendonck, Flora; Willems, Roel M.; Hagoort, Peter			Taking common ground into account: Specifying the role of the mentalizing network in communicative language production	PLOS ONE			English	Article							PERSPECTIVE-TAKING; PREFRONTAL CORTEX; ACTION SELECTION; HUMAN BRAIN; MIND; METAANALYSIS; COMPREHENSION; CONVERSATION; MECHANISMS; OTHERS	Several studies have shown that communicative language production as compared to non-communicative language production recruits parts of the mentalizing or theory of mind network, yet the exact role of this network in communication remains underspecified. In this study, we therefore aimed to test under what conditions the mentalizing network contributes to communicative language production. We were especially interested in distinguishing between situations in which speakers have to consider which information they do or do not share with their addressee (common vs. privileged ground information). We therefore manipulated whether speakers had to distinguish between common and privileged ground in order to communicate efficiently with the listener, in addition to comparing language production in a communicative and a non-communicative context. Participants performed a referential communicative game in the MRI-scanner as well as a similar, non-communicative task. We found that the medial prefrontal cortex, a core region of the mentalizing network, is especially sensitive to communicative contexts in which speakers have to take their addressee's needs into account in order to communicate efficiently. In addition, we found neural differences between the communicative and the non-communicative settings before speakers started to plan their utterances, suggesting that they continuously update common ground in a communicative context.	[Vanlangendonck, Flora; Willems, Roel M.; Hagoort, Peter] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Vanlangendonck, Flora] Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands; [Willems, Roel M.; Hagoort, Peter] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Willems, Roel M.] Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society; Max Planck Society; Radboud University Nijmegen	Willems, RM (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.; Willems, RM (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.; Willems, RM (corresponding author), Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands.	r.willems@let.ru.nl	Hagoort, Peter/B-7417-2012	Willems, Roel/0000-0002-4963-5387				Barr DJ, 2008, COGNITION, V109, P18, DOI 10.1016/j.cognition.2008.07.005; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Brennan SE, 2010, PSYCHOL LEARN MOTIV, V53, P301, DOI 10.1016/S0079-7421(10)53008-1; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Brown-Schmidt S, 2009, PSYCHON B REV, V16, P893, DOI 10.3758/PBR.16.5.893; Clark H.H., 1978, THEORETICAL ISSUES N, P57, DOI DOI 10.3115/980262.980272; Clark HH, 2004, J MEM LANG, V50, P62, DOI 10.1016/j.jml.2003.08.004; Clark HH, 1982, LANGUAGE COMPREHENSI, P287; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; de Langavant LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017719; Dodell-Feder D, 2011, NEUROIMAGE, V55, P705, DOI 10.1016/j.neuroimage.2010.12.040; Dumontheil I, 2012, J COGNITIVE NEUROSCI, V24, P2080, DOI 10.1162/jocn_a_00268; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Lane LW, 2008, J EXP PSYCHOL LEARN, V34, P1466, DOI 10.1037/a0013353; Lane LW, 2006, PSYCHOL SCI, V17, P273, DOI 10.1111/j.1467-9280.2006.01697.x; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Mozuraitis M, 2018, COGNITIVE SCI, V42, P974, DOI 10.1111/cogs.12582; Nilsen ES, 2015, COGNITIVE DEV, V36, P68, DOI 10.1016/j.cogdev.2015.09.001; Nilsen ES, 2009, COGNITIVE PSYCHOL, V58, P220, DOI 10.1016/j.cogpsych.2008.07.002; Noordzij ML, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.014.2009; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Poser BA, 2006, MAGN RESON MED, V55, P1227, DOI 10.1002/mrm.20900; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Ryskin RA, 2016, COGNITION, V147, P75, DOI 10.1016/j.cognition.2015.11.011; Ryskin RA, 2014, J MEM LANG, V74, P46, DOI 10.1016/j.jml.2014.04.003; Sassa Y, 2007, NEUROIMAGE, V37, P985, DOI 10.1016/j.neuroimage.2007.05.059; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Schurz M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00712; Stolk A, 2013, P NATL ACAD SCI USA, V110, P14574, DOI 10.1073/pnas.1303170110; van Ackeren MJ, 2012, J COGNITIVE NEUROSCI, V24, P2237, DOI 10.1162/jocn_a_00274; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vanlangendonck F, 2016, LANG COGN NEUROSCI, V31, P741, DOI 10.1080/23273798.2016.1148747; Wardlow L, 2013, PSYCHON B REV, V20, P766, DOI 10.3758/s13423-013-0396-1; Willems RM, 2010, PSYCHOL SCI, V21, P8, DOI 10.1177/0956797609355563; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Yoon SO, 2012, PSYCHON B REV, V19, P699, DOI 10.3758/s13423-012-0262-6	39	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0202943	10.1371/journal.pone.0202943	http://dx.doi.org/10.1371/journal.pone.0202943			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW7TO	30307952	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500004
J	de Almeida, FA; Carneiro, DG; Mendes, TAD; Barros, E; Pinto, UM; de Oliveira, LL; Vanetti, MCD				de Almeida, Felipe Alves; Carneiro, Deisy Guimaraes; de Oliveira Mendes, Tiago Antonio; Barros, Edvaldo; Pinto, Uelinton Manoel; de Oliveira, Leandro Licursi; Dantas Vanetti, Maria Cristina			N-dodecanoyl-homoserine lactone influences the levels of thiol and proteins related to oxidation-reduction process in Salmonella	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; OXYGEN-INSENSITIVE NITROREDUCTASES; CYCLOPROPANE FATTY-ACIDS; QUORUM SENSING SIGNALS; COMPARATIVE PROTEOMIC ANALYSIS; DISULFIDE BOND FORMATION; DNA-BINDING PROTEIN; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; STATIONARY-PHASE	Quorum sensing is a cell-cell communication mechanism mediated by chemical signals that leads to differential gene expression in response to high population density. Salmonella is unable to synthesize the autoinducer-1 (AI-1), N-acyl homoserine lactone (AHL), but is able to recognize AHLs produced by other microorganisms through SdiA protein. This study aimed to evaluate the fatty acid and protein profiles of Salmonella enterica serovar Enteritidis PT4 578 throughout time of cultivation in the presence of AHL. The presence of N-dodecanoyl-homoserine lactone (C12-HSL) altered the fatty acid and protein profiles of Salmonella cultivated during 4, 6, 7, 12 and 36 h in anaerobic condition. The profiles of Salmonella Enteritidis at logarithmic phase of growth (4 h of cultivation), in the presence of C12-HSL, were similar to those of cells at late stationary phase (36 h). In addition, there was less variation in both protein and fatty acid profiles along growth, suggesting that this quorum sensing signal anticipated a stationary phase response. The presence of C12-HSL increased the abundance of thiol related proteins such as Tpx, Q7CR42, Q8ZP25, YfgD, AhpC, NfsB, YdhD and TrxA, as well as the levels of free cellular thiol after 6 h of cultivation, suggesting that these cells have greater potential to resist oxidative stress. Additionally, the LuxS protein which synthesizes the AI-2 signaling molecule was differentially abundant in the presence of C12-HSL. The NfsB protein had its abundance increased in the presence of C12-HSL at all evaluated times, which is a suggestion that the cells may be susceptible to the action of nitrofurans or that AHLs present some toxicity. Overall, the presence of C12-HSL altered important pathways related to oxidative stress and stationary phase response in Salmonella.	[de Almeida, Felipe Alves; Carneiro, Deisy Guimaraes; Dantas Vanetti, Maria Cristina] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil; [de Oliveira Mendes, Tiago Antonio] Univ Fed Vicosa, Dept Biochem & Mol Biol, Vicosa, MG, Brazil; [Barros, Edvaldo] Univ Fed Vicosa, Nucleo Anal Biomol, Vicosa, MG, Brazil; [Pinto, Uelinton Manoel] Univ Sao Paulo, Fac Pharmaceut Sci, Food Res Ctr, Dept Food & Expt Nutr, Sao Paulo, SP, Brazil; [de Oliveira, Leandro Licursi] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade de Sao Paulo; Universidade Federal de Vicosa	Vanetti, MCD (corresponding author), Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil.	mvanetti@ufv.br	de Oliveira, Leandro Licursi/D-3616-2009; Carneiro, Deisy Guimarães/GPC-4473-2022; Barros, Edvaldo/AAG-8267-2019; Almeida, Felipe Alves de/O-7644-2018; Vanetti, Maria Cristina Dantas/L-6248-2016; Pinto, Uelinton/G-5385-2015; Mendes, Tiago/AAG-1709-2021	de Oliveira, Leandro Licursi/0000-0003-4353-7011; Almeida, Felipe Alves de/0000-0002-8020-6601; Vanetti, Maria Cristina Dantas/0000-0003-2432-765X; Pinto, Uelinton/0000-0002-5335-2400; Mendes, Tiago/0000-0002-5569-4893; Barros, Edvaldo/0000-0003-0561-0222	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Financiadora de Estudos e Projetos (Finep); Sistema Nacional de Laboratorios em Nanotecnologias (SisNANO); Ministerio da Ciencia, Tecnologia e Informacao (MCTI)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (Finep)(Financiadora de Inovacao e Pesquisa (Finep)); Sistema Nacional de Laboratorios em Nanotecnologias (SisNANO); Ministerio da Ciencia, Tecnologia e Informacao (MCTI)	Felipe Alves de Almeida was supported by a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and this research has been supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Financiadora de Estudos e Projetos (Finep), Sistema Nacional de Laboratorios em Nanotecnologias (SisNANO) and Ministerio da Ciencia, Tecnologia e Informacao (MCTI). The authors acknowledge the Mass Spectrometry Facility at Brazilian Biosciences National Laboratory (LNBio), CNPEM, Campinas, Brazil and the Nucleo de Analise de Biomoleculas (Nubiomol) at Universidade Federal de Vicosa, Vicosa, Brazil for their support on mass spectrometry and data analysis. The authors thank Professor Marcos Rogerio Totola of Department of Microbiology at Universidade Federal de Vicosa for equipment and software for fatty acids analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmer BMM, 1998, J BACTERIOL, V180, P1185, DOI 10.1128/JB.180.5.1185-1193.1998; Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Ammor MS, 2008, J FOOD PROTECT, V71, P1510, DOI 10.4315/0362-028X-71.7.1510; An DD, 2006, P NATL ACAD SCI USA, V103, P3828, DOI 10.1073/pnas.0511323103; Aragao AZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043521; Asad S, 2008, CRIT CARE, V12, DOI 10.1186/cc7101; Atkinson S, 2009, J R SOC INTERFACE, V6, P959, DOI 10.1098/rsif.2009.0203; Bai AJ, 2016, J FOOD SCI TECH MYS, V53, P3609, DOI 10.1007/s13197-016-2346-1; Balleza E, 2009, FEMS MICROBIOL REV, V33, P133, DOI 10.1111/j.1574-6976.2008.00145.x; Bearson BL, 2008, MICROB PATHOGENESIS, V44, P271, DOI 10.1016/j.micpath.2007.10.001; Bijtenhoorn P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026278; Bjur E, 2006, INFECT IMMUN, V74, P5140, DOI 10.1128/IAI.00449-06; Blana V, 2017, FOOD CONTROL, V80, P83, DOI 10.1016/j.foodcont.2017.04.037; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYANT DW, 1981, CAN J MICROBIOL, V27, P81, DOI 10.1139/m81-013; Campos-Galvao MEM, 2015, GENET MOL RES, V14, P4068, DOI 10.4238/2015.April.27.22; Carroll CC, 2002, MUTAT RES-FUND MOL M, V501, P79, DOI 10.1016/S0027-5107(02)00018-0; Case RJ, 2008, ISME J, V2, P345, DOI 10.1038/ismej.2008.13; Chen YY, 2016, INT J FOOD MICROBIOL, V222, P16, DOI 10.1016/j.ijfoodmicro.2016.01.017; Chowdhary PK, 2007, BIOCHEMISTRY-US, V46, P14429, DOI 10.1021/bi701945j; Cickovski T, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1659-z; Danon A, 2002, TRENDS BIOCHEM SCI, V27, P197, DOI 10.1016/S0968-0004(02)02066-2; de Almeida FA, 2017, ARCH MICROBIOL, V199, P475, DOI 10.1007/s00203-016-1313-6; de Almeida FA, 2017, MICROB PATHOGENESIS, V102, P148, DOI 10.1016/j.micpath.2016.11.027; de Almeida FA, 2016, MICROB PATHOGENESIS, V99, P178, DOI 10.1016/j.micpath.2016.08.024; Di Cagno R, 2011, J PROTEOMICS, V74, P19, DOI 10.1016/j.jprot.2010.09.003; Dourou D, 2011, FOOD MICROBIOL, V28, P1011, DOI 10.1016/j.fm.2011.02.004; Dyszel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008946; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ferreira DF, 2011, CIENC AGROTEC, V35, P1039, DOI 10.1590/S1413-70542011000600001; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Garcia V, 2017, MICROB DRUG RESIST, V23, P405, DOI 10.1089/mdr.2016.0227; Garcia-Contreras R, 2015, ISME J, V9, P115, DOI 10.1038/ismej.2014.98; Ghiraldi-Lopes LD, 2017, FUTURE MICROBIOL, V12, P867, DOI 10.2217/fmb-2017-0023; Gomi K, 2006, INFECT IMMUN, V74, P7029, DOI 10.1128/IAI.00038-06; Goo E, 2012, P NATL ACAD SCI USA, V109, P19775, DOI 10.1073/pnas.1218092109; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; GUCKERT JB, 1986, APPL ENVIRON MICROB, V52, P794, DOI 10.1128/AEM.52.4.794-801.1986; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Hughes DT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000553; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; John J, 2016, BIOFOULING, V32, P1029, DOI 10.1080/08927014.2016.1221946; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Kafle P, 2016, J BIOL CHEM, V291, P11776, DOI 10.1074/jbc.M116.719351; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; Kaufmann GF, 2005, P NATL ACAD SCI USA, V102, P309, DOI 10.1073/pnas.0408639102; Kaur A, 2005, CURR SCI INDIA, V89, P1103; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim J, 2015, J MICROBIOL, V53, P421, DOI 10.1007/s12275-015-5273-3; Koschutzki D, 2008, GENE REGUL SYST BIO, V2, P193, DOI 10.4137/GRSB.S702; Kristiansen S, 2008, APMIS, V116, P361, DOI 10.1111/j.1600-0463.2008.00966.x; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lago M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02362-3; Landeta C, 2018, NAT MICROBIOL, V3, P270, DOI 10.1038/s41564-017-0106-2; LAW JH, 1963, BIOCHIM BIOPHYS ACTA, V70, P143, DOI 10.1016/0926-6542(63)90023-4; Lazazzera BA, 2000, CURR OPIN MICROBIOL, V3, P177, DOI 10.1016/S1369-5274(00)00072-2; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Liu YH, 2015, INFECT IMMUN, V83, P2897, DOI 10.1128/IAI.02882-14; Liu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109808; Lumjiaktase P, 2006, MICROBIOL-SGM, V152, P3651, DOI 10.1099/mic.0.29226-0; Majerczyk C, 2014, J BACTERIOL, V196, P1412, DOI 10.1128/JB.01405-13; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; Campos-Galvao MEM, 2016, J BASIC MICROB, V56, P493, DOI 10.1002/jobm.201500471; Michael B, 2001, J BACTERIOL, V183, P5733, DOI 10.1128/JB.183.19.5733-5742.2001; MICHAEL NP, 1994, FEMS MICROBIOL LETT, V124, P195, DOI 10.1111/j.1574-6968.1994.tb07284.x; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Miyamoto KN, 2015, J PROTEOMICS, V119, P230, DOI 10.1016/j.jprot.2015.02.006; Moreira CG, 2010, INFECT IMMUN, V78, P914, DOI 10.1128/IAI.01038-09; Nesse LL, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-44; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Nguyen Y, 2015, MBIO, V6, DOI 10.1128/mBio.02429-14; Pagan R, 2000, APPL ENVIRON MICROB, V66, P2829, DOI 10.1128/AEM.66.7.2829-2834.2000; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; Peters SE, 2010, INFECT IMMUN, V78, P326, DOI 10.1128/IAI.00768-09; Pietschke C, 2017, P NATL ACAD SCI USA, V114, pE8488, DOI 10.1073/pnas.1706879114; Poger D, 2015, J PHYS CHEM B, V119, P5487, DOI 10.1021/acs.jpcb.5b00958; Prajapat MK, 2018, BIOSYSTEMS, V165, P88, DOI 10.1016/j.biosystems.2018.01.004; Quecan BXV, 2018, BIOTECHNOLOGICAL APP, P397, DOI [10.1007/978-981-10-9026-4_19, DOI 10.1007/978-981-10-9026-4_19]; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Rau J, 2003, APPL ENVIRON MICROB, V69, P3448, DOI 10.1128/AEM.69.6.3448-3455.2003; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Reniere ML, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00128-18; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Rudyk O, 2014, REDOX BIOL, V2, P803, DOI 10.1016/j.redox.2014.06.005; Sabag-Daigle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047720; Sabag-Daigle A, 2012, APPL ENVIRON MICROB, V78, P5424, DOI 10.1128/AEM.00046-12; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00885; Shahrezaei V, 2015, CURR OPIN MICROBIOL, V25, P127, DOI 10.1016/j.mib.2015.05.012; Smith JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002826; Smith JL, 2004, J FOOD PROTECT, V67, P1053, DOI 10.4315/0362-028X-67.5.1053; Smith JN, 2003, J BACTERIOL, V185, P1357, DOI 10.1128/JB.185.4.1357-1366.2003; Soares JA, 2011, CURR OPIN MICROBIOL, V14, P188, DOI 10.1016/j.mib.2011.01.006; Song M, 2016, CELL REP, V14, P2901, DOI 10.1016/j.celrep.2016.02.066; Soni KA, 2008, FOODBORNE PATHOG DIS, V5, P147, DOI 10.1089/fpd.2007.0050; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; Tran TK, 2016, BBA-PROTEINS PROTEOM, V1864, P1686, DOI 10.1016/j.bbapap.2016.09.003; Tsuru S, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036015; Uroz S, 2005, MICROBIOL-SGM, V151, P3313, DOI 10.1099/mic.0.27961-0; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Walters M, 2006, INT J MED MICROBIOL, V296, P125, DOI 10.1016/j.ijmm.2006.01.041; Walters M, 2006, J BACTERIOL, V188, P5668, DOI 10.1128/JB.00648-06; WANG AY, 1994, MOL MICROBIOL, V11, P1009, DOI 10.1111/j.1365-2958.1994.tb00379.x; Wang HH, 2013, FOOD CONTROL, V32, P650, DOI 10.1016/j.foodcont.2013.01.047; Whiteway J, 1998, J BACTERIOL, V180, P5529, DOI 10.1128/JB.180.21.5529-5539.1998; Wongtrakoongate P, 2012, MICROBIOL IMMUNOL, V56, P281, DOI 10.1111/j.1348-0421.2012.00447.x; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	118	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204673	10.1371/journal.pone.0204673	http://dx.doi.org/10.1371/journal.pone.0204673			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304064	Green Published, Green Submitted, gold			2022-12-26	WOS:000446921100063
J	Schiffman, C; McHale, CM; Hubbard, AE; Zhang, LP; Thomas, R; Vermeulen, R; Li, GL; Shen, M; Rappaport, SM; Yin, SN; Lan, Q; Smith, MT; Rothman, N				Schiffman, Courtney; McHale, Cliona M.; Hubbard, Alan E.; Zhang, Luoping; Thomas, Reuben; Vermeulen, Roel; Li, Guilan; Shen, Min; Rappaport, Stephen M.; Yin, Songnian; Lan, Qing; Smith, Martyn T.; Rothman, Nathaniel			Identification of gene expression predictors of occupational benzene exposure	PLOS ONE			English	Article							PERIPHERAL-BLOOD TRANSCRIPTOME; NF-KAPPA-B; DNA METHYLATION; REACTIVE METABOLITE; NASAL SINUSES; MDL-1 CLEC5A; AQUAPORIN 9; NICKEL; LUNG; WORKERS	Background Previously, using microarrays and mRNA-Sequencing (mRNA-Seq) we found that occupational exposure to a range of benzene levels perturbed gene expression in peripheral blood mononuclear cells. Objectives In the current study, we sought to identify gene expression biomarkers predictive of benzene exposure below 1 part per million (ppm), the occupational standard in the U.S. Methods First, we used the nCounter platform to validate altered expression of 30 genes in 33 unexposed controls and 57 subjects exposed to benzene (<1 to >= 5 ppm). Second, we used SuperLearner (SL) to identify a minimal number of genes for which altered expression could predict <1 ppm benzene exposure, in 44 subjects with a mean air benzene level of 0.55 +/- 0.248 ppm (minimum 0.203ppm). Results nCounter and microarray expression levels were highly correlated (coefficients >0.7, p<0.05) for 26 microarray-selected genes. nCounter and mRNA-Seq levels were poorly correlated for 4 mRNA-Seq-selected genes. Using negative binomial regression with adjustment for covariates and multiple testing, we confirmed differential expression of 23 microarray-selected genes in the entire benzene-exposed group, and 27 genes in the <1 ppm-exposed subgroup, compared with the control group. Using SL, we identified 3 pairs of genes that could predict <1 ppm benzene exposure with cross-validated AUC estimates >0.9 (p<0.0001) and were not predictive of other exposures (nickel, arsenic, smoking, stress). The predictive gene pairs are PRG2/CLEC5A, NFKBI/CLEC5A, and ACSL1/CLEC5A. They play roles in innate immunity and inflammatory responses. Conclusions Using nCounter and SL, we validated the altered expression of multiple mRNAs by benzene and identified gene pairs predictive of exposure to benzene at levels below the US occupational standard of 1ppm.	[Schiffman, Courtney; McHale, Cliona M.; Hubbard, Alan E.; Zhang, Luoping; Thomas, Reuben; Rappaport, Stephen M.; Smith, Martyn T.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Vermeulen, Roel] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Li, Guilan; Yin, Songnian] Chinese Ctr Dis Control & Prevent, Inst Occupat Hlth & Poison Control, Beijing, Peoples R China; [Shen, Min; Lan, Qing; Rothman, Nathaniel] NCI, Occupat & Environm Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,DHHS, Bethesda, MD 20892 USA	University of California System; University of California Berkeley; Utrecht University; Chinese Center for Disease Control & Prevention; National Institute of Occupational Health & Poison Control, Chinese Center for Disease Control & Prevention; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	McHale, CM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	cmchale@berkeley.edu		Vermeulen, Roel/0000-0003-4082-8163; Zhang, Luoping/0000-0001-7866-8391; McHale, Cliona/0000-0002-8520-6117	NIH [R01ES06721, P42ES04705]; NIEHS grant [P42ES05948, P30ES10126]; US National Institutes of Health, National Cancer Institute; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS grant; US National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by NIH grants R01ES06721 and P42ES04705 (to M.T.S.), and NIEHS grants P42ES05948 and P30ES10126 (to S.M.R.) and the intramural research program of the US National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KR, 2014, J BIOL CHEM, V289, P17406, DOI 10.1074/jbc.R113.546218; Aoki N, 2009, J LEUKOCYTE BIOL, V85, P508, DOI 10.1189/jlb.0508329; Arita A, 2013, CANCER EPIDEM BIOMAR, V22, P261, DOI 10.1158/1055-9965.EPI-12-1011; ATSDR, 2007, TOX PROF BENZ; ATSDR (Agency of Toxic Substances and Disease Registry), 2005, TOX PROF NICK; Baglietto L, 2017, INT J CANCER, V140, P50, DOI 10.1002/ijc.30431; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breiman, 1999, 567 U CAL DEP STAT, P29; Carbrey JM, 2009, P NATL ACAD SCI USA, V106, P15956, DOI 10.1073/pnas.0908108106; Carugno M, 2012, ENVIRON HEALTH PERSP, V120, P210, DOI 10.1289/ehp.1103979; Chen F, 2001, MOL CELL BIOCHEM, V222, P159, DOI 10.1023/A:1017962113235; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Chen ST, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00356-3; Cheng YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32000; Cheung R, 2011, J CLIN INVEST, V121, P4446, DOI 10.1172/JCI57682; Cole SW, 2011, P NATL ACAD SCI USA, V108, P3080, DOI 10.1073/pnas.1014218108; DOLL R, 1977, BRIT J IND MED, V34, P102; DOLL R, 1970, BRIT J CANCER, V24, P623, DOI 10.1038/bjc.1970.76; Eastmond DA, 2014, MUTAT RES-REV MUTAT, V761, P40, DOI 10.1016/j.mrrev.2014.04.001; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Falkenberg Virginia R, 2011, BMC Res Notes, V4, P324, DOI 10.1186/1756-0500-4-324; Fei Dennis Liang, 2013, Environ Health, V12, P58, DOI 10.1186/1476-069X-12-58; Filippini T, 2015, J ENVIRON SCI HEAL C, V33, P36, DOI 10.1080/10590501.2015.1002999; Forrest MS, 2005, ENVIRON HEALTH PERSP, V113, P801, DOI 10.1289/ehp.7635; Gao X, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0148-3; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Gonzalez-Dominguez E, 2015, J LEUKOCYTE BIOL, V98, P453, DOI 10.1189/jlb.3HI1114-531R; Grimsrud TK, 2002, AM J EPIDEMIOL, V156, P1123, DOI 10.1093/aje/kwf165; Hastie T., 1986, STAT SCI, V1, P297; Hayes RB, 2001, AM J IND MED, V40, P117, DOI 10.1002/ajim.1078.abs; Hebeda CB, 2012, ARCH TOXICOL, V86, P1773, DOI 10.1007/s00204-012-0886-3; Heck JE, 2014, INT J HYG ENVIR HEAL, V217, P662, DOI 10.1016/j.ijheh.2013.12.003; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Huan T, 2016, HUM MOL GENET, V25, P4611, DOI 10.1093/hmg/ddw288; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; Ibuki Y, 2004, BBA-MOL BASIS DIS, V1690, P11, DOI 10.1016/j.bbadis.2004.04.005; Ihaka R, 1996, J COMP GRAPHICAL STA; Joehanes R, 2016, CIRC-CARDIOVASC GENE, V9, P436, DOI 10.1161/CIRCGENETICS.116.001506; Kanter JE, 2013, TRENDS ENDOCRIN MET, V24, P137, DOI 10.1016/j.tem.2012.10.002; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Kim E, 2005, IMMUNOL LETT, V99, P24, DOI 10.1016/j.imlet.2004.11.025; Kim S, 2006, CARCINOGENESIS, V27, P772, DOI 10.1093/carcin/bgi297; Lan Q, 2006, SCIENCE, V312, P998; Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443; Laveti Durgaprasad, 2013, Inflammation & Allergy Drug Targets, V12, P349; LeDell E., 2014, CVAUC CROSS VALIDATE; Lee JY, 2007, MOL CELLS, V23, P198; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Lovreglio P, 2014, MUTAT RES-GEN TOX EN, V770, P55, DOI 10.1016/j.mrgentox.2014.04.022; Lu HT, 2005, MOL CELL BIOCHEM, V279, P45, DOI 10.1007/s11010-005-8215-2; Masud Rizwan, 2012, J Clin Bioinforma, V2, P6, DOI 10.1186/2043-9113-2-6; Matsushima A, 2014, SHOCK, V42, P322, DOI 10.1097/SHK.0000000000000218; McHale CM, 2011, ENVIRON HEALTH PERSP, V119, P628, DOI 10.1289/ehp.1002546; Mesko B, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-15; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Moniaga CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15319; Moro AM, 2015, ENVIRON RES, V137, P349, DOI 10.1016/j.envres.2014.11.003; Munoz A, 2015, TOXICOL APPL PHARM, V284, P330, DOI 10.1016/j.taap.2015.02.025; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Occupational Safety and Health Administration, 1987, OCC EXP BENZ; Ovsepyan VA, 2017, B EXP BIOL MED+, V162, P650, DOI 10.1007/s10517-017-3679-0; Polley E, 2012, SUPERLEARNER SUPER L; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Richard AC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-649; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1; Schmidt M, 2011, J MOL MED, V89, P961, DOI 10.1007/s00109-011-0780-0; Schuliga M, 2015, BIOMOLECULES, V5, P1266, DOI 10.3390/biom5031266; Shen M, 2011, EXP MOL MED, V43, P374, DOI 10.3858/emm.2011.43.6.041; Shenker NS, 2013, EPIDEMIOLOGY, V24, P712, DOI 10.1097/EDE.0b013e31829d5cb3; Shinkai Y, 2009, TOXICOL APPL PHARM, V237, P232, DOI 10.1016/j.taap.2009.03.014; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Soragni A, 2015, MOL CELL, V57, P1011, DOI 10.1016/j.molcel.2015.01.026; Srinivasan M, 2015, EXPERT OPIN THER TAR, V19, P471, DOI 10.1517/14728222.2014.989834; Steinmaus C, 2008, OCCUP ENVIRON MED, V65, P371, DOI 10.1136/oem.2007.036913; Sun ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017490; Teixeira VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006803; Teng OIE, 2017, J VIROL, V91, DOI 10.1128/JVI.01813-16; Thomas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091828; Thomas R, 2013, ENVIRON MOL MUTAGEN, V54, P566, DOI 10.1002/em.21801; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309; van der Laan MJ, 2007, WORKING PAPER SERIES, V222; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Veldman-Jones MH, 2015, CLIN CANCER RES, V21, P2367, DOI 10.1158/1078-0432.CCR-14-0357; Vermeulen R, 2004, ANN OCCUP HYG, V48, P105, DOI 10.1093/annhyg/meh005; Vukmirovic M, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-016-0356-4; Waidyanatha S, 2001, CARCINOGENESIS, V22, P279, DOI 10.1093/carcin/22.2.279; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; Weisel CP, 2010, CHEM-BIOL INTERACT, V184, P58, DOI 10.1016/j.cbi.2009.12.030; Weng DY, 2016, MOL CARCINOGEN, V55, P1424, DOI 10.1002/mc.22385; Wortham BW, 2016, J IMMUNOL, V196, P3227, DOI 10.4049/jimmunol.1500978; Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090; Yoshino Y, 2011, TOXICOL APPL PHARM, V257, P198, DOI 10.1016/j.taap.2011.09.006; Zhou Yanfeng, 2014, PLoS One, V9, pe110466, DOI 10.1371/journal.pone.0110466	95	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205427	10.1371/journal.pone.0205427	http://dx.doi.org/10.1371/journal.pone.0205427			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300410	Green Published, Green Submitted, gold			2022-12-26	WOS:000446897200062
J	Banerjee, K; Paneerselvam, A; Ramachandran, P; Ganguly, D; Singh, G; Ramesh, R				Banerjee, Kakolee; Paneerselvam, A.; Ramachandran, Purvaja; Ganguly, Dipnarayan; Singh, Gurmeet; Ramesh, R.			Seagrass and macrophyte mediated CO2 and CH4 dynamics in shallow coastal waters	PLOS ONE			English	Article							DISSOLVED INORGANIC CARBON; METHANE EMISSION; ORGANIC-CARBON; POSIDONIA-OCEANICA; ATMOSPHERIC CO2; CHILIKA LAKE; GAS-EXCHANGE; ECOSYSTEMS; LAGOON; METABOLISM	Seagrass meadows are among the most important coastal/marine ecosystems for long-term carbon storage and conditioning of coastal waters. A combined air-water flux of CO2 and CH4 from the seagrass meadows was studied for the first time from Asia's largest brackish-water lagoon, Chilika, India. Ecosystem-based comparisons were carried out during two hydrologically different conditions of dry and wet seasons in the seagrass dominated southern sector (SS); macrophyte-dominated northern sector (NS); the largely un-vegetated central sector (CS) and the tidally active outer channel (OC) of the lagoon. The mean fluxes of CO2 from SS, NS, CS and OC were 9.8, 146.6, 48.4 and 33.0mM m(-2)d(-1), and that of CH4 were 0.12, 0.11, 0.05 and 0.07mM m(-2)d(-1), respectively. The net emissions (in terms of CO2 equivalents), considering the global warming potential of CO2 (GWP: 1) and CH4 (GWP: 28) from seagrass meadows were over 14 times lower compared to the macrophyte-dominated sector of the lagoon. Contrasting emissivity characteristics of CO2 and CH4 were observed between macrophytes and seagrass, with the former being a persistent source of CO2. It is inferred that although seagrass meadows act as a weak source of CH4, they could be effective sinks of CO2 if land-based pollution sources are minimized.	[Banerjee, Kakolee; Paneerselvam, A.; Ramachandran, Purvaja; Ganguly, Dipnarayan; Singh, Gurmeet; Ramesh, R.] Govt India, Minist Environm Forest & Climate Change, NCSCM, Anna Univ Campus, Madras, Tamil Nadu, India	Anna University; Ministry of Earth Sciences (MoES) - India; National Institute of Ocean Technology (NIOT)	Ramesh, R (corresponding author), Govt India, Minist Environm Forest & Climate Change, NCSCM, Anna Univ Campus, Madras, Tamil Nadu, India.	rramesh_au@yahoo.com	Ramachandran, Ramesh/B-4814-2018; Singh, Gurmeet/ABB-7636-2020; Ganguly, Dipnarayan/J-4191-2014; Ramachandran, Ramesh/AAI-1583-2020; Singh, Gurmeet/D-4052-2012	Ramachandran, Ramesh/0000-0003-2471-7746; Ganguly, Dipnarayan/0000-0003-0016-7145; Ramachandran, Ramesh/0000-0003-2471-7746; BANERJEE, KAKOLEE/0000-0002-1260-8369; Singh, Gurmeet/0000-0002-1641-5070				Abril G, 2005, ENVIRONM SCI, P187; Anilkumar R, 2012, ENV GEOCHEM, V15, P65; [Anonymous], 2007, CO2SYS XLS CALCULATO; Attermeyer K, 2016, SCI REP-UK, V6, DOI 10.1038/srep20424; Bange HW, 2010, BIOGEOSCIENCES, V7, P1279, DOI 10.5194/bg-7-1279-2010; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; BARTLETT KB, 1987, BIOGEOCHEMISTRY, V4, P183, DOI 10.1007/BF02187365; Bauer JE, 2013, NATURE, V504, P61, DOI 10.1038/nature12857; Bonthu S, 2016, ESTUAR COAST SHELF S, V183, P360, DOI 10.1016/j.ecss.2016.07.016; Borges AV, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023053; Borges AV, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000571; Borges AV, 2004, LIMNOL OCEANOGR, V49, P1630, DOI 10.4319/lo.2004.49.5.1630; Champenois W, 2012, LIMNOL OCEANOGR, V57, P347, DOI 10.4319/lo.2012.57.1.0347; Cole JJ, 1998, LIMNOL OCEANOGR, V43, P647, DOI 10.4319/lo.1998.43.4.0647; Cole JJ, 1999, ECOSYSTEMS, V2, P215, DOI 10.1007/s100219900069; D'Angelo EM, 1999, SOIL BIOL BIOCHEM, V31, P815, DOI 10.1016/S0038-0717(98)00181-3; Duarte CM, 2013, OCEAN COAST MANAGE, V83, P32, DOI 10.1016/j.ocecoaman.2011.09.001; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Ganguly D, 2017, AMBIO, V46, P667, DOI 10.1007/s13280-017-0916-8; Garcias-Bonet N, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00340; Geevarghese G.A., 2016, NAT C MAN CONS SEAGR; Geevarghese GA, 2018, OCEAN COAST MANAGE, V159, P16, DOI 10.1016/j.ocecoaman.2017.10.032; Ghosh AK, 2005, MANAGING LAKES THEIR; Govindasamy C., 2013, INT J BIODIVERS CONS, V5, P408, DOI DOI 10.5897/UBC12.132; GRAN G, 1952, ANALYST, V77, P661, DOI 10.1039/an9527700661; Grimsditch G, 2011, SUSTAINABLE DEV LAW, V11, P22; Gupta GVM, 2008, BIOGEOCHEMISTRY, V87, P265, DOI 10.1007/s10533-008-9183-x; Gupta GVM, 2009, ECOSYSTEMS, V12, P1145, DOI 10.1007/s10021-009-9280-2; Hendriks IE, 2014, BIOGEOSCIENCES, V11, P333, DOI 10.5194/bg-11-333-2014; Hendriks IE, 2008, MAR ECOL PROG SER, V356, P163, DOI 10.3354/meps07316; Ho DT, 2014, GEOPHYS RES LETT, V41, P108, DOI 10.1002/2013GL058785; Hofmann H, 2013, GEOPHYS RES LETT, V40, P2779, DOI 10.1002/grl.50453; Hope D, 1996, J ENVIRON QUAL, V25, P1442, DOI 10.2134/jeq1996.00472425002500060039x; Johnston L.D., 2016, SCIENCE, P1, DOI 10.1017/CBO9781107415324.004; Kadekodi GK, 2005, DIMENSIONS ENV ECOLO, P527; Kanuri VV, 2013, CONT SHELF RES, V61-62, P52, DOI 10.1016/j.csr.2013.04.006; Krause-Jensen D, 2016, NAT GEOSCI, V9, P737, DOI [10.1038/NGEO2790, 10.1038/ngeo2790]; Laanbroek HJ, 2010, ANN BOT-LONDON, V105, P141, DOI 10.1093/aob/mcp201; Lavery PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073748; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Lo Iacono C, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034773; McAuliffe C. G. C, 1971, CHEM TECHNOL, V1, P46; McEwing KR, 2015, PLANT SOIL, V388, P37, DOI 10.1007/s11104-014-2377-1; McKenzie L.J., 2003, SEAGRASS WATCH MANUA, Vsecond, P100; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; McMillan AMS, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000198; Middelburg JJ, 2002, BIOGEOCHEMISTRY, V59, P95, DOI 10.1023/A:1015515130419; Muduli PR, 2013, CONT SHELF RES, V64, P75, DOI 10.1016/j.csr.2013.05.014; Muduli PR, 2012, ESTUAR COAST SHELF S, V113, P305, DOI 10.1016/j.ecss.2012.08.020; Nazneen S, 2017, J EARTH SYST SCI, V126, DOI 10.1007/s12040-016-0785-8; Nellemann C, 2009, UN ENV PROGRAMME BLU; Panda S, 2008, ATLAS OF CHILKA, P133; Panigrahi S, 2009, LIMNOL, V10, P231; Patra S, 2017, CHEM ECOL, V33, P708, DOI 10.1080/02757540.2017.1356292; Patra S, 2016, LIMNOLOGY, V17, P223, DOI 10.1007/s10201-015-0475-2; Pattanaik AK, 2016, DISTRIBUTION ABUNDAN, V4; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Poffenbarger HJ, 2011, WETLANDS, V31, P831, DOI 10.1007/s13157-011-0197-0; Priyadarsini P.M., 2014, INT RES J ENV SCI, V3, P92; Purvaja R, 2004, GLOBAL CHANGE BIOL, V10, P1825, DOI 10.1111/j.1365-2486.2004.00834.x; Purvaja R, 2000, REG ENVIRON CHANGE, V1, P86, DOI 10.1007/PL00011537; Rao GD, 2016, ESTUAR COAST, V39, P1639, DOI 10.1007/s12237-016-0112-2; Raymond PA, 2000, LIMNOL OCEANOGR, V45, P1707, DOI 10.4319/lo.2000.45.8.1707; REDFIELD AC, 1958, AM SCI, V46, P205; Robin RS, 2016, GEOMICROBIOL J, V33, P513, DOI 10.1080/01490451.2015.1059525; Roehm CL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003297; Sahu BK, 2014, J COAST CONSERV, V18, P285, DOI 10.1007/s11852-014-0318-z; Sansone FJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P463, DOI 10.1029/1999GB900012; Sarma VVSS, 2013, BIOGEOSCIENCES, V10, P7035, DOI 10.5194/bg-10-7035-2013; Srichandan S, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4212-9; UNEP-WCMC, 2003, GLOB DISTR SEAGR VER; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x; van der Heide T, 2012, SCIENCE, V336, P1432, DOI 10.1126/science.1219973; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Yang Le, 2014, Acta Ecologica Sinica - International Journal, V34, P204, DOI 10.1016/j.chnaes.2013.05.011	76	16	17	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0203922	10.1371/journal.pone.0203922	http://dx.doi.org/10.1371/journal.pone.0203922			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296285	Green Published, Green Submitted, gold			2022-12-26	WOS:000446632700009
J	Whelan, AO; Flick-Smith, HC; Homan, J; Shen, ZT; Carpenter, Z; Khoshkenar, P; Abraham, A; Walker, NJ; Levitz, SM; Ostroff, GR; Oyston, PCF				Whelan, Adam O.; Flick-Smith, Helen C.; Homan, Jane; Shen, Zu T.; Carpenter, Zoe; Khoshkenar, Payam; Abraham, Ambily; Walker, Nicola J.; Levitz, Stuart M.; Ostroff, Gary R.; Oyston, Petra C. F.			Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; INNATE IMMUNE-RESPONSE; VIRULENT TYPE-A; FISCHER-344 RATS; PASTEURELLA-TULARENSIS; AEROSOL CHALLENGE; BETA-GLUCANS; F TULARENSIS; O-ANTIGEN; T-CELLS	Francisella tularensis is an intracellular pathogen causing the disease tularemia, and an organism of concern to biodefence. There is no licensed vaccine available. Subunit approaches have failed to induce protection, which requires both humoral and cellular immune memory responses, and have been hampered by a lack of understanding as to which antigens are immunoprotective. We undertook a preliminary in silico analysis to identify candidate protein antigens. These antigens were then recombinantly expressed and encapsulated into glucan particles (GPs), purified Saccharomyces cerevisiae cell walls composed primarily of beta-1,3-glucans. Immunological profiling in the mouse was used to down-selection to seven lead antigens: FTT1043 (Mip), IglC, FTT0814, FTT0438, FTT0071 (GltA), FTT0289, FTT0890 (PilA) prior to transitioning their evaluation to a Fischer 344 rat model for efficacy evaluation. F344 rats were vaccinated with the GP protein antigens co-delivered with GP-loaded with Francisella LPS. Measurement of cell mediated immune responses and computational epitope analysis allowed down-selection to three promising candidates: FTT0438, FTT1043 and FTT0814. Of these, a GP vaccine delivering Francisella LPS and the FTT0814 protein was able to induce protection in rats against an aerosol challenge of F. tularensis SchuS4, and reduced organ colonisation and clinical signs below that which immunisation with a GP-LPS alone vaccine provided. This is the first report of a protein supplementing protection induced by LPS in a Francisella vaccine. This paves the way for developing an effective, safe subunit vaccine for the prevention of inhalational tularemia, and validates the GP platform for vaccine delivery where complex immune responses are required for prevention of infections by intracellular pathogens.	[Whelan, Adam O.; Flick-Smith, Helen C.; Carpenter, Zoe; Walker, Nicola J.; Oyston, Petra C. F.] Dstl Porton Down, CBR Div, Salisbury, Wilts, England; [Homan, Jane] ioGenetics LLC, Madison, WI USA; [Shen, Zu T.; Khoshkenar, Payam; Abraham, Ambily; Levitz, Stuart M.; Ostroff, Gary R.] Univ Massachusetts, Sch Med, Worcester, MA USA	Defence Science & Technology Laboratory; University of Massachusetts System; University of Massachusetts Worcester	Whelan, AO (corresponding author), Dstl Porton Down, CBR Div, Salisbury, Wilts, England.	aowhelan@dstl.gov.uk		Homan, Jane/0000-0002-2685-8852	US Defence Threat Reduction Agency [HDTRA1-12-D-0003 0008]; ioGenetics LLC	US Defence Threat Reduction Agency; ioGenetics LLC	This work was funded by the US Defence Threat Reduction Agency under contract number HDTRA1-12-D-0003 0008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ioGenetics LLC provided support in the form of salaries for author JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Atianand MK, 2011, J BIOL CHEM, V286, P39033, DOI 10.1074/jbc.M111.244079; Barker JH, 2006, INFECT IMMUN, V74, P3277, DOI 10.1128/IAI.02011-05; BENACH JL, 1982, INFECT IMMUN, V35, P947, DOI 10.1128/IAI.35.3.947-951.1982; Bremel RD, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00541; Bremel RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070115; Bremel Robert D, 2010, Immunome Res, V6, P8, DOI 10.1186/1745-7580-6-8; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; BURKE DS, 1977, J INFECT DIS, V135, P55, DOI 10.1093/infdis/135.1.55; CARLSSON HE, 1979, J CLIN MICROBIOL, V10, P615, DOI 10.1128/JCM.10.5.615-621.1979; Chu P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004439; Cole GT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003768; Cole LE, 2006, J IMMUNOL, V176, P6888, DOI 10.4049/jimmunol.176.11.6888; Conlan JW, 2007, ANN NY ACAD SCI, V1105, P325, DOI 10.1196/annals.1409.012; Conlan JW, 2002, VACCINE, V20, P3465, DOI 10.1016/S0264-410X(02)00345-6; Cormier CY, 2010, NUCLEIC ACIDS RES, V38, pD743, DOI 10.1093/nar/gkp999; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dotson RJ, 2013, J BIOL CHEM, V288, P23844, DOI 10.1074/jbc.M113.490086; DOWNS CM, 1947, J IMMUNOL, V56, P229; DOWNS CM, 1955, J BACTERIOL, V70, P305, DOI 10.1128/JB.70.3.305-313.1955; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Eyles JE, 2007, PROTEOMICS, V7, P2172, DOI 10.1002/pmic.200600985; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Forestal CA, 2008, MICROB PATHOGENESIS, V44, P512, DOI 10.1016/j.micpath.2008.01.003; FOSHAY L, 1950, ANNU REV MICROBIOL, V4, P313, DOI 10.1146/annurev.mi.04.100150.001525; Foshay L, 1942, AM J PUBLIC HEALTH N, V32, P1131, DOI 10.2105/AJPH.32.10.1131; FULOP M, 1995, VACCINE, V13, P1220, DOI 10.1016/0264-410X(95)00062-6; Fulop M, 1996, FEMS IMMUNOL MED MIC, V13, P245, DOI 10.1111/j.1574-695X.1996.tb00245.x; Fulop M, 2001, VACCINE, V19, P4465, DOI 10.1016/S0264-410X(01)00189-X; Gavrilin M, 2011, FRONTIERS MICROBIOLO, V2; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; GOLOVLIOV I, 1995, VACCINE, V13, P261, DOI 10.1016/0264-410X(95)93311-V; Gunn JS, 2007, ANN N Y ACAD SCI, V1105; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Hariharan K, 1998, ADV DRUG DELIVER REV, V32, P187, DOI 10.1016/S0169-409X(98)00010-6; Hartley MG, 2004, INFECT IMMUN, V72, P4109, DOI 10.1128/IAI.72.7.4109-4113.2004; Hong F, 2004, J IMMUNOL, V173, P797, DOI 10.4049/jimmunol.173.2.797; Huang HB, 2010, MBIO, V1, DOI 10.1128/mBio.00164-10; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Huntley JF, 2008, INFECT IMMUN, V76, P3664, DOI 10.1128/IAI.00374-08; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; Hutt JA, 2017, AM J PATHOL, V187, P252, DOI 10.1016/j.ajpath.2016.09.021; JEMSKI JV, 1981, INFECT IMMUN, V34, P766, DOI 10.1128/IAI.34.3.766-772.1981; Jia QM, 2013, INFECT IMMUN, V81, P1550, DOI 10.1128/IAI.01013-12; Jia QM, 2009, VACCINE, V27, P1216, DOI 10.1016/j.vaccine.2008.12.014; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lyons CR, 2007, ANN NY ACAD SCI, V1105, P238, DOI 10.1196/annals.1409.003; Maisonneuve C, 2014, P NATL ACAD SCI USA, V111, P12294, DOI 10.1073/pnas.1400478111; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Mayers C, 2003, COMP FUNCT GENOM, V4, P468, DOI 10.1002/cfg.319; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; Meyer F, 2009, NUCLEIC ACIDS RES, V37, P6643, DOI 10.1093/nar/gkp698; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Prior JL, 2003, J MED MICROBIOL, V52, P845, DOI 10.1099/jmm.0.05184-0; Ray HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009952; Raymond CR, 2009, MICROB PATHOGENESIS, V46, P231, DOI 10.1016/j.micpath.2009.01.002; Roberts LM, 2016, J IMMUNOL, V197, P2738, DOI 10.4049/jimmunol.1600879; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SJOSTEDT A, 1992, INFECT IMMUN, V60, P2855; Soto ER, 2008, BIOCONJUGATE CHEM, V19, P840, DOI 10.1021/bc700329p; Specht CA, 2015, MBIO, V6, DOI 10.1128/mBio.01905-15; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; TADA N, 1974, J IMMUNOGENET, V1, P265; TARNVIK A, 1989, REV INFECT DIS, V11, P440; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Wu TH, 2009, VACCINE, V27, P4684, DOI 10.1016/j.vaccine.2009.05.060	69	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0200213	10.1371/journal.pone.0200213	http://dx.doi.org/10.1371/journal.pone.0200213			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296254	Green Published, gold, Green Submitted			2022-12-26	WOS:000446632700005
J	Giordani, C; Rivera-Gutierrez, H; Zhe, S; Micheletto, R				Giordani, Cristiano; Rivera-Gutierrez, Hector; Zhe, Sun; Micheletto, Ruggero			Simulation of the song motor pathway in birds: A single neuron initiates a chain of events that produces birdsong with realistic spectra properties	PLOS ONE			English	Article							MODEL; NUCLEUS	Birdsong is a complex learned behavior regulated by Neuromuscular coordination of different muscle sets necessary for producing relevant sounds. We developed a heterogeneous and stochastically connected neural network representing the pathway from the high vocal center (HVC) to the robust nucleus of the arcopallium (RA) neurons that drive the muscles to generate sounds. We show that a single active neuron is sufficient to initiate a chain of spiking events that results to excite the entire network system. The network could synthesize realistic bird sounds spectra, with spontaneous generation of intermittent sound bursts typical of birdsong (song syllables). This study confirms experiments on animals and on humans, where results have shown that single neurons are responsible for the activation of complex behavior or are associated with high-level perception events.	[Giordani, Cristiano] Univ Antioquia, Inst Fis, Calle 70 52-21, Medellin, Colombia; [Rivera-Gutierrez, Hector] Univ Antioquia, Inst Biol, Calle 70 52-21, Medellin, Colombia; [Zhe, Sun] RIKEN, Head Off Informat Syst & Cybersecur, Computat Engn Applicat Unit, 2-1 Hirosawa, Wako, Saitama, Japan; [Zhe, Sun] Riken, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama, Japan; [Zhe, Sun; Micheletto, Ruggero] Yokohama City Univ, 22-2 Seto, Yokohama, Kanagawa, Japan	Universidad de Antioquia; Universidad de Antioquia; RIKEN; RIKEN; Yokohama City University	Micheletto, R (corresponding author), Yokohama City Univ, 22-2 Seto, Yokohama, Kanagawa, Japan.	ruggero@yokohama-cu.ac.jp	; Rivera-Gutierrez, Hector Fabio/C-8587-2011	zhe, sun/0000-0002-6531-0769; Micheletto, Ruggero/0000-0003-1707-6493; Rivera-Gutierrez, Hector Fabio/0000-0001-6025-3470; Giordani, Cristiano/0000-0001-5432-8085	Sabbatical research fund of Yokohama City University; University of Antioquia (CODI, UdeA, Medellin, Colombia) [IN641CE, Act 8700-3278]	Sabbatical research fund of Yokohama City University; University of Antioquia (CODI, UdeA, Medellin, Colombia)	This work has been partially funded by the Sabbatical research fund of Yokohama City University, 2015-2016 and by Committee for Research Development from University of Antioquia (CODI, UdeA, Medellin, Colombia) through grant n. IN641CE (Act 8700-3278, May 28, 2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel HDI, 2004, J NEUROPHYSIOL, V92, P96, DOI 10.1152/jn.01146.2003; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Catchpole CK, 2000, ADV STUD BEHAV, V29, P45, DOI 10.1016/S0065-3454(08)60103-5; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Gardner T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.208101; Gaunt AS, 1988, SOUND PRODUCTION BIR; Hahnloser RHR, 2003, NATURE, V421, P294, DOI 10.1038/nature01221; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2010, PHILOS T R SOC A, V368, P5061, DOI 10.1098/rsta.2010.0130; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Jin DZ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051902; Laje R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051921; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Nottebohm F, 2005, PLOS BIOL, V3, P759, DOI 10.1371/journal.pbio.0030164; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; NOWICKI S, 1988, MUSIC PERCEPT, V5, P391; Nowicki S, 1997, ENCY ACOUSTICS, P1813; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Podos J, 2009, ADV STUDY BEHAV, V40; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Spiro JE, 1999, J NEUROPHYSIOL, V81, P3007, DOI 10.1152/jn.1999.81.6.3007; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sugase-Miyamoto Y, 2014, J NEUROSCI, V34, P12457, DOI 10.1523/JNEUROSCI.0485-14.2014; Voigt BC, 2008, J NEUROSCI, V28, P12362, DOI 10.1523/JNEUROSCI.3046-08.2008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A	33	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0200998	10.1371/journal.pone.0200998	http://dx.doi.org/10.1371/journal.pone.0200998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289918	gold, Green Published, Green Submitted			2022-12-26	WOS:000446545500003
J	Otsuka, K; Takehara, A; Chiba, N; Matsui, Y				Otsuka, Kei; Takehara, Asuka; Chiba, Natsuko; Matsui, Yasuhisa			Identification of KLF9 and BCL3 as transcription factors that enhance reprogramming of primordial germ cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; IN-VITRO; CYCLIN D1; DERIVATION; CULTURE; MICE; PROLIFERATION; INDUCTION; GROWTH; P52	Primordial germ cells (PGCs) are precursors of eggs and sperm. Although PGCs are unipotent cells in vivo, they are reprogrammed into pluripotent stem cells (PSCs), also known as embryonic germ cells (EGCs), in the presence of leukemia inhibitory factor and basic fibro-blast growth factor (bFGF) in vitro. However, the molecular mechanisms responsible for their reprogramming are not fully understood. Here we show identification of transcription factors that mediate PGC reprogramming. We selected genes encoding transcription factors or epigenetic regulatory factors whose expression was significantly different between PGCs and PSCs with in silico analysis and RT-qPCR. Among the candidate genes, over-expression (OE) of Bcl3 or Klf9 significantly enhanced PGC reprogramming. Notably, EGC formation was stimulated by Klf9-OE even without bFGF. G-protein-coupled receptor signaling-related pathways, which are involved in PGC reprogramming, were enriched among genes down-regulated by Klf9-OE, and forskolin which activate adenylate cyclase, rescued repressed EGC formation by knock-down of Klf9, suggesting a molecular linkage between KLF9 and such signaling.	[Otsuka, Kei; Takehara, Asuka; Matsui, Yasuhisa] Tohoku Univ, IDAC, Cell Resource Ctr Biomed Res, Sendai, Miyagi, Japan; [Otsuka, Kei; Chiba, Natsuko] Tohoku Univ, Dept Canc Biol, Inst Dev Aging & Canc, Sendai, Miyagi, Japan; [Takehara, Asuka; Matsui, Yasuhisa] Japan Agcy Med Res & Dev Core Res Evolut Sci & Te, Chuo Ku, Tokyo, Japan; [Chiba, Natsuko; Matsui, Yasuhisa] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan; [Matsui, Yasuhisa] Tohoku Univ, Ctr Regulatory Epigenome & Dis, Sch Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Matsui, Y (corresponding author), Tohoku Univ, IDAC, Cell Resource Ctr Biomed Res, Sendai, Miyagi, Japan.; Matsui, Y (corresponding author), Japan Agcy Med Res & Dev Core Res Evolut Sci & Te, Chuo Ku, Tokyo, Japan.; Matsui, Y (corresponding author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan.; Matsui, Y (corresponding author), Tohoku Univ, Ctr Regulatory Epigenome & Dis, Sch Med, Sendai, Miyagi, Japan.	yasuhisa.matsui.d3@tohoku.ac.jp		Matsui, Yasuhisa/0000-0001-7026-6355	Ministry of Education, Culture, Sports, Science and Technology of Japan [25114003]; AMED-CREST from the Japan Agency for Medical Research and Development [JP17gm0510017h]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED-CREST from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was funded by a Grant-in-Aid for Scientific Research (KAKENHI) in the Innovative Areas, "Mechanisms regulating gamete formation in animals" (grant #25114003) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, http://www.jsps.go.jp/english/index.html, and AMED-CREST (grant #JP17gm0510017h) from the Japan Agency for Medical Research and Development, https://www.amed.go.jp/en/index.html.	Chen CY, 2015, STEM CELLS, V33, P3468, DOI 10.1002/stem.2201; Cook MS, 2011, DEVELOPMENT, V138, P23, DOI 10.1242/dev.057000; DEFELICI M, 1993, DEV BIOL, V157, P277, DOI 10.1006/dbio.1993.1132; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Gu W, 2018, BIOL OPEN, V7, DOI 10.1242/bio.032318; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Imamura M, 2010, MOL REPROD DEV, V77, P802, DOI 10.1002/mrd.21223; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; Koshimizu U, 1996, DEVELOPMENT, V122, P1235; Leitch HG, 2013, STEM CELL REP, V1, P66, DOI 10.1016/j.stemcr.2013.03.004; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Maeda I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2780; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Matsui Y, 2014, DEVELOPMENT, V141, P4457, DOI 10.1242/dev.113779; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nagamatsu G, 2015, STEM CELL REP, V5, P111, DOI 10.1016/j.stemcr.2015.05.007; Nagamatsu G, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096792; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Ohta H, 2017, EMBO J, V36, P1888, DOI 10.15252/embj.201695862; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; STEVENS LC, 1973, J NATL CANCER I, V50, P235, DOI 10.1093/jnci/50.1.235; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka T, 2015, J REPROD DEVELOP, V61, P473, DOI 10.1262/jrd.2015-059; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; Westerheide SD, 2001, MOL CELL BIOL, V21, P8428, DOI 10.1128/MCB.21.24.8428-8436.2001; Yoshimizu T, 1991, DEV GROWTH DIFFER, V4, P675; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595	36	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205004	10.1371/journal.pone.0205004	http://dx.doi.org/10.1371/journal.pone.0205004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286177	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500074
J	Peng, YF				Peng, YuFeng			B cell responses to apoptotic cells in MFG-E8-/- mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; OXIDATION-SPECIFIC EPITOPES; MARGINAL ZONE; OXIDIZED LDL; MFG-E8-DEFICIENT MICE; GERMINAL-CENTERS; IMPAIRED UPTAKE; RECEPTOR; MACROPHAGES; TOLERANCE	Defective clearance of apoptotic cells in MFG-E8 deficient mice results in lupus-like disease in the mixed B6x129, but not pure B6 background. The lack of overt autoimmunity in MFGE8-/- B6 mice suggests that accumulation of apoptotic cells is not sufficient to break central tolerance. However, the delayed clearance of apoptotic cells in the follicles of MFG-E8-/- B6 mice provides an excellent opportunity to investigate how B cells respond to excessive apoptotic cells in the periphery under relatively non-inflammatory conditions. In MFG-E8-/- B6 mice, we found increased IgG2c production against apoptotic cells and oxidized LDL. Apoptotic cell induced antibody responses depended on MyD88 signal and T cell help. In addition, MFG-E8-/- B6 mice had enlarged MZ B cell compartments as well as an enhanced antibody response to NP-Ficoll. Moreover, a significant percentage of MZ B cells in aged MFG-E8-/- B6 mice migrated into follicles. Injecting apoptotic cells or oxidized LDL into wild type mice as well as physiological accumulation of LDL in ApoE-/- mice recapitulated the translocation of MZ B cells. To determine how MFG-E8 deficiency affects the functions of autoreactive B cells specific for nucleic acids in the periphery under non-inflammatory conditions, we utilized BCR transgenic mice to bypass central selection and compared the differentiation of TLR9 dependent anti-dsDNA 56R B cells and TLR7 dependent anti-ssRNA H564 B cells in MFG-E8-/- mice. In MFG-E8-/- 56R mice, anti-dsDNA specific 56RNK38c B cells differentiated into MZ B cells but not AFCs. On the contrary, in MFG-E8-/-H564 mice, anti-ssRNA specific H564 B cells further differentiated into GC B cells and AFCs. Adoptive transfer of activated autoreactive B cells confirmed that H564 B cells were more sensitive to apoptotic cell antigens than 56R B cells. Our observations provide new insights about the MZ B cell translocation in lupus patients as well as the dichotomy of TLR9 and TLR7 signals in the pathogenesis of lupus.	[Peng, YuFeng] Univ Washington, Dept Med, Div Rheumatol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Peng, YF (corresponding author), Univ Washington, Dept Med, Div Rheumatol, Seattle, WA 98195 USA.	yfpeng2014@gmail.com	peng, yu/GXW-2071-2022		Lupus Research Institute	Lupus Research Institute	This work was funded by the Lupus Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Biggiogera M, 1998, J HISTOCHEM CYTOCHEM, V46, P999, DOI 10.1177/002215549804600903; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Chikazawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068468; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Dammers PM, 2000, J IMMUNOL, V165, P6156, DOI 10.4049/jimmunol.165.11.6156; Dammers PM, 2005, EUR J IMMUNOL, V35, P2089, DOI 10.1002/eji.200526118; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Gatto D, 2004, J IMMUNOL, V173, P4308, DOI 10.4049/jimmunol.173.7.4308; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; Grasset EK, 2015, P NATL ACAD SCI USA, V112, pE2030, DOI 10.1073/pnas.1421227112; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; ISHIBASHI S, 1994, P NATL ACAD SCI USA, V91, P4431, DOI 10.1073/pnas.91.10.4431; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; Kishi Y, 2012, P NATL ACAD SCI USA, V109, P7811, DOI 10.1073/pnas.1204509109; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Li H, 2015, J CLIN INVEST, V125, P2877, DOI 10.1172/JCI81059; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; Miyanishi M, 2012, INT IMMUNOL, V24, P551, DOI 10.1093/intimm/dxs064; Nundel K, 2015, J IMMUNOL, V194, P2504, DOI 10.4049/jimmunol.1402425; Peng YF, 2011, J CLIN INVEST, V121, P2221, DOI 10.1172/JCI43254; Pewzner-Jung Y, 1998, J IMMUNOL, V161, P4634; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Qian Y, 2004, J IMMUNOL, V172, P625, DOI 10.4049/jimmunol.172.1.625; Richardson C, 2013, J IMMUNOL, V191, P4926, DOI 10.4049/jimmunol.1202263; Rubtsov AV, 2008, J IMMUNOL, V180, P3882, DOI 10.4049/jimmunol.180.6.3882; Sekiguchi DR, 2006, J IMMUNOL, V176, P6879, DOI 10.4049/jimmunol.176.11.6879; Shao WH, 2010, J AUTOIMMUN, V35, P368, DOI 10.1016/j.jaut.2010.08.001; Soni C, 2014, J IMMUNOL, V193, P4400, DOI 10.4049/jimmunol.1401720; Stoehr AD, 2011, J IMMUNOL, V187, P2953, DOI 10.4049/jimmunol.1003340; Tsao PY, 2008, J IMMUNOL, V181, P7770, DOI 10.4049/jimmunol.181.11.7770; Wermeling F, 2007, J EXP MED, V204, P2259, DOI 10.1084/jem.20070600; Wermeling F, 2010, J EXP MED, V207, P943, DOI 10.1084/jem.20091314; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205172	10.1371/journal.pone.0205172	http://dx.doi.org/10.1371/journal.pone.0205172			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286201	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500094
J	Talavera-Velasco, B; Luceno-Moreno, L; Garcia, JM; Vazquez-Estevez, D				Talavera-Velasco, Beatriz; Luceno-Moreno, Lourdes; Martin Garcia, Jesus; Vazquez-Estevez, Daniel			DECORE-21: Assessment of occupational stress in police. Confirmatory factor analysis of the original model	PLOS ONE			English	Article							OFFICERS; BURNOUT	There is scarce research on stress in Spanish police officers and on the use of instruments to assess this construct in this professional group. In Spain, the DECORE questionnaire has been one of the most used. Nevertheless, it had not been previously applied to police officers. The aim of this study was to analyze both the construct validity and the reliability of the original model of 44 items. A cross-sectional design and a non-probabilistic quota sampling were used. A total of 223 Spanish police officers participated. 202 police personnel were men (90.6%) and 21 were women (9.4%). The average age was 41 years old (SD = 7.52). These police officers answered the DECORE questionnaire. Confirmatory Factor Analysis was carried out. The results showed an unsatisfactory adjustment using the original model of 44 items. A final solution of 21 items and four factors was formulated with both suitable validity and reliability indexes. In this model, 23 items that did not weigh highly in any of the four factors were removed. The DECORE-21 questionnaire is recommended to assess work-related stress in police officers.	[Talavera-Velasco, Beatriz; Luceno-Moreno, Lourdes; Martin Garcia, Jesus; Vazquez-Estevez, Daniel] Univ Complutense Madrid, Fac Psychol, Dept Social Org & Differential Psychol, Madrid, Spain	Complutense University of Madrid	Talavera-Velasco, B (corresponding author), Univ Complutense Madrid, Fac Psychol, Dept Social Org & Differential Psychol, Madrid, Spain.	beatriztalavera@ucm.es		Talavera Velasco, Beatriz/0000-0003-4662-1999; Vazquez, Daniel/0000-0003-0178-9114				AERA, 2014, STAND ED PSYCH TEST; Alvarez CJ, 2014, SPAN J PSYCHOL, V17, DOI 10.1017/sjp.2014.58; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Chalmers RP, 2012, J STAT SOFTW, V48, P1; de la Fuente EI, 2013, INT J CLIN HLTH PSYC, V13, P216, DOI 10.1016/S1697-2600(13)70026-7; Duxbury L, 2015, CRIM JUSTICE BEHAV, V42, P361, DOI 10.1177/0093854814551017; European Commission, 2010, WORK REL STRESS GUID; Fernandez CJ, 2014, STRATEGIC MANAGEMENT; Garbarino S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002791; Garcia-Albuerne Y, 2015, ANXIETY STRESS, V21, P57; Gerber M, 2013, J OCCUP HEALTH, V55, P376, DOI 10.1539/joh.13-0030-OA; Gu Guizhen, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P924; Houdmont J., 2010, CONT OCCUPATIONAL HL; IBM Corp, 2013, IBM SPSS STAT WINDOW; Karasek R., 1985, JOB CONTENT QUESTION; Kivimaki M, 2013, CAN MED ASSOC J, V185, P763, DOI 10.1503/cmaj.121735; Korre M, 2014, POLIC-J POLICY PRACT, V8, P109, DOI 10.1093/police/pau001; Lang J, 2012, SOC SCI MED, V75, P1163, DOI 10.1016/j.socscimed.2012.04.015; Lloret-Segura S, 2014, AN PSICOL-SPAIN, V30, P1151, DOI 10.6018/analesps.30.3.199361; Luceno-Moreno L, 2008, DECORE QUESTIONNAIRE; Luceuo L., 2010, ANSIEDAD ESTRES, V16, P237; Maran DA, 2015, OCCUP MED-OXFORD, V65, P466, DOI 10.1093/occmed/kqv060; McCreary D.R., 2006, INT J STRESS MANAGE, V13, P494, DOI [10.1037/1072-5245.13.4.494, DOI 10.1037/1072-5245.13.4.494]; McDonald RP, 1999, TEST THEORY UNIFIED; Moreno-Jimenez B, 2010, PSYCHOSOCIAL RISK FA; National Institute of Health and Safety NIHS, 1997, 2 NAT SURV WORK COND; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; Page KS, 2011, PSYCHOL SERV, V8, P12, DOI 10.1037/a0021796; Park HI, 2014, APPL PSYCHOL-INT REV, V63, P607, DOI 10.1111/apps.12008; Patil RR, 2014, INT J OCCUP MED ENV, V27, P523, DOI 10.2478/s13382-014-0285-5; R Core Team, 2016, R FDN STAT COMP; Racine JS, 2012, J APPL ECONOMET, V27, P167, DOI 10.1002/jae.1278; Revelle W, 2009, PSYCHOMETRIKA, V74, P145, DOI 10.1007/s11336-008-9102-z; Sanchez-Teruel D, 2014, J WORK ORGAN PSYCHOL, V30, P75, DOI [10.1016/j.rpto.2014.06.003, DOI 10.1016/J.RPTO.2014.06.003]; Siegrist J, 1998, THEORIES OF ORGANIZATIONAL STRESS, P190; Taris TW, 2010, J OCCUP ORGAN PSYCH, V83, P455, DOI 10.1348/096317909X424583; Vagg P R, 1999, J Occup Health Psychol, V4, P288, DOI 10.1037/1076-8998.4.3.288; van der Velden PG, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001720; Vilardell Molas Jordi, 2014, Med Clin (Barc), V142 Suppl 2, P30, DOI 10.1016/S0025-7753(14)70069-7; Violanti John M, 2011, Int J Emerg Ment Health, V13, P209	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205028	10.1371/journal.pone.0205028	http://dx.doi.org/10.1371/journal.pone.0205028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286155	Green Submitted, gold, Green Published			2022-12-26	WOS:000446383500079
J	Weiberg, D; Basic, M; Smoczek, M; Bode, U; Bornemann, M; Buettner, M				Weiberg, Desiree; Basic, Marijana; Smoczek, Margarethe; Bode, Ulrike; Bornemann, Melanie; Buettner, Manuela			Participation of the spleen in the IgA immune response in the gut	PLOS ONE			English	Article							INTESTINAL DENDRITIC CELLS; SPLENIC MARGINAL ZONE; T-CELLS; LYMPH-NODE; B-CELLS; B1B CELLS; RAT; HYPOSPLENISM; MEMORY; BLOOD	The role of the spleen in the induction of an immune response to orally administered antigens is still under discussion. Although it is well known that after oral antigen administration specific germinal centres are not only formed in the Peyers patches (PP) and the mesenteric lymph nodes (mLN) but also in the spleen, there is still a lack of functional data showing a direct involvement of splenic B cells in an IgA immune response in the gut. In addition, after removal of mLN a high level of IgA+ B cells was observed in the gut. Therefore, in this study we analysed the role of the spleen in the induction of IgA+ B cells in the gut after mice were orally challenged with antigens. Here we have shown that antigen specific splenic IgM+ B cells after in vitro antigen stimulation as well as oral immunisation of donor mice were able to migrate into the gut of recipient mice, where they predominantly switch to IgA+ plasma cells. Furthermore, stimulation of recipient mice by orally administered antigens enhanced the migration of the splenic B cells into the gut as well as their switch to IgA+ plasma cells. Removal of the mLN led to a higher activation level of the splenic B cells. Altogether, our results imply that splenic IgM+ B cells migrate in the intestinal lamina propria, where they differentiate into IgA+ plasma cells and subsequently proliferate. In conclusion, we demonstrated that the spleen plays a major role in the gut immune response serving as a reservoir of immune cells that migrate to the site of antigen entrance.	[Weiberg, Desiree; Bode, Ulrike; Bornemann, Melanie; Buettner, Manuela] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Weiberg, Desiree] Hannover Med Sch, Dept Nucl Med, Hannover, Germany; [Basic, Marijana; Smoczek, Margarethe; Buettner, Manuela] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Buettner, M (corresponding author), Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany.; Buettner, M (corresponding author), Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany.	Buettner.Manuela@MH-Hannover.de			German Research Foundation [SFB621/A10]	German Research Foundation(German Research Foundation (DFG))	The work was supported by German Research Foundation SFB621/A10; http://www.dfg.de/en/; UB recieved the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrendt M, 2008, J IMMUNOL, V181, P1898, DOI 10.4049/jimmunol.181.3.1898; Altamura M, 2001, IMMUNOPHARM IMMUNOT, V23, P153, DOI 10.1081/IPH-100103856; Awaad A, 2016, ACTA HISTOCHEM, V118, P596, DOI 10.1016/j.acthis.2016.06.005; Bode U, 1999, EUR J IMMUNOL, V29, P1487, DOI 10.1002/(SICI)1521-4141(199905)29:05<1487::AID-IMMU1487>3.0.CO;2-1; Bode U, 2001, EUR J IMMUNOL, V31, P2116, DOI 10.1002/1521-4141(200107)31:7<2116::AID-IMMU2116>3.0.CO;2-Q; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Buettner M, 2013, SCAND J IMMUNOL, V77, P238, DOI 10.1111/sji.12034; Crivellato E, 2004, TRENDS IMMUNOL, V25, P210, DOI 10.1016/j.it.2004.02.008; Di Sabatino A, 2007, J ALLERGY CLIN IMMUN, V120, P1461, DOI 10.1016/j.jaci.2007.07.054; Di Sabatino A, 2011, LANCET, V378, P86, DOI 10.1016/S0140-6736(10)61493-6; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Hahn A, 2010, IMMUNOLOGY, V129, P427, DOI 10.1111/j.1365-2567.2009.03197.x; Howe SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086656; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Jiang JQ, 2008, J VIROL, V82, P6812, DOI 10.1128/JVI.00450-08; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Lee DJ, 2013, J IMMUNOL, V191, P4103, DOI 10.4049/jimmunol.1300182; Liu LM, 1998, J IMMUNOL, V161, P1146; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lopes-Carvalho T, 2004, IMMUNOL REV, V197, P192, DOI 10.1111/j.0105-2896.2004.0112.x; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1034/j.1600-065X.2000.017515.x; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mebius RE, 2004, CRIT REV IMMUNOL, V24, P449, DOI 10.1615/CritRevImmunol.v24.i6.40; Mora JR, 2008, MUCOSAL IMMUNOL, V1, P96, DOI 10.1038/mi.2007.14; MULLER AF, 1995, GUT, V36, P165, DOI 10.1136/gut.36.2.165; Munyaka P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109272; Pabst O, 2004, J EXP MED, V199, P411, DOI 10.1084/jem.20030996; Pabst R, 1999, CLIN EXP IMMUNOL, V117, P423; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Pritchett-Corning KR, 2014, J AM ASSOC LAB ANIM, V53, P633; Quesenberry PJ, 1999, ANN NY ACAD SCI, V872, P40, DOI 10.1111/j.1749-6632.1999.tb08451.x; Rescigno M, 2010, ADV IMMUNOL, V107, P109, DOI 10.1016/B978-0-12-381300-8.00004-6; ROTHKOTTER HJ, 1993, CLIN EXP IMMUNOL, V92, P317; Sallusto F, 2004, CURR OPIN IMMUNOL, V16, P724, DOI 10.1016/j.coi.2004.09.012; Schulz O, 2013, TRENDS IMMUNOL, V34, P155, DOI 10.1016/j.it.2012.09.006; Spencer J, 2009, MUCOSAL IMMUNOL, V2, P380, DOI 10.1038/mi.2009.91; Svensson M, 2008, MUCOSAL IMMUNOL, V1, P38, DOI 10.1038/mi.2007.4; Svensson Marcus, 2006, Expert Rev Clin Immunol, V2, P759, DOI 10.1586/1744666X.2.5.759; Veninga H, 2015, EUR J IMMUNOL, V45, P747, DOI 10.1002/eji.201444983; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Wade WF, 2014, PATHOG DIS, V70, P153, DOI 10.1111/2049-632X.12085; Westermann J, 1996, EUR J IMMUNOL, V26, P1866, DOI 10.1002/eji.1830260830; William BM, 2007, HEMATOLOGY, V12, P89, DOI 10.1080/10245330600938463; William BM, 2007, HEMATOLOGY, V12, P1, DOI 10.1080/10245330600938422; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Yang LL, 2011, BLOOD, V118, P3039, DOI 10.1182/blood-2011-04-349746; Yang ZT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145807; Zandvoort A, 2002, CLIN EXP IMMUNOL, V130, P4, DOI 10.1046/j.1365-2249.2002.01953.x	53	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205247	10.1371/journal.pone.0205247	http://dx.doi.org/10.1371/journal.pone.0205247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286198	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500102
J	Jones, KA; Luo, Y; Dukes-Rimsky, L; Srivastava, DP; Koul-Tewari, R; Russell, TA; Shapiro, LP; Srivastava, AK; Penzes, P				Jones, Kelly A.; Luo, Yue; Dukes-Rimsky, Lynn; Srivastava, Deepak P.; Koul-Tewari, Richa; Russell, Theron A.; Shapiro, Lauren P.; Srivastava, Anand K.; Penzes, Peter			Neurodevelopmental disorder-associated ZBTB20 gene variants affect dendritic and synaptic structure	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; INTELLECTUAL DISABILITY; MENTAL-RETARDATION; NEURON DEVELOPMENT; PRIMROSE SYNDROME; MUTATIONS; PLASTICITY; HIPPOCAMPUS; MECHANISMS; ISOFORMS	Dendritic spine morphology and dendritic arborization are key determinants of neuronal connectivity and play critical roles in learning, memory and behavior function. Recently, defects of ZBTB20, a BTB and zinc finger domain containing transcriptional repressor, have been implicated in a wide range of neurodevelopmental disorders, including intellectual disability and autism. Here we show distinct effects of expression of two major isoforms, long and short, of ZBTB20, and its neurodevelopmental disorder-linked variants, on dendritic architecture of cultured rat cortical pyramidal neurons. The N-terminal of ZBTB20 showed a role in regulating dendritic spine morphology. Two ZBTB20 single nucleotide variants, located at the N-terminal and central regions of the protein and potentially conferring autism risk, altered dendritic spine morphology. In contrast, a single nucleotide variant identified in patients with intellectual disability and located at the C-terminus of ZBTB20 affected dendritic arborization and dendritic length but had no effect on dendritic spine morphology. Furthermore, truncation of the extreme C-terminus of ZBTB20 caused spine and dendritic morphological changes that were similar but distinct from those caused by the C-terminal variant. Taken together, our study suggests ZBTB20's role in dendritic and synaptic structure and provide possible mechanisms of its effect in neurodevelopmental disorders.	[Jones, Kelly A.; Srivastava, Deepak P.; Russell, Theron A.; Shapiro, Lauren P.; Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Luo, Yue; Dukes-Rimsky, Lynn; Koul-Tewari, Richa; Srivastava, Anand K.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Koul-Tewari, Richa; Srivastava, Anand K.] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA; [Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Greenwood Genetic Center; Clemson University; Northwestern University; Feinberg School of Medicine	Penzes, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.; Srivastava, AK (corresponding author), Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA.; Srivastava, AK (corresponding author), Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA.; Penzes, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA.	anand@ggc.org; p-penzes@northwestern.edu			National Institute of Child Health and Human Development [R01-HD039331]; Brain & Behavior Research Foundation; National Institute of Mental Health [R01MH107182-04]; National Institutes of Health [1F31MH085362]; MRC [MR/L021064/1, MR/N026063/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD039331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097216] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Brain & Behavior Research Foundation(NARSAD); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by grants from the National Institute of Child Health and Human Development (https://www.nichd.nih.gov/) (R01-HD039331) to A.K.S., the Brain & Behavior Research Foundation (formerly the National Alliance for Research on Schizophrenia and Depression; https://www.bbrfoundation.org/) and the National Institute of Mental Health (https://www.nimh.nih.gov/index.shtml) (R01MH107182-04) to P.P., and the National Institutes of Health (https://www.nih.gov/) (1F31MH085362) to K.A.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bhalla K, 2008, AM J HUM GENET, V83, P703, DOI 10.1016/j.ajhg.2008.10.020; Casertano A, 2017, AM J MED GENET A; Chen JL, 2010, CURR OPIN NEUROBIOL, V20, P557, DOI 10.1016/j.conb.2010.06.002; Cordeddu V, 2014, NAT GENET, V46, P815, DOI 10.1038/ng.3035; Dukes-Rimsky L, 2018, EUR J HUM GENET; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kim TA, 2005, J CELL SCI, V118, P5537, DOI 10.1242/jcs.02643; Koul R, 2013, AM SOC HUM GEN ANN M; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Li WJ, 2004, NEURON, V43, P823, DOI 10.1016/j.neuron.2004.08.040; Mattioli F, 2016, AM J MED GENET A, V170, P1626, DOI 10.1002/ajmg.a.37645; Mitchelmore C, 2002, J BIOL CHEM, V277, P7598, DOI 10.1074/jbc.M110023200; Nielsen JV, 2007, DEVELOPMENT, V134, P1133, DOI 10.1242/dev.000265; Nielsen JV, 2014, CEREB CORTEX, V24, P1216, DOI 10.1093/cercor/bhs400; Nielsen JV, 2010, CEREB CORTEX, V20, P1904, DOI 10.1093/cercor/bhp261; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Rasmussen MB, 2014, J MED GENET, V51, P605, DOI 10.1136/jmedgenet-2014-102535; Spletter ML, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-14; Tsai NP, 2012, CELL, V151, P1581, DOI 10.1016/j.cell.2012.11.040; Vaillend C, 2008, BEHAV BRAIN RES, V192, P88, DOI 10.1016/j.bbr.2008.01.009; Valnegri P, 2012, ADV EXP MED BIOL, V970, P433, DOI 10.1007/978-3-7091-0932-8_19; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; West AE, 2011, COLD SPRING HARB PER, V3; Xie ZF, 2010, P NATL ACAD SCI USA, V107, P6510, DOI 10.1073/pnas.0912315107; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Zhang WP, 2001, BIOCHEM BIOPH RES CO, V282, P1067, DOI 10.1006/bbrc.2001.4689; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203760	10.1371/journal.pone.0203760	http://dx.doi.org/10.1371/journal.pone.0203760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281617	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400028
J	Qiu, LL; Wang, C; Yao, S; Li, N; Hu, YH; Yu, YQ; Xia, R; Zhu, JS; Ji, MH; Zhang, Z; Wang, SL				Qiu, Liang-Lin; Wang, Chao; Yao, Shen; Li, Na; Hu, Yuhuan; Yu, Yongquan; Xia, Rong; Zhu, Jiansheng; Ji, Minghui; Zhang, Zhan; Wang, Shou-Lin			Fenvalerate induces oxidative hepatic lesions through an overload of intracellular calcium triggered by the ERK/IKK/NF-B pathway	FASEB JOURNAL			English	Article						pyrethroid pesticides; liver injury; reactive oxygen species; calcium signal pathway	HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAY; INDUCED APOPTOSIS; MAPK ACTIVATION; LIVER-INJURY; STRESS; EXPOSURE; MITOCHONDRIA; DAMAGE; INDUCTION	Fenvalerate (FEN), a mainstream pyrethroid pesticide, was initially recommended as a low-toxicity agent for controlling agricultural and domestic pests. Despite the widespread use of FEN worldwide, little data are available on FEN-induced hepatic lesions and molecular mechanisms. In the present study, we first performed an occupational cross-sectional study on FEN factory workers and found that the levels of serum alanine aminotransferase (ALT) and total antioxidant capacity increased, whereas malondialdehyde decreased in laborers in the working areas where the levels of airborne FEN were much higher compared with the office area. The results were then confirmed by animal experiments that abnormal hepatic histology, increased ALT level, and compromised hepatic oxidative capability were observed in rats exposed to a high concentration of FEN. Furthermore, the bioinformatics analysis of gene microarray in rat liver tissue showed that FEN significantly changed the expressions of genes related to the regulation of intracellular calcium ion homeostasis and the calcium signal pathway. Finally, the functional experiments in Buffalo rat liver (BRL) cells demonstrated that FEN first activated ERK MAPK, followed by IKK and NF-B, which triggered the transcription of genes responsible for accelerating an overload of intracellular calcium ions, prompted reactive oxygen species generation in the mitochondria, and finally, induced hepatic cellular apoptosis. The calcium signaling pathway and in particular, an overload of intracellular calcium play a critical role in this pathophysiological process via the ERK/IKK/NF-B pathway. Our study furthers the understanding of the mechanism of FEN-induced hepatic injuries and may have implications in the prevention and control of liver diseases induced by environmental pesticides.Qiu, L.-L., Wang, C., Yao, S., Li, N., Hu, Y., Yu, Y., Xia, R., Zhu, J., Ji, M., Zhang, Z., Wang S.-L. Fenvalerate induces oxidative hepatic lesions through an overload of intracellular calcium triggered by the ERK/IKK/NF-B pathway.	[Qiu, Liang-Lin; Wang, Chao; Yao, Shen; Li, Na; Hu, Yuhuan; Yu, Yongquan; Xia, Rong; Zhu, Jiansheng; Ji, Minghui; Zhang, Zhan; Wang, Shou-Lin] Nanjing Med Univ, Minist Educ, Sch Publ Hlth, Key Lab Modern Toxicol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China; [Wang, Chao; Hu, Yuhuan; Yu, Yongquan; Zhu, Jiansheng; Zhang, Zhan; Wang, Shou-Lin] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Qiu, Liang-Lin] Nantong Univ, Sch Publ Hlth, Nantong, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nantong University	Wang, SL (corresponding author), Nanjing Med Univ, Minist Educ, Sch Publ Hlth, Key Lab Modern Toxicol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.	wangshl@njmu.edu.cn	Zhang, Zhan/AAR-6278-2020	Zhang, Zhan/0000-0002-9685-5753	National Natural Science Foundation of China [81573194, 91743205, 81372956]; National 973 Program of China [2009CB941701]; Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP) [PPZY2015A067]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants from the National Natural Science Foundation of China (81573194, 91743205, and 81372956), National 973 Program of China (2009CB941701), Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP; PPZY2015A067), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The authors declare no conflicts of interest.	Anadon A, 2013, TOXICOL LETT, V220, P135, DOI 10.1016/j.toxlet.2013.04.015; Aouey B, 2017, ENVIRON SCI POLLUT R, V24, P5841, DOI 10.1007/s11356-016-8323-4; Atkinson L, 2002, NATURE, V420, P42, DOI 10.1038/420042a; Bhattacharyya S, 2012, FREE RADICAL RES, V46, P1296, DOI 10.3109/10715762.2012.712690; BLOCKI FA, 1992, NATURE, V360, P269, DOI 10.1038/360269a0; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; Cave M, 2010, ENVIRON HEALTH PERSP, V118, P1735, DOI 10.1289/ehp.1002720; Chaabane M, 2017, HUM EXP TOXICOL, V36, P854, DOI 10.1177/0960327116672911; Chien JM, 2013, ENVIRON TOXICOL PHAR, V35, P178, DOI 10.1016/j.etap.2012.12.007; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Du XF, 2013, CELL, V154, P118, DOI 10.1016/j.cell.2013.05.059; Du XL, 2017, J CELL PHYSIOL, V232, P3296, DOI 10.1002/jcp.25773; Espino J, 2011, J PINEAL RES, V51, P195, DOI 10.1111/j.1600-079X.2011.00876.x; Ghasemi-Niri SF, 2016, WORLD J GASTROENTERO, V22, P4999, DOI 10.3748/wjg.v22.i21.4999; Ghosh J, 2010, FREE RADICAL BIO MED, V49, P1779, DOI 10.1016/j.freeradbiomed.2010.09.011; Giray B, 2011, HUM EXP TOXICOL, V30, P1575, DOI 10.1177/0960327110393762; Han D, 2013, TRENDS PHARMACOL SCI, V34, P243, DOI 10.1016/j.tips.2013.01.009; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Lieven CJ, 2003, ANTIOXID REDOX SIGN, V5, P641, DOI 10.1089/152308603770310310; Medina J, 2005, DRUGS, V65, P2445, DOI 10.2165/00003495-200565170-00003; Miao YL, 2018, FASEB J, V32, P1328, DOI 10.1096/fj.201700908R; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Pizzutti IR, 2009, J CHROMATOGR A, V1216, P3305, DOI 10.1016/j.chroma.2009.01.088; Prasanthi K, 2005, FOOD CHEM TOXICOL, V43, P299, DOI 10.1016/j.fct.2004.10.005; Ramesh A, 2004, J ANAL TOXICOL, V28, P660, DOI 10.1093/jat/28.8.660; Richardson JR, 2015, FASEB J, V29, P1960, DOI 10.1096/fj.14-260901; Rodrigues ACM, 2015, ENVIRON POLLUT, V207, P273, DOI 10.1016/j.envpol.2015.09.035; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Tan LF, 2006, CONTRACEPTION, V73, P92, DOI 10.1016/j.contraception.2005.06.067; Tao GZ, 2013, J BIOL CHEM, V288, P17214, DOI 10.1074/jbc.M112.445965; Toledo FD, 2014, ARCH TOXICOL, V88, P1695, DOI 10.1007/s00204-014-1219-5; Tomlin C. D. S., 2006, PEST MAN 14 ED, P691; Tos-Luty S, 2001, ANN AGR ENV MED, V8, P245; Wang B, 2017, TOXICOL SCI, V157, P377, DOI 10.1093/toxsci/kfx052; Wang JC, 2014, BIOL TRACE ELEM RES, V161, P180, DOI 10.1007/s12011-014-0105-6; Wang J, 2009, TOXICOLOGY, V259, P122, DOI 10.1016/j.tox.2009.02.011; Wang WL, 2015, CANCER LETT, V358, P47, DOI 10.1016/j.canlet.2014.12.025; Wang X, 2013, CARCINOGENESIS, V34, P1323, DOI 10.1093/carcin/bgt058; Wu WS, 2008, CANCER METAST REV, V27, P303, DOI 10.1007/s10555-008-9112-4; Xing L, 2016, ELIFE, V5, DOI 10.7554/elite.11123; Zavodnik IB, 2013, LIFE SCI, V92, P1110, DOI 10.1016/j.lfs.2013.04.009; Zepeda-Arce R, 2017, ENVIRON TOXICOL, V32, P1754, DOI 10.1002/tox.22398; Zhang LS, 2017, ENVIRON POLLUT, V220, P843, DOI 10.1016/j.envpol.2016.10.067; Zhang Z, 2013, ARCH TOXICOL, V87, P1557, DOI 10.1007/s00204-013-1059-8; Zhao XF, 2011, ARCH TOXICOL, V85, P1101, DOI 10.1007/s00204-011-0654-9; Zhong L, 2018, FASEB J, V32, P4070, DOI 10.1096/fj.201701536R	50	8	8	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2782	2795		10.1096/fj.201801289R	http://dx.doi.org/10.1096/fj.201801289R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307764				2022-12-26	WOS:000457296600100
J	Schernberg, A; Mezquita, L; Boros, A; Botticella, A; Caramella, C; Besse, B; Escande, A; Planchard, D; Le Pechoux, C; Deutsch, E				Schernberg, Antoine; Mezquita, Laura; Boros, Angela; Botticella, Angela; Caramella, Caroline; Besse, Benjamin; Escande, Alexandre; Planchard, David; Le Pechoux, Cecile; Deutsch, Eric			Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer	PLOS ONE			English	Article							PRETREATMENT LEUKOCYTOSIS; CERVICAL-CANCER; POOR-PROGNOSIS; TUMOR; CELLS; METASTASIS; SURVIVAL; INFLAMMATION; ASSOCIATION; CARCINOMA	Objective To study the prognostic value of baseline leukocytosis or neutrophiliain two retrospective cohorts of stage III Non-Small Cell Lung Cancer (NSCLC) patients. Materials and methods Clinical records of consecutive previously untreated NSCLC patients in our Institution between June 2001 and September 2016 for stage III NSCLC were collected. The prognostic value of pretreatment leucocyte disorders was examined, with focus on patterns of relapse and survival. Leukocytosis and neutrophilia were defined as a leukocyte count or a neutrophil count exceeding 10 and 7 G/L, respectively. Results We identified 238 patients, displaying baseline leukocytosis or neutrophilia in 39% and 40% respectively. Most were diagnosed with adenocarcinoma (48%), and stage IIIB NSCLC (58%). 3-year actuarial overall survival (OS) and progression-free survival (PFS) were 35% and 27% respectively. Local relapses were reported in 100 patients (42%), and distant metastases in 132 patients (55%). In multivariate analysis, leukocytosis, neutrophilia, and induction chemotherapy regimen based on carboplatin/paclitaxel were associated with worse OS and PFS (p<0.05). Neutrophilia independently decreased Locoregional Control (LRC) (HR = 2.5, p<0.001) and Distant Metastasis Control (DMC) (HR = 2.1, p<0.001). Neutrophilia was significantly associated with worse brain metastasis control (p = 0.004), mostly in adenocarcinoma patients (p<0.001). Conclusion In stage III NSCLC patients, treated with concurrent cisplatin-based chemoradiation, baseline leukocytosis and neutrophilia were associated with worse OS, PFS, LRC, and DMC. In addition with previously available markers, this independent cost-effective biomarker could help to stratify stage III NSCLC population with more accuracy.	[Schernberg, Antoine; Boros, Angela; Botticella, Angela; Escande, Alexandre; Le Pechoux, Cecile; Deutsch, Eric] Radiat Oncol Dept, Gustave Roussy Canc Campus, Villejuif, France; [Schernberg, Antoine; Deutsch, Eric] INSERM 1030, Gustave Roussy Canc Campus, Villejuif, France; [Mezquita, Laura; Besse, Benjamin; Planchard, David] Univ Paris Saclay, Dept Med Oncol, Gustave Roussy, Villejuif, France; [Caramella, Caroline; Deutsch, Eric] Univ Paris Saclay, Dept Radiol, Gustave Roussy, Villejuif, France; [Besse, Benjamin; Deutsch, Eric] Univ Paris Sud, Univ Paris Saclay, Fac Med Kremlin Bicetre, Le Kremlin Bicetre, France	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Deutsch, E (corresponding author), Radiat Oncol Dept, Gustave Roussy Canc Campus, Villejuif, France.; Deutsch, E (corresponding author), INSERM 1030, Gustave Roussy Canc Campus, Villejuif, France.; Deutsch, E (corresponding author), Univ Paris Saclay, Dept Radiol, Gustave Roussy, Villejuif, France.; Deutsch, E (corresponding author), Univ Paris Sud, Univ Paris Saclay, Fac Med Kremlin Bicetre, Le Kremlin Bicetre, France.	eric.deutsch@gustaveroussy.fr	Boros, Angela/ABA-9648-2020; MEZQUITA, LAURA/AAH-8859-2020; Besse, Benjamin/V-1523-2019	MEZQUITA, LAURA/0000-0003-0936-7338; Besse, Benjamin/0000-0001-5090-8189; Boros, Angela/0000-0001-6077-7610				Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Banerjee R, 2013, DIS COLON RECTUM, V56, P1036, DOI 10.1097/DCR.0b013e31829ab0d4; Carvalho S, 2016, RADIOTHER ONCOL, V119, P487, DOI 10.1016/j.radonc.2016.04.024; Chen MH, 2009, J CANCER RES CLIN, V135, P1783, DOI 10.1007/s00432-009-0625-1; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Ding N, 2016, SCI REP-UK, V6, DOI 10.1038/srep34823; Erpenbeck L, 2017, ONCOGENE, V36, P2483, DOI 10.1038/onc.2016.406; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Garcia-Arias A, 2007, INT J GYNECOL CANCER, V17, P465, DOI 10.1111/j.1525-1438.2007.00816.x; Gros A, 2012, CLIN CANCER RES, V18, P5212, DOI 10.1158/1078-0432.CCR-12-1108; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Kargl J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14381; Kasuga I, 2001, CANCER-AM CANCER SOC, V92, P2399, DOI 10.1002/1097-0142(20011101)92:9<2399::AID-CNCR1588>3.0.CO;2-W; Kim K, 2014, P NATL ACAD SCI USA, V111, P11774, DOI 10.1073/pnas.1410626111; Koh YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep38585; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Liang W, 2016, CANCER IMMUNOL RES, V4, P83, DOI 10.1158/2326-6066.CIR-15-0313; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Mabuchi S, 2011, GYNECOL ONCOL, V122, P25, DOI 10.1016/j.ygyno.2011.03.037; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001; PAESMANS M, 1995, J CLIN ONCOL, V13, P1221, DOI 10.1200/JCO.1995.13.5.1221; Powell DR, 2016, TRENDS IMMUNOL, V37, P41, DOI 10.1016/j.it.2015.11.008; Rennard SI, 2015, AM J RESP CRIT CARE, V191, P1001, DOI 10.1164/rccm.201405-0992OC; Schalper KA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju435; Spiegel A, 2016, CANCER DISCOV, V6, P630, DOI 10.1158/2159-8290.CD-15-1157; Takeshima T, 2016, P NATL ACAD SCI USA, V113, P11300, DOI 10.1073/pnas.1613187113; Tomita M, 2009, ANTICANCER RES, V29, P2687; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Wilcox RA, 2010, MAYO CLIN PROC, V85, P656, DOI 10.4065/mcp.2010.0077	34	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204490	10.1371/journal.pone.0204490	http://dx.doi.org/10.1371/journal.pone.0204490			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304046	Green Published, Green Submitted, gold			2022-12-26	WOS:000446921100049
J	Sosa-Jurado, F; Melendez-Mena, D; Rosas-Murrieta, NH; Guzman-Flores, B; Mendoza-Torres, MA; Barcenas-Villalobos, R; Marquez-Dominguez, L; Cortes-Hernandez, P; Reyes-Leyva, J; Vallejo-Ruiz, V; Santos-Lopez, G				Sosa-Jurado, Francisca; Melendez-Mena, Daniel; Rosas-Murrieta, Nora H.; Guzman-Flores, Belinda; Mendoza-Torres, Miguel A.; Barcenas-Villalobos, Roberto; Marquez-Dominguez, Luis; Cortes-Hernandez, Paulina; Reyes-Leyva, Julio; Vallejo-Ruiz, Veronica; Santos-Lopez, Gerardo			Effectiveness of PCR primers for the detection of occult hepatitis B virus infection in Mexican patients	PLOS ONE			English	Article							HBV INFECTION; MUTATIONS; ANTIGEN; MUTANTS; IMPACT; DNA	Background Occult hepatitis B infection (OBI) is defined as the presence of hepatitis B virus (HVB) DNA in the liver of HBsAg negative individuals with or without detectable viral DNA in serum. OBI is a diagnostic challenge as it is characterized by a very low viral load, intermittently detectable through time. Individuals with OBI can develop chronic hepatic disease, including liver cirrhosis and hepatocellular carcinoma. The aim of this work was to produce tools to improve OBI detection of the HVB genotypes prevalent in Mexico. Methods We designed and tested primers to detect OBI in serum samples by nested and real-time PCR. Conserved sites in the viral genome were determined by alignment of the most frequent HBV genotypes in Mexico (H, G/H, F and D) and primers spanning the entire viral genome were designed for first round and nested PCR. Primers were tested in serum samples of 45 patients not co-infected with hepatitis C virus or with HIV, out of a group of 116 HBsAg (-)/anti-HBc (+) individuals. Primers were also tested in a control group with chronic HBV. Nested PCR products obtained from HBsAg (-)/anti-HBc (+) were sequenced and used to design primers for real-time PCR (SYBR Green). Results The most effective primer pairs to detect HBV products by nested PCR targeted ORF regions: PreS(2)/P, S/P, X/PreC, and C; while by real-time PCR they targeted ORF regions PreS(2)/P, S/P, X, and C. Out of the 45 HBsAg (-)/anti-HBc (+) patients tested, the viral genome was detected in 28 (62.2%) and 34 (75.5%), with nPCR and real time PCR respectively. Conclusion Primers designed for real-time PCR detected up to 75.5% of suspected OBI Mexican patients, with or without liver disease, which represents an improvement from previous PCR strategies.	[Sosa-Jurado, Francisca; Barcenas-Villalobos, Roberto; Marquez-Dominguez, Luis; Reyes-Leyva, Julio; Vallejo-Ruiz, Veronica; Santos-Lopez, Gerardo] Inst Mexicano Seguro Social, Lab Biol Mol & Virol, Ctr Invest Biomed Oriente, Metepec, Puebla, Mexico; [Melendez-Mena, Daniel; Mendoza-Torres, Miguel A.] Inst Mexicano Seguro Social, Unidad Med Alta Especialidad, Serv Gastroenterol, Ctr Med Nacl Gen Div Manuel Avila Camacho, Puebla, Puebla, Mexico; [Rosas-Murrieta, Nora H.] Benemerita Univ Autonoma Puebla, Ctr Quim, Inst Ciencias, Puebla, Puebla, Mexico; [Guzman-Flores, Belinda] Inst Mexicano Seguro Social, Ctr Med Nacl Gen Div Manuel Avila Camacho, Unidad Med Alta Especialidad, Banco Sangre, Puebla, Puebla, Mexico; [Cortes-Hernandez, Paulina] Inst Mexicano Seguro Social, Lab Biol Celular, Ctr Invest Biomed Oriente, Metepec, Puebla, Mexico	Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Benemerita Universidad Autonoma de Puebla; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social	Sosa-Jurado, F (corresponding author), Inst Mexicano Seguro Social, Lab Biol Mol & Virol, Ctr Invest Biomed Oriente, Metepec, Puebla, Mexico.	sosajurado@hotmail.com	Santos-López, Gerardo/AAD-6991-2019; Vallejo, Veronica/AAH-6739-2020; Cortes-Hernandez, Paulina/ABC-1133-2020; MARQUEZ, LUIS/AAO-1791-2021; Santos-López, Gerardo/M-2122-2014; Cortes-Hernandez, Paulina/GLQ-5915-2022	Cortes-Hernandez, Paulina/0000-0001-8226-1703; MARQUEZ, LUIS/0000-0002-2346-7389; Santos-López, Gerardo/0000-0002-3793-3117; Vallejo-Ruiz, Veronica/0000-0001-7884-1406; Reyes-Leyva, Julio/0000-0001-9415-6011; Rosas-Murrieta, Nora-Hilda/0000-0002-4605-670X	Consejo Nacional de Ciencia y Tecnologia, Mexico [CONACYT-SALUD-2011-1-1-161867, FIS/IMSS/PROT/1038]; Fundacion IMSS A.C., Mexico	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion IMSS A.C., Mexico	This work was funded by grant CONACYT-SALUD-2011-1-1-161867 (FIS/IMSS/PROT/1038) awarded to FSJ by Consejo Nacional de Ciencia y Tecnologia, Mexico (www.conacyt.gob.mx). JRRL has a research fellowship from Fundacion IMSS A.C., Mexico (www.fundacionimss.org.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de la Fuente RA, 2011, WORLD J GASTROENTERO, V17, P1543, DOI [10.3748/wjg.v17.i12.1543, 10.3748/wjg.v17.i12. 1543]; [Anonymous], GUIDELINES ON HEPATI; Chang MH, 2014, RECENT RESULTS CANC, V193, P75, DOI 10.1007/978-3-642-38965-8_5; de Almeida RW, 2017, MEM I OSWALDO CRUZ, V112, P485, DOI 10.1590/0074-02760160477; Echevarria JM, 2008, J MED VIROL, V80, P598, DOI 10.1002/jmv.21146; El Chaar M, 2010, HEPATOLOGY, V52, P1600, DOI 10.1002/hep.23886; Escobedo-Melendez G, 2014, MEM I OSWALDO CRUZ, V109, P728, DOI 10.1590/0074-0276140058; Gachara G, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0136-0; Han ZG, 2015, CLIN CHIM ACTA, V438, P266, DOI 10.1016/j.cca.2014.09.007; Hassan ZK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-90; Kim H, 2015, INT J MOL SCI, V16, P13595, DOI 10.3390/ijms160613595; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054486; Kim MH, 2017, YONSEI MED J, V58, P557, DOI 10.3349/ymj.2017.58.3.557; Krawczyk A, 2014, J CLIN VIROL, V59, P44, DOI 10.1016/j.jcv.2013.10.009; Lou SC, 2011, J CLIN VIROL, V51, P59, DOI 10.1016/j.jcv.2011.01.019; Malve B, 2017, VIRUS RES, V238, P141, DOI 10.1016/j.virusres.2017.06.028; Garcia-Montalvo BM, 2011, ANN HEPATOL, V10, P133; Jaramillo CM, 2015, REV CHIL INFECTOL, V32, P190, DOI 10.4067/S0716-10182015000300008; Minosse C, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.28751; Owczarzy R, 2008, NUCLEIC ACIDS RES, V36, pW163, DOI 10.1093/nar/gkn198; Raimondo G, 2010, PATHOL BIOL, V58, P254, DOI 10.1016/j.patbio.2010.02.003; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Raimondo G, 2008, J HEPATOL, V48, P743, DOI 10.1016/j.jhep.2008.01.023; Roman S, 2010, J MED VIROL, V82, P1527, DOI 10.1002/jmv.21846; SANYAL D, 1991, J MED MICROBIOL, V35, P291, DOI 10.1099/00222615-35-5-291; Schreiner S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050125; Seeger C, 2015, VIROLOGY, V479, P672, DOI 10.1016/j.virol.2015.02.031; Sosa-Jurado F, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.36942; Squadrito G, 2014, ANN GASTROENTEROL, V27, P15; Taha SE, 2013, EGYPT J MED HUM GENE, V14, P353; Alvarez-Munoz MT, 2014, WORLD J GASTROENTERO, V20, P13530, DOI 10.3748/wjg.v20.i37.13530; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Zhu HL, 2016, WORLD J GASTROENTERO, V22, P3531, DOI 10.3748/wjg.v22.i13.3531	33	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205356	10.1371/journal.pone.0205356	http://dx.doi.org/10.1371/journal.pone.0205356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304056	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100083
J	Webster, A; Chintala, SK; Kim, J; Ngan, M; Itakura, T; Panjwani, N; Argueso, P; Barr, JT; Jeong, S; Fini, ME				Webster, Andrew; Chintala, Shravan K.; Kim, Jasmine; Ngan, Michelle; Itakura, Tatsuo; Panjwani, Noorjahan; Argueso, Pablo; Barr, Joseph T.; Jeong, Shinwu; Fini, M. Elizabeth			Dynasore protects the ocular surface against damaging stress	PLOS ONE			English	Article							HUMAN CORNEAL-LIMBAL; CELLULAR MECHANISMS; GENE-EXPRESSION; DYNAMIN; FLUORESCEIN; ACTIVATION; INHIBITORS; FISSION; PATHWAY; TOOLS	Water soluble "vital" dyes are commonly used clinically to evaluate health of the ocular surface; however, staining mechanisms remain poorly understood. Recent evidence suggests that sublethal damage stimulates vital dye uptake by individual living cells. Since cell damage can also stimulate reparative plasma membrane remodeling, we hypothesized that dye uptake occurs via endocytic vesicles. In support of this idea, we show here that application of oxidative stress to relatively undifferentiated monolayer cultures of human corneal epithelial cells stimulates both dye uptake and endocytosis, and that dye uptake is blocked by co-treatment with three different endocytosis inhibitors. Stress application to stratified and differentiated corneal epithelial cell cultures, which are a better model of the ocular surface, also stimulated dye uptake; however, endocytosis was notstimulated, and two of the endocytosis inhibitors did not block dye uptake. The exception was Dynasore and its more potent analogue Dyngo-4a, both small molecules developed to target dynamin family GTPases, but also having off-target effects on the plasma membrane. Significantly, while Dynasore blocked stress-stimulated dye uptake at the ocular surface of ex vivo mouse eyes when treatment was performed at the same time as eyes were stressed, it had no effect when used afterstress was applied and the ocular surface was already damaged. Thus, Dynasore could not be working by inhibiting endocytosis. Employing cytotoxicity and western blotting assays, we went on to demonstrate an alternative mechanism. We show that Dynasore is remarkably protective of cells and their surface glycocalyx, preventing damage due to stress, and thus precluding dye entry. These unexpected and novel findings provide greater insight into the mechanisms of vital dye uptake and point the direction for future study. Significantly, they also suggest that Dynasore and its analogues might be used therapeutically to protect the ocular surface and to treat ocular surface disease.	[Webster, Andrew; Chintala, Shravan K.; Itakura, Tatsuo; Fini, M. Elizabeth] Univ Southern Calif, Keck Sch Med USC, USC Inst Genet Med, Los Angeles, CA 90007 USA; [Kim, Jasmine] Univ Southern Calif, Program Biol Sci USC Dana & David Dornsife Coll L, Los Angeles, CA USA; [Ngan, Michelle] Univ Southern Calif, Keck Sch Med USC, Program Prevent Med, Los Angeles, CA USA; [Panjwani, Noorjahan] Tufts Univ, Sch Med, Dept Ophthalmol, New England Eye Ctr, Boston, MA 02111 USA; [Panjwani, Noorjahan] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Argueso, Pablo] Harvard Med Sch, Dept Ophthalmol, Schepens Eye Res Inst Massachusetts Eye & Ear, Boston, MA USA; [Barr, Joseph T.] Ohio State Univ, Coll Optometry, Columbus, OH 43210 USA; [Jeong, Shinwu] Univ Southern Calif, Keck Sch Med USC, USC Inst Genet Med, Los Angeles, CA USA; [Jeong, Shinwu] Univ Southern Calif, Keck Sch Med USC, USC Roski Eye Inst, Dept Ophthalmol, Los Angeles, CA USA; [Fini, M. Elizabeth] Tufts Univ, Sch Med, Tufts Med Ctr, Boston, MA 02111 USA	University of Southern California; University of Southern California; University of Southern California; Tufts University; Tufts University; Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; University of Southern California; University of Southern California; Tufts Medical Center; Tufts University	Fini, ME (corresponding author), Univ Southern Calif, Keck Sch Med USC, USC Inst Genet Med, Los Angeles, CA 90007 USA.; Fini, ME (corresponding author), Tufts Univ, Sch Med, Tufts Med Ctr, Boston, MA 02111 USA.	mefini@tuftsmedicalcenter.org		Argueso, Pablo/0000-0001-7321-9503; Jeong, Shinwu/0000-0002-4847-813X; Ngan, Michelle/0000-0003-2593-9279; Fini, M. Elizabeth/0000-0001-9877-188X	University Research Associates Award (USC undergraduate student fellowship); Research to Prevent Blindness; Keck School of Medicine of;  [R01EY026479]; NATIONAL EYE INSTITUTE [P30EY003790, R01EY026479] Funding Source: NIH RePORTER	University Research Associates Award (USC undergraduate student fellowship); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Keck School of Medicine of; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by R01EY026479 (to MEF), The University Research Associates Award (USC undergraduate student fellowship to JK), Research to Prevent Blindness (to the University of Southern California), and start-up funding from the Keck School of Medicine of USC (to MEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson M.B., 2005, REV OPHTHALMOLOGY; Ambrosio R, 2011, REV BRAS OFTALMOL, V70, P408, DOI 10.1590/S0034-72802011000600014; Andrews NW, 2014, TRENDS CELL BIOL, V24, P734, DOI 10.1016/j.tcb.2014.07.008; Argueso P, 2006, INVEST OPHTH VIS SCI, V47, P113, DOI 10.1167/iovs.05-0735; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Bandamwar KL, 2014, CONTACT LENS ANTERIO, V37, P213, DOI 10.1016/j.clae.2013.11.003; Bauskar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138958; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Blalock TD, 2007, INVEST OPHTH VIS SCI, V48, P4509, DOI 10.1167/iovs.07-0430; Bron AJ, 2015, PROG RETIN EYE RES, V44, P36, DOI 10.1016/j.preteyeres.2014.10.001; Bron AJ, 2014, OCUL SURF, V12, pS1, DOI 10.1016/j.jtos.2014.02.002; Castro-Gomes T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152583; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Cejka C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/591530; Clapham DE, 2013, ELIFE, V2, DOI 10.7554/eLife.01738; Cullen AP, 2002, INT J TOXICOL, V21, P455, DOI 10.1080/10915810290169882; FEENSTRA RPG, 1992, OPHTHALMOLOGY, V99, P605; FEENSTRA RPG, 1992, ARCH OPHTHALMOL-CHIC, V110, P984, DOI 10.1001/archopht.1992.01080190090035; Gao DC, 2016, CELL PHYSIOL BIOCHEM, V39, P2121, DOI 10.1159/000447908; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gipson IK, 2007, INVEST OPHTH VIS SCI, V48, P4391, DOI 10.1167/iovs.07-0770; Gipson IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100393; Gordon GM, 2011, INVEST OPHTH VIS SCI, V52, P9188, DOI 10.1167/iovs.11-7658; Guzman-Aranguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036628; HANNA C, 1961, ARCH OPHTHALMOL-CHIC, V65, P695; HANNA C, 1960, ARCH OPHTHALMOL-CHIC, V64, P536; Jeyaprakash AA, 2005, J MOL BIOL, V347, P181, DOI 10.1016/j.jmb.2005.01.015; Kim J, 2000, Curr Opin Ophthalmol, V11, P241, DOI 10.1097/00055735-200008000-00005; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Latvala S, 2014, CLIN EXP IMMUNOL, V178, P320, DOI 10.1111/cei.12425; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mantelli F, 2013, J CELL PHYSIOL, V228, P2253, DOI 10.1002/jcp.24398; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; McDermott AM, 2018, CURR EYE RES, V43, P1097, DOI 10.1080/02713683.2018.1480043; Mokhtarzadeh M, 2011, INVEST OPHTH VIS SCI, V52, P2127, DOI 10.1167/iovs.10-6489; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ong SB, 2015, EUR J PHARMACOL, V763, P104, DOI 10.1016/j.ejphar.2015.04.056; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Peumans WJ, 1998, CRIT REV BIOCHEM MOL, V33, P209; Pfluger N., 1882, KLIN MONATSBL AUGENH, V20, P69; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; Preta G, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0102-1; Reddy PH, 2014, DRUG DISCOV TODAY, V19, P951, DOI 10.1016/j.drudis.2014.03.020; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Seen S, 2018, ACTA OPHTHALMOL, V96, pE412, DOI 10.1111/aos.13526; Sharp WW, 2015, J MOL MED, V93, P243, DOI 10.1007/s00109-015-1257-3; Shoham A, 2008, FREE RADICAL BIO MED, V45, P1047, DOI 10.1016/j.freeradbiomed.2008.07.021; Sjogren H, 1933, ACTA OPHTHALMOLOGICA, V2; Strober W, 2001, Curr Protoc Immunol, VAppendix 3, p3B, DOI 10.1002/0471142735.ima03bs21; Tran SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022876; Van der Paal J, 2016, CHEM SCI, V7, P489, DOI 10.1039/c5sc02311d; van Luijk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089981; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Wilson G, 1995, J Am Optom Assoc, V66, P435	56	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204288	10.1371/journal.pone.0204288	http://dx.doi.org/10.1371/journal.pone.0204288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303976	Green Published, gold			2022-12-26	WOS:000446921100037
J	Lambert, KA; Roff, AN; Panganiban, RP; Douglas, S; Ishmael, FT				Lambert, Kristin A.; Roff, Alanna N.; Panganiban, Ronaldo P.; Douglas, Scott; Ishmael, Faoud T.			MicroRNA-146a is induced by inflammatory stimuli in airway epithelial cells and augments the anti-inflammatory effects of glucocorticoids	PLOS ONE			English	Article							STEROID-INSENSITIVE ASTHMA; NECROSIS-FACTOR-ALPHA; KAPPA-B ACTIVITY; ALLERGIC INFLAMMATION; MEDIATED REGULATION; EXPRESSION; MIR-146A; RESPONSES; ACTIVATION; INDUCTION	Background MicroRNAs (miRNAs) are emerging as central regulators of inflammation, but their role in asthma and airway epithelial cells is not well studied. Glucocorticoids are the cornerstone of therapy in asthma and other inflammatory disease, yet their mechanisms of action are not completely elucidated, and it is not clear whether miRNAs modulate their effects. Objective We aimed to identify miRNAs that regulate cytokine and chemokine expression in airway epithelial cells and whether these miRNAs are subject to the effects of glucocorticoids. Methods and results MicroRNAomic analyses of immortalized, normal human bronchial epithelial cells identified 7 miRNAs that were altered by inflammatory cytokine treatment and 22 that were regulated by glucocorticoids (n = 3 for each treatment condition). MiR-146a emerged as a central candidate, whose expression was induced by TNF-alpha and repressed by glucocorticoids. Its role as a candidate in asthmatic inflammation was supported by expression profiling in human asthmatics, which showed that plasma miR-146a expression was elevated in asthma and associated with measures related to worse asthma outcomes, including elevated blood eosinophil counts, higher asthma control questionnaire scores, and need for higher doses of inhaled glucocorticoids. However, transfection of miR-146a in A549 cells treated with TNF-alpha +/- glucocorticoids produced an anti-inflammatory effect and increased efficacy of glucocorticoids. Conclusions We propose a model whereby miR-146a is induced by inflammatory conditions as a feedback mechanism to limit inflammation. Exogenous administration of miR-146a augmented the effects of glucocorticoids and could be a novel therapeutic strategy to enhance efficacy of these medications.	[Lambert, Kristin A.; Roff, Alanna N.; Panganiban, Ronaldo P.; Douglas, Scott; Ishmael, Faoud T.] Penn State Univ, Milton S Hershey Med Ctr, Dept Med, Div Pulm Allergy & Crit Care Med, Hershey, PA 17033 USA; [Lambert, Kristin A.; Roff, Alanna N.; Ishmael, Faoud T.] Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Roff, Alanna N.] Univ Colorado Denver, Dept Biostat & Informat, Anschutz Med Campus, Aurora, CO USA; [Douglas, Scott] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Virginia	Ishmael, FT (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Med, Div Pulm Allergy & Crit Care Med, Hershey, PA 17033 USA.; Ishmael, FT (corresponding author), Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.	faoudishmael@gmail.com		Lambert, Kristin/0000-0002-5637-8614; Panganiban, Ronaldo/0000-0002-5626-3147	Doris Duke Charitable Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	This work was supported in part by a grant from the Doris Duke Charitable Foundation awarded to Faoud T. Ishmael. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Babu KS, 2004, IMMUNOL ALLERGY CLIN, V24, P583, DOI 10.1016/j.iac.2004.06.010; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Beres NJ, 2016, INFLAMM BOWEL DIS, V22, P327, DOI 10.1097/MIB.0000000000000687; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Chakraborty Chiranjib, 2018, Oncotarget, V9, P10164, DOI 10.18632/oncotarget.24309; Chan MTS, 1998, J ALLERGY CLIN IMMUN, V101, P594, DOI 10.1016/S0091-6749(98)70165-4; Cheng Y, 2012, INFLAMMATION, V35, P1308, DOI 10.1007/s10753-012-9443-8; Deng YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139322; Denlinger LC, 2017, AM J RESP CRIT CARE, V195, P302, DOI 10.1164/rccm.201602-0419OC; Fahy JV, 2011, AM J RESP CRIT CARE, V184, P390, DOI 10.1164/rccm.201107-1258ED; Faiz A, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00310-2018; Fan JS, 2011, J IMMUNOL, V186, P2482, DOI 10.4049/jimmunol.0903634; Godard P, 2002, EUR RESPIR J, V19, P61, DOI 10.1183/09031936.02.00232001; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Houser KR, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-6; Howarth PH, 2005, THORAX, V60, P1012, DOI 10.1136/thx.2005.045260; Hu QM, 2018, ONCOL REP, V39, P3015, DOI 10.3892/or.2018.6391; Huang Y, 2012, FASEB J, V26, P3351, DOI 10.1096/fj.11-199240; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; Ishmael FT, 2011, J IMMUNOL, V186, P1189, DOI 10.4049/jimmunol.1001794; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Jurkin J, 2010, J IMMUNOL, V184, P4955, DOI 10.4049/jimmunol.0903021; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Li L, 2010, SCAND J IMMUNOL, V71, P227, DOI 10.1111/j.1365-3083.2010.02383.x; Liu LM, 2018, ENVIRON TOXICOL, V33, P743, DOI 10.1002/tox.22561; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Panganiban RP, 2016, J ALLERGY CLIN IMMUN, V137, P1423, DOI 10.1016/j.jaci.2016.01.029; Panganiban RPL, 2012, AM J CLIN EXP IMMUNO, V1, P154; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Pfeiffer D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179850; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062232; Roff AN, 2014, AM J CLIN EXP IMMUNO, V3, P68; Rudmann DG, 2000, AM J PHYSIOL-LUNG C, V279, pL1047, DOI 10.1152/ajplung.2000.279.6.L1047; Schlosser K, 2017, PULM CIRC, V8, DOI 10.1177/2045893217750613; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Vender R, 2017, TRANSLATIONAL GENETI; Wamboldt FS, 1999, ANN ALLERG ASTHMA IM, V83, P55, DOI 10.1016/S1081-1206(10)63513-2; Wang SF, 2013, J IMMUNOL, V191, P293, DOI 10.4049/jimmunol.1202100; Yang K, 2011, FEBS LETT, V585, P854, DOI 10.1016/j.febslet.2011.02.009; Zheng YJ, 2012, FREE RADICAL BIO MED, V52, P1307, DOI 10.1016/j.freeradbiomed.2012.01.031; Zhong L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20837-9	53	26	30	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205434	10.1371/journal.pone.0205434	http://dx.doi.org/10.1371/journal.pone.0205434			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300399	Green Submitted, gold, Green Published			2022-12-26	WOS:000446897200064
J	Cheruiyot, A; Li, S; Nickless, A; Roth, R; Fitzpatrick, JAJ; You, ZS				Cheruiyot, Abigael; Li, Shan; Nickless, Andrew; Roth, Robyn; Fitzpatrick, James A. J.; You, Zhongsheng			Compound C inhibits nonsense-mediated RNA decay independently of AMPK	PLOS ONE			English	Article							CANCER-CELL-PROLIFERATION; MESSENGER-RNA; MAMMALIAN-CELLS; PROTEIN-KINASE; MONITORING AUTOPHAGY; GENE-EXPRESSION; STRESS-RESPONSE; NMD; PATHWAY; MUTATIONS	The nonsense mediated RNA decay (NMD) pathway safeguards the integrity of the transcriptome by targeting mRNAs with premature translation termination codons (PTCs) for degradation. It also regulates gene expression by degrading a large number of non-mutant RNAs (including mRNAs and noncoding RNAs) that bear NMD-inducing features. Consequently, NMD has been shown to influence development, cellular response to stress, and clinical outcome of many genetic diseases. Small molecules that can modulate NMD activity provide critical tools for understanding the mechanism and physiological functions of NMD, and they also offer potential means for treating certain genetic diseases and cancer. Therefore, there is an intense interest in identifying small-molecule NMD inhibitors or enhancers. It was previously reported that both inhibition of NMD and treatment with the AMPK-selective inhibitor Compound C (CC) induce autophagy in human cells, raising the possibility that CC may be capable of inhibiting NMD. Here we show that CC indeed has a NMD-inhibitory activity. Inhibition of NMD by CC is, however, independent of AMPK activity. As a competitive ATP analog, CC does not affect the kinase activity of SMG1, an essential NMD factor and the only known kinase in the NMD pathway. However, CC treatment down-regulates the protein levels of several NMD factors. The induction of autophagy by CC treatment is independent of ATF4, a NMD target that has been shown to promote autophagy in response to NMD inhibition. Our results reveal a new activity of CC as a NMD inhibitor, which has implications for its use in basic research and drug development.	[Cheruiyot, Abigael; Li, Shan; Nickless, Andrew; Roth, Robyn; Fitzpatrick, James A. J.; You, Zhongsheng] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Roth, Robyn; Fitzpatrick, James A. J.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO USA; [Fitzpatrick, James A. J.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Fitzpatrick, James A. J.] Washington Univ, Sch Med, Ctr Cellular Imaging, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	You, ZS (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	zyou@wustl.edu		Cheruiyot, Abigael/0000-0003-0612-6280; You, Zhongsheng/0000-0002-9719-8791	NIH [R01GM098535]; American Cancer Society Research Scholar Grant [RSG-13-212-01-DMC]; Siteman Investment Program grant from the Siteman Cancer Center of Washington University [4036]; Howard Hughes Medical Institute International Student Research fellow; Washington University Center for Cellular Imaging (WUCCI) by Washington University School of Medicine; Children's Discovery Institute of Washington University; St. Louis Children's Hospital [CDI-CORE-2015-505]; Foundation for Barnes-Jewish Hospital [3770]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098535] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); Siteman Investment Program grant from the Siteman Cancer Center of Washington University; Howard Hughes Medical Institute International Student Research fellow; Washington University Center for Cellular Imaging (WUCCI) by Washington University School of Medicine; Children's Discovery Institute of Washington University; St. Louis Children's Hospital; Foundation for Barnes-Jewish Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.C., S.L., A.N. and Z.Y. were supported by a NIH grant (R01GM098535), an American Cancer Society Research Scholar Grant (RSG-13-212-01-DMC), and a Siteman Investment Program grant (4036) from the Siteman Cancer Center of Washington University to Z.Y. A.C. was also supported by a Howard Hughes Medical Institute International Student Research fellow. R.R. and J.A.J.F. were supported by the Washington University Center for Cellular Imaging (WUCCI) which was in turn supported by Washington University School of Medicine, The Children's Discovery Institute of Washington University and St. Louis Children's Hospital (CDI-CORE-2015-505) and the Foundation for Barnes-Jewish Hospital (3770).	Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bhuvanagiri M, 2014, EMBO MOL MED, V6, P1593, DOI 10.15252/emmm.201404461; Bordeira-Carrico R, 2012, TRENDS MOL MED, V18, P667, DOI 10.1016/j.molmed.2012.09.004; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Chen XQ, 2013, NUCLEIC ACIDS RES, V41, P9325, DOI 10.1093/nar/gkt672; Dai RY, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.419; Dang YJ, 2009, J BIOL CHEM, V284, P23613, DOI 10.1074/jbc.M109.009985; Durand S, 2007, J CELL BIOL, V178, P1145, DOI 10.1083/jcb.200611086; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Garulli C, 2014, CELL SIGNAL, V26, P352, DOI 10.1016/j.cellsig.2013.11.022; Gollavilli PN, 2015, FEBS J, V282, P3971, DOI 10.1111/febs.13391; Gong CG, 2009, GENE DEV, V23, P54, DOI 10.1101/gad.1717309; Gotlieb WH, 2008, GYNECOL ONCOL, V110, P246, DOI 10.1016/j.ygyno.2008.04.008; HA J, 1994, J BIOL CHEM, V269, P22162; HAO JJ, 2008, PLOS ONE, V3, DOI DOI 10.1371/JOURNAL.PONE.0002904; Hauer C, 2016, CELL REP, V16, P1588, DOI 10.1016/j.celrep.2016.06.096; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hu JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068291; Hu ZY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15943; Huang LL, 2011, MOL CELL, V43, P950, DOI 10.1016/j.molcel.2011.06.031; Huang SW, 2013, TOXICOL APPL PHARM, V267, P113, DOI 10.1016/j.taap.2012.12.016; Hwang J, 2011, CURR OPIN GENET DEV, V21, P422, DOI 10.1016/j.gde.2011.03.008; Isakovic A, 2007, CELL MOL LIFE SCI, V64, P1290, DOI 10.1007/s00018-007-7080-4; Jin JF, 2009, J LIPID RES, V50, P2389, DOI 10.1194/jlr.M900119-JLR200; Jin Y, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0070-z; Karam R, 2015, EMBO REP, V16, P599, DOI 10.15252/embr.201439696; Keeling KM, 2011, WIRES RNA, V2, P837, DOI 10.1002/wrna.95; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim N, 2016, J ENDOCRINOL, V228, P105, DOI 10.1530/JOE-15-0302; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Li TL, 2015, EMBO J, V34, P1630, DOI 10.15252/embj.201489947; Linde L, 2007, J CLIN INVEST, V117, P683, DOI 10.1172/JCI28523; Liu XN, 2014, MOL CANCER THER, V13, P596, DOI 10.1158/1535-7163.MCT-13-0579; Longman D, 2013, NUCLEIC ACIDS RES, V41, P8319, DOI 10.1093/nar/gkt585; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; Lou CH, 2016, STEM CELL REP, V6, P844, DOI 10.1016/j.stemcr.2016.05.008; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Madhu V, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1035374; Martin L, 2014, CANCER RES, V74, P3104, DOI 10.1158/0008-5472.CAN-13-2235; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nickless A, 2018, METHODS MOL BIOL, V1720, P213, DOI 10.1007/978-1-4939-7540-2_16; Nickless A, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0153-7; Nickless A, 2014, NAT MED, V20, P961, DOI 10.1038/nm.3620; Nomakuchi TT, 2016, NAT BIOTECHNOL, V34, P164, DOI 10.1038/nbt.3427; Pastor F, 2010, NATURE, V465, P227, DOI 10.1038/nature08999; Rios M, 2013, CANCER RES, V73, P2628, DOI 10.1158/0008-5472.CAN-12-0861; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Sanduja S, 2016, ONCOGENE, V35, P5295, DOI 10.1038/onc.2016.70; Tani H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055684; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Vucicevic L, 2011, AUTOPHAGY, V7, P40, DOI 10.4161/auto.7.1.13883; Wang G, 2013, BIOCHEM BIOPH RES CO, V435, P16, DOI 10.1016/j.bbrc.2013.03.129; Wengrod J, 2013, MOL CELL BIOL, V33, P2128, DOI 10.1128/MCB.00174-13; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yang WL, 2012, J SURG ONCOL, V106, P680, DOI 10.1002/jso.23184; Yepiskoposyan H, 2011, RNA, V17, P2108, DOI 10.1261/rna.030247.111; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	64	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204978	10.1371/journal.pone.0204978	http://dx.doi.org/10.1371/journal.pone.0204978			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289931	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500035
J	Katz, S; Backeris, P; Merck, C; Suprun, M; D'Souza, S; Bishop, DF; Desnick, RJ; Moore, K; Ubarretxena-Belandia, I; Lemischka, IR				Katz, Suzanna; Backeris, Peter; Merck, Christopher; Suprun, Maria; D'Souza, Sunita; Bishop, David F.; Desnick, Robert J.; Moore, Kateri; Ubarretxena-Belandia, Iban; Lemischka, Ihor R.			Design and validation of an open-source modular Microplate Photoirradiation System for high-throughput photobiology experiments	PLOS ONE			English	Article							INDUCED PROTOPORPHYRIN IX; PHOTODYNAMIC THERAPY; 5-AMINOLEVULINIC ACID; METHYL AMINOLEVULINATE; ACTINIC KERATOSES; LIGHT; PORPHYRINS; SKIN; INACTIVATION; EXPRESSION	Research in photobiology is currently limited by a lack of devices capable of delivering precise and tunable irradiation to cells in a high-throughput format. This limits researchers to using expensive commercially available or custom-built light sources which make it difficult to replicate, standardize, optimize, and scale experiments. Here we present an open-source Microplate Photoirradiation System (MPS) developed to enable high-throughput light experiments in standard 96 and 24-well microplates for a variety of applications in photobiology research. This open-source system features 96 independently controlled LEDs (4 LEDs per well in 24-well), Wi-Fi connected control and programmable graphical user interface (GUI) for control and programming, automated calibration GUI, and modular control and LED boards for maximum flexibility. A web-based GUI generates light program files containing irradiation parameters for groups of LEDs. These parameters are then uploaded wirelessly, stored and used on the MPS to run photoirradiation experiments inside any incubator. A rapid and semi-quantitative porphyrin metabolism assay was also developed to validate the system in wild-type fibroblasts. Protoporphyrin IX (PpIX) fluorescence accumulation was induced by incubation with 5-aminolevulinic acid (ALA), a photosensitization method leveraged clinically to destroy malignant cell types in a process termed photodynamic therapy (PDT), and cells were irradiated with 405nm light with varying irradiance, duration and pulsation parameters. Immediately after light treatment with the MPS, subsequent photobleaching was measured in live, adherent cells in both 96-well and a 24-well microplates using a microplate reader. Results demonstrate the utility and reliability of the Microplate Photoirradiation System to irradiate cells with precise irradiance and timing parameters in order to measure PpIx photobleaching kinetics in live adherent cells and perform comparable experiments with both 24 and 96 well microplate formats. The high-throughput capability of the MPS enabled measurement of enough irradiance conditions in a single microplate to fit PpIX fluorescence to a bioexponential decay model of photobleaching, as well as reveal a dependency of photobleaching on duty-cycle-but not frequency-in a pulsed irradiance regimen.	[Katz, Suzanna; D'Souza, Sunita; Moore, Kateri; Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA; [Backeris, Peter] Icahn Sch Med Mt Sinai, Dept Neurosurg, Sinai Biodesign, New York, NY 10029 USA; [Merck, Christopher] Merck Engn LLC, Hamburg, NJ 07495 USA; [Suprun, Maria] Icahn Sch Med Mt Sinai, Dept Pediat Allergy & Immunol, New York, NY 10029 USA; [Bishop, David F.; Desnick, Robert J.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Ubarretxena-Belandia, Iban; Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [Ubarretxena-Belandia, Iban] Univ Basque Country, UPV EHU, CSIC, Biofisika Inst, Leioa, Spain	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Backeris, P (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosurg, Sinai Biodesign, New York, NY 10029 USA.	peter.backeris@mssm.edu	Bishop, David F./X-4102-2019; Ubarretxena-Belandia, Iban/AAA-8939-2019; Suprun, Maria/ABE-8323-2020; Suprun, Maria/AAE-5507-2022	Suprun, Maria/0000-0001-9161-4021; Bishop, David/0000-0003-1958-8601	Graduate School of Biological Sciences; Black Family Stem Cell Institute at Icahn School of Medicine	Graduate School of Biological Sciences; Black Family Stem Cell Institute at Icahn School of Medicine	We thank the Graduate School of Biological Sciences and the Black Family Stem Cell Institute at Icahn School of Medicine for providing financial support for the project. Chris Merck is affiliated with his own LLC (Merck Engineering LLC). Merck Engineering LLC did not contribute funding to the development of the MPS or its biological validation and has no pecuniary interest in this study. Chris Merck worked as a volunteer collaborator not representing any company or institution. Merck Engineering LLC did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Akilov O.E., 2006, MED LASER APPL, V21, P251, DOI [DOI 10.1016/J.MLA.2006.07.002, 10.1016/j.mla.2006.07.002]; Alexiades-Armenakas Macrene, 2006, J Drugs Dermatol, V5, P45; Issa MCA, 2010, DERMATOL SURG, V36, P39, DOI 10.1111/j.1524-4725.2009.01385.x; Bagdonas S, 2000, PHOTOCHEM PHOTOBIOL, V72, P186, DOI 10.1562/0031-8655(2000)072<0186:POAAIP>2.0.CO;2; Boere IA, 2003, PHOTOCHEM PHOTOBIOL, V78, P271, DOI 10.1562/0031-8655(2003)078<0271:MISDAP>2.0.CO;2; Chen DX, 2012, ADV DIFFER EQU-NY, P1, DOI 10.1186/1687-1847-2012-33; Clements IP, 2016, PROC SPIE, V9690, DOI 10.1117/12.2213708; Curnow A, 2000, J PHOTOCH PHOTOBIO B, V58, P149, DOI 10.1016/S1011-1344(00)00120-2; Dragieva G, 2004, BRIT J DERMATOL, V151, P196, DOI 10.1111/j.1365-2133.2004.06054.x; GEBRIL M, 1990, NEPHRON, V55, P159, DOI 10.1159/000185945; Georgakoudi I, 1997, PHOTOCHEM PHOTOBIOL, V65, P135, DOI 10.1111/j.1751-1097.1997.tb01889.x; Georgakoudi I, 1998, PHOTOCHEM PHOTOBIOL, V67, P612, DOI 10.1111/j.1751-1097.1998.tb09463.x; Gerhardt KP, 2016, SCI REP-UK, V6, DOI 10.1038/srep35363; GUTNIAK O, 1966, ANAL BIOCHEM, V16, P20, DOI 10.1016/0003-2697(66)90076-5; Hadis MA, 2017, J BIOPHOTONICS, V10, P1514, DOI 10.1002/jbio.201600273; Haj-Hosseini N, 2009, PROC SPIE, V7161, DOI 10.1117/12.808156; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hannanta-anan P, 2016, CELL SYST, V2, P283, DOI 10.1016/j.cels.2016.03.010; Quintanar LFH, 2016, PHOTOMED LASER SURG, V34, P108, DOI 10.1089/pho.2015.4030; Hodgkinson N, 2017, CERVICAL CANC CELLS; Issa M, 2010, ANAIS BRASILEIROS DE; Issa MCA, 2009, BRIT J DERMATOL, V161, P647, DOI 10.1111/j.1365-2133.2009.09326.x; Jori G, 2004, PHOTOCH PHOTOBIO SCI, V3, P403, DOI 10.1039/b311904c; Kaestner L, 2004, PHOTOCH PHOTOBIO SCI, V3, P981, DOI 10.1039/b403127j; Karrer S, 2000, TOPICAL PHOTODYNAMIC; Kasermann F, 1997, ANTIVIR RES, V34, P65, DOI 10.1016/S0166-3542(96)01207-7; Katsambas A, 2008, DERMATOL THER, V21, P86, DOI 10.1111/j.1529-8019.2008.00175.x; Krishnamohan M, 2006, ENVIRON TOXICOL, V1, P192; Martinelli ALC, 1999, J CLIN GASTROENTEROL, V29, P327, DOI 10.1097/00004836-199912000-00006; Meier Daniela, 2014, J Vis Exp, DOI 10.3791/51213; Moan J, 1997, INT J CANCER, V70, P90, DOI 10.1002/(SICI)1097-0215(19970106)70:1<90::AID-IJC14>3.0.CO;2-H; Muller P J, 1996, J Clin Laser Med Surg, V14, P263; Nakai Y, 2015, PHOTODIAGN PHOTODYN, V12, P282, DOI 10.1016/j.pdpdt.2014.12.010; Niu TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138754; Oleinick N.L., 2011, BASIC PHOTOSENSITIZA; Orenstein A, 1997, FEMS IMMUNOL MED MIC, V19, P307, DOI 10.1016/S0928-8244(97)00097-7; Piacquadio DJ, 2004, ARCH DERMATOL, V140, P41, DOI 10.1001/archderm.140.1.41; Pieslinger A., 2006, MED LASER APPL, V21, P277; Pogue BW, 2008, PROTOPORPHYRIN 9 FLU, V13, DOI [10.1117/1.2937, 10.1117/1.2937476, DOI 10.1117/1.2937476]; Pollock B, 2004, BRIT J DERMATOL, V151, P616, DOI 10.1111/j.1365-2133.2004.06110.x; Reis SA, 2016, NAT CHEM BIOL, V12, P317, DOI [10.1038/NCHEMBIO.2042, 10.1038/nchembio.2042]; Rick K, 1997, J PHOTOCH PHOTOBIO B, V40, P313, DOI 10.1016/S1011-1344(97)00076-6; RIMINGTON C, 1960, BIOCHEM J, V75, P620, DOI 10.1042/bj0750620; Robinson DJ, 1999, PHOTOCHEM PHOTOBIOL, V69, P61, DOI 10.1111/j.1751-1097.1999.tb05307.x; Robinson DJ, 1998, PHOTOCHEM PHOTOBIOL, V67, P140, DOI 10.1562/0031-8655(1998)067<0140:FPOAIP>2.3.CO;2; Roeder B, 1990, LASERS MED SCI; Stringer MR, 2006, PHOTODIAGN PHOTODYN, V3, P19, DOI 10.1016/S1572-1000(05)00155-9; Sudworth CD, 2003, APPL SPECTROSC, V57, P682, DOI 10.1366/000370203322005382; Szeimies RM, 2007, DERMATOL CLIN, V25, P89, DOI 10.1016/j.det.2006.09.008; Wainwright M, 2000, INT J ANTIMICROB AG, V16, P381, DOI 10.1016/S0924-8579(00)00207-7; Wainwright M, 2002, CHEM SOC REV, V31, P128, DOI 10.1039/b101905h; Wainwright M, 2002, CURR MED CHEM, V9, P127, DOI 10.2174/0929867023371355; White B, 2016, 5 AMINOLEVULINIC ACI, DOI DOI 10.1089/PH0.2016.4091; Wilson BC, 1997, LASERS MED SCI; Yin L, 2013, CONTROLLING DELICATE; Yin L, 2013, CONTROLLING THE DELI; Zhang SJ, 2004, PHOTOCHEM PHOTOBIOL, V79, P545, DOI 10.1562/MU-03-32.1; Zhao JZ, 2013, CHEM SOC REV, V42, P5323, DOI 10.1039/c3cs35531d; Zhu TC, 2005, MED PHYS	60	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203597	10.1371/journal.pone.0203597	http://dx.doi.org/10.1371/journal.pone.0203597			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289930	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500005
J	Machado, MC; da Costa-Neto, JM; Portela, RD; D'Assis, MJMH; Martins, OA; Barrouin-Melo, SM; Borges, NF; Silva, FL; Estrela-Lima, A				Machado, Marilia Carneiro; da Costa-Neto, Joao Moreira; Portela, Ricardo Dias; Melhor Heine D'Assis, Mario Jorge; Martins-Filho, Olindo Assis; Barrouin-Melo, Stella Maria; Borges, Natalie Ferreira; Silva, Fabiana Lessa; Estrela-Lima, Alessandra			The effect of naltrexone as a carboplatin chemotherapy-associated drug on the immune response, quality of life and survival of dogs with mammary carcinoma	PLOS ONE			English	Article							LOW-DOSE NALTREXONE; REGULATORY T-CELL; CANCER; RECEPTORS; PAIN	The objective of this study was to evaluate the effect of low-dose naltrexone (LDN) as a carboplatin chemotherapy-associated drug in female dogs with mammary carcinoma in benign mixed tumors (MC-BMT) after mastectomy and to assess its association with quality of life and survival rates. Sixty female dogs were included in this study, all of which had histopathological diagnosis of MC-BMT and were divided into three groups: G1 (control), consisting of animals submitted only to mastectomy with or without regional metastasis; G2, composed of treated animals that did not present with metastasis; and G3, treated dogs that presented with metastasis. G2 and G3 were also subdivided according to the treatment administered: chemotherapy alone (MC-BMT(-) C/MC-BMT(+) C) or LDN and chemotherapy (MC-BMT(-) C+LDN/MC-BMT(+) C+LDN). All animals were subjected to clinical evaluation, mastectomy, peripheral blood lymphocyte immunophenotyping, beta-endorphin and met-enkephalin quantification, and evaluation of survival rates and quality of life scores. The results showed higher serum concentrations of beta-endorphin and met-enkephalin, fewer chemotherapy-related side effects, and better quality of life and survival rates in the LDN-treated groups than in LDN-untreated groups (P<0.05). Evaluation of clinical and pathological parameters indicated a significant association between the use of LDN and both prolonged survival and enhanced quality of life. These results indicate that LDN is a viable chemotherapy-associated treatment in female dogs with MC-BMT, maintaining their quality of life and prolonging survival rates.	[Machado, Marilia Carneiro; da Costa-Neto, Joao Moreira; Melhor Heine D'Assis, Mario Jorge; Barrouin-Melo, Stella Maria; Estrela-Lima, Alessandra] Univ Fed Bahia, Dept Anat, Pathol Clin, Salvador, BA, Brazil; [Machado, Marilia Carneiro; da Costa-Neto, Joao Moreira; Melhor Heine D'Assis, Mario Jorge; Barrouin-Melo, Stella Maria; Estrela-Lima, Alessandra] Univ Fed Bahia, Dept Anat, Vet Clin, Salvador, BA, Brazil; [Portela, Ricardo Dias] Univ Fed Bahia, Inst Hlth Sci, Lab Immunol & Mol Biol, Salvador, BA, Brazil; [Martins-Filho, Olindo Assis] Fundacao Oswaldo Cruz, Res Ctr Rene Rachou, Lab Diagnost & Monitoring Biomarkers, Belo Horizonte, MG, Brazil; [Borges, Natalie Ferreira] Fed Univ Reconcavo da Bahia, Ctr Agr Environm & Biol Sci, Cruz Das Almas, BA, Brazil; [Silva, Fabiana Lessa] Estadual Univ Santa Cruz, Dept Agr & Environm Sci, Ilheus, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Fundacao Oswaldo Cruz	Estrela-Lima, A (corresponding author), Univ Fed Bahia, Dept Anat, Pathol Clin, Salvador, BA, Brazil.; Estrela-Lima, A (corresponding author), Univ Fed Bahia, Dept Anat, Vet Clin, Salvador, BA, Brazil.	alestrela@gmail.com	Estrela-Lima, Alessandra/AAL-2745-2021; Martins-Filho, Olindo Assis/ABE-6278-2021; Barrouin-Melo, Stella Maria/B-5152-2013; Silva, Fabiana/GWU-9143-2022; Portela, RW/H-5638-2013; Portela, Ricardo/W-1794-2019	Estrela-Lima, Alessandra/0000-0002-9879-7999; Martins-Filho, Olindo Assis/0000-0002-5494-4889; Barrouin-Melo, Stella Maria/0000-0003-3501-7366; Portela, RW/0000-0001-9095-776X; Portela, Ricardo/0000-0001-9095-776X; Carneiro de Araujo Machado, Marilia/0000-0002-6867-4576	Foundation for Research Support of Bahia State (FAPESB) [3538/2013]	Foundation for Research Support of Bahia State (FAPESB)	This work was supported by the Foundation for Research Support of Bahia State (FAPESB - grant 3538/2013). The authors are profoundly grateful to the Program of Postgraduate Studies in Tropical Animal Science (PPgCAT). Marilia Carneiro Machado is a Master fellow from the Coordination on Higher Education Personnel Improvement (CAPES). Alessandra Estrela-Lima and Olindo Assis Martins-Filho are research fellows from National Council for Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, VET COMP ONCOL, V14, P417, DOI 10.1111/vco.283; Araujo MSS, 2008, VACCINE, V26, P2211, DOI 10.1016/j.vaccine.2008.02.044; Berkson BM, 2006, INTEGR CANCER THER, V5, P83, DOI 10.1177/1534735405285901; Bidlack JM, 2000, CLIN DIAGN LAB IMMUN, V7, P719, DOI 10.1128/CDLI.7.5.719-723.2000; Brown N, 2009, MED HYPOTHESES, V72, P333, DOI 10.1016/j.mehy.2008.06.048; Cassali G. D., 2014, Brazilian Journal of Veterinary Pathology, V7, P38; Cassali Geovanni Dantas, 2013, BMC Proc, V7 Suppl 2, pK6, DOI 10.1186/1753-6561-7-S2-K6; Coles EH, 1986, VET CLIN PATHOL, P516; Damasceno KA, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-195; Donahue RN, 2011, EXP BIOL MED, V236, P883, DOI 10.1258/ebm.2011.011096; Estrela-Lima A, 2012, BREAST CANCER RES TR, V131, P751, DOI 10.1007/s10549-011-1452-z; Estrela-Lima A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-256; Ferreira E, 2003, ARQ BRAS MED VET ZOO, V55, P105, DOI 10.1590/S0102-09352003000100017; HAZUM E, 1979, SCIENCE, V205, P1033, DOI 10.1126/science.224457; Lana SE, 2013, WITHROW MACEWENS SMA, P619; Lavalle GE, 2012, IN VIVO, V26, P375; Lee MW, 2009, EXPERT OPIN PHARMACO, V10, P1841, DOI 10.1517/14656560903048959; Metze D, 1999, J AM ACAD DERMATOL, V41, P533, DOI 10.1016/S0190-9622(99)80048-6; Misdorp W., 2002, Tumors in domestic animals, P575, DOI 10.1002/9780470376928.ch12; Moretti P, 2017, VET COMP ONCOL, V15, P215, DOI 10.1111/vco.12156; Oun R, 2018, DALTON T, V47, P6645, DOI 10.1039/c8dt00838h; Owen L. N., 1980, TNM classification of tumours in domestic animals.; Philibert JC, 2003, J VET INTERN MED, V17, P102, DOI 10.1111/j.1939-1676.2003.tb01330.x; Salas Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127381; Shafiee R, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-79; Sojka DK, 2008, IMMUNOLOGY, V124, P13, DOI 10.1111/j.1365-2567.2008.02813.x; Sontas BH, 2012, REPROD DOMEST ANIM, V47, P125, DOI 10.1111/j.1439-0531.2011.01810.x; Sorenmo K, 2003, VET CLIN N AM-SMALL, V33, P573, DOI 10.1016/S0195-5616(03)00020-2; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Yazbek KVB, 2005, JAVMA-J AM VET MED A, V226, P1354, DOI 10.2460/javma.2005.226.1354; Yoo KY, 2001, CANCER LETT, V167, P57, DOI 10.1016/S0304-3835(01)00463-3; Zagon IS, 2005, NEUROPEPTIDES, V39, P495, DOI 10.1016/j.npep.2005.07.001	33	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204830	10.1371/journal.pone.0204830	http://dx.doi.org/10.1371/journal.pone.0204830			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286124	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500047
J	Lou, B; Liu, Q; Hou, JH; Kabir, I; Liu, PP; Ding, T; Dong, JB; Mo, MG; Ye, DY; Chen, Y; Bui, HH; Roth, K; Cao, Y; Jiang, XC				Lou, Bin; Liu, Qi; Hou, Jiahui; Kabir, Inamul; Liu, Peipei; Ding, Tingbo; Dong, Jibin; Mo, Mingguang; Ye, Deyong; Chen, Yang; Bui, Hai H.; Roth, Kenneth; Cao, Yu; Jiang, Xian-Cheng			2-Hydroxy-oleic acid does not activate sphingomyelin synthase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sphingolipid; phospholipid; lipid; lipid metabolism; cancer; 2-hydroxy-oleic acid (2OHOA); anti-cancer drug; lysophosphatidylcholine acyltransferase (LPCAT); sphingomyelin synthase (SMS); sphingomyelin; phosphatidylcholine	LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; ANTICANCER ACTIVITY; MEMBRANE; METABOLISM; CANCER; LIVER; IDENTIFICATION; DEFICIENCY; CLONING; CELLS	2-Hydroxy-oleic acid (2OHOA) is a potent anticancer drug that induces cancer cell cycle arrest and apoptosis. Previous studies have suggested that 2OHOA's anticancer effect is mediated by SMS activation in cancer cells, including A549 and U118 cells. To confirm this phenomenon, in this study, we treated both A549 and U118 cells with 2OHOA and measured SMS activity. To our surprise, we found neither 2OHOA-mediated SMS activation nor sphingomyelin accumulation in the cells. However, we noted that 2OHOA significantly reduces phosphatidylcholine in these cells. We also did not observe 2OHOA-mediated SMS activation in mouse tissue homogenates. Importantly, 2OHOA inhibited rather than activated recombinant SMS1 (rSMS1) and rSMS2 in a dose-dependent fashion. Intra-gastric treatment of C57BL/6J mice with 2OHOA for 10 days had no effects on liver and small intestine SMS activities and plasma sphingomyelin levels. The treatment inhibited lysophosphatidylcholine acyltransferase (LPCAT) activity, consistent with the aforementioned reduction in plasma phosphatidylcholine. Because total cellular phosphatidylcholine is used as a predictive biomarker for monitoring tumor responses, the previously reported 2OHOA-mediated cancer suppression could be related to this phosphatidylcholine reduction, which may influence cell membrane structure and properties. We conclude that 2OHOA is not a SMS activator and that its anticancer property may be related to an effect on phosphatidylcholine metabolism.	[Lou, Bin; Liu, Qi; Hou, Jiahui; Liu, Peipei; Ding, Tingbo; Dong, Jibin; Mo, Mingguang; Ye, Deyong; Jiang, Xian-Cheng] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China; [Kabir, Inamul; Jiang, Xian-Cheng] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Chen, Yang; Cao, Yu] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Inst Precis Med, Shanghai 200000, Peoples R China; [Bui, Hai H.; Roth, Kenneth] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Jiang, Xian-Cheng] Vet Affairs New York Harbor Healthcare Syst, Mol & Cellular Cardiol Program, Brooklyn, NY 11209 USA	Fudan University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Shanghai Jiao Tong University; Eli Lilly	Lou, B (corresponding author), Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China.; Cao, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Inst Precis Med, Shanghai 200000, Peoples R China.	blou@shmu.edu.cn; yu.cao@shsmu.edu.cn	Ye, Deyong/AAE-2173-2022	Ye, Deyong/0000-0003-0498-3019; Kabir, Inamul/0000-0001-6207-1785	National Institutes of Health [1R01 HL139582-01A1]; Veterans Affairs Merit Grant [000900-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL139582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Grant(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant 1R01 HL139582-01A1 and Veterans Affairs Merit Grant 000900-01 (to X.-C. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barcelo-Coblijn G, 2011, P NATL ACAD SCI USA, V108, P19569, DOI 10.1073/pnas.1115484108; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Cheng ML, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00266; Dobrzynska I, 2005, MOL CELL BIOCHEM, V276, P113, DOI 10.1007/s11010-005-3557-3; Dobrzynska I, 2015, J MEMBRANE BIOL, V248, P301, DOI 10.1007/s00232-015-9770-4; Fan YF, 2010, ARTERIOSCL THROM VAS, V30, P2114, DOI 10.1161/ATVBAHA.110.213363; Fernandez R, 2016, ANAL CHEM, V88, P1022, DOI 10.1021/acs.analchem.5b03978; Gandola YB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/687037; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Ibarguren M, 2013, BBA-BIOMEMBRANES, V1828, P2553, DOI 10.1016/j.bbamem.2013.06.014; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Martin ML, 2013, BBA-BIOMEMBRANES, V1828, P1405, DOI 10.1016/j.bbamem.2013.01.013; Li Y, 2013, ARTERIOSCL THROM VAS, V33, P1513, DOI 10.1161/ATVBAHA.113.301498; Li ZQ, 2012, ARTERIOSCL THROM VAS, V32, P1577, DOI 10.1161/ATVBAHA.112.251538; Li ZQ, 2011, MOL CELL BIOL, V31, P4205, DOI 10.1128/MCB.05893-11; Liu J, 2009, CIRC RES, V105, P295, DOI 10.1161/CIRCRESAHA.109.194613; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Llado V, 2010, J CELL MOL MED, V14, P659, DOI 10.1111/j.1582-4934.2008.00625.x; Llado V, 2009, P NATL ACAD SCI USA, V106, P13754, DOI 10.1073/pnas.0907300106; Lou B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102641; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; Martinez J, 2005, J PHARMACOL EXP THER, V315, P466, DOI 10.1124/jpet.105.088716; Martinez J, 2005, MOL PHARMACOL, V67, P531, DOI 10.1124/mol.104.000778; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Ridgway ND, 2013, CRIT REV BIOCHEM MOL, V48, P20, DOI 10.3109/10409238.2012.735643; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; SAKAI K, 1992, CARCINOGENESIS, V13, P579, DOI 10.1093/carcin/13.4.579; Sakamoto H, 2017, BIOCHEM BIOPH RES CO, V482, P202, DOI 10.1016/j.bbrc.2016.11.041; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Sugimoto M, 2016, BBA-MOL CELL BIOL L, V1861, P688, DOI 10.1016/j.bbalip.2016.04.019; Szachowicz-Petelska B, 2013, J MEMBRANE BIOL, V246, P421, DOI 10.1007/s00232-013-9554-7; Teres S, 2012, P NATL ACAD SCI USA, V109, P8489, DOI 10.1073/pnas.1118349109; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Vance DE, 2014, BBA-BIOMEMBRANES, V1838, P1477, DOI 10.1016/j.bbamem.2013.10.018; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	43	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18328	18336		10.1074/jbc.RA118.005904	http://dx.doi.org/10.1074/jbc.RA118.005904			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30305392	Green Published, hybrid			2022-12-26	WOS:000451375200024
J	Ng, KP; Manjeri, A; Lee, LM; Chan, ZE; Tan, CY; Tan, QD; Majeed, A; Lee, KL; Chuah, C; Suda, T; Ong, ST				Ng, King Pan; Manjeri, Aditi; Lee, Lin Ming; Chan, Zhu En; Tan, Chin Yee; Tan, Qiancheng Darren; Majeed, A'Qilah; Lee, Kian Leong; Chuah, Charles; Suda, Toshio; Ong, S. Tiong			The arginase inhibitor N-omega-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; IMMUNOSUPPRESSIVE MICROENVIRONMENT; METABOLIC-REGULATION; ENDOTHELIAL FUNCTION; IMMUNE SUPPRESSION; INDUCIBLE FACTORS; MOUSE MODEL; CANCER; PROLIFERATION	Cancer cells, including in chronic myeloid leukemia (CML), depend on the hypoxic response to persist in hosts and evade therapy. Accordingly, there is significant interest in drugging cancer-specific hypoxic responses. However, a major challenge in leukemia is identifying differential and druggable hypoxic responses between leukemic and normal cells. Previously, we found that arginase 2 (ARG2), an enzyme of the urea cycle, is overexpressed in CML but not normal progenitors. ARG2 is a target of the hypoxia inducible factors (HIF1-alpha and HIF2-alpha), and is required for the generation of polyamines which are required for cell growth. We therefore explored if the clinically-tested arginase inhibitor N-omega-hydroxy-nor-arginine (nor-NOHA) would be effective against leukemic cells under hypoxic conditions. Remarkably, nor-NOHA effectively induced apoptosis in ARG2-expressing cells under hypoxia but not normoxia. Co-treatment with nor-NOHA overcame hypoxia-mediated resistance towards BCR-ABL1 kinase inhibitors. While nor-NOHA itself is promising in targeting the leukemia hypoxic response, we unexpectedly found that its anti-leukemic activity was independent of ARG2 inhibition. Genetic ablation of ARG2 using CRISPR/Cas9 had no effect on the viability of leukemic cells and their sensitivity towards nor-NOHA. This discrepancy was further evidenced by the distinct effects of ARG2 knockouts and nor-NOHA on cellular respiration. In conclusion, we show that nor -NOHA has significant but off-target anti-leukemic activity among ARG2-expressing hypoxic cells. Since nor-NOHA has been employed in clinical trials, and is widely used in studies on endothelial dysfunction, immunosuppression and metabolism, the diverse biological effects of nor-NOHA must be cautiously evaluated before attributing its activity to ARG inhibition.	[Ng, King Pan; Manjeri, Aditi; Lee, Lin Ming; Chan, Zhu En; Tan, Chin Yee; Lee, Kian Leong; Chuah, Charles; Ong, S. Tiong] Duke NUS Med Sch, Canc & Stem Cell Biol Signat Res Program, Singapore, Singapore; [Tan, Qiancheng Darren; Majeed, A'Qilah; Lee, Kian Leong; Suda, Toshio] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Chuah, Charles; Ong, S. Tiong] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore; [Suda, Toshio] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan; [Ong, S. Tiong] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; [Ong, S. Tiong] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Ng, King Pan] Sun Yat Sen Univ, Sch Med, Guangzhou, Guangdong, Peoples R China	National University of Singapore; National University of Singapore; Singapore General Hospital; Kumamoto University; National Cancer Centre Singapore (NCCS); Duke University; Sun Yat Sen University	Ong, ST (corresponding author), Duke NUS Med Sch, Canc & Stem Cell Biol Signat Res Program, Singapore, Singapore.; Ong, ST (corresponding author), Singapore Gen Hosp, Dept Haematol, Singapore, Singapore.; Ong, ST (corresponding author), Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore.; Ong, ST (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	ngkingp@mail.sysu.edu.cn; sintiong.ong@duke-nus.edu.sg	LEE, Kian Leong/E-3584-2013	LEE, Kian Leong/0000-0002-0443-2746; Ong, S. Tiong/0000-0001-9460-3483; Chan, Zhu En/0000-0002-9296-395X	National Medical Research Council of Singapore [NMRC/BNIG/2015/2014, NMRC/STaR/019/2013, NMRC/CSA/0051/2013, NMRC/CIRG/1404/2014]	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	K.P.N. was supported by a New Investigator Grant (NMRC/BNIG/2015/2014), T.S. was supported by the Singapore Translation Research Investigator Award (NMRC/STaR/019/2013) and S.T.O. was supported by a Clinician Scientist Award (NMRC/CSA/0051/2013) and CS-IRG (NMRC/CIRG/1404/2014) grant, all from the National Medical Research Council of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkawy KS, 2017, EUR J DRUG METAB PH, V42, P355, DOI 10.1007/s13318-016-0381-y; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chang CI, 2001, CANCER RES, V61, P1100; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Costa H, 2016, ONCOTARGET, V7, P47221, DOI 10.18632/oncotarget.9722; Cowburn AS, 2013, P NATL ACAD SCI USA, V110, P17570, DOI 10.1073/pnas.1306942110; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Deynoux M, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00041; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fiegl M, 2010, LEUKEMIA, V24, P1364, DOI 10.1038/leu.2010.94; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Gonon AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042038; Harrison JS, 2002, BLOOD, V99, P394, DOI 10.1182/blood.V99.1.394; Holtz MS, 2002, BLOOD, V99, P3792, DOI 10.1182/blood.V99.10.3792; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; Kaelin WG, 2017, NAT REV CANCER, V17, P441, DOI 10.1038/nrc.2017.32; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Kovamees O, 2016, J INTERN MED, V279, P477, DOI 10.1111/joim.12461; Kovamees O, 2016, J CLIN ENDOCR METAB, V101, P3952, DOI 10.1210/jc.2016-2007; Kovamees O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103260; Krotova K, 2010, AM J PHYSIOL-CELL PH, V299, pC1541, DOI 10.1152/ajpcell.00068.2010; KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105; Lasch M, 2016, LAB INVEST, V96, P830, DOI 10.1038/labinvest.2016.62; Lin A, 2017, ELIFE, V6, DOI 10.7554/eLife.24179; Mantel CR, 2015, CELL, V161, P1553, DOI 10.1016/j.cell.2015.04.054; McGovern N, 2017, NATURE, V546, P662, DOI 10.1038/nature22795; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Morris SM, 2004, J NUTR, V134, p2765S, DOI 10.1093/jn/134.10.2765S; Morris SM, 2004, J NUTR, V134, p2743S, DOI 10.1093/jn/134.10.2743S; Munder M, 2006, BLOOD, V108, P1627, DOI 10.1182/blood-2006-11-010389; Mussai F, 2015, CANCER RES, V75, P3043, DOI 10.1158/0008-5472.CAN-14-3443; Mussai F, 2013, BLOOD, V122, P749, DOI 10.1182/blood-2013-01-480129; Ng KP, 2014, BLOOD, V123, P3316, DOI 10.1182/blood-2013-07-511907; Pallett LJ, 2015, NAT MED, V21, P591, DOI 10.1038/nm.3856; Peng G, 2015, TRENDS PHARMACOL SCI, V36, P374, DOI 10.1016/j.tips.2015.03.003; Pernow J, 2013, CARDIOVASC RES, V98, P334, DOI 10.1093/cvr/cvt036; Perrotti D, 2010, J CLIN INVEST, V120, P2254, DOI 10.1172/JCI41246; Portwood S, 2013, CLIN CANCER RES, V19, P6506, DOI 10.1158/1078-0432.CCR-13-0674; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Rotondo R, 2008, INT J CANCER, V123, P1108, DOI 10.1002/ijc.23437; Rouault-Pierre K, 2016, EXPERT OPIN BIOL TH, V16, P463, DOI 10.1517/14712598.2016.1133582; Rouault-Pierre K, 2013, CELL STEM CELL, V13, P549, DOI 10.1016/j.stem.2013.08.011; Samoilenko O. A., 2015, Experimental Oncology, V37, P151; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schito L, 2017, ONCOGENE, V36, P5331, DOI 10.1038/onc.2017.119; Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001; Singh R, 2000, CANCER RES, V60, P3305; Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tate DJ, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-14; Tenu JP, 1999, NITRIC OXIDE-BIOL CH, V3, P427, DOI 10.1006/niox.1999.0255; Wang Y, 2014, BLOOD, V124, P1127, DOI 10.1182/blood-2013-12-544221; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Xiong YY, 2014, AUTOPHAGY, V10, P2223, DOI 10.4161/15548627.2014.981789; Xu WL, 2016, J CLIN INVEST, V126, P2465, DOI 10.1172/JCI82925; Yang JN, 2013, P NATL ACAD SCI USA, V110, P15049, DOI 10.1073/pnas.1307058110; Zhang HJ, 2012, BLOOD, V119, P2595, DOI 10.1182/blood-2011-10-387381	61	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205254	10.1371/journal.pone.0205254	http://dx.doi.org/10.1371/journal.pone.0205254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307989	Green Submitted, Green Published, gold			2022-12-26	WOS:000447173500052
J	Brea, D; Poon, C; Murphy, M; Lubitz, G; Iadecola, C; Anrather, J				Brea, David; Poon, Carrie; Murphy, Michelle; Lubitz, Gabrielle; Iadecola, Costantino; Anrather, Josef			Ablation of nasal-associated lymphoid tissue does not affect focal ischemic brain injury in mice	PLOS ONE			English	Article							DELTA-T-CELLS; SUBARACHNOID SPACE; INFECTION; SYSTEM; LYMPHATICS; MECHANISMS; FLUID	Stroke is a devastating disease with a strong inflammatory component. It has been shown that part of this response is mediated by IL17(+) gamma delta T cells gamma delta T cells constitute a lymphocyte population with innate features that mainly populates epithelial surfaces including skin, intestine, and airways. We have shown that in the context of stroke, T cells migrate from the small intestine to the meninges but whether they can migrate from other epithelial surfaces is still unknown. Because of its proximity, one possible source of stroke-associated IL17(+) gamma delta T cells could be the Nasal-Associated Lymphoid Tissue (NALT) from which T cells could migrate along olfactory nerve sheaths through the cribriform plate into the brain and/or meninges. In order to study the role of NALT as a source for immune cells and/or inflammatory mediators in the context of stroke, we analyzed the effect of NALT ablation on immune cell infiltration and infarct volume after stroke. Infarct volume analysis did not show any significant difference between sham and NALT-ablated animals. In addition, no significant differences were found in immune cell infiltration in the brain or meninges of stroke animals subjected to NALT or Sham-ablation surgery. In conclusion, NALT ablation does not affect ischemic brain damage or immune cell infiltration in the meninges or brain after stroke.	[Brea, David; Poon, Carrie; Murphy, Michelle; Lubitz, Gabrielle; Iadecola, Costantino; Anrather, Josef] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA	Cornell University	Anrather, J (corresponding author), Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA.	joa2006@med.cornell.edu	Lubitz, Gabrielle/V-7756-2019; Lubitz, Gabrielle/U-7293-2018; Iadecola, c/ABB-8377-2020; Brea López, David/M-1128-2015	Lubitz, Gabrielle/0000-0002-1534-0169; Lubitz, Gabrielle/0000-0002-1534-0169; Brea López, David/0000-0003-2365-7374	US National Institutes of Health (NIH) [NS094507]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094507, R01NS034179] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the US National Institutes of Health (NIH) grant NS094507 (to JA).	Arunachalam P, 2017, STROKE, V48, P1957, DOI 10.1161/STROKEAHA.117.016753; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Cisney ED, 2012, JOVE-J VIS EXP, DOI 10.3791/3960; Dando SJ, 2014, CLIN MICROBIOL REV, V27, P691, DOI 10.1128/CMR.00118-13; Dileepan T, 2016, J CLIN INVEST, V126, P303, DOI 10.1172/JCI80792; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Faber WM, 1937, AM J ANAT, V62, P121, DOI 10.1002/aja.1000620106; Furukawa M, 2008, BIOMED RES-TOKYO, V29, P289, DOI 10.2220/biomedres.29.289; Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jackman K, 2011, METHODS MOL BIOL, V793, P195, DOI 10.1007/978-1-61779-328-8_13; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Koh L, 2005, FLUIDS BARRIERS CNS, V2, DOI 10.1186/1743-8454-2-6; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; PLAKHOV IV, 1995, VIROLOGY, V209, P257, DOI 10.1006/viro.1995.1252; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Schwalbe G., 1869, ZENTRALBL MED WISS, V7, P465; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Sosa Gustavo A, 2004, Clin Dev Immunol, V11, P29, DOI 10.1080/10446670410001670463	23	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205470	10.1371/journal.pone.0205470	http://dx.doi.org/10.1371/journal.pone.0205470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300386	Green Published, gold, Green Submitted			2022-12-26	WOS:000446897200071
J	Inaba, S; Hinohara, A; Tachibana, M; Tsujikawa, K; Fukada, S				Inaba, Shoya; Hinohara, Atsushi; Tachibana, Masashi; Tsujikawa, Kazutake; Fukada, So-ichiro			Muscle regeneration is disrupted by cancer cachexia without loss of muscle stem cell potential	PLOS ONE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; PROGENITORS; CONTRIBUTE; CHEMOKINES; MONOCYTES; DAMAGE	Cancer cachexia is a severe, debilitating condition characterized by progressive body wasting associated with remarkable loss of skeletal muscle weight. It has been reported that cancer cachexia disturbs the regenerative ability of skeletal muscle, but the cellular mechanisms are still unknown. Here, we investigated the skeletal muscle regenerative process in mouse colon-26 (C26) tumor cell-bearing mice as a C26 cancer cachexia model. Although the proliferation and differentiation abilities of muscle stem cells derived from the C26 tumor cell-bearing mice were sustained in vitro, the proliferation and differentiation were severely impaired in the cachexic mice. The numbers of both macrophages and mesenchymal progenitors, which are critical players in muscle regeneration, were reduced in the cancer cachexic mice, indicating that the skeletal muscle regeneration process was disrupted by cancer cachexia. Furthermore, the number of infiltrated neutrophils was also reduced in cancer cachexia mice 24 hours after muscle injury, and the expression of critical chemokines for muscle regeneration was reduced in cancer cachexia model mice compared to control mice. Collectively, although the ability to regeneration of MuSCs was retained, cancer cachexia disturbed skeletal muscle regenerative ability by inhibiting the orchestrated muscle regeneration processes.	[Inaba, Shoya; Tsujikawa, Kazutake] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Suita, Osaka, Japan; [Inaba, Shoya; Fukada, So-ichiro] Osaka Univ, Grad Sch Pharmaceut Sci, Project Muscle Stem Cell Biol, Suita, Osaka, Japan; [Hinohara, Atsushi] Kyowa Hakko Kirin Co Ltd, Immunol & Allergy Res Labs, Immunol & Allergy R&D Unit, R&D Div, Nagaizumi, Shizuoka, Japan; [Hinohara, Atsushi] Kyowa Kirin Pharmaceut Res Inc, Business Dev Div, La Jolla, CA USA; [Tachibana, Masashi] Osaka Univ, Grad Sch Pharmaceut Sci, Project Vaccine & Immune Regulat, Suita, Osaka, Japan; [Tachibana, Masashi] Osaka Univ, Global Ctr Med Engn & Informat, Suita, Osaka, Japan	Osaka University; Kyowa Kirin Ltd; Osaka University	Fukada, S (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Project Muscle Stem Cell Biol, Suita, Osaka, Japan.	fukada@phs.osaka-u.ac.jp	Fukada, So-ichiro/AAI-9151-2020	Fukada, So-ichiro/0000-0003-4051-5108; Tachibana, Masashi/0000-0002-0376-508X	AMED [18am0101084j0002]; NCNP; Kyowa Hakko Kirin Co., Ltd.; Kyowa Kirin Pharmaceutical Research, Inc.	AMED; NCNP; Kyowa Hakko Kirin Co., Ltd.(Kyowa Kirin Ltd); Kyowa Kirin Pharmaceutical Research, Inc.	This work was supported by AMED under Grant Number 18am0101084j0002 to KT, Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP to SF, Grant-in-Aid for Scientific Research (B) to SF, and Kyowa Hakko Kirin Co., Ltd. The commercial affiliation (Kyowa Hakko Kirin Co., Ltd. and Kyowa Kirin Pharmaceutical Research, Inc.) provided support in the form of salaries for author [A.H.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of A.H. are articulated in the 'author contributions' section. The other funders also had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Bossola M, 2016, CLIN EXP PHARMACOL P, V43, P522, DOI 10.1111/1440-1681.12559; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Donati C, 2007, FEBS LETT, V581, P4384, DOI 10.1016/j.febslet.2007.08.007; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Fukada S, 2018, J BIOCHEM, V163, P353, DOI 10.1093/jb/mvy019; Fukada S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00317; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Iwata Y, 2016, J CACHEXIA SARCOPENI, V7, P366, DOI 10.1002/jcsm.12067; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Ojima K, 2004, BIOCHEM BIOPH RES CO, V321, P1050, DOI 10.1016/j.bbrc.2004.07.069; Penna F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013604; Pessina P, 2010, ONCOL REP, V24, P741, DOI 10.3892/or_00000916; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Suzuki H, 2013, J GASTROENTEROL, V48, P574, DOI 10.1007/s00535-013-0787-0; Talbert EE, 2016, SEMIN CELL DEV BIOL, V54, P82, DOI 10.1016/j.semcdb.2015.09.009; Talbert E, 2014, J CACHEXIA SARCOPENI, V5, P321, DOI 10.1007/s13539-014-0141-2; Teixeira CFP, 2003, MUSCLE NERVE, V28, P449, DOI 10.1002/mus.10453; Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Warren GL, 2004, AM J PHYSIOL-CELL PH, V286, pC1031, DOI 10.1152/ajpcell.00467.2003; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	31	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205467	10.1371/journal.pone.0205467	http://dx.doi.org/10.1371/journal.pone.0205467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300394	gold, Green Published, Green Submitted			2022-12-26	WOS:000446897200070
J	Raymond, SL; Hawkins, RB; Stortz, JA; Murphy, TJ; Ungaro, R; Dirain, ML; Nacionales, DC; Hollen, MK; Rincon, JC; Larson, SD; Brakenridge, SC; Moore, FA; Irimia, D; Efron, PA; Moldawer, LL				Raymond, Steven L.; Hawkins, Russell B.; Stortz, Julie A.; Murphy, Tyler J.; Ungaro, Ricardo; Dirain, Marvin L.; Nacionales, Dina C.; Hollen, McKenzie K.; Rincon, Jaimar C.; Larson, Shawn D.; Brakenridge, Scott C.; Moore, Frederick A.; Irimia, Daniel; Efron, Phil A.; Moldawer, Lyle L.			Sepsis is associated with reduced spontaneous neutrophil migration velocity in human adults	PLOS ONE			English	Article							CHEMOTAXIS; FAILURE; EPIDEMIOLOGY; EXPRESSION	Sepsis is a common and deadly complication among trauma and surgical patients. Neutrophils must mobilize to the site of infection to initiate an immediate immune response. To quantify the velocity of spontaneous migrating blood neutrophils, we utilized novel microfluidic approaches on whole blood samples from septic and healthy individuals. A prospective study at a level 1 trauma and tertiary care center was performed with peripheral blood samples collected at <12 hours, 4 days, and/or 14 days relative to study initiation. Blood samples were also collected from healthy subjects. Ex vivo spontaneous neutrophil migration was measured on 2 mu l of whole blood using microfluidic devices and time-lapse imaging. For each sample, individual neutrophils were tracked to calculate mean instantaneous velocity. Forty blood samples were collected from 33 patients with sepsis, and 15 blood samples were collected from age- and gender-matched healthy, control subjects. Average age was 61 years for septic patients with a male predominance (67%). Overall, average spontaneous neutrophil migration velocity in septic samples was 16.9 mu m/min, significantly lower than controls samples at 21.1 mu m/min (p = 0.0135). Neutrophil velocity was reduced the greatest at <12 hours after sepsis (14.5 mu m/min). Regression analysis demonstrated a significant, positive correlation between neutrophil velocity and days after sepsis (p = 0.0059). There was no significant association between neutrophil velocity and age, gender, APACHE II score, SOFA score, sepsis severity, total white blood cell count, or percentage of neutrophils. Circulating levels of the cytokines IL-6, IL-8, IL-10, MCP-1, IP-10, and TNF were additionally measured using bead-based multiplex assay and found to peak at <12 hours and be significantly increased in patients with sepsis at all three time points (<12 hours, 4 days, and 14 days after sepsis) compared to healthy subjects. In conclusion, these findings may demonstrate an impaired ability of neutrophils to respond to sites of infection during the proinflammatory phase of sepsis.	[Raymond, Steven L.; Hawkins, Russell B.; Stortz, Julie A.; Murphy, Tyler J.; Ungaro, Ricardo; Dirain, Marvin L.; Nacionales, Dina C.; Hollen, McKenzie K.; Rincon, Jaimar C.; Larson, Shawn D.; Brakenridge, Scott C.; Moore, Frederick A.; Efron, Phil A.; Moldawer, Lyle L.] Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32611 USA; [Irimia, Daniel] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Irimia, Daniel] Harvard Med Sch, Boston, MA USA	State University System of Florida; University of Florida; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Moldawer, LL (corresponding author), Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32611 USA.	moldawer@surgery.ufl.edu	Larson, Shawn D/AFD-9859-2022; Brakenridge, Scott/AAD-6691-2019	Larson, Shawn D/0000-0002-8564-0140; Moldawer, Lyle/0000-0002-9041-9838; Brakenridge, Scott/0000-0002-7327-3718; Murphy, Tyler/0000-0002-9040-592X	National Institute of General Medical Sciences (NIGMS) [R01 GM-104481, R01 GM-040586, R01 GM-097531, R01 GM-113945, P50 GM-111152]; Surgical Infection Society Foundation; NIGMS post-doctoral training grant [T32 GM008721]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD089939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM111152, R01GM104481, R01GM113945, R01GM097531, R01GM040586, T32GM008721] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Surgical Infection Society Foundation; NIGMS post-doctoral training grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of General Medical Sciences (NIGMS) R01 GM-104481 (LLM), R01 GM-040586 (LLM), R01 GM-097531 (SDL, LLM), R01 GM-113945 (PAE), and P50 GM-111152 (SCB, FAM, PAE, LLM). SLR was supported by a clinical research training fellowship awarded by the Surgical Infection Society Foundation. RBH and JAS were supported by a NIGMS post-doctoral training grant (T32 GM008721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves JC, 2005, MEM I OSWALDO CRUZ, V100, P223, DOI 10.1590/S0074-02762005000900038; Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arena ET, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.260; Arraes SMA, 2006, BLOOD, V108, P2906, DOI 10.1182/blood-2006-05-024638; Benjamim CF, 2000, J INFECT DIS, V182, P214, DOI 10.1086/315682; Butler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011921; Chishti AD, 2004, INTENS CARE MED, V30, P605, DOI 10.1007/s00134-004-2175-y; Croft CA, 2014, J TRAUMA ACUTE CARE, V76, P311, DOI 10.1097/TA.0000000000000121; Drost EM, 1999, AM J RESP CRIT CARE, V159, P1696, DOI 10.1164/ajrccm.159.6.9803061; Ellett F, 2018, NAT BIOMED ENG, V2, P207, DOI 10.1038/s41551-018-0208-z; Jones CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114509; Kurihara T, 2013, FASEB J, V27, P2270, DOI 10.1096/fj.12-219519; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Loftus TJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015136; Lu XG, 2016, IMMUNOL LETT, V173, P55, DOI 10.1016/j.imlet.2016.03.010; Moore LJ, 2011, J TRAUMA, V70, P672, DOI 10.1097/TA.0b013e31820e7803; Moore LJ, 2010, ARCH SURG-CHICAGO, V145, P695, DOI 10.1001/archsurg.2010.107; Phua J, 2013, CRIT CARE, V17, DOI 10.1186/cc12896; Stortz JA, 2018, SHOCK, V49, P249, DOI 10.1097/SHK.0000000000000981; Tavares-Murta BM, 2002, CRIT CARE MED, V30, P1056, DOI 10.1097/00003246-200205000-00017; Wafaisade A, 2011, CRIT CARE MED, V39, P621, DOI 10.1097/CCM.0b013e318206d3df; Zhang F, 2016, CHINESE MED J-PEKING, V129, P2741, DOI 10.4103/0366-6999.193447	23	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205327	10.1371/journal.pone.0205327	http://dx.doi.org/10.1371/journal.pone.0205327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300408	Green Published, gold, Green Submitted			2022-12-26	WOS:000446897200056
J	Niitsuma, ENA; Fernandes, GD; Lana, FCF				Alvarenga Niitsuma, Eyleen Nabyla; Fernandes, Gabriel da Rocha; Felix Lana, Francisco Carlos			The TLR1 gene is associated with higher protection from leprosy in women	PLOS ONE			English	Article							SEX-DIFFERENCES; SUSCEPTIBILITY; POLYMORPHISM; TUBERCULOSIS; INFECTION; RESPONSES; DISEASE; CELLS; N248S; NOD2	Leprosy is an infectious disease with a complex genetic and immunological background. Polymorphisms in genes that encode cytokines and receptors involved in the immune response, such as the Toll-like receptor 1 (TLR1), may be associated with disease risk. We hypothesized that polymorphisms in innate immunity genes confer susceptibility to leprosy that differs between women and men. In this study, we investigate sex differences in the association between a single nucleotide polymorphism (SNP) in TLR1 and Nucleotide-binding oligomerization domain containing 2 (NOD2) genes and leprosy susceptibility in 256 clinically classified leprosy patients and 233 control subjects in a Brazilian population. Our results showed no association between the SNP rs8057341 in NOD2 and leprosy in this population. However, the heterozygous genotype of the TLR1 SNP (rs4833095) showed a statistically significant association in women (OR = 0.54, P = 0.02). Our findings suggest that the TLR1 polymorphism was associated with an increased protection from leprosy in women.	[Alvarenga Niitsuma, Eyleen Nabyla] IFNMG, Inst Fed Educ Ciencia & Tecnol Norte Minas Gerais, Almenara, MG, Brazil; [Fernandes, Gabriel da Rocha] Fiocruz Minas, Inst Rene Rachou, Belo Horizonte, MG, Brazil; [Felix Lana, Francisco Carlos] Univ Fed Minas Gerais, Escola Enfermagem, Dept Maternal & Child Nursing & Publ Hlth, Belo Horizonte, MG, Brazil	Instituto Federal do Norte de Minas Gerais (IFNMG); Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Niitsuma, ENA (corresponding author), IFNMG, Inst Fed Educ Ciencia & Tecnol Norte Minas Gerais, Almenara, MG, Brazil.	eyleen.alvarenga@ifnmg.edu.br	Niitsuma, Eyleen Nabyla Alvarenga/AAQ-9344-2020; Lana, Francisco/AAD-1443-2019; da Rocha Fernandes, Gabriel/A-5383-2010; Lana, Francisco CF/I-1438-2012	Niitsuma, Eyleen Nabyla Alvarenga/0000-0002-5781-6313; Lana, Francisco/0000-0001-9043-3181; da Rocha Fernandes, Gabriel/0000-0002-4897-8521; Lana, Francisco CF/0000-0001-9043-3181	Health Surveillance Secretariat of the Ministry of Health. Government of Brazil [23072.039742 / 2012-29]	Health Surveillance Secretariat of the Ministry of Health. Government of Brazil	This study was funded by Health Surveillance Secretariat of the Ministry of Health. Government of Brazil (Grant number: 23072.039742 / 2012-29) to FCFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Alter A, 2011, MAMM GENOME, V22, P19, DOI 10.1007/s00335-010-9287-1; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P501; Brazil Ministry of Health, 2008, HLTH SURV EP SIT LEP; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Colombini A, 2015, INT J MOL SCI, V16, P3722, DOI 10.3390/ijms16023722; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Geluk A, 2013, LEPROSY REV, V84, P3; Griesbeck M, 2015, J IMMUNOL, V195, P5327, DOI 10.4049/jimmunol.1501684; Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390; Hart BE, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/415057; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Lastoria JC, 2014, AN BRAS DERMATOL, V89, P205, DOI 10.1590/abd1806-4841.20142450; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Manry J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012450; Marcinek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073103; Marques CD, 2013, J INFECT DIS, V208, P120, DOI 10.1093/infdis/jit133; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; Modlin RL, 2010, CURR OPIN IMMUNOL, V22, P48, DOI 10.1016/j.coi.2009.12.001; O'Neill LAJ, 2015, NATURE REV IMMUNOLOG; Pino-Yanes M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013759; Plantinga TS, 2012, J INFECT DIS, V205, P934, DOI 10.1093/infdis/jir867; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Sales-Marques C, 2014, HUM GENET, V133, P1525, DOI 10.1007/s00439-014-1502-9; Schuring RP, 2009, J INFECT DIS, V199, P1816, DOI 10.1086/599121; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh KD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/538053; Smith-Bouvier DL, 2008, J EXP MED, V205, P1099, DOI 10.1084/jem.20070850; Uciechowski P, 2011, J LEUKOCYTE BIOL, V90, P377, DOI 10.1189/jlb.0409233; van Lunzen J, 2014, J INFECT DIS, V209, pS79, DOI 10.1093/infdis/jiu159; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205234	10.1371/journal.pone.0205234	http://dx.doi.org/10.1371/journal.pone.0205234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289892	Green Submitted, Green Published, gold			2022-12-26	WOS:000446545500057
J	Bayati, M; Neher, T; Melchior, J; Diba, K; Wiskott, L; Cheng, S				Bayati, Mehdi; Neher, Torsten; Melchior, Jan; Diba, Kamran; Wiskott, Laurenz; Cheng, Sen			Storage fidelity for sequence memory in the hippocampal circuit	PLOS ONE			English	Article							DENTATE GYRUS; ENTORHINAL CORTEX; PYRAMIDAL CELLS; NEURAL-NETWORK; PLACE CELLS; DOUBLE DISSOCIATION; DORSAL HIPPOCAMPUS; PATTERN COMPLETION; RECURRENT NETWORK; PHASE PRECESSION	Episodic memories have been suggested to be represented by neuronal sequences, which are stored and retrieved from the hippocampal circuit. A special difficulty is that realistic neuronal sequences are strongly correlated with each other since computational memory models generally perform poorly when correlated patterns are stored. Here, we study in a computational model under which conditions the hippocampal circuit can perform this function robustly. During memory encoding, CA3 sequences in our model are driven by intrinsic dynamics, entorhinal inputs, or a combination of both. These CA3 sequences are hetero-associated with the input sequences, so that the network can retrieve entire sequences based on a single cue pattern. We find that overall memory performance depends on two factors: the robustness of sequence retrieval from CA3 and the circuit's ability to perform pattern completion through the feedforward connectivity, including CA3, CA1 and EC. The two factors, in turn, depend on the relative contribution of the external inputs and recurrent drive on CA3 activity. In conclusion, memory performance in our network model critically depends on the network architecture and dynamics in CA3.	[Bayati, Mehdi; Melchior, Jan; Wiskott, Laurenz; Cheng, Sen] Ruhr Univ Bochum, Inst Neuroinformat, Bochum, Germany; [Neher, Torsten] Ruhr Univ Bochum, Fac Psychol, Dept Clin Child & Adolescent Psychol, Mental Hlth Res & Treatment Ctr, Bochum, Germany; [Diba, Kamran] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA	Ruhr University Bochum; Ruhr University Bochum; University of Michigan System; University of Michigan	Cheng, S (corresponding author), Ruhr Univ Bochum, Inst Neuroinformat, Bochum, Germany.	sen.cheng@rub.de	Wiskott, Laurenz/P-7715-2017; Cheng, Sen/A-5722-2009	Wiskott, Laurenz/0000-0001-6237-740X; Cheng, Sen/0000-0002-6719-8029; Axmacher, Nikolai/0000-0002-0475-6492; Bayati, Mehdi/0000-0002-4040-198X	German Research Foundation (DFG) [SFB 874]; Stiftung Mercator; German Federal Ministry of Education and Research (BMBF) [01GQ1506]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS088798] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Stiftung Mercator; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the German Research Foundation (DFG) through the SFB 874, projects B2 (S.C.) and B3 (L.W.), from the Stiftung Mercator (S.C.), and from the German Federal Ministry of Education and Research (BMBF), grant 01GQ1506 (S.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agster KL, 2002, J NEUROSCI, V22, P5760; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Amit Daniel J., 1992, MODELING BRAIN FUNCT; Appleby PA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001063; Azizi AH, 2014, HIPPOCAMPUS, V24, P912, DOI 10.1002/hipo.22306; Azizi AH, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00161; Battaglia FP, 1998, NEURAL COMPUT, V10, P431, DOI 10.1162/089976698300017827; Bayati M, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00069; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cheng S, 2011, NEUROSCIENCE, V197, P293, DOI 10.1016/j.neuroscience.2011.09.002; Cheng S, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00088; CHIBA AA, 1994, BEHAV NEURAL BIOL, V61, P123, DOI 10.1016/S0163-1047(05)80065-2; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Cutsuridis V, 2010, SPR SER COMPUT NEURO, V5, P1, DOI 10.1007/978-1-4419-0996-1; de Camargo RY, 2018, PEERJ, V6, DOI 10.7717/peerj.4203; Deshmukh SS, 2003, J NEUROSCI, V23, P1903; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Gluck M.A., 2001, GATEWAY MEMORY INTRO; Gold AE, 2005, HIPPOCAMPUS, V15, P808, DOI 10.1002/hipo.20103; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Guzman SJ, 2016, SCIENCE, V353, P1117, DOI 10.1126/science.aaf1836; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hawkins J, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00023; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P699, DOI 10.1002/hipo.20429; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Itskov V, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00040; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaeger H., 2001, BONN GER GER NATL RE, V148, P2001; Jahnke S, 2015, J NEUROSCI, V35, P16236, DOI 10.1523/JNEUROSCI.3977-14.2015; Jensen O, 1996, LEARN MEMORY, V3, P264, DOI 10.1101/lm.3.2-3.264; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jerman T, 2006, LEARN MEMORY, V13, P458, DOI 10.1101/lm.246906; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Klempin F, 2007, EUR ARCH PSY CLIN N, V257, P271, DOI 10.1007/s00406-007-0731-5; Kloosterman F, 2000, ANN NY ACAD SCI, V911, P459; Kropff Emilio, 2007, Natural Computing, V6, P169, DOI 10.1007/s11047-006-9019-3; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuipers SD, 2015, NEUROBIOL AGING, V36, P365, DOI 10.1016/j.neurobiolaging.2014.07.033; Lazar A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.023.2009; Lazic SE, 2012, NEUROBIOL AGING, V33, P1664, DOI 10.1016/j.neurobiolaging.2011.03.008; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Leibold C, 2006, NEURAL COMPUT, V18, P904, DOI 10.1162/089976606775774714; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Maass W, 1998, ADV NEUR IN, V10, P194; Maass W, 1997, NEURAL NETWORKS, V10, P1659, DOI 10.1016/S0893-6080(97)00011-7; Maass W, 2007, PLOS COMPUT BIOL, V3, P15, DOI 10.1371/journal.pcbi.0020165; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Middleton SJ, 2016, NAT NEUROSCI, V19, P945, DOI 10.1038/nn.4311; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; Monaco JD, 2011, J NEUROSCI, V31, P9414, DOI 10.1523/JNEUROSCI.1433-11.2011; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moustafa AA, 2009, BRAIN RES, V1276, P180, DOI 10.1016/j.brainres.2009.04.020; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Neher T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181618; Neher T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004250; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Panzeri S, 2001, NETWORK-COMP NEURAL, V12, P423, DOI 10.1088/0954-898X/12/4/302; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pyka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085016; Rajan K, 2016, NEURON, V90, P128, DOI 10.1016/j.neuron.2016.02.009; Rao RPN, 2000, ADV NEUR IN, V12, P164; Renno-Costa C, 2010, NEURON, V68, P1051, DOI 10.1016/j.neuron.2010.11.024; Rolls ET, 2007, LEARN MEMORY, V14, P714, DOI 10.1101/lm.631207; Rolls ET, 1995, INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SUPPLEMENTARY ISSUE, 1995, P51; Romani S, 2015, HIPPOCAMPUS, V25, P94, DOI 10.1002/hipo.22355; Roudi Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000012; Salz DM, 2016, J NEUROSCI, V36, P7476, DOI 10.1523/JNEUROSCI.0087-16.2016; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; Senior TJ, 2008, J NEUROSCI, V28, P2274, DOI 10.1523/JNEUROSCI.4669-07.2008; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; SOMPOLINSKY H, 1986, PHYS REV LETT, V57, P2861, DOI 10.1103/PhysRevLett.57.2861; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; TAUBE JS, 1990, J NEUROSCI, V10, P420; Traub RD, 2002, REV NEUROSCIENCE, V13, P1; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; TREVES A, 1993, NETWORK-COMP NEURAL, V4, P259, DOI 10.1088/0954-898X/4/3/002; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsodyks M, 1999, HIPPOCAMPUS, V9, P481, DOI 10.1002/(SICI)1098-1063(1999)9:4<481::AID-HIPO14>3.0.CO;2-S; Vago DR, 2007, HIPPOCAMPUS, V17, P977, DOI 10.1002/hipo.20329; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; Willingham DB, 2000, MEM COGNITION, V28, P366, DOI 10.3758/BF03198552; Willshaw David J, 1969, NATURE; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Yoon J, 2012, LEARN MEMORY, V19, P1, DOI 10.1101/lm.024554.111; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	120	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204685	10.1371/journal.pone.0204685	http://dx.doi.org/10.1371/journal.pone.0204685			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286147	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500034
J	Bradford, BZ; Huseth, AS; Groves, RL				Bradford, Benjamin Z.; Huseth, Anders S.; Groves, Russell L.			Widespread detections of neonicotinoid contaminants in central Wisconsin groundwater	PLOS ONE			English	Article							COMPLEX-MIXTURES; SURFACE WATERS; COATED SEEDS; US STREAMS; INSECTICIDES; PESTICIDES; THIAMETHOXAM; EXPOSURE; CORN; BEES	Neonicotinoids are a popular and widely-used class of insecticides whose heavy usage rates and purported negative impacts on bees and other beneficial insects has led to questions about their mobility and accumulation in the environment. Neonicotinoid compounds are currently registered for over 140 different crop uses in the United States, with commercial growers continuing to rely heavily on neonicotinoid insecticides for the control of key insect pests through a combination of in-ground and foliar applications. In 2008, the Wisconsin Department of Agriculture, Trade and Consumer Protection (DATCP) began testing for neonicotinoids in groundwater test wells in the state, reporting detections of one or more neonicotinoids in dozens of shallow groundwater test wells. In 2011, similar detection levels were confirmed in several high-capacity overhead center-pivot irrigation systems in central Wisconsin. The current study was initiated to investigate the spatial extent and magnitude of neonicotinoid contamination in groundwater in and around areas of irrigated commercial agriculture in central Wisconsin. From 2013-2015 a total of 317 samples were collected from 91 unique high-capacity irrigation wells and tested for the presence of thiamethoxam (TMX), a neonicotinoid, using enzyme-linked immunosorbent assays. 67% of all samples were positive for TMX at a concentration above the analytical limit of quantification (0.05 mu g/L) and 78% of all wells tested positive at least once. Mean detection was 0.28 mu g/L, with a maximum detection of 1.67 mu g/L. Five wells had at least one detection exceeding 1.00 mu g/L. Furthermore, an analysis of the spatial structure of these well detects suggests that contamination profiles vary across the landscape, with differences in mean detection levels observed from landscape (25 km), to farm (5 km), to individual well (500 m) scales. We also provide an update of DATCP's neonicotinoid monitoring in Wisconsin's shallow groundwater test wells and private potable wells for the years 2011-2017.	[Bradford, Benjamin Z.; Groves, Russell L.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Huseth, Anders S.] North Carolina State Univ, Dept Entomol, Raleigh, NC USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; North Carolina State University	Groves, RL (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	groves@entomology.wisc.edu		Huseth, Anders/0000-0002-5273-8555	United States Department of Agriculture Natural Resources Conservation Service Conservation Innovation Grants [69-3A75-11-211]; United States Department of Agriculture Agricultural Marketing Service Specialty Crop Block Grant Program (USDA AMS SCBGP) [12-012]; Wisconsin Potato and Vegetable Growers Association	United States Department of Agriculture Natural Resources Conservation Service Conservation Innovation Grants; United States Department of Agriculture Agricultural Marketing Service Specialty Crop Block Grant Program (USDA AMS SCBGP); Wisconsin Potato and Vegetable Growers Association	This work was supported by United States Department of Agriculture Natural Resources Conservation Service Conservation Innovation Grants, #69-3A75-11-211, https://www.nrcs.usda.gov/wps/portal/nrcs/main/national/programs/financial/cig/, to RLG; United States Department of Agriculture Agricultural Marketing Service Specialty Crop Block Grant Program (USDA AMS SCBGP), # 12-012, https://www.ams.usda.gov/services/grants/scbgp, to RLG.r We thank the cooperating growers for generously allowing us to collect water samples on their farms and for assisting in these efforts. We thank Amy DeBaker, Rick Graham, Jeff Postle, and Stan Senger of Wisconsin DATCP for their support of this project and for sharing DATCP's groundwater monitoring data. We thank Bob Smail and Bill Phelps of Wisconsin DNR for their expertise with regards to high-capacity well issues in Wisconsin. We thank the Wisconsin Potato and Vegetable Growers Association for continued support of our research efforts.	Anderson TA, 2013, CHEMOSPHERE, V92, P84, DOI 10.1016/j.chemosphere.2013.02.054; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Carnemark M, 2015, WATER HAZARD AQUATIC; Chau NDG, 2015, ENVIRON SCI POLLUT R, V22, P9042, DOI 10.1007/s11356-014-4034-x; Chretien F, 2017, ENVIRON POLLUT, V224, P255, DOI 10.1016/j.envpol.2017.02.002; Code A, 2016, XERCES SOC; DeLorenzo ME, 2012, ENVIRON MONIT ASSESS, V184, P343, DOI 10.1007/s10661-011-1972-3; EPA, 2016, PREL AQ RISK ASS SUP, P305; Furlan L, 2021, ENVIRON SCI POLLUT R, V28, P11798, DOI 10.1007/s11356-017-1052-5; Giorio C, 2021, ENVIRON SCI POLLUT R, V28, P11716, DOI 10.1007/s11356-017-0394-3; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gupta S, 2008, B ENVIRON CONTAM TOX, V80, P431, DOI 10.1007/s00128-008-9420-y; Hladik ML, 2017, AGR ECOSYST ENVIRON, V241, P160, DOI 10.1016/j.agee.2017.03.015; Hladik ML, 2014, ENVIRON POLLUT, V193, P189, DOI 10.1016/j.envpol.2014.06.033; Hladik ML, 2018, YEAR ROUND PRESENCE, DOI [10.1016/j.envpol.2018.01.013, DOI 10.1016/J.ENVPOL.2018.01.013]; Huseth AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097081; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Johnson JD, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2127-2; Klarich KL, 2017, ENVIRON SCI TECH LET, V4, P168, DOI 10.1021/acs.estlett.7b00081; Kraft GJ, 2012, GROUND WATER, V50, P308, DOI 10.1111/j.1745-6584.2011.00836.x; Kraft GJ, 1998, NITRATE LOADING IMPA; Krupke CH, 2015, CURR OPIN INSECT SCI, V10, P8, DOI 10.1016/j.cois.2015.04.005; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kurwadkar S, 2014, J CONTAM HYDROL, V170, P86, DOI 10.1016/j.jconhyd.2014.09.009; Leake SA, 2013, UNDERSTANDING MANAGI; Main AR, 2016, AGR ECOSYST ENVIRON, V215, P76, DOI 10.1016/j.agee.2015.09.011; Main AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092821; Morrissey CA, 2015, ENVIRON INT, V74, P291, DOI 10.1016/j.envint.2014.10.024; Nowell LH, 2018, SCI TOTAL ENVIRON, V613, P1469, DOI 10.1016/j.scitotenv.2017.06.156; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pinheiro J, 2016, LINEAR NONLINEAR MIX; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Pisa L, 2021, ENVIRON SCI POLLUT R, V28, P11749, DOI 10.1007/s11356-017-0341-3; Samson-Robert O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108443; Sanchez-Bayo F, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00071; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Sur Robin, 2003, Bulletin of Insectology, V56, P35; Tapparo A, 2012, ENVIRON SCI TECHNOL, V46, P2592, DOI 10.1021/es2035152; U. S. Environmental Protection Agency, 2016, HUM HLTH BENCHM PEST; US Geological Survey, 2016, PEST NAT SYNTH PROJ; van Lexmond MB, 2015, ENVIRON SCI POLLUT R, V22, P1, DOI 10.1007/s11356-014-3220-1; Van Metre PC, 2017, ENVIRON POLLUT, V220, P431, DOI 10.1016/j.envpol.2016.09.085; Wettstein FE, 2016, J AGR FOOD CHEM, V64, P6407, DOI 10.1021/acs.jafc.6b02619; Wijnja H, 2014, B ENVIRON CONTAM TOX, V93, P228, DOI 10.1007/s00128-014-1251-4; Wisconsin Department of Agriculture Trade and Consumer Protection, 2011, 2011 BUR AGR MAN ANN; Wisconsin Department of Agriculture Trade and Consumer Protection, 2014, 2014 BUR AGR MAN ANN; Xing ZS, 2013, ARCH ENVIRON CON TOX, V64, P208, DOI 10.1007/s00244-012-9833-9	49	29	30	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0201753	10.1371/journal.pone.0201753	http://dx.doi.org/10.1371/journal.pone.0201753			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281610	Green Submitted, Green Published, gold			2022-12-26	WOS:000446342400007
J	Carro, J; Pueyo, E; Matas, JFR				Carro, Jesus; Pueyo, Esther; Matas, Jose F. Rodriguez			A response surface optimization approach to adjust ionic current conductances of cardiac electrophysiological models. Application to the study of potassium level changes	PLOS ONE			English	Article							TRANSMURAL HETEROGENEITY; ACTION-POTENTIALS; HUMAN HEART; REPOLARIZATION; MECHANISMS; MYOCYTES; ADAPTATION; CONDUCTION	Cardiac electrophysiological computational models are often developed from previously published models. The new models may incorporate additional features to adapt the model to a different species or may upgrade a specific ionic formulation based on newly available experimental data. A relevant challenge in the development of a new model is the estimation of certain ionic current conductances that cannot be reliably identified from experiments. A common strategy to estimate those conductances is by means of constrained non-linear least-squares optimization. In this work, a novel methodology is proposed for estimation of ionic current conductances of cardiac electrophysiological models by using a response surface approximation-based constrained optimization with trust region management. Polynomial response surfaces of a number of electrophysiological markers were built using statistical sampling methods. These markers included action potential duration (APD), triangulation, diastolic and systolic intracellular calcium concentration, and time constants of APD rate adaptation. The proposed methodology was applied to update the Carro et al. human ventricular action potential model after incorporation of intracellular potassium ([K+](i)) dynamics. While the Carro et al. model was well suited for investigation of arrhythmogenesis, it did not allow simulation of [K+](i) changes. With the methodology proposed in this study, the updated Carro et al. human ventricular model could be used to simulate [K+](i) changes in response to varying extracellular potassium ([K+](o)) levels. Additionally, it rendered values of evaluated electrophysiological markers within physiologically plausible ranges. The optimal values of ionic current conductances in the updated model were found in a notably shorter time than with previously proposed methodologies. As a conclusion, the response surface optimization-based approach proposed in this study allows estimating ionic current conductances of cardiac electrophysiological computational models while guaranteeing replication of key electrophysiological features and with an important reduction in computational cost with respect to previously published approaches. The updated Carro et al. model developed in this study is thus suitable for the investigation of arrhythmic risk-related conditions, including those involving large changes in potassium concentration.	[Carro, Jesus] Univ San Jorge, Zaragoza, Spain; [Carro, Jesus; Pueyo, Esther; Matas, Jose F. Rodriguez] Univ Zaragoza, IIS Aragon, Aragon Inst Engn Res, Zaragoza, Spain; [Carro, Jesus; Pueyo, Esther] CIBER Bioengn Biomat & Nanomedicne CIBER BBN, Zaragoza, Spain; [Matas, Jose F. Rodriguez] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, LaBS, Milan, Italy	Universidad San Jorge; University of Zaragoza; Polytechnic University of Milan	Carro, J (corresponding author), Univ San Jorge, Zaragoza, Spain.; Carro, J (corresponding author), Univ Zaragoza, IIS Aragon, Aragon Inst Engn Res, Zaragoza, Spain.; Carro, J (corresponding author), CIBER Bioengn Biomat & Nanomedicne CIBER BBN, Zaragoza, Spain.	jcarro@usj.es	Carro, Jesús/D-7488-2011; Pueyo, Esther/C-6945-2009; Matas, Jose F Rodriguez/H-4589-2011	Carro, Jesús/0000-0001-7789-2973; Pueyo, Esther/0000-0002-1960-407X; Matas, Jose F Rodriguez/0000-0001-7612-266X	Ministerio de Economia y Competitividad [DPI2016-75458-R]; CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through Instituto de Salud Carlos III; Grupo Consolidado BSICoS [T39_17R]; Grupo Consolidado AMB [T24_17R]	Ministerio de Economia y Competitividad(Spanish Government); CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through Instituto de Salud Carlos III; Grupo Consolidado BSICoS; Grupo Consolidado AMB	This work was supported by Ministerio de Economia y Competitividad (http://www.mineco.gob.es) under project DPI2016-75458-R, by CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN, http://www.ciber-bbn.es/) through Instituto de Salud Carlos III (http://www.isciii.es/), by Grupo Consolidado BSICoS (T39_17R) and Grupo Consolidado AMB (T24_17R), from DGA (http://www.aragon.es) and European Social Fund (http://ec.europa.eu/esf/home.jsp), and by the European Research Council (ERC, https://erc.europa.eu/) through project ERC-2014-StG 638284.	Bars DM, 2006, J PHARM SCI, V100, P315, DOI [10.1254/johs.C1:506001X, DOI 10.1254/JOHS.C1:506001X]; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; Bot CT, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00421; BOX G.E.P., 2005, STAT EXPT DESIGN INN; Carro J, 2017, PROG BIOPHYS MOL BIO, V129, P53, DOI 10.1016/j.pbiomolbio.2016.11.006; Carro J, 2011, PHILOS T R SOC A, V369, P4205, DOI 10.1098/rsta.2011.0127; Corsi C, 2017, SCI REP-UK, V7, DOI 10.1038/srep42492; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Dokos S, 2004, PROG BIOPHYS MOL BIO, V85, P407, DOI 10.1016/j.pbiomolbio.2004.02.002; DROUIN E, 1995, J AM COLL CARDIOL, V26, P185, DOI 10.1016/0735-1097(95)00167-X; Drouin E, 1998, J AM COLL CARDIOL, V32, P1063, DOI 10.1016/S0735-1097(98)00330-1; Dutta S, 2017, PROG BIOPHYS MOL BIO, V129, P40, DOI 10.1016/j.pbiomolbio.2017.02.007; Fabbri A, 2017, J PHYSIOL-LONDON, V595, P2365, DOI 10.1113/JP273259; Fink M, 2008, PROG BIOPHYS MOL BIO, V96, P357, DOI 10.1016/j.pbiomolbio.2007.07.011; FRANZ MR, 1988, J CLIN INVEST, V82, P972, DOI 10.1172/JCI113706; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; Groenendaal W, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004242; Guo T, 2013, COMP MATH MATH PHYS, V2013, P1, DOI [10.1155/2013/407917, DOI 10.1155/2013/407917]; Heidenreich EA, 2010, ANN BIOMED ENG, V38, P2331, DOI 10.1007/s10439-010-9997-2; Himeno Y, 2015, BIOPHYS J, V109, P415, DOI 10.1016/j.bpj.2015.06.017; Hondeghem LM, 2001, CIRCULATION, V103, P2004; Jost N, 2013, J PHYSIOL-LONDON, V591, P4189, DOI 10.1113/jphysiol.2013.261198; Kaur J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107984; Krogh-Madsen T, 2016, J PHYSIOL-LONDON, V594, P2525, DOI 10.1113/JP270618; Li GR, 1999, AM J PHYSIOL-HEART C, V276, pH98, DOI 10.1152/ajpheart.1999.276.1.H98; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; Livshitz L, 2009, BIOPHYS J, V97, P1265, DOI 10.1016/j.bpj.2009.05.062; Nygren A, 2001, PHILOS T ROY SOC A, V359, P1111, DOI 10.1098/rsta.2001.0819; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Pieske B, 1999, CIRC RES, V85, P38; Pueyo E, 2004, IEEE T BIO-MED ENG, V51, P1511, DOI 10.1109/TBME.2004.828050; Pueyo E, 2010, AM J PHYSIOL-HEART C, V298, pH1577, DOI 10.1152/ajpheart.00936.2009; Rodriguez JF, 1998, J MECH DESIGN, V120, P58, DOI 10.1115/1.2826677; Romero L, 2009, AM J PHYSIOL-HEART C, V297, pH1436, DOI 10.1152/ajpheart.00263.2009; Schmidt U, 1998, J MOL CELL CARDIOL, V30, P1929, DOI 10.1006/jmcc.1998.0748; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Syed Z, 2005, MED BIOL ENG COMPUT, V43, P561, DOI 10.1007/BF02351029; Taggart P, 2000, J MOL CELL CARDIOL, V32, P621, DOI 10.1006/jmcc.2000.1105; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Volders PGA, 2000, CARDIOVASC RES, V46, P376, DOI 10.1016/S0008-6363(00)00022-5; Walmsley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056359; Yao A, 1997, CELL CALCIUM, V22, P431, DOI 10.1016/S0143-4160(97)90070-1; Yue LX, 1996, AM J PHYSIOL-HEART C, V270, pH2157, DOI 10.1152/ajpheart.1996.270.6.H2157; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140	46	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204411	10.1371/journal.pone.0204411	http://dx.doi.org/10.1371/journal.pone.0204411			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281636	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400049
J	Soluri, MF; Boccafoschi, F; Cotella, D; Moro, L; Forestieri, G; Autiero, I; Cavallo, L; Oliva, R; Griffin, M; Wang, Z; Santoro, C; Sblattero, D				Soluri, Maria Felicia; Boccafoschi, Francesca; Cotella, Diego; Moro, Laura; Forestieri, Gabriela; Autiero, Ida; Cavallo, Luigi; Oliva, Romina; Griffin, Martin; Wang, Zhuo; Santoro, Claudio; Sblattero, Daniele			Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells	FASEB JOURNAL			English	Article						extracellular matrix; gelatin binding domain (GBD); ovarian cancer; cell adhesion	TISSUE TRANSGLUTAMINASE; WEB SERVER; EXTRACELLULAR-MATRIX; 3T3 FIBROBLASTS; OVARIAN-CANCER; PROTEIN; EXPRESSION; INTEGRIN; COMPLEXES; BETA	The interaction between the enzyme transglutaminase 2 (TG2) and fibronectin (FN) is involved in the cell-matrix interactions that regulate cell signaling, adhesion, and migration and play central roles in pathologic conditions, particularly fibrosis and cancer. A precise definition of the exact interaction domains on both proteins could provide a tool to design novel molecules with potential therapeutic applications. Although specific residues involved in the interaction within TG2 have been analyzed, little is known regarding the TG2 binding site on FN. This site has been mapped to a large internal 45-kDa protein fragment coincident with the gelatin binding domain (GBD). With the goal of defining the minimal FN interacting domain for TG2, we produced several expression constructs encoding different portions or modules of the GBD and tested their binding and functional properties. The results demonstrate that the I-8 module is necessary and sufficient for TG2-binding in vitro, but does not have functional effects on TG2-expressing cells. Modules I-7 and I-9 increase the strength of the binding and are required for cell adhesion. A 15-kDa fragment encompassing modules I7-9 behaves as the whole 45-kDa GBD and mediates signaling, adhesion, spreading, and migration of TG2(+) cells. This study provides new insights into the mechanism for TG2 binding to FN.Soluri, M. F., Boccafoschi, F., Cotella, D., Moro, L., Forestieri, G., Autiero, I., Cavallo, L., Oliva, R., Griffin, M., Wang, Z., Santoro, C., Sblattero, D. Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.	[Soluri, Maria Felicia; Boccafoschi, Francesca; Cotella, Diego; Forestieri, Gabriela; Santoro, Claudio] UPO, Dept Hlth Sci, Novara, Italy; [Soluri, Maria Felicia; Boccafoschi, Francesca; Cotella, Diego; Forestieri, Gabriela; Santoro, Claudio] UPO, IRCAD, Novara, Italy; [Moro, Laura] UPO, Dept Pharmaceut Sci, Novara, Italy; [Autiero, Ida; Cavallo, Luigi] KAUST, Catalysis Ctr KCC, Phys Sci & Engn Div, Thuwal, Saudi Arabia; [Oliva, Romina] KAUST, CBRC, Comp Elect & Math Sci & Engn CEMSE Div, Thuwal, Saudi Arabia; [Oliva, Romina] Univ Parthenope Naples, Dept Sci & Technol, Naples, Italy; [Griffin, Martin; Wang, Zhuo] Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England; [Sblattero, Daniele] Univ Trieste, Dept Life Sci, Via L Giorgieri 5, I-34127 Trieste, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Parthenope University Naples; Aston University; University of Trieste	Sblattero, D (corresponding author), Univ Trieste, Dept Life Sci, Via L Giorgieri 5, I-34127 Trieste, Italy.	dsblattero@units.it	Oliva, Romina/ABA-6313-2021; cotella, diego/J-8422-2019; Autiero, Ida/P-7002-2018; Boccafoschi, Francesca/ABG-1310-2020; Moro, Laura/ABF-2175-2020	Oliva, Romina/0000-0002-6156-6249; cotella, diego/0000-0003-2714-4744; Autiero, Ida/0000-0001-8886-8063; Boccafoschi, Francesca/0000-0002-6734-5447; Sblattero, Daniele/0000-0003-4309-242X; WANG, ZHUO/0000-0002-2212-8318; Griffin, Martin/0000-0003-3824-306X	Cariplo Foundation (Milan, Italy)	Cariplo Foundation (Milan, Italy)(Fondazione Cariplo)	This work was supported by the Cariplo Foundation (Milan, Italy). The authors declare no conflicts of interest.	Agnihotri N, 2017, AMINO ACIDS, V49, P425, DOI 10.1007/s00726-016-2320-2; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Assi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074437; Belkin AM, 2004, BIOCHEMISTRY-US, V43, P11760, DOI 10.1021/bi049266z; Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Cardoso I, 2017, AMINO ACIDS, V49, P489, DOI 10.1007/s00726-016-2296-y; Chen SH, 2010, ANTICANCER RES, V30, P4177; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; Chermak E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166460; D'Eletto M, 2009, AUTOPHAGY, V5, P1145, DOI 10.4161/auto.5.8.10040; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Di Niro R, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-46; Di Niro R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq052; Eckert RL, 2015, MOL CARCINOGEN, V54, P947, DOI 10.1002/mc.22375; Erat MC, 2013, J BIOL CHEM, V288, P17441, DOI 10.1074/jbc.M113.469841; Erat MC, 2010, J BIOL CHEM, V285, P33764, DOI 10.1074/jbc.M110.139394; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; FESUS L, 1986, EUR J BIOCHEM, V154, P371, DOI 10.1111/j.1432-1033.1986.tb09407.x; GENTILE V, 1992, J CELL BIOL, V119, P463, DOI 10.1083/jcb.119.2.463; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; Huang L, 2015, AM J CANCER RES, V5, P2756; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; INGHAM KC, 1995, ARCH BIOCHEM BIOPHYS, V316, P235, DOI 10.1006/abbi.1995.1033; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; JEONG JM, 1995, J BIOL CHEM, V270, P5654, DOI 10.1074/jbc.270.10.5654; Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200; Khanna M, 2011, MOL CANCER THER, V10, P626, DOI 10.1158/1535-7163.MCT-10-0912; Kotsakis P, 2011, AMINO ACIDS, V41, P909, DOI 10.1007/s00726-010-0790-1; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; LEMOSY EK, 1992, J BIOL CHEM, V267, P7880; Lensink MF, 2016, PROTEINS, V84, P323, DOI 10.1002/prot.25007; Lesort M, 1998, J BIOL CHEM, V273, P11991, DOI 10.1074/jbc.273.20.11991; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; LORAND L, 1988, P NATL ACAD SCI USA, V85, P1057, DOI 10.1073/pnas.85.4.1057; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lortat-Jacob H, 2012, J BIOL CHEM, V287, P18005, DOI 10.1074/jbc.M111.337089; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; MARTINEZ J, 1994, BIOCHEMISTRY-US, V33, P2538, DOI 10.1021/bi00175a024; Mishra S, 2007, J BIOL CHEM, V282, P18108, DOI 10.1074/jbc.M607413200; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Qiao SW, 2005, J IMMUNOL, V174, P1657, DOI 10.4049/jimmunol.174.3.1657; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; Rossin F, 2012, AMINO ACIDS, V42, P1793, DOI 10.1007/s00726-011-0899-x; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; Satpathy N, 2007, CANCER RES, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; Sblattero D, 2002, EUR J BIOCHEM, V269, P5175, DOI 10.1046/j.1432-1033.2002.03215.x; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Sottile J, 2000, J CELL SCI, V113, P4287; Stamnaes J, 2016, FEBS J, V283, P3994, DOI 10.1111/febs.13907; Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200; Torchala M, 2013, BIOINFORMATICS, V29, P807, DOI 10.1093/bioinformatics/btt038; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; TURNER PM, 1989, BIOCHEMISTRY-US, V28, P628, DOI 10.1021/bi00428a032; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; van Strien ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025037; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Wang Z, 2012, J BIOL CHEM, V287, P13063, DOI 10.1074/jbc.M111.294819; Wang Z, 2010, J BIOL CHEM, V285, P40212, DOI 10.1074/jbc.M110.123703; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Yakubov B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089285; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863; Zonca S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.30	71	8	8	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2327	2342		10.1096/fj.201800054RRR	http://dx.doi.org/10.1096/fj.201800054RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30285580				2022-12-26	WOS:000457296600064
J	Patten, G; Bernheimer, J; Fairlie, L; Rabie, H; Sawry, S; Technau, K; Eley, B; Davies, MA				Patten, Gabriela; Bernheimer, Jonathan; Fairlie, Lee; Rabie, Helena; Sawry, Shobna; Technau, Karl; Eley, Brian; Davies, Mary-Ann		IeDEA Southern Africa	Lamivudine monotherapy as a holding regimen for HIV-positive children	PLOS ONE			English	Article							INFECTED-CHILDREN; PHARMACOKINETICS; MUTATIONS; EFFICACY; THERAPY; FITNESS; VIRUS	Background In resource-limited settings holding regimens, such as lamivudine monotherapy (LM), are used to manage HIV-positive children failing combination antiretroviral therapy (cART) to mitigate the risk of drug resistance developing, whilst adherence barriers are addressed or when access to second- or third-line regimens is restricted. We aimed to investigate characteristics of children placed on LM and their outcomes. Methods We describe the characteristics of children (age <16 years at cART start) from 5 IeDEA-SA cohorts with a record of LM during their treatment history. Among those on LM for >90 days we describe their immunologic outcomes on LM and their immunologic and virologic outcomes after resuming cART. Findings We included 228 children in our study. At LM start their median age was 12.0 years (IQR 7.3-14.6), duration on cART was 3.6 years (IQR 2.0-5.9) and median CD4 count was 605.5 cells/mu L (IQR 427-901). Whilst 110 (48%) had no prior protease inhibitor (PI)-exposure, of the 69 with recorded PI-exposure, 9 (13%) patients had documented resistance to all Pls. After 6 months on LM, 70% (94/135) experienced a drop in CD4, with a predicted average CD4 decline of 46.5 cells/mu L (95% CI 37.7-55.4). Whilst on LM, 46% experienced a drop in CD4 to <500 cells/mu L, 18 (8%) experienced WHO stage 3 or 4 events, and 3 children died. On resumption of cART the average gain in CD4 was 15.65 cells/uL per month and 66.6% (95% CI 59.3-73.7) achieved viral suppression (viral load <1000) at 6 months after resuming cART. Interpretation Most patients experienced immune decline on LM. Its use should be avoided in those with low CD4 counts, but restricted use may be necessary when treatment options are limited. Managing children with virologic failure will continue to be challenging until more treatment options and better adherence strategies are available.	[Patten, Gabriela; Davies, Mary-Ann] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Bernheimer, Jonathan] Med Sans Frontieres Khayelitsha, Cape Town, South Africa; [Fairlie, Lee; Sawry, Shobna] Univ Witwatersrand, Sch Clin Med, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Rabie, Helena] Univ Stellenbosch, Tygerberg Acad Hosp, Stellenbosch, South Africa; [Technau, Karl] Univ Witwatersrand, Empilweni Serv & Res Unit, Dept Paediat & Child Hlth, Rahima Moosa Mother & Child Hosp, Johannesburg, South Africa; [Eley, Brian] Univ Cape Town, Red Cross War Mem Childrens Hosp, Cape Town, South Africa; [Eley, Brian] Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa	University of Cape Town; University of Witwatersrand; Stellenbosch University; University of Witwatersrand; University of Cape Town; University of Cape Town	Patten, G (corresponding author), Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa.	gem.patten@uct.ac.za	Rabie, Helena/ABH-1437-2020; Sawry, Shobna/CAF-9747-2022; Prozesky, Hans Walter/ABE-6956-2020; Patten, Gabriela/J-3461-2019; Boulle, Andrew/C-1413-2008	Rabie, Helena/0000-0001-6336-2963; Prozesky, Hans Walter/0000-0001-9715-3449; Patten, Gabriela/0000-0003-2511-1367; Tanser, Frank/0000-0001-9797-0000; Boulle, Andrew/0000-0002-7713-8062; Fatti, Geoffrey/0000-0002-6467-662X; Technau, Karl-Gunter/0000-0001-7367-7512	National Institute Of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), National Cancer Institute (NCI) [U01AI069924]; National Institute Of Allergy And Infectious Diseases of the National Institutes of Health [U01AI069924]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	National Institute Of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), National Cancer Institute (NCI); National Institute Of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute Of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), National Cancer Institute (NCI), (U01AI069924) (PIs Egger and Davies).; Research reported in this publication was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number U01AI069924. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors would like to acknowledge all patients, caregivers, and data managers involved in IeDEA-SA cohorts.	Agwu A, 2014, 6 INT WORKSH HIV PED; Agwu AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18579; Castagna A, 2006, AIDS, V20, P795, DOI 10.1097/01.aids.0000218542.08845.b2; Chadwick EG, 2008, AIDS, V22, P249, DOI 10.1097/QAD.0b013e3282f2be1d; Davies MA, 2011, JAIDS-J ACQ IMM DEF, V56, P270, DOI 10.1097/QAI.0b013e3182060610; Deval J, 2004, J BIOL CHEM, V279, P509, DOI 10.1074/jbc.M308806200; Devereux HL, 2001, J MED VIROL, V65, P218, DOI 10.1002/jmv.2023; Egger M, 2012, INT J EPIDEMIOL, V41, P1256, DOI 10.1093/ije/dyr080; Fairlie L, 2015, AIDS, V29, P2109, DOI 10.1097/QAD.0000000000000809; Gianotti N, 2008, J MED VIROL, V80, P201, DOI 10.1002/jmv.21085; Haberer Jessica, 2009, Curr HIV/AIDS Rep, V6, P194, DOI 10.1007/s11904-009-0026-8; Lazarus EM OK, J AIDS CLIN RES, V4; Lazarus Erica, 2017, Pediatr Infect Dis J, V36, P492, DOI 10.1097/INF.0000000000001481; Linder V, 2016, PEDIATR INFECT DIS J, V35, pE199, DOI 10.1097/INF.0000000000001156; Linder V, 2014, J INT AIDS SOC, V17, P164, DOI 10.7448/IAS.17.4.19763; Meyers T, 2007, J INFECT DIS, V196, pS474, DOI 10.1086/521116; National Department of Health SA, 2004, NAT ANT TREATM GUID; National Department of Health South Africa, 2015, NAT CONS GUID PREV M; Opravil M, 2010, JAIDS-J ACQ IMM DEF, V54, P51, DOI 10.1097/QAI.0b013e3181bef889; Quan YD, 2003, ANTIMICROB AGENTS CH, V47, P747, DOI 10.1128/AAC.47.2.747-754.2003; Rabie H, 2012, S AFR HIV CLIN SOC C; Rakhmanina N, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20936; Ren Y, 2008, JAIDS-J ACQ IMM DEF, V47, P566, DOI 10.1097/QAI.0b013e3181642257; Soria A, 2010, J CLIN VIROL, V47, P253, DOI 10.1016/j.jcv.2009.12.007; Steele RG, 2007, J DEV BEHAV PEDIATR, V28, P58; World Health Organisation, 2006, ANT THER HIV INF INF	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205455	10.1371/journal.pone.0205455	http://dx.doi.org/10.1371/journal.pone.0205455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308013	gold, Green Published			2022-12-26	WOS:000447173500081
J	De Bari, B; Breuneval, T; Zeverino, M; Godin, S; Deantonio, L; Geldhof, C; Bourhis, J; Schaefer, N; Moeckli, R; Prior, J; Ozsahin, M				De Bari, Berardino; Breuneval, Thomas; Zeverino, Michele; Godin, Sarah; Deantonio, Letizia; Geldhof, Christine; Bourhis, Jean; Schaefer, Nicklaus; Moeckli, Raphael; Prior, John; Ozsahin, Mahmut			Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study	PLOS ONE			English	Article							RADIATION-THERAPY; HEPATOCELLULAR-CARCINOMA; METASTASES	Purpose To study the potential of (99m)Tc-Mebrofenin hepatobiliary scintigraphy (HBS) in identifying the short-term variations of liver function after stereotactic body radiotherapy (SBRT) for liver cancers. Material and methods We treated with SBRT 3 patients (pts) affected by a cholangiocarcinoma and 3 patient presenting liver metastases (3x15 Gy, 4 pts; 5x8 Gy, 1 pt; 6x5 Gy, 1 pt). All patients received HBS before and 3 months after SBRT, which were co-registered with the simulation CT-scan. Structures corresponding to isodoses from 10-90 Gy were created, with intervals of 10 Gy. Finally, the variations of the mean activity (MBq) in each isodose structure have been calculated. Then, a linear regression analysis was performed. Results We showed a linear reduction of the activity, significantly related to the delivered dose (p<0.01), and a reduction of the perfusion of 0.78% for each delivered Gy. The linear equation has predictive value of the loss of the function of 96% (R2 = 0.9605). Conclusions HBS could improve treatment plans for liver SBRT, by allowing the identification of the liver function variations after SBRT and, potentially, the prediction of remnant liver function after SBRT. These preliminary results should be confirmed on long term prospective data and larger population.	[De Bari, Berardino; Breuneval, Thomas; Godin, Sarah; Bourhis, Jean; Ozsahin, Mahmut] CHU Vaudois, Serv Radiooncol, Lausanne, Switzerland; [De Bari, Berardino] Ctr Hosp Reg Univ Jean Minjoz, Serv Radiooncol, INSERM EFS BFC U1098, Besancon, France; [Zeverino, Michele; Moeckli, Raphael] CHU Vaudois, Inst Radiophys, Lausanne, Switzerland; [Deantonio, Letizia] Univ Hosp Maggiore della Carita, Dept Radiat Oncol, Novara, Italy; [Geldhof, Christine; Schaefer, Nicklaus; Prior, John] CHU Vaudois, Serv Med Nucl, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Eastern Piedmont Amedeo Avogadro; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	De Bari, B (corresponding author), CHU Vaudois, Serv Radiooncol, Lausanne, Switzerland.; De Bari, B (corresponding author), Ctr Hosp Reg Univ Jean Minjoz, Serv Radiooncol, INSERM EFS BFC U1098, Besancon, France.	bdebari@chu-besancon.fr	/AAA-3999-2021; Deantonio, Letizia/GLS-8282-2022; PRIOR, John O/I-5364-2017; Moeckli, Raphaël/CAG-0564-2022; /AGH-8966-2022	Deantonio, Letizia/0000-0002-2812-2283; PRIOR, John O/0000-0003-1429-1374; Moeckli, Raphaël/0000-0002-5885-934X; /0000-0002-5885-934X; Zeverino, Michele/0000-0001-9941-8252; Bourhis, Jean/0000-0001-5162-1171; De Bari, Berardino/0000-0003-0117-3360				De Bari B, 2010, CANCER RADIOTHER, V14, P344, DOI 10.1016/j.canrad.2010.02.013; De Bari B, 2016, TUMORI, V102, pE21, DOI 10.5301/tj.5000523; de Graaf W, 2010, J NUCL MED, V51, P742, DOI 10.2967/jnumed.109.069435; Deantonio L, 2016, CRIT REV ONCOL HEMAT; Dyk P, 2015, PRACT RADIAT ONCOL, V5, P176, DOI 10.1016/j.prro.2014.09.007; Ekman M, 1996, NUCL MED COMMUN, V17, P235, DOI 10.1097/00006231-199603000-00011; Franco P, 2014, TUMORI J, V100, pE214, DOI [10.1177/1778.19280, 10.1700/1778.19280]; Gunven P, 2011, MED ONCOL, V28, P958, DOI 10.1007/s12032-010-9567-3; Kalogeridi MA, 2015, WORLD J HEPATOL, V7, P101, DOI 10.4254/wjh.v7.i1.101; Lewis SL, 2017, AM J CLIN ONCOL-CANC, V40, P418, DOI 10.1097/COC.0000000000000169; Meng MB, 2015, DRUG DISCOV THER, V9, P372, DOI 10.5582/ddt.2015.01056; Pan CC, 2010, INT J RADIAT ONCOL, V76, pS94, DOI 10.1016/j.ijrobp.2009.06.092; Sanuki N, 2015, HEPATOL RES, V45, P540, DOI 10.1111/hepr.12383; Scorsetti M, 2014, J GASTROINTEST ONCOL, V5, P190, DOI 10.3978/j.issn.2078-6891.2014.039; Shen S, 2014, MED DOSIM, V39, P7, DOI 10.1016/j.meddos.2013.08.006; Wang PM, 2015, REP PRACT ONCOL RADI, V20, P417, DOI 10.1016/j.rpor.2015.03.005	16	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204013	10.1371/journal.pone.0204013	http://dx.doi.org/10.1371/journal.pone.0204013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304045	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100028
J	Ghosh, DK; Kokane, S; Kumar, P; Ozcan, A; Warghane, A; Motghare, M; Santra, S; Sharma, AK				Ghosh, Dilip Kumar; Kokane, Sunil; Kumar, Pranav; Ozcan, Ali; Warghane, Ashish; Motghare, Manali; Santra, Swadeshmukul; Sharma, Ashwani Kumar			Antimicrobial nano-zinc oxide-2S albumin protein formulation significantly inhibits growth of "Candidatus Liberibacter asiaticus" in planta	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; 2S ALBUMIN; CITRUS; DISEASE; ANTIBACTERIAL; NANOPARTICLES; ANTIFUNGAL; AMERICANUS; ADSORPTION; BACTERIAL	Huanglongbing (HLB, also known as citrus greening) is considered to be the most devastating disease that has significantly damaged the citrus industry globally. HLB is caused by the Candidatus Liberibacter asiaticus (CLas), the fastidious phloem-restricted gram-negative bacterium, vectored by the asian citrus psyllid. To date, there is no effective control available against CLas. To alleviate the effects of HLB on the industry and protect citrus farmers, there is an urgent need to identify or develop inhibitor molecules to suppress or eradicate CLas from infected citrus plant. In this paper, we demonstrate for the first time an in planta efficacy of two antimicrobial compounds against CLas viz. 2S albumin (a plant based protein; similar to 12.5 kDa), Nano-Zinc Oxide (Nano-ZnO similar to 4.0 nm diameter) and their combinations. Aqueous formulations of these compounds were trunk-injected to HLB affected Mosambi plants (Citrus sinensis) grafted on 3-year old rough lemon (C. jambhiri) rootstock with known CLas titer maintained inside an insect-free screen house. The effective concentration of 2S albumin (330 ppm) coupled with the Nano-ZnO (330 ppm) at 1:1 ratio was used. The dynamics of CLas pathogen load of treated Mosambi plants was assessed using TaqMan-qPCR assay every 30 days after treatment (DAT) and monitored till 120 days. We observed that 2S albumin-Nano-ZnO formulation performed the best among all the treatments decreasing CLas population by 96.2%, 97.6%, 95.6%, and 97% of the initial bacterial load (per 12.5 ng of genomic DNA) at 30, 60, 90, and 120 DAT, respectively. Our studies demonstrated the potency of 2S albumin-Nano-ZnO formulation as an antimicrobial treatment for suppressing CLas in planta and could potentially be developed as a novel anti CLas therapeutics to mitigate the HLB severity affecting the citrus industry worldwide.	[Ghosh, Dilip Kumar; Kokane, Sunil; Motghare, Manali] ICAR Cent Citrus Res Inst, Plant Virol Lab, Nagpur, Maharashtra, India; [Kumar, Pranav; Sharma, Ashwani Kumar] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttar Pradesh, India; [Ozcan, Ali; Santra, Swadeshmukul] Univ Cent Florida, Dept Chem, NanoSci Technol Ctr, Orlando, FL 32816 USA; [Warghane, Ashish; Santra, Swadeshmukul] Univ Cent Florida, Dept Mat Sci & Engn, Orlando, FL 32816 USA; [Santra, Swadeshmukul] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	Indian Council of Agricultural Research (ICAR); ICAR - Central Citrus Research Institute; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Sharma, AK (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttar Pradesh, India.; Santra, S (corresponding author), Univ Cent Florida, Dept Chem, NanoSci Technol Ctr, Orlando, FL 32816 USA.; Santra, S (corresponding author), Univ Cent Florida, Dept Mat Sci & Engn, Orlando, FL 32816 USA.; Santra, S (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	ssantra@ucf.edu; aksbsfbs@iitr.ac.in	kokane, sunil/W-2379-2019; Ozcan, Ali/AAR-1045-2020; Ghosh, Dilip/W-7874-2019; Warghane, Ashish/AAY-9078-2020; Ozcan, Ali/AAC-3457-2021; Warghane, Ashish/GRJ-7718-2022	kokane, sunil/0000-0001-6904-3672; Ozcan, Ali/0000-0001-6781-535X; Ghosh, Dilip/0000-0001-6237-7610; Warghane, Ashish/0000-0002-9778-2998; Ozcan, Ali/0000-0001-6781-535X; Warghane, Ashish/0000-0002-9778-2998	CDRE from the USDA National Institute of Food and Agriculture, USA [2015-70016-23010]; DBT, Government of India [BT/PR9877/BRB/10/1274/2014]; UGC, Government of India	CDRE from the USDA National Institute of Food and Agriculture, USA; DBT, Government of India(Department of Biotechnology (DBT) India); UGC, Government of India(University Grants Commission, India)	This work is partly supported by the CDRE Grant no. 2015-70016-23010 from the USDA National Institute of Food and Agriculture, USA; and DBT, Government of India Grant no. BT/PR9877/BRB/10/1274/2014.; Pranav Kumar thanks UGC, Government of India for fellowship. Authors thank Dr. Siddarame Gowda, CREC, University of Florida, USA for reviewing the manuscript. We also thank Mr Tyler Maxwell for editing this manuscript. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Department of Agriculture. AO and SS acknowledge the UCF Materials Innovation and Sustainable Agriculture Center for facilities and technical support for Nano-ZnO formulation.	Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; Aleaghil SA, 2016, INT J ADV BIOTECHNOL, V7, P1569; Ashish Warghane, 2017, Indian Phytopathology, V70, P359; Bassanezi R. B, 2007, PLANT HLTH PROGR, V8, P1, DOI DOI 10.1094/PHP-2007-0906-01-RV; Bhunia AK, 2016, CHEMISTRYSELECT, V1, P2872, DOI 10.1002/slct.201600446; Bove JM, 2006, J PLANT PATHOL, V88, P7; Canales E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146223; CHANEY RL, 1993, ZINC SOILS PLANTS, P135, DOI DOI 10.1007/978-94-011-0878-2_10; Dutt M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137134; Environmental Protection Agency (EPA), 2018, FED REG, V83, P42783; Etxeberria E, 2012, PROC FL STATE HORTIC, V125, P67; Fang EF, 2010, FEBS LETT, V584, P4089, DOI 10.1016/j.febslet.2010.08.041; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Garnier M., 2000, Proceedings of the 14th Conference of the International Organization of Citrus Virologists, Campinas, Sao Paulo State, Brazil, 13-18 September 1998, P369; Ghosh D, 2013, PHYTOPARASITICA, V41, P295, DOI 10.1007/s12600-013-0290-4; Ghosh DK, 2016, J PLANT BIOCHEM BIOT, V25, P219, DOI 10.1007/s13562-015-0332-8; Ghosh DK, 2015, PHYTOPATHOLOGY, V105, P1043, DOI 10.1094/PHYTO-09-14-0253-R; Graham JH, 2016, PLANT DIS, V100, P2442, DOI 10.1094/PDIS-05-16-0598-RE; Haapalainen M, 2014, ANN APPL BIOL, V165, P172, DOI 10.1111/aab.12149; Hadi N, 2016, WORLD SCI NEWS, V33, P1; Hu JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150433; Khodakovskaya MV, 2013, SMALL, V9, P115, DOI 10.1002/smll.201201225; Koh EJ, 2012, PROTOPLASMA, V249, P687, DOI 10.1007/s00709-011-0312-3; Lee G, 2017, SCI REP-UK, V7, DOI 10.1038/srep39432; Li M, 2011, ENVIRON SCI TECHNOL, V45, P1977, DOI 10.1021/es102624t; Li WB, 2008, PLANT DIS, V92, P854, DOI 10.1094/PDIS-92-6-0854; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Liu Y, 2009, J APPL MICROBIOL, V107, P1193, DOI 10.1111/j.1365-2672.2009.04303.x; Mafra V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-247; Maria-Neto S, 2011, PROTEIN J, V30, P340, DOI 10.1007/s10930-011-9337-x; MARTINEZ A. L., 1967, PLANT DIS REPORT, V51, P692; Meng S, 2010, CURR PROTEIN PEPT SC, V11, P264, DOI 10.2174/138920310791233369; Mishra S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00471; Nwugo CC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-59; Parker JK, 2014, PHYTOPATHOLOGY, V104, P15, DOI 10.1094/PHYTO-05-13-0119-R; Pitino M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00982; Ribeiro SFF, 2012, PROTEIN J, V31, P59, DOI 10.1007/s10930-011-9375-4; Sabir Sidra, 2014, ScientificWorldJournal, V2014, P925494, DOI 10.1155/2014/925494; Sasidharan NP, 2013, COLLOID SURFACE B, V102, P195, DOI 10.1016/j.colsurfb.2012.07.034; Sawai J, 1998, J FERMENT BIOENG, V86, P521, DOI 10.1016/S0922-338X(98)80165-7; SCHWARZ RE, 1973, FAO PLANT PROTECT B, V21, P132; Sechler A, 2009, PHYTOPATHOLOGY, V99, P480, DOI 10.1094/PHYTO-99-5-0480; Sharma A, 2017, PROTEIN PEPTIDE LETT, V24, P368, DOI 10.2174/0929866524666170126144936; Taning CNT, 2016, SCI REP-UK, V6, DOI 10.1038/srep38082; Teixeira DD, 2005, INT J SYST EVOL MICR, V55, P1857, DOI 10.1099/ijs.0.63677-0; Tomar PPS, 2014, BIOCHEM BIOPH RES CO, V448, P349, DOI 10.1016/j.bbrc.2014.04.158; Tripathi KM, 2017, ACS SUSTAIN CHEM ENG, V5, P2906, DOI 10.1021/acssuschemeng.6b01937; Verma SK, 2018, NANOMEDICINE-UK, V13, P43, DOI 10.2217/nnm-2017-0237; Wang N, 2017, ANNU REV PHYTOPATHOL, V55, P451, DOI 10.1146/annurev-phyto-080516-035513; Wang N, 2013, PHYTOPATHOLOGY, V103, P652, DOI 10.1094/PHYTO-12-12-0331-RVW; Wang YS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00933; Xie YP, 2011, APPL ENVIRON MICROB, V77, P2325, DOI 10.1128/AEM.02149-10; Yang CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155472; Yang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133826; Zhang A, 2010, J EXP BOT, V61, P4399, DOI 10.1093/jxb/erq243; Zhang MQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111032; Zhang MQ, 2011, PHYTOPATHOLOGY, V101, P1097, DOI 10.1094/PHYTO-09-10-0262; Zhao LJ, 2014, J AGR FOOD CHEM, V62, P2752, DOI 10.1021/jf405476u	59	21	22	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204702	10.1371/journal.pone.0204702	http://dx.doi.org/10.1371/journal.pone.0204702			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304000	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100065
J	Rong, F; Isenberg, AL; Sun, E; Hickok, G				Rong, Feng; Isenberg, A. Lisette; Sun, Erica; Hickok, Gregory			The neuroanatomy of speech sequencing at the syllable level	PLOS ONE			English	Article							SENSORY-MOTOR INTEGRATION; LEXICAL ACCESS; BROCAS AREA; FMRI; LANGUAGE; BEHAVIOR; LESION; MEMORY; ORDER; MODEL	Correctly ordering a sequence of speech sounds is a crucial aspect of speech production. Although studies have yielded a rich body of data on the neural substrates of visuomotor sequencing and sequence learning, research on brain regions and their functions involving speech sequence production hasn't attracted much attention until recently. Previous functional MRI studies manipulating the complexity of sequences at the phonemic, syllabic, and suprasyllabic levels have revealed a network of motor-related cortical and sub-cortical speech regions. In this study, we directly compared human brain activity measured with functional MRI during processing of a sequence of syllables compared with the same syllables processed individually. Among a network of regions independently identified as being part of the sensorimotor circuits for speech production, only the left posterior inferior frontal gyrus (pars opercularis, lIFG), the supplementary motor area (SMA), and the left inferior parietal lobe (lIPL) responded more during the production of syllable sequences compared to producing the same syllables articulated one at a time.	[Rong, Feng; Isenberg, A. Lisette; Sun, Erica; Hickok, Gregory] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine	Hickok, G (corresponding author), Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA.	Greg.hickok@uci.edu			NIDCD [R01 DC009659]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009659] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by NIDCD R01 DC009659.	Alamia A, 2016, J COGNITIVE NEUROSCI, V28, P402, DOI 10.1162/jocn_a_00911; Ashe J, 2006, CURR OPIN NEUROBIOL, V16, P213, DOI 10.1016/j.conb.2006.03.008; BAARS BJ, 1975, J VERB LEARN VERB BE, V14, P382, DOI 10.1016/S0022-5371(75)80017-X; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Balleine BW, 2015, CURR OPIN BEHAV SCI, V5, P1, DOI 10.1016/j.cobeha.2015.06.001; Becker JT, 1999, BRAIN COGNITION, V41, P27, DOI 10.1006/brcg.1999.1094; Bernstein N, 1967, COORDINATION REGULAT; Bohland JW, 2006, NEUROIMAGE, V32, P821, DOI 10.1016/j.neuroimage.2006.04.173; Botvinick MM, 2009, COGNITION, V113, P262, DOI 10.1016/j.cognition.2008.08.011; Buchsbaum BR, 2008, J COGNITIVE NEUROSCI, V20, P762, DOI 10.1162/jocn.2008.20501; Buchsbaum BR, 2011, BRAIN LANG, V119, P119, DOI 10.1016/j.bandl.2010.12.001; Clerget E, 2011, NEUROREPORT, V22, P965, DOI 10.1097/WNR.0b013e32834d87cd; Dell G.S., 1995, INVITATION COGNITIVE, V1, P183; Dell GS, 2013, COGNITION, V128, P380, DOI 10.1016/j.cognition.2013.05.007; Dell GS, 1997, PSYCHOL REV, V104, P801, DOI 10.1037/0033-295X.104.4.801; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Eriksson J, 2015, NEURON, V88, P33, DOI 10.1016/j.neuron.2015.09.020; Fedorenko E, 2015, J NEUROPHYSIOL, V113, P2376, DOI 10.1152/jn.00214.2014; FROMKIN VA, 1971, LANGUAGE, V47, P27, DOI 10.2307/412187; Garrett MF., 1975, PSYCHOL LEARN MOTIV, P133, DOI DOI 10.1016/S0079-7421(08)60270-4; Golfinopoulos E, 2010, NEUROIMAGE, V52, P862, DOI 10.1016/j.neuroimage.2009.10.023; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Guenther FH, 2016, NEURAL CONTROL OF SPEECH, P1, DOI 10.7551/mitpress/10471.001.0001; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Hickok G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00649; Hickok G, 2012, NAT REV NEUROSCI, V13, P135, DOI 10.1038/nrn3158; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Hickok G, 2009, J NEUROPHYSIOL, V101, P2725, DOI 10.1152/jn.91099.2008; Hillis AE, 2004, BRAIN, V127, P1479, DOI 10.1093/brain/awh172; Houde JF, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00082; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Levelt W., 1989, SPEAKING INTENTION A; Levelt WJM, 1999, TRENDS COGN SCI, V3, P223, DOI 10.1016/S1364-6613(99)01319-4; LEVELT WJM, 1994, COGNITION, V50, P239, DOI 10.1016/0010-0277(94)90030-2; Oppenheim GM, 2008, COGNITION, V106, P528, DOI 10.1016/j.cognition.2007.02.006; Pa J, 2008, NEUROPSYCHOLOGIA, V46, P362, DOI 10.1016/j.neuropsychologia.2007.06.024; Peeva MG, 2010, NEUROIMAGE, V50, P626, DOI 10.1016/j.neuroimage.2009.12.065; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Rhodes BJ, 2004, HUM MOVEMENT SCI, V23, P699, DOI 10.1016/j.humov.2004.10.008; Rosenbaum DA, 2007, HUM MOVEMENT SCI, V26, P525, DOI 10.1016/j.humov.2007.04.001; SCHRIEFERS H, 1990, J MEM LANG, V29, P86, DOI 10.1016/0749-596X(90)90011-N; Schubotz RI, 2004, J NEUROSCI, V24, P5467, DOI 10.1523/JNEUROSCI.1169-04.2004; Segawa JA, 2015, J COGNITIVE NEUROSCI, V27, P819, DOI 10.1162/jocn_a_00737; Shattuck-Hufnagel S, 2015, BLACKW HBK LINGUIST, P419; SHATTUCKHUFNAGEL S, 1992, COGNITION, V42, P213, DOI 10.1016/0010-0277(92)90044-I; Tian X, 2015, J COGNITIVE NEUROSCI, V27, P352, DOI 10.1162/jocn_a_00692; Walker GM, 2016, PSYCHON B REV, V23, P339, DOI 10.3758/s13423-015-0903-7; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Wilson SM, 2009, HUMAN BRAIN MAPPING	52	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0196381	10.1371/journal.pone.0196381	http://dx.doi.org/10.1371/journal.pone.0196381			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4OW	30300341	Green Submitted, gold, Green Published			2022-12-26	WOS:000446897200001
J	Bouazizi, K; Rahhal, A; Kusmia, S; Evin, M; Defrance, C; Cluzel, P; Berthet, M; Atassi, F; Leprince, P; Lebreton, G; Kachenoura, N; Hatem, SN; Redheuil, A				Bouazizi, Khaoula; Rahhal, Amer; Kusmia, Slawomir; Evin, Morgane; Defrance, Carine; Cluzel, Philippe; Berthet, Myriam; Atassi, Fabrice; Leprince, Pascal; Lebreton, Guillaume; Kachenoura, Nadjia; Hatem, Stephane N.; Redheuil, Alban			Differentiation and quantification of fibrosis, fat and fatty fibrosis in human left atrial myocardium using ex vivo MRI	PLOS ONE			English	Article							HISTOLOGICAL VALIDATION; TISSUE CHARACTERIZATION; ADIPOSE-TISSUE; T1; FIBRILLATION; MORTALITY; HEART	Background Atrial fibrillation is associated with an atrial cardiomyopathy composed mainly of fibrosis and adipose tissue accumulation. We hypothesized that MRI, when used in an optimal ex vivo setting allowing high spatial resolution without motion artifacts, can help characterizing the complex 3D left atrial (LA) wall composition in human myocardial samples, as compared to histology. Methods This prospective case-control study was approved by the institutional review board. 3D MRI acquisitions including saturation-recovery T1 mapping and DIXON imaging was performed at 4.0 T on 9 human LA samples collected from patients who underwent cardiac surgery. Histological quantification of fibrosis and fat was obtained. MRI T1 maps were clustered based on a Gaussian Mixture Model allowing quantification of total, interstitial and fatty fibrosis components. Fat maps were computed from DIXON images and fat fractions were calculated. MRI measurements were performed on the same location as the histological analysis (plane) and on the entire sample volume (3D). Results High correlations and levels of agreement were observed between MRI and histology for total (r = 0.93), interstitial (r = 0.93) and fatty fibrosis (r = 0.98) and fat (r = 0.96). Native T1 correlated with the amount of fibrosis from MRI and histology. The 3D MRI total, interstitial and fatty fibrosis ranges were between 6% and 23%, 4% and 17.3%; and 1.4% and 19.7% respectively. Conclusion High Field ex vivo MRI was able to quantify different LA myocardial components with high agreement in 2D with histology and moreover to provide 3D quantification of such components whereas in vivo application remains a challenge.	[Bouazizi, Khaoula; Kusmia, Slawomir; Evin, Morgane; Cluzel, Philippe; Hatem, Stephane N.; Redheuil, Alban] La Pitie Salpetriere Hosp, Inst Cardiometab & Nutr, Paris, France; [Bouazizi, Khaoula; Evin, Morgane; Cluzel, Philippe; Kachenoura, Nadjia; Redheuil, Alban] Sorbonne Univ, INSERM 1146, CNRS 7371, Lab Imagerie Biomed, Paris, France; [Rahhal, Amer; Berthet, Myriam; Atassi, Fabrice; Hatem, Stephane N.] Sorbonne Univ, Fac Med, Res Unit Cardiovasc Metab & Nutr Dis, UMRS 1166, Paris, France; [Defrance, Carine; Leprince, Pascal; Lebreton, Guillaume; Hatem, Stephane N.] La Pitie Salpetriere Hosp, AP HP, Dept Cardiovasc & Thorac Surg, Cardiol Inst, Paris, France; [Cluzel, Philippe; Redheuil, Alban] La Pitie Salpetriere Hosp, AP HP, Dept Cardiovasc Imaging Intervent & Thorac Radiol, Cardiol Inst, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Bouazizi, K (corresponding author), La Pitie Salpetriere Hosp, Inst Cardiometab & Nutr, Paris, France.; Bouazizi, K (corresponding author), Sorbonne Univ, INSERM 1146, CNRS 7371, Lab Imagerie Biomed, Paris, France.	k.bouazizi@ican-institute.org	Hatem, Stephane/D-1016-2017; Kachenoura, Nadjia/AAF-5338-2021	Kachenoura, Nadjia/0000-0002-5269-3246; Bouazizi, Khaoula/0000-0001-9492-4703; Lebreton, Guillaume/0000-0003-4308-506X; Kusmia, Slawomir/0000-0003-1328-3014	Agence Nationale de la Recherche [ANR-10-IAHU-05]; Agence Nationale de la Recherche RHU-CARMA [ANR-15-RHUS-0003]; H2020 European Research Council [633193]; Fondation pour la Recherche Medicale [DEQ20160334880]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Agence Nationale de la Recherche RHU-CARMA(French National Research Agency (ANR)); H2020 European Research Council; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by: Agence Nationale de la Recherche ANR-10-IAHU-05 to SNH; Agence Nationale de la Recherche RHU-CARMA ANR-15-RHUS-0003 to SNH and AR; H2020 European Research Council 633193 to SNH and AR; and Fondation pour la Recherche Medicale DEQ20160334880 FRM to SNH and AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Chekakie MO, 2010, J AM COLL CARDIOL, V56, P784, DOI 10.1016/j.jacc.2010.03.071; Andersson T, 2013, EUR HEART J, V34, P1061, DOI 10.1093/eurheartj/ehs469; Beinart R, 2013, HEART RHYTHM, V10, P1325, DOI 10.1016/j.hrthm.2013.05.003; Bohnen S, 2017, EUR HEART J-CARD IMG, V18, P744, DOI 10.1093/ehjci/jex007; Bull S, 2013, HEART, V99, P932, DOI 10.1136/heartjnl-2012-303052; Caudron J, 2013, EUR RADIOL, V23, P1871, DOI 10.1007/s00330-013-2801-6; Chow K, 2014, MAGN RESON MED, V71, P2082, DOI 10.1002/mrm.24878; Dass S, 2012, CIRC-CARDIOVASC IMAG, V5, P726, DOI 10.1161/CIRCIMAGING.112.976738; de Ravenstein CD, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0150-0; Ferreira VM, 2014, J THORAC IMAG, V29, P147, DOI 10.1097/RTI.0000000000000077; Fontana M, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-88; Germain P, 2014, CLIN MED INSIGHTS-CA, V8, P1, DOI 10.4137/CMC.S19005; Goette A, 2016, J ARRYTHM, V32, P247, DOI 10.1016/j.joa.2016.05.002; Goto Y, 2015, J CARDIOVASC MAGN R, P17; Grieve SM, 2000, MAGN RESON MED, V43, P747, DOI 10.1002/(SICI)1522-2594(200005)43:5<747::AID-MRM18>3.0.CO;2-Z; Haemers P, 2017, EUR HEART J, V38, P53, DOI 10.1093/eurheartj/ehv625; Hamilton-Craig CR, 2017, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00049; Hatem SN, 2016, CARDIOVASC RES, V109, P502, DOI 10.1093/cvr/cvw001; Hinojar R, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.003285; Huber A, 2018, RADIOLOGY, P286; Karamitsos TD, 2013, JACC-CARDIOVASC IMAG, V6, P488, DOI 10.1016/j.jcmg.2012.11.013; KELLMAN P, 2014, J CARDIOVASC MAGN R, V16, DOI DOI 10.1186/1532-429X-16-1; Kellman P, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0136-y; Liu CY, 2010, MAGN RESON MED, V63, P892, DOI 10.1002/mrm.22289; Messroghli DR, 2007, MAGN RESON MED, V58, P34, DOI 10.1002/mrm.21272; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Press W, 2007, SECTION 16 1 GAUSSIA; Puntmann VO, 2013, JACC-CARDIOVASC IMAG, V6, P475, DOI 10.1016/j.jcmg.2012.08.019; Robson MD, 2013, MAGN RESON MED, V70, P664, DOI 10.1002/mrm.24867; Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8; Sheskin D., 2003, HDB PARAMETRIC NONPA, P973; Siepen FAD, 2015, EUR HEART J-CARD IMG, V16, P210, DOI 10.1093/ehjci/jeu183; Yu HZ, 2011, MAGN RESON MED, V66, P199, DOI 10.1002/mrm.22840	33	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205104	10.1371/journal.pone.0205104	http://dx.doi.org/10.1371/journal.pone.0205104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296279	Green Published, Green Submitted, gold			2022-12-26	WOS:000446632700020
J	Ahs, JW; Dhejne, C; Magnusson, C; Dal, H; Lundin, A; Arver, S; Dalman, C; Kosidou, K				Ahs, Jill W.; Dhejne, Cecilia; Magnusson, Cecilia; Dal, Henrik; Lundin, Andreas; Arver, Stefan; Dalman, Christina; Kosidou, Kyriaki			Proportion of adults in the general population of Stockholm County who want gender-affirming medical treatment	PLOS ONE			English	Article							IDENTITY/GENDER DYSPHORIA QUESTIONNAIRE; HEALTH; ADOLESCENTS; PREVALENCE; CARE	The number of patients presenting for care at gender clinics is increasing, yet the proportion of adults in the general population who want gender-affirming medical treatment remains essentially unknown. We measured the wish for cross-sex hormones or gender-affirming surgery, as well as other aspects of gender incongruence, among the general adult population of Stockholm County, Sweden. A population-representative sample of 50,157 Stockholm County residents ages 22 and older comprise the Stockholm Public Health Cohort. They were enrolled in 2002, 2006, and 2010 and followed-up in roughly 4-year intervals, with questions on health, lifestyle and social characteristics. In 2014, participants received the item "I would like hormones or surgery to be more like someone of a different sex." Two additional items concerned other aspects of gender incongruence: "I feel like someone of a different sex, and I would like to live as or be treated as someone of a different sex." Each item had four answer options ("Not at all correct," "Somewhat or occasionally correct," "Quite correct," and "Absolutely correct"). For each item, any of the three affirmative answer choices were considered as some level of agreement. Calibration weights were used to estimate population-representative rates with 95% confidence intervals. The desire for cross-sex hormones or surgery was reported by 0.5% (95% CI, 0.4%-0.7%) of participants. Feeling like someone of a different sex was reported by 2.3% (95% CI, 2.1%-2.6%). Wanting to live as or be treated as a person of another sex was reported by 2.8% (95% CI, 2.4%-3.1%). These findings greatly exceed estimates of the number of patients receiving gender-affirming medical care. Clinicians must be prepared to recognize and care for patients experiencing discomfort due to gender incongruence and those who would like gender-affirming medical treatment.	[Ahs, Jill W.; Magnusson, Cecilia; Dal, Henrik; Lundin, Andreas; Dalman, Christina; Kosidou, Kyriaki] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Dhejne, Cecilia; Arver, Stefan] Karolinska Univ Hosp, ANOVA, Ctr Expertise Androl Sexual Med &Transgender Med, Stockholm, Sweden; [Dhejne, Cecilia; Arver, Stefan] Karolinska Inst, Dept Med, Stockholm, Sweden; [Dhejne, Cecilia; Arver, Stefan] Karolinska Univ Hosp, Stockholm, Sweden; [Magnusson, Cecilia; Dal, Henrik; Dalman, Christina; Kosidou, Kyriaki] Stockholm Cty Council, Ctr Epidemiol & Community Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Stockholm County Council	Ahs, JW (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	jill.w.ahs@gmail.com	Dhejne, Cecilia/AAH-5737-2019	Kosidou, Kyriaki/0000-0002-1165-9455; Dalman, Christina/0000-0002-3579-2357; Magnusson, Cecilia/0000-0002-8567-6725; Dhejne, Cecilia/0000-0003-1743-9012	Stockholm County Council; Swedish Research Council [2012-2264, 523-2010-1052]; Stockholm County Council [2007008]; Swedish Council for Working Life and Social Research [2007-2064]; Swedish Regional agreement on medical training and clinical research	Stockholm County Council(Stockholm County Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Regional agreement on medical training and clinical research	This work was supported by the Stockholm County Council and the Swedish Research Council (Grant # 2012-2264). The data linkages and staff costs have also been supported by grants from the Stockholm County Council (Grant # 2007008), Swedish Council for Working Life and Social Research (Grant # 2007-2064), Swedish Research Council (Grant # 523-2010-1052), and Swedish Regional agreement on medical training and clinical research. The study sponsors had no role in the design and conduct of the study; the analysis or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Aitken M, 2015, J SEX MED, V12, P756, DOI 10.1111/jsm.12817; Algars M, 2010, SEX ROLES, V63, P118, DOI 10.1007/s11199-010-9758-6; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; [Anonymous], 2016, STAT YB STOCKHOLM 20; Arcelus J, 2015, EUR PSYCHIAT, V30, P807, DOI 10.1016/j.eurpsy.2015.04.005; Atkinson SR, 2015, AUST FAM PHYSICIAN, V44, P792, DOI 10.1016/jc.2009-0345; Bockting WO, 2008, SEXOLOGIES, V17, P211, DOI 10.1016/j.sexol.2008.08.001; Byne W, 2012, ARCH SEX BEHAV, V41, P759, DOI 10.1007/s10508-012-9975-x; Collin L, 2016, J SEX MED, V13, P613, DOI 10.1016/j.jsxm.2016.02.001; Commission of the European Communities European Commission. Eurobarometer, 2012, 393 COMM EUR COMM, pv; de Vries A. L. C., 2015, TRANSGENDER HEALTHCA, P10; Deogracias JJ, 2007, J SEX RES, V44, P370, DOI 10.1080/00224490701586730; Socias ME, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0081-7; Flores AR, 2016, RACE ETHNICITY ADULT; Gooren LJ, 2014, CURR OPIN ENDOCRINOL, V21, P233, DOI 10.1097/MED.0000000000000064; Hannan P, 2014, J GEN INTERN MED, V29, pS506; Kuyper L, 2014, ARCH SEX BEHAV, V43, P377, DOI 10.1007/s10508-013-0140-y; Lai MC, 2010, ARCH SEX BEHAV, V39, P1415, DOI 10.1007/s10508-009-9570-y; Laitila T, 2012, RES DEV METHODOLOGY; Lundstrom Sixten., 1999, J OFF STAT, V15, P305, DOI DOI 10.1002/SIM.1903.; Pfaefflin F, 2003, 18 BIENN S HBIGDA GH; Raffoul M, 2016, J AM BOARD FAM MED, V29, P496, DOI 10.3122/jabfm.2016.04.150317; Satistics Sweden (SCB), 2014, LONG INT DAT HLTH IN; Schneider C, 2016, ARCH SEX BEHAV, V45, P551, DOI 10.1007/s10508-016-0702-x; Statistics Sweden (SCB), 2014, TEKN RAPPT HALS STOC; Svensson AC, 2013, INT J EPIDEMIOL, V42, P1263, DOI 10.1093/ije/dys126; Unger CA, 2015, J WOMENS HEALTH, V24, P114, DOI 10.1089/jwh.2014.4918; Van Caenegem E, 2015, ARCH SEX BEHAV, V44, P1281, DOI 10.1007/s10508-014-0452-6; Vance SR, 2015, J ADOLESCENT HEALTH, V56, P251, DOI 10.1016/j.jadohealth.2014.11.002; Winter S, 2016, LANCET, V388, P390, DOI 10.1016/S0140-6736(16)00683-8; World Health Organization, 1992, INT CLASS DIS ICD 10	31	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204606	10.1371/journal.pone.0204606	http://dx.doi.org/10.1371/journal.pone.0204606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289896	Green Submitted, Green Published, gold			2022-12-26	WOS:000446545500021
J	Sun, YQ; Zhong, S; Yu, JQ; Zhu, JX; Ji, DF; Hu, GY; Wu, CM; Li, YG				Sun, Yuqing; Zhong, Shi; Yu, Jiaqi; Zhu, Jianxun; Ji, Dongfeng; Hu, Guiyan; Wu, Chongming; Li, Yougui			The aqueous extract of Phellinus igniarius (SH) ameliorates dextran sodium sulfate-induced colitis in C57BL/6 mice	PLOS ONE			English	Article							MEDICINAL MUSHROOM; LINTEUS; CELLS; POLYSACCHARIDES; COMPLEX; CANCER	Phellinus igniarius, which is called Sanghuang in Chinese, is a fungal herb widely used in Traditional Chinese Medicine to treat stomachache, inflammation and tumors. Recent studies have demonstrated the antitumor, anti-diabetic, anti-inflammatory and immunity-modulating activities of P. igniarius. In the present study, we investigated that ameliorating effect of the aqueous extract of P. igniarius fruiting body (SH) on dextran sodium sulfate (DSS)-induced colitis in C57BL/6 mice. Treatment with SH (250 and 400 mg/kg) for 8 weeks effectively alleviated the pathological indicators of colitis such as bodyweight reduction, disease activity index score, shortening of colon length and abnormal colon histology. The plasma levels of lipopolysaccharide (LPS) and inflammatory factors such as interleukin-6 (IL-6), IL-1 beta and tumor necrosis factor (TNF)-alpha were all significantly reduced. Supplementation of SH (10 mg/L) also inhibited LPS-elicited IL-1 beta production by RAW264.7 macrophages. Real-time PCR and western blot showed that treatment with SH significantly inhibited the phosphorylation of nuclear factor kappa B inhibitor alpha (I kappa B alpha) and decreased the expression of IL-6/IL-1 beta-maturation genes such as apoptosis-associated speck-like protein (ASC3) and caspase-1 in the colon of DSS-induced colitis mice. These results suggest that SH is adequate for the treatment of colitis. Inhibiting the expression and release of inflammatory factors may participate in the colitis-ameliorating effect of SH.	[Sun, Yuqing; Zhong, Shi; Zhu, Jianxun; Ji, Dongfeng; Hu, Guiyan; Li, Yougui] Zhejiang Acad Agr Sci, Sericultural Res Inst, Hangzhou, Zhejiang, Peoples R China; [Yu, Jiaqi; Wu, Chongming] Chinese Acad Med Sci, Pharmacol & Toxicol Res Ctr, Inst Med Plant Dev, Beijing, Peoples R China; [Yu, Jiaqi; Wu, Chongming] Peking Union Med Coll, Beijing, Peoples R China	Zhejiang Academy of Agricultural Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, YG (corresponding author), Zhejiang Acad Agr Sci, Sericultural Res Inst, Hangzhou, Zhejiang, Peoples R China.; Wu, CM (corresponding author), Chinese Acad Med Sci, Pharmacol & Toxicol Res Ctr, Inst Med Plant Dev, Beijing, Peoples R China.; Wu, CM (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	cmwu@implad.ac.cn; liyougui3@126.com	Wu, Chongming/GOJ-9081-2022; Yu, Jiaqi/AAZ-7577-2020; Wu, Chongming/AAQ-9085-2021	Wu, Chongming/0000-0003-2898-370X	Science and Technology Department of Zhejiang Province [2018C02003, LGN18C170005]; National Natural Science Foundation of China [81673663]; Modern Agro-industry Technology Research System of China [CARS-22-ZJ0105]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-3-015]; Key Laboratory of Creative Agriculture(pilot run), Ministry of Agriculture, P.R. China	Science and Technology Department of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agro-industry Technology Research System of China; CAMS Innovation Fund for Medical Sciences (CIFMS); Key Laboratory of Creative Agriculture(pilot run), Ministry of Agriculture, P.R. China	This work was supported financially by Foundation from Science and Technology Department of Zhejiang Province (2018C02003, LGN18C170005), National Natural Science Foundation of China (81673663), Modern Agro-industry Technology Research System of China (CARS-22-ZJ0105), CAMS Innovation Fund for Medical Sciences (CIFMS) 2016-I2M-3-015 and Key Laboratory of Creative Agriculture(pilot run), Ministry of Agriculture, P.R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma YT, 2010, INT IMMUNOPHARMACOL, V10, P1261, DOI 10.1016/j.intimp.2010.07.007; Brat P, 2006, J NUTR, V136, P2368, DOI 10.1093/jn/136.9.2368; Cheng P, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00547; Dey G, 2017, CELL SIGNAL, V35, P24, DOI 10.1016/j.cellsig.2017.03.017; Dionne S, 1997, DIGEST DIS SCI, V42, P1557, DOI 10.1023/A:1018895500721; Gao WW, 2017, EXP THER MED, V14, P4627, DOI 10.3892/etm.2017.5191; He AQ, 2016, INFLAMMATION, V39, P172, DOI 10.1007/s10753-015-0236-8; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Im KH, 2016, INT J MED MUSHROOMS, V18, P1011, DOI 10.1615/IntJMedMushrooms.v18.i11.60; Jang BS, 2004, BIOTECHNOL LETT, V26, P31, DOI 10.1023/B:BILE.0000009456.63616.32; Lee S, 2017, MOLECULES, V22, DOI 10.3390/molecules22101583; Li L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/218274; Lin CJ, 2014, J BIOSCI BIOENG, V118, P88, DOI 10.1016/j.jbiosc.2014.01.001; Song MJ, 2014, J ETHNOPHARMACOL, V154, P311, DOI 10.1016/j.jep.2013.12.059; Song TY, 2008, J ETHNOPHARMACOL, V115, P50, DOI 10.1016/j.jep.2007.09.001; Stewart DC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200377; Suabjakyong P, 2015, FOOD FUNCT, V6, P2834, DOI [10.1039/C5FO00491H, 10.1039/c5fo00491h]; Suabjakyong P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122733; Sun ZM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186592; Vyleta ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036044; Wang FF, 2017, INT J MED MUSHROOMS, V19, P561, DOI 10.1615/IntJMedMushrooms.v19.i6.70; Wu CM, 2014, J CELL MOL MED, V18, P293, DOI 10.1111/jcmm.12187; Wu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035764; Yan Guang Hai, 2014, Immune Netw, V14, P107, DOI 10.4110/in.2014.14.2.107; Zheng SJ, 2018, FOOD FUNCT, V9, P614, DOI [10.1039/c7fo01460k, 10.1039/C7FO01460K]; Zhou C, 2014, ASIAN PAC J CANCER P, V15, P3659, DOI 10.7314/APJCP.2014.15.8.3659	26	13	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205007	10.1371/journal.pone.0205007	http://dx.doi.org/10.1371/journal.pone.0205007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289941	Green Submitted, gold, Green Published			2022-12-26	WOS:000446545500037
J	Djuric, O; Markovic-Denic, L; Jovanovic, B; Bumbasirevic, V				Djuric, Olivera; Markovic-Denic, Ljiljana; Jovanovic, Bojan; Bumbasirevic, Vesna			Agreement between CDC/NHSN surveillance definitions and ECDC criteria in diagnosis of healthcare-associated infections in Serbian trauma patients	PLOS ONE			English	Article							CDC DEFINITIONS; PRIORITIES	After three national point prevalence studies (PPS) of healthcare associated infections (HAI) conducted in Serbian acute care hospitals using US (CDC/NHSN) surveillance definitions, Serbia is about to switch to European (ECDC) criteria for the purpose of the fourth HAI PPS. The aim of this study was to compare the US and the European HAI definitions in Serbian trauma intensive care unit (ICU). Prospective surveillance was performed at two surgical-trauma ICUs of the Emergency department of Clinical Center of Serbia. HAIs were prospectively diagnosed by experienced clinician and epidemiologists using both types of HAI definitions simultaneously. The level of agreement between two case definitions was assessed by Cohen's kappa statistic (k). Of 406 patients, 107 (26.3%) acquired at least one HAI (total of 107 according to US definitions and 141 according to European criteria). For microbiologically confirmed pneumonia agreement was k = 0.99 (95% CI, 0.96-1.00) and for clinically defined k = 0.86 (95% CI, 0.58-1.00). Agreement for bloodstream infections (BSI) was 0.79 (CI 95%, 0.70-0.89). When secondary BSI was excluded from the European classification, (30.9% of all BSI), concordance was k = 1.00 and when microbiologically confirmed catheter related BSI were reported separately as recommended by latest ECDC protocol update, (20.0% of all BSI), concordance was 0.60 (CI 95%, 0.41-0.80). No agreement was found between CLABSI and CRI while slight agreement was found when compared CLABSI and CR13 (k = 0.11; 95%CI, 0.0-0.22). Agreement for overall UTI was moderate (k = 0.66; 95%CI, 0.53-0.79) while for microbiologically-confirmed symptomatic UTI was perfect (k = 1.00). For CAUTI good agreement was observed (k = 0.77; 95%CI, 0.34-1.0). Microbiological confirmation of PN and UTI should be stimulated and comparison of BSI should be done with emphasis on whether secondary BSI is included.	[Djuric, Olivera; Markovic-Denic, Ljiljana; Jovanovic, Bojan; Bumbasirevic, Vesna] Univ Belgrade, Fac Med, Belgrade, Serbia; [Djuric, Olivera; Markovic-Denic, Ljiljana] Univ Belgrade, Inst Epidemiol, Fac Med, Belgrade, Serbia; [Jovanovic, Bojan; Bumbasirevic, Vesna] Clin Ctr Serbia, Ctr Anaesthesiol, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Djuric, O (corresponding author), Univ Belgrade, Fac Med, Belgrade, Serbia.; Djuric, O (corresponding author), Univ Belgrade, Inst Epidemiol, Fac Med, Belgrade, Serbia.	oliveradjuric87@gmail.com	Djuric, Olivera/H-8580-2019	Djuric, Olivera/0000-0002-8574-5938	Ministry of Education, Science and technological development of Serbia [175046]	Ministry of Education, Science and technological development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education, Science and technological development of Serbia, contract No. 175046, 2011-2018.	Centers for Disease Control and Prevention/National Healthcare Safety Network, 2014, DEV ASS MOD; Centers for Disease Control and Prevention/National Healthcare Safety Network, 2014, NAT HEALTHC SAF NETW; Centers for Disease Control and Prevention/ National Healthcare Safety Network, 2017, CDC NHSN SURV DEF SP; Centers for Disease Control and Prevention/National Healthcare Safety Network, 2017, ID HEALTHC ASS INF H; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Drndarevic D, 2008, DEFINITIONS HOSP INF; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P349, DOI 10.1016/j.ajic.2011.04.011; ECDC, 2008, ANN EP REP COMM DIS; European Centre for Disease Prevention and Control, 2012, POINT PREV SURV HLTH; European Centre for Disease Prevention and Control, 2013, POINT PREV SURV HEAL; European Centre for Disease Prevention and Control, 2016, POINT PREV SURV HEAL; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Garner JS, 1970, P INT C NOSOCOMIAL I, P171; Gould C, 2009, CLIN INFECT DIS, V49, P1288, DOI 10.1086/605692; Hansen S, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-28; Hebden JN, 2012, AM J INFECT CONTROL, V40, pS29, DOI 10.1016/j.ajic.2012.03.009; HELICS-ICU working group, 2004, SURV NOS INF INT CAR; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Horan TC., 2004, HOSP EPIDEMIOL INFEC, P1659; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Krinsley JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11185; Licker M, 2017, J HOSP INFECT, V96, P85, DOI 10.1016/j.jhin.2016.12.024; Markovic-Denic L, 2017, HLTH CARE ASS INFECT; Mertens R, 1996, Euro Surveill, V1, P28; Mitchell Brett G, 2015, Nurs Stand, V29, P52, DOI 10.7748/ns.29.23.52.e9609; Press MJ, 2013, INFECT CONT HOSP EP, V34, P313, DOI 10.1086/669525; Safdar N, 2014, INFECT CONT HOSP EP, V35, P480, DOI 10.1086/675821; The Joint Commission, 2012, PREV CENTR LIN ASS B; Wilson APR, 2012, J ANTIMICROB CHEMOTH, V67, pI23, DOI 10.1093/jac/dks198	29	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204893	10.1371/journal.pone.0204893	http://dx.doi.org/10.1371/journal.pone.0204893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286119	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500059
J	Lee, CW; Schoenherr, C; Battmer, K; Ganser, A; Hilfiker-Kleiner, D; David, S; Eder, M; Scherr, M				Lee, Chun-Wei; Schoenherr, Caroline; Battmer, Karin; Ganser, Arnold; Hilfiker-Kleiner, Denise; David, Sascha; Eder, Matthias; Scherr, Michaela			miR-125b regulates chemotaxis and survival of bone marrow derived granulocytes in vitro and in vivo	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; MICRORNA-125B; EXPRESSION; INFLAMMATION; APOPTOSIS; MIGRATION; MIR-17-92; ALPHA; DEATH	The evolutionary conserved miR-125b is highly expressed in hematopoietic stem cells (HSC) enhancing self-renewal and survival. Accordingly, over-expression of miR-125b in HSC may induce myeloproliferative neoplasms and leukemia with long latency. During hematopoietic cell maturation miR-125b expression decreases, and the function of miR125b in mature granulocytes is not yet known. We here use transplantation of miR-125b over-expressing HSC into syngeneic hosts to generate and analyse miR-125b overexpressing granulocytes. Under steady state conditions, miR-125b over-expression inhibits granulocytic chemotaxis and LPS- but not PMA- and TNF alpha- induced cell death. Inflammatory signals modulate the effects of miR-125b over-expression as demonstrated in a sterile peritonitis and a polymicrobial sepsis model. In particular, survival of mice with miR-125b over-expressing granulocytes is significantly reduced as compared to controls in the polymicrobial sepsis model. These data demonstrate inflammation dependent effects of miR-125b in granulocytes and may point to therapeutic intervention strategies in the future.	[Lee, Chun-Wei; Schoenherr, Caroline; Battmer, Karin; Ganser, Arnold; Eder, Matthias; Scherr, Michaela] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Hilfiker-Kleiner, Denise] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [David, Sascha] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Eder, M; Scherr, M (corresponding author), Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany.	Eder.Matthias@mh-hannover.de; Scherr.Michaela@mh-hannover.de	David, Sascha/AAL-6909-2021		Deutsche Jose Carreras Leukaemie Stiftung [R14/21]; Deutsche Forschungsgemeinschaft [SCHE 550/6-1, ED34/4-1]; DFG-REBIRTH [SFB738/3 TP A08]	Deutsche Jose Carreras Leukaemie Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG-REBIRTH(German Research Foundation (DFG))	This work was supported by Deutsche Jose Carreras Leukaemie Stiftung R14/21 to MS and ME, www.carreras-stiftung.de; Deutsche Forschungsgemeinschaft SCHE 550/6-1 to MS, ED34/4-1 to ME, and DFG-REBIRTH to ME, SFB738/3 TP A08 to ME, www.dfg.de.	Ajuebor MN, 1999, J IMMUNOL, V162, P1685; Avraham R, 2012, BIOCHEM SOC T, V40, P26, DOI 10.1042/BST20110623; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bousquet M, 2012, HAEMATOL-HEMATOL J, V97, P1713, DOI 10.3324/haematol.2011.061515; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; David S, 2012, CRIT CARE MED, V40, P3034, DOI 10.1097/CCM.0b013e31825fdc31; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Duroux-Richard I, 2016, BLOOD, V128, P3125, DOI [10.1182/blood-2016-02-697003, 10.1182/blood-201602-697003]; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; Gong J, 2013, ONCOGENE, V32, P3071, DOI 10.1038/onc.2012.318; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Huang YF, 2016, EUR REV MED PHARMACO, V20, P4055; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Klusmann JH, 2010, GENE DEV, V24, P478, DOI 10.1101/gad.1856210; Liu J, 2017, BLOOD, V129, P1491, DOI 10.1182/blood-2016-06-721027; Matsukawa T, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4164; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Ooi AGL, 2010, P NATL ACAD SCI USA, V107, P21505, DOI 10.1073/pnas.1016218107; Romero PV, 2015, LEUKEMIA, V29, P2442, DOI 10.1038/leu.2015.117; Shaham L, 2012, LEUKEMIA, V26, P2011, DOI 10.1038/leu.2012.90; Surdziel E, 2011, BLOOD, V117, P4338, DOI 10.1182/blood-2010-06-289058; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Willimott S, 2012, LEUKEMIA, V26, P1113, DOI 10.1038/leu.2011.299; Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243; Yoon Hyonok, 2011, Environ Health Toxicol, V26, pe2011017, DOI 10.5620/eht.2011.26.e2011017; Yu XZ, 2015, CANCER GENET-NY, V208, P76, DOI 10.1016/j.cancergen.2015.01.006; Zhang H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-108; Zhang XH, 2017, ONCOTARGET, V8, P50642, DOI 10.18632/oncotarget.16892	28	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204942	10.1371/journal.pone.0204942	http://dx.doi.org/10.1371/journal.pone.0204942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286140	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500065
J	Gomez, JD; Vital, CE; Oliveira, MGA; Ramos, HJO				Gomez, Jenny D.; Vital, Camilo E.; Oliveira, Maria G. A.; Ramos, Humberto J. O.			Broad range flavonoid profiling by LC/MS of soybean genotypes contrasting for resistance to Anticarsia gemmatalis (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; CHEMICAL-COMPOUNDS; RUTIN; BIOLOGY; ACCUMULATION; ISOFLAVONES; MODULATION; GLYCOSIDES; GROUNDNUT	Attack by herbivores is a major biotic stress limiting the soybean crop production. Plant defenses against caterpillars include the production of secondary metabolites such as flavonoids, which constitute a diverse group of plant secondary metabolites. Thus, a more discriminate metabolic profiling between genotypes are important for a more comprehensive and reliable characterization of soybean resistance. Therefore, in this study a non-targeted LC/MS-based for analysis of flavonoid profiles of soybean genotypes contrasting to the resistance to A. gemmatalis was applied. Clustering analysis revealed profiles highly distinct between the susceptible UFV 105 AP and the resistant IAC 17 genotypes. This comparative approach enables to identify directly from leaf extract some new compounds related to resistance, some of which were present in higher abundance specifically in the IAC 17 genotype: four Quercetin conjugates, Rutin (Quercetin 3-O-Rutinoside), Quercetin-3,7-O- di-glucoside, Quercetin-3-O-rhamnosylglycoside-7-O-glucoside and Quercetin-3-O-rhamnopyranosyl-glucopyranoside-rhamnopyranoside; two Genistein conjugates, Genistein-7-O-diglucosidedimalonylated and Genistein-7-O-6-O-malonylglucoside; and one Daidzein conjugate, Daidzein-7-O-Glucoside-malonate. The most abundant flavonoid glycoconjugates in soybean leaves belongs to Quercetin and Kaempferol classes. However, only one from the identified compounds was classified as a Kaempferol. The Kaempferol-3-O-L-rhamnopyranosyl-glucopyranoside showed high abundance in the resistant genotype IAC 17. The metabolic profiles generated by LC/MS allowed the reconstruction of the flavonoid biosynthetic pathways, which revealed a constitutive character for herbivory resistance in the resistant genotype IAC-17 and a metabolic regulation for the rechanneling of Quercetin, Kaempferol and Genistein conjugates in soybean. Highest relative abundances were detected for glyconjugates, such as Rutin, Quercetin 3-O-rhamnosylglycoside-7-O-glucoside and Quercitin-3-O-rhamnopyranosyl-glucopyranoside-rhamnopyranoside in the leaves of the resistant genotype.	[Gomez, Jenny D.; Oliveira, Maria G. A.; Ramos, Humberto J. O.] Univ Fed Vicosa, Lab Enzymol Biochem Prot & Peptides, Dept Biochem & Mol Biol, BIOAGRO INCT IPP, Vicosa, MG, Brazil; [Vital, Camilo E.; Ramos, Humberto J. O.] Univ Fed Vicosa, Ctr Anal Biomol, NuBioMol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Ramos, HJO (corresponding author), Univ Fed Vicosa, Lab Enzymol Biochem Prot & Peptides, Dept Biochem & Mol Biol, BIOAGRO INCT IPP, Vicosa, MG, Brazil.; Ramos, HJO (corresponding author), Univ Fed Vicosa, Ctr Anal Biomol, NuBioMol, Vicosa, MG, Brazil.	humramos.ufv.br@gmail.com	OLIVEIRA, Maria Goreti A./AGP-5215-2022	Gomez Arrieta, Jenny Dimelza/0000-0001-9994-3030; Vital, Camilo/0000-0002-2567-9780	NuBioMol (Center of Analyses of Biomolecules-UFV, Brazil); National Institute of Science and Technology in Plant-Pest Interaction (INCT-IPP); Brazilian Soybean Genome Consortium (GENOSOJA); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	NuBioMol (Center of Analyses of Biomolecules-UFV, Brazil); National Institute of Science and Technology in Plant-Pest Interaction (INCT-IPP); Brazilian Soybean Genome Consortium (GENOSOJA); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by NuBioMol (Center of Analyses of Biomolecules-UFV, Brazil), the National Institute of Science and Technology in Plant-Pest Interaction (INCT-IPP), The Brazilian Soybean Genome Consortium (GENOSOJA), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Abranko L, 2015, J MASS SPECTROM, V50, P71, DOI 10.1002/jms.3474; Bentivenha JPF, 2018, ARTHROPOD-PLANT INTE, V12, P311, DOI 10.1007/s11829-017-9578-5; Bortolotto O.C., 2015, AGRON SCI BIOTECHNOL, V1, P25, DOI DOI 10.33158/ASB.2015V1I1P25; Boue SM, 2003, J CHROMATOGR A, V991, P61, DOI 10.1016/S0021-9673(03)00209-7; CABALLERO P, 1986, J NAT PROD, V49, P1126, DOI 10.1021/np50048a030; Farag MA, 2008, PLANT PHYSIOL, V146, P387, DOI 10.1104/pp.107.108431; Silva TRFB, 2016, ACTA SCI-AGRON, V38, P165, DOI 10.4025/actasciagron.v38i2.27956; Ferreira C. C. A., 2005, Bioscience Journal, V21, P49; Fugi CCQ, 2005, SCI AGR, V62, P31, DOI 10.1590/S0103-90162005000100006; Ganie, 2017, CHEM SCI REV LETT, V6, P1941; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Ho HM, 2002, BIOMED PHARMACOTHER, V56, P289, DOI 10.1016/S0753-3322(02)00191-9; Hoffmann-Campo C, 1995, THESIS; Hoffmann-Campo CB, 2001, ENTOMOL EXP APPL, V98, P181, DOI 10.1023/A:1018728515734; Hoffmann-Campo CB, 2006, PESQUI AGROPECU BRAS, V41, P1453, DOI 10.1590/S0100-204X2006001000001; Lourencao AL, 1989, WORLD SOYB RES C 4, V4, P1578; Lourencao AL, 2010, NEOTROP ENTOMOL, V39, P275, DOI 10.1590/S1519-566X2010000200020; Mallikarjuna N, 2004, J APPL ENTOMOL, V128, P321, DOI 10.1111/j.1439-0418.2004.00834.x; Matos Neto Fausto da Costa, 2002, Rev. Bras. entomol., V46, P237, DOI 10.1590/S0085-56262002000300002; Misra P, 2010, PLANT PHYSIOL, V152, P2258, DOI 10.1104/pp.109.150979; Mithofer A, 2017, TOXINOLOGY, P3, DOI 10.1007/978-94-007-6464-4_21; Murakami S, 2014, METABOLITES, V4, P532, DOI 10.3390/metabo4030532; O'Neill BF, 2010, J CHEM ECOL, V36, P35, DOI 10.1007/s10886-009-9727-0; Onkokesung N, 2014, J EXP BOT, V65, P2203, DOI 10.1093/jxb/eru096; Paixão Gilson Petrônio, 2016, Idesia, V34, P69; Pandey P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00537; Juhasz ACP, 2017, SOYBEAN BREEDING, P375, DOI 10.1007/978-3-319-57433-2_20; Piubelli GC, 2005, J CHEM ECOL, V31, P1509, DOI 10.1007/S10886-005-5794-z; ROSE RL, 1988, J ECON ENTOMOL, V81, P1288, DOI 10.1093/jee/81.5.1288; Salvador MC, 2010, NEOTROP ENTOMOL, V39, P774, DOI 10.1590/S1519-566X2010000500017; Song HH, 2014, METABOLOMICS, V10, P833, DOI 10.1007/s11306-014-0640-3; Souza ED, 2013, CHIL J AGR RES, V73, P351, DOI 10.4067/S0718-58392013000400004; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Stracke R, 2010, NEW PHYTOL, V188, P985, DOI 10.1111/j.1469-8137.2010.03421.x; Valle GE, 2002, NEOTROP ENTOMOL, V31, P285; War AR, 2015, PEST MANAG SCI, V71, P72, DOI 10.1002/ps.3764; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Wu QL, 2004, J AGR FOOD CHEM, V52, P2763, DOI 10.1021/jf035053p	38	36	36	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205010	10.1371/journal.pone.0205010	http://dx.doi.org/10.1371/journal.pone.0205010			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281662	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400075
J	Ilievski, V; Zuchowska, PK; Green, SJ; Toth, PT; Ragozzino, ME; Le, K; Aljewari, HW; O'Brien-Simpson, NM; Reynolds, EC; Watanabe, K				Ilievski, Vladimir; Zuchowska, Paulina K.; Green, Stefan J.; Toth, Peter T.; Ragozzino, Michael E.; Le, Khuong; Aljewari, Haider W.; O'Brien-Simpson, Neil M.; Reynolds, Eric C.; Watanabe, Keiko			Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice	PLOS ONE			English	Article							SPORADIC ALZHEIMERS-DISEASE; PORPHYROMONAS-GINGIVALIS; MATRIX METALLOPROTEINASES; CHLAMYDIA-PNEUMONIAE; VIRULENCE FACTORS; EPITHELIAL-CELLS; TRANSGENIC MICE; SEX-DIFFERENCES; MOUSE MODEL; TOOTH LOSS	Background The results from cross sectional and longitudinal studies show that periodontitis is closely associated with cognitive impairment (CI) and Alzhemer's Disease (AD). Further, studies using animal model of periodontitis and human post-mortem brain tissues from subjects with AD strongly suggest that a gram-negative periodontal pathogen, Porphyromonas gingivalis (Pg) and/or its product gingipain is/are translocated to the brain. However, neuropathology resulting from Pg oral application is not known. In this work, we tested the hypothesis that repeated exposure of wild type C57BU6 mice to orally administered Pg results in neuroinflammation, neurodegeneration, microgliosis, astrogliosis and formation of intra- and extracellular amyloid plaque and neurofibrillary tangles (NFTs) which are pathognomonic signs of AD. Methods Experimental chronic periodontitis was induced in ten wild type 8-week old C57BL/6 WT mice by repeated oral application (MWF/week) of Pg/gingipain for 22 weeks (experimental group). Another 10 wild type 8-week old C57BL/6 mice received vehicle alone (control group) MWF per week for 22 weeks. Brain tissues were collected and the presence of Pg/gingipain was determined by immunofluorescence (IF) microscopy, confocal microscopy, and quantitative PCR (qPCR). The hippocampi were examined for the signs of neuropathology related to AD: TNF alpha, IL1 beta, and IL6 expression (neuroinflammation), NeuN and Fluoro Jade C staining (neurodegeneration) and amyloid beta(1-42) (A beta(42)) production and phosphorylation of tau protein at Ser396 were assessed by IF and confocal microscopy. Further, gene expression of amyloid precursor protein (APP), beta-site APP cleaving enzyme 1 (BACE1), a disintegrin and metalloproteinase domain-containing protein10 (ADAM10) for alpha-secretase and presenilinl (PSEN1) for gamma-secretase, and NeuN (rbFox3) were determined by RT-qPCR. Microgliosis and astrogliosis were also determined by IF microscopy. Results Pg/gingipain was detected in the hippocampi of mice in the experimental group by immunohistochemistry, confocal microscopy, and qPCR confirming the translocation of orally applied Pg to the brain. Pg/gingipain was localized intra-nuclearly and peri-nuclearly in microglia (Iba1+), astrocytes (GFAP+), neurons (NeuN+) and was evident extracellularly. Significantly greater levels of expression of IL6, TNF alpha and IL1 beta were evident in experimental as compared to control group (p<0.01, p<0.00001, p<0.00001 respectively). In addition, microgliosis and astrogliosis were evident in the experimental but not in control group (p <0.01, p<0.0001 respectively). Neurodegeneration was evident in the experimental group based on a fewer number of intact neuronal cells assessed by NeuN positivity and rbFOX3 gene expression, and there was a greater number of degenerating neurons in the hippocampi of experimental mice assessed by Fluoro Jade C positivity. APP and BACE1 gene expression were increased in experimental group compared with control group (p<0.05, p<0.001 respectively). PSEN1 gene expression was higher in experimental than control group but the difference was not statistically significant (p = 0.07). ADAM10 gene expression was significantly decreased in experimental group compared with control group (p<0.01). Extracellular A beta(42) was detected in the parenchyma in the experimental but not in the control group (p<0.00001). Finally, phospho-Tau (Ser396) protein was detected and NFTs were evident in experimental but not in the control group (p<0.00001). Conclusions This study is the first to show neurodegeneration and the formation of extracellular A beta(42) in young adult WT mice after repeated oral application of Pg. The neuropathological features observed in this study strongly suggest that low grade chronic periodontal pathogen infection can result in the development of neuropathology that is consistent with that of AD.	[Ilievski, Vladimir; Aljewari, Haider W.; Watanabe, Keiko] Univ Illinois, Coll Dent, Dept Periodont, Chicago, IL 60607 USA; [Zuchowska, Paulina K.; Le, Khuong] Univ Illinois, Undergrad Program, Chicago, IL USA; [Green, Stefan J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Toth, Peter T.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL USA; [Ragozzino, Michael E.] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA; [O'Brien-Simpson, Neil M.; Reynolds, Eric C.] Univ Melbourne, Melbourne Dent Sch, Melbourne, Vic, Australia; [Green, Stefan J.] Univ Illinois, DNA Core Facil, Chicago, IL USA; [Toth, Peter T.] Univ Illinois, Fluorescence Imaging Core Facil, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Melbourne; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Watanabe, K (corresponding author), Univ Illinois, Coll Dent, Dept Periodont, Chicago, IL 60607 USA.	keiko@uic.edu	O'Brien-Simpson, Neil/B-2901-2009	O'Brien-Simpson, Neil/0000-0001-8462-5603; Aljewari, Haider/0000-0002-1509-3612; Toth, Peter/0000-0003-2168-0124	National Institute of Health [R01DE021405]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by R01DE021405, National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud Orwa, 2014, J Neurol Disord, V2; Aguilera G, 2018, ANTIOXID REDOX SIGN, V28, P1626, DOI 10.1089/ars.2017.7099; Arimatsu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04828; BAKER PJ, 1994, ARCH ORAL BIOL, V39, P1035, DOI 10.1016/0003-9969(94)90055-8; Balin BJ, 1998, MED MICROBIOL IMMUN, V187, P23, DOI 10.1007/s004300050071; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Boutaga K, 2003, J CLIN MICROBIOL, V41, P4950, DOI 10.1128/JCM.41.11.4950-4954.2003; Chakrabarti S, 2015, AGING DIS, V6, P282, DOI 10.14336/AD.2014.002; Chu J, 2015, BIOL PSYCHIAT, V77, P720, DOI 10.1016/j.biopsych.2014.06.003; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Djordjevic J, 2017, NEUROSCIENCE, V361, P81, DOI 10.1016/j.neuroscience.2017.08.006; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; Eke PI, 2016, PERIODONTOL 2000, V72, P76, DOI 10.1111/prd.12145; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; Emery DC, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00195; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Guo QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080706; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Herbst-Robinson KJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18286; Hujoel PP, 2001, J PERIODONTAL RES, V36, P48, DOI 10.1034/j.1600-0765.2001.00011.x; Ide M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151081; Ilievski V, 2017, J PERIODONTAL RES, V52, P1032, DOI 10.1111/jre.12474; Ilievski V, 2016, J ORAL BIOL, V3; Ilievski V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136502; Ishida N, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0015-x; Itzhaki RF, 2016, J ALZHEIMERS DIS, V51, P979, DOI 10.3233/JAD-160152; Iwai T, 2009, J PERIODONTAL RES, V44, P689, DOI 10.1111/j.1600-0765.2008.01165.x; Kinane JA, 2012, CELL MICROBIOL, V14, P1085, DOI 10.1111/j.1462-5822.2012.01780.x; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Li N, 2011, EUR J MICROBIOL IMMU, V1, P41, DOI 10.1556/EuJMI.1.2011.1.7; Little CS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00304; Liu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07465-5; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Martande SS, 2014, AM J ALZHEIMERS DIS, V29, P498, DOI 10.1177/1533317514549650; Matyi J, 2017, J GERONTOL A-BIOL, V72, P1607, DOI 10.1093/gerona/glx092; MIKLOSSY J, 1993, NEUROREPORT, V4, P841, DOI 10.1097/00001756-199307000-00002; Miklossy J, 2004, J ALZHEIMERS DIS, V6, P639; Miklossy J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-90; Mondragon-Rodriguez S, 2014, NEUROPATH APPL NEURO, V40, P121, DOI 10.1111/nan.12084; Moodley KK, 2014, FRONT NEUROL NEUROSC, V34, P95, DOI 10.1159/000356430; Mosconi L, 2017, NEUROLOGY, V89, P1382, DOI 10.1212/WNL.0000000000004425; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Noble JM, 2009, J NEUROL NEUROSUR PS, V80, P1206, DOI 10.1136/jnnp.2009.174029; O'Brien-Simpson NM, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.22; Okamoto M, 2005, BIOCHEM BIOPH RES CO, V336, P1214, DOI 10.1016/j.bbrc.2005.08.251; Polak D, 2009, J CLIN PERIODONTOL, V36, P406, DOI 10.1111/j.1600-051X.2009.01393.x; Poole S, 2015, J ALZHEIMERS DIS, V43, P67, DOI 10.3233/JAD-140315; Poole S, 2013, J ALZHEIMERS DIS, V36, P665, DOI 10.3233/JAD-121918; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Renvert S, 2013, J PERIODONTOL, V84, P1134, DOI 10.1902/jop.2012.120378; Riviere GR, 2002, ORAL MICROBIOL IMMUN, V17, P113, DOI 10.1046/j.0902-0055.2001.00100.x; Saido TC, 2006, NEUROSCI RES, V54, P235, DOI 10.1016/j.neures.2005.12.015; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Sastre M, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-25; Scragg MA, 2002, INFECT IMMUN, V70, P5740, DOI 10.1128/IAI.70.10.5740-5750.2002; Sheng JG, 2003, NEUROBIOL DIS, V14, P133, DOI 10.1016/S0969-9961(03)00069-X; Singhrao SK, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2016.1270602; Stein PS, 2007, J AM DENT ASSOC, V138, P1314, DOI 10.14219/jada.archive.2007.0046; Thal DR, 2012, EXP NEUROL, V236, P1, DOI 10.1016/j.expneurol.2012.04.021; Velsko IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097811; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Wu Z, 2017, BRAIN BEHAV IMMUN, V65, P350, DOI 10.1016/j.bbi.2017.06.002; Xu GL, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0252-9; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Yu YH, 2008, J AM GERIATR SOC, V56, P1693, DOI 10.1111/j.1532-5415.2008.01847.x; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zelkha SA, 2010, PERIODONTOL 2000, V54, P207, DOI 10.1111/j.1600-0757.2010.00358.x	73	141	144	7	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204941	10.1371/journal.pone.0204941	http://dx.doi.org/10.1371/journal.pone.0204941			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281647	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400070
J	Vickers, C; Liu, F; Abe, K; Salama-Alber, O; Jenkins, M; Springate, CMK; Burke, JE; Withers, SG; Boraston, AB				Vickers, Chelsea; Liu, Feng; Abe, Kento; Salama-Alber, Orly; Jenkins, Meredith; Springate, Christopher M. K.; Burke, John E.; Withers, Stephen G.; Boraston, Alisdair B.			Endo-fucoidan hydrolases from glycoside hydrolase family 107 (GH107) display structural and mechanistic similarities to -l-fucosidases from GH29	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						polysaccharide; glycoside hydrolase; enzyme catalysis; enzyme; X-ray crystallography; enzyme mechanism	ALPHA-L-FUCOSIDASE; SULFATED POLYSACCHARIDES; MOLECULAR-BASIS; CATALYTIC MECHANISM; BROWN SEAWEEDS; HYDROLYSIS; ENZYME; FUCANS; BETA; DEGRADATION	Fucoidans are chemically complex and highly heterogeneous sulfated marine fucans from brown macro algae. Possessing a variety of physicochemical and biological activities, fucoidans are used as gelling and thickening agents in the food industry and have anticoagulant, antiviral, antitumor, antibacterial, and immune activities. Although fucoidan-depolymerizing enzymes have been identified, the molecular basis of their activity on these chemically complex polysaccharides remains largely uninvestigated. In this study, we focused on three glycoside hydrolase family 107 (GH107) enzymes: MfFcnA and two newly identified members, P5AFcnA and P19DFcnA, from a bacterial species of the genus Psychromonas. Using carbohydrate-PAGE, we show that P5AFcnA and P19DFcnA are active on fucoidans that differ from those depolymerized by MfFcnA, revealing differential substrate specificity within the GH107 family. Using a combination of X-ray crystallography and NMR analyses, we further show that GH107 family enzymes share features of their structures and catalytic mechanisms with GH29 -l-fucosidases. However, we found that GH107 enzymes have the distinction of utilizing a histidine side chain as the proposed acid/base catalyst in its retaining mechanism. Further interpretation of the structural data indicated that the active-site architectures within this family are highly variable, likely reflecting the specificity of GH107 enzymes for different fucoidan substructures. Together, these findings begin to illuminate the molecular details underpinning the biological processing of fucoidans.	[Vickers, Chelsea; Abe, Kento; Salama-Alber, Orly; Jenkins, Meredith; Burke, John E.; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC 8W 3P6, Canada; [Liu, Feng; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Springate, Christopher M. K.] ARC Med Devices Inc, Richmond, BC V6X 2T4, Canada; [Abe, Kento] Univ Toronto, Dept Mol Genet, Rm 4396,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada	University of Victoria; University of British Columbia; University of Toronto	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC 8W 3P6, Canada.	boraston@uvic.ca	Burke, John/H-3922-2019; Withers, Stephen G/I-7229-2019	Burke, John/0000-0001-7904-9859; Withers, Stephen G/0000-0002-6722-5701; Boraston, Alisdair/0000-0001-6417-0592	Department of Energy Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; NIGMS; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr. Mark Okon for great help with NMR spectroscopy. We thank the beamline staff at the Stanford Synchrotron Research Laboratory BL7-1. SSRL is a Directorate of Stanford Linear Accelerator Center National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program P41RR001209, and the NIGMS.	Ale MT, 2013, RSC ADV, V3, P8131, DOI 10.1039/c3ra23373a; Ale MT, 2011, MAR DRUGS, V9, P2106, DOI 10.3390/md9102106; Anastyuk SD, 2009, CARBOHYD RES, V344, P779, DOI 10.1016/j.carres.2009.01.023; ANGSTWURM K, 1995, NEUROSCI LETT, V191, P1, DOI 10.1016/0304-3940(95)11541-4; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Barbeyron T, 2008, INT J SYST EVOL MICR, V58, P2107, DOI 10.1099/ijs.0.65674-0; Berteau O, 2002, GLYCOBIOLOGY, V12, P273, DOI 10.1093/glycob/12.4.273; Bilan MI, 2010, CARBOHYD RES, V345, P2038, DOI 10.1016/j.carres.2010.07.009; Bilan MI, 2006, CARBOHYD RES, V341, P238, DOI 10.1016/j.carres.2005.11.009; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Burmeister WP, 2000, J BIOL CHEM, V275, P39385, DOI 10.1074/jbc.M006796200; Chevolot L, 1999, CARBOHYD RES, V319, P154, DOI 10.1016/S0008-6215(99)00127-5; Chevolot L, 2001, CARBOHYD RES, V330, P529, DOI 10.1016/S0008-6215(00)00314-1; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Colin S, 2006, GLYCOBIOLOGY, V16, P1021, DOI 10.1093/glycob/cwl029; CONCHIE J, 1950, J CHEM SOC, P827, DOI 10.1039/jr9500000827; Daniel R, 1999, CARBOHYD RES, V322, P291, DOI 10.1016/S0008-6215(99)00223-2; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Descamps V, 2006, MAR BIOTECHNOL, V8, P27, DOI 10.1007/s10126-005-5107-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eneyskaya EV, 2001, GLYCOCONJUGATE J, V18, P827, DOI 10.1023/A:1021163720282; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ficko-Blean E, 2015, ACTA CRYSTALLOGR D, V71, P209, DOI 10.1107/S1399004714025024; Fowler ML, 2016, PROTEIN SCI, V25, P826, DOI 10.1002/pro.2879; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Guillotin L, 2014, BIOCHEMISTRY-US, V53, P1447, DOI 10.1021/bi400951q; Hehemann JH, 2012, J BIOL CHEM, V287, P13985, DOI 10.1074/jbc.M112.345645; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Jiao GL, 2011, MAR DRUGS, V9, P196, DOI 10.3390/md9020196; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Macdonald SS, 2015, J BIOL CHEM, V290, P4887, DOI 10.1074/jbc.M114.621110; MCCLURE MO, 1992, AIDS RES HUM RETROV, V8, P19, DOI 10.1089/aid.1992.8.19; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhail JA, 2017, STRUCTURE, V25, P121, DOI 10.1016/j.str.2016.11.016; Munoz-Munoz J, 2017, P NATL ACAD SCI USA, V114, P4936, DOI 10.1073/pnas.1701130114; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nieman CE, 2003, BIOCHEMISTRY-US, V42, P8054, DOI 10.1021/bi034293v; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATANKAR MS, 1993, J BIOL CHEM, V268, P21770; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Preobrazhenskaya ME, 1997, BIOCHEM MOL BIOL INT, V43, P443; Sakurama H, 2012, J BIOL CHEM, V287, P16709, DOI 10.1074/jbc.M111.333781; Siempelkamp BD, 2017, J BIOL CHEM, V292, P12256, DOI 10.1074/jbc.M117.789263; SOEDA S, 1994, JPN J CANCER RES, V85, P1144, DOI 10.1111/j.1349-7006.1994.tb02920.x; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Takayama M., 2002, U.S. Patent, Patent No. [No. US 6,489,155 B1, 6489155]; TANAKA K, 1970, FEBS LETT, V9, P45, DOI 10.1016/0014-5793(70)80307-6; Vishchuk OS, 2011, CARBOHYD RES, V346, P2769, DOI 10.1016/j.carres.2011.09.034; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967; Yang YH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004169; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yip VLY, 2004, J AM CHEM SOC, V126, P8354, DOI 10.1021/ja047632w; ZABLACKIS E, 1990, BOT MAR, V33, P273, DOI 10.1515/botm.1990.33.3.273	56	23	23	2	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18296	18308		10.1074/jbc.RA118.005134	http://dx.doi.org/10.1074/jbc.RA118.005134			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30282808	Green Published, hybrid			2022-12-26	WOS:000451375200021
J	Wang, L; Iwasaki, Y; Andra, KK; Pandey, K; Menon, AK; Butikofer, P				Wang, Lei; Iwasaki, Yugo; Andra, Kiran K.; Pandey, Kalpana; Menon, Anant K.; Butikofer, Peter			Scrambling of natural and fluorescently tagged phosphatidylinositol by reconstituted G protein-coupled receptor and TMEM16 scramblases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); liposome; phosphatidylinositol; Phospholipase C; glycerophospholipid; membrane transport; scramblase; TMEM16	SPIN-LABELED PHOSPHOLIPIDS; FLIP-FLOP; TRANSBILAYER DISTRIBUTION; ASYMMETRIC DISTRIBUTION; RAPID FLIP; MEMBRANE; PHOSPHATIDYLCHOLINE; FLIPPASES; PHOSPHATIDYLETHANOLAMINE; BIOSYNTHESIS	Members of the G protein-coupled receptor and TMEM16 (transmembrane protein 16) protein families are phospholipid scramblases that facilitate rapid, bidirectional movement of phospholipids across a membrane bilayer in an ATP-independent manner. On reconstitution into large unilamellar vesicles, these proteins scramble more than 10,000 lipids/protein/s as measured with co-reconstituted fluorescent nitrobenzoxadiazole (NBD)-labeled phospholipids. Although NBD-labeled phospholipids are ubiquitously used as reporters of scramblase activity, it remains unclear whether the NBD modification influences the quantitative outcomes of the scramblase assay. We now report a refined biochemical approach for measuring the activity of scramblase proteins with radiolabeled natural phosphatidylinositol ([H-3]PI) and exploiting the hydrolytic activity of bacterial PI-specific phospholipase C (PI-PLC) to detect the transbilayer movement of PI. PI-PLC rapidly hydrolyzed 50% of [H-3]PI in large symmetric, unilamellar liposomes, corresponding to the lipid pool in the outer leaflet. On reconstitution of a crude preparation of yeast endoplasmic reticulum scramblase, purified bovine opsin, or purified Nectria haematococca TMEM16, the extent of [H-3]PI hydrolysis increased, indicating that [H-3]PI from the inner leaflet had been scrambled to the outer leaflet. Using transphosphatidylation, we synthesized acyl-NBD-PI and used it to compare our PI-PLC-based assay with conventional fluorescence-based methods. Our results revealed quantitative differences between the two assays that we attribute to the specific features of the assays themselves rather than to the nature of the phospholipid. In summary, we have developed an assay that measures scrambling of a chemically unmodified phospholipid by a reconstituted scramblase.	[Wang, Lei; Butikofer, Peter] Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland; [Wang, Lei] Univ Bern, Grad Sch Cellular & Biochem Sci, CH-3012 Bern, Switzerland; [Iwasaki, Yugo] Nagoya Univ, Grad Sch Bioagr Sci, Lab Mol Biotechnol, Furo Cho, Nagoya, Aichi 4648601, Japan; [Andra, Kiran K.; Pandey, Kalpana; Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA	University of Bern; University of Bern; Nagoya University; Cornell University	Butikofer, P (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.; Menon, AK (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.	akm2003@med.cornell.edu; peter.buetikofer@ibmm.unibe.ch	Wang, Lei/D-7812-2019; Pandey, Kalpana/GNW-5078-2022; Menon, Anant/AAN-8663-2021	Wang, Lei/0000-0001-7103-9402; Menon, Anant/0000-0001-6924-2698; Pandey, Kalpana/0000-0002-7048-0690	Velux Foundation [881]; Swiss National Science Foundation [31003A_169355]; National Institutes of Health [EY028314, GM106717]; NATIONAL EYE INSTITUTE [R21EY028314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106717] Funding Source: NIH RePORTER	Velux Foundation(Velux Fonden); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 881 from the Velux Foundation (to P. B. and A. K. M.) and in part by Swiss National Science Foundation Grant 31003A_169355 (to P. B.) and National Institutes of Health Grants EY028314 and GM106717 (to A. K. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahyayauch H, 2015, BIOPHYS J, V108, P1672, DOI 10.1016/j.bpj.2015.02.020; BACKER JM, 1987, NATURE, V327, P341, DOI 10.1038/327341a0; BALLAS LM, 1980, BIOCHIM BIOPHYS ACTA, V602, P578, DOI 10.1016/0005-2736(80)90336-3; BISHOP WR, 1985, CELL, V42, P51, DOI 10.1016/S0092-8674(85)80100-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; BUTIKOFER P, 1990, J BIOL CHEM, V265, P16035; Chalat M, 2012, J BIOL CHEM, V287, P15523, DOI 10.1074/jbc.M112.343038; Chang QL, 2004, BIOCHEMISTRY-US, V43, P10710, DOI 10.1021/bi049063a; CHAP HJ, 1977, BIOCHIM BIOPHYS ACTA, V467, P146, DOI 10.1016/0005-2736(77)90192-4; Chauhan N, 2016, BBA-MOL CELL BIOL L, V1861, P757, DOI 10.1016/j.bbalip.2016.02.025; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; COLEMAN R, 1978, J CELL BIOL, V76, P245, DOI 10.1083/jcb.76.1.245; Damnjanovic J, 2016, BIOTECHNOL BIOENG, V113, P62, DOI 10.1002/bit.25697; Devaux PF, 2002, CHEM PHYS LIPIDS, V116, P115, DOI 10.1016/S0009-3084(02)00023-3; Ernst OP, 2015, PHOTOCH PHOTOBIO SCI, V14, P1922, DOI 10.1039/c5pp00195a; Goren MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6115; Griffith OH, 1999, BBA-MOL CELL BIOL L, V1441, P237, DOI 10.1016/S1388-1981(99)00153-5; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Hessel E, 2000, EUR J BIOCHEM, V267, P1473, DOI 10.1046/j.1432-1327.2000.01147.x; Hessel E, 2001, J BIOL CHEM, V276, P2538, DOI 10.1074/jbc.M009061200; HIGGINS JA, 1989, BIOCHEM J, V259, P913, DOI 10.1042/bj2590913; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; Larsen J, 2011, J AM CHEM SOC, V133, P10685, DOI 10.1021/ja203984j; Lee BC, 2016, BIOPHYS J, V111, P1919, DOI 10.1016/j.bpj.2016.09.032; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Marx U, 2000, BIOPHYS J, V78, P2628, DOI 10.1016/S0006-3495(00)76807-X; Masayama A, 2009, CHEMBIOCHEM, V10, P559, DOI 10.1002/cbic.200800651; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; MCNAMEE MG, 1973, BIOCHEMISTRY-US, V12, P2951, DOI 10.1021/bi00740a001; Menon AK, 2000, CURR BIOL, V10, P241, DOI 10.1016/S0960-9822(00)00356-0; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Montigny C, 2016, BBA-MOL CELL BIOL L, V1861, P767, DOI 10.1016/j.bbalip.2015.12.020; Morra G, 2018, STRUCTURE, V26, P356, DOI 10.1016/j.str.2017.11.020; Muraki M, 2016, J BIOSCI BIOENG, V122, P276, DOI 10.1016/j.jbiosc.2016.02.011; Pandey K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16842-z; Ploier B, 2016, JOVE-J VIS EXP, DOI 10.3791/54635; Ploier B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12832; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski T, 1996, J CELL SCI, V109, P687; Pomorski TG, 2016, PROG LIPID RES, V64, P69, DOI 10.1016/j.plipres.2016.08.003; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sanyal S, 2008, BIOCHEMISTRY-US, V47, P7937, DOI 10.1021/bi800723n; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; TSAI KH, 1975, NATURE, V253, P554, DOI 10.1038/253554a0; Vehring S, 2007, EUKARYOT CELL, V6, P1625, DOI 10.1128/EC.00198-07; Vishwakarma RA, 2005, ORG BIOMOL CHEM, V3, P1275, DOI 10.1039/b500300h; VOLWERK JJ, 1990, BIOCHEMISTRY-US, V29, P8056, DOI 10.1021/bi00487a010; Watanabe R, 2018, P NATL ACAD SCI USA, V115, P3066, DOI 10.1073/pnas.1717956115; WOLF DE, 1992, BIOCHEMISTRY-US, V31, P2865, DOI 10.1021/bi00126a004; WU G, 1993, BIOCHEMISTRY-US, V32, P879, DOI 10.1021/bi00054a020; Zhou C, 1997, BIOCHEMISTRY-US, V36, P347, DOI 10.1021/bi960601w	60	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18318	18327		10.1074/jbc.RA118.004213	http://dx.doi.org/10.1074/jbc.RA118.004213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30287690	hybrid, Green Published			2022-12-26	WOS:000451375200023
J	Thompson, LA; Ikenaka, Y; Darwish, WS; Yohannes, YB; van Vuren, JJ; Wepener, V; Smit, NJ; Assefa, AG; Tharwat, A; Eldin, WFS; Nakayama, SMM; Mizukawa, H; Ishizuka, M				Thompson, Lesa A.; Ikenaka, Yoshinori; Darwish, Wageh S.; Yohannes, Yared B.; van Vuren, Johan J.; Wepener, Victor; Smit, Nico J.; Assefa, Atnafu G.; Tharwat, Ahmed; Eldin, Walaa Fathy Saad; Nakayama, Shouta M. M.; Mizukawa, Hazuki; Ishizuka, Mayumi			Investigation of mRNA expression changes associated with field exposure to DDTs in chickens from KwaZulu-Natal, South Africa	PLOS ONE			English	Article							BREEDING GLAUCOUS GULLS; HUMAN HEALTH-RISK; ANTIMICROBIAL PEPTIDES; FUNCTIONAL-CHARACTERIZATION; ORGANOHALOGEN CONTAMINANTS; ORGANOCHLORINE PESTICIDES; TRANSOVARIAN EXPOSURE; GENE-EXPRESSION; IMMUNE FUNCTION; EDIBLE FISH	The objective of this study was to identify potential mRNA expression changes in chicken livers associated with environmental exposure to dichloro-diphenyl-trichloroethane (DDT) and its metabolites (DDTs). In particular, we focused on genes relating to the immune system and metabolism. We analyzed liver samples from free-ranging chickens in KwaZulu-Natal, South Africa, for contamination by DDTs. This area predominantly uses DDT in its malaria control program, and homes are sprayed annually with the pesticide. Genes relating to the immune system and metabolism were selected as potential genetic biomarkers that could be linked to higher contamination with DDTs. RT-qPCR analysis on 39 samples showed strong correlations between DDTs contamination and mRNA expression for the following genes: AvBD1, AvBD2, AvBD6 and AvBD7(down-regulated), and CYP17, ELOVL2 and SOLE (up-regulated). This study shows for the first time interesting and significant correlations between genetic material collected from environmentally-exposed chickens and mRNA expression of several genes involved in immunity and metabolism. These findings show the usefulness of analysis on field samples from a region with high levels of environmental contamination in detecting potential biomarkers of exposure. In particular, we observed clear effects from DDT contamination on mRNA expression of genes involved in immune suppression, endocrine-disrupting effects, and lipid dysregulation. These results are of interest in guiding future studies to further elucidate the pathways involved in and clinical importance of toxicity associated with DDT exposure from contaminated environments, to ascertain the health risk to livestock and any subsequent risks to food security for people.	[Thompson, Lesa A.; Ikenaka, Yoshinori; Darwish, Wageh S.; Yohannes, Yared B.; Assefa, Atnafu G.; Tharwat, Ahmed; Nakayama, Shouta M. M.; Ishizuka, Mayumi] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Lab Toxicol, Sapporo, Hokkaido, Japan; [Ikenaka, Yoshinori; van Vuren, Johan J.; Wepener, Victor; Smit, Nico J.] North West Univ, Unit Environm Sci & Management, Water Res Grp, Potchefstroom, South Africa; [Darwish, Wageh S.; Tharwat, Ahmed] Zagazig Univ, Fac Vet Med, Food Control Dept, Zagazig, Egypt; [Yohannes, Yared B.; Assefa, Atnafu G.] Univ Gondar, Coll Nat & Computat Sci, Dept Chem, Gondar, Ethiopia; [Eldin, Walaa Fathy Saad] Zagazig Univ, Fac Vet Med, Educ Vet Hosp, Zagazig, Egypt; [Mizukawa, Hazuki] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Sapporo, Hokkaido, Japan	Hokkaido University; North West University - South Africa; Egyptian Knowledge Bank (EKB); Zagazig University; University of Gondar; Egyptian Knowledge Bank (EKB); Zagazig University; Hokkaido University	Ishizuka, M (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Lab Toxicol, Sapporo, Hokkaido, Japan.	ishizum@vetmed.hokudai.ac.jp	Smit, Nico J/L-4905-2013; Wepener, Victor/AAV-2116-2020; Wepener, Victor/S-8421-2019; Darwish, Wageh/N-6136-2019; IKENAKA, Yoshinori/F-8529-2012	Smit, Nico J/0000-0001-7950-193X; Darwish, Wageh/0000-0002-4399-1401; Ikenaka, Yoshinori/0000-0002-6633-6637; Thompson, Lesa/0000-0002-2443-7659; Saad Eldin, Walaa/0000-0002-1310-2212; Yohannes, Yared Beyene/0000-0002-7629-6173; Wepener, Victor/0000-0002-9374-7191	Hokkaido University; Japan Society for the Promotion of Science (JSPS KAKENHI) [16J02013]; Ministry of Education, Culture, Sports, Science and Technology of Japan [16H0177906, 26304043, 15H0282505, 15K1221305, 17K2003807, 16K16197]; foundation of JSPS Core-to-Core Program; Soroptimist Japan; Nakajima Foundation; Sumitomo Foundation; Nihon Seimei Foundation; JST/JICA; SATREPS (Science and Technology Research Partnership for Sustainable Development);  [PG36150002];  [PG36150003]	Hokkaido University; Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); foundation of JSPS Core-to-Core Program; Soroptimist Japan; Nakajima Foundation; Sumitomo Foundation; Nihon Seimei Foundation; JST/JICA(Japan Science & Technology Agency (JST)); SATREPS (Science and Technology Research Partnership for Sustainable Development); ; 	We gratefully acknowledge support from the Leading Program at Hokkaido University and the Japan Society for the Promotion of Science (JSPS KAKENHI, grant number 16J02013) to L. Thompson. Also thanks to Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to M. Ishizuka (number 16H0177906), Y. Ikenaka (numbers 26304043, 15H0282505, 15K1221305, 17K2003807) and S.M.M. Nakayama (number 16K16197), the foundation of JSPS Core-to-Core Program (AA Science Platforms) and Bilateral Joint Research Project (PG36150002 and PG36150003). We also acknowledge support from the Soroptimist Japan, Nakajima, Sumitomo and Nihon Seimei Foundations, JST/JICA and SATREPS (Science and Technology Research Partnership for Sustainable Development).	Agilent Technologies, 2012, INTR QUANT PCR; Akazome Y, 2002, REPRODUCTION, V123, P721, DOI 10.1530/reprod/123.5.721; Akbari MR, 2008, CLIN VACCINE IMMUNOL, V15, P1689, DOI 10.1128/CVI.00242-08; Al-Othman AA, 2015, ENVIRON SCI POLLUT R, V22, P379, DOI 10.1007/s11356-014-3371-0; BRADLOW HL, 1995, ENVIRON HEALTH PERSP, V103, P147, DOI 10.2307/3432525; BRITTON WM, 1975, B ENVIRON CONTAM TOX, V13, P703, DOI 10.1007/BF01721940; BULGER WH, 1978, BIOCHEM PHARMACOL, V27, P2417, DOI 10.1016/0006-2952(78)90354-4; Bureau C, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-430, 10.3201/eid1508.080772]; Bustnes JO, 2004, ARCH ENVIRON CON TOX, V47, P530, DOI 10.1007/s00244-003-3203-6; Carson R, SILENT SPRING; Cruze L, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101360; Cuperus T, 2013, DEV COMP IMMUNOL, V41, P352, DOI 10.1016/j.dci.2013.04.019; D'Andre HC, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-43; Darwish WS, 2010, FOOD CHEM TOXICOL, V48, P3201, DOI 10.1016/j.fct.2010.08.022; DAVISON KL, 1972, J AGR FOOD CHEM, V20, P1198, DOI 10.1021/jf60184a043; DELOSREYES M, 1979, POULTRY SCI, V58, P1183, DOI 10.3382/ps.0581183; Derache C, 2009, DEV COMP IMMUNOL, V33, P959, DOI 10.1016/j.dci.2009.03.005; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Freking F, 2000, GEN COMP ENDOCR, V119, P140, DOI 10.1006/gcen.2000.7503; FRY DM, 1995, ENVIRON HEALTH PERSP, V103, P165, DOI 10.2307/3432528; FRY DM, 1981, SCIENCE, V213, P922, DOI 10.1126/science.7256288; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GLICK B, 1974, POULTRY SCI, V53, P1476, DOI 10.3382/ps.0531476; Gomez-Ramirez P, 2012, CHEMOSPHERE, V88, P903, DOI 10.1016/j.chemosphere.2012.03.014; Gregory MK, 2014, J NUTR, V144, P1234, DOI 10.3945/jn.114.194159; Gregory MK, 2013, J NUTR, V143, P12, DOI 10.3945/jn.112.170290; Gregory NG, 1998, NEW ZEAL J AGR RES, V41, P555, DOI 10.1080/00288233.1998.9513338; Hayes CL, 1996, P NATL ACAD SCI USA, V93, P9776, DOI 10.1073/pnas.93.18.9776; HEATH RG, 1969, NATURE, V224, P47, DOI 10.1038/224047a0; Hellgren Olof, 2010, Immunome Res, V6, P3, DOI 10.1186/1745-7580-6-3; Iwaniuk AN, 2006, BEHAV BRAIN RES, V173, P1, DOI 10.1016/j.bbr.2006.05.026; Jing M, 2013, PROSTAG LEUKOTR ESS, V89, P107, DOI 10.1016/j.plefa.2013.05.006; Kamata R, 2013, J TOXICOL SCI, V38, P903; Kamata R, 2009, ENVIRON TOXICOL CHEM, V28, P782, DOI 10.1897/08-218R.1; Kitamura S, 2000, TOXICOL SCI, V72; Konst H, 1946, Can J Comp Med Vet Sci, V10, P128; KORACH KS, 1988, MOL PHARMACOL, V33, P120; Labunska I, 2015, ENVIRON INT, V74, P209, DOI 10.1016/j.envint.2014.10.020; LATIMER JW, 1974, POULTRY SCI, V53, P1078, DOI 10.3382/ps.0531078; Lavoie ET, 2007, ARCH ENVIRON CON TOX, V53, P655, DOI 10.1007/s00244-006-0150-z; Lee DH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015977, 10.1371/journal.pone.0026172]; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Li XM, 2008, FOOD CHEM, V109, P348, DOI 10.1016/j.foodchem.2007.12.047; Lim U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043502; LUNDHOLM CE, 1992, ARCH TOXICOL, V66, P387, DOI 10.1007/BF02035127; LUNDHOLM CE, 1990, COMP BIOCHEM PHYS C, V96, P321, DOI 10.1016/0742-8413(90)90015-2; LUNDHOLM CE, 1988, COMP BIOCHEM PHYS C, V89, P361, DOI 10.1016/0742-8413(88)90238-1; Ma D, 3 NOVEL ANAS PLATYRH, V49, P84; Maharaj R, 2012, MALARIA J, V11, DOI [10.1186/1475-2875-11-320, 10.1186/1475-2875-11-423]; Mansouri A, 2017, APPL BIOCHEM BIOTECH, V181, P309, DOI 10.1007/s12010-016-2214-5; Morgenthal TL, 2006, S AFR J BOT, V72, P1, DOI 10.1016/j.sajb.2005.03.003; Mrema EJ, 2013, TOXICOLOGY, V307, P74, DOI 10.1016/j.tox.2012.11.015; Mureithi D, 2012, JPN J VET RES, V60, P205; Nakamura P, 1996, J BIOL CHEM, V271, P8053, DOI 10.1074/jbc.271.14.8053; NVOTA J, 1977, VET MED-CZECH, V22, P561; ORTELEE M F, 1958, AMA Arch Ind Health, V18, P433; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Semple F, 2011, EUR J IMMUNOL, V41, P3291, DOI 10.1002/eji.201141648; Sereda B, 2009, J TOXICOL ENV HEAL A, V72, P842, DOI 10.1080/15287390902800447; Sierra-Santoyo A, 2000, TOXICOL SCI, V54, P81, DOI 10.1093/toxsci/54.1.81; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; STOMER VV, 1970, CANADIAN VET J, V11, P215; Subedi K, 2007, REPRODUCTION, V133, P127, DOI 10.1530/REP-06-0083; Swedenborg E, 2009, J MOL ENDOCRINOL, V43, P1, DOI 10.1677/JME-08-0132; Thompson LA, 2017, NON TRADITIONAL REF; Van Dyk JC, 2010, SCI TOTAL ENVIRON, V408, P2745, DOI 10.1016/j.scitotenv.2010.03.002; Verreault J, 2004, ENVIRON HEALTH PERSP, V112, P532, DOI 10.1289/ehp.6756; Verreault J, 2007, ENVIRON POLLUT, V145, P138, DOI 10.1016/j.envpol.2006.03.049; Verreault J, 2006, ENVIRON TOXICOL CHEM, V25, P2990, DOI 10.1897/05-634R.1; Vine MF, 2001, AM J EPIDEMIOL, V153, P53, DOI 10.1093/aje/153.1.53; WAIBEL GP, 1972, POULTRY SCI, V51, P1963, DOI 10.3382/ps.0511963; Wang X, 2007, CYTOGENET GENOME RES, V117, P174, DOI 10.1159/000103178; WEIHE M, 1967, ACTA PHARMACOL TOX, VS 25, P54; Wepener V, 2012, B ENVIRON CONTAM TOX, V88, P277, DOI 10.1007/s00128-011-0439-0; Yohannes YB, 2014, ECOTOX ENVIRON SAFE, V106, P95, DOI 10.1016/j.ecoenv.2014.04.014; Yoshida K, 1996, GEN COMP ENDOCR, V102, P233, DOI 10.1006/gcen.1996.0064; Zhang GW, 2011, J POULT SCI, V48, P254, DOI 10.2141/jpsa.010065	77	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204400	10.1371/journal.pone.0204400	http://dx.doi.org/10.1371/journal.pone.0204400			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307967	Green Published, gold			2022-12-26	WOS:000447173500016
J	Farquharson, K; Hogan, TP; Hoffman, L; Wang, J; Green, KF; Green, JR				Farquharson, Kelly; Hogan, Tiffany P.; Hoffman, Lesa; Wang, Jun; Green, Kimber F.; Green, Jordan R.			A longitudinal study of infants' early speech production and later letter identification	PLOS ONE			English	Article							PHONOLOGICAL AWARENESS; INDIVIDUAL-DIFFERENCES; LANGUAGE IMPAIRMENT; READING ACQUISITION; PRESCHOOL-CHILDREN; LETTER NAMES; VOCABULARY DEVELOPMENT; PHONETIC INVENTORIES; LETTER KNOWLEDGE; YOUNG-CHILDREN	Letter identification is an early metric of reading ability that can be reliability tested before a child can decode words. We test the hypothesis that early speech production will be associated with children's later letter identification. We examined longitudinal growth in early speech production in 9 typically developing children across eight occasions, every 3 months from 9 months to 30 months. At each occasion, participants and their caregivers engaged in a speech sample in a research lab. This speech sample was transcribed for a variety of vocalizations, which were then transformed to calculate consonant-vowel ratio. Consonant-vowel ratio is a measure of phonetic complexity in speech production. At the age of 72 months, children's letter knowledge was measured. A multilevel model including fixed quadratic age change and a random intercept was estimated using letter identification as a predictor of the growth in early speech production from 9-30 months, measured by the outcome of consonant-vowel ratio. Results revealed that the relation between early speech production and letter identification differed over time. For each additional letter that a child identified, their consonant-vowel ratio at the age of 9 months increased. As such, these results confirmed our hypothesis: more robust early speech production is associated with more accurate letter identification.	[Farquharson, Kelly] Florida State Univ, Sch Commun Sci & Disorders, Tallahassee, FL 32306 USA; [Hogan, Tiffany P.; Green, Jordan R.] MGH Inst Hlth Profess, Dept Commun Sci & Disorders, Boston, MA USA; [Hoffman, Lesa] Univ Kansas, Child Language Doctoral Program, Lawrence, KS 66045 USA; [Wang, Jun] Univ Texas Dallas, Dept Biomed Engn, Richardson, TX 75083 USA; [Wang, Jun] Univ Texas Dallas, Callier Ctr Commun Disorders, Dallas, TX USA; [Green, Kimber F.] Kimber Green Therapies, Boston, MA USA	State University System of Florida; Florida State University; University of Kansas; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	Farquharson, K (corresponding author), Florida State Univ, Sch Commun Sci & Disorders, Tallahassee, FL 32306 USA.	kyfarq@gmail.com	Green, Jordan/N-3585-2019; Farquharson, Kelly/H-2779-2019	Green, Jordan/0000-0002-1464-1373; Farquharson, Kelly/0000-0003-1836-4681	National Institute of Health, National Institute on Deafness and Other Communication Disorders [R01 DC006463]	National Institute of Health, National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work has been supported by the National Institute of Health, National Institute on Deafness and Other Communication Disorders (R01 DC006463), awarded to Jordan R. Green. The funder provided support in the form of salaries for authors [KFG, JRG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Commercial affiliation of KFG did not play a role in the study.	American Speech-Language-Hearing Association, 1997, GUID AUD SCREEN; [Anonymous], 1998, WOODCOCK READING MAS; Apel K., 2009, COMMUN DISORD Q, V31, P42, DOI [10.1177/1525740108325553, DOI 10.1177/1525740108325553]; Bleile K. M, 2006, THE LATE 8; Boada R, 2006, J EXP CHILD PSYCHOL, V95, P153, DOI 10.1016/j.jecp.2006.04.003; Burgess SR, 1998, J EXP CHILD PSYCHOL, V70, P117, DOI 10.1006/jecp.1998.2450; Cain K, 2011, J LEARN DISABIL-US, V44, P431, DOI 10.1177/0022219411410042; Catts H., 1986, LANG SPEECH HEARING, V17, P329, DOI [10.1044/0161-1461.1704.329, DOI 10.1044/0161-1461.1704.329]; Catts HW, 2015, READ WRIT, V28, P1407, DOI 10.1007/s11145-015-9576-x; Catts HW, 2002, J SPEECH LANG HEAR R, V45, P1142, DOI 10.1044/1092-4388(2002/093); CATTS HW, 1993, J SPEECH HEAR RES, V36, P948, DOI 10.1044/jshr.3605.948; Chall J.S., 1967, THE GREAT DEBATE; de Jong PF, 1999, J EDUC PSYCHOL, V91, P450, DOI 10.1037/0022-0663.91.3.450; de Jong PF, 2004, J EXP CHILD PSYCHOL, V88, P254, DOI 10.1016/j.jecp.2004.03.007; DINNSEN DA, 1992, LINGUA, V86, P207, DOI 10.1016/0024-3841(92)90036-I; Duff D, 2015, J SPEECH LANG HEAR R, V58, P853, DOI 10.1044/2015_JSLHR-L-13-0310; Duff FJ, 2015, J CHILD PSYCHOL PSYC, V56, P848, DOI 10.1111/jcpp.12378; Eilers R. E, 1989, FIRST LANG, V9, P225; Elbro C, 1996, READ WRIT, V8, P453, DOI 10.1007/BF00577023; Evans MA, 2006, READ WRIT, V19, P959, DOI 10.1007/s11145-006-9026-x; Foy JG, 2001, APPL PSYCHOLINGUIST, V22, P301, DOI 10.1017/S0142716401003022; Gallagher A, 2000, J CHILD PSYCHOL PSYC, V41, P203, DOI 10.1111/1469-7610.00601; Gathercole S. E., 1989, J MEM LANG, V28, P1; Gillon GT, 2000, LANG SPEECH HEAR SER, V31, P126, DOI 10.1044/0161-1461.3102.126; Hoffman L, 2015, MULTIVAR APPL SER, P1; Hogan TP, 2005, LANG SPEECH HEAR SER, V36, P285, DOI 10.1044/0161-1461(2005/029); Hustad KC, 2014, DEV NEUROREHABIL, V17, P167, DOI 10.3109/17518423.2012.747009; Justice LM, 2006, EARLY CHILD RES Q, V21, P374, DOI 10.1016/j.ecresq.2006.07.010; Keren-Portnoy T, 2010, J SPEECH LANG HEAR R, V53, P1280, DOI 10.1044/1092-4388(2009/09-0003); Larrivee LS, 1999, AM J SPEECH-LANG PAT, V8, P118, DOI 10.1044/1058-0360.0802.118; Locke JL, 1989, FIRST LANG, V9, P191, DOI [10.1177/014272378900900606, DOI 10.1177/014272378900900606]; Lonigan CJ, 2000, DEV PSYCHOL, V36, P596, DOI 10.1037//0012-1649.36.5.596; Majorano M, 2014, LANG LEARN DEV, V10, P179, DOI 10.1080/15475441.2013.829740; Mann VA, 2007, ANN DYSLEXIA, V57, P51, DOI 10.1007/s11881-007-0002-1; McBride-Chang C, 1999, MERRILL PALMER QUART, V45, P285; McCathren RB, 1999, J SPEECH LANG HEAR R, V42, P915, DOI 10.1044/jslhr.4204.915; McCune L, 2001, J SPEECH LANG HEAR R, V44, P670, DOI 10.1044/1092-4388(2001/054); McGillion M, 2017, CHILD DEV, V88, P156, DOI 10.1111/cdev.12671; Metsala JL, 1999, J EDUC PSYCHOL, V91, P3, DOI 10.1037/0022-0663.91.1.3; Miller CA, 2001, J SPEECH LANG HEAR R, V44, P416, DOI 10.1044/1092-4388(2001/034); Murphy KA, 2016, READ WRIT, V29, P1745, DOI 10.1007/s11145-016-9651-y; Muter V, 2004, DEV PSYCHOL, V40, P665, DOI 10.1037/0012-1649.40.5.665; Nip ISB, 2011, J COMMUN DISORD, V44, P149, DOI 10.1016/j.jcomdis.2010.08.002; Oller D.K, 2000, EMERGENCE SPEECH CAP, DOI [10.4324/9781410602565, DOI 10.4324/9781410602565]; Oller DK, 1999, J COMMUN DISORD, V32, P223, DOI 10.1016/S0021-9924(99)00013-1; Oller DK, 1997, J CHILD LANG, V24, P407; Oller DK, CHILD PHONOLOGY, V1, P93; Saletta M, 2016, APPL PSYCHOLINGUIST, V37, P411, DOI 10.1017/S0142716415000053; SCARBOROUGH HS, 1990, CHILD DEV, V61, P1728, DOI 10.1111/j.1467-8624.1990.tb03562.x; Scarborough HS, 2002, J LIT RES, V34, P299, DOI 10.1207/s15548430jlr3403_3; Scarborough HS, 1998, SPECIFIC READING DISABILITY, P75; Share DL, 2004, J EXP CHILD PSYCHOL, V87, P267, DOI 10.1016/j.jecp.2004.01.001; SHARE DL, 1995, COGNITION, V55, P151, DOI 10.1016/0010-0277(94)00645-2; Share DL, 2004, J EXP CHILD PSYCHOL, V88, P213, DOI 10.1016/j.jecp.2004.03.005; SHARE DL, 1984, J EDUC PSYCHOL, V76, P1309, DOI 10.1037/0022-0663.76.6.1309; SHRIBERG LD, 1993, J SPEECH HEAR RES, V36, P105, DOI 10.1044/jshr.3601.105; Smith AB, 2008, J SPEECH LANG HEAR R, V51, P1300, DOI 10.1044/1092-4388(2008/06-0193); Smith AB, 2006, AM J SPEECH-LANG PAT, V15, P289, DOI 10.1044/1058-0360(2006/027); Smith SL, 2010, J LEARN DISABIL-US, V43, P294, DOI 10.1177/0022219410369094; Smith SL, 2009, READ WRIT, V22, P25, DOI 10.1007/s11145-007-9101-y; Snowling MJ, 2003, CHILD DEV, V74, P358, DOI 10.1111/1467-8624.7402003; Stoel-Gammon C., 1998, EXPLORING SPEECH LAN, P25; STOELGAMMON C, 1985, J SPEECH HEAR RES, V28, P505, DOI 10.1044/jshr.2804.505; Sutherland D, 2005, LANG SPEECH HEAR SER, V36, P294, DOI 10.1044/0161-1461(2005/030); Swan D, 1997, J EXP CHILD PSYCHOL, V66, P18, DOI 10.1006/jecp.1997.2375; Torppa M, 2006, DEV PSYCHOL, V42, P1128, DOI 10.1037/0012-1649.42.6.1128; TREIMAN R, 1994, APPL PSYCHOLINGUIST, V15, P97, DOI 10.1017/S0142716400006998; Treiman R, 1998, CHILD DEV, V69, P1524, DOI 10.1111/j.1467-8624.1998.tb06175.x; Vihman MM, 2014, LANG LEARN, V64, P121, DOI 10.1111/lang.12058; VIHMAN MM, 1987, J SPEECH HEAR RES, V30, P503, DOI 10.1044/jshr.3004.503; WAGNER RK, 1994, DEV PSYCHOL, V30, P73, DOI 10.1037/0012-1649.30.1.73; WHITEHURST GJ, 1991, J SPEECH HEAR RES, V34, P1121, DOI 10.1044/jshr.3405.1121; Wolter JA, 2010, J SPEECH LANG HEAR R, V53, P179, DOI 10.1044/1092-4388(2009/07-0130)	73	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204006	10.1371/journal.pone.0204006	http://dx.doi.org/10.1371/journal.pone.0204006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4VA	30304048	Green Published, Green Submitted, gold			2022-12-26	WOS:000446921100026
J	Wen, YF; Cheng, TT; Chen, XL; Huang, WJ; Peng, HH; Zhou, TC; Lin, XD; Zeng, LS				Wen, Yue-Feng; Cheng, Tian-Tian; Chen, Xiao-Long; Huang, Wen-Jin; Peng, Hai-Hua; Zhou, Tong-Chong; Lin, Xiao-Dan; Zeng, Li-Si			Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy	PLOS ONE			English	Article							UTERINE CERVIX; CONCURRENT CHEMOTHERAPY; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; RADIATION-THERAPY; CLINICAL VALIDITY; ONCOLOGY-GROUP; BREAST-CANCER; SCC ANTIGEN; CISPLATIN	Objective To evaluate the prognostic effects of combining serum circulating tumor cells (CTCs) and squamous cell carcinoma antigen (SCC-Ag) levels on patients with locally advanced cervical cancer treated with radiotherapy. Methods Ninety-nine patients with locally advanced cervical cancer ([FIGO] stage IIB-IVA) undergoing radiotherapy (RT) or concurrent chemoradiotherapy (CCRT) were identified. The association between serum CTC level and clinicopathological parameters was examined. Univariate and multivariate survival analyses were performed by using Cox's proportional hazards regression model. Results Elevated CTC and SCC-Ag levels were significantly associated with poor disease-free survival (DFS). Multivariate analysis suggest that serum CTC level, FIGO stage and serum SCC-Ag level were independent prognostic factors for two-year DFS. When CTC and SCC-Ag levels were combined into a new risk model to predict disease progression of cervical cancer patients, it performed a significantly better predictive efficiency compared with either biomarker alone. Conclusion Serum CTC and SCC-Ag levels are potentially useful biomarkers for prediction of prognosis in locally advanced cervical cancer patients and their combination significantly improves predictive ability for survival in locally advanced cervical cancer patients.	[Wen, Yue-Feng; Huang, Wen-Jin; Peng, Hai-Hua; Zhou, Tong-Chong; Lin, Xiao-Dan] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China; [Cheng, Tian-Tian] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Dept Good Clin Practice Ctr, Guangzhou, Guangdong, Peoples R China; [Chen, Xiao-Long] Guangdong Work Injury Rehabil Hosp, Dept Orthoped, Guangzhou, Guangdong, Peoples R China; [Zeng, Li-Si] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Dept Abdominal Surg, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Lin, XD (corresponding author), Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China.; Zeng, LS (corresponding author), Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Dept Abdominal Surg, Guangzhou, Guangdong, Peoples R China.	lxdlbllza@126.com; sisi713@163.com		Zhou, Tongchong/0000-0002-5179-8038	Natural Science Foundation of Guangdong Province [2017A030310413]; Guangzhou Key Medical Discipline Construction Project	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangzhou Key Medical Discipline Construction Project	This study was supported by grants from the Natural Science Foundation of Guangdong Province (No. 2017A030310413), Guangzhou Key Medical Discipline Construction Project.	Bayarri-Lara C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148659; Bidard FC, 2014, LANCET ONCOL, V15, P406, DOI 10.1016/S1470-2045(14)70069-5; Bork U, 2015, BRIT J CANCER, V112, P1306, DOI 10.1038/bjc.2015.88; BRIOSCHI PA, 1991, INT J CANCER, V47, P376, DOI 10.1002/ijc.2910470311; Cabel L, 2017, EJSO-EUR J SURG ONC, V43, P949, DOI 10.1016/j.ejso.2017.01.010; Cabel L, 2017, INT J CLIN ONCOL, V22, P421, DOI 10.1007/s10147-017-1105-2; Chen YY, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0240-0; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Dorsey JF, 2015, CANCER-AM CANCER SOC, V121, P139, DOI 10.1002/cncr.28975; Eifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferrigno R, 2003, INT J RADIAT ONCOL, V55, P695, DOI 10.1016/S0360-3016(02)03939-1; Gaarenstroom KN, 2000, GYNECOL ONCOL, V77, P164, DOI 10.1006/gyno.2000.5732; Hong JH, 1998, INT J RADIAT ONCOL, V41, P823, DOI 10.1016/S0360-3016(98)00147-3; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Huang EY, 2008, INT J RADIAT ONCOL, V72, P834, DOI 10.1016/j.ijrobp.2008.01.035; Huang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078070; Keys HM, 1999, NEW ENGL J MED, V340, P1154, DOI 10.1056/NEJM199904153401503; Lee M, 2017, GYNECOL ONCOL, V145, P361, DOI 10.1016/j.ygyno.2017.02.042; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Micke O, 2005, ANTICANCER RES, V25, P1663; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; NEUNTEUFEL W, 1989, ARCH GYNECOL OBSTET, V246, P243, DOI 10.1007/BF00934525; Oh Jinju, 2016, Obstet Gynecol Sci, V59, P269, DOI 10.5468/ogs.2016.59.4.269; Pras E, 2002, INT J RADIAT ONCOL, V52, P23, DOI 10.1016/S0360-3016(01)01805-3; Rack B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju066; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Salvatici M, 2016, GYNECOL ONCOL, V142, P115, DOI 10.1016/j.ygyno.2016.04.029; SCAMBIA G, 1994, J CLIN ONCOL, V12, P2309, DOI 10.1200/JCO.1994.12.11.2309; Sotelo MJ, 2015, ANN ONCOL, V26, P535, DOI 10.1093/annonc/mdu568; Thompson EW, 2011, NAT MED, V17, P1048, DOI 10.1038/nm.2437; Whitney CW, 1999, J CLIN ONCOL, V17, P1339, DOI 10.1200/JCO.1999.17.5.1339; Yoon SM, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-78	33	20	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204334	10.1371/journal.pone.0204334	http://dx.doi.org/10.1371/journal.pone.0204334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303986	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100042
J	Kemigisha, E; Nanjebe, D; Boum, Y; Langendorf, C; Aberrane, S; Nyehangane, D; Nackers, F; Mueller, Y; Charrel, R; Murphy, RA; Page, AL; Mwanga-Amumpaire, J				Kemigisha, Elizabeth; Nanjebe, Deborah, II; Boum, Yap; Langendorf, Celine; Aberrane, Said; Nyehangane, Dan; Nackers, Fabienne; Mueller, Yolanda; Charrel, Remi; Murphy, Richard A.; Page, Anne-Laure; Mwanga-Amumpaire, Juliet			Antimicrobial treatment practices among Ugandan children with suspicion of central nervous system infection	PLOS ONE			English	Article							BACTERIAL-MENINGITIS; STREPTOCOCCUS-PNEUMONIAE; SURVEILLANCE; ANTIBIOTICS; GUIDELINES; MALARIA; DISEASE; DELAYS; RISK	Acute central nervous system (CNS) infections in children in sub-Saharan Africa are often fatal. Potential contributors include late presentation, limited diagnostic capacity and inadequate treatment. A more nuanced understanding of treatment practices with a goal of optimizing such practices is critical to prevent avoidable case fatality. We describe empiric antimicrobial treatment, antibiotic resistance and treatment adequacy in a prospective cohort of 459 children aged two months to 12 years hospitalised for suspected acute CNS infections in Mbarara, Uganda, from 2009 to 2012. Among these 459 children, 155 had a laboratory-confirmed diagnosis of malaria (case-fatality rate [CFR] 14%), 58 had bacterial infections (CFR 24%) and 6 children had mixed malaria and bacterial infections (CFR 17%). Overall case fatality was 18.1% (n = 83). Of 219 children with laboratory-confirmed malaria and/or bacterial infections, 182 (83.1%) received an adequate antimalarial and/or antibiotic on the day of admission and 211 (96.3%) within 48 hours of admission. The proportion of those receiving adequate treatment was similar among survivors and non-survivors. All bacterial isolates were sensitive to ceftriaxone except one Escherichia coli isolate with extended-spectrum beta-lactamase (ESBL). The observed high mortality was not a result of inadequate initial antimicrobial treatment at the hospital. The epidemiology of CNS infection in this setting justifies empirical use of a third-generation cephalosporin, however antibiotic resistance should be monitored closely.	[Kemigisha, Elizabeth; Nanjebe, Deborah, II; Boum, Yap; Nyehangane, Dan; Mwanga-Amumpaire, Juliet] Epictr Mbarara Res Ctr, Mbarara, Uganda; [Kemigisha, Elizabeth; Boum, Yap; Mwanga-Amumpaire, Juliet] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Langendorf, Celine; Nackers, Fabienne; Page, Anne-Laure] Epicentre, Paris, France; [Aberrane, Said] Creteil Hosp, Microbiol Lab, Paris, France; [Mueller, Yolanda] Policlin Med Univ, Ctr Rech & Dev, Lausanne, Switzerland; [Charrel, Remi] EPV Emergence Pathol, UMR D 190, Marseille, France; [Murphy, Richard A.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA 90509 USA	Mbarara University of Science & Technology; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Kemigisha, E; Mwanga-Amumpaire, J (corresponding author), Epictr Mbarara Res Ctr, Mbarara, Uganda.; Kemigisha, E; Mwanga-Amumpaire, J (corresponding author), Mbarara Univ Sci & Technol, Mbarara, Uganda.	ekemigisha@must.ac.ug; juliet.mwanga@epicentre.msf.org	Nackers, Fabienne/X-6615-2019; Mueller, Yolanda/AAH-3571-2019	Mueller, Yolanda/0000-0002-8861-4538; Murphy, Richard/0000-0003-2249-7452; CELINE, LANGENDORF/0000-0002-0811-7540; Nackers, Fabienne/0000-0001-9870-1910	Medecins Sans Frontieres - Operational Center Paris (MSF-OCP)	Medecins Sans Frontieres - Operational Center Paris (MSF-OCP)	This study was funded by Medecins Sans Frontieres - Operational Center Paris (MSF-OCP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronin SI, 1998, ANN INTERN MED, V129, P862, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00004; Cavallo J. D., 2006, COMITE ANTIBIOGRAMME; Church J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-31; De Beaudrap P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-132; De Bruycker M, 2013, PUBLIC HEALTH ACTION, V3, P118, DOI 10.5588/pha.12.0060; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Kisakye A, 2009, CLIN INFECT DIS, V48, pS153, DOI 10.1086/596495; Kollef MH, 2000, CLIN INFECT DIS, V31, pS131, DOI 10.1086/314079; Mathlouthi N, 2016, J INFECT DEV COUNTR, V10, P718, DOI 10.3855/jidc.7426; MinistryOfHealth, 2012, UG CLIN GUID 2012 NA; Molyneux E, 1998, TROP MED INT HEALTH, V3, P610, DOI 10.1046/j.1365-3156.1998.00278.x; Mudhune S, 2009, CLIN INFECT DIS, V48, pS147, DOI 10.1086/596494; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Page AL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02741-w; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Price EH, 2000, J ANTIMICROB CHEMOTH, V46, P653, DOI 10.1093/jac/46.5.653; Proulx N, 2005, QJM-INT J MED, V98, P291, DOI 10.1093/qjmed/hci047; Ramakrishnan M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-47; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2009, AM J PUBLIC HEALTH, V99, P837, DOI 10.2105/AJPH.2008.134411; Sundararajan R, 2015, AM J TROP MED HYG, V92, P933, DOI 10.4269/ajtmh.14-0784; World Health Organization, 2014, ANT RES GLOB REP SUR; World Health Organization, 2015, GUID TREATM MAL, Vthird; World Health Organization Center for Disease Control, 2010, BAS MAL MICR TUT GUI	26	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205316	10.1371/journal.pone.0205316	http://dx.doi.org/10.1371/journal.pone.0205316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300411	Green Submitted, gold, Green Published			2022-12-26	WOS:000446897200054
J	Lee, CY; Choi, K; Kwon, H; Ko, GY; Han, Y; Kwon, TW; Cho, YP				Lee, Chung Yeop; Choi, Kyunghak; Kwon, Hyunwook; Ko, Gi-Young; Han, Youngjin; Kwon, Tae-Won; Cho, Yong-Pil			Outcomes of endovascular treatment versus bypass surgery for critical limb ischemia in patients with thromboangiitis obliterans	PLOS ONE			English	Article							BUERGERS-DISEASE; VENOUS ARTERIALIZATION; VASCULAR RECONSTRUCTION; SALVAGE; FLAP	We aimed to compare the clinical outcomes between endovascular treatment and inframalleolar bypass surgery for critical limb ischemia (CLI) in patients with thromboangiitis obliterans (TAO) and to assess the role of bypass surgery in the era of innovative endovascular treatment. Between January 2007 and December 2017, a total of 33 consecutive patients with the diagnosis of TAO presenting with CLI who underwent endovascular treatment (endovascular group, n = 22) or bypass surgery to the pedal or plantar vessels (bypass group, n = 11) were included and analyzed retrospectively. The primary endpoint was defined as a major amputation of the index limb, and the secondary endpoint was defined as graft occlusion, regardless of the number of subsequent procedures. In the bypass group, six patients (55%) had undergone previous failed endovascular procedures and/or arterial bypass surgery to the index limb before inframalleolar bypass, and two patients (18%) received microvascular flap reconstruction after bypass surgery. During the median follow-up period of 32 months (range 1-115 months), there were no significant differences in primary and secondary endpoints between the two groups although the bypass group had a higher Rutherford class than the endovascular group. Kaplan-Meier survival analysis showed that there were similar limb salvage (P = 0.95) and graft patency rates (P = 0.39). In conclusion, endovascular treatment is a valid strategy leading to an acceptable limb salvage rate for TAO patients, and surgical bypass to distal target vessels could play a vital role in cases of previous failed endovascular treatment or extensive soft tissue loss of the foot.	[Lee, Chung Yeop; Choi, Kyunghak; Kwon, Hyunwook; Han, Youngjin; Kwon, Tae-Won; Cho, Yong-Pil] Univ Ulsan, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Chung Yeop; Choi, Kyunghak; Kwon, Hyunwook; Ko, Gi-Young; Han, Youngjin; Kwon, Tae-Won; Cho, Yong-Pil] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea; [Ko, Gi-Young] Univ Ulsan, Coll Med, Dept Radiol, Seoul, South Korea	University of Ulsan; University of Ulsan; University of Ulsan	Cho, YP (corresponding author), Univ Ulsan, Coll Med, Dept Surg, Seoul, South Korea.; Cho, YP (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea.	ypcho@amc.seoul.kr						Chang H, 2001, BRIT J PLAST SURG, V54, P76, DOI 10.1054/bjps.2000.3482; Dilege S, 2002, SURG TODAY, V32, P1042; Dorweiler B, 2002, EUR J VASC ENDOVASC, V24, P309, DOI 10.1053/ejvs.2002.1735; Ferraresi R, 2009, EUR J VASC ENDOVASC, V37, P336, DOI 10.1016/j.ejvs.2008.12.001; Igari K, 2016, ANN VASC SURG, V30, P263, DOI 10.1016/j.avsg.2015.07.014; Ikeda K, 2012, ANN VASC SURG, V26, DOI 10.1016/j.avsg.2011.06.018; Iwasaki R, 2014, J FOOT ANKLE SURG, V53, P312, DOI 10.1053/j.jfas.2013.12.024; Kallio M, 2015, EUR J VASC ENDOVASC, V50, P223, DOI 10.1016/j.ejvs.2015.04.004; Lu XW, 2006, EUR J VASC ENDOVASC, V31, P493, DOI 10.1016/j.ejvs.2005.12.017; Neufang A, 2017, VASA, V46, P304, DOI 10.1024/0301-1526/a000624; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Ohta T, 2004, J VASC SURG, V39, P176, DOI 10.1016/j.jvs.2003.08.006; Ozbek C, 2005, EUR J VASC ENDOVASC, V29, P47, DOI 10.1016/j.ejvs.2004.09.027; Piazza G, 2010, CIRCULATION, V121, P1858, DOI 10.1161/CIRCULATIONAHA.110.942383; Pomposelli FB, 2003, J VASC SURG, V37, P207; Saarinen E, 2016, EUR J VASC ENDOVASC, V52, P815, DOI 10.1016/j.ejvs.2016.08.051; Sasajima T, 1997, EUR J VASC ENDOVASC, V13, P186, DOI 10.1016/S1078-5884(97)80017-2; Schreve MA, 2017, EUR J VASC ENDOVASC, V53, P387, DOI 10.1016/j.ejvs.2016.11.007; Shionoya S, 1998, INT J CARDIOL, V66, pS243, DOI 10.1016/S0167-5273(98)00175-2; Stoner MC, 2016, J VASC SURG, V64, pE1, DOI 10.1016/j.jvs.2016.03.420; Sugimoto M, 2015, SURG TODAY, V45, P466, DOI 10.1007/s00595-014-0904-6; Taylor RS, 1999, LANCET, V354, P1962, DOI 10.1016/S0140-6736(99)03164-5; Trubel W, 2004, BRIT J SURG, V91, P159, DOI 10.1002/bjs.4388; Uhl C, 2014, J VASC SURG, V59, P1583, DOI 10.1016/j.jvs.2013.11.071; Ye KC, 2017, J VASC SURG, V66, P1133, DOI 10.1016/j.jvs.2017.03.425	25	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205305	10.1371/journal.pone.0205305	http://dx.doi.org/10.1371/journal.pone.0205305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300407	Green Published, gold, Green Submitted			2022-12-26	WOS:000446897200051
J	Deshmukh, D; Chakrabarti, M; Jayasudha, R; Ali, MH; Tyagi, M; Sharma, S; Joseph, J				Deshmukh, Dhanshree; Chakrabarti, Moumita; Jayasudha, Rajagopalaboopathi; Ali, Mohammed Hasnat; Tyagi, Mudit; Sharma, Savitri; Joseph, Joveeta			Elevated cytokine levels in vitreous as biomarkers of disease severity in infectious endophthalmitis	PLOS ONE			English	Article							INFLAMMATORY MEDIATORS; PERSPECTIVES; UVEITIS	Purpose To investigate the immunopathogenesis of endophthalmitis, and determine if cytokine profiles could serve as biomarkers of disease severity in infectious endophthalmitis. Materials and methods Vitreous samples of 46 patients clinically diagnosed as endophthalmitis (of which 25 were culture positive) and 20 non-infectious controls from patients with Retinal Detachment (RD) or diabetic retinopathy were included in the study. The cytokine and chemokine expression patterns of 40 immune mediators including 6 antiinflammatory cytokines, 15 proinflammatory cytokines, 9 Growth factors and 10 proinflammatory chemokines in the vitreous were were analyzed by multiplex cytokine immunoassay. In addition, significant immune mediators were correlated with initial and final visual acuity (VA). Results Our results demonstrated elevated expression of 16 mediators such as GCSF, GRO, IFN-gamma, IL-1 alpha, IL-1 beta, IL-1 RA, IL-6, IL-8, IP-10, MCP-1, MCP-3, MIP-1 alpha, IL-1 beta, TGF-alpha, TNF-alpha in patients with culture positive endophthalmitis. Cytokine profile expression significantly differed between patients with proven endophthalmitis and the non-infectious controls in heat map analysis. PCoA plot indicated five mediators (IL-1RA, IL-6, IL-8, GRO, G-CSF) as biomarkers that could be Independent Predictors of Disease especially in culture negative cases. Correlation of cytokines with VA revealed strong association between the initial VA and intraocular levels of TGF-alpha, IL-1 beta and IL-8 but there was no correlation with the severity or visual outcome of infection. Conclusion In comparison to non-infectious ocular conditions, the pathogenesis of infectious endophthalmitis correlates with increased expression levels of IL-1RA, IL-6, IL-8, GRO, G-CSF. Understanding cytokine profiles in culture negative endophthalmitis patients could aid in therapy in non-responders to empirical antibiotic therapy.	[Deshmukh, Dhanshree; Chakrabarti, Moumita; Jayasudha, Rajagopalaboopathi; Sharma, Savitri; Joseph, Joveeta] LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Jhaveri Microbiol Ctr, Hyderabad, Telangana, India; [Ali, Mohammed Hasnat] LV Prasad Eye Inst, Ctr Clin Epidemiol & Biostat, Hyderabad, India; [Tyagi, Mudit] LV Prasad Eye Inst, Smt Kannuri Santhamma Ctr Vitreoretinal Dis, Kellam Anji Reddy Campus, Hyderabad, Telangana, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute	Joseph, J (corresponding author), LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Jhaveri Microbiol Ctr, Hyderabad, Telangana, India.	joveeta@lvpei.org	Tyagi, Mudit/AAP-6968-2020; Deshmukh, Dhanshree/AAG-2154-2021		DST-SERB India [EMR/2016/002259]; Hyderabad Eye Research Foundation	DST-SERB India; Hyderabad Eye Research Foundation	This work was supported by a grant from the DST-SERB (File Number: EMR/2016/002259) India.; We thank the Hyderabad Eye Research Foundation for supporting the study. We also thank Dr Jay Kumar Chhablani and Dr Padmaja Kumari Rani for providing vitreous samples and recruiting patients in the study.	Callegan MC, 2002, CLIN MICROBIOL REV, V15, P111, DOI 10.1128/CMR.15.1.111-124.2002; Durand ML, 2013, CLIN MICROBIOL INFEC, V19, P227, DOI 10.1111/1469-0691.12118; Escario P, 2014, J CLIN EXP OPHTHALMO, V5, P335; Foxman EF, 2002, J IMMUNOL, V168, P2483, DOI 10.4049/jimmunol.168.5.2483; Hao XL, 2016, MOL VIS, V22, P563; Kernt M, 2010, CLIN OPHTHALMOL, V4, P121; Lorenz HM, 2002, ARTHRITIS RES THER, V4, pS17, DOI 10.1186/ar564; Pollreisz A, 2012, BIOCHEM BIOPH RES CO, V418, P33, DOI 10.1016/j.bbrc.2011.12.102; ROSENBAUM JT, 1992, ARCH OPHTHALMOL-CHIC, V110, P547, DOI 10.1001/archopht.1992.01080160125049; Sauer A, 2017, OCUL IMMUNOL INFLAMM, V28, P1; Sharma S, 1996, RETINA-J RET VIT DIS, V16, P525, DOI 10.1097/00006982-199616060-00010; Vallejo-Garcia JL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/196094; Yu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028680	13	23	23	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205292	10.1371/journal.pone.0205292	http://dx.doi.org/10.1371/journal.pone.0205292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296277	Green Submitted, gold, Green Published			2022-12-26	WOS:000446632700028
J	Yue, L; Pang, Z; Li, H; Yang, T; Guo, L; Liu, LD; Mei, JJ; Song, X; Xie, TH; Zhang, Y; He, X; Lin, TJ; Xie, ZP				Yue, Lei; Pang, Zheng; Li, Hua; Yang, Ting; Guo, Lei; Liu, Longding; Mei, Junjie; Song, Xia; Xie, Tianhong; Zhang, Ye; He, Xin; Lin, Tong-Jun; Xie, Zhongping			CXCL4 contributes to host defense against acute Pseudomonas aeruginosa lung infection	PLOS ONE			English	Article							NEUTROPHIL INFILTRATION; PLATELET ACTIVATION; EPITHELIAL-CELLS; INNATE IMMUNITY; PLATELET-FACTOR-4; RECEPTOR; PROTEIN; KINASE; PHAGOCYTOSIS; INFLAMMATION	Platelets have been implicated in pulmonary inflammation following exposure to bacterial stimuli. The mechanisms involved in the platelet-mediated host response to respiratory bacterial infection remain incompletely understood. In this study, we demonstrate that platelet-derived chemokine (C-X-C motif) ligand 4 (CXCL4) plays critical roles in a mouse model of acute bacterial pneumonia using Pseudomonas aeruginosa. Platelets are activated during P. aeruginosa infection, and mice depleted of platelets display markedly increased mortality and impaired bacterial clearance. CXCL4 deficiency impairs bacterial clearance and lung epithelial permeability, which correlate with decreased neutrophil recruitment to BALF. Interestingly, CXCL4 deficiency selectively regulates chemokine production, suggesting that CXCL4 has an impact on other chemokine expression. In addition, CXCL4 deficiency reduces platelet-neutrophil interactions in blood following P. aeruginosa infection. Further studies revealed that platelet-derived CXCL4 contributes to the P. aeruginosa-killing of neutrophils. Altogether, these findings demonstrate that CXCL4 is a vital chemokine that plays critical roles in bacterial clearance during P. aeruginosa infection through recruiting neutrophils to the lungs and intracellular bacterial killing.	[Yue, Lei; Li, Hua; Yang, Ting; Guo, Lei; Liu, Longding; Mei, Junjie; Song, Xia; Xie, Tianhong; Zhang, Ye; He, Xin; Lin, Tong-Jun; Xie, Zhongping] Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Yue, Lei; Li, Hua; Yang, Ting; Guo, Lei; Liu, Longding; Mei, Junjie; Song, Xia; Xie, Tianhong; Zhang, Ye; He, Xin; Lin, Tong-Jun; Xie, Zhongping] Peking Union Med Coll, Kunming, Yunnan, Peoples R China; [Pang, Zheng; Lin, Tong-Jun] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Lin, Tong-Jun] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Lin, Tong-Jun] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Lin, Tong-Jun] Beatrice Hunter Canc Res Inst, Halifax, NS, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Dalhousie University; Dalhousie University; Dalhousie University	Lin, TJ; Xie, ZP (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China.; Lin, TJ; Xie, ZP (corresponding author), Peking Union Med Coll, Kunming, Yunnan, Peoples R China.; Lin, TJ (corresponding author), Dalhousie Univ, Dept Pathol, Halifax, NS, Canada.; Lin, TJ (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.; Lin, TJ (corresponding author), Dalhousie Univ, Dept Pediat, Halifax, NS, Canada.; Lin, TJ (corresponding author), Beatrice Hunter Canc Res Inst, Halifax, NS, Canada.	tong-jun.lin@dal.ca; xzp218@126.com	Guo, Lei/AEU-0178-2022	Guo, Lei/0000-0003-1733-1802	National Natural Science Foundation of China [81471564]; Yunnan Natural Science Foundation [2016FB037, 2017FB019]; PUMC Youth Fund [3332016114]; Fundamental Research Funds for the Central Universities [2016ZX350070]; CAMS Innovation Fund for Medical Sciences [2017-I2M-2-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); PUMC Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); CAMS Innovation Fund for Medical Sciences	TJL has received grant support from the National Natural Science Foundation of China (81471564) (http://www.nsfc.gov.cn). LY is supported by Yunnan Natural Science Foundation (2016FB037, 2017FB019) (http://www.ynstc.gov.cn), PUMC Youth Fund (3332016114) (http://www.cams.ac.cn), Fundamental Research Funds for the Central Universities (2016ZX350070) (http://www.cams.ac.cn) and CAMS Innovation Fund for Medical Sciences (2017-I2M-2-006) (http://www.cams.ac.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amison RT, 2017, AM J RESP CELL MOL B, DOI [DOI 10.1165/RCMB.2017-00830C, 10.1165/rcmb.2017-0083OC]; Arman M, 2014, BLOOD, V123, P3166, DOI 10.1182/blood-2013-11-540526; Assinger A, 2011, J THROMB HAEMOST, V9, P799, DOI 10.1111/j.1538-7836.2011.04193.x; Azghani AO, 2000, LUNG, V178, P261, DOI 10.1007/s004080000031; Bakogiannis C, 2017, CYTOKINE, DOI [10.1016/j.cyto.2017.09.013, DOI 10.1016/J.CYT0.2017.09.013]; Barbier M, 2013, MBIO, V4, DOI 10.1128/mBio.00207-13; Bdeir K, 2017, AM J RESP CELL MOL, V56, P261, DOI 10.1165/rcmb.2015-0245OC; Boudreau RTM, 2002, J BIOL CHEM, V277, P5322, DOI 10.1074/jbc.M108623200; Bryant-Hudson KM, 2012, INVEST OPHTH VIS SCI, V53, P6785, DOI 10.1167/iovs.12-10400; COUTINHO IR, 1988, THROMB RES, V51, P495, DOI 10.1016/0049-3848(88)90115-6; CRIPPS AW, 1995, IMMUNOL CELL BIOL, V73, P418, DOI 10.1038/icb.1995.65; Deppermann C, 2018, PLATELETS, V29, P549, DOI 10.1080/09537104.2018.1428739; Eslin DE, 2004, BLOOD, V104, P3173, DOI 10.1182/blood-2003-11-3994; Fang SS, 2014, INFLAMMATION, V37, P1744, DOI 10.1007/s10753-014-9903-4; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Gleissner CA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00001; Gleissner CA, 2010, J IMMUNOL, V184, P4810, DOI 10.4049/jimmunol.0901368; Golebiewska EM, 2015, BLOOD REV, V29, P153, DOI 10.1016/j.blre.2014.10.003; Gregory AD, 2007, BLOOD, V109, P3235, DOI 10.1182/blood-2005-01-015081; Gregson AL, 2013, AM J RESP CRIT CARE, V187, P518, DOI 10.1164/rccm.201207-1228OC; Grommes J, 2012, AM J RESP CRIT CARE, V185, P628, DOI 10.1164/rccm.201108-1533OC; Guo L, 2017, MUCOSAL IMMUNOL, V10, P1529, DOI 10.1038/mi.2017.1; Hurley SM, 2015, INFECT IMMUN, V83, P3515, DOI 10.1128/IAI.00508-15; Hwaiz R, 2015, BRIT J PHARMACOL, V172, P5347, DOI 10.1111/bph.13325; Junkins RD, 2014, AM J PATHOL, V184, P2310, DOI 10.1016/j.ajpath.2014.05.009; Junkins RD, 2013, J IMMUNOL, V190, P5178, DOI 10.4049/jimmunol.1203196; Kamath S, 1998, MOL MICROBIOL, V30, P933, DOI 10.1046/j.1365-2958.1998.01121.x; Kasper B, 2011, EUR J CELL BIOL, V90, P521, DOI 10.1016/j.ejcb.2010.12.002; Kernacki KA, 2000, J IMMUNOL, V164, P1037, DOI 10.4049/jimmunol.164.2.1037; Kerrigan SW, 2015, PLATELETS, V26, P293, DOI 10.3109/09537104.2014.997690; Kral JB, 2016, TRANSFUS MED HEMOTH, V43, P78, DOI 10.1159/000444807; Krauel K, 2012, BLOOD, V120, P3345, DOI 10.1182/blood-2012-06-434985; Krauel K, 2011, BLOOD, V117, P1370, DOI 10.1182/blood-2010-08-301424; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Losa D, 2014, J IMMUNOL, V192, P4804, DOI 10.4049/jimmunol.1301294; Lovewell RR, 2014, AM J PHYSIOL-LUNG C, V306, pL698, DOI 10.1152/ajplung.00319.2013; Machado GBS, 2010, SHOCK, V33, P315, DOI 10.1097/SHK.0b013e3181b2b0f4; Mantovani A, 2013, NAT IMMUNOL, V14, P768, DOI 10.1038/ni.2666; McMorran BJ, 2012, SCIENCE, V338, P1348, DOI 10.1126/science.1228892; O'Sullivan R, 2008, IMMUNOBIOLOGY, V213, P469, DOI 10.1016/j.imbio.2007.11.007; Page C, 2014, CLIN EXP ALLERGY, V44, P901, DOI 10.1111/cea.12322; POWDERLY WG, 1986, J CLIN INVEST, V78, P375, DOI 10.1172/JCI112587; Pucci F, 2016, CELL REP, V17, P1764, DOI 10.1016/j.celrep.2016.10.031; Rada B, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6010010; Ritchie AJ, 2003, INFECT IMMUN, V71, P4421, DOI 10.1128/IAI.71.8.4421-4431.2003; Roy S, 2014, J BIOL CHEM, V289, P1174, DOI 10.1074/jbc.M113.523167; Schneider T, 1996, J IMMUNOL METHODS, V198, P1, DOI 10.1016/0022-1759(96)00143-3; Speert D P, 1993, Trends Microbiol, V1, P217, DOI 10.1016/0966-842X(93)90135-E; Struyf S, 2011, BLOOD, V117, P480, DOI 10.1182/blood-2009-11-253591; van Bon L, 2014, NEW ENGL J MED, V370, P433, DOI 10.1056/NEJMoa1114576; Vandercappellen J, 2011, CYTOKINE GROWTH F R, V22, P1, DOI 10.1016/j.cytogfr.2010.10.011; Vikstrom E, 2005, MICROBES INFECT, V7, P1512, DOI 10.1016/j.micinf.2005.05.012; Wesselkamper SC, 2008, J IMMUNOL, V181, P5481, DOI 10.4049/jimmunol.181.8.5481; Wetterholm E, 2016, TRANSL RES, V176, P105, DOI 10.1016/j.trsl.2016.04.006; Weyrich AS, 2013, ANNU REV PHYSIOL, V75, P569, DOI 10.1146/annurev-physiol-030212-183752; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631; Yeaman MR, 2010, FUTURE MICROBIOL, V5, P471, DOI 10.2217/FMB.09.112; Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4; Yue L, 2016, AM J PATHOL, V186, P1234, DOI 10.1016/j.ajpath.2016.01.005; Zaldivar MM, 2010, HEPATOLOGY, V51, P1345, DOI 10.1002/hep.23435	60	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205521	10.1371/journal.pone.0205521	http://dx.doi.org/10.1371/journal.pone.0205521			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296305	Green Published, Green Submitted, gold			2022-12-26	WOS:000446632700039
J	Carley, S; Yahng, LL				Carley, Sanya; Yahng, Lilian			Willingness-to-pay for sustainable beer	PLOS ONE			English	Article							ORGANIC FOOD; FAIR TRADE; CONSUMPTION; CONSUMERS; PRODUCTS; BEHAVIOR; TRANSPORTATION; PREFERENCES; BREWERIES; PARADIGM	Breweries across the country are investing in energy efficient and low-carbon brewing practices. Drawing insights from the sustainable consumption and ecological economics literature, this analysis evaluates whether consumers are willing to pay more for sustainable beer and what predicts the value of the premium. Based on a survey of beer consumers from across the U.S. that contained one of two willingness-to-pay exercises, we evaluate what respondent attributes are associated with a higher willingness-to-pay for sustainably brewed beer. We find that the majority of beer consumers are willing to pay more for sustainable beer. Consumers who are prepared to pay a premium tend to already pay more per unit of beer, are more aware of their purchasing behavior and the manner in which their consumption patterns may affect the environment, and pursue lifestyles based on professional advancement, helping the environment, and helping other causes.	[Carley, Sanya] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA; [Yahng, Lilian] Indiana Univ, Ctr Survey Res, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Carley, S (corresponding author), Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA.	scarley@indiana.edu			Office of the Vice Provost of Research Award for Research Methods and Collaboration at Indiana University	Office of the Vice Provost of Research Award for Research Methods and Collaboration at Indiana University	This research was supported by the Office of the Vice Provost of Research Award for Research Methods and Collaboration at Indiana University.	[Anonymous], 2008, MBAA TQ; Ashenfelter OC, 2015, RAND J ECON, V46, P328, DOI 10.1111/1756-2171.12092; Association Brewers, 2015, BREW ASS DAT 2015; Axsen J, 2012, ECOL ECON, V82, P64, DOI 10.1016/j.ecolecon.2012.07.013; Barlow MA, 2016, J MANAGE, P1; Barr S, 2005, ENERG POLICY, V33, P1425, DOI 10.1016/j.enpol.2003.12.016; Barr S, 2006, GEOFORUM, V37, P906, DOI 10.1016/j.geoforum.2006.05.002; Brewers Association, 2015, 2015 SUST BENCHM REP; Cabuk S, 2014, INT J CONSUM STUD, V38, P337, DOI 10.1111/ijcs.12094; Carroll GR, 2000, AM J SOCIOL, V106, P715, DOI 10.1086/318962; Carrus G, 2008, J ENVIRON PSYCHOL, V28, P51, DOI 10.1016/j.jenvp.2007.09.003; Cordano M., 2003, J ENVIRON EDUC, V34, P22, DOI [10.1080/00958960309603490, DOI 10.1080/00958960309603490]; De Young R, 2000, J SOC ISSUES, V56, P509, DOI 10.1111/0022-4537.00181; Didier T, 2008, INT J CONSUM STUD, V32, P479, DOI 10.1111/j.1470-6431.2008.00714.x; DUNLAP RE, 1978, J ENVIRON EDUC, V9, P10, DOI 10.1080/00958964.1978.10801875; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Essoussi LH, 2010, J CONSUM MARK, V27, P458, DOI 10.1108/07363761011063358; Galitsky C, 2001, TECHNICAL Q, V28, P189; Grebitus C, 2013, ECOL ECON, V88, P67, DOI 10.1016/j.ecolecon.2013.01.006; Guyader H, 2017, J RETAIL CONSUM SERV, V34, P319, DOI 10.1016/j.jretconser.2016.07.008; Hansla A, 2011, ENERG EFFIC, V4, P185, DOI 10.1007/s12053-010-9096-0; Harrison J., 2016, MALT HOPS NEW DEMOGR; Hede AM, 2013, J MARKET MANAG-UK, V29, P207, DOI 10.1080/0267257X.2012.762422; Hoalst-Pullen N., 2014, GEOGRAPHY BEER, P109; Huff C, 2015, RES POLITICS, V2, DOI 10.1177/2053168015604648; Krupnikov Yanna., 2014, J EXP POLIT SCI, V1, P59, DOI DOI 10.1017/XPS.2014.7; Krystallis A, 2005, BRIT FOOD J, V107, P320, DOI 10.1108/00070700510596901; Laroche M, 2001, J CONSUM MARK, V18, P503, DOI 10.1108/EUM0000000006155; Levay K. E., 2016, SAGE OPEN, P1, DOI 10.1177/2158244016636433; Loomis JB, 2014, J AGR RESOUR ECON, V39, P34; Loureiro ML, 2005, ECOL ECON, V53, P129, DOI 10.1016/j.ecolecon.2004.11.002; Loureiro ML., 2002, J AGR APPL EC, V34, P477, DOI [DOI 10.1017/S1074070800009251, 10.1017/S1074070800009251]; Munksgaard J, 2000, ENERG ECON, V22, P423, DOI 10.1016/S0140-9883(99)00033-X; Muster-Slawitsch B, 2011, APPL THERM ENG, V31, P2123, DOI 10.1016/j.applthermaleng.2011.03.033; Nixon H, 2009, ENVIRON BEHAV, V41, P101, DOI 10.1177/0013916507310053; Olajire AA, 2020, J CLEAN PROD, V256, DOI 10.1016/j.jclepro.2012.03.003; ORIORDAN T, 1985, ENVIRON PLANN A, V17, P1431, DOI 10.1068/a171431; Peattie K, 2010, ANNU REV ENV RESOUR, V35, P195, DOI 10.1146/annurev-environ-032609-094328; Ropke I, 2009, ECOL ECON, V68, P2490, DOI 10.1016/j.ecolecon.2009.05.015; Royne MB, 2011, J CONSUM AFF, V45, P329, DOI 10.1111/j.1745-6606.2011.01205.x; SANNE C., 2002, ECOLOGICAL EC, P273; Sheehan Kim Bartel, 2016, AMAZONS MECH TURK AC; Shove Elizabeth, 2003, J CONSUM POLICY DORD, V26, P395, DOI [10.1023/A:1026362829781, 10.1023/a:1026362829781, DOI 10.1023/A:1026362829781]; Toro-Gonzalez D, 2014, J AGR RESOUR ECON, V39, P174; Van Loo EJ, 2015, ECOL ECON, V118, P215, DOI 10.1016/j.ecolecon.2015.07.011; Vlosky RP, 1999, J CONSUM MARK, V16, P122, DOI 10.1108/07363769910260498; Woolverton A. E., 2008, Journal of Food Distribution Research, V39, P50; Young W, 2010, SUSTAIN DEV, V18, P20, DOI 10.1002/sd.394	48	22	22	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204917	10.1371/journal.pone.0204917	http://dx.doi.org/10.1371/journal.pone.0204917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289903	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500027
J	Arepalli, S; Srivastava, SK; Hu, M; Kaiser, PM; Dukles, N; Reese, JL; Ehlers, JP				Arepalli, Sruthi; Srivastava, Sunil K.; Hu, Ming; Kaiser, Peter M.; Dukles, Neeley; Reese, Jamie L.; Ehlers, Justis P.			Assessment of inner and outer retinal layer metrics on the Cirrus HD-OCT Platform in normal eyes	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; 2ND REFLECTIVE BAND; SPECTRAL-DOMAIN OCT; ELLIPSOID ZONE; MACULAR THICKNESS; AXIAL LENGTH; QUANTITATIVE-ANALYSIS; DISEASED RETINA; AGE	Purpose Ellipsoid zone (EZ) and outer retinal integrity are strongly linked to visual prognosis, but quantitative normative data is lacking. This study evaluates the EZ, outer retina, and inner retina in eyes without macular disease across a wide age spectrum. Methods An IRB-approved study was performed for eyes without macular pathology undergoing Spectral Domain Optical Coherence Tomography (SD-OCT) scans on the Cirrus HD-OCT system (Carl Zeiss Meditec, Oberkochen, Germany). Scans were analyzed using a previously described automated EZ mapping tool with line-by-line manual verification. Segmentation included internal limiting membrane (ILM), outer nuclear layer/Henle fiber layer complex (ONUHFL), EZ, and the retinal pigment epithelium (RPE). The output included metrics for the inner retina (ILM-OPUHFL), outer retina (ONUHFL-RPE), EZ-RPE area and volume, and en face EZ mapping. EZ-RPE attenuation on en face mapping was defined as EZ-RPE thickness < 20 um, and total attenuation was 0 um. Imaging parameters were assessed for the group and compared to age, sex, visual acuity and spherical equivalent. Results 167 eyes from 167 subjects were included. Mean age was 49.7 years (range 10-84 years). The mean foveal retinal thickness was 200.58 +/- 19.22 um. Mean inner retinal thickness was 21.47 +/- 13.60 um. Mean outer retinal thickness was 179.11 +/- 18.52 um. Mean EZ-RPE thickness was 50.58 +/- 6.01um. The mean EZ-RPE volume was 1.20 +/- 0.10 mm(3). Mean EZ attenuation percentage per macular map area was 0.87% +/- 1.13% and mean percentage total attenuation was 0.12% +/- 0.14%. Total and inner retinal thickness metrics decreased with age. Mean outer retinal thickness increased with age. EZ-RPE parameters were unchanged with age. However, EZ attenuation was negatively correlated with age. Conclusion This study provides important information for inner and outer retinal parameters. Future research on quantitative EZ integrity can utilize this data for comparison.	[Arepalli, Sruthi; Srivastava, Sunil K.; Hu, Ming; Dukles, Neeley; Reese, Jamie L.; Ehlers, Justis P.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Srivastava, Sunil K.; Hu, Ming; Kaiser, Peter M.; Dukles, Neeley; Reese, Jamie L.; Ehlers, Justis P.] Cleveland Clin, Tony & Leona Campane Ctr Excellence Image Guided, Cleveland, OH 44106 USA; [Hu, Ming] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Ehlers, JP (corresponding author), Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA.; Ehlers, JP (corresponding author), Cleveland Clin, Tony & Leona Campane Ctr Excellence Image Guided, Cleveland, OH 44106 USA.	ehlersj@ccf.org		Ehlers, Justis/0000-0001-6763-7768; Kaiser, Peter Murano/0000-0002-7814-4552; Srivastava, Sunil/0000-0002-0398-8806	Ohio Department of Development [TECH-13-059]; Research to Prevent Blindness (Cole Eye Institutional);  [NIH/NEI K23-EY022947-01A1]; NATIONAL EYE INSTITUTE [K23EY022947] Funding Source: NIH RePORTER	Ohio Department of Development; Research to Prevent Blindness (Cole Eye Institutional); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided through the following grant mechanisms: NIH/NEI K23-EY022947-01A1 (JPE); Ohio Department of Development TECH-13-059 (JPE); and Research to Prevent Blindness (Cole Eye Institutional). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GW, 2013, LIST VIDEO CONTRIBUT, pxxiii; Arepalli S, 2017, ELLIPSOID ZONE MAPPI, DOI [10.1097/iae.0000000000001716, DOI 10.1097/IAE.0000000000001716]; Asefzadeh B, 2007, OPTOMETRY VISION SCI, V84, P941; Asrani S, 1999, OPHTHALMOLOGY, V106, P269, DOI 10.1016/S0161-6420(99)90057-X; Barthelmes D, 2006, INVEST OPHTH VIS SCI, V47, P1161, DOI 10.1167/iovs.05-0783; Birch DG, 2011, INVEST OPHTH VIS SCI, V52, P7141, DOI 10.1167/iovs.11-7509; Bressler NM, 2008, AM J OPHTHALMOL, V145, P894, DOI 10.1016/j.ajo.2007.12.025; Chang LK, 2008, RETINA-J RET VIT DIS, V28, P969, DOI 10.1097/IAE.0b013e3181744165; Channa R, 2012, J OPHTHALMIC INFLAMM, V2, P113, DOI 10.1007/s12348-011-0054-6; Chen J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28013-9; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Demirkaya N, 2013, INVEST OPHTH VIS SCI, V54, P4934, DOI 10.1167/iovs.13-11913; Eriksson U, 2009, BRIT J OPHTHALMOL, V93, P1448, DOI 10.1136/bjo.2007.131094; GAO H, 1992, INVEST OPHTH VIS SCI, V33, P1; Grover S, 2009, AM J OPHTHALMOL, V148, P266, DOI 10.1016/j.ajo.2009.03.006; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P9703, DOI 10.1167/iovs.11-8650; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P101, DOI 10.1167/iovs.10-5799; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang YJ, 2012, INVEST OPHTH VIS SCI, V53, P2133, DOI 10.1167/iovs.11-8755; Ikram MK, 2013, OPHTHALMOLOGICA, V229, P125, DOI 10.1159/000342158; Inoue M, 2009, GRAEF ARCH CLIN EXP, V247, P325, DOI 10.1007/s00417-008-0999-9; Itoh Y, 2016, RETINA-J RET VIT DIS, V36, P2290, DOI 10.1097/IAE.0000000000001110; Itoh Y, 2016, BRIT J OPHTHALMOL, V100, P295, DOI 10.1136/bjophthalmol-2015-307105; Itoh Y, 2012, AM J OPHTHALMOL, V153, P111, DOI 10.1016/j.ajo.2011.05.039; Jonas JB, 2016, INVEST OPHTH VIS SCI, V57, P1791, DOI 10.1167/iovs.15-18529; Kashani AH, 2010, AM J OPHTHALMOL, V149, P496, DOI 10.1016/j.ajo.2009.09.025; Kelty PJ, 2008, INVEST OPHTH VIS SCI, V49, P2668, DOI 10.1167/iovs.07-1000; Kitaguchi Y, 2011, CLIN OPHTHALMOL, V5, P345, DOI 10.2147/OPTH.S17335; Lai WW, 2010, BRIT J OPHTHALMOL, V94, P311, DOI 10.1136/bjo.2009.163584; Lam DSC, 2007, INVEST OPHTH VIS SCI, V48, P376, DOI 10.1167/iovs.06-0426; Lazow MA, 2011, INVEST OPHTH VIS SCI, V52, P9581, DOI 10.1167/iovs.11-8554; Manassakorn A, 2008, JPN J OPHTHALMOL, V52, P450, DOI 10.1007/s10384-008-0538-6; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Massin P, 2002, EUR J OPHTHALMOL, V12, P102, DOI 10.1177/112067210201200205; Oh J, 2010, INVEST OPHTH VIS SCI, V51, P1651, DOI 10.1167/iovs.09-4420; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Parikh RS, 2007, OPHTHALMOLOGY, V114, P921, DOI 10.1016/j.ophtha.2007.01.023; Runkle AP, 2017, INVEST OPHTH VIS SCI, V58, P3683, DOI 10.1167/iovs.16-20976; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; Spaide RF, 2008, AM J OPHTHALMOL, V146, P111, DOI 10.1016/j.ajo.2008.02.027; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Sundaram V, 2014, OPHTHALMOLOGY, V121, P234, DOI 10.1016/j.ophtha.2013.08.017; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Tao LW, 2016, CLIN EXP OPHTHALMOL, V44, P422, DOI 10.1111/ceo.12685; Tong KK, 2016, OPTOMETRY VISION SCI, V93, P714, DOI 10.1097/OPX.0000000000000861; Toprak I, 2017, INT OPHTHALMOL, V37, P801, DOI 10.1007/s10792-016-0331-3; Wong ACM, 2005, EYE, V19, P292, DOI 10.1038/sj.eye.6701466; Wu ZC, 2013, OPHTHALMOLOGY, V120, P1307, DOI 10.1016/j.ophtha.2012.12.047; Wu ZC, 2013, INVEST OPHTH VIS SCI, V54, P2800, DOI 10.1167/iovs.13-11613; YUODELIS C, 1986, VISION RES, V26, P847, DOI 10.1016/0042-6989(86)90143-4	52	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203324	10.1371/journal.pone.0203324	http://dx.doi.org/10.1371/journal.pone.0203324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286099	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500008
J	Blank, M; Sjogren, KG; Knipper, C; Frei, KM; Stora, J				Blank, Malou; Sjogren, Karl-Goran; Knipper, Corina; Frei, Karin M.; Stora, Jan			Isotope values of the bioavailable strontium in inland southwestern Sweden-A baseline for mobility studies	PLOS ONE			English	Article							FUNNEL BEAKER CULTURE; ORIGIN ASSIGNMENT; SR-87/SR-86 RATIO; BRONZE-AGE; MIGRATION; ISLAND; ARCHAEOLOGY; WATERS; OLAND	The inland area of southwestern Sweden is well known for its well-preserved archaeological animal and human remains dating back to the Mesolithic and Neolithic (10000-4000 and 4000-1700 BC). They allow application of multiple bioarchaeological methods, giving insights into various and complementary aspects of prehistoric human life, as well as economic and social structures. One important aspect concerns human mobility and its relation to social networks and to circulation of objects. Here, strontium isotope analysis plays a crucial role. The present study aims to construct a strontium isotope baseline of southwestern Sweden with considerably greater coverage and higher resolution than previously published data. As the region has been affected by glacial events, the relation between bedrock geology and isotope signals of the bioavailable strontium in such areas is given special attention. We determined strontium isotope ratios for 61 water and five archaeological animal samples, and combined the data with previous measurements of two water and 21 non-domestic faunal samples. The results reveal a complex pattern. Several areas with distinct baseline ranges can be distinguished, although with overlaps between some of them. Overall, the bioavailable strontium isotope signals mirror the basement geology of the region. The highest ratios occur in the geologically oldest eastern parts of the Precambrian terrain, while lower ratios are found in the western part, and the lowest ratios occur in the youngest Paleozoic areas. At the same time, there are minor deviations compared to the underlying bedrock, due to glacial transport, overlying sediments, and local intrusions of younger rocks. The background data set now available allows for more nuanced and detailed interpretations of human and animal mobility in the region, in particular by identification of subregions with differing strontium isotope ratios within the Precambrian province. Also, we can now identify long distance mobility with greater confidence.	[Blank, Malou; Sjogren, Karl-Goran] Univ Gothenburg, Dept Hist Studies, Gothenburg, Sweden; [Knipper, Corina] Curt Engelhorn Ctr Archaeometry gGmbH, Mannheim, Germany; [Frei, Karin M.] Natl Museum Denmark, Environm Archaeol & Mat Sci, Brede, Denmark; [Stora, Jan] Stockholm Univ, Dept Archaeol & Class Studies, Stockholm, Sweden	University of Gothenburg; Stockholm University	Blank, M (corresponding author), Univ Gothenburg, Dept Hist Studies, Gothenburg, Sweden.	malou.blank.backlund@gu.se		Sjogren, Karl-Goran/0000-0003-1791-3175; Blank, Malou/0000-0002-0057-8756; Frei, Karin Margarita/0000-0001-5198-073X	Atlas of Ancient Human Genomes in Sweden; Swedish Research Council [VR 2013-1905]; Swedish Foundation for Humanities and Social Sciences [RJ M13-0904:1]	Atlas of Ancient Human Genomes in Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Humanities and Social Sciences	The analyses were financed by The Atlas of Ancient Human Genomes in Sweden, funded by The Swedish Research Council -VR 2013-1905, and The Swedish Foundation for Humanities and Social Sciences, RJ M13-0904:1.	ABERG F, 1987, NORD HYDROL, V18, P33; ABERG G, 1995, WATER AIR SOIL POLL, V79, P309, DOI 10.1007/BF01100444; Ahlberg P., 2013, RAPPORTER MEDDELANDE, P37; Ahlstrom T., 2009, UNDERJORDISKA DODSRI; Anderbjork JE, 1932, V STERG TLANDS FORNM, VIV, P5; Andersson J, 1999, PRECAMBRIAN RES, V98, P151, DOI 10.1016/S0301-9268(99)00048-0; Andersson M., 2014, GEOKEMISK ATLAS SVER; ANTHONY DW, 1990, AM ANTHROPOL, V92, P895, DOI 10.1525/aa.1990.92.4.02a00030; Arcini C, 2015, ENV SOC BLACK DEATH; Bataille CP, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00155.1; Beard BL, 2000, J FORENSIC SCI, V45, P1049; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bergerbrant S., 2017, NEW PERSPECTIVES BRO, P37, DOI [DOI 10.2307/J.CTV1PZK2C1.8, 10.2307/j.ctv1pzk2c1.8]; Blank M, MAKING JOURNEYS ARCH; Blank M, 2018, OPEN ARCHAEOL, V4, P1, DOI 10.1515/opar-2018-0001; Bronnimann D, 2018, J ARCHAEOL SCI-REP, V17, P279, DOI 10.1016/j.jasrep.2017.11.009; Burmeister S, 2000, CURR ANTHROPOL, V41, P539, DOI 10.1086/317383; Cassel Kerstin, 2000, CURR SWED ARCHAEOL, V8, P33; Copeland Sandi R., 2010, Journal of Taphonomy, V8, P115; Crowley BE, 2017, BIOL REV, V92, P43, DOI 10.1111/brv.12217; Cullberg Carl, 1963, MEGALITGRAVEN ROSSBE; Daggers Apel J., 2001, DAGGERS KNOWLEDGE PO; ERICSON JE, 1985, J HUM EVOL, V14, P503, DOI 10.1016/S0047-2484(85)80029-4; Eriksson G, 2018, J ARCHAEOL SCI-REP, V17, P904, DOI 10.1016/j.jasrep.2016.05.052; Evans JA, 2010, J GEOLOGICAL SOC LON, V167, P754; Faure G., 1986, PRINCIPLES ISOTOPE G, V2nd; Faure G., 2004, ISOTOPES PRINCIPLES; Flockhart DTT, 2015, ISOT ENVIRON HEALT S, V51, P372, DOI 10.1080/10256016.2015.1021345; Fornander E, 2015, BAR INT SERIES, V2, P183; Fraser M, 2018, J ARCHAEOL SCI-REP, V20, P324, DOI 10.1016/j.jasrep.2018.02.045; Fraser M, 2018, J ARCHAEOL SCI-REP, V17, P325, DOI 10.1016/j.jasrep.2017.09.002; Frei K., 2015, NATURE SCI REPORTS, V5, DOI [10.1038/srep10431, DOI 10.1038/SREP10431]; Frei K. M., 2009, FORNVANNEN, V104, P313; Frei KM, 2011, APPL GEOCHEM, V26, P325, DOI 10.1016/j.apgeochem.2010.12.006; Frei KM, 2012, ARCHAEOL ANTHROP SCI, V4, P103, DOI 10.1007/s12520-011-0087-7; Frei KM, 2009, J ARCHAEOL SCI, V36, P1965, DOI 10.1016/j.jas.2009.05.007; Frei KM, 2014, OPEN J ARCHAEOM, V2, P5239, DOI [10.4081/arc.2014.5239, DOI 10.4081/ARC.2014.5239]; Frei R, 2013, APPL GEOCHEM, V38, P147, DOI 10.1016/j.apgeochem.2013.09.007; Gerling C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180164; Gillberg G., 1965, GEOL FOREN STOCK FOR, V86, P433; Glykou A, 2018, RAPID COMMUN MASS SP, DOI [10.1002/7cm.8158, DOI 10.1002/7CM.8158]; Grimstead DN, 2017, ADV ARCHAEOL PRACT, V5, P184, DOI 10.1017/aap.2017.6; Gron KJ, 2016, J ARCHAEOL SCI-REP, V6, P248, DOI 10.1016/j.jasrep.2016.02.015; Gron KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131267; Gustafsson MER, 2000, ATMOS ENVIRON, V34, P313, DOI 10.1016/S1352-2310(99)00198-3; HILLSON S, 1996, DENT ANTHR; Hobson KA, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P273, DOI 10.1007/978-90-481-3354-3_13; Hodell DA, 2004, J ARCHAEOL SCI, V31, P585, DOI 10.1016/j.jas.2003.10.009; Kirkbride MP, 2002, MODERN PAST GLACIAL, P47; Klassen L, 2015, CONTACT FORSKNINGSPR, P132; Klassen L, E JUTLAND MUSEUM PUB, V5; Knipper C, 2012, MIGRATIONS PREHISTOR, P293; Knipper C., 2011, BAR INTERNATIONAL SE, V2305; Knipper C, 2017, P NATL ACAD SCI USA, V114, P10083, DOI 10.1073/pnas.1706355114; Knipper C, 2014, J ARCHAEOL SCI, V41, P818, DOI 10.1016/j.jas.2013.09.019; Kootker LM, 2016, J ARCHAEOL SCI-REP, V6, P1, DOI 10.1016/j.jasrep.2016.01.015; Larsson SA., 2015, SVERIGES BERGGRUND G; Lewis J, 2017, SCI TECHNOL ARCHAEOL, V3, P45, DOI 10.1080/20548923.2017.1303124; Lewis J, 2014, CHEM GEOL, V390, P173, DOI 10.1016/j.chemgeo.2014.10.021; Lindstrom J., 2009, BRONSALDERSMORDET AR; Lindstrom M., 2000, Sveriges geologi fran urtid till nutid, V2nd; Loberg B., 1999, GEOLOGI MAT PROCESSE, V6; LOFVENDAHL R, 1990, AQUAT SCI, V52, P315, DOI 10.1007/BF00879760; Maurer AF, 2012, SCI TOTAL ENVIRON, V433, P216, DOI 10.1016/j.scitotenv.2012.06.046; Menzies J.M., 2013, TREATISE GEOMORPHOLO, V8, P127; Montgomery J, 2006, APPL GEOCHEM, V21, P1626, DOI 10.1016/j.apgeochem.2006.07.002; Montgomery J., 2014, J N ATLANTIC SPECIAL, V7, P54, DOI [10.3721/037.002.sp705, DOI 10.3721/037.002.SP705]; Montgomery J., 2006, SOCIAL ARCHAEOLOGY F, P122; Montgomery J, 2010, ANN HUM BIOL, V37, P325, DOI 10.3109/03014461003649297; Muller-Sohnius D., 2007, GEOLOGICA BAVARICA, V110, P1; Naumann E, 2014, AM J PHYS ANTHROPOL, V155, P322, DOI 10.1002/ajpa.22551; Oelze VM, 2012, ARCHAEOMETRY, V54, P752, DOI 10.1111/j.1475-4754.2011.00644.x; Passe T, 2016, BESKRIVNINGAR JORDAR, P534; Persson P, 2001, ARKEOLOGISKA SKRIFTE, V34; Peschel EM, 2017, J ARCHAEOL SCI-REP, V13, P175, DOI 10.1016/j.jasrep.2017.03.049; Pilz J, 2008, STOCH ENV RES RISK A, V22, P621, DOI 10.1007/s00477-007-0165-7; Poszwa A, 2004, BIOGEOCHEMISTRY, V67, P1, DOI 10.1023/B:BIOG.0000015162.12857.3e; Price T.D., 2004, EUR J ARCHAEOL, V7, P9, DOI [DOI 10.1177/1461957104047992, 10.1177/1461957104047992]; Price TD, 2018, J ANTHROPOL ARCHAEOL, V49, P19, DOI 10.1016/j.jaa.2017.10.002; Price TD, 2017, J ARCHAEOL SCI, V80, P1, DOI 10.1016/j.jas.2017.01.013; Price TD, 2011, ANTIQUITY, V85, P476, DOI 10.1017/S0003598X00067880; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Price TD, 2015, J N ATLANTIC, V7, P103; Price TD, 2013, STUDIES UPPAKRA IRON, P157; Rauch E, 2007, FORENSIC SCI INT, V168, P215, DOI 10.1016/j.forsciint.2006.02.011; Retzius G., 1899, CRANIA SUECICA ANTIG; Rossmann A, 2000, EUR FOOD RES TECHNOL, V211, P32, DOI 10.1007/s002170050585; SEALY J, 1995, ANTIQUITY, V69, P290, DOI 10.1017/S0003598X00064693; Sillen A, 1998, GEOCHIM COSMOCHIM AC, V62, P2463, DOI 10.1016/S0016-7037(98)00182-3; Sjogren KG, 2013, J ARCHAEOL SCI, V40, P690, DOI 10.1016/j.jas.2012.08.001; Sjogren K. G, 2015, NEOLITHIC DIVERSITIE, P200; Sjogren K-G, 2003, GOT B; Sjogren K-G, 2008, 200823 VAST MUS, P23; Sjogren KG, 2009, J ANTHROPOL ARCHAEOL, V28, P85, DOI 10.1016/j.jaa.2008.10.001; Tilly C., 1978, HUMAN MIGRATION PATT, P48; Tipple BJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21359-0; Voerkelius S, 2010, FOOD CHEM, V118, P933, DOI 10.1016/j.foodchem.2009.04.125; Vretemark M., 2014, MEDELTIDA STORGARDAR, P131; Whiteman MP, 2002, MODERN PAST GLACIAL, P171; WICKMAN FE, 1987, NORD HYDROL, V18, P21; Wilhelmson H, 2017, J ARCHAEOL SCI-REP, V12, P183, DOI 10.1016/j.jasrep.2017.01.031; Wilhelmson H, 2015, J ARCHAEOL SCI, V64, P30, DOI 10.1016/j.jas.2015.09.007; Willmes M, 2014, EARTH SYST SCI DATA, V6, P117, DOI 10.5194/essd-6-117-2014	103	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204649	10.1371/journal.pone.0204649	http://dx.doi.org/10.1371/journal.pone.0204649			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286158	Green Submitted, gold, Green Published			2022-12-26	WOS:000446383500031
J	De la Casa, LG; Carcel, L; Ruiz-Salas, JC; Vicente, L; Mena, A				Gonzalo De la Casa, Luis; Carcel, Lucia; Carlos Ruiz-Salas, Juan; Vicente, Lucia; Mena, Auxiliadora			Conditioned increase of locomotor activity induced by haloperidol	PLOS ONE			English	Article							UNCONDITIONED STIMULUS; DOPAMINERGIC ACTIVITY; AMPHETAMINE; APOMORPHINE; BEHAVIOR; RATS; CATALEPSY; MORPHINE; SENSITIZATION; ACQUISITION	Dopamine antagonist drugs have profound effects on locomotor activity. In particular, the administration of the D2 antagonist haloperidol produces a state that is similar to catalepsy. In order to confirm whether the modulation of the dopaminergic activity produced by haloperidol can act as an unconditioned stimulus, we carried out two experiments in which the administration of haloperidol was repeatedly paired with the presence of distinctive contextual cues that served as a Conditioned Stimulus. Paradoxically, the results revealed a dose-dependent increase in locomotor activity following conditioning with dopamine antagonist (Experiments 1) that was susceptible of extinction when the conditioned stimulus was presented repeatedly by itself after conditioning (Experiment 2). These data are interpreted from an associative perspective, considering them as a result of a classical conditioning process.	[Gonzalo De la Casa, Luis; Carcel, Lucia; Carlos Ruiz-Salas, Juan; Vicente, Lucia; Mena, Auxiliadora] Univ Seville, Dept Expt Psychol, Seville, Spain	University of Sevilla	De la Casa, LG (corresponding author), Univ Seville, Dept Expt Psychol, Seville, Spain.	delacasa@us.es	De la Casa, Luis/E-7128-2010; VICENTE, LIERN/B-6112-2008	De la Casa, Luis/0000-0001-5199-5851; VICENTE, LIERN/0000-0001-5883-9640; RUIZ-SALAS, JUAN CARLOS/0000-0002-4862-2939; Vicente, Lucia/0000-0003-2769-5028	MINECO, FEDER, UE [PSI2015-64965-P]	MINECO, FEDER, UE	This research was supported by PSI2015-64965-P grant (MINECO, FEDER, UE).	Ahmed SH, 1996, PSYCHOPHARMACOLOGY, V123, P325, DOI 10.1007/BF02246642; Ahmed SH, 1998, BEHAV NEUROSCI, V112, P1167; Amtage J, 2003, BEHAV PHARMACOL, V14, P563, DOI 10.1097/00008877-200311000-00009; Banasikowski TJ, 2012, INT J NEUROPSYCHOPH, V15, P1525, DOI 10.1017/S1461145711001696; BARR GA, 1983, LIFE SCI, V33, P1341, DOI 10.1016/0024-3205(83)90817-2; Battisti JJ, 2000, PHARMACOL BIOCHEM BE, V66, P671, DOI 10.1016/S0091-3057(00)00214-8; BENINGER RJ, 1983, SCIENCE, V220, P1304, DOI 10.1126/science.6857251; Bouton ME, 2007, LEARNING BEHAV CONT, V19; Brudzynski SM, 1997, PHYSIOL BEHAV, V62, P635, DOI 10.1016/S0031-9384(97)00189-3; Carey RJ, 2008, PROG BRAIN RES, V172, P347, DOI 10.1016/S0079-6123(08)00917-5; Carrera MP, 2012, PSYCHOPHARMACOLOGY, V220, P281, DOI 10.1007/s00213-011-2474-2; Dias FRC, 2012, BEHAV BRAIN RES, V229, P153, DOI 10.1016/j.bbr.2011.12.042; Dias FRC, 2010, PSYCHOPHARMACOLOGY, V209, P137, DOI 10.1007/s00213-009-1768-0; Damianopoulos E N, 1992, Rev Neurosci, V3, P65, DOI 10.1515/REVNEURO.1992.3.1.65; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; DICKINSON A, 1978, ANNU REV PSYCHOL, V29, P587, DOI 10.1146/annurev.ps.29.020178.003103; EIKELBOOM R, 1981, PSYCHOPHARMACOLOGY, V75, P96, DOI 10.1007/BF00433511; EIKELBOOM R, 1982, PSYCHOL REV, V89, P507, DOI 10.1037/0033-295X.89.5.507; EIKELBOOM R, 1979, PSYCHOPHARMACOLOGY, V61, P31, DOI 10.1007/BF00426807; ELIAS JW, 1983, PHYSIOL BEHAV, V31, P639; Ford CP, 2014, NEUROSCIENCE, V282, P13, DOI 10.1016/j.neuroscience.2014.01.025; FUREDY JJ, 1976, BIOL PSYCHOL, V4, P93, DOI 10.1016/0301-0511(76)90010-7; GEYER MA, 1987, PHARMACOL BIOCHEM BE, V28, P393, DOI 10.1016/0091-3057(87)90460-6; GOLD LH, 1988, BEHAV NEUROSCI, V102, P544, DOI 10.1037/0735-7044.102.4.544; Hilgard ER, 1936, PSYCHOL REV, V43, P366, DOI 10.1037/h0058976; KUSCHINSKY K, 1972, EUR J PHARMACOL, V19, P119, DOI 10.1016/0014-2999(72)90086-6; LIDSKY TI, 1993, J PHARMACOL EXP THER, V265, P1193; MartinIverson MT, 1996, BEHAV PHARMACOL, V7, P24; Mena A, 2013, BEHAV BRAIN RES, V252, P188, DOI 10.1016/j.bbr.2013.06.005; MIKSIC S, 1975, Neuropsychobiology, V1, P277, DOI 10.1159/000117501; MOREIRA LFD, 1982, PHARMACOLOGY, V25, P1; Pavlov IP, 2010, ANN NEUROSCI, V17, P136, DOI 10.5214/ans.0972-7531.1017309; PICKENS RW, 1967, PSYCHOPHARMACOLOGIA, V11, P88, DOI 10.1007/BF00401511; POULOS CX, 1982, SCIENCE, V218, P491, DOI 10.1126/science.6889765; Santos BG, 2017, PHARMACOL BIOCHEM BE, V156, P24, DOI 10.1016/j.pbb.2017.04.002; Santos BG, 2015, PHARMACOL BIOCHEM BE, V129, P79, DOI 10.1016/j.pbb.2014.12.003; SCHIFF SR, 1982, BIOL PSYCHIAT, V17, P135; Schmidt WJ, 2006, NEUROTOX RES, V10, P161, DOI 10.1007/BF03033244; SIEGEL S, 1977, J EXP PSYCHOL ANIM B, V3, P1, DOI 10.1037/0097-7403.3.1.1; Siegel S., 1979, PSYCHOPATHOL ANIM RE, P498; SOLOMON RL, 1980, AM PSYCHOL, V35, P691, DOI 10.1037/0003-066X.35.8.691; TILSON HA, 1973, PHARM BIO B, V1, P149; WIKLER A, 1967, PSYCHOPHARMACOLOGIA, V10, P255, DOI 10.1007/BF00401386	43	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0200178	10.1371/journal.pone.0200178	http://dx.doi.org/10.1371/journal.pone.0200178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281607	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400005
J	Jena, B; Kumar, A; Ravichandran, M; Kern, S				Jena, Babula; Kumar, Avinash; Ravichandran, M.; Kern, Stefan			Mechanism of sea-ice expansion in the Indian Ocean sector of Antarctica: Insights from satellite observation and model reanalysis	PLOS ONE			English	Article							SOUTHERN-OCEAN; ANNULAR MODE; OZONE HOLE; VARIABILITY; TRENDS; TEMPERATURE; ATMOSPHERE; SALINITY; DRIVEN; COVER	In the backdrop of global warming, Antarctic sea-ice variability showed an overall expansion with the regional heterogeneity of increasing and decreasing patterns. Analysis of satellite derived sea-ice extent, during 1979 to 2015, in the Indian Ocean sector of Antarctica (IOA) revealed expansion of 2.4 +/- 1.2% decade(-1). We find strengthening of westerly wind during the austral summer (between 50 degrees S to 62 degrees S) facilitated northward advection of a cool and fresh layer. Also, the strong westerly wind cools the upper ocean due to net heat loss from the ocean surface. The combined effect of northward advection of cold fresh layer and net heat loss from the surface, favours sea-ice expansion in the subsequent seasons, in the IOA region, north of 62 degrees S. However, sea-ice retreat was observed near the Kerguelen Plateau, due to upper ocean warming, and hence a non-annular pattern of sea-ice extent in the IOA was observed.	[Jena, Babula; Kumar, Avinash; Ravichandran, M.] Govt India, Minist Earth Sci, ESSO Natl Ctr Antarctic & Ocean Res, Vasco Da Gama, India; [Kern, Stefan] Univ Hamburg, Ctr Earth Syst Res & Sustainabil, Integrated Climate Data Ctr, Hamburg, Germany	Ministry of Earth Sciences (MoES) - India; National Centre for Polar and Ocean Research (NCPOR); University of Hamburg	Jena, B (corresponding author), Govt India, Minist Earth Sci, ESSO Natl Ctr Antarctic & Ocean Res, Vasco Da Gama, India.	bjena@ncaor.gov.in	Ravichandran, M./AAM-1351-2020	Kern, Stefan/0000-0001-7281-3746; Avinash, Kumar/0000-0002-6511-8435				Balmaseda MA, 2008, MON WEATHER REV, V136, P3018, DOI 10.1175/2008MWR2433.1; Balmaseda MA, 2013, Q J ROY METEOR SOC, V139, P1132, DOI 10.1002/qj.2063; Bell RE, 2017, NATURE, V544, P344, DOI 10.1038/nature22048; Bintanja R, 2013, NAT GEOSCI, V6, P376, DOI [10.1038/NGEO1767, 10.1038/ngeo1767]; Bitz CM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053393; Boening C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053316; Comiso JC, 2017, J CLIMATE, V30, P2251, DOI [10.1175/JCLI-D-16-0408.1, 10.1175/jcli-d-16-0408.1]; Deb P, 2017, INT J CLIMATOL, V37, P648, DOI 10.1002/joc.4730; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; England MH, 2008, T ROYAL SOC VICTORIA, V120, pi; Ferreira D, 2015, J CLIMATE, V28, P1206, DOI 10.1175/JCLI-D-14-00313.1; Good SA, 2013, J GEOPHYS RES-OCEANS, V118, P6704, DOI 10.1002/2013JC009067; Goosse H, 2009, CLIM DYNAM, V33, P999, DOI 10.1007/s00382-008-0500-9; Groh A, 2016, EGU GEN ASS C; Haumann FA, 2016, NATURE, V537, P89, DOI 10.1038/nature19101; Hellmer HH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019506; Helm KP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044222; Hendricks S, 2018, SEA ICE CLIMATE CHAN, DOI [10.5285/b1f1ac03077b4aa784c5a413a2210bf5, DOI 10.5285/B1F1AC03077B4AA784C5A413A2210BF5]; Herraiz-Borreguero L, 2016, J GEOPHYS RES-OCEANS, V121, P4946, DOI 10.1002/2016JC011858; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Jacobs SS, 2002, SCIENCE, V297, P386, DOI 10.1126/science.1069574; Khan SA, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/4/046801; Khazendar A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13243; Kusahara K, 2017, J GEOPHYS RES-OCEANS, V122, P6238, DOI 10.1002/2017JC012911; Kwok R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015415; Lavergne T, 2018, CRYOSPHERE DISCUSSIO, V2018, P1, DOI [10.5194/tc-2018-127, DOI 10.5194/TC-2018-127]; Liu JP, 2010, P NATL ACAD SCI USA, V107, P14987, DOI 10.1073/pnas.1003336107; Liu JP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018732; Marshall GJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019952; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Mayewski PA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000231; Mogensen K., 2012, ECMWF TECHNICAL MEMO, DOI 10.21957/x5y9yrtm; Nitsche FO, 2017, GEOPHYS RES LETT, V44, P8936, DOI 10.1002/2017GL074433; Nowicki S, 2013, J GEOPHYS RES-EARTH, V118, P1002, DOI 10.1002/jgrf.20081; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Paolo FS, 2015, SCIENCE, V348, P327, DOI 10.1126/science.aaa0940; Parkinson CL, 2012, CRYOSPHERE, V6, P871, DOI 10.5194/tc-6-871-2012; Parkinson CL, 2016, REMOTE SENS ENVIRON, V183, P198, DOI 10.1016/j.rse.2016.05.020; Paul S, 2018, EMPIRICAL PARAMETRIZ, P2437; Pauling AG, 2017, GEOPHYS RES LETT, V44, P10454, DOI 10.1002/2017GL075017; Polvani LM, 2011, J CLIMATE, V24, P795, DOI 10.1175/2010JCLI3772.1; Previdi M, 2014, Q J ROY METEOR SOC, V140, P2401, DOI 10.1002/qj.2330; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Raphael MN, 2011, CLIM DYNAM, V36, P1403, DOI 10.1007/s00382-010-0892-1; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Rignot E, 2013, SCIENCE, V341, P266, DOI 10.1126/science.1235798; Rintoul SR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601610; Santoso A, 2006, J PHYS OCEANOGR, V36, P1523, DOI 10.1175/JPO2930.1; Schlosser E, 2018, CRYOSPHERE, V12, P1103, DOI 10.5194/tc-12-1103-2018; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Sigmond M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044301; Sigmond M, 2014, J CLIMATE, V27, P1336, DOI 10.1175/JCLI-D-13-00590.1; Smith WO, 2008, J GEOPHYS RES, V113, P1, DOI [10.1029/2007JCOO4251, DOI 10.1029/2007JC004251]; Spence P, 2010, J CLIMATE, V23, P5332, DOI 10.1175/2010JCLI3098.1; Tamsitt V, 2017, NATURE COMMUNICATION, V8, P1, DOI [10.1038/s41467-016-0009-6, DOI 10.1038/S41467-016-0009-6]; Thompson DWJ, 2011, NAT GEOSCI, V4, P741, DOI [10.1038/ngeo1296, 10.1038/NGEO1296]; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Tschudi MA, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8060457; Turner J, 2017, GEOPHYS RES LETT, V44, P6868, DOI 10.1002/2017GL073656; Turner J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037524; Williams GD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12577; Wong APS, 1999, NATURE, V400, P440, DOI 10.1038/22733; Zhang JL, 2007, J CLIMATE, V20, P2515, DOI 10.1175/JCLI4136.1; Zhang JL, 2014, J CLIMATE, V27, P202, DOI 10.1175/JCLI-D-12-00139.1; Zwally HJ, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000733; Zwally HJ, 2002, J GEODYN, V34, P405, DOI 10.1016/S0264-3707(02)00042-X	66	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203222	10.1371/journal.pone.0203222	http://dx.doi.org/10.1371/journal.pone.0203222			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281612	Green Published, gold			2022-12-26	WOS:000446342400017
J	Poupeau, A; Garde, C; Sulek, K; Citirikkaya, K; Treebak, JT; Arumugam, M; Simar, D; Olofsson, LE; Backhed, F; Barres, R				Poupeau, Audrey; Garde, Christian; Sulek, Karolina; Citirikkaya, Kiymet; Treebak, Jonas T.; Arumugam, Manimozhiyan; Simar, David; Olofsson, Louise E.; Backhed, Fredrik; Barres, Romain			Genes controlling the activation of natural killer lymphocytes are epigenetically remodeled in intestinal cells from germ-free mice	FASEB JOURNAL			English	Article						DNA methylation; epigenetic; gut microbiota; inflammation	HIGH-FAT DIET; DNA METHYLATION; GUT MICROBIOTA; FOLATE UPTAKE; INSULIN-RESISTANCE; ADAPTER PROTEIN; SKELETAL-MUSCLE; HOST GENE; EXPRESSION; MECHANISM	Remodeling of the gut microbiota is implicated in various metabolic and inflammatory diseases of the gastrointestinal tract. We hypothesized that the gut microbiota affects the DNA methylation profile of intestinal epithelial cells (IECs) which could, in turn, alter intestinal function. In this study, we used mass spectrometry and methylated DNA capture to respectively investigate global and genome-wide DNA methylation of intestinal epithelial cells from germ-free (GF) and conventionally raised mice. In colonic IECs from GF mice, DNA was markedly hypermethylated. This was associated with a dramatic loss of ten-eleven-translocation activity, a lower DNA methyltransferase activity and lower circulating levels of the 1-carbon metabolite, folate. At the gene level, we found an enrichment for differentially methylated regions proximal to genes regulating the cytotoxicity of NK cells (false-discovery rate < 8.9E(-6)), notably genes regulating the cross-talk between NK cells and target cells, such as members of the NK group 2 member D ligand superfamily Raet. This distinct epigenetic signature was associated with a marked decrease in Raet1 expression and a loss of CD56(+)/CD45(+) cells in the intestine of GF mice. Thus, our results indicate that altered activity of methylation-modifying enzymes in GF mice influences the IEC epigenome and modulates the crosstalk between IECs and NK cells. Epigenetic reprogramming of IECs may modulate intestinal function in diseases associated with altered gut microbiota.Poupeau, A., Garde, C., Sulek, K., Citirikkaya, K., Treebak, J. T., Arumugam, M., Simar, D., Olofsson, L. E., Backhed, F., Barres, R. Genes controlling the activation of natural killer lymphocytes are epigenetically remodeled in intestinal cells from germ-free mice.	[Poupeau, Audrey; Garde, Christian; Sulek, Karolina; Citirikkaya, Kiymet; Treebak, Jonas T.; Arumugam, Manimozhiyan; Simar, David; Backhed, Fredrik; Barres, Romain] Univ Copenhagen, Novo Nordisk Fdn, Fac Hlth & Med Sci, Ctr Basic Metab Res, Copenhagen, Denmark; [Simar, David] Univ New South Wales, Sch Med Sci, Mech Dis & Translat Res, Sydney, NSW, Australia; [Olofsson, Louise E.; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Olofsson, Louise E.; Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Inst Med, Gothenburg, Sweden	Novo Nordisk Foundation; University of Copenhagen; University of New South Wales Sydney; University of Gothenburg; University of Gothenburg	Barres, R (corresponding author), Univ Copenhagen, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	barres@sund.ku.dk	Treebak, Jonas Thue/B-4521-2017; Arumugam, Manimozhiyan/AAJ-2394-2020; Backhed, Fredrik/ABE-6613-2020; Sulek, Karolina/GLN-8212-2022; BARRES, Romain/N-2501-2016; Arumugam, Manimozhiyan/E-1211-2011	Treebak, Jonas Thue/0000-0003-1488-7012; Arumugam, Manimozhiyan/0000-0002-0886-9101; Backhed, Fredrik/0000-0002-4871-8818; Sulek, Karolina/0000-0002-7117-3756; BARRES, Romain/0000-0002-0158-519X; Arumugam, Manimozhiyan/0000-0002-0886-9101; Olofsson, Louise/0000-0002-2302-2005; Simar, David/0000-0002-3862-1932	European Foundation for the Study of Diabetes (EFSD)/EFSD/Novo Nordisk Programme for Diabetes Research in Europe grant	European Foundation for the Study of Diabetes (EFSD)/EFSD/Novo Nordisk Programme for Diabetes Research in Europe grant	The authors acknowledge Pattarawan Pattamaprapanont (Mahidol University, Bangkok, Thailand), Louise Manneras Holm (Wallenberg Laboratory and Sahlgrenska Center for Cardiovascular and Metabolic Research), and Thomas Svava Nielsen (Novo Nordisk Foundation Center for Basic Metabolic Research) for their gracious help with mice experiments. The authors also thank The Danish National High-Throughput DNA Sequencing Centre (University of Copenhagen), for sequencing service, and Lene Ravn and Camilla Gitte Thomsen (Klinisk Biokemisk Afdeling, Rigshospitalet, Denmark) for analysis of methyl donors in plasma. R.B., F.B., and M.A. are recipients of a European Foundation for the Study of Diabetes (EFSD)/EFSD/Novo Nordisk Programme for Diabetes Research in Europe grant. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation. The authors declare no conflicts of interest.	Agardh E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0421-5; Aufreiter S, 2009, AM J CLIN NUTR, V90, P116, DOI 10.3945/ajcn.2008.27345; Barres R, 2005, EXP CELL RES, V308, P334, DOI 10.1016/j.yexcr.2005.05.008; Barres R, 2006, MOL ENDOCRINOL, V20, P2864, DOI 10.1210/me.2005-0455; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Burcelin R, 2016, MOL METAB, V5, P771, DOI 10.1016/j.molmet.2016.05.016; Crott JW, 2008, J NUTR BIOCHEM, V19, P328, DOI 10.1016/j.jnutbio.2007.05.003; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Dudeja PK, 2001, AM J PHYSIOL-GASTR L, V281, pG54, DOI 10.1152/ajpgi.2001.281.1.G54; Dudeja PK, 1997, AM J PHYSIOL-GASTR L, V272, pG1408, DOI 10.1152/ajpgi.1997.272.6.G1408; Farias N, 2015, J NUTR BIOCHEM, V26, P818, DOI 10.1016/j.jnutbio.2015.02.002; Galuska D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028294; Galuska D, 2009, AM J PHYSIOL-ENDOC M, V297, pE38, DOI 10.1152/ajpendo.90990.2008; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Huang CZ, 2015, STEM CELLS DEV, V24, P2733, DOI 10.1089/scd.2015.0235; Jacobsen MJ, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8539057; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Kelsey G, 1997, BIOESSAYS, V19, P361, DOI 10.1002/bies.950190502; Kim YI, 2004, CANCER EPIDEM BIOMAR, V13, P511; Kirchner H, 2014, SURG OBES RELAT DIS, V10, P671, DOI 10.1016/j.soard.2013.12.019; Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116; Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Loddo I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00551; Mischke M, 2013, AM J PHYSIOL-REG I, V304, pR1065, DOI 10.1152/ajpregu.00551.2012; Nik AM, 2013, BIOTECHNIQUES, V55, P42, DOI 10.2144/000114055; Nylander V, 2016, DIABETES, V65, P3573, DOI 10.2337/db16-0364; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Perez-Munoz ME, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0268-4; Pompei A, 2007, APPL ENVIRON MICROB, V73, P179, DOI 10.1128/AEM.01763-06; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RONG N, 1991, J NUTR, V121, P1955, DOI 10.1093/jn/121.12.1955; Roostaee A, 2016, J CELL PHYSIOL, V231, P2361, DOI 10.1002/jcp.25401; Rossi M, 2011, NUTRIENTS, V3, P118, DOI 10.3390/nu3010118; Said HM, 2000, AM J PHYSIOL-CELL PH, V279, pC1889, DOI 10.1152/ajpcell.2000.279.6.C1889; SEMCHUK GM, 1994, J NUTR, V124, P1118, DOI 10.1093/jn/124.7.1118; Sepehr E, 2003, J NUTR, V133, P1347; Simar D, 2014, METABOLISM, V63, P1188, DOI 10.1016/j.metabol.2014.05.014; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Song J, 2000, CANCER RES, V60, P3191; Stempak JM, 2005, CARCINOGENESIS, V26, P981, DOI 10.1093/carcin/bgi037; Takahashi K, 2011, J BIOL CHEM, V286, P35755, DOI 10.1074/jbc.M111.271007; Thomes PG, 2015, BIOCHEM PHARMACOL, V96, P30, DOI 10.1016/j.bcp.2015.04.018; Trembath AP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00231; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Winer DA, 2016, CELL METAB, V23, P413, DOI 10.1016/j.cmet.2016.01.003; Yang Y, 2016, INT J BIOCHEM CELL B, V79, P222, DOI 10.1016/j.biocel.2016.08.040; Yu DH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0763-5; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	61	6	6	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2719	2731		10.1096/fj.201800787R	http://dx.doi.org/10.1096/fj.201800787R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303739	Green Published, hybrid			2022-12-26	WOS:000457296600095
J	Walter, F; O'Brien, A; Concannon, CG; Dussmann, H; Prehn, JHM				Walter, Franziska; O'Brien, Aisling; Concannon, Caoimhin G.; Duessmann, Heiko; Prehn, Jochen H. M.			ER stress signaling has an activating transcription factor 6 (ATF6)-dependent "off-switch"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); unfolded protein response (UPR); c-Jun N-terminal kinase (JNK); imaging; protein misfolding; stress response; X-box binding protein 1 (XBP1); APY29; ATF6; high content imaging; IRE1; UPR reporters; fluorescent reporter; cell death; GRP78; lentivirus	MESSENGER-RNA; IRE1-ALPHA; ATF6; IRE1; SINGLE; ATF6-ALPHA; INHIBITION; CLEAVAGE; RATHER; GENES	In response to an accumulation of unfolded proteins in the endoplasmic reticulum (ER) lumen, three ER transmembrane signaling proteins, inositol-requiring enzyme 1 (IRE1), PRKR-like ER kinase (PERK), and activating transcription factor 6 (ATF6), are activated. These proteins initiate a signaling and transcriptional network termed the unfolded protein response (UPR), which re-establishes cellular proteostasis. When this restoration fails, however, cells undergo apoptosis. To investigate cross-talk between these different UPR enzymes, here we developed a high-content live cell screening platform to image fluorescent UPR-reporter cell lines derived from human SH-SY5Y neuroblastoma cells in which different ER stress signaling proteins were silenced through lentivirus-delivered shRNA constructs. We observed that loss of ATF6 expression results in uncontrolled IRE1-reporter activity and increases X box-binding protein 1 (XBP1) splicing. Transient increases in both IRE1 mRNA and IRE1 protein levels were observed in response to ER stress, suggesting that IRE1 up-regulation is a general feature of ER stress signaling and was further increased in cells lacking ATF6 expression. Moreover, overexpression of the transcriptionally active N-terminal domain of ATF6 reversed the increases in IRE1 levels. Furthermore, inhibition of IRE1 kinase activity or of downstream JNK activity prevented an increase in IRE1 levels during ER stress, suggesting that IRE1 transcription is regulated through a positive feed-forward loop. Collectively, our results indicate that from the moment of activation, IRE1 signaling during ER stress has an ATF6-dependent off-switch.	[Walter, Franziska; O'Brien, Aisling; Concannon, Caoimhin G.; Duessmann, Heiko; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Ctr Syst Med, 123 St Stephens Green, Dublin 6, Ireland	Royal College of Surgeons - Ireland	Prehn, JHM (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Ctr Syst Med, 123 St Stephens Green, Dublin 6, Ireland.	jprehn@rcsi.ie		Dussmann, Heiko/0000-0002-3582-8057; Walter, Franziska/0000-0003-4396-6131	Science Foundation Ireland Investigator Award [13/IA/1881]	Science Foundation Ireland Investigator Award(Science Foundation Ireland)	This work was supported by the Science Foundation Ireland Investigator Award 13/IA/1881 (to J. H. M. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Guo FJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.194; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Nolan K, 2016, EUR J NEUROSCI, V43, P640, DOI 10.1111/ejn.13160; Ramapathiran L, 2014, J CELL SCI, V127, P609, DOI 10.1242/jcs.137158; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Sun SY, 2015, NAT CELL BIOL, V17, P1546, DOI 10.1038/ncb3266; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tsuru A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24217; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter F, 2015, CELL DEATH DIFFER, V22, P1502, DOI 10.1038/cdd.2014.241; Wang LK, 2012, NAT CHEM BIOL, V8, P982, DOI [10.1038/NCHEMBIO.1094, 10.1038/nchembio.1094]; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	32	38	41	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18270	18284		10.1074/jbc.RA118.002121	http://dx.doi.org/10.1074/jbc.RA118.002121			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30287689	hybrid, Green Published			2022-12-26	WOS:000451375200019
J	Ferrara-Romeo, L; Martinez, P; Blasco, MA				Ferrara-Romeo, Lole; Martinez, Paula; Blasco, Maria A.			Mice lacking RAP1 show early onset and higher rates of DEN-induced hepatocellular carcinomas in female mice	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; GENE-EXPRESSION; TELOMERE DYSFUNCTION; MAMMALIAN TELOMERES; METABOLIC SYNDROME; LIPID HOMEOSTASIS; PPAR-ALPHA; LIVER; CARCINOGENESIS; HEPATOCARCINOGENESIS	RAP1, a component of the telomere-protective shelterin complex, has been shown to have both telomeric and non-telomeric roles. In the liver, RAP1 is involved in the regulation of metabolic transcriptional programs. RAP1 -deficient mice develop obesity and hepatic steatosis, these phenotypes being more severe in females than in males. As hepatic steatosis and obesity have been related to increased liver cancer in mice and humans, we set out to address whether RAP1 deficiency resulted in increased liver cancer upon chemical liver carcinogenesis. We found that Rapl(-/-) females were more susceptible to DEN-induced liver damage and hepatocellular carcinoma (HCC). DEN-treated Rap(-/-) female livers showed an earlier onset of both premalignant and malignant liver lesions, which were characterized by increased abundance of yH2AX-positive cells, increased proliferation and shorter telomeres. These findings highlight an important role for RAP1 in protection from liver damage and liver cancer.	[Ferrara-Romeo, Lole; Martinez, Paula; Blasco, Maria A.] Spanish Natl Canc Ctr CNIO, Telomeres & Telomerase Grp, Mol Oncol Program, Melchor Fernandez Almagro 3, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Ctr CNIO, Telomeres & Telomerase Grp, Mol Oncol Program, Melchor Fernandez Almagro 3, Madrid, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X	Societal Changes Program of the Spanish Ministry of Economics and Competitiveness (MINECO) [SAF2013-45111-R]	Societal Changes Program of the Spanish Ministry of Economics and Competitiveness (MINECO)	This work was supported by the Societal Changes Program of the Spanish Ministry of Economics and Competitiveness (MINECO) (SAF2013-45111-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama TE, 2001, J BIOL CHEM, V276, P39088, DOI 10.1074/jbc.M107073200; Bakiri L, 2017, J EXP MED, V214, P1387, DOI 10.1084/jem.20160935; Bakiri L, 2013, MOL ONCOL, V7, P206, DOI 10.1016/j.molonc.2013.01.005; Begus-Nahrmann Y, 2012, J CLIN INVEST, V122, P2283, DOI 10.1172/JCI61745; Beier F, 2015, J HEPATOL, V63, P446, DOI 10.1016/j.jhep.2015.03.022; Bhalla K, 2011, CANCER RES, V71, P6888, DOI 10.1158/0008-5472.CAN-11-1011; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Boege Y, 2017, CANCER CELL, V32, P342, DOI 10.1016/j.ccell.2017.08.010; Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173; Calado RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007926; CARLSSON G, 1983, J CANCER RES CLIN, V105, P20, DOI 10.1007/BF00391826; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Deschl U, 2001, INT CLASIFICATION RO; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; El Idrissi M, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-64; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2003, CANCER RES, V63, P5021; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Harada T., 1999, PATHOLOGY MOUSE, P119; Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217; Jors S, 2015, J CLIN INVEST, V125, P2445, DOI 10.1172/JCI78585; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kidani Y, 2012, IMMUNOL REV, V249, P72, DOI 10.1111/j.1600-065X.2012.01153.x; Kim Bang Hyun, 2003, J Vet Sci, V4, P239; Lechel A, 2007, GASTROENTEROLOGY, V132, P1465, DOI 10.1053/j.gastro.2007.01.045; Lee S.-Y., 1995, J CHIN MED, V6, P1; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lenaerts AJ, 2005, INT J ANTIMICROB AG, V26, P152, DOI 10.1016/j.ijantimicag.2005.04.011; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li BB, 2003, MOL BIOL CELL, V14, P5060, DOI 10.1091/mbc.e03-06-0403; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu XC, 2011, J HEPATOL, V55, P96, DOI 10.1016/j.jhep.2010.10.020; Martinez P, 2017, J CELL BIOL, V216, P875, DOI 10.1083/jcb.201610111; Martinez P, 2016, AGING CELL, V15, P1113, DOI 10.1111/acel.12517; Martinez P, 2013, CELL REP, V3, P2059, DOI 10.1016/j.celrep.2013.05.030; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Martinez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x; Martinez P, 2010, NAT CELL BIOL, V12, P768, DOI 10.1038/ncb2081; Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9; Nakatani T, 2001, JPN J CANCER RES, V92, P249, DOI 10.1111/j.1349-7006.2001.tb01089.x; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Plentz RR, 2005, HEPATOLOGY, V42, P522, DOI 10.1002/hep.20847; Plentz RR, 2007, HEPATOLOGY, V45, P968, DOI 10.1002/hep.21552; Preidis GA, 2017, J CLIN INVEST, V127, P1193, DOI [10.1172/jci88893, 10.1172/JCI88893]; Rahman R, 2013, WORLD J GASTRO ONCOL, V5, P186, DOI 10.4251/wjgo.v5.i9.186; Ringelhan M, 2018, NAT IMMUNOL, V19, P222, DOI 10.1038/s41590-018-0044-z; Sarthy J, 2009, EMBO J, V28, P3390, DOI 10.1038/emboj.2009.275; Satyanarayana A, 2004, HEPATOLOGY, V40, P276, DOI 10.1002/hep.20308; Schlageter M, 2014, WORLD J GASTROENTERO, V20, P15955, DOI 10.3748/wjg.v20.i43.15955; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Siegel AB, 2009, CANCER-AM CANCER SOC, V115, P5651, DOI 10.1002/cncr.24687; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tejera A, 2010, DEV CELL, V18, P691, DOI DOI 10.1016/J.DEVCEL.2010.05.003; Teo HL, 2010, NAT CELL BIOL, V12, P758, DOI 10.1038/ncb2080; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; VESSELINOVITCH SD, 1983, CANCER RES, V43, P4253; VESSELINOVITCH SD, 1984, J CANCER RES CLIN, V108, P60, DOI 10.1007/BF00390974; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Yang D, 2011, CELL RES, V21, P1013, DOI 10.1038/cr.2011.39; Yeung F, 2013, CELL REP, V3, P1847, DOI 10.1016/j.celrep.2013.05.032; Zhang N, 2014, ONCOTARGET, V5, P8330, DOI 10.18632/oncotarget.2212	72	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204909	10.1371/journal.pone.0204909	http://dx.doi.org/10.1371/journal.pone.0204909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307978	gold, Green Published, Green Submitted			2022-12-26	WOS:000447173500032
J	Gholipour, K; Tabrizi, JS; Jafarabadi, MA; Iezadi, S; Mardi, A				Gholipour, Kamal; Tabrizi, Jafar Sadegh; Jafarabadi, Mohammad Asghari; Iezadi, Shabnam; Mardi, Ahmad			Effects of customer self-audit on the quality of maternity care in Tabriz: A cluster-randomized controlled trial	PLOS ONE			English	Article							GROUP PRENATAL-CARE; GROUP ANTENATAL CARE; SERVICE QUALITY; HEALTH-CARE; PATIENT SATISFACTION; CENTERING PREGNANCY; TECHNICAL QUALITY; PERCEPTIONS; IMPACT; AUSTRALIA	Objective To study the effects of customer self-audit on the service quality (SQ) and customer quality (CQ) of maternity care. Design A community-based cluster-randomized controlled trial. Setting Twenty-one health centres and health posts in Tabriz, Iran. Participants Of 21 health centres/health posts, 10 were randomly assigned to the intervention group and 11 randomly assigned to the control group. Participants were 185 pregnant women selected from health centre/post registration lists (intervention group: n = 92; control group: n = 93). Interventions The intervention was a customer self-audit based on the CenteringPregnancy((R)) model of prenatal group care. The intervention group attended group support sessions focused on participants' opinions, questions, and self-management concerns. They also received sessions on experiential learning, coping, problem-solving, and goal-setting by a family health expert, a midwife, and a doctor. Control group participants continued to receive individual care. Primary outcome measures SQ and CQ were assessed using questionnaires. Patients rated the importance and performance of non-health quality dimensions. SQ was calculated as: SQ = 10 - (Importance x Performance). Results Total mean SQ scores were 7.63 (0.91) and 8.91 (0.76) for the control and intervention groups, respectively, a statistically significant difference (p<0.001). Compared with the control group, the intervention group scored higher on the SQ aspects confidentiality, communication, autonomy, availability of support group, dignity, safety, prevention, and accessibility. Total mean CQ scores for the control and intervention groups were 82.63(7.21) and 87.47 (6.75), respectively, a statistically significant difference (p<0.001). After intervention, 82.6% of intervention group participants and 50.5% of control group participants reached the highest stage of self-management, showing an ability to take care of themselves under stress and financial constraints. Conclusions The group prenatal care customer self-audit improved the SQ and CQ of maternity care by increased involvement of participants and giving them active roles in the care process.	[Gholipour, Kamal] Tabriz Univ Med Sci, Iranian Ctr Excellence Hlth Management, Sch Management & Med Informat, Tabriz, Iran; [Gholipour, Kamal; Tabrizi, Jafar Sadegh] Tabriz Univ Med Sci, Hlth Serv Management Res Ctr, Hlth Management & Safety Promot Res Inst, Tabriz, Iran; [Jafarabadi, Mohammad Asghari] Tabriz Univ Med Sci, Hlth Management & Safety Promot Res Inst, Rd Traff Injury Res Ctr, Tabriz, Iran; [Jafarabadi, Mohammad Asghari] Tabriz Univ Med Sci, Fac Hlth, Dept Stat & Epidemiol, Tabriz, Iran; [Iezadi, Shabnam] Tabriz Univ Med Sci, Social Determinants Hlth Res Ctr, Hlth Management & Safety Promot Res Inst, Tabriz, Iran; [Mardi, Ahmad] Tabriz Univ Med Sci, East Azerbaijan Prov Hlth Ctr, Tabriz, Iran	Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science	Iezadi, S (corresponding author), Tabriz Univ Med Sci, Social Determinants Hlth Res Ctr, Hlth Management & Safety Promot Res Inst, Tabriz, Iran.	sh_iezadi@yahoo.com	Gholipour, Kamal/L-1269-2017; tabrizi, jafarsadegh/L-5036-2017; Iezadi, Shabnam/R-5434-2018	Gholipour, Kamal/0000-0002-6595-4150; tabrizi, jafarsadegh/0000-0002-1458-8672; Iezadi, Shabnam/0000-0002-9644-5105	Tabriz Health Services Management Research Centre, Health Deputy of Tabriz University of Medical Sciences; National Public health Management Centre (NPMC)	Tabriz Health Services Management Research Centre, Health Deputy of Tabriz University of Medical Sciences; National Public health Management Centre (NPMC)	This study was supported by Tabriz Health Services Management Research Centre, Health Deputy of Tabriz University of Medical Sciences and National Public health Management Centre (NPMC). The code of ethics is TBZMED. REC. 5/4/12323 plan.	Afsharnia F, 2011, IMPROVING TECHNICAL; ALEXANDER GR, 1995, FUTURE CHILD, V5, P103, DOI 10.2307/1602510; Andersson E, 2013, SEX REPROD HEALTHC, V4, P113, DOI 10.1016/j.srhc.2013.08.002; Barber SL, 2009, HEALTH POLICY PLANN, V24, P18, DOI 10.1093/heapol/czn039; Berman P, 2000, B WORLD HEALTH ORGAN, V78, P791; Berwick DM, 2003, MED CARE, V41, pI30; Carter EB, 2016, OBSTET GYNECOL, V128, P551, DOI 10.1097/AOG.0000000000001560; Cunningham SD, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1327-3; Dai L., 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.0113377; DeCesare JZ, 2015, ARCH GYNECOL OBSTET, V291, P499, DOI 10.1007/s00404-014-3467-2; Doaee S, 2013, J PAK MED ASSOC, V63, P50; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feijen-de Jong EI, 2015, WOMEN BIRTH, V28, P87, DOI 10.1016/j.wombi.2015.01.005; Garretto D, 2014, AM J OBSTET GYNECOL, V210, P14, DOI 10.1016/j.ajog.2013.10.002; Gennaro S, 2016, MCN-AM J MATERN-CHIL, V41, P147, DOI 10.1097/NMC.0000000000000227; Gholipour K, 2016, E MEDITERR HEALTH J, V22, P309; Goldberg H, 2009, J PERINAT EDUC, V18, P32, DOI 10.1624/105812409X396219; Hale N, 2014, AM J OBSTET GYNECOL, V210, pE1; Health F, 1999, MAT CAR SERV ISL REP; Heberlein EC, 2016, J MIDWIFERY WOM HEAL, V61, P224, DOI 10.1111/jmwh.12379; Herrman JW, 2012, MCN-AM J MATERN-CHIL, V37, P19, DOI 10.1097/NMC.0b013e3182385204; Hibbard JH, 2003, MED CARE, V41, pi61; Ickovics JR, 2007, OBSTET GYNECOL, V110, P330, DOI 10.1097/01.AOG.0000275284.24298.23; Jafari F, 2010, IRAN J PUBLIC HEALTH, V39, P52; John J., 2015, P 1989 AC MARK SCI A, P518; Joshi C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-94; Kennedy HP, 2009, J MIDWIFERY WOM HEAL, V54, P176, DOI 10.1016/j.jmwh.2008.11.004; Kitapci O, 2014, PROCD SOC BEHV, V148, P161, DOI 10.1016/j.sbspro.2014.07.030; Klima C, 2009, J MIDWIFERY WOM HEAL, V54, P27, DOI 10.1016/j.jmwh.2008.05.008; Klima CS, 2003, J MIDWIFERY WOM HEAL, V48, P220, DOI 10.1016/S1526-9523(03)00062-X; Koch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036613; Kumaraswamy S, 2012, INT J BUSINESS SOCIA, V3, P141; Lathrop B, 2013, NURS WOMENS HLTH, V17, P120; Lin HC, 2004, INT J QUAL HEALTH C, V16, P437, DOI 10.1093/intqhc/mzh072; Maizes V, 2009, EXPLORE NY; Martins Maria de Fatima da Silva Vieira, 2014, Rev Bras Enferm, V67, P1008, DOI 10.1590/0034-7167.2014670621; Massey Z, 2006, JOGNN-J OBST GYN NEO, V35, P286, DOI 10.1111/J.1552-6909.2006.00040.x; Mehdizadeh A, 2003, RAZI J MED SCI, V10, P455; Moghani Lankarani Maryam, 2014, J Family Reprod Health, V8, P97; Mpinganjira M, 2011, AFR J BUS MANAGE, V5, P3690; Neupane S, 2014, EUR J PEDIATR, V173, P99, DOI 10.1007/s00431-013-2136-y; Novick G, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.03.026; Oyelese Y, 2005, AM FAM PHYSICIAN, V71, P1264; Papanikolaou V, 2014, HEALTH EXPECT, V17, P197, DOI 10.1111/j.1369-7625.2011.00747.x; Patil CL, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1493-3; Picklesimer A, 2015, CLIN OBSTET GYNECOL, V58, P380, DOI 10.1097/GRF.0000000000000095; Picklesimer A, 2012, AM J OBSTET GYNECOL, V206, pS55, DOI 10.1016/j.ajog.2011.10.109; Tabrizi JS, 2008, DIABETIC MED, V25, P612, DOI 10.1111/j.1464-5491.2008.02420.x; Tabrizi JS, 2013, HOSPITAL, V12, P9; Tabrizi JS, 2012, J CLIN RES GOV, V1, P11; Teate A, 2011, MIDWIFERY, V27, P138, DOI 10.1016/j.midw.2009.03.001; Tuncalp O, 2015, BJOG-INT J OBSTET GY, V122, P1045, DOI 10.1111/1471-0528.13451; van der Eijk I, 2001, AM J GASTROENTEROL, V96, P3329, DOI 10.1016/S0002-9270(01)03896-5; Wedin K, 2010, MIDWIFERY, V26, P389, DOI 10.1016/j.midw.2008.10.010; WHO (World Health Organization), SEX REPR HLTH; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; Wilson A, 2013, HEALTH PROMOT PERSPE, V3, P23, DOI 10.5681/hpp.2013.003	58	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0203255	10.1371/journal.pone.0203255	http://dx.doi.org/10.1371/journal.pone.0203255			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW7TO	30307957	gold, Green Published, Green Submitted			2022-12-26	WOS:000447173500006
J	Song, BS; Jeong, PS; Lee, JH; Lee, MH; Yang, HJ; Choi, SA; Lee, HY; Yoon, SB; Park, YH; Jeong, KJ; Kim, YH; Jin, YB; Kim, JS; Sim, BW; Huh, JW; Lee, SR; Koo, DB; Chang, KT; Kim, SU				Song, Bong-Seok; Jeong, Pil-Soo; Lee, Jong-Hee; Lee, Moon-Hyung; Yang, Hae-Jun; Choi, Seon-A; Lee, Hwal-Yong; Yoon, Seung-Bin; Park, Young-Ho; Jeong, Kang-Jin; Kim, Young-Hyun; Jin, Yeung Bae; Kim, Ji-Su; Sim, Bo-Woong; Huh, Jae-Won; Lee, Sang-Rae; Koo, Deog-Bon; Chang, Kyu-Tae; Kim, Sun-Uk			The effects of kinase modulation on in vitro maturation according to different cumulus-oocyte complex morphologies	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; MESSENGER-RNA TRANSLATION; PORCINE OOCYTES; MEIOTIC MATURATION; MOUSE OOCYTES; VITRO MATURATION; PIG OOCYTES; DEVELOPMENTAL COMPETENCE; PHOSPHATIDYLINOSITOL 3-KINASE	Successful production of transgenic pigs requires oocytes with a high developmental competence. However, cumulus-oocyte complexes (COCs) obtained from antral follicles have a heterogeneous morphology. COCs can be classified into one of two classes: class I, with five or more layers of cumulus cells; and class II, with one or two layers of cumulus cells. Activator [e.g., epidermal growth factor (EGF)] or inhibitors (e.g., wortmannin and U0126) are added to modulate kinases in oocytes during meiosis. In the present study, we investigated the effects of kinase modulation on nuclear and cytoplasmic maturation in COCs. Class I COCs showed a significantly higher developmental competence than class II COCs. Moreover, the expression of two kinases, AKT and ERK, differed between class I and class II COCs during in vitro maturation (IVM). Initially, inhibition of the PI3K/AKT signaling pathway in class I COCs during early IVM (0-22 h) decreased developmental parameters, such as blastocyst formation rate, blastomere number, and cell survival. Conversely, EGF-mediated AKT activation in class II COCs enhanced developmental capacity. Regarding the MAPK signaling pathway, inhibition of ERK by U0126 in class II COCs during early IVM impaired developmental competence. However, transient treatment with U0126 in class II COCs increased oocyte maturation and AKT activity, improving embryonic development.Additionally, western blotting showed that inhibition of ERK activity negatively regulated the AKT signaling pathway, indicative of a relationship between AKT and MAPK signaling in the process underlying meiotic progression in pigs. These findings may help increase the developmental competence and utilization rate of pig COCs with regard to the production of transgenic pigs and improve our understanding of kinase-associated meiosis events.	[Song, Bong-Seok; Jeong, Pil-Soo; Lee, Jong-Hee; Lee, Moon-Hyung; Yang, Hae-Jun; Choi, Seon-A; Lee, Hwal-Yong; Yoon, Seung-Bin; Park, Young-Ho; Jeong, Kang-Jin; Kim, Young-Hyun; Jin, Yeung Bae; Kim, Ji-Su; Sim, Bo-Woong; Huh, Jae-Won; Lee, Sang-Rae; Chang, Kyu-Tae; Kim, Sun-Uk] Korea Res Inst Biosci & Biotechnol, Futurist Anim Resource & Res Ctr, Chungcheongbuk Do, South Korea; [Song, Bong-Seok; Jeong, Pil-Soo; Lee, Jong-Hee; Lee, Moon-Hyung; Yang, Hae-Jun; Choi, Seon-A; Lee, Hwal-Yong; Yoon, Seung-Bin; Park, Young-Ho; Jeong, Kang-Jin; Kim, Young-Hyun; Jin, Yeung Bae; Kim, Ji-Su; Sim, Bo-Woong; Huh, Jae-Won; Lee, Sang-Rae; Chang, Kyu-Tae; Kim, Sun-Uk] Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Chungcheongbuk Do, South Korea; [Song, Bong-Seok] Univ Sci & Technol, Dept Biosci, Daejeon, South Korea; [Jeong, Pil-Soo; Lee, Moon-Hyung; Koo, Deog-Bon] Daegu Univ, Coll Engn, Dept Biotechnol, Gyeongbuk, South Korea; [Yang, Hae-Jun] Wonkwang Univ, Coll Nat Sci, Dept Biol Sci, Jeollabuk Do, South Korea; [Yoon, Seung-Bin; Kim, Ji-Su] Korea Res Inst Biosci & Biotechnol, Primate Resource Ctr, Jeollabuk Do, South Korea; [Kim, Young-Hyun; Huh, Jae-Won; Lee, Sang-Rae; Chang, Kyu-Tae; Kim, Sun-Uk] Univ Sci & Technol, Dept Funct Genom, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Daegu University; Wonkwang University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST)	Chang, KT; Kim, SU (corresponding author), Korea Res Inst Biosci & Biotechnol, Futurist Anim Resource & Res Ctr, Chungcheongbuk Do, South Korea.; Chang, KT; Kim, SU (corresponding author), Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Chungcheongbuk Do, South Korea.; Chang, KT; Kim, SU (corresponding author), Univ Sci & Technol, Dept Funct Genom, Daejeon, South Korea.	changkt@kribb.re.kr; sunuk@kribb.re.kr		Jeong, Pil-Soo/0000-0002-8477-4358; YOON, SEUNG-BIN/0000-0002-0056-4995	KRIBB Research Initiative Programs [KGM4241844, KGM4251824]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIT [2018M3A9H1023142]	KRIBB Research Initiative Programs; Bio & Medical Technology Development Program of the NRF - Korean government, MSIT	This study was supported by grants from the KRIBB Research Initiative Programs (KGM4241844), KRIBB Research Initiative Programs (KGM4251824), and Republic of Korea and the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIT (2018M3A9H1023142).	Abeydeera LR, 1998, MOL REPROD DEV, V51, P395, DOI 10.1002/(SICI)1098-2795(199812)51:4&lt;395::AID-MRD6&gt;3.0.CO;2-Y; Alvarez GM, 2012, REPROD DOMEST ANIM, V47, P856, DOI 10.1111/j.1439-0531.2011.01943.x; Andrade GM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185045; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chen J, 2013, NAT CELL BIOL, V15, P1415, DOI 10.1038/ncb2873; CREWS CM, 1992, P NATL ACAD SCI USA, V89, P8205, DOI 10.1073/pnas.89.17.8205; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; De Benedetti A, 1999, INT J BIOCHEM CELL B, V31, P59, DOI 10.1016/S1357-2725(98)00132-0; EPPIG JJ, 1987, DEV BIOL, V119, P313, DOI 10.1016/0012-1606(87)90037-6; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Fan HY, 2003, BIOL REPROD, V68, P968, DOI 10.1095/biolreprod.102.008839; FERRELL JE, 1991, MOL CELL BIOL, V11, P1965, DOI 10.1128/MCB.11.4.1965; Fissore RA, 1996, BIOL REPROD, V55, P1261, DOI 10.1095/biolreprod55.6.1261; Hatch KR, 2001, MOL REPROD DEV, V58, P69, DOI 10.1002/1098-2795(200101)58:1&lt;69::AID-MRD10&gt;3.0.CO;2-O; Hoshino Y, 2008, DEV BIOL, V314, P215, DOI 10.1016/j.ydbio.2007.12.005; INOUE M, 1995, ZYGOTE, V3, P265, DOI 10.1017/S0967199400002665; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kalous J, 2006, BIOL CELL, V98, P111, DOI 10.1042/BC20050020; Kalous J, 2009, REPRODUCTION, V138, P645, DOI 10.1530/REP-08-0461; Kim JS, 2008, THERIOGENOLOGY, V69, P290, DOI 10.1016/j.theriogenology.2007.09.024; Kim JS, 2011, FERTIL STERIL, V95, P2582, DOI 10.1016/j.fertnstert.2011.03.013; Kim JS, 2010, REPROD FERT DEVELOP, V22, P437, DOI 10.1071/RD08287; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; Kwak SS, 2014, THERIOGENOLOGY, V81, P291, DOI 10.1016/j.theriogenology.2013.09.028; Lin T, 2016, THERIOGENOLOGY, V85, P396, DOI 10.1016/j.theriogenology.2015.09.001; Liu XH, 2010, J CLIN INVEST, V120, P2497, DOI 10.1172/JCI42382; Lopez-Cardona AP, 2017, FASEB J, V31, P3372, DOI 10.1096/fj.201601382RR; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Alvarez GM, 2009, BIOCELL, V33, P167; Ni HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142669; Ohashi S, 2003, BIOL REPROD, V68, P604, DOI 10.1095/biolreprod.102.008334; Park HJ, 2017, MOL REPROD DEV, V84, P702, DOI 10.1002/mrd.22848; Prochazka R, 2011, REPRODUCTION, V141, P425, DOI 10.1530/REP-10-0418; Raught B, 1999, INT J BIOCHEM CELL B, V31, P43, DOI 10.1016/S1357-2725(98)00131-9; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sha QQ, 2017, DEVELOPMENT, V144, P452, DOI 10.1242/dev.144410; Shimada M, 2003, J ENDOCRINOL, V179, P25, DOI 10.1677/joe.0.1790025; Shimada M, 2001, BIOL REPROD, V64, P1106, DOI 10.1095/biolreprod64.4.1106; Su JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036181; Sun QY, 1999, REPROD FERT DEVELOP, V11, P443, DOI 10.1071/RD00014; Tomek W, 2005, REPRODUCTION, V130, P423, DOI 10.1530/rep.1.00754; Tong C, 2003, CELL RES, V13, P375, DOI 10.1038/sj.cr.7290183; Wang WH, 1995, ZYGOTE, V3, P345, DOI 10.1017/S096719940000277X; Wu D, 2006, BIOL REPROD, V75, P547, DOI 10.1095/biolreprod.106.051300; Yip WK, 2008, ONCOL REP, V19, P319; Zhang DX, 2011, J REPROD DEVELOP, V57, P49, DOI 10.1262/jrd.10-087H; Zmajkovicova K, 2013, MOL CELL, V50, P43, DOI 10.1016/j.molcel.2013.01.037	49	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205495	10.1371/journal.pone.0205495	http://dx.doi.org/10.1371/journal.pone.0205495			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308003	gold, Green Published			2022-12-26	WOS:000447173500089
J	Cukor, J; Havranek, F; Linda, R; Bukovjan, K; Painter, MS; Hart, V				Cukor, Jan; Havranek, Frantisek; Linda, Rostislav; Bukovjan, Karel; Painter, Michael Scott; Hart, Vlastimil			First findings of brown hare (Lepus europaeus) reintroduction in relation to seasonal impact	PLOS ONE			English	Article							FOXES VULPES-VULPES; LONG-TERM CHANGES; EUROPEAN HARE; RED FOX; CLIMATE-CHANGE; AGRICULTURAL LANDSCAPE; ORYCTOLAGUS-CUNICULUS; SPATIAL-DISTRIBUTION; HABITAT PREFERENCES; POPULATION-DENSITY	In Europe, brown hare (Lepus europaeus) populations have been declining steadily since the 1970s. Gamekeepers can help to support brown hare wild populations by releasing cage-reared hares into the wild. Survival rates of cage-reared hares has been investigated in previous studies, however, survival times in relation to seasonality, which likely plays a crucial role for the efficacy of this management strategy, has not been evaluated. Here we examine the survival duration and daytime home ranges of 22 hares released and radio-tracked during different periods of the year in East Bohemia, Czech Republic. The majority of hares (82%) died within the first six months after release, and 41% individuals died within the first 10 days. Significant differences were found in the duration of survival with respect to the release date. Hares released in the summer months (July and August) survived the longest (on average 103.2 days, SD +/- 23.8) and hares released throughout all other months of the year survived for significantly shorter periods of time (on average 20.4 days, SD +/- 11.5). The most likely cause of death was red fox predation (38.9%) followed by disease (coccidiosis and other health problems) (27.8%). Three hares (16.6%) were killed by automobile traffic. After six months of radiotracking, we found the average survival time of all hares released was 58 (SD +/- 70.9) days. Hares in this study preferred to remain in the vicinity of the release area and the average distance from release point to the center of the home range was 471 m.	[Cukor, Jan; Havranek, Frantisek; Bukovjan, Karel] Forestry & Game Management Res Inst, Jiloviste, Czech Republic; [Cukor, Jan; Linda, Rostislav] Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Dept Silviculture, Suchdol, Czech Republic; [Painter, Michael Scott; Hart, Vlastimil] Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Dept Game Management & Wildlife Biol, Suchdol, Czech Republic	Forestry & Game Management Research Institute; Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	Linda, R (corresponding author), Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Dept Silviculture, Suchdol, Czech Republic.	lindar@fld.czu.cz	Cukor, Jan/ABC-5008-2021; Cukor, Jan/AAB-1311-2019	Cukor, Jan/0000-0002-0003-3174; Linda, Rostislav/0000-0002-9602-7915; Hart, Vlastimil/0000-0003-4901-3817	Grant Agency of Czech State Forests [49]; Internal Grant Agency of Faculty of Forestry and Wood Sciences; CULS Prague [IGA B03/18]; project NAZV by the Department of Agriculture in the Czech Republic - Program of Complex sustainable systems in agriculture [QJI530348]	Grant Agency of Czech State Forests; Internal Grant Agency of Faculty of Forestry and Wood Sciences; CULS Prague; project NAZV by the Department of Agriculture in the Czech Republic - Program of Complex sustainable systems in agriculture	This study was funded by the Grant Agency of Czech State Forests (project number 49), Internal Grant Agency of Faculty of Forestry and Wood Sciences, CULS Prague (IGA B03/18) and by project NAZV, provided by the Department of Agriculture in the Czech Republic - Program of Complex sustainable systems in agriculture 2012-2018, QJI530348.	Angelici FM, 1999, BEHAV PROCESS, V47, P205, DOI 10.1016/S0376-6357(99)00064-9; Angelici FM, 2000, WILDLIFE BIOL, V6, P173, DOI 10.2981/wlb.2000.013; Baldi A, 2007, AGR ECOSYST ENVIRON, V118, P307, DOI 10.1016/j.agee.2006.05.021; BOUTIN S, 1986, CAN J ZOOL, V64, P606, DOI 10.1139/z86-090; BRAND CJ, 1975, J WILDLIFE MANAGE, V39, P741, DOI 10.2307/3800236; Ciaian P, 2014, APPL ECON PERSPECT P, V36, P643, DOI 10.1093/aepp/ppu016; Dematteis A, 2005, RIPOPOLAMENTI LEPRE; Edwards PJ, 2000, AGR ECOSYST ENVIRON, V79, P95, DOI 10.1016/S0167-8809(99)00153-X; ERLINGE S, 1984, HOLARCTIC ECOL, V7, P300; European Commission, 2011, EUR COMM OUR LIF INS; Frolich K, 2003, J WILDLIFE DIS, V39, P751; Frolich K, 2001, J WILDLIFE DIS, V37, P803, DOI 10.7589/0090-3558-37.4.803; Gautestad AO, 2011, J THEOR BIOL, V287, P26, DOI 10.1016/j.jtbi.2011.07.010; Geva-Sagiv M, 2015, NAT REV NEUROSCI, V16, P94, DOI 10.1038/nrn3888; Giorgi F, 2005, CLIMATIC CHANGE, V73, P239, DOI 10.1007/a10584-005-6857-4; Goldyn B, 2003, Z JAGDWISS, V49, P191, DOI 10.1007/BF02189737; GOSZCZYNSKI J, 1992, ACTA THERIOL, V37, P329, DOI 10.4098/AT.arch.92-33; Hacklander K, 2002, J COMP PHYSIOL B, V172, P183, DOI 10.1007/s00360-001-0243-y; Haerer G, 2010, SCHWEIZ ARCH TIERH, V143, P193; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hartova-Nentvichova M, 2010, MAMM BIOL, V75, P334, DOI 10.1016/j.mambio.2009.09.003; HEISEY DM, 1985, J WILDLIFE MANAGE, V49, P668, DOI 10.2307/3801692; Hell P, 2005, EUR J WILDLIFE RES, V51, P35, DOI 10.1007/s10344-004-0068-6; Henry HAL, 2008, CLIMATIC CHANGE, V87, P421, DOI 10.1007/s10584-007-9322-8; Hoflechner-Poltl A, 2000, TIERARZTL UMSCHAU, V55, P264; Husek J, 2015, ETHOLOGY, V121, P593, DOI 10.1111/eth.12373; Jaeger JAG, 2004, CONSERV BIOL, V18, P1651, DOI 10.1111/j.1523-1739.2004.00304.x; Jennings N, 2006, WILDLIFE BIOL, V12, P179, DOI 10.2981/0909-6396(2006)12[179:VIDCAD]2.0.CO;2; Kamieniarz R, 2013, ACTA THERIOL, V58, P39, DOI 10.1007/s13364-012-0091-z; Karmiris I, 2006, SUSTAINABLE MANAGEME, P203; Katona K, 2010, ACTA ZOOL ACAD SCI H, V56, P89; KEITH LB, 1984, WILDLIFE MONOGR, P1; Kenward R., 1993, WILDLIFE RADIO TAGGI; Knauer F, 2010, WILDLIFE BIOL, V16, P56, DOI 10.2981/07-040; Kuijper DPJ, 2009, EUR J WILDLIFE RES, V55, P455, DOI 10.1007/s10344-009-0311-2; Kunst PJG, 2001, ACTA THERIOL, V46, P287, DOI 10.1007/BF03192435; Kusta T, 2015, TRANSPORT RES D-TR E, V38, P1, DOI 10.1016/j.trd.2015.04.017; Lanszki J, 2005, FOLIA ZOOL, V54, P213; Lemnell P.A., 1982, Viltrevy (Stockholm), V12, P115; LEWANDOWSKI K, 1993, ACTA THERIOL, V38, P435, DOI 10.4098/AT.arch.93-34; LINDSTROM ER, 1994, ECOLOGY, V75, P1042, DOI 10.2307/1939428; Lundstrom-Gillieron C, 2003, ECOL MODEL, V168, P283, DOI 10.1016/S0304-3800(03)00142-X; MacDonald D. W., 2000, MANAGING BRIT MAMMAL; Marboutin E, 1996, WILDLIFE BIOL, V2, P83, DOI 10.2981/wlb.1996.036; McCollin D, 2000, BIOL CONSERV, V92, P249, DOI 10.1016/S0006-3207(99)00070-1; Misiorowska M, 2008, ANN ZOOL FENN, V45, P286, DOI 10.5735/086.045.0408; Misiorowska M, 2012, ACTA THERIOL, V57, P305, DOI 10.1007/s13364-012-0081-1; Murray DL, 2002, J ANIM ECOL, V71, P614, DOI 10.1046/j.1365-2656.2002.00632.x; NYENHUIS H, 1995, Z JAGDWISS, V41, P182, DOI 10.1007/BF02239947; Panek M, 2006, ACTA THERIOL, V51, P187, DOI 10.1007/BF03192670; Panek M, 2013, EUR J WILDLIFE RES, V59, P581, DOI 10.1007/s10344-013-0709-8; Panek M, 2009, WILDLIFE BIOL, V15, P345, DOI 10.2981/07-042; Panek P, 1999, ACTA THERIOL, V44, P67, DOI 10.4098/AT.arch.99-7; Pavliska PL, 2018, MAMM BIOL, V88, P8, DOI 10.1016/j.mambio.2017.11.003; Pepin D, 2007, EUR J WILDLIFE RES, V53, P183, DOI 10.1007/s10344-007-0087-1; Petrovan SO, 2013, ANIM CONSERV, V16, P344, DOI 10.1111/acv.12002; R Core Team, 2018, R LANG ENV STAT COMP; Rea RV, 2003, WILDLIFE BIOL, V9, P81, DOI 10.2981/wlb.2003.030; Reichlin T, 2006, EUR J WILDLIFE RES, V52, P109, DOI 10.1007/s10344-005-0013-3; REITZ F, 1994, ACTA THERIOL, V39, P143, DOI 10.4098/AT.arch.94-18; Reynolds JC, 1995, WILDLIFE BIOL, V1, P145, DOI 10.2981/wlb.1995.019; Reynolds JC, 2010, EUR J WILDLIFE RES, V56, P541, DOI 10.1007/s10344-009-0355-3; Roedenbeck IA, 2008, EUR J WILDLIFE RES, V54, P425, DOI 10.1007/s10344-007-0166-3; Ronnenberg K, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0093-9; Runge M, 2011, EUR J WILDLIFE RES, V57, P1085, DOI 10.1007/s10344-011-0522-1; Schai-Braun SC, 2014, ACTA THERIOL, V59, P277, DOI 10.1007/s13364-013-0162-9; Schai-Braun SC, 2013, EUR J WILDLIFE RES, V59, P387, DOI 10.1007/s10344-012-0684-5; Schmidt Niels M., 2004, BMC Ecology, V4, P15, DOI 10.1186/1472-6785-4-15; Sidorovich VE, 2006, MAMM BIOL, V71, P74, DOI 10.1016/j.mambio.2005.12.001; Signer J, 2015, WILDLIFE SOC B, V39, P358, DOI 10.1002/wsb.539; Slamecka J, 1997, ACTA SCI NAT BRNO, V31, P10; Smith RK, 2005, MAMMAL REV, V35, P1, DOI 10.1111/j.1365-2907.2005.00057.x; Smith RK, 2004, J APPL ECOL, V41, P1092, DOI 10.1111/j.0021-8901.2004.00976.x; Sokos C, 2015, ENVIRON MANAGE, V55, P19, DOI 10.1007/s00267-014-0388-6; Stott P, 2003, MAMM BIOL, V68, P317, DOI 10.1078/1616-5047-00099; Takacs V, 2009, CENT EUR J BIOL, V4, P427, DOI 10.2478/s11535-009-0020-6; Treml F, 2007, VET MED-CZECH, V52, P451, DOI 10.17221/2050-VETMED; Vaughan N, 2003, J APPL ECOL, V40, P163, DOI 10.1046/j.1365-2664.2003.00784.x; Weterings MJA, 2016, ANIM BEHAV, V115, P107, DOI 10.1016/j.anbehav.2016.03.011; Williams CM, 2015, BIOL REV, V90, P214, DOI 10.1111/brv.12105; Winkelmayer R, 2005, WIEN TIERARZTL MONAT, V92, P131; Wrzesien M, 2016, ACTA BOT CROAT, V75, P217, DOI 10.1515/botcro-2016-0027; Zellweger-Fischer J, 2011, BIOL CONSERV, V144, P1364, DOI 10.1016/j.biocon.2010.11.021	83	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205078	10.1371/journal.pone.0205078	http://dx.doi.org/10.1371/journal.pone.0205078			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304009	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100071
J	Wang, L; Jiang, H; Shen, SM; Wen, CX; Xing, Z; Shi, Y				Wang, Lan; Jiang, Hao; Shen, Si-mei; Wen, Chun-xia; Xing, Zheng; Shi, Yi			Inhibition of autophagy and chemokine induction by sphingosine 1-phosphate receptor 1 through NF-kappa B signaling in human pulmonary endothelial cells infected with influenza A viruses	PLOS ONE			English	Article							H5N1; INFLAMMATION; IMMUNE; SPHINGOSINE-1-PHOSPHATE; REPLICATION; PATHWAY; DISEASE; PROTEIN; RNA	Endothelial cells have been considered the central regulators of cytokine storm in the respiratory system during influenza virus infection. Studies have found that elevated autophagy could be an essential component of viral pathogenesis in influenza infection. However, few studies have been performed to examine whether autophagy occurs in human pulmonary endothelial cells (HPMECs). In addition, specific mechanisms about how inflammatory responses are regulated in the endothelial cells remain unclear. We hypothesized that infection of influenza A viruses subtypes H1N1 and H9N2 triggered autophagy, which played an important role in the induction of proinflammatory cytokines, both in human lung epithelial A549 cells and in HPMECs. In this report, we showed our evidence that blockage of autophagy significantly inhibited influenza virus-induced proinflammatory responses and suppressed viral replication. Our data indicated that the inhibition of the cytokine response and viral replication was affected by increasing the expression of endothelial sphingosine 1-phosphate receptor 1 (S1PR1), which might be through the regulation of NF-kappa B signaling. Overexpression of S1PR1 decreased p65 phosphorylation and translocation into the nucleus. Furthermore, we demonstrated that S1PR1 stimulation inhibited Akt-mTOR signaling, which might contribute to activation of autophagy in HPMECs. Thus, our study provides knowledge crucial to better understanding novel mechanisms underlying the S1PR1-mediated attenuation of cytokine amplification in the pulmonary system during influenza virus infection.	[Wang, Lan; Shen, Si-mei; Shi, Yi] Nanjing Med Univ, Jinling Clin Med Coll, Dept Resp & Crit Care Med, Nanjing, Jiangsu, Peoples R China; [Wang, Lan] Southeast Univ, Dept Resp Med, Affiliated Jiangyin Hosp, Jiangyin, Peoples R China; [Jiang, Hao] Southeast Univ, Affiliated Hosp 2, Dept TB, Nanjing, Jiangsu, Peoples R China; [Xing, Zheng] Nanjing Univ, Med Sch, Nanjing, Jiangsu, Peoples R China; [Xing, Zheng] Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China; [Wen, Chun-xia; Xing, Zheng] Univ Minnesota, Coll Vet Med, Vet & Biomed Sci, St Paul, MN 55108 USA	Nanjing Medical University; Southeast University - China; Southeast University - China; Nanjing University; Nanjing University; University of Minnesota System; University of Minnesota Twin Cities	Shi, Y (corresponding author), Nanjing Med Univ, Jinling Clin Med Coll, Dept Resp & Crit Care Med, Nanjing, Jiangsu, Peoples R China.; Xing, Z (corresponding author), Nanjing Univ, Med Sch, Nanjing, Jiangsu, Peoples R China.; Xing, Z (corresponding author), Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China.; Xing, Z (corresponding author), Univ Minnesota, Coll Vet Med, Vet & Biomed Sci, St Paul, MN 55108 USA.	zing@nju.edu.cn; tishi201607@163.com	Xing, Zheng/O-3137-2015	Xing, Zheng/0000-0002-7288-0268; wang, lan/0000-0001-8100-5783	National Natural Science Foundation of China [81470206, 81571993]; National Natural Science Foundation of Jiangsu Province, China [BK20151372]; Minnesota Department of Agriculture [CON000000058786-00056110, CON000000058786-00056111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Minnesota Department of Agriculture	This project was supported by National Natural Science Foundation of China (81470206, to Dr. Yi Shi) and by National Natural Science Foundation of Jiangsu Province, China (BK20151372, to Dr. Yi Shi). Zheng Xing was supported by the Minnesota Department of Agriculture Award (UMN Response to AI; Award #CON000000058786-00056110 & 00056111) and by National Natural Science Foundation of China (Grant No. 81571993). The funder did not have any role in the experiment design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beale R, 2014, CELL HOST MICROBE, V15, P239, DOI 10.1016/j.chom.2014.01.006; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Chi HB, 2011, TRENDS PHARMACOL SCI, V32, P16, DOI 10.1016/j.tips.2010.11.002; Dai JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042706; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Fabri M, 2011, CURR OPIN IMMUNOL, V23, P65, DOI 10.1016/j.coi.2010.10.010; Feizi N, 2017, J MED MICROBIOL, V66, P536, DOI 10.1099/jmm.0.000455; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Jiang H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175188; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Law AHY, 2010, CELL MOL IMMUNOL, V7, P263, DOI 10.1038/cmi.2010.25; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liu G, 2016, INT J BIOCHEM CELL B, V72, P100, DOI 10.1016/j.biocel.2016.01.012; Ma JH, 2011, J GENET GENOMICS, V38, P533, DOI 10.1016/j.jgg.2011.10.002; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Pan H, 2014, AM J PHYSIOL-LUNG C, V306, pL183, DOI 10.1152/ajplung.00147.2013; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Sun Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001931; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Xiao GT, 2007, CYTOKINE GROWTH F R, V18, P233, DOI 10.1016/j.cytogfr.2007.04.006; Xing Z, 2011, AM J RESP CELL MOL, V44, P24, DOI 10.1165/rcmb.2009-0120OC; Zang FR, 2016, IMMUNOLOGY, V148, P56, DOI 10.1111/imm.12587; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	26	6	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205344	10.1371/journal.pone.0205344	http://dx.doi.org/10.1371/journal.pone.0205344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304001	Green Published, Green Submitted, gold			2022-12-26	WOS:000446921100080
J	Chiappa, P; Singh, S; Pellicer, F				Chiappa, Pilar; Singh, Suneeta; Pellicer, Francisco			The degree of altriciality and performance in a cognitive task show correlated evolution	PLOS ONE			English	Article							BRAIN SIZE; LIFE-HISTORY; RELATIVE BRAIN; BIRDS; MAMMALS; INTELLIGENCE; PHYLOGENY; ANIMALS; PRIMATE; SMART	Previous comparative research on the evolution of cognition has tested what we call the "altricial intelligence hypothesis". This posits that a relationship between evolutionary changes in the altricial period length and cognition exists across animal species. However, the evidence available thus far either comes from indirect measurements of cognition or has not been conclusive. We performed a phylogenetic analysis of published data from various sources on 31 homeothermic species to test for an evolutionary association between the degree of altriciality and a direct measure of self-control. For each species, the degree of altriciality was determined based on the residual altricial period (i.e., the time from birth to fledging in birds and to weaning in mammals) on lifespan. The percentage of success in the cylinder task was the measure of self-control. Our results showed that the degree of altriciality covaried positively with the measure of self-control. Based on the results of this study, we sustain that evolutionary changes in the length of the altricial period are associated with evolutionary changes in the cognitive system used by homeotherms to perform the cylinder task.	[Chiappa, Pilar] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Dept Etol, Mexico City, DF, Mexico; [Singh, Suneeta; Pellicer, Francisco] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Lab Neurofisiol Integrat, Mexico City, DF, Mexico	Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz	Pellicer, F (corresponding author), Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Lab Neurofisiol Integrat, Mexico City, DF, Mexico.	pellicer@imp.edu.mx		Pellicer, Francisco/0000-0001-7935-0510; Singh, Suneeta/0000-0001-9057-884X	Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz [PC-NC 093320.4, FP-NC 13FMA3230.0, SSDIN/COP/005/2018]	Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz	This research was sponsored by the Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz (Project of PC-NC 093320.4; FP-NC 13FMA3230.0; SSDIN/COP/005/2018).	ANDREN H, 1990, ECOLOGY, V71, P1796, DOI 10.2307/1937587; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Barton RA, 2011, P NATL ACAD SCI USA, V108, P6169, DOI 10.1073/pnas.1019140108; Baumhofer E., 2017, LEMUR CATTA; BEKOFF M, 1977, Mammalian Species, V79, P1; Benson-Amram S, 2016, P NATL ACAD SCI USA, V113, P2532, DOI 10.1073/pnas.1505913113; Bhagat S., 2002, CANIS LUPUS FAMILIAR; Bharti N., 2000, EULEMUR FULVUS; Botelho JF, 2015, EVOL DEV, V17, P221, DOI 10.1111/ede.12126; Boucher E., 2007, DAUBENTONIA MADAGASC; Charvet CJ, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00004; Chen J., 2001, MERIONES UNGUICULATU; Fahey B., 2001, SCIURUS NIGER; Fox RA, 2004, APPL ANIM BEHAV SCI, V89, P117, DOI 10.1016/j.applanim.2004.05.002; Garamszegi LZ, 2007, NEUROSCI BIOBEHAV R, V31, P498, DOI 10.1016/j.neubiorev.2006.11.008; Garamszegi LZ, 2004, ECOL LETT, V7, P1216, DOI 10.1111/j.1461-0248.2004.00685.x; Ghirlanda S, 2014, THEOR POPUL BIOL, V91, P44, DOI 10.1016/j.tpb.2013.09.005; Gomez E., 2000, MELOSPIZA MELODIA; GORE AC, 1991, ENDOCRINOLOGY, V129, P3009, DOI 10.1210/endo-129-6-3009; Grellet A, 2014, PREV VET MED, V117, P260, DOI 10.1016/j.prevetmed.2014.07.016; Hallgren J, 1999, VARECIA VARIEGATA; Healy K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0298; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Heyes C, 2012, J COMP PSYCHOL, V126, P193, DOI 10.1037/a0025180; Isler K, 2012, J HUM EVOL, V63, P52, DOI 10.1016/j.jhevol.2012.03.009; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; Isler K, 2009, BIOL LETTERS, V5, P125, DOI 10.1098/rsbl.2008.0469; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; Iwaniuk AN, 2004, P ROY SOC B-BIOL SCI, V271, pS148, DOI 10.1098/rsbl.2003.0127; Iwaniuk AN, 2003, CAN J ZOOL, V81, P1913, DOI 10.1139/Z03-190; Iwaniuk AN, 2004, ETHOLOGY, V110, P203, DOI 10.1111/j.1439-0310.2003.00957.x; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kabadayi C, 2017, ANIM COGN, V20, P1137, DOI 10.1007/s10071-017-1131-5; Kotrschal A, 2013, CURR BIOL, V23, P168, DOI 10.1016/j.cub.2012.11.058; Leigh SR, 2004, AM J PRIMATOL, V62, P139, DOI 10.1002/ajp.20012; LINDSTEDT SL, 1981, Q REV BIOL, V56, P1, DOI 10.1086/412080; Lundrigan B, 2000, EULEMUR MACACO; Lundrigan B, 2000, LEONTOPITHECUS CHRYS; MacLean E. L., 2017, APA HDB COMP PSYCHOL, P201; MacLean EL, 2014, P NATL ACAD SCI USA, V111, pE2140, DOI 10.1073/pnas.1323533111; Madden J, 2001, P ROY SOC B-BIOL SCI, V268, P833, DOI 10.1098/rspb.2000.1425; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; MECH L D, 1974, Mammalian Species, V37, P1; Munoz P., 1999, RHINOPITHECUS ROXELL; Myers P., 2017, ANIMAL DIVERSITY WEB; Oldenkamp R., 2011, PROPITHECUS COQUEREL; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Rosindell J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001406; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Rowe N, 1996, PICTORIAL GUIDE LIVI; Roycewicz J., 2001, EULEMUR MONGOZ; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Scheiber IBR, 2017, FRONT ZOOL, V14, DOI 10.1186/s12983-016-0185-6; Scott J., 2014, APHELOCOMA CALIFORNI; Shefferly N., 2004, PAPIO ANUBIS; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Starck J. Matthias, 1998, Oxford Ornithology Series, V8, P3; STEARNS SC, 1983, OIKOS, V41, P173, DOI 10.2307/3544261; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Van Schaik C, 2006, SCI AM, V294, P64, DOI 10.1038/scientificamerican0406-64; van Schaik CP, 2012, TRENDS COGN SCI, V16, P277, DOI 10.1016/j.tics.2012.04.004; van Schaik CP, 2011, PHILOS T R SOC B, V366, P1008, DOI 10.1098/rstb.2010.0304; Vargas S., 2002, ANSER ANSER; Venables WN., 2002, MODERN APPL STAT S 4; Walker R, 2006, J HUM EVOL, V51, P480, DOI 10.1016/j.jhevol.2006.06.002; Weisbecker V, 2010, P NATL ACAD SCI USA, V107, P16216, DOI 10.1073/pnas.0906486107; Werfel J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173677; White R., 2007, TAENIOPYGIA GUTTATA; Zenner A., 2002, EULEMUR RUBRIVENTER	70	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205128	10.1371/journal.pone.0205128	http://dx.doi.org/10.1371/journal.pone.0205128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4OW	30300365	gold, Green Published, Green Submitted			2022-12-26	WOS:000446897200040
J	Kobayashi, G; Araya, JF				Kobayashi, Genki; Francisco Araya, Juan			Southernmost records of Escarpia spicata and Lamellibrachia barhami (Annelida: Siboglinidae) confirmed with DNA obtained from dried tubes collected from undiscovered reducing environments in northern Chile	PLOS ONE			English	Article							VESTIMENTIFERAN TUBEWORM ANNELIDA; PACIFIC HYDROTHERMAL VENTS; PAPUA-NEW-GUINEA; GULF-OF-MEXICO; EASTERN PACIFIC; PHYLOGENETIC RELATIONSHIP; MOLECULAR TAXONOMY; RIFTIA-PACHYPTILA; WESTERN PACIFIC; SOUTHEASTERN PACIFIC	Deep-sea fishing bycatch enables collection of samples of rare species that are not easily accessible, for research purposes. However, these specimens are often degraded, losing diagnostic morphological characteristics. Several tubes of vestimentiferans, conspicuous annelids endemic to chemosynthetic environments, were obtained from a single batch of deep-sea fishing bycatch at depths of around 1,500 m off Huasco, northern Chile, as part of an ongoing study examining bycatch species. DNA sequences of the mitochondrial cytochrome c oxidase subunit I (COI) gene and an intron region within the hemoglobin subunit B2 (hbB2i) were successfully determined using vestimentiferans' dried-up tubes and their degraded inner tissue. Molecular phylogenetic analyses based on DNA sequence identified the samples as Escarpia spicata Jones, 1985, and Lamellibrachia barhami Webb, 1969. These are the southernmost records, vastly extending the geographical ranges of both species from Santa Catalina Island, California to northern Chile for E. spicata (over 8,000 km), and from Vancouver Island Margin to northern Chile for L. barhami (over 10,000 km). We also determined a 16S rRNA sequence of symbiotic bacteria of L. barhami. The sequence of the bacteria is the same as that of E. laminata, Lamellibrachia sp. 1, and Lamellibrachia sp. 2 known from the Gulf of Mexico. The present study provides sound evidence forthe presence of reducing environments along the continental margin of northern Chile.	[Kobayashi, Genki] Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba, Japan; [Francisco Araya, Juan] UDA, CIC, Copayapu 485, Copiapo, Region De Ataca, Chile; [Francisco Araya, Juan] Univ Concepcion, Programa Doctorado Sistemat & Biodiversidad, Concepcion, Chile	University of Tokyo; Universidad de Concepcion	Araya, JF (corresponding author), UDA, CIC, Copayapu 485, Copiapo, Region De Ataca, Chile.; Araya, JF (corresponding author), Univ Concepcion, Programa Doctorado Sistemat & Biodiversidad, Concepcion, Chile.	jfaraya@u.uchile.cl	Araya, Juan Francisco/N-4942-2017; Araya, Juan Francisco/HGV-1247-2022	Araya, Juan Francisco/0000-0002-4087-9641; Kobayashi, Genki/0000-0002-5938-0824				Andersen AC, 2004, CAN J ZOOL, V82, P980, DOI 10.1139/Z04-049; Arana PM, 2013, J CRUSTACEAN BIOL, V33, P198, DOI 10.1163/1937240X-00002123; Baco AR, 2010, MAR GEOL, V272, P251, DOI 10.1016/j.margeo.2009.06.015; Becker EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074459; Bright M, 2010, OCEANOGR MAR BIOL, V48, P213; Cowart DA, 2014, HYDROBIOLOGIA, V736, P139, DOI 10.1007/s10750-014-1900-y; Cowart DA, 2013, MOL ECOL, V22, P4147, DOI 10.1111/mec.12379; DANDO PR, 1992, NATURE, V356, P667, DOI 10.1038/356667a0; Manso CLD, 2018, THALASSAS, V34, P93, DOI 10.1007/s41208-017-0042-1; Desbruyeres D., 2006, HDB DEEP SEA HYDROTH; Duperron S, 2009, FEMS MICROBIOL ECOL, V69, P395, DOI 10.1111/j.1574-6941.2009.00724.x; Eilertsen MH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23076-0; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forget NL, 2015, MAR ECOL-EVOL PERSP, V36, P35, DOI 10.1111/maec.12169; Araya JF, 2018, MAR BIODIVERS, V48, P1637, DOI 10.1007/s12526-016-0616-9; Araya JF, 2018, MAR BIODIVERS, V48, P1601, DOI 10.1007/s12526-016-0591-1; Araya JF, 2018, ZOOTAXA, V4407, P443, DOI 10.11646/zootaxa.4407.3.11; Araya JF, 2017, ZOOTAXA, V4312, P189, DOI 10.11646/zootaxa.4312.1.11; Araya JF, 2016, MAR BIODIVERS, V46, P725, DOI 10.1007/s12526-015-0416-7; GAILL F, 1986, MAR ECOL PROG SER, V34, P267, DOI 10.3354/meps034267; Gambi M. C., 2011, MAR BIODIVERS REC, V4, pe24, DOI DOI 10.1017/S1755267211000261; Georgieva MN, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0559-y; Govenar B, 2005, MAR ECOL PROG SER, V305, P67, DOI 10.3354/meps305067; Govenar B, 2007, MAR ECOL-EVOL PERSP, V28, P3, DOI 10.1111/j.1439-0485.2007.00148.x; Hughes D. J., 2008, MAR BIODIVERS REC, V1, pe21, DOI DOI 10.1017/S1755267206001989; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; Jarnegren J, 2005, BIOL BULL-US, V209, P87, DOI 10.2307/3593126; Jones M., 1985, B BIOL SOC WASH, V6, P117; JUNIPER SK, 1992, CAN J ZOOL, V70, P1792, DOI 10.1139/z92-247; Karaseva NP, 2016, BIOL BULL+, V43, P937, DOI 10.1134/S1062359016090132; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kobayashi G, 2018, DEEP-SEA RES PT II, V154, P159, DOI 10.1016/j.dsr2.2017.12.016; Kobayashi Genki, 2017, Marine Biodiversity Records, V10, P25, DOI 10.1186/s41200-017-0127-9; Kobayashi G, 2015, ZOOTAXA, V4018, P97, DOI 10.11646/zootaxa.4018.1.5; Kojima S, 2003, MAR BIOL, V142, P625, DOI 10.1007/s00227-002-0954-y; Kojima S, 2002, MAR BIOL, V141, P57, DOI 10.1007/s00227-002-0818-5; Kojima S, 2001, MAR BIOL, V139, P211; Krylova EM, 2014, SYST BIODIVERS, V12, P225, DOI 10.1080/14772000.2014.900133; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Maldonaldo M, 1998, J MAR BIOL ASSOC UK, V78, P795, DOI 10.1017/S0025315400044787; McMullin ER, 2003, SYMBIOSIS, V34, P1; Miyake H., 2004, MAR BIOTECHNOL, V6, pS174, DOI 10.1007/s10126-004-8366-2; Olu K, 1996, MAR ECOL PROG SER, V132, P109, DOI 10.3354/meps132109; Palmer ANS, 2008, CONSERV GENET, V9, P229, DOI 10.1007/s10592-007-9320-4; Ravaux J, 2003, MAR BIOL, V143, P405, DOI 10.1007/s00227-003-1086-8; Reiswig HM, 2014, ZOOTAXA, V3889, P414, DOI 10.11646/zootaxa.3889.3.4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sellanes J, 2008, ICES J MAR SCI, V65, P1102, DOI 10.1093/icesjms/fsn099; Sellanes J, 2012, LAT AM J AQUAT RES, V40, P980, DOI 10.3856/vol40-issue4-fulltext-14; Sen Gupta BK, 2007, MAR MICROPALEONTOL, V62, P1, DOI 10.1016/j.marmicro.2006.06.007; Shillito Bruce, 1995, Geological Society Special Publication, V87, P295, DOI 10.1144/GSL.SP.1995.087.01.22; Southward EC, 2002, J NAT HIST, V36, P1179, DOI 10.1080/00222930110040402; SOUTHWARD EC, 1991, J NAT HIST, V25, P859, DOI 10.1080/00222939100770571; SOUTHWARD EC, 1995, CAN J ZOOL, V73, P282, DOI 10.1139/z95-033; Southward EC, 2011, ZOOSYSTEMA, V33, P245, DOI 10.5252/z2011n3a1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thiel V, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00423; Tunnicliffe V, 2004, J MAR BIOL ASSOC UK, V84, P121, DOI 10.1017/S0025315404008987h; Tunnicliffe V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110578; van der Land J., 1975, Z ZOOL SYST EVOL, V1, P86, DOI DOI 10.1126/SCIENCE.1064574; Webb M., 1977, Zoologische Jb (Anat), V97, P455; Webb M., 1997, ZOOL JB ANAT BD, V97, P455; WILLIAMS NA, 1993, J MAR BIOL ASSOC UK, V73, P437, DOI 10.1017/S0025315400032987; Zapata-Hernandez G, 2014, J MAR BIOL ASSOC UK, V94, P659, DOI 10.1017/S0025315413001914; Zardus JD, 2006, MOL ECOL, V15, P639, DOI 10.1111/j.1365-294X.2005.02832.x; Zhang HB, 2015, DEEP-SEA RES PT II, V121, P53, DOI 10.1016/j.dsr2.2015.04.028	67	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0204959	10.1371/journal.pone.0204959	http://dx.doi.org/10.1371/journal.pone.0204959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300424	Green Submitted, Green Published, gold			2022-12-26	WOS:000446897200026
J	Yue, Q; Yin, FT; Zhang, Q; Yuan, C; Ye, MY; Wang, XL; Li, JJ; Gan, YH				Yue, Qi; Yin, Fei-Ting; Zhang, Qian; Yuan, Chao; Ye, Mei-Yan; Wang, Xiao-Ling; Li, Ji-Jun; Gan, Ye-Hua			Carious status and supragingival plaque microbiota in hemodialysis patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ORAL-HEALTH; STREPTOCOCCUS-MUTANS; DENTAL-CARIES; PERIODONTAL-DISEASE; MORTALITY; SUCROSE; PREVALENCE; XEROSTOMIA; CHILDREN	Objective The aim of this study was to evaluate the carious status and the microbial profiles of supragingival plaque in patients with chronic kidney disease undergoing hemodialysis. Methods This study included 30 patients with chronic kidney disease undergoing hemodialysis as well as 30 control subjects. Dental examination was performed and the decayed-missing-filled-teeth was recorded. Supragingival plaque was taken and analyzed using 16S rRNA gene amplicon by Illumina MiSeq sequencing to detect microbial composition and community diversity and structure. Results The level of decayed-missing-filled-teeth was higher in the hemodialysis group than that in the control group. Microbial analysis showed a decrease in a diversity and a increase in relative abundance and prevalence of many acidogenic and aciduric caries related species in the supragingival plaque samples of the hemodialysis patients, including Streptococcus mutans, Lactobacillus salivarius, Lactobacillus fermentum, Lactobacillus vaginalis, Scardovia wiggsiae F0424, and Actinomyces naeslundii. Conclusion Our results suggested that the hemodialysis patients were more susceptible to caries. More attentions for caries prevention and treatment should be paid to improve their life quality, and even to reduce their cardiovascular events and survival.	[Yue, Qi; Zhang, Qian; Wang, Xiao-Ling; Gan, Ye-Hua] Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing, Peoples R China; [Yue, Qi; Zhang, Qian; Yuan, Chao; Ye, Mei-Yan; Wang, Xiao-Ling; Gan, Ye-Hua] Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Yue, Qi; Zhang, Qian; Yuan, Chao; Ye, Mei-Yan; Wang, Xiao-Ling; Gan, Ye-Hua] Beijing Key Lab Digital Stomatol, Beijing, Peoples R China; [Yin, Fei-Ting; Ye, Mei-Yan; Li, Ji-Jun] PLA, Gen Hosp, Affiliated Hosp 1, Dept Nephrol, Beijing, Peoples R China; [Yuan, Chao] Peking Univ, Sch & Hosp Stomatol, Dept Prevent Dent, Beijing, Peoples R China; [Ye, Mei-Yan] Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing, Peoples R China	Peking University; Peking University; Peking University	Wang, XL; Gan, YH (corresponding author), Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing, Peoples R China.; Wang, XL; Gan, YH (corresponding author), Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China.; Wang, XL; Gan, YH (corresponding author), Beijing Key Lab Digital Stomatol, Beijing, Peoples R China.; Li, JJ (corresponding author), PLA, Gen Hosp, Affiliated Hosp 1, Dept Nephrol, Beijing, Peoples R China.	kqwxl@bjmu.edu.cn; lijj9536@sina.com; kqyehuagan@bjmu.edu.cn			National Natural Science Foundation of China [81472764]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant number: 81472764 to YHG); (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Akar H, 2011, CLIN J AM SOC NEPHRO, V6, P218, DOI 10.2215/CJN.05470610; Al Nowaiser A, 2003, PEDIATR NEPHROL, V18, P39, DOI 10.1007/s00467-002-0999-7; Anuradha Beela Ram, 2015, J Indian Soc Periodontol, V19, P297, DOI 10.4103/0972-124X.154178; Badger JH, 2011, METAGENOMICS OF THE HUMAN BODY, P1, DOI 10.1007/978-1-4419-7089-3_1; Bossola M, 2012, NAT REV NEPHROL, V8, P176, DOI 10.1038/nrneph.2011.218; Bots CP, 2007, BRIT DENT J, V202, DOI 10.1038/sj.bdj.47; Bots CP, 2005, NEPHROL DIAL TRANSPL, V20, P578, DOI 10.1093/ndt/gfh675; Carlen A, 2010, CARIES RES, V44, P341, DOI 10.1159/000315273; Cunningham LL, 2014, OR SURG OR MED OR PA, V117, P435, DOI 10.1016/j.oooo.2013.11.502; de Souza CM, 2014, J PERIODONTOL, V85, pE169, DOI 10.1902/jop.2013.130427; Durso SC, 2014, CARIES RES, V48, P214, DOI 10.1159/000354410; Eberhard J, 2017, CLIN ORAL INVEST, V21, P447, DOI 10.1007/s00784-016-1811-6; Gosmanov AR, 2016, NEPHROL DIAL TRANSPL, V31, P8, DOI 10.1093/ndt/gfv258; Hayashi T, 2015, NEPHROLOGY, V20, P1, DOI 10.1111/nep.12642; Kim J, 2006, ODONTOLOGY, V94, P10, DOI 10.1007/s10266-006-0060-6; Kshirsagar AV, 2009, KIDNEY INT, V75, P746, DOI 10.1038/ki.2008.660; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Li Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137030; Manley KJ, 2014, J REN CARE, V40, P172, DOI 10.1111/jorc.12062; Marsh P D, 1994, Adv Dent Res, V8, P263; Marsh Philip D, 2006, BMC Oral Health, V6 Suppl 1, pS14, DOI 10.1186/1472-6831-6-S1-S14; Montebugnoli L, 2004, J CLIN PERIODONTOL, V31, P25, DOI 10.1111/j.0303-6979.2004.00432.x; Nakano K, 2009, ORAL MICROBIOL IMMUN, V24, P64, DOI 10.1111/j.1399-302X.2008.00479.x; Nakano K, 2006, J CLIN MICROBIOL, V44, P3313, DOI 10.1128/JCM.00377-06; Naugle K, 1998, Ann Periodontol, V3, P197, DOI 10.1902/annals.1998.3.1.197; Novak MJ, 2008, J PERIODONTOL, V79, P1870, DOI 10.1902/jop.2008.070554 ; Olsen I, 2015, ACTA ODONTOL SCAND, V73, P563, DOI 10.3109/00016357.2015.1007480; Palmer SC, 2015, AM J KIDNEY DIS, V66, P666, DOI 10.1053/j.ajkd.2015.04.051; PEARCE E I F, 1991, Proceedings of the Finnish Dental Society, V87, P527; Marques PLP, 2015, ARTIF ORGANS, V39, P181, DOI 10.1111/aor.12334; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ruospo M, 2014, NEPHROL DIAL TRANSPL, V29, P364, DOI 10.1093/ndt/gft401; Sanz M, 2017, J CLIN PERIODONTOL, V44, pS5, DOI 10.1111/jcpe.12682; Saraithong P, 2015, CLIN ORAL INVEST, V19, P1955, DOI 10.1007/s00784-015-1437-0; Sobrado Marinho Jorge Serafin, 2007, Med Oral Patol Oral Cir Bucal, V12, pE305; Takeuchi Y, 2007, NEPHROLOGY, V12, P182, DOI 10.1111/j.1440-1797.2007.00767.x; Andrade MRTC, 2014, PEDIATR NEPHROL, V29, P771, DOI 10.1007/s00467-013-2437-4; Tian J, 2015, BIOCHEM BIOPH RES CO, V468, P294, DOI 10.1016/j.bbrc.2015.10.110; Tomas I, 2008, ARCH ORAL BIOL, V53, P528, DOI 10.1016/j.archoralbio.2008.01.006; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Tsamtsouris A, 1980, J Pedod, V5, P51; Wang XL, 2015, CHIN J DENT RES, V18, P185, DOI 10.3290/j.cjdr.a34783; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th; Xie T, 2014, HEMODIAL INT, V18, P668, DOI 10.1111/hdi.12149; Xu X, 2015, ENVIRON MICROBIOL, V17, P699, DOI 10.1111/1462-2920.12502; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Yu Y, 2017, ORAL DIS, V23, P353, DOI 10.1111/odi.12618	49	2	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0204674	10.1371/journal.pone.0204674	http://dx.doi.org/10.1371/journal.pone.0204674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300382	Green Published, gold, Green Submitted			2022-12-26	WOS:000446897200015
J	Nwosu, BU; Kum-Nji, P				Nwosu, Benjamin Udoka; Kum-Nji, Philip			Tobacco smoke exposure is an independent predictor of vitamin D deficiency in US children	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; PARATHYROID-HORMONE; PARENTAL SMOKING; NATIONAL-HEALTH; COTININE; NICOTINE; ASSOCIATION; PREVALENCE; PREVENTION; CHILDHOOD	Importance The role of tobacco-smoke exposure on serum vitamin D concentration in US pediatric population is not known. We hypothesized that tobacco smoke exposure would increase the prevalence of vitamin D deficiency in US children. Methods Representative national data were accessed from the National Health and Nutrition Examination Survey (NHANES) 2009-2010 databank on 2,263 subjects of ages 3 to 17 years. Subjects were categorized into two groups based on their age: children, if <10 years; and youth if 10 to 17 years. Descriptive and multiple logistic regression analyses were conducted to determine the effect of serum cotinine-verified tobacco smoke exposure on vitamin D status after controlling for key sociodemographic confounders. Vitamin D deficiency was defined as 25(OH) D <20 ng/mL, insufficiency as 25(OH) D of 20-29.9 ng/mL, and sufficiency as 25(OH) D of >= 30 ng/mL. Tobacco smoke exposure status was defined by serum cotinine concentration as follows: unexposed and non-smoking (<0.05 ng/mL) and exposed (passive and active smokers combined) (>= 0.05ng/mL). Specifically, passive and active smoking were defined as cotinine of 0.05-10ng/mL, and >= 10ng/mL respectively. Results The prevalence of second-hand smoke exposure was 42.0% (95% CI, 36.7%-47.5%); while the prevalence of active smoking among teenagers was 9.0% (95% CI, 6.2%-12.5%). Vitamin D deficiency occurred at a frequency of 15.1% in children unexposed to tobacco smoke, 20.9% in children exposed to passive tobacco smoke, and 18.0% among actively smoking youth (p<0.001). Tobacco smoke exposure independently predicted vitamin D deficiency after controlling for age, sex, race, BMI, maternal education, and family socio-economic status (OR: 1.50; 95% CI, 1.14-1.85, p = 0.002). Conclusions This analysis of a nationwide database reports that tobacco smoke exposure is an independent predictor of vitamin D deficiency in US children.	[Nwosu, Benjamin Udoka] Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA 01655 USA; [Kum-Nji, Philip] Virginia Commonwealth Univ, Sch Med, Childrens Hosp Richmond, Dept Gen Pediat, Richmond, VA USA	University of Massachusetts System; University of Massachusetts Worcester; Virginia Commonwealth University	Nwosu, BU (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA 01655 USA.	Benjamin.Nwosu@umassmemorial.org		Nwosu, Benjamin/0000-0003-2212-0276	NIDDK NIH HHS [R21 DK113353] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adorini L, 2003, J CELL BIOCHEM, V88, P227, DOI 10.1002/jcb.10340; Banihosseini SZ, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-19; Bikle DD, 2016, ANN NY ACAD SCI, V1376, P29, DOI 10.1111/nyas.13219; Brot C, 1999, EUR J CLIN NUTR, V53, P920, DOI 10.1038/sj.ejcn.1600870; BROULIK PD, 1993, HORM METAB RES, V25, P219, DOI 10.1055/s-2007-1002080; Byun EJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016409; Caprio M, 2017, EAT WEIGHT DISORD-ST, V22, P27, DOI 10.1007/s40519-016-0312-6; Caraballo RS, 2011, CANCER EPIDEM BIOMAR, V20, P1329, DOI 10.1158/1055-9965.EPI-10-1330; Carpenter TO, 2012, AM J CLIN NUTR, V95, P137, DOI 10.3945/ajcn.111.018721; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; Cutillas-Marco E, 2012, PHOTODERMATOL PHOTO, V28, P159, DOI 10.1111/j.1600-0781.2012.00649.x; Diaz-Gomez NM, 2007, J PEDIATR-US, V151, P618, DOI 10.1016/j.jpeds.2007.05.003; Drincic AT, 2012, OBESITY, V20, P1444, DOI 10.1038/oby.2011.404; Golden NH, 2014, PEDIATRICS, V134, pE1229, DOI 10.1542/peds.2014-2173; Gurkan F, 2000, EUR J EPIDEMIOL, V16, P465, DOI 10.1023/A:1007658411953; Hermann AP, 2000, J BONE MINER RES, V15, P780, DOI 10.1359/jbmr.2000.15.4.780; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Iwaniec UT, 2001, CALCIFIED TISSUE INT, V68, P358, DOI 10.1007/s00223-001-0011-8; JACOB P, 1991, BIOL MASS SPECTROM, V20, P247, DOI 10.1002/bms.1200200503; Jorde R, 2005, EUR J ENDOCRINOL, V152, P39, DOI 10.1530/eje.1.01816; Kacsoh B., 2000, ENDOCRINE PHYSL; Kim SH, 2014, PUBLIC HEALTH NUTR, V17, P122, DOI 10.1017/S1368980012004703; Krall EA, 1999, J BONE MINER RES, V14, P215, DOI 10.1359/jbmr.1999.14.2.215; Kuchuk NO, 2009, J CLIN ENDOCR METAB, V94, P1244, DOI 10.1210/jc.2008-1832; Kum-Nji P, 2012, ACAD MED, V87, P1772, DOI 10.1097/ACM.0b013e318272f5e7; Kumar J, 2009, PEDIATRICS, V124, pE362, DOI 10.1542/peds.2009-0051; Manavi KR, 2015, ANTICANCER RES, V35, P1211; Mannino DM, 2001, ARCH PEDIAT ADOL MED, V155, P36, DOI 10.1001/archpedi.155.1.36; Mirhosseini N, 2017, J CLIN ENDOCR METAB, V102, P3097, DOI 10.1210/jc.2017-01024; Moon JH, 2018, INT J PREVENTIVE MED, V9, DOI 10.4103/ijpvm.IJPVM_280_16; Need AG, 2002, OSTEOPOROSIS INT, V13, P83, DOI 10.1007/s198-002-8342-9; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; Schwender K, 2016, FORENSIC SCI MED PAT, V12, P399, DOI 10.1007/s12024-016-9812-y; Stocks J, 2003, RESPIROLOGY, V8, P266, DOI 10.1046/j.1440-1843.2003.00478.x; Strachan DP, 1998, THORAX, V53, P204, DOI 10.1136/thx.53.3.204; WATTS RR, 1990, ENVIRON HEALTH PERSP, V84, P173, DOI 10.2307/3430719; Wintergerst ES, 2007, ANN NUTR METAB, V51, P301, DOI 10.1159/000107673; Yetley EA, 2010, J NUTR, V140, p2030S, DOI 10.3945/jn.110.121483; Yuan Hongwei, 2007, BMC Cardiovasc Disord, V7, P1, DOI 10.1186/1471-2261-7-1; Zhu K, 2017, AM J CLIN NUTR, V106, P276, DOI 10.3945/ajcn.116.150524; Zittermann A, 2006, PROG BIOPHYS MOL BIO, V92, P39, DOI 10.1016/j.pbiomolbio.2006.02.001	44	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205342	10.1371/journal.pone.0205342	http://dx.doi.org/10.1371/journal.pone.0205342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296288	Green Published, gold, Green Submitted			2022-12-26	WOS:000446632700032
J	Tsai, JJ; Lin, PC; Tsai, CY; Wang, YH; Liu, LT				Tsai, Jih-Jin; Lin, Ping-Chang; Tsai, Ching-Yi; Wang, Ying-Hui; Liu, Li-Teh			Low frequency of asymptomatic dengue virus-infected donors in blood donor centers during the largest dengue outbreak in Taiwan	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; HEMORRHAGIC-FEVER; SOUTHERN TAIWAN; SAUDI-ARABIA; PUERTO-RICO; VIREMIA; ASSAY; SEROPREVALENCE; ENCEPHALOPATHY; SURVEILLANCE	To determine the prevalence of asymptomatic dengue virus-infected blood donors during the largest dengue outbreak in Taiwan history occurred in 2015, we examined the evidence of dengue virus (DENV) infection by the detection of DENV RNA genome using real-time reverse transcription-polymerase chain reaction (real-time RT-PCR), DENV NS1 antigen using rapid diagnosis test (RDT) and anti-dengue antibody using IgM/IgG capture enzyme-linked immunosorbent assay (capture ELISA) and RDT in eight thousand serum samples from blood donations to the blood centers of the Taiwan Blood Services Foundation (TBSF) in Kaohsiung City and Tainan City during the largest dengue outbreak in Taiwan history occurred in 2015. Only one serum sample was positive for DENV RNA detection by using dengue-specific real-time RT-PCR, the virus was DENV-2 determined by serotype-specific real-time RT-PCR and sequencing, and the DENVs in the serum were confirmed as being infectious by a plaque assay. The recipient of this blood did not develop any dengue fever symptom on follow-up. None of the samples was NS1 RDT-reactive. Seventeen IgM-positive samples were identified. There was a low prevalence of asymptomatic confirmed or probable DENV-infected blood donors in our study (0.013% and 0.21%, respectively), and no symptomatic transfusion-transmitted dengue (TT dengue) was developed during the largest dengue outbreak in Taiwan history in highly endemic areas and periods.	[Tsai, Jih-Jin; Lin, Ping-Chang; Tsai, Ching-Yi; Wang, Ying-Hui; Liu, Li-Teh] Kaohsiung Med Univ, Ctr Dengue Fever Control & Res, Kaohsiung, Taiwan; [Tsai, Jih-Jin; Lin, Ping-Chang; Tsai, Ching-Yi; Wang, Ying-Hui] Kaohsiung Med Univ Hosp, Trop Med Ctr, Kaohsiung, Taiwan; [Tsai, Jih-Jin] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Tsai, Jih-Jin] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Liu, Li-Teh] Chung Hwa Univ Med Technol, Coll Med Technol, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chung Hua University	Liu, LT (corresponding author), Kaohsiung Med Univ, Ctr Dengue Fever Control & Res, Kaohsiung, Taiwan.; Liu, LT (corresponding author), Chung Hwa Univ Med Technol, Coll Med Technol, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.	liult0119@gmail.com	TSAI, JIH-JIN/GOP-2776-2022	TSAI, JIH-JIN/0000-0003-2226-8916; Liu, Li-Teh/0000-0002-7993-7263	Ministry of Health and Welfare, Taiwan [MOHW104-CDC-C-114-114901, MOHW107-TDU-B-212-123006]; National Health Research Institutes, Taiwan [MR107-PP-40]	Ministry of Health and Welfare, Taiwan; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	The funding was supported by the Ministry of Health and Welfare, Taiwan (https://www.mohw.gov.tw/mp-2.html, MOHW104-CDC-C-114-114901 to JJT and LTL, and MOHW107-TDU-B-212-123006 to JJT), and the National Health Research Institutes, Taiwan (grant no. MR107-PP-40, http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do, to JJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002; Anga G, 2010, ANN TROP PAEDIATR, V30, P109, DOI 10.1179/146532810X12703902243818; Ashshi AM, 2015, BLOOD TRANSFUS-ITALY, V13, P135, DOI 10.2450/2014.0134-14; Ashshi AM, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0768-7; Busch MP, 2016, J INFECT DIS, V214, P49, DOI 10.1093/infdis/jiw122; Cam BV, 2001, AM J TROP MED HYG, V65, P848, DOI 10.4269/ajtmh.2001.65.848; Chang SF, 2016, AM J TROP MED HYG, V94, P804, DOI 10.4269/ajtmh.15-0534; Chen HL, 2008, AM J TROP MED HYG, V79, P495, DOI 10.4269/ajtmh.2008.79.495; Chien YW, 2017, TRANSFUSION, V57, P2649, DOI 10.1111/trf.14281; Chu PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074165; Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; Dias LL, 2012, TRANSFUSION, V52, P1667, DOI 10.1111/j.1537-2995.2012.03729.x; Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112; Faddy HM, 2013, EMERG INFECT DIS, V19, P787, DOI 10.3201/eid1905.121664; Flipse J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29201; Gao Z, 2018, TRANSFUSION MED, V28, P236, DOI 10.1111/tme.12448; Harif Nurdianah F, 2014, Asian J Transfus Sci, V8, P64, DOI 10.4103/0973-6247.126702; Huang JH, 2007, AM J TROP MED HYG, V77, P903, DOI 10.4269/ajtmh.2007.77.903; Liao Q, 2017, J MED VIROL, V89, P2037, DOI 10.1002/jmv.24883; Lin CC, 2010, AM J TROP MED HYG, V82, P731, DOI 10.4269/ajtmh.2010.09-0549; Linnen JM, 2008, TRANSFUSION, V48, P1355, DOI 10.1111/j.1537-2995.2008.01772.x; Low SL, 2015, AM J TROP MED HYG, V93, P40, DOI 10.4269/ajtmh.14-0671; Mangwana Sadhana, 2015, Asian J Transfus Sci, V9, P177, DOI 10.4103/0973-6247.154253; Mohammed H, 2008, TRANSFUSION, V48, P1348, DOI 10.1111/j.1537-2995.2008.01771.x; Pipattanaboon C, 2013, BIOL-TARGETS THER, V7, P175, DOI 10.2147/BTT.S47438; Ranjan P, 2016, J CLIN DIAGN RES, V10, pDC8, DOI 10.7860/JCDR/2016/21262.8711; Ribas-Silva Rejane Cristina, 2012, Rev. Bras. Hematol. Hemoter., V34, P193, DOI 10.5581/1516-8484.20120048; Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326; Shu PY, 2009, AM J TROP MED HYG, V80, P1039, DOI 10.4269/ajtmh.2009.80.1039; Shu PY, 2003, CLIN DIAGN LAB IMMUN, V10, P622, DOI 10.1128/CDLI.10.4.622-630.2003; Shu PY, 2003, J CLIN MICROBIOL, V41, P2408, DOI 10.1128/JCM.41.6.2408-2416.2003; Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x; Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673; Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142; Tsai JJ, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01865-17, 10.1128/jcm.01865-17]; Wang SF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.124; WHO, 1997, DENG HAEM FEV DIAGN; World Health Organization, 2009, DENGUE GUIDELINES DI; WU Y-C, 1986, Chinese Journal of Microbiology and Immunology (Taipei), V19, P203	40	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205248	10.1371/journal.pone.0205248	http://dx.doi.org/10.1371/journal.pone.0205248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296301	Green Published, Green Submitted, gold			2022-12-26	WOS:000446632700027
J	Azizova, TV; Bannikova, MV; Grigoryeva, ES; Rybkina, VL				Azizova, Tamara, V; Bannikova, Maria, V; Grigoryeva, Evgeniya S.; Rybkina, Valentina L.			Risk of malignant skin neoplasms in a cohort of workers occupationally exposed to ionizing radiation at low dose rates	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; CUTANEOUS MELANOMA; CANCER-MORTALITY; LUNG-CANCER; MAYAK; BONE; METAANALYSIS; DAMAGE; LIVER	Recently an increasing trend in skin cancer rates has been observed in various populations including those exposed to different radiation types. Risk and dose-response following prolonged radiation exposure remain unclear. The present study was aimed to assess skin melanoma (SM) and non-melanoma skin cancer (NMSC) incidence risks in a cohort of workers occupationally exposed to ionizing radiation at low dose rates over prolonged periods. The study cohort included workers of a Russian nuclear production facility, Mayak Production Association (PA), who were first employed in 1948 +/- 1982 and followed up till the end of 2013 (the total of 22,377 individuals with 25% of females). Using AMFIT module of EPICURE software, relative risk and excess relative risk per unit dose (RR and ERR/Sv) were calculated. 60 SM and 294 NMSC cases were registered in members of the study cohort. SM and NMSC incidence was dependent on sex, attained age, age at first employment at the enterprise, type of facility, education level and was not dependent on calendar period of first employment, calendar period of diagnosis, duration of employment, smoking and alcohol consumption statuses. The risk of NMSC incidence was found to be significantly increased in workers occupationally exposed to ionizing radiation at cumulative doses above 2.0 Sv (RR = 2.52; 95% CI: 1.60, 3.97) compared to a reference dose category (0-0.05 Sv). NMSC incidence was found to be significantly associated with cumulative external gamma-dose with ERR/Sv of 0.49 (95% CI: 0.22, 0.90) without an adjustment for neutron dose and 0.51 (95% CI: 0.22, 0.93) while adjusted for neutron dose. Results of the analysis did not reveal a significant association of SM incidence with cumulative dose from external gamma-rays with ERR/Sv of 0.22 (95% CI: -0.29, 1.46) not including a neutron dose adjustment and of 0.15 (95% CI: -0.41, 1.31) while adjusted for dose from neutron exposure.	[Azizova, Tamara, V; Bannikova, Maria, V; Grigoryeva, Evgeniya S.; Rybkina, Valentina L.] SUBI, Clin Dept, Ozyorsk, Chelyabinsk Reg, Russia	Southern Urals Biophysics Institute	Azizova, TV (corresponding author), SUBI, Clin Dept, Ozyorsk, Chelyabinsk Reg, Russia.	clinic@subi.su	Bannikova, Maria V./Z-1343-2019; Grigoryeva, Evgeniya S./B-9142-2016; Azizova, Tamara V./R-5295-2019; Rybkina, Valentina L./AAA-7420-2019	Bannikova, Maria V./0000-0002-2755-6282; Grigoryeva, Evgeniya S./0000-0003-1806-9922; Azizova, Tamara V./0000-0001-6954-2674; Rybkina, Valentina L./0000-0001-5096-9774				[Anonymous], 2011, RCE19 AGIR HPA, P1; Azizova TV, 2008, HEALTH PHYS, V94, P449, DOI 10.1097/01.HP.0000300757.00912.a2; Bauer A, 2011, BRIT J DERMATOL, V165, P612, DOI 10.1111/j.1365-2133.2011.10425.x; Ferlay JSH, 2008, IARC CANCERBASE; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gilbert ES, 2013, RADIAT RES, V179, P332, DOI 10.1667/RR3054.1; Gilbert ES, 2004, RADIAT RES, V162, P505, DOI 10.1667/RR3259; Hunter N, 2013, BRIT J CANCER, V109, P1989, DOI 10.1038/bjc.2013.543; Karagas MR, 1996, J NATL CANCER I, V88, P1848, DOI 10.1093/jnci/88.24.1848; Karpin AD, 2016, MORBIDITY MORTALITY; Khalesi M, 2013, CANCER EPIDEM BIOMAR, V22, P1483, DOI 10.1158/1055-9965.EPI-13-0424; Koshurnikova NA, 2000, RADIAT RES, V154, P237, DOI 10.1667/0033-7587(2000)154[0237:BCIMW]2.0.CO;2; Kungurova NV, 2016, DERMATOONCOLOGIYA MA; Kuznetsova IS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162710; Lee T, 2015, OCCUP ENVIRON MED, V72, P862, DOI 10.1136/oemed-2015-102880; Ouyang Yun-Hsuan, 2010, Semin Plast Surg, V24, P117, DOI 10.1055/s-0030-1255329; Petrova GV, 2015, MALIGNANT NEOPLASMS, P250; PRESTON D. L., 1993, EPICURE USERS GUIDE; Rajaraman P, 2016, AJR, V206, P1, DOI [10.2214/AJR.15.15725, DOI 10.2214/AJR.15.15725]; Rastrelli M, 2014, IN VIVO, V28, P1005; Rota M, 2014, BRIT J DERMATOL, V170, P1021, DOI 10.1111/bjd.12856; Sanlorenzo M, 2015, JAMA DERMATOL, V151, P51, DOI 10.1001/jamadermatol.2014.1077; Shilnikova NS, 2003, RADIAT RES, V159, P787, DOI 10.1667/0033-7587(2003)159[0787:CMRAWA]2.0.CO;2; Shore RE, 2001, MED PEDIATR ONCOL, V36, P549, DOI 10.1002/mpo.1128; Sokolnikov ME, 2008, INT J CANCER, V123, P905, DOI 10.1002/ijc.23581; Song FJ, 2012, INT J EPIDEMIOL, V41, P1694, DOI 10.1093/ije/dys146; Sugiyama H, 2014, RADIAT RES, V181, P531, DOI 10.1667/RR13494.1; Valentin Jack, 2007, Annals of the ICRP, V37, P3; Vasilenko EK, 2010, AAHP SPEC SESS HLTH; World Health Organization, 1980, ICD 9 GUID COD DIS T, P752; Yen H, 2017, BRIT J DERMATOL, V177, P696, DOI 10.1111/bjd.15647; Yoshinaga S, 2005, INT J CANCER, V115, P828, DOI 10.1002/ijc.20939	33	14	20	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205060	10.1371/journal.pone.0205060	http://dx.doi.org/10.1371/journal.pone.0205060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289933	gold, Green Submitted, Green Published			2022-12-26	WOS:000446545500043
J	Nasir, SA; Ramli, R; Abd Jabar, N				Nasir, Suraya Ahmad; Ramli, Roszalina; Abd Jabar, Nazimi			Predictors of enophthalmos among adult patients with pure orbital blowout fractures	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; FLOOR FRACTURES; RETROSPECTIVE ANALYSIS; WALL FRACTURE; REPAIR; RECONSTRUCTION; CLASSIFICATION; SURGERY; SIZE	The aim of this study was to determine the predictors of post-traumatic enophthalmos (PE) in relation to the internal orbital changes following pure orbital blowout fractures. The design was a 10-year retrospective cross-sectional study analysing 629 medical records and computed tomography (CT) data of patients with orbital fractures from January 2008 to January 2017. Demographic, etiology, co-morbidity and clinical characteristics were obtained from the medical records. Assessment of the PE, fracture site and size, intraorbital structures and muscle change were performed using the Digital Imaging and Communications in Medicine (DICOM) viewer software, OsiriX v5.8.2. Of the 629 patients with orbital fractures, 87 were pure orbital blowout fractures. Demographic pattern showed that males outnumbered females in the series, with male: female ratio of 5.7:1. The mean age was 37.2 +/- 14.7 and the main etiology was motor vehicle accident. Orbital floor fracture was the most common fracture location (67.8%). The involvement of the posterior ledge and inferior orbital fissure showed statistical significant difference with PE (Fisher's exact test, p = 0.03). Binary logistic regression showed that after controlling for age, patients with fracture size of more than 150 mm 2 had three times the odds of sustaining a PE, (adjusted odds ratio (AOR) = 3.01 (95% CI 1.17-7.92). Fracture size larger than 150 mm(2) was a radiological predictor of PE. Additional research investigating further on the role of concurrent fracture of the posterior ledge and inferior orbital fissure is advocated.	[Nasir, Suraya Ahmad; Ramli, Roszalina; Abd Jabar, Nazimi] Univ Kebangsaan Malaysia, Fac Dent, Ctr Oral & Maxillofacial Surg, Jalan Raja Muda Abdul Aziz, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia	Ramli, R (corresponding author), Univ Kebangsaan Malaysia, Fac Dent, Ctr Oral & Maxillofacial Surg, Jalan Raja Muda Abdul Aziz, Kuala Lumpur, Malaysia.	roszalina@ppukm.ukm.edu.my	nasir, suraya ahmad/AAM-8194-2021; Jabar, Nazimi Abdul/M-6175-2014	Jabar, Nazimi Abdul/0000-0003-3761-1342				Allen RC, 2006, ESSENT OPHTHALMOL, P237; Ang CH, 2015, CRANIOMAX TRAUM REC, V8, P289, DOI 10.1055/s-0034-1399800; Ben Simon GJ, 2009, OPHTHAL SURG LAS IM, V40, P141, DOI 10.3928/15428877-20090301-05; Burm JS, 1999, PLAST RECONSTR SURG, V104, P1350, DOI 10.1097/00006534-199910000-00017; Burnstine MA, 2002, OPHTHALMOLOGY, V109, P1207, DOI 10.1016/S0161-6420(02)01057-6; Burnstine Michael A, 2003, Curr Opin Ophthalmol, V14, P236, DOI 10.1097/00055735-200310000-00002; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Chang AA, 1995, AUST NZ J OPHTHALMOL, V23, P315, DOI 10.1111/j.1442-9071.1995.tb00182.x; Chen Chien-Tzung, 2006, Chang Gung Med J, V29, P251; Chen HH, 2016, FORMOS J SURG, V49, P1, DOI 10.1016/j.fjs.2015.06.002; Chiasson G, 2010, CRANIOMAX TRAUM REC, V3, P125, DOI 10.1055/s-0030-1262954; Choi Woong Kyu, 2016, Arch Craniofac Surg, V17, P128, DOI 10.7181/acfs.2016.17.3.128; Clauser L, 2008, J CRANIOFAC SURG, V19, P351, DOI 10.1097/SCS.0b013e3180534361; de Silva DJ, 2011, OPHTHALMOLOGY, V118, P1677, DOI 10.1016/j.ophtha.2011.05.001; Ellis E, 2003, J ORAL MAXIL SURG, V61, P442, DOI 10.1053/joms.2003.50085; Escaravage GK, 2013, OPHTHAL PLAST RECONS, V29, P150, DOI 10.1097/IOP.0b013e3182859716; Eski M, 2006, J CRANIOFAC SURG, V17, P1059, DOI 10.1097/01.scs.0000235111.92988.b2; Essig H, 2013, HEAD FACE MED, V9, DOI 10.1186/1746-160X-9-18; Furuta M, 2001, JPN J OPHTHALMOL, V45, P600, DOI 10.1016/S0021-5155(01)00419-1; Garcia BG, 2016, REV ESP CIR ORAL MAX, V38, P42, DOI [10.1016/j.maxilo.2014.03.011, DOI 10.1016/J.MAXILO.2014.03.011]; Gart MS, 2014, PLAST RECONSTR SURG, V134, P1345, DOI 10.1097/PRS.0000000000000719; Hammond D, 2013, J SURG CASE REP, DOI 10.1093/jscr/rjt054; HAWES MJ, 1983, OPHTHALMOLOGY, V90, P1066; Hazani R, 2012, ARCH PLAST SURG-APS, V39, P11, DOI 10.5999/aps.2012.39.1.11; He Y, 2012, J CRANIOFAC SURG, V23, P1050, DOI 10.1097/SCS.0b013e3182564ef3; Higashino T, 2011, J CRANIOFAC SURG, V22, P1210, DOI 10.1097/SCS.0b013e31821c0d13; Hosal Banu M, 2002, Orbit, V21, P27; Kim G, 2012, J DIGIT IMAGING, V25, P486, DOI 10.1007/s10278-012-9458-6; Kim YK, 2009, J PLAST RECONSTR AES, V62, P1379, DOI 10.1016/j.bjps.2008.06.042; Koo L, 2006, OPHTHAL PLAST RECONS, V22, P274, DOI 10.1097/01.iop.0000226865.22184.6a; Kunz C, 2014, CRANIOMAX TRAUM REC, V7, pS92, DOI 10.1055/s-0034-1389562; Lang W., 1889, T OPHTHAL SOC UK, V9, P41; Layton CJ, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/412397; Lee HB, 2016, J ORAL MAXIL SURG, V74, P2457, DOI 10.1016/j.joms.2016.07.013; Lee WT, 2009, J CRANIOFAC SURG, V20, P75, DOI 10.1097/SCS.0b013e318190df0d; Lima LB, 2015, REV PORT ESTOMATOL M, V56, P122, DOI 10.1016/j.rpemd.2015.04.010; Lin KY, 2012, SAUDI J OPHTHALMOL, V26, P427, DOI 10.1016/j.sjopt.2012.08.002; Matic DB, 2007, J CRANIOFAC SURG, V18, P127, DOI 10.1097/SCS.0b013e31802ccdc8; NOLASCO FP, 1995, OTOLARYNG HEAD NECK, V112, P549, DOI 10.1016/S0194-5998(95)70210-5; Nordin R, 2015, J ORAL MAX SURG MED, V27, P166, DOI 10.1016/j.ajoms.2014.01.001; Novelli G, 2014, J CRANIO MAXILL SURG, V42, P2025, DOI 10.1016/j.jcms.2014.09.009; Raskin EM, 1998, OPHTHALMIC PLAST REC, V14, P19, DOI 10.1097/00002341-199801000-00006; Shah HA, 2013, AM J OTOLARYNG, V34, P695, DOI 10.1016/j.amjoto.2013.02.006; Shin JW, 2013, J CRANIOFAC SURG, V24, P703, DOI 10.1097/SCS.0b013e31829026ca; SMITH B, 1957, AM J OPHTHALMOL, V44, P734; Sung YS, 2013, ARCH PLAST SURG-APS, V40, P335, DOI 10.5999/aps.2013.40.4.335; Tong L, 2001, PLAST RECONSTR SURG, V108, P612, DOI 10.1097/00006534-200109010-00003; WHITEHOUSE RW, 1994, BRIT J OPHTHALMOL, V78, P618, DOI 10.1136/bjo.78.8.618	48	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204946	10.1371/journal.pone.0204946	http://dx.doi.org/10.1371/journal.pone.0204946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289909	Green Published, Green Submitted, gold			2022-12-26	WOS:000446545500031
J	Foister, S; Doeschl-Wilson, A; Roehe, R; Arnott, G; Boyle, L; Turner, S				Foister, Simone; Doeschl-Wilson, Andrea; Roehe, Rainer; Arnott, Gareth; Boyle, Laura; Turner, Simon			Social network properties predict chronic aggression in commercial pig systems	PLOS ONE			English	Article							BEHAVIOR; CONNECTIONS; FITNESS; STRESS; GROWTH	Post-mixing aggression in pigs is a harmful and costly behaviour which negatively impacts both animal welfare and farm efficiency. There is vast unexplained variation in the amount of acute and chronic aggression that dyadic behaviours do not fully explain. This study hypothesised that certain pen-level network properties may improve prediction of lesion outcomes due to the incorporation of indirect social interactions that are not captured by dyadic traits. Utilising current SNA theory, we investigate whether pen-level network properties affect the number of aggression-related injuries at 24 hours and 3 weeks post-mixing (24hr-PM and 3wk-PM). Furthermore we compare the predictive value of network properties to conventional dyadic traits. A total of 78 pens were video recorded for 24hr post-mixing. Each aggressive interaction that occurred during this time period was used to construct the pen-level networks. The relationships between network properties at 24hr and the pen level injuries at 24hr-PM and 3wk-PM were analysed using mixed models and verified using permutation tests. The results revealed that network properties at 24hr could predict long term aggression (3wk-PM) better than dyadic traits. Specifically, large clique formation in the first 24hr-PM predicted fewer injuries at 3wk-PM and high betweenness centralisation at 24hr-PM predicted increased rates of injury at 3wk-PM. This study demonstrates that network properties present during the first 24hr-PM have predictive value for chronic aggression, and have potential to allow identification and intervention for at risk groups.	[Foister, Simone; Roehe, Rainer; Turner, Simon] SRUC, Roslin Inst Bldg, Anim & Vet Sci, Easter Bush, Midlothian, Scotland; [Doeschl-Wilson, Andrea] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Doeschl-Wilson, Andrea] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Arnott, Gareth] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Boyle, Laura] TEAGASC, Anim & Grassland Res & Innovat Ctr, Pig Dev Dept, Fermoy, Cork, Ireland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Queens University Belfast; Teagasc	Foister, S (corresponding author), SRUC, Roslin Inst Bldg, Anim & Vet Sci, Easter Bush, Midlothian, Scotland.	simone.foister@sruc.ac.uk		Roehe, Rainer/0000-0002-4880-3756; Turner, Simon/0000-0001-9198-9448; Boyle, Laura/0000-0001-7080-1776; Wilson, Andrea/0000-0002-2658-6973	Teagasc Walsh Fellowship Scheme (2015) [REF 2015004]; Scottish Government; BBSRC [BBS/E/D/30002276] Funding Source: UKRI	Teagasc Walsh Fellowship Scheme (2015); Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded through the Teagasc Walsh Fellowship Scheme (2015, REF 2015004). SRUC receives financial support from the Scottish Government.	[Anonymous], 2011, SAS 9 3 MACR LANG RE; Bhadra A, 2009, ECOL COMPLEX, V6, P48, DOI 10.1016/j.ecocom.2008.10.004; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Borgatti S.P., 2018, ANAL SOCIAL NETWORKS; Boyland NK, 2016, APPL ANIM BEHAV SCI, V174, P1, DOI 10.1016/j.applanim.2015.11.016; Brent LJN, 2015, ANIM BEHAV, V103, P211, DOI 10.1016/j.anbehav.2015.01.020; Buttner K, 2015, APPL ANIM BEHAV SCI, V168, P24, DOI 10.1016/j.applanim.2015.04.017; Camerlink I, 2013, APPL ANIM BEHAV SCI, V145, P84, DOI 10.1016/j.applanim.2013.02.008; Canario L, 2012, J ANIM SCI, V90, P4706, DOI 10.2527/jas.2012-5392; Cheney DL, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160255; Coutellier L, 2007, APPL ANIM BEHAV SCI, V105, P102, DOI 10.1016/j.applanim.2006.05.007; Croft DP, 2016, CURR OPIN BEHAV SCI, V12, P52, DOI 10.1016/j.cobeha.2016.09.001; Croft DP, 2011, TRENDS ECOL EVOL, V26, P502, DOI 10.1016/j.tree.2011.05.012; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Csardi G, 2006, INTERJOURNAL; D'Eath RB, 2010, ANIMAL, V4, P604, DOI 10.1017/S1751731109991406; Desire S, 2015, APPL ANIM BEHAV SCI, V166, P52, DOI 10.1016/j.applanim.2015.02.015; Farine DR, 2017, METHODS ECOL EVOL, V8, P1309, DOI 10.1111/2041-210X.12772; Farine DR, 2015, J ANIM ECOL, V84, P1144, DOI 10.1111/1365-2656.12418; Faucitano L, 2001, CAN J ANIM SCI, V81, P39, DOI 10.4141/A00-031; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gilby IC, 2013, BEHAV ECOL SOCIOBIOL, V67, P373, DOI 10.1007/s00265-012-1457-6; Griffin RH, 2012, EVOL ECOL, V26, P779, DOI 10.1007/s10682-011-9526-2; Lehmann J, 2016, BEHAV ECOL, V27, P20, DOI 10.1093/beheco/arv169; Li YZ, 2018, ANIMALS, V8, DOI 10.3390/ani8010013; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Madden JR, 2009, BEHAV ECOL SOCIOBIOL, V64, P81, DOI 10.1007/s00265-009-0820-8; Makagon MM, 2012, APPL ANIM BEHAV SCI, V138, P152, DOI 10.1016/j.applanim.2012.02.003; Marchant JN, 1995, APPL ANIM BEHAV SCI, V46, P49, DOI 10.1016/0168-1591(95)00636-2; McCowan B, 2008, APPL ANIM BEHAV SCI, V109, P396, DOI 10.1016/j.applanim.2007.02.009; McCowan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022350; MEESE GB, 1973, ANIM BEHAV, V21, P326, DOI 10.1016/S0003-3472(73)80074-0; MENDL M, 1992, ANIM BEHAV, V44, P1107, DOI 10.1016/S0003-3472(05)80323-9; MORROWTESCH JL, 1994, J ANIM SCI, V72, P2599, DOI 10.2527/1994.72102599x; Olesen LS, 1996, APPL ANIM BEHAV SCI, V46, P167, DOI 10.1016/0168-1591(95)00650-8; Pitts AD, 2000, APPL ANIM BEHAV SCI, V68, P191, DOI 10.1016/S0168-1591(00)00104-0; Stanton MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047508; STOOKEY JM, 1994, J ANIM SCI, V72, P2804, DOI 10.2527/1994.72112804x; TAN SSL, 1991, ANIM PROD, V52, P201, DOI 10.1017/S0003356100005845; Turner SP, 2009, J ANIM SCI, V87, P3076, DOI 10.2527/jas.2008-1558; Turner SP, 2017, APPL ANIM BEHAV SCI, V191, P98, DOI 10.1016/j.applanim.2017.02.002; Turner SP, 2006, APPL ANIM BEHAV SCI, V96, P245, DOI 10.1016/j.applanim.2005.06.009; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Wilson ADM, 2014, BEHAV ECOL SOCIOBIOL, V68, P915, DOI 10.1007/s00265-014-1704-0	45	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205122	10.1371/journal.pone.0205122	http://dx.doi.org/10.1371/journal.pone.0205122			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286157	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500089
J	Gao, J; Tomonaga, M				Gao, Jie; Tomonaga, Masaki			The body inversion effect in chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							FACE PERCEPTION; OBJECTS; EXPERTISE; NEURONS; MONKEY	Bodies are important social cues for animals. Body recognition in humans is deteriorated by inversion. This inversion effect suggests the configural processing of bodies, which is different from the processing used for other objects. However, it is not known if this type of body processing exists in non-human primates. We tested seven chimpanzees using upright and inverted chimpanzee body stimuli and other stimuli in matching-to-sample tasks to examine the body inversion effect and the body parts that invoke it. Our results reflected the body inversion effect for intact chimpanzee bodies, bodies with complete body contours, and bodies with clear faces but not for the objects and other conditions that did not present complete body contours and clear faces. The results show that chimpanzees share configural body processing with humans and that bodies are special to them compared with other objects. The results also revealed the functions of faces and body contours in configural processing by chimpanzees.	[Gao, Jie; Tomonaga, Masaki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan; [Gao, Jie] Japan Soc Promot Sci, Tokyo, Japan	Kyoto University; Japan Society for the Promotion of Science	Gao, J (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan.; Gao, J (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	gao.jie.87c@kyoto-u.jp	Gao, Jie/Q-8597-2019	Gao, Jie/0000-0002-1463-8481	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); KAKENHI [23220006, 24000001, 15H05709, 16H06283, 18J21474]; JSPS Core-to-Core CCSN; National Bio Resource Project-Great Ape Information Network (NBRP-GAIN) [152121];  [JSPS-LGP-U04]	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Core-to-Core CCSN; National Bio Resource Project-Great Ape Information Network (NBRP-GAIN); 	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT; URL: http://www.mext.go.jp/en/)/Japan Society for the Promotion of Science (JSPS; URL: http://www.jsps.go.jp/english/) KAKENHI (23220006, 24000001, 15H05709, 16H06283, and 18J21474), JSPS-LGP-U04, JSPS Core-to-Core CCSN, National Bio Resource Project-Great Ape Information Network (NBRP-GAIN; URL: http://www.nbrp.jp/), and MEXT Scholarship (#152121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1999, NEUROREPORT, V10, P189, DOI 10.1097/00001756-199901180-00036; Barraclough NE, 2006, PROG BRAIN RES, V154, P135, DOI 10.1016/S00079-6123(06)54007-5; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; CAREY S, 1992, PHILOS T ROY SOC B, V335, P95, DOI 10.1098/rstb.1992.0012; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Dahl CD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02504; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 1998, VISION RES, V38, P2401, DOI 10.1016/S0042-6989(97)00442-2; Hobaiter C, 2014, CURR BIOL, V24, P1596, DOI 10.1016/j.cub.2014.05.066; Hobaiter C, 2011, ANIM COGN, V14, P827, DOI 10.1007/s10071-011-0416-3; Jellema T, 2003, NEUROPSYCHOLOGIA, V41, P1728, DOI 10.1016/S0028-3932(03)00175-1; Jones Clyde, 1996, Mammalian Species, V529, P1; Kaneko T, 2011, P ROY SOC B-BIOL SCI, V278, P3694, DOI 10.1098/rspb.2011.0611; Martinez L, 2009, ANIM COGN, V12, pS71, DOI 10.1007/s10071-009-0269-1; Matsuno T, 2008, PERCEPTION, V37, P162; Matsuzawa T, 2003, ANIM COGN, V6, P199, DOI 10.1007/s10071-003-0199-2; Matsuzawa T, 2011, THE CHIMPANZEES OF B; Matsuzawa T, 2011, PRIMATE ORIGINS HUMA; Matsuzawa T., 2006, COGNITIVE DEV CHIMPA; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Parr LA, 1998, J COGNITIVE NEUROSCI, V10, P615, DOI 10.1162/089892998563013; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; PERRETT DI, 1985, BEHAV BRAIN RES, V16, P153, DOI 10.1016/0166-4328(85)90089-0; R Core Team, 2021, R LANGUAGE ENV STAT; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P73, DOI 10.1037/0096-1523.32.1.73; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; RHODES G, 1989, BRIT J PSYCHOL, V80, P313, DOI 10.1111/j.2044-8295.1989.tb02323.x; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; TOMONAGA M, 1993, FOLIA PRIMATOL, V61, P110, DOI 10.1159/000156737; Tomonaga M, 1999, PRIMATES, V40, P417, DOI 10.1007/BF02557579; Tomonaga M, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P55; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Yovel G, 2010, J EXP PSYCHOL HUMAN, V36, P759, DOI 10.1037/a0017451	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204131	10.1371/journal.pone.0204131	http://dx.doi.org/10.1371/journal.pone.0204131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281635	Green Submitted, Green Published, gold			2022-12-26	WOS:000446342400042
J	Ha, HJ; Park, HH				Ha, Hyun Ji; Park, Hyun Ho			RAIDD mutations underlie the pathogenesis of thin lissencephaly (TLIS)	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; CASPASE-2 ACTIVATION; PIDDOSOME; APOPTOSIS; COMPLEX; PIDD; SUPERFAMILY; PEPTIDES; STRESS; CARD	Abnormal regulation of caspase-2-mediated neuronal cell death causes neurodegenerative diseases and defective brain development. PIDDosome is caspase-2 activating complex composed of PIDD, RAIDD, and caspase-2. Recent whole-exome sequencing study showed that the RAIDD mutations in the death domain (DD), including G128R, F164C, R170C, and R170H mutations, cause thin lissencephaly (TLIS) by reducing caspase-2-mediated neuronal apoptosis. Given that the molecular structure of the RAIDD DD:PIDD DD complex is available, in this study, we analyzed the molecular mechanisms underlying TLIS caused by the RAIDD TLIS variants by performing mutagenesis and biochemical assays.	[Ha, Hyun Ji; Park, Hyun Ho] Chung Ang Univ, Coll Pharm, Seoul, South Korea	Chung Ang University	Park, HH (corresponding author), Chung Ang Univ, Coll Pharm, Seoul, South Korea.	xrayleox@cau.ac.kr		park, hyun ho/0000-0001-9928-0847	Basic Science Research Program through the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology [NRF-2017M3A9D8062960, NRF-2018R1A2B2003635]; Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI17C0155]	Basic Science Research Program through the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology; Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (NRF-2017M3A9D8062960 and NRF-2018R1A2B2003635) and a grant from the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI17C0155).	Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Bouchier-Hayes L, 2012, CELL DEATH DIFFER, V19, P51, DOI 10.1038/cdd.2011.157; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; Choi JY, 2017, P NATL ACAD SCI USA, V114, P7361, DOI 10.1073/pnas.1705949114; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Denault JB, 2002, CHEM REV, V102, P4489, DOI 10.1021/cr010183n; Di Donato N, 2016, AM J HUM GENET, V99, P1117, DOI 10.1016/j.ajhg.2016.09.010; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Fisher DE, 2001, HEMATOL ONCOL CLIN N, V15, P931, DOI 10.1016/S0889-8588(05)70258-6; Ha HJ, 2017, FEBS LETT, V591, P2919, DOI 10.1002/1873-3468.12783; Harvey N L, 1998, Adv Biochem Eng Biotechnol, V62, P107; Heger K, 2018, NATURE, V559, P120, DOI 10.1038/s41586-018-0256-2; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jang TH, 2016, SCI REP-UK, V6, DOI 10.1038/srep31198; Jang TH, 2012, BIOCHEM PHARMACOL, V83, P218, DOI 10.1016/j.bcp.2011.10.013; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Manzl C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.470; Manzl C, 2009, J CELL BIOL, V185, P291, DOI 10.1083/jcb.200811105; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Navratil J S, 2001, Curr Rheumatol Rep, V3, P191, DOI 10.1007/s11926-001-0018-1; Nematollahi LA, 2015, J MOL BIOL, V427, P737, DOI 10.1016/j.jmb.2014.11.021; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Niizuma K, 2008, P NATL ACAD SCI USA, V105, P16368, DOI 10.1073/pnas.0806222105; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park HH, 2007, ACTA CRYSTALLOGR F, V63, P229, DOI 10.1107/S1744309107007889; Peltzer N, 2018, NATURE, V557, P112, DOI 10.1038/s41586-018-0064-8; RAFF MC, 1994, PHILOS T ROY SOC B, V345, P265, DOI 10.1098/rstb.1994.0104; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Salvesen GS, 2002, ESSAYS BIOCHEM, V38, P9, DOI 10.1042/bse0380009; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tiwari M, 2011, J BIOL CHEM, V286, P8493, DOI 10.1074/jbc.M110.163824; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	44	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205042	10.1371/journal.pone.0205042	http://dx.doi.org/10.1371/journal.pone.0205042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281648	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400079
J	Pellock, SJ; Walton, WG; Biernat, KA; Torres-Rivera, D; Creekmore, BC; Xu, YM; Liu, J; Tripathy, A; Stewart, LJ; Redinbo, MR				Pellock, Samuel J.; Walton, William G.; Biernat, Kristen A.; Torres-Rivera, Dariana; Creekmore, Benjamin C.; Xu, Yongmei; Liu, Jian; Tripathy, Ashutosh; Stewart, Lance J.; Redinbo, Matthew R.			Three structurally and functionally distinct beta-glucuronidases from the human gut microbe Bacteroides uniformis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; INHIBITION; PROTEIN; INTESTINE; RECEPTOR; ENTEROPATHY; REVEALS	The glycoside hydrolases encoded by the human gut microbiome play an integral role in processing a variety of exogenous and endogenous glycoconjugates. Here we present three structurally and functionally distinct beta-glucuronidase (GUS) glycoside hydrolases from a single human gut commensal microbe, Bacteroides uniformis. We show using nine crystal structures, biochemical, and biophysical data that whereas these three proteins share similar overall folds, they exhibit different structural features that create three structurally and functionally unique enzyme active sites. Notably, quaternary structure plays an important role in creating distinct active site features that are hard to predict via structural modeling methods. The enzymes display differential processing capabilities toward glucuronic acid-containing polysaccharides and SN-38-glucuronide, a metabolite of the cancer drug irinotecan. We also demonstrate that GUS-specific and nonselective inhibitors exhibit varying potencies toward each enzyme. Together, these data highlight the diversity of GUS enzymes within a single Bacteroides gut commensal and advance our understanding of how structural details impact the specific roles microbial enzymes play in processing drug-glucuronide and glycan substrates.	[Pellock, Samuel J.; Walton, William G.; Biernat, Kristen A.; Torres-Rivera, Dariana; Creekmore, Benjamin C.; Redinbo, Matthew R.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Xu, Yongmei; Liu, Jian] Univ N Carolina, Dept Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Tripathy, Ashutosh; Redinbo, Matthew R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Redinbo, Matthew R.] Univ N Carolina, Dept Microbiol, Chapel Hill, NC 27599 USA; [Redinbo, Matthew R.] Univ N Carolina, Dept Immunol, Chapel Hill, NC 27599 USA; [Redinbo, Matthew R.] Univ N Carolina, Integrat Program Biol & Genome Sci, Chapel Hill, NC 27599 USA; [Stewart, Lance J.] Univ Washington, Dept Biochem, Inst Prot Design, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle	Redinbo, MR (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.	redinbo@unc.edu		Creekmore, Benjamin/0000-0001-7973-9438	National Institutes of Health [CA098468, CA207416, GM102137, HL094463]; NATIONAL CANCER INSTITUTE [R01CA207416, R01CA098468] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM102137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grants CA098468 and CA207416 (to M. R. R.) and GM102137 and HL094463 (to J. L.). M. R. R. is the scientific founder of Symberix, Inc., which is developing microbiome-targeted therapeutics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andberg M, 2012, J BIOL CHEM, V287, P17662, DOI 10.1074/jbc.M111.335240; Boelsterli UA, 2013, TOXICOL SCI, V131, P654, DOI 10.1093/toxsci/kfs310; CONCHIE J, 1967, BIOCHEM J, V102, P929, DOI 10.1042/bj1020929; Dong RZ, 2018, BIOINFORMATICS, V34, P1719, DOI 10.1093/bioinformatics/btx828; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; LoGuidice A, 2012, J PHARMACOL EXP THER, V341, P447, DOI 10.1124/jpet.111.191122; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Mani S, 2014, ANNU REV PHARMACOL, V54, P559, DOI 10.1146/annurev-pharmtox-011613-140007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Ovchinnikov S, 2018, PROTEINS, V86, P113, DOI 10.1002/prot.25390; Park H, 2018, P NATL ACAD SCI USA, V115, P3054, DOI 10.1073/pnas.1719115115; Park H, 2018, PROTEINS, V86, P283, DOI 10.1002/prot.25387; Pellock SJ, 2017, J BIOL CHEM, V292, P8569, DOI 10.1074/jbc.R116.767434; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pollet RM, 2017, STRUCTURE, V25, P967, DOI 10.1016/j.str.2017.05.003; Roberts AB, 2013, MOL PHARMACOL, V84, P208, DOI 10.1124/mol.113.085852; Saitta KS, 2014, XENOBIOTICA, V44, P28, DOI 10.3109/00498254.2013.811314; SALYERS AA, 1977, APPL ENVIRON MICROB, V33, P319, DOI 10.1128/AEM.33.2.319-322.1977; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Schallus T, 2008, MOL BIOL CELL, V19, P3404, DOI 10.1091/mbc.E08-04-0354; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Wallace BD, 2015, CHEM BIOL, V22, P1238, DOI 10.1016/j.chembiol.2015.08.005; Wallace BD, 2013, CURR OPIN CHEM BIOL, V17, P379, DOI 10.1016/j.cbpa.2013.04.011; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Xu YM, 2014, NAT CHEM BIOL, V10, P248, DOI [10.1038/NCHEMBIO.1459, 10.1038/nchembio.1459]; Zitomersky NL, 2011, INFECT IMMUN, V79, P2012, DOI 10.1128/IAI.01348-10	37	37	38	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18559	18573		10.1074/jbc.RA118.005414	http://dx.doi.org/10.1074/jbc.RA118.005414			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30301767	Green Published, hybrid			2022-12-26	WOS:000458467300012
J	Pimviriyakul, P; Chaiyen, P				Pimviriyakul, Panu; Chaiyen, Pimchai			A complete bioconversion cascade for dehalogenation and denitration by bacterial flavin-dependent enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; CHLOROPHENOL 4-MONOOXYGENASE TFTD; DEGRADATION GENE-CLUSTER; OXYGEN ACTIVATION; ESCHERICHIA-COLI; REDUCED FLAVIN; 2,4,6-TRICHLOROPHENOL DEGRADATION; ACINETOBACTER-BAUMANNII; NITROAROMATIC COMPOUNDS; OXIDOREDUCTASE TFTC	Halogenated phenol and nitrophenols are toxic compounds that are widely accumulated in the environment. Enzymes in the had operon from the bacterium Ralstonia pickettii DTP0602 have the potential for application as biocatalysts in the degradation of many of these toxic chemicals. HadA monooxygenase previously was identified as a two-component reduced FAD (FADH(-))-utilizing monooxygenase with dual activities of dehalogenation and denitration. However, the partner enzymes of HadA, that is, the flavin reductase and quinone reductase that provide the FADH(-) for HadA and reduce quinone to hydroquinone, remain to be identified. In this report, we overexpressed and purified the flavin reductases, HadB and HadX, to investigate their functional and catalytic properties. Our results indicated that HadB is an FMN-dependent quinone reductase that converts the quinone products from HadA to hydroquinone compounds that are more stable and can be assimilated by downstream enzymes in the pathway. Transient kinetics indicated that HadB prefers NADH and menadione as the electron donor and acceptor, respectively. We found that HadX is an FAD-bound flavin reductase, which can generate FADH(-) for HadA to catalyze dehalogenation or denitration reactions. Thermodynamic and transient kinetic experiments revealed that HadX prefers to bind FAD over FADH(-) and that HadX can transfer FADH(-) from HadX to HadA via free diffusion. Moreover, HadX rapidly catalyzed NADH-mediated reduction of flavin and provided the FADH(-) for a monooxygenase of a different system. Combination of all three flavin-dependent enzymes, i.e. HadA/HadB/HadX, reconstituted an effective dehalogenation and denitration cascade, which may be useful for future bioremediation applications.	[Pimviriyakul, Panu; Chaiyen, Pimchai] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Wangchan Valley 21210, Rayong, Thailand; [Pimviriyakul, Panu] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 14000, Thailand; [Pimviriyakul, Panu] Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok 14000, Thailand	Vidyasirimedhi Institute of Science & Technology; Mahidol University; Mahidol University	Chaiyen, P (corresponding author), Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Wangchan Valley 21210, Rayong, Thailand.	pimchai.chaiyen@vistec.ac.th	Chaiyen, Pimchai/R-5052-2019	Chaiyen, Pimchai/0000-0002-8533-1604; Pimviriyakul, Panu/0000-0002-0410-0610	Thailand Research Fund [RTA5980001]; Vidyasirimedhi Institute of Science and Technology (VISTEC); Development and Promotion of Science and Technology Talents Project (DPST) Scholarship from VISTEC; VISTEC	Thailand Research Fund(Thailand Research Fund (TRF)); Vidyasirimedhi Institute of Science and Technology (VISTEC); Development and Promotion of Science and Technology Talents Project (DPST) Scholarship from VISTEC; VISTEC	This work was supported by The Thailand Research Fund Grant RTA5980001, a grant from Vidyasirimedhi Institute of Science and Technology (VISTEC) (to P. C.), and Development and Promotion of Science and Technology Talents Project (DPST) Scholarship and postdoctoral fellowship from VISTEC (to P. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Arora PK, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-31; Arora PK, 2014, J HAZARD MATER, V266, P42, DOI 10.1016/j.jhazmat.2013.12.011; Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Belchik SM, 2008, J BACTERIOL, V190, P1615, DOI 10.1128/JB.01697-07; Blaza JN, 2017, SCI REP-UK, V7, DOI 10.1038/srep40165; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Cho SY, 2017, BIORESOURCE TECHNOL, V245, P1800, DOI 10.1016/j.biortech.2017.05.006; Collins FA, 2018, BIOCHEMISTRY-US, V57, P3493, DOI 10.1021/acs.biochem.8b00255; Deller S, 2008, CELL MOL LIFE SCI, V65, P141, DOI 10.1007/s00018-007-7300-y; Filisetti L, 2005, FEBS LETT, V579, P2817, DOI 10.1016/j.febslet.2005.04.019; Filisetti L, 2003, J BIOL CHEM, V278, P296, DOI 10.1074/jbc.M209689200; Flores E, 2018, BIOCHEMISTRY-US, V57, P3050, DOI 10.1021/acs.biochem.8b00090; Gadda G, 2012, BIOCHEMISTRY-US, V51, P2662, DOI 10.1021/bi300227d; Gisi MR, 2003, J BACTERIOL, V185, P2786, DOI 10.1128/JB.185.9.2786-2792.2003; Gonzalez CF, 2005, J BIOL CHEM, V280, P22590, DOI 10.1074/jbc.M501654200; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Hatta T, 1999, J BIOSCI BIOENG, V87, P267, DOI 10.1016/S1389-1723(99)80030-9; Hatta T, 2012, BIOSCI BIOTECH BIOCH, V76, P892, DOI 10.1271/bbb.110843; Igbinosa EO, 2013, SCI WORLD J, DOI [10.1155/2013/460215, 10.1155/2013/798096]; Jarrom D, 2009, BIOCHEMISTRY-US, V48, P7665, DOI 10.1021/bi900674m; Karci A, 2014, CHEMOSPHERE, V99, P1, DOI 10.1016/j.chemosphere.2013.10.034; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; Kishko I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043902; Kitagawa W, 2004, J BACTERIOL, V186, P4894, DOI 10.1128/JB.186.15.4894-4902.2004; Lam LKM, 2012, BIOCHEMISTRY-US, V51, P5014, DOI 10.1021/bi300477z; Leferink NGH, 2009, J BIOL CHEM, V284, P4392, DOI 10.1074/jbc.M808202200; Louie TM, 2003, BIOCHEMISTRY-US, V42, P7509, DOI 10.1021/bi034092r; Luanloet T, 2015, FEBS J, V282, P3107, DOI 10.1111/febs.13220; McDonald CA, 2011, J AM CHEM SOC, V133, P16809, DOI 10.1021/ja2081873; Miseviciene L, 2006, ACTA BIOCHIM POL, V53, P569; Nijvipakul S, 2008, J BACTERIOL, V190, P1531, DOI 10.1128/JB.01660-07; Nijvipakul S, 2010, BIOCHEMISTRY-US, V49, P9241, DOI 10.1021/bi1009985; Olaniran AO, 2011, CHEMOSPHERE, V83, P1297, DOI 10.1016/j.chemosphere.2011.04.009; Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; Payne KAP, 2015, NATURE, V517, P513, DOI 10.1038/nature13901; Pera-Titus M, 2004, APPL CATAL B-ENVIRON, V47, P219, DOI 10.1016/j.apcatb.2003.09.010; Perry LL, 2007, J BACTERIOL, V189, P7563, DOI 10.1128/JB.01849-06; Phongsak T, 2012, J BIOL CHEM, V287, P26213, DOI 10.1074/jbc.M112.354472; Pimviriyakul P, 2018, CHEM SCI, V9, DOI 10.1039/c8sc01482e; Pimviriyakul P, 2017, J BIOL CHEM, V292, P4818, DOI 10.1074/jbc.M116.774448; Pitsawong W, 2014, J BIOL CHEM, V289, P15203, DOI 10.1074/jbc.M113.547117; Rau J, 2003, APPL ENVIRON MICROB, V69, P3448, DOI 10.1128/AEM.69.6.3448-3455.2003; Romero E, 2018, CHEM REV, V118, P1742, DOI 10.1021/acs.chemrev.7b00650; Ross D, 2004, DRUG METAB REV, V36, P639, DOI 10.1081/DMR-200033465; Sollner S, 2007, FEBS J, V274, P1328, DOI 10.1111/j.1742-4658.2007.05682.x; Sollner S, 2009, BIOCHEMISTRY-US, V48, P8636, DOI 10.1021/bi900734a; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Sucharitakul J, 2016, FEBS J, V283, P860, DOI 10.1111/febs.13636; Sucharitakul J, 2014, ARCH BIOCHEM BIOPHYS, V555, P33, DOI 10.1016/j.abb.2014.05.009; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Takeo M, 2008, J BACTERIOL, V190, P7367, DOI 10.1128/JB.00742-08; TEDESCHI G, 1995, J BIOL CHEM, V270, P1198, DOI 10.1074/jbc.270.3.1198; Tinikul R, 2013, BIOCHEMISTRY-US, V52, P6834, DOI 10.1021/bi4006545; Valiauga B, 2017, ARCH BIOCHEM BIOPHYS, V614, P14, DOI 10.1016/j.abb.2016.12.005; Valton J, 2006, J BIOL CHEM, V281, P27, DOI 10.1074/jbc.M506146200; Valton J, 2004, J BIOL CHEM, V279, P44362, DOI 10.1074/jbc.M407722200; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; Visitsatthawong S, 2015, J AM CHEM SOC, V137, P9363, DOI 10.1021/jacs.5b04328; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135; Wongnate T, 2014, J AM CHEM SOC, V136, P241, DOI 10.1021/ja4088055; XUN LY, 1992, J BACTERIOL, V174, P5745, DOI 10.1128/JB.174.17.5745-5747.1992; Yamamoto K, 2011, J BIOSCI BIOENG, V111, P687, DOI 10.1016/j.jbiosc.2011.01.016; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; Zaborina O, 1998, J BACTERIOL, V180, P4667, DOI 10.1128/JB.180.17.4667-4675.1998; Zhao GH, 2008, BIOCHEMISTRY-US, V47, P9124, DOI 10.1021/bi8008642	72	14	14	8	39	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18525	18539		10.1074/jbc.RA118.005538	http://dx.doi.org/10.1074/jbc.RA118.005538			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30282807	Green Published, hybrid			2022-12-26	WOS:000458467300010
J	Klapak, D; Broadfoot, S; Penner, G; Singh, A; Inapuri, E				Klapak, Daniel; Broadfoot, Sarah; Penner, Gregory; Singh, Anup; Inapuri, Eshwar			Development of novel aptamers for low-density lipoprotein particle quantification	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CHOLESTEROL; RISK	Cardiovascular disease (CVD) remains the leading cause of death worldwide. Low-density lipoprotein cholesterol (LDL-C) is commonly used for CVD risk assessment; however, recent research has shown LDL particle (LDL-P) number to be a more sensitive indicator of CVD risk than both LDL-C and non-high-density lipoprotein cholesterol (HDL-C). Described herein are five single stranded DNA aptamers with dissociation constants in the low picomolar range specific to LDL-P and its subfractions. Furthermore, a set of antisense sequences have been developed and characterized that are capable of binding to the best aptamers and undergoing displacement by LDL-P for use in a simple, affordable diagnostic assay.	[Klapak, Daniel; Broadfoot, Sarah; Penner, Gregory] NeoVentures Biotechnol Inc, London, ON, Canada; [Singh, Anup; Inapuri, Eshwar] InnaMed Inc, Philadelphia, PA 19104 USA		Singh, A; Inapuri, E (corresponding author), InnaMed Inc, Philadelphia, PA 19104 USA.	Anup.Singh@InnaMed.com; Eshwar.Inapuri@InnaMed.com		Inapuri, Eshwar/0000-0002-9040-3991	InnaMed, Inc.; NeoVentures Biotechnology Inc.	InnaMed, Inc.; NeoVentures Biotechnology Inc.	This study was funded by InnaMed, Inc. (www.InnaMed.com) and NeoVentures Biotechnology Inc. Members of the funding organization were involved in the design, analysis, decision to publish and preparation of the manuscript.	Caulfield MP, 2008, CLIN CHEM, V54, P1307, DOI 10.1373/clinchem.2007.100586; Cromwell WC, 2007, J CLIN LIPIDOL, V1, P583, DOI 10.1016/j.jacl.2007.10.001; Curfman G, 2017, JAMA INTERN MED, V177, P966, DOI 10.1001/jamainternmed.2017.1457; Davidson MH, 2011, J CLIN LIPIDOL, V5, P338, DOI 10.1016/j.jacl.2011.07.005; deGoma EM, 2013, ATHEROSCLEROSIS, V229, P517, DOI 10.1016/j.atherosclerosis.2013.03.012; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gopinath SCB, 2016, BIOTECHNOL ADV, V34, P198, DOI 10.1016/j.biotechadv.2016.02.003; Hopkins PN, 2015, ATHEROSCLEROSIS, V243, P99, DOI 10.1016/j.atherosclerosis.2015.08.042; Lakhin AV, 2013, ACTA NATURAE, V5, P34, DOI 10.32607/20758251-2013-5-4-34-43; Lecocq S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190212; McKeague M., 2012, J NUCLEIC ACIDS, V2012, DOI DOI 10.1155/2012/748913; Otvos JD, 2011, J CLIN LIPIDOL, V5, P105, DOI 10.1016/j.jacl.2011.02.001; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; SWINKELS DW, 1987, J LIPID RES, V28, P1233; Toth PP, 2014, ATHEROSCLEROSIS, V235, P585, DOI 10.1016/j.atherosclerosis.2014.05.914; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang RE, 2011, CURR MED CHEM, V18, P4126	19	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205460	10.1371/journal.pone.0205460	http://dx.doi.org/10.1371/journal.pone.0205460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307996	gold, Green Published, Green Submitted			2022-12-26	WOS:000447173500083
J	Pongcharoen, B; Chanalithichai, N				Pongcharoen, Boonchana; Chanalithichai, Nuttawut			Clinical outcomes of patients with residual medial osteophytes following mobile bearing unicompartmental knee arthroplasty	PLOS ONE			English	Article							QUALITY-OF-LIFE; INDEPENDENT ASSOCIATION; SURVIVAL ANALYSIS; 10-YEAR SURVIVAL; RETAINED CEMENT; CARTILAGE LOSS; OSTEOARTHRITIS; JOINT; JAPAN	Introduction The surgical technique used in unicompartmental knee arthroplasty (UKA) is crucial for achieving good short and long term clinical outcomes. The medial mobile bearing UKA has shown excellent clinical outcomes and survivorship. But release of the medial collateral ligament during entering joint is cause of mobile bearing dislocation in short term outcomes and lateral compartment osteoarthritis may occur in the mid to long term outcomes. Removing all osteophytes at the time of UKA is sometime impossible due to their large size and extend to the inferior part of medial tibial plateau and removing them completely my result in release of the MCL. But no data exist on clinical outcomes in such patients. Methods We conducted a prospective study from 2010 to 2015 of patients undergoing mobile bearing UKA and classified them in to two groups: those with (Gp1) and without (Gp2) residual osteophytes. Osteophyte size was measured using Hernborg's technique. The primary outcomes were pain score, functional score, and knee scores and the presence of reported medial knee pain. Results 176 patients who underwent 199 mobile bearing UKAs were recruited: Gp1 = 42 patients (46 knees) and Gp2 = 134 patients (153 knees). Residual osteophyte sizes ranged from 2.13-9.42 mm (mean 4.12). The mean Gp1 Gp2 pain score (49.04, 48.92, p = 0.84), functional score (83.75, 84.04, p = 0.83) and knee score (89.86, 98.7, p = 0.0.78) scores were almost identical and no one complained of medial joint pain. Followed up ranged from 2 - 7 years (mean 4.23). No patients were lost to follow up. Conclusion The patients with residual osteophytes of length less than 9 mm had good and similar clinical outcomes as patients without residual osteophytes following mobile bearing UKA.	[Pongcharoen, Boonchana; Chanalithichai, Nuttawut] Thammasat Univ, Dept Orthopaed Surg, Pathum Thani, Thailand	Thammasat University	Pongcharoen, B (corresponding author), Thammasat Univ, Dept Orthopaed Surg, Pathum Thani, Thailand.	boonbigbear@hotmail.com		Chanalithichai, Nuttawut/0000-0002-1356-7888	Faculty of Medicine, Thammasat University, Thailand	Faculty of Medicine, Thammasat University, Thailand	Funding was provided by the Faculty of Medicine, Thammasat University, Thailand to BP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlb?ck S., 1968, ACTA RADIOL STOCKH S, V277, P7, DOI DOI 10.1556/AALIM.2015.0002; Alnachoukati OK, 2018, J ARTHROPLASTY, V33, P677, DOI 10.1016/j.arth.2017.10.015; Bennell KL, 2011, ANN RHEUM DIS, V70, P1770, DOI 10.1136/ard.2010.147082; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Bonasia D E, 2012, Iowa Orthop J, V32, P173; Elmadag M, 2013, ACTA ORTHOP TRAUMATO, V47, P291, DOI 10.3944/AOTT.2013.3043; Emerson RH, 2016, BONE JOINT J, V98B, P34, DOI 10.1302/0301-620X.98B10.BJJ-2016-0480.R1; Felson DT, 2005, RHEUMATOLOGY, V44, P100, DOI 10.1093/rheumatology/keh411; Hamilton TW, 2017, BONE JOINT J, V99B, P475, DOI [10.1302/0301-620X.99B4.BJJ-2016-1061.R1, 10.1302/0301-620X.99B5.BJJ-2016-0695.R2]; HERNBORG J, 1973, ACTA ORTHOP SCAND, V44, P69, DOI 10.3109/17453677308988675; Howe DJ, 2004, J BONE JOINT SURG AM, V86A, P2283, DOI 10.2106/00004623-200410000-00022; Hurst JM, 2018, J ARTHROPLASTY, V33, P3268, DOI 10.1016/j.arth.2018.05.031; INSALL JN, 1989, CLIN ORTHOP RELAT R, P13; Jacobs CA, 2016, J ARTHROPLASTY, V31, P491, DOI 10.1016/j.arth.2015.09.023; Jung Kwang Am, 2009, Orthopedics, V32, P361; Kim Yeong-Joon, 2017, Knee Surg Relat Res, V29, P122, DOI 10.5792/ksrr.16.045; Konttinen YT, 2012, ARTHRITIS RHEUM-US, V64, P613, DOI 10.1002/art.33451; LaPrade RE, 2007, J BONE JOINT SURG AM, V89A, P2000, DOI 10.2106/JBJS.F.01176; Lee WC, 2017, KNEE SURG SPORT TR A, V25, P3354, DOI 10.1007/s00167-016-4208-9; Lisowski LA, 2016, BONE JOINT J, V98B, P41, DOI 10.1302/0301-620X.98B10.BJJ-2016-0474.R1; Mohammad HR, 2018, ACTA ORTHOP, V89, P101, DOI 10.1080/17453674.2017.1367577; Muraki S, 2015, CLIN RHEUMATOL, V34, P1589, DOI 10.1007/s10067-014-2687-y; Muraki S, 2011, ARTHRITIS RHEUM-US, V63, P3859, DOI 10.1002/art.30641; Murray DW, 1998, J BONE JOINT SURG BR, V80B, P983, DOI 10.1302/0301-620X.80B6.8177; Nagaosa Y, 2002, ANN RHEUM DIS, V61, P319, DOI 10.1136/ard.61.4.319; Pongcharoen B, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1914-1; Price AJ, 2005, CLIN ORTHOP RELAT R, P171, DOI 10.1097/01.blo.0000155347.89533.c5; Takegami Y, 2017, J ORTHOP SCI, V22, P1096, DOI 10.1016/j.jos.2017.08.014; Yamakado K, 2012, BMC SPORTS SCI MED R, V4, DOI 10.1186/1758-2555-4-8	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205469	10.1371/journal.pone.0205469	http://dx.doi.org/10.1371/journal.pone.0205469			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308011	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500085
J	Brinkhof, J; Olsen, SH; Ingolfsson, OA; Herrmann, B; Larsen, RB				Brinkhof, Jesse; Olsen, Stein H.; Ingolfsson, Olafur A.; Herrmann, Bent; Larsen, Roger B.			Sequential codend improves quality of trawl-caught cod	PLOS ONE			English	Article							GADUS-MORHUA CAUGHT; FISH SIZE; STRESS; CAPTURE; DECOMPRESSION; TEMPERATURE; SELECTION; BEHAVIOR; ESCAPE; IMPACT	Trawl-caught fish are frequently associated with deteriorated catch quality. This study presents a new dual sequential codend concept with the aim of improving the quality of trawl-caught fish by minimizing the frequency and severity of catch damage. During towing, the fish are retained in an anterior codend segment with the legislated mesh size. A quality improving codend segment, is attached to the aft part of the first codend segment. Its entrance is closed during the towing phase and opened at a predefined depth during haul-back. Comparing the quality of cod (Gadus morhua L.) retained in the sequential codend with cod caught in a conventional codend, demonstrated a significant improvement in the catch quality, i.e. reduction in catch damages. Cod caught in a conventional codend had only a 3.6% probability of being without visually detectable catch damage. The probability for catching cod without catch damage was five times higher when using the dual sequential codend. Furthermore, cod caught in the sequential codend had a significantly reduced probability of incurring specific catch damage, such as gear marks, poor exsanguination, ecchymosis, and skin abrasions.	[Brinkhof, Jesse; Herrmann, Bent; Larsen, Roger B.] Univ Tromso, Norwegian Coll Fishery & Aquat Sci, Tromso, Norway; [Olsen, Stein H.] Nofima AS, Tromso, Norway; [Ingolfsson, Olafur A.] Inst Marine Res, Bergen, Norway; [Herrmann, Bent] SINTEF Ocean, Hirtshals, Denmark	UiT The Arctic University of Tromso; Nofima; Institute of Marine Research - Norway; SINTEF	Brinkhof, J (corresponding author), Univ Tromso, Norwegian Coll Fishery & Aquat Sci, Tromso, Norway.	jesse.brinkhof@uit.no	Larsen, Roger B./AAY-4314-2021	Brinkhof, Jesse/0000-0003-2275-8894; Ingolfsson, Olafur Arnar/0000-0003-4975-6186; Herrmann, Bent/0000-0003-1325-6198	Norwegian Research Council [203477]; Nofima AS; SINTEF Ocean	Norwegian Research Council(Research Council of NorwayEuropean Commission); Nofima AS(Nofima); SINTEF Ocean(SINTEF)	This study was part of the project 'Centre of Research-based Innovation in Sustainable Fish Capture and Processing Technology (CRISP)', which is funded by The Norwegian Research Council (Grant No. 203477). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nofima AS and SINTEF Ocean provided support in the form of salaries for authors SH and BH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Batsleer J, 2015, REV FISH BIOL FISHER, V25, P715, DOI 10.1007/s11160-015-9403-0; Bonilla AC, 2007, FOOD CONTROL, V18, P352, DOI 10.1016/j.foodcont.2005.10.019; Borderias AJ, 2011, J FOOD SCI, V76, pR1, DOI 10.1111/j.1750-3841.2010.01900.x; BOTTA JR, 1986, CAN I FOOD SC TECH J, V19, P186, DOI 10.1016/S0315-5463(86)71629-5; Brinkhof J, 2018, FISH RES, V206, P209, DOI 10.1016/j.fishres.2018.05.021; Brinkhof J, 2018, ICES J MAR SCI, V75, P805, DOI 10.1093/icesjms/fsx200; Brinkhof J, 2017, FISH RES, V186, P269, DOI 10.1016/j.fishres.2016.10.008; Cole RG, 2003, FISH RES, V60, P381, DOI 10.1016/S0165-7836(02)00133-9; Digre H, 2017, FISH RES, V189, P42, DOI 10.1016/j.fishres.2017.01.004; Digre H, 2010, FISHERIES SCI, V76, P549, DOI 10.1007/s12562-010-0254-2; Efron B, 1982, JACKKNIFE BOOTSTRAP; Erikson U, 2016, FISH RES, V179, P148, DOI 10.1016/j.fishres.2016.02.017; Esaiassen M, 2013, FOOD CONTROL, V29, P231, DOI 10.1016/j.foodcont.2012.05.065; Herrmann Bent, 2012, Journal of Northwest Atlantic Fishery Science, V44, P1, DOI 10.2960/J.v44.m680; Humborstad OB, 2013, MAR BIOL RES, V9, P383, DOI 10.1080/17451000.2012.742546; ICES, 2015, REP ARCT FISH WORK G; Kenney JL, 2015, FISH RES, V172, P79, DOI 10.1016/j.fishres.2015.06.026; Margeirsson S, 2007, J FOOD ENG, V80, P503, DOI 10.1016/j.jfoodeng.2006.05.032; Mello LGS, 2005, ICES J MAR SCI, V62, P1006, DOI 10.1016/j.icesjms.2005.03.008; Midling KO, 2012, MAR BIOL RES, V8, P373, DOI 10.1080/17451000.2011.638640; MILLAR RB, 1993, FISH B-NOAA, V91, P564; Nichol DG, 2006, ICES J MAR SCI, V63, P83, DOI 10.1016/j.icesjms.2005.05.021; Olsen SH, 2014, FISH RES, V153, P103, DOI 10.1016/j.fishres.2014.01.011; Olsen SH, 2013, FISH RES, V147, P446, DOI 10.1016/j.fishres.2013.03.009; Olsen SH, 2008, AQUACULTURE, V284, P90, DOI 10.1016/j.aquaculture.2008.07.042; R Core Team, 2021, R LANGUAGE ENV STAT; Rankin PS, 2017, FISH RES, V186, P258, DOI 10.1016/j.fishres.2016.09.004; Rotabakk BT, 2011, FISH RES, V112, P44, DOI 10.1016/j.fishres.2011.08.009; Rummer JL, 2005, T AM FISH SOC, V134, P1457, DOI 10.1577/T04-235.1; Ryer CH, 2004, FISH RES, V66, P261, DOI 10.1016/S0165-7836(03)00197-8; Ryer CH, 2002, MAR ECOL PROG SER, V232, P269, DOI 10.3354/meps232269; Sartoris FJ, 2003, J FISH BIOL, V62, P1239, DOI 10.1046/j.1095-8649.2003.00099.x; Sistiaga M, 2016, FISH RES, V183, P340, DOI 10.1016/j.fishres.2016.06.022; Suuronen P, 2005, FISH RES, V71, P151, DOI 10.1016/j.fishres.2004.08.022; Wienbeck H, 2014, FISH RES, V150, P28, DOI 10.1016/j.fishres.2013.10.007; XU XC, 1993, CAN J FISH AQUAT SCI, V50, P2485, DOI 10.1139/f93-273; Yaragina N.A., 2011, BARENTS SEA ECOSYSTE, P225	37	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204328	10.1371/journal.pone.0204328	http://dx.doi.org/10.1371/journal.pone.0204328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303983	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000446921100041
J	Zhao, HL; Zhang, HJ; Shar, AG; Liu, JF; Chen, YL; Chu, SJ; Tian, XH				Zhao, Huili; Zhang, Huijie; Shar, Abdul Ghaffar; Liu, Jifei; Chen, Yanlong; Chu, Songjie; Tian, Xiaohong			Enhancing organic and inorganic carbon sequestration in calcareous soil by the combination of wheat straw and wood ash and/or lime	PLOS ONE			English	Article							CO2 SEQUESTRATION; CLIMATE-CHANGE; NITROGEN DON; FOREST SOIL; ACID SOIL; CHINA; DYNAMICS; MATTER; GRASSLAND; CROPLAND	Increasing organic carbon sequestration in agricultural soils is important for improving soil fertility and mitigating climate change. Wood ash is generally applied as a potassium fertilizer, but the effects of simultaneous incorporation of wood ash and crop straw on the turnover of soil organic carbon (SOC) and inorganic carbon (SIC) are not well understood. In this study, a 118-day lab incubation experiment was conducted using a calcareous soil (with 10 years of continuous maize cropping history) to study the effects of adding wheat straw, wood ash and lime. Our study showed that straw addition led to an increase in both SOC (19%) and SIC (3%). Wood ash and lime addition decreased CO2 emission by 182 and 1210 mg kg(-1) and increased SIC by 125 and 1001 mg kg(-1) during the incubation, respectively, which was due to supply of CaO from wood ash and lime. The increase of SOC content was 2.4% due to the addition of lime. In addition to straw addition enhanced straw-derived OC content, the addition of lime also increased straw-derived OC content by 34.5%. This study demonstrated that lime was more effective in reducing CO2 emission and and enhancing SOC than wood ash. In conclusion, adding lime to calcareous soil might be an effective method of enhancing carbon sequestration and slowing climate change.	[Zhao, Huili; Zhang, Huijie; Shar, Abdul Ghaffar; Liu, Jifei; Chen, Yanlong; Chu, Songjie; Tian, Xiaohong] Northwest A&F Univ, Key Lab Plant Nutr & Agrienvironm Northwest China, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China; [Tian, Xiaohong] Minist Agr, Heyang Field Stn Agr Environm & Farmland Conserva, Fuping, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Tian, XH (corresponding author), Northwest A&F Univ, Key Lab Plant Nutr & Agrienvironm Northwest China, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China.; Tian, XH (corresponding author), Minist Agr, Heyang Field Stn Agr Environm & Farmland Conserva, Fuping, Shaanxi, Peoples R China.	txhong@hotmail.com	Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022; Chen, Yanlong/U-1885-2019	Tian, Xiaohong/0000-0002-7594-9726; Chen, Yanlong/0000-0001-8657-5590	National Key RD Program [2016YFD0200308]; Key Technologies R&D Program of China during the 12th Five-Year Plan period [2012BAD14B11]	National Key RD Program; Key Technologies R&D Program of China during the 12th Five-Year Plan period	This work was financed by National Key R&D Program (2016YFD0200308) and by the Key Technologies R&D Program of China during the 12th Five-Year Plan period (2012BAD14B11) to XT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad W, 2013, SOIL BIOL BIOCHEM, V57, P549, DOI 10.1016/j.soilbio.2012.10.013; Alef K., 1995, METHODS APPL SOIL MI, P350; Andersson S, 2000, SOIL BIOL BIOCHEM, V32, P1, DOI 10.1016/S0038-0717(99)00103-0; Athanase N., 2013, Agricultural Advances, V2, P259; Augusto L, 2008, PLANT SOIL, V306, P181, DOI 10.1007/s11104-008-9570-z; Bao S.D., 2008, SOIL AGROCHEMISTRY A; Bolan NS, 2003, HDB SOIL ACIDITY, P215; Bougnom B.P., 2009, BODENKULT, V60, P5; Chiang PN, 2004, CHEMOSPHERE, V54, P217, DOI 10.1016/j.chemosphere.2003.07.005; Ernani PR, 2004, COMMUN SOIL SCI PLAN, V35, P889, DOI 10.1081/CSS-120030365; Fornara DA, 2011, GLOBAL CHANGE BIOL, V17, P1925, DOI 10.1111/j.1365-2486.2010.02328.x; Garbuio FJ, 2011, SOIL SCI SOC AM J, V75, P1723, DOI 10.2136/sssaj2010.0291; Gong Z.T., 2007, PEDOGENESIS SOIL TAX; Guo Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep36105; Hansen M, 2016, SOIL BIOL BIOCHEM, V99, P179, DOI 10.1016/j.soilbio.2016.05.012; Jastrow JD, 2007, CLIMATIC CHANGE, V80, P5, DOI 10.1007/s10584-006-9178-3; Jones DL, 2006, SOIL BIOL BIOCHEM, V38, P991, DOI 10.1016/j.soilbio.2005.08.012; Juarez MFD, 2013, BIOL FERT SOILS, V49, P575, DOI 10.1007/s00374-012-0747-5; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kirkby CA, 2014, SOIL BIOL BIOCHEM, V68, P402, DOI 10.1016/j.soilbio.2013.09.032; Kleber M, 2015, ADV AGRON, V130, P1, DOI 10.1016/bs.agron.2014.10.005; Kunhikrishnan A, 2016, ADV AGRON, V139, P1, DOI 10.1016/bs.agron.2016.05.001; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Lal R, 2002, ENVIRON POLLUT, V116, P353, DOI 10.1016/S0269-7491(01)00211-1; Lee S, 2016, J CO2 UTIL, V16, P336, DOI 10.1016/j.jcou.2016.09.003; Leytem, 2005, BETTER CROP, V89, P11; Ludwig B, 2002, SCAND J FOREST RES, V17, P225, DOI 10.1080/028275802753742891; Maljanen M, 2006, FOREST ECOL MANAG, V237, P143, DOI 10.1016/j.foreco.2006.09.039; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; Ohlsson KEA, 2000, SOIL SCI SOC AM J, V64, P2155, DOI 10.2136/sssaj2000.6462155x; Park BB, 2005, BIOMASS BIOENERG, V28, P355, DOI 10.1016/j.biombioe.2004.09.001; Pitman RM, 2006, FORESTRY, V79, P563, DOI 10.1093/forestry/cpl041; Pugliese S, 2014, CAN J SOIL SCI, V94, P621, DOI [10.4141/CJSS-2014-037, 10.4141/cjss-2014-037]; Reed EY, 2017, SOIL BIOL BIOCHEM, V110, P134, DOI 10.1016/j.soilbio.2017.03.012; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Soong Y, 2006, ENERG CONVERS MANAGE, V47, P1676, DOI 10.1016/j.enconman.2005.10.021; Thuries L, 2000, COMMUN SOIL SCI PLAN, V31, P289, DOI 10.1080/00103620009370437; Vance ED, 1996, J ENVIRON QUAL, V25, P937, DOI 10.2134/jeq1996.00472425002500050002x; Wang JP, 2015, EUR J SOIL SCI, V66, P95, DOI 10.1111/ejss.12188; Wang JZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11409; Wang XJ, 2014, PLANT SOIL, V380, P89, DOI 10.1007/s11104-014-2077-x; Wang XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11439; Yan HM, 2007, AGR ECOSYST ENVIRON, V121, P325, DOI 10.1016/j.agee.2006.11.008; Zhang KR, 2015, GLOBAL CHANGE BIOL, V21, P2762, DOI 10.1111/gcb.12886; Zhao HL, 2017, SOIL SCI PLANT NUTR, V63, P591, DOI 10.1080/00380768.2017.1409603; Zhao HL, 2018, SOIL TILL RES, V175, P178, DOI 10.1016/j.still.2017.09.012; Zimmermann S, 2002, SOIL BIOL BIOCHEM, V34, P1727, DOI 10.1016/S0038-0717(02)00160-8	48	5	6	9	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205361	10.1371/journal.pone.0205361	http://dx.doi.org/10.1371/journal.pone.0205361			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304053	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100084
J	Coscas, F; Cabral, D; Pereira, T; Geraldes, C; Narotamo, H; Miere, A; Lupidi, M; Sellam, A; Papoila, A; Coscas, G; Souied, E				Coscas, Florence; Cabral, Diogo; Pereira, Telmo; Geraldes, Carlos; Narotamo, Hemaxi; Miere, Alexandra; Lupidi, Marco; Sellam, Alexandre; Papoila, Ana; Coscas, Gabriel; Souied, Eric			Quantitative optical coherence tomography angiography biomarkers for neovascular age-related macular degeneration in remission	PLOS ONE			English	Article							CHOROIDAL NEOVASCULARIZATION; SWEPT-SOURCE; RANIBIZUMAB; LACUNARITY; GUIDELINES; THERAPY	Purpose To characterize quantitative optical coherence tomography angiography (OCT-A) parameters in active neovascular age-related macular degeneration (nAMD) patients under treatment and remission nAMD patients. Design Retrospective, cross-sectional study. Participants One hundred and four patients of whom 72 were in Group 1 (active nAMD) and 32 in Group 2 (remission nAMD) based on SD-OCT (Spectral Domain OCT) qualitative morphology. Methods This study was conducted at the Centre Ophtalmologique de l'Odeon between June 2016 and December 2017. Eyes were analyzed using SD-OCT and high-speed (100 000 Ascans/second) 1050-nm wavelength swept-source OCT-A. Speckle noise removal and choroidal neovascularization (CNV) blood flow delineation were automatically performed. Quantitative parameters analyzed included blood flow area (Area), vessel density, fractal dimension (FD) and lacunarity. OCT-A image algorithms and graphical user interfaces were built as a unified tool in Matlab coding language. Generalized Additive Models were used to study the association between OCT-A parameters and nAMD remission on structural OCT. The models' performance was assessed by the Akaike Information Criterion (AIC), Brier Score and by the area under the receiver operating characteristic curve (AUC). A p value of <= 0.05 was considered as statistically significant. Results Area, vessel density and FD were different (p<0.001) in the two groups. Regarding the association with CNV activity, Area alone had the highest AUC (AUC = 0.85; 95% CI: 0.77-0.93) followed by FD (AUC = 0.80; 95% CI: 0.71-0.88). Again, Area obtained the best values followed by FD in the AIC and Brier Score evaluations. The multivariate model that included both these variables attained the best performance considering all assessment criteria. Conclusions Blood flow characteristics on OCT-A may be associated with exudative signs on structural OCT. In the future, analyses of OCT-A quantitative parameters could potentially help evaluate CNV activity status and to develop personalized treatment and follow-up cycles.	[Coscas, Florence; Cabral, Diogo; Coscas, Gabriel] Ctr Ophtalmol Odeon, Paris, France; [Coscas, Florence; Miere, Alexandra; Coscas, Gabriel; Souied, Eric] Creteil Univ Paris Est Creteil XIl, Ctr Hosp Intercommunal, Dept Ophthalmol, Creteil, France; [Cabral, Diogo; Pereira, Telmo; Geraldes, Carlos; Papoila, Ana] Univ Nova Lisboa, Fac Ciencias Med, NOVA Med Sch, Lisbon, Portugal; [Cabral, Diogo; Pereira, Telmo; Narotamo, Hemaxi] Univ Nova Lisboa, Chron Dis Res Ctr, CEDOC, Lisbon, Portugal; [Cabral, Diogo] Inst Oftalmol Dr Gama Pinto, Lisbon, Portugal; [Geraldes, Carlos; Papoila, Ana] Univ Lisbon, Ctr Estat & Aplicacoes, CEAUL, Lisbon, Portugal; [Lupidi, Marco] Univ Perugia, S Maria Misericordia Hosp, Dept Biomed & Surg Sci, Sect Ophthalmol, Perugia, Italy; [Sellam, Alexandre] Sorbonne Univ, Fac Med, Quinze Vingts Natl Eye Hosp, Paris, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Universidade de Lisboa; University of Perugia; CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite	Cabral, D (corresponding author), Ctr Ophtalmol Odeon, Paris, France.; Cabral, D (corresponding author), Univ Nova Lisboa, Fac Ciencias Med, NOVA Med Sch, Lisbon, Portugal.; Cabral, D (corresponding author), Univ Nova Lisboa, Chron Dis Res Ctr, CEDOC, Lisbon, Portugal.; Cabral, D (corresponding author), Inst Oftalmol Dr Gama Pinto, Lisbon, Portugal.	diogo.cabral@nms.unl.pt	Cabral, Diogo/AAG-3865-2019; Miere, Alexandra/AIC-4074-2022; Geraldes, Carlos/A-4358-2019; Papoila, Ana/S-2164-2019	Cabral, Diogo/0000-0003-1968-3561; Miere, Alexandra/0000-0003-4123-8210; Geraldes, Carlos/0000-0002-1551-6531; Papoila, Ana/0000-0002-2918-8364; Lupidi, Marco/0000-0002-6817-2488; Narotamo, Hemaxi/0000-0003-1933-4273; Pereira, Telmo/0000-0002-6903-9187				al Sharaa M, 2017, NATO SCI PEACE SEC, V138, P1, DOI 10.3233/978-1-61499-802-0-1; Al-Sheikh M, 2017, OSLI RETINA, V48, P385, DOI 10.3928/23258160-20170428-04; Amoroso F, 2018, BRIT J OPHTHALMOL, V102, P821, DOI 10.1136/bjophthalmol-2017-310569; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Coscas GJ, 2015, RETINA-J RET VIT DIS, V35, P2219, DOI 10.1097/IAE.0000000000000766; Costanzo E, 2016, INVEST OPHTH VIS SCI, V57, pOCT307, DOI 10.1167/iovs.15-18830; Dutheil C, 2018, EUR J OPHTHALMOL; Freund KB, 2010, RETINA-J RET VIT DIS, V30, P1333, DOI 10.1097/IAE.0b013e3181e7976b; Gess AJ, 2011, SEMIN OPHTHALMOL, V26, P225, DOI 10.3109/08820538.2011.582533; Guidolin D, 2004, LEUKEMIA, V18, P1745, DOI 10.1038/sj.leu.2403526; Hastie T, 1990, CHAPMAN HALL CRC MON, DOI [10.1093/jncimonographs/lgu023, DOI 10.1093/JNCIMONOGRAPHS/LGU023]; Ho AC, 2014, OPHTHALMOLOGY, V121, P2181, DOI 10.1016/j.ophtha.2014.05.009; Inoue M, 2016, INVEST OPHTH VIS SCI, V57, pOCT314, DOI 10.1167/iovs.15-18900; Jia YL, 2014, OPHTHALMOLOGY, V121, P1435, DOI 10.1016/j.ophtha.2014.01.034; Jung JJ, 2014, AM J OPHTHALMOL, V158, P769, DOI 10.1016/j.ajo.2014.07.006; Masters BR, 2004, ANNU REV BIOMED ENG, V6, P427, DOI 10.1146/annurev.bioeng.6.040803.140100; Miere A, 2019, RETINA-J RET VIT DIS, V39, P548, DOI 10.1097/IAE.0000000000001964; Miere A, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/3751702; Muakkassa NW, 2015, RETINA-J RET VIT DIS, V35, P2252, DOI 10.1097/IAE.0000000000000836; Munk MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177059; Phansalkar Neerad, 2011, 2011 International Conference on Communications and Signal Processing (ICCSP), P218, DOI 10.1109/ICCSP.2011.5739305; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts PK, 2017, RETINA-J RET VIT DIS, V37, P1492, DOI 10.1097/IAE.0000000000001400; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schmidt-Erfurth U, 2014, BRIT J OPHTHALMOL, V98, P1144, DOI 10.1136/bjophthalmol-2014-305702; Smith TG, 1996, J NEUROSCI METH, V69, P123, DOI 10.1016/S0165-0270(96)00080-5; Spaide RF, 2017, RETINA-J RET VIT DIS, V37, P609, DOI 10.1097/IAE.0000000000001575; Spaide RF, 2015, AM J OPHTHALMOL, V160, P6, DOI 10.1016/j.ajo.2015.04.012; STERNBERG P, 1991, ARCH OPHTHALMOL-CHIC, V109, P1242; Tolle CR, 2008, PHYSICA D, V237, P306, DOI 10.1016/j.physd.2007.09.017; Xu D, 2018, AM J OPHTHALMOL, V187, P10, DOI 10.1016/j.ajo.2017.12.005; Zhang QQ, 2017, OPHTHALMOL RETINA, V1, P124, DOI 10.1016/j.oret.2016.08.005; Zheng F, 2017, INVEST OPHTH VIS SCI, V58, P5098, DOI 10.1167/iovs.17-22506	33	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205513	10.1371/journal.pone.0205513	http://dx.doi.org/10.1371/journal.pone.0205513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300393	Green Published, Green Submitted, gold			2022-12-26	WOS:000446897200072
J	Taniguchi, H; Matsumoto-Oda, A				Taniguchi, Haruka; Matsumoto-Oda, Akiko			Wound healing in wild male baboons: Estimating healing time from wound size	PLOS ONE			English	Article							SELF-INJURIOUS-BEHAVIOR; FLIGHT MEMBRANES; AGGRESSION; FEMALE; COMPETITION; STRATEGIES; MORTALITY; MACAQUES; INSIGHTS; ANIMALS	Wound healing in animals is important to minimize the fitness costs of infection. Logically, a longer healing time is associated with higher risk of infection and higher energy loss. In wild mammals, wounds caused by aggressive intraspecific interactions can potentially have lethal repercussions. Clarifying wounding rate and healing time is therefore important for measuring the severity of the attacks. In addition, impact of secondary damage of wounds (e.g., accidental peeling off of scabs) on heeling time is unknown despite the risk of infection in wild mammals. In baboons, most male injuries have been reported to result from male to male fights. Here, we investigated the relationship between wound size and healing time in wild anubis baboons to clarify the healing cost of physical attacks including secondary damage of wounds. Observations were conducted daily between August 2016 and July 2017 in Kenya for seven adult male anubis baboons. The individual wound rate was one per month on average. In 16 cases, we were able to assess the number of days required for wound healing, and the median healing time was 13 d. Wound healing time was longer for larger wounds. When the scab was peeled off accidentally because of external factors, healing time became longer. One of the causes of scabs' peeling off was baboons' scab-picking behavior, and the behaviour was considered self-injurious behavior. However, its predicted healing cost might not be high. We concluded that wounds less than 800 mm 2 (the largest observed in this study) in baboon males have little effect on survival. Our results suggest that lethal wounds by physical attacks rarely occur in male baboons, and that healing time and delay caused by secondary damages can be estimated by measuring wound area.	[Taniguchi, Haruka] Univ Ryukyus, Fac Global & Reg Studies, Nishihara, Okinawa, Japan; [Taniguchi, Haruka; Matsumoto-Oda, Akiko] Mpala Res Ctr, Nanyuki, Kenya; [Matsumoto-Oda, Akiko] Univ Ryukyus, Grad Sch Tourism Sci, Nishihara, Okinawa, Japan	University of the Ryukyus	Matsumoto-Oda, A (corresponding author), Mpala Res Ctr, Nanyuki, Kenya.; Matsumoto-Oda, A (corresponding author), Univ Ryukyus, Grad Sch Tourism Sci, Nishihara, Okinawa, Japan.	a_matsu@tm.u-ryukyu.ac.jp			Japan Society for the Promotion of Science (JSPS) [16H05776]; Gender Equality Promotion Office (GEPO), University of the Ryukyus	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Gender Equality Promotion Office (GEPO), University of the Ryukyus	This study was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-aid for Scientific Research (16H05776) to AMO and by the Gender Equality Promotion Office (GEPO), University of the Ryukyus, to HT. JSPS bore costs for field research, postdoctoral salaries, and publishing fee. GEPO provided expenses for English proofreading.	Archie EA, 2013, PARASITE IMMUNOL, V35, P374, DOI 10.1111/pim.12048; Archie EA, 2014, BEHAV ECOL SOCIOBIOL, V68, P1183, DOI 10.1007/s00265-014-1729-4; Archie EA, 2012, P NATL ACAD SCI USA, V109, P9017, DOI 10.1073/pnas.1206391109; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Aureli F, 2007, BIOL LETTERS, V3, P147, DOI 10.1098/rsbl.2007.0041; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Ceballos-Vasquez A, 2015, BIOL OPEN, V4, P95, DOI 10.1242/bio.201410264; CHAMOVE A S, 1984, Primates, V25, P319, DOI 10.1007/BF02382270; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; Dellinger-Ness LA, 2006, CLIN PSYCHOL REV, V26, P503, DOI 10.1016/j.cpr.2006.03.004; Demas GE, 2011, J ANIM ECOL, V80, P710, DOI 10.1111/j.1365-2656.2011.01813.x; Deutsch Charles J., 1994, P169; DITTUS WPJ, 1989, INT J PRIMATOL, V10, P215, DOI 10.1007/BF02735201; Drews C, 1996, BEHAVIOUR, V133, P443, DOI 10.1163/156853996X00530; French SS, 2008, GEN COMP ENDOCR, V155, P148, DOI 10.1016/j.ygcen.2007.04.007; GEIST V, 1974, NATURE, V250, P354, DOI 10.1038/250354c0; Georgiev AV, 2013, EVOL PSYCHOL-US, V11, P678, DOI 10.1177/147470491301100313; Leeds A, 2015, ZOO BIOL, V34, P296, DOI 10.1002/zoo.21218; Lionelli GT, 2003, SURG CLIN N AM, V83, P617, DOI 10.1016/S0039-6109(02)00192-5; Lutz C, 2003, PHYSIOL BEHAV, V78, P33, DOI 10.1016/S0031-9384(02)00886-7; MacCormick HA, 2012, BEHAV ECOL, V23, P684, DOI 10.1093/beheco/ars021; Gomez JM, 2016, NATURE, V538, P233, DOI 10.1038/nature19758; Matsumoto-Oda A, 2015, ANTHROPOL SCI, V123, P13, DOI 10.1537/ase.150223; Novak MA, 2003, AM J PRIMATOL, V59, P3, DOI 10.1002/ajp.10063; Owens IPF, 1999, TRENDS ECOL EVOL, V14, P170, DOI 10.1016/S0169-5347(98)01580-8; OWENS NW, 1975, ANIM BEHAV, V23, P757, DOI 10.1016/0003-3472(75)90103-7; PACKER C, 1979, ANIM BEHAV, V27, P37, DOI 10.1016/0003-3472(79)90127-1; PLAVCAN JM, 1995, J HUM EVOL, V28, P245, DOI 10.1006/jhev.1995.1019; Pollock T, 2016, J WILDLIFE MANAGE, V80, P19, DOI 10.1002/jwmg.997; Popp JL, 1978, MALE BABOONS EVOLUTI; R Core Team, 2021, R LANGUAGE ENV STAT; Reichard JD, 2009, ACTA CHIROPTEROL, V11, P457, DOI 10.3161/150811009X485684; Rennert R, 2009, ADV SKIN WOUND CARE, V22, P32, DOI 10.1097/01.ASW.0000343718.30567.cb; Scott EM, 2005, BEHAVIOUR, V142, P21, DOI 10.1163/1568539053627712; Semple S, 2002, P ROY SOC B-BIOL SCI, V269, P1031, DOI 10.1098/rspb.2001.1950; Sherrow HM, 2012, OXFORD HDB EVOLUTION, P23; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smuts B.B., 1987, P400; Steinstraesser L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039373; Tucker BTP, 2011, J ANXIETY DISORD, V25, P88, DOI 10.1016/j.janxdis.2010.08.007; Weaver KN, 2009, ACTA CHIROPTEROL, V11, P220, DOI 10.3161/150811009X465866; WILKINSON PF, 1976, ANIM BEHAV, V24, P756, DOI 10.1016/S0003-3472(76)80004-8; WILSON BS, 1992, OECOLOGIA, V92, P145, DOI 10.1007/BF00317275; Wilson ML, 2014, NATURE, V513, P414, DOI 10.1038/nature13727; WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0; Wood SN, 2006, GEN ADDITIVE MODELS	49	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205017	10.1371/journal.pone.0205017	http://dx.doi.org/10.1371/journal.pone.0205017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4OW	30300389	Green Submitted, gold, Green Published			2022-12-26	WOS:000446897200031
J	Zhou, XN; Dong, Q; Kan, XZ; Peng, LH; Xu, XY; Fang, Y; Yang, JL				Zhou, Xiaonan; Dong, Qun; Kan, Xianzhao; Peng, Lihong; Xu, Xingyu; Fang, Yun; Yang, Jialiang			Immunomodulatory activity of a novel polysaccharide from Lonicera japonica in immunosuppressed mice induced by cyclophosphamide	PLOS ONE			English	Article							OXIDATIVE STRESS; T-LYMPHOCYTES; TREATED MICE; BALB/C MICE; IN-VITRO; COMPLEX; ALLEVIATION; INFECTION; CYTOKINES; VIRUS	Lonicera japonica is a typical Chinese herbal medicine. We previously reported a method to isolate polysaccharides from Lonicera japonica (LJP). In this study, we first performed a qualitative analysis of LJP using the Fourier Transform Infrared Spectrometer (FT-IR) and explored the monosaccharide composition of LJP using the pre-column derivatization high performance liquid chromatography (HPLC) method. We then investigated the immunomodulatory function of LJP in cyclophosphamide (CTX)-induced immunosuppressed mouse models. The results showed that LJP had the characteristic absorption of typical polysaccharides consisting of 6 types of monosaccharides. In addition, LJP can increase significantly the organ index, splenic lymphocyte proliferation, macrophage phagocytosis, and natural killer (NK) cell activity in CTX-treated mice. LJP could also restore the levels of serum cytokines interleukin (IL-2), tumor necrosis factor (TNF-alpha) and Interferon-gamma (IFN-gamma) in the CTX-treated mice. Finally, the results on measuring the T-lymphocytes subsets of spleen also confirmed LJP-induced immunomodulatory activity in immunosuppressed mice from another perspective. Therefore, LJP could be used as a potential immunomodulatory agent.	[Zhou, Xiaonan; Dong, Qun] Wannan Med Coll, Key Lab Polysaccharide Drug Engn Anhui, Wuhu, Anhui, Peoples R China; [Kan, Xianzhao] Anhui Normal Univ, Coll Life Sci, Wuhu, Peoples R China; [Peng, Lihong; Yang, Jialiang] Changsha Med Univ, Coll Informat Engn, Changsha, Hunan, Peoples R China; [Xu, Xingyu] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Fang, Yun] Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China; [Yang, Jialiang] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA	Wannan Medical College; Anhui Normal University; Changsha Medical University; Zhejiang Sci-Tech University; Shanghai Normal University; Icahn School of Medicine at Mount Sinai	Yang, JL (corresponding author), Changsha Med Univ, Coll Informat Engn, Changsha, Hunan, Peoples R China.; Fang, Y (corresponding author), Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China.; Yang, JL (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA.	fangyun0919@shu.edu.cn; jialiang.yang@mssm.edu	Kan, Xianzhao/AAA-5050-2021	Kan, Xianzhao/0000-0002-9225-407X; Yang, Jialiang/0000-0003-4689-8672	National Science Foundation of China [11201306, 61572327]; Innovation Program of Shanghai Municipal Education Commission [13YZ065]; Natural Science Foundation of Hunan, China [2018JJ2461]; Wannan Medical College Young Scientists Research Fund [WK201102]; Anhui Key Laboratory of Polysaccharide Drug Engineering Foundation [XZ201176]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Natural Science Foundation of Hunan, China(Natural Science Foundation of Hunan Province); Wannan Medical College Young Scientists Research Fund; Anhui Key Laboratory of Polysaccharide Drug Engineering Foundation	This work was financially supported by the National Science Foundation of China (No. 11201306 and No. 61572327); the Innovation Program of Shanghai Municipal Education Commission (No. 13YZ065); the Natural Science Foundation of Hunan, China (Grant No. 2018JJ2461); the Wannan Medical College Young Scientists Research Fund (No. WK201102); and the Anhui Key Laboratory of Polysaccharide Drug Engineering Foundation (No. XZ201176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achdout H, 2008, J VIROL, V82, P8030, DOI 10.1128/JVI.00870-08; Bao QW, 2017, J FOOD PROCESS PRES, V41, DOI 10.1111/jfpp.13016; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Barrea L, 2017, CRIT REV FOOD SCI NU, V11, P1; Chatzinasiou E, 2017, MICROB PATHOGENESIS, V104, P318, DOI 10.1016/j.micpath.2017.01.048; Chen JW, 2015, MED SCI MONITOR, V21, P505, DOI 10.12659/MSM.893271; Chi X, 2017, POULTRY SCI, V96, P3058, DOI 10.3382/ps/pex127; Dirchwolf M, 2016, CYTOKINE, V77, P14, DOI 10.1016/j.cyto.2015.10.006; Gong Y, 2015, INT J CLIN EXP MED, V8, P20631; Ha T.K., 2011, IMMUNOMODULATORY EFF, V26; Hidaka Y, 2014, J NEUROL SCI, V340, P117, DOI 10.1016/j.jns.2014.02.039; Huang JQ, 2017, FOOD AGR IMMUNOL, V28, P328, DOI 10.1080/09540105.2016.1272553; Huang XJ, 2015, FOOD RES INT, V72, P168, DOI 10.1016/j.foodres.2015.01.035; Jia D, 2016, SCAND J IMMUNOL, V84, P20, DOI 10.1111/sji.12442; Kumar VP, 2016, J ETHNOPHARMACOL, V186, P280, DOI 10.1016/j.jep.2016.04.006; Liu N, 2018, INT J BIOL MACROMOL, V107, P796, DOI 10.1016/j.ijbiomac.2017.09.051; Meng FX, 2017, SAUDI PHARM J, V25, P460, DOI 10.1016/j.jsps.2017.04.006; Miao MS, 2015, HUM VACC IMMUNOTHER, V11, P2659, DOI 10.1080/21645515.2015.1082694; Oda K, 2014, RESPIR INVESTIG, V52, P179, DOI 10.1016/j.resinv.2013.12.003; Ozbey G, 2014, EUR CYTOKINE NETW, V25, P30, DOI 10.1684/ecn.2014.0353; Qiao DL, 2016, J FOOD SCI, V81, pH1288, DOI 10.1111/1750-3841.13288; Rajasagi NK, 2016, MICROBES INFECT, V18, P735, DOI 10.1016/j.micinf.2016.10.010; Robert P, 2005, J AGR FOOD CHEM, V53, P7014, DOI 10.1021/jf051145y; Robic A, 2009, J APPL PHYCOL, V21, P451, DOI 10.1007/s10811-008-9390-9; Sakthivel KM, 2015, J IMMUNOTOXICOL, V12, P154, DOI 10.3109/1547691X.2014.914988; Shen T, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1344523; Shirani K, 2015, ENVIRON TOXICOL PHAR, V39, P1262, DOI 10.1016/j.etap.2015.04.012; Singh VK, 2016, PHYTOTHER RES, V30, P341, DOI 10.1002/ptr.5514; Suerth JD, 2016, J MOL MED, V94, P83, DOI 10.1007/s00109-015-1327-6; Sun YY, 2016, EXP THER MED, V12, P3773, DOI 10.3892/etm.2016.3840; Tian J, 2012, CARBOHYD POLYM, V90, P1642, DOI 10.1016/j.carbpol.2012.07.044; Wang H, 2011, INT IMMUNOPHARMACOL, V11, P1946, DOI 10.1016/j.intimp.2011.06.006; Wang YJ, 2016, J ETHNOPHARMACOL, V194, P72, DOI 10.1016/j.jep.2016.08.046; Wei H, 2007, APPL MICROBIOL BIOT, V75, P427, DOI 10.1007/s00253-006-0818-3; Wu Y, 2012, CARBOHYD POLYM, V88, P926, DOI 10.1016/j.carbpol.2012.01.035; Xie JH, 2016, J AGR FOOD CHEM, V64, P1291, DOI 10.1021/acs.jafc.5b06177; Yi Y, 2011, MOLECULES, V16, P10324, DOI 10.3390/molecules161210324; Yu Q, 2015, J FUNCT FOODS, V15, P52, DOI 10.1016/j.jff.2015.03.015; Yu Q, 2014, INT J BIOL MACROMOL, V64, P395, DOI 10.1016/j.ijbiomac.2013.12.029; Zheng Y, 2017, INT J BIOL MACROMOL, V95, P1216, DOI 10.1016/j.ijbiomac.2016.11.013; Zhu ZY, 2016, FOOD FUNCT, V7, P3566, DOI 10.1039/c6fo00667a	41	44	46	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0204152	10.1371/journal.pone.0204152	http://dx.doi.org/10.1371/journal.pone.0204152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296293	Green Published, gold, Green Submitted			2022-12-26	WOS:000446632700010
J	Alemao, E; Al, MJ; Boonen, AA; Stevenson, MD; Verstappen, SMM; Michaud, K; Weinblatt, ME; Rutten-van Molken, MPMH				Alemao, Evo; Al, Maiwenn J.; Boonen, Annelies A.; Stevenson, Matthew D.; Verstappen, Suzanne M. M.; Michaud, Kaleb; Weinblatt, Michael E.; Rutten-van Molken, Maureen P. M. H.			Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis	PLOS ONE			English	Article							COLLEGE-OF-RHEUMATOLOGY; RAPID RADIOGRAPHIC PROGRESSION; MODIFYING ANTIRHEUMATIC DRUGS; COST-EFFECTIVENESS ANALYSIS; DISEASE-ACTIVITY; AMERICAN-COLLEGE; TREATMENT STRATEGIES; EXTRAARTICULAR MANIFESTATIONS; METHOTREXATE MONOTHERAPY; SERIOUS INFECTIONS	The objective of this study was to evaluate current approaches to economic modeling in rheumatoid arthritis (RA) and propose a new conceptual model for evaluation of the cost-effectiveness of RA interventions. We followed recommendations from the International Society of Pharmacoeconomics and Outcomes Research-Society of Medical Decision Making (ISPOR-SMDM) Modeling Good Research Practices Task Force-2. The process involved scoping the decision problem by a working group and drafting a preliminary cost-effectiveness model framework. A systematic literature review (SLR) of existing decision-analytic models was performed and analysis of an RA registry was conducted to inform the structure of the draft conceptual model. Finally, an expert panel was convened to seek input on the draft conceptual model. The proposed conceptual model consists of three separate modules: 1) patient characteristic module, 2) treatment module, and 3) outcome module. Consistent with the scope, the conceptual model proposed six changes to current economic models in RA. These changes proposed are to: 1) use composite measures of disease activity to evaluate treatment response as well as disease progression (at least two measures should be considered, one as the base case and one as a sensitivity analysis); 2) conduct utility mapping based on disease activity measures; 3) incorporate subgroups based on guideline-recommended prognostic factors; 4) integrate realistic treatment patterns based on clinical practice/registry datasets; 5) assimilate outcomes that are not joint related (extra-articular outcomes); and 6) assess mortality based on disease activity. We proposed a conceptual model that incorporates the current understanding of clinical and real-world evidence in RA, as well as of existing modeling assumptions. The proposed model framework was reviewed with experts and could serve as a foundation for developing future cost-effectiveness models in RA.	[Alemao, Evo] BMS, Worldwide Hlth Econ & Outcomes Res, Lawrence, NJ 08648 USA; [Alemao, Evo] Erasmus Univ, Rotterdam, Netherlands; [Al, Maiwenn J.; Rutten-van Molken, Maureen P. M. H.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Boonen, Annelies A.] Maastricht Univ, Med Ctr, Div Rheumatol, Dept Internal Med, Maastricht, Netherlands; [Stevenson, Matthew D.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Verstappen, Suzanne M. M.] Univ Manchester, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Epidemiol,Ctr Musculoskeletal, Manchester, Lancs, England; [Michaud, Kaleb] Univ Nebraska Med Ctr, Dept Rheumatol & Immunol, Omaha, NE USA; [Weinblatt, Michael E.] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Rutten-van Molken, Maureen P. M. H.] Erasmus Univ, iMTA, Rotterdam, Netherlands; [Boonen, Annelies A.] Maastricht Univ, Care & Publ Hlth Res Inst, Maastricht, Netherlands; [Verstappen, Suzanne M. M.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England	Erasmus University Rotterdam; Erasmus University Rotterdam; Maastricht University; University of Sheffield; University of Manchester; University of Nebraska System; University of Nebraska Medical Center; Harvard University; Brigham & Women's Hospital; Erasmus University Rotterdam; Maastricht University; Maastricht University Medical Centre (MUMC); University of Manchester	Alemao, E (corresponding author), BMS, Worldwide Hlth Econ & Outcomes Res, Lawrence, NJ 08648 USA.; Alemao, E (corresponding author), Erasmus Univ, Rotterdam, Netherlands.	evo.alemao@bms.com	Molken, Maureen PMH Rutten-van/G-8481-2014; Molken, Maureen Rutten-van/X-8712-2019	Molken, Maureen PMH Rutten-van/0000-0001-8706-3159; Molken, Maureen Rutten-van/0000-0001-8706-3159; , Matt/0000-0002-3099-9877				Alava MH, 2013, RHEUMATOLOGY, V52, P944, DOI 10.1093/rheumatology/kes400; Alemao E, 2018, SEMIN ARTHRITIS RHEU, V47, P630, DOI 10.1016/j.semarthrit.2017.10.009; Alemao E, 2018, VALUE HEALTH, V21, P193, DOI 10.1016/j.jval.2017.05.020; Alemao E, 2017, RHEUMATOLOGY, V56, P777, DOI 10.1093/rheumatology/kew440; Alemao E, 2016, RHEUMATOLOGY, V55, P809, DOI 10.1093/rheumatology/kev427; Alemao E, 2016, ARTHRIT CARE RES, V68, P308, DOI 10.1002/acr.22678; Aletaha D, 2007, BEST PRACT RES CL RH, V21, P663, DOI 10.1016/j.berh.2007.02.004; Allison P.D., 2005, FIXED EFFECTS REGRES; Barnabe C, 2011, ARTHRIT CARE RES, V63, P522, DOI 10.1002/acr.20371; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Brennan A, 2007, RHEUMATOLOGY, V46, P1345, DOI 10.1093/rheumatology/kem115; Bruce B, 2003, J RHEUMATOL, V30, P167; Davies A, 2009, J RHEUMATOL, V36, P16, DOI 10.3899/jrheum.080257; de Jong PHP, 2016, RHEUMATOLOGY, V55, P2138, DOI 10.1093/rheumatology/kew321; Emery P, 2015, ANN RHEUM DIS, V74, P19, DOI 10.1136/annrheumdis-2014-206106; Eriksson JK, 2015, ANN RHEUM DIS, V74, P1094, DOI 10.1136/annrheumdis-2013-205060; Feldmann M, 2015, ARTHRITIS RHEUMATOL, V67, P2283, DOI 10.1002/art.39269; Felson D, 2007, ARTHRIT RHEUM-ARTHR, V57, P193, DOI 10.1002/art.22552; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Finckh A, 2009, ANN INTERN MED, V151, P612, DOI 10.7326/0003-4819-151-9-200911030-00006; Gaujoux-Viala C, 2012, JOINT BONE SPINE, V79, P149, DOI 10.1016/j.jbspin.2011.04.008; Geryk LL, 2015, CLIN EXP RHEUMATOL, V33, P366; Gibson L, 2018, PROGR DIS PEOPLE RHE; Gissel C, 2016, Z RHEUMATOL, V75, P1006, DOI 10.1007/s00393-016-0071-9; Gottenberg JE, 2016, ARTHRITIS RHEUMATOL, V68, P1346, DOI 10.1002/art.39595; Hallinen TA, 2010, RHEUMATOLOGY, V49, P767, DOI 10.1093/rheumatology/kep425; Harrold LR, 2016, ANN RHEUM DIS, V75, P505, DOI 10.1136/annrheumdis-2016-eular.1514; Hochberg MC, 2008, CURR MED RES OPIN, V24, P469, DOI [10.1185/030079908X261177, 10.1185/030079908X261177 ]; Jonsson B, 2008, EUR J HEALTH ECON, V8, pS61, DOI 10.1007/s10198-007-0089-7; Kang EH, 2017, ANN RHEUM DIS, V76, P802, DOI 10.1136/annrheumdis-2017-eular.2407; Kelly CA, 2014, RHEUMATOLOGY, V53, P1676, DOI 10.1093/rheumatology/keu165; Kielhorn A, 2008, CURR MED RES OPIN, V24, P2639, DOI [10.1185/03007990802321683, 10.1185/03007990802321683 ]; Kievit W, 2016, ANN RHEUM DIS, V75, P1939, DOI 10.1136/annrheumdis-2015-208317; Kirchhoff T, 2011, RHEUMATOLOGY, V50, P756, DOI 10.1093/rheumatology/keq398; Klarenbeek NB, 2011, ANN RHEUM DIS, V70, P1815, DOI 10.1136/ard.2010.149260; Kobelt G, 1999, ARTHRITIS RHEUM-US, V42, P347, DOI 10.1002/1529-0131(199902)42:2<347::AID-ANR18>3.0.CO;2-P; Kobelt G, 2003, RHEUMATOLOGY, V42, P326, DOI 10.1093/rheumatology/keg107; Kobelt G, 2009, SCAND J RHEUMATOL, V38, P409, DOI 10.3109/03009740902865464; Kobelt G, 2011, INT J TECHNOL ASSESS, V27, P193, DOI 10.1017/S0266462311000195; Kubo S, 2016, ANN RHEUM DIS, V75, P1321, DOI 10.1136/annrheumdis-2015-207784; Lekander I, 2010, INT J TECHNOL ASSESS, V26, P54, DOI 10.1017/S0266462309990596; Madan J, 2015, RHEUMATOL THER, V2, P113, DOI 10.1007/s40744-015-0020-0; Manders SHM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0630-5; Meissner Y, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1077-z; Mennini FS, 2017, CLIN DRUG INVEST, V37, P375, DOI 10.1007/s40261-016-0491-y; Merkesdal S, 2010, EUR J HEALTH ECON, V11, P95, DOI 10.1007/s10198-009-0205-y; Michaud K, 2003, ARTHRITIS RHEUM-US, V48, P2750, DOI 10.1002/art.11439; Moghadam MG, 2016, ARTHRITIS RHEUMATOL, V68, P1810, DOI 10.1002/art.39626; Nam JL, 2017, ANN RHEUM DIS, V76, P1108, DOI 10.1136/annrheumdis-2016-210713; Nikiphorou E, 2012, RHEUMATOLOGY, V51, P385, DOI 10.1093/rheumatology/ker401; Ollendorf Daniel A, 2005, J Manag Care Pharm, V11, P383; Ollendorf DA, 2009, CLIN THER, V31, P825, DOI 10.1016/j.clinthera.2009.04.002; Prete M, 2011, AUTOIMMUN REV, V11, P123, DOI 10.1016/j.autrev.2011.09.001; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Putrik P, 2014, ANN RHEUM DIS, V73, P198, DOI 10.1136/annrheumdis-2012-202603; Roberts M, 2012, MED DECIS MAKING, V32, P678, DOI [10.1177/0272989X12454941, 10.1016/j.jval.2012.06.016]; Russell A, 2009, CLIN RHEUMATOL, V28, P403, DOI 10.1007/s10067-008-1060-4; Ruyssen-Witrand A, 2010, JOINT BONE SPINE, V77, P246, DOI 10.1016/j.jbspin.2010.02.009; Sacks JJ, 2010, ARTHRIT CARE RES, V62, P460, DOI 10.1002/acr.20041; Saraux A, 2010, RHEUMATOLOGY, V49, P733, DOI 10.1093/rheumatology/kep434; Schett G, 2016, ANN RHEUM DIS, V75, P1428, DOI 10.1136/annrheumdis-2016-209201; Schipper LG, 2011, RHEUMATOLOGY, V50, P1320, DOI 10.1093/rheumatology/ker084; Schoels M, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1346-5; Scholz S, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0018-2; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Silman A., 2001, EPIDEMIOLOGY RHEUMAT, V2nd; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smolen JS, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2017-211455; Smolen JS, 2013, LANCET, V381, P918, DOI 10.1016/S0140-6736(12)61811-X; Spalding JR, 2006, PHARMACOECONOMICS, V24, P1221, DOI 10.2165/00019053-200624120-00006; Stephens S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006560; Stevenson MD, 2017, J RHEUMATOL, V44, P973, DOI 10.3899/jrheum.160941; Syversen SW, 2008, ANN RHEUM DIS, V67, P212, DOI 10.1136/ard.2006.068247; Tanaka E, 2015, MOD RHEUMATOL, V25, P503, DOI 10.3109/14397595.2014.1001475; Tanno Makoto, 2006, Mod Rheumatol, V16, P77; Taylor PC, 2015, ARTHRITIS RHEUMATOL, V67, P14, DOI 10.1002/art.38893; Turesson C, 2006, ANN RHEUM DIS, V65, P1533, DOI 10.1136/ard.2006.052803; Uhlig T, 2007, J RHEUMATOL, V34, P1241; Valle-Mercado C, 2013, RHEUMATOL INT, V33, P2993, DOI 10.1007/s00296-013-2834-9; van den Hoek J, 2017, RHEUMATOL INT, V37, P487, DOI 10.1007/s00296-016-3638-5; van Haalen HGM, 2014, PHARMACOECONOMICS, V32, P429, DOI 10.1007/s40273-014-0139-9; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Vastesaeger N, 2009, RHEUMATOLOGY, V48, P1114, DOI 10.1093/rheumatology/kep155; Vencovsky J, 2003, ANN RHEUM DIS, V62, P427, DOI 10.1136/ard.62.5.427; Vera-Llonch M, 2008, J RHEUMATOL, V35, P1745; Verhoef LM, 2017, RHEUMATOL THER, V4, P1, DOI 10.1007/s40744-017-0055-5; Vermeer M, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-350; Visser K, 2010, ANN RHEUM DIS, V69, P1333, DOI 10.1136/ard.2009.121160; Wailoo AJ, 2008, ARTHRITIS RHEUM-US, V58, P939, DOI 10.1002/art.23374; Widdifield J, 2013, ARTHRIT CARE RES, V65, P353, DOI 10.1002/acr.21812; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yuan Yong, 2010, J Med Econ, V13, P33, DOI 10.3111/13696990903508021	93	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205013	10.1371/journal.pone.0205013	http://dx.doi.org/10.1371/journal.pone.0205013			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289926	Green Published, gold, Green Accepted			2022-12-26	WOS:000446545500039
J	Naha, D; Sathyakumar, S; Rawat, GS				Naha, Dipanjan; Sathyakumar, S.; Rawat, G. S.			Understanding drivers of human-leopard conflicts in the Indian Himalayan region: Spatio-temporal patterns of conflicts and perception of local communities towards conserving large carnivores	PLOS ONE			English	Article								Human killing is the decisive and most critical expression of human-leopard conflict and needs to be addressed sensitively to maintain local support for leopard conservation in India. This research was undertaken to investigate the ecological aspects of human killing and injury, spatial characteristic and pattern of such sites, temporal and seasonal trends of attacks and perception of local communities towards leopard in the Indian Himalayan region (IHR). We surveyed two sites i) Pauri Garhwal in the western part and ii) North Bengal (Dooars) in the eastern part of IHR, compiled secondary data on human-leopard conflict records and made field visits to (N = 101) conflict sites. We also conducted (N = 186) semi-structured questionnaire surveys in each of the sites to assess perception of local communities towards leopard. We analyzed the conflict data using rare events model in a binary logistic regression framework to understand spatial patterns of such incidents for Pauri Garhwal and North Bengal. The average number of injuries and deaths to leopard attacks in Pauri was estimated to be 11 (SE 1.13) and 3 (SE 0.6) per year between 2006-2016 whereas in North Bengal it was estimated to be 70 (SE 9.2) and 1.6 (SE 0.3) respectively between 2004-2016. About 97% of the leopard attacks in North Bengal and 60% of the leopard attacks in Pauri resulted in human injuries. Majority of the leopard attack victims in Pauri were children and young people, whereas in North Bengal it was middle aged tea estate workers. Attack on humans in Pauri were recorded mostly near areas with dense scrub cover whereas in North Bengal it was reported within tea-estates. The percentage of human deaths to leopard attacks in Pauri were higher (40%) compared to a mere (3%) in North Bengal. Forty-one percent of respondents in Pauri and 75% in North Bengal were positive towards presence and conservation of leopard. A predictive risk map revealed central and northern regions of Pauri Garhwal and protected areas, peripheral areas in central and south-western dooars (North Bengal) as high "human-leopard conflict risk zones". This analytical procedure can be adopted in other sites to identify potential human-carnivore conflict risk zones.	[Naha, Dipanjan; Sathyakumar, S.] Wildlife Inst India, Dept Endangered Species Management, Dehra Dun, Uttarakhand, India; [Rawat, G. S.] Wildlife Inst India, Dehra Dun, Uttarakhand, India	Wildlife Institute of India; Wildlife Institute of India	Sathyakumar, S (corresponding author), Wildlife Inst India, Dept Endangered Species Management, Dehra Dun, Uttarakhand, India.	ssk@wii.gov.in		SATHYAKUMAR, SAMBANDAM/0000-0003-2027-4706	Ministry of Environment, Forest and Climate Change, Government of India under the National Mission on Himalayan Studies [NMHS/LG-2016/009/8510-2]	Ministry of Environment, Forest and Climate Change, Government of India under the National Mission on Himalayan Studies	This study was funded by the Ministry of Environment, Forest and Climate Change, Government of India under the National Mission on Himalayan Studies NMHS/LG-2016/009/8510-2. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161717; Agarwal M, 2011, INT J SCI ENG RES, V9; Anand Shaurabh, 2017, Journal of Asia-Pacific Biodiversity, V10, P154; Anderson CR, 2005, WILDLIFE SOC B, V33, P179, DOI 10.2193/0091-7648(2005)33[179:EEOPTA]2.0.CO;2; Athreya V, 2007, J BOMBAY NATURAL HIS, V98, P267; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Banerjee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049457; Bath AJ, 1987, THESIS; Bernard HR, 1995, SOCIAL RES METHODS Q; Bhatia S, 2016, HUMAN DIMENSIONS WIL, V22, P30; Bhattacharjee Anushree, 2013, Human Dimensions of Wildlife, V18, P20, DOI 10.1080/10871209.2012.698403; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carter NH, 2012, ORYX, V46, P525, DOI 10.1017/S0030605312000245; Champion H. G., 1968, REVISED SURVEY FORES, P404; Chatterjee Piya, 2001, TIME TEA WOMEN LABOR; Choirat C, 2017, RARE EVENTS LOGISTIC; Corbett, 1991, J CORBETT OMNIBUS MA; Daly B, 2005, P WORKSH CONS BREDD; Doubleday KF, 2018, SOC ANIM, V26, P148, DOI 10.1163/15685306-12341498; Dutta T, 2016, REG ENVIRON CHANGE, V16, P53, DOI 10.1007/s10113-015-0877-z; Edgaonar A, 1998, PRELIMINARY STUDY EC; Femke Broekhuis, 2017, ECOLOGY EVOLUTION, DOI [10.1002/ece3.3565, DOI 10.1002/ECE3.3565]; Fick S. E., 2017, INT J CLIMATOLOGY; Forest Survey of India, 2017, FOR TREE RES STAT UN; Gaba KM, 2016, 20 YEARS INDIA LIGHT; Gangopadhay S, 2017, THESIS; Garcia KC, 2016, URSUS, V27, P5, DOI 10.2192/URSUS-D-15-00012.1; Ghosal S, 2015, SOC NATUR RESOUR, V28, P1092, DOI 10.1080/08941920.2015.1014597; Goyal S. P., 2007, STATUS ECOLOGY LEOPA; Goyal S. P., 2000, STUDY DISTRIBUTION R; Gubbi S, 2016, ORYX, V50, P336, DOI 10.1017/S0030605314000751; Guha Abhijit, 2000, Journal of Human Ecology, V11, P471; Guha Ramachandra, 2007, INDIA GANDHI HIST WO; Gurung B, 2008, J BIOL CONSERVATION, DOI [10.1017/S0030605316001587, DOI 10.1017/S0030605316001587]; Habib B, 2014, ECOLOGY LEOPARD PAN; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Inskip C, 2013, HUM ECOL, V41, P169, DOI 10.1007/s10745-012-9556-6; Jhamvar-Shingote Ramaa, 2013, Human Dimensions of Wildlife, V18, P32, DOI 10.1080/10871209.2012.694578; Kansky R, 2014, BIOL CONSERV, V179, P93, DOI 10.1016/j.biocon.2014.09.008; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; Kaushik M, 2015, MANAGEMENT HUMAN WIL; Kshettry A, 2018, TROP CONSERV SCI, V11, DOI 10.1177/1940082918764635; Kshettry A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177013; Kumar D., 2011, THESIS; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; Lumley T, 2006, RELATIVE RISK REGRES; Madden F, 2014, BIOL CONSERV, V178, P97, DOI 10.1016/j.biocon.2014.07.015; Mamgain PR, 2015, OUTMIGRATION HILL RE; Mathur N, 2014, J ROY ANTHROPOL INST, V20, P148, DOI 10.1111/1467-9655.12098; Miller JB, 2015, BIODIVERS CONSERV, DOI [10.1002/ece3.1440, DOI 10.1002/ECE3.1440]; Miller JRB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162685; Naha D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152119; Nyhus PJ, 2004, ORYX, V38, P68, DOI 10.1017/S0030605304000110; Odden M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112044; OLI MK, 1994, BIOL CONSERV, V68, P63, DOI 10.1016/0006-3207(94)90547-9; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Peebles KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079713; Ramakrishnan U, 1999, BIOL CONSERV, V89, P113, DOI 10.1016/S0006-3207(98)00159-1; Ramkumar K., 2018, INDIAN HOTSPOTS, P359, DOI [10.1007/978-981-10-6605-4_18, DOI 10.1007/978-981-10-6605-4_18]; Rangarajan M., 2006, INDIAS WILDLIFE HIST; Redpath SM, 2015, ORYX, V49, P222, DOI 10.1017/S0030605314000799; Rodgers WA, 1998, PLANNING PROTECTED A, V1; Rodriguez E, 2006, PHOTOGRAMMETRIC ENG; SABERWAL VK, 1994, CONSERV BIOL, V8, P501, DOI 10.1046/j.1523-1739.1994.08020501.x; Sankar K, 2002, MAMMALIA, V66, P285, DOI 10.1515/mamm.2002.66.2.285; Technology Outreach Services D ITOS D University of Georgia, 2013, GLOB ROADS OP ACC DA; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; Wegge P., 2016, ORYX, P1; Wielgus RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113505; Wilson S, 2015, ORYX, V49, P140, DOI 10.1017/S0030605313000513; Zar JH., 2010, BIOSTAT ANAL, V5th; Zarco-Gonzalez MM, 2013, BIOL CONSERV, DOI [10.1007/s10745-012-9505-4, DOI 10.1007/S10745-012-9505-4]; Zedrosser A, 2011, BIOL CONSERV, V144, P2163, DOI 10.1016/j.biocon.2011.05.005	74	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204528	10.1371/journal.pone.0204528	http://dx.doi.org/10.1371/journal.pone.0204528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289908	gold, Green Published, Green Submitted			2022-12-26	WOS:000446545500017
J	Sheen, M; Yekani, HAK; Jordan, TR				Sheen, Mercedes; Yekani, Hajar Aman Key; Jordan, Timothy R.			Investigating the effect of wearing the hijab: Perception of facial attractiveness by Emirati Muslim women living in their native Muslim country	PLOS ONE			English	Article							BIAS; PREFERENCES; FACES	The Hijab and other forms of Islamic veiling are important social, cultural, and religious symbols that are central to the identity of millions of Muslim women across the world. However, despite the large body of literature that exists on the political and socio-cultural aspects of Islamic veiling, little is known about how the appearance of women wearing the hijab is perceived by other Muslim women within their native Muslim country. To throw light on this important issue, the current study focussed on the effects of the hijab on female facial attractiveness perceived by practising Muslim Emirati women living in their native Muslim country (the United Arab Emirates) who themselves wore the hijab as everyday attire. Participants were shown frontal-head images of women in three different conditions: covered (heads fully covered by the hijab except for the face), partially covered (heads fully covered by the hijab except for the face and the hair around the forehead) and uncovered (heads with no covering). The findings showed that faces in images where heads were covered and partially covered by the hijab were rated as equally attractive but both were rated as significantly less attractive than faces in images where heads were uncovered. These findings suggest that, even for practising Muslim Emirati females living in their native Muslim country for whom wearing the hijab is a normal aspect of everyday life, perception of facial attractiveness is compromised by wearing this garment. We argue that this effect of wearing the hijab is not consistent with a preference for one's own cultural group (cultural endogamy) and may, instead, occur because wearing a hijab occludes external features, such as hair and ears, which normally contribute to the perception of human facial attractiveness. In sum, while wearing the hijab may be dominated by male attitudes towards suppressing female attractiveness towards males, the findings from this study suggest that female Muslims too perceive the negative influence of wearing the hijab on female facial attractiveness.	[Sheen, Mercedes; Yekani, Hajar Aman Key] Zayed Univ, Dept Psychol, Dubai, U Arab Emirates; [Jordan, Timothy R.] Middle East Tech Univ, Dept Psychol, Northern Cyprus Campus, Kapouti, Northern Cyprus, Turkey	Zayed University; Middle East Technical University	Jordan, TR (corresponding author), Middle East Tech Univ, Dept Psychol, Northern Cyprus Campus, Kapouti, Northern Cyprus, Turkey.	ProfTimJordan@gmail.com		Aman key yekani, Hajar/0000-0002-5083-9774	RIF grant by Zayed University	RIF grant by Zayed University	This work was a supported by a RIF grant awarded to Tim Jordan by Zayed University.	Ahmed L., 1992, WOMEN GENDER ISLAM H; Allen C., 2013, EXPERIENCE IMPACT AN; Allen P, 2010, DAILY MAIL; Allen P, 2009, DAILY MAIL; BAILEY IL, 1980, AM J OPTOM PHYS OPT, V57, P378; Bereczkei T., 2006, REV PSYCHOL, V13, P35; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Buss DM, 1998, HANDBOOK OF EVOLUTIONARY PSYCHOLOGY, P405; Chan JPK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00087; Dijkstra W, 2001, QUAL QUANT, V35, P107, DOI 10.1023/A:1004816210439; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; El Guindi Fadwa., 1999, FASH THEORY, V3, P51, DOI [10.2752/136270499779165626, DOI 10.2752/136270499779165626]; Everett JAC, 2015, J APPL SOC PSYCHOL, V45, P90, DOI 10.1111/jasp.12278; Favelle S, 2015, VISION RES, V112, P26, DOI 10.1016/j.visres.2015.05.002; Hydock C, 2018, BEHAV RES METHODS, V50, P1563, DOI 10.3758/s13428-017-0984-5; Jordan TR, 2011, PERCEPTION, V40, P873, DOI 10.1068/p6940; Koenig HG, 2010, RELIGIONS, V1, P78, DOI 10.3390/rel1010078; Kramer RSS, 2010, Q J EXP PSYCHOL, V63, P2273, DOI 10.1080/17470211003770912; Little AC, 2003, P ROY SOC B-BIOL SCI, V270, P1759, DOI 10.1098/rspb.2003.2445; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; LIU JH, 1995, EUR J SOC PSYCHOL, V25, P95, DOI 10.1002/ejsp.2420250108; Mahmud Y, 2010, BODY IMAGE, V7, P90, DOI 10.1016/j.bodyim.2009.09.003; Maitner AT, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00703; Merton RK, 1948, ANTIOCH REV, V8, P193, DOI DOI 10.2307/4609267; Mesko N, 2004, HUM NATURE-INT BIOS, V15, P251, DOI 10.1007/s12110-004-1008-6; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Pasha-Zaidi N, 2015, J INT WOMENS STUDIES, V16, P29; Pazhoohi F, 2017, EVOL PSYCHOL SCI, V3, P118, DOI DOI 10.1007/S40806-016-0079-Z; Pazhoohi F, 2014, ARCH SEX BEHAV, V43, P1083, DOI 10.1007/s10508-014-0259-5; PERRETT DI, 1994, NATURE, V368, P239, DOI 10.1038/368239a0; Sheridan LP, 2006, J INTERPERS VIOLENCE, V21, P317, DOI 10.1177/0886260505282885; Swami V, 2012, PSYCHOL WOMEN DIVERS, P128; Taubert J, 2011, VISION RES, V51, P1273, DOI 10.1016/j.visres.2011.04.002; Toseeb U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084754; Toseeb U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034144; Trujillo L, 2014, COGN AFFECT BEHAV NE, V14, P1061, DOI 10.3758/s13415-013-0230-2; Unkelbach C, 2008, J EXP SOC PSYCHOL, V44, P1409, DOI 10.1016/j.jesp.2008.04.003; Unkelbach C, 2010, SOC PSYCHOL PERS SCI, V1, P378, DOI 10.1177/1948550610378381; Wang Y, 2015, PERCEPTION, V44, P328, DOI 10.1068/p7940	40	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0199537	10.1371/journal.pone.0199537	http://dx.doi.org/10.1371/journal.pone.0199537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289895	Green Submitted, Green Published, gold			2022-12-26	WOS:000446545500002
J	Sudirman, S; Hsu, YH; He, JL; Kong, ZL				Sudirman, Sabri; Hsu, Yuan-Hua; He, Jia-Ling; Kong, Zwe-Ling			Dietary polysaccharide-rich extract from Eucheuma cottonii modulates the inflammatory response and suppresses colonic injury on dextran sulfate sodium-induced colitis in mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; KAPPAPHYCUS-ALVAREZII; COLORIMETRIC DETERMINATION; MARINE-ALGAE; FIBER; SEAWEEDS; DISEASE; TUMOR; HOST; 3,6-ANHYDROGALACTOSE	Inflammatory bowel disease (IBD) is a known medical burden in most developed countries and a significant cause of morbidity. The IBD label includes Crohn's disease (CD) and ulcerative colitis (UC). Pharmacological and surgical intervention are the two main management approaches for IBD. Some drugs have been developed for IBD therapy, but accessibility is limited due to high costs. Furthermore, these agents have demonstrated inactivity over long-term treatment courses. Therefore, an urgent need is present for new treatment options that are safe, able to sustain clinical remission, and improve mucosal gut healing. Seaweed has received much attention in the pharmacological field owing to its various biomedical properties, including the prolongation of blood clotting time, as well as antitumor, anti-inflammation, and antioxidant effects. This study therefore aimed to examine the effects of a dietary polysaccharide-rich extract obtained from Eucheuma cottonii (EC) on a model of colitis. Colitis was induced in male BALB/c mice by the administration of 2.5% (w/v) dextran sulfate sodium (DSS) for 7 days. DSS-induced mice were treated with either one of three different doses of EC extracts (0.35, 0.70, and 1.75 g/kg body weight) or curcumin as a positive control (0.10 g/kg). Mice were sacrificed post-treatment and blood samples were collected. The disease activity index (DAI) and inflammatory cytokine levels (tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6, IL-10) were measured. After treatment for 7 days, EC extract administration protected against weight loss and decreased the colon weight per length ratio. EC extract administration also decreased pro-inflammatory cytokine expression, increased IL-10 levels, and reduced colonic damage. Therefore, a dietary polysaccharide-rich extract from E. cottonii reduced DSS-induced bowel inflammation, thereby becoming a promising candidate for the treatment of colitis.	[Sudirman, Sabri; Hsu, Yuan-Hua; He, Jia-Ling; Kong, Zwe-Ling] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan	National Taiwan Ocean University	Kong, ZL (corresponding author), Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan.	kongzl@mail.ntou.edu.tw	Kong, Zwe-Ling/E-8763-2013; Kong, Zwe-Ling/AAB-5328-2019; Sudirman, Sabri/O-2980-2018; Kong, Zwe-Ling/AAB-5261-2019	Kong, Zwe-Ling/0000-0002-4877-6524; Kong, Zwe-Ling/0000-0002-4877-6524; Sudirman, Sabri/0000-0003-2821-3772; He, Jia-Ling/0000-0002-1194-2533				Abdelali A, 2016, TOXICOL APPL PHARM, V311, P61, DOI 10.1016/j.taap.2016.09.023; Abu Bakar N, 2015, J FUNCT FOODS, V19, P710, DOI 10.1016/j.jff.2015.10.011; Arafa HMM, 2009, FOOD CHEM TOXICOL, V47, P1311, DOI 10.1016/j.fct.2009.03.003; Bakar Nurul'Ain Abu, 2017, J Microsc Ultrastruct, V5, P70, DOI 10.1016/j.jmau.2016.08.001; Barbalho SM, 2018, J MED FOOD, V21, P633, DOI 10.1089/jmf.2017.0120; Bitencourt MAO, 2015, REV BRAS FARMACOGN, V25, P677, DOI 10.1016/j.bjp.2015.10.001; da Matta CBB, 2011, MAR DRUGS, V9, P307, DOI 10.3390/md9030307; Brito TV, 2016, CARBOHYD POLYM, V151, P957, DOI 10.1016/j.carbpol.2016.06.047; Brumatti LV, 2014, MOLECULES, V19, P21127, DOI 10.3390/molecules191221127; Campo VL, 2009, CARBOHYD POLYM, V77, P167, DOI 10.1016/j.carbpol.2009.01.020; Chang VS, 2017, BIOMED PHARMACOTHER, V87, P296, DOI 10.1016/j.biopha.2016.12.092; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Cho EJ, 2011, J ETHNOPHARMACOL, V136, P428, DOI 10.1016/j.jep.2010.04.047; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; D'Orazio N, 2012, MAR DRUGS, V10, P812, DOI 10.3390/md10040812; de Souza ET, 2009, MAR DRUGS, V7, P689, DOI 10.3390/md7040689; Dhingra D, 2012, J FOOD SCI TECH MYS, V49, P255, DOI 10.1007/s13197-011-0365-5; Fard SG, 2011, J ANIM VET ADV, V10, P601, DOI 10.3923/javaa.2011.601.605; Fayaz M, 2005, J AGR FOOD CHEM, V53, P792, DOI 10.1021/jf0493627; Galvez J, 2005, MOL NUTR FOOD RES, V49, P601, DOI 10.1002/mnfr.200500013; Ghani NAA, 2019, ARAB J CHEM, V12, P370, DOI 10.1016/j.arabjc.2018.06.008; Gomez-Ordonez E, 2010, FOOD RES INT, V43, P2289, DOI 10.1016/j.foodres.2010.08.005; Gommeaux J, 2007, MOL CELL BIOL, V27, P2215, DOI 10.1128/MCB.01454-06; Hamamoto N, 1999, CLIN EXP IMMUNOL, V117, P462; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Hwang Eun-Sun, 2014, Prev Nutr Food Sci, V19, P40, DOI 10.3746/pnf.2014.19.1.040; Ilott NE, 2016, ISME J, V10, P2389, DOI 10.1038/ismej.2016.40; Jeon YD, 2016, MOLECULES, V21, DOI 10.3390/molecules21040523; Jimenez-Escrig A, 2000, NUTR RES, V20, P585, DOI 10.1016/S0271-5317(00)00149-4; Kai Y, 2005, GASTROENTEROLOGY, V128, P922, DOI 10.1053/j.gastro.2005.01.013; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; KIM DB, 2013, EVID-BASED COMPL ALT, DOI DOI 10.1155/2013/671281; Kim SJ, 2010, MOLECULES, V15, P7208, DOI 10.3390/molecules15107208; Kitajima S, 2000, EXP ANIM TOKYO, V49, P9, DOI 10.1538/expanim.49.9; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kumar KS, 2008, FOOD CHEM, V107, P289, DOI 10.1016/j.foodchem.2007.08.016; Lean QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128453; Lee J, 2017, ANN PHARM PHARM, V2, P1056; Li MC, 2004, WORLD J GASTROENTERO, V10, P620, DOI 10.3748/wjg.v10.i5.620; Liang WA, 2014, CARBOHYD POLYM, V101, P776, DOI 10.1016/j.carbpol.2013.10.010; Lim C.L., 2015, J MED BIOENG, V4, P461, DOI [10.12720/jomb.4.6.461-465, DOI 10.12720/JOMB.4.6.461-465]; Makki K, 2018, CELL HOST MICROBE, V23, P705, DOI 10.1016/j.chom.2018.05.012; Matanjun P, 2008, J APPL PHYCOL, V20, P367, DOI 10.1007/s10811-007-9264-6; MATSUHIRO B, 1983, CARBOHYD RES, V118, P276, DOI 10.1016/0008-6215(83)88056-2; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Myers KJ, 2003, J PHARMACOL EXP THER, V304, P411, DOI 10.1124/jpet.102.040329; Namvar F, 2014, INDIAN J CLIN BIOCHE, V29, P13, DOI 10.1007/s12291-013-0313-4; Namvar F, 2012, FOOD CHEM, V130, P376, DOI 10.1016/j.foodchem.2011.07.054; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Park Yo Han, 2015, J Cancer Prev, V20, P260, DOI 10.15430/JCP.2015.20.4.260; Pugliese D, 2017, EXPERT REV CLIN IMMU, V13, P223, DOI 10.1080/1744666X.2017.1243468; Raman M, 2015, J FUNCT FOODS, V15, P354, DOI 10.1016/j.jff.2015.03.037; Randhawa PK, 2014, KOREAN J PHYSIOL PHA, V18, P279, DOI 10.4196/kjpp.2014.18.4.279; Rodriguez-Cabezas ME, 2002, J NUTR, V132, P3263, DOI 10.1093/jn/132.11.3263; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Shamsabadi FT, 2013, NUTR CANCER, V65, P255, DOI 10.1080/01635581.2013.756528; Soriano A, 2000, LAB INVEST, V80, P1541, DOI 10.1038/labinvest.3780164; Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011; Torres FAE, 2014, REV BRAS FARMACOGN, V24, P265, DOI 10.1016/j.bjp.2014.07.001; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Ung VYL, 2010, DIGEST DIS SCI, V55, P1272, DOI 10.1007/s10620-009-0843-z; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Wanyonyi S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111261; Yang Joon-Yeop, 2013, J Cancer Prev, V18, P186; YAPHE W, 1960, ANAL CHEM, V32, P1327, DOI 10.1021/ac60166a030	65	25	25	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205252	10.1371/journal.pone.0205252	http://dx.doi.org/10.1371/journal.pone.0205252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289911	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500059
J	Zante, B; Reichenspurner, H; Kubik, M; Kluge, S; Schefold, JC; Pfortmueller, CA				Zante, Bjoern; Reichenspurner, Hermann; Kubik, Mathias; Kluge, Stefan; Schefold, Joerg C.; Pfortmueller, Carmen A.			Base excess is superior to lactate-levels in prediction of ICU mortality after cardiac surgery	PLOS ONE			English	Article							LENGTH-OF-STAY; CARDIOPULMONARY BYPASS; SERUM LACTATE; CRITICAL ILLNESS; DEFICIT; HYPERLACTATEMIA; ACIDOSIS; TRAUMA; RISK; COMPLICATIONS	Introduction Cardiac surgery with the use of cardiopulmonary bypass is known to induce distinct metabolic changes. Respective changes in acid-base status including increased systemic lactate levels were previously related to clinical outcomes, but data remain controversial. Therefore, we aim to investigate the relevance of lactate and base excess (BE) levels on ICU-mortality in patients admitted to the ICU after cardiac surgery. Materials and methods Perioperative data of patients treated in a tertiary care academic center admitted to the ICU after on-pump surgery were analyzed in a retrospective fashion. Receiver operation characteristic (ROC) curves were constructed for admission lactate-levels and BE with calculation of optimal cut-off values to predict ICU mortality. Univariate followed by multivariate regression models were constructed to identify potential outcome-relevant indices. Results Data from 1,058 patients were included in the analysis. Area under the curves for prediction of ICU mortality were 0.79 for lactate levels at ICU admission (sensitivity 61.9%/specificity 87.5%; optimal cut-off level 3.9mmol/l), and 0.7 for BE (sensitivity 52.4%/specificity 93.8%, optimal cut-off level -6.7), respectively. Multivariate regression identified BE < -6.7 as the single metabolic predictor of ICU-mortality (HR 4.78, 95%-CI 1.4 +/- 16.33, p = 0.01). Explorative subgroup analyses revealed that the combination of lactate <= 3.9mmol/l and BE <= -6.7 has stronger impact on mortality than a combination of lactate of >3.9mmol/l and BE > -6.7 (HR 2.56, 95%-CI 0.18 +/- 37.17). Conclusions At ICU-admission, severely reduced BE appears superior to hyperlactatemia with regard to prediction of ICU-mortality in patients after cardiac surgery.	[Zante, Bjoern; Schefold, Joerg C.; Pfortmueller, Carmen A.] Univ Bern, Bern Univ Hosp, Dept Intens Care Med, Inselspital, Bern, Switzerland; [Zante, Bjoern; Reichenspurner, Hermann; Kubik, Mathias] Univ Heart Ctr Hamburg, Dept Cardiovasc Surg, Hamburg, Germany; [Kubik, Mathias; Kluge, Stefan] Univ Med Ctr Hamburg Eppendorf, Ctr Anesthesiol & Intens Care Med, Dept Intens Care Med, Hamburg, Germany	University of Bern; University Hospital of Bern; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Zante, B (corresponding author), Univ Bern, Bern Univ Hosp, Dept Intens Care Med, Inselspital, Bern, Switzerland.; Zante, B (corresponding author), Univ Heart Ctr Hamburg, Dept Cardiovasc Surg, Hamburg, Germany.	bjoern.zante@insel.ch		Pfortmueller, Carmen/0000-0003-0326-2770; Schefold, Joerg C./0000-0001-9162-5724				Andersen LW, 2015, J CARDIOTHOR VASC AN, V29, P1454, DOI 10.1053/j.jvca.2015.06.007; BRODER G, 1964, SCIENCE, V143, P1457, DOI 10.1126/science.143.3613.1457; Chawla LS, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-18; Chawla Lakhmir S, 2008, J Intensive Care Med, V23, P122, DOI 10.1177/0885066607312985; Davis JW, 2018, AM J SURG, V215, P682, DOI 10.1016/j.amjsurg.2018.01.025; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; De Backer D, 2009, ANN THORAC SURG, V88, P1396, DOI 10.1016/j.athoracsur.2009.07.002; Gale SC, 2016, J SURG RES, V205, P446, DOI 10.1016/j.jss.2016.06.103; Haas SA, 2016, INTENS CARE MED, V42, P202, DOI 10.1007/s00134-015-4127-0; Hajjar LA, 2013, J THORAC CARDIOV SUR, V146, P455, DOI 10.1016/j.jtcvs.2013.02.003; Hatherill M, 2005, ARCH DIS CHILD, V90, P1288, DOI 10.1136/adc.2005.078006; Hayhoe M, 1999, INTENS CARE MED, V25, P680, DOI 10.1007/s001340050930; Hugot P, 2003, INTENS CARE MED, V29, P257, DOI 10.1007/s00134-002-1587-9; Husain FA, 2003, AM J SURG, V185, P485, DOI 10.1016/S0002-9610(03)00044-8; Ibrahim I, 2016, AM J EMERG MED, V34, P626, DOI 10.1016/j.ajem.2015.12.012; Inoue S, 2001, EUR J ANAESTH, V18, P576, DOI 10.1046/j.1365-2346.2001.00893.x; Jakob SM, 2010, NUTRITION, V26, P349, DOI 10.1016/j.nut.2009.07.014; Jeng JC, 2002, BURNS, V28, P161, DOI 10.1016/S0305-4179(01)00098-5; Lopez-Delgado JC, 2015, J CARDIOTHOR VASC AN, V29, P1441, DOI 10.1053/j.jvca.2015.04.024; Maillet JM, 2003, CHEST, V123, P1361, DOI 10.1378/chest.123.5.1361; Martin MJ, DISCORDANCE LACTATE; Mustafa I, 2003, INTENS CARE MED, V29, P1279, DOI 10.1007/s00134-003-1860-6; Pfortmueller CA, 2018, WIEN KLIN WOCHENSCHR, V130, P273, DOI 10.1007/s00508-018-1327-y; Pfortmueller CA, 2018, INTENS CARE MED EXP, V6, DOI 10.1186/s40635-018-0174-5; Pfortmueller CA, 2017, J CRIT CARE, V42, P168, DOI 10.1016/j.jcrc.2017.06.019; Ranucci M, 2006, CRIT CARE, V10, DOI 10.1186/cc5113; Raper RF, 1997, CRIT CARE MED, V25, P46, DOI 10.1097/00003246-199701000-00011; Renew JR, 2016, J THORAC CARDIOV SUR, V151, P825, DOI 10.1016/j.jtcvs.2015.10.063; RUTHERFORD EJ, 1992, J TRAUMA, V33, P417, DOI 10.1097/00005373-199209000-00014; Schefold JC, 2016, NAT REV NEPHROL, V12, P610, DOI 10.1038/nrneph.2016.113; Schumacher KR, 2014, J THORAC CARDIOV SUR, V148, P589, DOI 10.1016/j.jtcvs.2013.09.002; Siegel LB, 1996, INTENS CARE MED, V22, P1418, DOI 10.1007/s001340050276; Smith I, BASE EXCESS LACTATE; Takala J, 1996, New Horiz, V4, P483; Teloh JK, 1734, TRANSIENT DILUTIONAL, P1734; Toraman F, 2004, HEART SURG FORUM, V7, pE155, DOI 10.1532/HSF98.20041002; Totaro RJ, 1997, CRIT CARE MED, V25, P1693, DOI 10.1097/00003246-199710000-00019; Wigger O, 2018, EUR HEART J-ACUTE CA, V7, P45, DOI 10.1177/2048872616683526	38	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205309	10.1371/journal.pone.0205309	http://dx.doi.org/10.1371/journal.pone.0205309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289956	Green Submitted, gold, Green Published			2022-12-26	WOS:000446545500065
J	Qiu, LL; Chang, GB; Bi, YL; Liu, XP; Chen, GH				Qiu, Lingling; Chang, Guobin; Bi, Yulin; Liu, Xiangping; Chen, Guohong			Circular RNA and mRNA profiling reveal competing endogenous RNA networks during avian leukosis virus, subgroup J-induced tumorigenesis in chickens	PLOS ONE			English	Article							CELL-GROWTH; CHINA; INFECTION; EFFICIENT; HPRS-103; LEUKEMIA; ABUNDANT; TOPHAT; STRAIN; CANCER	Avian leukosis virus subgroup J (ALV-J) can induce myeloid tumors and hemangiomas in chickens and causes severe economic losses with commercial layer chickens and meat-type chickens. Here, we generated ribominus RNA sequencing data from three normal chicken spleen tissues and three ALV-J-infected chicken spleen tissues. Structure analysis of transcripts showed that, compared to mRNAs and IncRNAs, chicken circRNAs shared relatively shorter transcripts and similar GC content. Differentially expression analysis showed 152 differentially expressed circRNAs with 106 circRNAs up regulated and 46 circRNAs down regulated. Through comparing differentially expressed circRNA host genes and mRNAs and performed ceRNA network analysis, we found several tumor or immune-related genes, in which, there were four genes existed in both differentially expressed mRNAs and circRNA host genes (Dock4, Fmr1, Zfhx3, Ralb) and two genes (Mll, Aoc3) involved in ceRNA network. We further characterized one exon-intron circRNA derived from HRH4 gene in the ceRNA network, termed circHRH4, which is an abundant and stable circRNA expressed in various tissues and cells in chicken and localizes in cytoplasm. Our results provide new insight into the pathology of ALV-J infection and circRNAs may also mediate tumorigenesis in chicken.	[Qiu, Lingling; Chang, Guobin; Bi, Yulin; Chen, Guohong] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China; [Liu, Xiangping] Chinese Acad Agr Sci, Poultry Inst, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Chinese Academy of Agricultural Sciences	Chang, GB (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.	gbchang@yzu.edu.cn			National Science & Technology Pillar Program of China [2015BAD03B03]; priority academic program development of Jiangsu Higher Education Institutions	National Science & Technology Pillar Program of China; priority academic program development of Jiangsu Higher Education Institutions	This work was funded by National Science & Technology Pillar Program of China (2015BAD03B03) and the priority academic program development of Jiangsu Higher Education Institutions. The funders conceived and designed the study.	Adler HT, 1999, MOL CELL BIOL, V19, P7050; Aldoss I, 2018, BLOOD, V131, P2507, DOI 10.1182/blood-2018-02-834911; Arshad SS, 1997, VET PATHOL, V34, P127, DOI 10.1177/030098589703400205; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Cheng ZQ, 2010, J VET MED SCI, V72, P1027, DOI 10.1292/jvms.09-0564; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Cui Z, 2006, J AVIAN LEUKOSIS VIR; Cui ZZ, 2003, AVIAN DIS, V47, P1321, DOI 10.1637/6085; Das S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098965; Devaux Y, 2017, EUR J HEART FAIL, V19, P701, DOI 10.1002/ejhf.801; Ding JiaBo, 2007, Chinese Journal of Veterinary Science, V27, P39; Dong X, 2015, AVIAN PATHOL, V44, P43, DOI 10.1080/03079457.2014.993359; Falsetti SC, 2007, MOL CELLULAR BIOL, V27; Gao YL, 2010, EMERG INFECT DIS, V16, P1637, DOI 10.3201/eid1610.100780; Gao Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0571-3; Gao YL, 2012, J CLIN MICROBIOL, V50, P953, DOI 10.1128/JCM.06179-11; Gleicher N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102370; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Ji R.L., 2001, CHIN J VET DRUG, V35, P1; Johnstone RW, 2001, MOL CELL BIOL, V21, P1672, DOI 10.1128/MCB.21.5.1672-1681.2001; Lai HZ, 2011, VET MICROBIOL, V151, P275, DOI 10.1016/j.vetmic.2011.03.037; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Liu D, 2016, SCI REP-UK, V6, DOI 10.1038/srep20188; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mori Y, 2007, INT J CANCER, V121, P241, DOI 10.1002/ijc.22654; Ouyang HJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00172; Payne LN, 2012, AVIAN PATHOL, V41, P11, DOI 10.1080/03079457.2011.646237; PAYNE LN, 1991, J GEN VIROL, V72, P801, DOI 10.1099/0022-1317-72-4-801; PAYNE LN, 1993, VET REC, V132, P555, DOI 10.1136/vr.132.22.555; Qiu LL, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00996; Qiu LL, 2017, DEV COMP IMMUNOL, V76, P292, DOI 10.1016/j.dci.2017.06.015; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sironi G, 2006, J VET MED B, V53, P347, DOI 10.1111/j.1439-0450.2006.00961.x; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang YM, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0598-7; Wang Z, 2018, AGING-US, V10, P775, DOI 10.18632/aging.101427; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yu JR, 2015, GENE DEV, V29, P250, DOI 10.1101/gad.248963.114; Zhang S., 2010, CHINA POULT, V32, P11, DOI [10.16372/j.issn.1004-6364.2010.12.003, DOI 10.16372/J.ISSN.1004-6364.2010.12.003]; Zhang XO, 2016, GENOME RES, V26, P1277, DOI 10.1101/gr.202895.115; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang XH, 2017, ONCOTARGET, V8, P34961, DOI 10.18632/oncotarget.16442; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215	50	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204931	10.1371/journal.pone.0204931	http://dx.doi.org/10.1371/journal.pone.0204931			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286182	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500062
J	Heinonen, M; Milliat, F; Benadjaoud, MA; Francois, A; Buard, V; Tarlet, G; d'Alche-Buc, F; Guipaud, O				Heinonen, Markus; Milliat, Fabien; Benadjaoud, Mohamed Amine; Francois, Agnes; Buard, Valerie; Tarlet, Georges; d'Alche-Buc, Florence; Guipaud, Olivier			Temporal clustering analysis of endothelial cell gene expression following exposure to a conventional radiotherapy dose fraction using Gaussian process clustering	PLOS ONE			English	Article							IONIZING-RADIATION; NORMAL TISSUE; TIME-SERIES; COEFFICIENT	The vascular endothelium is considered as a key cell compartment for the response to ionizing radiation of normal tissues and tumors, and as a promising target to improve the differential effect of radiotherapy in the future. Following radiation exposure, the global endothelial cell response covers a wide range of gene, miRNA, protein and metabolite expression modifications. Changes occur at the transcriptional, translational and post-translational levels and impact cell phenotype as well as the microenvironment by the production and secretion of soluble factors such as reactive oxygen species, chemokines, cytokines and growth factors. These radiation-induced dynamic modifications of molecular networks may control the endothelial cell phenotype and govern recruitment of immune cells, stressing the importance of clearly understanding the mechanisms which underlie these temporal processes. A wide variety of time series data is commonly used in bioinformatics studies, including gene expression, protein concentrations and metabolomics data. The use of clustering of these data is still an unclear problem. Here, we introduce kernels between Gaussian processes modeling time series, and subsequently introduce a spectral clustering algorithm. We apply the methods to the study of human primary endothelial cells (HUVECs) exposed to a radiotherapy dose fraction (2 Gy). Time windows of differential expressions of 301 genes involved in key cellular processes such as angiogenesis, inflammation, apoptosis, immune response and protein kinase were determined from 12 hours to 3 weeks post-irradiation. Then, 43 temporal clusters corresponding to profiles of similar expressions, including 49 genes out of 301 initially measured, were generated according to the proposed method. Forty-seven transcription factors (TFs) responsible for the expression of clusters of genes were predicted from sequence regulatory elements using the MotifMap system. Their temporal profiles of occurrences were established and clustered. Dynamic network interactions and molecular pathways of TFs and differential genes were finally explored, revealing key node genes and putative important cellular processes involved in tissue infiltration by immune cells following exposure to a radiotherapy dose fraction.	[Heinonen, Markus] Aalto Univ, Dept Informat & Comp Sci, Aalto, Finland; [Milliat, Fabien; Francois, Agnes; Buard, Valerie; Tarlet, Georges; Guipaud, Olivier] Inst Radiol Protect & Nucl Safety IRSN, PSE SANTE, SERAMED, LRMed, Fontenay Aux Roses, France; [Benadjaoud, Mohamed Amine] Inst Radiol Protect & Nucl Safety IRSN, PSE SANTE, SERAMED, Fontenay Aux Roses, France; [d'Alche-Buc, Florence] Univ Paris Saclay, LTCI, Telecom ParisTech, Paris, France	Aalto University; IMT - Institut Mines-Telecom; Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay	Guipaud, O (corresponding author), Inst Radiol Protect & Nucl Safety IRSN, PSE SANTE, SERAMED, LRMed, Fontenay Aux Roses, France.	olivier.guipaud@irsn.fr		Milliat, Fabien/0000-0001-8249-9498; TARLET, Georges/0000-0002-4756-5127	Electricite de France (Groupe Gestion Projet Radioprotection); Institut de Radioprotection et de Surete Nucleaire (programme ROSIRIS)	Electricite de France (Groupe Gestion Projet Radioprotection); Institut de Radioprotection et de Surete Nucleaire (programme ROSIRIS)	This work has been supported by Electricite de France (Groupe Gestion Projet Radioprotection) and Institut de Radioprotection et de Surete Nucleaire (programme ROSIRIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijo T, 2009, BIOINFORMATICS, V25, P2937, DOI 10.1093/bioinformatics/btp511; Angelini C, 2007, STAT APPL GENET MOL, V6; Bach FR, 2004, ADV NEUR IN, V16, P305; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; Borghini A, 2013, ATHEROSCLEROSIS, V230, P40, DOI 10.1016/j.atherosclerosis.2013.06.010; Caldas J, 2009, BIOINFORMATICS, V25, pI145, DOI 10.1093/bioinformatics/btp215; Chawla S, 2013, P 2013 SIAM INT C DA; Cheng JD, 2002, BIOCHEM BIOPH RES CO, V297, P1128, DOI 10.1016/S0006-291X(02)02301-X; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Cooke EJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-399; Corre I, 2013, INT J MOL SCI, V14, P22678, DOI 10.3390/ijms141122678; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Daily K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-495; Dent P, 2003, RADIAT RES, V159, P283, DOI 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO;2; DeVita VT, 2011, ROSENBERGS CANC PRIN; Dudoit S, 2002, STAT SINICA, V12, P111; Duong T, 2011, KS KERNEL SMOOTHING; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Gao P, 2008, BIOINFORMATICS, V24, pI70, DOI 10.1093/bioinformatics/btn278; Guipaud O, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170762; Heinonen M, 2015, BIOINFORMATICS, V31, P728, DOI 10.1093/bioinformatics/btu699; Hensman J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-252; Holsclaw T, 2013, TECHNOMETRICS, V55, P57, DOI 10.1080/00401706.2012.723918; INMAN HF, 1989, COMMUN STAT THEORY, V18, P3851, DOI 10.1080/03610928908830127; Jaakkola T, 1999, Proc Int Conf Intell Syst Mol Biol, P149; Jebara T, 2003, LECT NOTES ARTIF INT, V2777, P57, DOI 10.1007/978-3-540-45167-9_6; Kalaitzis AA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-180; Karhunen K., 1947, ANN ACAD SCI FENN A1, V37, P1; Kim J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-310; Kirk PDW, 2009, BIOINFORMATICS, V25, P1300, DOI 10.1093/bioinformatics/btp139; Laube M, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5020014; Lawrence N. D., 2007, ADV NEURAL INFORM PR, P785; LEE YJ, 1995, J BIOL CHEM, V270, P28790, DOI 10.1074/jbc.270.48.28790; Liauw SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005148; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Moding EJ, 2013, NAT REV DRUG DISCOV, V12, P526, DOI 10.1038/nrd4003; Moreno PJ, 2004, ADV NEUR IN, V16, P1385; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Potters L, 2010, INT J RADIAT ONCOL, V76, P326, DOI 10.1016/j.ijrobp.2009.09.042; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Rannou E, 2015, SCI REP-UK, V5, DOI 10.1038/srep15738; Rasmussen CE, 2003, BAYESIAN STATISTICS 7, P651; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Riihimaki J., 2010, J MACH LEARN RES, V9, P645; Schliep A, 2005, IEEE ACM T COMPUT BI, V2, P179, DOI 10.1109/TCBB.2005.31; Schmid F, 2006, COMPUT STAT DATA AN, V50, P1583, DOI 10.1016/j.csda.2005.01.014; Simone CB, 2013, CHEST, V143, P1784, DOI 10.1378/chest.12-2580; Snyder AR, 2004, CANCER METAST REV, V23, P259, DOI 10.1023/B:CANC.0000031765.17886.fa; Solak E., 2002, P ADV NEUR INF PROC, P1033; Stegle O, 2010, J COMPUT BIOL, V17, P355, DOI 10.1089/cmb.2009.0175; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Tamm I, 1998, CANCER RES, V58, P5315; Valerie K, 2007, MOL CANCER THER, V6, P789, DOI 10.1158/1535-7163.MCT-06-0596; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Weitzman M.S., 1970, MEASURES OVERLAP INC; Xie XH, 2009, BIOINFORMATICS, V25, P167, DOI 10.1093/bioinformatics/btn605; Yang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016229; Yao F., 2015, PACE PACKAGE FUNCTIO; Yuan M, 2006, COMPUT STAT DATA AN, V51, P1754, DOI 10.1016/j.csda.2005.11.017	62	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204960	10.1371/journal.pone.0204960	http://dx.doi.org/10.1371/journal.pone.0204960			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281653	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400072
J	Yuan, T; Li, JP; Fl, Y; Xu, T; Li, J; Wang, XQ; Zhou, Y; Dong, YY; Zhao, WG				Yuan, Tao; Li, Jiapei; Fl, Yong; Xu, Tao; Li, Juan; Wang, Xiangqing; Zhou, Ying; Dong, Yingyue; Zhao, Weigang			A cardiac risk score based on sudomotor function to evaluate cardiovascular autonomic neuropathy in asymptomatic Chinese patients with diabetes mellitus	PLOS ONE			English	Article							INDICATOR TEST; SKIN VASOMOTOR; DIAGNOSIS; DYSFUNCTION; TOOL; COMPLICATIONS; PATHOGENESIS; MORTALITY	Backgrounds Cardiac autonomic neuropathy is a common but always overlooked. More convenient diagnostic methods are needed. Hypothesis Cardiac autonomic neuropathy risk score evaluated by SUDOSCAN has a fine diagnostic efficacy detecting cardiac autonomic neuropathy. Methods This is a cross-sectional study among patients with diabetes mellitus. Subjects undertook SUDOSCAN tests and cardiac autonomic reflex tests, including heart rate variability due to Valsalva maneuver, heart rate response due to deep breathing and heart rate response due to standing up. Presenting 2 abnormal results was defined as cardiac autonomic neuropathy. Results Subjects with cardiac autonomic neuropathy has significantly higher cardiac autonomic neuropathy risk score (32.88 +/- 1.60 vs 27.64 +/- 1.24,P = 0.010). Cardiac autonomic neuropathy risk score was correlated significantly with the heart rate response due to deep breathing (P = 0.004). Multiple regression analysis including significant variables showed an independent association of cardiac autonomic neuropathy risk score and heart rate response due to deep breathing (P = 0.031) and age (P = 0.000). In receiver operating characteristic curve analysis evaluating the relationship between cardiac autonomic neuropathy risk score and cardiac autonomic neuropathy, The cut-off value was 20.5, with the sensitivity of 90.48%, the specificity of 29.5%, and the positive predictive value of 46.9%. In two-step diagnostic methods, Setting 20.5 as the cut-off value of cardiac autonomic neuropathy risk score and abnormal heart rate response due to standing up as the second diagnostic step's positive result, and setting 16.5 as the cut-off value of cardiac autonomic neuropathy risk score and abnormal heart rate response due to deep breathing as the second diagnostic step's positive result, both achieved good diagnostic efficacy. Conclusion Cardiac autonomic neuropathy risk score evaluated by SUDOSCAN is a good screening test for cardiac autonomic neuropathy. The two-step diagnostic methods could be considered as surrogate diagnostic methods.	[Yuan, Tao; Li, Jiapei; Fl, Yong; Li, Juan; Wang, Xiangqing; Zhou, Ying; Dong, Yingyue; Zhao, Weigang] Peking Union Med Coll Hosp, Peking Union Med Coll, Key Lab Endocrinol Natl Hlth & Family Planning Co, Dept Endocrinol, Beijing, Peoples R China; [Yuan, Tao; Li, Jiapei; Fl, Yong; Li, Juan; Wang, Xiangqing; Zhou, Ying; Dong, Yingyue; Zhao, Weigang] Chinese Acad Med Sci, Beijing, Peoples R China; [Xu, Tao] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Sch Basic Med,Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhao, WG (corresponding author), Peking Union Med Coll Hosp, Peking Union Med Coll, Key Lab Endocrinol Natl Hlth & Family Planning Co, Dept Endocrinol, Beijing, Peoples R China.; Zhao, WG (corresponding author), Chinese Acad Med Sci, Beijing, Peoples R China.	xiehezhaoweigang@163.com	Li, Jiapei/AAX-7482-2021					Akaogi Y, 2009, NEUROLOGY, V73, P59, DOI 10.1212/WNL.0b013e3181aae83c; American Diabetes Association, 2017, CLIN DIABETES, V35, P5, DOI [10.2337/cd16-0067, DOI 10.2337/CD16-0067]; Aminoff M, 1996, NEUROLOGY, V46, P873; [Anonymous], 1988, DIABETES CARE, V11, P592, DOI 10.2337/diacare.11.7.592; Asahina M, 2008, J DIABETES COMPLICAT, V22, P278, DOI 10.1016/j.jdiacomp.2007.03.009; Balcioglu AS, 2015, WORLD J DIABETES, V6, P80, DOI 10.4239/wjd.v6.i1.80; Bilen H, 2007, ADV THER, V24, P1020, DOI 10.1007/BF02877707; Cameron NE, 1997, DIABETES, V46, pS31, DOI 10.2337/diab.46.2.S31; Casellini CM, 2013, DIABETES TECHNOL THE, V15, P948, DOI 10.1089/dia.2013.0129; Deli G, 2013, NEUROENDOCRINOLOGY, V98, P267, DOI 10.1159/000358728; Eranki VG, 2013, DIABETES RES CLIN PR, V101, pE11, DOI 10.1016/j.diabres.2013.07.003; Freedman BI, 2015, AM J NEPHROL, V41, P438, DOI 10.1159/000437342; GREENE DA, 1988, DIABETES, V37, P688, DOI 10.2337/diabetes.37.6.688; He TY, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8289740; Hilz MJ, 2006, MUSCLE NERVE, V33, P6, DOI 10.1002/mus.20365; Jiang Y, 2002, MODERN MED J, V30, P317; Liatis S, 2007, DIABETIC MED, V24, P1375, DOI 10.1111/j.1464-5491.2007.02280.x; Low PA, 2004, DIABETES CARE, V27, P2942, DOI 10.2337/diacare.27.12.2942; LOW PA, 1993, MAYO CLIN PROC, V68, P748, DOI 10.1016/S0025-6196(12)60631-4; Luk AOY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134981; Maser RE, 2003, DIABETES CARE, V26, P1895, DOI 10.2337/diacare.26.6.1895; Papanas N, 2013, DIABETIC MED, V30, P525, DOI 10.1111/dme.12000; Papanas N, 2014, ENDOCRINE, V47, P690, DOI 10.1007/s12020-014-0285-z; Pop-Busui R, 2012, J CARDIOVASC TRANSL, V5, P463, DOI 10.1007/s12265-012-9367-6; Pop-Busui R, 2010, DIABETES CARE, V33, P1578, DOI 10.2337/dc10-0125; Selvarajah D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138224; Serhiyenko VA, 2015, WORLD J DIABETES, V6, P245, DOI 10.4239/wjd.v6.i2.245; Spallone V, 2009, DIABETIC MED, V26, P686, DOI 10.1111/j.1464-5491.2009.02760.x; Spallone V, 2011, DIABETES-METAB RES, V27, P639, DOI 10.1002/dmrr.1239; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Valensi P, 2003, METABOLISM, V52, P815, DOI 10.1016/S0026-0495(03)00095-7; Veves A, 2001, J CLIN INVEST, V107, P1215, DOI 10.1172/JCI13038; Vinik Aaron I., 2003, Comprehensive Therapy, V29, P130, DOI 10.1007/s12019-003-0017-4; Vinik AI, 2013, CURR DIABETES REP, V13, P517, DOI 10.1007/s11892-013-0392-x; Vinik AI, 2003, SEMIN NEUROL, V23, P365; Yajnik CS, 2013, DIABETES METAB, V39, P126, DOI 10.1016/j.diabet.2012.09.004; ZIEGLER D, 1993, DIABETES METAB, V19, P143	37	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204804	10.1371/journal.pone.0204804	http://dx.doi.org/10.1371/journal.pone.0204804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281621	Green Submitted, Green Published, gold			2022-12-26	WOS:000446342400059
J	Houdou, M; Lebredonchel, E; Garat, A; Duvet, S; Legrand, D; Decool, V; Klein, A; Ouzzine, M; Gasnier, B; Potelle, S; Foulquier, F				Houdou, Marine; Lebredonchel, Elodie; Garat, Anne; Duvet, Sandrine; Legrand, Dominique; Decool, Valerie; Klein, Andre; Ouzzine, Mohamed; Gasnier, Bruno; Potelle, Sven; Foulquier, Francois			Involvement of thapsigargin- and cyclopiazonic acid-sensitive pumps in the rescue of TMEM165-associated glycosylation defects by Mn2+	FASEB JOURNAL			English	Article						manganese homeostasis; congenital disorders of glycosylation; Golgi apparatus	MANGANESE TRANSPORT; CONGENITAL DISORDER; GOLGI; HOMEOSTASIS; ATPASE; DEFICIENCY; MEMBRANE; MUTATION; CELLS	Congenital disorders of glycosylation are severe inherited diseases in which aberrant protein glycosylation is a hallmark. Transmembrane protein 165 (TMEM165) is a novel Golgi transmembrane protein involved in type II congenital disorders of glycosylation. Although its biologic function is still a controversial issue, we have demonstrated that the Golgi glycosylation defect due to TMEM165 deficiency resulted from a Golgi Mn2+ homeostasis defect. The goal of this study was to delineate the cellular pathway by which extracellular Mn2+ rescues N-glycosylation in TMEM165 knockout (KO) cells. We first demonstrated that after extracellular exposure, Mn2+ uptake by HEK293 cells at the plasma membrane did not rely on endocytosis but was likely done by plasma membrane transporters. Second, we showed that the secretory pathway Ca2+-ATPase 1, also known to mediate the influx of cytosolic Mn2+ into the lumen of the Golgi apparatus, is not crucial for the Mn2+-induced rescue glycosylation of lysosomal-associated membrane protein 2 (LAMP2). In contrast, our results demonstrate the involvement of cyclopiazonic acid- and thapsigargin (Tg)-sensitive pumps in the rescue of TMEM165-associated glycosylation defects by Mn2+. Interestingly, overexpression of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) 2b isoform in TMEM165 KO cells partially rescues the observed LAMP2 glycosylation defect. Overall, this study indicates that the rescue of Golgi N-glycosylation defects in TMEM165 KO cells by extracellular Mn2+ involves the activity of Tg and cyclopiazonic acid-sensitive pumps, probably the SERCA pumps.Houdou, M., Lebredonchel, E., Garat, A., Duvet, S., Legrand, D., Decool, V., Klein, A., Ouzzine, M., Gasnier, B., Potelle, S., Foulquier, F. Involvement of thapsigargin- and cyclopiazonic acid-sensitive pumps in the rescue of TMEM165-associated glycosylation defects by Mn2+.	[Houdou, Marine; Lebredonchel, Elodie; Duvet, Sandrine; Legrand, Dominique; Klein, Andre; Potelle, Sven; Foulquier, Francois] Univ Lille, CNRS, UMR 8576, UGSF, F-59000 Lille, France; [Garat, Anne; Decool, Valerie] Univ Lille, CHU Lille, Inst Pasteur Lille, EA 4483,Impact Environm Chim Sante Humaine IMPECS, Lille, France; [Ouzzine, Mohamed] Univ Lorraine, CNRS, UMR 7365, Biopole Fac Med, Vandoeuvre Les Nancy, France; [Gasnier, Bruno] Paris Descartes Univ, Sorbonne Paris Cite, CNRS, Neurophoton Lab,UMR 8250, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Foulquier, F (corresponding author), Univ Lille, CNRS, UMR 8576, UGSF, F-59000 Lille, France.	francois.foulquier@univ-lille1.fr	Ouzzine, Mohamed/G-4368-2013; Gasnier, Bruno/AAD-9124-2022; Garat, Anne/AAC-6868-2022; foulquier, francois/ABE-5886-2020; FOULQUIER, FRANCOIS/AAI-1182-2021; Lebredonchel, Elodie/W-4628-2019; Klein, Andre/H-2830-2015; Legrand, Dominique/AAT-5715-2021	Gasnier, Bruno/0000-0003-4458-6296; foulquier, francois/0000-0002-6551-3240; Klein, Andre/0000-0001-9234-2080; Lebredonchel, Elodie/0000-0001-5119-6005; Potelle, Sven/0000-0002-7044-688X; LEGRAND, Dominique/0000-0002-0814-221X; OUZZINE, Mohamed/0000-0003-0058-4950; HOUDOU, Marine/0000-0002-9766-3163	French National Research Agency (SOLV-CDG); Mizutani Foundation for Glycoscience	French National Research Agency (SOLV-CDG)(French National Research Agency (ANR)); Mizutani Foundation for Glycoscience	The authors are indebted to D. Legrand [Federation of Research Structural and Functional Biochemistry of Biomolecular Assemblies (FRABio), University of Lille] for providing the scientific and technical environment conducive to achieving this work. The authors thank the staff of the BioImagingCenter of Lille, especially C. Slomianny and E. Richard, for the use of the Leica LSM700 and LSM780 devices. The authors are indebted to D. Mouajjah (Centre National de la Recherche Scientifique Unites Mixte de Recherche 8576, University of Lille) for her helpful assistance in mass spectrometry experiments, and D. Allorge (Centre Hospitalier Universitaire Lille, EA 4483) for her kind assistance in ICP-MS experiments. This work was supported by the French National Research Agency (SOLV-CDG to F.F.) and the Mizutani Foundation for Glycoscience (to F.F.). The authors declare no conflicts of interest.	Au C, 2008, NEUROTOXICOLOGY, V29, P569, DOI 10.1016/j.neuro.2008.04.022; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Chen JL, 2017, J BIOL CHEM, V292, P6938, DOI 10.1074/jbc.M117.778431; Chen Pan, 2015, Worm, V4, pe1042648, DOI 10.1080/21624054.2015.1042648; Chen P, 2015, J NEUROCHEM, V134, P601, DOI 10.1111/jnc.13170; CHIESI M, 1981, ARCH BIOCHEM BIOPHYS, V208, P586, DOI 10.1016/0003-9861(81)90547-6; CHIESI M, 1980, BIOCHEMISTRY-US, V19, P2912, DOI 10.1021/bi00554a015; Delannoy CP, 2017, J PROTEOME RES, V16, P156, DOI 10.1021/acs.jproteome.6b00161; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Dutta Dipannita, 2012, Cell Logist, V2, P203; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; He WF, 2012, NEUROCHEM RES, V37, P455, DOI 10.1007/s11064-011-0644-6; Micaroni M, 2010, TRAFFIC, V11, P1315, DOI 10.1111/j.1600-0854.2010.01096.x; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Potelle S, 2016, HUM MOL GENET, V25, P1489, DOI 10.1093/hmg/ddw026; POWELL JT, 1976, J BIOL CHEM, V251, P3645; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Roth JA, 2006, BIOL RES, V39, P45, DOI 10.4067/S0716-97602006000100006; Schneider A, 2016, PLANT CELL, V28, P892, DOI 10.1105/tpc.15.00812; Van Baelen K, 2004, BBA-MOL CELL RES, V1742, P103, DOI 10.1016/j.bbamcr.2004.08.018; Vandecaetsbeek Ilse, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004184; Yonekura SI, 2016, FEBS LETT, V590, P2086, DOI 10.1002/1873-3468.12244; Zeevaert R, 2013, JIMD REP, V8, P145, DOI 10.1007/8904_2012_172	28	15	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2669	2679		10.1096/fj.201800387R	http://dx.doi.org/10.1096/fj.201800387R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307768	Green Submitted			2022-12-26	WOS:000457296600091
J	Ye, YZ; Tang, Y; Xiong, Y; Feng, LP; Li, XT				Ye, Yunzhen; Tang, Yao; Xiong, Yu; Feng, Liping; Li, Xiaotian			Bisphenol A exposure alters placentation and causes preeclampsia-like features in pregnant mice involved in reprogramming of DNA methylation of WNT2	FASEB JOURNAL			English	Article						trophoblast invasion; DNMT; maternal; endocrine disruptor; birth outcomes	INTRAUTERINE GROWTH RESTRICTION; ENDOCRINE DISRUPTORS; IN-VITRO; EXPRESSION; PROMOTER; INVASION; BPA; DIFFERENTIATION; NONYLPHENOL; METABOLISM	Preeclampsia leads to adverse outcomes for pregnant women. Bisphenol A (BPA) is an environmental endocrine disruptor and has been shown to be positively associated with increased risk of preeclampsia in human studies. We investigated whether BPA exposure causes preeclampsia-like features in pregnant mice and the associated underlying mechanisms. Experiments were performed in animal models and cell cultures. In pregnant mice, BPA-exposed mice exhibited preeclampsia-like features including hypertension, disruption of the circulation, and the placental angiogenesis biomarkers fms-related tyrosine kinase 1 and placenta growth factor, and glomerular atrophy; urinary protein was not affected. These preeclampsia-like features correlated with increased retention of smooth muscle cells and reduced vessel areas at the junctional zone of the placenta. In addition, there were disrupted expression of invasion-related genes including increased tissue inhibitors of metalloproteinases, decreased metalloproteinases, and Wnt family member WNT2/-catenin, which correlated with increased DNA methylation in its promoter region and upregulation of DNA methyltransferase (Dnmt)1. BPA exposure impeded the interaction between the human cytotrophoblast cell line, HTR-8/SVneo, and endothelium cells. BPA exposure down-regulated WNT2 expression, and elevated the DNA methylation of WNT2; these results were consistent with in vivo observations. Inhibition of DNMT in HTR-8/SVneo cells resulted in reduced DNA methylation and increased expression of WNT2. Taken together, these data demonstrate that BPA exposure alters trophoblast cell invasion and causes abnormal placental vessel remodeling, both of which lead to the development of preeclampsia-like features in pregnant mice. Our results suggest that this phenomenon involves the epigenetic reprogramming and down-regulation of WNT2 mediated by DNMT1.Ye, Y., Tang, Y., Xiong, Y., Feng, L., Li, X. Bisphenol A exposure alters placentation and causes preeclampsia-like features in pregnant mice involved in reprogramming of DNA methylation of WNT2.	[Ye, Yunzhen; Tang, Yao; Xiong, Yu; Li, Xiaotian] Fudan Univ, Obstet & Gynecol Hosp, Fangxie Rd 419, Shanghai, Peoples R China; [Li, Xiaotian] Fudan Univ, Inst Biochem Sci, Shanghai, Peoples R China; [Ye, Yunzhen; Tang, Yao; Xiong, Yu; Li, Xiaotian] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China; [Feng, Liping] Duke Univ, Sch Med, Dept Obstet & Gynecol, 246 Sands Bldg,303 Res Dr, Durham, NC 27710 USA; [Feng, Liping] Minist Educ, Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China; [Li, Xiaotian] Shanghai Key Lab Birth Defects, Shanghai, Peoples R China	Fudan University; Fudan University; Duke University	Li, XT (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Fangxie Rd 419, Shanghai, Peoples R China.; Feng, LP (corresponding author), Duke Univ, Sch Med, Dept Obstet & Gynecol, 246 Sands Bldg,303 Res Dr, Durham, NC 27710 USA.	liping.feng@duke.edu; xiaotianli555@163.com	Li, Xiaotian/ABI-3309-2020	Li, Xiaotian/0000-0002-2051-4581	National Science Fund of China Emergency Management Project [81741047]; National Science Fund of China [81270712]; Shanghai Key Program of Clinical Science and Technology Innovation [17411950500, 17411950501]; Shanghai Medical Center of Key Programs for Female Reproductive Diseases Grant [2017ZZ01016]; National Key Basic Research Plan of China (973 Plan) [2015CB943300]; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases; Shanghai Key Laboratory of Birth Defects; Key Specialty Project of the Ministry of Health, People's Republic of China; FOGARTY INTERNATIONAL CENTER [K01TW010828] Funding Source: NIH RePORTER	National Science Fund of China Emergency Management Project; National Science Fund of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Program of Clinical Science and Technology Innovation; Shanghai Medical Center of Key Programs for Female Reproductive Diseases Grant; National Key Basic Research Plan of China (973 Plan)(National Basic Research Program of China); Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases; Shanghai Key Laboratory of Birth Defects; Key Specialty Project of the Ministry of Health, People's Republic of China; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by National Science Fund of China Emergency Management Project Grant 81741047 (to X.L); National Science Fund of China Grant 81270712 (to X.L); Shanghai Key Program of Clinical Science and Technology Innovation Grants 17411950500 and 17411950501 (to X.L); Shanghai Medical Center of Key Programs for Female Reproductive Diseases Grant 2017ZZ01016 (to X.L); National Key Basic Research Plan of China (973 Plan) Grant 2015CB943300 (to X.L); the Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases; Shanghai Key Laboratory of Birth Defects (to X.L); and the Key Specialty Project of the Ministry of Health, People's Republic of China (to X.L). The authors declare no conflicts of interest.	[Anonymous], 2013, HYPERTENSION PREGNAN; Benachour N, 2009, TOXICOL APPL PHARM, V241, P322, DOI 10.1016/j.taap.2009.09.005; Cantonwine DE, 2016, ENVIRON HEALTH PERSP, V124, P1651, DOI 10.1289/EHP188; Cantonwine DE, 2015, ENVIRON HEALTH PERSP, V123, P895, DOI 10.1289/ehp.1408126; Chou WC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-94; Degen GH, 2000, INT ARCH OCC ENV HEA, V73, P433, DOI 10.1007/s004200000163; Dodson RE, 2012, ENVIRON HEALTH PERSP, V120, P935, DOI 10.1289/ehp.1104052; Ferreira JC, 2011, EPIGENETICS-US, V6, P441, DOI 10.4161/epi.6.4.14554; Gao T, 2018, J OBSTET GYNAECOL RE, V44, P756, DOI 10.1111/jog.13560; Giannakou K, 2018, ULTRASOUND OBST GYN, V51, P720, DOI 10.1002/uog.18959; Gupta SK, 2016, AM J REPROD IMMUNOL, V75, P361, DOI 10.1111/aji.12436; Hu JY, 2003, WATER RES, V37, P1213, DOI 10.1016/S0043-1354(02)00378-0; Jobe SO, 2013, HYPERTENSION, V61, P480, DOI 10.1161/HYPERTENSIONAHA.111.201624; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; Kohan-Ghadr HR, 2016, CELL ADHES MIGR, V10, P126, DOI 10.1080/19336918.2015.1098800; Kovanecz I, 2013, J SEX MED, V10, P2952, DOI 10.1111/jsm.12336; Kurosawa T, 2002, ENDOCR J, V49, P465, DOI 10.1507/endocrj.49.465; Lan X, 2017, ONCOTARGET, V8, P51507, DOI 10.18632/oncotarget.17882; Leclerc F, 2014, HYPERTENS PREGNANCY, V33, P341, DOI 10.3109/10641955.2014.892607; Matthews JB, 2001, CHEM RES TOXICOL, V14, P149, DOI 10.1021/tx0001833; McElrath TF, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.010; Morck TJ, 2010, REPROD TOXICOL, V30, P131, DOI 10.1016/j.reprotox.2010.02.007; Nahar MS, 2015, CHEMOSPHERE, V124, P54, DOI 10.1016/j.chemosphere.2014.10.071; Ogawa M, 2007, PLACENTA, V28, P224, DOI 10.1016/j.placenta.2006.01.023; Peretz J, 2014, ENVIRON HEALTH PERSP, V122, P775, DOI 10.1289/ehp.1307728; Poidatz D, 2015, FERTIL STERIL, V104, P483, DOI 10.1016/j.fertnstert.2015.05.005; Rahat B, 2016, REPRODUCTION, V152, P11, DOI 10.1530/REP-16-0060; Rebuli ME, 2014, TOXICOL SCI, V140, P190, DOI 10.1093/toxsci/kfu074; Saura M, 2014, FASEB J, V28, P4719, DOI 10.1096/fj.14-252460; Shen YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127886; Sonderegger S, 2010, ENDOCRINOLOGY, V151, P211, DOI 10.1210/en.2009-0557; Spagnoletti A, 2015, MOL CELL ENDOCRINOL, V412, P56, DOI 10.1016/j.mce.2015.05.023; Susiarjo M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003401; Suzuki M, 2004, CANCER RES, V64, P3137, DOI 10.1158/0008-5472.CAN-03-3046; Tachibana T, 2007, J REPROD DEVELOP, V53, P509, DOI 10.1262/jrd.18171; Tait S, 2015, GENOM DATA, V4, P109, DOI 10.1016/j.gdata.2015.04.004; Tait S, 2015, J APPL TOXICOL, V35, P1278, DOI 10.1002/jat.3176; Tang Y, 2015, MOL HUM REPROD, V21, P736, DOI 10.1093/molehr/gav037; Tiwari SK, 2015, MOL NEUROBIOL, V52, P1735, DOI 10.1007/s12035-014-8940-1; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Wang ZY, 2015, INT J CLIN EXP PATHO, V8, P14355; Xiao J, 2011, BIOMED ENVIRON SCI, V24, P40, DOI 10.3967/0895-3988.2011.01.005; Ye YZ, 2017, EUR J PUBLIC HEALTH, V27, P1102, DOI 10.1093/eurpub/ckx148; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zhang Z, 2013, REPROD SCI, V20, P981, DOI 10.1177/1933719112472740	45	39	42	1	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2732	2742		10.1096/fj.201800934RRR	http://dx.doi.org/10.1096/fj.201800934RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303745	Green Accepted, Green Published			2022-12-26	WOS:000457296600096
J	Weimann, E; Silva, MBB; Murata, GM; Bortolon, JR; Dermargos, A; Curi, R; Hatanaka, E				Weimann, Elaine; Barros Silva, Maysa Braga; Murata, Gilson Masahiro; Bortolon, Jose Ricardo; Dermargos, Alexandre; Curi, Rui; Hatanaka, Elaine			Topical anti-inflammatory activity of palmitoleic acid improves wound healing	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; LINOLEIC ACIDS; IN-VITRO; NEUTROPHILS; N-3; INFLAMMATION; MECHANISMS; GENERATION; MEDIATORS; STIMULATE	This study investigated the effects of palmitoleic acid on different phases of the healing process. Macroscopic analyses were performed on wounds in rats with or without palmitoleic acid treatment, and the results showed that palmitoleic acid directly hastened wound closure. The topical treatment of wounds with palmitoleic acid resulted in smaller wounds than those observed in the control group. The anti-inflammatory activity of palmitoleic acid may be responsible for healing, especially in the stages of granulation tissue formation and remodelling. Palmitoleic acid modified TNF-alpha, IL-1 beta, IL-6, CINC-2 alpha/beta, MIP-3 alpha and VEGF-alpha profiles at the wound site 24, 48, 120, 216 and 288 hours post-wounding. Assays assessing neutrophil migration and exudate formation in sterile inflammatory air pouches revealed that palmitoleic acid had potent anti-inflammatory activity, inhibiting the LPS-induced release of TNF-alpha (73.14%, p <= 0.05), IL-1 beta (66.19%, p <= 0.001), IL-6 (75.19%, p <= 0.001), MIP-3 alpha (70.38%, p <= 0.05), and 1-selectin (16%, p <= 0.05). Palmitoleic acid also inhibited LPS-stimulated neutrophil migration. We concluded that palmitoleic acid accelerates wound healing via an anti-inflammatory effect.	[Weimann, Elaine; Barros Silva, Maysa Braga; Murata, Gilson Masahiro; Bortolon, Jose Ricardo; Dermargos, Alexandre; Curi, Rui; Hatanaka, Elaine] Univ Cruzeiro Sul, Inst Ciencias Atividade Fis & Esportes, Sao Paulo, SP, Brazil; [Dermargos, Alexandre] Univ Paulista, Sao Paulo, SP, Brazil	Universidade Cruzeiro do Sul; Universidade Paulista	Hatanaka, E (corresponding author), Univ Cruzeiro Sul, Inst Ciencias Atividade Fis & Esportes, Sao Paulo, SP, Brazil.	ehata@usp.br	Hatanaka, Elaine/D-6337-2012; Curi, Rui/AAT-7970-2021; Hatanaka, Elaine/AFL-1791-2022; Hatanaka Dermargos, Elaine/HHZ-1180-2022	Curi, Rui/0000-0001-5095-9154; Hatanaka, Elaine/0000-0002-9716-1163; Braga Barros Silva, Maysa/0000-0001-9253-4066; Weimann, Eleine/0000-0002-2456-2548	FAPESP (Sao Paulo Research Foundation) [14/03947-1, 11/15360-7]; CNPq (National Council for Scientific and Technological Development [307769/2014-3]	FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the Brazilian research funding agencies FAPESP (Sao Paulo Research Foundation, #14/03947-1 and # 11/15360-7) and CNPq (National Council for Scientific and Technological Development (#307769/2014-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMATSU H, 1990, ARCH DERMATOL RES, V282, P449, DOI 10.1007/BF00402621; Calder PC, 2004, LIPIDS, V39, P1147, DOI 10.1007/s11745-004-1342-z; Calder PC, 2003, BRAZ J MED BIOL RES, V36, P433, DOI 10.1590/S0100-879X2003000400004; Cardoso CR, 2011, IMMUNOBIOLOGY, V216, P409, DOI 10.1016/j.imbio.2010.06.007; Cardoso CRB, 2004, WOUND REPAIR REGEN, V12, P235; De Lima TM, 2007, CLIN SCI, V113, P65, DOI 10.1042/CS20070006; Farsky SHP, 1997, TOXICON, V35, P185, DOI 10.1016/S0041-0101(96)00135-3; Fischer CL, 2012, ANTIMICROB AGENTS CH, V56, P1157, DOI 10.1128/AAC.05151-11; Gao ZL, 2003, WORLD J GASTROENTERO, V9, P1615, DOI 10.3748/wjg.v9.i7.1615; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Gwak JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174203; Hatanaka E, 2006, FREE RADICAL BIO MED, V41, P1124, DOI 10.1016/j.freeradbiomed.2006.06.014; Hatanaka E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058626; Kolouchova I, 2015, BIORESOURCE TECHNOL, V192, P726, DOI 10.1016/j.biortech.2015.06.048; Lima MHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036974; Magdalon J, 2012, LIPIDS, V47, P803, DOI 10.1007/s11745-012-3687-9; Magdalon J, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-218; Maria J, 2017, FOOD FUNCT, V8, P2394, DOI [10.1039/C7FO00161D, 10.1039/c7fo00161d]; Nakatsuji T, 2010, J INVEST DERMATOL, V130, P985, DOI 10.1038/jid.2009.384; Pereira LA, 2008, CELL BIOCHEM FUNCT, V26, P197, DOI 10.1002/cbf.1432; Pieper Barbara, 2003, J Wound Ostomy Continence Nurs, V30, P175, DOI 10.1067/mjw.2003.131; Rodrigues HG, 2012, J INVEST DERMATOL, V132, P208, DOI 10.1038/jid.2011.265; Rodrigues HG, 2010, LIPIDS, V45, P809, DOI 10.1007/s11745-010-3461-9; Ruthig DJ, 1999, J NUTR, V129, P1791, DOI 10.1093/jn/129.10.1791; Svensjo T, 2000, PLAST RECONSTR SURG, V106, P602, DOI 10.1097/00006534-200009030-00012; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Vinolo MAR, 2009, CLIN SCI, V117, P331, DOI 10.1042/CS20080642; Vinolo MAR, 2009, CELL BIOCHEM FUNCT, V27, P48, DOI 10.1002/cbf.1533; Wille JJ, 2003, SKIN PHARMACOL APPL, V16, P176, DOI 10.1159/000069757; Yoon WJ, 2010, J OLEO SCI, V59, P315, DOI 10.5650/jos.59.315; Ziboh VA, 2000, AM J CLIN NUTR, V71, p361S, DOI 10.1093/ajcn/71.1.361s	31	24	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205338	10.1371/journal.pone.0205338	http://dx.doi.org/10.1371/journal.pone.0205338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307983	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500062
J	Jembrek, MJ; Vlainic, J; Cadez, V; Segota, S				Jembrek, Maja Jazvinscak; Vlainic, Josipa; Cadez, Vida; Segota, Suzana			Atomic force microscopy reveals new biophysical markers for monitoring subcellular changes in oxidative injury: Neuroprotective effects of quercetin at the nanoscale	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; PLASMA-MEMBRANE; NEURONAL DEATH; CELLS; APOPTOSIS; JNK; ACTIVATION; PROTECTS; SURVIVAL; ERK1/2	Oxidative stress has been recognised as an important pathological mechanism underlying the development of neurodegenerative diseases. The biomarkers for assessing the degree of oxidative stress have been attracting much interest because of their potential clinical relevance in understanding the cellular effects of free radicals and evaluation of the efficacy of drug treatment. Here, an interdisciplinary approach using atomic force microscopy (AFM) and cellular and biological molecular methods were used to investigate oxidative damage in P19 neurons and to reveal the underlying mechanism of protective action of quercetin. Biological methods demonstrated the oxidative damage of P19 neurons and showed that quercetin improved neuronal survival by preventing H2O2-induced p53 and Bcl-2 down-regulation and modulated Akt and ERK1/2 signalling pathways. For the first time, AFM was employed to evaluate morphologically (roughness, height, Feret dimension) and nanomechanical (elasticity) properties in H2O2-induced neuronal damage. The AFM analysis revealed that quercetin suppressed H2O2-provoked changes in cell membrane elasticity and morphological properties, thus confirming its neuroprotective activity. The obtained results indicate the potential of AFM-measured parameters as a biophysical markers of oxidative stress-induced neurodegeneration. In general, our study suggests that AFM can be used as a highly valuable tool in other biomedical applications aimed at screening and monitoring of drug-induced effects at cellular level.	[Jembrek, Maja Jazvinscak; Vlainic, Josipa] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia; [Jembrek, Maja Jazvinscak] Croatian Catholic Univ, Dept Psychol, Zagreb, Croatia; [Cadez, Vida; Segota, Suzana] Rudjer Boskovic Inst, Div Phys Chem, Zagreb, Croatia	Rudjer Boskovic Institute; Rudjer Boskovic Institute	Jembrek, MJ (corresponding author), Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia.; Jembrek, MJ (corresponding author), Croatian Catholic Univ, Dept Psychol, Zagreb, Croatia.; Segota, S (corresponding author), Rudjer Boskovic Inst, Div Phys Chem, Zagreb, Croatia.	Maja.Jazvinscak.Jembrek@irb.hr; ssegota@irb.hr	Šegota, Suzana/O-8062-2019; Jembrek, Jazvinšćak/H-3558-2019	Šegota, Suzana/0000-0001-6416-3835; Strasser, Vida/0000-0001-5152-4929	Croatian Science Foundation [IP-2016-06-8415]	Croatian Science Foundation	This research was supported by the Croatian Science Foundation, IP-2016-06-8415, to SS; http://www.hrzz.hr/default.aspx?id=47. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2011, NEUROCHEM RES, V36, P1360, DOI 10.1007/s11064-011-0458-6; Anderson CNG, 1999, J NEUROSCI, V19, P664; Arredondo F, 2010, FREE RADICAL BIO MED, V49, P738, DOI 10.1016/j.freeradbiomed.2010.05.020; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; Ban J, 2011, STEM CELLS DEV, V20, P1031, DOI 10.1089/scd.2010.0217; Baptista FI, 2014, ACS CHEM NEUROSCI, V5, P83, DOI 10.1021/cn400213r; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Bisht K, 2010, TOXICOLOGY, V278, P88, DOI 10.1016/j.tox.2009.11.008; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; Chen L, 2016, J RECEPT SIG TRANSD, V36, P98, DOI 10.3109/10799893.2015.1049363; Costa LG, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2986796; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Crossthwaite AJ, 2002, J NEUROCHEM, V80, P24, DOI 10.1046/j.0022-3042.2001.00637.x; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; D'agostino DP, 2009, NEUROSCIENCE, V159, P1011, DOI 10.1016/j.neuroscience.2009.01.062; Dajas F, 2012, J ETHNOPHARMACOL, V143, P383, DOI 10.1016/j.jep.2012.07.005; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Echeverry C, 2010, J AGR FOOD CHEM, V58, P2111, DOI 10.1021/jf902951v; Espinosa-Diez C, 2015, REDOX BIOL, V6, P183, DOI 10.1016/j.redox.2015.07.008; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Francis LW, 2010, J MICROSC-OXFORD, V240, P111, DOI 10.1111/j.1365-2818.2010.03392.x; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Girasole M, 2007, BBA-BIOMEMBRANES, V1768, P1268, DOI 10.1016/j.bbamem.2007.01.014; Grimm KB, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/21/215101; Hwang NR, 2009, BIOCHEM J, V423, P253, DOI 10.1042/BJ20090854; Ishikawa Y, 2000, KIDNEY INT, V58, P1078, DOI 10.1046/j.1523-1755.2000.00265.x; Jembrek MJ, 2018, PROG NEUROBIOL, V168, P104, DOI 10.1016/j.pneurobio.2018.05.001; Jembrek MJ, 2018, TOXICOLOGY, V406, P58, DOI 10.1016/j.tox.2018.05.014; Jembrek MJ, 2015, TRANSL NEUROSCI, V6, P117, DOI 10.1515/tnsci-2015-0011; Jembrek MJ, 2012, N-S ARCH PHARMACOL, V385, P1185, DOI 10.1007/s00210-012-0799-y; Jembrek MJ, 2012, J MOL NEUROSCI, V47, P286, DOI 10.1007/s12031-012-9737-1; Johnson MD, 1999, J NEUROSCI, V19, P2996; KANE DJ, 1995, J NEUROSCI RES, V40, P269, DOI 10.1002/jnr.490400216; Kelsey NA, 2010, MOLECULES, V15, P7792, DOI 10.3390/molecules15117792; Kim KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030066; Kim SO, 2017, NANO CONVERG, V4, DOI 10.1186/s40580-017-0099-9; Lee CW, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-016-0161-5; Lennicke C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0118-6; Li M, 2018, SPRINGER THESES-RECO, P1, DOI 10.1007/978-981-10-6829-4_1; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Natsume Y, 2009, BIOSCI BIOTECH BIOCH, V73, P722, DOI 10.1271/bbb.80484; Notas G, 2012, J NUTR BIOCHEM, V23, P656, DOI 10.1016/j.jnutbio.2011.03.010; Philpott KL, 1997, J CELL BIOL, V139, P809, DOI 10.1083/jcb.139.3.809; Reister E, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025003; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; Roshanzamir F, 2014, NEUROSCIENCE, V277, P780, DOI 10.1016/j.neuroscience.2014.07.036; Ruffels J, 2004, EUR J PHARMACOL, V483, P163, DOI 10.1016/j.ejphar.2003.10.032; Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021; Sharma DR, 2016, NEUROSCIENCE, V324, P163, DOI 10.1016/j.neuroscience.2016.02.055; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Smolyakov G, 2018, BRAIN STRUCT FUNCT, V223, P255, DOI 10.1007/s00429-017-1486-z; Spedden E., 2012, MRS P, V1420, pmrsf11, DOI [10.1557/opl.2012.485, DOI 10.1557/OPL.2012.485]; Spedden E, 2013, INT J MOL SCI, V14, P16124, DOI 10.3390/ijms140816124; Spedden E, 2012, BIOPHYS J, V103, P868, DOI 10.1016/j.bpj.2012.08.005; Spencer JPE, 2007, GENES NUTR, V2, P257, DOI 10.1007/s12263-007-0056-z; Suematsu N, 2011, NEUROSCI LETT, V504, P223, DOI 10.1016/j.neulet.2011.09.028; Wang X, 1999, CLIN HEMORHEOL MICRO, V21, P137; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Xilouri M, 2006, EUR J NEUROSCI, V23, P43, DOI 10.1111/j.1460-9568.2005.04548.x; Xiong Y, 2009, BIOPHYS J, V96, P5060, DOI 10.1016/j.bpj.2009.03.032; Yamaguchi A, 2001, J BIOL CHEM, V276, P5256, DOI 10.1074/jbc.M008552200; Youl E, 2010, BRIT J PHARMACOL, V161, P799, DOI 10.1111/j.1476-5381.2010.00910.x; Yu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089520; Zhai DX, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-20	64	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0200119	10.1371/journal.pone.0200119	http://dx.doi.org/10.1371/journal.pone.0200119			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303965	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100008
J	Peitz, M; Behringer, M; Granacher, U				Peitz, Matti; Behringer, Michael; Granacher, Urs			A systematic review on the effects of resistance and plyometric training on physical fitness in youth-What do comparative studies tell us?	PLOS ONE			English	Review							STRETCH-SHORTENING CYCLE; WHOLE-BODY VIBRATION; OF-DIRECTION SPEED; ENDURANCE PERFORMANCE; MOTOR-PERFORMANCE; MUSCULAR FITNESS; ATHLETIC PERFORMANCE; SURFACE INSTABILITY; JUMPING PERFORMANCE; THROWING VELOCITY	Introduction To date, several meta-analyses clearly demonstrated that resistance and plyometric training are effective to improve physical fitness in children and adolescents. However, a methodological limitation of meta-analyses is that they synthesize results from different studies and hence ignore important differences across studies (i.e., mixing apples and oranges). Therefore, we aimed at examining comparative intervention studies that assessed the effects of age, sex, maturation, and resistance or plyometric training descriptors (e.g., training intensity, volume etc.) on measures of physical fitness while holding other variables constant. Methods To identify relevant studies, we systematically searched multiple electronic databases (e.g., PubMed) from inception to March 2018. We included resistance and plyometric training studies in healthy young athletes and non-athletes aged 6 to 18 years that investigated the effects of moderator variables (e.g., age, maturity, sex, etc.) on components of physical fitness (i.e., muscle strength and power). Results Our systematic literature search revealed a total of 75 eligible resistance and plyometric training studies, including 5,138 participants. Mean duration of resistance and plyometric training programs amounted to 8.9 +/- 3.6 weeks and 7.1 +/- 1.4 weeks, respectively. Our findings showed that maturation affects plyometric and resistance training outcomes differently, with the former eliciting greater adaptations pre-peak height velocity (PHV) and the latter around-and post-PHV. Sex has no major impact on resistance training related outcomes (e.g., maximal strength, 10 repetition maximum). In terms of plyometric training, around-PHV boys appear to respond with larger performance improvements (e.g., jump height, jump distance) compared with girls. Different types of resistance training (e.g., body weight, free weights) are effective in improving measures of muscle strength (e.g., maximum voluntary contraction) in untrained children and adolescents. Effects of plyometric training in untrained youth primarily follow the principle of training specificity. Despite the fact that only 6 out of 75 comparative studies investigated resistance or plyometric training in trained individuals, positive effects were reported in all 6 studies (e.g., maximum strength and vertical jump height, respectively). Conclusions The present review article identified research gaps (e.g., training descriptors, modern alternative training modalities) that should be addressed in future comparative studies.	[Peitz, Matti] German Sport Univ Cologne, German Res Ctr Elite Sport Momentum, Cologne, Germany; [Behringer, Michael] Goethe Univ Frankfurt, Inst Sports Sci, Frankfurt, Germany; [Granacher, Urs] Univ Potsdam, Fac Human Sci, Div Training & Movement Sci, Potsdam, Germany	German Sport University Cologne; Goethe University Frankfurt; University of Potsdam	Granacher, U (corresponding author), Univ Potsdam, Fac Human Sci, Div Training & Movement Sci, Potsdam, Germany.	urs.granacher@uni-potsdam.de	Granacher, Urs/GXM-3858-2022; Granacher, Urs/N-1963-2019; Granacher, Urs/T-9900-2017	Granacher, Urs/0000-0002-7095-813X; Granacher, Urs/0000-0002-7095-813X; Granacher, Urs/0000-0002-7095-813X				Altman DG., 2008, ASSESSING RISK BIAS; [Anonymous], 1983, Phys Sportsmed, V11, P157, DOI 10.1080/00913847.1983.11708490; [Anonymous], 2016, J TRAINOL, DOI DOI 10.17338/trainology.5.1_6; Asadi A, 2017, J STRENGTH COND RES, V31, P2609, DOI 10.1519/JSC.0000000000001994; Bass SL, 2000, SPORTS MED, V30, P73, DOI 10.2165/00007256-200030020-00001; Bazett-Jones DM, 2008, J STRENGTH COND RES, V22, P25, DOI 10.1519/JSC.0b013e31815f99a4; Bedoya AA, 2015, J STRENGTH COND RES, V29, P2351, DOI 10.1519/JSC.0000000000000877; Behm DG, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00423; Behm DG, 2006, J SPORT SCI MED, V5, P33; Behringer M, 2013, PEDIATR EXERC SCI, V25, P370, DOI 10.1123/pes.25.3.370; Behringer M, 2011, PEDIATR EXERC SCI, V23, P186, DOI 10.1123/pes.23.2.186; Behringer M, 2010, PEDIATRICS, V126, pE1199, DOI 10.1542/peds.2010-0445; Benson AC, 2008, INT J OBESITY, V32, P1016, DOI 10.1038/ijo.2008.5; BLIMKIE CJR, 1992, CAN J SPORT SCI, V17, P264; Bolger R, 2015, J STRENGTH COND RES, V29, P1146, DOI 10.1519/JSC.0000000000000720; Bottaro M, 2011, PEDIATR EXERC SCI, V23, P311, DOI 10.1123/pes.23.3.311; Brughelli M, 2008, SPORTS MED, V38, P1045, DOI 10.2165/00007256-200838120-00007; Bulgakova NZ, 1987, THEORY PRACTICE PHYS, P31; Busch D., 2015, SPORTS ORTHOP TRAUMA, V31, P299, DOI [DOI 10.1016/J.ORTHTR.2015.07.007, 10.1016/j.orthtr.2015.07.007]; Chaabene H, 2017, INT J SPORT PHYSIOL, V9, P1, DOI [DOI 10.1123/IJSPP.2016-0372, 10.1123/ijspp.2016-0372]; Channell BT, 2008, J STRENGTH COND RES, V22, P1522, DOI 10.1519/JSC.0b013e318181a3d0; Chaouachi A, 2014, J STRENGTH COND RES, V28, P1483, DOI 10.1519/JSC.0000000000000305; Chaouachi A, 2014, J STRENGTH COND RES, V28, P401, DOI 10.1519/JSC.0b013e3182987059; Coutts AJ, 2004, J STRENGTH COND RES, V18, P316, DOI 10.1519/00124278-200405000-00021; Crowther RG, 2007, J STRENGTH COND RES, V21, P460; DAVIES BN, 1991, J SPORT MED PHYS FIT, V31, P532; Davies G, 2015, INT J SPORTS PHYS TH, V10, P760; de Hoyo M, 2016, J STRENGTH COND RES, V30, P368, DOI 10.1519/JSC.0000000000001094; Deley G, 2011, J STRENGTH COND RES, V25, P520, DOI 10.1519/JSC.0b013e3181bac451; DeRenne C, 1996, J STRENGTH CONDITION, V10; Deschenes MR, 2002, AM J PHYS MED REHAB, V81, pS3, DOI 10.1097/01.PHM.0000029722.06777.E9; Desmangles JC, 2006, J PEDIATR ENDOCR MET, V19, P213; Escamilla RF, 2012, J STRENGTH COND RES, V26, P1767, DOI 10.1519/JSC.0b013e3182578301; Faigenbaum AD, 2005, PEDIATR EXERC SCI, V17, P237, DOI 10.1123/pes.17.3.237; Faigenbaum AD, 2002, RES Q EXERCISE SPORT, V73, P416, DOI 10.1080/02701367.2002.10609041; Faigenbaum AD, 2001, J STRENGTH COND RES, V15, P459; Faigenbaum AD, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e5; Faigenbaum AD, 2007, J SPORT SCI MED, V6, P519; Faigenbaum AD, 2009, J STRENGTH COND RES, V23, pS60, DOI 10.1519/JSC.0b013e31819df407; Faigenbaum AD, 2008, PEDIATR EXERC SCI, V20, P457, DOI 10.1123/pes.20.4.457; Filipovic A, 2012, J STRENGTH COND RES, V26, P2600, DOI 10.1519/JSC.0b013e31823f2cd1; Filipovic A, 2011, J STRENGTH COND RES, V25, P3218, DOI 10.1519/JSC.0b013e318212e3ce; Flanagan SP, 2002, RES Q EXERCISE SPORT, V73, P340, DOI 10.1080/02701367.2002.10609029; Ford P, 2011, J SPORT SCI, V29, P389, DOI 10.1080/02640414.2010.536849; Foschini D, 2010, OBESITY, V18, P766, DOI 10.1038/oby.2009.247; Gabbett TJ, 2008, J STRENGTH COND RES, V22, P910, DOI 10.1519/JSC.0b013e31816a5fa5; Gomez-Bruton A, 2017, WORLD J PEDIATR, V13, P112, DOI 10.1007/s12519-016-0076-0; Gonzalez-Badillo JJ, 2006, J STRENGTH COND RES, V20, P73; Gonzalez-Badillo JJ, 2005, J STRENGTH COND RES, V19, P689; Granacher U, 2015, INT J SPORTS MED, V36, P386, DOI 10.1055/s-0034-1395519; Granacher U, 2009, DEUT Z SPORTMED, V60, P41; Granacher U, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00164; Granados A, 2015, J CLIN RES PEDIATR E, V7, P235, DOI 10.4274/jcrpe.2007; Harries SK, 2016, J SCI MED SPORT, V19, P163, DOI 10.1016/j.jsams.2015.01.007; Harries SK, 2015, J STRENGTH COND RES, V29, P1113, DOI 10.1519/JSC.0000000000000712; Harries SK, 2012, J SCI MED SPORT, V15, P532, DOI 10.1016/j.jsams.2012.02.005; Hassan SE, 1991, LEISTUNGSSPORT, P17; Heitkamp HC, 2015, J SPORT MED PHYS FIT, V55, P446; HORTOBAGYI T, 1985, INT J SPORTS MED, V6, P317, DOI 10.1055/s-2008-1025862; Johnson BA, 2011, J STRENGTH COND RES, V25, P2623, DOI 10.1519/JSC.0b013e318204caa0; Klusemann MJ, 2012, J STRENGTH COND RES, V26, P2677, DOI 10.1519/JSC.0b013e318241b021; Kokkonen J, 2007, MED SCI SPORT EXER, V39, P1825, DOI 10.1249/mss.0b013e3181238a2b; Kraemer WJ, 1998, J ORTHOP SPORT PHYS, V28, P110, DOI 10.2519/jospt.1998.28.2.110; Legerlotz K, 2016, PEDIATR EXERC SCI, V28, P501, DOI 10.1123/pes.2016-0023; Lephart SM, 2005, BRIT J SPORT MED, V39, P932, DOI 10.1136/bjsm.2005.019083; Lesinski M, 2018, INT J SPORTS MED, V39, P50, DOI 10.1055/s-0043-117610; Lesinski M, 2016, BRIT J SPORT MED, V50, P781, DOI 10.1136/bjsports-2015-095497; Letzelter M, 1984, DTSCH Z SPORTMEDIZIN, P62; Lillegard W A, 1997, Pediatr Rehabil, V1, P147; Lloyd RS, 2011, J SPORT MED PHYS FIT, V51, P595; Lloyd RS, 2016, J STRENGTH COND RES, V30, P1239, DOI 10.1519/JSC.0000000000001216; Lloyd RS, 2014, BRIT J SPORT MED, V48, P498, DOI 10.1136/bjsports-2013-092952; Lloyd RS, 2012, J STRENGTH COND RES, V26, P2812, DOI 10.1519/JSC.0b013e318242d2ec; Lloyd RS, 2012, STRENGTH COND J, V34, P61, DOI 10.1519/SSC.0b013e31825760ea; Loturco I, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01034; Mahieu NN, 2006, J ATHL TRAINING, V41, P286; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; Marginson V, 2005, J APPL PHYSIOL, V99, P1174, DOI 10.1152/japplphysiol.01193.2004; Marques MC, 2012, PERCEPT MOTOR SKILL, V115, P895, DOI 10.2466/25.23.PMS.115.6.895-902; Marta CC, 2014, AM J HUM BIOL, V26, P469, DOI 10.1002/ajhb.22549; Matavulj D, 2001, J SPORT MED PHYS FIT, V41, P159; Matute-Llorente A, 2014, J ADOLESCENT HEALTH, V54, P385, DOI 10.1016/j.jadohealth.2013.11.001; McCormick BT, 2016, INT J SPORT PHYSIOL, V11, P102, DOI 10.1123/ijspp.2015-0058; McKay D, 2012, BRIT J SPORT MED, V46, P727, DOI 10.1136/bjsports-2012-091417; Medeiros Radamés Maciel Vitor, 2014, Rev. paul. pediatr., V32, P229, DOI 10.1590/0103-0582201432313; Meinhardt U, 2013, PEDIATRICS, V132, P1105, DOI 10.1542/peds.2013-1343; Meylan CMP, 2014, SCAND J MED SCI SPOR, V24, pE156, DOI 10.1111/sms.12128; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Moraes E, 2013, J STRENGTH COND RES, V27, P3310, DOI 10.1519/JSC.0b013e31828de8c3; Moran J, 2018, SPORTS MED, V48, P1661, DOI 10.1007/s40279-018-0914-4; Moran J, 2018, J STRENGTH COND RES, V32, P139, DOI 10.1519/JSC.0000000000001780; Moran J, 2017, PEDIATR EXERC SCI, V29, P194, DOI 10.1123/pes.2016-0151; Moran JJ, 2017, J STRENGTH COND RES, V31, P552, DOI 10.1519/JSC.0000000000001444; Muehlbauer T, 2012, PERCEPT MOTOR SKILL, V115, P953, DOI 10.2466/06.10.30.PMS.115.6.953-968; Myer GD, 2013, CURR SPORT MED REP, V12, P304, DOI 10.1097/01.CSMR.0000434106.12813.69; Negra Y, 2017, INT J SPORTS MED, V38, P370, DOI 10.1055/s-0042-122337; Nielsen B, 1980, TRAINING FUNCTIONAL, P69; O'Brien TD, 2010, EXP PHYSIOL, V95, P202, DOI 10.1113/expphysiol.2009.048967; Olsen OE, 2005, BRIT MED J, V330, P449, DOI 10.1136/bmj.38330.632801.8F; Park SY, 2015, J EXERC REHABIL, V11, P289, DOI 10.12965/jer.150254; PFEIFFER RD, 1986, PHYSICIAN SPORTSMED, V14, P134, DOI 10.1080/00913847.1986.11709173; Piazza Marina, 2014, Italian Journal of Anatomy and Embryology, V119, P10; Prieske O, 2013, EUR J APPL PHYSIOL, V113, P2943, DOI 10.1007/s00421-013-2724-6; Radnor JM, 2017, J STRENGTH COND RES, V31, P787, DOI 10.1519/JSC.0000000000001527; Ramirez-Campillo R, 2018, SPORTS MED, V48, P1059, DOI 10.1007/s40279-018-0870-z; Ramirez-Campillo R, 2015, J STRENGTH COND RES, V29, P1884, DOI 10.1519/JSC.0000000000000836; Ramirez-Campillo R, 2015, J STRENGTH COND RES, V29, P1784, DOI 10.1519/JSC.0000000000000827; Ramirez-Campillo R, 2015, J STRENGTH COND RES, V29, P1317, DOI 10.1519/JSC.0000000000000762; Ramirez-Campillo R, 2015, J STRENGTH COND RES, V29, P972, DOI 10.1519/JSC.0000000000000283; Ramirez-Campillo R, 2014, J SPORT SCI MED, V13, P287; Ramirez-Campillo R, 2013, J STRENGTH COND RES, V27, P2714, DOI 10.1519/JSC.0b013e318280c9e9; Rarick GL, 1958, AM ASS HLTH PHYS ED, V29, P333, DOI [10.1080/10671188.1958.10762026, DOI 10.1080/10671188.1958.10762026]; Reuter K., 2003, GENTLE STRENGTH TRAI; Rhea MR, 2004, RES Q EXERCISE SPORT, V75, P413, DOI 10.1080/02701367.2004.10609174; Rhea MR, 2004, J STRENGTH COND RES, V18, P918, DOI 10.1519/00124278-200411000-00040; Riviere M, 2017, J STRENGTH COND RES, V31, P947, DOI 10.1519/JSC.0000000000001574; Roig M, 2009, BRIT J SPORT MED, V43, P556, DOI 10.1136/bjsm.2008.051417; Rosas F, 2016, INT J SPORTS MED, V37, P1060, DOI 10.1055/s-0042-111046; Rubini EC, 2007, SPORTS MED, V37, P213, DOI 10.2165/00007256-200737030-00003; Ryan J R, 1976, Am J Sports Med, V4, P26, DOI 10.1177/036354657600400105; de Villarreal ESS, 2008, J STRENGTH COND RES, V22, P715, DOI 10.1519/JSC.0b013e318163eade; Sarwar R, 1996, J PHYSIOL-LONDON, V493, P267, DOI 10.1113/jphysiol.1996.sp021381; Schoenfeld BJ, 2016, SPORTS MED, V46, P1689, DOI 10.1007/s40279-016-0543-8; Schranz N, 2013, SPORTS MED, V43, P893, DOI 10.1007/s40279-013-0062-9; Scott BR, 2016, J SCI MED SPORT, V19, P360, DOI 10.1016/j.jsams.2015.04.014; SHIELDS C L JR, 1985, Physician and Sportsmedicine, V13, P49, DOI 10.1080/00913847.1985.11708745; Siegel J.A., 1989, PEDIATR EXERC SCI, V1, P145, DOI [10.1123/pes.1.2.145, DOI 10.1123/PES.1.2.145]; Sipaviciene S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/243572; Skurvydas A, 2010, PEDIATR EXERC SCI, V22, P547, DOI 10.1123/pes.22.4.547; Smart DJ, 2013, J STRENGTH COND RES, V27, P708, DOI 10.1519/JSC.0b013e31825d99b0; Smith JJ, 2014, SPORTS MED, V44, P1209, DOI 10.1007/s40279-014-0196-4; SMITH MJ, 1981, AM J SPORT MED, V9, P275, DOI 10.1177/036354658100900420; Soria-Gila MA, 2015, J STRENGTH COND RES, V29, P3260, DOI 10.1519/JSC.0000000000000971; STEBEN RE, 1981, J SPORT MED PHYS FIT, V21, P28; Steele J, 2017, APPL PHYSIOL NUTR ME, V42, P193, DOI 10.1139/apnm-2016-0418; Steinmann W., 1990, SPORTUNTERRICHT, V39, P326; Szymanski DJ, 2007, J STRENGTH COND RES, V21, P894; Tan B, 1999, J STRENGTH COND RES, V13, P289, DOI 10.1519/00124278-199908000-00019; TANNER JM, 1962, GROWTH ADOLESCENCE, P326; Thomas K, 2009, J STRENGTH COND RES, V23, P332, DOI 10.1519/JSC.0b013e318183a01a; Tibana RA, 2012, J STRENGTH COND RES, V26, P1027, DOI 10.1519/JSC.0b013e31822dfefb; Toigo M, 2006, EUR J APPL PHYSIOL, V97, P643, DOI 10.1007/s00421-006-0238-1; Tous-Fajardo J, 2016, INT J SPORT PHYSIOL, V11, P66, DOI 10.1123/ijspp.2015-0010; Ullrich B, 2016, J STRENGTH COND RES, V30, P2083, DOI 10.1519/JSC.0000000000001305; Uppal A, 1991, TELESNA VYCHOVA SPOR, V1, P18; van den Tillaar R, 2013, J STRENGTH COND RES, V27, P1196, DOI 10.1519/JSC.0b013e318267a494; Vom Heede A., 2007, HALTUNG BEWEGUNG, V27, P11; Vrijens J, 1978, MED SPORT, V11, P152, DOI 10.1159/000401890; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wisloff U, 2004, BRIT J SPORT MED, V38, P285, DOI 10.1136/bjsm.2002.002071; Yuktasir B, 1998, NEW STUD ATHLETICS, V13, P41	151	35	35	11	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205525	10.1371/journal.pone.0205525	http://dx.doi.org/10.1371/journal.pone.0205525			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4VA	30304033	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100103
J	Whillier, A; Hommel, S; Neef, NE; von Gudenberg, AW; Paulus, W; Sommer, M				Whillier, Alexander; Hommel, Sina; Neef, Nicole E.; von Gudenberg, Alexander Wolff; Paulus, Walter; Sommer, Martin			Adults who stutter lack the specialised pre-speech facilitation found in non-stutterers	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PRIMARY MOTOR CORTEX; CORTICOSPINAL EXCITABILITY; BRAIN; INHIBITION; POTENTIALS; AREAS; STOP	Objectives Persistent developmental stuttering is a speech fluency disorder defined by its symptoms, where the underlying neurophysiological causes remain uncertain. This study examined the underlying neurophysiological mechanisms of the speech planning process, using facilitation in the motor cortex during speech preparation as an analogue. Methods transcranial magnetic stimulation (TMS) pulses induced motor evoked potentials (MEPs), which were recorded from the tongue. Eighteen adults who stutter (AWS) and 17 adults who do not stutter (ANS) completed three experiments, which involved reading a German prefix+verb utterance from a screen. Each experiment involved 120 trials with three distinct levels of speech production: immediate speech, delayed speech without pacing and delayed speech with predefined pacing. TMS was applied shortly before speech onset. Trial MEPs were normalised to average non-speech MEPs. MEP amplitude, MEP facilitation ratio (amplitude: pre-speech offset) and group difference were the outcomes of interest analysed by multiple regression, as well as speech reaction time analysed by correlation. Results MEP values were 11.1%-23.4% lower in AWS than ANS (by standardised Beta), across all three experiments. MEP facilitation ratio slopes were also 4.9%-18.3% flatter in AWS than ANS across all three experiments. Reaction times for AWS were only significantly slower than for ANS in immediate speech and predefined pacing experiments. No stuttering was detected during the trials. The group difference in immediate speech was 100% and 101% greater than the other two experiments respectively. Discussion While performance of both ANS and AWS worsens under disturbed speech conditions, greater disturbance conditions affected controls worse than AWS. Future research and therapy in stuttering should focus on non-disturbed speech.	[Whillier, Alexander; Hommel, Sina; Paulus, Walter; Sommer, Martin] Univ Med Ctr Gottingen, Dept Clin Neurophysiol, Gottingen, Germany; [Neef, Nicole E.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany; [von Gudenberg, Alexander Wolff] Inst Kasseler Stottertherapie, Bad Emstal, Germany	University of Gottingen; Max Planck Society	Sommer, M (corresponding author), Univ Med Ctr Gottingen, Dept Clin Neurophysiol, Gottingen, Germany.	msommer@gwdg.de	Paulus, Walter/A-3544-2009; Neef, Nicole E./F-4103-2018	Paulus, Walter/0000-0001-5549-8377; Neef, Nicole E./0000-0003-2414-7595	Deutsche Forschungsgemeinschaft [SO 429/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (SO 429/4-1) to M.S.	Allen PJ, 2010, PASW STAT SPSS PRACT; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Antal A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00317; Bajaj A, 2007, J FLUENCY DISORD, V32, P218, DOI 10.1016/j.jfludis.2007.03.002; Blomgren M, 2005, J SPEECH LANG HEAR R, V48, P509, DOI 10.1044/1092-4388(2005/035); Bloodstein O., 2008, HDB STUTTERING; Bosshardt HG, 2006, CLIN LINGUIST PHONET, V20, P371, DOI 10.1080/02699200500074321; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Buchel C, 2004, PLOS BIOL, V2, P159, DOI 10.1371/journal.pbio.0020046; Busan P, 2017, CLIN NEUROPHYSIOL, V128, P952, DOI 10.1016/j.clinph.2017.03.039; Busan P, 2013, CORTEX, V49, P781, DOI 10.1016/j.cortex.2011.12.002; Cai S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00054; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; Chang SE, 2013, BRAIN, V136, P3709, DOI 10.1093/brain/awt275; Chang SE, 2011, CEREB CORTEX, V21, P2507, DOI 10.1093/cercor/bhr028; Colebatch JG, 2007, MOVEMENT DISORD, V22, P601, DOI 10.1002/mds.21323; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Euler HA, 2009, SPRACHE-STIMME-GEHOR, V33, P193, DOI 10.1055/s-0029-1242747; Euler HA, 2014, J FLUENCY DISORD, V39, P1, DOI 10.1016/j.jfludis.2014.01.002; Gordon N, 2002, DEV MED CHILD NEUROL, V44, P278, DOI 10.1017/S0012162201002067; Kaneko K, 1996, ELECTROMYOGR MOTOR C, V101, P478, DOI 10.1016/S0921-884X(96)96021-X; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kell CA, 2009, BRAIN, V132, P2747, DOI 10.1093/brain/awp185; Maassen B, 2004, SPEECH MOTOR CONTROL; Manenti R, 2016, MOVEMENT DISORD, V31, P715, DOI 10.1002/mds.26561; Markett S, 2016, NEUROPSYCHOLOGIA, V91, P444, DOI 10.1016/j.neuropsychologia.2016.09.008; Michelet T, 2010, J NEUROPHYSIOL, V104, P119, DOI 10.1152/jn.00819.2009; Muellbacher W, 2001, J CLIN NEUROPHYSIOL, V18, P550, DOI 10.1097/00004691-200111000-00005; Neef NE, 2011, CLIN NEUROPHYSIOL, V122, P1802, DOI 10.1016/j.clinph.2011.02.003; Neef NE, 2016, NEUROIMAGE, V142, P628, DOI 10.1016/j.neuroimage.2016.08.030; Neef NE, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0579-4; Neef NE, 2015, BRAIN, V138, P712, DOI 10.1093/brain/awu390; Neef NE, 2011, CORTEX, V47, P945, DOI 10.1016/j.cortex.2010.06.007; REICH A, 1981, J SPEECH HEAR RES, V24, P192, DOI 10.1044/jshr.2402.192; Reilly J, 2005, CONT ISSUES COMMUNIC, V32, P38, DOI [10.1044/cicsd_32_S_38, DOI 10.1044/CICSD_32_S_38]; Reilly S, 2013, PEDIATRICS, V132, P460, DOI 10.1542/peds.2012-3067; Riley G., 1994, STUTTERING SEVERITY; Rodel RMW, 2003, ANN OTO RHINOL LARYN, V112, P71; Salvador R, 2011, CLIN NEUROPHYSIOL, V122, P748, DOI 10.1016/j.clinph.2010.09.022; Sandrieser P, 2008, STOTTERN KINDESALTER; Sommer M, 2006, CLIN NEUROPHYSIOL, V117, P838, DOI 10.1016/j.clinph.2005.10.029; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Stinear CM, 2009, NEUROSCI BIOBEHAV R, V33, P662, DOI 10.1016/j.neubiorev.2008.08.013; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; van der Salm SMA, 2012, J NEUROL NEUROSUR PS, V83, P1162, DOI 10.1136/jnnp-2012-303081; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; Wood Heather, 2016, Nat Rev Neurol, V12, P126, DOI 10.1038/nrneurol.2016.16	47	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0202634	10.1371/journal.pone.0202634	http://dx.doi.org/10.1371/journal.pone.0202634			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4VA	30303960	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100011
J	Pedroso, J; Toral, N; Gubert, MB				Pedroso, Jessica; Toral, Natacha; Gubert, Muriel Bauermann			Maternal dissatisfaction with their children's body size in private schools in the Federal District, Brazil	PLOS ONE			English	Article							WEIGHT STATUS; FEEDING PRACTICES; NUTRITIONAL-STATUS; PERCEPTIONS; MOTHERS; IMAGE; SATISFACTION; STRATEGIES; CALIFORNIA; MEXICO	We investigated the prevalence of maternal dissatisfaction with their child's body size and its associated factors among mothers of first- to third-grade elementary school students in private schools in the Federal District, Brazil. This is a cross-sectional study with 548 mother-schoolchildren pairs. We measured children's weight and height, and collected their mother's sociodemographic data and Body Mass Index using an online questionnaire. We also verified maternal body dissatisfaction and maternal dissatisfaction with their child's body size using Shape Scales. Most mothers (50.5%) were dissatisfied with their child's body size. Mothers of boys (Adjusted OR = 2.85) were more likely to want a larger silhouette for their child, while mothers of girls (Adjusted OR = 3.18), overweight (Adjusted OR = 24.83) and obese (Adjusted OR = 189.86) children were more likely to want a thinner silhouette for their child. A positive correlation was observed between maternal dissatisfaction with their own body and maternal dissatisfaction with their children's body size (r(s) = 0.178). There was a high prevalence of maternal dissatisfaction with their child's body size, particularly among mothers of overweight and obese children. Additional studies should be conducted to better understand the influence of this dissatisfaction on maternal practices and attitudes related to their child's body, food consumption, and lifestyle.	[Pedroso, Jessica; Toral, Natacha; Gubert, Muriel Bauermann] Univ Brasilia, Postgrad Program Human Nutr, Brasilia, DF, Brazil	Universidade de Brasilia	Pedroso, J (corresponding author), Univ Brasilia, Postgrad Program Human Nutr, Brasilia, DF, Brazil.	jessicapedroso1211@gmail.com		Pedroso, Jessica/0000-0001-5446-4319; Toral, Natacha/0000-0003-0297-2340	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001.	Alm S, 2015, APPETITE, V89, P112, DOI 10.1016/j.appet.2015.02.002; Aparicio G, 2013, ATEN PRIM, V45, P194, DOI 10.1016/S0212-6567(13)70022-2; Binkin N, 2013, NUTR METAB CARDIOVAS, V23, P410, DOI 10.1016/j.numecd.2011.09.006; Blissett J, 2006, APPETITE, V47, P212, DOI 10.1016/j.appet.2006.04.002; Brasil Ministerio da Saude, 2017, VIG FAT RISC PROT DO; Damiano SR, 2015, J EAT DISORD, V3, DOI 10.1186/s40337-015-0048-0; Duarte LS, 2016, REV ESC ENFERM USP, V50, P771, DOI [10.1590/s0080-623420160000600009, 10.1590/S0080-623420160000600009]; Duarte LS, 2016, J PEDIATR NURS, V31, P490, DOI 10.1016/j.pedn.2016.03.022; Duchin O, 2016, PUBLIC HEALTH NUTR, V19, P287, DOI 10.1017/S1368980015001317; Fitzsimmons-Craft EE, 2012, BODY IMAGE, V9, P43, DOI 10.1016/j.bodyim.2011.09.002; Fonseca Maria de Jesus Mendes da, 2004, Rev. Saúde Pública, V38, P392; Peixoto MDG, 2006, REV SAUDE PUBL, V40, P1065, DOI 10.1590/S0034-89102006000700015; Gualdi-Russo E, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-85; Guendelman S, 2010, J AM DIET ASSOC, V110, P222, DOI 10.1016/j.jada.2009.10.033; Hager ER, 2012, ARCH PEDIAT ADOL MED, V166, P417, DOI 10.1001/archpediatrics.2011.1900; Instituto Brasileiro de Geografia e Estatistica, 2010, CENS DEM 2010 ED DES; Kakeshita I. S., 2008, THESIS; Kakeshita Idalina Shiraishi, 2009, Psic.: Teor. e Pesq., V25, P263, DOI 10.1590/S0102-37722009000200015; Killion L, 2006, INT J PEDIATR OBES, V1, P96, DOI 10.1080/17477160600684286; Larsen PS, 2015, HARVARD REV PSYCHIAT, V23, P395, DOI 10.1097/HRP.0000000000000073; Lindsay AC, 2009, J BIOSOC SCI, V41, P21, DOI 10.1017/S0021932008003039; Lorenzato L., 2012, THESIS; Loth KA, 2013, APPETITE, V60, P140, DOI 10.1016/j.appet.2012.09.019; May AL, 2007, J AM DIET ASSOC, V107, P1167, DOI 10.1016/j.jada.2007.04.009; Maynard LM, 2003, PEDIATRICS, V111, P1226; McCabe MP, 2005, J APPL DEV PSYCHOL, V26, P559, DOI 10.1016/j.appdev.2005.06.007; Moraes André Guerra Esteves de, 2014, Nova econ., V24, P409, DOI 10.1590/0103-6351/1564; Pedroso J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176344; Ricca Valdo, 2010, Clin Pract Epidemiol Ment Health, V6, P59, DOI 10.2174/1745017901006010059; Rosas LG, 2010, MATERN CHILD HLTH J, V14, P886, DOI 10.1007/s10995-009-0534-6; Runfola CD, 2013, EUR EAT DISORD REV, V21, P52, DOI 10.1002/erv.2201; Scaglioni S, 2011, AM J CLIN NUTR, V94, p2006S, DOI 10.3945/ajcn.110.001685; Schreiber AC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-450; Waldrop JB, 2016, MATERN CHILD HLTH J, V20, P2012, DOI 10.1007/s10995-016-2022-0; Warschburger P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-295; Warschburger P, 2009, PEDIATRICS, V124, pE60, DOI 10.1542/peds.2008-1845; Webber L, 2010, AM J CLIN NUTR, V92, P1423, DOI 10.3945/ajcn.2010.30112; WHO, 2009, ANTHROPLUS PERS COMP; WHO, 1997, WHO TECHN REP SER	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0204848	10.1371/journal.pone.0204848	http://dx.doi.org/10.1371/journal.pone.0204848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4OW	30300380	Green Published, gold, Green Submitted			2022-12-26	WOS:000446897200020
J	Takeda, S; Shimoda, H; Takarada, T; Imokawa, G				Takeda, Shogo; Shimoda, Hiroshi; Takarada, Toru; Imokawa, Genji			Strawberry seed extract and its major component, tiliroside, promote ceramide synthesis in the stratum corneum of human epidermal equivalents	PLOS ONE			English	Article							PERMEABILITY BARRIER HOMEOSTASIS; N-ACYL LINKAGE; ATOPIC-DERMATITIS; KERATINOCYTE DIFFERENTIATION; SPHINGOMYELIN DEACYLASE; ABNORMAL EXPRESSION; LIPID-METABOLISM; TRANS-TILIROSIDE; ETIOLOGIC FACTOR; DRY SKIN	The activation of peroxisomeproliferator-activated receptor (PPAR) a can stimulate the expression of ceramide-related enzymes, and a major component of strawberry seed extract (SSE) tiliroside enhances the expression of PPAR alpha. We determined whether SSE and tiliroside may stimulate ceramide synthesis in the stratum corneum (SC) of the human epidermal equivalents (HEEs) culture model. Treatment with SSE at 1.0 and 3.0 mu g/mL elicited a significant increase in the total ceramide content in the SC, which was accompanied by a significant increase in almost all ceramide species except for ceramide [EOS] and [AP]. Treatment with tiliroside at 0.3 mu g/mL slightly accentuated the total ceramide content in the SC together with a significant increase in the ceramide [NS, NDS] content. Messenger RNA analysis demonstrated that SSE at 1 or 3 mu g/mL significantly stimulated the gene expression of serine palmitoyltransferase (SPT) 2, ceramide synthase (CerS) 3, glucosylceramide synthase (GCS), and beta-glucocerebrosidase (GBA) but not of SPT1, sphingomyelin synthase (SMS) 1/2 and acid sphingomyelinase (ASM). In contrast, tiliroside elicited significant increases in the gene expression levels of GCS and GBA only at 0.3 and/or 0.1 mu g/mL. Western blotting analysis revealed that both SSE and tiliroside enhanced the protein expression levels of GCS and GBA but not of SPT2 at 1 or 3 and 0.1 or 0.3 mu g/mL, respectively. These findings suggested that both SSE and tiliroside have a distinct potential to stimulate the level of ceramide [NS, NDS] in the SC by enhancing the expression of GCS and GBA. The higher stimulatory effect with SSE than tiliroside on SC ceramide synthesis correlates with the significant increase observed with SSE but not tiliroside in the gene expression levels of SPT2 and CerS3. Therefore, it is anticipated that SSE is effective in improving skin barrier function and moisture retention in several ceramide-deficit skin conditions, including surfactant-induced roughened skin, xerosis, and atopic dermatitis.	[Takeda, Shogo; Shimoda, Hiroshi; Takarada, Toru] Oryza Oil & Fat Chem Co Ltd, Res & Dev Div, Ichinomiya, Aichi, Japan; [Imokawa, Genji] Chubu Univ, Res Inst Biol Funct, Kasugai, Aichi, Japan; [Imokawa, Genji] Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi, Japan	Chubu University; Utsunomiya University	Imokawa, G (corresponding author), Chubu Univ, Res Inst Biol Funct, Kasugai, Aichi, Japan.; Imokawa, G (corresponding author), Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi, Japan.	imokawag@dream.ocn.ne.jp		TAKARADA, TORU/0000-0001-9993-4433	Oryza Oil and Fat Chemical Co., Ltd.	Oryza Oil and Fat Chemical Co., Ltd.	This work was supported by Oryza Oil and Fat Chemical Co., Ltd. The funder provided support in the form of salaries for authors [ST, HS, TT] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto Kayoko, 1993, Journal of Dermatology (Tokyo), V20, P1; Baranowski M, 2007, J PHYSIOL PHARMACOL, V58, P57; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Funasaka Y., 2004, SKI, V31, P62; Goto T, 2012, MOL NUTR FOOD RES, V56, P435, DOI 10.1002/mnfr.201100458; GREEN H, 1978, CELL, V15, P801, DOI 10.1016/0092-8674(78)90265-9; Hamanaka S, 2002, J INVEST DERMATOL, V119, P416, DOI 10.1046/j.1523-1747.2002.01836.x; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hara J, 2000, J INVEST DERMATOL, V115, P406, DOI 10.1046/j.1523-1747.2000.00072.x; Hata M, 2002, NISHINIHON J DERMATO, V64, P413; Higuchi K, 2000, BIOCHEM J, V350, P747, DOI 10.1042/0264-6021:3500747; IMOKAWA G, 1991, J INVEST DERMATOL, V96, P523, DOI 10.1111/1523-1747.ep12470233; IMOKAWA G, 1989, J SOC COSMET CHEM, V40, P273; Imokawa G., 2014, J CLIN EXPT DERMATOL, V05; Imokawa G, 2009, J DERMATOL SCI, V55, P1, DOI 10.1016/j.jdermsci.2009.04.006; Ishibashi M, 2003, LAB INVEST, V83, P397, DOI 10.1097/01.LAB.0000059931.66821.92; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Jin X, 2016, EXP THER MED, V12, P499, DOI 10.3892/etm.2016.3305; Jurgonski A, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.26104; Komuves LG, 2000, J INVEST DERMATOL, V115, P353, DOI 10.1046/j.1523-1747.2000.00073.x; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Man MQ, 2006, J INVEST DERMATOL, V126, P386, DOI 10.1038/sj.jid.5700046; Mao-Qiang M, 2004, J INVEST DERMATOL, V123, P305, DOI 10.1111/j.0022-202X.2004.23235.x; Masukawa Y, 2008, J LIPID RES, V49, P1466, DOI 10.1194/jlr.M800014-JLR200; Masukawa Y, 2009, J LIPID RES, V50, P1708, DOI 10.1194/jlr.D800055-JLR200; Matsuda H, 2002, BIOORGAN MED CHEM, V10, P707, DOI 10.1016/S0968-0896(01)00321-2; Matsuki H., 2006, NISHINIHON J DERMATO, V68, P413; Matsuki H., 2004, EXOG DERMATOL, V3, P293, DOI [10.1159/000091910, DOI 10.1159/000091910]; Mizutani H., 2001, NISHINIHON J DERMATO, V63, P457, DOI [10.2336/nishinihonhifu.63.457, DOI 10.2336/NISHINIHONHIFU.63.457]; Murata Y, 1996, J INVEST DERMATOL, V106, P1242, DOI 10.1111/1523-1747.ep12348937; Nakamura T., 2000, SKIN RES, V42, P264; Ninomiya K, 2007, BIOORG MED CHEM LETT, V17, P3059, DOI 10.1016/j.bmcl.2007.03.051; Okamoto R, 2003, J LIPID RES, V44, P93, DOI 10.1194/jlr.M200225-JLR200; Pieszka M, 2013, ENVIRON TOXICOL PHAR, V36, P1055, DOI 10.1016/j.etap.2013.09.007; Qiao W, 2011, J ETHNOPHARMACOL, V135, P515, DOI 10.1016/j.jep.2011.03.062; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rivier M, 2000, J INVEST DERMATOL, V114, P681, DOI 10.1046/j.1523-1747.2000.00939.x; Sala A, 2003, EUR J PHARMACOL, V461, P53, DOI 10.1016/S0014-2999(02)02953-9; Sawada E, 2012, J DERMATOL SCI, V68, P25, DOI 10.1016/j.jdermsci.2012.07.004; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Schmuth M, 2008, J INVEST DERMATOL, V128, P2211, DOI [10.1038/jid, DOI 10.1038/JID]; Schmuth M, 2014, BBA-MOL CELL BIOL L, V1841, P463, DOI 10.1016/j.bbalip.2013.11.012; Shimoda H, 2012, J MED FOOD, V15, P1064, DOI 10.1089/jmf.2011.2137; Staumont-Salle D, 2008, J ALLERGY CLIN IMMUN, V121, P962, DOI 10.1016/j.jaci.2007.12.1165; Sugiura A, 2014, ARCH DERMATOL RES, V306, P427, DOI 10.1007/s00403-013-1430-x; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Takagi Y, 1999, J LIPID RES, V40, P861; Takagi Y, 2004, J INVEST DERMATOL, V123, P1102, DOI 10.1111/j.0022-202X.2004.23491.x; Takashima I., 2002, NISHIHIHON J DERM, V64, P612, DOI [10.2336/nishinihonhifu.64.612, DOI 10.2336/NISHINIHONHIFU.64.612]; Uchida Y, 2000, J LIPID RES, V41, P2071; Velagapudi R, 2014, BBA-GEN SUBJECTS, V1840, P3311, DOI 10.1016/j.bbagen.2014.08.008; Yamanaka M, 2001, SKIN, V43, P341; Yoshida N, 2012, ARCH DERMATOL RES, V304, P563, DOI 10.1007/s00403-012-1232-6	53	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205061	10.1371/journal.pone.0205061	http://dx.doi.org/10.1371/journal.pone.0205061			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300355	gold, Green Published, Green Submitted			2022-12-26	WOS:000446897200033
J	van Griensven, F; Mock, PA; Benjarattanaporn, P; Premsri, N; Thienkrua, W; Sabin, K; Varangrat, A; Zhao, JK; Chitwarakorn, A; Hladik, W				van Griensven, Frits; Mock, Philip A.; Benjarattanaporn, Patchara; Premsri, Nakorn; Thienkrua, Warunee; Sabin, Keith; Varangrat, Anchalee; Zhao, Jinkao; Chitwarakorn, Anupong; Hladik, Wolfgang			Estimating recent HIV incidence among young men who have sex with men: Reinvigorating, validating and implementing Osmond's algorithm for behavioral imputation	PLOS ONE			English	Article							PREVALENCE DATA; INCIDENCE RATES; SEROPREVALENCE DATA; INFECTION; THAILAND; EPIDEMIC; AGE; BANGKOK; RISK; POPULATION	HIV incidence information is essential for epidemic monitoring and evaluating preventive interventions. However, reliable HIV incidence data is difficult to obtain, especially among marginalized populations, such as young men who have sex with men (YMSM). Here we evaluate the reliability of an alternative HIV incidence assessment method, behavioral imputation, as compared to serologically estimated HIV incidence. Recent HIV incidence among YMSM (aged 18 to 21 and 18 to 24 years) enrolled in a cohort study in Bangkok from 2006 to 2014 was estimated using two mid-point methods for seroconversion: 1) between age of first anal intercourse and first HIV-positive test (without previous HIV-negative test) (behavioral imputation) and 2) between the date of last negative and first positive HIV test (serological estimation). Serologically estimated HIV incidence was taken as the "gold standard" to evaluate between-method agreement. At baseline, 314 YMSM age 18 to 21 years accumulated 674 person-years (PY) of follow-up since first anal intercourse. Considering that 50 men had prevalent HIV infection, the behaviorally imputed HIV incidence was 7.4 per 100 PY. Of the remaining 264 HIV-negative men, 54 seroconverted for HIV infection during the study, accumulating 724 PY of follow-up and a serologically estimated HIV incidence of 7.5 per 100 PY. At baseline, 712 YMSM age 18 to 24 years (including 18 to 21-year-old men analyzed above) accumulated 2143 PY of follow-up since first anal intercourse. Considering that 151 men had prevalent HIV infection, the behaviorally imputed HIV incidence was 7.0 per 100 PY. Of the remaining 561 HIV-negative men, 125 seroconverted for HIV infection during the study, accumulating 1700 PY of follow-up and a serologically estimated HIV incidence of 7.4 per 100 PY. Behavioral imputation and serological estimation are in good agreement when estimating recent HIV incidence in YMSM.	[van Griensven, Frits] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [van Griensven, Frits] UCSF, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Mock, Philip A.; Thienkrua, Warunee; Varangrat, Anchalee; Chitwarakorn, Anupong] Thailand Minist Publ Hlth US Ctr Dis Control & Pr, Nonthaburi, Thailand; [Benjarattanaporn, Patchara] UNAIDS, Bangkok, Thailand; [Premsri, Nakorn] Minist Publ Hlth, Dept Dis Control, Global Fund Principal Recipient Off, Nonthaburi, Thailand; [Sabin, Keith] UNAIDS, Geneva, Switzerland; [Zhao, Jinkao] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Hladik, Wolfgang] US Ctr Dis Control & Prevent, Atlanta, GA USA	Thai Red Cross Society; University of California System; University of California San Francisco; Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; UNAIDS; Centers for Disease Control & Prevention - USA	van Griensven, F (corresponding author), Thai Red Cross AIDS Res Ctr, Bangkok, Thailand.; van Griensven, F (corresponding author), UCSF, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	fritsvg@trcarc.org	van Griensven, Frits/G-4719-2013	van Griensven, Frits/0000-0002-0971-2843; Zhao, Jinkou/0000-0001-9184-3385; Sabin, Keith/0000-0002-2290-8621	US Centers for Disease Control and Prevention; Global Fund to Fight AIDS, Tuberculosis and Malaria	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Global Fund to Fight AIDS, Tuberculosis and Malaria	The current study was funded by the US Centers for Disease Control and Prevention and the Global Fund to Fight AIDS, Tuberculosis and Malaria to FvG. The findings and conclusions reported in this manuscript are those of the authors and not represents the views of the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2013, MMWR-MORBID MORTAL W, V62, P518; Armitage P., 2002, STAT METHODS MED RES; Balaji AB, 2013, AIDS, V27, P269, DOI 10.1097/QAD.0b013e32835ad489; Baral SD, 2014, CURR OPIN HIV AIDS, V9, P156, DOI 10.1097/COH.0000000000000037; BATTER V, 1994, AIDS, V8, P811, DOI 10.1097/00002030-199406000-00014; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Brown T, 2010, SEX TRANSM INFECT, V86, pI3, DOI 10.1136/sti.2010.044784; Chariyalertsak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024295; Cleghorn FR, 1998, AM J EPIDEMIOL, V147, P834, DOI 10.1093/oxfordjournals.aje.a009536; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Gregson S, 1996, AIDS, V10, P1689, DOI 10.1097/00002030-199612000-00014; Hallett TB, 2008, PLOS MED, V5, P611, DOI 10.1371/journal.pmed.0050080; Hallett TB, 2010, AIDS, V24, P147, DOI 10.1097/QAD.0b013e32833062dc; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kellogg TA, 2005, JAIDS-J ACQ IMM DEF, V39, P112, DOI 10.1097/01.qai.0000144444.44518.a3; Longosz AF, 2014, AIDS, V28, P1227, DOI 10.1097/QAD.0000000000000221; Longosz AF, 2014, AIDS RES HUM RETROV, V30, P339, DOI [10.1089/aid.2013.0169, 10.1089/AID.2013.0169]; McDougal JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014748; OSMOND DH, 1994, AM J PUBLIC HEALTH, V84, P1933, DOI 10.2105/AJPH.84.12.1933; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Rajan SS, 2011, J EPIDEMIOL COMMUN H, V65, P111, DOI 10.1136/jech.2009.091959; Saidel T, 1996, AM J EPIDEMIOL, V144, P214, DOI 10.1093/oxfordjournals.aje.a008916; Thienkrua W, 2018, AIDS BEHAV, V22, P2137, DOI 10.1007/s10461-017-1963-7; van Griensven F, 2015, LANCET HIV, V2, pE64, DOI 10.1016/S2352-3018(14)00031-9; van Griensven F, 2014, SEX HEALTH, V11, P180, DOI 10.1071/SH13119; van Griensven F, 2013, AIDS, V27, P825, DOI 10.1097/QAD.0b013e32835c546e; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; van Griensven F, 2010, JAIDS-J ACQ IMM DEF, V53, P234, DOI 10.1097/QAI.0b013e3181c2fc86; van Griensven G, 1997, NED T GENEESKD, V14, P2293; Williams B, 2001, STAT MED, V20, P2003, DOI 10.1002/sim.840; Zaba B, 2000, AIDS, V14, P1633, DOI 10.1097/00002030-200007280-00020; Zhao J, 2010, CHIN PREV MED, V11, P643	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0204793	10.1371/journal.pone.0204793	http://dx.doi.org/10.1371/journal.pone.0204793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300373	Green Published, gold, Green Submitted			2022-12-26	WOS:000446897200017
J	Maier, S; Goebel, U; Krause, S; Benk, C; Schick, MA; Buerkle, H; Beyersdorf, F; Kari, FA; Wollborn, J				Maier, Sven; Goebel, Ulrich; Krause, Sonja; Benk, Christoph; Schick, Martin A.; Buerkle, Hartmut; Beyersdorf, Friedhelm; Kari, Fabian A.; Wollborn, Jakob			Somatosensory and transcranial motor evoked potential monitoring in a porcine model for experimental procedures	PLOS ONE			English	Article							SPINAL-CORD; PIG MODEL; BLOOD-FLOW; SURGERY; INJURY	Evoked potential monitoring has evolved as an essential tool not only for elaborate neurological diagnostics, but also for general clinical practice. Moreover, it is increasingly used to guide surgical procedures and prognosticate neurological outcome in the critical care unit, e.g. after cardiac arrest. Experimental animal models aim to simulate a human-like scenario to deduct relevant clinical information for patient treatment and to test novel therapeutic opportunities. Porcine models are particularly ideal due to a comparable cardiovascular system and size. However, certain anatomic disparities have to be taken into consideration when evoked potential monitoring is used in animal models. We describe a non-invasive and reproducible set-up useful for different modalities in porcine models. We further illustrate hints to overcome multi-faceted problems commonly occurring while using this sophisticated technique. Our descriptions can be used to answer a plethora of experimental questions, and help to further facilitate experimental therapeutic innovation.	[Maier, Sven; Krause, Sonja; Benk, Christoph; Beyersdorf, Friedhelm; Kari, Fabian A.] Univ Heart Ctr Freiburg, Dept Cardiovasc Surg, Freiburg, Germany; [Maier, Sven; Goebel, Ulrich; Krause, Sonja; Benk, Christoph; Schick, Martin A.; Buerkle, Hartmut; Beyersdorf, Friedhelm; Kari, Fabian A.; Wollborn, Jakob] Univ Freiburg, Fac Med, Freiburg, Germany; [Goebel, Ulrich; Schick, Martin A.; Buerkle, Hartmut; Wollborn, Jakob] Univ Freiburg, Dept Anesthesiol & Crit Care, Med Ctr, Freiburg, Germany	Universitats Herzzentrum Freiburg; University of Freiburg; University of Freiburg	Wollborn, J (corresponding author), Univ Freiburg, Fac Med, Freiburg, Germany.; Wollborn, J (corresponding author), Univ Freiburg, Dept Anesthesiol & Crit Care, Med Ctr, Freiburg, Germany.	jakob.wollborn@uniklinik-freiburg.de	Beyersdorf, Friedhelm/AAK-3718-2020; Schick, Martin/ABH-6971-2020; Kari, Fabian A/AAE-5604-2021; Maier, Sven/ADH-5286-2022; Goebel, Ulrich M./AGG-1495-2022; Goebel, Ulrich/Q-7613-2016	Beyersdorf, Friedhelm/0000-0003-2975-2751; Wollborn, Jakob/0000-0002-6767-7978; Goebel, Ulrich/0000-0002-9991-3226	Department of Cardiovascular Surgery, University Heart Center Freiburg; Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg; German Research Foundation (DFG); University of Freiburg; Faculty of Medicine, University of Freiburg	Department of Cardiovascular Surgery, University Heart Center Freiburg; Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg; Faculty of Medicine, University of Freiburg	The study was supported by departmental funds (Department of Cardiovascular Surgery, University Heart Center Freiburg and the Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg and Faculty of Medicine, University of Freiburg). The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.	Benavides FD, 2017, J NEUROTRAUM, V34, P2595, DOI 10.1089/neu.2016.4511; Chomiak J, 1995, Eur Spine J, V4, P180, DOI 10.1007/BF00298243; Endisch C, 2015, NEUROLOGY, V85, P1752, DOI 10.1212/WNL.0000000000002123; Freye Enno, 2005, J Clin Monit Comput, V19, P77, DOI 10.1007/s10877-005-0713-y; Haapanen H, 2016, J THORAC CARDIOV SUR, V151, P777, DOI 10.1016/j.jtcvs.2015.07.036; Hadley MN, 2017, NEUROSURGERY, V81, P713, DOI 10.1093/neuros/nyx466; Kari FA, 2016, SEMIN THORAC CARDIOV, V28, P378, DOI 10.1053/j.semtcvs.2016.06.004; Kim SM, 2013, J KOREAN MED SCI, V28, P1261, DOI 10.3346/jkms.2013.28.9.1261; Kumar A, 2000, ANAESTHESIA, V55, P225, DOI 10.1046/j.1365-2044.2000.01120.x; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Lascano AM, 2017, J NEUROL NEUROSUR PS, V88, P688, DOI 10.1136/jnnp-2016-314791; LUDERS H, 1985, J CLIN NEUROPHYSIOL, V2, P383; Lyon R, 2009, J CLIN MONIT COMPUT, V23, P403, DOI 10.1007/s10877-009-9205-9; Meissner A, 2011, EUR SURG RES, V47, P141, DOI 10.1159/000330756; Mok JM, 2008, SPINE, V33, pE465, DOI 10.1097/BRS.0b013e318178e67f; Moller AR, 1991, INTRAOPERATIVE NEURO, P42, DOI [10.1007/978-3-642-75750-1_5, DOI 10.1007/978-3-642-75750-1_5]; Morota N, 1997, NEUROSURGERY, V41, P1327, DOI 10.1097/00006123-199712000-00017; NAITO M, 1992, SPINE, V17, P1154, DOI 10.1097/00007632-199210000-00005; OWEN JH, 1988, SPINE, V13, P1111, DOI 10.1097/00007632-198810000-00010; Park JH, 2015, WORLD J CLIN CASES, V3, P765, DOI 10.12998/wjcc.v3.i9.765; Puschel A, 2018, ANN VASC SURG, V49, P191, DOI 10.1016/j.avsg.2018.01.095; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Singh H, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/1751245; Sloan TB, 2013, J CARDIOTHOR VASC AN, V27, P1364, DOI 10.1053/j.jvca.2012.09.027; Usakli Ali Bulent, 2010, Comput Intell Neurosci, P630649, DOI 10.1155/2010/630649; Wang YZ, 2005, CLIN NEUROPHYSIOL, V116, P2420, DOI 10.1016/j.clinph.2005.07.004	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205410	10.1371/journal.pone.0205410	http://dx.doi.org/10.1371/journal.pone.0205410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296297	gold, Green Submitted, Green Published			2022-12-26	WOS:000446632700037
J	Kattelus, H; Kesaniemi, YA; Huikuri, H; Ukkola, O				Kattelus, Helena; Kesaniemi, Y. Antero; Huikuri, Heikki; Ukkola, Olavi			Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study)	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; PREVALENCE; SURGERY; SOCIETY	Introduction Relation between atrial fibrillation (AF) and cancer is known but not very well understood. The purpose of this prospective study was to find out whether subjects with cancer were at greater risk of AF than subjects without cancer. Materials and methods The study was based on the OPERA (Oulu Project Elucidating Risk of Atherosclerosis) material and had 1045 subjects and the mean follow-up time of 16.3 years. During the follow-up AF and cancer diagnosis were made (atrial flutter included) if these events were listed in the National Death Registry and/or hospital discharge registry. Results In this study 130 subjects (12%) had cancer and 19% of these had AF, whereas only 9% of those without cancer experienced AF during the follow-up (p<0.001). Subjects in the cancer group had greater probability of developing atrial fibrillation during the follow-up time in comparison to the subjects without cancer (Hazard ratio (HR) 2.47 (95%CI) 1.57-3.88) in multi-variate model including relevant confounding factors. Conclusion The main finding of this OPERA study was that cancer is an independent risk factor of atrial fibrillation. Still it remains unclear whether this association is causative or whether cancer and atrial fibrillation just share the same pathophysiologic mechanisms.	[Ukkola, Olavi] Oulu Univ Hosp, Med Res Ctr Oulu, Res Unit Internal Med, Oulu, Finland; Univ Oulu, Oulu, Finland	University of Oulu; University of Oulu	Ukkola, O (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu, Res Unit Internal Med, Oulu, Finland.	olavi.ukkola@oulu.fi						Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Erichsen R, 2012, INTERN EMERG MED, V7, P431, DOI 10.1007/s11739-011-0701-9; Farmakis D, 2014, J AM COLL CARDIOL, V63, P945, DOI 10.1016/j.jacc.2013.11.026; Ferreira C, 2015, ARQ BRAS CARDIOL, V105, P519, DOI 10.5935/abc.20150142; Garner M, 2017, INTERACT CARDIOV TH, V24, P260, DOI 10.1093/icvts/ivw348; Guzzetti S, 2008, INTERN EMERG MED, V3, P227, DOI 10.1007/s11739-008-0124-4; Hu YF, 2013, INT J CARDIOL, V165, P355, DOI 10.1016/j.ijcard.2012.08.036; Iwata T, 2016, SURG TODAY, V46, P877, DOI 10.1007/s00595-015-1258-4; Karajamaki AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142937; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Krawczuk-Rybak M, 2017, J MED IMAG RADIAT ON, V61, P85, DOI 10.1111/1754-9485.12510; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Marijon E, 2013, CIRCULATION, V128, P2192, DOI 10.1161/CIRCULATIONAHA.112.000491; Melichar B, 2012, ANTICANCER RES, V32, P4077; Mery B, 2017, INT J CARDIOL, V240, P196, DOI 10.1016/j.ijcard.2017.03.132; Muranishi Y, 2017, SURG TODAY, V47, P252, DOI 10.1007/s00595-016-1380-y; O'Neal WT, 2015, AM J CARDIOL, V115, P1090, DOI 10.1016/j.amjcard.2015.01.540; Onaitis M, 2010, ANN THORAC SURG, V90, P368, DOI 10.1016/j.athoracsur.2010.03.100; Ostenfeld EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102861; Perkiomaki J, 2014, J CARDIOVASC ELECTR, V25, P719, DOI 10.1111/jce.12402; Rantala AO, 1999, J INTERN MED, V245, P163, DOI 10.1046/j.1365-2796.1999.00429.x; Siu CW, 2005, PACE, V28, pS120, DOI 10.1111/j.1540-8159.2005.00024.x; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; Suter TM, 2013, EUR HEART J, V34, P1102, DOI 10.1093/eurheartj/ehs181	25	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205454	10.1371/journal.pone.0205454	http://dx.doi.org/10.1371/journal.pone.0205454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289944	Green Published, Green Submitted, gold			2022-12-26	WOS:000446545500068
J	Lee, D; Kim, P				Lee, Dongryul; Kim, Pilwon			Isolation and exploitation of minority: Game theoretical analysis	PLOS ONE			English	Article							DISCRIMINATION; COOPERATION; PROPERTY	We investigate various group-size distributions occurring in a situation where each group's resource is exposed to appropriation by other groups. The amount of appropriation depends on the size difference between groups. Our work focuses on the cases where the entire community isolates a small group or even an individual to maximize its gain. While people's basic motivation to form a group can be understood based on the group-size effect on multi-plying a collective asset, sensitive factors that induce a asymmetric group distribution are the group efficiency and the ratio of secured assets to assets pending in a competition. We show that social rejection to a minor group may occur when the group efficiency is relatively low and their asset is severely exposed to possible appropriation.	[Lee, Dongryul] Sungshin Univ, Dept Econ, Seoul 136742, South Korea; [Kim, Pilwon] UNIST, Sch Nat Sci, Dept Math Sci, Ulsan 689798, South Korea	Sungshin Women's University; Ulsan National Institute of Science & Technology (UNIST)	Kim, P (corresponding author), UNIST, Sch Nat Sci, Dept Math Sci, Ulsan 689798, South Korea.	pwkim@unist.ac.kr		Kim, Pilwon/0000-0003-2230-7815	Ministry of Education of the Republic of Korea; National Research Foundation of Korea [NRF-2015S1A5A2A03049830, 2017R1D1A1B04032921]	Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2015S1A5A2A03049830, 2017R1D1A1B04032921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altonji J, 1999, HDB LABOR EC C, V3C, P3143, DOI DOI 10.1016/S1573-4463(99)30039-0; Arrow K., 1973, DISCRIMINATION LABOR, V3, P3; Aumann R. J., 1974, International Journal of Game Theory, V3, P217, DOI 10.1007/BF01766876; Becker G. S., 2010, EC DISCRIMINATION; BLANZ M, 1995, EUR J SOC PSYCHOL, V25, P231, DOI 10.1002/ejsp.2420250208; Demange G, 2005, GROUP FORMATION IN ECONOMICS: NETWORKS, CLUBS, AND COALITIONS, P1, DOI 10.1017/CBO9780511614385; Fix Michael E., 1993, CLEAR CONVINCING EVI; Garfinkel M.R., 2007, HDB DEFENSE EC, V2, P649; GROSSMAN HI, 1995, J POLIT ECON, V103, P1275, DOI 10.1086/601453; HIRSHLEIFER D, 1989, J ECON BEHAV ORGAN, V12, P87, DOI 10.1016/0167-2681(89)90078-4; Hirshleifer J., 1991, ECON POLIT-OXFORD, V3, P177, DOI [10.1111/j.1468-0343.1991.tb00046.x, DOI 10.1111/J.1468-0343.1991.TB00046.X]; Hirshleifer Jack, 1995, HDB DEFENSE EC, V1, P165, DOI DOI 10.1016/S1574-0013(05)80009-2; Kim P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094333; Maier-Rigaud FP, 2010, J ECON BEHAV ORGAN, V73, P387, DOI 10.1016/j.jebo.2009.11.001; Myerson R. B., 1977, Mathematics of Operations Research, V2, P225, DOI 10.1287/moor.2.3.225; Neumark D, 1996, Q J ECON, V111, P915, DOI 10.2307/2946676; Ouwerkerk J.W., 2005, SOCIAL OUTCAST OSTRA, P321, DOI DOI 10.4324/978020; Owen G., 1977, Mathematical economics and game thoery, P76; PHELPS ES, 1972, AM ECON REV, V62, P659; Ray D., 2007, GAME THEORETIC PERSP; Seyranian V, 2008, GROUP PROCESS INTERG, V11, P21, DOI 10.1177/1368430207084843; Shenoy P. P., 1979, International Journal of Game Theory, V8, P133, DOI 10.1007/BF01770064; SKAPERDAS S, 1992, AM ECON REV, V82, P720; Tavoni A, 2012, J THEOR BIOL, V299, P152, DOI 10.1016/j.jtbi.2011.07.003	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205241	10.1371/journal.pone.0205241	http://dx.doi.org/10.1371/journal.pone.0205241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289913	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500058
J	Zapata, C; Puente, A; Garcia, A; Garcia-Alba, J; Espinoza, J				Zapata, Carlos; Puente, Araceli; Garcia, Andres; Garcia-Alba, Javier; Espinoza, Jorge			Assessment of ecosystem services of an urbanized tropical estuary with a focus on habitats and scenarios	PLOS ONE			English	Article							GUAYAS RIVER ESTUARY; PROTECTED AREA; LAND-USE; MANAGEMENT; MODEL; GULF	Tropical estuaries are one of the most valuable ecosystems on the planet because of the number of ecosystem services they provide. The increasing anthropogenic pressure to which these estuaries are subject has caused a reduction in their natural capital stock. Therefore, the application of a pragmatic and rational ecosystem-based management approach to sustainably manage the multiple ecosystem services provided by this ecosystem is necessary. The aim of our study is to present an approach that combines prospective scenarios with habitat-based perspective to assess the supply capacity of ecosystem services, plus determine the impact of protected areas in an urbanized tropical estuary. The current situation and two scenarios were generated to evaluate the capacity of habitats to supply ecosystem services. This type of assessment will allow the decision makers to visualize the effect of their choices or the occurrence of events which might produce significant changes in the estuary. Thus, over time, measures can be taken to sustain the supply of ecosystem services. We determined that the establishment of protected areas have a positive impact; however, the effect is not the same for all of them. Consequently, indicating that actions such as community participation, research, education, management planning and infrastructure development must accompany the development of a protected area.	[Zapata, Carlos; Espinoza, Jorge] Inst Oceanog Armada INOCAR, Dept Hydrog, Guayaquil, Guayas, Ecuador; [Zapata, Carlos; Puente, Araceli; Garcia, Andres; Garcia-Alba, Javier] Univ Cantabria, Enviromental Hydraul Inst, Santander, Cantabria, Spain	Universidad de Cantabria	Zapata, C (corresponding author), Inst Oceanog Armada INOCAR, Dept Hydrog, Guayaquil, Guayas, Ecuador.; Zapata, C (corresponding author), Univ Cantabria, Enviromental Hydraul Inst, Santander, Cantabria, Spain.	carlos.zapata@inocar.mil.ec	Alba, Javier García/I-1614-2015; Puente, Araceli/H-3163-2015; Alba, Javier García/O-9743-2019; Gómez, Andrés García/I-2409-2015; Puente, Araceli/ABG-9362-2021	Alba, Javier García/0000-0003-3693-3753; Puente, Araceli/0000-0001-7627-4743; Alba, Javier García/0000-0003-3693-3753; Gómez, Andrés García/0000-0002-2658-7765; Puente, Araceli/0000-0001-7627-4743; zapata, carlos/0000-0001-7823-5342	Oceanographic Institute of the Ecuadorian Navy	Oceanographic Institute of the Ecuadorian Navy	This article is part of my research to obtain my phd degree. My studies are financed by the Oceanographic Institute of the Ecuadorian Navy.	Amer M, 2013, FUTURES, V46, P23, DOI 10.1016/j.futures.2012.10.003; angela Rodriguez L, 2014, VISIONES DESARROLLO; Arcade J, 2004, ANALISIS ESTRUCTURAL, P165; Arkema KK, 2012, AM FISH S S, V79, P9; Balbi ER, 2014, CONSTRUYENDO FUTURO; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Berg C, 2016, FUTURES, V81, P68, DOI 10.1016/j.futures.2015.10.014; Bitar S., 2016, SERIE GESTION PUBLIC, V85, P70; Bradfield R, 2005, FUTURES, V37, P795, DOI 10.1016/j.futures.2005.01.003; Brochier T, 2013, AQUAT LIVING RESOUR, V26, P147, DOI 10.1051/alr/2012028; Cabral P, 2015, ECOSYST SERV, V16, P306, DOI 10.1016/j.ecoser.2014.09.007; Hernandez JJC, 2010, LECT NOTES COMPUT SC, V6134, P113, DOI 10.1007/978-3-642-13681-8_14; Cardenas M., 2016, COMMUNITY STRUCTURE; Carvalho TM, 2013, LAND USE POLICY, V34, P134, DOI 10.1016/j.landusepol.2013.02.007; Castro T., 2016, SISTEMA PORTUARIO EC; CEPLAN, 2016, FAS AN LIS PROSP SEC; Chua T-E, 1990, EVALUACION CULTIVO C; CIIFEN, 2010, INF FIN MED AD RES M; CLIRSEN PMRC; MAE, 2006, ACT EST MULT MANGL C; Costanza R, 1998, ECOL ECON, V25, P67, DOI 10.1016/S0921-8009(98)00019-6; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Cruz Manuel, 2003, Gayana (Concepc.), V67, P232; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Ellison AM, 2008, J SEA RES, V59, P2, DOI 10.1016/j.seares.2007.05.003; Escobar J., 2002, CONTAMINACION RIOS S, DOI [10.3989/arbor.2000.i653.1000, DOI 10.3989/ARBOR.2000.I653.1000]; Fares I., 2016, COMERCIALIZACION CAM; Flores J., 2012, CADENA VALOR CANGREJ; FONTELA E, 1993, FUTURES, V25, P139, DOI 10.1016/0016-3287(93)90160-U; Gibbes B, 2014, ESTUARIES AUST 2050, V296, DOI [10.1007/978-94-007-7019-5, DOI 10.1007/978-94-007-7019-5]; Godet M., 2007, PROSPECTIVA ESTRATEG, V2; Godet Michael, 1993, ANTICIPACION ACCION; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hazen Sawyer, 2015, ESTUDIO IMPACTO AMBI, DOI [10.15713/ins.mmj.3, DOI 10.15713/INS.MMJ.3]; Helmut Anheier K, 2009, GLOBAL CIVIL SOC 200, P238; Hemingway KL, 2013, TIDE TOOL CONFLICT M; Herbeck LS., 2011, THESIS; Huang SL, 2009, ENVIRON IMPACT ASSES, V29, P116, DOI 10.1016/j.eiar.2008.03.003; Iturralde G, 2016, ECUADOR RESERVA ECOL, P36; Jacobs S., 2013, ECOSYSTEM SERVICE AS; Jacobs S, 2015, ECOSYST SERV, V16, P378, DOI 10.1016/j.ecoser.2014.10.006; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Lindgren M., 2003, SCENARIO PLANNING LI, DOI DOI 10.1057/9780230511620; Logan B, 2011, J PALEOLIMNOL, V46, P597, DOI 10.1007/s10933-010-9457-x; Lopoukhine N., 2012, SAPIENS, V5, p117?131, DOI DOI 10.1017/CBO9781107415324.004; Lund K., 2007, HABITAT CLASSIFICATI; MAE, 2008, PLAN MAN RES PROD FA; Martinez-Harms MJ, 2017, ECOSYST SERV, V25, P56, DOI 10.1016/j.ecoser.2017.03.021; Mascarenhas A, 2016, ECOSYST SERV, V18, P87, DOI 10.1016/j.ecoser.2016.02.011; McCann MJ, 2017, FRONT ECOL ENVIRON, V15, P142, DOI 10.1002/fee.1474; McLusky D.S., 2005, ESTUARINE ECOSYSTEM; MEA, 2005, EC HUM WELL BEING SY, DOI [10.1196/annals.1439.003, DOI 10.1196/ANNALS.1439.003]; Mukul SA, 2017, ECOSYST SERV, V26, P355, DOI 10.1016/j.ecoser.2017.04.001; Palaima A., 2013, ECOL CONSERV RESTOR, P207; Potschin M, 2013, LANDSCAPE ECOL, V28, P1053, DOI 10.1007/s10980-012-9756-x; Robinson D., 2009, ACCLIMATING NEW BAY; Rodriguez A., 2005, ACTA OCEAN PACIFICO, V103, P2005; Sadio O, 2015, OCEAN COAST MANAGE, V116, P257, DOI 10.1016/j.ocecoaman.2015.08.004; Schonig D., 2014, RESILIENCE BASED RES; SENPLADES, 2016, PLAN ESP MAR COST; Stevenson M., 1981, BOLETN CIENTFICO TEC, V4, P1; Templado J., 2012, GUIA INTERPRETATIVA; Thrush SF, 2013, ECOSYST SERV NZ; Thrush SF, 2010, ANNU REV MAR SCI, V2, P419, DOI 10.1146/annurev-marine-120308-081129; Torres G., 2014, ESTRATEGIAS PREVENTI; Twilley RR, 1997, OECOLOGIA, V111, P109, DOI 10.1007/s004420050214; Twilley RR, 2001, ECOL STU AN, V144, P245; TWILLEY RR, 1998, ENVIRON SCI POLICY, V1, P271, DOI DOI 10.1016/S1462-9011(98)00012-4; USAID, 2009, SIT ACT CONC MANGL R; Vester F., 1988, SYST PRACTICE, V1, P399	70	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203927	10.1371/journal.pone.0203927	http://dx.doi.org/10.1371/journal.pone.0203927			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289936	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500009
J	Albanna, W; Kotliar, K; Luke, JN; Alpdogan, S; Conzen, C; Lindauer, U; Clusmann, H; Hescheler, J; Vilser, W; Schneider, T; Schubert, GA				Albanna, Walid; Kotliar, Konstantin; Lueke, Jan Niklas; Alpdogan, Serdar; Conzen, Catharina; Lindauer, Ute; Clusmann, Hans; Hescheler, Juergen; Vilser, Walthard; Schneider, Toni; Schubert, Gerrit Alexander			Non-invasive evaluation of neurovascular coupling in the murine retina by dynamic retinal vessel analysis	PLOS ONE			English	Article							SUBARACHNOID HEMORRHAGE; CEREBRAL AUTOREGULATION; FLICKERING LIGHT; BLOOD-FLOW; AGE; VASODILATION; DIAMETER; RAT	Background Impairment of neurovascular coupling (NVC) was recently reported in the context of subarachnoid hemorrhage and may correlate with disease severity and outcome. However, previous techniques to evaluate NVC required invasive procedures. Retinal vessels may represent an alternative option for non-invasive assessment of NVC. Methods A prototype of an adapted retinal vessel analyzer was used to assess retinal vessel diameter in mice. Dynamic vessel analysis (DVA) included an application of monochromatic flicker light impulses in predefined frequencies for evaluating NVC. All retinae were harvested after DVA and electroretinograms were performed. Results A total of 104 retinal scans were conducted in 21 male mice (90 scans). Quantitative arterial recordings were feasible only in a minority of animals, showing an emphasized reaction to flicker light impulses (8 mice; 14 scans). A characteristic venous response to flicker light, however, could observed in the majority of animals. Repeated measurements resulted in a significant decrease of baseline venous diameter (7 mice; 7 scans, p < 0.05). Ex-vivo electroretinograms, performed after in-vivo DVA, demonstrated a significant reduction of trans-retinal signaling in animals with repeated DVA (n = 6, p < 0.001). Conclusions To the best of our knowledge, this is the first non-invasive study assessing murine retinal vessel response to flicker light with characteristic changes in NVC. The imaging system can be used for basic research and enables the investigation of retinal vessel dimension and function in control mice and genetically modified animals.	[Albanna, Walid; Lueke, Jan Niklas; Alpdogan, Serdar; Hescheler, Juergen; Schneider, Toni] Univ Cologne, Inst Neurophysiol, Cologne, Germany; [Albanna, Walid; Conzen, Catharina; Lindauer, Ute; Clusmann, Hans; Schubert, Gerrit Alexander] Rhein Westfal TH Aachen, Dept Neurosurg, Aachen, Germany; [Kotliar, Konstantin] FH Aachen Univ Appl Sci, Dept Med Engn & Technomath, Aachen, Germany; [Lindauer, Ute] Rhein Westfal TH Aachen, Tranlat Neurosurg & Neurobiol, Aachen, Germany; [Vilser, Walthard] IMEDOS Syst UG, Jena, Germany	University of Cologne; RWTH Aachen University; RWTH Aachen University	Albanna, W (corresponding author), Univ Cologne, Inst Neurophysiol, Cologne, Germany.; Albanna, W (corresponding author), Rhein Westfal TH Aachen, Dept Neurosurg, Aachen, Germany.	walbanna@ukaachen.de	Schubert, Gerrit Alexander/Q-9192-2017; Alpdogan, Serdar/AAA-4233-2022	Schubert, Gerrit Alexander/0000-0001-9135-6042; Alpdogan, Serdar/0000-0002-5188-9925; Kotliar, Konstantin/0000-0003-2087-957X; Albanna, Walid/0000-0001-9986-8739	START-Program of the Faculty of Medicine, RWTH Aachen University	START-Program of the Faculty of Medicine, RWTH Aachen University	This research program is supported by the START-Program of the Faculty of Medicine, RWTH Aachen University. One of the authors (WV), is affiliated to IMEDOS Systems, employed as CEO of the company. IMEDOS Systems gave technical instruction and support for the imaging device. The funder provided support in the form of research material, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Albanna W, 2017, CURR EYE RES, V42, P1518, DOI 10.1080/02713683.2017.1339807; Albanna W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158781; Aschinger GC, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20598; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Balbi M, 2017, J CEREB BLOOD FLOW M; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Budohoski KP, 2013, J CEREBR BLOOD F MET, V33, P449, DOI 10.1038/jcbfm.2012.189; Conzen C, 2017, TRANSL STROKE RES; Filosa JA, 2016, NEUROSCIENCE, V323, P96, DOI 10.1016/j.neuroscience.2015.03.064; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Kneser M, 2009, MED SCI MONITOR, V15, pCR436; Koide M, 2013, ACTA NEUROCHIR SUPPL, V115, P167, DOI 10.1007/978-3-7091-1192-5_32; Kornfield TE, 2014, J NEUROSCI, V34, P11504, DOI 10.1523/JNEUROSCI.1971-14.2014; Kotliar KE, 2004, GRAEF ARCH CLIN EXP, V242, P377, DOI 10.1007/s00417-003-0847-x; Kotliar K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13349-5; Kotliar KE, 2011, MICROVASC RES, V81, P123, DOI 10.1016/j.mvr.2010.11.007; Lanzl IM, 2011, ACTA OPHTHALMOL, V89, P472, DOI 10.1111/j.1755-3768.2009.01718.x; Link D, 2011, BIOMED OPT EXPRESS, V2, P3094, DOI 10.1364/BOE.2.003094; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Mandecka A, 2007, DIABETES CARE, V30, P3048, DOI 10.2337/dc07-0927; McGeechan K, 2009, AM J EPIDEMIOL, V170, P1323, DOI 10.1093/aje/kwp306; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Nagel E, 2004, INVEST OPHTH VIS SCI, V45, P1486, DOI 10.1167/iovs.03-0667; Newman EA, 2013, J CEREBR BLOOD F MET, V33, P1685, DOI 10.1038/jcbfm.2013.145; Nguyen TT, 2009, DIABETES CARE, V32, P2075, DOI 10.2337/dc09-0075; Pappas AC, 2015, J NEUROSCI, V35, P13375, DOI 10.1523/JNEUROSCI.1551-15.2015; Polak K, 2002, INVEST OPHTH VIS SCI, V43, P2721; Sharifizad M, 2016, INVEST OPHTH VIS SCI, V57, P3306, DOI 10.1167/iovs.16-19261; Szel A, 1996, MICROSC RES TECHNIQ, V35, P445	31	9	9	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204689	10.1371/journal.pone.0204689	http://dx.doi.org/10.1371/journal.pone.0204689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286110	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500035
J	Chen, X; Zhu, QY; Yu, F; Zhang, W; Wang, RN; Ye, XF; Jin, LF; Liu, YC; Li, SF; Chen, Y				Chen, Xiao; Zhu, Qiaoyun; Yu, Fei; Zhang, Wen; Wang, Ruonan; Ye, Xianfei; Jin, Linfeng; Liu, Yanchao; Li, Shufei; Chen, Yu			Serology, virulence and molecular characteristics of Vibrio parahaemolyticus isolated from seafood in Zhejiang province	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; CLINICAL STRAINS; PREVALENCE; DIVERSITY; THAILAND; WATERS; MEXICO; O3-K6; CHINA; CLONE	Vibrio parahaemolyticus is a leading foodborne pathogen in southeastern China. In this study, 105 strains of V. parahaemolyticus were isolated from fresh seafood in 2013 and 2014. The serotypes, virulence-associated genes and sequence types (STs) of these strains were analyzed. 26 defined serotypes were identified and 69 strains (65.7%) had untypeable O or K antigen. 8 strains (7.6%) had the virulence-associated gene tdh and no strain carried the trh gene. 45.7% (48/105) of isolates contained all four T3SS1 genes and 50% (4/8) tdh(+) trh(-) V. parahaemolyticus isolates lacked at least one of the four tested T3SS2a genes. 105 strains could be categorized into 84 STs and only 3 STs (ST3, ST8, ST675) had appeared in clinical strains. V. parahaemolyticus strains from seafood have more diverse and untypeable serotypes, less virulence-associated genes and more STs than strains from clinical sources.	[Chen, Xiao; Jin, Linfeng; Chen, Yu] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Affiliated Hosp 1,Sch Med, Hangzhou, Zhejiang, Peoples R China; [Chen, Xiao; Zhu, Qiaoyun; Yu, Fei; Zhang, Wen; Wang, Ruonan; Ye, Xianfei; Liu, Yanchao; Li, Shufei; Chen, Yu] Zhejiang Univ, Key Lab Clin Vitro Diagnost Tech Zhejiang Prov, Dept Clin Lab, Affiliated Hosp 1,Sch Med, Hangzhou, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University	Chen, Y (corresponding author), Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Affiliated Hosp 1,Sch Med, Hangzhou, Zhejiang, Peoples R China.; Chen, Y (corresponding author), Zhejiang Univ, Key Lab Clin Vitro Diagnost Tech Zhejiang Prov, Dept Clin Lab, Affiliated Hosp 1,Sch Med, Hangzhou, Zhejiang, Peoples R China.	chenyuzy@zju.edu.cn	Chen, Yu/Y-3292-2019; Chen, Yi/HIR-2608-2022		National Key Programs for Infectious Diseases of China [2012ZX10004210, 2017ZX10103008]	National Key Programs for Infectious Diseases of China	This work was supported by the National Key Programs for Infectious Diseases of China (2012ZX10004210, 2017ZX10103008)(YC,XC).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee SK, 2014, J CLIN MICROBIOL, V52, P1081, DOI 10.1128/JCM.03047-13; Caburlotto G, 2008, EURO SURVEILLANCE B, V13; Chao GX, 2010, FOODBORNE PATHOG DIS, V7, P649, DOI 10.1089/fpd.2009.0441; Chen Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.11.003; Hernandez-Diaz LD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00221; DePaola A, 2003, APPL ENVIRON MICROB, V69, P3999, DOI 10.1128/AEM.69.7.3999-4005.2003; Ellis CN, 2012, APPL ENVIRON MICROB, V78, P3778, DOI 10.1128/AEM.07794-11; Gavilan RG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002210; Jones JL, 2012, J CLIN MICROBIOL, V50, P2343, DOI 10.1128/JCM.00196-12; KANEKO T, 1973, J BACTERIOL, V113, P24, DOI 10.1128/JB.113.1.24-32.1973; Laohaprertthisan V, 2003, EPIDEMIOL INFECT, V130, P395, DOI 10.1017/S0950268803008458; Letchumanan V, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00705; Li JJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00787; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Nordstrom JL, 2007, J CARDIOVASCULAR ELE, V14, P616; Noriea NF, 2010, J APPL MICROBIOL, V109, P953, DOI 10.1111/j.1365-2672.2010.04722.x; Ottaviani D, 2013, ENVIRON MICROBIOL, V15, P1377, DOI 10.1111/j.1462-2920.2012.02839.x; Powell A, 2013, MICROB ECOL, V65, P924, DOI 10.1007/s00248-013-0201-8; Raghunath P, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00805; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Theethakaew C, 2013, APPL ENVIRON MICROB, V79, P2358, DOI 10.1128/AEM.03067-12; Tsai SE, 2013, INT J FOOD MICROBIOL, V165, P18, DOI 10.1016/j.ijfoodmicro.2013.04.017; Turner JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055726; Velazquez-Roman J, 2012, APPL ENVIRON MICROB, V78, P1794, DOI 10.1128/AEM.06953-11; Vengadesh L, 2015, FRONTIERS MICROBIOLO, V6; Yan WX, 2015, EPIDEMIOL INFECT, V143, P1020, DOI 10.1017/S0950268814001599; Yan YF, 2011, INT J FOOD MICROBIOL, V145, P106, DOI 10.1016/j.ijfoodmicro.2010.11.038	28	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204892	10.1371/journal.pone.0204892	http://dx.doi.org/10.1371/journal.pone.0204892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286209	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500058
J	Singh, R; Kalra, MK; Nitiwarangkul, C; Patti, JA; Homayounieh, F; Padole, A; Rao, P; Putha, P; Muse, VV; Sharma, A; Digumarthy, SR				Singh, Ramandeep; Kalra, Mannudeep K.; Nitiwarangkul, Chayanin; Patti, John A.; Homayounieh, Fatemeh; Padole, Atul; Rao, Pooja; Putha, Preetham; Muse, Victorine V.; Sharma, Amita; Digumarthy, Subba R.			Deep learning in chest radiography: Detection of findings and presence of change	PLOS ONE			English	Article							TUBERCULOSIS	Background Deep learning (DL) based solutions have been proposed for interpretation of several imaging modalities including radiography, CT, and MR. For chest radiographs, DL algorithms have found success in the evaluation of abnormalities such as lung nodules, pulmonary tuberculosis, cystic fibrosis, pneumoconiosis, and location of peripherally inserted central catheters. Chest radiography represents the most commonly performed radiological test for a multitude of non-emergent and emergent clinical indications. This study aims to assess accuracy of deep learning (DL) algorithm for detection of abnormalities on routine frontal chest radiographs (CXR), and assessment of stability or change in findings over serial radiographs. Methods and findings We processed 874 de-identified frontal CXR from 724 adult patients (> 18 years) with DL (Qure Al). Scores and prediction statistics from DL were generated and recorded for the presence of pulmonary opacities, pleural effusions, hilar prominence, and enlarged cardiac silhouette. To establish a standard of reference (SOR), two thoracic radiologists assessed all CXR for these abnormalities. Four other radiologists (test radiologists), unaware of SOR and DL findings, independently assessed the presence of radiographic abnormalities. A total 724 radiographs were assessed for detection of findings. A subset of 150 radiographs with follow up examinations was used to asses change over time. Data were analyzed with receiver operating characteristics analyses and post-hoc power analysis. Results About 42% (305/ 724) CXR had no findings according to SOR; single and multiple abnormalities were seen in 23% (168/724) and 35% (251/724) of CXR. There was no statistical difference between DL and SOR for all abnormalities (p = 0.2-0.8). The area under the curve (AUC) for DL and test radiologists ranged between 0.837-0.929 and 0.693-0.923, respectively. DL had lowest AUC (0.758) for assessing changes in pulmonary opacities over follow up CXR. Presence of chest wall implanted devices negatively affected the accuracy of DL algorithm for evaluation of pulmonary and hilar abnormalities. Conclusions DL algorithm can aid in interpretation of CXR findings and their stability over follow up CXR. However, in its present version, it is unlikely to replace radiologists due to its limited specificity for categorizing specific findings.	[Singh, Ramandeep; Kalra, Mannudeep K.; Nitiwarangkul, Chayanin; Patti, John A.; Homayounieh, Fatemeh; Padole, Atul; Muse, Victorine V.; Sharma, Amita; Digumarthy, Subba R.] Massachusetts Gen Hosp, Dept Radiol, 32 Fruit St, Boston, MA 02114 USA; [Singh, Ramandeep; Kalra, Mannudeep K.; Nitiwarangkul, Chayanin; Patti, John A.; Homayounieh, Fatemeh; Padole, Atul; Muse, Victorine V.; Sharma, Amita; Digumarthy, Subba R.] Harvard Med Sch, Boston, MA 02115 USA; [Nitiwarangkul, Chayanin] Mahidol Univ, Ramathibodi Hosp, Div Diagnost Radiol, Dept Diagnost & Therapeut Radiol,Fac Med, Bangkok, Thailand; [Rao, Pooja; Putha, Preetham] Qure Ai, 101 Raheja Titanium, Bombay, Maharashtra, India	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Mahidol University	Digumarthy, SR (corresponding author), Massachusetts Gen Hosp, Dept Radiol, 32 Fruit St, Boston, MA 02114 USA.; Digumarthy, SR (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	sdigumarthy@mgh.harvard.edu	Singh, Ramandeep/AAI-8987-2020	Nitiwarangkul, Chayanin/0000-0001-7018-2012; Singh, Ramandeep/0000-0001-5840-9907; Rao, Pooja/0000-0002-4846-7895				Becker AS, 2018, INT J TUBERC LUNG D, V22, P328, DOI 10.5588/ijtld.17.0520; Dagunts Dmitry, 2017, ARXIV171010501CS; FORREST JV, 1981, WESTERN J MED, V134, P485; He K., 2016, PROC IEEE COMPUT SOC; Huang G., ARXIV160806993; Hwang S., 2016, P SPIE MED IMAGING 2, V9785; Jaeger S, 2014, IEEE T MED IMAGING, V33, P233, DOI 10.1109/TMI.2013.2284099; Lakhani P, 2017, DEEP LEARNING CHEST, V2, P574; Lee MZ, 2013, IEEE ENG MED BIO, P3965, DOI 10.1109/EMBC.2013.6610413; Maduskar P, 2013, INT J TUBERC LUNG D, V17, P1613, DOI 10.5588/ijtld.13.0325; Melendez J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25265; Pande T, 2016, INT J TUBERC LUNG D, V20, P1226, DOI 10.5588/ijtld.15.0926; Quekel LGBA, 1999, CHEST, V115, P720, DOI 10.1378/chest.115.3.720; Rajpurkar P, 2017, RADIOLOGIST LEVEL PN; SHWACHMAN H, 1958, AMA J DIS CHILD, V96, P6, DOI 10.1001/archpedi.1958.02060060008002; Tudor GR, 1997, CLIN RADIOL, V52, P235, DOI 10.1016/S0009-9260(97)80280-2; van't Hoog AH, 2011, INT J TUBERC LUNG D, V15, P1308, DOI 10.5588/ijtld.11.0004; Wang X, 2017, IEEE CVPR; Xu H, 2010, COMPUTER AIDED DETEC, V9, P129; Yu PC, 2011, J DIGIT IMAGING, V24, P382, DOI 10.1007/s10278-010-9276-7; Zhu BY, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-141	21	81	84	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204155	10.1371/journal.pone.0204155	http://dx.doi.org/10.1371/journal.pone.0204155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286097	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500015
J	Yasuda, S; Kusakawa, S; Kuroda, T; Miura, T; Tano, K; Takada, N; Matsuyama, S; Matsuyama, A; Nasu, M; Umezawa, A; Hayakawa, T; Tsutsumi, H; Sato, Y				Yasuda, Satoshi; Kusakawa, Shinji; Kuroda, Takuya; Miura, Takumi; Tano, Keiko; Takada, Nozomi; Matsuyama, Satoko; Matsuyama, Akifumi; Nasu, Michiyo; Umezawa, Akihiro; Hayakawa, Takao; Tsutsumi, Hideki; Sato, Yoji			Tumorigenicity-associated characteristics of human iPS cell lines	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN FIBROBLASTS; GENETIC-VARIATION; TERATOMAS; PROLIFERATION; EXPRESSION; THERAPIES; PROGRAM; MICE	Human induced pluripotent stem cells (hiPSCs) represent promising raw materials of human cell-based therapeutic products (hCTPs). As undifferentiated hiPSCs exhibit intrinsic tumorigenicity properties that enable them to form teratomas, hCTPs containing residual undifferentiated hiPSCs may cause tumor formation following transplantation. We first established quantitative and sensitive tumorigenicity testing of hiPSCs dissociated into single cells using NOD/Shi-scid IL2Ry(null) (NOG) mice by inhibiting apoptosis of hiPSCs with a Rho kinase inhibitor. To examine different features in tumorigenicity of various hiPSCs, 10 commonly available hiPSC lines were subjected to in vivo tumorigenicity testing. Transplanted hiPSC lines showed remarkable variation in tumor incidence, formation latency, and volumes. Most of the tumors formed were classified as immature teratomas. However, no signs of malignancies, such as carcinoma and sarcoma, were recognized in the tumors. Characteristics associated tumorigenicity of hiPSCs were investigated with microarray analysis, karyotype analysis, and whole exome sequencing. Gene expression profiling and pathway analysis supported different features of hiPSC lines in tumorigenicity. hiPSC lines showed chromosomal abnormalities in some lines and 61-77 variants of cancer-related genes carrying effective nonsynonymous mutations, which were confirmed in the COSMIC databases. In this study, the chromosomal abnormalities and cancer-related gene mutations observed in hiPSC lines did not lead to the malignancy of tumors derived from hiPSCs. Our results suggest that the potential tumorigenicity risk of hCTPs containing residual undifferentiated hiPSCs is dependent on not only amounts of undifferentiated hiPSCs but also features of the cell lines used as raw materials, a finding that should be considered from the perspective of quality of hCTPs used.	[Yasuda, Satoshi; Kusakawa, Shinji; Kuroda, Takuya; Miura, Takumi; Tano, Keiko; Matsuyama, Satoko; Sato, Yoji] Natl Inst Hlth Sci, Div Cell Based Therapeut Prod, Kawasaki, Kanagawa, Japan; [Takada, Nozomi; Matsuyama, Satoko; Matsuyama, Akifumi] Natl Inst Biomed Innovat Hlth & Nutr, Ctr Rare Dis Res, Osaka, Japan; [Nasu, Michiyo; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Ctr Regenerat Med, Tokyo, Japan; [Hayakawa, Takao] Kindai Univ, Pharmaceut Res & Technol Inst, Osaka, Japan; [Tsutsumi, Hideki] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Sato, Yoji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Qual Assurance Sci Pharmaceut, Nagoya, Aichi, Japan; [Sato, Yoji] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Cellular & Gene Therapy Prod, Osaka, Japan; [Sato, Yoji] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Translat Pharmaceut Sci, Fukuoka, Fukuoka, Japan	National Institute of Health Sciences - Japan; National Center for Child Health & Development - Japan; Kindai University (Kinki University); Nagoya City University; Osaka University; Kyushu University	Sato, Y (corresponding author), Natl Inst Hlth Sci, Div Cell Based Therapeut Prod, Kawasaki, Kanagawa, Japan.; Sato, Y (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Qual Assurance Sci Pharmaceut, Nagoya, Aichi, Japan.; Sato, Y (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Dept Cellular & Gene Therapy Prod, Osaka, Japan.; Sato, Y (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Translat Pharmaceut Sci, Fukuoka, Fukuoka, Japan.	yoji@nihs.go.jp		YASUDA, Satoshi/0000-0002-1011-0815	Japanese Ministry of Health, Labour and Welfare [H25-JITSUYOKA(SAISEI)-IPPAN-008]; Japan Agency for Medical Research and Development [15bk0104014h0103, 15bk0104014h0203, 16bk0104006h0104, 16bk0104006h0204, 17bk0104006j0105, 17bk0104006j0205]	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	The present work was supported by a Research Grant from the Japanese Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/english/) (H25-JITSUYOKA(SAISEI)-IPPAN-008) and the Japan Agency for Medical Research and Development (https://www.amed.go.jp/en/) (15bk0104014h0103 to YS, 15bk0104014h0203 to SY, 16bk0104006h0104 to YS, 16bk0104006h0204 to SY, 17bk0104006j0105 to YS, and 17bk0104006j0205 to SY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu H, 2016, REGEN THER, V5, P31, DOI 10.1016/j.reth.2016.06.003; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Andrews PW, 2017, STEM CELL REP, V9, P1, DOI 10.1016/j.stemcr.2017.05.029; [Anonymous], 1987, LAB ANIMAL SCI, V37; Ben-David U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5825; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Chang YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep41913; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cunningham JJ, 2012, NAT BIOTECHNOL, V30, P849, DOI 10.1038/nbt.2329; Damjanov I, 2016, INT J DEV BIOL, V60, P337, DOI 10.1387/ijdb.160274id; Glantz S.A., 2002, PRIMER BIOSTATISTICS; Gropp M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045532; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Higasa K, 2016, J HUM GENET, V61, P547, DOI 10.1038/jhg.2016.12; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kanemura H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02334; Kusakawa S, 2015, REGEN THER, V1, P30, DOI 10.1016/j.reth.2014.12.001; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H., 2013, ARXIV PREPRINT; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lorenz R. J., 1973, Laboratory techniques in rabies. WHO Monograph Series No.23., P321; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; OCONNOR DM, 1994, INT J GYNECOL PATHOL, V13, P283, DOI 10.1097/00004347-199410000-00001; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Volodko N, 2014, FEBS LETT, V588, P2671, DOI 10.1016/j.febslet.2014.02.041; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; WHO Expert Committee on Biological Standardization, 2013, WHO TECHN REP SER, P79; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013	32	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205022	10.1371/journal.pone.0205022	http://dx.doi.org/10.1371/journal.pone.0205022			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286143	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500077
J	Basurko, C; Everhard, S; Matheus, S; Restrepo, M; Hilderal, H; Lambert, V; Boukhari, R; Duvernois, JP; Favre, A; Valmy, L; Nacher, M; Carles, G				Basurko, Celia; Everhard, Sibille; Matheus, Severine; Restrepo, Marion; Hilderal, Helene; Lambert, Veronique; Boukhari, Rachida; Duvernois, Jean-Pierre; Favre, Anne; Valmy, Larissa; Nacher, Mathieu; Carles, Gabriel			A prospective matched study on symptomatic dengue in pregnancy	PLOS ONE			English	Article							TRANSMISSION; DEPRIVATION; OUTCOMES	Dengue fever is an increasing problem worldwide, but consequences during pregnancy remain unclear. Much of the available literature suffers from methodological biases that compromise the validity of clinical recommendations. We conducted a matched cohort study during an epidemic in French Guiana to compare events and pregnancy outcomes between two paired groups of pregnant women: women having presented with symptomatic dengue during pregnancy (n = 73) and women having had neither fever nor dengue during pregnancy (n = 219). Women in each arm were matched by place of follow up, gestation weeks at inclusion, and place of residence. Dengue infection was considered to be confirmed if viral RNA, N S1 antigen, the seroconversion of IgM antibodies or the presence of IgM was detected in collected samples. According to the 2009 WHO classification, 27% of the women with symptomatic dengue had at least one clinical or biological warning sign. These complications occurred after the 28th week of gestation in 55% of cases. The medical history, socioeconomic status and demographic characteristics were included in multivariate analysis. Exposure to dengue during pregnancy was not significantly associated with prematurity, small for gestational age infants, hypertension or emergency caesarian section. Maternal dengue with warning signs was a risk factor for peripartum hemorrhage with adjusted relative risk = 8.6(95% CI = 1.2-62). There was a near significant association between dengue and in utero death (p = 0.09). This prospective comparative study underlined the importance of taking into account potential confounders between exposure to dengue and the occurrence of obstetrical events. It also confirms the need for increased vigilance for pregnant women with dengue, particularly for women who present with severe dengue.	[Basurko, Celia; Everhard, Sibille; Restrepo, Marion; Hilderal, Helene; Valmy, Larissa; Nacher, Mathieu] Ctr Hosp Cayenne, Ctr Invest Clin Antilles Guyane, Inserm CIC1424, Cayenne, French Guiana; [Basurko, Celia; Nacher, Mathieu] Univ Guyane, Equipe EA3593, Ecosyst Amazoniens & Pathol Trop, Cayenne, French Guiana; [Matheus, Severine] Inst Pasteur Guyane Cayenne, Lab Virol, Ctr Natl Reference Arbovirus, Cayenne, French Guiana; [Restrepo, Marion; Lambert, Veronique; Carles, Gabriel] Ctr Hosp Ouest Guyanais, Serv Gynecol & Obstet, St Laurent Du Maroni, French Guiana; [Restrepo, Marion] Ctr Hosp Ouest Guyanais, Pole Sante Publ, St Laurent Du Maroni, French Guiana; [Boukhari, Rachida] Ctr Hosp Ouest Guyanais, Serv Anal Med, St Laurent Du Maroni, French Guiana; [Duvernois, Jean-Pierre] Croix Rouge Francaise, Serv Gynecol & Obstet, Ctr Medicochirurg Kourou, Kourou, French Guiana; [Favre, Anne] Reseau Perinat Guyane, Cayenne, French Guiana		Basurko, C; Nacher, M (corresponding author), Ctr Hosp Cayenne, Ctr Invest Clin Antilles Guyane, Inserm CIC1424, Cayenne, French Guiana.; Basurko, C; Nacher, M (corresponding author), Univ Guyane, Equipe EA3593, Ecosyst Amazoniens & Pathol Trop, Cayenne, French Guiana.	cbasurko@gmail.com; mathieu.nacher66@gmail.com	Basurko, Célia/AAM-8297-2021; amsalu, ribka/G-8780-2019; nacher, mathieu/AAH-4796-2021	nacher, mathieu/0000-0001-9397-3204; LAMBERT, veronique/0000-0001-6453-8983; Matheus, Severine/0000-0001-9171-1964	European public funds (PO-FEDER 2007-2013 program) [31257]; Pasteur Institute; Cayenne General Hospital	European public funds (PO-FEDER 2007-2013 program); Pasteur Institute; Cayenne General Hospital	This work was supported by European public funds (PO-FEDER 2007-2013 program; presage number 31257), by Pasteur Institute, and by Cayenne General Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam I, 2010, PARITY, V2, P2; [Anonymous], 2012, WHO REC PREV POSTP H; Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028; Boussemart T, 2001, J Perinatol, V21, P255, DOI 10.1038/sj.jp.7200530; Bunyavejchevin S, 1997, J Obstet Gynaecol Res, V23, P445; Carles G, 2016, LANCET INFECT DIS, V16, P765, DOI 10.1016/S1473-3099(16)00130-4; Carroll I Dale, 2007, Travel Med Infect Dis, V5, P183, DOI 10.1016/j.tmaid.2006.11.002; Convers M, 2012, GYNECOL OBSTET FERTI, V40, P208, DOI 10.1016/j.gyobfe.2011.10.014; Cummings P, 2003, EPIDEMIOL REV, V25, P43, DOI 10.1093/epirev/mxg002; Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06; Friedman EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003226; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Ismail Nor Azlin Mohamed, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P681; Janjindamai Waricha, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P793; Kerdpanich Angkool, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P488; Labbe E, 2015, EUR J PUBLIC HEALTH, V25, P604, DOI 10.1093/eurpub/cku231; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lumbiganon P, 2014, BJOG-INT J OBSTET GY, V121, P32, DOI 10.1111/1471-0528.12647; Machain-Williams C, 2018, BIOMED RES INT, V2018, DOI [10.1155/2018/9643083, 10.1016/j.bjp.2018.10.005]; Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459; Phillips B, 2011, BJU INT, V107, P348, DOI DOI 10.1111/J.1464-410X.2011.10141.X; Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc; Restrepo Berta N, 2003, Biomedica, V23, P416; Ribeiro CF, 2012, INT J INFECT DIS, V16, pE72, DOI 10.1016/j.ijid.2011.09.005; Silver RM, 2007, AM J OBSTET GYNECOL, V196, P433, DOI 10.1016/j.ajog.2006.11.041; Tagore S, 2007, Singapore Med J, V48, pe281; Talarmin A, 1998, J CLIN MICROBIOL, V36, P1189, DOI 10.1128/JCM.36.5.1189-1192.1998; Tan PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001637; THAITHUMYANON P, 1994, CLIN INFECT DIS, V18, P248, DOI 10.1093/clinids/18.2.248; Waduge R, 2006, J CLIN VIROL, V37, P27, DOI 10.1016/j.jcv.2006.06.002; WHO, 2009, WHO TECH REP SER, V958, P1; Wiwanitkit V, 2010, J INFECT DEV COUNTR, V4, P51, DOI 10.3855/jidc.145; Woodward M., 2013, EPIDEMIOLOGY STUDY D	34	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202005	10.1371/journal.pone.0202005	http://dx.doi.org/10.1371/journal.pone.0202005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281605	gold, Green Published, Green Submitted			2022-12-26	WOS:000446342400009
J	Nalado, AM; Mahlangu, JN; Duarte, R; Paget, G; Olorunfemi, G; Jacobson, BF; Naicker, S				Nalado, Aishatu Muhammad; Mahlangu, Johnny N.; Duarte, Raquel; Paget, Graham; Olorunfemi, Gbenga; Jacobson, Barry F.; Naicker, Saraladevi			Utility of reticulocyte haemoglobin content and percentage hypochromic red cells as markers of iron deficiency anaemia among black CKD patients in South Africa	PLOS ONE			English	Article							DIAGNOSIS; ERYTHROPOIESIS; MANAGEMENT; INDEXES	Introduction Iron deficiency anaemia (IDA) worsens the prognosis and outcomes of chronic kidney disease (CKD). However, while the haemoglobin level is unreliable for early detection of IDA, reticulocyte haemoglobin content (CHr) and hypochromic red cells (%HYPO) are early markers of IDA. Methods This was a cross sectional study of black adult participants (n = 258) with CKD and apparently healthy members of staff and patients' relatives (n = 141) at the Charlotte Maxeke Johannesburg Academic Hospital, South Africa, between 1 June 2016 and 31 December 2016. Serum iron, serum ferritin and transferrin were measured using standard laboratory methods, while the haematology analyser was employed to measure CHr and %HYPO. The validity of CHr and %HYPO as markers of IDA were evaluated. Multivariable binary logistic regression was conducted to determine predictors of the relationship between IDA, CHr and %HYPO. The area under the receiver operator characteristics (ROC) curve (AUC) of the final models were utilised to evaluate the discriminatory value of CHr and %HYPO respectively. Results About one-quarter (26.1%) of the participants had IDA which was more than three times more frequent among CKD patients, compared to controls (35.3% vs 9.2%); 32.3% (95%CI: 27.90%- 37.10%) of the study population had iron deficiency without anaemia and the prevalence of iron deficiency without anaemia was lower in CKD patients compared to controls (29.5% vs 37.6%). The mean age of CKD patients was higher than in controls (52.7 +/- 14.3 vs 40.4 +/- 12.6 years, P-value<0.001). The sensitivity and specificity for diagnosing IDA among CKD participants was 62.6% and 80.2% respectively for CHr (at a cut-off value of <28pg) and 63.3% and 79.8% respectively for %HYPO. CKD participants with CHr levels >28pg were 82% less likely to be diagnosed as having IDA as compared to those with CHr levels < 28pg) (adj odds ratio = 0.18, 95% CI: 0.09-0.37). The AUC of CHr (0.81, 95% CI: 0.76-0.87) was higher than the AUC of %HYPO (0.76, 95%CI: 0.70-0.82). Conclusion The diagnostic usefulness of CHr and the screening performance of %HYPO in predicting IDA among CKD patients are high. Their lower cost compared to conventional markers of ID recommend their use in clinical practice. Further cost effectiveness studies of these parameters are warranted.	[Nalado, Aishatu Muhammad; Duarte, Raquel; Paget, Graham; Jacobson, Barry F.; Naicker, Saraladevi] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med, Johannesburg, South Africa; [Nalado, Aishatu Muhammad] Bayero Univ, Coll Hlth Sci, Dept Internal Med, Kano, Nigeria; [Mahlangu, Johnny N.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [Olorunfemi, Gbenga] Univ Witwatersrand, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa	University of Witwatersrand; Bayero University; University of Witwatersrand; University of Witwatersrand	Nalado, AM (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med, Johannesburg, South Africa.; Nalado, AM (corresponding author), Bayero Univ, Coll Hlth Sci, Dept Internal Med, Kano, Nigeria.	aishnld@yahoo.co.uk	Olorunfemi, Gbenga/AAU-6640-2021; Mahlangu, Johnny Ndoni/H-7558-2019; Barretti, Pasqual/K-4156-2012; NALADO, AISHATU/C-7357-2019	Mahlangu, Johnny Ndoni/0000-0001-5781-7669; Barretti, Pasqual/0000-0003-4979-4836; Naicker, Saraladevi/0000-0002-7058-9725; NALADO, AISHATU/0000-0003-3662-8150				Aoun M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191541; Bain BJ, 2005, J CLIN PATHOL, V58, P406, DOI 10.1136/jcp.2004.022178; Brugnara C, 2003, CLIN CHEM, V49, P1573, DOI 10.1373/49.10.1573; Dalimunthe NN, 2016, ROM J INTERN MED, V54, P31, DOI 10.1515/rjim-2016-0003; ESCHBACH JW, 1989, KIDNEY INT, V35, P134, DOI 10.1038/ki.1989.18; Fishbane S, 1997, KIDNEY INT, V52, P217, DOI 10.1038/ki.1997.323; Fishbane S, 2009, CLIN J AM SOC NEPHRO, V4, P57, DOI 10.2215/CJN.01670408; Kim JM, 2008, INT J LAB HEMATOL, V30, P46, DOI 10.1111/j.1751-553X.2007.00901.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Lorenz L, 2015, ARCH DIS CHILD-FETAL, V100, pF198, DOI 10.1136/archdischild-2014-306076; Lukaszyk E, 2015, KIDNEY BLOOD PRESS R, V40, P366, DOI 10.1159/000368512; McMurray J., 2012, KIDNEY INT SUPPL, V2, P279, DOI [10.1038/kisup.2012.37, DOI 10.1038/KISUP.2012.37]; Mei Chung, 2012, AHRQ COMP EFFECTIVEN; National Clinical Guideline C, 2011, NAT I HLTH CLIN EXC; Ratcliffe LEK, 2016, AM J KIDNEY DIS, V67, P548, DOI 10.1053/j.ajkd.2015.11.012; Riekert PD, 2014, S AFRICAN J CHILD HL, V8, P23; Schapkaitz E, 2016, SAMJ S AFR MED J, V106, P53, DOI [10.7196/SAMJ.2016.v106i1.9934, 10.7196/SAMJ.2016.V106I1.9934]; Suzuki M, 2012, INT HEART J, V53, P238, DOI 10.1536/ihj.53.238; Thomas C, 2002, CLIN CHEM, V48, P1066; Ullrich C, 2005, JAMA-J AM MED ASSOC, V294, P924, DOI 10.1001/jama.294.8.924; Wish JB, 2006, CLIN J AM SOC NEPHRO, V1, pS4, DOI 10.2215/CJN.01490506	22	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204899	10.1371/journal.pone.0204899	http://dx.doi.org/10.1371/journal.pone.0204899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281654	gold, Green Submitted, Green Published			2022-12-26	WOS:000446342400064
J	Wang, QR; Zhu, CQ; Sun, MM; Maimaiti, R; Ford, SP; Nathanielsz, PW; Ren, J; Guo, W				Wang, Qiurong; Zhu, Chaoqun; Sun, Mingming; Maimaiti, Rexiati; Ford, Stephen P.; Nathanielsz, Peter W.; Ren, Jun; Guo, Wei			Maternal obesity impairs fetal cardiomyocyte contractile function in sheep	FASEB JOURNAL			English	Article						cardiac programming; myofilament; Ca2+ sensitivity	MYOSIN HEAVY-CHAIN; TROPONIN-T ISOFORMS; BODY-MASS INDEX; CARDIAC RYANODINE RECEPTOR; CONGENITAL HEART-DEFECTS; DIET-INDUCED OBESITY; CALCIUM OVERLOAD; ALPHA-MYOSIN; INSULIN-RESISTANCE; GENE-EXPRESSION	Obesity is a major public health problem worldwide. In the United States, one-third of women of reproductive age are obese. Human studies show that maternal obesity (MO) predisposes offspring to cardiovascular disease. However, the underlying mechanisms remain unclear. Given the similarities between pregnancy in sheep and humans, we studied sheep to examine the impact of MO on fetal cardiomyocyte contractility at term. We observed that MO impaired cardiomyocyte contractility by reducing peak shortening and shortening/relengthening velocity, prolonging time to relengthening. MO disrupted Ca2+ homeostasis in fetal cardiomyocytes, increasing intracellular Ca2+ and inducing cellular Ca2+ insensitivity. The Ca2+-release channel was impaired, but Ca2+ uptake was unaffected by MO. The upstream kinases that phosphorylate the Ca2+-release channelryanodine receptor-2, PKA, and calmodulin-dependent protein kinase IIwere activated in MO fetuses. Contractile dysfunction was associated with an increased ratio of myosin heavy chain (MHC)- to MHC- and upregulated cardiac troponin (cTn)-T and tropomyosin, as well as cTn-I phosphorylation. In summary, this is the first characterization of the effects of MO on fetal cardiomyocyte contractility. Our findings indicate that MO impairs fetal cardiomyocyte contractility through altered intracellular Ca2+ handling, overloading fetal cardiomyocyte intracellular Ca2+ and aberrant myofilament protein composition. These mechanisms may contribute to developmental programming by MO of offspring cardiac function and predisposition to later life cardiovascular disease in the offspring.Wang, Q., Zhu, C., Sun, M., Maimaiti, R., Ford, S. P., Nathanielsz, P. W., Ren, J., Guo, W. Maternal obesity impairs fetal cardiomyocyte contractile function in sheep.	[Wang, Qiurong; Ford, Stephen P.; Nathanielsz, Peter W.; Guo, Wei] Univ Wyoming, Ctr Study Fetal Programming, Laramie, WY 82071 USA; [Wang, Qiurong; Zhu, Chaoqun; Sun, Mingming; Maimaiti, Rexiati; Ford, Stephen P.; Nathanielsz, Peter W.; Guo, Wei] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA; [Ren, Jun; Guo, Wei] Univ Wyoming, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming; University of Wyoming	Guo, W (corresponding author), Univ Wyoming, 1000 E Univ Ave, Laramie, WY 82071 USA.	wguo3@uwyo.edu	Ren, Jun/ACG-5366-2022	Ren, Jun/0000-0002-0275-0783; Nathanielsz, Peter/0000-0001-8410-6280; Wang, Qiurong/0000-0001-9654-9126	National Institutes of Health (NIH), National Institute of General Medical Sciences [GMSP20GM103432]; American Heart Association [16BGIA27790136]; U.S. Department of Agriculture, National Institute of Food and Agriculture Hatch Project [1009266]; NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development [1R01HD070096-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103432] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); U.S. Department of Agriculture, National Institute of Food and Agriculture Hatch Project; NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. John F. Odhiambo, Dr. Adel Ghnenis, Dr. Shuyi Wang, Dr. Guorong Ruan, Dr. Zhilong Chen, Christopher Pankey, Dallas Sturdevant, and Ashley Smith (all from the University of Wyoming) for performing tissue collection and sheep necropsy; and Pan Chen (University of Wyoming) for help in obtaining immunofluorescence microscopic images of fetal sheep LV sections. The authors dedicate this work to the late Stephen P. Ford, M.D., a cofounder of the University of Wyoming Fetal Programming Center. This work was supported by National Institutes of Health (NIH), National Institute of General Medical Sciences Grant GMSP20GM103432; American Heart Association, Beginning Grant-in-Aid award to 16BGIA27790136 (to W.G.); a U.S. Department of Agriculture, National Institute of Food and Agriculture Hatch Project 1009266 (to WG); NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant 1R01HD070096-01A1 (to S.P.F. and P.W.N.). The authors declare no conflicts of interest.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; American College of Obstetricians and Gynecologists, 2005, Obstet Gynecol, V106, P671; Anderson MS, 2001, AM J PHYSIOL-REG I, V281, pR1256, DOI 10.1152/ajpregu.2001.281.4.R1256; Anderson MS, 2001, AM J PHYSIOL-REG I, V281, pR1545, DOI 10.1152/ajpregu.2001.281.5.R1545; ANDERSON PAW, 1995, CIRC RES, V76, P681, DOI 10.1161/01.RES.76.4.681; Anthony RV, 2003, REPRODUCTION, P183; Barbera A, 2000, AM J PHYSIOL-REG I, V279, pR1157, DOI 10.1152/ajpregu.2000.279.4.R1157; BARRY WH, 1993, CIRCULATION, V87, P1806, DOI 10.1161/01.CIR.87.6.1806; Bers Donald M, 2006, Biochem J, V396, pe1; Blackmore HL, 2014, ENDOCRINOLOGY, V155, P3970, DOI 10.1210/en.2014-1383; Brite J, 2014, INT J OBESITY, V38, P878, DOI 10.1038/ijo.2013.244; Cai GJ, 2014, AM J OBSTET GYNECOL, V211, P91, DOI 10.1016/j.ajog.2014.03.028; Chandrashekhar Y, 1999, J AM COLL CARDIOL, V34, P594, DOI 10.1016/S0735-1097(99)00222-3; CLUSIN WT, 1983, LANCET, V1, P272, DOI 10.1016/S0140-6736(83)91688-4; DIGIACOMO JE, 1990, AM J PHYSIOL, V259, pE506; Dong F, 2005, GROWTH HORM IGF RES, V15, P291, DOI 10.1016/j.ghir.2005.05.003; Dong F, 2008, J NUTR BIOCHEM, V19, P409, DOI 10.1016/j.jnutbio.2007.06.003; Dong ML, 2013, J MOL CELL CARDIOL, V55, P111, DOI 10.1016/j.yjmcc.2012.08.023; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Fan XJ, 2011, J NUTR BIOCHEM, V22, P30, DOI 10.1016/j.jnutbio.2009.11.006; Fernandez-Twinn DS, 2012, ENDOCRINOLOGY, V153, P5961, DOI 10.1210/en.2012-1508; Ford SP, 2009, AM J PHYSIOL-REG I, V297, pR835, DOI 10.1152/ajpregu.00072.2009; George LA, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-75; Ghnenis AB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189977; Giraud GD, 2006, ENDOCRINOLOGY, V147, P3643, DOI 10.1210/en.2006-0061; Gomes AV, 2004, J BIOL CHEM, V279, P49579, DOI 10.1074/jbc.M407340200; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Griffiths EJ, 2000, CARDIOVASC RES, V47, P116, DOI 10.1016/S0008-6363(00)00061-4; Guo W, 2018, INT J BIOL SCI, V14, P369, DOI 10.7150/ijbs.24117; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; Gupta M, 2003, J BIOL CHEM, V278, P44935, DOI 10.1074/jbc.M307696200; HAY WW, 1995, REPROD FERT DEVELOP, V7, P365, DOI 10.1071/RD9950365; HAY WW, 1989, AM J PHYSIOL, V256, pE704; HIGGINS TJC, 1980, J MOL CELL CARDIOL, V12, P909, DOI 10.1016/0022-2828(80)90059-0; Hillemeier MM, 2011, J WOMENS HEALTH, V20, P703, DOI 10.1089/jwh.2010.2397; Huang Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE968, DOI 10.1152/ajpendo.00434.2010; Ingul CB, 2016, ULTRASOUND OBST GYN, V47, P433, DOI 10.1002/uog.14841; Jonker SS, 2007, J APPL PHYSIOL, V102, P1130, DOI 10.1152/japplphysiol.00937.2006; Jonker SS, 2007, AM J PHYSIOL-REG I, V292, pR913, DOI 10.1152/ajpregu.00484.2006; JOSEPHSON RA, 1991, J BIOL CHEM, V266, P2354; Kandadi MR, 2013, J NUTR BIOCHEM, V24, P1982, DOI 10.1016/j.jnutbio.2013.07.003; Karachaliou M, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.038; Katz AM, 2000, CIRCULATION, V102, P69; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; KITAZAWA T, 1984, J PHYSIOL-LONDON, V355, P635, DOI 10.1113/jphysiol.1984.sp015443; Klabunde R. E., 2010, CARDIOVASCULAR PHYSL; Ku PM, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-57; Kushnir A, 2010, P NATL ACAD SCI USA, V107, P10274, DOI 10.1073/pnas.1005843107; KUSUOKA H, 1987, J CLIN INVEST, V79, P950, DOI 10.1172/JCI112906; Lee KK, 2015, HYPERTENSION, V66, P938, DOI 10.1161/HYPERTENSIONAHA.115.05920; Li HQ, 2013, MOL BIOL CELL, V24, P3511, DOI 10.1091/mbc.E13-06-0352; Limesand SW, 2007, AM J PHYSIOL-ENDOC M, V293, pE1716, DOI 10.1152/ajpendo.00459.2007; Loche E, 2018, CARDIOVASC RES, V114, P1372, DOI 10.1093/cvr/cvy082; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; MALHOTRA A, 1995, MOL CELL BIOCHEM, V151, P165, DOI 10.1007/BF01322339; MCAULIFFE JJ, 1991, PEDIATR RES, V29, P580, DOI 10.1203/00006450-199106010-00012; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; MORGAN JP, 1991, NEW ENGL J MED, V325, P625; Morrison JL, 2007, AM J PHYSIOL-REG I, V293, pR306, DOI 10.1152/ajpregu.00798.2006; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; Nathanielsz PW, 2013, NUTR REV, V71, pS78, DOI 10.1111/nure.12062; National Research Council, 1985, NUTR REQ SHEEP; Nicholas LM, 2016, INT J OBESITY, V40, P229, DOI 10.1038/ijo.2015.178; Norby FL, 2002, AM J PHYSIOL-ENDOC M, V283, pE658, DOI 10.1152/ajpendo.00003.2002; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ogden Cynthia L, 2007, NCHS Data Brief, P1; Rabadan-Diehl C, 2013, J DEV ORIG HLTH DIS, V4, P3, DOI 10.1017/S2040174412000487; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Rankin J, 2010, INT J OBESITY, V34, P1371, DOI 10.1038/ijo.2010.66; Reiffert SU, 1998, BIOCHEMISTRY-US, V37, P13516, DOI 10.1021/bi980280j; Reiser PJ, 2001, AM J PHYSIOL-HEART C, V280, pH1814, DOI 10.1152/ajpheart.2001.280.4.H1814; Ren J, 2008, CRIT CARE MED, V36, P2106, DOI 10.1097/CCM.0b013e31817bf925; Ren Jun, 2001, Biological Procedures Online, V3, P43, DOI 10.1251/bpo22; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Sucharov CC, 2004, MOL CELL BIOL, V24, P8705, DOI 10.1128/MCB.24.19.8705-8715.2004; Sundgren NC, 2003, AM J PHYSIOL-REG I, V285, pR1481, DOI 10.1152/ajpregu.00232.2003; Sundgren NC, 2003, J PHYSIOL-LONDON, V548, P881, DOI 10.1113/jphysiol.2003.038778; Thompson M, 2000, PEDIATR RES, V47, P669, DOI 10.1203/00006450-200005000-00019; Thornburg KL, 2015, J DEV ORIG HLTH DIS, V6, P366, DOI 10.1017/S2040174415001300; Toemen L, 2016, INT J OBESITY, V40, P1070, DOI 10.1038/ijo.2016.86; Tuersunjiang N, 2013, AM J PHYSIOL-ENDOC M, V305, pE868, DOI 10.1152/ajpendo.00117.2013; Uchinoumi H, 2016, J MOL CELL CARDIOL, V98, P62, DOI 10.1016/j.yjmcc.2016.06.007; Vassalle M, 2004, J BIOMED SCI, V11, P542, DOI 10.1159/000079666; Vega CC, 2015, INT J OBESITY, V39, P712, DOI 10.1038/ijo.2013.150; Wallace JM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1233, DOI 10.1152/ajpendo.00294.2007; Wang JY, 2010, FASEB J, V24, P2066, DOI 10.1096/fj.09-142315; Wang KCW, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.100388; Wang QR, 2016, PHARMACOL RES, V111, P357, DOI 10.1016/j.phrs.2016.06.024; Wang QR, 2014, TOXICOL SCI, V142, P6, DOI 10.1093/toxsci/kfu158; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; World Health Organization,, 2015, OB OV; Yin ZY, 2015, BBA-MOL BASIS DIS, V1852, P47, DOI 10.1016/j.bbadis.2014.11.003; Zambrano E, 2010, J PHYSIOL-LONDON, V588, P1791, DOI 10.1113/jphysiol.2010.190033; Zambrano E, 2013, NUTR REV, V71, pS42, DOI 10.1111/nure.12068; Zhang S, 2011, PROG BIOPHYS MOL BIO, V106, P307, DOI 10.1016/j.pbiomolbio.2010.12.004; Zhu MJ, 2008, J PHYSIOL-LONDON, V586, P2651, DOI 10.1113/jphysiol.2007.149633	105	24	25	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2587	2598		10.1096/fj.201800988R	http://dx.doi.org/10.1096/fj.201800988R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30289749	Green Submitted, Green Published			2022-12-26	WOS:000457296600084
J	Keown, JR; Black, MM; Ferron, A; Yap, M; Barnett, MJ; Pearce, FG; Stoye, JP; Goldstone, DC				Keown, Jeremy R.; Black, Moyra M.; Ferron, Aaron; Yap, Melvyn; Barnett, Michael J.; Pearce, F. Grant; Stoye, Jonathan P.; Goldstone, David C.			A helical LC3-interacting region mediates the interaction between the retroviral restriction factor Trim5 and mammalian autophagy-related ATG8 proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; retrovirus; human immunodeficiency virus (HIV); protein-protein interaction; protein complex; antiviral protein; LC3B; LIR; retroviral restriction factor; Trim5alpha	REGULATE AUTOPHAGY; HUMAN TRIM5-ALPHA; HOST RESTRICTION; HIV-1; MOTIF; RECOGNITION; COMPLEX; FAMILY; REQUIREMENTS; INHIBITION	The retroviral restriction factor tripartite motif-containing 5 (Trim5) acts during the early postentry stages of the retroviral life cycle to block infection by a broad range of retroviruses, disrupting reverse transcription and integration. The mechanism of this restriction is poorly understood, but it has recently been suggested to involve recruitment of components of the autophagy machinery, including members of the mammalian autophagy-related 8 (ATG8) family involved in targeting proteins to the autophagosome. To better understand the molecular details of this interaction, here we utilized analytical ultracentrifugation to characterize the binding of six ATG8 isoforms and determined the crystal structure of the Trim5 Bbox coiled-coil region in complex with one member of the mammalian ATG8 proteins, autophagy-related protein LC3 B (LC3B). We found that Trim5 binds all mammalian ATG8s and that, unlike the typical LC3-interacting region (LIR) that binds to mammalian ATG8s through a -strand motif comprising approximately six residues, LC3B binds to Trim5 via the -helical coiled-coil region. The orientation of the structure demonstrated that LC3B could be accommodated within a Trim5 assembly that can bind the retroviral capsid. However, mutation of the binding interface does not affect retroviral restriction. Comparison of the typical linear -strand LIR with our atypical helical LIR reveals a conservation of the presentation of residues that are required for the interaction with LC3B. This observation expands the range of LC3B-binding proteins to include helical binding motifs and demonstrates a link between Trim5 and components of the autophagosome.	[Keown, Jeremy R.; Black, Moyra M.; Barnett, Michael J.; Goldstone, David C.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; [Ferron, Aaron; Stoye, Jonathan P.] Francis Crick Inst, London NW1 1ST, England; [Pearce, F. Grant] Univ Canterbury, Sch Biol Sci, Christchurch 8041, New Zealand; [Goldstone, David C.] Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand; [Keown, Jeremy R.] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England	University of Auckland; Francis Crick Institute; University of Canterbury; University of Auckland; University of Oxford	Goldstone, DC (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand.	d.goldstone@auckland.ac.nz	Keown, Jeremy/AAH-4361-2021	Goldstone, David/0000-0003-0069-9408; Ferron, Aaron/0000-0002-5776-7304; Stoye, Jonathan/0000-0003-3377-323X; Keown, Jeremy/0000-0003-0159-9257	Maurice Wilkins Centre for Molecular Biodiscovery, a Centre of Research Excellence - New Zealand government; MRC [MC_U117512710] Funding Source: UKRI	Maurice Wilkins Centre for Molecular Biodiscovery, a Centre of Research Excellence - New Zealand government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Plasmids encoding LC3A-C and GABARAP proteins used for subcloning were a kind gift from Prof. Ren Dobson (University of Canterbury). We acknowledge the New Zealand Synchrotron group for access to the MX Beamlines at the Australian Synchrotron. Access to analytical ultracentrifuge facilities was supported by funds the Maurice Wilkins Centre for Molecular Biodiscovery (to D. C. G.), a Centre of Research Excellence funded by the New Zealand government.	Adams PD, 2013, ANNU REV BIOPHYS, V42, P265, DOI 10.1146/annurev-biophys-083012-130253; Anderson JL, 2006, J VIROL, V80, P9754, DOI 10.1128/JVI.01052-06; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Biris N, 2012, P NATL ACAD SCI USA, V109, P13278, DOI 10.1073/pnas.1203536109; Chauhan S, 2016, DEV CELL, V39, P13, DOI 10.1016/j.devcel.2016.08.003; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Dodding MP, 2005, J VIROL, V79, P10571, DOI 10.1128/JVI.79.16.10571-10577.2005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Forshey BM, 2005, J VIROL, V79, P869, DOI 10.1128/JVI.79.2.869-875.2005; Goldstone DC, 2014, P NATL ACAD SCI USA, V111, P9609, DOI 10.1073/pnas.1402448111; Imam S, 2016, J VIROL, V90, P3400, DOI 10.1128/JVI.03033-15; Jia XF, 2015, CURR OPIN STRUC BIOL, V31, P106, DOI 10.1016/j.sbi.2015.04.004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keown JR, 2016, SCI REP-UK, V6, DOI 10.1038/srep26837; Kimura T, 2016, J CELL SCI, V129, P881, DOI 10.1242/jcs.163758; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Kutluay SB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003214; Li YL, 2016, ELIFE, V5, DOI 10.7554/eLife.16269; Mandell MA, 2014, AUTOPHAGY, V10, P2387, DOI 10.4161/15548627.2014.984278; Mandell MA, 2014, DEV CELL, V30, P394, DOI 10.1016/j.devcel.2014.06.013; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McEwan DG, 2015, MOL CELL, V57, P39, DOI 10.1016/j.molcel.2014.11.006; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Ohkura S, 2006, J VIROL, V80, P8554, DOI 10.1128/JVI.00688-06; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Popelka H, 2015, AUTOPHAGY, V11, P2153, DOI 10.1080/15548627.2015.1111503; Rajsbaum R, 2014, J MOL BIOL, V426, P1265, DOI 10.1016/j.jmb.2013.12.005; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Ribeiro CMS, 2016, NATURE, V540, P448, DOI 10.1038/nature20567; Roa A, 2012, J VIROL, V86, P1717, DOI 10.1128/JVI.05811-11; Rogov VV, 2017, EMBO REP, V18, P1382, DOI 10.15252/embr.201643587; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Tareen SU, 2011, VIROLOGY, V409, P113, DOI 10.1016/j.virol.2010.09.018; Uchil PD, 2013, J VIROL, V87, P257, DOI 10.1128/JVI.01804-12; Wagner JM, 2016, ELIFE, V5, DOI [10.7554/elife.16309, 10.7554/eLife.16309]; Weinert C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10819; Yang HT, 2012, P NATL ACAD SCI USA, V109, P18372, DOI 10.1073/pnas.1210903109; Yap MW, 2006, J VIROL, V80, P4061, DOI 10.1128/JVI.80.8.4061-4067.2006; Zaffagnini G, 2016, J MOL BIOL, V428, P1714, DOI 10.1016/j.jmb.2016.02.004	45	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18378	18386		10.1074/jbc.RA118.004202	http://dx.doi.org/10.1074/jbc.RA118.004202			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30282803	Green Published, hybrid			2022-12-26	WOS:000451375200028
J	Mukai, S; Ogawa, Y; Saya, H; Kawakami, Y; Tsubota, K				Mukai, Shin; Ogawa, Yoko; Saya, Hideyuki; Kawakami, Yutaka; Tsubota, Kazuo			Therapeutic potential of tranilast for the treatment of chronic graft-versus-host disease in mice	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; EPITHELIAL-MESENCHYMAL TRANSITION; THIOREDOXIN-INTERACTING PROTEIN; NF-KAPPA-B; DRY EYE; OXIDATIVE STRESS; INTERFERON-GAMMA; GROWTH-FACTOR; ER STRESS; T-CELLS	Chronic graft-versus-host disease (cGVHD) is a marked complication of hematopoietic stem cell transplantation, and multiple organs can be affected by cGVHD-induced inflammation and fibrosis. In clinical settings, immunosuppressive agents have been the last resort to treat cGVHD. However, it has been only partially effective for cGVHD. Hence, efficacious treatment of cGVHD is eagerly awaited. Our previous work suggested that oxidative stress was elevated in cGVHD-disordered lacrimal glands and that epithelial-to-mesenchymal transition (EMT) was implicated in fibrosis caused by ocular cGVHD. In addition, our recent article demonstrated that thioredoxin interaction protein (TXNIP) and transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-KB) were associated with the development of cGVHD. After our search for effective drugs, we chose tranilast to combat systemic cGVHD. Tranilast is known to (1) act as an inhibitor of the inflammatory molecules TXNIP and NF-kappa B and (2) exert anti-fibrotic, anti-EMT and anti-oxidative effects. To investigate the effectiveness of tranilast for cGVHD, we used an MHC-compatible, multiple minor histocompatibility antigen-mismatched murine model of cGVHD. Tranilast or a solvent-vehicle were orally given to the allogeneic bone marrow transplantation (allo-BMT) recipients from the day before allo-BMT (Day-1) to Day 27 after allo-BMT. Their cGVHD-vulnerable organs were collected Day 28 after allo-BMT and analyzed by using various methods such as histology, immunohistochemistry and immunoblotting. As indicated by our results, tranilast alleviated cGVHD-elicited inflammation and fibrosis by suppressing the expression and/or activation of TXNIP and NF-kappa B and preventing EMT. Taken together, although this strategy may not be a complete cure for cGVHD, tranilast could be a promising medication to ameliorate cGVHD-triggered disabling symptoms.	[Mukai, Shin; Ogawa, Yoko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Mukai, Shin; Kawakami, Yutaka] Keio Univ, Sch Med, Div Cellular Signaling, Inst Adv Med Res, Tokyo, Japan; [Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan	Keio University; Keio University; Keio University	Ogawa, Y; Tsubota, K (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	yoko@z7.keio.jp; tsubota@z3.keio.jp	Ogawa, Yoko/AAV-1932-2021; Tsubota, Kazuo/M-1915-2013	Ogawa, Yoko/0000-0002-2906-9621; Saya, Hideyuki/0000-0001-6610-1902; Tsubota, Kazuo/0000-0002-8874-7111	Japanese Ministry of Education, Science, Sports and Culture [26462668]; Japan Agency for Medical Research and Development (AMED), for the Project for Early/Exploratory Research Development project, Center of Immunology and Intractable Disease [JP15lk0103004]	Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED), for the Project for Early/Exploratory Research Development project, Center of Immunology and Intractable Disease(Japan Agency for Medical Research and Development (AMED))	This study was supported by the Japanese Ministry of Education, Science, Sports and Culture, #26462668" and Japan Agency for Medical Research and Development (AMED), for the Project for Early/Exploratory Research Development project, Center of Immunology and Intractable Disease, under Grant Number JP15lk0103004. The funders have no role in the study design; collection and analysis, and interpretation of data; preparation and writing of the paper; and/or decision to submit for publication.	Ai D, 2012, J CLIN INVEST, V122, P1677, DOI 10.1172/JCI61248; Anderson Graeme, 1996, P47; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; BERG R, 2001, BR J NUTR, V86, pS121, DOI DOI 10.1079/BJN2001340; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Ceredig R, 2012, IMMUNOL CELL BIOL, V90, P253, DOI 10.1038/icb.2011.62; Chen X, 2009, BLOOD, V114, P891, DOI 10.1182/blood-2009-01-197178; Darakhshan S, 2015, PHARMACOL RES, V91, P15, DOI 10.1016/j.phrs.2014.10.009; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Devi TS, 2013, EXP CELL RES, V319, P1001, DOI 10.1016/j.yexcr.2013.01.012; Flowers MED, 2015, BLOOD, V125, P606, DOI 10.1182/blood-2014-08-551994; Hopwood D, 1996, THEORY PRACTICE HIST, P23; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamoi M, 2007, CURR EYE RES, V32, P937, DOI 10.1080/02713680701586409; Kawai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02455; Kim SW, 2016, EXP HEMATOL, V44, P332, DOI 10.1016/j.exphem.2016.02.002; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Mandrekar P, 2011, HEPATOLOGY, V54, P2185, DOI 10.1002/hep.24599; Mukai S, 2017, SCI REP; Murray S, 2015, BLOOD MARROW TRANSPL; Ogawa Y, 2005, INVEST OPHTH VIS SCI, V46, P4519, DOI 10.1167/iovs.05-0227; Ogawa Y, 2003, CORNEA, V22, pS19, DOI 10.1097/00003226-200310001-00004; Ogawa Y, 2010, BONE MARROW TRANSPL, V45, P565, DOI 10.1038/bmt.2009.173; Ogawa Y, 2001, CORNEA, V20, P430, DOI 10.1097/00003226-200105000-00020; Ogawa Y, 2007, INVEST OPHTH VIS SCI, V48, P1079, DOI 10.1167/iovs.06-0601; Ogawa Y, 2016, ELIFE, V5, DOI 10.7554/eLife.09394; Ogawa Y, 2009, AM J PATHOL, V175, P2372, DOI 10.2353/ajpath.2009.090318; Oxenkrug G, 2011, AGING DIS, V2, P474; Pai CCS, 2014, BLOOD, V124, P1677, DOI 10.1182/blood-2014-02-554279; Pollard KM, 2013, DISCOV MED, V16, P123; Radojcic V, 2010, J IMMUNOL, V184, P764, DOI 10.4049/jimmunol.0903006; Ranganathan P, 2017, BLOOD, V129, P2463, DOI 10.1182/blood-2017-03-772103; Sato S, 2000, J RHEUMATOL, V27, P149; Shulman HM, 2015, BIOL BLOOD MARROW TR, V21, P589, DOI 10.1016/j.bbmt.2014.12.031; Spiecker M, 2002, MOL PHARMACOL, V62, P856, DOI 10.1124/mol.62.4.856; Spriewald BM, 2009, BLOOD, V114, P4490; SUZAWA H, 1992, JPN J PHARMACOL, V60, P91, DOI 10.1254/jjp.60.91; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Tan SM, 2011, NEPHROL DIAL TRANSPL, V26, P100, DOI 10.1093/ndt/gfq355; Toubai T, 2008, BEST PRACT RES CL HA, V21, P101, DOI 10.1016/j.beha.2008.02.005; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Yaguchi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064724; Yoon HK, 2010, TRANSPLANTATION, V90, P853, DOI 10.1097/TP.0b013e3181f2c92b; Zhang Y, 2002, J IMMUNOL, V168, P3088, DOI 10.4049/jimmunol.168.6.3088	46	7	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0203742	10.1371/journal.pone.0203742	http://dx.doi.org/10.1371/journal.pone.0203742			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307955	gold, Green Submitted, Green Published			2022-12-26	WOS:000447173500009
J	Sandhya, S; Maulik, A; Giri, M; Singh, M				Sandhya, Sankaran; Maulik, Aditi; Giri, Malyasree; Singh, Mahavir			Domain architecture of BAF250a reveals the ARID and ARM-repeat domains with implication in function and assembly of the BAF remodeling complex	PLOS ONE			English	Article							HYDROPHOBIC CLUSTER-ANALYSIS; CRYSTAL-STRUCTURE; BETA-CATENIN; SWI/SNF COMPLEXES; PROTEIN-SEQUENCE; BINDING; FAMILY; CANCER; DNA; INFORMATION	BAF250a and BAF250b are subunits of the SWI/SNF chromatin-remodeling complex that recruit the complex to chromatin allowing transcriptional activation of several genes. Despite being the central subunits of the SWI/SNF complex, the structural and functional annotation of BAF250a/b remains poorly understood. BAF250a (nearly 2200 residues protein) harbors an N-terminal DNA binding ARID (similar to 110 residues) and a C-terminal folded region (similar to 250 residues) of unknown structure and function, recently annotated as BAF250_C. Using hydrophobic core analysis, fold prediction and comparative modeling, here we have defined a domain boundary and associate a beta-catenin like ARM-repeat fold to the C-terminus of BAF250a that encompass BAF250_C. The N-terminal DNA-binding ARID is found in diverse domain combinations in proteins imparting unique functions. We used a comparative sequence analysis based approach to study the ARIDs from diverse domain contexts and identified conserved residue positions that are important to preserve its core structure. Supporting this, mutation of one such conserved residue valine, at position 1067, to glycine, resulted in destabilization, loss of structural integrity and DNA binding affinity of ARID. Additionally, we identified a set of conserved and surface-exposed residues unique to the ARID when it co-occurs with the ARM repeat containing BAF250_C in BAF250a. Several of these residues are found mutated in somatic cancers. We predict that these residues in BAF250a may play important roles in mediating protein-DNA and protein-protein interactions in the BAF complex.	[Sandhya, Sankaran; Maulik, Aditi; Giri, Malyasree; Singh, Mahavir] Indian Inst Sci, Mol Biophys Unit, Bengaluru, India; [Singh, Mahavir] Indian Inst Sci, NMR Res Ctr, Bengaluru, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Sandhya, S; Singh, M (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bengaluru, India.; Singh, M (corresponding author), Indian Inst Sci, NMR Res Ctr, Bengaluru, India.	sandhyas@iisc.ac.in; singh@iisc.ac.in		Sandhya, Sankaran/0000-0003-0055-302X; Maulik, Aditi/0000-0002-0781-9188	Indian Institute of Science; IISc-DBT Partnership program; Department of Biotechnology (DBT), India [BT/RLF/Reentry/23/2013]; Department of Science and Technology (DST), India [ECR/2015/000023]; DBT, India; India Alliance [IA/E/15/1/502321]; DST, India	Indian Institute of Science; IISc-DBT Partnership program; Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), India(Department of Science & Technology (India)); DBT, India(Department of Biotechnology (DBT) India); India Alliance(Wellcome Trust DBT India Alliance); DST, India(Department of Science & Technology (India))	This work is supported by Indian Institute of Science (M.S), IISc-DBT Partnership program (M.S.), Ramalingaswami Fellowship (BT/RLF/Reentry/23/2013) (M.S.) from Department of Biotechnology (DBT), India, and Early Career Award (ECR/2015/000023) (M.S.) from Department of Science and Technology (DST), India. A. M would like to acknowledge DBT, India for the Research Associateship and India Alliance for current Early Career Fellowship (IA/E/15/1/502321). M.G. would like to acknowledge DST, India for INSPIRE fellowship. Authors acknowledge DST and DBT, India for the NMR facilities at the Indian Institute of Science, Bengaluru. Authors acknowledge ITC facility at National Centre for Biological Sciences, Bengaluru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bao Yunhe, 2007, Cell, V129, P632, DOI 10.1016/j.cell.2007.04.018; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bhaskara RM, 2014, PROTEINS, V82, P1219, DOI 10.1002/prot.24486; Brown NP, 1998, BIOINFORMATICS, V14, P380, DOI 10.1093/bioinformatics/14.4.380; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Chandler RL, 2013, MOL CELL BIOL, V33, P265, DOI 10.1128/MCB.01008-12; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Coatham M, 2016, MODERN PATHOL, V29, P1586, DOI 10.1038/modpathol.2016.156; Dallas PB, 1998, MOL CELL BIOL, V18, P3596, DOI 10.1128/MCB.18.6.3596; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engin HB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152929; Faure G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003280; Faure G, 2013, BIOINFORMATICS, V29, P1726, DOI 10.1093/bioinformatics/btt271; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Flores-Alcantar A, 2011, CELL TISSUE RES, V345, P137, DOI 10.1007/s00441-011-1182-x; Forbes S A, 2016, Curr Protoc Hum Genet, V91, DOI 10.1002/cphg.21; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Graham TA, 2002, MOL CELL, V10, P563, DOI 10.1016/S1097-2765(02)00637-8; Graham TA, 2001, NAT STRUCT BIOL, V8, P1048, DOI 10.1038/nsb718; Gul IS, 2017, CELL MOL LIFE SCI, V74, P525, DOI 10.1007/s00018-016-2319-6; Helming KC, 2014, CANCER CELL, V26, P309, DOI 10.1016/j.ccr.2014.07.018; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Hubbard S, 1993, NACCESS V2 1 1 SOLVE; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kasten MM, 2011, CELL, V144, DOI 10.1016/j.cell.2011.01.007; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim S, 2004, J BIOL CHEM, V279, P16670, DOI 10.1074/jbc.M312115200; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Lovell SC, 2010, MOL BIOL EVOL, V27, P2567, DOI 10.1093/molbev/msq144; McCrea PD, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.3; Muratcioglu S, 2015, BIOPHYS J, V109, P1227, DOI 10.1016/j.bpj.2015.06.044; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Poy F, 2001, NAT STRUCT BIOL, V8, P1053, DOI 10.1038/nsb720; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Pundir S, 2017, METHODS MOL BIOL, V1558, P41, DOI 10.1007/978-1-4939-6783-4_2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Skrabana R, 2006, CELL MOL NEUROBIOL, V26, P1085, DOI 10.1007/s10571-006-9083-3; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; St Pierre R, 2017, CURR OPIN GENET DEV, V42, P56, DOI 10.1016/j.gde.2017.02.004; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sun Q, 2015, J HUAZHONG U SCI-MED, V35, P469, DOI 10.1007/s11596-015-1455-9; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Trotter KW, 2004, MOL CELL BIOL, V24, P3347, DOI 10.1128/MCB.24.8.3347-3358.2004; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vasileiou G, 2015, AM J HUM GENET, V97, P445, DOI 10.1016/j.ajhg.2015.08.002; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang XF, 2014, CLIN CANCER RES, V20, P21, DOI 10.1158/1078-0432.CCR-13-0280; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Zinzalla G, 2016, CHEMBIOCHEM, V17, P677, DOI 10.1002/cbic.201500565	75	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205267	10.1371/journal.pone.0205267	http://dx.doi.org/10.1371/journal.pone.0205267			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307988	gold, Green Published, Green Submitted			2022-12-26	WOS:000447173500055
J	Breitling, B; Brunkhorst, R; Verhoff, M; Foerch, C				Breitling, Benedict; Brunkhorst, Robert; Verhoff, Marcel; Foerch, Christian			Post-mortem serum concentrations of GFAP correlate with agony time but do not indicate a primary cerebral cause of death	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; INTRACEREBRAL HEMORRHAGE; BRAIN-INJURY; FORENSIC MEDICINE; TRAUMATIC BRAIN; ACUTE STROKE; EXPRESSION; ISCHEMIA; RELEASE; STRESS	Background and purpose The astroglial protein GFAP is a blood biomarker indicative of intracerebral hemorrhage in patients with acute stroke. Due to its brain specificity and the necessity of brain damage for its detectability in blood, we hypothesized that GFAP could be an interesting marker in cases with primary cerebral cause of death, e.g., traumatic brain injury. Methods All corpses scheduled for an autopsy in the Frankfurt Department of Forensic medicine within a 15-month period were included in the study. Cases with a known history of brain disease in the 3 months before death were excluded. During autopsy, blood was collected and GFAP serum levels were determined using a commercially available ELISA. The autopsy protocols were reviewed for the presence of a primary cerebral or a primary non-cerebral cause of death. Agony time was also determined. Results A total of 129 autopsy cases were included. GFAP concentrations did not differ between cerebral (median 0.96 mu g/l, IQR 5.03) and non-cerebral causes of death (1.21 mu g/l, 3.58). GFAP levels were found to be unaffected by hemolysis or post-mortem interval. GFAP levels were found to be increased in cases with prolonged agony times (median 1.76 mu g/l [IQR 4.70]) compared to short (0.58 mu g/l [0.58]; p<0.001) and ultra-short agony times (0.21 mu g/l [0.12]; p = 0.002). Conclusion Post-mortem GFAP serum concentrations correlate with agony time and might therefore be useful for the evaluation of the severity of brain damage in prolonged death. Elevated GFAP serum levels do not indicate a primary cerebral cause of death.	[Breitling, Benedict; Brunkhorst, Robert; Foerch, Christian] Goethe Univ, Dept Neurol, Frankfurt, Germany; [Verhoff, Marcel] Goethe Univ, Dept Forens Med, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Foerch, C (corresponding author), Goethe Univ, Dept Neurol, Frankfurt, Germany.	foerch@em.uni-frankfurt.de						Brunkhorst R, 2010, TRANSL STROKE RES, V1, P246, DOI 10.1007/s12975-010-0040-6; Chandana R, 2009, INDIAN J MED RES, V129, P189; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; Harish G, 2011, BIOPRESERV BIOBANK, V9, P379, DOI 10.1089/bio.2011.0033; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Helwig K, 2017, NEUROCRIT CARE, V27, P68, DOI 10.1007/s12028-016-0371-6; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; HOZUMI I, 1990, BRAIN RES, V534, P291, DOI 10.1016/0006-8993(90)90142-X; Katsanos AH, 2017, STROKE, V48, P2586, DOI 10.1161/STROKEAHA.117.018409; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Luger S, 2017, CLIN CHEM, V63, P377, DOI 10.1373/clinchem.2016.263335; Magerkurth O, 1996, THESIS; Mayer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062101; Missler U, 1999, CLIN CHEM, V45, P138; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Petzold A, 2015, BRAIN RES, V1600, P17, DOI 10.1016/j.brainres.2014.12.027; Piette MHA, 2011, INT J LEGAL MED, V125, P333, DOI 10.1007/s00414-010-0434-8; Scendoni R, 2016, INT J LEGAL MED, V130, P1639, DOI 10.1007/s00414-016-1402-8; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Strasser S, 2007, FORENSIC SCI INT, V170, P8, DOI 10.1016/j.forsciint.2006.08.023; Wilke N, 2007, INT J LEGAL MED, V121, P385, DOI 10.1007/s00414-006-0132-8; Wunderlich MT, 2006, EUR J NEUROL, V13, P1118, DOI 10.1111/j.1468-1331.2006.01435.x	26	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205323	10.1371/journal.pone.0205323	http://dx.doi.org/10.1371/journal.pone.0205323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304049	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100079
J	Ecklu-Mensah, G; Olsen, RW; Bengtsson, A; Ofori, MF; Hviid, L; Jensen, ATR; Adams, Y				Ecklu-Mensah, Gertrude; Olsen, Rebecca W.; Bengtsson, Anja; Ofori, Michael F.; Hviid, Lars; Jensen, Anja T. R.; Adams, Yvonne			Blood outgrowth endothelial cells (BOECs) as a novel tool for studying adhesion of Plasmodium falciparum-infected erythrocytes	PLOS ONE			English	Article							SEVERE MALARIA; PARASITE SEQUESTRATION; BINDING; CYTOADHERENCE; PFEMP1; FAMILY; ICAM-1; CD36; ADHERENCE; DISEASE	The lack of suitable animal models for the study of cytoadhesion of P. falciparum-infected erythrocytes (IEs) has necessitated in vitro studies employing a range of cell lines of either human tumour origin (e.g., BeWo and C32 cells) or non-human origin (e.g., CHO cells). Of the human cells available, many were isolated from adults, or derived from a pool of donors (e.g., HBEC-5i). Here we demonstrate, for the first time, the successful isolation of blood outgrowth endothelial cells (BOECs) from frozen stabilates of peripheral blood mononuclear cells obtained from small-volume peripheral blood samples from paediatric malaria patients. BOECs are a sub-population of human endothelial cells, found within the peripheral blood. We demonstrate that these cells express receptors such as Intercellular Adhesion Molecule 1 (ICAM-1/CD54), Endothelial Protein C Receptor (EPCR/CD201), platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31), Thrombomodulin (CD141), and support adhesion of P. falciparum IEs.	[Ecklu-Mensah, Gertrude; Ofori, Michael F.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Legon, Ghana; [Ecklu-Mensah, Gertrude; Olsen, Rebecca W.; Bengtsson, Anja; Hviid, Lars; Jensen, Anja T. R.; Adams, Yvonne] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, Dept Immunol & Microbiol ISIM, Copenhagen, Denmark; [Hviid, Lars] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark	University of Ghana; University of Copenhagen; Rigshospitalet; University of Copenhagen	Adams, Y (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, Dept Immunol & Microbiol ISIM, Copenhagen, Denmark.	yadams@sund.ku.dk	Adams, Yvonne/GRX-3572-2022; Hviid, Lars/G-3705-2012; Jensen, Anja Tatiana TR Ramstedt/T-3583-2017; Jensen, Anja Ramstedt/AAL-3119-2021; Adams, Yvonne/AAX-8901-2021; Ofori, Michael F/H-9072-2013	Hviid, Lars/0000-0002-1698-4927; Jensen, Anja Tatiana TR Ramstedt/0000-0002-4004-7554; Jensen, Anja Ramstedt/0000-0002-4004-7554; Adams, Yvonne/0000-0001-8041-6580; Ofori, Michael F/0000-0003-2341-7514; Olsen, Rebecca Wendelboe/0000-0003-4034-4302; Ecklu-Mensah, Gertrude/0000-0003-1770-3071; Bengtsson, Anja/0000-0001-9523-8369	Novo Nordisk Fonden [NNF15OC0017654]; Consultative Committee for Development Research [DFC 12 081RH]; Augustinus Fonden [12-0378, 15-3000]; Danish Council for Independent Research [4004-00032]	Novo Nordisk Fonden(Novo Nordisk Foundation); Consultative Committee for Development Research; Augustinus Fonden; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was supported by Novo Nordisk Fonden [http://novonordiskfonden.dk/da - grant number NNF15OC0017654] to ATRJ, The Consultative Committee for Development Research [http://dfcentre.com/research/consultative-research-committee-for-development-research-2/grant number DFC 12 081RH] to ATRJ, Augustinus Fonden (https://augustinusfonden.dk - grant numbers 12-0378 and 15-3000 to ATRJ and 14-4499 to YA), and the Danish Council for Independent Research (https://ufm.dk/en/researchand-innovation/funding-programmes-for-research-and-innovation/find-danish-funding-programmes grant number 4004-00032) to ATRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KT, 2005, INT J PARASITOL, V35, P1127, DOI 10.1016/j.ijpara.2005.05.007; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Balaji S, 2013, ADV WOUND CARE, V2, P283, DOI 10.1089/wound.2012.0398; Bengtsson A, 2013, J IMMUNOL, V190, P240, DOI 10.4049/jimmunol.1202578; Chaiyaroj SC, 1996, AM J TROP MED HYG, V55, P76, DOI 10.4269/ajtmh.1996.55.76; Chakravorty SJ, 2008, BIOCHEM SOC T, V36, P221, DOI 10.1042/BST0360221; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; COOKE BM, 1994, BRIT J HAEMATOL, V87, P162, DOI 10.1111/j.1365-2141.1994.tb04887.x; Cunnington AJ, 2013, TRENDS PARASITOL, V29, P585, DOI 10.1016/j.pt.2013.10.004; Cunnington AJ, 2013, J INFECTION, V67, P220, DOI 10.1016/j.jinf.2013.04.013; Dorovini-Zis Katerina, 2003, Methods Mol Med, V89, P325; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; HASLER T, 1993, AM J TROP MED HYG, V48, P332, DOI 10.4269/ajtmh.1993.48.332; Hviid L, 2015, ADV PARASIT, V88, P51, DOI 10.1016/bs.apar.2015.02.004; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kolbe M, 2010, TISSUE ENG PART C-ME, V16, P877, DOI [10.1089/ten.tec.2009.0492, 10.1089/ten.TEC.2009.0492]; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; Lennartz F, 2017, CELL HOST MICROBE, V21, P403, DOI 10.1016/j.chom.2017.02.009; Lennartz F, 2015, J IMMUNOL, V195, P3273, DOI 10.4049/jimmunol.1501404; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Lin Y, 2002, BLOOD, V99, P457, DOI 10.1182/blood.V99.2.457; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Milbauer LC, 2009, TRANSL RES, V153, P179, DOI 10.1016/j.trsl.2008.12.009; Mkumbaye SI, 2017, INFECT IMMUN, V85, DOI [10.1128/iai.00841-16, 10.1128/IAI.00841-16]; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Olsen RW, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00622-17, 10.1128/iai.00622-17]; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; Starke RD, 2013, BLOOD, V121, P2773, DOI 10.1182/blood-2012-06-435727; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Viebig NK, 2006, EXP PARASITOL, V112, P121, DOI 10.1016/j.exppara.2005.09.007; Wassmer SC, 2011, CELL MICROBIOL, V13, P198, DOI 10.1111/j.1462-5822.2010.01528.x; World Health Organization, FACT SHEET WORLD MAL	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0204177	10.1371/journal.pone.0204177	http://dx.doi.org/10.1371/journal.pone.0204177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300360	Green Published, Green Submitted, gold			2022-12-26	WOS:000446897200010
J	Hosomi, K; Fujimoto, M; Ushio, K; Mao, LL; Kato, J; Takada, M				Hosomi, Kouichi; Fujimoto, Mai; Ushio, Kazutaka; Mao, Lili; Kato, Juran; Takada, Mitsutaka			An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SEQUENCE SYMMETRY ANALYSIS; SPONTANEOUS REPORTING DATABASE; NF-KAPPA-B; CONNECTIVITY MAP; SIGNAL-DETECTION; GENE-EXPRESSION; CLAIMS DATABASE; ADVERSE EVENTS; STATIN USE	Different computational approaches are employed to efficiently identify novel repositioning possibilities utilizing different sources of information and algorithms. It is critical to propose high-valued candidate-repositioning possibilities before conducting lengthy in vivo validation studies that consume significant resources. Here we report a novel multi-methodological approach to identify opportunities for drug repositioning. We performed analyses of real-world data (RWD) acquired from the United States Food and Drug Administration's Adverse Event Reporting System (FAERS) and the claims database maintained by the Japan Medical Data Center (JMDC). These analyses were followed by cross-validation through bioinformatics analyses of gene expression data. Inverse associations revealed using disproportionality analysis (DPA) and sequence symmetry analysis (SSA) were used to detect potential drug-repositioning signals. To evaluate the validity of the approach, we conducted a feasibility study to identify marketed drugs with the potential for treating inflammatory bowel disease (IBD). Primary analyses of the FAERS and JMDC claims databases identified psycholeptics such as haloperidol, diazepam, and hydroxyzine as candidates that may improve the treatment of IBD. To further investigate the mechanistic relevance between hit compounds and disease pathology, we conducted bioinformatics analyses of the associations of the gene expression profiles of these compounds with disease. We identified common biological features among genes differentially expressed with or without compound treatment as well as disease-perturbation data available from open sources, which strengthened the mechanistic rationale of our initial findings. We further identified pathways such as cytokine signaling that are influenced by these drugs. These pathways are relevant to pathologies and can serve as alternative targets of therapy. Integrative analysis of RWD such as those available from adverse-event databases, claims databases, and transcriptome analyses represent an effective approach that adds value to efficiently identifying potential novel therapeutic opportunities.	[Hosomi, Kouichi; Fujimoto, Mai; Takada, Mitsutaka] Kindai Univ, Sch Pharm, Div Clin Drug Informat, Higashiosaka, Osaka, Japan; [Ushio, Kazutaka; Mao, Lili; Kato, Juran] Takeda Pharmaceut Co Ltd, Innovat & Entrepreneurship Res, 2 Chome, Fujisawa, Kanagawa, Japan; [Ushio, Kazutaka] Chugai Pharmaceut Co Ltd, Med Liaison Dept, Med Affairs Div, Shinagawa Ku, Kitashinagawa 5 Chome, Tokyo, Japan; [Mao, Lili; Kato, Juran] GEXVal Inc, 2 Chome, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Chugai Pharmaceutical Co., Ltd.	Takada, M (corresponding author), Kindai Univ, Sch Pharm, Div Clin Drug Informat, Higashiosaka, Osaka, Japan.	takada@phar.kindai.ac.jp		Hosomi, Kouichi/0000-0002-2091-2766; Ushio, Kazutaka/0000-0002-1263-1948	Takeda Pharmaceutical Company Limited; Chugai Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd); Chugai Pharmaceutical Company Limited	This work was supported by Takeda Pharmaceutical Company Limited in the form of salaries to KU, LM, JK. Additional support came from Chugai Pharmaceutical Company Limited in the form of salaries to KU. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almenoff JS, 2007, CLIN PHARMACOL THER, V82, P157, DOI 10.1038/sj.clpt.6100258; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; Bohm R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157753; De Plaen IG, 2006, IMMUNOLOGY, V118, P153, DOI 10.1111/j.1365-2567.2006.02344.x; Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013; Fujimoto M, 2015, INT J MED SCI, V12, P223, DOI 10.7150/ijms.10656; Hallas J, 1997, EPIDEMIOLOGY, V8, P666, DOI 10.1097/00001648-199710000-00009; Hallas J, 1996, EPIDEMIOLOGY, V7, P478, DOI 10.1097/00001648-199609000-00005; Hodos RA, 2016, WIRES SYST BIOL MED, V8, P186, DOI 10.1002/wsbm.1337; Hurle MR, 2013, CLIN PHARMACOL THER, V93, P335, DOI 10.1038/clpt.2013.1; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Kimura S, 2010, J EPIDEMIOL, V20, P413, DOI 10.2188/jea.JE20090066; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; LECHIN F, 1982, J CLIN GASTROENTEROL, V4, P445, DOI 10.1097/00004836-198210000-00010; Li J, 2016, BRIEF BIOINFORM, V17, P2, DOI 10.1093/bib/bbv020; Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lussier YA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001512; Mizoguchi A, 2012, PROG MOL BIOL TRANSL, V105, P263, DOI 10.1016/B978-0-12-394596-9.00009-3; Montero-Melendez T, 2014, DRUG DISCOV TODAY, V19, P820, DOI 10.1016/j.drudis.2013.11.022; MORRIS JA, 1988, BRIT MED J, V296, P1313, DOI 10.1136/bmj.296.6632.1313; Musa A, 2018, BRIEF BIOINFORM, V19, P506, DOI 10.1093/bib/bbw112; Nagashima T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26375; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nosengo N, 2016, NATURE, V534, P314, DOI 10.1038/534314a; Qu XYA, 2012, DRUG DISCOV TODAY, V17, P1289, DOI 10.1016/j.drudis.2012.07.017; Sakaeda T, 2013, INT J MED SCI, V10, P796, DOI 10.7150/ijms.6048; Santiago JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34579; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Shah SB, 2007, REV GASTROENTEROL DI, V7, pS3; Shameer K, 2015, CURR TOP MED CHEM, V15, P5, DOI 10.2174/1568026615666150112103510; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Straus DS, 2000, P NATL ACAD SCI US; Takada M, 2016, INT J MED SCI, V13, P825, DOI 10.7150/ijms.16185; Takada M, 2016, INT J MED SCI, V13, P48, DOI 10.7150/ijms.13834; Takada M, 2014, DRUG SAFETY, V37, P421, DOI 10.1007/s40264-014-0163-x; Tsiropoulos I, 2009, PHARMACOEPIDEM DR S, V18, P483, DOI 10.1002/pds.1736; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668; Wahab IA, 2013, ADV PHARMACOEPIDEMIO, P02; Wahab IA, 2016, DRUG SAFETY, V39, P347, DOI 10.1007/s40264-015-0391-8; Wahab IA, 2013, PHARMACOEPIDEM DR S, V22, P496, DOI 10.1002/pds.3417; Wang KJ, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4541; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028025; Yella JK, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11020057; Zhao S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006548; Zhao ZJ, 2012, INT IMMUNOPHARMACOL, V12, P169, DOI 10.1016/j.intimp.2011.11.007	50	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0204648	10.1371/journal.pone.0204648	http://dx.doi.org/10.1371/journal.pone.0204648			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300381	Green Submitted, gold, Green Published			2022-12-26	WOS:000446897200013
J	Diaz-Delgado, J; Fernandez, A; Sierra, E; Sacchini, S; Andrada, M; Vela, AI; Quesada-Canales, O; Paz, Y; Zucca, D; Groch, K; Arbelo, M				Diaz-Delgado, Josue; Fernandez, Antonio; Sierra, Eva; Sacchini, Simona; Andrada, Marisa; Vela, Ana Isabel; Quesada-Canales, Oscar; Paz, Yania; Zucca, Daniele; Groch, Katia; Arbelo, Manuel			Pathologic findings and causes of death of stranded cetaceans in the Canary Islands (2006-2012)	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; PORPOISES PHOCOENA-PHOCOENA; ST-LAWRENCE ESTUARY; ERYSIPELOTHRIX-RHUSIOPATHIAE SEPTICEMIA; WHALES DELPHINAPTERUS-LEUCAS; GAS-BUBBLE LESIONS; T-CELL LYMPHOMA; TURSIOPS-TRUNCATUS; HARBOR PORPOISES; STENELLA-COERULEOALBA	This study describes the pathologic findings and most probable causes of death (CD) of 224 cetaceans stranded along the coastline of the Canary Islands (Spain) over a 7-year period, 2006-2012. Most probable CD, grouped as pathologic categories (PCs), was identified in 208/224 (92.8%) examined animals. Within natural PCs, those associated with good nutritional status represented 70/208 (33.6%), whereas, those associated with significant loss of nutritional status represented 49/208 (23.5%). Fatal intra- and interspecific traumatic inter-actions were 37/208 (17.8%). Vessel collisions included 24/208 (11.5%). Neonatal/perinatal pathology involved 13/208 (6.2%). Fatal interaction with fishing activities comprised 10/208 (4.8%). Within anthropogenic PCs, foreign body-associated pathology represented 5/208 (2.4%). A CD could not be determined in 16/208 (7.7%) cases. Natural PCs were dominated by infectious and parasitic disease processes. Herein, our results suggest that between 2006 and 2012, in the Canary Islands, direct human activity appeared responsible for 19% of cetaceans deaths, while natural pathologies accounted for 81%. These results, integrating novel findings and published reports, aid in delineating baseline knowledge on cetacean pathology and may be of value to rehabilitators, caregivers, diagnosticians and future conservation policies.	[Diaz-Delgado, Josue; Fernandez, Antonio; Sierra, Eva; Sacchini, Simona; Andrada, Marisa; Quesada-Canales, Oscar; Paz, Yania; Zucca, Daniele; Arbelo, Manuel] Univ Las Palmas Gran Canaria, Inst Anim Hlth & Food Hyg IUSA, Vet Histol & Pathol, Las Palmas Gran Canaria, Spain; [Diaz-Delgado, Josue; Groch, Katia] Univ Sao Paulo, Sch Vet Med & Anim Sci, Wildlife Comparat Pathol Lab, Sao Paulo, Brazil; [Vela, Ana Isabel] Univ Complutense Madrid, Vet Coll, Dept Anim Hlth, Madrid, Spain; [Vela, Ana Isabel] Univ Complutense Madrid, Ctr Vigilancia Sanitaria Vet VISAVET, Madrid, Spain	Universidad de Las Palmas de Gran Canaria; Universidade de Sao Paulo; Complutense University of Madrid; Complutense University of Madrid	Diaz-Delgado, J; Fernandez, A (corresponding author), Univ Las Palmas Gran Canaria, Inst Anim Hlth & Food Hyg IUSA, Vet Histol & Pathol, Las Palmas Gran Canaria, Spain.; Diaz-Delgado, J (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Wildlife Comparat Pathol Lab, Sao Paulo, Brazil.	josue.diaz101@alu.ulpgc.es; antonio.fernandez@ulpgc.es	Fernandez, Antonio/G-3448-2015; Borzollino, Marisa Ana Andrada/M-3870-2014; Sacchini, Simona/N-1714-2019; Arbelo, Manuel/D-6789-2013; Sierra, Eva/H-9352-2015; Vela, Ana I/K-8015-2014	Fernandez, Antonio/0000-0001-5281-0521; Sacchini, Simona/0000-0001-6493-1275; Arbelo, Manuel/0000-0002-1623-5010; Sierra, Eva/0000-0003-3749-8845; Vela, Ana I/0000-0001-5004-3103; Andrada Borzollino, Marisa Ana/0000-0002-2411-9714	Ministry of Education of Spain through an FPU grant [AP2010-0002]; Regional National Research Project [CGL2012-39681]; Canary Islands Government [TEC0002955]	Ministry of Education of Spain through an FPU grant; Regional National Research Project; Canary Islands Government	This study was designed and was held as part of a long-lasting collective effort for monitoring health of cetacean populations inhabiting the Canary archipelago. It was performed and defended as a PhD Thesis (JDD) that was funded by the Ministry of Education of Spain (https://www.mecd.gob.es/ministerio-mecd/en/organizacion.html) through an FPU grant (AP2010-0002). Additional funding included a Regional National Research Project CGL2012-39681 and a Technical Assistant Contract by Canary Islands Government (TEC0002955).	Adams SD, 2014, EARLY HUM DEV, V90, P921, DOI 10.1016/j.earlhumdev.2014.09.017; Almuzara MN, 2011, J CLIN MICROBIOL, V49, P2333, DOI 10.1128/JCM.00001-11; Alstrup AKO, 2016, AQUAT MAMM, V42, P292, DOI 10.1578/AM.42.3.2016.292; Andre A M, 1997, REP INT WHALING COMM; [Anonymous], PATHOBIOLOGY MARINE; Anthony SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068239; Arbelo M, 2014, J COMP PATHOL, V150, P336, DOI 10.1016/j.jcpa.2013.09.003; Arbelo M, 2013, DIS AQUAT ORGAN, V103, P87, DOI 10.3354/dao02558; Arbelo M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-243; Arbelo M, 2010, DIS AQUAT ORGAN, V89, P261, DOI 10.3354/dao02208; Baily JL, 2013, J COMP PATHOL, V149, P514, DOI 10.1016/j.jcpa.2013.06.003; BAKER JR, 1992, VET REC, V130, P569, DOI 10.1136/vr.130.26.569; BALBUENA JA, 1993, PARASITOLOGY, V106, P327, DOI 10.1017/S0031182000075156; BALDRIDGE A, 1972, J MAMMAL, V53, P898, DOI 10.2307/1379230; Barlow Jay, 1994, Reports of the International Whaling Commission Special Issue, V15, P405; Bateman TFK, 2014, INTEGRATIVE COMP BIO, pE241; Baulch S, 2014, MAR POLLUT BULL, V80, P210, DOI 10.1016/j.marpolbul.2013.12.050; Begeman L, 2013, VET PATHOL, V50, P590, DOI 10.1177/0300985812465327; Belliere EN, 2010, ARCH VIROL, V155, P1307, DOI 10.1007/s00705-010-0697-x; Blanchard TW, 2001, J WILDLIFE DIS, V37, P297, DOI 10.7589/0090-3558-37.2.297; Bogomolni AL, 2010, DIS AQUAT ORGAN, V88, P143, DOI 10.3354/dao02146; Bonsembiante F, 2017, J VET MED SCI, V79, P1013, DOI 10.1292/jvms.17-0023; Bossart GD, 2011, VET PATHOL, V48, P676, DOI 10.1177/0300985810388525; Bossart GD, 1997, J VET DIAGN INVEST, V9, P454, DOI 10.1177/104063879700900427; Bossart Gregory D., 2003, Florida Scientist, V66, P226; Bossart Gregory D., 2013, Florida Scientist, V76, P36; Bowater RO, 2003, AUST VET J, V81, P627, DOI 10.1111/j.1751-0813.2003.tb12509.x; BRIEVA LM, 1991, ARCH MED VET, V23, P97; Campagna C, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P18; Campbell-Malone R, 2008, J ZOO WILDLIFE MED, V39, P37, DOI 10.1638/2006-0057.1; Cantile C, 2016, JUBB KENNEDY PALMERS, V6th, P250, DOI DOI 10.1016/B978-0-7020-5317-7.00004-7>; Carrillo M, 2006, P 20 C ECS GDYN POLL; Carrillo Manuel, 2010, Journal of Cetacean Research and Management, V11, P131; Casalone C, 2014, DIS AQUAT ORGAN, V109, P81, DOI 10.3354/dao02726; Cassle SE, 2016, J VET DIAGN INVEST, V28, P729, DOI 10.1177/1040638716664761; CHASTEL C, 1975, NOUV PRESSE MED, V4, P1803; Choi YK, 2003, VET REC, V153, P714; COLGROVE GS, 1978, J AM VET MED ASSOC, V173, P1121; Cornaglia E, 2000, J VET MED A, V47, P129, DOI 10.1046/j.1439-0442.2000.00268.x; Cowan DF, 2008, J COMP PATHOL, V139, P24, DOI 10.1016/j.jcpa.2007.11.009; COWAN DF, 1967, J PARASITOL, V53, P166, DOI 10.2307/3276641; Cox TM, 1998, FISH B-NOAA, V96, P727; CUSICK PK, 1973, J AM VET MED ASSOC, V163, P578; Dagleish MP, 2006, VET REC, V159, P458, DOI 10.1136/vr.159.14.458; Dagleish MR, 2008, VET REC, V163, P602, DOI 10.1136/vr.163.20.602; DAILEY M, 1978, J WILDLIFE DIS, V14, P503, DOI 10.7589/0090-3558-14.4.503; Dailey M.D., 1985, P805; Dailey MD., 2001, CRC HDB MARINE MAMMA; De Guise S, 1992, P 23 C INT ASS AQ AN, P115; de Quiros YB, 2018, DIS AQUAT ORGAN, V127, P83, DOI 10.3354/dao03189; Degollada E, 2002, VET REC, V150, P81, DOI 10.1136/vr.150.3.81; DEGUISE S, 1994, VET PATHOL, V31, P444, DOI 10.1177/030098589403100406; DEGUISE S, 1995, J COMP PATHOL, V112, P257, DOI 10.1016/S0021-9975(05)80079-9; Delyamure S. L., 1955, HELMINTHOFAUNA MARIN; Denuncio P, 2011, MAR POLLUT BULL, V62, P1836, DOI 10.1016/j.marpolbul.2011.05.003; Di Guardo G, 2013, RES VET SCI, V94, P132, DOI 10.1016/j.rvsc.2012.07.030; Diaz-Delgado J, 2017, DIS AQUAT ORGAN, V124, P247, DOI 10.3354/dao03124; Diaz-Delgado J, 2016, VET PATHOL, V53, P1233, DOI 10.1177/0300985816642228; Diaz-Delgado J, 2016, J COMP PATHOL, V155, P267, DOI 10.1016/j.jcpa.2016.06.002; Diaz-Delgado J, 2015, DIS AQUAT ORGAN, V116, P75, DOI 10.3354/dao02900; Diaz-Delgado J, 2015, J COMP PATHOL, V152, P278, DOI 10.1016/j.jcpa.2014.12.016; Diaz-Delgado J, 2015, J WILDLIFE DIS, V51, P538, DOI 10.7589/2014-08-199; Diaz-Delgado J, 2015, J WILDLIFE DIS, V51, P283, DOI 10.7589/2014-03-072; Dierauf L.A., 2018, CRC HDB MARINE MAMMA; DIGUARDO G, 1995, VET REC, V136, P439, DOI 10.1136/vr.136.17.439; DOMINGO M, 1992, VET PATHOL, V29, P1, DOI 10.1177/030098589202900101; Duignan Padraig J., 2000, Aquatic Mammals, V26, P143; DUIGNAN PJ, 1992, CAN J VET RES, V56, P242; Dunn DG, 2002, J WILDLIFE DIS, V38, P505, DOI 10.7589/0090-3558-38.3.505; Eberle KC, 2015, VIRUS GENES, V51, P198, DOI 10.1007/s11262-015-1224-7; Ebert Mariana Bertholdi, 2013, Check List, V9, P1538; Epstein PR, 2003, ENVIRON HEALTH PERSP, V111, pA506, DOI 10.1289/ehp.111-a506; Esperon F, 2008, DIS AQUAT ORGAN, V81, P73, DOI 10.3354/dao01915; Faris F, 1994, SEAS DEBR SUMM 3 INT; Felix, 2013, REPORTED INCIDENCES; Fenton H, 2017, DIS AQUAT ORGAN, V122, P171, DOI 10.3354/dao03080; Fernandez A, 2005, VET PATHOL, V42, P446, DOI 10.1354/vp.42-4-446; Fernandez A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14038-z; Fletcher D, 1998, NEMATODE ASSOCIATED, P59; Nery MF, 2009, MAR MAMMAL SCI, V25, P450, DOI 10.1111/j.1748-7692.2008.00275.x; GALES NJ, 1992, J WILDLIFE DIS, V28, P651, DOI 10.7589/0090-3558-28.4.651; Garcia-Hartmann M, 1994, DIAGNOSIS CATCH PREL, P16; GEORGE JC, 1994, ARCTIC, V47, P247; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; GERSON HB, 1985, CAN J ZOOL, V63, P2083, DOI 10.1139/z85-306; Giamarellos-Bourboulis EJ, 2004, ANTIMICROB AGENTS CH, V48, P93, DOI 10.1128/AAC.48.1.93-99.2004; Gibson DI, 1998, J ZOOL, V244, P563, DOI 10.1111/j.1469-7998.1998.tb00061.x; Giorda F, 2017, J WILDLIFE DIS, V53, P795, DOI 10.7589/2016-07-150; Godinho AIA, 2010, THESIS; Greenwood AG, 1974, FUNCTIONAL PATHOLOGI; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Groch KR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194872; Hancock D., 1965, Journal of Mammalogy, V46, P341, DOI 10.2307/1377867; Heje LB, 1994, MICROSCOPICAL EXAMIN, P4; Herraez P, 2007, J WILDLIFE DIS, V43, P770, DOI 10.7589/0090-3558-43.4.770; Herraez P, 2013, VET J, V196, P181, DOI 10.1016/j.tvjl.2012.09.021; HOBERG EP, 1993, J HELMINTHOL SOC W, V60, P205; Howard EB, 1983, PATHOBIOLOGY MARINE, P119; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; do Sul JAI, 2007, MAR POLLUT BULL, V54, P1087, DOI 10.1016/j.marpolbul.2007.05.004; Jabbar A, 2015, PARASITOL RES, V114, P835, DOI 10.1007/s00436-014-4245-6; Jaber JR, 2005, J COMP PATHOL, V132, P242, DOI 10.1016/j.jcpa.2004.09.009; Jacobsen JK, 2010, MAR POLLUT BULL, V60, P765, DOI 10.1016/j.marpolbul.2010.03.008; Jauniaux T, 2002, J COMP PATHOL, V126, P243, DOI 10.1053/jcpa.2001.0547; Jauniaux T, 1998, J WILDLIFE DIS, V34, P99, DOI 10.7589/0090-3558-34.1.99; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Jepson PD, 2005, VET PATHOL, V42, P291, DOI 10.1354/vp.42-3-291; Jonsgard A, 1969, ICES, P1; Joseph B. E., 2000, BOTTL DOLPH BREED WO, P43; Kaplan JD, 2009, MAR MAMMAL SCI, V25, P970, DOI 10.1111/j.1748-7692.2009.00323.x; Katsanevakis S., 2008, MARINE POLLUTION NEW, P53; Kennedy S, 1998, J COMP PATHOL, V119, P201, DOI 10.1016/S0021-9975(98)80045-5; KENNEDY S, 1991, VET PATHOL, V28, P1, DOI 10.1177/030098589102800101; Kikuchi Shigeru, 1993, Japanese Journal of Parasitology, V42, P398; Kinsel MJ, 1997, J ZOO WILDLIFE MED, V28, P494; Knowlton Amy R., 2001, Journal of Cetacean Research and Management Special Issue, V2, P193; KRAUS SD, 1990, MAR MAMMAL SCI, V6, P278, DOI 10.1111/j.1748-7692.1990.tb00358.x; KUIKEN T, 1994, VET REC, V134, P81, DOI 10.1136/vr.134.4.81; Kuiken T, 1991, DISSECTION TECHNIQUE, P1; Lair S, 2016, VET PATHOL, V53, P22, DOI 10.1177/0300985815604726; Laist David W., 1997, P99; LAIST DW, 1987, MAR POLLUT BULL, V18, P319, DOI 10.1016/S0025-326X(87)80019-X; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; Lambertsen R.H., 1990, P395; Lambertsen R.H., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P1131; LAMBERTSEN RH, 1986, J MAMMAL, V67, P353, DOI 10.2307/1380889; Lebeuf M, 2014, SCI TOTAL ENVIRON, V485, P377, DOI 10.1016/j.scitotenv.2014.03.097; LESLIE CE, 1988, J MED VET MYCOL, V26, P335; LEWIS RJ, 1988, J WILDLIFE DIS, V24, P577, DOI 10.7589/0090-3558-24.3.577; Macfadyen G., 2009, FAO Fisheries and Aquaculture Technical Paper; MacLeod CD, 2007, UNDERSTANDING IMPACT; Di Beneditto APM, 2014, MAR POLLUT BULL, V83, P298, DOI 10.1016/j.marpolbul.2014.03.057; Madsen PT, 2014, CURR BIOL, V24, pR728, DOI 10.1016/j.cub.2014.06.041; MARTINEAU D, 1988, J COMP PATHOL, V98, P287, DOI 10.1016/0021-9975(88)90038-2; McAloose D, 2016, DIS AQUAT ORGAN, V119, P17, DOI 10.3354/dao02986; Mcfee WE, 2009, J WILDLIFE DIS, V45, P575; Melero M, 2011, DIS AQUAT ORGAN, V97, P167, DOI 10.3354/dao02412; Miclard J, 2006, J COMP PATHOL, V135, P254, DOI 10.1016/j.jcpa.2006.08.005; Miller M., 2018, CRC HDB MARINE MAMMA, P425, DOI [10.1111/mms.12698, DOI 10.1111/MMS.12698]; Mittal Rahul, 2009, J Infect Public Health, V2, P101, DOI 10.1016/j.jiph.2009.08.003; Moore MJ, 2013, DIS AQUAT ORGAN, V103, P229, DOI 10.3354/dao02566; Moore MJ, 2006, OC 06 MTS IEEE BOST; MORIMITSU T, 1987, J WILDLIFE DIS, V23, P586, DOI 10.7589/0090-3558-23.4.586; MORIMITSU T, 1986, J PARASITOL, V72, P469, DOI 10.2307/3281689; NEILAND KA, 1970, J PARASITOL, V56, P305, DOI 10.2307/3277662; Oliveira JB, 2011, VET PARASITOL, V182, P319, DOI 10.1016/j.vetpar.2011.05.014; Oremland MS, 2010, MAR MAMMAL SCI, V26, P1, DOI 10.1111/j.1748-7692.2009.00334.x; OSHEA TJ, 1991, J WILDLIFE DIS, V27, P706, DOI 10.7589/0090-3558-27.4.706; Panel-GEF, 2012, TECHNICAL SERIES, P61; Panigada S, 2006, MAR POLLUT BULL, V52, P1287, DOI 10.1016/j.marpolbul.2006.03.014; Parsons ECM, 2000, J WILDLIFE DIS, V36, P342, DOI 10.7589/0090-3558-36.2.342; Parsons Kim M., 2003, Aquatic Mammals, V29, P360, DOI 10.1578/01675420360736532; Patterson IAP, 1998, P ROY SOC B-BIOL SCI, V265, P1167, DOI 10.1098/rspb.1998.0414; PILLERI G, 1966, PATHOL VET, V3, P341, DOI 10.1177/030098586600300404; PILLERI G, 1968, PATHOL VET, V5, P35, DOI 10.1177/030098586800500104; Pintore MD, 2018, J WILDLIFE DIS, V54, P295, DOI 10.7589/2017-02-035; Pitman RL, 2001, MAR MAMMAL SCI, V17, P494, DOI 10.1111/j.1748-7692.2001.tb01000.x; Poncelet Eric, 2000, European Research on Cetaceans, V14, P44; Raga J. A., 1997, Parassitologia (Rome), V39, P293; RAGA JA, 1990, ANN PARASIT HUM COMP, V65, P255, DOI 10.1051/parasite/1990655255; RALLS K, 1980, REP INT WHAL COMM SP, V2, P223; Ramos-Vara JA, 2008, J VET DIAGN INVEST, V20, P393, DOI 10.1177/104063870802000401; Rebaudet S, 2009, EMERG INFECT DIS, V15, P985, DOI 10.3201/eid1506.080232; Reeves RR, 2013, ENDANGER SPECIES RES, V20, P71, DOI 10.3354/esr00481; Reidenberg JS, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P220; Resendes AR, 2002, J PARASITOL, V88, P1029, DOI 10.1645/0022-3395(2002)088[1029:DTIAMP]2.0.CO;2; Reynolds J.E., 1999, BIOL MARINE MAMMALS; Ridgway SH, 2002, ANAT REC, V268, P441, DOI 10.1002/ar.10183; Ridgway SH, 1965, J AM VET MED ASSOC, V71, P237; Roe WD, 2013, VET PARASITOL, V192, P67, DOI 10.1016/j.vetpar.2012.11.001; Rubini S, 2018, FORENSIC SCI INT, V290, pE19, DOI 10.1016/j.forsciint.2018.06.033; Santos MB, 2007, J MAR BIOL ASSOC UK, V87, P243, DOI 10.1017/S0025315407054380; Santos MB, 2001, J MAR BIOL ASSOC UK, V81, P687, DOI 10.1017/S0025315401004386; Siebert U, 2006, J COMP PATHOL, V134, P134, DOI 10.1016/j.jcpa.2005.09.002; Siebert U, 2001, J COMP PATHOL, V124, P102, DOI 10.1053/jcpa.2000.0436; Sierra E, 2017, VET PATHOL, V54, P298, DOI 10.1177/0300985816660747; Sierra E, 2018, DIS AQUAT ORGAN, V129, P165, DOI 10.3354/dao03248; Sierra E, 2014, J CLIN MICROBIOL, V52, P2390, DOI 10.1128/JCM.02906-13; Sierra E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088780; Simmonds Mark P., 1997, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V67, P29; Simmonds Mark Peter, 2012, Journal of Marine Biology, P1; Simpson JG, 1983, PATHOBIOLOGY MARINE, P29; Stewart JR, 2014, DIS AQUAT ORGAN, V108, P91, DOI 10.3354/dao02705; Stockin Karen A., 2009, Pacific Conservation Biology, V15, P217; Stolen MK, 2003, MAR MAMMAL SCI, V19, P630, DOI 10.1111/j.1748-7692.2003.tb01121.x; Stolk A, 1962, P KON NED AC WET, P250; STROUD RK, 1979, J WILDLIFE DIS, V15, P91, DOI 10.7589/0090-3558-15.1.91; Tajima Y, 2015, J VET MED SCI, V77, P45, DOI 10.1292/jvms.13-0454; Tarpley R. J., 1993, Aquatic Mammals, V19, P93; Tejedor M, 2013, CANARY ISLANDS ARE R; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thaiwong T, 2014, J CLIN MICROBIOL, V52, P2245, DOI 10.1128/JCM.00382-14; THURMAN GD, 1983, J S AFR VET ASSOC, V54, P193; Towers JR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22714-x; UNEP, 2009, MAR LITT GLOB CHALL; van Beurden SJ, 2017, ARCH VIROL, V162, P2035, DOI 10.1007/s00705-017-3310-8; Van Bressem MF, 2014, VIRUSES-BASEL, V6, P5145, DOI 10.3390/v6125145; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; Van der Hoop JM, 2013, CONSERV BIOL, V27, P121, DOI 10.1111/j.1523-1739.2012.01934.x; Van Waerebeek K, 2008, SC60BC5; Van Waerebeek K, 2007, SC59BC12; Walker WA, 1989, SURVEY MARINE DEBRIS; Wang QN, 2010, VET MICROBIOL, V140, P405, DOI 10.1016/j.vetmic.2009.08.012; Wellard R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166670; WHITEHEAD H, 1985, J MAMMAL, V66, P183, DOI 10.2307/1380982; WOODARD JC, 1969, PATHOL VET, V6, P257, DOI 10.1177/030098586900600307; YONEZAWA M, 1989, J COMP PATHOL, V100, P203, DOI 10.1016/0021-9975(89)90132-1; Young NM, 2007, NMFSOPR36, P276	210	47	48	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204444	10.1371/journal.pone.0204444	http://dx.doi.org/10.1371/journal.pone.0204444			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289951	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500015
J	Liu, LF; Zhao, WA; Liu, JX; Gan, Y; Liu, LJ; Tian, J				Liu, Lifei; Zhao, Weian; Liu, Jianxia; Gan, Yi; Liu, Lingjuan; Tian, Jie			Epigallocatechin-3 gallate prevents pressure overload-induced heart failure by up-regulating SERCA2a via histone acetylation modification in mice	PLOS ONE			English	Article							ADENOVIRAL GENE-TRANSFER; SARCOPLASMIC-RETICULUM CA2+-ATPASE; GREEN TEA POLYPHENOLS; CARDIAC-HYPERTROPHY; RAT HEARTS; CLASS-I; EXPRESSION; EGCG; CATECHINS; (-)-EPIGALLOCATECHIN-3-GALLATE	Heart failure is a common, costly, and potentially fatal condition. The cardiac sarcoplasmic reticulum Ca-ATPase (SERCA2a) plays a critical role in the regulation of cardiac function. Previously, low SERCA2a expression was revealed in mice with heart failure. Epigallocatechin-3-gallate (EGCG) can function as an epigenetic regulator and has been reported to enhance cardiac function. However, the underlying epigenetic regulatory mechanism is still unclear. In this study, we investigated whether EGCG can up-regulate SERCA2a via histone acetylation and play role in preventing heart failure. For this, we generated a mouse model of heart failure by performing a minimally invasive transverse aortic constriction (TAC) operation and used this to test the effects of EGCG. The TAC+EGCG group showed nearly normal cardiac function compared to that in the SHAM group. The expression of SERCA2a was decreased at both the mRNA and protein levels in the TAC group but was enhanced in the TAC+EGCG group. Levels of AcH3 and AcH3K9 were determined to decrease near the promoter region of Atp2a2 (the gene encoding SERCA-2a) in the TAC group, but were elevated in the TAC+EGCG group. Meanwhile, HDAC1 activity and binding near the Atp2a2 promoter were increased in the TAC group but decreased with EGCG addition. Further, binding levels of GATA4 and Mef2c near the Atp2a2 promoter region were reduced in TAC hearts, which might have been caused by histone hypoacetylation; this was reversed by EGCG. Together, upregulation of SERCA2a via the modification of histone acetylation plays a role in EGCG-mediated prevention of pressure overload-induced heart failure, and this might represent a novel pharmacological target for the treatment of heart failure.	[Liu, Lifei; Liu, Jianxia] Chongqing Med Univ, Dept Anesthesiol, Childrens Hosp, Chongqing, Peoples R China; [Zhao, Weian; Tian, Jie] Chongqing Med Univ, Childrens Hosp, Dept Cardiol, Heart Ctr, Chongqing, Peoples R China; [Gan, Yi] Minist Educ, Key Lab Child Dev & Disorders, Beijing, Peoples R China; [Liu, Lingjuan] Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Liu, Lingjuan] Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Tian, J (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Cardiol, Heart Ctr, Chongqing, Peoples R China.	jietian@cqmu.edu.cn			Natural Science Foundation of China [81670212]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Natural Science Foundation of China (81670212 to JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrisano T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106024; ARAI M, 1993, CIRC RES, V72, P463, DOI 10.1161/01.RES.72.2.463; Bavendiek U, 1998, BASIC RES CARDIOL, V93, P76; Cai Y, 2013, PHYTOMEDICINE, V20, P106, DOI 10.1016/j.phymed.2012.10.002; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Eng QY, 2018, J ETHNOPHARMACOL, V210, P296, DOI 10.1016/j.jep.2017.08.035; FELDMAN AM, 1993, CIRC RES, V73, P184, DOI 10.1161/01.RES.73.1.184; Feng W, 2012, MOL PHARMACOL, V82, P993, DOI 10.1124/mol.112.079707; Frank KF, 2003, CARDIOVASC RES, V57, P20, DOI 10.1016/S0008-6363(02)00694-6; Hajjar RJ, 1997, CIRC RES, V81, P145, DOI 10.1161/01.RES.81.2.145; Hajjar RJ, 1997, CIRCULATION, V95, P423; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Hayward C, 2015, HUM GENE THER, V26, P293, DOI 10.1089/hum.2015.018; Hu P, 2003, AM J PHYSIOL-HEART C, V285, pH1261, DOI 10.1152/ajpheart.00108.2003; Ikeda I, 2008, ASIA PAC J CLIN NUTR, V17, P273; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin P, 2014, CELL TISSUE RES, V356, P381, DOI 10.1007/s00441-014-1797-9; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; KISS E, 1995, CIRC RES, V77, P759, DOI 10.1161/01.RES.77.4.759; Koh YW, 2011, J NUTR BIOCHEM, V22, P1074, DOI 10.1016/j.jnutbio.2010.09.005; Kondo T, 2002, CANCER LETT, V180, P139, DOI 10.1016/S0304-3835(02)00007-1; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Krum H, 2009, LANCET, V373, P941, DOI 10.1016/S0140-6736(09)60236-1; Li YY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-274; Lim YC, 2008, CANCER LETT, V271, P140, DOI 10.1016/j.canlet.2008.05.048; Liu Z, 2017, J BIOCHEM MOL TOXIC, V31, DOI 10.1002/jbt.21932; Madhan B, 2007, INT J BIOL MACROMOL, V41, P16, DOI 10.1016/j.ijbiomac.2006.11.013; Man Y, 2017, BIOMED RES INT, V2017, P1, DOI [DOI 10.1155/2017/5615647, 10.1155/2017/5615647, DOI 10.18632/oncotarget.13723]; MATSUI H, 1995, AM J PHYSIOL-CELL PH, V268, pC252, DOI 10.1152/ajpcell.1995.268.1.C252; MERCADIER JJ, 1990, J CLIN INVEST, V85, P305, DOI 10.1172/JCI114429; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Muller OJ, 2003, CARDIOVASC RES, V59, P380, DOI 10.1016/S0008-6363(03)00429-2; Nandakumar V, 2011, CARCINOGENESIS, V32, P537, DOI 10.1093/carcin/bgq285; Pan B, 2017, J CELL MOL MED, V21, P2481, DOI 10.1111/jcmm.13169; Quan JunJun, 2017, Journal of Third Military Medical University, V39, P436; Roychoudhury S, 2017, REPROD BIOMED ONLINE, V34, P487, DOI 10.1016/j.rbmo.2017.02.006; Sakata R, 2004, J HEPATOL, V40, P52, DOI 10.1016/S0168-8278(03)00477-X; Sakata S, 2007, J MOL CELL CARDIOL, V42, P852, DOI 10.1016/j.yjmcc.2007.01.003; Shareef MA, 2014, EUR J PHARMACOL, V724, P1, DOI 10.1016/j.ejphar.2013.12.018; Sheehan A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00243; Sheng R, 2009, PLANTA MED, V75, P113, DOI 10.1055/s-0028-1088387; Smith Robert E, 2016, Diseases, V4, DOI 10.3390/diseases4040034; Thakur VS, 2012, INT J ONCOL, V41, P353, DOI 10.3892/ijo.2012.1449; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006; Zhang QC, 2022, IEEE T BIG DATA, V8, P25, DOI 10.1109/TBDATA.2017.2701816; Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25	48	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205123	10.1371/journal.pone.0205123	http://dx.doi.org/10.1371/journal.pone.0205123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286210	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500090
J	Szymanski, L; Cios, A; Lewicki, S; Szymanski, P; Stankiewicz, W				Szymanski, Lukasz; Cios, Aleksandra; Lewicki, Slawomir; Szymanski, Pawel; Stankiewicz, Wanda			Fas/FasL pathway and cytokines in keratinocytes in atopic dermatitis - Manipulation by the electromagnetic field	PLOS ONE			English	Article							MAPK SIGNALING PATHWAYS; FAS LIGAND; STEM-CELLS; IN-VITRO; EXPOSURE; LEVEL; SKIN; ACTIVATION; RADIATION; APOPTOSIS	Background Atopic dermatitis (AD) is one of the most frequent skin diseases. Changes of the keratinocytes functionality play a major role in the development of AD. For example, activation of the Fas (CD95)/FasL (CD178) pathway in AD does not lead to extensive apoptosis in skin. Binding of the Fas receptor to its protein ligand-FasL, which are present on the (AD)-modified keratinocytes, should result in the sequential induction of cell death, but there is no evidence of extensive apoptosis of these cells. This suggests that non-apoptotic mechanism of Fas/FasL pathway is commonly encountered, although not examined in the case of AD, phenomenon. An electromagnetic field, which was used to influence cultured cells in this study, can modulate proliferation, apoptosis, differentiation, and metabolism in various cells. Objective Here, we evaluate the possibility to manipulate the immune activation of AD keratinocytes and their response to the electromagnetic field, which was not tested before. Methods Keratinocytes isolated from the skin of healthy subjects (n = 20) and patients with atopic dermatitis (n = 20) as well as HaCaT and PCS-200-010 cell were exposed to the 900 MHz electromagnetic field for 60 minutes. Cytometric analysis of viability, Fas/FasL, p-ERK, p-p38 and p-JNK expression and Luminex analysis of cytokine concentration were performed in two-time points: 4 and 24 hours after the exposition. Results This research has shown upregulated Fas, FasL, p-ERK, p-p38, and p-JNK expression along with increased cytokine secretion (IL-1 beta, IL-4, IL-8, IL-10, IL-12p70, IL-13, IL-17A, IL-31 and TNF alpha) by keratinocytes derived from the skin of patients with the AD when compared with healthy control. Exposure of keratinocyte cultures obtained from AD patients to EMF resulted in a decrease of 1 beta, IL-4, IL-10, IL-12, I L-13, IL-17, IL-31 and TNF alpha levels. Keratinocytes derived from the skin of AD patients are characterized by elevated Fas and FasL expression when compared to healthy control. Conclusion Apoptotic and nonapoptotic activation of the Fas/FasL-dependent signaling pathway may play a significant role in the pathogenesis of AD, by adjusting the local cytokine and chemokine environment at the site of inflammation. Moreover, the electromagnetic field exhibits strong immunomodulatory effects on AD-modified keratinocytes.	[Szymanski, Lukasz; Cios, Aleksandra; Szymanski, Pawel; Stankiewicz, Wanda] Mil Inst Hyg & Epidemiol, Dept Microwave Safety, Warsaw, Poland; [Lewicki, Slawomir] Mil Inst Hyg & Epidemiol, Dept Regenerat Med & Cell Biol, Warsaw, Poland	Military Institute of Hygiene & Epidemiology (MIHE); Military Institute of Hygiene & Epidemiology (MIHE)	Szymanski, L (corresponding author), Mil Inst Hyg & Epidemiol, Dept Microwave Safety, Warsaw, Poland.	lukas91.sz@gmail.com	Szymanski, Lukasz/HDM-8142-2022	Szymanski, Lukasz/0000-0003-0148-541X; Lewicki, Slawomir/0000-0002-0539-0680	Polish Ministry of Science and Higher Education	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was funded by Polish Ministry of Science and Higher Education grant for Young Scientist.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Bien K, 2017, INFLAMM RES, P1; Boehm I, 2006, CURR MOL MED, V6, P375, DOI 10.2174/156652406777435390; Bort A, 2017, MOL PAIN, V13, P1, DOI 10.1177/1744806916688220; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; D'Angelo C, 2015, SAUDI J BIOL SCI, V22, P75, DOI 10.1016/j.sjbs.2014.07.006; Dabrowski MP, 2003, ELECTROMAGN BIOL MED, V22, P1, DOI 10.1081/JBC-120020347; Farley SM, 2006, J INVEST DERMATOL, V126, P2438, DOI 10.1038/sj.jid.5700477; Gazel A, 2006, J BIOL CHEM, V281, P20530, DOI 10.1074/jbc.M602712200; Huang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113424; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kennedy NJ, 2010, HDB CELL SIGNALING, P1315, DOI [10.1016/B978-0-12-374145-5.00164-9, DOI 10.1016/B978-0-12-374145-5.00164-9]; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kjellerup RB, 2008, EXP DERMATOL, V17, P498, DOI 10.1111/j.1600-0625.2007.00672.x; Lee SH, 1998, BRIT J DERMATOL, V139, P186; Leshem YA, 2015, BRIT J DERMATOL, V172, P1353, DOI 10.1111/bjd.13662; Lesniak M, 2018, TISSUE ENG REGEN MED, V15, P211, DOI 10.1007/s13770-017-0103-9; Lu B, 2002, AM J PHYSIOL-CELL PH, V283, pC831, DOI 10.1152/ajpcell.00045.2002; Maier E, 2014, J IMMUNOL, V193, P645, DOI 10.4049/jimmunol.1301836; Mutou Y, 2010, J HEALTH SCI, V56, P675, DOI 10.1248/jhs.56.675; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; Nylund R, 2004, PROTEOMICS, V4, P1359, DOI 10.1002/pmic.200300773; Patruno A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139644; Rosado MM, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00085; Sobiech Jaromir, 2015, Przeglad Elektrotechniczny, V91, P218, DOI 10.15199/48.2015.12.56; Stankiewicz W, 2006, ELECTROMAGN BIOL MED, V25, P45, DOI 10.1080/15368370600572961; Sun YJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40605; Tan Q, 2017, MOL MED REP, V16, P8863, DOI 10.3892/mmr.2017.7689; Wajant H, 2003, CYTOKINE GROWTH F R, V14, P53, DOI 10.1016/S1359-6101(02)00072-2; Wolf-Goldberg T, 2013, BBA-MOL CELL RES, V1833, P1396, DOI 10.1016/j.bbamcr.2013.02.011; Wu D, 2013, CELL BIOCHEM BIOPHYS, V67, P1115, DOI 10.1007/s12013-013-9615-7; Zhang HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026805; Zhi WJ, 2017, MILITARY MED RES, V4, DOI 10.1186/s40779-017-0139-0; Zmyslony M, 2004, BIOELECTROMAGNETICS, V25, P324, DOI 10.1002/bem.10191	34	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205103	10.1371/journal.pone.0205103	http://dx.doi.org/10.1371/journal.pone.0205103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286163	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500085
J	Allen, KD; Regier, MJ; Hsieh, C; Tsokas, P; Barnard, M; Phatarpekar, S; Wolk, J; Sacktor, TC; Fenton, AA; Hernandez, AI				Allen, Kim D.; Regier, Matthew J.; Hsieh, Changchi; Tsokas, Panayiotis; Barnard, Maya; Phatarpekar, Shwetha; Wolk, Jason; Sacktor, Todd C.; Fenton, Andre A.; Hernandez, A. Ivan			Learning-induced ribosomal RNA is required for memory consolidation in mice-Evidence of differentially ex-pressed rRNA variants in learning and memory	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; LONG-TERM FACILITATION; SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; GENE-EXPRESSION; NUCLEOLUS; APLYSIA; RDNA; TURNOVER; DISEASE	The transition from short-term to long-term forms of synaptic plasticity requires protein synthesis and new gene expression. Most efforts to understand experience-induced changes in neuronal gene expression have focused on the transcription products of RNA polymerase II-primarily mRNAs and the proteins they encode. We recently showed that nucleolar integrity and activity-dependent ribosomal RNA (rRNA) synthesis are essential for the maintenance of hippocampal long-term potentiation (LTP). Consequently, the synaptic plasticity and memory hypothesis predicts that nucleolar integrity and activity dependent rRNA synthesis would be required for Long-term memory (LTM). We tested this prediction using the hippocampus-dependent, Active Place Avoidance (APA) spatial memory task and found that training induces de novo rRNA synthesis in mouse dorsal hippocampus. This learning-induced increase in nucleolar activity and rRNA synthesis persists at least 24 h after training. In addition, intra-hippocampal injection of the Pol I specific inhibitor, CX-5461 prior to training, revealed that de novo rRNA synthesis is required for 24 h memory, but not for learning. Using qPCR to assess activity-dependent changes in gene expression, we found that of seven known rRNA expression variants (v-rRNAs), only one, v-rRNA IV, is significantly upregulated right after training. These data indicate that learning induced v-rRNAs are crucial for LTM, and constitute the first evidence that differential rRNA gene expression plays a role in memory.	[Allen, Kim D.; Regier, Matthew J.; Barnard, Maya; Phatarpekar, Shwetha; Hernandez, A. Ivan] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA; [Allen, Kim D.] CUNY Medgar Evers Coll, Sch Sci Hlth & Technol, Dept Biol, Brooklyn, NY 11225 USA; [Regier, Matthew J.; Phatarpekar, Shwetha] Suny Downstate Med Ctr, Grad Program Neural & Behav Sci, Brooklyn, NY 11203 USA; [Hsieh, Changchi; Tsokas, Panayiotis; Sacktor, Todd C.; Fenton, Andre A.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Tsokas, Panayiotis; Sacktor, Todd C.] Suny Downstate Med Ctr, Dept Anesthesiol, Brooklyn, NY 11203 USA; [Wolk, Jason] NYU, Dept Phys, 4 Washington Pl, New York, NY 10003 USA; [Sacktor, Todd C.] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Sacktor, Todd C.; Fenton, Andre A.; Hernandez, A. Ivan] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [Fenton, Andre A.] NYU, Ctr Neural Sci, New York, NY 10003 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; City University of New York (CUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University	Hernandez, AI (corresponding author), Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA.; Hernandez, AI (corresponding author), Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA.	ivan.hernandez@downstate.edu		Regier, Matthew/0000-0002-4641-3316; Allen, Kim D/0000-0001-9774-5014; Hsieh, Changchi/0000-0003-0488-1565; tsokas, panayiotis/0000-0002-1679-8980	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057068] Funding Source: NIH RePORTER; NIMH NIH HHS [R37 MH057068] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Allen KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104364; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bellavia D, 2016, GENE, V580, P118, DOI 10.1016/j.gene.2016.01.010; Capitano F, 2016, J NEUROCHEM, V136, P706, DOI 10.1111/jnc.13504; CASTELLUCCI VF, 1986, J PHYSIOL-PARIS, V81, P349; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Dimarco E, 2012, GENE, V508, P21, DOI 10.1016/j.gene.2012.07.067; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; GONZALEZ IL, 1995, GENOMICS, V27, P320, DOI 10.1006/geno.1995.1049; Gonzalez IL, 2001, GENOMICS, V73, P255, DOI 10.1006/geno.2001.6540; GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666; Goosens KA, 2002, HIPPOCAMPUS, V12, P592, DOI 10.1002/hipo.10099; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Grummt I, 2013, CHROMOSOMA, V122, P487, DOI 10.1007/s00412-013-0430-0; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Hernandez A Ivan, 2015, Commun Integr Biol, V8, pe1017163, DOI 10.1080/19420889.2015.1017163; Hernandez AI, 2009, J NEUROSCI, V29, P9553, DOI 10.1523/JNEUROSCI.1512-09.2009; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Hetman M, 2012, TRENDS NEUROSCI, V35, P305, DOI 10.1016/j.tins.2012.01.002; Higa-Nakamine S, 2012, NUCLEIC ACIDS RES, V40, P391, DOI 10.1093/nar/gkr700; HIRSCH CA, 1966, J BIOL CHEM, V241, P5936; Ihara M, 2011, BIOL REPROD, V84, P944, DOI 10.1095/biolreprod.110.089680; JUNERA HR, 1995, J CELL SCI, V108, P3427; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KATZ JOSEPH J., 1950, COMPAR PSYCHOL MONOGR, V20, P1; Kiryk A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00207; Kuo BA, 1996, NUCLEIC ACIDS RES, V24, P4817, DOI 10.1093/nar/24.23.4817; Lee J, 2014, BBA-MOL BASIS DIS, V1842, P785, DOI 10.1016/j.bbadis.2013.09.017; Lesburgueres E, 2016, HIPPOCAMPUS, V26, P1481, DOI 10.1002/hipo.22666; Li DF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04072-4; Mathis AD, 2017, MOL CELL PROTEOMICS, V16, P243, DOI 10.1074/mcp.M116.063255; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; NIKOLOV EN, 1983, INT J BIOCHEM, V15, P1255, DOI 10.1016/0020-711X(83)90215-X; Parks MM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao0665; Parlato R, 2014, BBA-MOL BASIS DIS, V1842, P791, DOI 10.1016/j.bbadis.2013.12.014; Parlato R, 2013, J MOL MED, V91, P541, DOI 10.1007/s00109-012-0981-1; Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Pavlowsky A, 2017, NEUROBIOL LEARN MEM, V138, P182, DOI 10.1016/j.nlm.2016.08.015; Pietrzak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022585; Pontvianne F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001225; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; Shiao YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022266; Tseng H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001843; Tsokas P, 2016, ELIFE, V5, DOI 10.7554/eLife.14846; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Waters AP, 1997, J BIOL CHEM, V272, P3583, DOI 10.1074/jbc.272.6.3583; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Zeng JY, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8987928	53	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203374	10.1371/journal.pone.0203374	http://dx.doi.org/10.1371/journal.pone.0203374			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281601	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400020
J	Hirota, Y; Nakagawa, K; Isomoto, K; Sakaki, T; Kubodera, N; Kamao, M; Osakabe, N; Suhara, Y; Okano, T				Hirota, Yoshihisa; Nakagawa, Kimie; Isomoto, Keigo; Sakaki, Toshiyuki; Kubodera, Noboru; Kamao, Maya; Osakabe, Naomi; Suhara, Yoshitomo; Okano, Toshio			Eldecalcitol is more effective in promoting osteogenesis than alfacalcidol in Cyp27b1-knockout mice	PLOS ONE			English	Article							VITAMIN-D ANALOG; BONE-MINERAL DENSITY; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; OSTEOPOROTIC PATIENTS; POSTMENOPAUSAL WOMEN; CALCIUM-METABOLISM; D-RECEPTOR; RAT MODEL; GENE; ED-71	Calcium (Ca) absorption from the intestinal tract is promoted by active vitamin D (1 alpha,25D(3)). Vitamin D not only promotes Ca homeostasis, but it also inhibits bone resorption and promotes osteogenesis, thus playing a role in the maintenance of normal bone metabolism. Because 1 alpha,25D(3) plays an important role in osteogenesis, vitamin D formulations, such as alfacalcidol (ALF) and eldecalcitol (ELD), are used for treating osteoporosis. While it is known that, in contrast to ALF, ELD is an active ligand that directly acts on bone, the reason for its superior osteogenesis effects is unknown. Cyp27b1-knockout mice (Cyp27b1(-/-)mice) are congenitally deficient in 1 alpha,25D(3) and exhibit marked hypocalcemia and high parathyroid hormone levels, resulting in osteodystrophy involving bone hypocalcification and growth plate cartilage hypertrophy. However, because the vitamin D receptor is expressed normally in Cyp27b1(-/-)mice, they respond normally to 1 alpha,25D(3). Accordingly, in Cyp27b1(-/-)mice, the pharmacological effects of exogenously administered active vitamin D derivatives can be analyzed without being affected by 1 alpha,25D(3). We used Cyp27b1(-/-)mice to characterize and clarify the superior osteogenic effects of ELD on the bone in comparison with ALF. The results indicated that compared to ALF, ELD strongly induces ECaC2, calbindin-D-9k, and CYP24A1 in the duodenum, promoting Ca absorption and decreasing the plasma concentration of 1 alpha,25D(3), resulting in improved osteogenesis. Because bone morphological measurements demonstrated that ELD has stronger effects on bone calcification, trabecular formation, and cancellous bone density than ALF, ELD appears to be a more effective therapeutic agent for treating postmenopausal osteoporosis, in which cancellous bone density decreases markedly. By using Cyp27b1(-/-)mice, this study was the first to succeed in clarifying the osteogenic effect of ELD without any influence of endogenous 1 alpha,25D(3).	[Hirota, Yoshihisa] Shibaura Inst Technol, Coll Syst Engn & Sci, Dept Biosci & Engn, Lab Biochem,Minuma Ku, Saitama, Japan; [Hirota, Yoshihisa; Nakagawa, Kimie; Isomoto, Keigo; Kamao, Maya; Okano, Toshio] Kobe Pharmaceut Univ, Lab Hygien Sci, Higashinada Ku, Motoyamakita Machi, Kobe, Hyogo, Japan; [Sakaki, Toshiyuki] Toyama Prefectural Univ, Fac Engn, Dept Pharmaceut Engn, Imizu, Toyama, Japan; [Kubodera, Noboru] Int Inst Act Vitamin D Analogs, Mishima, Shizuoka, Japan; [Osakabe, Naomi] Shibaura Inst Technol, Coll Syst Engn & Sci, Dept Biosci & Engn, Food & Nutr Lab,Minuma Ku, Saitama, Japan; [Suhara, Yoshitomo] Shibaura Inst Technol, Coll Syst Engn & Sci, Dept Biosci & Engn, Lab Organ Synth & Med Chem,Minuma Ku, Saitama, Japan	Shibaura Institute of Technology; Kobe Pharmaceutical University; Toyama Prefectural University; Shibaura Institute of Technology; Shibaura Institute of Technology	Hirota, Y (corresponding author), Shibaura Inst Technol, Coll Syst Engn & Sci, Dept Biosci & Engn, Lab Biochem,Minuma Ku, Saitama, Japan.; Hirota, Y; Okano, T (corresponding author), Kobe Pharmaceut Univ, Lab Hygien Sci, Higashinada Ku, Motoyamakita Machi, Kobe, Hyogo, Japan.	hirotay@shibaura-it.ac.jp; t-okano@kobepharma-u.ac.jp	Hirota, Yoshihisa/R-6741-2019	Hirota, Yoshihisa/0000-0002-6462-9479; Suhara, Yoshitomo/0000-0002-4770-2910	JSPS [17K00900, 18K11056, 16K18924]; Precise Measurement Technology Promotion Foundation (PMTP-F)	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Precise Measurement Technology Promotion Foundation (PMTP-F)	This work was supported in part by a Grant-in-aid for Scientific Research (C) [grant number 17K00900:https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-17K00900/ and 18K11056:https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-18K11056/] from JSPS and a grant-in-aid for Scientific Research Young Scientists (B) (grant number 16K18924:https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-16K18924/) from JSPS. This work was partly supported by the Precise Measurement Technology Promotion Foundation (PMTP-F)http://www.pmtp-f.or.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe D, 2005, DRUG METAB DISPOS, V33, P778, DOI 10.1124/dmd.104.003038; Akiyama H, 1996, J BONE MINER RES, V11, P22; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Colnot S, 2000, ENDOCRINOLOGY, V141, P2301, DOI 10.1210/en.141.7.2301; DAIGER SP, 1975, P NATL ACAD SCI USA, V72, P2076, DOI 10.1073/pnas.72.6.2076; Dardenne O, 2004, J STEROID BIOCHEM, V89-90, P327, DOI 10.1016/j.jsbmb.2004.03.026; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; Darwish Hisham, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P89; GALANTE L, 1972, NATURE, V238, P271, DOI 10.1038/238271a0; GILL RK, 1993, P NATL ACAD SCI USA, V90, P2984, DOI 10.1073/pnas.90.7.2984; Harada S, 2012, J BONE MINER RES, V27, P461, DOI 10.1002/jbmr.555; Hatakeyama S, 2006, BIOORGAN MED CHEM, V14, P8050, DOI 10.1016/j.bmc.2006.07.039; Hayashi Y., 1992, J BONE MINER METAB, V10, P184; Hirota Y, 2017, BIOCHEM BIOPH RES CO, V483, P359, DOI 10.1016/j.bbrc.2016.12.139; IKEDA T, 1992, BIOCHEM BIOPH RES CO, V189, P1231, DOI 10.1016/0006-291X(92)92336-V; Ishizawa M, 2008, J LIPID RES, V49, P763, DOI 10.1194/jlr.M700293-JLR200; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; Kubodera N, 2003, J CELL BIOCHEM, V88, P286, DOI 10.1002/jcb.10346; Matsumoto T, 2005, J CLIN ENDOCR METAB, V90, P5031, DOI 10.1210/jc.2004-2552; MIYAMOTO K, 1993, CHEM PHARM BULL, V41, P1111; MORIMOTO S, 1989, BIOCHEM INT, V19, P1143; MURAYAMA E, 1986, CHEM PHARM BULL, V34, P4410; OHYAMA Y, 1993, BIOCHEMISTRY-US, V32, P76, DOI 10.1021/bi00052a011; OKANO T, 1989, BIOCHEM BIOPH RES CO, V163, P1444, DOI 10.1016/0006-291X(89)91140-6; Okuda N, 2007, BONE, V40, P281, DOI 10.1016/j.bone.2006.08.017; ORIMO H, 1994, CALCIFIED TISSUE INT, V54, P370, DOI 10.1007/BF00305521; Panda DK, 2001, P NATL ACAD SCI USA, V98, P7498, DOI 10.1073/pnas.131029498; Parfitt AM, 2002, BONE, V30, P807, DOI 10.1016/S8756-3282(02)00735-4; Rachez C, 2000, GENE, V246, P9, DOI 10.1016/S0378-1119(00)00052-4; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Sairanen S, 2000, CALCIFIED TISSUE INT, V67, P122, DOI 10.1007/s00223001118; Saito H, 2013, J STEROID BIOCHEM, V136, P178, DOI 10.1016/j.jsbmb.2012.10.004; Sanford M, 2011, DRUGS, V71, P1755, DOI 10.2165/11206790-000000000-00000; Serizawa K, 2016, J ENDOCRINOL, V228, P75, DOI 10.1530/JOE-15-0332; Shams-White MM, 2017, AM J CLIN NUTR, V105, P1528, DOI 10.3945/ajcn.116.145110; Shiraishi A, 2002, CALCIFIED TISSUE INT, V71, P69, DOI 10.1007/s00223-001-2090-y; Takasu H, 2006, J CLIN INVEST, V116, P528, DOI 10.1172/JCI24742; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; TSURUKAMI H, 1994, CALCIFIED TISSUE INT, V54, P142, DOI 10.1007/BF00296065; Uchiyama Y, 2002, BONE, V30, P582, DOI 10.1016/S8756-3282(02)00682-8; Vanhooke JL, 2006, P NATL ACAD SCI USA, V103, P75, DOI 10.1073/pnas.0509734103; Yasuda K, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.120	42	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0199856	10.1371/journal.pone.0199856	http://dx.doi.org/10.1371/journal.pone.0199856			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281599	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400004
J	Jonas, JB; Wei, WB; Xu, L; Wang, YX				Jonas, Jost B.; Wei, Wen Bin; Xu, Liang; Wang, Ya Xing			Systemic inflammation and eye diseases. The Beijing Eye Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; COMPLEMENT FACTOR-H; POLYPOIDAL CHOROIDAL VASCULOPATHY; TYPE-2 DIABETES-MELLITUS; MACULAR DEGENERATION; COGNITIVE IMPAIRMENT; RISK-FACTORS; RETINOPATHY; ASSOCIATION; PREVALENCE	Purpose Systemic inflammation is potentially associated with ocular diseases such as late age-related macular degeneration (AMD). Using the serum concentration of high-sensitive C-reactive protein (hs-CRP) as surrogate of systemic inflammation, we examined potential associations between the serum hs-CRP concentration and the presence and degree of eye diseases. Methods The population-based Beijing Eye Study included 3468 Chinese individuals. The study participants underwent a standardized interview and a detailed ophthalmic examination. The serum concentration of hs-CRP was determined. Results Out of 3468 participants, 2452 (70.7%) individuals (mean age:63.4 +/- 9.4 year; range:50-91 years) had hs-CRP measurements (mean:1.96 +/- 4.07mg/L). In multivariate analysis, higher serum concentration of hs-CRP was significantly (regression coefficient r: 0.21) associated with a higher level of diabetic retinopathy (P= 0.007; standardized regression coefficient beta:0.06; non-standardized regression coefficient B:1.35; 95% confidence interval (CI):0.37,2.22) and polypoidal choroidal vasculopathy (P= 0.002;beta:0.06;B:6.22;95% CI:2.24,10.2) after adjusting for higher serum concentration of high-density lipoproteins (P<0.001;beta:-0.12;B:-1.31;95%CI:-1.77,-0.85), higher body mass index (P= 0.01; beta:0.06;B:0.06;95%CI:0.01, 0.11), lower level of education (P = 0.04;beta:-0.06;B:0.22;95%CI:-0.42,-0.02), lower cognitive function score (P= 0.01;beta:-0.07;B:-0.08;95% CI:-0.13,-0.02). If the presences of other ocular diseases were added to the model, the presence of glaucoma (P = 0.99), open-angle glaucoma (P = 0.80), angle-closure glaucoma (P= 0.67), pseudoexfoliation (P = 0.18), nuclear cataract (P = 0.30), cortical cataract (P = 0.15), subcapsular cataract (P= 0.59), retinal vein occlusions (P= 0.33), central serous choroidopathy (P = 0.44), early stage of age-related macular degeneration (AMD) (P = 0.46), intermediate stage of AMD (P= 0.20) and late stage of AMD (P= 0.91) including geographic atrophy (P= 0.60) or neovascular AMD (P= 0.68) were not significantly associated with the serum concentration of hs-CRP. Conclusions In Chinese aged 50+ years, higher serum concentration of hs-CRP was significantly associated with a higher level of diabetic retinopathy and higher frequency of polypoidal choroidal vasculopathy. Other major ocular disorders, namely glaucoma including open-angle glaucoma and angle-closure glaucoma, pseudoexfoliation, nuclear, cortical or subcapsular cataract, retinal vein occlusions, central serous choroidopathy, early, intermediate or late stage of AMD including geographic atrophy, were not significantly associated with hs-CRP serum concentrations. It suggests that these diseases, in contrast to diabetic retinopathy and polypoidal choroidal vasculopathy, were not associated with a major systemic inflammatory component.	[Jonas, Jost B.; Xu, Liang; Wang, Ya Xing] Capital Med Univ, Beijing Tongren Hosp, Beijing Key Lab Ophthalmol & Visual Sci, Beijing Tongren Eye Ctr,Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Wei, Wen Bin] Capital Med Univ, Beijing Tongren Hosp, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing Tongren Eye Ctr, Beijing, Peoples R China	Capital Medical University; Ruprecht Karls University Heidelberg; Capital Medical University	Wang, YX (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Key Lab Ophthalmol & Visual Sci, Beijing Tongren Eye Ctr,Beijing Inst Ophthalmol, Beijing, Peoples R China.; Wei, WB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	weiwenbintr@163.com; yaxingw@gmail.com	wang, YA XING/K-9671-2016; wei, wei/HHR-8613-2022	wang, YA XING/0000-0003-2749-7793; Jonas, Jost/0000-0003-2972-5227	National Natural Science Foundation of China [81570835]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by National Natural Science Foundation of China (grant # 81570835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Aryan Z, 2018, ANN NUTR METAB, V72, P287, DOI 10.1159/000488537; Cheng HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110818; Chirco KR, 2016, J PATHOL, V240, P173, DOI 10.1002/path.4766; Chuengsamarn S, 2017, DIABETES METAB SYND, V11, P103, DOI 10.1016/j.dsx.2016.08.012; Cipriani V, 2017, JAMA OPHTHALMOL, V135, P909, DOI 10.1001/jamaophthalmol.2017.2191; Despriet DDG, 2006, JAMA-J AM MED ASSOC, V296, P301, DOI 10.1001/jama.296.3.301; Dong N, 2015, INVEST OPHTH VIS SCI, V56, P4177, DOI 10.1167/iovs.15-16470; Feng XF, 2009, OPHTHALMOLOGY, V116, P1908, DOI 10.1016/j.ophtha.2009.03.011; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Jonas JB, 2009, ACTA OPHTHALMOL, V87, P247, DOI 10.1111/j.1755-3768.2008.01385.x; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kikuchi M, 2007, OPHTHALMOLOGY, V114, P1722, DOI 10.1016/j.ophtha.2006.12.021; Laursen JVN, 2013, CURR EYE RES, V38, P174, DOI 10.3109/02713683.2012.713153; Lim LS, 2010, INVEST OPHTH VIS SCI, V51, P4458, DOI 10.1167/iovs.09-4939; Noble JM, 2010, ARCH NEUROL-CHICAGO, V67, P87, DOI 10.1001/archneurol.2009.308; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Peng DF, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0006-5; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Roberts RO, 2009, ALZHEIMERS DEMENT, V5, P398, DOI 10.1016/j.jalz.2009.01.025; Robman L, 2010, OPHTHALMOLOGY, V117, P1982, DOI 10.1016/j.ophtha.2010.02.003; Sabatine MS, 2007, CIRCULATION, V115, P1528, DOI 10.1161/CIRCULATIONAHA.106.649939; Sakurada Y, 2015, OPHTHALMIC RES, V53, P2, DOI 10.1159/000365487; Sasongko MB, 2015, DIABETIC MED, V32, P686, DOI 10.1111/dme.12640; Schaumberg DA, 2006, INVEST OPHTH VIS SCI, V47, P2336, DOI 10.1167/iovs.05-1456; Seddon JM, 2010, OPHTHALMOLOGY, V117, P1560, DOI 10.1016/j.ophtha.2009.11.020; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Song J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144406; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Xu J, 2013, OPHTHALMOLOGY, V120, P2023, DOI 10.1016/j.ophtha.2013.03.009; Yan YN, 2015, OPHTHALMOLOGY, V122, P1873, DOI 10.1016/j.ophtha.2015.05.031; Yang HS, 2014, INVEST OPHTH VIS SCI, V55, P5989, DOI 10.1167/iovs.14-14864; Yang XF, 2016, INT J OPHTHALMOL-CHI, V9, P111, DOI 10.18240/ijo.2016.01.19; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zhou JQ, 2013, OPHTHALMOLOGY, V120, P803, DOI 10.1016/j.ophtha.2012.09.033; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	39	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204263	10.1371/journal.pone.0204263	http://dx.doi.org/10.1371/journal.pone.0204263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281641	Green Submitted, Green Published, gold			2022-12-26	WOS:000446342400046
J	Malik, NA				Malik, Nadeem A.			Turbulent particle pair diffusion: A theory based on local and non-local diffusional processes	PLOS ONE			English	Article							RELATIVE DISPERSION; 2-PARTICLE DISPERSION; HOMOGENEOUS TURBULENCE; ISOTROPIC TURBULENCE; TRACKING VELOCIMETRY; 3-DIMENSIONAL FLOWS; FLUID; SIMULATION	A re-appraisal of the Richardson's 1926 dataset [Richardson, L. F. Proc. Roy. Soc. Lond. A 100, 709-737, (1926)] displays an unequivocal non-local scaling for the pair diffusion coefficient, K similar to sigma(1.564)(l), quite different to the previously assumed locality scaling law similar to sigma(4/3)(l), where sigma(l) is the pair separation. Consequently, the foundations of turbulent pair diffusion theory are re-examined here and it is shown that pair diffusion is governed by both local and non-local diffusional processess inside the inertial subrange. In the context of generalised energy spectra, E(k) similar to K-p for 1 < p <= 3, the new theory predicts two non-Richardson regimes depending on the size of the inertial subrange: (1) in the limit of asymptotically infinite subrange, non-local scaling laws is obtained, K similar to sigma(gamma)(l), with y intermediate between the purely local and the purely non-local scalings, i.e. (1 +p)/2 < y <= 2; and (2) for finite (short) inertial subrange, local scaling laws are obtained, K similar to sigma l((1+p)/2). The theory features a novel mathematical approach expressing the pair diffusion coefficient through a Fourier integral decomposition.	[Malik, Nadeem A.] King Fand Univ Petr & Minerals, Dept Math & Stat, POB 5046, Dhahran 31261, Saudi Arabia; [Malik, Nadeem A.] Florida Atlantic Univ, Charles E Schmidt Coll Sci, Dept Math & Stat, Boca Raton, FL 33431 USA	King Fahd University of Petroleum & Minerals; State University System of Florida; Florida Atlantic University	Malik, NA (corresponding author), King Fand Univ Petr & Minerals, Dept Math & Stat, POB 5046, Dhahran 31261, Saudi Arabia.; Malik, NA (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Sci, Dept Math & Stat, Boca Raton, FL 33431 USA.	nadeem_malik@cantab.net	Malik, Nadeem/D-4883-2015	Malik, Nadeem/0000-0001-5053-9360	Saudi Arabian Basic Industries Corporation (SABIC) [SB101011]; SABIC [SB101011]	Saudi Arabian Basic Industries Corporation (SABIC); SABIC	Saudi Arabian Basic Industries Corporation (SABIC). SB101011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author would like to thank SABIC for funding this work through project number SB101011, and the ITC Department at KFUPM for making available the High Performance Computing facility for this project.	Akerblom F., 1908, NOVA ACTA REG SOC UP; Batchelor G. K., 1953, THEORY HOMOGENEOUS T; BATCHELOR GK, 1952, P CAMB PHILOS SOC, V48, P345, DOI 10.1017/S0305004100027687; Benzi R., 2011, VOAYAGE TURBULENCE; Berg J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016304; Berloff PS, 2002, J PHYS OCEANOGR, V32, P764, DOI 10.1175/1520-0485(2002)032<0764:MTIOGP>2.0.CO;2; Biferale L, 2014, J FLUID MECH, V757, P550, DOI 10.1017/jfm.2014.515; Bitane R, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.045302; Boffetta G, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/36/363001; Boffetta G, 2002, PHYS FLUIDS, V14, P3224, DOI 10.1063/1.1498121; Boffetta G, 2000, PHYSICA A, V280, P1, DOI 10.1016/S0378-4371(99)00613-5; Boradwell J. F., 1988, J FLUID MECH, V125, P397, DOI [10.1017/S0022112082003401, DOI 10.1017/S0022112082003401]; Bourgoin M, 2006, SCIENCE, V311, P835, DOI 10.1126/science.1121726; Defant A., GEOGAF ANN, V3, P209; Defant A., 1921, WIEN AKAD WISS SI 2A, V130, P401; DURBIN PA, 1980, J FLUID MECH, V100, P279, DOI 10.1017/S0022112080001152; EuHIT, DAT TRAJ; Eyink GL, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.023011; Falkovich G, 2001, REV MOD PHYS, V73, P913, DOI 10.1103/RevModPhys.73.913; FUNG JCH, 1992, J FLUID MECH, V236, P281, DOI 10.1017/S0022112092001423; Fung JCH, 1996, FLUID MEC A, V36, P617; Huber M, 2001, J ATMOS SCI, V58, P2377, DOI 10.1175/1520-0469(2001)058<2377:ACOTDI>2.0.CO;2; Ishihara T, 2002, PHYS FLUIDS, V14, pL69, DOI 10.1063/1.1508443; Ishihara T, 2009, ANNU REV FLUID MECH, V41, P165, DOI 10.1146/annurev.fluid.010908.165203; Johns Hopkins University, TURB DAT; Jorgensen JB, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1863259; Julian P., 1977, Bulletin of the American Meteorological Society, V58, P936, DOI 10.1175/1520-0477(1977)058<0936:TTE>2.0.CO;2; Jullien MC, 1999, PHYS REV LETT, V82, P2872, DOI 10.1103/PhysRevLett.82.2872; Kay G. W. C., 1982, PHYS CHEM CONSTANTS, VI; KLAFTER J, 1987, PHYS REV A, V35, P3081, DOI 10.1103/PhysRevA.35.3081; Klafter J., 1987, REV GEOPHYS, V58, P1101; KOLMOGOROV AN, 1991, P ROY SOC LOND A MAT, V434, P9, DOI 10.1098/rspa.1991.0075; Koszalka I, 2009, J MAR RES, V67, P411, DOI 10.1357/002224009790741102; La Porta A, 2001, NATURE, V409, P1017, DOI 10.1038/35059027; LaCasce JH, 2003, J MAR RES, V61, P285, DOI 10.1357/002224003322201205; Lacorata G, 2004, J ATMOS SCI, V61, P2936, DOI 10.1175/JAS-3292.1; MAAS HG, 1993, EXP FLUIDS, V15, P133, DOI 10.1007/BF00190953; MALIK NA, 1993, EXP FLUIDS, V15, P279; Malik NA, 1996, FLUID MEC A, V36, P619; Malik NA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202940; MOREL P, 1974, J ATMOS SCI, V31, P2189, DOI 10.1175/1520-0469(1974)031<2189:RDOCBI>2.0.CO;2; Obukhov A., 1941, DOKL AKAD NAUK SSSR, V5, P453; Ogasawara T, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.104402; Ollitrault M, 2005, J FLUID MECH, V533, P381, DOI 10.1017/S0022112005004556; Ouellette NT, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/6/109; Peters N., 1988, P S COMB SEATTL, P163; POPE SB, 1994, ANNU REV FLUID MECH, V26, P23, DOI 10.1146/annurev.fl.26.010194.000323; Richardson L. F., 1922, WEATHER PREDICTION N, P221; RICHARDSON LF, 1948, J METEOROL, V5, P238, DOI 10.1175/1520-0469(1948)005<0238:NOEDIT>2.0.CO;2; Richardson LF, 1926, P R SOC LOND A-CONTA, V110, P709, DOI 10.1098/rspa.1926.0043; Richardson LF, 1926, MEM R METROL SOC, V1, P1; Salazar JPLC, 2009, ANNU REV FLUID MECH, V41, P405, DOI 10.1146/annurev.fluid.40.111406.102224; Sawford BL, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2946442; Scatamacchia R, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.144501; Schmidt W., 1917, WIEN AKAD SITZB 2A, V126, P773; Shlesinger M. F., 1993, LECT NOTES PHYS, V450; Shraiman BI, 2000, NATURE, V405, P639, DOI 10.1038/35015000; Sokolov IM, 1999, PHYS REV E, V60, P5528, DOI 10.1103/PhysRevE.60.5528; STOMMEL H, 1949, J MAR RES, V8, P199; SULLIVAN PJ, 1971, J FLUID MECH, V47, P601, DOI 10.1017/S0022112071001253; Sverdrup H. U, 1915, LEIPZIG GEOPHYS I 2; Tatarski V. I., 1960, IZV VYSSH UCHEBN ZAV, V4, P551; Taylor G. I., 1915, PHILOS T R SOC A, V215, P1, DOI DOI 10.1098/RSTA.1915.0001; THOMSON DJ, 1987, J FLUID MECH, V180, P529, DOI 10.1017/S0022112087001940; Thomson DJ, 2005, J FLUID MECH, V526, P277, DOI 10.1017/S0022112004002915; Vaillancourt PA, 2000, B AM METEOROL SOC, V81, P285, DOI 10.1175/1520-0477(2000)081<0285:ROPIAC>2.3.CO;2; Virant M, 1997, MEAS SCI TECHNOL, V8, P1539, DOI 10.1088/0957-0233/8/12/017; WILKINS EM, 1958, J METEOROL, V15, P324, DOI 10.1175/1520-0469(1958)015<0324:OOTSOP>2.0.CO;2; Wolf MC, 2004, J CHEM ECOL, V30, P501, DOI 10.1023/B:JOEC.0000018625.83906.95; YEUNG PK, 1994, PHYS FLUIDS, V6, P3416, DOI 10.1063/1.868399; Yeung PK, 2004, J FLUID MECH, V503, P93, DOI 10.1017/S0022112003007584	73	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202940	10.1371/journal.pone.0202940	http://dx.doi.org/10.1371/journal.pone.0202940			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281611	gold, Green Published, Green Submitted			2022-12-26	WOS:000446342400016
J	Wang, HN; Deng, GX; Ai, ML; Xu, ZJ; Mou, TY; Yu, J; Liu, H; Wang, S; Li, GX				Wang, Huanan; Deng, Guangxu; Ai, Meiling; Xu, Zhijun; Mou, Tingyu; Yu, Jiang; Liu, Hao; Wang, Shuang; Li, Guoxin			Hsp90ab1 stabilizes LRP5 to promote epithelial-mesenchymal transition via activating of AKT and Wnt/beta-catenin signaling pathways in gastric cancer progression	ONCOGENE			English	Article							SHOCK-PROTEIN 90; HIGH-LEVEL EXPRESSION; LUNG-CANCER; PERITONEAL DISSEMINATION; CELL-PROLIFERATION; DOWN-REGULATION; POOR SURVIVAL; BETA-CATENIN; ER STRESS; METASTASIS	Hsp90ab1 is upregulated in numerous solid tumors, which is thought to induce the angiogenesis and promote cancer metastasis. However, it's actions in gastric cancer (GC) has not been exhibited. In this study, Hsp90ab1 was demonstrated to be overexpressed and correlated with the poor prognosis, proliferation and invasion of GC. Ectopic expression of Hsp90ab1 promoted the proliferation and metastasis of GC cells both in vitro in cell line models of GC and in vivo using two different xenograft mouse models, while opposite effects were observed in Hsp90ab1 silenced cells. Moreover, the underlining molecular mechanism was explored by the co-immunoprecipitation, immunofluorescence, GST pull-down and in vitro ubiquitination assay. Namely, Hsp90ab1 exerted these functions via the interaction of LRP5 and inhibited ubiquitin-mediated degradation of LRP5, an indispensable coreceptor of the Wnt/beta-catenin signaling pathway. In addition, the crosstalk between Hsp90ab1 and LRP5 contributed to the upregulation of multiple mesenchymal markers, which are also targets of Wnt/beta-catenin. Collectively, this study uncovers the details of the Hsp90ab1-LRP5 axis, providing novel insights into the role and mechanism of invasion and metastasis in GC.	[Wang, Huanan; Deng, Guangxu; Xu, Zhijun; Mou, Tingyu; Yu, Jiang; Liu, Hao; Li, Guoxin] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangdong Prov Engn Technol Res Ctr Minimally Inv, Guangzhou 510515, Guangdong, Peoples R China; [Ai, Meiling; Wang, Shuang] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China; [Ai, Meiling] Guangzhou Med Univ, Dept Radiotherapy, Affiliated Canc Hosp & Inst, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Shuang] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Guangzhou Medical University; Southern Medical University - China	Li, GX (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangdong Prov Engn Technol Res Ctr Minimally Inv, Guangzhou 510515, Guangdong, Peoples R China.; Wang, S (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China.; Wang, S (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China.	shuangw@126.com; gzliguoxin@163.com	Liu, Hao/I-9884-2019	Liu, Hao/0000-0003-1227-2954	State's Key Project of Research and Development Plan [2017YFC0108300, 2017YFC0108301]; National Natural Science Foundation of China [81672446]; Guangdong Provincial Science and Technology Key Project [2014A020215014]; Research Fund of Public Welfare in the Health Industry; National Health and Family Planning Commission of China [201402015]; Southern Medical University Clinical Research Start-Up Project [LC2016ZD003]; Guangzhou Science and Technology Project [201400000004-5]; Key Clinical Specialty Discipline Construction Program [[2011]170]	State's Key Project of Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Key Project; Research Fund of Public Welfare in the Health Industry; National Health and Family Planning Commission of China; Southern Medical University Clinical Research Start-Up Project; Guangzhou Science and Technology Project; Key Clinical Specialty Discipline Construction Program	This work was supported by the grants from the State's Key Project of Research and Development Plan (2017YFC0108300, 2017YFC0108301), National Natural Science Foundation of China (81672446), Guangdong Provincial Science and Technology Key Project (2014A020215014), Research Fund of Public Welfare in the Health Industry, the National Health and Family Planning Commission of China (201402015), the Southern Medical University Clinical Research Start-Up Project (LC2016ZD003), Guangzhou Science and Technology Project (201400000004-5) and the Key Clinical Specialty Discipline Construction Program ([2011]170).	Cai J, 2015, BRIT J CANCER, V113, P1720, DOI 10.1038/bjc.2015.367; Canella A, 2017, CLIN CANCER RES, V23, P6215, DOI 10.1158/1078-0432.CCR-16-3151; Casagolda D, 2010, J CELL SCI, V123, P2621, DOI 10.1242/jcs.067512; Chen DH, 2017, CELL PHYSIOL BIOCHEM, V42, P1025, DOI 10.1159/000478685; Chen Y, 2017, CLIN CANCER RES, V23, P1552, DOI 10.1158/1078-0432.CCR-16-1333; Cheng Q, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3168; Choi HJ, 2018, JNCI-J NATL CANCER I, V110, P400, DOI 10.1093/jnci/djx207; Correia AL, 2013, GENE DEV, V27, P805, DOI 10.1101/gad.211383.112; de la Mare JA, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3190-z; DeBruine ZJ, 2017, GENE DEV, V31, P916, DOI 10.1101/gad.298331.117; Didelot C, 2008, CELL DEATH DIFFER, V15, P859, DOI 10.1038/sj.cdd.4402320; Fu YJ, 2011, INT J CANCER, V129, P1541, DOI 10.1002/ijc.26102; Giessrigl B, 2012, HUM MOL GENET, V21, P4615, DOI 10.1093/hmg/dds303; Gu Y, 2016, J PATHOL, V239, P60, DOI 10.1002/path.4697; Ha GH, 2013, CANCER LETT, V332, P63, DOI 10.1016/j.canlet.2013.01.013; Hamamoto R, 2014, CANCER LETT, V351, P126, DOI 10.1016/j.canlet.2014.05.014; Hu YF, 2016, J CLIN ONCOL, V34, P1350, DOI 10.1200/JCO.2015.63.7215; Huang J, 2014, ONCOGENE, V33, P2737, DOI 10.1038/onc.2013.238; Jeon YK, 2007, J PATHOL, V213, P170, DOI 10.1002/path.2219; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kannan A, 2014, EUR J CANCER, V50, P204, DOI 10.1016/j.ejca.2013.08.016; Kim SH, 2015, HISTOPATHOLOGY, V67, P509, DOI 10.1111/his.12675; Knoblich K, 2014, CELL MOL LIFE SCI, V71, P1305, DOI 10.1007/s00018-013-1444-8; Kurashige J, 2015, CARCINOGENESIS, V36, P133, DOI 10.1093/carcin/bgu232; Li CF, 2008, CLIN CANCER RES, V14, P7822, DOI 10.1158/1078-0432.CCR-08-1369; Li S, 2017, ONCOL REP, V37, P849, DOI 10.3892/or.2016.5295; Liang L, 2013, GASTROENTEROLOGY, V144, P624, DOI 10.1053/j.gastro.2012.11.033; Liu SGH, 2015, MOL ONCOL, V9, P834, DOI 10.1016/j.molonc.2014.12.009; Lyou Y, 2017, BRIT J PHARMACOL, V174, P4589, DOI 10.1111/bph.13963; Marzook H, 2017, ONCOGENE, V36, P5263, DOI 10.1038/onc.2017.19; Meng J, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0640-9; Ohkubo S, 2015, MOL CANCER THER, V14, P14, DOI 10.1158/1535-7163.MCT-14-0219; Okubo K, 2017, GASTRIC CANCER, V20, P802, DOI 10.1007/s10120-017-0705-x; Park S, 2017, REDOX BIOL, V13, P470, DOI 10.1016/j.redox.2017.07.010; Pavlakis N, 2016, J CLIN ONCOL, V34, P2728, DOI 10.1200/JCO.2015.65.1901; Perotti C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2193; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Qiu SL, 2015, J PATHOL, V237, P330, DOI 10.1002/path.4579; Rong BX, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-70; Saveliev SV, 2013, ANAL CHEM, V85, P907, DOI 10.1021/ac302423t; Shi ZM, 2017, ONCOGENE, V36, P2577, DOI 10.1038/onc.2016.414; Singh A, 2015, J INVEST DERMATOL, V135, P1098, DOI 10.1038/jid.2014.460; Sun Y, 2018, THERANOSTICS, V8, P2044, DOI 10.7150/thno.23304; Tsutsumi S, 2009, FUTURE ONCOL, V5, P679, DOI 10.2217/FON.09.30; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; Vinyoles M, 2017, ONCOGENE, V36, P429, DOI 10.1038/onc.2016.209; Wang KN, 2016, GUT, V65, P1619, DOI 10.1136/gutjnl-2015-309276; Wang L, 2016, GASTROENTEROLOGY, V150, P1183, DOI 10.1053/j.gastro.2016.01.034; Westekemper H, 2011, BRIT J OPHTHALMOL, V95, P853, DOI 10.1136/bjo.2010.183939; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wu SM, 2016, J PINEAL RES, V60, P142, DOI 10.1111/jpi.12295; Wu YK, 2015, INT J CLIN EXP PATHO, V8, P8252; Xiao HJ, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0221-7; Xiong XY, 2014, EXP CELL RES, V326, P78, DOI 10.1016/j.yexcr.2014.05.018; Yanaka Y, 2015, CARCINOGENESIS, V36, P1363, DOI 10.1093/carcin/bgv106; Yang SS, 2017, BRIT J CANCER, V117, P1164, DOI 10.1038/bjc.2017.260; Yano M, 1999, CANCER LETT, V137, P45, DOI 10.1016/S0304-3835(98)00338-3; Zhang B, 2015, CANCER LETT, V356, P704, DOI 10.1016/j.canlet.2014.10.016; Zhang P, 2017, BRIT J CANCER, V117, P525, DOI 10.1038/bjc.2017.181; Zhao L, 2013, CLIN CANCER RES, V19, P6419, DOI 10.1158/1078-0432.CCR-13-0254; Zhao X, 2014, CELL DEATH DIFFER, V21, P1900, DOI 10.1038/cdd.2014.109; Zheng RS, 2017, CHIN J CANCER, V36, DOI 10.1186/s40880-017-0234-3; Zhu XH, 2017, INT J CANCER, V141, P172, DOI 10.1002/ijc.30701	63	49	50	4	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2019	38	9					1489	1507		10.1038/s41388-018-0532-5	http://dx.doi.org/10.1038/s41388-018-0532-5			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN1KL	30305727	Green Published, hybrid			2022-12-26	WOS:000459945800009
J	Zhelay, T; Wieczerzak, KB; Beesetty, P; Alter, GM; Matsushita, M; Kozak, JA				Zhelay, Tetyana; Wieczerzak, Krystyna B.; Beesetty, Pavani; Alter, Gerald M.; Matsushita, Masayuki; Kozak, J. Ashot			Depletion of plasma membrane-associated phosphoinositides mimics inhibition of TRPM7 channels by cytosolic Mg2+, spermine, and pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						channel activation; phosphoinositide; polyamine; magnesium; transfection; transient receptor potential channels (TRP channels); mutant; gain-of-function mutation; TRPM; voltage-sensitive phosphatase	VOLTAGE-SENSING PHOSPHATASE; POTENTIAL MELASTATIN 7; CI-VSP; POLYVALENT CATIONS; KINASE-ACTIVITY; MIC CHANNELS; ATP; PIP2; SENSITIVITY; MAGNESIUM	Transient receptor potential cation channel subfamily M member 7 (TRPM7) is an ion channel/protein kinase belonging to the TRP melastatin and eEF2 kinase families. Under physiological conditions, most native TRPM7 channels are inhibited by cytoplasmic Mg2+, protons, and polyamines. Currents through these channels (I-TRPM7) are robustly potentiated when the cell interior is exchanged with low Mg2+-containing buffers. I-TRPM7 is also potentiated by phosphatidyl inositol bisphosphate (PI(4,5)P-2) and suppressed by its hydrolysis. Here we characterized internal Mg2+- and pH-mediated inhibition of TRPM7 channels in HEK293 cells overexpressing WT voltage-sensing phospholipid phosphatase (VSP) or its catalytically inactive variant VSP-C363S. VSP-mediated depletion of membrane phosphoinositides significantly increased channel sensitivity to Mg2+ and pH. Proton concentrations that were too low to inhibit I-TRPM7 when the VSP-C363S variant was expressed (pH 8.2) became inhibitory in WT VSP-expressing cells. At pH 6.5, protons inhibited I-TRPM7 both in WT and VSP C363S-expressing cells but with a faster time course in the WT VSP-expressing cells. Inhibition by 150 m Mg2+ was also significantly faster in the WT VSP-expressing cells. Cellular PI(4,5)P-2 depletion increased the sensitivity of TRPM7 channels to the inhibitor 2-aminoethyl diphenyl borinate, which acidifies the cytosol. Single substitutions at Ser-1107 of TRPM7, reducing its sensitivity to Mg2+, also decreased its inhibition by spermine and acidic pH. Furthermore, these channel variants were markedly less sensitive to VSP-mediated PI(4,5)P-2 depletion than the WT. We conclude that the internal Mg2+-, polyamine-, and pH-mediated inhibition of TRPM7 channels is not direct but, rather, reflects electrostatic screening and resultant disruption of PI(4,5)P-2-channel interactions.	[Zhelay, Tetyana; Wieczerzak, Krystyna B.; Beesetty, Pavani; Kozak, J. Ashot] Wright State Univ, Dept Neurosci Cell Biol & Physiol, Biol Sci Bldg 2,Rm 251, Dayton, OH 45435 USA; [Alter, Gerald M.] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Matsushita, Masayuki] Univ Ryukyus, Grad Sch Med, Dept Mol & Cellular Physiol, Nishihara, Okinawa 9030215, Japan	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton; University of the Ryukyus	Kozak, JA (corresponding author), Wright State Univ, Dept Neurosci Cell Biol & Physiol, Biol Sci Bldg 2,Rm 251, Dayton, OH 45435 USA.	juliusz.kozak@wright.edu			NIAID, National Institutes of Health [1R15AI090613, 1R01AI114804]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI090613, R01AI114804] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health grants 1R15AI090613 and 1R01AI114804 (to J.A.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Babai N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008602; Badheka D, 2015, J GEN PHYSIOL, V146, P65, DOI 10.1085/jgp.201411336; Ballester LY, 2007, CHANNELS, V1, P209, DOI 10.4161/chan.4770; Brandao K, 2013, IMMUNOL RES, V55, P261, DOI 10.1007/s12026-012-8371-x; Cabezas-Bratesco D, 2015, CURR MED CHEM, V22, P2943, DOI 10.2174/0929867322666150716115644; Cai N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42739; Chaigne-Delalande B, 2014, TRENDS IMMUNOL, V35, P332, DOI 10.1016/j.it.2014.05.001; Chokshi R, 2012, CHANNELS, V6, P362, DOI 10.4161/chan.21628; Chokshi R, 2012, AM J PHYSIOL-CELL PH, V302, pC1642, DOI 10.1152/ajpcell.00037.2012; Chokshi R, 2012, AM J PHYSIOL-CELL PH, V302, pC1004, DOI 10.1152/ajpcell.00422.2011; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Chubanov Vladimir, 2014, Cells, V3, P1089, DOI 10.3390/cells3041089; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Fliegert R, 2007, FEBS J, V274, P704, DOI 10.1111/j.1742-4658.2006.05614.x; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gwanyanya A, 2006, AM J PHYSIOL-CELL PH, V291, pC627, DOI 10.1152/ajpcell.00074.2006; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Hilgemann DW, 1997, ANNU REV PHYSIOL, V59, P193, DOI 10.1146/annurev.physiol.59.1.193; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Hofmann T, 2014, PFLUG ARCH EUR J PHY, V466, P2177, DOI 10.1007/s00424-014-1488-0; Hossain MI, 2008, J BIOL CHEM, V283, P18248, DOI 10.1074/jbc.M706184200; Hsu K, 2010, BIOPHYS J, V99, P1718, DOI 10.1016/j.bpj.2010.07.027; Inoue H, 2014, FREE RADICAL BIO MED, V72, P257, DOI 10.1016/j.freeradbiomed.2014.04.015; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Kaitsuka T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05718; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kerschbaum HH, 2003, BIOPHYS J, V84, P2293, DOI 10.1016/S0006-3495(03)75035-8; Kim TY, 2012, BIOCHEM BIOPH RES CO, V417, P1030, DOI 10.1016/j.bbrc.2011.12.085; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Lee J, 2005, J GEN PHYSIOL, V126, P439, DOI 10.1085/jgp.200509314; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Lindner M, 2011, J PHYSIOL-LONDON, V589, P3149, DOI 10.1113/jphysiol.2011.208983; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Macianskiene R, 2008, CELL PHYSIOL BIOCHEM, V22, P109, DOI 10.1159/000149788; Marius P, 2008, BIOPHYS J, V94, P1689, DOI 10.1529/biophysj.107.117507; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; Mezulis S, 2016, J MOL BIOL, V428, P702, DOI 10.1016/j.jmb.2015.10.017; Middelbeek J, 2010, CELL MOL LIFE SCI, V67, P875, DOI 10.1007/s00018-009-0215-z; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nilius B, 2007, BIOCHEM SOC T, V35, P105, DOI 10.1042/BST0350105; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Qin X, 2013, BRIT J PHARMACOL, V168, P1294, DOI 10.1111/bph.12012; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Rjasanow A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00127; Romagnani A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01960-z; Runnels LW, 2011, CURR PHARM BIOTECHNO, V12, P42; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Sakata S, 2014, J PHYSIOL-LONDON, V592, P899, DOI 10.1113/jphysiol.2013.263640; Sakata S, 2011, J PHYSIOL-LONDON, V589, P2687, DOI 10.1113/jphysiol.2011.208165; Saleem F, 2009, BRIT J PHARMACOL, V156, P143, DOI 10.1111/j.1476-5381.2008.00011.x; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Suh BC, 2007, J GEN PHYSIOL, V130, P241, DOI 10.1085/jgp.200709821; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Visser D, 2014, EUR J CELL BIOL, V93, P455, DOI 10.1016/j.ejcb.2014.07.001; Wang YH, 2014, CHEM PHYS LIPIDS, V182, P38, DOI 10.1016/j.chemphyslip.2014.01.001; Xie J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00146; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yee Nelson S, 2014, Cells, V3, P751, DOI 10.3390/cells3030751; Yogi A, 2009, AM J PHYSIOL-REG I, V296, pR201, DOI 10.1152/ajpregu.90602.2008; Zakharian E, 2011, FASEB J, V25, P3915, DOI 10.1096/fj.11-184630; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; Zhang YH, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0282-4; Zhang Z, 2014, J BIOL CHEM, V289, P5217, DOI 10.1074/jbc.M113.512285; Zheng J, 2013, COMPR PHYSIOL, V3, P221, DOI 10.1002/cphy.c120001; Zierler S, 2016, J PHYSIOL-LONDON, V594, P2957, DOI 10.1113/JP271564	76	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18151	18167		10.1074/jbc.RA118.004066	http://dx.doi.org/10.1074/jbc.RA118.004066			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30305398	Green Published, hybrid			2022-12-26	WOS:000451375200011
J	Barros, MC; Hochhegger, B; Altmayer, S; Watte, G; Zanon, M; Sartori, AP; Blanco, DC; Pacini, GS; Chatkin, JM				Barros, Marcelo Cardoso; Hochhegger, Bruno; Altmayer, Stephan; Watte, Guilherme; Zanon, Matheus; Sartori, Ana Paula; Blanco, Daniela Cavalet; Pacini, Gabriel Sartori; Chatkin, Jose Miguel			Quantitative computed tomography phenotypes, spirometric parameters, and episodes of exacerbation in heavy smokers: An analysis from South America	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION DECLINE; EMPHYSEMA; COPD; CT; PREDICT	Objective To evaluate the quantitative computed tomography (QCT) phenotypes, airflow limitations, and exacerbation-like episodes in heavy smokers in Southern Brazil. Methods We enrolled 172 smokers with a smoking history >= 30 pack-years who underwent pulmonary function tests (PFTs) and CT scan for lung cancer screening. Patients were classified regarding airflow limitation (FEV1/FVC <0.7 forced expiratory volume in 1 second/forced vital capacity) and the presence of emphysema on the QCT. The QCT were analyzed in specialized software and patients were classified in two disease-predominant phenotypes: emphysema-predominant (EP) and non-emphysema-predominant (NEP). EP was determined as >= 6% of percent low-attenuation areas (LAA%) with less than -950 Hounsfield units. NEP was defined as having a total LAA% of less than 6%. Results Most of our patients were classified in the EP phenotype. The EP group had significantly worse predicted FEV1(60.6 +/- 22.9 vs. 89.7 +/- 15.9, p <0.001), higher rates of airflow limitation (85.7% vs. 15%; p <0.001), and had more exacerbation-like episodes (25.8% vs. 8.3%, p <0.001) compared to the NEP group. Smoking history, ethnicity, and BMI did not differ between the groups. The total LAA% was the QCT parameter with the strongest correlation to FEV1(r = -0.669) and FEV1/FVC (r = -0.787). Conclusions Heavy smokers with the EP phenotype on QCT were more likely to have airflow limitation, worse predicted FEV1, and a higher rate of exacerbation-like episodes than those with the NEP phenotype. Approximately 23% of patients with no airflow limitation on PFTs were classified in EP phenotype.	[Barros, Marcelo Cardoso; Blanco, Daniela Cavalet; Chatkin, Jose Miguel] Pontificia Univ Catolica Rio Grande do Sul, Dept Pulmonol, Porto Alegre, RS, Brazil; [Hochhegger, Bruno; Altmayer, Stephan; Watte, Guilherme; Zanon, Matheus; Sartori, Ana Paula; Pacini, Gabriel Sartori] Irmandade Santa Casa Misericordia Porto Alegre, Dept Radiol, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul	Barros, MC (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Dept Pulmonol, Porto Alegre, RS, Brazil.	macardosob@hotmail.com	Zanon, Matheus/AAP-3630-2020; Pacini, Gabriel Sartori/W-3052-2018; Hochhegger, Bruno/AAH-9945-2019; Watte, G./ABC-7864-2020; Chatkin, Jose M/Q-3925-2016	Pacini, Gabriel Sartori/0000-0002-4822-7082; Watte, G./0000-0002-6948-3982; Chatkin, Jose M/0000-0002-4343-025X; Hochhegger, Bruno/0000-0003-1984-4636; Blanco, Daniela/0000-0002-3125-1385; Zanon, Matheus/0000-0001-7851-5125; Barros, Marcelo Cardoso/0000-0002-4985-6374				Agusti A, 2011, AM J RESP CRIT CARE, V184, P507, DOI 10.1164/rccm.201103-0405PP; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Akira M, 2009, AM J ROENTGENOL, V192, P267, DOI 10.2214/AJR.07.3953; [Anonymous], 2017, GLOB IN CHRON OBSTR; Bodduluri S, 2018, ANN AM THORAC SOC, V15, P281, DOI 10.1513/AnnalsATS.201705-377FR; Calverley P, 2018, ANN AM THORAC SOC, V15, P390, DOI 10.1513/AnnalsATS.201711-902LE; Coxson HO, 2013, LANCET RESP MED, V1, P129, DOI 10.1016/S2213-2600(13)70006-7; Diaz AA, 2015, RESP MED, V109, P882, DOI 10.1016/j.rmed.2015.04.009; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Dransfield MT, 2017, AM J RESP CRIT CARE, V195, P324, DOI 10.1164/rccm.201605-1014OC; Duarte AA, 2007, J BRAS PNEUMOL, V35; Fang XC, 2011, CHEST, V139, P920, DOI 10.1378/chest.10-1393; Fernandes L, 2016, LUNG INDIA, V33, P646, DOI 10.4103/0970-2113.192880; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; Guder G, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-13; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Hoesein FAAM, 2011, THORAX, V66, P782, DOI 10.1136/thx.2010.145995; Kanner RE, 2001, AM J RESP CRIT CARE, V164, P358, DOI 10.1164/ajrccm.164.3.2010017; KLEIN JS, 1992, RADIOLOGY, V182, P817, DOI 10.1148/radiology.182.3.1535900; Lynch DA, 2015, RADIOLOGY, V277, P192, DOI 10.1148/radiol.2015141579; Lynch DA, 2013, J THORAC IMAG, V28, P284, DOI 10.1097/RTI.0b013e318298733c; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Michiels B, 2003, J EPIDEMIOLOGY COMMU, V57, P542; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Newell JD, 2013, J THORAC IMAG, V28, P266, DOI 10.1097/RTI.0b013e31829f6796; Van Tho,, 2015, ANN AM THORAC SOC, V12, P988, DOI 10.1513/AnnalsATS.201411-501OC; Pauwels R, 2000, CHEST, V117, p332S, DOI 10.1378/chest.117.5_suppl_2.332S; Pereira Carlos Alberto de Castro, 2007, J. bras. pneumol., V33, P397, DOI 10.1590/S1806-37132007000400008; Regan EA, 2015, JAMA INTERN MED, V175, P1539, DOI 10.1001/jamainternmed.2015.2735; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Schroeder JD, 2013, AM J ROENTGENOL, V201, pW460, DOI 10.2214/AJR.12.10102; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seemungal Terence A R, 2009, Int J Chron Obstruct Pulmon Dis, V4, P203; Subramanian DR, 2016, EUR RESPIR J, V48, P92, DOI 10.1183/13993003.01878-2015; Swanney MP, 2008, THORAX, V63, P1046, DOI 10.1136/thx.2008.098483; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971; Yahaba M, 2014, EUR J RADIOL, V83, P1022, DOI 10.1016/j.ejrad.2014.03.003	39	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205273	10.1371/journal.pone.0205273	http://dx.doi.org/10.1371/journal.pone.0205273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307987	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500056
J	Guo, HQ; Shangguan, JY; Tang, J; Sun, Q; Wu, HT				Guo, Hongqiang; Shangguan, Jinyong; Tang, Juan; Sun, Qun; Wu, Hongting			Receding horizon control strategy for an electric vehicle with dual-motor coupling system in consideration of stochastic vehicle mass	PLOS ONE			English	Article							PONTRYAGINS MINIMUM PRINCIPLE; ENERGY MANAGEMENT; POWER MANAGEMENT; OPTIMIZATION; DESIGN	Additional degrees of freedom existed in dual-motor coupling system bring considerable challenge to the optimal control of electric vehicles. Moreover, the stochastic characteristic of vehicle mass can further increase this challenge. A receding horizon control (RHC) strategy in consideration of stochastic vehicle mass is proposed in this study to respond to this challenge. Aiming at an electric vehicle with dual-motor coupling, a Markov chain is firstly deployed to predict future driving conditions by a formulated state transition probability matrix, based on historical driving cycles in real-world. Then, future required power is predicted by the predicted driving conditions, stochastic vehicle mass and road gradient, where the stochastic vehicle mass is formulated as stochastic variables in different bus stops. Finally, dynamic programming is employed to calculate the optimal vector of the vehicle within the defined prediction horizon, and only the first control values extracted from the optimal control vector are used to execute real-time power distribution control. The simulation results show that the proposed strategy is reasonable and can at least reduce electric consumption by 4.64%, compared with rule-based strategy.	[Guo, Hongqiang; Shangguan, Jinyong; Tang, Juan; Sun, Qun] Liaocheng Univ, Dept Sch Mech & Automot Engn, Liaocheng, Shandong, Peoples R China; [Wu, Hongting] Dept Zhongtong Bus Holding Co Ltd, Liaocheng, Shandong, Peoples R China	Liaocheng University	Guo, HQ (corresponding author), Liaocheng Univ, Dept Sch Mech & Automot Engn, Liaocheng, Shandong, Peoples R China.	guohongqiang@lcu.edu.cn			national science and technology support plan, China [2015BAG02B01]; natural science foundation of Shandong Province, China [ZR2014EL023, ZR2014EEQ027]; major scientific and technological innovation project of Shandong Province [2017CXGC0907]	national science and technology support plan, China; natural science foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); major scientific and technological innovation project of Shandong Province	This research was funded by the national science and technology support plan, China grant number [No. 2015BAG02B01] to HG, natural science foundation of Shandong Province, China grant number [No. ZR2014EL023 to HG and No. ZR2014EEQ027 to JT], the project supported by major scientific and technological innovation project of Shandong Province grant number [No. 2017CXGC0907] to QS.	Chen Z, 2014, J POWER SOURCES, V272, P160, DOI 10.1016/j.jpowsour.2014.08.057; Degirmenci Kenan, 2017, International Journal of Automotive Technology and Management, V17, P294; Gao BZ, 2015, MECH SYST SIGNAL PR, V50-51, P615, DOI 10.1016/j.ymssp.2014.05.045; Guo H, 2014, THESIS, P6; Guo HQ, 2018, ENERGY, V148, P1006, DOI 10.1016/j.energy.2018.01.152; Islam MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189170; Jin LQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179526; Kong ZH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180491; Li HP, 2016, AUTOMATICA, V68, P148, DOI 10.1016/j.automatica.2016.01.057; Li L, 2017, MECH SYST SIGNAL PR, V87, P17, DOI 10.1016/j.ymssp.2016.03.002; Li L, 2016, IEEE-ASME T MECH, V21, P2682, DOI 10.1109/TMECH.2016.2517088; Li L, 2016, J DYN SYST-T ASME, V138, DOI 10.1115/1.4032830; Ma Y, 2018, IEEE T IND ELECTRON, V65, P6762, DOI 10.1109/TIE.2018.2795578; Peng JK, 2017, APPL ENERG, V185, P1633, DOI 10.1016/j.apenergy.2015.12.031; Ruan JG, 2017, ENERGY, V140, P291, DOI 10.1016/j.energy.2017.08.119; Sun FC, 2016, VEHICLE SYST DYN, V54, P1031, DOI 10.1080/00423114.2016.1180404; Urbina Coronado P D, 2015, MATH PROBLEMS ENG; Wang XY, 2016, IEEE T TRANSP ELECTR, V2, P231, DOI 10.1109/TTE.2016.2535316; Xie S, 2018, IEEE T VEHICULAR TEC; Zhang CN, 2017, IEEE T IND ELECTRON, V64, P3873, DOI 10.1109/TIE.2016.2645166; Zhang JX, 2016, INT J PRECIS ENG MAN, V17, P1215, DOI 10.1007/s12541-016-0146-1; Zhang LP, 2014, SCI CHINA TECHNOL SC, V57, P2265, DOI 10.1007/s11431-014-5651-9; Zhang S., 2014, SCI WORLD J; Zhang S, 2016, ENERGY, V96, P437, DOI 10.1016/j.energy.2015.12.089; Zhang S, 2015, APPL ENERG, V159, P370, DOI 10.1016/j.apenergy.2015.08.129; Zhao X, 2018, CLUSTER COMPUT, V2, P1573; Zhao X., 2018, IEE IFIP NETW OP MAN, P1; Zhao X, 2018, ADV MECH ENG, V10, DOI 10.1177/1687814018760039; Zhong ZM, 2012, MECH SYST SIGNAL PR, V31, P316, DOI 10.1016/j.ymssp.2012.02.008	29	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205212	10.1371/journal.pone.0205212	http://dx.doi.org/10.1371/journal.pone.0205212			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308000	gold, Green Published, Green Submitted			2022-12-26	WOS:000447173500048
J	dos Santos, ADM; Ricart, CAO; Fontes, AH; Fontes, W; de Souza, AR; Castro, MS; de Sousa, MV; de Lima, BD				Moreira dos Santos Junior, Agenor de Castro; Ornelas Ricart, Carlos Andre; Fontes, Arthur Henriques; Fontes, Wagner; de Souza, Agnelo Rodrigues; Castro, Mariana Souza; de Sousa, Marcelo Valle; de Lima, Beatriz Dolabela			Proteome analysis of Phytomonas serpens, a phytoparasite of medical interest	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; TRYPANOSOMA-CRUZI; DEVELOPMENTAL-STAGES; EUPHORBIA-CHARACIAS; LEISHMANIA-DONOVANI; GLUCOSE-METABOLISM; MASS-SPECTROMETRY; CHAGAS-DISEASE; NITRIC-OXIDE; PARASITE	The protozoan Phytomonas serpens (class Kinetoplastea) is an important phytoparasite that has gained medical importance due to its similarities to Trypanosoma cruzi, the etiological agent of Chagas disease. The present work describes the first proteome analysis of P. serpens. The parasite was separated into cytosolic and high density organelle fractions, which, together with total cell extract, were subjected to LC-MS/MS analyses. Protein identification was conducted using a comprehensive database composed of genome sequences of other related kinetoplastids. A total of 1,540 protein groups were identified among the three sample fractions. Sequences from Phytomonas sp. in the database allowed the highest number of identifications, with T. cruzi and T. brucei the human pathogens providing the greatest contribution to the identifications. Based on the proteomics data obtained, we proposed a central metabolic map of P. serpens, which includes all enzymes of the citric acid cycle. Data also revealed a new range of proteins possibly responsible for immunological cross-reactivity between P. serpens and T. cruzi.	[Moreira dos Santos Junior, Agenor de Castro; Ornelas Ricart, Carlos Andre; Fontes, Arthur Henriques; Fontes, Wagner; de Souza, Agnelo Rodrigues; Castro, Mariana Souza; de Sousa, Marcelo Valle] Univ Brasilia, Dept Cell Biol, Lab Prot Chem & Biochem, Brasilia, DF, Brazil; [Moreira dos Santos Junior, Agenor de Castro; de Souza, Agnelo Rodrigues; de Lima, Beatriz Dolabela] Univ Brasilia, Dept Cell Biol, Lab Gene Biol, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia	Ricart, CAO (corresponding author), Univ Brasilia, Dept Cell Biol, Lab Prot Chem & Biochem, Brasilia, DF, Brazil.	ricart@unb.br	de Sousa, Marcelo Valle/H-1838-2016; Fontes, Wagner/A-1771-2008	de Sousa, Marcelo Valle/0000-0002-2871-4430; Fontes, Wagner/0000-0001-5140-8573; S. Castro, Mariana/0000-0001-5143-152X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [423006/2016-9, 407855/2013]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG); Financiadora de Estudos e Projetos (FINEP) [0439/11, 0694/13]; Brazilian National Council for Scientific and Technological Development (CNPq) [423006/2016-9]; Coordination for the Improvement of Higher Education Personnel (CAPES); Financing Agency for Studies and Projects (FINEP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financing Agency for Studies and Projects (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	The work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grants 423006/2016-9 and 407855/2013), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG) and Financiadora de Estudos e Projetos (FINEP, grants 0439/11 and 0694/13 to M.V.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the receipt of financial support from the Brazilian National Council for Scientific and Technological Development (CNPq - grant number 423006/2016-9), Coordination for the Improvement of Higher Education Personnel (CAPES), Financing Agency for Studies and Projects (FINEP). The authors also would like to thank Prof. Robert Miller (University of Brasilia) and Prof. Consuelo M. R. Lima (University of Brasilia) for diligent proofreading of this manuscript.	Alcolea PJ, 2011, J EUKARYOT MICROBIOL, V58, P352, DOI 10.1111/j.1550-7408.2011.00549.x; Araujo PR, 2011, MEM I OSWALDO CRUZ, V106, P257, DOI 10.1590/S0074-02762011000300002; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bregano JW, 2003, FEMS IMMUNOL MED MIC, V39, P257, DOI 10.1016/S0928-8244(03)00256-6; Carolina M, 2002, EUKARYOT CELL, V1, P944, DOI 10.1128/EC.1.6.944-953.2002; Cavalier-Smith T, 2016, EUR J PROTISTOL, V56, P250, DOI 10.1016/j.ejop.2016.09.003; Cermakova P, 2007, FEBS J, V274, P3150, DOI 10.1111/j.1742-4658.2007.05847.x; CHAUMONT F, 1994, MOL BIOCHEM PARASIT, V67, P321, DOI 10.1016/0166-6851(94)00141-3; Cirovic O, 2014, METHODS MOL BIOL, V1188, P47, DOI 10.1007/978-1-4939-1142-4_4; Cuervo P, 2007, MOL BIOCHEM PARASIT, V154, P6, DOI 10.1016/j.molbiopara.2007.03.013; D'Orso I, 2003, TRENDS PARASITOL, V19, P151, DOI 10.1016/S1471-4922(03)00035-7; da Silva RV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068299; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; de Mendonca SCF, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00524; Gonzalez-Halphen D, 2004, PARASITOL RES, V92, P341, DOI 10.1007/s00436-003-1058-4; Graca-de Souza VK, 2010, BIOL RES, V43, P233, DOI [/S0716-97602010000200011, 10.4067/S0716-97602010000200011]; HOARE CA, 1966, NATURE, V212, P1385, DOI 10.1038/2121385a0; Ienne S, 2012, INFECT GENET EVOL, V12, P539, DOI 10.1016/j.meegid.2012.01.016; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; JANKEVICIUS JV, 1989, J PROTOZOOL, V36, P265, DOI 10.1111/j.1550-7408.1989.tb05361.x; Jaskowska E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004484; Koreny L, 2012, P NATL ACAD SCI USA, V109, P3808, DOI 10.1073/pnas.1201089109; Maslov DA, 1999, MOL BIOCHEM PARASIT, V99, P207, DOI 10.1016/S0166-6851(99)00028-6; Maugeri DA, 2011, ESSAYS BIOCHEM, V51, P15, DOI [10.1042/BSE0510015, 10.1042/bse0510015]; dos Santos ADM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138667; Nakayasu ES, 2012, J PROTEOME RES, V11, P237, DOI 10.1021/pr200806s; Nawathean P, 2000, CURR GENET, V38, P95, DOI 10.1007/s002940000135; Nesvizhskii AI, 2014, NAT METHODS, V11, P1114, DOI [10.1038/NMETH.3144, 10.1038/nmeth.3144]; Nugent PG, 2004, MOL BIOCHEM PARASIT, V136, P51, DOI 10.1016/j.molbiopara.2004.02.009; Oliveira DM, 2005, OMICS, V9, P173, DOI 10.1089/omi.2005.9.173; OPPERDOES FR, 1990, BIOCHEM SOC T, V18, P729, DOI 10.1042/bst0180729; Paba J, 2004, J PROTEOME RES, V3, P517, DOI 10.1021/pr034075o; Paba J, 2004, PROTEOMICS, V4, P1052, DOI 10.1002/pmic.200300637; Parodi-Talice A, 2004, INT J PARASITOL, V34, P881, DOI 10.1016/j.ijpara.2004.05.002; Pawar H, 2012, PROTEOMICS, V12, P832, DOI 10.1002/pmic.201100505; Pinge-Filho P, 2005, IMMUNOL LETT, V96, P283, DOI 10.1016/j.imlet.2004.09.010; Pontes AH, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00040; Porcel BM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004007; Prasad TSK, 2017, GENOME RES, V27, P133, DOI 10.1101/gr.201368.115; Rodriguez-Morales O, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/489758; SANCHEZMORENO M, 1992, MOL BIOCHEM PARASIT, V54, P185, DOI 10.1016/0166-6851(92)90111-V; Santos ALS, 2007, MICROBES INFECT, V9, P915, DOI 10.1016/j.micinf.2007.03.018; SOLARI AJ, 1980, CHROMOSOMA, V78, P239, DOI 10.1007/BF00328395; SOLARI AJ, 1995, BIOCELL, V19, P65; Souza W, 2002, CURR PHARM DESIGN, V8, P1; Tarleton RL, 1996, INT IMMUNOL, V8, P13, DOI 10.1093/intimm/8.1.13; Taylor SW, 2003, TRENDS BIOTECHNOL, V21, P82, DOI 10.1016/S0167-7799(02)00037-9; Tielens AGM, 1998, PARASITOL TODAY, V14, P265, DOI 10.1016/S0169-4758(98)01263-0; van Deursen FJ, 2003, MOL BIOCHEM PARASIT, V128, P107, DOI 10.1016/S0166-6851(03)00042-2; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhou WX, 2006, J BIOL CHEM, V281, P6290, DOI 10.1074/jbc.M511749200	53	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204818	10.1371/journal.pone.0204818	http://dx.doi.org/10.1371/journal.pone.0204818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303999	Green Published, Green Submitted, gold			2022-12-26	WOS:000446921100066
J	Andjelkovic, M; Minic, P; Vreca, M; Stojiljkovic, M; Skakic, A; Sovtic, A; Rodic, M; Skodric-Trifunovic, V; Maric, N; Visekruna, J; Spasovski, V; Pavlovic, S				Andjelkovic, Marina; Minic, Predrag; Vreca, Misa; Stojiljkovic, Maja; Skakic, Anita; Sovtic, Aleksandar; Rodic, Milan; Skodric-Trifunovic, Vesna; Maric, Nina; Visekruna, Jelena; Spasovski, Vesna; Pavlovic, Sonja			Genomic profiling supports the diagnosis of primary ciliary dyskinesia and reveals novel candidate genes and genetic variants	PLOS ONE			English	Article							INNER DYNEIN ARMS; SELENOCYSTEINE INSERTION; IDENTIFIES MUTATIONS; DEFECTS; EUKARYOTES; APPARATUS; AXONEME; CODONS; CCDC39; DNAH5	Primary ciliary dyskinesia (PCD) is a rare inherited autosomal recessive or X-linked disorder that mainly affects lungs. Dysfunction of respiratory cilia causes symptoms such as chronic rhinosinusitis, coughing, rhinitis, conductive hearing loss and recurrent lung infections with bronchiectasis. It is now well known that pathogenic genetic changes lead to ciliary dysfunction. Here we report usage of clinical-exome based NGS approach in order to reveal underlying genetic causes in cohort of 21 patient with diagnosis of PCD. By detecting 18 (12 novel) potentially pathogenic genetic variants, we established the genetic cause of 11 (9 unrelated) patients. Genetic variants were detected in six PCD disease-causing genes, as well as in SPAG16 and SPAG17 genes, that were not detected in PCD patients so far, but were related to some symptoms of PCD. The most frequently mutated gene in our cohort was DNAH5 (27.77%). Identified variants were in homozygous, compound heterozygous and trans-heterozygous state. For detailed characterization of one novel homozygous genetic variant in DNAI1 gene (c. 947_948insG, p. Thr318TyrfsTer11), RT-qPCR and Western Blot analysis were performed. Molecular diagnostic approach applied in this study enables analysis of 29 PCD disease-causing and related genes. It resulted in mutation detection rate of 50% and enabled discovery of twelve novel mutations and pointed two possible novel PCD candidate genes.	[Andjelkovic, Marina; Vreca, Misa; Stojiljkovic, Maja; Skakic, Anita; Spasovski, Vesna; Pavlovic, Sonja] Univ Belgrade, Inst Mol Genet & Genet Engn, Lab Mol Biomed, Belgrade, Serbia; [Minic, Predrag; Sovtic, Aleksandar; Rodic, Milan; Visekruna, Jelena] Mother & Child Hlth Care Inst Serbia Dr Vukan Cup, Belgrade, Serbia; [Minic, Predrag; Skodric-Trifunovic, Vesna] Univ Belgrade, Sch Med, Belgrade, Serbia; [Skodric-Trifunovic, Vesna] Clin Ctr Serbia, Clin Pulmonol, Belgrad, Serbia; [Maric, Nina] Univ Clin Ctr Republ Srpska, Clin Children Dis, Banja Luka, Bosnia & Herceg	University of Belgrade; University of Belgrade	Pavlovic, S (corresponding author), Univ Belgrade, Inst Mol Genet & Genet Engn, Lab Mol Biomed, Belgrade, Serbia.	sonya@sezampro.rs	Spasovski, Vesna/AAB-3751-2019	Skakic, Anita/0000-0002-1213-4458	Ministry of Education, Science and Technological Development, Republic of Serbia [III 41004]	Ministry of Education, Science and Technological Development, Republic of Serbia	This work has been funded by grant from the Ministry of Education, Science and Technological Development, Republic of Serbia (III 41004) (http://www.mpn.gov.rs/), SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Antony D, 2013, HUM MUTAT, V34, P462, DOI 10.1002/humu.22261; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Beier H, 2001, NUCLEIC ACIDS RES, V29, P4767, DOI 10.1093/nar/29.23.4767; Boaretto F, 2016, J MOL DIAGN, V18, P912, DOI 10.1016/j.jmoldx.2016.07.002; Boon M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-11; Casey JP, 2015, EUR J HUM GENET, V23, P210, DOI 10.1038/ejhg.2014.79; Copeland PR, 2001, MOL CELL BIOL, V21, P1491, DOI 10.1128/MCB.21.5.1491-1498.2001; Coren ME, 2002, ACTA PAEDIATR, V91, P667, DOI 10.1080/080352502760069089; Djakow J, 2016, PEDIATR PULM, V51, P498, DOI 10.1002/ppul.23261; Djakow J, 2012, PEDIATR PULM, V47, P864, DOI 10.1002/ppul.22520; Frija-Masson J, 2017, THORAX, V72, P154, DOI 10.1136/thoraxjnl-2015-207891; Geremek M, 2008, EUR J HUM GENET, V16, P688, DOI 10.1038/ejhg.2008.5; Goutaki M, 2016, EUR RESPIR J, V48, P1081, DOI 10.1183/13993003.00736-2016; Guo T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08510-z; Halbert SA, 1997, HUM REPROD, V12, P55, DOI 10.1093/humrep/12.1.55; Horani A, 2014, PEDIATR RES, V75, P158, DOI 10.1038/pr.2013.200; Howard MT, 2005, EMBO J, V24, P1596, DOI 10.1038/sj.emboj.7600642; Knowles MR, 2013, AM J RESP CRIT CARE, V188, P913, DOI 10.1164/rccm.201301-0059CI; Knowles MR, 2012, THORAX, V67, P433, DOI 10.1136/thoraxjnl-2011-200301; Kurkowiak M, 2015, J MED GENET, V52, P1, DOI 10.1136/jmedgenet-2014-102755; Leigh M, 2015, EXPERT OPIN ORPHAN D, V3, P31, DOI 10.1517/21678707.2015.989212; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; Lucas JS, 2014, EUR RESPIR J, V44, P1418, DOI 10.1183/09031936.00175614; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Morillas HN, 2007, RESPIRATION, V74, P252, DOI 10.1159/000101783; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; O'Callaghan C, 2011, EUR RESPIR J, V38, P603, DOI 10.1183/09031936.00108410; O'Callaghan C, 2010, ARCH DIS CHILD, V95, P51, DOI 10.1136/adc.2009.158493; O'Callaghan C, 2007, THORAX, V62, P656, DOI 10.1136/thx.2007.083147; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Olin JT, 2011, PEDIATR PULM, V46, P483, DOI 10.1002/ppul.21402; Onoufriadis A, 2014, HUM MOL GENET, V23, P3362, DOI 10.1093/hmg/ddu046; Onoufriadis A, 2014, J MED GENET, V51, P61, DOI 10.1136/jmedgenet-2013-101938; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Raidt J, 2014, EUR RESPIR J, V44, P1579, DOI 10.1183/09031936.00052014; Takeuchi K, 2018, AURIS NASUS LARYNX, V45, P585, DOI 10.1016/j.anl.2017.09.007; Teves ME, 2013, AM J RESP CELL MOL, V48, P765, DOI 10.1165/rcmb.2012-0362OC; Thornton B, 2011, BIOCHEM MOL BIOL EDU, V39, P145, DOI 10.1002/bmb.20461; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Weiss R B, 1990, Prog Nucleic Acid Res Mol Biol, V39, P159, DOI 10.1016/S0079-6603(08)60626-1; Zhang ZB, 2005, MOL CELL PROTEOMICS, V4, P914, DOI 10.1074/mcp.M400177-MCP200; Zhang ZB, 2007, BIOL REPROD, V77, P864, DOI 10.1095/biolreprod.107.063206	45	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205422	10.1371/journal.pone.0205422	http://dx.doi.org/10.1371/journal.pone.0205422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300419	Green Submitted, gold, Green Published			2022-12-26	WOS:000446897200061
J	Bonnet, I; Millon, B; Meugnier, H; Vandenesch, F; Maurin, M; Pavese, P; Boisset, S				Bonnet, Isabelle; Millon, Brune; Meugnier, Helene; Vandenesch, Francois; Maurin, Max; Pavese, Patricia; Boisset, Sandrine			High prevalence of spa type t571 among methicillin-susceptible Staphylococcus aureus from bacteremic patients in a French University Hospital	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; CLONAL COMPLEX 398; RESISTANT; ENDOCARDITIS; POPULATION; STRAINS; CC398; ECHOCARDIOGRAPHY; EPIDEMIOLOGY; SURVEILLANCE	Staphylococcus aureus bacteremia is one of the most frequent severe bacterial infections worldwide, with an associated mortality of about 20-40% in developed countries. In 2013, we noted an increase in this infection in the teaching hospital in Grenoble, France, compared to 2012. The mean incidence of S. aureus bacteremia was 0.28 per 1,000 patient-days in 2012 and 0.35 per 1,000 patient-days in 2013. This trend was confirmed in 2014 (0.35 per 1,000 patient-days). In the present work we aimed to study the population of patients presenting with S. aureus bacteremia in 2013 and to genotype the corresponding S. aureus strains in order to identify a successful and/or virulent genotype to design a specific infection control program. One hundred ninety-one S. aureus isolates (including 9 methicillin-resistant) out of 199 corresponding cases of bacteremia were characterized with the spa typing method. Among 108 spa types, t571, t002, t008 and t084 were the most prevalent. Although not widely prevalent, t571 was the most frequently identified clone (8.4% of all isolates). Spa type t571 has been described in previous studies as belonging to the clonal complex CC398, which is consistent with the recent emergence of methicillin-susceptible S. aureus CC398 reported in blood cultures in Europe.	[Bonnet, Isabelle; Maurin, Max; Boisset, Sandrine] Grenoble Alpes Univ Hosp, Bacteriol Lab, Grenoble, France; [Millon, Brune; Pavese, Patricia] Grenoble Alpes Univ Hosp, Serv Malad Infect, Grenoble, France; [Meugnier, Helene; Vandenesch, Francois] Hosp Civils Lyon, Bacteriol Lab, Ctr Biol & Pathol Est, Bron, France; [Meugnier, Helene; Vandenesch, Francois] Univ Lyon, CIRI, Lyon, France; [Meugnier, Helene; Vandenesch, Francois] INSERM, U1111, Lyon, France; [Meugnier, Helene; Vandenesch, Francois] Ecole Normale Super Lyon, Lyon, France; [Meugnier, Helene; Vandenesch, Francois] Univ Lyon 1, Lyon, France; [Meugnier, Helene; Vandenesch, Francois] CNRS, UMR 5308, Lyon, France; [Maurin, Max; Boisset, Sandrine] Grenoble Alpes Univ Hosp, CNRS, UMR 5525, TIMC TheREx Lab, Grenoble, France; [Bonnet, Isabelle] Grp Hosp Univ Pitie Salpetriere, Bacteriol Lab, Paris, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Bonnet, I (corresponding author), Grenoble Alpes Univ Hosp, Bacteriol Lab, Grenoble, France.; Bonnet, I (corresponding author), Grp Hosp Univ Pitie Salpetriere, Bacteriol Lab, Paris, France.	isabelle.bonnet2@aphp.fr	Vandenesch, Francois/C-7209-2014; Maurin, Max/D-8164-2014; Bonnet, Isabelle/AAA-2288-2022	Vandenesch, Francois/0000-0001-9412-7106; Maurin, Max/0000-0003-4156-3208; Bonnet, Isabelle/0000-0002-4569-147X				Asgeirsson H, 2011, CLIN MICROBIOL INFEC, V17, P513, DOI 10.1111/j.1469-0691.2010.03265.x; Bassetti M, 2012, CLIN MICROBIOL INFEC, V18, P862, DOI 10.1111/j.1469-0691.2011.03679.x; Becker K, 2017, VET MICROBIOL, V200, P33, DOI 10.1016/j.vetmic.2015.11.013; Bouiller K, 2016, CLIN MICROBIOL INFEC, V22, P451, DOI 10.1016/j.cmi.2016.01.018; Chroboczek T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068462; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Cuny C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083165; David MZ, 2013, J CLIN MICROBIOL, V51, P2443, DOI 10.1128/JCM.01057-13; Diene SM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3516-x; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Forsblom E, 2011, J HOSP INFECT, V78, P102, DOI 10.1016/j.jhin.2011.03.010; Grontvedt CA, 2016, CLIN INFECT DIS, V63, P1431, DOI 10.1093/cid/ciw552; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hallin M, 2007, J CLIN MICROBIOL, V45, P127, DOI 10.1128/JCM.01866-06; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Jacobsson G, 2007, SCAND J INFECT DIS, V39, P6, DOI 10.1080/00365540600810026; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P465, DOI 10.1111/j.1469-0691.2012.03903.x; Le Moing V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127385; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lyytikainen O, 2005, EUR J CLIN MICROBIOL, V24, P399, DOI 10.1007/s10096-005-1345-3; Mellmann A, 2008, J CLIN MICROBIOL, V46, P2805, DOI 10.1128/JCM.00071-08; Miko BA, 2013, J CLIN MICROBIOL, V51, P874, DOI 10.1128/JCM.00923-12; Mitchell BG, 2014, CLIN INFECT DIS, V59, P969, DOI 10.1093/cid/ciu508; Nienaber JJC, 2011, J INFECT DIS, V204, P704, DOI 10.1093/infdis/jir389; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; O'Hara FP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051172, DOI 10.1371/JOURNAL.PONE.0051172]; Orscheln RC, 2009, CLIN INFECT DIS, V49, P536, DOI 10.1086/600881; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rasmussen RV, 2011, EUR J ECHOCARDIOGR, V12, P414, DOI 10.1093/ejechocard/jer023; Salmenlinna S, 2010, EMERG INFECT DIS, V16, P1626, DOI 10.3201/eid1610.091571; Sharma M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01741; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; Tristan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051172; Uslan DZ, 2007, ARCH INTERN MED, V167, P834, DOI 10.1001/archinte.167.8.834; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; van der Mee-Marquet N, 2013, INFECT GENET EVOL, V18, P299, DOI 10.1016/j.meegid.2013.06.009; van Wamel WJB, 2010, EUR J CLIN MICROBIOL, V29, P119, DOI 10.1007/s10096-009-0816-3; Vandendriessche S, 2011, J ANTIMICROB CHEMOTH, V66, P2455, DOI 10.1093/jac/dkr348; Verkade E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041855; Vogel M, 2016, J INFECTION, V72, P19, DOI 10.1016/j.jinf.2015.09.037; Vos FJ, 2011, NETH J MED, V69, P335	45	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0204977	10.1371/journal.pone.0204977	http://dx.doi.org/10.1371/journal.pone.0204977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300375	Green Published, Green Submitted, gold			2022-12-26	WOS:000446897200028
J	Leong, CXR; Price, JM; Pitchford, NJ; van Heuven, WJB				Leong, Christine Xiang Ru; Price, Jessica M.; Pitchford, Nicola J.; van Heuven, Walter J. B.			High variability phonetic training in adaptive adverse conditions is rapid, effective, and sustained	PLOS ONE			English	Article							R-VERTICAL-BAR; NONNATIVE SPEECH-PERCEPTION; LONG-TERM RETENTION; JAPANESE LISTENERS; LEARNING-ENGLISH; TALKER VARIABILITY; AMERICAN ENGLISH; NATIVE SPEAKERS; DISCRIMINATION; LANGUAGE	This paper evaluates a novel high variability phonetic training paradigm that involves presenting spoken words in adverse conditions. The effectiveness, generalizability, and longevity of this high variability phonetic training in adverse conditions was evaluated using English phoneme contrasts in three experiments with Malaysian multilinguals. Adverse conditions were created by presenting spoken words against background multi-talker babble. In Experiment 1, the adverse condition level was set at a fixed level throughout the training and in Experiment 2 the adverse condition level was determined for each participant before training using an adaptive staircase procedure. To explore the effectiveness and sustainability of the training, phonemic discrimination ability was assessed before and immediately after training (Experiments 1 and 2) and 6 months after training (Experiment 3). Generalization of training was evaluated within and across phonemic contrasts using trained and untrained stimuli. Results revealed significant perceptual improvements after just three 20-minute training sessions and these improvements were maintained after 6 months. The training benefits also generalized from trained to untrained stimuli. Crucially, perceptual improvements were significantly larger when the adverse conditions were adapted before each training session than when it was set at a fixed level. As the training improvements observed here are markedly larger than those reported in the literature, this indicates that the individualized phonetic training regime in adaptive adverse conditions (HVPT-AAC) is highly effective at improving speech perception.	[Leong, Christine Xiang Ru; Price, Jessica M.] Univ Nottingham Malaysia Campus, Sch Psychol, Semenyih, Selangor, Malaysia; [Pitchford, Nicola J.; van Heuven, Walter J. B.] Univ Nottingham, Sch Psychol, Nottingham, England	University of Nottingham	van Heuven, WJB (corresponding author), Univ Nottingham, Sch Psychol, Nottingham, England.	walter.vanheuven@nottingham.ac.uk	van Heuven, Walter J B/K-9034-2013	van Heuven, Walter J B/0000-0003-3183-4449; Leong, Christine, Xiang Ru/0000-0003-1110-545X; Price, Jessica/0000-0001-7200-8691	Experimental Psychology Society; University of Nottingham Malaysia campus; University of Nottingham	Experimental Psychology Society; University of Nottingham Malaysia campus; University of Nottingham	This research was partly supported by a summer bursary from the Experimental Psychology Society awarded to WJBVH. CLXR was supported by a funded PhD scholarship from the University of Nottingham Malaysia campus. The development of the HVPT-AAC paradigm was supported by funding from the University of Nottingham, which included an Innovation Fellowship awarded to NJP and WJBVH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliaga-Garcia C., 2009, RECENT RES 2 LANGUAG, P2; Aliaga-Garcoaa C, RECENT RES 2 LANGUAG; Bent T, 2010, J ACOUST SOC AM, V128, P3142, DOI 10.1121/1.3493428; Best CT, 2001, J ACOUST SOC AM, V109, P775, DOI 10.1121/1.1332378; Boersma Paul, 2002, GLOT INT, V5, P341; Bradlow AR, 2007, J ACOUST SOC AM, V121, P2339, DOI 10.1121/1.2642103; Bradlow AR, 2002, J ACOUST SOC AM, V112, P272, DOI 10.1121/1.1487837; Bradlow AR, 1997, J ACOUST SOC AM, V101, P2299, DOI 10.1121/1.418276; Bradlow AR, 1999, PERCEPT PSYCHOPHYS, V61, P977, DOI 10.3758/BF03206911; Brosseau-Lapre F, 2013, APPL PSYCHOLINGUIST, V34, P419, DOI 10.1017/S0142716411000750; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Burk MH, 2006, EAR HEARING, V27, P263, DOI 10.1097/01.aud.0000215980.21158.a2; Calandruccio L, 2014, J AM ACAD AUDIOL, V25, P355, DOI 10.3766/jaaa.25.4.7; Callan DE, 2003, NEUROIMAGE, V19, P113, DOI 10.1016/S1053-8119(03)00020-X; Cebrian J, 2014, CAN MOD LANG REV, V70, P474, DOI 10.3138/cmlr.2318; Clopper CG, 2004, LANG SPEECH, V47, P207, DOI 10.1177/00238309040470030101; Cooke M, 2008, J ACOUST SOC AM, V123, P414, DOI 10.1121/1.2804952; Flege J., 1995, 2 LANGUAGE SPEECH LE, P233; FLEGE JE, 1989, J ACOUST SOC AM, V86, P1684, DOI 10.1121/1.398599; Lecumberri MLG, 2010, SPEECH COMMUN, V52, P864, DOI 10.1016/j.specom.2010.08.014; GAT IB, 1978, AUDIOLOGY, V17, P339; Giannakopoulou A, 2017, PEERJ, V5, DOI 10.7717/peerj.3209; Giannakopoulou A, 2013, CHILD LANG TEACH THE, V29, P201, DOI 10.1177/0265659012467473; Handley Z, 2009, SPEECH LANGUAGE TECH; Hassan A, 2005, LINGUISTIK AM, P77; Hazan V, 2005, SPEECH COMMUN, V47, P360, DOI 10.1016/j.specom.2005.04.007; Hazan V, 2010, SPEECH COMMUN, V52, P996, DOI 10.1016/j.specom.2010.05.003; Heeren WFL, 2010, J PHONETICS, V38, P594, DOI 10.1016/j.wocn.2010.08.005; Huang L.M., 1992, B NATL TAIWAN NORMAL, V37, P363; Huensch A, 2015, J PHONETICS, V52, P105, DOI 10.1016/j.wocn.2015.06.007; Iverson P, 2005, J ACOUST SOC AM, V118, P3267, DOI 10.1121/1.2062307; Iverson P, 2012, APPL PSYCHOLINGUIST, V33, P145, DOI 10.1017/S0142716411000300; JAMIESON DG, 1986, PERCEPT PSYCHOPHYS, V40, P205, DOI 10.3758/BF03211500; Jenkins J, 2018, ROUTLEDGE HDB ENGLIS; Karim NS, 2015, TATABAHASA DEWAN, P617; KRAUS N, 1995, J COGNITIVE NEUROSCI, V7, P25, DOI 10.1162/jocn.1995.7.1.25; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; Lengeris A, 2010, J ACOUST SOC AM, V128, P3757, DOI 10.1121/1.3506351; LIVELY SE, 1994, J ACOUST SOC AM, V96, P2076, DOI 10.1121/1.410149; LIVELY SE, 1993, J ACOUST SOC AM, V94, P1242, DOI 10.1121/1.408177; LOGAN JS, 1991, J ACOUST SOC AM, V89, P874, DOI 10.1121/1.1894649; Mattys SL, 2012, LANG COGNITIVE PROC, V27, P953, DOI 10.1080/01690965.2012.705006; Mayo LH, 1997, J SPEECH LANG HEAR R, V40, P686, DOI 10.1044/jslhr.4003.686; McCandliss BD, 2002, COGN AFFECT BEHAV NE, V2, P89, DOI 10.3758/CABN.2.2.89; Meador D., 2000, BILING-LANG COGN, V3, P55, DOI DOI 10.1017/S1366728900000134; Miller JD, 2011, ROLE CALL HYBRID ONL; Moore DR, 2005, BRAIN LANG, V94, P72, DOI 10.1016/j.bandl.2004.11.009; Munro M. J., 2004, SYSTEM, V32, P539, DOI DOI 10.1016/J.SYSTEM.2004.09.011; Nishi K, 2007, J SPEECH LANG HEAR R, V50, P1496, DOI 10.1044/1092-4388(2007/103); Nobre-Oliveira D., 2008, NEW SOUNDS 2007 P 5, P382; Peng ZE, 2016, J ACOUST SOC AM, V139, P2772, DOI 10.1121/1.4948564; Perrachione TK, 2011, J ACOUST SOC AM, V130, P461, DOI 10.1121/1.3593366; Pillai S, 2010, WORLD ENGLISH, V29, P159, DOI 10.1111/j.1467-971X.2010.01636.x; Richie C, 2008, J SPEECH LANG HEAR R, V51, P1607, DOI 10.1044/1092-4388(2008/07-0069); Shinohara Y, 2018, J PHONETICS, V66, P242, DOI 10.1016/j.wocn.2017.11.002; STRANGE W, 1984, PERCEPT PSYCHOPHYS, V36, P131, DOI 10.3758/BF03202673; TAKATA Y, 1990, J ACOUST SOC AM, V88, P663, DOI 10.1121/1.399769; Wang XC, 2013, MOD LANG J, V97, P144, DOI 10.1111/j.1540-4781.2013.01386.x; Thai YN, 2010, PERTANIKA J SOC SCI, V18, P379	61	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0204888	10.1371/journal.pone.0204888	http://dx.doi.org/10.1371/journal.pone.0204888			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4OW	30300372	Green Published, gold, Green Submitted			2022-12-26	WOS:000446897200025
J	Chong, KC; Hu, P; Lau, S; Jia, KM; Liang, WJ; Wang, MHT; Zee, BCY; Sun, RY; Zheng, HZ				Chong, Ka Chun; Hu, Pei; Lau, Steven; Jia, Katherine Min; Liang, Wenjia; Wang, Maggie Haitian; Zee, Benny Chung Ying; Sun, Riyang; Zheng, Huizhen			Monitoring the age-specificity of measles transmissions during 2009-2016 in Southern China	PLOS ONE			English	Article							REPRODUCTION-NUMBER; INFECTIOUS-DISEASE; EPIDEMIC; IMMUNIZATION; ELIMINATION; MODELS; ADULTS	Background Despite several immunization efforts, China saw a resurgence of measles in 2012. Monitoring of transmissions of individuals from different age groups could offer information that would be valuable for planning adequate disease control strategies. We compared the age-specific effective reproductive numbers (R) of measles during 2009-2016 in Guangdong, China. Methods We estimated the age-specific R values for 7 age groups: 0-8 months, 9-18 months, 19 months to 6 years, 7-15 years, 16-25 years, 26-45 years, and >= 46 years adapting the contact matrix of China. The daily numbers of laboratory and clinically confirmed cases reported to the Center for Disease Control and Prevention of Guangdong were used. Results The peak R values of the entire population were above unity from 2012 to 2016, indicating the persistence of measles in the population. In general, children aged 0-6 years and adults aged 26-45 years had larger values of R when comparing with other age groups after 2012. While the peaks of R values for children aged 0-6 years dropped steadily after 2013, the peaks of R values for adults aged 26-45 years kept at a high range every year. Conclusions Although the provincial supplementary immunization activities (SIAs) conducted in 2009 and 2010 were able to reduce the transmissions from 2009 to 2011, larger values of R for children aged 0-6 years were observed after 2012, indicating that the benefits of the SIAs were short-lived. In addition, the transmissions from adults aged between 26 and 45 years increased over time. Disease control strategies should target children and adult groups that carry high potential for measles transmission.	[Chong, Ka Chun; Lau, Steven; Jia, Katherine Min; Wang, Maggie Haitian; Zee, Benny Chung Ying; Sun, Riyang] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Chong, Ka Chun; Wang, Maggie Haitian; Zee, Benny Chung Ying] Chinese Univ Hong Kong, Shenzhen Res Inst, Clin Trials & Biostat Lab, Hong Kong, Hong Kong, Peoples R China; [Hu, Pei; Liang, Wenjia; Zheng, Huizhen] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Sun, RY (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.; Zheng, HZ (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	anna_Sun@link.cuhk.edu.hk; zhzgdcdc@163.com	Zee, Benny Chung Ying/G-5606-2017; Chong, Marc Ka-chun/S-7258-2019; Wang, Maggie Haitian/F-5954-2017	Zee, Benny Chung Ying/0000-0002-7238-845X; Chong, Marc Ka-chun/0000-0001-5610-1298; Wang, Maggie Haitian/0000-0003-1223-4595	Shenzhen Municipal Science and Technology Program [JCYJ20150630165236958]; National Natural Science Foundation of China [81473035]	Shenzhen Municipal Science and Technology Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work is supported by Basic research project from Shenzhen Municipal Science and Technology Program (Grant number: JCYJ20150630165236958) to KCC and National Natural Science Foundation of China (Grant number: 81473035) to MHW.	Ai J, 2016, J MICROB INFECT, V11, P8; Amundsen EJ, 2004, EPIDEMIOL INFECT, V132, P1139, DOI 10.1017/S0950268804002997; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P205; BIN D, 1991, B WORLD HEALTH ORGAN, V69, P415; Boulton ML, 2017, CHINA J INFECT DIS, V216, P1122, DOI [10.1093/infdis/jix453, DOI 10.1093/INFDIS/JIX453]; Cauchemez S, 2008, J R SOC INTERFACE, V5, P885, DOI 10.1098/rsif.2007.1292; Chen M, 2015, EMERG INFECT DIS, V21, P477, DOI 10.3201/eid2103.140646; Chong KC, 2017, VACCINE, V35, P1024, DOI 10.1016/j.vaccine.2017.01.010; Du D, 2015, J PREV MED PUBLIC HL, V26, P57; Fu CX, 2017, VACCINE, V35, P3817, DOI 10.1016/j.vaccine.2017.06.002; Gang L, 2007, CHIN J SCH HLTH, V28, P2; Glass K, 2011, J R SOC INTERFACE, V8, P1248, DOI 10.1098/rsif.2010.0679; Glass K, 2012, EPIDEMIOLOGY, V23, P86, DOI 10.1097/EDE.0b013e31823a44a5; Heesterbeek JAP, 2007, MATH BIOSCI, V206, P3, DOI 10.1016/j.mbs.2004.10.013; Klinkenberg D, 2011, J THEOR BIOL, V284, P52, DOI 10.1016/j.jtbi.2011.06.015; Leuridan E, 2010, BMJ, V340, pc1626, DOI 10.1136/bmj.c1626; Li Z., 2017, CHIN J SCH HLTH, V38, P80; Lu L, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P663, DOI 10.3760/cma.j.issn.0254-6450.2016.05.015; Ma C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0752-z; Ma C, 2014, B WORLD HEALTH ORGAN, V92, P340, DOI 10.2471/BLT.13.130195; Ma Rui, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P1036; Moser CB, 2018, STAT METHODS MED RES, V27, P2050, DOI 10.1177/0962280216673676; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ogbuanu IU, 2014, CLIN INFECT DIS, V58, P1086, DOI 10.1093/cid/ciu037; OGRA PL, 1968, NEW ENGL J MED, V279, P893, DOI 10.1056/NEJM196810242791701; Pannuti CS, 2004, CLIN DIAGN LAB IMMUN, V11, P119, DOI 10.1128/CDLI.11.1.119-122.2004; Prem K, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005697; Roberts MG, 2003, P ROY SOC B-BIOL SCI, V270, P1359, DOI 10.1098/rspb.2003.2339; Smetana J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170257; The National People's Congress of the People's Republic of China, 2007, ADM LAW; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; White LF, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-4; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; WHO, 2018, LEG BAC LIM COUNTR; World Health Organization, 2017, DIS SURV BURD; World Health Organization, 2016, FACTSH MEASL CHIN; Youlan F., 2009, ZHEJIANG J PREVENTIV, V21, P31; Zhang F, 2016, CHINA MODERN MED, V30, P176; [张秀山 Zhang Xiushan], 2015, [军事医学, Military Medical Sciences], V39, P360; Zhang Y, 2010, EMERG INFECT DIS, V16, P943, DOI 10.3201/eid1606.100089; Zheng X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133983	41	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205339	10.1371/journal.pone.0205339	http://dx.doi.org/10.1371/journal.pone.0205339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296273	Green Submitted, Green Published, gold			2022-12-26	WOS:000446632700031
J	Silva, R; de Almeida, DM; Cabral, BCA; Dias, VHG; Mello, ICDE; Urmenyi, TP; Woerner, AE; Neto, RSD; Budowle, B; Nassar, CAG				Silva, Rosane; de Almeida, Darcy Muniz; Azeredo Cabral, Bianca Catarina; Giordano Dias, Victor Hugo; de Toledo e Mello, Isadora Cristina; Urmenyi, Turan Peter; Woerner, August E.; de Moura Neto, Rodrigo Soares; Budowle, Bruce; Gomes Nassar, Cristina Aparecida			Microbial enrichment and gene functional categories revealed on the walls of a spent fuel pool of a nuclear power plant	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; BACTERIA; USTILAGO; URANIUM; FUNGI; BASIDIOMYCOTA; SPORISORIUM; RADIATION; WASTE; PH	Microorganisms developing in the liner of the spent fuel pool (SFP) and the fuel transfer channel (FTC) of a Nuclear Power Plant (NPP) can form high radiation resistant biofilms and cause corrosion. Due to difficulties and limitations to obtain large samples from SFP and FTC, cotton swabs were used to collect the biofilm from the wall of these installations. Molecular characterization was performed using massively parallel sequencing to obtain a taxonomic and functional gene classification. Also, samples from the drainage system were evaluated because microorganisms may travel over the 12-meter column of the pool water of the Brazilian Nuclear Power Plant (Angra1), which has been functioning since 1985. Regardless of the treatment of the pool water, our data reveal the unexpected presence of Fungi (Basidiomycota and Ascomycota) as the main contaminators of the SFP and FTC. Ustilaginomycetes (Basidiomycota) was the major class contributor (70%) in the SFP and FTC reflecting the little diversity in these sites; nevertheless, Proteobacteria, Actinobacteria, Firmicutes (Bacilli) were present in small proportions. Mapping total reads against six fungal reference genomes indicate that there is, in fact, a high abundance of fungal sequences in samples collected from SFP and FTC. Analysis of the ribosomal internal transcribed spacer (ITS) 1 and 2 regions and the protein found in the mitochondria of eukaryotic cells, cytochrome b (cytb) grouped our sample fungi in the Glade 7 as Ustilago and Pseudozyma. In contrast, in the drainage system, Alphaproteobacteria were present in high abundances (55%). The presence of Sphingopyxis, Mesorhizobium, Erythrobacter, Sphingomonas, Novosphingobium, Sphingobium, Chelativorans, Oceanicaulis, Acidovorax, and Cyanobacteria was observed. Based on genomic annotation data, the assessment of the biological function found a higher proportion of protein-coding sequences related to respiration and protein metabolism in SFP and FTC samples. The knowledge of this biological inventory present in the system may contribute to further studies of potential microorganisms that might be useful for bioremediation of nuclear waste.	[Silva, Rosane; Azeredo Cabral, Bianca Catarina; Giordano Dias, Victor Hugo; de Toledo e Mello, Isadora Cristina; Urmenyi, Turan Peter] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [de Almeida, Darcy Muniz] Univ Fed Rio de Janeiro, Escola Politecn, Rio De Janeiro, Brazil; [de Almeida, Darcy Muniz] Univ Fed Rio de Janeiro, Escola Quim, Rio De Janeiro, Brazil; [Woerner, August E.; Budowle, Bruce] Univ North Texas, Hlth Sci Ctr, Ctr Human Identificat, Ft Worth, TX USA; [de Moura Neto, Rodrigo Soares; Gomes Nassar, Cristina Aparecida] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Budowle, Bruce] King Abdulaziz Univ, CEGMR, Jeddah, Saudi Arabia	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; University of North Texas System; University of North Texas Denton; Universidade Federal do Rio de Janeiro; King Abdulaziz University	Silva, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.	silvaros@biof.ufrj.br	Moura-Neto, Rodrigo S/F-6770-2012; Nassar, Cristina/AAI-6888-2021; Silva, Rosane/U-6913-2019; Nassar, Cristina/AGZ-0090-2022	Moura-Neto, Rodrigo S/0000-0002-4292-6878; Nassar, Cristina/0000-0003-3306-0862; Silva, Rosane/0000-0002-2998-6999; Nassar, Cristina/0000-0003-3306-0862; Azeredo Cabral, Bianca Catarina/0000-0002-9131-0113; Giordano Dias, Victor Hugo/0000-0003-4113-7639	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 305833/2013-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES PE 99999.000335/2016-09]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by research grants of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq 305833/2013-8 (RS - USD 12,375) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES PE 99999.000335/2016-09 (RS - USD 27,000).	Adachi J, 1996, J MOL EVOL, V42, P459; Aime MC, 2018, IMA FUNGUS, V9, P75, DOI 10.5598/imafungus.2018.09.01.06; Cervantes-Montelongo JA, 2016, J BASIC MICROB, V56, P1222, DOI 10.1002/jobm.201600130; Castelvecchi D., 2009, SCI NEWS, V171, P325, DOI [10.1002/scin.2007.5591712106, DOI 10.1002/SCIN.2007.5591712106]; Chicote E, 2005, J IND MICROBIOL BIOT, V32, P155, DOI 10.1007/s10295-005-0216-3; Chicote E, 2004, BIOFOULING, V20, P35, DOI 10.1080/08927010410001662670; Dighton J, 2008, FEMS MICROBIOL LETT, V281, P109, DOI 10.1111/j.1574-6968.2008.01076.x; Flemming HC, 2002, APPL MICROBIOL BIOT, V59, P629, DOI 10.1007/s00253-002-1066-9; Fonseca JP, 2018, GENE, V642, P389, DOI 10.1016/j.gene.2017.11.039; HOLLIDAY R, 1971, NATURE-NEW BIOL, V232, P233, DOI 10.1038/newbio232233a0; Holloman WK, 2007, TRENDS MICROBIOL, V15, P525, DOI 10.1016/j.tim.2007.10.007; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kalin M, 2005, J ENVIRON RADIOACTIV, V78, P151, DOI 10.1016/j.jenvrad.2004.05.002; Karley D, 2018, ENVIRON SCI POLLUT R, V25, P20518, DOI 10.1007/s11356-017-0376-5; Kip N, 2015, ISME J, V9, P542, DOI 10.1038/ismej.2014.169; LICINA GJ, 1989, JOM-J MIN MET MAT S, V41, P23, DOI 10.1007/BF03220842; Lloyd JR, 2005, CURR OPIN BIOTECH, V16, P254, DOI 10.1016/j.copbio.2005.04.012; Maeda T, 2012, FEBS J, V279, P1407, DOI 10.1111/j.1742-4658.2012.08548.x; Matthies C, 1997, J BASIC MICROB, V37, P335, DOI 10.1002/jobm.3620370506; McLaughlin DJ, 2009, TRENDS MICROBIOL, V17, P488, DOI 10.1016/j.tim.2009.08.001; McTaggart AR, 2012, PERSOONIA, V29, P55, DOI 10.3767/003158512X660283; McTaggart AR, 2016, IMA FUNGUS, V7, P309, DOI 10.5598/imafungus.2016.07.02.10; Merroun ML, 2008, J CONTAM HYDROL, V102, P285, DOI 10.1016/j.jconhyd.2008.09.019; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mumtaz S, 2013, J ENVIRON RADIOACTIV, V120, P39, DOI 10.1016/j.jenvrad.2013.01.007; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pizzorno Lara, 2015, Integr Med (Encinitas), V14, P35; Pollmann K, 2006, BIOTECHNOL ADV, V24, P58, DOI 10.1016/j.biotechadv.2005.06.002; Ragon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021764; Rajasekar A, 2017, ENVIRON SCI POLLUT R, V24, P8120, DOI 10.1007/s11356-017-8501-z; Rivasseau C, 2016, J PHYCOL, V52, P689, DOI 10.1111/jpy.12442; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Ruiz-Gonzalez MX, 2016, SCI REP-UK, V6, DOI 10.1038/srep22969; Sarro MI, 2007, J IND MICROBIOL BIOT, V34, P433, DOI 10.1007/s10295-007-0215-7; Sarro MI, 2005, INT MICROBIOL, V8, P223; Sayin Z, 2016, BIOL TRACE ELEM RES, V173, P241, DOI 10.1007/s12011-016-0637-z; Stoll M, 2005, MYCOL RES, V109, P342, DOI 10.1017/S0953756204002229; Stoll M, 2003, CAN J BOT, V81, P976, DOI [10.1139/b03-094, 10.1139/B03-094]; Thines M, 2016, TAXON, V65, P1170, DOI 10.12705/655.20; Vaishampayan P, 2010, INT J SYST EVOL MICR, V60, P1031, DOI 10.1099/ijs.0.008979-0; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Vylkova S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006149; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Wang QM, 2015, STUD MYCOL, P55, DOI 10.1016/j.simyco.2015.10.004; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Wollenberg T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004218; Zambanini T, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0809-x; Zavilgelsky GB, 1998, J PHOTOCH PHOTOBIO B, V43, P152, DOI 10.1016/S1011-1344(98)00099-2	49	4	4	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205228	10.1371/journal.pone.0205228	http://dx.doi.org/10.1371/journal.pone.0205228			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286173	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500099
J	Limmer, M; Platen, P				Limmer, Mirjam; Platen, Petra			The influence of hypoxia and prolonged exercise on attentional performance at high and extreme altitudes: A pilot study	PLOS ONE			English	Article							ACUTE MOUNTAIN-SICKNESS; COGNITIVE PERFORMANCE; WORKING-MEMORY; REACTION-TIME; SLEEP; IMPAIRMENT; PSILOCYBIN; PRESSURE; HEADACHE; SCALE	Introduction Exposure to hypoxic conditions is reported to impair cognitive performance. Further, moderate physical exercise improves cognitive function, but little is known about the influence of exercise on cognitive function in hypoxia. Therefore, the current study aimed to examine the influence of hypoxia (HYP) and prolonged exercise (EX) on attentional performance. Methods A total of 80 participants (female: n = 29; male: n = 51) were assigned to four groups: HYP + EX (n = 15), HYP (n = 25), EX (n = 21) and normoxia (NOR) (n = 21). The Frankfurt Attention Inventory-2 (FAIR-2) was performed at four testing points (day 1, 14, 16 and 18) to assess attentional performance. All groups completed a pretest (D1) and a follow-up test (D18). In HYP + EX conditions, the cognitive task was performed in a hypoxic state after prolonged exercise (D14: 3950 m, D16: 5739 m) during a mountain climb on Mt. Kilimanjaro. Participants in HYP were tested under intermittent hypoxia at rest in a hypoxic chamber (D14: 3500 m, D16: 5800 m), and those in EX were tested under normoxia after prolonged exercise during a 7-day backcountry ski hiking tour. NOR was a control group, and participants completed all tests under normoxia and at rest. Results Hypoxia impaired the attentional functions performance value (PV) and continuity value (CV) for the HYP + EX (p = 0.000) and HYP (L: p = 0.025; K: p = 0.043) groups at 5739 m and 5800 m, respectively, but not the function quality value (QV). In contrast, the EX group did not exhibit changes in attentional function. Conclusion The current results suggest that attentional performance is impaired during extreme normobaric and hypobaric hypoxic exposure. We further conclude that greater cognitive impairment under hypobaric hypoxia during a mountain climb compared with normobaric hypoxia at rest is not caused by prolonged exercise, but may be influenced by other factors (e.g. low temperatures, dehydration, or sleep deprivation) that remain to be verified.	[Limmer, Mirjam; Platen, Petra] Ruhr Univ Bochum, Dept Sports Med & Sports Nutr, Bochum, Germany; [Limmer, Mirjam] German Sports Univ Cologne, Inst Outdoor Sports & Environm Sci, Cologne, Germany	Ruhr University Bochum; German Sport University Cologne	Limmer, M (corresponding author), Ruhr Univ Bochum, Dept Sports Med & Sports Nutr, Bochum, Germany.; Limmer, M (corresponding author), German Sports Univ Cologne, Inst Outdoor Sports & Environm Sci, Cologne, Germany.	mirjam.limmer@rub.de		Platen, Petra/0000-0002-3440-8245; Limmer, Mirjam/0000-0002-8032-6152	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063630; Ando S, 2010, J APPL PHYSIOL, V108, P1210, DOI 10.1152/japplphysiol.01115.2009; Bartsch P, 2008, SCAND J MED SCI SPOR, V18, P96, DOI 10.1111/j.1600-0838.2008.00837.x; BERRY DTR, 1989, J CLIN EXP NEUROPSYC, V11, P241, DOI 10.1080/01688638908400886; Bonnon M, 2000, AVIAT SPACE ENVIR MD, V71, P678; Chang YK, 2014, PSYCHOL SPORT EXERC, V15, P464, DOI 10.1016/j.psychsport.2014.04.007; Chang YK, 2014, J SCI MED SPORT, V17, P51, DOI 10.1016/j.jsams.2013.02.007; Cohen J., 1992, PSYCHOL B; DiPasquale DM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6245609; Dobashi S, 2016, HIGH ALT MED BIOL, V17, P214, DOI 10.1089/ham.2016.0036; Finnoff JT, 2008, CURR SPORT MED REP, V7, P28, DOI 10.1097/01.CSMR.0000308669.99816.71; Fruhauf A, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3313-z; Gao YX, 2015, EUR J NEUROL, V22, P1363, DOI 10.1111/ene.12507; Griva K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174277; Harris GA, 2009, WILD ENVIRON MED, V20, P261, DOI 10.1580/08-WEME-OR-261R.1; Hasler F, 2004, PSYCHOPHARMACOLOGY, V172, P145, DOI 10.1007/s00213-003-1640-6; Hext F, 2011, HIGH ALT MED BIOL, V12, P329, DOI 10.1089/ham.2010.1055; Hill CM, 2014, NEUROPSYCHOLOGY, V28, P752, DOI 10.1037/neu0000065; Hurdiel R, 2015, J SPORT SCI, V33, P670, DOI 10.1080/02640414.2014.960883; Kimoto K, 2011, INTERNAL MED, V50, P1923, DOI 10.2169/internalmedicine.50.5640; Komiyama T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10332-y; Komiyama T, 2015, PHYSIOL BEHAV, V139, P290, DOI 10.1016/j.physbeh.2014.11.057; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Latshang TD, 2013, SLEEP, V36, P1969, DOI 10.5665/sleep.3242; Leach J, 2016, EXTREME PHYSIOL MED, V5, DOI 10.1186/s13728-016-0048-y; Lemos VD, 2012, PSYCHOPHYSIOLOGY, V49, P1298, DOI 10.1111/j.1469-8986.2012.01411.x; MacInnis MJ, 2013, HIGH ALT MED BIOL, V14, P334, DOI 10.1089/ham.2013.1030; Malle C, 2016, HIGH ALT MED BIOL, V17, P359, DOI 10.1089/ham.2016.0022; McMorris T, 2017, NEUROSCI BIOBEHAV R, V74, P225, DOI 10.1016/j.neubiorev.2017.01.019; Merz TM, 2013, EUR J APPL PHYSIOL, V113, P2025, DOI 10.1007/s00421-013-2635-6; Moosbrugger H, 2011, FAIR 2 FRANKFURTER A, V2; Niedermeier M, 2017, PHYSIOL BEHAV, V173, P236, DOI 10.1016/j.physbeh.2017.02.018; Ochi G, 2018, J PHYSIOL SCI, V68, P847, DOI 10.1007/s12576-018-0603-y; Ozeki K, 2015, INT J BIOMETEOROL, V59, P447, DOI 10.1007/s00484-014-0859-8; Pavlicek V, 2005, AVIAT SPACE ENVIR MD, V76, P28; Petermann F, 2011, Z PSYCHIATR PSYCH PS, V59, P325, DOI 10.1024/1661-4747/a000088; Petrassi FA, 2012, AVIAT SPACE ENVIR MD, V83, P975, DOI 10.3357/ASEM.3315.2012; Pilmanis AA, 2016, AEROSP MED HUM PERF, V87, P596, DOI 10.3357/AMHP.4558.2016; Pramsohler S, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0362-3; Roach EB, 2014, NEUROREPORT, V25, P814, DOI 10.1097/WNR.0000000000000169; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Roach RC, 2018, HIGH ALT MED BIOL, V19, P4, DOI 10.1089/ham.2017.0164; Roeggla G, 1996, J ROY SOC MED, V89, P141, DOI 10.1177/014107689608900307; SAVOUREY G, 1995, AVIAT SPACE ENVIR MD, V66, P963; Seo Y, 2015, HIGH ALT MED BIOL, V16, P298, DOI 10.1089/ham.2015.0027; Sharma VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101448; Singh S B, 2003, Indian J Physiol Pharmacol, V47, P52; Stivalet P, 2000, ERGONOMICS, V43, P474, DOI 10.1080/001401300184350; Tomporowski PD, 2007, INT J SPORTS MED, V28, P891, DOI 10.1055/s-2007-965004; Uebel-von Sandersleben H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178866; Virues-Ortega J, 2006, DEVELOPMENTAL SCI, V9, P400, DOI 10.1111/j.1467-7687.2006.00505.x; Virues-Ortega Javier, 2004, Neuropsychology Review, V14, P197; Vollenweider FX, 2007, NEUROPSYCHOPHARMACOL, V32, P1876, DOI 10.1038/sj.npp.1301324; Wagner DR, 2007, HIGH ALT MED BIOL, V8, P27, DOI 10.1089/ham.2006.0814; Wagner DR, 2012, HIGH ALT MED BIOL, V13, P245, DOI 10.1089/ham.2012.1030; Wang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04443; West JB, 2013, HIGH ALT MED BIOL, V14, P191, DOI 10.1089/ham.2013.1431; West JB, 2011, HIGH ALT MED BIOL, V12, P23, DOI 10.1089/ham.2010.1068; Westhoff K, 2003, DIAGNOSTICA, V49, P110, DOI 10.1026//0012-1924.49.3.110; Wickens C. D., 2015, J HUMAN PERFORMANCE, V12, P1, DOI [10.7771/2327-2937.1065, DOI 10.7771/2327-2937.1065]; Yan XA, 2011, EXP BRAIN RES, V208, P437, DOI 10.1007/s00221-010-2494-x; Zillmer E., 2010, D2 TEST ATTENTION	62	14	14	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205285	10.1371/journal.pone.0205285	http://dx.doi.org/10.1371/journal.pone.0205285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281651	gold, Green Published, Green Submitted			2022-12-26	WOS:000446342400088
J	Yousseu, FBS; Nemg, FBS; Ngouanet, SA; Mekanda, FMO; Demanou, M				Yousseu, Francine Berlange Sado; Nemg, Fredy Brice Simo; Ngouanet, Sandra Ateutchia; Mekanda, Franck Martin Obam; Demanou, Maurice			Detection and serotyping of dengue viruses in febrile patients consulting at the New-Bell District Hospital in Douala, Cameroon	PLOS ONE			English	Article							CHIKUNGUNYA-VIRUS; ARBOVIRAL INFECTIONS; ANGOLA; SEROPREVALENCE; OUTBREAK	Arboviruses are a major public health problem worldwide and are predominantly present in intertropical areas. Chikungunya, dengue and zika viruses have been implicated in recent epidemics in Asia, America and Africa. In Cameroon, data on these viruses are fragmentary. The purpose of this study was to determine the frequency of detection of these three viruses in febrile patients in Douala, Cameroon. A cross-sectional and descriptive study was conducted from March to April 2017 at the New-Bell District Hospital in Douala. Blood samples were collected from febrile patients and tested for malaria infections using Rapid Diagnostic test. Plasma harvested was later analyzed for the presence of chikungunya, dengue and zika viruses by a Trioplex real-time RT-PCR at Centre Pasteur of Cameroon. A total of 114 participants were included, of which 63.2% were females, reflecting a sex ratio (female/male) of 1.7. The median age was 26 years, range [0.25-81]. Eight (7%) of the 114 participants were infected with Dengue virus (DENV) among which 5 were identified as serotype 1. No cases of infection by either Zika virus or Chikungunya virus were detected. Three cases of dengue-malaria co-infection (13%) were recorded. No association was found between socio-demographic factors and dengue infection. The phylogenetic analysis of the partial envelope E gene showed that all the five DENV serotype 1 samples belonged to sub-type V, similarly to strains from West African countries, particularly those from Nigeria, Senegal and Cote d'Ivoire. This study showed the circulation of DENV serotype 1 in febrile patients and raises the alarm for the establishment of a sustained surveillance system to detect cases and prevent potential outbreaks in Cameroon. The existence of dengue-malaria co-infections suggests that surveillance of arboviruses should not be limited to febrile, non-malarial cases.	[Yousseu, Francine Berlange Sado; Nemg, Fredy Brice Simo; Mekanda, Franck Martin Obam; Demanou, Maurice] CPC, Natl Reference Lab Chikungunya & Dengue, Dept Virol, Yaounde, Centre, Cameroon; [Yousseu, Francine Berlange Sado; Ngouanet, Sandra Ateutchia] Univ Dschang, Dept Biomed Sci, Dschang, West, Cameroon		Demanou, M (corresponding author), CPC, Natl Reference Lab Chikungunya & Dengue, Dept Virol, Yaounde, Centre, Cameroon.	demanou@pasteur-yaounde.org		Demanou, Maurice/0000-0002-9275-0874				Abreu C, 2016, J CLIN VIROL, V79, P77, DOI 10.1016/j.jcv.2016.04.011; Achonduh-Atijegbe OA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1996-y; Ageep AK, 2006, SAUDI MED J, V27, P1711; [Anonymous], CDC TRIOPL REAL TIM; [Anonymous], WEEKL B OUTBR OTH EM; Ayorinde AF, 2016, J INFECT PUBLIC HEAL, V9, P52, DOI 10.1016/j.jiph.2015.06.009; Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006; Demanou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002950; Demanou Maurice, 2010, BMC Res Notes, V3, P128, DOI 10.1186/1756-0500-3-128; Epelboin L, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax028; Esposito S, 2012, EUR J CLIN MICROBIOL, V31, P3251, DOI 10.1007/s10096-012-1692-9; Fokam E B, 2010, East Afr Med J, V87, P262; Fontenille D, 2001, EMERG INFECT DIS, V7, P1066, DOI 10.3201/eid0706.010631; Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018; Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686; Gulati S, 2012, SCAND J INFECT DIS, V44, P522, DOI 10.3109/00365548.2012.669044; Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182; Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078; Lefkowitz EJ, 2018, NUCLEIC ACIDS RES, V46, pD708, DOI 10.1093/nar/gkx932; Mamoudou Savadogo, 2016, Pan Afr Med J, V23, P168, DOI 10.11604/pamj.2016.23.168.9234; Masson E, 2018, FIEVRE JAUNE DENGUE; Maurice D, 2015, VIROL SIN, V30, P470, DOI 10.1007/s12250-015-3663-7; Monamele GC, 2018, PAN AFR MED J, V29, DOI 10.11604/pamj.2018.29.227.15316; Ndip LM, 2004, EMERG INFECT DIS, V10, P432, DOI 10.3201/eid1003.020713; Ong SH, 2008, INFECT GENET EVOL, V8, P191, DOI 10.1016/j.meegid.2007.12.005; Parreira R, 2014, EUROSURVEILLANCE, V19, P7; Parreira R, 2014, J INFECT DEV COUNTR, V8, P1210, DOI 10.3855/jidc.4910; Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500; Rodhain F, 1996, B SOC PATHOL EXOT, V89, P87; Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005496	32	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204143	10.1371/journal.pone.0204143	http://dx.doi.org/10.1371/journal.pone.0204143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281633	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400043
J	de Boer, HR; Pool, M; Joosten, E; Everts, M; Samplonius, DF; Helfrich, W; Groen, HJM; van Cooten, S; Fusetti, F; Fehrmann, RSN; de Vries, EGE; van Vugt, MATM				de Boer, H. Rudolf; Pool, Martin; Joosten, Esmee; Everts, Marieke; Samplonius, Douwe F.; Helfrich, Wijnand; Groen, Harry J. M.; van Cooten, Suzanne; Fusetti, Fabrizia; Fehrmann, Rudolf S. N.; de Vries, Elisabeth G. E.; van Vugt, Marcel A. T. M.			Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition	ONCOGENE			English	Article							LUNG-CANCER; UP-REGULATION; MET AMPLIFICATION; STAT3 ACTIVATION; DRUG DEVELOPMENT; EXPRESSION; RESISTANCE; FAMILY; GEFITINIB; PROGNOSIS	Tumor responses to cancer therapeutics are generally monitored every 2-3 months based on changes in tumor size. Dynamic biomarkers that reflect effective engagement of targeted therapeutics to the targeted pathway, so-called "effect sensors", would fulfill a need for non-invasive, drug-specific indicators of early treatment effect. Using a proteomics approach to identify effect sensors, we demonstrated MUC1 upregulation in response to epidermal growth factor receptor (EGFR)targeting treatments in breast and lung cancer models. To achieve this, using semi-quantitative mass spectrometry, we found MUC1 to be significantly and durably upregulated in response to erlotinib, an EGFR-targeting treatment. MUC1 upregulation was regulated transcriptionally, involving PI3K-signaling and STAT3. We validated these results in erlotinib-sensitive human breast and non-small lung cancer cell lines. Importantly, erlotinib treatment of mice bearing SUM149 xenografts resulted in increased MUC1 shedding into plasma. Analysis of MUC1 using serial blood sampling may therefore be a new, relatively non-invasive tool to monitor early and drug-specific effects of EGFR-targeting therapeutics.	[de Boer, H. Rudolf; Pool, Martin; Joosten, Esmee; Everts, Marieke; van Cooten, Suzanne; Fehrmann, Rudolf S. N.; de Vries, Elisabeth G. E.; van Vugt, Marcel A. T. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Samplonius, Douwe F.; Helfrich, Wijnand] Univ Groningen, Univ Med Ctr Groningen, Dept Surg Oncol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Groen, Harry J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Fusetti, Fabrizia] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, Netherlands Prote Ctr, Groningen, Netherlands; [Fusetti, Fabrizia] Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	van Vugt, MATM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	m.vugt@umcg.nl	Groen, Harry/AAP-2242-2021; Institute, Zernike/W-7033-2019; Fehrmann, Rudolf/E-2551-2011	Fehrmann, Rudolf/0000-0002-7516-315X; de Boer, Harmen Rudolf/0000-0002-8386-8184; Pool, Martin/0000-0002-4892-3109; Groen, Harry J.M./0000-0002-2978-5265; de Vries, Elisabeth/0000-0002-8949-7425	European Research Council (ERC-Advanced Grant) [ERC-2011-293-445]	European Research Council (ERC-Advanced Grant)(European Research Council (ERC))	We thank members of the Medical Oncology Department and Cancer Research Center Groningen for helpful discussions. This work is financially supported by the European Research Council (ERC-Advanced Grant ERC-2011-293-445 to E.G.E.d.V.). E.G. E.d.V. and M.A.T.M.v.V. conceived the study. H.R.d.B., E.J.,S.v.C., and M.E. designed and performed in vitro experiments. E.J. and F.F. performed MS experiments and analysis. R.S.N.F. and H.R.d.B. performed pathway analysis. M.P., D.F.S., and W.H. designed and manufactured molecular imaging tools. H.R.d.B. and M.P. performed in vivo experiments. H.R.d.B., E.G. E.d.V., and M.A.T.M.v.V. wrote the manuscript and all authors contributed to editing of the manuscript. The mass spectrometry proteomics data have been deposited to the Proteome-Xchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository 51 with the dataset identifier PXD005985.	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bearz A, 2007, INT J BIOL MARKER, V22, P307, DOI 10.1177/172460080702200411; Busse D, 2000, J BIOL CHEM, V275, P6987, DOI 10.1074/jbc.275.10.6987; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; D'Alessandro R, 2001, BREAST CANCER RES TR, V68, P9, DOI 10.1023/A:1017903724176; de Vries EGE, 2015, J CLIN ONCOL, V33, P2585, DOI 10.1200/JCO.2015.61.6425; de Vries EGE, 2011, CANCER DISCOV, V1, P25, DOI 10.1158/2159-8274.CD-11-0051; Duffy MJ, 2015, ADV CLIN CHEM, V71, P1, DOI [10.1016/bs.acc.2015.05.001, 10.1016/B978-0-12-801401-1.00001-3]; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Fujiwara Y, 2008, LUNG CANCER, V59, P81, DOI 10.1016/j.lungcan.2007.07.018; Gaemers IC, 2001, J BIOL CHEM, V276, P6191, DOI 10.1074/jbc.M009449200; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Heijink AM, 2015, P NATL ACAD SCI USA, V112, P15160, DOI 10.1073/pnas.1505283112; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Ishikawa N, 2008, INT J CANCER, V122, P2612, DOI 10.1002/ijc.23411; Kani K, 2012, MOL CANCER THER, V11, P1071, DOI 10.1158/1535-7163.MCT-11-0852; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Kovarik A, 1996, J BIOL CHEM, V271, P18140, DOI 10.1074/jbc.271.30.18140; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Lee SI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r76; Lopez JS, 2017, NAT REV CLIN ONCOL, V14, P57, DOI 10.1038/nrclinonc.2016.96; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Petrylak DP, 2006, J NATL CANCER I, V98, P516, DOI 10.1093/jnci/djj129; Pool M, 2017, EUR J NUCL MED MOL I, V44, P1328, DOI 10.1007/s00259-017-3672-x; Pool M, 2017, THERANOSTICS, V7, P2111, DOI 10.7150/thno.17934; Pool M, 2016, ONCOTARGET, V7, P68111, DOI 10.18632/oncotarget.11827; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Savage P, 2017, CELL REP, V21, P1140, DOI 10.1016/j.celrep.2017.10.015; Sequist LV, 2013, J CLIN ONCOL, V31; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Starsichova A, 2010, CELL SIGNAL, V22, P1734, DOI 10.1016/j.cellsig.2010.06.014; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Ueno NT, 2011, J CANCER, V2, P324, DOI 10.7150/jca.2.324; Vargas AJ, 2016, NAT REV CANCER, V16, P525, DOI 10.1038/nrc.2016.56; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; White DE, 2006, CANCER RES, V66, P11594, DOI 10.1158/0008-5472.CAN-06-4138; Yamasaki F, 2007, MOL CANCER THER, V6, P2168, DOI 10.1158/1535-7163.MCT-06-0514	51	7	7	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2019	38	9					1477	1488		10.1038/s41388-018-0522-7	http://dx.doi.org/10.1038/s41388-018-0522-7			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN1KL	30305724	Green Published			2022-12-26	WOS:000459945800008
J	Ali, A; Biswas, A; Pal, M				Ali, Asif; Biswas, Anindya; Pal, Mahadeb			HSF1 mediated TNF- production during proteotoxic stress response pioneers proinflammatory signal in human cells	FASEB JOURNAL			English	Article						heat shock response; NF-B; heat shock elements; LEF1; TNFR1	NF-KAPPA-B; FACTOR-ALPHA GENE; HEAT-SHOCK RESPONSE; PROTEIN-QUALITY CONTROL; TRANSCRIPTION FACTOR; NUCLEAR-FACTOR; DNA-BINDING; ACTIVATION; EXPRESSION; INFLAMMATION	The proteotoxic stress response that safeguards the cellular proteome from various stressors was shown to activate NF-B signaling pathways (NBS) with an underlying mechanism that is poorly understood. We show here that the TNF- gene, a pleiotropic NBS inducer, is a direct target of heat shock factor 1 (HSF1). Human HSF1 drives this process by assembling a multiprotein activation complex at a heat shock element (HSE) located at the 3-UTR of the TNF- gene (HSE5). HSF1 associated with the HSE5 at the TNF- 3-UTR communicates with the promoter through chromatin looping by recruiting lymphoid enhancer-binding factor 1 at an adjacent Wnt-responsive element through its transactivation domain. TNF- thus produced guides the activation of NBS by acting through TNF- receptor 1 (TNFR1). Notably, cells with TNFR1(-/-) background or masked HSE5 through Clustered Regularly Interspaced Short Palindromic Repeats/dead CRISPR-associated protein 9 were defective in NBS and exhibited marked alteration in cellular biology, which includes loss of ability of cancer cells to migrate, to clear the protein aggregates, and associated toxicity upon heat shock. For the first time, our results suggest that TNF- thus produced pioneers the proinflammatory signal during proteotoxic stress response with an important implication for inflammation and cancer.Ali, A., Biswas, A., Pal, M. HSF1 mediated TNF- production during proteotoxic stress response pioneers proinflammatory signal in human cells.	[Ali, Asif; Pal, Mahadeb] Bose Inst, Div Mol Med, Kolkata, India; [Biswas, Anindya] Bose Inst, Dept Biochem, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Pal, M (corresponding author), Bose Inst, P1-12 CIT Scheme VIIM, Kolkata 700054, India.	mahadeb@jcbose.ac.in		Biswas, Anindya/0000-0003-1645-2856; ali, asif/0000-0001-8520-857X	SERB, DBT; Bose Institute plan program IV	SERB, DBT; Bose Institute plan program IV(Department of Science & Technology (India))	The authors thank Christian Buske (University Hospital Ulm, Ulm, Germany) for LEF1 shRNA construct, Jia-Da Li (Central South University, Changsha, China) for HA-LEF1 expression construct, Lajos Haracska (Institute of Genetics, Biological Research Center, Szeged, Hungary) for HLTF shRNA construct, Akira Nakai (Osaka University, Osaka, Japan) for human GST-HSF1 fusion constructs, and Jin-Soo Kim (Seoul University, Seoul, Korea) for the HEK293 TNFR1<SUP>-/-</SUP> cell line. Kind help from Subrata Sau (Bose Institute) during DNA footprinting experiment is appreciated. Thanks are due to Don Luse (Cleveland Clinic, Cleveland, OH, USA), George Stark (Cleveland Clinic, Cleveland, OH, USA), and Katerina Gurova (Roswell Park Cancer Institute, Buffalo, NY, USA) for their comments on this work. The authors appreciate the valuable comments from Shamila Sarwar (Bose Institute) on the manuscript editing. The authors thank Katerina Gurova for SSRP1 siRNA and Vinod Kumar Nelson (Bose Institute) for azadiradione. The authors thank Srabani Pal (BioBharati LifeScience) for her expert help during some plasmid construction used in the study. The authors also thank R. Chattopadhyay (Bose Institute), Zhumur Ghosh (Bose Institute), and Koustav Pal (Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India) for their comments. The work was supported by funding from SERB, DBT, and Bose Institute plan program IV. A.A. is a CSIR ad hoc fellow. The authors declare no conflicts of interest.	AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Brunquell J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2837-5; Bunch H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10191; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Chen K, 2017, MOL ONCOL, V11, P1475, DOI 10.1002/1878-0261.12116; Chowdhary S, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00292-17; Coccia M, 2017, P NATL ACAD SCI USA, V114, P1045, DOI 10.1073/pnas.1616112114; Dai CK, 2012, J CELL PHYSIOL, V227, P2982, DOI 10.1002/jcp.24017; Ding QX, 2002, J BIOL CHEM, V277, P13935, DOI 10.1074/jbc.M107706200; Dokladny K, 2015, AUTOPHAGY, V11, P200, DOI 10.1080/15548627.2015.1009776; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; Fujimoto M, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00051-18; Fujimoto M, 2012, MOL CELL, V48, P182, DOI 10.1016/j.molcel.2012.07.026; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Grossi V, 2018, NUCLEIC ACIDS RES, V46, P5587, DOI 10.1093/nar/gky331; Grumolato L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003603; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hazra J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168165; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Holwerda Sjoerd, 2012, Frontiers in Genetics, V3, P217, DOI 10.3389/fgene.2012.00217; Hunter P, 2012, EMBO REP, V13, P968, DOI 10.1038/embor.2012.142; Janus P, 2015, MOL GENET GENOMICS, V290, P1979, DOI 10.1007/s00438-015-1055-1; Jash A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040828; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; KRAMER B, 1995, J BIOL CHEM, V270, P6577; Kremer SB, 2009, J BIOL CHEM, V284, P32914, DOI 10.1074/jbc.M109.058610; Kretz-Remy C, 2001, J BIOL CHEM, V276, P43723, DOI 10.1074/jbc.M010821200; Kwon J, 1996, J BIOL CHEM, V271, P22383, DOI 10.1074/jbc.271.37.22383; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Laramie JM, 2008, SHOCK, V29, P623, DOI 10.1097/SHK.0b013e318157f33c; Li L, 2015, MOL CELL, V58, P216, DOI 10.1016/j.molcel.2015.02.023; Li Y, 2015, ONCOTARGET, V6, P2421, DOI 10.18632/oncotarget.2965; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lis JT, 2000, GENE DEV, V14, P792; Liu YN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13547; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Markovina S, 2008, MOL CANCER RES, V6, P1356, DOI 10.1158/1541-7786.MCR-08-0108; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nivon M, 2016, MOL BIOL CELL, V27, P1712, DOI 10.1091/mbc.E15-12-0835; Nivon M, 2012, J CELL SCI, V125, P1141, DOI 10.1242/jcs.091041; Pal S, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-23; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; Ramesh V, 1996, J MOL BIOL, V260, P22, DOI 10.1006/jmbi.1996.0379; Rao R, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.5297.5297; Rossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031304; Rossi A, 2010, J BIOL CHEM, V285, P13607, DOI 10.1074/jbc.M109.082693; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; Sullivan EK, 2001, MOL CELL BIOL, V21, P5826, DOI 10.1128/MCB.21.17.5826-5837.2001; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Ting AT, 2016, TRENDS IMMUNOL, V37, P535, DOI 10.1016/j.it.2016.06.002; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; Tsytsykova AV, 2002, MOL CELL BIOL, V22, P2620, DOI 10.1128/MCB.22.8.2620-2631.2002; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; Vera M, 2014, ELIFE, V3, DOI 10.7554/eLife.03164; Vihervaara A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00151-0; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xu WP, 2011, CANCER CELL, V20, P281, DOI 10.1016/j.ccr.2011.08.020; Yu HX, 2007, CARDIOVASC DRUG REV, V25, P175, DOI 10.1111/j.1527-3466.2007.00011.x; Yun K, 2009, J IMMUNOL, V183, P5129, DOI 10.4049/jimmunol.0802744; Zhou Z., 2017, CELL PROLIF, V50	79	7	7	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2621	2635		10.1096/fj.201801482R	http://dx.doi.org/10.1096/fj.201801482R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307772				2022-12-26	WOS:000457296600087
J	Okamoto, M; Fukushima, Y; Kouwaki, T; Daito, T; Kohara, M; Kida, H; Oshiumi, H				Okamoto, Masaaki; Fukushima, Yoshimi; Kouwaki, Takahisa; Daito, Takuji; Kohara, Michinori; Kida, Hiroshi; Oshiumi, Hiroyuki			MicroRNA-451a in extracellular, blood-resident vesicles attenuates macrophage and dendritic cell responses to influenza whole-virus vaccine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; RIG-I; CIRCULATING MICRORNAS; SPLIT-PRODUCT; IMMUNE CELLS; MECHANISM; EXOSOMES; DIFFERENTIATION; RECOGNITION; EXPRESSION	The innate immune system is important for the efficacy of vaccines, but excessive innate immune responses can cause adverse reactions after vaccination. Extracellular vesicles (EVs) are enriched in the blood and can deliver functional RNAs, such as microRNAs (miRNAs), to recipient cells, thereby mediating intercellular communication. However, the role of EVs in controlling the innate immune responses to vaccines has not been fully elucidated. Here, we found that miR-451a is abundant in human serum EVs and that its presence in blood-circulating EVs affects the innate immune responses of macrophages and dendritic cells to inactivated whole-virus vaccines (WV) against influenza. miR-451a in human serum EVs was stable for a week in healthy subjects, and its levels gradually fluctuated over several months. miR-451a within serum EVs was internalized into serum-cultured macrophages and dendritic cells and reduced endogenous 14-3-3 zeta protein levels and decreased the expression of type I IFN and interleukin 6 in response to WV stimulation. miR-451a levels in blood-circulating EVs were positively correlated with intracellular miR-451a levels in mouse splenic CD11c(+) cells and inversely correlated with the innate immune response to inactivated WV in vivo. These findings suggest that miR-451a in circulating EVs is internalized into recipient cells in vivo and that this internalization results in an attenuation of the innate immune response to WV. Moreover, a microarray analysis identified several other miRNAs that affect the macrophage response to inactivated WV. Our results reveal that miR-NAs in circulating EVs significantly modify the responses of macrophages and dendritic cells to inactivated WV.	[Okamoto, Masaaki; Fukushima, Yoshimi; Kouwaki, Takahisa; Oshiumi, Hiroyuki] Kumamoto Univ, Dept Immunol, Grad Sch Med Sci, Fac Life Sci, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Daito, Takuji; Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, GI CoRE Global Stn Zoonosis Control, Kita Ku, North 20,West 10, Sapporo, Hokkaido 0010020, Japan; [Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 1568506, Japan; [Oshiumi, Hiroyuki] Japan Sci & Technol Agcy JST, PRESTO, 1-1-1 Honjo, Kumamoto 8608556, Japan	Kumamoto University; Hokkaido University; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Kumamoto University	Oshiumi, H (corresponding author), Kumamoto Univ, Dept Immunol, Grad Sch Med Sci, Fac Life Sci, 1-1-1 Honjo, Kumamoto 8608556, Japan.	oshiumi@kumamoto-u.ac.jp		Oshiumi, Hiroyuki/0000-0003-1567-8722	Ministry of Education, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED), JST PREST, Tokyo Metropolitan Government; Takeda Science Foundation; Kao Research Council for the Study of Healthcare Science; NOVARTIS Foundation (Japan) for the Promotion of Science; Uehara Memorial Foundation; Japanese Association for Complement Research; Waksman Foundation of Japan; Daiichi Sankyo Foundation of Life Science	Ministry of Education, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED), JST PREST, Tokyo Metropolitan Government; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kao Research Council for the Study of Healthcare Science; NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Uehara Memorial Foundation(Uehara Memorial Foundation); Japanese Association for Complement Research; Waksman Foundation of Japan(Waksman Foundation of Japan Inc.); Daiichi Sankyo Foundation of Life Science	This work was supported in part by grants-in-aid from the Ministry of Education, Science, and Technology (MEXT), a grant-in-aid from the Japan Agency for Medical Research and Development (AMED), JST PREST, Tokyo Metropolitan Government, the Takeda Science Foundation, Kao Research Council for the Study of Healthcare Science, The NOVARTIS Foundation (Japan) for the Promotion of Science, The Uehara Memorial Foundation, the Japanese Association for Complement Research, the Waksman Foundation of Japan, and the Daiichi Sankyo Foundation of Life Science. The authors declare that they have no conflicts of interest with the contents of this article.	Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andreu Z, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.31655; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Atay S, 2011, AM J REPROD IMMUNOL, V65, P65, DOI 10.1111/j.1600-0897.2010.00880.x; Balusu S, 2016, EMBO MOL MED, V8, P1162, DOI 10.15252/emmm.201606271; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chang CK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188214; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dinarello CA, 2004, J ENDOTOXIN RES, V10, P201, DOI 10.1179/096805104225006129; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Grasedieck S, 2013, BLOOD, V121, P4977, DOI 10.1182/blood-2013-01-480079; GROSS PA, 1977, NEW ENGL J MED, V296, P567, DOI 10.1056/NEJM197703102961012; GROSS PA, 1977, J INFECT DIS, V136, P623, DOI 10.1093/infdis/136.5.623; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Hur W, 2015, INT J BIOCHEM CELL B, V64, P265, DOI 10.1016/j.biocel.2015.04.016; Koppers-Lalic D, 2014, CELL REP, V8, P1649, DOI 10.1016/j.celrep.2014.08.027; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kouwaki T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030666; Kouwaki T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00335; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Luron L, 2012, EUR J IMMUNOL, V42, P1030, DOI 10.1002/eji.201141969; Moldovan Leni, 2013, Methods Mol Biol, V1024, P129, DOI 10.1007/978-1-62703-453-1_10; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Nguyen TA, 2017, IMMUNITY, V47, P498, DOI 10.1016/j.immuni.2017.08.007; Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669; Pal S, 2011, VIRUS RES, V158, P12, DOI 10.1016/j.virusres.2011.02.017; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; Paul R, 2003, BRAIN, V126, P1873, DOI 10.1093/brain/awg171; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Rhorer J, 2009, VACCINE, V27, P1101, DOI 10.1016/j.vaccine.2008.11.093; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Rosenberger CM, 2012, J IMMUNOL, V189, P5965, DOI 10.4049/jimmunol.1201437; Santangelo L, 2016, CELL REP, V17, P799, DOI 10.1016/j.celrep.2016.09.031; Sato M, 2001, CYTOKINE GROWTH F R, V12, P133, DOI 10.1016/S1359-6101(00)00032-0; Schichl YM, 2009, J BIOL CHEM, V284, P29571, DOI 10.1074/jbc.M109.031237; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shurtleff MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19276; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Smyth LA, 2015, IMMUNOLOGY, V144, P197, DOI 10.1111/imm.12390; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Swaminathan S, 2013, BIOCHEM BIOPH RES CO, V434, P228, DOI 10.1016/j.bbrc.2013.03.046; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Uno S, 2011, MICROBIOL IMMUNOL, V55, P783, DOI 10.1111/j.1348-0421.2011.00381.x; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wang YM, 2014, VIROLOGY, V449, P53, DOI 10.1016/j.virol.2013.11.009; Xiang MQ, 2014, BIOCHEM BIOPH RES CO, V454, P210, DOI 10.1016/j.bbrc.2014.10.064; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xie JX, 2017, GENE, V627, P1, DOI 10.1016/j.gene.2017.06.003; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	64	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18585	18600		10.1074/jbc.RA118.003862	http://dx.doi.org/10.1074/jbc.RA118.003862			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30282637	Green Published, hybrid			2022-12-26	WOS:000458467300014
J	Mathew, J; Danion, FR				Mathew, James; Danion, Frederic R.			Ups and downs in catch-up saccades following single-pulse TMS-methodological considerations	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PURSUIT EYE-MOVEMENTS; PRIMARY MOTOR CORTEX; SMOOTH-PURSUIT; COIL ORIENTATION; HEAD MOVEMENTS; CONTROL-SYSTEM; CEREBELLUM; TRACKING; COORDINATION	Transcranial magnetic stimulation (TMS) can interfere with smooth pursuit or with saccades initiated from a fixed position toward a fixed target, but little is known about the effect of TMS on catch-up saccade made to assist smooth pursuit. Here we explored the effect of TMS on catch-up saccades by means of a situation in which the moving target was driven by an external agent, or moved by the participants' hand, a condition known to decrease the occurrence of catch-up saccade. Two sites of stimulation were tested, the vertex and M1 hand area. Compared to conditions with no TMS, we found a consistent modulation of saccadic activity after TMS such that it decreased at 40-100ms, strongly resumed at 100-160ms, and then decreased at 200-300ms. Despite this modulatory effect, the accuracy of catch-up saccade was maintained, and the mean saccadic activity over the 0-300ms period remained unchanged. Those findings are discussed in the context of studies showing that single-pulse TMS can induce widespread effects on neural oscillations as well as perturbations in the latency of saccades during reaction time protocols. At a more general level, despite challenges and interpretational limitations making uncertain the origin of this modulatory effect, our study provides direct evidence that TMS over presumably non-oculomotor regions interferes with the initiation of catch-up saccades, and thus offers methodological considerations for future studies that wish to investigate the underlying neural circuitry of catch-up saccades using TMS.	[Mathew, James; Danion, Frederic R.] Aix Marseille Univ, Inst Neurosci Timone, CNRS, UMR 7289, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Danion, FR (corresponding author), Aix Marseille Univ, Inst Neurosci Timone, CNRS, UMR 7289, Marseille, France.	frederic.danion@univ-amu.fr	Danion, Frederic/ABS-1799-2022	mathew, james/0000-0002-5315-5212	European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie [642961]	European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie	This work was part of Innovative Training Network 'Perception and Action in Complex Environment' (http://itn-pace.eu/) that has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 642961. This paper reflects only the authors' view and that the Research Executive Agency (REA) of the European Commission is not responsible for any use that may be made of the information it contains. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL RW, 1972, J EXP PSYCHOL, V96, P92, DOI 10.1037/h0033457; Ariff G, 2002, J NEUROSCI, V22, P7721; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Buttner-Ennever JA, 2004, HUMAN NERVOUS SYSTEM, P479; Carlsen AN, 2004, J MOTOR BEHAV, V36, P253, DOI 10.3200/JMBR.36.3.253-264; Castellote JM, 2007, EXP BRAIN RES, V177, P129, DOI 10.1007/s00221-006-0659-4; Chen J, 2016, J NEUROPHYSIOL, V116, P18, DOI 10.1152/jn.00184.2016; Colnaghi S, 2010, FUNCT NEUROL, V25, P165; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1646, DOI 10.1152/jn.00432.2001; de Xivry JJO, 2007, J PHYSIOL-LONDON, V584, P11, DOI 10.1113/jphysiol.2007.139881; de Xivry JJO, 2006, J NEUROPHYSIOL, V95, P418, DOI 10.1152/jn.00596.2005; Fuggetta G, 2005, NEUROIMAGE, V27, P896, DOI 10.1016/j.neuroimage.2005.05.013; Gagnon D, 2006, J NEUROSCI, V26, P458, DOI 10.1523/JNEUROSCI.2789-05.2006; Goffart L, 2017, PROG BRAIN RES, V236, P243, DOI 10.1016/bs.pbr.2017.07.009; Haarmeier T, 2010, CEREB CORTEX, V20, P2234, DOI 10.1093/cercor/bhp285; Haith AM, 2016, J NEUROSCI, V36, P3007, DOI 10.1523/JNEUROSCI.3245-15.2016; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Krauzlis RJ, 2000, J NEUROPHYSIOL, V84, P876, DOI 10.1152/jn.2000.84.2.876; Landelle C, 2016, J NEUROPHYSIOL, V116, P1859, DOI 10.1152/jn.00007.2016; MATHER J, 1975, EXP BRAIN RES, V24, P103; Mathew J, 2017, J NEUROSCI, V37, P9730, DOI 10.1523/JNEUROSCI.0564-17.2017; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Nagel M, 2003, J NEUROL SCI, V213, P35, DOI 10.1016/S0022-510X(03)00145-X; Nagel M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-89; Nuding U, 2009, CEREB CORTEX, V19, P1144, DOI 10.1093/cercor/bhn162; Nyffeler T, 2004, EUR J NEUROSCI, V20, P2240, DOI 10.1111/j.1460-9568.2004.03667.x; Ohtsuka K, 1998, BRAIN, V121, P429, DOI 10.1093/brain/121.3.429; Paus T, 2001, J NEUROPHYSIOL, V86, P1983, DOI 10.1152/jn.2001.86.4.1983; PRIORI A, 1993, BRAIN, V116, P355, DOI 10.1093/brain/116.2.355; Ro T, 1997, J COGNITIVE NEUROSCI, V9, P433, DOI 10.1162/jocn.1997.9.4.433; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Scarchilli K, 1999, NEUROSCI LETT, V265, P139, DOI 10.1016/S0304-3940(99)00224-4; STEINBACH MJ, 1968, SCIENCE, V161, P187, DOI 10.1126/science.161.3837.187; Takagi M, 1998, J NEUROPHYSIOL, V80, P1911, DOI 10.1152/jn.1998.80.4.1911; Takagi M, 2000, J NEUROPHYSIOL, V83, P2047, DOI 10.1152/jn.2000.83.4.2047; Thickbroom GW, 1996, J NEUROL SCI, V144, P114, DOI 10.1016/S0022-510X(96)00194-3; Valero-Cabre A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038674; Valls-Sole J, 1999, J PHYSIOL-LONDON, V516, P931, DOI 10.1111/j.1469-7793.1999.0931u.x; Van Der Werf YD, 2006, EXP BRAIN RES, V175, P246, DOI 10.1007/s00221-006-0548-x; Van der Werf YD, 2006, EXP BRAIN RES, V175, P231, DOI 10.1007/s00221-006-0551-2; Vercher JL, 2003, PROG BRAIN RES, V142, P203; Vernet M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00066; Xu-Wilson M, 2011, J NEUROSCI, V31, P11537, DOI 10.1523/JNEUROSCI.1584-11.2011; Zangemeister WH, 2001, ACTA OTO-LARYNGOL, P140	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205208	10.1371/journal.pone.0205208	http://dx.doi.org/10.1371/journal.pone.0205208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307976	Green Submitted, gold, Green Published			2022-12-26	WOS:000447173500047
J	Suzuki-Eguchi, N; Murata, M; Itabashi, Y; Shirakawa, K; Fukuda, M; Endo, J; Tsuruta, H; Arai, T; Hayashida, K; Shimizu, H; Fukuda, K				Suzuki-Eguchi, Noriko; Murata, Mitsushige; Itabashi, Yuji; Shirakawa, Kousuke; Fukuda, Memori; Endo, Jin; Tsuruta, Hikaru; Arai, Takahide; Hayashida, Kentaro; Shimizu, Hideyuki; Fukuda, Keiichi			Prognostic value of pre-procedural left ventricular strain for clinical events after transcatheter aortic valve implantation	PLOS ONE			English	Article							HIGH-RISK PATIENTS; CONSECUTIVE PATIENTS; DIASTOLIC FUNCTION; EJECTION FRACTION; STENOSIS; REPLACEMENT; IMPROVEMENT; MASS; OUTCOMES; IMPACT	Background Transcatheter aortic valve implantation (TAVI) is an alternative therapy for surgically high-risk patients with severe aortic stenosis (AS). Although TAVI improves survival of patients with severe AS, the mechanism of this effect remains to be clarified. We investigated the effects of TAVI on left ventricular (LV) function and identified the predictive parameters for cardiac events after TAVI. Methods and results We studied 128 patients with severe symptomatic AS who underwent TAVI. Echocardiographic assessments were performed before and after TAVI. In addition to the conventional echocardiographic parameters such as LV ejection fraction (LVEF) and LV mass index (LVMI), the LV global longitudinal strain (GLS) and early diastolic peak strain rate (SR_E) using two-dimensional speckle tracking echocardiography were also evaluated. All patients were assessed for clinical events including major adverse cardiac events and stroke according to Valve Academic Research Consortium-2 criteria. GLS, early diastolic peak velocity (e'), aortic regurgitation (AR) severity, and SR_E were significantly improved after TAVI. Thirteen patients had an event during the observational period of 591 days (median). Patients with events had higher LVMI, more severe AR, and worse GLS compared to those without events. Furthermore, receiver-operating curve analysis revealed that GLS was the strongest predictor for clinical events (p = 0.009; area under the curve, 0.73). Conclusion Preoperative LV geometric deformation and dysfunction, as a consequence of the cumulative burden of pressure overload, improved after TAVI and could predict cardiac events after TAVI.	[Suzuki-Eguchi, Noriko; Shirakawa, Kousuke; Fukuda, Memori; Endo, Jin; Tsuruta, Hikaru; Arai, Takahide; Hayashida, Kentaro; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Murata, Mitsushige] Keio Univ Hosp, Ctr Prevent Med, Tokyo, Japan; [Itabashi, Yuji] Keio Univ, Sch Med, Dept Lab Med, Tokyo, Japan; [Shimizu, Hideyuki] Keio Univ, Sch Med, Cardiovasc Surg, Tokyo, Japan; [Suzuki-Eguchi, Noriko] Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chiba, Japan	Keio University; Keio University; Keio University; Keio University; Chiba University	Murata, M (corresponding author), Keio Univ Hosp, Ctr Prevent Med, Tokyo, Japan.	muratam@keio.jp	Hayashida, Kentaro/J-5071-2014	Hayashida, Kentaro/0000-0002-1750-1982; Fukuda, Memori/0000-0003-3860-9316				Becker M, 2007, J AM SOC ECHOCARDIOG, V20, P681, DOI 10.1016/j.echo.2006.11.003; Bleiziffer S, 2009, J THORAC CARDIOV SUR, V138, P1073, DOI 10.1016/j.jtcvs.2009.07.031; Clavel MA, 2010, CIRCULATION, V122, P1928, DOI 10.1161/CIRCULATIONAHA.109.929893; Costantino MF, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-18; D'Ascenzi F, 2013, INT J CARDIOVAS IMAG, V29, P1007, DOI 10.1007/s10554-012-0175-5; Dahl JS, 2016, JACC-CARDIOVASC IMAG, V9, P519, DOI 10.1016/j.jcmg.2015.06.029; Delgado V, 2009, EUR HEART J, V30, P3037, DOI 10.1093/eurheartj/ehp351; Dobson LE, 2016, CAN J CARDIOL, V32, P1411, DOI 10.1016/j.cjca.2016.04.009; Dweck MR, 2011, J AM COLL CARDIOL, V58, P1271, DOI 10.1016/j.jacc.2011.03.064; Fuster Rafael Garcia, 2005, Interact Cardiovasc Thorac Surg, V4, P260, DOI 10.1510/icvts.2004.098194; Giannini C, 2011, AM J CARDIOVASC DIS, V1, P264; Goncalves A, 2011, EUR J ECHOCARDIOGR, V12, P790, DOI 10.1093/ejechocard/jer147; Gurvitch R, 2011, CATHETER CARDIO INTE, V78, P977, DOI 10.1002/ccd.22961; Ishizu T, 2014, HYPERTENSION, V63, P500, DOI 10.1161/HYPERTENSIONAHA.113.02149; Kasapkara HA, 2015, CARDIOL J, V22, P645, DOI 10.5603/CJ.a2015.0025; Kupari M, 2005, EUR HEART J, V26, P1790, DOI 10.1093/eurheartj/ehi290; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lefevre T, 2011, EUR HEART J, V32, P148, DOI 10.1093/eurheartj/ehq427; Mehta RH, 2001, J THORAC CARDIOV SUR, V122, P919, DOI 10.1067/mtc.2001.116558; Pasic M, 2010, J AM COLL CARDIOL, V56, P813, DOI 10.1016/j.jacc.2010.02.065; Poulsen SH, 2007, J AM SOC ECHOCARDIOG, V20, P877, DOI 10.1016/j.echo.2006.11.020; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Schattke S, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-15; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533; Van Mieghem NM, 2013, AM HEART J, V165, P183, DOI 10.1016/j.ahj.2012.11.002; Walther T, 2010, EUR HEART J, V31, P1398, DOI 10.1093/eurheartj/ehq060; Wang JW, 2007, CIRCULATION, V115, P1376, DOI 10.1161/CIRCULATIONAHA.106.662882	28	8	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205190	10.1371/journal.pone.0205190	http://dx.doi.org/10.1371/journal.pone.0205190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308001	Green Submitted, Green Published, gold			2022-12-26	WOS:000447173500045
J	Li, XC; Guo, M; Zhu, Y; Xu, XY				Li, Xingchen; Guo, Min; Zhu, Yuan; Xu, Xiangyang			The excessive length of first ray as a risk factor for hallux valgus recurrence	PLOS ONE			English	Article							METATARSAL; OSTEOTOMY	Background It is still unknown whether the excessive length of the first ray is a risk factor for hallux valgus recurrence. The purpose of this study is to clarify the relationship between the excessive length of the first ray and the recurrence of hallux valgus. Methods Between 2008 and 2011, a total of 186 feet (left 105, right 81) who underwent chevron osteotomy combined with distal soft tissue procedure in our foot and ankle center were retrospectively reviewed. A postoperative hallux valgus angle(HVA) >= 20 degrees was defined as recurrence. Patients were divided into two groups: recurrence and non-recurrence group. Weight-bearing radiographs were evaluated preoperatively and at the time of last follow-up for both groups. Radiographic parameters including the length of the great toe(P1), the length of the second toe(P2), the length distance between the first and second metatarsal (D), the hallux valgus angle(HVA) were obtained. The excessive length of the first ray(EL) was calculated using the equation of EL = P1-P2-D. Results A total of 45 patients (24.2%) had hallux valgus recurrence at the time of last follow-up with a mean follow-up of 83.7 +/- 12.1 months (range, 66-110). The mean postoperative P1 was 5.06 +/- 0.39cm for recurrence group and 4.84 +/- 0.34cm for no recurrence group(p<0.001). The mean post operative EL was 5.71 +/- 5.01 mm for recurrence group and 1.61 +/- 4.09mm for no recurrence group(p<0.001). The predictive cutoff value of postoperative P1 and postoperative EL for hallux valgus recurrence was 4.9cm [odds ratio (OR) = 8.67, p = 0.03] and 0.4cm (OR = 6.79, p = 0.001) respectively. Conclusions Significant relationships between postoperative P1, postoperative EL and hallux valgus recurrence were identified according to our radiographic results. A postoperative P1>4.9cm and postoperative EL>0.4cm can be risk factors for hallux valgus recurrence. The appreciation of the excessive length of the first ray prior to surgery may help to improve the surgical outcome.	[Li, Xingchen; Xu, Xiangyang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp North, Orthopaed Dept, Shanghai, Peoples R China; [Guo, Min] Anhui Univ, Sch Med, Anqing Hosp, Orthopaed Dept, Hefei, Anhui, Peoples R China; [Zhu, Yuan; Xu, Xiangyang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Foot & Ankle Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Anhui University; Shanghai Jiao Tong University	Xu, XY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp North, Orthopaed Dept, Shanghai, Peoples R China.; Xu, XY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Foot & Ankle Ctr, Shanghai, Peoples R China.	xu664531@hotmail.com			Shanghai Municipal Commission of Health and Family Planning [201540102]	Shanghai Municipal Commission of Health and Family Planning	This study was supported by grants from the Shanghai Municipal Commission of Health and Family Planning (Grant Number 201540102). URLs: http://www.wsjsw.gov.cn/wsj/.	Bock P, 2015, J BONE JOINT SURG AM, V97A, P1238, DOI 10.2106/JBJS.N.00971; Branthwaite H, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-28; Chi TD, 2002, FOOT ANKLE INT, V23, P722, DOI 10.1177/107110070202300808; Easley ME, 2007, FOOT ANKLE INT, V28, P748, DOI 10.3113/FAI.2007.0748; FREY C, 1991, FOOT ANKLE, V12, P1; Hofstaetter SG, 2005, J BONE JOINT SURG BR, V87B, P1507, DOI 10.1302/0301-620X.87B11.16590; Jung HG, 2005, FOOT ANKLE INT, V26, P748, DOI 10.1177/107110070502600913; Lee KT, 2014, FOOT ANKLE CLIN, V19, P361, DOI 10.1016/j.fcl.2014.06.003; Mancuso John E, 2003, J Foot Ankle Surg, V42, P319, DOI 10.1053/j.jfas.2003.09.001; Menz HB, 2005, GERONTOLOGY, V51, P346, DOI 10.1159/000086373; Munuera PV, 2008, INT ORTHOP, V32, P489, DOI 10.1007/s00264-007-0350-9; Okuda R, 2007, J BONE JOINT SURG AM, V89A, P2163, DOI 10.2106/JBJS.F.01455; Okuda R, 2011, J ORTHOP SCI, V16, P760, DOI 10.1007/s00776-011-0136-1; Okuda R, 2009, J BONE JOINT SURG AM, V91A, P1637, DOI 10.2106/JBJS.H.00796; Raikin SM, 2014, FOOT ANKLE CLIN, V19, P259, DOI 10.1016/j.fcl.2014.02.008; Roukis Thomas S, 2005, J Foot Ankle Surg, V44, P13, DOI 10.1053/j.jfas.2004.11.012; TANAKA Y, 1995, J BONE JOINT SURG AM, V77A, P205, DOI 10.2106/00004623-199502000-00006; THOMPSON FM, 1990, ORTHOPEDICS, V13, P1059; Toth K, 2007, FOOT ANKLE INT, V28, P61, DOI 10.3113/FAI.2007.0011; Wu D, 2008, FOOT ANKLE INT, V29, P464, DOI 10.3113/FAI.2008.0464	20	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205560	10.1371/journal.pone.0205560	http://dx.doi.org/10.1371/journal.pone.0205560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304018	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100107
J	Matsuno, T; Fujita, K				Matsuno, Toyomi; Fujita, Kazuo			Body inversion effect in monkeys	PLOS ONE			English	Article							TUFTED CAPUCHIN MONKEYS; FACE RECOGNITION; CEBUS-APELLA; REPRESENTATIONS; PERCEPTION; HUMANS; EXPERTISE; POSTURE; SEARCH; BODIES	Humans visually process human body images depending on the configuration of the parts. However, little is known about whether this function is evolutionarily shared with nonhuman animals. In this study, we examined the body posture discrimination performance of capuchin monkeys, a highly social platyrrhine primate, in comparison to humans. We demonstrate that, like humans, monkeys exhibit a body inversion effect: body posture discrimination is impaired by inversion, which disrupts the configural relationships of body parts. The inversion effect in monkeys was observed when human body images were used, but not when the body parts were replaced with cubic and cylindrical figures, the positions of the parts were scrambled, or only part of a body was presented. Results in human participants showed similar patterns, though they also showed the inversion effect when the cubic/cylindrical body images were used. These results provide the first evidence for configural processing of body forms in monkeys and suggest that the visual attunement to social signals mediated by body postures is conserved through the evolution of primate vision.	[Matsuno, Toyomi] Hosei Univ, Dept Econ, Machida, Tokyo, Japan; [Matsuno, Toyomi; Fujita, Kazuo] Kyoto Univ, Grad Sch Letters, Dept Psychol, Kyoto, Japan	Hosei University; Kyoto University	Matsuno, T (corresponding author), Hosei Univ, Dept Econ, Machida, Tokyo, Japan.; Matsuno, T (corresponding author), Kyoto Univ, Grad Sch Letters, Dept Psychol, Kyoto, Japan.	toyomi.matsuno@hosei.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25870794, 17300085, 20220004, 16H06301]; Japan Society for the Promotion of Science [19/9127]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported by Grants-in-Aid for Scientific Research (25870794 to TM; 17300085, 20220004, and 16H06301 to KF) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.mext.go.jp/english/), and also supported by Research Fellowship (19/9127 to TM) from the Japan Society for the Promotion of Science for Young Scientists (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2009, CURR BIOL, V19, P1270, DOI 10.1016/j.cub.2009.05.067; Anderson JR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2495; Arizpe JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169148; Barra J, 2017, COGNITION, V158, P208, DOI 10.1016/j.cognition.2016.10.018; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauser DAS, 2013, CLIN NEUROPHYSIOL, V124, P686, DOI 10.1016/j.clinph.2012.09.030; Bauser DAS, 2011, VISION RES, V51, P195, DOI 10.1016/j.visres.2010.11.007; Bosbach S, 2006, NEUROPSYCHOLOGIA, V44, P2950, DOI 10.1016/j.neuropsychologia.2006.06.018; Brandman T, 2010, J NEUROSCI, V30, P10534, DOI 10.1523/JNEUROSCI.0911-10.2010; BRUCE C, 1982, NEUROPSYCHOLOGIA, V20, P515, DOI 10.1016/0028-3932(82)90025-2; Call J., 2007, GESTURAL COMMUNICATI; Cohen J.E., 1988, STAT POWER ANAL BEHA; da Costa BLSA, 2000, VISION RES, V40, P2395, DOI 10.1016/S0042-6989(00)00104-8; Dahl CD, 2007, P R SOC B, V274, P2069, DOI 10.1098/rspb.2007.0477; Dahl CD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02504; DASSER V, 1987, ETHOLOGY, V76, P65; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Downing PE, 2004, COGNITION, V93, pB27, DOI 10.1016/j.cognition.2003.10.010; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Faraway JJ., 2005, EXTENDING LINEAR MOD; Fragaszy D. M., 2004, COMPLETE CAPUCHIN BI; Fujita K, 2002, ANIM COGN, V5, P19, DOI 10.1007/s100710100099; Fujita K, 2009, ANIM COGN, V12, P575, DOI 10.1007/s10071-009-0217-0; Harris A, 2016, PSYCHON B REV, V23, P1513, DOI 10.3758/s13423-016-1027-4; Hattori Y, 2005, J COMP PSYCHOL, V119, P335, DOI 10.1037/0735-7036.119.3.335; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Hirai M, 2007, BRAIN RES, V1165, P105, DOI 10.1016/j.brainres.2007.05.078; Hiramatsu C, 2015, VISION RES, V115, P71, DOI 10.1016/j.visres.2015.07.006; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Kirchhofer KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030913; Kuroshima H, 2008, ANIM COGN, V11, P599, DOI 10.1007/s10071-008-0150-7; Melin AD, 2013, VISION RES, V86, P87, DOI 10.1016/j.visres.2013.04.013; Minnebusch DA, 2009, J COGNITIVE NEUROSCI, V21, P865, DOI 10.1162/jocn.2009.21074; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neiworth JJ, 2007, ANIM COGN, V10, P125, DOI 10.1007/s10071-006-0045-4; O'Toole AJ, 2011, VISION RES, V51, P74, DOI 10.1016/j.visres.2010.09.035; Papeo L, 2017, PSYCHOL SCI, V28, P369, DOI 10.1177/0956797616685769; Parr L., 1999, ANIM COGN, V2, P123, DOI [10.1007/s100710050032, DOI 10.1007/S100710050032]; Parr LA, 2011, ACTA PSYCHOL, V138, P204, DOI 10.1016/j.actpsy.2011.06.005; Parr LA, 2011, PHILOS T R SOC B, V366, P1764, DOI 10.1098/rstb.2010.0358; Parron C, 2007, J EXP PSYCHOL-ANIM B, V33, P381, DOI 10.1037/0097-7403.33.4.381; Paukner A, 2009, SCIENCE, V325, P880, DOI 10.1126/science.1176269; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Pokorny JJ, 2011, ANIM COGN, V14, P839, DOI 10.1007/s10071-011-0417-2; R Core Team, 2021, R LANGUAGE ENV STAT; Reed CL, 2007, J AUTISM DEV DISORD, V37, P1576, DOI 10.1007/s10803-006-0220-0; Reed CL, 2012, PERCEPTION, V41, P436, DOI 10.1068/p7029; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P73, DOI 10.1037/0096-1523.32.1.73; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Reed CL., 2006, HUMAN BODY PERCEPTIO, P229; Ro T, 2007, VIS COGN, V15, P322, DOI 10.1080/13506280600590434; Robbins RA, 2012, Q J EXP PSYCHOL, V65, P1962, DOI 10.1080/17470218.2012.674145; Robbins RA, 2012, J EXP PSYCHOL HUMAN, V38, P1098, DOI 10.1037/a0028584; ROSENFELD SA, 1979, NEUROPSYCHOLOGIA, V17, P503, DOI 10.1016/0028-3932(79)90057-5; Saito A, 2005, AM J PRIMATOL, V67, P425, DOI 10.1002/ajp.20197; Selst VM, 1994, Q J EXP PSYCHOL-A, V47A, P631, DOI [10.1080/14640749408401131, DOI 10.1080/14640749408401131]; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Stein T, 2012, COGNITION, V125, P64, DOI 10.1016/j.cognition.2012.06.005; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Tanaka M, 2003, PRIMATES, V44, P157, DOI 10.1007/s10329-002-0022-8; Tanaka M, 2007, ANIM COGN, V10, P169, DOI 10.1007/s10071-006-0056-1; Tao WD, 2014, NEUROREPORT, V25, P1099, DOI 10.1097/WNR.0000000000000234; Taubert J, 2009, BRAIN COGNITION, V71, P187, DOI 10.1016/j.bandc.2009.09.002; TAYLER CK, 1973, BEHAVIOUR, V44, P286, DOI 10.1163/156853973X00436; Tomasello M, 2002, COGNITIVE ANIMAL, P293; Tomasello Michael, 1996, P319, DOI 10.1016/B978-012273965-1/50016-9; Tomonaga M, 2001, PSYCHOLOGIA, V44, P46; Urgesi C, 2007, J NEUROSCI, V27, P8023, DOI 10.1523/JNEUROSCI.0789-07.2007; Vannuscorps G, 2016, P NATL ACAD SCI USA, V113, P86, DOI 10.1073/pnas.1516978112; Visalberghi E, 2002, FROM ANIM ANIMAT, P471; Visalberghi E, 1990, LANGUAGE INTELLIGENC, P243; Weiss Daniel J., 2001, Animal Cognition, V3, P191, DOI 10.1007/s100710000076; Weldon KB, 2013, ANIM COGN, V16, P691, DOI 10.1007/s10071-013-0604-4; Welsh TN, 2014, COGNITION, V132, P398, DOI 10.1016/j.cognition.2014.05.003; Willems S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00618; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7; Yovel G, 2010, J EXP PSYCHOL HUMAN, V36, P759, DOI 10.1037/a0017451	79	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204353	10.1371/journal.pone.0204353	http://dx.doi.org/10.1371/journal.pone.0204353			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4VA	30303982	gold, Green Published, Green Submitted			2022-12-26	WOS:000446921100043
J	Zhang, L; Qian, HH; Fu, H				Zhang, Lei; Qian, Haihong; Fu, Hua			To be thin but not healthy - The body-image dilemma may affect health among female university students in China	PLOS ONE			English	Article							PERCEIVED WEIGHT; ADOLESCENT GIRLS; PRETERM BIRTH; UNITED-STATES; MASS INDEX; DISSATISFACTION; WOMEN; UNDERWEIGHT; EXPOSURE; ADULT	An increasing number of young girls have attached great importance to their body-image in China. Body-image dissatisfaction has resulted in increased weight loss behavior. The aim of this study was to investigate the factors that were associated with underweight body-image in female college students. Self-administered questionnaires were completed by 2,023 young female participants from eight Chinese universities. In addition, 160 participants were involved in a qualitative study. The ideal body-image and the factors that influence weight were determined using descriptive and analytical statistics. We found that 1,484 out of 2,023 participants (73.36%) had taken action to lose weight in the past six months. Among these participants, 618 (30.55%, out of 2023) participants were already underweight, and 1,161 (57.39%, out of 2023) would like to be much thinner, which would lead to more underweight individuals. Moreover, non-scientific physical activity and diets were found to lead participants to the underweight subgroup. The participants' Body Mass Index (BMI), peer advice and western culture influenced the problematic thin-ideal (ideal BMI < 18.5 was considered as the problematic thin-ideal) (P<0.05). Together, western influences leading to the "problematic thin-ideal" and "unhealthy weight-control behavior" have brought about an increased prevalence of desired underweight body-image among female college students in China, which might be harmful for their health.	[Zhang, Lei; Fu, Hua] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China; [Qian, Haihong] Fudan Univ, Sch Basic Med Sci, Shanghai, Peoples R China	Fudan University; Fudan University	Fu, H (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China.; Qian, HH (corresponding author), Fudan Univ, Sch Basic Med Sci, Shanghai, Peoples R China.	hhqian@fudan.edu.cn; hfu@fudan.edu.cn			Chinese education sciences planning foundation [ALA130003]; Shanghai Municipal Commission of Health and Family Planning [15GWZK1001]	Chinese education sciences planning foundation; Shanghai Municipal Commission of Health and Family Planning	This study was sponsored by a grant from Chinese education sciences planning foundation (ALA130003) and Shanghai Municipal Commission of Health and Family Planning (15GWZK1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anschutz DJ, 2008, HEALTH PSYCHOL, V27, P401, DOI 10.1037/0278-6133.27.4.401; Anschutz DJ, 2011, BODY IMAGE, V8, P26, DOI 10.1016/j.bodyim.2010.11.003; Anstine D, 2000, J ADOLESCENT HEALTH, V26, P338, DOI 10.1016/S1054-139X(99)00120-2; Arroyo M, 2010, ARCH LATINOAM NUTR, V60, P126; Barrett SC, 2011, REV PANAM SALUD PUBL, V29, P267, DOI 10.1590/S1020-49892011000400008; Calado M, 2011, WOMEN HEALTH ISS, V21, P390, DOI 10.1016/j.whi.2011.02.013; Chen H, 2009, DEV PSYCHOL, V45, P1618, DOI 10.1037/a0016820; Coetzee V, 2011, EAT BEHAV, V12, P72, DOI 10.1016/j.eatbeh.2010.09.006; Costa Larissa da Cunha Feio, 2010, Rev. bras. epidemiol., V13, P665, DOI 10.1590/S1415-790X2010000400011; Cousins A, 2015, JOGNN-J OBST GYN NEO, V44, P380, DOI 10.1111/1552-6909.12573; Desan C, 2009, CHINESE J PHARM TECH, V3, P7; Dittmar H, 2004, BRIT J SOC PSYCHOL, V43, P477, DOI 10.1348/0144666042565407; Ferguson CJ, 2011, REV GEN PSYCHOL, V15, P11, DOI 10.1037/a0022607; Fredrickson BL, 1997, PSYCHOL WOMEN QUART, V21, P173, DOI 10.1111/j.1471-6402.1997.tb00108.x; Green SP, 2003, SOC BEHAV PERSONAL, V31, P215, DOI 10.2224/sbp.2003.31.3.215; Gumble A, 2012, BODY IMAGE, V9, P101, DOI 10.1016/j.bodyim.2011.07.005; Han Z, 2011, INT J EPIDEMIOL, V40, P65, DOI 10.1093/ije/dyq195; Jacobi C., 2010, OXFORD HDB EATING DI, V1st ed., P123, DOI [10.1093/oxfordhb/9780195373622.013.0008, DOI 10.1093/OXFORDHB/9780195373622.013.0008]; Jaworowska A, 2009, BIOMED PHARMACOTHER, V63, P679, DOI 10.1016/j.biopha.2008.08.005; Johnson F, 2005, J ABNORM PSYCHOL, V114, P119, DOI 10.1037/0021-843X.114.1.119; Kang SH, 2016, INT J CARDIOL, V215, P449, DOI 10.1016/j.ijcard.2016.04.036; Khan AN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-379; Kostanski M, 1998, J CHILD PSYCHOL PSYC, V39, P255, DOI 10.1017/S0021963097001807; Lake AJ, 2000, INT J EAT DISORDER, V27, P83, DOI 10.1002/(SICI)1098-108X(200001)27:1&lt;83::AID-EAT9&gt;3.0.CO;2-J; Lavin MA, 2001, INT J EAT DISORDER, V29, P51, DOI 10.1002/1098-108X(200101)29:1<51::AID-EAT8>3.3.CO;2-H; Lev-Ari L, 2014, EAT BEHAV, V15, P397, DOI 10.1016/j.eatbeh.2014.04.015; Lewis D M, 2001, Eat Disord, V9, P29, DOI 10.1080/106402601300187713; Mahmud N, 2007, BRIT J PSYCHOL, V98, P187, DOI 10.1348/000712606X112446; Malete L, 2013, J OBES, V2013, DOI 10.1155/2013/763624; National Health Commission of the People's Republic of China, CRIT WEIGHT AD; Neggers YH, 2015, REPROD TOXICOL, V56, P170, DOI 10.1016/j.reprotox.2015.03.005; Neumark-Sztainer D, 2006, J ADOLESCENT HEALTH, V39, P244, DOI 10.1016/j.jadohealth.2005.12.001; Rasheed P, 1998, PUBLIC HEALTH, V112, P409, DOI 10.1016/S0033-3506(98)00288-1; Ronnenberg AG, 2003, J NUTR, V133, P3449, DOI 10.1093/jn/133.11.3449; ROSS CE, 1994, J HEALTH SOC BEHAV, V35, P63, DOI 10.2307/2137335; Sharps MJ, 2001, J PSYCHOL, V135, P518, DOI 10.1080/00223980109603716; Shroff H, 2006, J HEALTH PSYCHOL, V11, P533, DOI 10.1177/1359105306065015; Stevens SD, 2017, J HEALTH PSYCHOL, V22, P1084, DOI 10.1177/1359105315624749; Thomas FC, 2002, BODY IMAGE HDB THEOR; Touchette E, 2011, PSYCHIAT RES, V185, P185, DOI 10.1016/j.psychres.2010.04.005; Wardle J, 2006, INT J OBESITY, V30, P644, DOI 10.1038/sj.ijo.0803050; World Health Organization, 2000, WHO TECHN REP SER, V894; Xuan F, 2016, J CHINA WOMENS U, V28, P55; Yaemsiri S, 2011, INT J OBESITY, V35, P1063, DOI 10.1038/ijo.2010.229; Zhu GW, 2015, CHINA SOFT SCI, V2, P146	45	20	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205282	10.1371/journal.pone.0205282	http://dx.doi.org/10.1371/journal.pone.0205282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4VA	30304026	Green Submitted, gold, Green Published			2022-12-26	WOS:000446921100077
J	Cortez, V; Canal, E; Dupont-Turkowsky, JC; Quevedo, T; Albujar, C; Chang, TC; Salmon-Mulanovich, G; Guezala-Villavicencio, MC; Simons, MP; Margolis, E; Schultz-Cherry, S; Pacheco, V; Bausch, DG				Cortez, Valerie; Canal, Enrique; Catherine Dupont-Turkowsky, J.; Quevedo, Tatiana; Albujar, Christian; Chang, Ti-Cheng; Salmon-Mulanovich, Gabriela; Guezala-Villavicencio, Maria C.; Simons, Mark P.; Margolis, Elisa; Schultz-Cherry, Stacey; Pacheco, Victor; Bausch, Daniel G.			Identification of Leptospira and Bartonella among rodents collected across a habitat disturbance gradient along the Inter-Oceanic Highway in the southern Amazon Basin of Peru	PLOS ONE			English	Article							CAPTIVE COLLARED PECCARIES; SPP.; INFECTION; SEROPREVALENCE; DIAGNOSIS; ECOLOGY; FLEAS	Background The southern Amazon Basin in the Madre de Dios region of Peru has undergone rapid deforestation and habitat disruption, leading to an unknown zoonotic risk to the growing communities in the area. Methodology/Principal findings We surveyed the prevalence of rodent-borne Leptospira and Bartonella, as well as potential environmental sources of human exposure to Leptospira, in 4 communities along the Inter-Oceanic Highway in Madre de Dios. During the rainy and dry seasons of 2014-2015, we captured a total of 97 rodents representing 8 genera in areas that had experienced different degrees of habitat disturbance. Primarily by using 16S metagenomic sequencing, we found that most of the rodents (78%) tested positive for Bartonella, whereas 24% were positive for Leptospira; however, the patterns differed across seasons and the extent of habitat disruption. A high prevalence of Bartonella was identified in animals captured across both trapping seasons (72%-83%) and the relative abundance was correlated with increasing level of land disturbance. Leptospira-positive animals were more than twice as prevalent during the rainy season (37%) as during the dry season (14%). A seasonal fluctuation across the rainy, dry, and mid seasons was also apparent in environmental samples tested for Leptospira (range, 55%-89% of samples testing positive), and there was a high prevalence of this bacteria across all sites that were sampled in the communities. Conclusions/Significance These data indicate the need for increased awareness of rodent-borne disease and the potential for environmental spread along the communities in areas undergoing significant land-use change.	[Cortez, Valerie; Canal, Enrique; Catherine Dupont-Turkowsky, J.; Quevedo, Tatiana; Albujar, Christian; Salmon-Mulanovich, Gabriela; Guezala-Villavicencio, Maria C.; Simons, Mark P.; Bausch, Daniel G.] US Naval Med Res Unit 6, Callao, Peru; [Cortez, Valerie; Chang, Ti-Cheng; Margolis, Elisa; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Salmon-Mulanovich, Gabriela] Pontificia Univ Catolica Peru, Lima, Peru; [Pacheco, Victor] Univ Nacl Mayor San Marcos, Museo Hist Nat, Lima, Peru; [Bausch, Daniel G.] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA	Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); St Jude Children's Research Hospital; Pontificia Universidad Catolica del Peru; Universidad Nacional Mayor de San Marcos; Tulane University	Cortez, V (corresponding author), US Naval Med Res Unit 6, Callao, Peru.; Cortez, V (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.	Valerie.Cortez@stjude.org	Chang, Ti-Cheng/HHS-7370-2022; Pacheco, Víctor R./F-5882-2011; Margolis, Elisa/N-8084-2018; Salmon-Mulanovich, Gabriela/L-7697-2016	Pacheco, Víctor R./0000-0002-1005-135X; Margolis, Elisa/0000-0001-6217-0564; Salmon-Mulanovich, Gabriela/0000-0002-8918-7689; Cortez, Valerie/0000-0002-1267-5596	Fogarty International Center; US National Institutes of Health [R25 TW009345]; Inter-American Institute [CRN3076]; Hartwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI106700] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Inter-American Institute; Hartwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by grants from the Fogarty International Center, the US National Institutes of Health (R25 TW009345) awarded to V.C., the Inter-American Institute CRN3076 awarded to D.G.B., and the Hartwell Foundation awarded to S.S-C.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcón-Villaverde Jorge O, 2014, Rev. perú. med. exp. salud publica, V31, P195; Angelakis E, 2014, INT J ANTIMICROB AG, V44, P16, DOI 10.1016/j.ijantimicag.2014.04.006; Babraham Bioinformatics, FASTQC QUALITY CONTR; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Billeter SA, 2011, J MED ENTOMOL, V48, P1257, DOI 10.1603/ME10240; Blair PJ, 2004, AM J TROP MED HYG, V70, P357; Bunnell JE, 2000, AM J TROP MED HYG, V63, P255, DOI 10.4269/ajtmh.2000.63.255; Cespedes Z.M., 2003, REV PERUANA MED EXPT, V20, P80; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; DEHIDALGO JL, 1984, J CLIN MICROBIOL, V19, P944; Diniz PPVP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002393; FelixKrueger, 2017, TRIMGALORE; Galan M, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00032-16; Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308; Ganoza CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000612; Gutierrez R, 2015, VECTOR-BORNE ZOONOT, V15, P27, DOI 10.1089/vbz.2014.1606; Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jori F, 2009, RES VET SCI, V86, P383, DOI 10.1016/j.rvsc.2008.09.009; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Maguina C, 2000, INFECT DIS CLIN N AM, V14, P1, DOI 10.1016/S0891-5520(05)70215-4; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Manuel Cespedes, 2006, REV PERU MED EXP SAL, V23; Martin-Alonso A, 2014, EMERG INFECT DIS, V20, P1069, DOI 10.3201/eid2006.131194; Mason MR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004895; Matthias MA, 2005, AM J TROP MED HYG, V73, P964, DOI 10.4269/ajtmh.2005.73.964; Mendoza P, 2007, EMERG INFECT DIS, V13, P793, DOI 10.3201/eid1305.060027; Mills James N., 2006, BIODIVERSITY-OTTAWA, V7, P9; Mogollon-Pasapera E, 2009, INT J INFECT DIS, V13, P3, DOI 10.1016/j.ijid.2008.04.002; Munoz-Zanzi C, 2014, AM J TROP MED HYG, V90, P497, DOI 10.4269/ajtmh.13-0334; Murray KA, 2013, CURR OPIN VIROL, V3, P79, DOI 10.1016/j.coviro.2013.01.006; Mwachui MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003843; Parola P, 2002, AM J TROP MED HYG, V67, P135, DOI 10.4269/ajtmh.2002.67.135; Picardeau M, 2013, MED MALADIES INFECT, V43, P1, DOI 10.1016/j.medmal.2012.11.005; Razzauti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003929; Rizzo MF, 2015, J MED ENTOMOL, V52, P1374, DOI 10.1093/jme/tjv137; Saito M, 2013, APPL ENVIRON MICROB, V79, P601, DOI 10.1128/AEM.02728-12; Salmon-Mulanovich G, 2015, AM J TROP MED HYG, V93, P213; Salmon-Mulanovich G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3420-3; SCHULTZ MG, 1968, NEW ENGL J MED, V278, P1323, DOI 10.1056/NEJM196806132782405; Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110; Silva-Diaz H, 2015, REV CHIL INFECTOL, V32, P530, DOI 10.4067/S0716-10182015000600006; SMITH MF, 1991, MOL BIOL EVOL, V8, P85; Southworth J, 2011, REMOTE SENS-BASEL, V3, P1047, DOI 10.3390/rs3051047; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46	47	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205068	10.1371/journal.pone.0205068	http://dx.doi.org/10.1371/journal.pone.0205068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300359	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000446897200034
J	Lemaire, P; de Benaze, GD; Mul, D; Heger, S; Oostdijk, W; Brauner, R				Lemaire, Pierre; de Benaze, Gwenaelle Duhil; Mul, Dick; Heger, Sabine; Oostdijk, Wilma; Brauner, Raja			A mathematical model for predicting the adult height of girls with idiopathic central precocious puberty: A European validation	PLOS ONE			English	Article							TERM-FOLLOW-UP; AGONIST TREATMENT; STANDARDS; DIAGNOSIS	Background A previous single-center study established a mathematical model for predicting the adult height (AH) in girls with idiopathic central precocious puberty (CPP). Objective To perform internal and external validations by comparing the actual AH to the calculated AH established by this model and to update it. Methods The original formula, calculated AH (cm) = 2.21 (height at initial evaluation, SD) + 2.32 (target height, SD) - 1.83 (luteinizing hormone/follicle-stimulating hormone peaks ratio) + 159.68, was established in a sample of 134 girls (group 4) and was applied to additional girls with CPP seen in the same center (group 1, n = 35), in Germany (group 2, n = 43) and in the Netherlands (group 3, n = 72). This formula has been updated based on these extended data, and both versions are available at the following location: http://www.kamick.org/lemaire/med/girls-cpp15.html. Results Despite the differences among the 4 groups in terms of their characteristics at the initial evaluation and the percentages of patients treated with the gonadotropin-releasing hormone analogue, they have similar calculated and actual AHs. The actual AHs are 162.2 +/- 7.0, 163.0 +/- 7.6, 162.4 +/- 7.7 and 162.1 +/- 5.6 cm in groups 1 to 4, respectively. They are highly correlated with the AHs calculated by the formula established in the original group (group 4), with R at 0.84, 0.67 and 0.69 in groups 1 to 3, respectively. When the actual AHs and the AHs predicted by the Bayley and Pinneau method are compared, the R is 0.76, 0.51 and 0.64 in groups 1 to 3, respectively. The absolute differences between actual AHs and the calculated AHs are greater than 1 SD (5.6 cm) in 15%, 35% and 28% of the patients in groups 1 to 3, respectively. Conclusion This study validates and updates the previously established formula for predicting AH in girls with CPP. This updated formula can help clinicians to make treatment decisions.	[Lemaire, Pierre] Univ Grenoble Alpes, CNRS, Grenoble INP, G SCOP, Grenoble, France; [de Benaze, Gwenaelle Duhil; Brauner, Raja] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [de Benaze, Gwenaelle Duhil; Brauner, Raja] Univ Paris 05, Paris, France; [Mul, Dick] Ctr Pediat & Adolescent Diabet Care & Res, Rotterdam, Netherlands; [Heger, Sabine] Childrens Hosp Bult, Janusz Korczak Allee, Hannover, Germany; [Oostdijk, Wilma] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Fondation Adolphe de Rothschild; UDICE-French Research Universities; Universite Paris Cite; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Brauner, R (corresponding author), Fdn Ophtalmol Adolphe Rothschild, Paris, France.; Brauner, R (corresponding author), Univ Paris 05, Paris, France.	raja.brauner@wanadoo.fr	Heger, Sabine/AAW-5360-2020; Mul, Dick/AAJ-1058-2020	Mul, Dick/0000-0001-8095-9155; Brauner, Raja/0000-0002-4456-4508				BAYLEY N, 1952, J PEDIATR-US, V40, P423, DOI 10.1016/S0022-3476(52)80205-7; Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783; Chalumeau M, 2003, J PEDIATR-US, V143, P445, DOI 10.1067/S0022-3476(03)00328-7; Chemaitilly W, 2001, CLIN ENDOCRINOL, V54, P289, DOI 10.1046/j.1365-2265.2001.01229.x; FONTOURA M, 1989, ARCH DIS CHILD, V64, P1170, DOI 10.1136/adc.64.8.1170; Giabicani E, PLOS ONE, V8; Giabicani E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120588; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; Guaraldi F, 2016, EUR J ENDOCRINOL, V174, pR79, DOI 10.1530/EJE-15-0590; Heger S, 2006, MOL CELL ENDOCRINOL, V254, P217, DOI 10.1016/j.mce.2006.04.012; Lazar L, 2014, CLIN ENDOCRINOL, V80, P570, DOI 10.1111/cen.12319; Lopes MC, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e480; Magiakou MA, 2010, J CLIN ENDOCR METAB, V95, P109, DOI 10.1210/jc.2009-0793; Mogensen SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029829; Moons KG, 2015, ANN INTERN MED, V162, DOI [10.1210/jcem.84.2.5430, DOI 10.1210/JCEM.84.2.5430]; Mul D, 2000, J PEDIATR ENDOCR MET, V13, P765, DOI 10.1515/JPEM.2000.13.S1.765; Palmert MR, 1999, J CLIN ENDOCR METAB, V84, P415, DOI 10.1210/jc.84.2.415; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Sempe A, 1979, AUXOLOGIE METHODE SE; Silverman LA, 2015, J CLIN ENDOCR METAB, V100, P2354, DOI 10.1210/jc.2014-3031; TANNER JM, 1970, ARCH DIS CHILD, V45, P755, DOI 10.1136/adc.45.244.755; Willemsen RH, 2014, NAT REV ENDOCRINOL, V10, P352, DOI 10.1038/nrendo.2014.40	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205318	10.1371/journal.pone.0205318	http://dx.doi.org/10.1371/journal.pone.0205318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300409	Green Published, Green Submitted, gold			2022-12-26	WOS:000446897200055
J	Lievin-Bazin, A; Pineaux, M; Clerc, O; Gahr, M; von Bayern, AMP; Bovet, D				Lievin-Bazin, Agatha; Pineaux, Maxime; Clerc, Olivier; Gahr, Manfred; von Bayern, Auguste M. P.; Bovet, Dalila			Emotional responses to conspecific distress calls are modulated by affiliation in cockatiels (Nymphicus hollandicus)	PLOS ONE			English	Article							PARROTLETS FORPUS CONSPICILLATUS; CONTACT CALLS; PAIR RELATIONSHIPS; RECOGNITION; CONTAGION; BEHAVIOR; EXPRESSION; STRENGTH; BABOONS; CONURES	Vocal communication is used across the animal kingdom to transfer information from emitters to receivers, such as size, sex, age, dominance status or even emotional states. The transmission of an emotional state from one individual to another is called "emotional contagion" and is classified as the first level of empathy. Emotional contagion is thought to be stronger between familiar individuals. While affiliation represents a stronger relation between individuals than mere familiarity, it remains understudied whether affiliation modulates emotional reactions as well. Using cockatiels (Nymphicus hollandicus), we played back three types of audio stimuli to individual birds: a partner's distress call (emitted when birds are caught or forcibly restrained), a non-partner's distress call, and a control sound (white noise). The calls were recorded from familiar birds with either low (non-partners) or high levels of affiliation (partners). The subjects' response was scored using four behavioural parameters: the time spent near the loudspeaker, the amount of movements, the number of calls emitted, and the position of the crest. Across all variables, birds were more attentive and active when confronted to distress calls compared to control sounds, particularly when the distress call was emitted from a partner rather than a non-partner. These results raise the possibility that distress calls do not only function as a stimulus-triggering automatic reaction in cockatiels but also transmit emotions. Moreover, affiliation enhanced emotional reactions to conspecific distress calls. Our data provides first insights into the mechanisms of emotional contagion in parrots.	[Lievin-Bazin, Agatha; Clerc, Olivier; Bovet, Dalila] Univ Paris Nanterre, Lab Ethol Cognit Dev, EA, Nanterre, France; [Pineaux, Maxime] Univ Toulouse III Paul Sabatier, Lab Evolut & Div Biol, UMR 5174, Toulouse, France; [Gahr, Manfred; von Bayern, Auguste M. P.] Max Planck Inst Omithol, Dept Behav Ecol & Evolutionary Genet, Seewiesen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Lievin-Bazin, A (corresponding author), Univ Paris Nanterre, Lab Ethol Cognit Dev, EA, Nanterre, France.	agatha.lievin@gmail.com		von Bayern, Auguste/0000-0002-0981-9456	Region Ile de France; DIM Cerveau et pensee	Region Ile de France(Region Ile-de-France); DIM Cerveau et pensee	This work received support from Region Ile de France, DIM Cerveau et pensee, to ALB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; AUBIN T, 1991, BEHAV PROCESS, V23, P103, DOI 10.1016/0376-6357(91)90061-4; AUBIN T, 1989, Bioacoustics, V2, P23; Balsby TJS, 2008, P ROY SOC B-BIOL SCI, V275, P2147, DOI 10.1098/rspb.2008.0517; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baxter A, 1999, INTERSPECIFICITY DIS; Berg KS, 2011, ANIM BEHAV, V81, P241, DOI 10.1016/j.anbehav.2010.10.012; Boeckle M, 2012, CURR BIOL, V22, P801, DOI 10.1016/j.cub.2012.03.023; Boucherie PH, 2017, CURR ZOOL, V63, P379, DOI 10.1093/cz/zow083; Boucherie PH, 2016, BEHAVIOUR, V153, P897, DOI 10.1163/1568539X-00003372; Branch CL, 2012, BEHAV ECOL, V23, P854, DOI 10.1093/beheco/ars041; Briefer EF, 2012, J ZOOL, V288, P1, DOI 10.1111/j.1469-7998.2012.00920.x; Briefer EF, 2017, FRONT ZOOL, V14, DOI 10.1186/s12983-017-0193-1; Briefer EF, 2015, ANIM BEHAV, V99, P131, DOI 10.1016/j.anbehav.2014.11.002; Bugnyar T, 2013, COMP COGN BEHAV REV, V8, P1, DOI 10.3819/ccbr.2013.80001; Buhrman-Deever SC, 2008, ANIM BEHAV, V76, P1715, DOI 10.1016/j.anbehav.2008.08.007; CONOVER MR, 1981, Z TIERPSYCHOL, V57, P163; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Dupjan S, 2011, PHYSIOL BEHAV, V103, P445, DOI 10.1016/j.physbeh.2011.03.017; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; Emery NJ, 2004, COMP ANAL MINDS, V181, pe213; FENTON MB, 1976, CAN J ZOOL, V54, P1443, DOI 10.1139/z76-167; Fraser ON, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010605; Fraser ON, 2010, ANIM BEHAV, V79, P927, DOI 10.1016/j.anbehav.2010.01.008; Gallup AC, 2017, J COMP PSYCHOL, V131, P69, DOI 10.1037/com0000047; Gallup AC, 2015, ANIM COGN, V18, P1051, DOI 10.1007/s10071-015-0873-1; GARNETZKESTOLLMANN K, 1991, BEHAVIOUR, V119, P1, DOI 10.1163/156853991X00346; Gill SA, 2013, ETHOLOGY, V119, P449, DOI 10.1111/eth.12097; Gonzalez-Liencres C, 2014, BEHAV BRAIN RES, V263, P16, DOI 10.1016/j.bbr.2014.01.020; Griffin AS, 2008, ANIM BEHAV, V75, P79, DOI 10.1016/j.anbehav.2007.04.008; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; HILL GE, 1986, ANIM BEHAV, V34, P590, DOI 10.1016/S0003-3472(86)80128-2; Kotrschal K., 2012, EMOTIONS ANIMALS HUM, P3; Labra A, 2016, ETHOLOGY, V122, P758, DOI 10.1111/eth.12522; Lemasson A, 2009, ANIM COGN, V12, P693, DOI 10.1007/s10071-009-0229-9; Lenth RV., 2021, EMMEANS ESTIMATED MA; Lievin-Bazin A, 2017, THESIS; Linhart P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135414; Lockie J. D., 1956, Bird Study, V3, P180; Loretto Matthias-Claudio, 2012, Int J Comp Psychol, V25, P180; Mathevon N, 1997, CR ACAD SCI III-VIE, V320, P869, DOI 10.1016/S0764-4469(97)80871-2; Mathevon Nicolas, 2010, BMC Ecology, V10, P9, DOI 10.1186/1472-6785-10-9; Mazerolle MJ, 2006, AMPHIBIA-REPTILIA, V27, P169, DOI 10.1163/156853806777239922; Miller ML, 2012, BEHAV PROCESS, V89, P264, DOI 10.1016/j.beproc.2011.12.012; Miller ML, 2010, ANIM BEHAV, V80, P615, DOI 10.1016/j.anbehav.2010.05.018; Mitani JC, 2000, ANIM BEHAV, V59, P885, DOI 10.1006/anbe.1999.1389; Neudorf DL, 2002, BIOTROPICA, V34, P118, DOI 10.1111/j.1744-7429.2002.tb00247.x; Nishida T., 1972, Kyoto Univ Afr Stud, V7, P131; Osvath M., 2014, ANIM BEHAV COGN, V2, P197, DOI [10.12966/abc.05.09.2014, DOI 10.12966/ABC.05.09.2014]; Palagi E, 2009, P NATL ACAD SCI USA, V106, P19262, DOI 10.1073/pnas.0910891106; Palagi E, 2014, PEERJ, V2, DOI 10.7717/peerj.519; Parr M, 2010, PARROTS GUIDE PARROT; Perez EC, 2012, HORM BEHAV, V61, P573, DOI 10.1016/j.yhbeh.2012.02.004; Peron F, 2011, ANIM COGN, V14, P545, DOI 10.1007/s10071-011-0389-2; Peron F, 2013, ANIM COGN, V16, P197, DOI 10.1007/s10071-012-0564-0; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Prochazkova E, 2017, NEUROSCI BIOBEHAV R, V80, P99, DOI 10.1016/j.neubiorev.2017.05.013; Quervel-Chaumette M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152920; R Core Team, 2021, R LANGUAGE ENV STAT; Ramseyer A, 2009, BEHAVIOUR, V146, P351, DOI 10.1163/156853909X410955; RAVELING DG, 1969, AUK, V86, P671, DOI 10.2307/4083454; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; ROELL A, 1978, BEHAVIOUR, V64, P1; ROGERS LJ, 1981, BIRD BEHAV, V3, P80, DOI 10.3727/015613881791560694; Russ JM, 1998, ANIM BEHAV, V55, P705, DOI 10.1006/anbe.1997.0665; Saito Y, 2016, BEHAV PROCESS, V132, P5, DOI 10.1016/j.beproc.2016.08.005; SAUNDERS DA, 1983, AUST WILDLIFE RES, V10, P527, DOI 10.1071/WR9830527; Schwing R, 2017, CURR BIOL, V27, pR213, DOI 10.1016/j.cub.2017.02.020; Seibert LM, 2001, APPL ANIM BEHAV SCI, V71, P155, DOI 10.1016/S0168-1591(00)00172-6; Seibert LM, 2006, MANUAL OF PARROT BEHAVIOR, P43, DOI 10.1002/9780470344651.ch5; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Simpson M.J.A., 1973, P411; Spoon TR, 2006, ANIM BEHAV, V71, P315, DOI 10.1016/j.anbehav.2005.03.034; Spoon TR, 2004, BEHAVIOUR, V141, P1211, DOI 10.1163/1568539042729711; van Horik JO., 2012, OXFORD HDB COMP EVOL, P80, DOI [10.1093/oxfordhb/9780199738182.013.0005, DOI 10.1093/OXFORDHB/9780199738182.013.0005]; von Bayern AMP, 2007, BEHAVIOUR, V144, P711, DOI 10.1163/156853907781347826; Wanker R, 1998, BEHAV ECOL SOCIOBIOL, V43, P197, DOI 10.1007/s002650050481; Wanker R, 2001, BEHAVIOUR, V138, P709, DOI 10.1163/156853901752233361; Wanker R, 1996, J ORNITHOL, V137, P447, DOI 10.1007/BF01661101; Wascher CAF, 2008, P ROY SOC B-BIOL SCI, V275, P1653, DOI 10.1098/rspb.2008.0146; WECHSLER B, 1989, ETHOLOGY, V80, P307	82	10	10	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205314	10.1371/journal.pone.0205314	http://dx.doi.org/10.1371/journal.pone.0205314			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4OW	30300404	Green Published, Green Submitted, gold			2022-12-26	WOS:000446897200053
J	Papademetriou, I; Vedula, E; Charest, J; Porter, T				Papademetriou, Iason; Vedula, Else; Charest, Joseph; Porter, Tyrone			Effect of flow on targeting and penetration of angiopep-decorated nanoparticles in a microfluidic model blood-brain barrier	PLOS ONE			English	Article							IN-VITRO MODEL; MICROVASCULAR ENDOTHELIAL-CELLS; ORGANS-ON-CHIPS; SHEAR-STRESS; DRUG-DELIVERY; HYDRAULIC CONDUCTIVITY; ADHESION MOLECULE-1; CARBON NANOTUBES; PERMEABILITY; TRANSPORT	The blood-brain barrier (BBB) limits transport of nanoparticles from the circulation to the brain parenchyma. Angiopep-2, a peptide which functions as a brain transport vector, can be coupled to nanoparticles in order to facilitate binding and internalization by brain endothelial cells (ECs), and subsequent BBB penetration. This multi-step process may be affected by blood flow over brain ECs, as flow influences endothelial cell phenotype as well as interactions of nanoparticles with ECs. In the present study a microfluidic BBB model was constructed to evaluate binding and internalization by brain ECs, as well as BBB penetration of Angiopep-2 coupled liposomes (Ang2-Liposomes) in static and flow conditions. Ang2 conjugation to liposomes markedly improved binding relative to unconjugated liposomes. Ang2-Liposomes bound and were internalized efficiently by brain endothelial cells after static incubation or with 1 dyne/cm(2) of fluid shear stress (FSS), while binding was reduced at a FSS of 6 dyne/cm(2). Penetration of the model microfluidic BBB by Ang2-Liposomes was higher at a FSS of 1 dyne/cm(2) and 6 dyne/cm(2) than with static incubation. Analysis of barrier function and control experiments for receptor-mediated penetration provided insight into the magnitude of transcellular versus paracellular transport at each tested FSS. Overall, the results demonstrate that flow impacted the binding and BBB penetration of Ang2-functionalized nanoparticles. This highlights the relevance of the local flow environment for in vitro modeling of the performance of nanoparticles functionalized with BBB penetrating ligands.	[Papademetriou, Iason; Porter, Tyrone] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA; [Papademetriou, Iason; Vedula, Else; Charest, Joseph] Draper Lab, Human Organ Syst, Cambridge, MA USA; [Porter, Tyrone] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University	Porter, T (corresponding author), Boston Univ, Dept Mech Engn, Boston, MA 02215 USA.; Porter, T (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	tmp@bu.edu	Porter, Tyrone/GSD-7665-2022		National Institutes of Health [R01EB016102, R21 NS105837]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this study was provided by the National Institutes of Health grants R01EB016102 and R21 NS105837 (TP), www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Achyuta AKH, 2013, LAB CHIP, V13, P542, DOI 10.1039/c2lc41033h; Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Apawu AK, 2018, NANOMED-NANOTECHNOL, V14, P1999, DOI 10.1016/j.nano.2018.04.003; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Bhowmick T, 2012, J CONTROL RELEASE, V157, P485, DOI 10.1016/j.jconrel.2011.09.067; Blanchette M, 2015, MECH DEVELOP, V138, P8, DOI 10.1016/j.mod.2015.07.007; Booth R, 2014, ANN BIOMED ENG, V42, P2379, DOI 10.1007/s10439-014-1086-5; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Brown JA, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4934713; Calderon AJ, 2009, BIORHEOLOGY, V46, P323, DOI 10.3233/BIR-2009-0544; Charoenphol P, 2012, J BIOMECH, V45, P2822, DOI 10.1016/j.jbiomech.2012.08.035; Charoenphol P, 2010, BIOMATERIALS, V31, P1392, DOI 10.1016/j.biomaterials.2009.11.007; Cho A, 1997, CIRC RES, V81, P328, DOI 10.1161/01.RES.81.3.328; Cho HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15222; Colgan OC, 2007, AM J PHYSIOL-HEART C, V292, pH3190, DOI 10.1152/ajpheart.01177.2006; Cooley M, 2018, NANOSCALE, V10, P15350, DOI 10.1039/c8nr04042g; Cucullo L, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-18; Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40; DAVIES PF, 1984, J CLIN INVEST, V73, P1121, DOI 10.1172/JCI111298; Deli MA, 2011, SOLUBILITY, DELIVERY AND ADME PROBLEMS OF DRUGS AND DRUG CANDIDATES, P144; Demaio L, 2001, AM J PHYSIOL-HEART C, V281, pH105, DOI 10.1152/ajpheart.2001.281.1.H105; Demeule M, 2008, J PHARMACOL EXP THER, V324, P1064, DOI 10.1124/jpet.107.131318; Demeule M, 2008, J NEUROCHEM, V106, P1534, DOI 10.1111/j.1471-4159.2008.05492.x; Deosarkar SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142725; DeStefano JG, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0068-z; Dimmeler S, 1996, FEBS LETT, V399, P71, DOI 10.1016/S0014-5793(96)01289-6; Doshi N, 2010, J CONTROL RELEASE, V146, P196, DOI 10.1016/j.jconrel.2010.04.007; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Eniola AO, 2003, BIOPHYS J, V85, P2720, DOI 10.1016/S0006-3495(03)74695-5; Esch EW, 2015, NAT REV DRUG DISCOV, V14, P248, DOI 10.1038/nrd4539; Farokhzad OC, 2005, ANAL CHEM, V77, P5453, DOI 10.1021/ac050312q; Fish MB, 2017, BIOMATERIALS, V124, P169, DOI 10.1016/j.biomaterials.2017.02.002; Frohlich EM, 2013, LAB CHIP, V13, P2311, DOI 10.1039/c3lc50199j; Frohlich EM, 2012, INTEGR BIOL-UK, V4, P75, DOI 10.1039/c1ib00096a; Fromen CA, 2016, BIOENG TRANSL MED, V1, P103, DOI 10.1002/btm2.10008; Gao HL, 2011, BIOMATERIALS, V32, P8669, DOI 10.1016/j.biomaterials.2011.07.069; Gao JQ, 2013, BIOMATERIALS, V34, P5628, DOI 10.1016/j.biomaterials.2013.03.097; Gao XH, 2013, PHARM RES-DORDR, V30, P2538, DOI 10.1007/s11095-013-1004-9; Gooch KJ, 1997, J CELL PHYSIOL, V171, P252, DOI 10.1002/(SICI)1097-4652(199706)171:3<252::AID-JCP3>3.3.CO;2-3; Hajal C, 2018, BIOMICROFLUIDICS, V12, DOI 10.1063/1.5027118; Han JY, 2015, J CONTROL RELEASE, V210, P39, DOI 10.1016/j.jconrel.2015.05.006; Han JY, 2012, ACS NANO, V6, P8824, DOI 10.1021/nn302687n; Helms HC, 2016, J CEREBR BLOOD F MET, V36, P862, DOI 10.1177/0271678X16630991; Ishibazawa A, 2013, EXP EYE RES, V116, P308, DOI 10.1016/j.exer.2013.10.001; Jamieson JJ, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-017-0076-1; JO H, 1991, AM J PHYSIOL, V260, pH1992, DOI 10.1152/ajpheart.1991.260.6.H1992; Johnsen KB, 2018, THERANOSTICS, V8, P3416, DOI 10.7150/thno.25228; Kafa H, 2016, J CONTROL RELEASE, V225, P217, DOI 10.1016/j.jconrel.2016.01.031; Kang H, 2014, ATHEROSCLEROSIS, V233, P682, DOI 10.1016/j.atherosclerosis.2014.01.056; Ke WL, 2009, BIOMATERIALS, V30, P6976, DOI 10.1016/j.biomaterials.2009.08.049; Khor SY, 2018, SMALL, V14, DOI 10.1002/smll.201801702; Kim JA, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4917508; Kim JS, 2018, J CONTROL RELEASE, V269, P245, DOI 10.1016/j.jconrel.2017.11.026; Kolhar P, 2013, P NATL ACAD SCI USA, V110, P10753, DOI 10.1073/pnas.1308345110; Liu J, 2011, BIOPHYS J, V101, P319, DOI 10.1016/j.bpj.2011.05.063; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; MORIGI M, 1995, BLOOD, V85, P1696, DOI 10.1182/blood.V85.7.1696.bloodjournal8571696; Murase T, 1998, CIRC RES, V83, P328, DOI 10.1161/01.RES.83.3.328; Muro S, 2006, J PHARMACOL EXP THER, V317, P1161, DOI 10.1124/jpet.105.098970; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Niwa K, 2004, ANN BIOMED ENG, V32, P537, DOI 10.1023/B:ABME.0000019173.79939.54; Noria S, 1999, CIRC RES, V85, P504, DOI 10.1161/01.RES.85.6.504; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Pang ZY, 2005, ANN BIOMED ENG, V33, P1536, DOI 10.1007/s10439-005-7786-0; Papademetriou IT, 2015, THER DELIV, V6, P989, DOI [10.4155/tde.15.48, 10.4155/TDE.15.48]; Papademetriou J, 2013, J INHERIT METAB DIS, V36, P467, DOI 10.1007/s10545-012-9534-6; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Park J, 2015, LAB CHIP, V15, P141, DOI 10.1039/c4lc00962b; Partyka PP, 2017, BIOMATERIALS, V115, P30, DOI 10.1016/j.biomaterials.2016.11.012; Paulis LEM, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-25; Pradhan S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21075-9; Preston Jane E, 2014, Adv Pharmacol, V71, P147, DOI 10.1016/bs.apha.2014.06.001; Rappaport J, 2016, DRUG DELIVERY ACROSS PHYSIOLOGICAL BARRIERS, P313; Ren JF, 2012, BIOMATERIALS, V33, P3324, DOI 10.1016/j.biomaterials.2012.01.025; Rizzo V, 2003, AM J PHYSIOL-HEART C, V285, pH1720, DOI 10.1152/ajpheart.00344.2002; Rizzo V, 1998, J BIOL CHEM, V273, P34724, DOI 10.1074/jbc.273.52.34724; Ruan SB, 2014, BIOCONJUGATE CHEM, V25, P2252, DOI 10.1021/bc500474p; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Sellgren KL, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4935594; Shao K, 2012, BIOMATERIALS, V33, P6898, DOI 10.1016/j.biomaterials.2012.06.050; Siddharthan V, 2007, BRAIN RES, V1147, P39, DOI 10.1016/j.brainres.2007.02.029; SILL HW, 1995, AM J PHYSIOL-HEART C, V268, pH535, DOI 10.1152/ajpheart.1995.268.2.H535; SPRAGUE EA, 1987, CIRCULATION, V76, P648, DOI 10.1161/01.CIR.76.3.648; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; Sun RJ, 2002, EUR BIOPHYS J BIOPHY, V30, P605, DOI 10.1007/s00249-001-0195-x; Swaminathan TN, 2011, IUBMB LIFE, V63, P640, DOI 10.1002/iub.475; Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146; Terrell-Hall TB, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0050-9; Tian XH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11990; Walter FR, 2016, SENSOR ACTUAT B-CHEM, V222, P1209, DOI 10.1016/j.snb.2015.07.110; Wang JD, 2016, MOL PHARMACEUT, V13, P895, DOI 10.1021/acs.molpharmaceut.5b00805; Wang YI, 2017, BIOTECHNOL BIOENG, V114, P184, DOI 10.1002/bit.26045; Xin HL, 2012, BIOMATERIALS, V33, P1673, DOI 10.1016/j.biomaterials.2011.11.018; Xu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep36670; Yang H, 2013, INT J NANOMED, V8, DOI 10.2147/IJN.S44997; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	97	40	40	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205158	10.1371/journal.pone.0205158	http://dx.doi.org/10.1371/journal.pone.0205158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300391	gold, Green Published, Green Submitted			2022-12-26	WOS:000446897200042
J	Vazquez, DE; Ilina, N; Pagano, EA; Zavala, JA; Farina, WM				Vazquez, Diego E.; Ilina, Natalia; Pagano, Eduardo A.; Zavala, Jorge A.; Farina, Walter M.			Glyphosate affects the larval development of honey bees depending on the susceptibility of colonies	PLOS ONE			English	Article							APIS-MELLIFERA; GENE-EXPRESSION; RISK-ASSESSMENT; DIVERSITY; DETOXIFICATION; HYMENOPTERA; PESTICIDES; MANAGEMENT; WEED	As the main agricultural insect pollinator, the honey bee (Apis mellifera) is exposed to a number of agrochemicals, including glyphosate (GLY), the most widely used herbicide. Actually, GLY has been detected in honey and bee pollen baskets. However, its impact on the honey bee brood is poorly explored. Therefore, we assessed the effects of GLY on larval development under chronic exposure during in vitro rearing. Even though this procedure does not account for social compensatory mechanisms such as brood care by adult workers, it allows us to control the herbicide dose, homogenize nutrition and minimize environmental stress. Our results show that brood fed with food containing GLY traces (1.25-5.0 mg per litre of food) had a higher proportion of larvae with delayed moulting and reduced weight. Our assessment also indicates a non-monotonic dose-response and variability in the effects among colonies. Differences in genetic diversity could explain the variation in susceptibility to GLY. Accordingly, the transcription of immune/detoxifying genes in the guts of larvae exposed to GLY was variably regulated among the colonies studied. Consequently, under laboratory conditions, the response of honey bees to GLY indicates that it is a stressor that affects larval development depending on individual and colony susceptibility.	[Vazquez, Diego E.; Farina, Walter M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Lab Insectos Sociales, Buenos Aires, DF, Argentina; [Vazquez, Diego E.; Farina, Walter M.] Univ Buenos Aires, CONICET, Inst Fisiol Biol Mol & Neurociencias IFIBYNE, Buenos Aires, DF, Argentina; [Ilina, Natalia; Pagano, Eduardo A.; Zavala, Jorge A.] Univ Buenos Aires, Fac Agron, Catedra Bioquim, Buenos Aires, DF, Argentina; [Ilina, Natalia; Pagano, Eduardo A.; Zavala, Jorge A.] Univ Buenos Aires, CONICET, Inst Invest Biociencias Agr & Ambientales, INBA, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Farina, WM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Lab Insectos Sociales, Buenos Aires, DF, Argentina.; Farina, WM (corresponding author), Univ Buenos Aires, CONICET, Inst Fisiol Biol Mol & Neurociencias IFIBYNE, Buenos Aires, DF, Argentina.	walter@fbmc.fcen.uba.ar		Zavala, Jorge/0000-0001-6265-0920; Vazquez, Diego Eduardo/0000-0003-1303-590X; Farina, Walter/0000-0001-6411-489X	ANPCYT; University of Buenos Aires; CONICET; Fondo para la Investigacion Cientifica y Tecnologica [PICT 2016 2084]	ANPCYT(ANPCyT); University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondo para la Investigacion Cientifica y Tecnologica	This study was partly supported by grants from ANPCYT, University of Buenos Aires, CONICET, and Fondo para la Investigacion Cientifica y Tecnologica (PICT 2016 2084) to W.M. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux Cedric, 2010, Biol Lett, V6, P562, DOI 10.1098/rsbl.2009.0986; Arregui MC, 2004, PEST MANAG SCI, V60, P163, DOI 10.1002/ps.775; Aupinel Pierrick, 2005, Bulletin of Insectology, V58, P107; Bertholf LM, 1925, J ECON ENTOMOL, V18, P380, DOI 10.1093/jee/18.2.380; Bohan DA, 2005, P ROY SOC B-BIOL SCI, V272, P463, DOI 10.1098/rspb.2004.3049; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; CARLISLE SM, 1988, WATER AIR SOIL POLL, V39, P409; Cauble K, 2005, B ENVIRON CONTAM TOX, V75, P429, DOI 10.1007/s00128-005-0771-3; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Couture G, 1995, MINISTERE RESSOURCES; Crailsheim K., 2012, J APICULT RES, V52, P1; Dai PL, 2018, J AGR FOOD CHEM, V66, P7786, DOI 10.1021/acs.jafc.8b02212; Decanini LI, 2007, J HERED, V98, P195, DOI 10.1093/jhered/esm008; Dill G.M, 2010, GLYPHOSATE RESISTANC, P1, DOI DOI 10.1002/9780470634394.CH1; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Dutra BK, 2011, ECOTOXICOLOGY, V20, P255, DOI 10.1007/s10646-010-0577-x; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3295; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; FAO Plant production and protection paper 183, 2005, JOINT M FAO PAN EXP; Fukuda H., 1968, Researches on Population Ecology Kyoto University, V10, P31, DOI 10.1007/BF02514731; GARY N E, 1972, Environmental Entomology, V1, P71, DOI 10.1093/ee/1.1.71; Giesy JP, 2000, REV ENVIRON CONTAM T, V167, P35; Gregorc A, 2012, J INSECT PHYSIOL, V58, P1042, DOI 10.1016/j.jinsphys.2012.03.015; Gregorc A, 2011, PESTIC BIOCHEM PHYS, V99, P200, DOI 10.1016/j.pestbp.2010.12.005; Helmer SH, 2015, ENVIRON SCI POLLUT R, V22, P8010, DOI 10.1007/s11356-014-2879-7; Herbert LT, 2014, J EXP BIOL, V217, P3457, DOI 10.1242/jeb.109520; HUANG ZY, 1991, J INSECT BEHAV, V4, P305, DOI 10.1007/BF01048280; Jensen AB, 2009, APIDOLOGIE, V40, P524, DOI 10.1051/apido/2009029; Johnson RM, 2015, ANNU REV ENTOMOL, V60, P415, DOI 10.1146/annurev-ento-011613-162005; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; Kaftanoglu O, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.9601; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koo J, 2015, J ASIA-PAC ENTOMOL, V18, P583, DOI 10.1016/j.aspen.2015.06.011; Lagarde F, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-13; LE CONTE Y, 1995, J ECON ENTOMOL, V88, P798, DOI 10.1093/jee/88.4.798; Mao W, 2013, P NATL ACAD SCI USA, V110, P8842, DOI 10.1073/pnas.1303884110; Marc J, 2004, BIOL CELL, V96, P245, DOI 10.1016/j.biolcel.2003.11.010; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McGregor S.E, 1976, INSECT POLLINATION C, V496, P1; Medrzycki P, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.14; Gonalons CM, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.176644; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; MYSER WILLARD C., 1954, ANN ENT SOC AMER, V47, P683; Nandula V. K., 2005, Outlooks on Pest Management, V16, P183, DOI 10.1564/16aug11; OECD, 2007, JOINT M CHEM COMM WO; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; Paganelli A, 2010, CHEM RES TOXICOL, V23, P1586, DOI 10.1021/tx1001749; Palmer KA, 2003, NATURWISSENSCHAFTEN, V90, P265, DOI 10.1007/s00114-003-0418-3; Peruzzo PJ, 2008, ENVIRON POLLUT, V156, P61, DOI 10.1016/j.envpol.2008.01.015; Poquet Y, 2016, APIDOLOGIE, V47, P412, DOI 10.1007/s13592-016-0429-7; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; Rubio F., 2015, J ENV ANAL TOXICOL, V250, DOI [10.4172/2161- 0525.1000249, DOI 10.4172/2161-0525.1000249]; Simone-Finstrom M, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.1007; Balbuena MS, 2015, J EXP BIOL, V218, P2799, DOI 10.1242/jeb.117291; Solomon KR, 2003, J TOXICOL ENV HEAL B, V6, P289, DOI 10.1080/10937400306468; Tarpy DR, 2013, NATURWISSENSCHAFTEN, V100, P723, DOI 10.1007/s00114-013-1065-y; Tate TM, 1997, ARCH ENVIRON CON TOX, V33, P286, DOI 10.1007/s002449900255; Thompson HM, 2014, INTEGR ENVIRON ASSES, V10, P463, DOI 10.1002/ieam.1529; US EPA, 2012, WHITE PAPER SUPPORT; VANDENBERG JD, 1987, J APICULT RES, V26, P90, DOI 10.1080/00218839.1987.11100743; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; Wilson RG, 2011, PEST MANAG SCI, V67, P771, DOI 10.1002/ps.2176; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720	65	48	48	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205074	10.1371/journal.pone.0205074	http://dx.doi.org/10.1371/journal.pone.0205074			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300390	Green Published, Green Submitted, gold			2022-12-26	WOS:000446897200036
J	Baker, KK; Story, WT; Walser-Kuntz, E; Zimmerman, MB				Baker, Kelly K.; Story, William T.; Walser-Kuntz, Evan; Zimmerman, M. Bridget			Impact of social capital, harassment of women and girls, and water and sanitation access on premature birth and low infant birth weight in India	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; FOR-GESTATIONAL-AGE; PRETERM BIRTH; PSYCHOSOCIAL STRESS; RISK-FACTORS; OUTCOMES; GROWTH; EPIDEMIOLOGY; ASSOCIATIONS; METAANALYSIS	Background Globally, preterm birth (PTB) and low infant birth weight (LBW) are leading causes of maternal and child morbidity and mortality. Inadequate water and sanitation access (WASH) are risk factors for PTB and LBW in low-income countries. Physical stress from carrying water and psychosocial stress from addressing sanitation needs in the open may be mechanisms underlying these associations. If so, then living in a community with strong social capital should be able to buffer the adverse effects of WASH on birth outcomes. The objective of this study is to assess the relationships between WASH access and social conditions (including harassment and social capital) on PTB and LBW outcomes among Indian women, and to test whether social conditions modified the association between WASH and birth outcomes. Methods and findings This cohort study examined the effect of pre-birth WASH and social conditions on self-reported PTB status and LBW status for 7,926 women who gave birth between 2004/2005 and 2011/2012 Waves of the India Human Development Survey. PTB and LBW occurred in 14.9% and 15.5% of women, respectively. After adjusting for maternal biological and socioeconomic conditions, PTB was associated with sharing a building/compound latrine (Odds Ratio (OR) = 1.55; 95% Confidence Interval (CI) = 1.01, 2.38) versus private latrine access, but suggested an effect in the opposite direction for sharing a community/public latrine (OR = 0.67; CI = 0.45, 1.01). Open defecation, type of drinking water source, minutes per day spent fetching water, and one-way time to a drinking water source were not associated with PTB. LBW was associated with spending more than two hours per day fetching water compared to less than two hours (OR = 1.33; CI = 1.05, 1.70) and suggested an association with open defecation (OR = 1.22; CI = 1.00, 1.48), but was not associated with other types of sanitation, type of drinking water source, or time to a drinking water source. Harassment of women and girls in the community was associated with both PTB (OR = 1.33; CI = 1.09, 1.62) and LBW (OR = 1.26; CI = 1.03, 1.54). The data also showed a possible association of local crime with LBW (OR = 1.30; CI = 1.00, 1.68). Statistically significant (p<0.05) evidence of effect modification was only found for collective efficacy on the association between type of sanitation access and PTB. In addition, stratified analyses identified differences in effect size for walking time to the primary drinking water source and PTB by crime, sanitation access and PTB by harassment, and total hours per day fetching water and LBW by collective efficacy. Limitations of this observational study include risk of bias, inability to confirm causality, reliance on self-reported outcomes, and limited sub-group sample sizes for testing effect modification. Conclusions The relationship between adverse birth outcomes and sanitation access, domestic water fetching, crime, and gender-based harassment suggests physical and psychosocial stress are possible mechanisms by which WASH access affects PTB and LBW among Indian women. Interventions that reduce domestic responsibilities related to water and sanitation and change social norms related to gender-based harassment may reduce rates of PTB and LBW in India.	[Baker, Kelly K.] Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm Hlth, Iowa City, IA 52242 USA; [Story, William T.] Univ Iowa, Dept Community & Behav Hlth, Coll Publ Hlth, Iowa City, IA USA; [Walser-Kuntz, Evan; Zimmerman, M. Bridget] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa	Baker, KK (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm Hlth, Iowa City, IA 52242 USA.	kelly-k-baker@uiowa.edu		Baker, Kelly/0000-0002-3774-2628; Story, William/0000-0003-0229-966X	University of Iowa College of Public Health; National Institutes of Health [R01HD041455, R01HD061048]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	University of Iowa College of Public Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This specific study was funded by a pilot grant from the University of Iowa College of Public Health to K.K.B. and W.T.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for the original IHDS study was provided to the University of Maryland and the National Council of Applied Economic Research (NCAER), New Delhi by the National Institutes of Health, grants R01HD041455 and R01HD061048.	Adur SM, 2018, J GENDER STUD, V27, P114, DOI 10.1080/09589236.2016.1264296; Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Baker KK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188234; Bakshi RK, 2015, J DEV STUD, V51, P1603, DOI [10.1080/00220388.2015.1068291, 10.1080/002203]; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Belizan JM, 2012, AM J PERINAT, V29, P649, DOI 10.1055/s-0032-1314885; Benova L, 2014, TROP MED INT HEALTH, V19, P368, DOI 10.1111/tmi.12275; Bisung E, 2014, SOC SCI MED, V108, P194, DOI 10.1016/j.socscimed.2014.01.042; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Brittain K, 2015, PAEDIATR PERINAT EP, V29, P505, DOI 10.1111/ppe.12216; Caruso BA, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000414; Caruso BA, 2015, LANCET, V386, P650, DOI 10.1016/S0140-6736(15)61497-0; Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109; COPPER RL, 1993, AM J OBSTET GYNECOL, V168, P78, DOI 10.1016/S0002-9378(12)90889-3; Das P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130777; Desai Sonalde., 2005, INDIA HUMAN DEV SURV; Dibaba Y, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-135; Eno EE, 2014, INT J GYNECOL OBSTET, V125, P170, DOI 10.1016/j.ijgo.2013.11.007; Esplin MS, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.011; Frey HA, 2016, SEMIN FETAL NEONAT M, V21, P68, DOI 10.1016/j.siny.2015.12.011; Geere JAL, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-52; Gelaye B, 2016, LANCET PSYCHIAT, V3, P973, DOI 10.1016/S2215-0366(16)30284-X; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Harpham T, 2002, HEALTH POLICY PLANN, V17, P106, DOI 10.1093/heapol/17.1.106; Howson C, 2012, BORN TOO SOON GLOBAL; Hulland KRS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141883; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P178, DOI 10.1111/j.1365-3016.2012.01308.x; Joseph G, 2017, UNDERREPORTING GENDE; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kawachi I, 2008, SOCIAL CAPITAL HLTH, DOI [10.1007/978-0-387-71311-3_1, DOI 10.1007/978-0-387-71311-3_1]; Khan MN, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0063-4; Krishna A., 1999, MAPPING MEASURING SO; Kwiringira J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1180; Kwiringira J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-624; LAUNER LJ, 1990, BRIT J OBSTET GYNAEC, V97, P62, DOI 10.1111/j.1471-0528.1990.tb01718.x; Lee ACC, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3677; Manuck TA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.02.010; MENON SA, 1992, J APPL SOC PSYCHOL, V22, P1940, DOI 10.1111/j.1559-1816.1992.tb01531.x; Messer LC, 2008, SOC SCI MED, V67, P1247, DOI 10.1016/j.socscimed.2008.06.009; Mudege NN, 2011, GLOB PUBLIC HEALTH, V6, P221, DOI 10.1080/17441692.2010.487494; Murray E, 2015, BJOG-INT J OBSTET GY, V122, P1062, DOI 10.1111/1471-0528.13435; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Ncube CN, 2016, SOC SCI MED, V153, P156, DOI 10.1016/j.socscimed.2016.02.014; Newman RB, 2001, AM J OBSTET GYNECOL, V184, P438, DOI 10.1067/mob.2001.110312; Olusanya BO, 2010, MATERN CHILD HLTH J, V14, P978, DOI 10.1007/s10995-009-0528-4; Padhi BK, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001851; Payal Hathi, 2016, Waterlines, V35, P118, DOI 10.3362/1756-3488.2016.011; Platt MJ, 2014, PUBLIC HEALTH, V128, P399, DOI 10.1016/j.puhe.2014.03.010; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; Ruark A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188561; Rubens CE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009871; Sahoo KC, 2015, SOC SCI MED, V139, P80, DOI 10.1016/j.socscimed.2015.06.031; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Saurel-Cubizolles MJ, 2004, J EPIDEMIOL COMMUN H, V58, P395, DOI 10.1136/jech.2003.008029; Shapiro GD, 2013, J PERINAT MED, V41, P631, DOI 10.1515/jpm-2012-0295; South SJ, 2014, DEMOGRAPHY, V51, P1019, DOI 10.1007/s13524-014-0289-6; Story WT, 2015, QUAL HEALTH RES, V25, P806, DOI 10.1177/1049732315580106; Story WT, 2012, SOC SCI MED, V75, P2403, DOI 10.1016/j.socscimed.2012.09.017; Taillieu TL, 2010, AGGRESS VIOLENT BEH, V15, P14, DOI 10.1016/j.avb.2009.07.013; Vogel JP, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-56; Wado YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096304	63	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205345	10.1371/journal.pone.0205345	http://dx.doi.org/10.1371/journal.pone.0205345			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW1KF	30296283	Green Published, Green Submitted, gold			2022-12-26	WOS:000446632700033
J	Jiang, Y; Su, DR				Jiang, Ying; Su, Derong			Models of turfgrass seed germination related to water content	PLOS ONE			English	Article							HYDROTHERMAL THRESHOLD MODELS; OPTIMAL TEMPERATURES; L.	Turfgrasses have been widely utilized by humans to enhance the environment for more than several centuries. Seed germination is of great importance in the development of the turfgrass industry. In this study, the seed germination models of the responses of three types of turfgrasses to water were studied. The results indicated that irrigation water was mainly related to the variation of seed volume rather than a fixed value in this experiment. The maximum k value of tall fescue, Kentucky bluegrass and perennial ryegrass is 1.1548, 1.6946 and 4.0940, respectively. The optimal value of k is 1.0617 for tall fescue, 1.4610 for Kentucky bluegrass, and 1.6614 for perennial ryegrass. Perennial ryegrass seeds are more sensitive to water than those of tall fescue and Kentucky bluegrass, and this turfgrass is the fastest to reach the maximum value of the germination rate. Based on the results from the present experiment, the seed germination function can describe the response of turfgrass seed germination to external water content variation and their sensitivities. The function obtained could be used to perform quantitative studies on the dynamic changes of seed germination under different water conditions that will contribute to improved predictions of the optimal fitting curves of the germination over a range of water.	[Jiang, Ying] Guizhou Bot Garden, Guiyang, Guizhou, Peoples R China; [Su, Derong] Beijing Forestry Univ, Grassland Resources & Ecol Res Ctr, Beijing, Peoples R China	Beijing Forestry University	Su, DR (corresponding author), Beijing Forestry Univ, Grassland Resources & Ecol Res Ctr, Beijing, Peoples R China.	suderong@bjfu.edu.cn			National Natural Science Foundation of China [51379011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financed by the National Natural Science Foundation of China (No. 51379011 to DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baki Haji Bakar, 2003, Weed Biology and Management, V3, P8, DOI 10.1046/j.1445-6664.2003.00075.x; BEARD JB, 1994, J ENVIRON QUAL, V23, P452, DOI 10.2134/jeq1994.00472425002300030007x; Bidgoly RO, 2018, IND CROP PROD, V113, P121, DOI 10.1016/j.indcrop.2018.01.017; BRADFORD KJ, 1990, PLANT PHYSIOL, V94, P840, DOI 10.1104/pp.94.2.840; Finch-Savage WE, 2005, NEW PHYTOL, V165, P825, DOI 10.1111/j.1469-8137.2004.01272.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Gurvich DE, 2017, FLORA, V227, P18, DOI 10.1016/j.flora.2016.12.003; [李海燕 Li Haiyan], 2004, [草地学报, Acta agrestia sinica], V12, P45; Mesgaran MB, 2017, ECOL MODEL, V351, P87, DOI 10.1016/j.ecolmodel.2017.02.020; Oweis TY, 2011, AGR WATER MANAGE, V98, P1239, DOI 10.1016/j.agwat.2011.02.009; Ribeirooliveira J, 2017, PLANT BIOSYST, V152, P1; Roberto GG, 2011, SEED SCI TECHNOL, V39, P559, DOI 10.15258/sst.2011.39.3.03; Rowse HR, 2003, NEW PHYTOL, V158, P101, DOI 10.1046/j.1469-8137.2003.00707.x; Vandelook F, 2008, FUNCT ECOL, V22, P470, DOI 10.1111/j.1365-2435.2008.01385.x; Xiong JL, 2018, PLANT PHYSIOL BIOCH, V129, P130, DOI 10.1016/j.plaphy.2018.05.026; Yuan X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191710; [郑红星 Zheng Hongxing], 2004, [水科学进展, Advances in Water Science], V15, P626	17	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0204983	10.1371/journal.pone.0204983	http://dx.doi.org/10.1371/journal.pone.0204983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296292	Green Published, Green Submitted, gold			2022-12-26	WOS:000446632700016
J	Smith, PA; Edwards, DB				Smith, Paul A.; Edwards, Darryl B.			Deceptive nest defence in ground-nesting birds and the risk of intermediate strategies	PLOS ONE			English	Article							ANTIPREDATOR BEHAVIOR; SHOREBIRD INCUBATION; BREEDING SUCCESS; GOLDEN-PLOVER; PREDATION; HABITAT; SITE; INVESTMENT; WADERS; FOXES	Nest predation is an important determinant of reproductive success and ground-nesting birds exhibit a variety of nest defence strategies to mitigate the risk. Many small-bodied, ground nesting birds rely on deceptive behaviours such as injury-feigning to reduce nest predation: we call this behaviour active deception. However, active deception may entail risks to adults, and passive deceptive behaviour, where individuals effectively sneak away from the nest by flushing at long distances, may be an alternative means of avoiding nest predation. We provide a simple model to demonstrate that these tails of the flush distance distribution could minimize predation risk; an intermediate strategy of moderate flush distances means that birds flush more often than with short-distance flushes, and once flushed, the nest is more easily located than for long-distance flushes. We tested this model using two species of ground nesting shorebirds, the White-rumped Sandpiper (Calidris fuscicollis) and the Red Phalarope (Phalaropus fulicarius). We demonstrate that short-distance flushes are associated with active deception and intermediate-distance flushes are associated with an increased risk of nest predation. However, we found no evidence that this potential selective pressure against intermediate strategies has produced a bimodal distribution of nest defence traits. The heritability of defence behaviours, or the ability of individuals to learn, is unknown and other factors such as energetic constraints or risks to adults might also influence flush distances and defence behaviours.	[Smith, Paul A.] Environm & Climate Change Canada, Natl Wildlife Res Ctr, Wildlife Res Div, Ottawa, ON, Canada; [Edwards, Darryl B.] Cambrian Coll, Sudbury, ON, Canada	Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; Wildlife Research Division - Environment Canada	Smith, PA (corresponding author), Environm & Climate Change Canada, Natl Wildlife Res Ctr, Wildlife Res Div, Ottawa, ON, Canada.	paulallen.smith@canada.ca	Oosterveld, Ernst/AET-8555-2022	Smith, Paul/0000-0001-9573-5218	Natural Sciences and Engineering Research Council; Northern Scientific Training Program; Polar Continental Shelf Program; Environment and Climate Change Canada	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Northern Scientific Training Program; Polar Continental Shelf Program; Environment and Climate Change Canada	Financial assistance for this project came from the Natural Sciences and Engineering Research Council, the Northern Scientific Training Program, the Polar Continental Shelf Program and Environment and Climate Change Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1980, ANIM BEHAV, V28, P536, DOI 10.1016/S0003-3472(80)80062-5; [Anonymous], 2021, LANG ENV STAT COMP; BLANCHER PJ, 1982, ANIM BEHAV, V30, P929, DOI 10.1016/S0003-3472(82)80167-X; BRUNTON DH, 1986, WILSON BULL, V98, P605; Bulla M, 2016, NATURE, V540, P109, DOI 10.1038/nature20563; BYRKJEDAL I, 1987, CONDOR, V89, P40, DOI 10.2307/1368758; Freeman JB, 2013, BEHAV RES METHODS, V45, P83, DOI 10.3758/s13428-012-0225-x; Garcia JT, 2003, BIRD STUDY, V50, P142, DOI 10.1080/00063650309461305; Ghalambor CK, 2002, BEHAV ECOL, V13, P101, DOI 10.1093/beheco/13.1.101; Gochfeld M., 1984, Behavior of Marine Animals, V5, P289; Golawski A, 2008, FOLIA ZOOL, V57, P403; GREIGSMITH PW, 1980, ANIM BEHAV, V28, P604, DOI 10.1016/S0003-3472(80)80069-8; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hatch MI, 1997, CONDOR, V99, P282, DOI 10.2307/1369934; HENRY JD, 1977, BEHAVIOUR, V61, P82, DOI 10.1163/156853977X00496; KNIGHT RL, 1986, ANIM BEHAV, V34, P561, DOI 10.1016/S0003-3472(86)80125-7; Koivula K, 1998, OECOLOGIA, V116, P348, DOI 10.1007/s004420050597; Larsen T, 1996, BIOL J LINN SOC, V58, P409; LARSEN T, 1991, ANIM BEHAV, V41, P1057, DOI 10.1016/S0003-3472(05)80643-8; Liebezeit JR, 2008, ARCTIC, V61, P153; Liebezeit JR, 2007, CONDOR, V109, P32, DOI 10.1650/0010-5422(2007)109[32:ATDOSE]2.0.CO;2; Mabee TJ, 1997, WILSON BULL, V109, P307; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1993, AM NAT, V141, P897, DOI 10.1086/285515; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; MONTGOMERIE RD, 1988, Q REV BIOL, V63, P167, DOI 10.1086/415838; Newton I., 1998, POPULATION LIMITATIO; Olendorf R, 2004, P ROY SOC B-BIOL SCI, V271, P177, DOI 10.1098/rspb.2003.2586; Reneerkens J, 2005, J EXP BIOL, V208, P4199, DOI 10.1242/jeb.01872; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Skrade PDB, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00246.1; Smith PA, 2007, AUK, V124, P276, DOI 10.1642/0004-8038(2007)124[276:AVITBO]2.0.CO;2; Smith PA, 2012, STUD AVIAN BIOL, P89; Smith PA, 2012, ANIM BEHAV, V84, P835, DOI 10.1016/j.anbehav.2012.07.004; Smith PA, 2010, OECOLOGIA, V163, P613, DOI 10.1007/s00442-010-1644-y; Smith PA, 2007, CONDOR, V109, P15; SONERUD GA, 1988, OIKOS, V51, P233, DOI 10.2307/3565647; Troy DM., 1996, INT WADER STUD, V8, P15; Whittingham MJ, 2002, J AVIAN BIOL, V33, P184, DOI 10.1034/j.1600-048X.2002.330210.x	39	12	12	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205236	10.1371/journal.pone.0205236	http://dx.doi.org/10.1371/journal.pone.0205236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296281	gold, Green Published			2022-12-26	WOS:000446632700026
J	Arganaraz, JP; Landi, MA; Scavuzzo, CM; Bellis, LM				Arganaraz, Juan P.; Landi, Marcos A.; Marcelo Scavuzzo, Carlos; Bellis, Laura M.			Determining fuel moisture thresholds to assess wildfire hazard: A contribution to an operational early warning system	PLOS ONE			English	Article							FIRE DANGER ASSESSMENT; MODIS IMAGES; VEGETATION; FOREST; CORDOBA; SPREAD; MOUNTAINS; IGNITION; MANAGEMENT; SHRUBLAND	Fuel moisture content (FMC) is an important fuel property for assessing wildfire hazard, since it influences fuel flammability and fire behavior. The relationship between FMC and fire activity differs among land covers and seems to be a property of each ecosystem. Our objectives were to analyze pre-fire FMC among different land covers and to propose a wildfire hazard classification for the Sierras Chicas in the Chaco Serrano subregion (Argentina), by analyzing pre-fire FMC distributions observed for grasslands, shrublands and forests and using percentiles to establish thresholds. For this purpose, we used a fire database derived from Landsat imagery (30 m) and derived FMC maps every 8 days from 2002 to 2016 using MODIS reflectance products and empirical equations of FMC. Our results indicated that higher FMC constrains the extent of wildfires, whereas at lower FMC there are other factors affecting their size. Extreme and high fire hazard thresholds for grasslands were established at FMC of 55% and 67% respectively, at 72% and 105% for forests and at 106% and 121% for shrublands. Our FMC thresholds were sensitive to detect extreme fire hazard conditions during years with high fire activity in comparison to average conditions. The differences in the distributions of pre-fire FMC among land covers and between ecosystems highlighted the need to locally determine land cover-specific FMC thresholds to assess wildfire hazard. Our wildfire hazard classification applied to FMC maps in an operational framework will contribute to improving early warning systems in the Sierras Chicas. However, moisture alone is not sufficient to represent true fire hazard in Chaco forests and the combination with other variables would provide better hazard assessments. These operational wildfire hazard maps will help to better allocation of fire protective resources to minimize negative impact on people, property and ecosystems. To the best of our knowledge, this is the first study analyzing pre-fire FMC over several fire seasons in a non-Mediterranean ecosystem, aiming at assessing wildfire hazard.	[Arganaraz, Juan P.; Landi, Marcos A.; Bellis, Laura M.] Univ Nacl Cordoba, IDEA, CONICET, Cordoba, Argentina; [Arganaraz, Juan P.; Landi, Marcos A.; Bellis, Laura M.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Cordoba, Argentina; [Arganaraz, Juan P.; Marcelo Scavuzzo, Carlos; Bellis, Laura M.] Univ Nacl Cordoba, Inst Altos Estudios Espaciales Mario Gulich, Comis Nacl Actividades Espaciales, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; National University of Cordoba	Arganaraz, JP (corresponding author), Univ Nacl Cordoba, IDEA, CONICET, Cordoba, Argentina.; Arganaraz, JP (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Cordoba, Argentina.; Arganaraz, JP (corresponding author), Univ Nacl Cordoba, Inst Altos Estudios Espaciales Mario Gulich, Comis Nacl Actividades Espaciales, Cordoba, Argentina.	argajuan@gmail.com	scavuzzo, carlos marcelo/M-9829-2015; Argañaraz, Juan/W-8022-2019; Landi, Marcos Alejandro/ADZ-2022-2022	/0000-0003-1388-9219; carlos marcelo, scavuzzo/0000-0003-0905-6361	Secretaria de Ciencia y Tecnica (SECyT) - Universidad Nacional de Cordoba; Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) (PICT) [1147-2012]; CONICET	Secretaria de Ciencia y Tecnica (SECyT) - Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) (PICT)(FONCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was funded by grants to L.M. B. from Secretaria de Ciencia y Tecnica (SECyT) - Universidad Nacional de Cordoba and Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) (PICT No 1147-2012). J.P.A. and M.A.L. have Postdoctoral fellowships from CONICET and L.M.B. is a researcher at CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi S, 2014, J FOREST RES-JPN, V19, P105, DOI 10.1007/s10310-012-0388-4; Andrews PL, 2003, INT J WILDLAND FIRE, V12, P213, DOI 10.1071/WF02059; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arganaraz JP, 2017, J ENVIRON MANAGE, V196, P499, DOI 10.1016/j.jenvman.2017.03.058; Arganaraz JP, 2016, DINAMICA ESPACIAL FU; Arganaraz JP, 2018, IEEE LAT AM T, V16, P977; Arganaraz JP, 2015, SCI TOTAL ENVIRON, V520, P1, DOI 10.1016/j.scitotenv.2015.02.081; Arganaraz JP, 2015, FIRE ECOL, V11, P55, DOI 10.4996/fireecology.1101055; Barraza V, 2014, IEEE J-STARS, V7, P421, DOI 10.1109/JSTARS.2013.2268011; Bellis LM, 2015, IGARSS 2015; Bianchi LO, 2015, INT J WILDLAND FIRE, V24, P340, DOI 10.1071/WF13099; Bonansea M, 2013, WATER SCI TECHNOL, V67, P217, DOI 10.2166/wst.2012.560; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bucher E.H., 2004, ACAD NACL CIENCIAS C, V101, P1; Cabido M, 2018, APPL VEG SCI, V21, P298, DOI 10.1111/avsc.12369; Caccamo G, 2012, INT J WILDLAND FIRE, V21, P257, DOI 10.1071/WF11024; Calkin D.E., 2013, RMRSGTR315 USDA FOR; Calkin DE, 2014, P NATL ACAD SCI USA, V111, P746, DOI 10.1073/pnas.1315088111; CHLADIL MA, 1995, INT J WILDLAND FIRE, V5, P165, DOI 10.1071/WF9950165; Chowdhury EH, 2015, ISPRS J PHOTOGRAMM, V104, P224, DOI 10.1016/j.isprsjprs.2014.03.011; Chuvieco E, 2014, INT J WILDLAND FIRE, V23, P606, DOI 10.1071/WF12052; Chuvieco E, 2002, INT J REMOTE SENS, V23, P2145, DOI 10.1080/01431160110069818; Chuvieco E, 2009, INT J WILDLAND FIRE, V18, P430, DOI 10.1071/WF08020; Cingolani AM, 2013, RANGELAND J, V35, P285, DOI 10.1071/RJ12095; Cruz MG, 2015, INT J WILDLAND FIRE, V24, P838, DOI 10.1071/WF14146; Davidson A, 2006, INT J APPL EARTH OBS, V8, P225, DOI 10.1016/j.jag.2005.10.002; Davies GM, 2011, FIRE TECHNOL, V47, P421, DOI 10.1007/s10694-010-0162-0; Davies GM, 2009, J APPL ECOL, V46, P1054, DOI 10.1111/j.1365-2664.2009.01681.x; de Jong MC, 2016, NAT HAZARD EARTH SYS, V16, P1217, DOI 10.5194/nhess-16-1217-2016; de Torres Curth Monica I., 2008, Ecologia Austral, V18, P153; Dennison PE, 2008, INT J WILDLAND FIRE, V17, P18, DOI 10.1071/WF07017; Dennison PE, 2009, INT J WILDLAND FIRE, V18, P1021, DOI 10.1071/WF08055; Dentoni MC, 2001, METEOROL APPL, V8, P361, DOI 10.1017/S1350482701003127; Dibble AC, 2007, INT J WILDLAND FIRE, V16, P426, DOI 10.1071/WF05103; Gander W, 1993, SOLVING PROBLEMS SCI, P121, DOI DOI 10.1007/978-3-642-975333-2_9; Gavier-Pizarro GI, 2012, REMOTE SENS ENVIRON, V122, P134, DOI 10.1016/j.rse.2011.09.023; Giorgis MA, 2013, B SOC ARGENT BOT, V48, P493; Giorgis Melisa A, 2011, Kurtziana, V36, P9; Govender N, 2006, J APPL ECOL, V43, P748, DOI 10.1111/j.1365-2664.2006.01184.x; Hantson S, 2015, GLOBAL ECOL BIOGEOGR, V24, P77, DOI 10.1111/geb.12246; Hawbaker TJ, 2013, ECOL APPL, V23, P565, DOI 10.1890/12-1816.1; Heinsch FA, 2009, P 8 S FIR FOR MET; Hsu C. W., 2010, TECHNICAL REPORT; Hurtado Hernandez A., 2018, PHYTOMA ESPANA, V301, P50; Jaureguiberry P, 2011, AUSTRAL ECOL, V36, P821, DOI 10.1111/j.1442-9993.2010.02222.x; Jolly WM, 2012, FOREST ECOL MANAG, V269, P52, DOI 10.1016/j.foreco.2011.12.022; Jonsson P, 2004, COMPUT GEOSCI-UK, V30, P833, DOI 10.1016/j.cageo.2004.05.006; Jurdao S, 2013, REMOTE SENS ENVIRON, V132, P59, DOI 10.1016/j.rse.2013.01.004; Jurdao S, 2012, FIRE ECOL, V8, P77, DOI 10.4996/fireecology.0801077; KOENKER R., 2013, QUANTREG QUANTILE RE; Kunst C, 2015, RIA. Rev. investig. agropecu., V41, P83; Kunst C, 2014, RIA. Rev. investig. agropecu., V40, P165; McAllister S, 2017, COMBUST SCI TECHNOL, V189, P231, DOI 10.1080/00102202.2016.1206086; McKenzie D, 2011, ECOL STUD-ANAL SYNTH, V213, P1, DOI 10.1007/978-94-007-0301-8; Melnik O.M., 2016, THESIS U ALBERTA EDM, DOI [10.7939/R3862BH01, DOI 10.7939/R3862BH01]; Meyer D, 2015, MISC FUNCTIONS DEP S; NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x; Arganaraz JP, 2016, IEEE J-STARS, V9, P5339, DOI 10.1109/JSTARS.2016.2575366; Pellizzaro G, 2007, INT J WILDLAND FIRE, V16, P232, DOI 10.1071/WF06081; Peterson SH, 2008, REMOTE SENS ENVIRON, V112, P4272, DOI 10.1016/j.rse.2008.07.012; Qi Y, 2012, FIRE ECOL, V8, P71, DOI 10.4996/fireecology.0803071; Renison D, 2002, REV CHIL HIST NAT, V75, P719; Rossa CG, 2017, FOREST SYST, V26, DOI 10.5424/fs/2017263-12019; Rossa CG, 2017, INT J WILDLAND FIRE, V26, P24, DOI 10.1071/WF16049; Schoenberg FP, 2003, INT J WILDLAND FIRE, V12, P1, DOI 10.1071/WF02053; Syphard AD, 2009, CONSERV BIOL, V23, P758, DOI 10.1111/j.1523-1739.2009.01223.x; Talamo A, 2003, FOREST ECOL MANAG, V184, P79, DOI 10.1016/S0378-1127(03)00150-6; Tiribelli F, 2018, J VEG SCI, V29, P147, DOI 10.1111/jvs.12620; TURNER MG, 1994, J VEG SCI, V5, P731, DOI 10.2307/3235886; Van Wagner C.E., 1987, DEV STRUCTURE CANADI; Viegas DX, 2001, INT J WILDLAND FIRE, V10, P223, DOI 10.1071/WF01022; Weise DR, 2016, INT J WILDLAND FIRE, V25, P980, DOI 10.1071/WF15177; Weise DR, 2005, INT J WILDLAND FIRE, V14, P99, DOI 10.1071/WF04049; Weise DR, 1998, FIR EC MAN SHIFT PAR; Yebra M, 2008, AGR FOREST METEOROL, V148, P523, DOI 10.1016/j.agrformet.2007.12.005; Yebra M, 2013, REMOTE SENS ENVIRON, V136, P455, DOI 10.1016/j.rse.2013.05.029; Zak M., 2008, PATRONES ESPACIALES; Zak MR, 2008, ENVIRON MANAGE, V42, P181, DOI 10.1007/s00267-008-9101-y; Zylstra PJ, 2018, AUSTRAL ECOL, V43, P578, DOI 10.1111/aec.12594	79	18	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204889	10.1371/journal.pone.0204889	http://dx.doi.org/10.1371/journal.pone.0204889			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286128	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500057
J	Kim, Y; Kang, H; Powathil, G; Kim, H; Trucu, D; Lee, W; Lawler, S; Chaplain, M				Kim, Yangjin; Kang, Hyunji; Powathil, Gibin; Kim, Hyeongi; Trucu, Dumitru; Lee, Wanho; Lawler, Sean; Chaplain, Mark			Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma	PLOS ONE			English	Article							CHONDROITIN-SULFATE PROTEOGLYCANS; GLIOMA-CELL MIGRATION; SPINAL-CORD-INJURY; ADULT-RAT BRAIN; REACTIVE ASTROCYTES; FACTOR RECEPTOR; HYBRID MODEL; IN-VITRO; FUNCTIONAL RECOVERY; ALZHEIMERS-DISEASE	The cellular dispersion and therapeutic control of glioblastoma, the most aggressive type of primary brain cancer, depends critically on the migration patterns after surgery and intracellular responses of the individual cancer cells in response to external biochemical cues in the microenvironment. Recent studies have shown that miR-451 regulates downstream molecules including AMPK/CAB39/MARK and mTOR to determine the balance between rapid proliferation and invasion in response to metabolic stress in the harsh tumor microenvironment. Surgical removal of the main tumor is inevitably followed by recurrence of the tumor due to inaccessibility of dispersed tumor cells in normal brain tissue. In order to address this complex process of cell proliferation and invasion and its response to conventional treatment, we propose a mathematical model that analyzes the intracellular dynamics of the miR-451-AMPK- mTOR-cell cycle signaling pathway within a cell. The model identifies a key mechanism underlying the molecular switches between proliferative phase and migratory phase in response to metabolic stress in response to fluctuating glucose levels. We show how up- or down-regulation of components in these pathways affects the key cellular decision to infiltrate or proliferate in a complex microenvironment in the absence and presence of time delays and stochastic noise. Glycosylated chondroitin sulfate proteoglycans (CSPGs), a major component of the extracellular matrix (ECM) in the brain, contribute to the physical structure of the local brain microenvironment but also induce or inhibit glioma invasion by regulating the dynamics of the CSPG receptor LAR as well as the spatiotemporal activation status of resident astrocytes and tumor-associated microglia. Using a multi-scale mathematical model, we investigate a CSPG-induced switch between invasive and non-invasive tumors through the coordination of ECM-cell adhesion and dynamic changes in stromal cells. We show that the CSPG-rich microenvironment is associated with non-invasive tumor lesions through LAR-CSGAG binding while the absence of glycosylated CSPGs induce the critical glioma invasion. We illustrate how high molecular weight CSPGs can regulate the exodus of local reactive astrocytes from the main tumor lesion, leading to encapsulation of non-invasive tumor and inhibition of tumor invasion. These different CSPG conditions also change the spatial profiles of ramified and activated microglia. The complex distribution of CSPGs in the tumor microenvironment can determine the nonlinear invasion behaviors of glioma cells, which suggests the need for careful therapeutic strategies.	[Kim, Yangjin] Konkuk Univ, Dept Math, Seoul, South Korea; [Kim, Yangjin] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Kang, Hyunji; Kim, Hyeongi] Korea Inst Radiol & Med Sci, Mol Imaging Res Ctr, Seoul, South Korea; [Powathil, Gibin] Swansea Univ, Dept Math, Swansea, W Glam, Wales; [Trucu, Dumitru] Univ Dundee, Div Math, Dundee, Scotland; [Lee, Wanho] Natl Inst Math Sci, Daejeon, South Korea; [Lawler, Sean] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Lawler, Sean] Harvard Med Sch, Boston, MA USA; [Chaplain, Mark] Univ St Andrews, Sch Math & Stat, Math Inst, St Andrews, Fife, Scotland	Konkuk University; University System of Ohio; Ohio State University; Korea Institute of Radiological & Medical Sciences; Swansea University; University of Dundee; National Institute for Mathematical Sciences (NIMS), Republic of Korea; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of St Andrews	Kim, Y (corresponding author), Konkuk Univ, Dept Math, Seoul, South Korea.; Kim, Y (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	ahyouhappy@konkuk.ac.kr	Kim, Yangjin/C-9681-2014; Chaplain, Mark AJ/A-5355-2010; POWATHIL, GIBIN/D-4711-2014	Kim, Yangjin/0000-0002-8905-8481; Chaplain, Mark AJ/0000-0001-5727-2160; POWATHIL, GIBIN/0000-0002-8372-7349	Konkuk University	Konkuk University	This paper was supported by Konkuk University in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Alfonso JCL, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0490; Alfonso JCL, 2016, SCI REP-UK, V6, DOI 10.1038/srep37283; Andrews EM, 2012, EXP NEUROL, V235, P174, DOI 10.1016/j.expneurol.2011.09.008; Angeli S, 2016, J BIOMECH, V49, P1524, DOI 10.1016/j.jbiomech.2016.03.029; Arslan F, 2007, BRIT J CANCER, V96, P1560, DOI 10.1038/sj.bjc.6603766; Aubert M, 2008, ACTA BIOTHEOR, V56, P297, DOI 10.1007/s10441-008-9061-x; Baker GJ, 2014, NEOPLASIA, V16, P543, DOI 10.1016/j.neo.2014.06.003; Barbero S, 2002, ANN NY ACAD SCI, V973, P60, DOI 10.1111/j.1749-6632.2002.tb04607.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Biasoli D, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.36; Black PC, 2007, UROL ONCOL-SEMIN ORI, V25, P433, DOI 10.1016/j.urolonc.2007.05.011; Boele FW, 2015, NEUROPSYCH DIS TREAT, V11, P1413, DOI 10.2147/NDT.S65874; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chintala SK, 1999, INT J DEV NEUROSCI, V17, P495, DOI 10.1016/S0736-5748(99)00010-6; Chistiakov DA, 2012, EUR J PHARMACOL, V684, P8, DOI 10.1016/j.ejphar.2012.03.031; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Coniglio SJ, 2013, MATRIX BIOL, V32, P372, DOI 10.1016/j.matbio.2013.07.008; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; COOPER NGF, 1986, J COMP NEUROL, V249, P157, DOI 10.1002/cne.902490204; Crespo D, 2007, EXP NEUROL, V206, P159, DOI 10.1016/j.expneurol.2007.05.001; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; Dallon JC, 2004, J THEOR BIOL, V231, P203, DOI 10.1016/j.jtbi.2004.06.015; Davis F G, 2001, Expert Rev Anticancer Ther, V1, P395, DOI 10.1586/14737140.1.3.395; Davis ME, 2016, CLIN J ONCOL NURS, V20, P2, DOI 10.1188/16.CJON.S1.2-8; de los Reyes AA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1392; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Dmitrieva N, 2011, CLIN CANCER RES, V17, P1362, DOI 10.1158/1078-0432.CCR-10-2213; Edwards LA, 2011, JNCI-J NATL CANCER I, V103, P1162, DOI 10.1093/jnci/djr224; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; FAISSNER A, 1995, GLIA, V13, P233, DOI 10.1002/glia.440130402; Fernandez-Gonzalez R, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2101pe78; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Floyd D, 2014, NEURO-ONCOLOGY, V16, P622, DOI 10.1093/neuonc/nou049; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedman BA, 2018, CELL REP, V22, P832, DOI 10.1016/j.celrep.2017.12.066; Gagliano N, 2009, ONCOL REP, V22, P1349, DOI 10.3892/or_00000574; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Godlewski J, 2010, CELL CYCLE, V9, P2742, DOI 10.4161/cc.9.14.12248; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Golding JP, 1999, DEV BIOL, V216, P85, DOI 10.1006/dbio.1999.9497; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Green NK, 2008, J GENE MED, V10, P280, DOI 10.1002/jgm.1121; Griveau A, 2018, CANCER CELL, V33, P874, DOI 10.1016/j.ccell.2018.03.020; Grumet M, 1996, PERSPECT DEV NEUROBI, V3, P319; Gu WL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-128; Guan X, 2018, MOL NEUROBIO, V55, P1; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Han JF, 2015, AM J CANCER RES, V5, P945; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hatzikirou H, 2012, MATH MED BIOL, V29, P49, DOI 10.1093/imammb/dqq011; Hayashi N, 2007, BIOCHEM BIOPH RES CO, V364, P410, DOI 10.1016/j.bbrc.2007.10.040; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HEYMAN I, 1995, DEV DYNAM, V204, P301, DOI 10.1002/aja.1002040308; Hines DJ, 2009, GLIA, V57, P1610, DOI 10.1002/glia.20874; Hosseinahli N, 2018, J CELL PHYSIOL, V233, P5574, DOI 10.1002/jcp.26514; Jacobs VL, 2011, ASN NEURO, V3, DOI 10.1042/AN20110014; JAIN RK, 1987, CANCER RES, V47, P3039; Jhaveri S, 1993, Perspect Dev Neurobiol, V1, P237; Juratli TA, 2013, PHARMACOL THERAPEUT, V139, P341, DOI 10.1016/j.pharmthera.2013.05.003; Katsushima K, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00014; Khain E, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031920; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Kim J, 2012, BIOMATERIALS, V33, P1838, DOI 10.1016/j.biomaterials.2011.11.020; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim Y, 2007, MATH MOD METH APPL S, V17, P1773, DOI 10.1142/S0218202507002479; Kim Y, 2018, P NATL ACAD SCI USA, V115, P4927, DOI 10.1073/pnas.1715295115; Kim Y, 2017, IEEE T BIO-MED ENG, V64, P519, DOI 10.1109/TBME.2016.2637828; Kim Y, 2015, MATH BIOSCI ENG, V12, P1141, DOI 10.3934/mbe.2015.12.1141; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114370; Kim Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102499; Kim Y, 2013, B MATH BIOL, V75, P1304, DOI 10.1007/s11538-012-9787-0; Kim Y, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00053; Kim Y, 2013, DISCRETE CONT DYN-B, V18, P969, DOI 10.3934/dcdsb.2013.18.969; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Kim Y, 2011, PROG BIOPHYS MOL BIO, V106, P353, DOI 10.1016/j.pbiomolbio.2011.06.006; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; Kobayashi Takashi, 2017, Biochem Biophys Rep, V9, P72, DOI 10.1016/j.bbrep.2016.11.009; Koh I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22681-3; Kundu S, 2014, EUR ASS NEUROONCOL M, V4, P75; Kwon SJ, 2005, CLIN CANCER RES, V11, P4694, DOI 10.1158/1078-0432.CCR-04-2530; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lang BT, 2011, SOC NEUR ABSTR, V37, P892; Lawler S, 2009, J NEURO-ONCOL, V92, P297, DOI 10.1007/s11060-009-9843-2; Le DM, 2003, J NEUROSCI, V23, P4034; Lee S, 2017, J CONTROL RELEASE, V263, P68, DOI 10.1016/j.jconrel.2017.02.035; Lee W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171312; LI CKN, 1982, CANCER-AM CANCER SOC, V50, P2066, DOI 10.1002/1097-0142(19821115)50:10<2066::AID-CNCR2820501017>3.0.CO;2-X; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Logun MT, 2016, J MATER CHEM B, V4, P6052, DOI [10.1039/c6tb01083k, 10.1039/C6TB01083K]; Lokody I, 2014, NAT REV CANCER, V14, DOI 10.1038/nrc3727; Manini I, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010147; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Matias D, 2017, BBA-REV CANCER, V1868, P333, DOI 10.1016/j.bbcan.2017.05.007; MCCABE M, 1975, BIOCHIM BIOPHYS ACTA, V399, P131, DOI 10.1016/0304-4165(75)90219-6; Mens MMJ, 2018, STEM CELL REV REP, V14, P309, DOI 10.1007/s12015-018-9808-y; Mentlein R, 2012, BBA-REV CANCER, V1825, P178, DOI 10.1016/j.bbcan.2011.12.001; Mettang M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23592-z; Mok W, 2007, CANCER RES, V67, P10664, DOI 10.1158/0008-5472.CAN-07-3107; Moon LDF, 2003, J NEUROSCI RES, V71, P23, DOI 10.1002/jnr.10449; Morrison J, 2008, MOL THER, V16, P244, DOI 10.1038/sj.mt.6300363; MUELLERKLIESER WF, 1984, ADV EXP MED BIOL, V180, P311; Muller S, 2003, ONCOGENE, V22, P6661, DOI 10.1038/sj.onc.1206763; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Novak B, 2003, BIOCHEM SOC T, V31, P1526; O'Brien ER, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00040; Okolie O, 2016, NEURO-ONCOLOGY, V18, P1622, DOI 10.1093/neuonc/now117; Owen MR, 2004, J THEOR BIOL, V226, P377, DOI 10.1016/j.jtbi.2003.09.004; Paolillo M, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010015; Pearson JRD, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.40; Placone AL, 2016, TUMOR BIOL, V37, P61, DOI 10.1007/s13277-015-4242-0; Powathil G, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/410602; Powathil GG, 2012, J THEOR BIOL, V308, P1, DOI 10.1016/j.jtbi.2012.05.015; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Rajesh Y, 2017, EXP CELL RES, V359, P299, DOI 10.1016/j.yexcr.2017.08.032; Rape A, 2014, ADV DRUG DELIVER REV, V79-80, P172, DOI 10.1016/j.addr.2014.08.012; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; Rong ZM, 2006, ANALYST, V131, P816, DOI 10.1039/b600334f; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Sander LM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051901; Schattler H, 2013, IEEE DECIS CONTR P, P1810, DOI 10.1109/CDC.2013.6760145; Silver DJ, 2014, CURR OPIN NEUROBIOL, V27, P171, DOI 10.1016/j.conb.2014.03.016; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; STEINDLER DA, 1988, J COMP NEUROL, V267, P357, DOI 10.1002/cne.902670306; Stolarska MA, 2009, PHILOS T R SOC A, V367, P3525, DOI 10.1098/rsta.2009.0095; Strickland M, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00043; Stylli SS, 2005, J CLIN NEUROSCI, V12, P389, DOI 10.1016/j.jocn.2005.01.006; Subramaniam SR, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00176; Szabo A, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016010; Tektonidis M, 2011, J THEOR BIOL, V287, P131, DOI 10.1016/j.jtbi.2011.07.012; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tyson JJ, 2001, J THEOR BIOL, V210, P249, DOI 10.1006/jtbi.2001.2293; Verheije MH, 2009, J VIROL, V83, P7507, DOI 10.1128/JVI.00495-09; Viapiano M., 2009, GLIOMA INVASION MECH; Viapiano MS, 2006, TRENDS MOL MED, V12, P488, DOI 10.1016/j.molmed.2006.08.007; Viapiano MS, 2008, J NEURO-ONCOL, V88, P261, DOI 10.1007/s11060-008-9575-8; Viapiano MS, 2005, CANCER RES, V65, P6726, DOI 10.1158/0008-5472.CAN-05-0585; Wang Y, 2013, ONCOGENE, V32, P872, DOI 10.1038/onc.2012.104; Wani R, 2011, CELL CYCLE, V10, P3263, DOI 10.4161/cc.10.19.17738; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Watts C, 2014, CLIN ONCOL-UK, V26, P385, DOI 10.1016/j.clon.2014.04.001; Wesolowska A, 2008, ONCOGENE, V27, P918, DOI 10.1038/sj.onc.1210683; Westhoff MA, 2009, DRUG RESIST UPDATE, V12, P127, DOI 10.1016/j.drup.2009.08.001; WINDLE WF, 1950, J COMP NEUROL, V93, P241, DOI 10.1002/cne.900930206; Zhang H, 1998, J NEUROSCI, V18, P2370; Zhou Jing, 2008, Kobe J Med Sci, V53, P283	163	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204865	10.1371/journal.pone.0204865	http://dx.doi.org/10.1371/journal.pone.0204865			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286133	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500053
J	Massoud, D; Lao-Perez, M; Hurtado, A; Abdo, W; Palomino-Morales, R; Carmona, FD; Burgos, M; Jimenez, R; Barrionuevo, FJ				Massoud, Diaa; Lao-Perez, Miguel; Hurtado, Alicia; Abdo, Walied; Palomino-Morales, Rogelio; David Carmona, Francisco; Burgos, Miguel; Jimenez, Rafael; Barrionuevo, Francisco J.			Germ cell desquamation-based testis regression in a seasonal breeder, the Egyptian long-eared hedgehog, Hemiechinus auritus	PLOS ONE			English	Article							HAMSTERS MESOCRICETUS-AURATUS; PERITUBULAR MYOID CELLS; LARGE HAIRY ARMADILLO; MINK MUSTELA-VISION; SEMINIFEROUS EPITHELIUM; CHAETOPHRACTUS-VILLOSUS; TESTICULAR REGRESSION; IBERIAN MOLE; APOPTOSIS; PROLIFERATION	Testes of seasonally breeding species experience a severe functional regression before the non-breeding period, which implies a substantial mass reduction due to massive germ-cell depletion. Two alternative mechanisms of seasonal germ-cell depletion have been described in mammals, apoptosis and desquamation (sloughing), but their prevalence has not been determined yet due to reduced number of species studied. We performed a morphological, hormonal, and molecular study of the mechanism of seasonal testicular regression in males of the Egyptian long eared-hedgehog (Hemiechinus auritus). Our results show that live, non-apoptotic, germ cells are massively depleted by desquamation during the testis regression process. This is concomitant with both decreased levels of serum testosterone and irregular distribution of the cell-adhesion molecules in the seminiferous epithelium. The inactive testes maintain some meiotic activity as meiosis onset is not halted and spermatocytes die by apoptosis at the pachytene stage. Our data support the notion that apoptosis is not the major testis regression effector in mammals. Instead, desquamation appears to be a common mechanism in this class.	[Massoud, Diaa] Fayoum Univ, Fac Sci, Dept Zool, Al Fayyum, Egypt; [Lao-Perez, Miguel; Hurtado, Alicia; David Carmona, Francisco; Burgos, Miguel; Jimenez, Rafael; Barrionuevo, Francisco J.] Univ Granada, Dept Genet, Granada, Spain; [Lao-Perez, Miguel; Hurtado, Alicia; David Carmona, Francisco; Burgos, Miguel; Jimenez, Rafael; Barrionuevo, Francisco J.] Univ Granada, Inst Biotecnol, Granada, Spain; [Abdo, Walied] Kafr El Sheikh Univ, Fac Vet Med, Dept Pathol, Kafr Al Sheikh, Egypt; [Palomino-Morales, Rogelio] Univ Granada, Dept Bioquim & Biol Mol 1, Granada, Spain	Egyptian Knowledge Bank (EKB); Fayoum University; University of Granada; University of Granada; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; University of Granada	Jimenez, R (corresponding author), Univ Granada, Dept Genet, Granada, Spain.; Jimenez, R (corresponding author), Univ Granada, Inst Biotecnol, Granada, Spain.	rjimenez@ugr.es	Abdo, Walied/AAF-2032-2019; Carmona, F. David/F-9953-2016; Jiménez, Rafael/AAQ-3775-2021; Palomino-Morales, Rogelio J/L-5720-2014; Jiménez, Rafael/J-4103-2012; Barrionuevo, Francisco/AAA-7639-2019; Massoud, Diaa/A-6492-2018; Burgos, Miguel/L-3709-2014	Carmona, F. David/0000-0002-1427-7639; Jiménez, Rafael/0000-0003-4103-8219; Palomino-Morales, Rogelio J/0000-0003-3507-343X; Jiménez, Rafael/0000-0003-4103-8219; Barrionuevo, Francisco/0000-0003-2651-1530; , Walied/0000-0003-4635-8342; Massoud, Diaa/0000-0001-8646-9253; Burgos, Miguel/0000-0003-4446-9313	Agencia de Innovacion y Desarrollo de la "Junta de Andalucia" through Group PAI [BIO-109]; Spanish "Secretaria de Estado de Investigacion, Desarrollo e Innovacion" [CGL-2015-67108-P]; FEDER	Agencia de Innovacion y Desarrollo de la "Junta de Andalucia" through Group PAI; Spanish "Secretaria de Estado de Investigacion, Desarrollo e Innovacion"; FEDER(European Commission)	This study has been supported by the Agencia de Innovacion y Desarrollo de la "Junta de Andalucia" through Group PAI BIO-109 and the Spanish "Secretaria de Estado de Investigacion, Desarrollo e Innovacion" through the grant CGL-2015-67108-P, which includes FEDER funds.	ASAWA SC, 1981, ACTA ANAT, V111, P259; Barrionuevo FJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15635; Batias C, 1999, CELL TISSUE RES, V298, P113, DOI 10.1007/s004419900076; Berg KA, 2001, INT J ANDROL, V24, P284, DOI 10.1046/j.1365-2605.2001.00300.x; BLOTTNER S, 1995, THERIOGENOLOGY, V44, P321, DOI 10.1016/0093-691X(95)00187-D; Blottner S, 2007, CELL TISSUE RES, V327, P615, DOI 10.1007/s00441-006-0328-8; CHAPMAN DL, 1994, INT J DEV BIOL, V38, P491; Dadhich RK, 2011, SEX DEV, V5, P77, DOI 10.1159/000323805; Dadhich RK, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106708; Dadhich RK, 2010, BIOL REPROD, V83, P83, DOI 10.1095/biolreprod.109.080135; Flower MSS., 1932, P ZOOL SOC LOND, V102, P369, DOI [10.1111/j.1096-3642.1932.tb01081.x, DOI 10.1111/J.1096-3642.1932.TB01081.X]; FURUTA I, 1994, BIOL REPROD, V51, P1315, DOI 10.1095/biolreprod51.6.1315; Gonzalez CR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191126; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; GOYAL RP, 1974, ACTA ANAT, V90, P462; Hamer G, 2008, THERIOGENOLOGY, V69, P333, DOI 10.1016/j.theriogenology.2007.09.029; Islam MN, 2012, THERIOGENOLOGY, V77, P1854, DOI 10.1016/j.theriogenology.2012.01.002; Jimenez R, 2015, SEX DEV, V9, P205, DOI 10.1159/000439039; Kaur G, 2014, SEMIN CELL DEV BIOL, V30, P36, DOI 10.1016/j.semcdb.2014.02.011; Kingdon J, 2013, MAMMALS AFRICA BLOOM; KIRKPATRICK CM, 1955, AM J ANAT, V97, P229, DOI 10.1002/aja.1000970203; Luaces JP, 2013, REPROD FERT DEVELOP, V25, P547, DOI 10.1071/RD12127; Luaces JP, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113118; Massoud D, 2014, J EXP ZOOL PART B, V322, P304, DOI 10.1002/jez.b.22582; McClusky LM, 2012, CELL TISSUE RES, V349, P703, DOI 10.1007/s00441-011-1288-1; Morales E, 2002, INT J ANDROL, V25, P281, DOI 10.1046/j.1365-2605.2002.00363.x; Morales E, 2007, J ANDROL, V28, P123, DOI 10.2164/jandrol.106.000778; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Neill JD, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1; PALOMBI F, 1992, ANAT REC, V233, P32, DOI 10.1002/ar.1092330106; Pastor LM, 2011, REPROD DOMEST ANIM, V46, P155, DOI 10.1111/j.1439-0531.2009.01573.x; PELLETIER RM, 1988, AM J ANAT, V183, P68, DOI 10.1002/aja.1001830105; PELLETIER RM, 1986, AM J ANAT, V175, P91, DOI 10.1002/aja.1001750109; Prakash I., 1960, INDIA J MAMMAL, V41, P386, DOI DOI 10.2307/1377497; RICHARDSON LL, 1995, BIOL REPROD, V52, P320, DOI 10.1095/biolreprod52.2.320; SCHOENFELD M, 1985, MAMMALIA, V49, P339, DOI 10.1515/mamm.1985.49.3.339; Seco-Rovira V, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.112649; Shukla Kamla Kant, 2012, Front Biosci (Elite Ed), V4, P746; Stanton PG, 2016, SEMIN CELL DEV BIOL, V59, P166, DOI 10.1016/j.semcdb.2016.06.018; Strbenc M, 2003, ANAT HISTOL EMBRYOL, V32, P48, DOI 10.1046/j.1439-0264.2003.00437.x; Tarulli GA, 2008, REPRODUCTION, V135, P867, DOI 10.1530/REP-07-0572; Tripathi R, 2009, J REPROD IMMUNOL, V83, P31, DOI 10.1016/j.jri.2009.05.009; Wright S, 1932, P 6 INT C GEN ITH NE; Yazawa T, 2000, ENDOCRINOLOGY, V141, P2027, DOI 10.1210/en.141.6.2027; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Young KA, 2001, REPRODUCTION, V122, P677, DOI 10.1530/rep.0.1220677; Young KA, 2001, BIOL REPROD, V64, P706, DOI 10.1095/biolreprod64.2.706; Young KA, 1999, ENDOCRINOLOGY, V140, P3133, DOI 10.1210/en.140.7.3133; Zhang L, 2008, THERIOGENOLOGY, V69, P1148, DOI 10.1016/j.theriogenology.2008.01.028	49	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204851	10.1371/journal.pone.0204851	http://dx.doi.org/10.1371/journal.pone.0204851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286149	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500050
J	Van Treuren, T; Vishwanatha, JK				Van Treuren, Timothy; Vishwanatha, Jamboor K.			CRISPR deletion of MIEN1 in breast cancer cells	PLOS ONE			English	Article							METASTASIS; C17ORF37; GENE; MIGRATION; NUCLEASES; AMPLICON; C35	Migration and Invasion Enhancer (MIEN1) is an oncogene which is involved in facilitating motility of cancer cells through actin dynamics and gene expression. Increased MIEN1 expression in many types of tumors leads to disease progression and metastatic propensity. It is unclear precisely how MIEN1 is involved in this process and more studies are required to tease out the mechanisms. Here we show that Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) genome editing effectively produced specific genomic deletions in the MIEN1 gene which led to the abrogation of its expression in breast cancer cells. The single guide RNAs (sgRNAs) mediated targeting of MIEN1 was specific and none of the clones screened for off-target cleavage revealed any insertions or deletions (indels). Additionally, disruption of the MIEN1 gene did not alter the cell morphology, growth, proliferation or survival. Knocking out MIEN1 in these breast cancer cells will allow future studies to determine the exact role MIEN1 plays in breast tumor metastasis, which might lead to production of novel therapeutics to treat this and other cancers.	[Van Treuren, Timothy; Vishwanatha, Jamboor K.] Univ North Texas, Hlth Sci Ctr, Dept Microbiol Immunol & Genet, Inst Canc Res, Ft Worth, TX 76107 USA; [Vishwanatha, Jamboor K.] Univ North Texas, Hlth Sci Ctr, Texas Ctr Hlth Dispar, Ft Worth, TX USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Van Treuren, T (corresponding author), Univ North Texas, Hlth Sci Ctr, Dept Microbiol Immunol & Genet, Inst Canc Res, Ft Worth, TX 76107 USA.	tim.vantreuren@gmail.com		Vishwanatha, Jamboor/0000-0002-0266-6020	National Institute on Minority Health and Health Disparities [1P20 MD006882]	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institute on Minority Health and Health Disparities Grant 1P20 MD006882 to JKV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer DE, 2015, JOVE-J VIS EXP, DOI 10.3791/52118; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cho S. W., 2013, GENOME RES; Dasgupta S, 2009, ONCOGENE, V28, P2860, DOI 10.1038/onc.2009.145; Dasgupta S, 2011, J BIOL CHEM, V286, P25935, DOI 10.1074/jbc.M111.254599; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Evans EE, 2006, MOL CANCER THER, V5, P2919, DOI 10.1158/1535-7163.MCT-06-0389; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Katz E, 2010, BRIT J CANCER, V103, P401, DOI 10.1038/sj.bjc.6605763; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kpetemey M, 2016, ONCOTARGET; Kpetemey M, 2016, ONCOTARGET, V7, P54913, DOI 10.18632/oncotarget.10798; Lin A, 2017, ELIFE, V6, DOI 10.7554/eLife.24179; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Rajendiran S, 2015, CANCER BIOL THER, V16, P876, DOI 10.1080/15384047.2015.1040962; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Smith I, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003213; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Zhao H, 2017, GENETICS MOL RES GMR, V16; Zheng QP, 2014, BIOTECHNIQUES, V57, P115, DOI 10.2144/000114196	22	19	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204976	10.1371/journal.pone.0204976	http://dx.doi.org/10.1371/journal.pone.0204976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286132	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500069
J	Pasupala, N; Morrow, ME; Que, LT; Malynn, BA; Ma, A; Wolberger, C				Pasupala, Nagesh; Morrow, Marie E.; Que, Lauren T.; Malynn, Barbara A.; Ma, Averil; Wolberger, Cynthia			OTUB1 non-catalytically stabilizes the E2 ubiquitin-conjugating enzyme UBE2E1 by preventing its autoubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); ubiquitin; ubiquitin thioesterase (OTUB1); ubiquitin-conjugating enzyme (E2 enzyme); histone; UBE2E1	BREAST-CANCER; INHIBITION; BINDING; H2A; MONOUBIQUITINATION; UBIQUITYLATION; DEGRADATION; SPECIFICITY; MECHANISM; TRIGGERS	OTUB1 is a deubiquitinating enzyme that cleaves Lys-48-linked polyubiquitin chains and also regulates ubiquitin signaling through a unique, noncatalytic mechanism. OTUB1 binds to a subset of E2 ubiquitin-conjugating enzymes and inhibits their activity by trapping the E2 approximate to ubiquitin thioester and preventing ubiquitin transfer. The same set of E2s stimulate the deubiquitinating activity of OTUB1 when the E2 is not charged with ubiquitin. Previous studies have shown that, in cells, OTUB1 binds to E2-conjugating enzymes of the UBE2D (UBCH5) and UBE2E families, as well as to UBE2N (UBC13). Cellular roles have been identified for the interaction of OTUB1 with UBE2N and members of the UBE2D family, but not for interactions with UBE2E E2 enzymes. We report here a novel role for OTUB1-E2 interactions in modulating E2 protein ubiquitination. We observe that Otub1(-/-) knockout mice exhibit late-stage embryonic lethality. We find that OTUB1 depletion dramatically destabilizes the E2-conjugating enzyme UBE2E1 (UBCH6) in both mouse and human OTUB1 knockout cell lines. Of note, this effect is independent of the catalytic activity of OTUB1, but depends on its ability to bind to UBE2E1. We show that OTUB1 suppresses UBE2E1 autoubiquitination in vitro and in cells, thereby preventing UBE2E1 from being targeted to the proteasome for degradation. Taken together, we provide evidence that OTUB1 rescues UBE2E1 from degradation in vivo.	[Pasupala, Nagesh; Morrow, Marie E.; Que, Lauren T.; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94117 USA	Johns Hopkins University; University of California System; University of California San Francisco	Wolberger, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu	PASUPALA, NAGESH/O-4611-2018	PASUPALA, NAGESH/0000-0003-4271-8144; Wolberger, Cynthia/0000-0001-8578-2969	National Institutes of Health NIGMS [GM109102]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109102] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIGMS Grant GM109102 (to C. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Baietti MF, 2016, EMBO MOL MED, V8, P288, DOI 10.15252/emmm.201505972; Banka PA, 2015, J MOL BIOL, V427, P2290, DOI 10.1016/j.jmb.2015.04.011; Berndsen CE, 2011, ANAL BIOCHEM, V418, P102, DOI 10.1016/j.ab.2011.06.034; Bhatnagar S, 2014, NATURE, V516, P116, DOI 10.1038/nature13955; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chen YX, 2017, ONCOTARGET, V8, P11053, DOI 10.18632/oncotarget.14278; Clague MJ, 2015, TRENDS CELL BIOL, V25, P417, DOI 10.1016/j.tcb.2015.03.002; DiBello A, 2016, J MOL BIOL, V428, P4639, DOI 10.1016/j.jmb.2016.09.018; Doudna JA, 2014, METHOD ENZYMOL, V546, pXIX, DOI 10.1016/B978-0-12-801185-0.09983-9; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Fuchs G, 2014, BBA-GENE REGUL MECH, V1839, P694, DOI 10.1016/j.bbagrm.2014.01.002; Goncharov T, 2013, EMBO J, V32, P1103, DOI 10.1038/emboj.2013.62; Herhaus L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3519; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; JENTSCH S, 1990, TRENDS BIOCHEM SCI, V15, P195, DOI 10.1016/0968-0004(90)90161-4; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Karunarathna U, 2016, ONCOGENE, V35, P1433, DOI 10.1038/onc.2015.208; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Li YH, 2014, J BIOL CHEM, V289, P5097, DOI 10.1074/jbc.M113.533109; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Mirza S, 2010, MOL VIS, V16, P2425; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rape M, 2018, NAT REV MOL CELL BIO, V19, P59, DOI 10.1038/nrm.2017.83; Rehman SAA, 2016, MOL CELL, V63, P146, DOI 10.1016/j.molcel.2016.05.009; Sato Y, 2012, J BIOL CHEM, V287, P25860, DOI 10.1074/jbc.M112.364752; Schumacher FR, 2013, J MOL BIOL, V425, P4099, DOI 10.1016/j.jmb.2013.06.039; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stanisic V, 2009, J BIOL CHEM, V284, P16135, DOI 10.1074/jbc.M109.007484; Sun LD, 2016, MOL CELL, V62, P958, DOI 10.1016/j.molcel.2016.04.022; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wheaton K, 2017, J BIOL CHEM, V292, P2893, DOI 10.1074/jbc.M116.749564; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Zhao LL, 2018, J BIOL CHEM, V293, P4883, DOI 10.1074/jbc.M117.809533	52	21	22	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18285	18295		10.1074/jbc.RA118.004677	http://dx.doi.org/10.1074/jbc.RA118.004677			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30282802	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000451375200020
J	Karl, D; Kamutzki, F; Zocca, A; Goerke, O; Guenster, J; Gurlo, A				Karl, David; Kamutzki, Franz; Zocca, Andrea; Goerke, Oliver; Guenster, Jens; Gurlo, Aleksander			Towards the colonization of Mars by in-situ resource utilization: Slip cast ceramics from Martian soil simulant	PLOS ONE			English	Article							DIAMETRAL COMPRESSION; FIRING TEMPERATURE; TENSILE STRENGTH; LUNAR; RING; CRATER	Here we demonstrate that by applying exclusively Martian resources a processing route involving suspensions of mineral particles called slurries or slips can be established for manufacturing ceramics on Mars. We developed water-based slurries without the use of additives that had a 51 wt. % solid load resembling commercial porcelain slurries in respect to the particle size distribution and rheological properties. These slurries were used to slip cast discs, rings and vases that were sintered at temperatures between 1000 and 1130 degrees C using different sintering schedules, the latter were set-up according the results of hot-stage microscopic characterization. The microstructure, porosity and the mechanical properties were characterized by SEM, X-ray computer tomography and Weibull analysis. Our wet processing of minerals yields ceramics with complex shapes that show similar mechanical properties to porcelain and could serve as a technology for future Mars colonization. The best quality parts with completely vitrificated matrix supporting a few idiomorphic crystals are obtained at 1130 degrees C with 10 h dwell time with volume and linear shrinkage as much as similar to 62% and similar to 17% and a characteristic compressive strength of 51 MPa.	[Karl, David; Kamutzki, Franz; Goerke, Oliver; Gurlo, Aleksander] Tech Univ Berlin, Fachgebiet Keram Werkstoffe, Chair Adv Ceram Mat, Berlin, Germany; [Zocca, Andrea; Guenster, Jens] Bundesanstalt Mat Forsch & Prufung BAM, Berlin, Germany	Technical University of Berlin; Federal Institute for Materials Research & Testing	Karl, D (corresponding author), Tech Univ Berlin, Fachgebiet Keram Werkstoffe, Chair Adv Ceram Mat, Berlin, Germany.	david.karl@ceramics.tu.berlin.de	Kamutzki, Franz/GZK-9594-2022; Zocca, Andrea/AAJ-8583-2020; Karl, David/ABA-6473-2021	Karl, David/0000-0002-7481-5128; Gurlo, Aleksander/0000-0001-7047-666X; Zocca, Andrea/0000-0002-0213-2766	Technische Universitat Berlin; German Research Foundation; Open Access Publication Funds of TU Berlin	Technische Universitat Berlin; German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of TU Berlin	This work was supported by Technische Universitat Berlin through an internal funding grant. We acknowledge support by the German Research Foundation and the Open Access Publication Funds of TU Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C.C., 1998, EOS T AGU, V79, P405, DOI DOI 10.1029/98E000309; [Anonymous], 1969, MECH THERMAL PROPERT; Banin A, 1992, SPACE SCI SERIES; Barlow NG, 2008, CAMBRIDGE PLANETARY, V8, pxii; Batista M, 1996, J STRAIN ANAL ENG, V31, P75, DOI 10.1243/03093247V311075; Blacic J.D., 1985, LUNAR BASES SPACE AC, P487; Chow BJ, 2017, SCI REP, V7, P317; Corrias G, 2012, ACTA ASTRONAUT, V70, P69, DOI 10.1016/j.actaastro.2011.07.022; Dalton C, 1972, CR129164 NASA; DEWITH G, 1984, J MATER SCI LETT, V3, P1000, DOI 10.1007/BF00720340; Dundas CM, 2018, SCIENCE, V359, P199, DOI 10.1126/science.aao1619; DURELLI AJ, 1986, EXP MECH, V26, P28, DOI 10.1007/BF02319952; Goulas A, 2017, APPL MATER TODAY, V6, P54, DOI 10.1016/j.apmt.2016.11.004; Happel J.A., 1993, APPL MECH REV, V46, P313; HUDSON JA, 1969, INT J ROCK MECH MIN, V6, P91, DOI 10.1016/0148-9062(69)90029-1; ISO, 2008, 5402008E ISO; Jakus AE, SCI REP, V7, P44931; KOBAYASHI Y, 1992, J AM CERAM SOC, V75, P1801, DOI 10.1111/j.1151-2916.1992.tb07200.x; Martin-Marquez J, 2008, CERAM INT, V34, P1867, DOI 10.1016/j.ceramint.2007.06.006; McEwen AS, 2014, NAT GEOSCI, V7, P53, DOI [10.1038/ngeo2014, 10.1038/NGEO2014]; Meek T. T., 1987, LUNAR PLANET SCI, V18, P635; MELLOR M, 1971, ENG GEOL, V5, P173, DOI 10.1016/0013-7952(71)90001-9; Ming DW, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003195; Montes C, 2015, ADV SPACE RES, V56, P1212, DOI 10.1016/j.asr.2015.05.044; Morris RV, 2010, SCIENCE, V329, P421, DOI 10.1126/science.1189667; Nachon M, 2014, J GEOPHYS RES-PLANET, V119, P1991, DOI 10.1002/2013JE004588; Richerson DW, 2012, MAGIC CERAMICS, VXIV; Rieder R, 1997, SCIENCE, V278, P1771, DOI 10.1126/science.278.5344.1771; Sherriff BL, 2002, GEOARCHAEOLOGY, V17, P863, DOI 10.1002/gea.10044; SIMONDS CH, 1973, AM J SCI, V273, P428, DOI 10.2475/ajs.273.5.428; Squyres SW, 2012, SCIENCE, V336, P570, DOI 10.1126/science.1220476; van Morris R, 2008, J GEOPHYS RES, V113, DOI [10.1029/2008JE003201, DOI 10.1029/2008JE003201]; Westman AER, 1928, J AM CERAM SOC, V11, P715, DOI 10.1111/j.1151-2916.1928.tb16530.x; Witze A, 2017, NATURE, V547, P146, DOI 10.1038/nature.2017.22228; Zhang YH, 2002, J EUR CERAM SOC, V22, P135, DOI 10.1016/S0955-2219(01)00243-6	35	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204025	10.1371/journal.pone.0204025	http://dx.doi.org/10.1371/journal.pone.0204025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307968	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500013
J	Koppelmans, V; Scott, JM; Downs, ME; Cassady, KE; Yuan, P; Pasternak, O; Wood, SJ; De Dios, YE; Gadd, NE; Kofman, I; Riascos, R; Reuter-Lorenz, PA; Bloomberg, JJ; Mulavara, AP; Ploutz-Snyder, LL; Seidler, RD				Koppelmans, Vincent; Scott, Jessica M.; Downs, Meghan E.; Cassady, Kaitlin E.; Yuan, Peng; Pasternak, Ofer; Wood, Scott J.; De Dios, Yiri E.; Gadd, Nichole E.; Kofman, Igor; Riascos, Roy; Reuter-Lorenz, Patricia A.; Bloomberg, Jacob J.; Mulavara, Ajitkumar P.; Ploutz-Snyder, Lori L.; Seidler, Rachael D.			Exercise effects on bed rest-induced brain changes	PLOS ONE			English	Article							LONG-DURATION SPACEFLIGHT; AEROBIC EXERCISE; HUMAN CEREBELLUM; MANUAL MOTOR; PLASTICITY; MRI; WEIGHTLESSNESS; RESISTANCE; FMRI	Purpose Spaceflight negatively affects sensorimotor behavior; exercise mitigates some of these effects. Head down tilt bed rest (HDBR) induces body unloading and fluid shifts, and is often used to investigate spaceflight effects. Here, we examined whether exercise mitigates effects of 70 days HDBR on the brain and if fitness and brain changes with HDBR are related. Methods HDBR subjects were randomized to no-exercise (n = 5) or traditional aerobic and resistance exercise (n = 5). Additionally, a flywheel exercise group was included (n = 8). Exercise protocols for exercise groups were similar in intensity, therefore these groups were pooled in statistical analyses. Pre and post-HDBR MRI (structure and structural/functional connectivity) and physical fitness measures (lower body strength, muscle cross sectional area, VO2 max, body composition) were collected. Voxel-wise permutation analyses were used to test group differences in brain changes, and their associations with fitness changes. Results Comparisons of exercisers to controls revealed that exercise led to smaller fitness deterioration with HDBR but did not affect brain volume or connectivity. Group comparisons showed that exercise modulated post-HDBR recovery of brain connectivity in somatosensory regions. Posthoc analysis showed that this was related to functional connectivity decrease with HDBR in non-exercisers but not in exercisers. Correlational analyses between fitness and brain changes showed that fitness decreases were associated with functional connectivity and volumetric increases (all r >.74), potentially reflecting compensation. Modest brain changes or even decreases in connectivity and volume were observed in subjects who maintained or showed small fitness gains. These results did not survive Bonferroni correction, but can be considered meaningful because of the large effect sizes. Conclusion Exercise performed during HDBR mitigates declines in fitness and strength. Associations between fitness and brain connectivity and volume changes, although unadjusted for multiple comparisons in this small sample, suggest that supine exercise reduces compensatory HDBR-induced brain changes.	[Koppelmans, Vincent; Yuan, Peng; Ploutz-Snyder, Lori L.; Seidler, Rachael D.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Koppelmans, Vincent] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Scott, Jessica M.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Scott, Jessica M.; Ploutz-Snyder, Lori L.] NASA, Univ Space Res Assoc, Johnson Space Ctr, Houston, TX USA; [Downs, Meghan E.; De Dios, Yiri E.; Gadd, Nichole E.; Kofman, Igor; Mulavara, Ajitkumar P.] KBRwyle, Houston, TX USA; [Cassady, Kaitlin E.; Reuter-Lorenz, Patricia A.; Seidler, Rachael D.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Pasternak, Ofer] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat & Radiol, Boston, MA USA; [Wood, Scott J.; Bloomberg, Jacob J.] NASA, Johnson Space Ctr, Houston, TX USA; [Riascos, Roy] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Reuter-Lorenz, Patricia A.] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA; [Seidler, Rachael D.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA	University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; Memorial Sloan Kettering Cancer Center; National Aeronautics & Space Administration (NASA); Universities Space Research Association (USRA); University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Aeronautics & Space Administration (NASA); University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan; State University System of Florida; University of Florida	Seidler, RD (corresponding author), Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA.; Seidler, RD (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.; Seidler, RD (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA.	rachaelseidler@ufl.edu	Riascos, Roy/AAE-3822-2019; Koppelmans, Vincent/V-2604-2019	Riascos, Roy/0000-0002-3081-0413; Koppelmans, Vincent/0000-0003-2036-7603; Seidler, Rachael/0000-0003-2452-9024; Scott, Jessica/0000-0002-4845-5800	The National Space Biomedical Research Institute [NCC 9-58, MA02701, PF04101]; National Aeronautics and Space Administration [NNX11AR02G]; National Institutes of Health, National Center for Advancing Translational Sciences; NASA Flight Analogs Project [1UL1RR029876-01]; The National Center for Advancing Translational Sciences [UL1TR000071]; National Institutes of Health (NIH) [P41 EB015902]; KBRwyle; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015902] Funding Source: NIH RePORTER	The National Space Biomedical Research Institute; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Institutes of Health, National Center for Advancing Translational Sciences; NASA Flight Analogs Project; The National Center for Advancing Translational Sciences; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KBRwyle; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work is supported by grants from the following institutions: 1) The National Space Biomedical Research Institute (http://nsbri.org/funding/): a. NASA cooperative agreement NCC 9-58 awarded to RDS. b. MA02701 awarded to RDS. c. PF04101 awarded to VK. 2) The National Aeronautics and Space Administration (https://www.nasa.gov/about/research/index.html): a. NASA; NNX11AR02G awarded to RDS. b. NASA Flight Analogs Project. 3) National Institutes of Health (https://www.nih.gov), National Center for Advancing Translational Sciences (https://ncats.nih.gov), NASA Flight Analogs Project (1UL1RR029876-01) awarded to AR Brasier. 4) The National Center for Advancing Translational Sciences (UL1TR000071). 5) The National Institutes of Health (NIH P41 EB015902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MED, YED, NEG, IK, and APM are employed by KBRwyle. KBRwyle only provided support in the form of salaries for these authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alperin N, 2017, NEUROLOGY, V89, P2187, DOI 10.1212/WNL.0000000000004475; Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Bherer L., 2013, J AGING RES, V2013, DOI [10.1155/2013/657508., 10.1155/2013/657508]; Bloomberg JJ, 2003, IEEE ENG MED BIOL, V22, P58, DOI 10.1109/MEMB.2003.1195697; Buehring B, 2011, J APPL PHYSIOL, V111, P87, DOI 10.1152/japplphysiol.01294.2010; Carpenter R. D., 2010, J COSMOLOGY, V12, P3778; Cassady K, 2016, NEUROIMAGE, V141, P18, DOI 10.1016/j.neuroimage.2016.07.029; Cohen HS, 2012, J VESTIBUL RES-EQUIL, V22, P191, DOI 10.3233/VES-2012-0456; Cromwell RL, 2018, MED SCI SPORT EXER, V50, P1909, DOI 10.1249/MSS.0000000000001617; Demertzi A, 2016, BRAIN STRUCT FUNCT, V221, P2873, DOI 10.1007/s00429-015-1054-3; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; Eickhoff SB, 2006, HUM BRAIN MAPP, V27, P611, DOI 10.1002/hbm.20205; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Gomez-Pinilla F, 2013, COMPR PHYSIOL, V3, P403, DOI 10.1002/cphy.c110063; Hargens AR, 2016, J APPL PHYSIOL, V120, P891, DOI 10.1152/japplphysiol.00935.2015; Hayes SM, 2014, CURR GERIATR REP, V3, P282, DOI 10.1007/s13670-014-0101-x; Hillman CH, 2011, PREV MED, V52, pS21, DOI 10.1016/j.ypmed.2011.01.024; Kassem MS, 2013, MOL NEUROBIOL, V47, P645, DOI 10.1007/s12035-012-8365-7; Kilgour AHM, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-85; Koppelmans V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03311-w; Koppelmans V, 2017, BRAIN STRUCT FUNCT, V222, P1929, DOI 10.1007/s00429-016-1317-7; Koppelmans V, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/s41526-016-0001-9; Koppelmans V, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00121; Koppelmans V, 2015, HUM BRAIN MAPP, V36, P2352, DOI 10.1002/hbm.22775; Koppelmans V, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-205; Langer N, 2012, NEUROLOGY, V78, P182, DOI 10.1212/WNL.0b013e31823fcd9c; Lautenschlager NT, 2012, BBA-MOL BASIS DIS, V1822, P474, DOI 10.1016/j.bbadis.2011.07.010; Li K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135835; Lustig C, 2009, NEUROPSYCHOL REV, V19, P504, DOI 10.1007/s11065-009-9119-9; Mulavara AP, 2018, MED SCI SPORT EXER, V50, P1961, DOI 10.1249/MSS.0000000000001615; Mulavara AP, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00117; Mulavara AP, 2010, EXP BRAIN RES, V202, P649, DOI 10.1007/s00221-010-2171-0; Mulder E, 2014, J MUSCULOSKEL NEURON, V14, P359; Murach KA, 2018, MED SCI SPORT EXER, V50, P1950, DOI 10.1249/MSS.0000000000001620; PARKER DE, 1985, AVIAT SPACE ENVIR MD, V56, P601; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Ploutz-Snyder LL, 2018, MED SCI SPORT EXER, V50, P1920, DOI 10.1249/MSS.0000000000001618; Ploutz-Snyder LL, 2014, MED SCI SPORT EXER, V46, P358, DOI 10.1249/MSS.0b013e3182a62f85; Rao LL, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00187; Roberts DR, 2017, NEW ENGL J MED, V377, P1746, DOI 10.1056/NEJMoa1705129; Roberts DR, 2010, AVIAT SPACE ENVIR MD, V81, P30, DOI 10.3357/ASEM.2532.2009; Scott JM, 2011, MED SCI SPORT EXER, V43, P823, DOI 10.1249/01.MSS.0000402294.26570.46; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Singh MAF, 2014, J AM MED DIR ASSOC, V15, P873, DOI 10.1016/j.jamda.2014.09.010; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Taibbi G, 2014, AVIAT SPACE ENVIR MD, V85, P983, DOI 10.3357/ASEM.4055.2014; Thomas AG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00086; Xu HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084729; YOUNG LR, 1984, SCIENCE, V225, P205, DOI 10.1126/science.6610215; Yuan P, 2018, J NEUROPHYSIOL, V119, P2145, DOI 10.1152/jn.00693.2017; Yuan P, 2018, HUM BRAIN MAPP, V39, P2753, DOI 10.1002/hbm.24037; Yuan P, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00071	53	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205515	10.1371/journal.pone.0205515	http://dx.doi.org/10.1371/journal.pone.0205515			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308004	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500093
J	Hellbach, N; Peterson, S; Haehnke, D; Shankar, A; LaBarge, S; Pivaroff, C; Saenger, S; Thomas, C; McCarthy, K; Ebeling, M; Bennett, MH; Schmidt, U; Metzger, F				Hellbach, Nicole; Peterson, Suzanne; Haehnke, Daniel; Shankar, Aditi; LaBarge, Samuel; Pivaroff, Cullen; Saenger, Stefanie; Thomas, Carolin; McCarthy, Kathleen; Ebeling, Martin; Bennett, Monica Hayhurst; Schmidt, Uli; Metzger, Friedrich			Impaired myogenic development, differentiation and function in hESC-derived SMA myoblasts and myotubes	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; SINGLE NUCLEOTIDE; SURVIVAL; PROTEIN; MODEL; DEFICIENCY; ASTROCYTES; DERIVATION; MUSCLE; MOUSE	Spinal muscular atrophy (SMA) is a severe genetic disorder that manifests in progressive neuromuscular degeneration. SMA originates from loss-of-function mutations of the SMN1 (Survival of Motor Neuron 1) gene. Recent evidence has implicated peripheral deficits, especially in skeletal muscle, as key contributors to disease progression in SMA. In this study we generated myogenic cells from two SMA-affected human embryonic stem cell (hESC) lines with deletion of SMN1 bearing two copies of the SMN2 gene and recapitulating the molecular phenotype of Type 1 SMA. We characterized myoblasts and myotubes by comparing them to two unaffected, control hESC lines and demonstrate that SMA myoblasts and myotubes showed altered expression of various myogenic markers, which translated into an impaired in vitro myogenic maturation and development process. Additionally, we provide evidence that these SMN1 deficient cells display functional deficits in cholinergic calcium signaling response, glycolysis and oxidative phosphorylation. Our data describe a novel human myogenic SMA model that might be used for interrogating the effect of SMN depletion during skeletal muscle development, and as model to investigate biological mechanisms targeting myogenic differentiation, mitochondrial respiration and calcium signaling processes in SMA muscle cells.	[Hellbach, Nicole; Haehnke, Daniel; Saenger, Stefanie; Thomas, Carolin; McCarthy, Kathleen; Ebeling, Martin; Metzger, Friedrich] Roche Innovat Ctr Basel, Roche pRED, Pharma Res & Early Dev, Grenzacherstr, Basel, Switzerland; [Peterson, Suzanne; Shankar, Aditi; LaBarge, Samuel; Pivaroff, Cullen; Bennett, Monica Hayhurst; Schmidt, Uli] Genea Biocells, North Torrey Pines Rd, San Diego, CA USA	Roche Holding	Metzger, F (corresponding author), Roche Innovat Ctr Basel, Roche pRED, Pharma Res & Early Dev, Grenzacherstr, Basel, Switzerland.	friedrich.metzger@versameb.com		Hahnke, Daniel/0000-0002-7008-6503	F. Hoffmann-La Roche Ltd.; Genea Biocells;  [P30GM114736];  [P20GM103446]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114736, P20GM103446] Funding Source: NIH RePORTER	F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche); Genea Biocells; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work has been funded by F. Hoffmann-La Roche Ltd. The funder and Genea Biocells provided support in the form of salaries for authors [NH, DH, SS, CT, KM, ME, FM (F. Hoffmann-La Roche) and SP, AS, SL, CP, MHB, US (Genea Biocells)], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Matthew Butchbach at the University of Delaware and The Nemours/A.I. duPont Hospital for Children Biomolecular Core Lab (supported by grants P30GM114736 [COBRE] and P20GM103446 [INBRE]) for SMN copy number determination.	Boyer JG, 2013, FRONT PHYSIOL, V4, P1, DOI [10.3389/fphys.2013.00001, DOI 10.3389/FPHYS.2013.00001]; Bricceno KV, 2014, HUM MOL GENET, V23, P4745, DOI 10.1093/hmg/ddu189; Butchbach MER., 2016, FRONT MOL BIOSCI, V3, P1, DOI [10.3389/fmolb.2016.00001, DOI 10.3389/FMOLB.2016.00001]; Caron L, 2016, STEM CELL TRANSL MED, V5, P1145, DOI 10.5966/sctm.2015-0224; Cifuentes-Diaz C, 2001, J CELL BIOL, V152, P1107, DOI 10.1083/jcb.152.5.1107; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Crawford TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033572; Czech C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139950; DiDonato CJ, 2001, HUM MOL GENET, V10, P2727, DOI 10.1093/hmg/10.23.2727; Dumevska B, 2016, STEM CELL RES, V16, P397, DOI 10.1016/j.scr.2016.02.008; Dumevska B, 2016, STEM CELL RES, V16, P24, DOI 10.1016/j.scr.2015.11.009; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Groen EJN, 2018, NAT REV NEUROL, V14, P214, DOI 10.1038/nrneurol.2018.4; Guettier-Sigrist S, 2001, FUND CLIN PHARMACOL, V15, P31, DOI 10.1046/j.1472-8206.2001.00006.x; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Harada A, 2017, SEMIN CELL DEV BIOL, V72, P77, DOI 10.1016/j.semcdb.2017.10.022; Hoffmann C, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Hosoyama T, 2014, STEM CELL TRANSL MED, V3, P564, DOI 10.5966/sctm.2013-0143; Le Verche V, 2017, SPINAL MUSCULAR ATROPHY: DISEASE MECHANISMS AND THERAPY, P341, DOI 10.1016/B978-0-12-803685-3.00021-5; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Martin JE, 2017, J NEUROSCI, V37, P5309, DOI 10.1523/JNEUROSCI.3472-16.2017; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; McGivern JV, 2013, GLIA, V61, P1418, DOI 10.1002/glia.22522; Mercuri E, 2012, LANCET NEUROL, V11, P443, DOI 10.1016/S1474-4422(12)70061-3; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Park GH, 2010, CURR NEUROL NEUROSCI, V10, P108, DOI 10.1007/s11910-010-0095-5; Patitucci TN, 2016, HUM MOL GENET, V25, P514, DOI 10.1093/hmg/ddv489; Perez-Garcia MJ, 2017, SPINAL MUSCULAR ATROPHY: DISEASE MECHANISMS AND THERAPY, P21, DOI 10.1016/B978-0-12-803685-3.00002-1; Pottecher J, 2013, J VASC SURG, V57, P1100, DOI 10.1016/j.jvs.2012.09.020; Prior TW, 2009, AM J HUM GENET, V85, P408, DOI 10.1016/j.ajhg.2009.08.002; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; Robbins KL, 2014, HUM MOL GENET, V23, P4559, DOI 10.1093/hmg/ddu169; Shababi M, 2014, J ANAT, V224, P15, DOI 10.1111/joa.12083; Shafey D, 2005, EXP CELL RES, V311, P49, DOI 10.1016/j.yexcr.2005.08.019; Simone C, 2016, CELL MOL LIFE SCI, V73, P1003, DOI 10.1007/s00018-015-2106-9; Stabley DL, 2015, MOL GENET GENOM MED, V3, P248, DOI 10.1002/mgg3.141; Talbot K, 2017, GENE THER, V24, P529, DOI 10.1038/gt.2017.52; Vezain M, 2010, HUM MUTAT, V31, pE1110, DOI 10.1002/humu.21173; Walker MP, 2008, HUM MOL GENET, V17, P3399, DOI 10.1093/hmg/ddn234; Zaworski P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150640	48	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205589	10.1371/journal.pone.0205589	http://dx.doi.org/10.1371/journal.pone.0205589			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304024	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100002
J	Komnik, I; David, S; Funken, J; Haberer, C; Potthast, W; Weiss, S				Komnik, Igor; David, Sina; Funken, Johannes; Haberer, Christine; Potthast, Wolfgang; Weiss, Stefan			Compromised knee internal rotation in total knee arthroplasty patients during stair climbing	PLOS ONE			English	Article							IN-VIVO DETERMINATION; CRUCIATE LIGAMENT-DEFICIENT; MUSCLE ACTIVATION; JOINT KINEMATICS; HIGH-FLEXION; GAIT; REPLACEMENT; WALKING; UNICONDYLAR; OSTEOARTHRITIS	Due to the significant role of rotational properties for normal knee function, this study aimed to investigate transverse plane kinematics and kinetics in total knee arthroplasty and unicondylar knee arthroplasty patients during activities of daily living compared to a healthy control group, including stair ascent and descent. The study participants consisted of a total knee arthroplasty group including posterior cruciate retaining and posterior stabilized designs as well as a unicondylar knee arthroplasty group and a healthy control group. Three-dimensional kinematics and kinetics were captured using a Vicon system and two Kistler force plates embedded in the floor and another two in a staircase. Inverse dynamics of the lower limbs was computed in Anybody (TM) Modeling System. Transverse plane joint angles and joint moments were analyzed utilizing the statistical non-parametric mapping approach, considering the entire curve shape for statistical analysis. The patients with total knee arthroplasty exhibited significantly reduced knee internal rotation of the operated knee compared to the control group and the patients' unimpaired limb, especially during the stair climbing tasks. Both unicondylar and total knee arthroplasty patients were found to have similar reduced internal rotation motion time series in stair descent. In conclusion, potential kinematic and kinetic benefits of unicondylar knee arthroplasty over total knee arthroplasty could not be proven in the current study. Aside from the usually mentioned reasons inducing constrained knee internal rotation in total knee arthroplasty patients, future studies should investigate to what extent co-contraction may contribute to this functional impairment in patients after knee arthroplasty surgery.	[Komnik, Igor; David, Sina; Funken, Johannes; Potthast, Wolfgang] German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Nordrhein Westf, Germany; [Haberer, Christine; Weiss, Stefan] ARCUS Clin Pforzheim, Baden, Switzerland	German Sport University Cologne	Komnik, I (corresponding author), German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Nordrhein Westf, Germany.	i.komnik@dshs-koeln.de	Funken, Johannes/AAR-8238-2020	Funken, Johannes/0000-0002-0093-8686	ARCUS Clinics Pforzheim	ARCUS Clinics Pforzheim	The study was supported by ARCUS Clinics Pforzheim. All knee arthroplasty subjects, who participated in the current study, were operated in the mentioned institution. ARCUS Clinics Pforzheim provided support in the form of salary for the author SW and CH (URL: http://www.sportklinik-germany.com/index.html). The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of SW and CG are articulated in the "author contributions" section. The graduate college of the German Sport University funded the PhD studies for the corresponding author IK in the form of salary (URL: http://www.dshskoeln.de/visitenkarte/einrichtung/graduiertenkolleg-mechanobiologie/). The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Verein fur Wissenschaft und Weiterbildung in der Orthopadie e.V. (English: "Science and Advanced Training Society in the field of orthopedics") funded the knee arthroplasty subject's accommodation and travel costs to Cologne (URL: http://www.sportklinik.de/wissenschaft_publikation/). The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The German Knee Society supported the study in form of grant (URL: http://deutsche-kniegesellschaft.de/en/). The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizuki S, 2009, J ARTHROPLASTY, V24, P963, DOI 10.1016/j.arth.2008.06.013; ALBREKTSSON BEJ, 1990, J BONE JOINT SURG BR, V72, P252, DOI 10.1302/0301-620X.72B2.2312565; Andersen MS, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037100; ANDRIACCHI TP, 1982, J BONE JOINT SURG AM, V64, P1328, DOI 10.2106/00004623-198264090-00008; Ardestani MM, 2016, J BIOMECH, V49, P1620, DOI 10.1016/j.jbiomech.2016.03.047; Argenson JNA, 2005, J BIOMECH, V38, P277, DOI 10.1016/j.jbiomech.2004.02.027; Argenson JNA, 2002, J ARTHROPLASTY, V17, P1049, DOI 10.1054/arth.2002.34527; Banks SA, 2005, KNEE SURG SPORT TR A, V13, P551, DOI 10.1007/s00167-004-0565-x; Banks SA, 2004, CLIN ORTHOP RELAT R, P187, DOI 10.1097/01.blo.0000138956.04316.ac; Bergmann G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086035; Borjesson M, 2005, KNEE, V12, P121, DOI 10.1016/j.knee.2004.04.002; Cates HE, 2008, J ARTHROPLASTY, V23, P1057, DOI 10.1016/j.arth.2007.09.019; CICCOTTI MG, 1994, AM J SPORT MED, V22, P651, DOI 10.1177/036354659402200513; Della Croce U, 2005, GAIT POSTURE, V21, P226, DOI 10.1016/j.gaitpost.2004.05.003; Deluzio KJ, 2007, GAIT POSTURE, V25, P86, DOI 10.1016/j.gaitpost.2006.01.007; Dennis DA, 2004, CLIN ORTHOP RELAT R, P180, DOI 10.1097/01.blo.0000148777.98244.84; Grieco TF, 2016, J ARTHROPLASTY, V31, P694, DOI 10.1016/j.arth.2015.10.029; Halawi Mohamad J, 2017, J Clin Orthop Trauma, V8, P11, DOI 10.1016/j.jcot.2016.08.010; Hatfield GL, 2011, J ARTHROPLASTY, V26, P309, DOI 10.1016/j.arth.2010.03.021; Heyse TJ, 2014, KNEE SURG SPORT TR A, V22, P1902, DOI 10.1007/s00167-013-2752-0; Hurst JM, 2014, CLIN SPORT MED, V33, P105, DOI 10.1016/j.csm.2013.06.004; Johnson TS, 2001, WEAR, V250, P222, DOI 10.1016/S0043-1648(01)00650-0; Jung MC, 2014, KNEE SURG SPORT TR A, V22, P1879, DOI 10.1007/s00167-014-3064-8; Kanekasu K, 2004, J ARTHROPLASTY, V19, P998, DOI 10.1016/j.arth.2004.03.012; Kellis E, 1998, SPORTS MED, V25, P37, DOI 10.2165/00007256-199825010-00004; Komistek RD, 2008, J ARTHROPLASTY, V23, P41, DOI 10.1016/j.arth.2007.01.016; Komnik I, 2015, GAIT POSTURE, V41, P370, DOI 10.1016/j.gaitpost.2015.01.019; Komnik I, 2016, NONSAGITTAL KNEE JOI, V11, DOI [10.1371/journal.pone.0168566, DOI 10.1371/JOURNAL.PONE.0168566]; KOZINN SC, 1989, J BONE JOINT SURG AM, V71A, P145, DOI 10.2106/00004623-198971010-00023; KRAEMER WJ, 1995, J ARTHROPLASTY, V10, P227, DOI 10.1016/S0883-5403(05)80132-9; Kweon C, 2013, MULTIPLE LIGAMENT IN, P17; Li G, 1999, J BIOMECH, V32, P395, DOI 10.1016/S0021-9290(98)00181-X; Lund M.E., 2015, INT BIOMECH, V2, P1, DOI [10.1080/23335432.2014.993706, DOI 10.1080/23335432.2014.993706]; MacWilliams BA, 1999, J ORTHOPAED RES, V17, P817, DOI 10.1002/jor.1100170605; McClelland JA, 2007, KNEE, V14, P253, DOI 10.1016/j.knee.2007.04.003; McClelland JA, 2011, KNEE, V18, P151, DOI 10.1016/j.knee.2010.04.005; Milner CE, 2009, J ORTHOP SCI, V14, P114, DOI 10.1007/s00776-008-1285-8; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pandit H, 2008, KNEE, V15, P101, DOI 10.1016/j.knee.2007.11.008; Pataky TC, 2016, PEERJ, V4, DOI 10.7717/peerj.2652; Pataky TC, 2016, J BIOMECH, V49, P1468, DOI 10.1016/j.jbiomech.2016.03.032; Pataky TC, 2015, J BIOMECH, V48, P1277, DOI 10.1016/j.jbiomech.2015.02.051; Pataky TC, 2012, COMPUT METHOD BIOMEC, V15, P295, DOI 10.1080/10255842.2010.527837; Pataky TC, 2010, J BIOMECH, V43, P1976, DOI 10.1016/j.jbiomech.2010.03.008; Patil S, 2005, J BONE JOINT SURG AM, V87A, P332, DOI 10.2106/JBJS.C.01467; PENNOCK GR, 1990, J BIOMECH, V23, P1209, DOI 10.1016/0021-9290(90)90378-G; Pozzi F, 2015, CLIN BIOMECH, V30, P78, DOI 10.1016/j.clinbiomech.2014.11.001; Riddle DL, 2008, J ARTHROPLASTY, V23, P408, DOI 10.1016/j.arth.2007.04.012; Robinson MA, 2015, J ELECTROMYOGR KINES, V25, P14, DOI 10.1016/j.jelekin.2014.10.018; Schmalzried TP, 1998, J BONE JOINT SURG AM, V80A, P54, DOI 10.2106/00004623-199801000-00010; Schroer WC, 2013, J ARTHROPLASTY, V28, P116, DOI 10.1016/j.arth.2013.04.056; Smith AJ, 2004, J ORTHOP RES, V22, P260, DOI 10.1016/S0736-0266(03)00184-0; Smith JW, 2014, WORLD J ORTHOP, V5, P69, DOI 10.5312/wjo.v5.i2.69; Standifird TW, 2014, J ARTHROPLASTY, V29, P1857, DOI 10.1016/j.arth.2014.03.040; Takeda K, 2014, J BIOMECH, V47, P2526, DOI 10.1016/j.jbiomech.2014.03.027; van der List JP, 2016, J ARTHROPLASTY, V31, P1016, DOI 10.1016/j.arth.2015.11.030; Wahid F, 2016, CLIN BIOMECH, V32, P92, DOI 10.1016/j.clinbiomech.2015.12.012; Watanabe T, 2014, J ORTHOP SCI, V19, P552, DOI 10.1007/s00776-014-0578-3; Wegrzyn J, 2013, CLIN ORTHOP RELAT R, V471, P46, DOI 10.1007/s11999-012-2486-1; Wilson DAJ, 2012, CLIN BIOMECH, V27, P936, DOI 10.1016/j.clinbiomech.2012.06.012; Wilson JLA, 2015, J ARTHROPLASTY, V30, P118, DOI 10.1016/j.arth.2014.07.028; Wimmer MA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/157541; Winter DA, 2009, BIOMECHANICS MOTOR C, p[xiv, 370]; Wolterbeek N, 2012, GAIT POSTURE, V36, P394, DOI 10.1016/j.gaitpost.2012.03.022; Wunschel M, 2013, KNEE, V20, P416, DOI 10.1016/j.knee.2013.03.005	65	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205492	10.1371/journal.pone.0205492	http://dx.doi.org/10.1371/journal.pone.0205492			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304032	gold, Green Published, Green Submitted			2022-12-26	WOS:000446921100097
J	Bonwitt, J; Oltean, H; Lang, M; Kelly, RM; Goldoft, M				Bonwitt, Jesse; Oltean, Hanna; Lang, Misty; Kelly, Rochelle M.; Goldoft, Marcia			Bat rabies in Washington State: Temporal-spatial trends and risk factors for zoonotic transmission (2000-2017)	PLOS ONE			English	Article							BIG BROWN BATS; UNITED-STATES; MYOTIS-YUMANENSIS; BRITISH-COLUMBIA; EPIDEMIOLOGY; SURVEILLANCE; VIRUS; HOST; ENCOUNTERS; LUCIFUGUS	Background Rabies is a zoonotic viral disease that can affect all mammals. In the United States, the majority of human rabies cases are caused by bats, which are the only known reservoirs for rabies virus (RABV) in Washington State. We sought to characterize bat RABV epidemiology in Washington among bats submitted by the public for RABV testing. Methods We examined temporal and spatial trends in RABV positivity (% positive) for taxonomically identified bats submitted to diagnostic laboratories during 2006-2017. For a subset of Myotis species, we evaluated sensitivity and predictive value positive (PPV) of morphological identification keys, using mitochondrial markers (cytochrome b) as a reference. For bats tested during 2000-2016, we analyzed RABV positivity by circumstances of encounters with humans, cats, and dogs. Results During 2006-2017, RABV positivity for all bat species was 6.0% (176/2,928). Among species with >= 100 submissions, RABV positivity was 2.0%-11.7% and highest among big brown bats (Eptesicus fuscus). An increasing trend in annual positivity was significant only for big brown bats (P = 0.02), and was circumstantially linked to a geographic cluster. Sensitivity and PPV of morphological identification keys was high for M. evotis but varied for M. lucifugus, M. californicus, M. yumanensis, and M. septentrionalis. A positive RABV result was significantly associated with nonsynanthropic species, abnormal behavior, abnormal hiding, injury, biting, found in a body of water, found alive, found outdoors, and caught by a dog. Conclusion Monitoring passive RABV surveillance trends enables public health authorities to perform more accurate risk assessments. Differences in temporal and spatial trends in RABV positivity by bat species indicate the importance of collecting taxonomic data, although morphological identification can be unreliable for certain Myotis species. Current public health practices for RABV exposures should be maintained as RABV infection in bats can never be excluded without diagnostic testing.	[Bonwitt, Jesse] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA; [Bonwitt, Jesse; Oltean, Hanna; Goldoft, Marcia] Washington State Dept Hlth, Off Communicable Dis Epidemiol, Shoreline, WA 98155 USA; [Bonwitt, Jesse] Univ Durham, Dept Anthropol, Durham, England; [Lang, Misty] Washington State Dept Hlth, Publ Hlth Labs, Shoreline, WA USA; [Kelly, Rochelle M.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Kelly, Rochelle M.] Univ Washington, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA	Centers for Disease Control & Prevention - USA; Durham University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bonwitt, J (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.; Bonwitt, J (corresponding author), Washington State Dept Hlth, Off Communicable Dis Epidemiol, Shoreline, WA 98155 USA.; Bonwitt, J (corresponding author), Univ Durham, Dept Anthropol, Durham, England.	jbonwitt@cdc.gov	PAN, ZEQIANG/X-6341-2018; Bonwitt, Jesse/AAQ-7182-2021	Bonwitt, Jesse/0000-0002-0510-2802				BCCDC, 2017, BRIT COL ANN SUMM RE; BCI, 2018, SPEC PROF EPT FUSC B; Bemis K, 2017, PUBLIC HEALTH REP, V132, p59S, DOI 10.1177/0033354917708355; Birhane MG, 2017, JAVMA-J AM VET MED A, V250, P1117, DOI 10.2460/javma.250.10.1117; Burnett CD, 1989, BAT RABIES ILLINOIS; CDC, 2018, PROT POSTM DIAGN RAB; CDC, 1995, MMWR-MORBID MORTAL W, V1, P625; CDC, 1997, MMWR-MORBID MORTAL W, V1997, P770; CHILDS JE, 1994, EPIDEMIOL INFECT, V113, P501, DOI 10.1017/S0950268800068515; Constantine DG, 2009, 1329 US GEOL SURV; Dato VM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159443; De Serres G, 2008, CLIN INFECT DIS, V46, P1329, DOI 10.1086/586745; De Serres G, 2009, CLIN INFECT DIS, V48, P1493, DOI 10.1086/598998; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falxa Greg, 2007, Northwestern Naturalist, V88, P98, DOI 10.1898/1051-1733(2007)88[98:WFOSAC]2.0.CO;2; Felsenstein J, CONFIDENCE LIMITS PH; Georgea DB, 2011, P NATL ACAD SCI USA, V108, P10208, DOI 10.1073/pnas.1010875108; Gigante CM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197074; Gilbert AT, 2015, J WILDLIFE DIS, V51, P821, DOI 10.7589/2014-12-277; Hayes G, 2013, WASHINGTON STATE BAT; ICTV, 2018, RHABD GEN LYSSN ICTV; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klug BJ, 2011, J WILDLIFE DIS, V47, P64, DOI 10.7589/0090-3558-47.1.64; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuzmin IV, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002786; Lausen CL, 2006, J MAMMAL, V87, P362, DOI 10.1644/05-MAMM-A-127R1.1; Leslie MJ, 2006, EMERG INFECT DIS, V12, P1274, DOI 10.3201/eid1708.051526; Liesener AL, 2006, VECTOR-BORNE ZOONOT, V6, P208, DOI 10.1089/vbz.2006.6.208; Lorch JM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00148-16; Luszcz Tanya M.J., 2016, Northwestern Naturalist, V97, P13; Manning SE, 2008, MMWR RECOMM REP, V23, P1; Mayes BC, 2013, JAVMA-J AM VET MED A, V243, P1129, DOI 10.2460/javma.243.8.1129; Mercaldo ND, CONFIDENCE INTERVALS; Messenger SL, 2002, CLIN INFECT DIS, V35, P738, DOI 10.1086/342387; Nadin-Davis S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005541; Nagorsen DW, 1993, ROYAL BRIT COLUMBIA, V1; O'Shea TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086261; OHA, 2017, SEL REP COMM DIS SUM; Ommundsen Peter, 2017, Northwestern Naturalist, V98, P132; Pape WJ, 1999, EMERG INFECT DIS, V5, P433, DOI 10.3201/eid0503.990315; Parker EK, 1999, J WILDLIFE DIS, V35, P557, DOI 10.7589/0090-3558-35.3.557; Patyk K, 2012, VECTOR-BORNE ZOONOT, V12, P666, DOI 10.1089/vbz.2011.0839; Picard-Meyer E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098622; PRINS B, 1988, CAN VET J, V29, P41; PYBUS MJ, 1986, J WILDLIFE DIS, V22, P307, DOI 10.7589/0090-3558-22.3.307; Rabies Franka R., 2004, CONTROL COMMUNICABLE; Rodhouse TJ, 2008, WEST N AM NATURALIST, V68, P437, DOI 10.3398/1527-0904-68.4.437; Rupprecht CE, 2018, OVERVIEW RABIES MERC; SCHOWALTER DB, 1980, CAN J COMP MED, V44, P70; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Turmelle AS, 2010, J GEN VIROL, V91, P2360, DOI 10.1099/vir.0.020073-0; USDFW, 2018, NO LONG EAR BAT RANG; Velasco-Villa A, 2017, ANTIVIR RES, V146, P221, DOI 10.1016/j.antiviral.2017.03.013; Wallace RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107539; Wang XT, 2010, EMERG INFECT DIS, V16, P1285, DOI 10.3201/eid1608.100205	56	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205069	10.1371/journal.pone.0205069	http://dx.doi.org/10.1371/journal.pone.0205069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300384	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000446897200035
J	Cincinelli, R; Musso, L; Artali, R; Guglielmi, MB; La Porta, I; Melito, C; Colelli, F; Cardile, F; Signorino, G; Fucci, A; Frusciante, M; Pisano, C; Dallavalle, S				Cincinelli, Raffaella; Musso, Loana; Artali, Roberto; Guglielmi, Mario B.; La Porta, Ilaria; Melito, Carmela; Colelli, Fabiana; Cardile, Francesco; Signorino, Giacomo; Fucci, Alessandra; Frusciante, Martina; Pisano, Claudio; Dallavalle, Sabrina			Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CELL LUNG-CANCER; ANTITUMOR-ACTIVITY; SOLID TUMORS; FORCE-FIELD; CAMPTOTHECIN; ANALOGS; PERSPECTIVES; MESOTHELIOMA; MALIGNANCIES	Recent studies have shown that HDAC inhibitors act synergistically with camptothecin derivatives in combination therapies. To exploit this synergy, new hybrid molecules targeting simultaneously topoisomerase I and HDAC were designed. In particular, a selected multivalent agent containing a camptothecin and a SAHA-like template showed a broad spectrum of antiproliferative activity, with IC50 values in the nanomolar range. Preliminary in vivo results indicated a strong antitumor activity on human mesothelioma primary cell line MM473 orthotopically xenografted in CD-1 nude mice and very high tolerability.	[Cincinelli, Raffaella; Musso, Loana; Dallavalle, Sabrina] Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy; [Artali, Roberto] Scientia Advice, Desio, Monza & Brianza, Italy; [Guglielmi, Mario B.; La Porta, Ilaria; Melito, Carmela; Colelli, Fabiana; Cardile, Francesco; Signorino, Giacomo; Fucci, Alessandra; Frusciante, Martina; Pisano, Claudio] Res Inst, Biogem, Avellino, Italy	University of Milan	Dallavalle, S (corresponding author), Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy.; Pisano, C (corresponding author), Res Inst, Biogem, Avellino, Italy.	claudio.pisano@biogem.it; sabrina.dallavalle@unimi.it	Pisano, Claudio/AAM-4514-2021; Dallavalle, Sabrina/AGY-7086-2022	pisano, claudio/0000-0001-8624-2980; Signorino, Giacomo/0000-0002-5366-6020	Scientia Advice	Scientia Advice	The authors received no specific funding for this work. Scientia Advice provided support in the form of salaries for author RA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abbot V, 2017, RSC ADV, V7, P28313, DOI 10.1039/c6ra24662a; Berube G, 2016, EXPERT OPIN DRUG DIS, V11, P281, DOI 10.1517/17460441.2016.1135125; Botella P, 2017, J CONTROL RELEASE, V247, P28, DOI 10.1016/j.jconrel.2016.12.023; Bruzzese F, 2009, MOL CANCER THER, V8, P3075, DOI 10.1158/1535-7163.MCT-09-0254; Chen B, 2005, BIOORG MED CHEM LETT, V15, P1389, DOI 10.1016/j.bmcl.2005.01.006; Chen Y., 2012, Preparation of HDAC inhibiting derivatives of camptothecin, Patent No. [WO2012096832, 2012096832]; Chun P, 2015, ARCH PHARM RES, V38, P933, DOI 10.1007/s12272-015-0571-1; Cincinelli R, 2018, EUR J MED CHEM, V143, P2005, DOI 10.1016/j.ejmech.2017.11.021; Cincinelli R, 2013, EUR J MED CHEM, V63, P387, DOI 10.1016/j.ejmech.2013.02.022; Dallavalle S, 2000, J MED CHEM, V43, P3963, DOI 10.1021/jm000944z; Dallavalle S, 2001, J MED CHEM, V44, P3264, DOI 10.1021/jm0108092; Dallavalle S, 2006, J MED CHEM, V49, P5177, DOI 10.1021/jm060285b; De Cesare M, 2007, BIOCHEM PHARMACOL, V73, P656, DOI 10.1016/j.bcp.2006.11.004; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Ghamande S, 2014, INVEST NEW DRUG, V32, P445, DOI 10.1007/s10637-013-0044-7; Gire V, 2015, CELL CYCLE, V14, P297, DOI 10.1080/15384101.2014.1000134; Gray J, 2012, CANCER BIOL THER, V13, P614, DOI 10.4161/cbt.19848; Guerrant W, 2013, BIOORG MED CHEM LETT, V23, P3283, DOI 10.1016/j.bmcl.2013.03.108; Hsu KC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03417-1; Hu GH, 2015, PHYTOCHEM REV, V14, P429, DOI 10.1007/s11101-015-9397-1; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Kim N, 2017, DNA REPAIR, V56, P33, DOI 10.1016/j.dnarep.2017.06.005; Kozikowski AP, 2007, J MED CHEM, V50, P3054, DOI 10.1021/jm070178x; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu YQ, 2015, MED RES REV, V35, P753, DOI 10.1002/med.21342; Martino E, 2017, BIOORG MED CHEM LETT, V27, P701, DOI 10.1016/j.bmcl.2016.12.085; Munster PN, 2011, EXPERT OPIN INV DRUG, V20, P1565, DOI 10.1517/13543784.2011.617740; Musso L, 2015, BIOCHEM PHARMACOL, V96, P297, DOI 10.1016/j.bcp.2015.06.006; Na YS, 2010, ONCOL REP, V24, P1509, DOI 10.3892/or_00001012; Pasini A, 2017, ACS MED CHEM LETT, V8, P1218, DOI 10.1021/acsmedchemlett.7b00289; Patel SC, 2016, LUNG CANCER-TARGETS, V7, P63, DOI 10.2147/LCTT.S83338; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Roche J, 2016, EUR J MED CHEM, V121, P451, DOI 10.1016/j.ejmech.2016.05.047; Sampson VB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142704; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sarcar B, 2010, J NEURO-ONCOL, V99, P201, DOI 10.1007/s11060-010-0127-7; Sato A, 2011, ONCOL RES, V19, P217, DOI 10.3727/096504011X12970940207841; Slingerland M, 2012, INVEST NEW DRUG, V30, P1208, DOI 10.1007/s10637-011-9679-4; SOLIS FJ, 1981, MATH OPER RES, V6, P19, DOI 10.1287/moor.6.1.19; Sundar R, 2017, CLIN CANCER RES, V23, P1123, DOI 10.1158/1078-0432.CCR-16-2399; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wasim L, 2016, BIOMED PHARMACOTHER, V84, P1393, DOI 10.1016/j.biopha.2016.10.057; Yap TA, 2017, NAT REV CANCER, V17, P475, DOI 10.1038/nrc.2017.42; Zou JL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0700-0	45	11	12	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205018	10.1371/journal.pone.0205018	http://dx.doi.org/10.1371/journal.pone.0205018			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300374	Green Published, gold, Green Submitted			2022-12-26	WOS:000446897200032
J	Coppola, U; Caccavale, F; Scelzo, M; Holland, ND; Ristoratore, F; D'Aniello, S				Coppola, Ugo; Caccavale, Filomena; Scelzo, Marta; Holland, Nicholas D.; Ristoratore, Filomena; D'Aniello, Salvatore			Ran GTPase, an eukaryotic gene novelty, is involved in amphioxus mitosis	PLOS ONE			English	Article							PROVIDES INSIGHTS; PROTEIN; GENOME; EXPRESSION; EVOLUTION; TRANSPORT; DUPLICATION	Ran (ras-related nuclear protein) is a small GTPase belonging to the RAS superfamily that is specialized in nuclear trafficking. Through different accessory proteins, Ran plays key roles in several processes including nuclear import-export, mitotic progression and spindle assembly. Consequently, Ran dysfunction has been linked to several human pathologies. This work illustrates the high degree of amino acid conservation of Ran orthologues across evolution, reflected in its conserved role in nuclear trafficking. Moreover, we studied the evolutionary scenario of the pre-metazoan genetic linkage between Ran and Stx, and we hypothesized that chromosomal proximity of these two genes across metazoans could be related to a regulatory logic or a functional linkage. We studied, for the first time, Ran expression during amphioxus development and reported its presence in the neural vesicle, mouth, gill slits and gut corresponding to body regions involved in active cell division.	[Coppola, Ugo; Caccavale, Filomena; Scelzo, Marta; Ristoratore, Filomena; D'Aniello, Salvatore] Stn Zool Anton Dohrn Napoli, Biol & Evolut Marine Organisms, Naples, Italy; [Scelzo, Marta] UPMC Observ Oceanol, CNRS, Lab Dev Biol Villefranche Sur Mer, UMR7009, Villefranche Sur Mer, France; [Holland, Nicholas D.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of California System; University of California San Diego; Scripps Institution of Oceanography	D'Aniello, S (corresponding author), Stn Zool Anton Dohrn Napoli, Biol & Evolut Marine Organisms, Naples, Italy.	salvatore.daniello@szn.it	caccavale, filomena/AAT-9316-2020	D'Aniello, Salvatore/0000-0001-7294-1465	FP7 People: Marie Curie Actions [PCIG09-GA-2011-293871]	FP7 People: Marie Curie Actions(European Commission)	Funded by FP7 People: Marie Curie Actions PCIG09-GA-2011-293871 to Dr Salvatore D'Aniello.	Abi-Rached L, 2002, NAT GENET, V31, P100, DOI 10.1038/ng855; Albalat R, 2016, NAT REV GENET, V17, P379, DOI 10.1038/nrg.2016.39; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Annona G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08157-w; Austin CM, 2015, GENOME BIOL EVOL, V7, P2885, DOI 10.1093/gbe/evv186; Battistoni A, 1997, J CELL SCI, V110, P2345; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Brunetti R, 2015, J ZOOL SYST EVOL RES, V53, P186, DOI 10.1111/jzs.12101; Caceres-Gorriti KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091000; Caputo E, 2015, CANCER LETT, V357, P286, DOI 10.1016/j.canlet.2014.11.033; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; Coppola U, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0596-1; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deane R, 1997, MOL CELL BIOL, V17, P5087, DOI 10.1128/MCB.17.9.5087; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Fuentes M, 2007, J EXP ZOOL PART B, V308B, P484, DOI 10.1002/jez.b.21179; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Giovannone AJ, 2018, J BIOL CHEM, V293, P5478, DOI 10.1074/jbc.RA117.000874; Hilbi Hubert, 2014, Small GTPases, V5, P1, DOI 10.4161/21541248.2014.972859; Holland Linda Z., 1996, P267; Holland ND, 2006, EVOL DEV, V8, P142, DOI 10.1111/j.1525-142X.2006.00085.x; Hsiao PW, 1999, J BIOL CHEM, V274, P20229, DOI 10.1074/jbc.274.29.20229; Hughes M, 1998, J CELL SCI, V111, P3017; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Imai KS, 2012, SCIENCE, V337, P964, DOI 10.1126/science.1222488; Irimia M, 2012, GENOME RES, V22, P2356, DOI 10.1101/gr.139725.112; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Koizumi K, 2001, DEV GENES EVOL, V211, P67, DOI 10.1007/s004270000122; Kuraku S, 2009, INT J DEV BIOL, V53, P765, DOI 10.1387/ijdb.072533km; Ladstein RG, 2012, J INVEST DERMATOL, V132, P1247, DOI 10.1038/jid.2011.464; Lavia P, 2016, CHROMOSOME RES, V24, P53, DOI 10.1007/s10577-015-9514-4; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Lin CY, 2015, INT J DEV BIOL, V59, P435, DOI 10.1387/ijdb.150310ht; Lopez-Casas PP, 2002, MECH DEVELOP, V113, P103, DOI 10.1016/S0925-4773(02)00007-2; Lundin MH, 2000, DNA SEQUENCE, V11, P41, DOI 10.3109/10425170009033968; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Onuma Y, 2000, DEV GENES EVOL, V210, P325, DOI 10.1007/s004270050320; Palmieri D, 2016, ONCOTARGET, V7, P18371, DOI 10.18632/oncotarget.7813; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Sazer S, 2000, J CELL SCI, V113, P1111; Schubert M, 1998, MECH DEVELOP, V76, P203, DOI 10.1016/S0925-4773(98)00120-8; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Zhou FL, 2012, MOL BIOL REP, V39, P3821, DOI 10.1007/s11033-011-1160-0	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0196930	10.1371/journal.pone.0196930	http://dx.doi.org/10.1371/journal.pone.0196930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300344	Green Submitted, gold, Green Published			2022-12-26	WOS:000446897200002
J	Thiesen, DM; Prange, F; Berger-Groch, J; Ntalos, D; Petersik, A; Hofstatter, B; Rueger, JM; Klatte, TO; Hartel, MJ				Thiesen, Darius M.; Prange, Felix; Berger-Groch, Josephine; Ntalos, Dimitris; Petersik, Andreas; Hofstaetter, Bernhard; Rueger, Johannes M.; Klatte, Till O.; Hartel, Maximilian J.			Femoral antecurvation-A 3D CT Analysis of 1232 adult femurs	PLOS ONE			English	Article							PROXIMAL FEMUR; INTRAMEDULLARY NAILS; ANATOMIC BASIS; DISTAL FEMUR; ENTRY POINT; CURVATURE; RADIUS; BOW; DESIGN	Introduction For optimal treatment of femoral fractures, it is essential to understand the anatomical antecurvation of the human femur. Recent clinical studies have highlighted the problem of distal anterior encroachment or even perforation of the nail tip. The aim of this study was to accurately describe the femoral antecurvation in a large cohort. Another objective was to identify the most important influences on femoral antecurvation, such as age, femur length, gender and ethnicity. Methods A three dimensional modelling and analytical technology was applied for the analysis of 1,232 femurs. Individual femoral antecurvation was precisely computed to determine whether gender, femur length, age, ethnicity or body mass index influence the radius of curvature (ROC). Results The calculated mean ROC for all femurs was 943 mm. The lowest ROC of 826 mm was found in female Asian femurs. A regression analysis demonstrated that age and femur length could predict the variability of the curvature, with femoral length as most powerful predictor. A matched pair subgroup analysis between Asians and Caucasians could not show any significant differences of ROC values. Conclusions The mean radius of the femoral antecurvation may be smaller than previously reported revealing a significant mismatch between the actual individual anatomy and existing implants. In opposite to existing literature, this study suggests, that antecurvation differences between various ethnicities may exclusively be attributed to differences in femoral length and age. The findings of this study may be found helpful in the development of novel designs for intra- and extramedullary implants.	[Thiesen, Darius M.; Prange, Felix; Berger-Groch, Josephine; Ntalos, Dimitris; Rueger, Johannes M.; Klatte, Till O.; Hartel, Maximilian J.] Univ Med Ctr Hamburg Eppendorf, Dept Trauma Hand & Reconstruct Surg, Hamburg, Germany; [Petersik, Andreas; Hofstaetter, Bernhard] Stryker Trauma GmbH, Kiel, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Hartel, MJ (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Trauma Hand & Reconstruct Surg, Hamburg, Germany.	mhartel@uke.de	Hartel, Maximilian/AAV-2710-2020	Hartel, Maximilian/0000-0003-4978-2878	Stryker GmbH	Stryker GmbH	The funder, Stryker GmbH, provided support in the form of salaries for authors [AP, BH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bazylewicz DB, 2013, J ORTHOP TRAUMA, V27, P303, DOI 10.1097/BOT.0b013e318283f24f; Blaimont P, 1993, Acta Orthop Belg, V59 Suppl 1, P170; Buford WL, 2014, J ORTHOP TRAUMA, V28, P10, DOI 10.1097/BOT.0000000000000019; Collinge CA, 2013, J ORTHOP TRAUMA, V27, P299, DOI 10.1097/BOT.0b013e318283f231; Egol KA, 2004, J ORTHOP TRAUMA, V18, P410, DOI 10.1097/00005131-200408000-00003; Harma A, 2005, SURG RADIOL ANAT, V27, P502, DOI 10.1007/s00276-005-0019-2; HARPER MC, 1987, CLIN ORTHOP RELAT R, P155; Hartel MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149480; Jiang Yong, 2014, J Med Case Rep, V8, P383, DOI 10.1186/1752-1947-8-383; Kanawati AJ, 2014, J ORTHOP, V11, P68, DOI 10.1016/j.jor.2014.04.010; Karaka HM, 2008, DIAGN INTERV RADIOL, V14, P29; Kuntscher G., 1940, MARKNAGELUNG KNOCHEN, V19, P6, DOI [10.1007/BF01763725, DOI 10.1007/BF01763725]; Laine HJ, 2000, J ARTHROPLASTY, V15, P86, DOI 10.1016/S0883-5403(00)91311-1; Maratt J, 2014, J ORTHOP TRAUMA, V28, P6, DOI 10.1097/BOT.0b013e31829ff3c9; Massin P, 2000, J ARTHROPLASTY, V15, P93, DOI 10.1016/S0883-5403(00)91337-8; NOBLE PC, 1988, CLIN ORTHOP RELAT R, P148; NOBLE PC, 1995, CLIN ORTHOP RELAT R, P31; Ostrum RE, 2005, J ORTHOP TRAUMA, V19, P681, DOI 10.1097/01.bot.0000184145.75201.1b; Pu JS, 2009, INT ORTHOP, V33, P1441, DOI 10.1007/s00264-009-0776-3; RUBIN PJ, 1992, J BONE JOINT SURG BR, V74, P28, DOI 10.1302/0301-620X.74B1.1732260; Schmutz B, 2017, ARCH ORTHOP TRAUM SU, V137, P321, DOI 10.1007/s00402-016-2621-7; Schmutz B, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0389-7; Schroder M., 2014, OPEN MED J, V1, P15, DOI DOI 10.2174/1874220301401010015; STAPERT JWJL, 1993, J TRAUMA, V34, P394, DOI 10.1097/00005373-199303000-00015; Su XY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/318391; Young EY, 2013, CLIN ORTHOP RELAT R, V471, P1593, DOI 10.1007/s11999-012-2704-x; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091058; Zickel RE, CLIN ORTHOP RELAT RE, V54, P115; ZUBER K, 1988, UNFALLCHIRURG, V91, P314	29	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0204961	10.1371/journal.pone.0204961	http://dx.doi.org/10.1371/journal.pone.0204961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300421	Green Published, gold, Green Submitted			2022-12-26	WOS:000446897200027
J	Gao, ZP; Hwang, A; Zhai, GT; Peli, E				Gao, Zhongpai; Hwang, Alex; Zhai, Guangtao; Peli, Eli			Correcting geometric distortions in stereoscopic 3D imaging	PLOS ONE			English	Article							DEPTH; INTEGRATION; DISPLAYS	Motion in a distorted virtual 3D space may cause visually induced motion sickness. Geometric distortions in stereoscopic 3D can result from mismatches among image capture, display, and viewing parameters. Three pairs of potential mismatches are considered, including 1) camera separation vs. eye separation, 2) camera field of view (FOV) vs. screen FOV, and 3) camera convergence distance (i.e., distance from the cameras to the point where the convergence axes intersect) vs. screen distance from the observer. The effect of the viewer's head positions (i.e., head lateral offset from the screen center) is also considered. The geometric model is expressed as a function of camera convergence distance, the ratios of the three parameter-pairs, and the offset of the head position. We analyze the impacts of these five variables separately and their interactions on geometric distortions. This model facilitates insights into the various distortions and leads to methods whereby the user can minimize geometric distortions caused by some parameter-pair mismatches through adjusting of other parameter pairs. For example, in postproduction, viewers can correct for a mismatch between camera separation and eye separation by adjusting their distance from the real screen and changing the effective camera convergence distance.	[Gao, Zhongpai; Hwang, Alex; Peli, Eli] Harvard Med Sch, Schepens Eye Res Inst, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA 02115 USA; [Gao, Zhongpai; Zhai, Guangtao] Shanghai Jiao Tong Univ, Inst Image Commun & Informat Proc, Shanghai, Peoples R China	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Shanghai Jiao Tong University	Peli, E (corresponding author), Harvard Med Sch, Schepens Eye Res Inst, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA 02115 USA.	Eli_Peli@meei.harvard.edu	Zhai, Guangtao/X-5949-2019; Gao, Zhongpai/ABA-9234-2021	Zhai, Guangtao/0000-0001-8165-9322; Gao, Zhongpai/0000-0003-4344-4501; Hwang, Alex D./0000-0001-5895-5270	Faculty Research Awards from Google Inc. [P30EY003790]; China Scholarship Council [201606230159]; National Natural Science Foundation of China (NSFC) [61331014, 61521062]; NATIONAL EYE INSTITUTE [P30EY003790] Funding Source: NIH RePORTER	Faculty Research Awards from Google Inc.; China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a Faculty Research Awards from Google Inc. to Sechpens Eye Research Institute, NIH core grant P30EY003790, by the Joint Ph.D. Program from China Scholarship Council No. 201606230159, and by the National Natural Science Foundation of China (NSFC) No. 61331014, 61521062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Banks Martin S, 2009, Inf Disp (1975), V25, P12; Broberg DK, 2011, PROC SPIE, V7863, DOI 10.1117/12.888016; BULTHOFF HH, 1988, J OPT SOC AM A, V5, P1749, DOI 10.1364/JOSAA.5.001749; Dodgson NA, 2004, PROC SPIE, V5291, P36, DOI 10.1117/12.529999; Goldmann L, P INT WORKSH VID PRO; Guide T., 2016, SET YOUR IPD CORRECT; Hands P, 2015, J VISION, V15, DOI 10.1167/15.5.6; Held RT, 2008, APGV 2008: PROCEEDINGS OF THE SYMPOSIUM ON APPLIED PERCEPTION IN GRAPHICS AND VISUALIZATION, P23; HERMAN S, 1971, J SMPTE, V80, P539; Hettinger LJ, 1992, PRESENCE, V1, P306, DOI DOI 10.1162/PRES.1992.1.3.306; Hwang AD, 2014, I-PERCEPTION, V5, P515, DOI 10.1068/i0647; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; JOHNSTON EB, 1993, VISION RES, V33, P813, DOI 10.1016/0042-6989(93)90200-G; Kennedy RS, 2010, APPL ERGON, V41, P494, DOI 10.1016/j.apergo.2009.11.006; Komatsu T, 1993, 92104 IEICE IE; Masaoka K, 2006, J ELECTRON IMAGING, V15, DOI 10.1117/1.2181178; McIntire JP, 2014, DISPLAYS, V35, P18, DOI 10.1016/j.displa.2013.10.004; Mendiburu, 2012, 3D MOVIE MAKING STER; Nojiri Y, 2004, PROC SPIE, V5291, P303, DOI 10.1117/12.522018; Peli E., 1999, OPTOMETRIC PERCEPTUA, P205, DOI DOI 10.1117/1.1839231; Peli E., 2001, P SID INT S, V32, P1296, DOI DOI 10.1889/1.1831799; Pollock B, 2012, IEEE T VIS COMPUT GR, V18, P581, DOI 10.1109/TVCG.2012.58; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; TODD J, 1955, Can Med Assoc J, V73, P701; Vishwanath D, 2005, NAT NEUROSCI, V8, P1401, DOI 10.1038/nn1553; Wartrell Z, 1999, COMP GRAPH, P351, DOI 10.1145/311535.311587; WOODS A, 1993, P SOC PHOTO-OPT INS, V1915, P36, DOI 10.1117/12.157041; Yamanoue H, 2006, IEEE T CIRC SYST VID, V16, P744, DOI 10.1109/TCSVT.2006.875213	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205032	10.1371/journal.pone.0205032	http://dx.doi.org/10.1371/journal.pone.0205032			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296289	Green Published, gold, Green Submitted			2022-12-26	WOS:000446632700018
J	Ataguba, JEO				Ataguba, John Ele-Ojo			A reassessment of global antenatal care coverage for improving maternal health using sub-Saharan Africa as a case study	PLOS ONE			English	Article							PRENATAL-CARE; BIRTH-WEIGHT; QUALITY; OUTCOMES; CONTEXT; DEMAND	Background Antenatal period is an opportunity for reaching pregnant women with vital interventions. In fact, antenatal care (ANC) coverage was an indicator for assessing progress towards the Millennium Development Goals. This paper applies a novel index of service coverage using ANC, which accounts for every ANC visit. An index of service coverage gap is also proposed. These indices are additively decomposable by population groups and they are sensitive to the receipt of more ANC visits below a defined threshold. These indices have also been generalised to account for the quality of services. Methods Data from recent rounds of the Demographic and Health Survey (DHS) are used to reassess ANC service coverage in 35 sub-Saharan African countries. An index of ANC coverage was estimated. These countries were ranked, and their ranks are compared with those based on attaining at least four ANC visits (ANC4+). Findings The index of ANC coverage reflected the level of service coverage in countries. Further, disparities exist in country ranking as some countries, e.g. Cameroon, Benin Republic and Nigeria are ranked better using the ANC4+ indicator but poorly using the proposed index. Also, Rwanda and Malawi are ranked better using the proposed index. Conclusion The proposed ANC index allows for the assessment of progressive realisation, rooted in the move towards universal health coverage. In fact, the index reflects progress that countries make in increasing service coverage. This is because every ANC visit counts. Beyond ANC coverage, the proposed index is applicable to assessing service coverage generally including quality education.	[Ataguba, John Ele-Ojo] Univ Cape Town, Hlth Econ Unit, Sch Publ Hlth & Family Med, Hlth Sci Fac, Cape Town, South Africa	University of Cape Town	Ataguba, JEO (corresponding author), Univ Cape Town, Hlth Econ Unit, Sch Publ Hlth & Family Med, Hlth Sci Fac, Cape Town, South Africa.	John.Ataguba@uct.ac.za		Ataguba, John Ele-Ojo/0000-0002-7746-3826	National Research Foundation [103687]	National Research Foundation	The work is supported by the National Research Foundation (Fund number: 103687). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MDG REP ASS PROGR AF; Arunda M, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1328796; BACKE B, 1993, BRIT J OBSTET GYNAEC, V100, P727, DOI 10.1111/j.1471-0528.1993.tb14263.x; Beeckman K, 2013, EUR J PUBLIC HEALTH, V23, P366, DOI 10.1093/eurpub/cks123; Boller C, 2003, B WORLD HEALTH ORGAN, V81, P116; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Diamond-Smith N, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0208-y; Evans WN, 2005, J ECONOMETRICS, V125, P207, DOI 10.1016/j.jeconom.2004.04.007; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Habibov NN, 2011, ECON HUM BIOL, V9, P56, DOI 10.1016/j.ehb.2010.08.003; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Hosseinpoor AR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001727; Izugbara CO, 2018, HEALTH POLICY PLANN, V33, P1, DOI 10.1093/heapol/czx131; Koroma MM, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0218-4; Kyei NNA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-151; Linard M, 2018, BJOG-INT J OBSTET GY, V125, P587, DOI 10.1111/1471-0528.14794; Ng M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001730; ROSENZWEIG MR, 1983, J POLIT ECON, V91, P723, DOI 10.1086/261179; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Uganda Bureau of Statistics (UBOS) and ICF, 2018, UG DEM HLTH SURV 201; United Nations Development Programme, 2015, SUST DEV GOALS; Wehby GL, 2009, ECON HUM BIOL, V7, P84, DOI 10.1016/j.ehb.2008.10.001; WHO, 2022, WHO RECOMMENDATIONS; *WHO, COUNTD 2015 DEC REP; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization, 2014, EV NEWB ACT PLAN END	29	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204822	10.1371/journal.pone.0204822	http://dx.doi.org/10.1371/journal.pone.0204822			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289886	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500024
J	Cheek, M; Lebbie, A				Cheek, Martin; Lebbie, Aiah			Lebbiea (Podostemaceae-Podostemoideae), a new, nearly extinct genus with foliose tepals, in Sierra Leone	PLOS ONE			English	Article							SP-NOV PODOSTEMACEAE; WEST-AFRICA; LEDERMANNIELLA PODOSTEMACEAE; CAMEROON; GUINEA; RUBIACEAE	Lebbiea grandiflora (Podostemaceae), a rheophytic herb from the Sewa River rapids in Sierra Leone, is described as a new species. It is the first new African genus of Podostemaceae published for 30 years. First collected in May 2017, the species is assessed as Critically Endangered using the IUCN 2012 standard. It is on the edge of extinction with a small population at a single site threatened by deposition of gravel and sand from alluvial gold and diamond mining upstream, and a planned hydro-electric dam. The new genus is unique in Podostemaceae in a) its highly developed and robust style-stigma structure in which the bases of the two style-stigmas unite to form a bifurcate funneliform-cylindrical structure, with a reflexed, blade-like apex that extends half-way around the perimeter of the ovary-fruit towards the base of the ovary-fruit, b) a specialised andropodium, with robust, self-supporting capacity, having differentiated thickened central, and angled, thinner marginal areas (in other Podostemaceae the andropodial structures are undifferentiated), c) the pillar-like haptera which completely elevate the crustose root above the substrate. Lebbiea is placed in Podostemoideae, necessitating amplification of the delimitation of that subfamily in which it is additionally unique in having the foliose tepals characteristic of the basal subfamilies Wed-dellinoideae and Tristichoideae.	[Cheek, Martin] Royal Bot Gardens, Sci, Richmond, Surrey, England; [Lebbie, Aiah] Njala Univ, Natl Herbarium Sierra Leone, Dept Biol Sci, Freetown, Sierra Leone	Royal Botanic Gardens, Kew; Njala University	Cheek, M (corresponding author), Royal Bot Gardens, Sci, Richmond, Surrey, England.	m.cheek@kew.org		LEBBIE, AIAH/0000-0001-8725-3593	Joule Engineering as part of baseline studies for a hydroelectric dam at Bumbuna-Yiben, Sierra Leone	Joule Engineering as part of baseline studies for a hydroelectric dam at Bumbuna-Yiben, Sierra Leone	The fieldwork which produced the specimen which triggered this study was funded by Joule Engineering as part of baseline studies for a hydroelectric dam at Bumbuna-Yiben, Sierra Leone. Joule had no role in study design, data-collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Beentje H., 2005, FLORA TROPICAL E AFR; Bogner J, 2011, WILLDENOWIA, V41, P57, DOI 10.3372/wi.41.41106; Cheek M, 2017, BLUMEA, V62, P125, DOI 10.3767/blumea.2017.62.02.07; Cheek M, 2016, KEW B, V17, P2, DOI DOI 10.1007/S12225-016-9634-9; Cheek M, 2018, PEERJ, V6, DOI 10.7717/peerj.4666; Cheek M, 2017, KEW BULL, V72, DOI 10.1007/S12225-017-9699-0; Cheek M, 2016, KEW BULL, V71, DOI 10.1007/S12225-016-9673-2; Cheek M, 2016, KEW BULL, V71, DOI [10.1007/S12225-016-9638-5, 10.1007/s12225-016-9638-5]; Cheek M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152110; Cheek M, 2015, KEW BULL, V70, DOI 10.1007/S12225-015-9559-8; Cheek Martin, 2010, Kew Bulletin, V65, P83, DOI 10.1007/s12225-010-9180-9; Cheek M, 2008, NORD J BOT, V26, P214, DOI 10.1111/j.1756-1051.2008.00162.x; Cheek Martin, 2003, Kew Bulletin, V58, P733, DOI 10.2307/4111153; Clark Ruth, 2011, Kew Bulletin, V66, P589; COOK CDK, 2007, FAMILIES GENERA VASC, V9, P304, DOI DOI 10.1007/978-3-540-32219-1_40; CUSSET C, 1973, Adansonia, V13, P307; CUSSET C, 1974, Adansonia, V14, P271; CUSSET C, 1978, ADANSONIA, V17, P293; Cusset C, 1984, ADANSONIA, V3, P249; Cusset C., 1987, FLORE CAMEROUN; CUSSET C, 1997, FLORA ZAMBEZIACA, V9, P1; Cusset C, 1983, ADANSONIA, V4, P361; Darbyshire Iain, 2011, Kew Bulletin, V66, P425; Davis PH, 1963, PRINCIPLES ANGIOSPER; de la Estrella M, 2012, NORD J BOT, V30, P136, DOI 10.1111/j.1756-1051.2012.01357.x; Fischer Eberhard, 2011, Kew Bulletin, V66, P441, DOI 10.1007/s12225-011-9296-6; Goyder D. J., 2008, Kew Bulletin, V63, P473, DOI 10.1007/s12225-008-9059-1; Jongkind CCH, 2012, PLANT ECOL EVOL, V145, P126, DOI 10.5091/plecevo.2012.594; Jongkind Carel C. H., 2003, Systematics and Geography of Plants, V73, P95; Kita Yoko, 2008, APG Acta Phytotaxonomica et Geobotanica, V59, P223; Koi S, 2012, BOT J LINN SOC, V169, P461, DOI 10.1111/j.1095-8339.2012.01258.x; McNeill J, 2012, INT CODE NOMENCLATUR; Pfeifer E, 2009, NOVON, V19, P102, DOI 10.3417/2007080; Philbrick C.T., 2004, SYST BOT MONOGR, V70, P1; Phillips SM, 2015, KEW BULL, V70, DOI 10.1007/S12225-014-9557-2; Phillips Sylvia M., 2012, Kew Bulletin, V67, P273, DOI 10.1007/s12225-012-9353-9; Prance GT, 2015, KEW BULL, V70, DOI [10.1007/s12225-014-9547-4, 10.1007/S12225-014-9547-4]; Rial Anabel, 2002, Adansonia (Paris), V24, P295; Ruhfel BR, 2011, AM J BOT, V98, P306, DOI 10.3732/ajb.1000354; Rutishauser R., 2004, PODOSTEMACEAE AFRICA; Schenk JJ, 2004, NOVON, V14, P227; Schenk JJ, 2015, SYST BOT, V40, P539, DOI 10.1600/036364415X688330; Thiers B., INDEX HERBARIORUM GL	44	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203603	10.1371/journal.pone.0203603	http://dx.doi.org/10.1371/journal.pone.0203603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289915	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500006
J	Al Baki, MA; Jung, JK; Maharjan, R; Yi, H; Ahn, JJ; Gu, XJ; Kim, Y				Al Baki, Md. Abdullah; Jung, Jin Kyo; Maharjan, Rameswor; Yi, Hwijong; Ahn, Jeong Joon; Gu, Xiaojun; Kim, Yonggyun			Application of insulin signaling to predict insect growth rate in Maruca vitrata (Lepidoptera: Crambidae)	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; LEGUME POD BORER; PROTHORACICOTROPIC HORMONE; BOMBYX-MORI; DROSOPHILA; IDENTIFICATION; PEPTIDES; EXPRESSION; SECRETION; EVOLUTION	Insect growth is influenced by two major environmental factors: temperature and nutrient. These environmental factors are internally mediated by insulin/insulin-like growth factor signal (I IS) to coordinate tissue or organ growth. Maruca vitrata, a subtropical lepidopteran insect, migrates to different climate regions and feeds on various crops. The objective of this study was to determine molecular tools to predict growth rate of M. vitrata using IIS components. Four genes [insulin receptor (InR), Forkhead Box O (FOXO), Target of Rapamycin (TOR), and serine-threonine protein kinase (Akt)] were used to correlate their expression levels with larval growth rates under different environmental conditions. The functional association of IIS and larval growth was confirmed because RNA interference of these genes significantly decreased larval growth rate and pupal weight. Different rearing temperatures altered expression levels of these four IIS genes and changed their growth rate. Different nutrient conditions also significantly changed larval growth and altered expression levels of IIS components. Different local populations of M. vitrata exhibited significantly different larval growth rates under the same nutrient and temperature conditions along with different expression levels of IIS components. Under a constant temperature (25 degrees C), larval growth rates showed significant correlations with IIS gene expression levels. Subsequent regression formulas of expression levels of four IIS components against larval growth rate were applied to predict growth patterns of M. vitrata larvae reared on different natural hosts and natural local populations reared on the same diet. All four formulas well predicted larval growth rates with some deviations. These results indicate that the IIS expression analysis explains the growth variation at the same temperature due to nutrient and genetic background.	[Al Baki, Md. Abdullah; Kim, Yonggyun] Andong Natl Univ, Dept Plant Med, Andong, South Korea; [Jung, Jin Kyo] Rural Dev Adm, Div Crop Cultivat & Environm Res, Dept Cent Area Crop Sci, Natl Inst Crop Sci, Suwon, South Korea; [Maharjan, Rameswor; Yi, Hwijong] Rural Dev Adm, Dept Southern Area Crop Sci, Natl Inst Crop Sci, Miryang, South Korea; [Ahn, Jeong Joon] Rural Dev Adm, Res Inst Climate Change & Agr, Natl Inst Hort & Herbal Sci, Jeju, South Korea; [Gu, Xiaojun] Fujian Agr & Forestry Univ, Coll Plant Protect, Fuzhou, Fujian, Peoples R China	Andong National University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Fujian Agriculture & Forestry University	Kim, Y (corresponding author), Andong Natl Univ, Dept Plant Med, Andong, South Korea.	hosanna@anu.ac.kr		Kim, Yonggyun/0000-0002-6840-2167	Agenda Research Grant - Rural Development Administration, Republic of Korea [PJ01182003]	Agenda Research Grant - Rural Development Administration, Republic of Korea	This study was supported by an Agenda Research Grant (Project number: PJ01182003) funded by the Rural Development Administration, Republic of Korea.	Agunbiade TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092072; Al Baki MA, 2018, PEPTIDES, V106, P28, DOI 10.1016/j.peptides.2018.06.006; Antonova Y., 2012, INSECT ENDOCRINOL, P63, DOI DOI 10.1016/B978-0-12-384749-2.10002-0; Aslam AFM, 2011, ZOOL SCI, V28, P609, DOI 10.2108/zsj.28.609; Barcelo H, 2002, GENESIS, V34, P83, DOI 10.1002/gene.10132; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Dabour N, 2011, DEV GROWTH DIFFER, V53, P857, DOI 10.1111/j.1440-169X.2011.01291.x; Das R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109530; Ding BY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020357; Dobens LL, 2012, DEV DYNAM, V241, P1239, DOI 10.1002/dvdy.23822; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Ghosh A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004750; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; Iga M, 2011, PEPTIDES, V32, P531, DOI 10.1016/j.peptides.2010.10.033; Jung Jin Kyo, 2016, Korean Journal of Applied Entomology, V55, P439, DOI 10.5656/KSAE.2016.11.0.060; Jung Jin Kyo, 2009, Korean Journal of Applied Entomology, V48, P29; Kim Y, 2017, ENVIRON ENTOMOL, V46, P1432, DOI 10.1093/ee/nvx153; Koyama T, 2018, CURR OPIN INSECT SCI, V25, P1, DOI 10.1016/j.cois.2017.11.002; Koyama T, 2014, ELIFE, V3, DOI 10.7554/eLife.03091; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Liu Y, 2010, J INSECT PHYSIOL, V56, P1436, DOI 10.1016/j.jinsphys.2010.02.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HL, 2011, INSECT MOL BIOL, V20, P637, DOI 10.1111/j.1365-2583.2011.01094.x; Mattila J, 2009, MOL CELL BIOL, V29, P5357, DOI 10.1128/MCB.00302-09; NAGASAWA H, 1984, SCIENCE, V226, P1344, DOI 10.1126/science.226.4680.1344; NAGASAWA H, 1986, P NATL ACAD SCI USA, V83, P5840, DOI 10.1073/pnas.83.16.5840; Nijhout HF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00245; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Okamoto N, 2015, CURR OPIN INSECT SCI, V11, P21, DOI 10.1016/j.cois.2015.08.001; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sang M, 2016, GENE, V585, P196, DOI 10.1016/j.gene.2016.02.034; Sano H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005209; SAS Institute Inc, 1989, SAS STAT USERS GUIDE; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Sharma HC, 1998, CROP PROT, V17, P373, DOI 10.1016/S0261-2194(98)00045-3; Sureshan CS, 2015, APPL TRANSL GENOM, V7, P2, DOI 10.1016/j.atg.2015.10.003; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Van de Velde S, 2007, GEN COMP ENDOCR, V153, P72, DOI 10.1016/j.ygcen.2007.05.001; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; Wen ZM, 2010, MOL CELL ENDOCRINOL, V328, P47, DOI 10.1016/j.mce.2010.07.003; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011	46	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204935	10.1371/journal.pone.0204935	http://dx.doi.org/10.1371/journal.pone.0204935			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286156	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500064
J	Kumar, S; Mahajan, S; Jain, S				Kumar, Santhust; Mahajan, Saurabh; Jain, Sanjay			Feedbacks from the metabolic network to the genetic network reveal regulatory modules in E. coli and B. subtilis	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; HIERARCHICAL STRUCTURE; ORGANIZATION; EVOLUTION; CONSERVATION; PRINCIPLES; MODELS; MOTIFS	The genetic regulatory network (GRN) plays a key role in controlling the response of the cell to changes in the environment. Although the structure of GRNs has been the subject of many studies, their large scale structure in the light of feedbacks from the metabolic network (MN) has received relatively little attention. Here we study the causal structure of the GRNs, namely the chain of influence of one component on the other, taking into account feedback from the MN. First we consider the GRNs of E. coli and B. subtilis without feedback from MN and illustrate their causal structure. Next we augment the GRNs with feedback from their respective MNs by including (a) links from genes coding for enzymes to metabolites produced or consumed in reactions catalyzed by those enzymes and (b) links from metabolites to genes coding for transcription factors whose transcriptional activity the metabolites alter by binding to them. We find that the inclusion of feedback from MN into GRN significantly affects its causal structure, in particular the number of levels and relative positions of nodes in the hierarchy, and the number and size of the strongly connected components (SCCs). We then study the functional significance of the SCCs. For this we identify condition specific feedbacks from the MN into the GRN by retaining only those enzymes that are essential for growth in specific environmental conditions simulated via the technique of flux balance analysis (FBA). We find that the SCCs of the GRN augmented by these feedbacks can be ascribed specific functional roles in the organism. Our algorithmic approach thus reveals relatively autonomous subsystems with specific functionality, or regulatory modules in the organism. This automated approach could be useful in identifying biologically relevant modules in other organisms for which network data is available, but whose biology is less well studied.	[Kumar, Santhust; Jain, Sanjay] Univ Delhi, Dept Phys & Astrophys, Delhi 110007, India; [Mahajan, Saurabh] Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Jain, Sanjay] Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA	University of Delhi; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); The Santa Fe Institute	Jain, S (corresponding author), Univ Delhi, Dept Phys & Astrophys, Delhi 110007, India.; Jain, S (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	jain@physics.du.ac.in			Department of Biotechnology, Government of India [BT/COE/34/SP15246/2015]; Science and Engineering Research Board, Government of India [SR/S4/MS:791/12]; University Grants Commission, Government of India; Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Science and Engineering Research Board, Government of India; University Grants Commission, Government of India(University Grants Commission, India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by Department of Biotechnology, Government of India (http://www.dbtindia.nic.in/), grant no. BT/COE/34/SP15246/2015 to SJ; and Science and Engineering Research Board, Government of India (www.serb.gov.in), grant no. SR/S4/MS:791/12 to SJ. SK acknowledges a Junior Research Fellowship and Senior Research Fellowship from the University Grants Commission, Government of India. SM acknowledges a Senior Research Fellowship from the Department of Biotechnology, Government of India. SJ acknowledges the Addie and Harold Broitman Membership of the Simons Center for Systems Biology, Institute of Advanced Study, Princeton, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Axelsen JB, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/01/P01018; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI 10.1093/nar/gkg210; Bhardwaj N, 2010, P NATL ACAD SCI USA, V107, P6841, DOI 10.1073/pnas.0910867107; Cookson NA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.94; Corominas-Murtra B, 2013, P NATL ACAD SCI USA, V110, P13316, DOI 10.1073/pnas.1300832110; Cosentino Lagomarsino M, 2007, P NATL ACAD SCI USA, V104, P5516, DOI 10.1073/pnas.0609023104; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farkas IJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-478; Freyre-Gonzalez JA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r154; Freyre-Gonzalez JA, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-127; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goelzer A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-20; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; Henry CS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r69; Herrgard MJ, 2006, GENOME RES, V16, P627, DOI 10.1101/gr.4083206; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Jothi R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.52; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Klosik DF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00587-4; KREDICH NM, 1992, MOL MICROBIOL, V6, P2747, DOI 10.1111/j.1365-2958.1992.tb01453.x; Krishna S, 2007, P NATL ACAD SCI USA, V104, P20815, DOI 10.1073/pnas.0706231105; Kumar S, 2015, MOL BIOSYST, V11, P930, DOI 10.1039/c4mb00298a; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Ma HW, 2004, BIOINFORMATICS, V20, P1870, DOI 10.1093/bioinformatics/bth167; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Robison K, 1998, J MOL BIOL, V284, P241, DOI 10.1006/jmbi.1998.2160; Rodriguez-Caso C, 2009, MOL BIOSYST, V5, P1617, DOI [10.1039/b904960f, 10.1039/B904960f]; Salgado H, 2001, NUCLEIC ACIDS RES, V29, P72, DOI 10.1093/nar/29.1.72; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Samal A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-21; Santillan M, 2004, J THEOR BIOL, V231, P287, DOI 10.1016/j.jtbi.2004.06.023; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segal Eran, 2003, Genome Biol, V4, P317, DOI 10.1186/gb-2003-4-5-317; Seshasayee ASN, 2009, GENOME RES, V19, P79, DOI 10.1101/gr.079715.108; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shlomi T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100141; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; Yanofsky C, 2007, RNA, V13, P1141, DOI 10.1261/rna.620507; Yeang CH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-332; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	61	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203311	10.1371/journal.pone.0203311	http://dx.doi.org/10.1371/journal.pone.0203311			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286091	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500007
J	Prasannan, CB; Jaiswal, D; Davis, R; Wangikar, PP				Prasannan, Charulata B.; Jaiswal, Damini; Davis, Rose; Wangikar, Pramod P.			An improved method for extraction of polar and charged metabolites from cyanobacteria	PLOS ONE			English	Article							C-13 FLUX ANALYSIS; METABOLOMICS; YEAST; IDENTIFICATION; TOOLS	A key requirement for C-13 Metabolic flux analysis (C-13-MFA), a widely used technique to estimate intracellular metabolic fluxes, is an efficient method for the extraction of intermediate metabolites for analysis via liquid chromatography mass spectrometry (LC/MS). The C-13 isotopic labeling results in further distribution of an already sparse pool of intermediate metabolites into isotopologues, each appearing as a separate chromatographic feature. We examined some of the reported solvent systems for the extraction of polar intracellular metabolites from three strains of cyanobacteria of the genus Synechococcus, viz., Synechococcus sp. PCC 7002, Synechococcus elongatus PCC 7942, and a newly isolated Synechococcus elongatus PCC 11801 (manuscript under review). High resolution-LC/MS was used to assess the relative abundance of the extracted metabolites. The different solvent systems used for extraction led to statistically significant changes in the extraction efficiency for a large number of metabolites. While a few hundred m/z features or potential metabolites were detected with different solvent systems, the abundance of over a quarter of all metabolites varied significantly from one solvent system to another. Further, the extraction methods were evaluated for a targeted set of metabolites that are important in C-13-MFA studies of photosynthetic organisms. While for the strain PCC 7002, the reported method using methanol-chloroform-water system gave satisfactory results, a mild base in the form of NH4OH had to be used in place of water to achieve adequate levels of extraction for PCC 7942 and PCC 11801. While minor changes in extraction solvent resulted in dramatic changes in the extraction efficiency of a number of compounds, certain metabolites such as amino acids and organic acids were adequately extracted in all the solvent systems tested. Overall, we present a new improved method for extraction using a methanol-chloroform-NH4OH system. Our method improves the extraction of polar compounds such as sugar phosphates, bisphosphates, that are central to C-13-MFA studies.	[Prasannan, Charulata B.; Jaiswal, Damini; Davis, Rose; Wangikar, Pramod P.] Indian Inst Technol, Dept Chem Engn, Bombay, Maharashtra, India; [Prasannan, Charulata B.; Wangikar, Pramod P.] Indian Inst Technol, DBT Pan IIT Ctr Bioenergy, Bombay, Maharashtra, India; [Wangikar, Pramod P.] Indian Inst Technol, Wadhwani Res Ctr Bioengn, Bombay, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; DBT-Pan IIT Centre for Bioenergy; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Wangikar, PP (corresponding author), Indian Inst Technol, Dept Chem Engn, Bombay, Maharashtra, India.; Wangikar, PP (corresponding author), Indian Inst Technol, DBT Pan IIT Ctr Bioenergy, Bombay, Maharashtra, India.; Wangikar, PP (corresponding author), Indian Inst Technol, Wadhwani Res Ctr Bioengn, Bombay, Maharashtra, India.	wangikar@iitb.ac.in		Wangikar, Pramod/0000-0003-0108-7585; Jaiswal, Damini/0000-0002-5822-2541				Alagesan S, 2013, PHOTOSYNTH RES, V118, P191, DOI 10.1007/s11120-013-9911-5; Baran R, 2011, MOL BIOSYST, V7, P3200, DOI 10.1039/c1mb05196b; Benton HP, 2015, ANAL CHEM, V87, P884, DOI 10.1021/ac5025649; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; Cassier-Chauvat C, 2017, APPL MICROBIOL BIOT, V101, P1359, DOI 10.1007/s00253-017-8105-z; Crown SB, 2013, METAB ENG, V20, P42, DOI 10.1016/j.ymben.2013.08.005; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; Dempo Y, 2014, METABOLITES, V4, P499, DOI 10.3390/metabo4020499; ENTIAN KD, 1977, MOL GEN GENET, V156, P99, DOI 10.1007/BF00272258; Faijes M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-27; Folch J, 1987, J BIOL CHEM, V55, P999, DOI DOI 10.1016/J.ULTRASMEDBIO.2011.03.005; Forsberg EM, 2018, NAT PROTOC, V13, P633, DOI 10.1038/nprot.2017.151; GALE EF, 1958, BIOCHEM J, V69, P611, DOI 10.1042/bj0690611; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; Hendry JI, 2017, BIOTECHNOL BIOENG, V114, P2298, DOI 10.1002/bit.26350; Hendry JI, 2016, BIORESOURCE TECHNOL, V213, P190, DOI 10.1016/j.biortech.2016.02.128; Jaiswal D, 2018, ANAL CHEM, V90, P6486, DOI 10.1021/acs.analchem.7b05329; Jazmin LJ, 2017, METAB ENG, V42, P9, DOI 10.1016/j.ymben.2017.05.001; Jazmin LJ, 2013, METHOD MOL BIOL, V985, P149, DOI [10.1007/978-1-62703-299-5_9, DOI 10.1007/978-1-62703-299-5_9]; Kalisiak J, 2009, J AM CHEM SOC, V131, P378, DOI 10.1021/ja808172n; Lai MC, 2015, METABOLITES, V5, P636, DOI 10.3390/metabo5040636; LELOIR LF, 1957, METHOD ENZYMOL, V3, P840, DOI 10.1016/S0076-6879(57)03459-X; Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123; Li X, 2013, J MICROBIOL METH, V94, P61, DOI 10.1016/j.mimet.2013.04.006; Lu WY, 2017, ANNU REV BIOCHEM, V86, P277, DOI 10.1146/annurev-biochem-061516-044952; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; Mathe EA, 2014, CANCER RES, V74, P3259, DOI 10.1158/0008-5472.CAN-14-0109; Misra BB, 2018, ELECTROPHORESIS, V39, P909, DOI 10.1002/elps.201700441; Mosier AC, 2013, MBIO, V4, DOI 10.1128/mBio.00484-12; Narainsamy K, 2013, METABOLOMICS, V9, P21, DOI 10.1007/s11306-011-0382-4; Noh K, 2006, BIOTECHNOL BIOENG, V94, P234, DOI 10.1002/bit.20803; Noh K, 2006, METAB ENG, V8, P554, DOI 10.1016/j.ymben.2006.05.006; Park C, 2012, APPL BIOCHEM BIOTECH, V167, P425, DOI 10.1007/s12010-012-9685-9; Patti GJ, 2013, ANAL CHEM, V85, P798, DOI 10.1021/ac3029745; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Pinu FR, 2017, METABOLITES, V7, DOI 10.3390/metabo7040053; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Riekeberg Eli, 2017, F1000Res, V6, P1148, DOI 10.12688/f1000research.11495.1; Sana T, 2007, 59897407EN AG TECHN, P5989; Sengupta A., 2018, APPL MICROBIOL BIOT, P1, DOI DOI 10.1007/S00253-017-8535-7; SHRYOCK JC, 1986, ANAL BIOCHEM, V159, P73, DOI 10.1016/0003-2697(86)90309-X; Silipo A, 2002, J LIPID RES, V43, P2188, DOI 10.1194/jlr.D200021-JLR200; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Villas-Boas SG, 2005, BIOCHEM J, V388, P669, DOI 10.1042/BJ20041162; Wu C, 2015, PLANT PHYSIOL, V167, P586, DOI 10.1104/pp.114.250688; Xiong W, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.53; Yang FF, 2014, MAR DRUGS, V12, P1258, DOI 10.3390/md12031258; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; Young JD, 2011, METAB ENG, V13, P656, DOI 10.1016/j.ymben.2011.08.002; Zamboni N, 2015, MOL CELL, V58, P699, DOI 10.1016/j.molcel.2015.04.021; Zhu ZJ, 2013, NAT PROTOC, V8, P451, DOI 10.1038/nprot.2013.004; Zur Y., 2000, PROC 2 INT C GEOSPAT, P1	55	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204273	10.1371/journal.pone.0204273	http://dx.doi.org/10.1371/journal.pone.0204273			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286115	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500016
J	Schafer, N; Friedrich, M; Jorgensen, ME; Kollert, S; Koepsell, H; Wischmeyer, E; Lesch, KP; Geiger, D; Doring, F				Schaefer, Nadine; Friedrich, Maximilian; Jorgensen, Morten Egevang; Kollert, Sina; Koepsell, Hermann; Wischmeyer, Erhard; Lesch, Klaus-Peter; Geiger, Dietmar; Doering, Frank			Functional analysis of a triplet deletion in the gene encoding the sodium glucose transporter 3, a potential risk factor for ADHD	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NA+/GLUCOSE COTRANSPORTER; MOLECULAR-GENETICS; RENAL GLUCOSURIA; SUGAR-BINDING; LINKAGE; MODELER; FAMILY; SGLT1	Sodium-glucose transporters (SGLT) belong to the solute carrier 5 family, which is characterized by sodium dependent transport of sugars and other solutes. In contrast, the human SGLT3 (hSGLT3) isoform, encoded by SLC5A4, acts as a glucose sensor that does not transport sugar but induces membrane depolarization by Na+ currents upon ligand binding. Whole-exome sequencing (WES) of several extended pedigrees with high density of attention-deficit/hyperactivity disorder (ADHD) identified a triplet ATG deletion in SLC5A4 leading to a single amino acid loss (Delta M500) in the hSGLT3 protein imperfectly co-segregating with the clinical phenotype of ADHD. Since mutations in homologous domains of hSGLT1 and hSGLT2 were found to affect intestinal and renal function, respectively, we analyzed the functional properties of hSGLT3[wt] and [Delta M500] by voltage clamp and current clamp recordings from cRNA-injected Xenopus laevis oocytes. The cation conductance of hSGLT3[wt] was activated by application of glucose or the specific agonist 1-desoxpojirimycin (DNJ) as revealed by inward currents in the voltage clamp configuration and cell depolarization in the current clamp mode. Almost no currents and changes in membrane potential were observed when glucose or DNJ were applied to hSGLT3 [Delta M500]-injected oocytes, demonstrating a loss of function by this amino acid deletion in hSGLT3. To monitor membrane targeting of wt and mutant hSGLT3, fusion constructs with YFP were generated, heterologously expressed in Xenopus laevis oocytes and analyzed for membrane fluorescence by confocal microscopy. In comparison to hSGLT3[wt] the fluorescent signal of mutant [Delta M500] was reduced by 43% indicating that the mutant phenotype might mainly result from inaccurate membrane targeting. As revealed by homology modeling, residue M500 is located in TM11 suggesting that in addition to the core structure (TM1-TM10) of the transporter, the surrounding TMs are equally crucial for transport/sensor function. In conclusion, our findings indicate that the deletion [Delta M500] in hSGLT3 inhibits membrane targeting and thus largely disrupts glucose-induced sodium conductance, which may, in interaction with other ADHD risk-related gene variants, influence the risk for ADHD in deletion carriers.	[Schaefer, Nadine; Jorgensen, Morten Egevang; Koepsell, Hermann; Geiger, Dietmar] Univ Wurzburg, Julius von Sachs Inst, Dept Mol Plant Physiol & Biophys, Wurzburg, Germany; [Friedrich, Maximilian; Kollert, Sina; Lesch, Klaus-Peter] Univ Hosp Wurzburg, Div Mol Psychiat, Ctr Mental Hlth, Wurzburg, Germany; [Kollert, Sina; Wischmeyer, Erhard; Doering, Frank] Univ Wurzburg, Inst Physiol, Div Mol Electrophysiol, Wurzburg, Germany; [Kollert, Sina; Lesch, Klaus-Peter] Sechenov First Moscow State Med Univ, Inst Mol Med, Lab Psychiat Neurobiol, Moscow, Russia; [Wischmeyer, Erhard; Doering, Frank] Univ Hosp Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Ctr Mental Hlth, Wurzburg, Germany; [Lesch, Klaus-Peter] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Dept Neurosci, Maastricht, Netherlands	University of Wurzburg; University of Wurzburg; University of Wurzburg; Sechenov First Moscow State Medical University; University of Wurzburg; Maastricht University	Doring, F (corresponding author), Univ Wurzburg, Inst Physiol, Div Mol Electrophysiol, Wurzburg, Germany.; Doring, F (corresponding author), Univ Hosp Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Ctr Mental Hlth, Wurzburg, Germany.	fdoering@uni-wuerzburg.de	Geiger, Dietmar/AAH-8140-2019; Lesch, Klaus-Peter/J-4906-2013; Jorgensen, Morten Egevang/A-2795-2016	Geiger, Dietmar/0000-0003-0715-5710; Lesch, Klaus-Peter/0000-0001-8348-153X; Jorgensen, Morten Egevang/0000-0001-6503-0495; Doring, Frank/0000-0003-1017-1498	King Saud University, Saudi Arabia; Danish Council for Independent Research [DFF-6108-00122]; German Research Foundation [SFB TRR58-A05]; European Union [602805]; Horizon 2020 Research and Innovation Programme (grant Eat2beNICE) [728018]; 5-100 Russian Academic Excellence Project; German Research Foundation; University of Wuerzburg	King Saud University, Saudi Arabia(King Saud University); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); German Research Foundation(German Research Foundation (DFG)); European Union(European Commission); Horizon 2020 Research and Innovation Programme (grant Eat2beNICE); 5-100 Russian Academic Excellence Project(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation); German Research Foundation(German Research Foundation (DFG)); University of Wuerzburg	NS and DG were supported by the King Saud University, Saudi Arabia. MEJ was supported by a grant from the Danish Council for Independent Research (grant DFF-6108-00122). KPL was supported by the German Research Foundation (grant SFB TRR58-A05), the European Union's Seventh Framework Programme (grant FP7/2007-2013/No. 602805), the Horizon 2020 Research and Innovation Programme (grant Eat2beNICE/No. 728018), and the 5-100 Russian Academic Excellence Project. Publication was supported by the German Research Foundation and the Open Access Publication Fund of the University of Wuerzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; Calado J, 2008, NEPHROL DIAL TRANSPL, V23, P3874, DOI 10.1093/ndt/gfn386; Carpaneto A, 2005, J BIOL CHEM, V280, P21437, DOI 10.1074/jbc.M501785200; Chapman NH, 2015, HUM GENET, V134, P1055, DOI 10.1007/s00439-015-1585-y; Chen Jian, 2010, Diabetes Ther, V1, P57, DOI 10.1007/s13300-010-0006-4; Corominas J, 2020, MOL PSYCHIATR, V25, P2047, DOI 10.1038/s41380-018-0210-6; Cristino AS, 2014, MOL PSYCHIATR, V19, P294, DOI 10.1038/mp.2013.16; Cross-Disorder Group of Psychiatric Genomics Consortium, 2013, GEN REL 5 PSYCH DIS, V45, P984; Dahmen B, 2012, J NEURAL TRANSM, V119, P1023, DOI 10.1007/s00702-012-0809-8; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Diez-Sampedro A, 2001, J BIOL CHEM, V276, P49188, DOI 10.1074/jbc.M108286200; Diez-Sampedro A, 2011, J BIOL CHEM, V286, P7975, DOI 10.1074/jbc.M110.187880; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Faraone SV, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.20; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Franke B, 2012, MOL PSYCHIATR, V17, P960, DOI 10.1038/mp.2011.138; Hawi Z, 2015, MOL PSYCHIATR, V20, P289, DOI 10.1038/mp.2014.183; Hirayama BA, 2007, BIOCHEMISTRY-US, V46, P13391, DOI 10.1021/bi701562k; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Killeen PR, 2013, NEUROSCI BIOBEHAV R, V37, P625, DOI 10.1016/j.neubiorev.2013.02.011; Klaassen P, 2016, AM J MED GENET B, V171, P790, DOI 10.1002/ajmg.b.32441; Koepsell H, 2017, PHARMACOL THERAPEUT, V170, P148, DOI 10.1016/j.pharmthera.2016.10.017; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Lyon GJ, 2011, DISCOV MED, V11, P41; Martin MG, 1996, NAT GENET, V12, P216, DOI 10.1038/ng0296-216; Merker S, 2017, J CHILD PSYCHOL PSYC, V58, P798, DOI 10.1111/jcpp.12702; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Romanos M, 2008, MOL PSYCHIATR, V13, P522, DOI 10.1038/mp.2008.12; Santer R., 2000, Journal of Inherited Metabolic Disease, V23, P178; Santer R, 2003, J AM SOC NEPHROL, V14, P2873, DOI 10.1097/01.ASN.0000092790.89332.D2; Sotak M, 2017, ESP PHYSL, V103, P5; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; TURK E, 1991, NATURE, V350, P354, DOI 10.1038/350354a0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Voss AA, 2007, MOL PHARMACOL, V71, P628, DOI 10.1124/mol.106.030288; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Vrhovac I, 2015, PFLUG ARCH EUR J PHY, V467, P1881, DOI 10.1007/s00424-014-1619-7; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wright EM, 2013, MOL ASPECTS MED, V34, P183, DOI 10.1016/j.mam.2012.11.002; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Zhou KX, 2008, AM J MED GENET B, V147B, P1392, DOI 10.1002/ajmg.b.30878	54	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205109	10.1371/journal.pone.0205109	http://dx.doi.org/10.1371/journal.pone.0205109			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286162	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500087
J	Stasiak, A; Sayles, M; Winter, IM				Stasiak, Arkadiusz; Sayles, Mark; Winter, Ian M.			Perfidious synaptic transmission in the guinea-pig auditory brainstem	PLOS ONE			English	Article							ANTEROVENTRAL COCHLEAR NUCLEUS; SPHERICAL BUSHY CELLS; CAT TRAPEZOID BODY; NERVE FIBERS; TEMPORAL REPRESENTATION; REGULARITY ANALYSIS; DISCHARGE PATTERNS; MONGOLIAN GERBIL; HELD SYNAPSE; WAVE-FORMS	The presence of 'giant' synapses in the auditory brainstem is thought to be a specialization designed to encode temporal information to support perception of pitch, frequency, and sound-source localisation. These 'giant' synapses have been found in the ventral cochlear nucleus, the medial nucleus of the trapezoid body and the ventral nucleus of the lateral lemniscus. An interpretation of these synapses as simple relays has, however, been challenged by the observation in the gerbil that the action potential frequently fails in the ventral cochlear nucleus. Given the prominence of these synapses it is important to establish whether this phenomenon is unique to the gerbil or can be observed in other species. Here we examine the responses of units, thought to be the output of neurons in receipt of 'giant' synaptic endings, in the ventral cochlear nucleus and the medial nucleus of the trapezoid body in the guinea pig. We found that failure of the action-potential component, recorded from cells in the ventral cochlear nucleus, occurred in similar to 60% of spike waveforms when recording spontaneous activity. In the medial nucleus of the trapezoid body, we did not find evidence for actionpotential failure. In the ventral cochlear nucleus action-potential failures transform the receptive field between input and output of bushy cells. Additionally, the action-potential failures result in "non-primary-like" temporal-adaptation patterns. This is important for computational models of the auditory system, which commonly assume the responses of ventral cochlear nucleus bushy cells are very similar to their "primary like" auditory-nerve-fibre inputs.	[Stasiak, Arkadiusz; Sayles, Mark; Winter, Ian M.] Ctr Neural Basis Hearing, Physiol Lab, Downing St, Cambridge, England; [Sayles, Mark] Purdue Univ, Brainstem Neurophysiol Lab, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	University of Cambridge; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Winter, IM (corresponding author), Ctr Neural Basis Hearing, Physiol Lab, Downing St, Cambridge, England.	imw1001@cam.ac.uk	Stasiak, Arkadiusz/AAI-1325-2020	Stasiak, Arkadiusz/0000-0002-7953-4739; Sayles, Mark/0000-0002-4313-6878	BBSRC; Wellcome Trust; University of Cambridge MD PhD program	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Cambridge MD PhD program	This work was supported by the BBSRC and the Wellcome Trust. M. S. was supported by a scholarship from the University of Cambridge MD PhD program.	BANKS MI, 1991, J NEUROPHYSIOL, V65, P606, DOI 10.1152/jn.1991.65.3.606; BLACKBURN CC, 1990, J NEUROPHYSIOL, V63, P1191, DOI 10.1152/jn.1990.63.5.1191; BLACKBURN CC, 1989, J NEUROPHYSIOL, V62, P1303, DOI 10.1152/jn.1989.62.6.1303; Borst JGG, 2012, SPRINGER HANDB AUDIT, V41, P95, DOI 10.1007/978-1-4419-9517-9_5; Bourk TR, 1976, THESIS; BROWNELL WE, 1975, BRAIN RES, V94, P413, DOI 10.1016/0006-8993(75)90226-7; Campagnola L, 2014, J NEUROSCI, V34, P2214, DOI 10.1523/JNEUROSCI.4669-13.2014; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1698, DOI 10.1152/jn.1996.76.3.1698; Dehmel S, 2010, HEARING RES, V268, P234, DOI 10.1016/j.heares.2010.06.005; Englitz B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007014; Galambos R, 1943, J NEUROPHYSIOL, V6, P39, DOI 10.1152/jn.1943.6.1.39; Gleich O, 1998, AUDIOL NEURO-OTOL, V3, P1, DOI 10.1159/000013775; HACKNEY C M, 1986, British Journal of Audiology, V20, P215, DOI 10.3109/03005368609079018; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; Joris P, 2007, TRENDS NEUROSCI, V30, P70, DOI 10.1016/j.tins.2006.12.004; Joris PX, 2016, ADV EXP MED BIOL, V894, P347, DOI 10.1007/978-3-319-25474-6_36; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1037, DOI 10.1152/jn.1994.71.3.1037; Keine C, 2017, ELIFE, V6, DOI [10.7554/eLife.29639.001, 10.7554/eLife.29639]; Keine C, 2016, ELIFE, V5, DOI 10.7554/eLife.19295; Keine C, 2015, J NEUROSCI, V35, P8579, DOI 10.1523/JNEUROSCI.0133-15.2015; Kopp-Scheinpflug C, 2003, JARO-J ASSOC RES OTO, V4, P1, DOI 10.1007/s10162-002-2010-5; Kopp-Scheinpflug C, 2002, J NEUROSCI, V22, P11004; Kuenzel T, 2011, J NEUROSCI, V31, P4260, DOI 10.1523/JNEUROSCI.5433-10.2011; Lloyd M.E.A., 2002, INT J AUDIOL, V41, P263; Lorteije JAM, 2009, J NEUROSCI, V29, P13770, DOI 10.1523/JNEUROSCI.3285-09.2009; Louage DHG, 2005, J NEUROSCI, V25, P1560, DOI 10.1523/JNEUROSCI.4742-04.2005; Manis PB, 2012, SPRINGER HANDB AUDIT, V41, P61, DOI 10.1007/978-1-4419-9517-9_4; Mc Laughlin M, 2008, J NEUROSCI, V28, P10206, DOI 10.1523/JNEUROSCI.2735-08.2008; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; Nerlich J, 2014, J NEUROSCI, V34, P11604, DOI 10.1523/JNEUROSCI.0719-14.2014; OSEN KK, 1969, J COMP NEUROL, V136, P453, DOI 10.1002/cne.901360407; Palmer AR, 1996, ADVANCES IN SPEECH H, V3; PFEIFFER RR, 1966, SCIENCE, V154, P667, DOI 10.1126/science.154.3749.667; Rhode WS, 2008, NEUROSCIENCE, V154, P87, DOI 10.1016/j.neuroscience.2008.03.013; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; Sayles M, 2008, J NEUROSCI, V28, P11925, DOI 10.1523/JNEUROSCI.3137-08.2008; Sayles M, 2008, NEURON, V58, P789, DOI 10.1016/j.neuron.2008.03.029; Sayles M, 2017, SPRINGER HANDB AUDIT, V62, P215, DOI 10.1007/978-3-319-52073-5_8; Sayles M, 2015, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00248; Sayles M, 2013, J PHYSIOL-LONDON, V591, P3401, DOI 10.1113/jphysiol.2013.253062; SHOFNER WP, 1985, J NEUROPHYSIOL, V54, P917, DOI 10.1152/jn.1985.54.4.917; SMITH PH, 1991, J COMP NEUROL, V304, P387, DOI 10.1002/cne.903040305; Smith PH, 2005, J COMP NEUROL, V482, P349, DOI 10.1002/cne.20407; Spirou GA, 2005, NEUROSCIENCE, V136, P843, DOI 10.1016/j.neuroscience.2005.08.068; SPIROU GA, 1990, J NEUROPHYSIOL, V63, P1169, DOI 10.1152/jn.1990.63.5.1169; Typlt M, 2010, EUR J NEUROSCI, V31, P1574, DOI 10.1111/j.1460-9568.2010.07188.x; Verschooten E, 2013, ASSESSMENT NEURAL PH; WICKESBERG RE, 1990, J NEUROSCI, V10, P1762; WINTER IM, 1990, J ACOUST SOC AM, V88, P1437, DOI 10.1121/1.399720; WINTER IM, 1990, HEARING RES, V44, P161, DOI 10.1016/0378-5955(90)90078-4	50	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203712	10.1371/journal.pone.0203712	http://dx.doi.org/10.1371/journal.pone.0203712			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286113	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500010
J	Wang, J; Duan, Y; Meng, QH; Gong, R; Guo, C; Zhao, Y; Zhang, YL				Wang, Juan; Duan, Yong; Meng, Qing-He; Gong, Rong; Guo, Chong; Zhao, Ying; Zhang, Yanliang			Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China	PLOS ONE			English	Article							SHOCK-PROTEIN 20; FUNCTIONAL TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; AIR-POLLUTION; BETA-CATENIN; BCL6B; PATTERNS; METASTASIS; ACTIVATION	Background Aberrant DNA methylation occurs frequently in cancer. The aim of this study was to identify novel methylation markers in lung cancer in Xuanwei, China, through integrated genome-wide DNA methylation and gene expression studies. Methods Differentially methylated regions (DMRs) and differentially expressed genes (DEGs) were detected on 10 paired lung cancer tissues and noncancerous lung tissues by methylated DNA immunoprecipitation combined with microarray (MeDIP-chip) and gene expression microarray analyses, respectively. Integrated analysis of DMRs and DEGs was performed to screen out candidate methylation-related genes. Both methylation and expression changes of the candidate genes were further validated and analyzed. Results Compared with normal lung tissues, lung cancer tissues expressed a total of 6,899 DMRs, including 5,788 hypermethylated regions and 1,111 hypomethylated regions. Integrated analysis of DMRs and DEGs identified 45 tumor-specific candidate genes: 38 genes whose DMRs were hypermethylated and expression was downregulated, and 7 genes whose DMRs were hypomethylated and expression was upregulated. The methylation and expression validation results identified 4 candidate genes (STXBP6, BCL6B, FZD10, and HSPB6) that were significantly hypermethylated and downregulated in most of the tumor tissues compared with the noncancerous lung tissues. Conclusions This integrated analysis of genome-wide DNA methylation and gene expression in lung cancer in Xuanwei revealed several genes regulated by promoter methylation that have not been described in lung cancer before. These results provide new insight into the carcinogenesis of lung cancer in Xuanwei and represent promising new diagnostic and therapeutic targets.	[Wang, Juan; Duan, Yong; Gong, Rong; Guo, Chong; Zhao, Ying; Zhang, Yanliang] Kunming Med Univ, Dept Clin Lab, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Wang, Juan; Duan, Yong; Gong, Rong; Guo, Chong; Zhao, Ying; Zhang, Yanliang] Yunnan Inst Expt Diag, Kunming, Yunnan, Peoples R China; [Wang, Juan; Duan, Yong; Gong, Rong; Guo, Chong; Zhao, Ying; Zhang, Yanliang] Yunnan Key Lab Lab Med, Kunming, Yunnan, Peoples R China; [Meng, Qing-He] Univ Texas MD Anderson Canc Ctr, Dept Lab Med, Houston, TX 77030 USA	Kunming Medical University; University of Texas System; UTMD Anderson Cancer Center	Zhang, YL (corresponding author), Kunming Med Univ, Dept Clin Lab, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China.; Zhang, YL (corresponding author), Yunnan Inst Expt Diag, Kunming, Yunnan, Peoples R China.; Zhang, YL (corresponding author), Yunnan Key Lab Lab Med, Kunming, Yunnan, Peoples R China.	zylyh2007@163.com			National Natural Science Foundation of China [81160292, 81460325]; Key Project of Science and Technology Department of Yunnan Province-Kunming Medical University Union Found [2014FA014]; High Level Talents of Health Technology in Yunnan Province [L-201202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology Department of Yunnan Province-Kunming Medical University Union Found; High Level Talents of Health Technology in Yunnan Province	This study was supported by the National Natural Science Foundation of China (Grant number: 81160292,Yanliang Zhang), the National Natural Science Foundation of China (Grant number: 81460325,Yong Duan), the Key Project of Science and Technology Department of Yunnan Province-Kunming Medical University Union Found (Grant number: 2014FA014,Yong Duan) and High Level Talents of Health Technology in Yunnan Province (Grant number: L-201202,Yong Duan). Yanliang Zhang:preparation manuscript. Yong Duan:decision to publish.	Ambrosone CB, 2014, ONCOTARGET, V5, P237, DOI 10.18632/oncotarget.1599; Bind MA, 2014, EPIGENETICS-US, V9, P448, DOI 10.4161/epi.27584; Bjaanaes MM, 2016, MOL ONCOL, V10, P330, DOI 10.1016/j.molonc.2015.10.021; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Bu FF, 2015, ONCOTARGET, V6, P2120, DOI 10.18632/oncotarget.2940; Chen C, 2009, CANCER INVEST, V27, P582, DOI 10.1080/07357900802620869; Chen GB, 2015, LUNG CANCER, V90, P155, DOI 10.1016/j.lungcan.2015.08.006; Deng JY, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140067; Fernandez SV, 2010, MUTAT RES-FUND MOL M, V688, P28, DOI 10.1016/j.mrfmmm.2010.02.007; Fukukawa C, 2009, ONCOGENE, V28, P1110, DOI 10.1038/onc.2008.467; Gaedcke J, 2014, ONCOTARGET, V5, P8123, DOI 10.18632/oncotarget.2347; Gong C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6406; Hashimoto Y, 2016, EPIGENOMICS-UK, V8, P685, DOI 10.2217/epi-2015-0013; Hu S, 2015, AM J CANCER RES, V5, P651; Ju YT, 2015, J CELL BIOCHEM, V116, P277, DOI 10.1002/jcb.24966; Kawano H, 2014, ANN SURG ONCOL, V21, pS696, DOI 10.1245/s10434-014-3818-z; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kun W, 2017, SOFT SCI HLTH, V31, P7; Li X, 2015, ONCOTARGET, V6, P11547, DOI 10.18632/oncotarget.3413; Liu WB, 2015, ONCOTARGET, V6, P21225, DOI 10.18632/oncotarget.4237; Matsushima-Nishiwaki R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151907; Matsushima-Nishiwaki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078440; Min ZH, 2016, MODERN PREVENTIVE ME, V43, P6; Mullapudi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143826; MUMFORD JL, 1987, SCIENCE, V235, P217, DOI 10.1126/science.3798109; Nagasawa T, 2015, ARCH BIOCHEM BIOPHYS, V565, P1, DOI 10.1016/j.abb.2014.10.010; Nagasawa T, 2014, ONCOL REP, V32, P1291, DOI 10.3892/or.2014.3278; Nagayama S, 2005, ONCOGENE, V24, P6201, DOI 10.1038/sj.onc.1208780; Nagayama S, 2009, CANCER SCI, V100, P405, DOI 10.1111/j.1349-7006.2008.01052.x; Qiao NA, 2014, EUR J GYNAECOL ONCOL, V35, P576; Spisak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046215; Terasaki H, 2002, INT J MOL MED, V9, P107; Wang BX, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-11; Wang J, 2014, CANCER LETT, V355, P192, DOI 10.1016/j.canlet.2014.08.025; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Wang WL, 2015, ONCOTARGET, V6, P20252, DOI 10.18632/oncotarget.3857; Wu HF, 2016, EUR J CANCER PREV, V25, P508, DOI 10.1097/CEJ.0000000000000214; Xu LX, 2012, GUT, V61, P977, DOI 10.1136/gutjnl-2011-300411; Yang QF, 2013, BIOMARKERS, V18, P721, DOI 10.3109/1354750X.2013.853839; Zahnow CA, 2016, ADV CANCER RES, V130, P55, DOI 10.1016/bs.acr.2016.01.007; Zhang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032765; Zheng RS, 2016, THORAC CANCER, V7, P94, DOI 10.1111/1759-7714.12286; Zhu C., 2008, THE THIRD CHINESE NA	43	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203155	10.1371/journal.pone.0203155	http://dx.doi.org/10.1371/journal.pone.0203155			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286088	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500005
J	Noureini, SK; Fatemi, L; Wink, M				Noureini, Sakineh Kazemi; Fatemi, Leili; Wink, Michael			Telomere shortening in breast cancer cells (MCF7) under treatment with low doses of the benzylisoquinoline alkaloid chelidonine	PLOS ONE			English	Article							CATALYTIC SUBUNIT GENE; HTERT TRANSCRIPTION; LENGTH REGULATION; G-QUADRUPLEX; TUMOR-CELLS; MAJUS; ASSAY; INHIBITION; SENESCENCE; DYNAMICS	Telomeres, the specialized dynamic structures at chromosome ends, regularly shrink with every replication. Thus, they function as an internal molecular clock counting down the number of cell divisions. However, most cancer cells escape this limitation by activating telomerase, which can maintain telomere length. Previous studies showed that the benzylisoquinoline alkaloid chelidonine stimulates multiple modes of cell death and strongly down-regulates telomerase. It is still unknown if down-regulation of telomerase by chelidonine boosts substantial telomere shortening. The breast cancer cell line MCF7 was sequentially treated with very low concentrations of chelidonine over several cell passages. Telomere length and telomerase activity were measured by a monochrome multiplex quantitative PCR and a q-TRAP assay, respectively. Changes in population size and doubling time correlated well with telomerase inhibition and telomere shortening. MCF7 cell growth was arrested completely after three sequential treatments with 0.1 mu M chelidonine, each ending after 48 h, while telomere length was reduced to almost 10% of the untreated control. However, treatment with 0.01 mu M chelidonine did not have any apparent consequence. In addition to dose and time dependent telomerase inhibition, chelidonine changed the splicing pattern of hTERT towards non-enzyme coding isoforms of the transcript. In conclusion, telomere length and telomere stability are strongly affected by chelidonine in addition to microtubule formation.	[Noureini, Sakineh Kazemi; Fatemi, Leili] Hakim Sabzevari Univ, Fac Basic Sci, Dept Biol, Sabzevar, Iran; [Wink, Michael] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Dept Biol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Noureini, SK (corresponding author), Hakim Sabzevari Univ, Fac Basic Sci, Dept Biol, Sabzevar, Iran.	Kazemibio@gmail.com	Noureini, Sakineh Kazemi/AAD-4340-2020; Wink, Michael/E-3803-2012	Noureini, Sakineh Kazemi/0000-0001-5876-3295; Wink, Michael/0000-0002-7875-4510	Hakim Sabzevari University	Hakim Sabzevari University	The authors received a limited grant budget by Hakim Sabzevari University, who had no role in the design of the study, in the collection, analyses, or interpretation of data, or in the writing of the manuscript.	Aisner DL, 2002, CURR OPIN GENET DEV, V12, P80, DOI 10.1016/S0959-437X(01)00268-4; Allegra A, 2017, LEUKEMIA RES, V56, P60, DOI 10.1016/j.leukres.2017.02.002; Bolzan A.D, 2016, TELOMERE TELOMERASE, V3; Bryan TM, 1998, EXP CELL RES, V239, P370, DOI 10.1006/excr.1997.3907; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chuaire Lilian, 2006, Colomb. Med., V37, P332; Collins K, 1996, CURR OPIN CELL BIOL, V8, P374, DOI 10.1016/S0955-0674(96)80013-5; Colombo ML, 1996, PHARMACOL RES, V33, P127, DOI 10.1006/phrs.1996.0019; Cookson JC, 2005, MOL PHARMACOL, V68, P1551, DOI 10.1124/mol.105.013300; Deng YB, 2007, LAB INVEST, V87, P1071, DOI 10.1038/labinvest.3700673; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; HOHENWARTER O, 1992, DRUG EXP CLIN RES, V18, P1; Hou M, 2001, CLIN CHEM, V47, P519; Jafri MA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0324-x; Kaminskyy V, 2008, CELL BIOL INT, V32, P271, DOI 10.1016/j.cellbi.2007.09.004; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; Kong F, 2014, SCI CHINA LIFE SCI, V57, P564, DOI 10.1007/s11427-014-4666-6; Lan Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059230; Li AYJ, 2011, MOL CELL BIOL, V31, P2605, DOI 10.1128/MCB.05447-11; Lu LG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2893; Mattern KA, 2004, MOL CELL BIOL, V24, P5587, DOI 10.1128/MCB.24.12.5587-5594.2004; Mazzanti G, 2009, J ETHNOPHARMACOL, V126, P518, DOI 10.1016/j.jep.2009.09.004; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neumann AA, 2002, NAT REV CANCER, V2, P879, DOI 10.1038/nrc929; Noureini SK, 2017, BBA-GEN SUBJECTS, V1861, P2020, DOI 10.1016/j.bbagen.2017.05.002; Noureini SK, 2014, CHEM-BIOL INTERACT, V223, P141, DOI 10.1016/j.cbi.2014.09.013; Noureini SK, 2009, WORLD J GASTROENTERO, V15, P3603, DOI 10.3748/wjg.15.3603; Panzer A, 2001, EUR J CELL BIOL, V80, P111, DOI 10.1078/0171-9335-00135; Paul Avijit, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P1025, DOI 10.3736/jcim20120912; Qu SM, 2013, AM J EPIDEMIOL, V177, P617, DOI 10.1093/aje/kws291; RHODES D, 1995, CURR OPIN STRUC BIOL, V5, P311, DOI 10.1016/0959-440X(95)80092-1; Rodriguez-Brenes IA, 2010, P NATL ACAD SCI USA, V107, P5387, DOI 10.1073/pnas.0914502107; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Strahl C, 1996, MOL CELL BIOL, V16, P53; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Tian XP, 2010, APPL BIOCHEM BIOTECH, V160, P1460, DOI 10.1007/s12010-009-8633-9; Ulaner GA, 1998, CANCER RES, V58, P4168; Ulaner GA, 2001, INT J CANCER, V91, P644, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1103>3.3.CO;2-M; Van Wyk B.-E., 2015, PHYTOMEDICINES HERBA; Van Wyk B.-E., 2017, MED PLANTS WORLD; Wang XJ, 2016, MOLECULES, V21, DOI 10.3390/molecules21070906; Ward RJ, 2005, MOL PHARMACOL, V68, P779, DOI 10.1124/mol.105.011494; Wong MS, 2014, TRENDS GENET, V30, P430, DOI 10.1016/j.tig.2014.07.006; Yi XM, 2000, NEOPLASIA, V2, P433, DOI 10.1038/sj.neo.7900113; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579; Zou CS, 2017, PESTIC BIOCHEM PHYS, V142, P123, DOI 10.1016/j.pestbp.2017.04.009; Zvereva MI, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1563, DOI 10.1134/S0006297910130055	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204901	10.1371/journal.pone.0204901	http://dx.doi.org/10.1371/journal.pone.0204901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281650	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400065
J	Thomas, NE; Wu, C; Morrison, EA; Robinson, AE; Werner, JP; Henzler-Wildman, KA				Thomas, Nathan E.; Wu, Chao; Morrison, Emma A.; Robinson, Anne E.; Werner, Josephine P.; Henzler-Wildman, Katherine A.			The C terminus of the bacterial multidrug transporter EmrE couples drug binding to proton release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; LIGAND-BINDING; PROTEIN; DYNAMICS; SITE; MECHANISMS; ANTIPORTER; PLASTICITY; GLUTAMATE	Ion-coupled transporters must regulate access of ions and substrates into and out of the binding site to actively transport substrates and minimize dissipative leak of ions. Within the single-site alternating access model, competitive substrate binding forms the foundation of ion-coupled antiport. Strict competition between substrates leads to stoichiometric antiport without slippage. However, recent NMR studies of the bacterial multidrug transporter EmrE have demonstrated that this multidrug transporter can simultaneously bind drug and proton, which will affect the transport stoichiometry and efficiency of coupled antiport. Here, we investigated the nature of substrate competition in EmrE using multiple methods to measure proton release upon the addition of saturating concentrations of drug as a function of pH. The resulting proton-release profile confirmed simultaneous binding of drug and proton, but suggested that a residue outside EmrE's Glu-14 binding site may release protons upon drug binding. Using NMR-monitored pH titrations, we trace this drug-induced deprotonation event to His-110, EmrE's C-terminal residue. Further NMR experiments disclosed that the C-terminal tail is strongly coupled to EmrE's drug-binding domain. Consideration of our results alongside those from previous studies of EmrE suggests that this conserved tail participates in secondary gating of EmrE-mediated proton/drug transport, occluding the binding pocket of fully protonated EmrE in the absence of drug to prevent dissipative proton transport.	[Thomas, Nathan E.; Werner, Josephine P.; Henzler-Wildman, Katherine A.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Wu, Chao; Morrison, Emma A.; Robinson, Anne E.; Henzler-Wildman, Katherine A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Morrison, Emma A.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Robinson, Anne E.] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA	University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); University of Iowa; Washington University (WUSTL)	Henzler-Wildman, KA (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	henzlerwildm@wisc.edu	WU, CHAO/J-7119-2019	WU, CHAO/0000-0002-9342-1968; Thomas, Nathan/0000-0003-3221-6060; Morrison, Emma/0000-0001-6722-7961; Henzler-Wildman, Katherine/0000-0002-5295-2121; Robinson, Anne/0000-0003-1641-397X	National Institutes of Health [P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, S10RR029220]; University of Wisconsin-Madison; NSF [DMB-8415048, OIA-9977486, BIR-9214394]; United States Department of Agriculture (USDA); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025062, S10RR029220, S10RR002781, P41RR002301, S10RR023438, S10RR008438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM095839, P41GM103399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison; NSF(National Science Foundation (NSF)); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Geoff Chang for the EmrE expression plasmid. This study made use of the National Magnetic Resonance Facility at Madison, which is supported by National Institutes of Health Grant P41GM103399 (NIGMS), old number: P41RR002301. Equipment was purchased with funds from the University of Wisconsin-Madison, the National Institutes of Health (P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, S10RR029220), the NSF (DMB-8415048, OIA-9977486, BIR-9214394), and the United States Department of Agriculture (USDA).	Adam Y, 2007, P NATL ACAD SCI USA, V104, P17989, DOI 10.1073/pnas.0704425104; Amadi ST, 2010, J BIOL CHEM, V285, P26710, DOI 10.1074/jbc.M110.132621; Armstrong KM, 2007, BIOPHYS J, V93, P597, DOI 10.1529/biophysj.107.104570; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Bazzone A, 2017, BIOPHYS J, V113, P2736, DOI 10.1016/j.bpj.2017.09.038; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Brill S, 2015, J MOL BIOL, V427, P468, DOI 10.1016/j.jmb.2014.11.015; Brill S, 2012, P NATL ACAD SCI USA, V109, P16894, DOI 10.1073/pnas.1211831109; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Cho MK, 2014, J AM CHEM SOC, V136, P8072, DOI 10.1021/ja503145x; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; Dastvan R, 2016, P NATL ACAD SCI USA, V113, P1220, DOI 10.1073/pnas.1520431113; Drew D, 2016, ANNU REV BIOCHEM, V85, P543, DOI 10.1146/annurev-biochem-060815-014520; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Gayen A, 2013, ANGEW CHEM INT EDIT, V52, P10321, DOI 10.1002/anie.201303091; Glaubitz C, 2000, FEBS LETT, V480, P127, DOI 10.1016/S0014-5793(00)01916-5; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; Korkhov VM, 2008, J MOL BIOL, V377, P1094, DOI 10.1016/j.jmb.2008.01.056; Kozlov AG, 2000, PROTEINS, P8; Lloris-Garcera P, 2014, J MOL BIOL, V426, P2246, DOI 10.1016/j.jmb.2014.03.012; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Morrison EA, 2015, J GEN PHYSIOL, V146, P445, DOI 10.1085/jgp.201511404; Morrison EA, 2014, J BIOL CHEM, V289, P6825, DOI 10.1074/jbc.M113.535328; Morrison EA, 2012, BBA-BIOMEMBRANES, V1818, P814, DOI 10.1016/j.bbamem.2011.12.020; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Ninio S, 2001, J BIOL CHEM, V276, P48250, DOI 10.1074/jbc.M108231200; PELTON JG, 1993, PROTEIN SCI, V2, P543; Robinson AE, 2017, P NATL ACAD SCI USA, V114, pE10083, DOI 10.1073/pnas.1708671114; Rotem D, 2004, J BIOL CHEM, V279, P48787, DOI 10.1074/jbc.M408187200; Schuldiner S, 2001, NEWS PHYSIOL SCI, V16, P130; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Soskine M, 2004, J BIOL CHEM, V279, P9951, DOI 10.1074/jbc.M312853200; Tate CG, 2003, J MOL BIOL, V332, P229, DOI 10.1016/S0022-2836(03)00895-7; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Yerushalmi H, 2000, FEBS LETT, V476, P93, DOI 10.1016/S0014-5793(00)01677-X; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Zomot E, 2018, J MOL BIOL, V430, P1368, DOI 10.1016/j.jmb.2018.02.026	44	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19137	19147		10.1074/jbc.RA118.005430	http://dx.doi.org/10.1074/jbc.RA118.005430			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30287687	hybrid, Green Published			2022-12-26	WOS:000458467400026
J	Jimenez-Franco, MV; Martinez-Fernandez, J; Martinez, JE; Pagan, I; Calvo, JF; Esteve, MA				Jimenez-Franco, Maria, V; Martinez-Fernandez, Julia; Martinez, Jose E.; Pagan, Iluminada; Calvo, Jose F.; Esteve, Miguel A.			Nest sites as a key resource for population persistence: A case study modelling nest occupancy under forestry practices	PLOS ONE			English	Article							GOSHAWKS ACCIPITER-GENTILIS; EAGLE HIERAAETUS-PENNATUS; REPRODUCTIVE OUTPUT; TERRITORIAL OCCUPANCY; HABITAT SELECTION; HARVESTED FORESTS; BIRD COMMUNITIES; DWELLING RAPTORS; BREEDING SUCCESS; TIMBER HARVEST	Natural nest sites are important breeding resource in terms of population dynamics, especially in forest systems where nest trees limit populations or timber harvesting destroys nests. Nest structures usually have a long life and can be reused by breeding pairs across multiple breeding seasons, so studying their dynamics is of relevance for biodiversity conservation. In this study, we develop a dynamic model to evaluate nest site availability and its influence on the breeding settlement of a forest raptor community composed of booted eagle (Hieraaetus pennatus), common buzzard (Buteo buteo) and northern goshawk (Accipiter gentilis) in a Mediterranean forest ecosystem in southeast Spain. This model approach is also applied to analyse the influence of forestry practices on the dynamics of occupied nests for a simulated period (2010-2050). The simulated scenarios include unmanaged forest and timber harvesting practices of clearcuttings every ten years considering two factors: the age class of trees for clearcutting (40, 50, 60 and 70 years old) and the type of forest management (with or without nest protection). Our simulated results show that the number of breeding pairs is constant during the period without timber harvest, whereas breeding pairs gradually decrease in the scenario of clearcutting trees aged from 70 to 50-years without nest protection, and populations become extinct with the clearcutting of 40-year old trees. Considering the practice of clearcutting and nest protection, nest occupancy can reach the maximum number of occupied nests for the scenarios of cutting 70 and 60year old trees, and maintain populations without extinction for the scenarios of cutting 40-year old trees. We conclude that nest sites (whether occupied or not) are key resources for increasing the occupancy of the forest raptor community and that nest protection measures buffer the effects of clearcuttings, thus preventing population extinction.	[Jimenez-Franco, Maria, V] Univ Miguel Hernandez, Dept Biol Aplicada, Area Ecol, Elche, Spain; [Jimenez-Franco, Maria, V; Martinez, Jose E.; Pagan, Iluminada; Calvo, Jose F.; Esteve, Miguel A.] Univ Murcia, Dept Ecol & Hidrol, Murcia, Spain; [Martinez-Fernandez, Julia] Fdn Nueva Culture Agua, Zaragoza, Spain; [Martinez, Jose E.] Bonellis Eagle Study & Conservat Grp, Murcia, Spain	Universidad Miguel Hernandez de Elche; University of Murcia	Jimenez-Franco, MV (corresponding author), Univ Miguel Hernandez, Dept Biol Aplicada, Area Ecol, Elche, Spain.; Jimenez-Franco, MV (corresponding author), Univ Murcia, Dept Ecol & Hidrol, Murcia, Spain.	maria.jimenezf@umh.es	Jiménez-Franco, Maria Victoria/M-2041-2014; Esteve-Selma, Miguel Angel/ABG-7689-2020; Martinez-Fernandez, Julia/J-9681-2012; Calvo, José Francisco/C-7076-2009	Jiménez-Franco, Maria Victoria/0000-0002-7254-0431; Esteve-Selma, Miguel Angel/0000-0003-1803-3217; Martinez-Fernandez, Julia/0000-0001-8675-947X; Calvo, José Francisco/0000-0002-3813-4333; Martinez, Jose Enrique/0000-0002-1200-5795	Spanish Ministerio de Educacion y Ciencia [REN2002-324 01884/GLO]; FEDER; Consejeria de Agricultura y Agua of the Region of Murcia; "Juan de la Cierva-formacion" postdoctoral grant of the Spanish Ministry of Economy and Competitiveness [JCI-2015-23508]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); FEDER(European Commission); Consejeria de Agricultura y Agua of the Region of Murcia; "Juan de la Cierva-formacion" postdoctoral grant of the Spanish Ministry of Economy and Competitiveness	This work was funded by the Spanish Ministerio de Educacion y Ciencia (project REN2002-324 01884/GLO, partially financed by FEDER funds) and the Consejeria de Agricultura y Agua of the Region of Murcia. M.V.J.F. is supported by "Juan de la Cierva-formacion" postdoctoral grant of the Spanish Ministry of Economy and Competitiveness (reference JCI-2015-23508). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan MD, 2011, ENVIRON MANAGE, V47, P983, DOI 10.1007/s00267-011-9640-5; Aitken KEH, 2012, J WILDLIFE MANAGE, V76, P557, DOI 10.1002/jwmg.286; Barlas Y, 1996, SYST DYNAM REV, V12, P183, DOI 10.1002/(SICI)1099-1727(199623)12:3<183::AID-SDR103>3.0.CO;2-4; Bjorklund H, 2013, ANIM CONSERV, V16, P546, DOI 10.1111/acv.12028; Burnham KK, 2009, IBIS, V151, P514, DOI 10.1111/j.1474-919X.2009.00939.x; Charter M, 2016, J ENVIRON MANAGE, V181, P129, DOI 10.1016/j.jenvman.2016.06.021; Cockle KL, 2011, FRONT ECOL ENVIRON, V9, P377, DOI 10.1890/110013; Codorniu R, 1900, C AGR MURC TIP PROV; Cornelius C, 2008, ORNITOL NEOTROP, V19, P253; Cruz JN, 2019, J BIOMOL STRUCT DYN, V37, P1616, DOI 10.1080/07391102.2018.1462734; De la Montana E, 2006, J APPL ECOL, V43, P651, DOI 10.1111/j.1365-2664.2006.01171.x; Donazar JA, 2002, ECOL APPL, V12, P1445, DOI 10.1890/1051-0761(2002)012[1445:EOFAOL]2.0.CO;2; Edworthy AB, 2013, J WILDLIFE MANAGE, V77, P770, DOI 10.1002/jwmg.526; Edworthy AB, 2012, ECOL APPL, V22, P1733, DOI 10.1890/11-1594.1; Garcia Dios Ignacio S., 2000, Ardeola, V47, P183; GARCIA JP, 1998, REPOBLACIONES FOREST; Gil-Tena A, 2009, GLOBAL CHANGE BIOL, V15, P474, DOI 10.1111/j.1365-2486.2008.01730.x; Gil-Tena A, 2010, FOREST ECOL MANAG, V259, P1338, DOI 10.1016/j.foreco.2009.10.026; Griesser M, 2012, FOREST ECOL MANAG, V271, P58, DOI 10.1016/j.foreco.2012.01.037; Jimenez-Franco MV, 2014, J ZOOL, V292, P64, DOI 10.1111/jzo.12085; Jimenez-Franco MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093628; Jimenez-Franco MV, 2013, J ORNITHOL, V154, P311, DOI 10.1007/s10336-012-0895-2; Jimenez-Franco MV, 2011, OECOLOGIA, V166, P507, DOI 10.1007/s00442-010-1857-0; Jorgensen SE, 2001, FUNDAMENTALS ECOLOGI; Khaleghizadeh A, 2014, OCEAN COAST MANAGE, V93, P60, DOI 10.1016/j.ocecoaman.2014.03.015; Kochert MN, 2012, J RAPTOR RES, V46, P239, DOI 10.3356/JRR-12-00001.1; Kohler P, 2002, BIOL CONSERV, V108, P35, DOI 10.1016/S0006-3207(02)00088-5; Lafortezza R, 2013, IFOREST, V6, P342, DOI 10.3832/ifor0960-006; Lambrechts M, 2012, J ORNITHOL, V153, P23, DOI 10.1007/s10336-011-0720-3; Lohmus A, 2005, ANIM CONSERV, V8, P443, DOI 10.1017/S1367943005002349; Lohmus Asko, 2006, Proceedings of the Estonian Academy of Sciences Biology Ecology, V55, P31; Mahon T, 2005, J RAPTOR RES, V39, P335; Mainwaring MC, 2015, J NAT CONSERV, V25, P17, DOI 10.1016/j.jnc.2015.02.007; Mainwaring MC, 2014, ECOL EVOL, V4, P3909, DOI 10.1002/ece3.1054; Mangas JG, 2010, FOREST ECOL MANAG, V260, P1274, DOI 10.1016/j.foreco.2010.07.001; Manning AD, 2013, ANIM CONSERV, V16, P395, DOI 10.1111/acv.12006; Martinez JE, 2006, IBIS, V148, P807, DOI 10.1111/j.1474-919X.2006.00586.x; Martinez JE, 2016, EUR J WILDLIFE RES, V62, P109, DOI 10.1007/s10344-015-0981-x; Martinez JE, 2013, ACTA OECOL, V48, P47, DOI 10.1016/j.actao.2013.01.017; McClure CJW, 2017, ECOL APPL, V27, P1155, DOI 10.1002/eap.1509; Millsap BA, 2015, GLOB ECOL CONSERV, V3, P234, DOI 10.1016/j.gecco.2014.11.017; Mitchell MS, 2008, FOREST ECOL MANAG, V256, P1884, DOI 10.1016/j.foreco.2008.07.012; Mitsopoulos ID, 2014, EUR J FOREST RES, V133, P73, DOI 10.1007/s10342-013-0740-z; Mooney Nick J., 1996, P275, DOI 10.1016/B978-012100130-8/50028-6; Moser BW, 2009, J RAPTOR RES, V43, P1, DOI 10.3356/JRR-07-57.1; Muller KL, 1997, AM NAT, V150, P650, DOI 10.1086/286087; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Pagan I, 2009, J ZOOL, V279, P36, DOI 10.1111/j.1469-7998.2009.00587.x; Pagan I, 2008, THESIS; Poysa H, 2002, J APPL ECOL, V39, P502, DOI 10.1046/j.1365-2664.2002.00726.x; Ramirez L, 1992, EVALUACION ECOLOGICA; Reunanen P, 2015, ANN ZOOL FENN, V52, P221, DOI 10.5735/086.052.0401; Rodriguez SA, 2016, FOREST ECOL MANAG, V374, P220, DOI 10.1016/j.foreco.2016.04.052; Rosenvald R, 2003, FOREST ECOL MANAG, V185, P217, DOI 10.1016/S0378-1127(03)00216-0; Saga O, 2012, FOREST ECOL MANAG, V270, P66, DOI 10.1016/j.foreco.2012.01.015; Santangeli A, 2013, ANIM CONSERV, V16, P500, DOI 10.1111/acv.12017; Santangeli A, 2012, ANIM CONSERV, V15, P571, DOI 10.1111/j.1469-1795.2012.00551.x; Santangeli A, 2015, ENVIRON MANAGE, V55, P321, DOI 10.1007/s00267-014-0385-9; Saurola PL, 1997, J RAPTOR RES, V31, P129; Sergio F, 2005, ECOLOGY, V86, P340, DOI 10.1890/04-0137; Shave ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185701; Suarez-Rubio M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067593, 10.1371/journal.pone.0081143]; Tobolka M, 2013, BIRD STUDY, V60, P399, DOI 10.1080/00063657.2013.818934; Torras O, 2008, FOREST ECOL MANAG, V255, P3322, DOI 10.1016/j.foreco.2008.02.013; Vadell E, 2016, LAND USE POLICY, V55, P37, DOI 10.1016/j.landusepol.2016.03.017; van der Hoek Y, 2017, DIVERS DISTRIB, V23, P1120, DOI 10.1111/ddi.12601; Varela E, 2017, REG ENVIRON CHANGE, V17, P539, DOI 10.1007/s10113-016-1038-8; Ventana Systems, 2016, VENS DSS WIND; Villard P, 2014, IBIS, V156, P132, DOI 10.1111/ibi.12106; Wesolowski T, 2012, BIOL CONSERV, V153, P118, DOI 10.1016/j.biocon.2012.04.017; Williams MR, 2001, J APPL ECOL, V38, P910, DOI 10.1046/j.1365-2664.2001.00645.x; Zhou T, 2009, PROG NAT SCI-MATER, V19, P1253, DOI 10.1016/j.pnsc.2009.03.006; Zuberogoitia I, 2006, ARDEOLA, V53, P83	73	7	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205404	10.1371/journal.pone.0205404	http://dx.doi.org/10.1371/journal.pone.0205404			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308009	Green Submitted, Green Published, gold			2022-12-26	WOS:000447173500068
J	Greigert, V; Abou-Bacar, A; Brunet, J; Nourrisson, C; Pfaff, AW; Benarbia, L; Pereira, B; Randrianarivelojosia, M; Razafindrakoto, JL; Rakotomalala, RS; Morel, E; Candolfi, E; Poirier, P				Greigert, Valentin; Abou-Bacar, Ahmed; Brunet, Julie; Nourrisson, Celine; Pfaff, Alexander W.; Benarbia, Leila; Pereira, Bruno; Randrianarivelojosia, Milijaona; Razafindrakoto, Jean-Louis; Rakotomalala, Rivo Solotiana; Morel, Eugene; Candolfi, Ermanno; Poirier, Philippe			Human intestinal parasites in Mahajanga, Madagascar: The kingdom of the protozoa	PLOS ONE			English	Article							REAL-TIME PCR; DIENTAMOEBA-FRAGILIS; STOOL SPECIMENS; MOLECULAR CHARACTERIZATION; QUANTITATIVE DETECTION; ENTAMOEBA-HISTOLYTICA; CRYPTOSPORIDIUM SPP.; COMMUNITIES; ASSAY; BLASTOCYSTIS	Introduction Intestinal parasitic infections are a major public health problem in inter-tropical areas. The aim of our study was to describe the situation in Mahajanga, Madagascar with a particular focus on two protozoa, Dientamoeba fragilis and Blastocystis sp. Methods This was a prospective study from February to June 2015. Stool samples from symptomatic hospitalized patients and asymptomatic volunteers were submitted to microscopy and molecular assays in order to detect parasites. Results A wide panel of intestinal parasites were identified among the 265 included subjects, protozoa being the most prevalent with 72.8% whereas the prevalence of helminths and microsporidia was of 7.9% and 4.5%, respectively. Blastocystis sp. was the most prevalent protozoa (64.5% of the entire cohort) followed by various amoebas (35.5%) and flagellates (27,5%). We only detected subtypes 1, 2 and 3 of Blastocystis sp. Among the patients positive for D. fragilis (9.4%), 23 carried genotype 1 and 1 genotype 2. For the first time, we detected in 4 human stools the DNA of a recently described protozoon, Simplicimonas similis. Interestingly, subjects living in urban areas harbored significantly more different parasitic species than subjects living in rural areas with a correlation between sanitary level of neighborhood and protozoan infection. However, there was no difference in prevalence of digestive symptoms between parasite-free and parasite-infected subjects, except for Giardia intestinalis which had more symptomatic carriers. Discussion Our study reveals a high overall parasite prevalence, similar to what had been found in 2003 in the same city and to other prevalence studies conducted in Africa. The poor access of the population to sanitary infrastructures may explain this result. Data from our study provide valuable key for sanitation programs and prevention of fecal-related infectious diseases.	[Greigert, Valentin] Hop Civils Colmar, Serv Med Interne, Colmar, France; [Greigert, Valentin; Abou-Bacar, Ahmed; Brunet, Julie; Pfaff, Alexander W.; Benarbia, Leila; Candolfi, Ermanno] Univ Strasbourg, Inst Parasitol & Pathol Trop, Strasbourg, France; [Abou-Bacar, Ahmed; Brunet, Julie; Pfaff, Alexander W.; Candolfi, Ermanno] CHU Strasbourg, Lab Parasitol Mycol, Plateau Tech Microbiol, Strasbourg, France; [Nourrisson, Celine; Poirier, Philippe] CHU Clermont Ferrand, Lab Parasitol Mycol, Clermont Ferrand, France; [Nourrisson, Celine; Poirier, Philippe] Univ Clermont Auvergne, CNRS, LMGE, Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, Direct Rech Clin DRCI, Unite Biostat, Clermont Ferrand, France; [Randrianarivelojosia, Milijaona; Razafindrakoto, Jean-Louis; Rakotomalala, Rivo Solotiana] CHU PZaGa, Lab Anal Med, Mahajanga, Madagascar; [Morel, Eugene] CHU Mahavoky Atsimo, Serv Hepatogastro Enterol, Mahajanga, Madagascar	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Clermont Ferrand; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Greigert, V (corresponding author), Hop Civils Colmar, Serv Med Interne, Colmar, France.; Greigert, V (corresponding author), Univ Strasbourg, Inst Parasitol & Pathol Trop, Strasbourg, France.; Poirier, P (corresponding author), CHU Clermont Ferrand, Lab Parasitol Mycol, Clermont Ferrand, France.; Poirier, P (corresponding author), Univ Clermont Auvergne, CNRS, LMGE, Clermont Ferrand, France.	valentin.greigert@gmail.com; ppoirier@chu-clermontferrand.fr	Nourrisson, Céline/AAC-1527-2019; Greigert, Valentin/J-6087-2019	Nourrisson, Céline/0000-0002-4003-805X; Greigert, Valentin/0000-0002-0975-1949; Randrianarivelojosia, Milijaona/0000-0003-2767-0349; Poirier, Philippe/0000-0001-9173-2634				Alfellani MA, 2013, ACTA TROP, V126, P11, DOI 10.1016/j.actatropica.2012.12.011; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Arneberg P, 2002, ECOGRAPHY, V25, P88, DOI 10.1034/j.1600-0587.2002.250110.x; Barratt JLN, 2011, GUT MICROBES, V2, P3, DOI 10.4161/gmic.2.1.14755; Buchy P, 2003, Bull Soc Pathol Exot, V96, P41; Caccio SM, 2016, INT J PARASITOL, V46, P793, DOI 10.1016/j.ijpara.2016.07.002; Calderaro A, 2010, DIAGN MICR INFEC DIS, V67, P239, DOI 10.1016/j.diagmicrobio.2010.02.016; Cepicka I, 2010, PROTIST, V161, P400, DOI 10.1016/j.protis.2009.11.005; David EB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0714-8; Dimasuay Kris Genelyn B, 2013, J Parasitol Res, V2013, P831947, DOI 10.1155/2013/831947; DOBELL CLIFFORD, 1926, PARASITOLOGY, V18, P283, DOI 10.1017/S0031182000005278; Garcia LS, 2016, DIAGN MED PARASITOL; Gonin P, 2003, J CLIN MICROBIOL, V41, P237, DOI 10.1128/JCM.41.1.237-241.2003; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Hamad I, 2016, PARASITE IMMUNOL, V38, P12, DOI 10.1111/pim.12284; HODES RM, 1988, NEW ENGL J MED, V319, P918, DOI 10.1056/NEJM198810063191406; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Idowu O A, 2006, Afr Health Sci, V6, P160; Lollis L, 2011, J PARASITOL, V97, P610, DOI 10.1645/GE-2648.1; Mary C, 2013, J CLIN MICROBIOL, V51, P2556, DOI 10.1128/JCM.03458-12; Mengistu Legesse, 2017, ETHIOP J HLTH D 0104, V18; Menotti J, 2003, J INFECT DIS, V187, P1469, DOI 10.1086/374620; Menotti J, 2003, J CLIN MICROBIOL, V41, P1410, DOI 10.1128/JCM.41.4.1410-1413.2003; Miandra Rova F. H, 2010, ANAL ENV SANITAIRE Q; Ministere de l'economie et de l'industrie, 2010, ENQ PER AUPR MEN 201; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Oberhelman RA, 1998, AM J TROP MED HYG, V58, P470, DOI 10.4269/ajtmh.1998.58.470; Peek R, 2004, J CLIN MICROBIOL, V42, P631, DOI 10.1128/JCM.42.2.631-635.2004; Poirier P, 2011, J CLIN MICROBIOL, V49, P975, DOI 10.1128/JCM.01392-10; Scanlan PD, 2014, FEMS MICROBIOL ECOL, V90, P326, DOI 10.1111/1574-6941.12396; Silberman JD, 1996, MOL BIOCHEM PARASIT, V76, P311, DOI 10.1016/0166-6851(95)02516-2; Smejkalova P, 2014, FOLIA PARASIT, V61, P189, DOI 10.14411/fp.2014.025; Stark D, 2006, J CLIN MICROBIOL, V44, P232, DOI 10.1128/JCM.44.1.232-235.2006; Stark D, 2011, J CLIN MICROBIOL, V49, P257, DOI 10.1128/JCM.01796-10; Stark D, 2010, AM J TROP MED HYG, V82, P614, DOI 10.4269/ajtmh.2010.09-0478; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; Tobie J, 1938, AM J TROP MED HYG  S, V1-18, P169, DOI [10.4269/ajtmh.1938.s1-18.169, DOI 10.4269/AJTMH.1938.S1-18.169]; Traub RJ, 2008, VET PARASITOL, V155, P67, DOI 10.1016/j.vetpar.2008.05.001; van Coppenraet LESB, 2009, CLIN MICROBIOL INFEC, V15, P869, DOI 10.1111/j.1469-0691.2009.02894.x; Watkins WE, 1997, PSYCHOL BULL, V121, P171, DOI 10.1037/0033-2909.121.2.171; Wawrzyniak I, 2013, THER ADV INFECT DIS, V1, P167, DOI 10.1177/2049936113504754; Windsor JJ, 2006, J EUKARYOT MICROBIOL, V53, P188, DOI 10.1111/j.1550-7408.2006.00092.x	42	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204576	10.1371/journal.pone.0204576	http://dx.doi.org/10.1371/journal.pone.0204576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304028	gold, Green Published, Green Submitted			2022-12-26	WOS:000446921100055
J	Ibanez, M; Carbonell-Caballero, J; Such, E; Garcia-Alonso, L; Liguori, A; Lopez-Pavia, M; Llop, M; Alonso, C; Barragan, E; Gomez-Segui, I; Neef, A; Hervas, D; Montesinos, P; Sanz, G; Sanz, MA; Dopazo, J; Cervera, J				Ibanez, Mariam; Carbonell-Caballero, Jose; Such, Esperanza; Garcia-Alonso, Luz; Liguori, Alessandro; Lopez-Pavia, Maria; Llop, Marta; Alonso, Carmen; Barragan, Eva; Gomez-Segui, Ines; Neef, Alexander; Hervas, David; Montesinos, Pau; Sanz, Guillermo; Angel Sanz, Miguel; Dopazo, Joaquin; Cervera, Jose			The modular network structure of the mutational landscape of Acute Myeloid Leukemia	PLOS ONE			English	Article							SUBSTRATE LYMPHOCYTE TYPE; ETS-RELATED GENE; EXPRESSION PROFILES; SOMATIC MUTATIONS; NORMAL KARYOTYPE; EPHB1 PROTEIN; CANCER; ERG; TRANSFORMATION; PREDICTS	Acute myeloid leukemia (AML) is associated with the sequential accumulation of acquired genetic alterations. Although at diagnosis cytogenetic alterations are frequent in AML, roughly 50% of patients present an apparently normal karyotype (NK), leading to a highly heterogeneous prognosis. Due to this significant heterogeneity, it has been suggested that different molecular mechanisms may trigger the disease with diverse prognostic implications. We performed whole-exome sequencing (WES) of tumor-normal matched samples of de novo AML-NK patients lacking mutations in NPM1, CEBPA or FLT3-ITD to identify new gene mutations with potential prognostic and therapeutic relevance to patients with AML. Novel candidate-genes, together with others previously described, were targeted resequenced in an independent cohort of 100 de novo AML patients classified in the cytogenetic intermediate-risk (IR) category. A mean of 4.89 mutations per sample were detected in 73 genes, 35 of which were mutated in more than one patient. After a network enrichment analysis, we defined a single in silico model and established a set of seed-genes that may trigger leukemogenesis in patients with normal karyotype. The high heterogeneity of gene mutations observed in AML patients suggested that a specific alteration could not be as essential as the interaction of deregulated pathways.	[Ibanez, Mariam; Such, Esperanza; Liguori, Alessandro; Lopez-Pavia, Maria; Gomez-Segui, Ines; Neef, Alexander; Montesinos, Pau; Sanz, Guillermo; Angel Sanz, Miguel; Cervera, Jose] Hosp Univ & Politecn La Fe, Hematol Serv, Valencia, Spain; [Ibanez, Mariam; Such, Esperanza; Liguori, Alessandro; Llop, Marta; Barragan, Eva; Gomez-Segui, Ines; Montesinos, Pau; Sanz, Guillermo; Angel Sanz, Miguel; Cervera, Jose] Inst Carlos III, Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain; [Ibanez, Mariam] Univ CEU Cardenal Herrera, Dept Ciencias Biomed, Fac Ciencias Salud, Valencia, Spain; [Carbonell-Caballero, Jose] Bellvitge Inst Biomed Res IDIBELL, ProCURE, Catalan Inst Oncol, Barcelona, Spain; [Garcia-Alonso, Luz] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge, England; [Llop, Marta; Barragan, Eva] Hosp Univ La Fe, Dept Med Pathol, Valencia, Spain; [Alonso, Carmen] Hosp Arnau de Villanoba, Hematol Serv, Valencia, Spain; [Hervas, David] IIS La Fe Valencia, Biostat Unit, Valencia, Spain; [Dopazo, Joaquin] CIPF, Spanish Natl Inst Bioinformat, Funct Genom Node, Valencia, Spain; [Dopazo, Joaquin] CIBER Enfermedades Raras CIBERER, Bioinformat Rare Dis BIER, Valencia, Spain; [Dopazo, Joaquin] Hosp Virgen del Rocio, CDCA, Clin Bioinformat Area, FPS, Seville, Spain; [Cervera, Jose] Hosp Univ & Politecn La Fe, Genet Unit, Valencia, Spain	Hospital Universitari i Politecnic La Fe; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Universidad CEU Cardenal Herrera; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); European Molecular Biology Laboratory (EMBL); Hospital Universitari i Politecnic La Fe; Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Virgen del Rocio University Hospital; Hospital Universitari i Politecnic La Fe	Cervera, J (corresponding author), Hosp Univ & Politecn La Fe, Hematol Serv, Valencia, Spain.; Cervera, J (corresponding author), Inst Carlos III, Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain.; Dopazo, J (corresponding author), CIPF, Spanish Natl Inst Bioinformat, Funct Genom Node, Valencia, Spain.; Dopazo, J (corresponding author), CIBER Enfermedades Raras CIBERER, Bioinformat Rare Dis BIER, Valencia, Spain.; Dopazo, J (corresponding author), Hosp Virgen del Rocio, CDCA, Clin Bioinformat Area, FPS, Seville, Spain.; Cervera, J (corresponding author), Hosp Univ & Politecn La Fe, Genet Unit, Valencia, Spain.	joaquin.dopazo@gmail.com; cervera_jos@gva.es	IBAÑEZ COMPANY, MARIAM/AAW-9082-2021; Sanz, Miguel A./F-7485-2018; Cervera, Jose/ABF-2143-2020; Seguí, Inés Gómez/ABH-5290-2020; Neef, Alexander/A-7900-2012; Liquori, Alessandro/K-7934-2015; Hervas, David/L-1322-2016	IBAÑEZ COMPANY, MARIAM/0000-0002-7486-4659; Sanz, Miguel A./0000-0003-1489-1177; Cervera, Jose/0000-0001-8252-1106; Neef, Alexander/0000-0002-4170-9425; Liquori, Alessandro/0000-0002-4842-5986; SANZ, GUILLERMO/0000-0002-2767-8191; Lopez Pavia, Maria/0000-0002-8529-4372; Montesinos, Pau/0000-0002-3275-5593; Such, Esperanza/0000-0001-6892-403X; Hervas, David/0000-0003-0635-4961; Carbonell Caballero, Jose/0000-0002-9170-0533	FEDER fund (CIBERONC) [CB16/12/00284]; FEDER fund "Red Temaatica de Investigacion Cooperativa en Cancer" grant [RD12/0036/0014]; Instituto de Salud Carlos III grants [PI12/01047, PI13/01640, PI13/02837, PT13/0010/0026, PT13/0001/0007, PIE13/00046, PI16/00665, PI16/011113]; Conselleria de Educacion, Cultura y Deporte [AC15/00068, PROMETEOII/2015/008]; Spanish Ministry of Economy and Competitiveness (MINECO) [SAF2017-88908-R]	FEDER fund (CIBERONC); FEDER fund "Red Temaatica de Investigacion Cooperativa en Cancer" grant; Instituto de Salud Carlos III grants(Instituto de Salud Carlos III); Conselleria de Educacion, Cultura y Deporte; Spanish Ministry of Economy and Competitiveness (MINECO)	This study was supported in part by research funding from FEDER funds (CIBERONC (CB16/12/00284)), "Red Temaatica de Investigacion Cooperativa en Cancer" grant (RD12/0036/0014,); "Instituto de Salud Carlos III" grants PI12/01047, PI13/01640, PI13/02837, PT13/0010/0026, PT13/0001/0007, PIE13/00046, PI16/00665 and PI16/011113; from the "Conselleria de Educacion, Cultura y Deporte" AC15/00068 and PROMETEOII/2015/008 and supported by grant SAF2017-88908-R from the Spanish Ministry of Economy and Competitiveness (MINECO).	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amasaki Y, 2002, J BIOL CHEM, V277, P25640, DOI 10.1074/jbc.M201860200; Baldus CD, 2006, J CLIN ONCOL, V24, P4714, DOI 10.1200/JCO.2006.06.1580; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Dolnik A, 2012, BLOOD, V120, pE83, DOI 10.1182/blood-2011-12-401471; Eid MA, INT J LAB HEMATOL, V32; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fernandez CA, 2015, BLOOD, V126, P69, DOI 10.1182/blood-2015-02-628800; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goldberg L, 2013, BLOOD, V122, P2694, DOI 10.1182/blood-2013-01-477133; Gough SM, 2011, BLOOD, V118, P6247, DOI 10.1182/blood-2011-07-328880; Gui J, 2005, BIOINFORMATICS, V21, P3001, DOI 10.1093/bioinformatics/bti422; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hollink IHIM, 2011, BLOOD, V118, P3645, DOI 10.1182/blood-2011-04-346643; Ibanez M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148346; Kharas MG, 2004, BLOOD, V103, P4268, DOI 10.1182/blood-2003-07-2193; Kuang SQ, 2010, BLOOD, V115, P2412, DOI 10.1182/blood-2009-05-222208; Kwon MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071626; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li Y, 2011, ONCOGENE, V30, P2633, DOI 10.1038/onc.2010.632; Liu Y, 2017, NAT GENET, V49, P1211, DOI 10.1038/ng.3909; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marcucci G, 2005, J CLIN ONCOL, V23, P9234, DOI 10.1200/JCO.2005.03.6137; Marcucci G, 2007, J CLIN ONCOL, V25, P3337, DOI 10.1200/JCO.2007.10.8720; Metzeler KH, 2009, J CLIN ONCOL, V27, P5031, DOI 10.1200/JCO.2008.20.5328; Minguez P, 2009, NUCLEIC ACIDS RES, V37, pW109, DOI 10.1093/nar/gkp402; Mitra K, 2013, NAT REV GENET, V14, P719, DOI 10.1038/nrg3552; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Nakamoto T, 2008, J CELL BIOCHEM, V105, P121, DOI 10.1002/jcb.21799; Nikonova AS, 2014, IUBMB LIFE, V66, P387, DOI 10.1002/iub.1282; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; Pallares V, 2017, ONCOTARGET, V8, P76003, DOI 10.18632/oncotarget.18537; Pan J, 2017, LEUKEMIA LYMPHOMA, V58, P1655, DOI 10.1080/10428194.2016.1260124; Papaemmanuil E, 2016, N ENGL J MED; Patel VN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003237; Pritchard CC, 2014, J MOL DIAGN, V16, P56, DOI 10.1016/j.jmoldx.2013.08.004; Quayle SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049466; Radmacher MD, 2006, BLOOD, V108, P1677, DOI 10.1182/blood-2006-02-005538; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Schwind S, 2010, BLOOD, V116, P5660, DOI 10.1182/blood-2010-06-290536; Seo S, 2005, J IMMUNOL, V175, P3492, DOI 10.4049/jimmunol.175.6.3492; Seo S, 2011, CANCER SCI, V102, P2109, DOI 10.1111/j.1349-7006.2011.02066.x; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; SKORSKI T, 1995, BLOOD, V86, P726, DOI 10.1182/blood.V86.2.726.bloodjournal862726; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Soler G, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.20; Stoll G, 2013, NUCLEIC ACIDS RES, V41, P8853, DOI 10.1093/nar/gkt678; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Waldron L, 2011, BIOINFORMATICS, V27, P3399, DOI 10.1093/bioinformatics/btr591; Wang HY, 2014, INT J CLIN EXP PATHO, V7, P313; Wang JD, 2007, ONCOLOGY-BASEL, V73, P238, DOI 10.1159/000127421; Xiao SJ, 2015, MOL CLIN ONCOL, V3, P880, DOI 10.3892/mco.2015.562; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Zhong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035058	62	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0202926	10.1371/journal.pone.0202926	http://dx.doi.org/10.1371/journal.pone.0202926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303964	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100013
J	Siepi, M; Oliva, R; Petraccone, L; Del Vecchio, P; Ricca, E; Isticato, R; Lanzilli, M; Maglio, O; Lombardi, A; Leone, L; Notomista, E; Donadio, G				Siepi, Marialuisa; Oliva, Rosario; Petraccone, Luigi; Del Vecchio, Pompea; Ricca, Ezio; Isticato, Rachele; Lanzilli, Mariamichela; Maglio, Ornella; Lombardi, Angela; Leone, Linda; Notomista, Eugenio; Donadio, Giuliana			Fluorescent peptide dH3w: A sensor for environmental monitoring of mercury (II)	PLOS ONE			English	Article							TRANSITION-METAL IONS; AQUEOUS-SOLUTION; ULTRASENSITIVE DETECTION; CHEMOSENSOR; HEAVY; BINDING; WATER; SPECTROSCOPY; COMPLEXES; HISTIDINE	Heavy metals are hazardous environmental contaminants, often highly toxic even at extremely low concentrations. Monitoring their presence in environmental samples is an important but complex task that has attracted the attention of many research groups. We have previously developed a fluorescent peptidyl sensor, dH3w, for monitoring Zn2+ in living cells. This probe, designed on the base on the internal repeats of the human histidine rich glycoprotein, shows a turn on response to Zn2+ and a turn off response to Cu2+. Other heavy metals (Mn2+, Fe2+, Ni2+, Co2+, Pb2+ and Cd 2+) do not interfere with the detection of Zn2+ and Cu2+. Here we report that dH3w has an affinity for Hg2+ considerably higher than that for Zn2+ or Cu2+, therefore the strong fluorescence of the Zn2+/dH3w complex is quenched when it is exposed to aqueous solutions of Hg2+, allowing the detection of sub-micromolar levels of Hg2+. Fluorescence of the Zn2+/dH3w complex is also quenched by Cu2+ whereas other heavy metals (Mn-2(+), Fe2+, Ni2+, Co2+, Cd2+, Pb2+, Sn2+ and Cr3+) have no effect. The high affinity and selectivity suggest that dH3w and the Zn2+/dH3w complex are suited as fluorescent sensor for the detection of Hg2+ and Cu2+ in environmental as well as biological samples.	[Siepi, Marialuisa; Ricca, Ezio; Isticato, Rachele; Lanzilli, Mariamichela; Notomista, Eugenio; Donadio, Giuliana] Univ Naples Federico II, Dept Biol, Naples, Italy; [Oliva, Rosario; Petraccone, Luigi; Del Vecchio, Pompea; Maglio, Ornella; Lombardi, Angela; Leone, Linda] Univ Naples Federico II, Dept Chem Sci, Naples, Italy; [Maglio, Ornella] CNR, IBB, Naples, Italy	University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Notomista, E; Donadio, G (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	notomist@unina.it; giuliana.donadio@unina.it	Leone, Linda/L-7792-2019; ISTICATO, Rachele/AAX-9972-2021; Isticato, Rachele/J-3476-2012; Ricca, Ezio/AAG-2998-2020; Oliva, Rosario/AAH-2669-2020; Lombardi, Angela/D-2778-2011	ISTICATO, Rachele/0000-0001-9141-4038; Ricca, Ezio/0000-0002-7355-0332; Lombardi, Angela/0000-0002-2013-3009; Leone, Linda/0000-0001-7293-1814; Lanzilli, Mariamichela/0000-0001-5699-5105; Oliva, Rosario/0000-0003-1763-1768; Del Vecchio, Pompea Giuseppina Grazia/0000-0002-9760-3478	University of Naples "Federico II", Italy [STAR Linea 1-2017]	University of Naples "Federico II", Italy	This work was supported by a grant (STAR Linea 1-2017) from the University of Naples "Federico II", Italy.	BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Behrendt R, 2016, J PEPT SCI, V22, P4, DOI 10.1002/psc.2836; BROOKS P, 1960, J AM CHEM SOC, V82, P2118, DOI 10.1021/ja01494a008; DeSilva TM, 2002, BIOPOLYMERS, V64, P189, DOI 10.1002/bip.10149; Ding J, 2017, POLYM CHEM-UK, V8, P2221, DOI 10.1039/c7py00035a; Donadio G, 2016, J MATER CHEM B, V4, P6979, DOI 10.1039/c6tb00671j; Fang Y, 2018, SENSOR ACTUAT B-CHEM, V255, P1182, DOI 10.1016/j.snb.2017.06.050; GRIESINGER C, 1987, J MAGN RESON, V75, P261, DOI 10.1016/0022-2364(87)90035-7; Gui SL, 2018, ANAL CHEM, V90, P9708, DOI 10.1021/acs.analchem.8b00059; Guo XF, 2004, J AM CHEM SOC, V126, P2272, DOI 10.1021/ja037604y; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Joshi BP, 2010, ORG BIOMOL CHEM, V8, P3220, DOI 10.1039/b925744f; Joshi BP, 2009, TALANTA, V78, P903, DOI 10.1016/j.talanta.2008.12.062; KAUPP M, 1994, INORG CHEM, V33, P2555, DOI 10.1021/ic00090a014; Kim SH, 2006, ORG LETT, V8, P371, DOI 10.1021/ol052282j; Knecht S, 2009, J MOL RECOGNIT, V22, P270, DOI 10.1002/jmr.941; KUMAR A, 1981, J AM CHEM SOC, V103, P3654, DOI 10.1021/ja00403a008; Makam P, 2018, BIOSENS BIOELECTRON, V100, P556, DOI 10.1016/j.bios.2017.09.051; Martinez R, 2005, ORG LETT, V7, P5869, DOI 10.1021/ol052508i; Moon SY, 2005, J ORG CHEM, V70, P2394, DOI 10.1021/jo0482054; Murphy K, 2015, TALANTA, V132, P520, DOI 10.1016/j.talanta.2014.09.045; Neupane LN, 2016, ANAL CHEM, V88, P3333, DOI 10.1021/acs.analchem.5b04892; Pandeeswar M, 2016, ACS APPL MATER INTER, V8, P30362, DOI 10.1021/acsami.6b10527; Parella T, 1997, J MAGN RESON, V126, P274, DOI 10.1006/jmre.1997.1164; Park SM, 2007, J ORG CHEM, V72, P3550, DOI 10.1021/jo062516s; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; Rasheed T, 2018, SENSOR ACTUAT B-CHEM, V258, P115, DOI 10.1016/j.snb.2017.11.100; Rasheed T, 2018, SCI TOTAL ENVIRON, V615, P476, DOI 10.1016/j.scitotenv.2017.09.126; Shiraishi Y, 2008, J ORG CHEM, V73, P8571, DOI 10.1021/jo8012447; Shrivastava A., 2011, CHRONICLES YOUNG SCI, V2, P21, DOI [DOI 10.4103/2229-5186.79345, 10.4103/2229-5186.79345]; Singh AK, 2004, SENSOR ACTUAT B-CHEM, V99, P36, DOI 10.1016/j.snb.2003.09.004; SJOBERG S, 1977, ACTA CHEM SCAND A, V31, P718, DOI 10.3891/acta.chem.scand.31a-0718; Sundeberg RJ, 1974, CHEM REV, V74; Talanova GG, 1999, ANAL CHEM, V71, P3106, DOI 10.1021/ac990205u; Tchounwou PB, 2003, ENVIRON TOXICOL, V18, P149, DOI 10.1002/tox.10116; Thirupathi P, 2013, BIOORGAN MED CHEM, V21, P7964, DOI 10.1016/j.bmc.2013.09.058; Valeur B, 2001, MOL FLUORESCENCE PRI, V2nd; Wakabayashi S, 2013, INT REV CEL MOL BIO, V304, P467, DOI 10.1016/B978-0-12-407696-9.00009-9; Wang P, 2015, J MATER CHEM B, V3, P3617, DOI 10.1039/c5tb00142k; White BR, 2008, ANALYST, V133, P65, DOI 10.1039/b711777a; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhang H, 2005, ORG LETT, V7, P4217, DOI 10.1021/ol051614h	43	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204164	10.1371/journal.pone.0204164	http://dx.doi.org/10.1371/journal.pone.0204164			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303991	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100032
J	Zhang, YP; Liu, ZX; Xu, YY				Zhang, Yinpeng; Liu, Zhixin; Xu, Yingying			Carbon price volatility: The case of China	PLOS ONE			English	Article							EMISSIONS TRADING SCHEME; AUTOREGRESSIVE TIME-SERIES; EU-ETS; UNIT-ROOT; CONDITIONAL HETEROSKEDASTICITY; STOCK RETURNS; MARKET; DYNAMICS; ALLOWANCES; STATIONARITY	Based on carbon spot prices selected from seven carbon pilots, we assess the financial performances related to carbon volatility in China on the overall perspective. According to the results, the Chinese carbon market fluctuated severely at the beginning of carbon trading, but has stabilised in general, despite several dramatic changes related to 'yearly compliance events'. Long-term memory exists in the volatility series. Moreover, asymmetry exists in the Chinese carbon market, and volatility reacts more severely to good news than to bad news. Finally, we discuss our empirical results, and make certain suggestions regarding firms' awareness, international cooperation and individual investors not only for policy makers in China but also for other developing countries who are contemplating either commencing carbon trading or improving the current market.	[Zhang, Yinpeng; Liu, Zhixin] Beihang Univ, Sch Econ & Management, Beijing, Peoples R China; [Xu, Yingying] Univ Sci & Technol Beijing, Donlinks Sch Econ & Management, Beijing, Peoples R China	Beihang University; University of Science & Technology Beijing	Xu, YY (corresponding author), Univ Sci & Technol Beijing, Donlinks Sch Econ & Management, Beijing, Peoples R China.	xuying1221@126.com						Akerlof GA, 2009, AM J AGR ECON, V91, P1175, DOI 10.1111/j.1467-8276.2009.01281.x; Alberola E, 2008, ENERG POLICY, V36, P787, DOI 10.1016/j.enpol.2007.10.029; Benz E, 2009, ENERG ECON, V31, P4, DOI 10.1016/j.eneco.2008.07.003; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Bushnell JB, 2013, AM ECON J-ECON POLIC, V5, P78, DOI 10.1257/pol.5.4.78; CAMPBELL JY, 1992, J FINANC ECON, V31, P281, DOI 10.1016/0304-405X(92)90037-X; Chang K, 2017, ENERG ECON, V67, P213, DOI 10.1016/j.eneco.2017.07.006; Chen J., 2011, THESIS; Chevallier J, 2011, RESOUR ENERGY ECON, V33, P855, DOI 10.1016/j.reseneeco.2011.07.002; Chevallier J, 2011, ENERG ECON, V33, P99, DOI 10.1016/j.eneco.2010.09.006; DICKEY DA, 1981, ECONOMETRICA, V49, P1057, DOI 10.2307/1912517; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Ellerman AD, 2008, ENVIRON RESOUR ECON, V41, P267, DOI 10.1007/s10640-008-9191-2; Engle R. F., 1986, ECONOMET REV, V5, P1, DOI [DOI 10.1080/07474938608800095, 10.1080/07474938608800095]; Fan JH, 2017, APPL ENERG, V208, P1452, DOI 10.1016/j.apenergy.2017.09.007; Feng ZH, 2011, APPL ENERG, V88, P590, DOI 10.1016/j.apenergy.2010.06.017; Huang Y., 2013, E ASIA-NETHERLANDS, V30, P67; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Ibrahim BM, 2016, J BANK FINANC, V63, P76, DOI 10.1016/j.jbankfin.2015.11.004; Jones CP, 2004, J FINANC RES, V27, P585, DOI [DOI 10.1111/J.1475-6803.2004.00109.X, 10.1111/j.1475-6803.2004.00109.x]; KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y; Lee D, 1996, J ECONOMETRICS, V73, P285, DOI 10.1016/0304-4076(95)01741-0; Li Qiwei, 2015, FORUM SCI TECHNOLOGY, V5, P128, DOI [10.13580/j.cnki.fstc.2015.05.020, DOI 10.13580/J.CNKI.FSTC.2015.05.020]; Lo AY, 2015, SUSTAIN DEV, V23, P369, DOI 10.1002/sd.1597; Lo AY, 2016, CLIM POLICY, V16, P109, DOI 10.1080/14693062.2014.991907; Luo CC, 2016, ENVIRON RES, V149, P297, DOI 10.1016/j.envres.2016.02.007; MANDELBR.BB, 1969, WATER RESOUR RES, V5, P967, DOI 10.1029/WR005i005p00967; Mansanet-Bataller M, 2009, J ENERGY MARKETS, V2, P75; Moreno B, 2016, ENERGY, V103, P240, DOI 10.1016/j.energy.2016.02.094; NELSON DB, 1991, ECONOMETRICA, V59, P347, DOI 10.2307/2938260; Oestreich AM, 2015, J BANK FINANC, V58, P294, DOI 10.1016/j.jbankfin.2015.05.005; Ren C, 2017, APPL ENERG, V193, P414, DOI 10.1016/j.apenergy.2017.02.037; SAID SE, 1984, BIOMETRIKA, V71, P599; Sanin ME, 2015, ENERG POLICY, V82, P321, DOI 10.1016/j.enpol.2015.02.024; SCHWERT GW, 1990, REV FINANC STUD, V3, P77, DOI 10.1093/rfs/3.1.77; Seifert J, 2008, J ENVIRON ECON MANAG, V56, P180, DOI 10.1016/j.jeem.2008.03.003; Stavins RN, 1999, SOCIAL SCI ELECT PUB, V01-58, P355, DOI [DOI 10.1016/S1574-0099(03)01014-3, 10.1016/S1574-0099(03)01014-3]; Wu LB, 2014, ENERG POLICY, V75, P22, DOI 10.1016/j.enpol.2014.04.022; Yang L, 2016, ENERG POLICY, V98, P254, DOI 10.1016/j.enpol.2016.08.039; Yu L, 2015, ENERG ECON, V51, P300, DOI 10.1016/j.eneco.2015.07.005; Zhang YP, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9030437; Zhang ZX, 2016, ASIA PAC POLICY STUD, V3, P187, DOI 10.1002/app5.138; Zhao XG, 2017, RENEW SUST ENERG REV, V79, P1, DOI 10.1016/j.rser.2017.05.034; Zhao XG, 2016, RENEW SUST ENERG REV, V59, P1229, DOI 10.1016/j.rser.2016.01.052; Zheng Shuang, 2014, ENERGY CHINA, V2, P23, DOI [10.3969/j.issn.1003-2355.2014.02.005, DOI 10.3969/J.ISSN.1003-2355.2014.02.005]	46	13	14	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205317	10.1371/journal.pone.0205317	http://dx.doi.org/10.1371/journal.pone.0205317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4VA	30304004	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100078
J	Klahr, AC; Kate, M; Kosior, J; Buck, B; Shuaib, A; Emery, D; Butcher, K				Klahr, Ana C.; Kate, Mahesh; Kosior, Jayme; Buck, Brian; Shuaib, Ashfaq; Emery, Derek; Butcher, Kenneth			Early hematoma retraction in intracerebral hemorrhage is uncommon and does not predict outcome	PLOS ONE			English	Article							PERIHEMATOMAL EDEMA; STROKE; GUIDELINES; ENLARGEMENT; MANAGEMENT	Background Clot retraction in intracerebral hemorrhage (ICH) has been described and postulated to be related to effective hemostasis and perihematoma edema (PHE) formation. The incidence and quantitative extent of hematoma retraction (HR) is unknown. Our aim was to determine the incidence of HR between baseline and time of admission. We also tested the hypothesis that patients with HR had higher PHE volume and good prognosis. Methods This was a retrospective single-centre study in which serial planimetric volume measurements of the total hematoma volume (parenchymal (IPH) and intraventricular (IVH)) and PHE were performed in ICH patients with baseline non-contrast computed tomography (CT) completed within 6 hours of onset and follow-up CT 24 (+/- 12) hours from symptom onset. HR was defined as a decrease in volume of > 3ml or > 15%, and hematoma expansion (HE) as an increase of > 6ml or > 30%. All other patients were categorized as stable hematoma (HS). Good outcome was defined as modified Rankin Scale (mRS) 0 - 2 at 90 days. Results A total of 136 patients (mean age = 69.3 +/- 13.39 years, 58.1% male) were included. Median (interquartile range) baseline total hematoma volume was 14.96 (7.80, 31.88) ml. HR > 3ml and > 15% occurred in 6 (4.4%) and 8 (5.9%) patients, respectively. Neither definition of HR was associated with follow-up PHE (p>0.297) or good outcome (p>0.249). IVH was the only independent predictor of HR (p<0.0241). Conclusions Early HR is rare and associated with IVH, but not with PHE or clinical outcome. There was no relationship between HR, PHE, and patient prognosis. Therefore, HR is unlikely to be a useful endpoint in clinical ICH studies.	[Klahr, Ana C.; Kosior, Jayme; Buck, Brian; Shuaib, Ashfaq; Butcher, Kenneth] Univ Alberta, Div Neurol, Dept Med, Edmonton, AB, Canada; [Kate, Mahesh] Christian Med Coll Ludhiana, Dept Neurol, Ludhiana, Punjab, India; [Emery, Derek] Univ Alberta, Dept Radiol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Butcher, K (corresponding author), Univ Alberta, Div Neurol, Dept Med, Edmonton, AB, Canada.	ken.butcher@ualberta.ca	Emery, Derek/V-4913-2019; Butcher, Ken/ABC-6632-2020; Buck, Brian H/B-8482-2009; Kate, Mahesh/W-5490-2019; Butcher, Ken/AEP-3693-2022	Emery, Derek/0000-0003-2678-3077; Butcher, Ken/0000-0002-0590-7918; Buck, Brian H/0000-0002-7984-6062; Kate, Mahesh/0000-0003-4794-2882; Butcher, Ken/0000-0002-0590-7918	Heart and Stroke Foundation Canada [GIA G-14-0006004]	Heart and Stroke Foundation Canada(Heart & Stroke Foundation of Canada)	This research was supported by the Heart and Stroke Foundation Canada (HSFC GIA G-14-0006004 to KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Butcher KS, 2013, STROKE, V44, P620, DOI 10.1161/STROKEAHA.111.000188; Butcher KS, 2004, STROKE, V35, P1879, DOI 10.1161/01.STR.0000131807.54742.1a; Casaubon LK, 2015, INT J STROKE, V10, P924, DOI 10.1111/ijs.12551; CLASEN RA, 1981, J COMPUT ASSIST TOMO, V5, P313, DOI 10.1097/00004728-198106000-00001; Dowlatshahi D, 2011, NEUROLOGY, V76, P1238, DOI 10.1212/WNL.0b013e3182143317; Dowlatshahi D, 2012, STROKE, V43, P1812, DOI 10.1161/STROKEAHA.112.652065; FUJII Y, 1994, J NEUROSURG, V80, P51, DOI 10.3171/jns.1994.80.1.0051; Gebel JM, 2002, STROKE, V33, P2631, DOI 10.1161/01.STR.0000035284.12699.84; Gebel JM, 2000, STROKE, V31, P596, DOI 10.1161/01.STR.31.3.596; Gladstone DJ, SPOT SIGN SELECTION; Gould B, 2014, STROKE, V45, P2894, DOI 10.1161/STROKEAHA.114.005614; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Kazui S, 1996, STROKE, V27, P1783, DOI 10.1161/01.STR.27.10.1783; Kosior JC, 2011, INT J STROKE, V6, P302, DOI 10.1111/j.1747-4949.2010.00579.x; Majidi S, 2016, J NEUROIMAGING, V26, P346, DOI 10.1111/jon.12306; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Qureshi AI, 2016, NEW ENGL J MED, V375, P1033, DOI 10.1056/NEJMoa1603460; ROBB RA, 1989, COMPUT MED IMAG GRAP, V13, P433, DOI 10.1016/0895-6111(89)90285-1; Roux DTL, 2000, BLOOD, V96, P1399, DOI 10.1182/blood.V96.4.1399.h8001399_1399_1408; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Sutherland GR, 2006, J CLIN NEUROSCI, V13, P511, DOI 10.1016/j.jocn.2004.12.012; TAKASUGI S, 1985, STROKE, V16, P651, DOI 10.1161/01.STR.16.4.651; Templeton GF, 2011, COMMUN ASSOC INF SYS, V28, P41; Veltkamp R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0783-5; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD; Wu G, 2006, ACTA NEUROCHIR SUPPL, V96, P78; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580; Zazulia AR, 2011, NEUROCRIT CARE, V15, P436, DOI 10.1007/s12028-011-9578-8; Zerhouni E, 2004, SCIENCE, V38, P15, DOI [10.1016/j.transci.2007.12.005.Thrombin, DOI 10.1016/J.TRANSCI.2007.12.005.THROMBIN]	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205436	10.1371/journal.pone.0205436	http://dx.doi.org/10.1371/journal.pone.0205436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300383	Green Published, Green Submitted, gold			2022-12-26	WOS:000446897200065
J	Seguin, R; Flax, VL; Jagger, P				Seguin, Ryan; Flax, Valerie L.; Jagger, Pamela			Barriers and facilitators to adoption and use of fuel pellets and improved cookstoves in urban Rwanda	PLOS ONE			English	Article							SOCIAL PERCEPTIONS; COOKING; STOVES	Background The environmental and health impacts of reliance on solid fuels and traditional cookstoves in low-income countries have motivated the promotion of household cooking energy systems that use cleaner burning fuels and cookstoves that lead to reduced exposure to harmful pollutants. Little is known about adoption and use of such systems from the users' perspective. Methods We explored the facilitators and barriers to adoption and use of a private sector marketed household cooking energy system that uses sustainably produced biomass pellets and the cleanest burning fan micro-gasification stove currently available. We conducted 48 in-depth qualitative interviews in Gisenyi, Rwanda with decision-makers and cooks in 16 households that adopted the improved cookstove system and 8 non-adopter households. Results Reported facilitators and barriers to adoption and non-adoption, as well as use and non-use were complex, and in some cases, contradictory. Some adopters noted that cleanliness and low smoke production were major facilitators to adoption and use, while other adopters and non-adopters said the cookstoves blackened and damaged cooking pots and produced excessive smoke. Our findings suggest that correct use of the stove mediates user experience. Cost was likewise reported as a facilitator among some adopters and a barrier among other adopters and non-adopters. Peer influence played a significant role as both a barrier and a facilitator to adoption and transcended other factors. Positive peer influence describing the cleanliness, affordability, and efficiency of the cookstove system encouraged adoption and use, while negative comments by peers regarding excessive smoke and damaged cooking pots discouraged adoption. Commentaries by some participants suggest that inadequate training and instruction may be primary causes of the discrepancies. Conclusion Cost, cleanliness, communication among peer networks, and adequate training and instruction are important factors associated with the adoption and use of improved cookstoves and should be prioritized in the implementation of improved cookstove programs.	[Seguin, Ryan] UNC Project Malawi, Lilongwe, Malawi; [Flax, Valerie L.] RTI Int, Res Triangle Pk, NC USA; [Jagger, Pamela] Univ N Carolina, Dept Publ Policy, Chapel Hill, NC 27515 USA; [Jagger, Pamela] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Seguin, R (corresponding author), UNC Project Malawi, Lilongwe, Malawi.	j.ryan.seguin@gmail.com		Flax, Valerie/0000-0003-0200-3355	United Nations Foundation/Global Alliance for Clean Cookstoves [UNF-15-708]; National Institutes of Health/National Institute of Environmental Health Sciences [R01ES023861]; Carolina Population Center [P2C HD050924]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023861] Funding Source: NIH RePORTER	United Nations Foundation/Global Alliance for Clean Cookstoves; National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Carolina Population Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Author VLF is currently employed by the independent, nonprofit institute, RTI International. She was employed by the University of North Carolina when the data were collected and analyzed. The funder provided support in the form of salaries for author VLF. Funding was also provided by United Nations Foundation/Global Alliance for Clean Cookstoves (UNF-15-708) to PJ; National Institutes of Health/National Institute of Environmental Health Sciences (R01ES023861) to PJ; and the Carolina Population Center (P2C HD050924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H., 2014, COMPR PSYCHOL, V3, DOI [10.2466/03.CP.3.4, DOI 10.2466/03.CP.3.4, https://doi.org/10.2466/03.CP.3.4]; Beltramo T, 2015, J HEALTH COMMUN, V20, P55, DOI 10.1080/10810730.2014.994244; Bensch G, 2015, J ECON BEHAV ORGAN, V116, P187, DOI 10.1016/j.jebo.2015.04.023; Bielecki C, 2014, ENERG POLICY, V66, P350, DOI 10.1016/j.enpol.2013.10.082; Catalan-Vazquez M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193238; Gibbs G.R., 2007, ANAL QUALITATIVE DAT; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hollada J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020182; IEA, 2017, WORLD EN OUTL; Jagger P, 2018, ENERGY SUSTAIN DEV, V46, P32, DOI 10.1016/j.esd.2018.06.005; Lewis JJ, 2012, ENVIRON HEALTH PERSP, V120, P637, DOI 10.1289/ehp.1104194; Loo JD, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020167; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Miller G., 2011, INTRAHOUSEHOLD EXTER; Miller G, 2015, MARKET SCI, V34, P480, DOI 10.1287/mksc.2014.0845; Muneer SET, 2003, SCI TOTAL ENVIRON, V307, P259, DOI 10.1016/S0048-9697(02)00541-7; Rehfuess EA, 2014, ENVIRON HEALTH PERSP, V122, P120, DOI 10.1289/ehp.1306639; Rhodes EL, 2014, INT J ENV RES PUB HE, V11, P10310, DOI 10.3390/ijerph111010310; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Schlag N, 2008, MARKET BARRIERS CLEA; Shankar A, 2014, GLOB HEALTH-SCI PRAC, V2, P268, DOI 10.9745/GHSP-D-14-00060; Slaski X., 2009, COOKSTOVES OBSTACLES; Troncoso K, 2007, ENERG POLICY, V35, P2799, DOI 10.1016/j.enpol.2006.12.011; WHO, 2017, INT RED IND AIR POLL; WHO, 2017, HOUS AIR POLL HLTH	25	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0203775	10.1371/journal.pone.0203775	http://dx.doi.org/10.1371/journal.pone.0203775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW1KF	30296300	Green Published, Green Submitted, gold			2022-12-26	WOS:000446632700007
J	Price, CA; Green-Thompson, L; Mammen, VG; Madhim, SA; Lala, SG; Dangor, Z				Price, Caris A.; Green-Thompson, Lionel; Mammen, Vijay G.; Madhim, Shabir A.; Lala, Sanjay G.; Dangor, Ziyaad			Knowledge gaps among South African healthcare providers regarding the prevention of neonatal group B streptococcal disease	PLOS ONE			English	Article							UNITED-STATES; SEPSIS; METAANALYSES; GUIDELINES; MORTALITY; VACCINE; INFANTS	Objective To evaluate obstetric healthcare provider knowledge regarding the prevention of group B streptococcal disease in South African infants. Methods Questionnaires exploring knowledge, attitudes and beliefs around group B streptococcal prevention were administered to consenting doctors and maternity nurses in a tertiary academic hospital. Qualitative assessments (focus groups) were undertaken with junior doctors and nurses. Results 238 participants completed the questionnaire: 150 (63.0%) doctors and 88 (37.0%) nurses. Overall, 22.7% of participants correctly identified the risk-based prevention protocol recommended at this hospital. Most doctors (68.0%) and nurses (94.3%) could not correctly list a single risk factor. A third of doctors did not know the correct antibiotic protocols, and most (80.0%) did not know the recommended timing of antibiotics in relation to delivery. Focus group discussions highlighted the lack of knowledge, awareness and effective implementation of protocols regarding disease prevention. Conclusions Our study highlighted knowledge gaps on the risk-based prevention strategy in a setting which has consistently reported among the highest incidence of invasive group B streptococcal disease globally. In these settings, education and prioritization of the risk-based intrapartum antibiotic strategy is warranted, but an alternative vaccine-based strategy may prove more effective in preventing invasive group B streptococcal disease in the long-term.	[Price, Caris A.; Mammen, Vijay G.; Lala, Sanjay G.; Dangor, Ziyaad] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat & Child Hlth, Johannesburg, South Africa; [Green-Thompson, Lionel] Univ Witwatersrand, Fac Hlth Sci, Off Teaching & Learning, Johannesburg, South Africa; [Madhim, Shabir A.; Dangor, Ziyaad] Univ Witwatersrand, Fac Hlth Sci, Med Res Council Resp & Meningeal Pathogens Res Un, Johannesburg, South Africa; [Madhim, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis Res Chair, Johannesburg, South Africa; [Lala, Sanjay G.] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Price, CA (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Paediat & Child Hlth, Johannesburg, South Africa.	caris.ronan@outlook.com		Dangor, Ziyaad/0000-0003-4089-147X				Bianchi-Jassir F, 2017, CLIN INFECT DIS, V65, pS133, DOI 10.1093/cid/cix661; Buchmann EJ, 2015, BJOG-INT J OBSTET GY, V122, P220, DOI 10.1111/1471-0528.13064; Cutland CL, 2012, PEDIATRICS, V130, pE581, DOI 10.1542/peds.2011-1548; Dangor Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169101; Dangor Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123014; Darlow BA, 2016, AUST NZ J OBSTET GYN, V56, P69, DOI 10.1111/ajo.12378; [Department of Economic Development Department of Economic Development], 2012, 5 YEAR SOW EC DEV PL; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Heath PT, 2009, ARCH DIS CHILD, V94, P674, DOI 10.1136/adc.2008.148874; Kim SY, 2014, VACCINE, V32, P1954, DOI 10.1016/j.vaccine.2014.01.062; Kwatra G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098778; Le Doare K, 2017, CLIN INFECT DIS, V65, pS143, DOI 10.1093/cid/cix654; Madhi SA, 2017, VACCINE, V35, P4457, DOI 10.1016/j.vaccine.2017.02.025; Madrid L, 2017, CLIN INFECT DIS, V65, pS160, DOI 10.1093/cid/cix656; Motsohi T, 2015, POVERTY INEQUALITY B; Oster G, 2014, VACCINE, V32, P4778, DOI 10.1016/j.vaccine.2014.06.003; Schrag SJ, 2013, VACCINE, V31, pD20, DOI 10.1016/j.vaccine.2012.11.056; Schrag SJ, 2012, PEDIATR INFECT DIS J, V31, P821, DOI 10.1097/INF.0b013e31825c4b5a; Seale AC, 2017, CLIN INFECT DIS, V65, pS125, DOI 10.1093/cid/cix585; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Vergnano S, 2010, ARCH DIS CHILD-FETAL, V95, pF72, DOI 10.1136/adc.2009.160333; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205157	10.1371/journal.pone.0205157	http://dx.doi.org/10.1371/journal.pone.0205157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289900	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500053
J	Ashrafzadeh, MR; Djan, M; Szendrei, L; Paulauskas, A; Scandura, M; Bagi, Z; Ilie, DE; Kerdikoshvili, N; Marek, P; Soos, N; Kusza, S				Ashrafzadeh, Mohammad Reza; Djan, Mihajla; Szendrei, Laszlo; Paulauskas, Algimantas; Scandura, Massimo; Bagi, Zoltan; Ilie, Daniela Elena; Kerdikoshvili, Nikoloz; Marek, Panek; Soos, Noemi; Kusza, Szilvia			Large-scale mitochondrial DNA analysis reveals new light on the phylogeography of Central and Eastern-European Brown hare (Lepus europaeus Pallas, 1778)	PLOS ONE			English	Article							POSTGLACIAL RANGE EXPANSION; EVOLUTIONARY RELATIONSHIPS; GENETIC DIFFERENTIATION; POPULATION-GENETICS; MAXIMUM-LIKELIHOOD; VOJVODINA SERBIA; INTROGRESSION; TIMIDUS; MTDNA; COLONIZATION	European brown hare, Lepus europaeus, from Central and Eastern European countries (Hungary, Poland, Serbia, Lithuania, Romania, Georgia and Italy) were sampled, and phylogenetic analyses were carried out on two datasets: 1.) 137 sequences (358 bp) of control region mtDNA; and 2.) 105 sequences of a concatenated fragment (916 bp), including the cytochrome b, tRNA-Thr, tRNA-Pro and control region mitochondrial DNA. Our sequences were aligned with additional brown hare sequences from GenBank. A total of 52 and 51 haplotypes were detected within the two datasets, respectively, and assigned to two previously described major lineages: Anatolian/Middle Eastern (AME) and European (EUR). Furthermore, the European lineage was divided into two subclades including South Eastern European (SEE) and Central European (CE). Sympatric distribution of the lineages of the brown hare in South-Eastern and Eastern Europe revealed contact zones there. BAPS analysis assigned sequences from L. europaeus to five genetic clusters, whereas CE individuals were assigned to only one cluster, and AME and SEE sequences were each assigned to two clusters. Our findings uncover numerous novel haplotypes of Anatolian/Middle Eastern brown hare outside their main range, as evidence for the combined influence of Late Pleistocene climatic fluctuations and anthropogenic activities in shaping the phylogeographic structure of the species. Our results support the hypothesis of a postglacial brown hare expansion from Anatolia and the Balkan Peninsula to Central and Eastern Europe, and suggest some slight introgression of individual haplotypes from L. timidus to L. europaeus.	[Ashrafzadeh, Mohammad Reza] Shahrekord Univ, Fac Nat Resources & Earth Sci, Dept Fisheries & Environm Sci, Shahrekord, Iran; [Djan, Mihajla] Univ Novi Sad, Dept Biol & Ecol, Fac Sci, Novi Sad, Serbia; [Szendrei, Laszlo; Soos, Noemi; Kusza, Szilvia] Univ Debrecen, Inst Anim Husb Biotechnol & Nat Conservat, Debrecen, Hungary; [Paulauskas, Algimantas] Vytautas Magnus Univ, Fac Nat Sci, Dept Biol, Kaunas, Lithuania; [Scandura, Massimo] Univ Sassari, Dept Vet Med, Sassari, Italy; [Bagi, Zoltan] Univ Debrecen, Inst Agr Res & Educ Farm, Debrecen, Hungary; [Ilie, Daniela Elena] Acad Agr & Forestry Sci, Res & Dev Stn Bovine Arad, Arad, Romania; [Kerdikoshvili, Nikoloz] Tbilisi Zoo, Tbilisi, Georgia; [Marek, Panek] Polish Hunting Assoc, Res Stn, Czempin, Poland	Shahrekord University; University of Novi Sad; University of Debrecen; Vytautas Magnus University; University of Sassari; University of Debrecen	Kusza, S (corresponding author), Univ Debrecen, Inst Anim Husb Biotechnol & Nat Conservat, Debrecen, Hungary.	kusza@agr.unideb.hu	Ashrafzadeh, Mohammad Reza/AAZ-8065-2021; Ilie, Daniela Elena/D-7257-2015; Bagi, Zoltán/GPX-7288-2022	Ashrafzadeh, Mohammad Reza/0000-0003-2968-906X; Ilie, Daniela Elena/0000-0002-0464-3199; Djan, Mihajla/0000-0002-2427-0676	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; European Union; European Social Fund;  [EFOP-3.6.3-VEKOP-16-2017-00008]	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Union(European Commission); European Social Fund(European Social Fund (ESF)); 	This work was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The publication is supported by the EFOP-3.6.3-VEKOP-16-2017-00008 project. The project is co-financed by the European Union and the European Social Fund.	Alexandri P, 2012, J BIOGEOGR, V39, P713, DOI 10.1111/j.1365-2699.2011.02636.x; Alves PC, 2008, MOL PHYLOGENET EVOL, V46, P1191, DOI 10.1016/j.ympev.2007.11.010; Alves PC, 2003, MOL PHYLOGENET EVOL, V27, P70, DOI 10.1016/S1055-7903(02)00417-7; Antoniou A, 2013, GENETICA, V141, P23, DOI 10.1007/s10709-013-9703-z; Ashrafzadeh MR, 2016, MAMM BIOL, V81, P1, DOI 10.1016/j.mambio.2015.09.001; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Ben Slimen H, 2006, J ZOOL SYST EVOL RES, V44, P88, DOI 10.1111/j.1439-0469.2005.00345.x; Ben Slimen H, 2008, BIOCHEM SYST ECOL, V36, P22, DOI 10.1016/j.bse.2007.06.014; Bilgin R, 2011, INT J MOL SCI, V12, P4080, DOI 10.3390/ijms12064080; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Canu A, 2013, EUR J WILDLIFE RES, V59, P783, DOI 10.1007/s10344-013-0731-x; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; CORBET GB, 1986, MAMMAL REV, V16, P105, DOI 10.1111/j.1365-2907.1986.tb00029.x; Djan M, 2015, BALKAN J WILDLIFE RE, V2, P18, DOI [10.15679/bjwr.v2i1.22, DOI 10.15679/BJWR.V2I1.22]; Djan M, 2006, EUR J WILDLIFE RES, V52, P288, DOI 10.1007/s10344-006-0050-6; Djan M, 2017, HYSTRIX, V28, P186, DOI 10.4404/hystrix-28.2-12202; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fickel J, 2005, J WILDLIFE MANAGE, V69, P760, DOI 10.2193/0022-541X(2005)069[0760:GSOPOE]2.0.CO;2; Fickel J, 2008, EUR J WILDLIFE RES, V54, P495, DOI 10.1007/s10344-008-0175-x; Flux J.E.C., 1990, P61; Fontanesi L, 2016, J HERED, V107, P295, DOI 10.1093/jhered/esw010; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Fu YX, 1997, GENETICS, V147, P915; Giannoulis T, 2018, MITOCHONDRIAL DNA A, V29, P353, DOI 10.1080/24701394.2016.1278540; Gissi C, 1998, GENOMICS, V50, P161, DOI 10.1006/geno.1998.5282; Gokasan E, 1997, MAR GEOL, V140, P183, DOI 10.1016/S0025-3227(97)00022-4; Guberti V, 2000, P 5 INT C EUR SOC VE, V8, P27; HARTL GB, 1993, ACTA THERIOL, V38, P33, DOI 10.4098/AT.arch.93-41; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Kasapidis P, 2005, MOL PHYLOGENET EVOL, V34, P55, DOI 10.1016/j.ympev.2004.09.007; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Levanen R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191790; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mamuris Z, 2001, BIOL CONSERV, V101, P187, DOI 10.1016/S0006-3207(01)00065-9; Mamuris Z, 2010, MAMM BIOL, V75, P233, DOI 10.1016/j.mambio.2009.01.004; Melo-Ferreira J, 2005, MOL ECOL, V14, P2459, DOI 10.1111/j.1365-294X.2005.02599.x; Melo-Ferreira J, 2012, SYST BIOL, V61, P367, DOI 10.1093/sysbio/syr114; Melo-Ferreira J, 2009, MOL ECOL, V18, P2643, DOI 10.1111/j.1365-294X.2009.04221.x; Neigel JE, 2002, CONSERV GENET, V3, P167, DOI 10.1023/A:1015213626922; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Ojeda AA, 2010, J MAMMAL, V91, P302, DOI 10.1644/09-MAMM-A-177.1; Pierpaoli M, 1999, MOL ECOL, V8, P1805, DOI 10.1046/j.1365-294x.1999.00766.x; Pietri C., 2007, CONSERVAZIONE LEPUS, P52; Pietri C, 2011, EUR J WILDLIFE RES, V57, P313, DOI 10.1007/s10344-010-0430-9; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Schmitt T, 2006, MOL ECOL, V15, P1889, DOI 10.1111/j.1365-294X.2006.02900.x; SLATKIN M, 1991, GENETICS, V129, P555; Smith Andrew T., 2008, P297, DOI 10.1007/978-3-540-72446-9_20; Stamatis C, 2009, J BIOGEOGR, V36, P515, DOI 10.1111/j.1365-2699.2008.02013.x; Suchentrunk F, 2006, HUM EVOL, V21, P151, DOI DOI 10.1007/S11598-006-9016-7; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thulin C.-G., 1997, Gibier Faune Sauvage, V14, P463; Thulin CG, 2006, HEREDITAS, V143, P68, DOI 10.1111/j.2006.0018-0661.01952.x; Vapa L, 2007, ACTA ZOOL ACAD SCI H, V53, P75; Vapa L, 2002, Z JAGDWISS, V48, P261, DOI 10.1007/BF02192416; Xia XH, 2017, J HERED, V108, P431, DOI 10.1093/jhered/esx033; Yu L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-198; Zhou TC, 2014, MITOCHONDRION, V18, P70, DOI 10.1016/j.mito.2014.07.012	65	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204653	10.1371/journal.pone.0204653	http://dx.doi.org/10.1371/journal.pone.0204653			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286121	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000446383500033
J	Martinecz, A; Niitsuma, M				Martinecz, Antal; Niitsuma, Mihoko			Fractional integral-like processing in retinal cones reduces noise and improves adaptation	PLOS ONE			English	Article							HORIZONTAL CELL FEEDBACK; DARK-ADAPTATION; VISUAL PIGMENT; GANGLION-CELLS; MOUSE RETINA; PHOTOTRANSDUCTION; PHOTORECEPTORS; RHODOPSIN; ARRESTIN; BINDING	In the human retina, rod and cone cells detect incoming light with a molecule called rhodopsin. After rhodopsin molecules are activated (by photon impact), these molecules activate the rest of the signalling process for a brief period of time until they are deactivated by a multistage process. First, active rhodopsin is phosphorylated multiple times. Following this, they are further inhibited by the binding of molecules called arrestins. Finally, they decay into opsins. The time required for each of these stages becomes progressively longer, and each stage further reduces the activity of rhodopsin. However, while this deactivation process itself is well researched, the roles of the above stages in signal (and image) processing are poorly understood. In this paper, we will show that the activity of rhodopsin molecules during the deactivation process can be described as the fractional integration of an incoming signal. Furthermore, we show how this affects an image; specifically, the effect of fractional integration in video and signal processing and how it reduces noise and the improves adaptability under different lighting conditions. Our experimental results provide a better understanding of vertebrate and human vision, and why the rods and cones of the retina differ from the light detectors in cameras.	[Martinecz, Antal; Niitsuma, Mihoko] Chuo Univ, Dept Precis Mech, Tokyo, Japan; [Martinecz, Antal] Univ Tromso, Dept Pharm, Tromso, Norway	Chuo University; UiT The Arctic University of Tromso	Martinecz, A (corresponding author), Chuo Univ, Dept Precis Mech, Tokyo, Japan.; Martinecz, A (corresponding author), Univ Tromso, Dept Pharm, Tromso, Norway.	antal.martinecz@uit.no						ANASTASIO TJ, 1994, BIOL CYBERN, V72, P69, DOI 10.1007/BF00206239; Arshavsky Vadim Y, 2014, Cell Logist, V4, pe29390; Ascano M, 2006, BIOCHEMISTRY-US, V45, P2398, DOI 10.1021/bi052021h; Atangana A, 2017, NUMERICAL METHODS PA; Atangana A, 2016, ADV DIFFER EQU-NY, DOI 10.1186/s13662-016-0871-x; Atangana A, 2015, ADV MECH ENG, V7, DOI 10.1177/1687814015613758; Babai N, 2009, J PHYSIOL-LONDON, V587, P2353, DOI 10.1113/jphysiol.2009.169656; Bai J, 2007, IEEE T IMAGE PROCESS, V16, P2492, DOI 10.1109/TIP.2007.904971; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Burns ME, 2010, PHYSIOLOGY, V25, P72, DOI 10.1152/physiol.00001.2010; Chevalier A, 2013, MED C CONTR AUTOMAT, P206, DOI 10.1109/MED.2013.6608723; Coronel-Escamilla A, 2017, MULTIBODY SYSTEM DYN; Coronel-Escamilla A, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19020055; Cuesta E, 2012, SIGNAL PROCESS, V92, P553, DOI 10.1016/j.sigpro.2011.09.001; Das S, 2012, SPRINGERBR APPL SCI, P13, DOI 10.1007/978-3-642-23117-9_2; Dell'Orco D, 2009, MOL BIOSYST, V5, P1232, DOI 10.1039/b908123b; Devillard F, 2014, J COMPUTER COMMUNICA, V2, P78, DOI [10.4236/jcc.2014.214008, DOI 10.4236/JCC.2014.214008]; Morales-Delgado VF, 2016, ADV DIFFER EQU-NY, DOI 10.1186/s13662-016-0891-6; GLOCKLE WG, 1995, BIOPHYS J, V68, P46, DOI 10.1016/S0006-3495(95)80157-8; Golobokova EY, 2006, VISION RES, V46, P2287, DOI 10.1016/j.visres.2005.12.017; Gomez-Aguilar JF, 2017, ADV DIFFER EQU-NY, DOI 10.1186/s13662-017-1120-7; Gould S, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2115; Gross OP, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00006; Hamer RD, 2005, VISUAL NEUROSCI, V22, P417, DOI 10.1017/S0952523805224045; Hu ZH, 2013, ADV INTEL SYS RES, V41, P692; Ichinose T, 2014, J NEUROSCI, V34, P8761, DOI 10.1523/JNEUROSCI.3965-13.2014; Ingram NT, 2016, J PHYSIOL-LONDON, V594, P5415, DOI 10.1113/JP272556; Korenbrot JI, 2012, PROG RETIN EYE RES, V31, P442, DOI 10.1016/j.preteyeres.2012.05.002; Korenbrot JI, 2012, J GEN PHYSIOL, V139, P31, DOI 10.1085/jgp.201110654; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Marc RE, 2012, CURR OPIN NEUROBIOL, V22, P568, DOI 10.1016/j.conb.2012.03.011; Martinecz A, 2015, ICIMCO 2015 PROCEEDINGS OF THE 12TH INTERNATIONAL CONFERENCE ON INFORMATICS IN CONTROL, AUTOMATION AND ROBOTICS, VOL. 1, P481; Podlubny I, 1999, IEEE T AUTOMAT CONTR, V44, P208, DOI 10.1109/9.739144; Reuter T, 2011, VISION RES, V51, P2243, DOI 10.1016/j.visres.2011.08.021; Shah P, 2016, MECHATRONICS, V38, P29, DOI 10.1016/j.mechatronics.2016.06.005; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Sinha A, 2014, BIOCHEMISTRY-US, V53, P3294, DOI 10.1021/bi401534y; Tatler BW, 2010, I-PERCEPTION, V1, P7, DOI 10.1068/i0382; van Hateren H, 2005, J VISION, V5, P331, DOI 10.1167/5.4.5; Vinagre B.M., 2000, J FRACTIONAL CALCULU, P231; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Wang JS, 2011, CONE SPECIFIC VISUAL; Werblin FS, 2011, J PHYSIOL-LONDON, V589, P3691, DOI 10.1113/jphysiol.2011.210617; Yang KF, 2013, PROC CVPR IEEE, P2810, DOI 10.1109/CVPR.2013.362; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Yepez-Martinez H, 2016, REV MEX FIS, V62, P310; Zilany MSA, 2010, J NEUROSCI, V30, P10380, DOI 10.1523/JNEUROSCI.0647-10.2010	50	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205099	10.1371/journal.pone.0205099	http://dx.doi.org/10.1371/journal.pone.0205099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286168	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500084
J	Takahashi, A; Moriya, K; Ohira, H; Arinaga-Hino, T; Zeniya, M; Torimura, T; Abe, M; Takaki, A; Kang, JH; Inui, A; Fujisawa, T; Yoshizawa, K; Suzuki, Y; Nakamoto, N; Koike, K; Yoshiji, H; Goto, A; Tanaka, A; Younossi, ZM; Takikawa, H				Takahashi, Atsushi; Moriya, Kei; Ohira, Hiromasa; Arinaga-Hino, Teruko; Zeniya, Mikio; Torimura, Takuji; Abe, Masanori; Takaki, Akinobu; Kang, Jong-Hon; Inui, Ayano; Fujisawa, Tomoo; Yoshizawa, Kaname; Suzuki, Yoshiyuki; Nakamoto, Nobuhiro; Koike, Kazuhiko; Yoshiji, Hitoshi; Goto, Aya; Tanaka, Atsushi; Younossi, Zobair M.; Takikawa, Hajime		Japan AIH Study Grp	Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; MANAGEMENT	Aim Health-related quality of life is impaired in patients with autoimmune hepatitis, but the association between health-related quality of life and patients' backgrounds remains unknown. We assessed health-related quality of life in patients with autoimmune hepatitis and identified factors associated with its impairment. Methods We assessed health-related quality of life in patients with autoimmune hepatitis, patients with chronic hepatitis C, and healthy subjects using the Japanese version of the Chronic Liver Disease Questionnaire and the 36-Item Short Form Survey. We compared health-related quality of life in patients with autoimmune hepatitis with that of patients with chronic hepatitis C and healthy subjects. Results A total of 265 patients with autoimmune hepatitis, 88 patients with chronic hepatitis C, and 97 healthy subjects were enrolled; most patients were women. The median ages of patients were 65, 66, and 57 years, respectively. Of these patients with autoimmune hepatitis, 10.6% and 57.0% had cirrhosis and comorbid diseases, respectively. The overall Chronic Liver Disease Questionnaire scores (5.5 vs. 6.2, P < 0.001) and physical (48.1 vs. 54.2, P < 0.001) and mental (51.8 vs. 55.0, P= 0.004) component summaries of 36-Item Short Form Survey were significantly lower in patients with autoimmune hepatitis than in healthy subjects, and similar to scores in patients with chronic hepatitis C. Having cirrhosis, comorbid diseases, and treatment for autoimmune hepatitis were associated with impaired health-related quality of life among patients with autoimmune hepatitis. In particular, prednisolone use was associated with lower scores on the worry domain of the Chronic Liver Disease Questionnaire. Conclusions Patients with autoimmune hepatitis showed impairment in health-related quality of life, which was associated with not only disease progression, but also comorbid diseases and treatment. Ways to improve health-related quality of life should be considered in patients with AIH when disease outcome is not favorable and when using prednisolone.	[Takahashi, Atsushi; Ohira, Hiromasa] Fukushima Med Univ, Sch Med, Dept Gastroenterol, Fukushima, Japan; [Moriya, Kei; Yoshiji, Hitoshi] Nara Med Univ, Sch Med, Dept Gastroenterol & Hepatol, Kashihara, Nara, Japan; [Arinaga-Hino, Teruko; Torimura, Takuji] Kurume Univ, Sch Med, Dept Med, Kurume, Fukuoka, Japan; [Zeniya, Mikio] Int Univ Hlth & Welf, Sanno Med Ctr, Minato Ku, Tokyo, Japan; [Abe, Masanori] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan; [Takaki, Akinobu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Kita Ku, Okayama, Japan; [Kang, Jong-Hon] Teine Keijinkai Hosp, Ctr Gastroenterol, Teine Ku, Sapporo, Hokkaido, Japan; [Inui, Ayano; Fujisawa, Tomoo] Saiseikai Yokohama Tobu Hosp, Dept Pediat Hepatol & Gastroenterol, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Yoshizawa, Kaname] Natl Hosp Org, Shinshu Ueda Med Ctr, Dept Gastroenterol, Ueda, Nagano, Japan; [Suzuki, Yoshiyuki] Toranomon Gen Hosp, Dept Hepatol, Minato Ku, Tokyo, Japan; [Nakamoto, Nobuhiro] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo, Japan; [Koike, Kazuhiko] Jikei Univ, Sch Med, Hosp 3, Dept Gastroenterol & Hepatol, Komae, Tokyo, Japan; [Goto, Aya] Fukushima Med Univ, Ctr Integrated Sci & Humanities, Fukushima, Japan; [Tanaka, Atsushi; Takikawa, Hajime] Teikyo Univ, Sch Med, Dept Med, Itabashi Ku, Tokyo, Japan; [Younossi, Zobair M.] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA	Fukushima Medical University; Nara Medical University; Kurume University; International University of Health & Welfare; Ehime University; Okayama University; Teine Keijinkai Hospital; Toranomon Hospital; Keio University; Jikei University; Fukushima Medical University; Teikyo University; Inova Health System	Takahashi, A (corresponding author), Fukushima Med Univ, Sch Med, Dept Gastroenterol, Fukushima, Japan.	junior@fmu.ac.jp		Takahashi, Atsushi/0000-0003-0568-8361; Yoshiji, Hitoshi/0000-0002-5243-8544	Health Labor Science Research Grants from Research on Measures for Intractable Diseases, the Intractable Hepato-Biliary Diseases Study Group in Japan	Health Labor Science Research Grants from Research on Measures for Intractable Diseases, the Intractable Hepato-Biliary Diseases Study Group in Japan	This study was conducted and supported by Health Labor Science Research Grants from Research on Measures for Intractable Diseases, the Intractable Hepato-Biliary Diseases Study Group in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dan AA, 2007, ALIMENT PHARM THER, V26, P815, DOI 10.1111/j.1365-2036.2007.03426.x; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Gao F, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-131; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Onji M, 2014, HEPATOL RES, V44, P368, DOI 10.1111/hepr.12300; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Schramm C, 2014, J HEPATOL, V60, P618, DOI 10.1016/j.jhep.2013.10.035; Sockalingam S, 2012, J HEPATOL, V57, P1299, DOI 10.1016/j.jhep.2012.07.032; Suzukamo Y, 2011, J CLIN EPIDEMIOL, V64, P301, DOI 10.1016/j.jclinepi.2010.04.017; Tanaka A, 2016, HEPATOL RES, V46, pE45, DOI 10.1111/hepr.12524; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; van der Plas SM, 2007, QUAL LIFE RES, V16, P375, DOI 10.1007/s11136-006-9131-y; Yoshizawa K, 2012, HEPATOLOGY, V56, P668, DOI 10.1002/hep.25658; Younossi ZM, 2000, AM J GASTROENTEROL, V95, P497; Younossi ZM, 1999, GUT, V45, P295, DOI 10.1136/gut.45.2.295; Younossi ZM, 2016, LIVER INT, V36, P42, DOI 10.1111/liv.12886	16	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204772	10.1371/journal.pone.0204772	http://dx.doi.org/10.1371/journal.pone.0204772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286131	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500040
J	Cherairia, M; Adler, PH				Cherairia, Mouna; Adler, Peter H.			Genetic variation in a colonization specialist, Simulium ruficorne (Diptera: Simuliidae), the world's most widely distributed black fly	PLOS ONE			English	Article							VITTATUM COMPLEX DIPTERA; SAHARA; FLIES; BIODIVERSITY; DISPERSAL; EVOLUTION; ISLAND; PHYLOGEOGRAPHY; EPIDEMIOLOGY; ASSEMBLAGES	The ability of aquatic insects to colonize Earth's most remote freshwater habitats, such as those of islands and deserts, is limited to select taxa. Among black flies, the premiere colonization specialist is Simulium ruficorne Macquart, the only species known from both the Afrotropical and Palearctic regions. We investigated the cytogenetics of S. ruficorne to gain insight into its wide geographic distribution and ability to colonize oceanic islands and deserts. On the basis of larval polytene chromosomes from 14 locations, we documented 17 novel and previously known chromosomal rearrangements and established five cytoforms (A1, A2, B, C, and D), of which probably four (A1/A2, B, C, and D) are distinct species and two (A1 and A2) represent sex-chromosome polymorphism involving a heteroband in the long arm of chromosome III. The chromosome restructuring phenomena associated with the five cytoforms are consistent with the trend in the Simuliidae that one and the same rearrangement can assume different functions in the various descendants of a common ancestor in which the rearrangement was polymorphic. The most widely distributed cytoforms are A1 and A2, which are found in North Africa, the Canary Islands, and Majorca. Simulium ruficorne, the only known black fly in the Hoggar Mountains of the central Sahara Desert, represents a cohesive population of cytoform A1 little differentiated from other North African populations of A1 and A2. Cytoform B inhabits the West African mainland, cytoform C is on Tenerife, and cytoform D is on Cape Verde. We suggest that dispersal and colonization specialists, such as S. ruficorne, are multivoltine inhabitants of temporary streams, and must relocate as their habitats deteriorate. Simulium ruficorne, therefore, should have adaptations that contribute to successful dispersal and colonization, perhaps largely physiological in nature, such as tolerance of high temperatures and droughts.	[Cherairia, Mouna] Univ 8 Mai 1945 Guelma, Lab Rech & Conservat Zones Humides, Guelma, Algeria; [Adler, Peter H.] Clemson Univ, Dept Plant & Environm Sci, Clemson, SC USA	Universite 8 Mai 1945 de Guelma; Clemson University	Cherairia, M (corresponding author), Univ 8 Mai 1945 Guelma, Lab Rech & Conservat Zones Humides, Guelma, Algeria.	cherairia.mouna@univ-guelma.dz		CHERAIRIA, MOUNA/0000-0003-4463-4489				Adler PH, 2015, MED VET ENTOMOL, V29, P276, DOI 10.1111/mve.12115; Adler PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158272; Adler PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147673; Adler PH, 2015, ZOOTAXA, V3975, P1, DOI 10.11646/zootaxa.3975.1.1; Adler PH, 2015, BIOL J LINN SOC, V114, P163, DOI 10.1111/bij.12403; Adler PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070765; Adler Peter H., 1997, American Entomologist, V43, P153; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; ADLER PH, 1984, CAN J ZOOL, V62, P1308, DOI 10.1139/z84-188; Adler PH, 2005, J BIOGEOGR, V32, P211, DOI 10.1111/j.1365-2699.2004.01156.x; Adler PH, 2004, BLACK FLIES SIMULIID; Alacs EA, 2011, CONSERV GENET, V12, P297, DOI 10.1007/s10592-010-0140-6; ANDERSEN NM, 1993, OIKOS, V67, P433, DOI 10.2307/3545355; Ayadi A, 2000, PHYS EARTH PLANET IN, V118, P111, DOI 10.1016/S0031-9201(99)00134-X; BEDO DG, 1989, GENOME, V32, P570, DOI 10.1139/g89-484; Beebe NW, 2002, INT J PARASITOL, V32, P563, DOI 10.1016/S0020-7519(01)00359-9; BELAZZOUG S, 1980, Archives de l'Institut Pasteur d'Algerie, V54, P107; Belqat B, 2018, ZOOTAXA, V4442, P201, DOI 10.11646/zootaxa.4442.2.1; Ben Faleh AR, 2012, J ZOOL, V286, P208, DOI 10.1111/j.1469-7998.2011.00868.x; Bouzid A, 2015, GEOL SOC AM SPEC PAP, V514, P239, DOI 10.1130/2015.2514(15); Bradley E, 2017, NEW ZEAL J ECOL, V41, P245, DOI 10.20417/nzjeco1.41.21; Charalambous M, 1996, MED VET ENTOMOL, V10, P111, DOI 10.1111/j.1365-2915.1996.tb00716.x; Cherairia M, 2014, ZOOTAXA, V3796, P166, DOI 10.11646/zootaxa.3796.1.8; CLASTRIER J, 1961, Arch Inst Pasteur Alger, V39, P106; COYNE JA, 1987, AM NAT, V129, P847, DOI 10.1086/284679; Craig DA, 1999, CAN J ZOOL, V77, P610, DOI 10.1139/cjz-77-4-610; CROSSKEY R W, 1987, Entomologist's Gazette, V38, P143; Crosskey R.W., 1982, Fauna of Saudi Arabia, V4, P398; Crosskey R.W., 1990, NATURAL HIST BLACKFL; Crosskey Roger W., 2002, V19, P419; Crosskey RW, 2004, J NAT HIST, V38, P2085, DOI 10.1080/0022293032000140958; CROSSKEY RW, 1981, ANN TROP MED PARASIT, V75, P647, DOI 10.1080/00034983.1981.11687496; Douady CJ, 2003, P NATL ACAD SCI USA, V100, P8325, DOI 10.1073/pnas.0832467100; Foley JA, 2003, ECOSYSTEMS, V6, P524, DOI 10.1007/s10021-002-0227-0; Forsman A, 2011, P ROY SOC B-BIOL SCI, V278, P225, DOI 10.1098/rspb.2010.1325; Gomard Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202015; GRENIER P, 1960, Arch Inst Pasteur Alger, V38, P329; Khadem M, 2015, J MED ENTOMOL, V52, P1175, DOI 10.1093/jme/tjv094; Kroepelin S, 2006, SCIENCE, V312, P1138; LAZELL J., 2005, ISLAND FACT THEORY N; Le Houerou HN, 1997, J ARID ENVIRON, V37, P619, DOI 10.1006/jare.1997.0315; Low VL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0911-5; Lytle DA, 2015, ECOLOGY AND GENERAL BIOLOGY, VOL I: THORP AND COVICH'S FRESHWATER INVERTEBRATES, 4TH EDITION, P951, DOI 10.1016/B978-0-12-385026-3.00037-1; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; McCreadie JW, 2006, ECOGRAPHY, V29, P603, DOI 10.1111/j.0906-7590.2006.04541.x; Myers A.A., 1988, ANAL BIOGEOGRAPHY; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nicolas V, 2018, J ZOOL SYST EVOL RES, V56, P102, DOI 10.1111/jzs.12185; Pramual P, 2009, HYDROBIOLOGIA, V625, P173, DOI 10.1007/s10750-009-9706-z; PROCUNIER WS, 1989, GENOME, V32, P559, DOI 10.1139/g89-483; PROCUNIER WS, 1982, CAN J ZOOL, V60, P2852, DOI 10.1139/z82-364; ROFF D, 1977, J ANIM ECOL, V46, P443, DOI 10.2307/3822; ROTHFELS K. H., 1956, JOUR HEREDITY, V47, P113; Rothfels K.H., 1980, Symposia of the Royal Entomological Society of London, P207; Schuster M, 2006, SCIENCE, V311, P821, DOI 10.1126/science.1120161; Seitz Gunther, 2012, Lauterbornia, V74, P1; Takaoka H., 1988, Japanese Journal of Tropical Medicine and Hygiene, V16, P221; Tierney JE, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601503; Vaillant F, 1955, MEMOIRES MUSEUM NATL, V11; World Wildlife Federation, 2018, WILDF; Zettler JA, 1998, INVERTEBR BIOL, V117, P245, DOI 10.2307/3226989; Zhang ZS, 2014, NATURE, V513, P401, DOI 10.1038/nature13705	62	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205137	10.1371/journal.pone.0205137	http://dx.doi.org/10.1371/journal.pone.0205137			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281665	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400085
J	Le Menn, G; Sibille, B; Murdaca, J; Rousseau, AS; Squillace, R; Vergoni, B; Cormont, M; Niot, I; Grimaldi, PA; Mothe-Satney, I; Neels, JG				Le Menn, Gwenaelle; Sibille, Brigitte; Murdaca, Joseph; Rousseau, Anne-Sophie; Squillace, Raphaelle; Vergoni, Bastien; Cormont, Mireille; Niot, Isabelle; Grimaldi, Paul A.; Mothe-Satney, Isabelle; Neels, Jaap G.			Decrease in alpha beta/gamma T-cell ratio is accompanied by a reduction in high-fat diet-induced weight gain, insulin resistance, and inflammation	FASEB JOURNAL			English	Article						obesity; adipose tissue; immune cells	ADIPOSE-TISSUE; INDUCED OBESITY; ADIPOGENESIS; ACCUMULATION; ACTIVATION; IMMUNITY	The implication of and T cells in obesity-associated inflammation and insulin resistance (IR) remains uncertain. Mice lacking T cells show either no difference or a decrease in high-fat diet (HFD)-induced IR, whereas partial depletion in T cells does not protect from HFD-induced IR. T-cell deficiency leads to a decrease in white adipose tissue (WAT) inflammation and IR without weight change, but partial depletion of these cells has not been studied. We previously described a mouse model overexpressing peroxisome proliferator-activated receptor (PPAR-) specifically in T cells [transgenic (Tg) T-PPAR-] that exhibits a partial depletion in T cells and no change in T-cell number. This results in a decreased / T-cell ratio in lymphoid organs. We now show that Tg T-PPAR- mice are partially protected against HFD-induced weight gain and exhibit decreased IR and liver steatosis independently of animal weight. These mice display an alteration of WAT-depots distribution with an increased epididymal-WAT mass and a decreased subcutaneous WAT mass. Immune cell number is decreased in both WAT-depots, except for T cells, which are increased in epididymal-WAT. Overall, we show that decreasing / T-cell ratio in WAT-depots alters their inflammatory state and mass repartition, which might be involved in improvement of insulin sensitivity.Le Menn, G., Sibille, B., Murdaca, J., Rousseau, A.-S., Squillace, R., Vergoni, B., Cormont, M., Niot, I., Grimaldi, P. A., Mothe-Satney, I., Neels, J. G. Decrease in / T-cell ratio is accompanied by a reduction in high-fat diet-induced weight gain, insulin resistance, and inflammation.	[Le Menn, Gwenaelle; Sibille, Brigitte; Murdaca, Joseph; Rousseau, Anne-Sophie; Squillace, Raphaelle; Vergoni, Bastien; Cormont, Mireille; Grimaldi, Paul A.; Mothe-Satney, Isabelle; Neels, Jaap G.] Univ Cote Azur, INSERM, Ctr Mediterran Med Mol C3M, Nice, France; [Niot, Isabelle] Univ Bourgogne, INSERM, U866, Physiol Nutr & Toxicol NUTox,UMR,AgroSup Dijon, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Neels, JG (corresponding author), Univ Nice Sophia Antipolis, INSERM, Team 9 Metab Challenges Immune Cells Obes Diabet, Mediterranean Ctr Mol Med C3M,Unite 1065, Batiment Univ Archimed,Room M3-109bis, F-06204 Nice 3, France.	jaap.neels@unice.fr	Neels, Jaap G/F-5534-2010; Sibille, Brigitte/Q-8240-2016; MOTHE-SATNEY, ISABELLE/Q-6377-2016	Neels, Jaap G/0000-0002-5900-8395; Sibille, Brigitte/0000-0001-6806-0454; MOTHE-SATNEY, ISABELLE/0000-0002-2693-8385; Le Menn, Gwenaelle/0000-0001-5436-9397; Anne-Sophie, Rousseau/0000-0002-7672-0237; CORMONT, Mireille/0000-0001-6918-2410	INSERM; Universite Cote d'Azur; Fondation pour la Recherche Medicale (FRM) [DRM20101220437]; French National Research Agency (ANR) [ANR-14-CE12-0008-02]; Agence Francaise de Lutte contre le Dopage (AFLD)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Cote d'Azur; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French National Research Agency (ANR)(French National Research Agency (ANR)); Agence Francaise de Lutte contre le Dopage (AFLD)	The authors thank Veronique Corcelle and the INSERM Unite 1065 Animal Facility staff for their excellent care of mice. Image acquisition and image analysis were performed on the Centre Mediterraneen de Medecine Moleculaire (C3M) Imaging Core Facility [part of Microscopy and Imaging Platform Cote d'Azur (MICA)] with the help of Maeva Gesson. The authors thank Giulia Chinetti and Philippe Gual [Universite Cote d'Azur, Centre Hospitalier Universitaire (CHU), INSERM, C3M) for critical reading of the manuscript and scientific discussions, respectively. This work was financially supported by INSERM, the Universite Cote d'Azur, the Fondation pour la Recherche Medicale (FRM; Grant DRM20101220437), the French National Research Agency (ANR; No ANR-14-CE12-0008-02), and the Agence Francaise de Lutte contre le Dopage (AFLD). The authors declare no conflicts of interest.	Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Cho KW, 2014, CELL REP, V9, P605, DOI 10.1016/j.celrep.2014.09.004; Choe SS, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00030; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Hur KY, 2015, DIABETES METAB J, V39, P198, DOI 10.4093/dmj.2015.39.3.198; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Jeffery E, 2016, CELL METAB, V24, P142, DOI 10.1016/j.cmet.2016.05.012; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Khan IM, 2014, ATHEROSCLEROSIS, V233, P419, DOI 10.1016/j.atherosclerosis.2014.01.011; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Le Thuc O, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00197; Liang XB, 2006, AM J PHYSIOL-ENDOC M, V290, pE103, DOI 10.1152/ajpendo.00605.2004; McLaughlin T, 2017, J CLIN INVEST, V127, P5, DOI 10.1172/JCI88876; Mehta P, 2015, J LEUKOCYTE BIOL, V97, P121, DOI 10.1189/jlb.3A0414-211RR; Montes VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067709; Mothe-Satney I, 2016, SCI REP-UK, V6, DOI 10.1038/srep34317; Paul S, 2014, INT REV IMMUNOL, V33, P537, DOI 10.3109/08830185.2013.863306; Shin JH, 2009, BIOCHEM PHARMACOL, V77, P1835, DOI 10.1016/j.bcp.2009.03.008; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Yan LN, 2016, PHARM RES-DORDR, V33, P395, DOI 10.1007/s11095-015-1797-9; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	22	6	6	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2553	2562		10.1096/fj.201800696RR	http://dx.doi.org/10.1096/fj.201800696RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30285581	Green Submitted			2022-12-26	WOS:000457296600081
J	Palygin, O; Miller, BS; Nishijima, Y; Zhang, DX; Staruschenko, A; Sorokin, A				Palygin, Oleg; Miller, Bradley S.; Nishijima, Yoshinori; Zhang, David X.; Staruschenko, Alexander; Sorokin, Andrey			Endothelin receptor A and p66Shc regulate spontaneous Ca2+ oscillations in smooth muscle cells controlling renal arterial spontaneous motion	FASEB JOURNAL			English	Article						calcium; ET-1; vasomotion; vascular tone; endothelium; cell signaling	VASOMOTOR RESPONSES; OXIDATIVE STRESS; LIFE-SPAN; P66(SHC); PROTEIN; HYPERTENSION; MECHANISMS; PHYSIOLOGY; PHOSPHORYLATION; AUTOREGULATION	Adaptor protein p66Shc is overexpressed in smooth muscle cells of renal resistance vessels of hypertensive salt-sensitive rats and is involved in the regulation of renal vascular tone. We applied 2-photon laser scanning fluorescence microscopy to analyze spontaneous dynamic fluctuations in intracellular calcium concentrations ([Ca2+](i)) in smooth muscle cells embedded in the walls of freshly isolated renal resistance arteries. The amplitude, number of events, and frequency of spontaneous [Ca2+](i) oscillations triggered by endogenously released endothelin-1 were recorded in smooth muscle cells of the renal arteries. Endothelin receptor A antagonist BQ123 dramatically reduced the amplitude and frequency of spontaneous Ca2+ events, producing marked inhibition of renal vessels spontaneous motion. Spontaneous Ca2+ fluctuations in smooth muscle cells of p66Shc knockout (p66ShcKO) rats had significantly higher amplitude than in control rats. The frequency of spontaneous [Ca2+](i) oscillations did not change in p66ShcKO rats, suggesting that p66Shc expression did not affect endothelin-1 release from resident endothelial cells. Acute application of endothelin-1 revealed significantly elevated production of the total [Ca2+](i) in p66ShcKO rats. Spontaneous cytosolic Ca2+ oscillations in smooth muscle cells of renal vessels mediate their spontaneous motion via the endothelin-1/endothelin receptor A pathway. p66Shc decreases the amplitude of individual changes in [Ca2+](i), which mitigates the spontaneous motion of renal vessels.Palygin, O., Miller, B. S., Nishijima, Y., Zhang, D. X., Staruschenko, A., Sorokin, A. Endothelin receptor A and p66Shc regulate spontaneous Ca2+ oscillations in smooth muscle cells controlling renal arterial spontaneous motion.	[Palygin, Oleg; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Palygin, Oleg; Miller, Bradley S.; Nishijima, Yoshinori; Zhang, David X.; Staruschenko, Alexander; Sorokin, Andrey] Med Coll Wisconsin, Cardiovasc Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Miller, Bradley S.; Sorokin, Andrey] Med Coll Wisconsin, Dept Med, Div Nephrol, Milwaukee, WI 53226 USA; [Nishijima, Yoshinori; Zhang, David X.] Med Coll Wisconsin, Div Cardiol, Milwaukee, WI 53226 USA; [Nishijima, Yoshinori; Zhang, David X.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Staruschenko, A (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Staruschenko, A; Sorokin, A (corresponding author), Med Coll Wisconsin, Cardiovasc Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	staruschenko@mcw.edu; sorokin@mcw.edu	Palygin, Oleg/AAT-3047-2020	Palygin, Oleg/0000-0002-3680-5527; Staruschenko, Alexander/0000-0002-5190-8356; , Yoshinori/0000-0002-5547-4508	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK098159]; NIH National Heart, Lung, and Blood Institute [R35 HL135749, P01 HL116264, R01 HL096647]; American Heart Association [17SDG33660149]; Wisconsin Breast Cancer Showhouse; Medical College of Wisconsin Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096647, R35HL135749, P01HL116264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098159] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Wisconsin Breast Cancer Showhouse; Medical College of Wisconsin Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. Marie Schulte and William Cashdollar and the Northwestern Mutual Foundation Imaging Center (Blood Research Institute of Wisconsin, Milwaukee, WI, USA) for help with the imaging studies. This research was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant R01 DK098159 (to A. Sorokin), NIH National Heart, Lung, and Blood Institute Grants R35 HL135749 (to A. Staruschenko), P01 HL116264 (to A. Staruschenko), and R01 HL096647 (to D.X.Z.), American Heart Association Grant 17SDG33660149 (to O.P.), and a grant from the Wisconsin Breast Cancer Showhouse and the Medical College of Wisconsin Cancer Center (to A. Sorokin). The authors declare no conflicts of interest.	Aalkjaer C, 2011, ACTA PHYSIOL, V202, P253, DOI 10.1111/j.1748-1716.2011.02320.x; AKATA T, 1995, JPN J PHARMACOL, V68, P331, DOI 10.1254/jjp.68.331; Barton M, 2000, J CARDIOVASC PHARM, V36, pS153, DOI 10.1097/00005344-200036051-00048; Barton M, 2015, SEMIN NEPHROL, V35, P156, DOI 10.1016/j.semnephrol.2015.02.005; Bertero E, 2018, CIRC RES, V122, P1460, DOI 10.1161/CIRCRESAHA.118.310082; Briones AM, 2010, CURR HYPERTENS REP, V12, P135, DOI 10.1007/s11906-010-0100-z; Burke M, 2014, CURR VASC PHARMACOL, V12, P845, DOI 10.2174/15701611113116660149; Camici GG, 2008, J APPL PHYSIOL, V105, P1628, DOI 10.1152/japplphysiol.90579.2008; Cao S, 2018, J BIOL CHEM, V293, P5307, DOI 10.1074/jbc.M117.811075; Carlstrom M, 2015, PHYSIOL REV, V95, P405, DOI 10.1152/physrev.00042.2012; Chahdi A, 2008, MOL BIOL CELL, V19, P2609, DOI 10.1091/mbc.E07-05-0424; Chahdi A, 2010, CELL SIGNAL, V22, P325, DOI 10.1016/j.cellsig.2009.09.039; Chen XP, 2010, J CELL MOL MED, V14, P2483, DOI 10.1111/j.1582-4934.2009.00890.x; Dubow J, 2011, CURR ATHEROSCLER REP, V13, P298, DOI 10.1007/s11883-011-0187-y; Foschi M, 2001, J BIOL CHEM, V276, P26640, DOI 10.1074/jbc.M102008200; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Geurts AM, 2010, METHODS MOL BIOL, V597, P211, DOI 10.1007/978-1-60327-389-3_15; Gustafsson F, 1999, ACTA PHYSIOL SCAND, V167, P11; Hall JE, 2012, COMPR PHYSIOL, V2, P2393, DOI 10.1002/cphy.c110058; Haller M, 2016, J BIOL CHEM, V291, P23557, DOI 10.1074/jbc.M116.752766; Imig JD, 2008, MICROCIRCULATION, V15, P137, DOI 10.1080/10739680701456960; Kohan DE, 2011, COMPR PHYSIOL, V1, P883, DOI 10.1002/cphy.c100039; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; Kvernmo HD, 1999, MICROVASC RES, V57, P298, DOI 10.1006/mvre.1998.2139; LEVESQUE H, 1994, DRUG AGING, V4, P221, DOI 10.2165/00002512-199404030-00005; Levey AS, 2010, KIDNEY INT, V78, P19, DOI 10.1038/ki.2010.115; Levin ER, 1996, AM J NEPHROL, V16, P246, DOI 10.1159/000169004; Lukaszewicz KM, 2016, MICROCIRCULATION, V23, P540, DOI 10.1111/micc.12304; Maguire JJ, 2015, SEMIN NEPHROL, V35, P125, DOI 10.1016/j.semnephrol.2015.02.002; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miller B, 2016, J CLIN INVEST, V126, P2533, DOI 10.1172/JCI75079; Nishijima Y, 2017, CIRC RES, V120, P658, DOI 10.1161/CIRCRESAHA.116.309491; Okada M, 2002, CARDIOVASC DRUG REV, V20, P53; Oshikawa J, 2012, AM J PHYSIOL-HEART C, V302, pH724, DOI 10.1152/ajpheart.00739.2011; Palygin O, 2016, LIFE SCI, V159, P140, DOI 10.1016/j.lfs.2015.12.022; Peng HL, 2001, CIRC RES, V88, P810, DOI 10.1161/hh0801.089603; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Rahman A, 2005, J VASC RES, V42, P301, DOI 10.1159/000086002; Reho JJ, 2014, AM J PHYSIOL-HEART C, V306, pH163, DOI 10.1152/ajpheart.00493.2013; Ren YL, 2014, AM J PHYSIOL-RENAL, V307, pF533, DOI 10.1152/ajprenal.00283.2014; Schiffrin EL, 2001, AM J HYPERTENS, V14, p83S, DOI 10.1016/S0895-7061(01)02074-X; Sgouralis I, 2012, AM J PHYSIOL-RENAL, V303, pF229, DOI 10.1152/ajprenal.00589.2011; Sorokin A, 2003, AM J PHYSIOL-RENAL, V285, pF579, DOI 10.1152/ajprenal.00019.2003; Sorokin A, 2011, CONTRIB NEPHROL, V172, P50, DOI 10.1159/000328680; Szczech LA, 2004, KIDNEY INT, V66, pS3, DOI 10.1111/j.1523-1755.2004.09002.x; Tomilov AA, 2010, J BIOL CHEM, V285, P1153, DOI 10.1074/jbc.M109.017491; Trolliet MR, 2001, KIDNEY BLOOD PRESS R, V24, P116, DOI 10.1159/000054217; Tykocki NR, 2010, CLIN SCI, V119, P361, DOI 10.1042/CS20100145; Wright KD, 2018, AM J PHYSIOL-RENAL, V314, pF143, DOI 10.1152/ajprenal.00414.2017; Xu XL, 2017, AGING DIS, V8, P486, DOI 10.14336/AD.2017.0507; Zhao XY, 2005, HYPERTENSION, V46, P562, DOI 10.1161/01.HYP.0000179584.39937.41	52	4	4	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2636	2645		10.1096/fj.201800776RR	http://dx.doi.org/10.1096/fj.201800776RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303741	Green Published			2022-12-26	WOS:000457296600088
J	Zhang, GW; Isaji, T; Xu, ZW; Lu, X; Fukuda, T; Gu, JG				Zhang, Guowei; Isaji, Tomoya; Xu, Zhiwei; Lu, Xu; Fukuda, Tomohiko; Gu, Jianguo			N-acetylglucosaminyltransferase-I as a novel regulator of epithelial-mesenchymal transition	FASEB JOURNAL			English	Article						cell adhesion; N-glycosylation; integrins	E-CADHERIN; SIGNALING PATHWAY; CELL-SURFACE; HIGH-MANNOSE; LUNG-CANCER; GLYCOSYLATION; EMT; SWAINSONINE; ACTIVATION; EXPRESSION	N-Glycans are involved in numerous biologic processes, such as cell adhesion, migration, and invasion. To distinguish the functions of complex high-mannose types of N-glycans, we used the clustered, regularly interspaced, short palindromic repeats/Cas9 system to establish N-acetylglucosaminyltransferase (GnT)-I-knockout (KO) cells. Loss of GnT-I greatly induced cell-cell adhesion and decreased cell migration. In addition, the expression levels of epithelial-mesenchymal transition (EMT) markers such as -SMA, vimentin, and N-cadherin were suppressed, whereas the expression of claudin-1 was promoted, suggesting a mesenchymal-epithelial transition-like phenotype, an opposite process to the EMT, was occurred in the KO cells. The phosphorylation levels of Smad-2, epidermal growth factor receptor, and integrin-mediated focal adhesion kinase (FAK) were consistently suppressed. Furthermore, the restoration of GnT-I in the KO cells suppressed the cell-cell adhesion and augmented the expression of EMT markers as well as that of FAK activation. The expression levels of integrins were upregulated in the KO cells, although their functions were decreased, whereas their expression levels were downregulated in the rescued cells, which suggests a negative feedback loop between function and expression. Finally, we also found that the expression of GnT-I was important for cell survival, resistance to cancer drugs, and increased colony formation. The results of the present study demonstrate that GnT-I works as a switch to turn on/off EMT, which further supports the notion that on most surface receptors, the N-glycans differentially play essential roles in biologic functions.Zhang, G., Isaji, T., Xu, Z., Lu, X., Fukuda, T., Gu, J. N-acetylglucosaminyltransferase-I as a novel regulator of epithelial-mesenchymal transition.	[Zhang, Guowei; Isaji, Tomoya; Xu, Zhiwei; Lu, Xu; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi, Japan	Tohoku Medical & Pharmaceutical University	Gu, JG (corresponding author), Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsusima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-mpu.ac.jp	Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021		Japanese Society for the Promotion of Science [15H04354]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [18H04868]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in part, by Grant-in-Aid for Scientific Research 15H04354 (to J.G.) from the Japanese Society for the Promotion of Science, and by Grant-in-Aid for Scientific Research on Innovative Areas 18H04868 (to J.G.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare no conflicts of interest.	Adhikary A, 2014, J BIOL CHEM, V289, P25431, DOI 10.1074/jbc.M113.527267; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Banerjee A, 2015, ADV EXP MED BIOL, V842, P355, DOI 10.1007/978-3-319-11280-0_22; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; Cai DF, 2014, CELL, V157, P1146, DOI 10.1016/j.cell.2014.03.045; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Chen QK, 2013, DIFFERENTIATION, V86, P126, DOI 10.1016/j.diff.2013.03.003; Cui J, 2018, J PATHOL, V245, P41, DOI 10.1002/path.5054; Davis FM, 2014, TRENDS PHARMACOL SCI, V35, P479, DOI 10.1016/j.tips.2014.06.006; de Leoz Maria Lorna A, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.M110.002717; Draheim V, 2010, EUR J PHARM SCI, V41, P201, DOI 10.1016/j.ejps.2010.06.005; Du BW, 2016, MOLECULES, V21, DOI 10.3390/molecules21070965; DUBAND JL, 1987, DEVELOPMENT, V101, P461; Fanata WID, 2013, PLANT J, V73, P966, DOI 10.1111/tpj.12087; Ganguly KK, 2013, CELL ADHES MIGR, V7, P251, DOI 10.4161/cam.23840; Goh KL, 1997, DEVELOPMENT, V124, P4309; Goss PE, 1997, CLIN CANCER RES, V3, P1077; Gu JG, 2012, GLYCOCONJUGATE J, V29, P599, DOI 10.1007/s10719-012-9386-1; Gu W, 2013, FASEB J, V27, P3947, DOI 10.1096/fj.12-225805; Guo P, 2004, CELL MOL LIFE SCI, V61, P1795, DOI 10.1007/s00018-004-4122-z; He X, 2012, GLYCOBIOLOGY, V22, P492, DOI 10.1093/glycob/cwr157; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Ho WL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0334-6; Hou S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18430; Huang CY, 2015, FEBS J, V282, P4295, DOI 10.1111/febs.13419; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Jin ZC, 2018, J BIOL CHEM, V293, P5572, DOI 10.1074/jbc.M117.813030; Jolly MK, 2017, MOL ONCOL, V11, P755, DOI 10.1002/1878-0261.12083; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; Kim YW, 2012, BIOCHEM J, V445, P403, DOI 10.1042/BJ20111923; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li N, 2014, J CELL MOL MED, V18, P1975, DOI 10.1111/jcmm.12331; Li QH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15166; Li WL, 2018, ONCOGENE, V37, P4903, DOI 10.1038/s41388-018-0341-x; Li X, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00033; Li XL, 2017, SCI REP-UK, V7, DOI 10.1038/srep40464; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Ma JX, 2018, ONCOL RES, V26, P1207, DOI 10.3727/096504017X15046134836575; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mittal A, 2010, MECH DEVELOP, V127, P472, DOI 10.1016/j.mod.2010.08.005; Mori S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137486; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; NEWGREEN D, 1980, CELL TISSUE RES, V211, P269; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; OLDEN K, 1991, PHARMACOL THERAPEUT, V50, P285, DOI 10.1016/0163-7258(91)90046-O; Ozcan S, 2014, CANCER PREV RES, V7, P226, DOI 10.1158/1940-6207.CAPR-13-0235; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Peiris D, 2017, SCI REP-UK, V7, DOI 10.1038/srep43006; Pinho SS, 2013, BBA-GEN SUBJECTS, V1830, P2690, DOI 10.1016/j.bbagen.2012.10.021; Pinho SS, 2009, BIOCHEM BIOPH RES CO, V379, P1091, DOI 10.1016/j.bbrc.2009.01.024; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; Pochec E, 2015, ANAL CELL PATHOL, V2015, DOI 10.1155/2015/324980; Porwoll S, 1998, J BIOL CHEM, V273, P1075, DOI 10.1074/jbc.273.2.1075; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Seres M, 2011, INT J MOL SCI, V12, P7772, DOI 10.3390/ijms12117772; Shaheen PE, 2005, INVEST NEW DRUG, V23, P577, DOI 10.1007/s10637-005-0793-z; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shao K, 2016, GLYCOBIOLOGY, V26, P142, DOI 10.1093/glycob/cwv089; Stanley P, 2015, ESSENTIALS GLYCOBIOL, P99, DOI DOI 10.1101/GLYCOBIOLOGY.3E.009; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; Terao M, 2011, J BIOL CHEM, V286, P28303, DOI 10.1074/jbc.M111.220376; Thompson EW, 2011, NAT MED, V17, P1048, DOI 10.1038/nm.2437; Tu CF, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0904-8; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wojtowicz K, 2015, BIOMED PHARMACOTHER, V74, P49, DOI 10.1016/j.biopha.2015.07.001; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; You N, 2012, ONCOL REP, V28, P2091, DOI 10.3892/or.2012.2035; Zavareh RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043721; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	77	11	12	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2823	2835		10.1096/fj.201801478R	http://dx.doi.org/10.1096/fj.201801478R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307765	Bronze			2022-12-26	WOS:000457296600103
J	Paolini-Bertrand, M; Cerini, F; Martins, E; Scurci, I; Hartley, O				Paolini-Bertrand, Marianne; Cerini, Fabrice; Martins, Elsa; Scurci, Ilaria; Hartley, Oliver			Rapid and low-cost multiplex synthesis of chemokine analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL-SYNTHESIS; HIGHLY POTENT; RECEPTOR 5; PROTEIN; INHIBITION; ENTRY; IDENTIFICATION; TRANSMISSION; PURIFICATION; EXPRESSION	Peptides represent a promising source of new medicines, but improved technologies are needed to facilitate discovery and optimization campaigns. In particular, longer peptides with multiple disulfide bridges are challenging to produce, and producing large numbers of structurally related variants is dissuasively costly and time-consuming. The principal cost and time drivers are the multiple column chromatography purification steps that are used during the multistep chemical synthesis procedure, which involves both ligation and oxidative refolding steps. In this study, we developed a method for multiplex parallel synthesis of complex peptide analogs in which the structurally variant region of the molecule is produced as a small peptide on a 384-well synthesizer with subsequent ligation to the longer, structurally invariant region and oxidative refolding carried out in-well without any column purification steps. To test the method, we used a panel of 96 analogs of the chemokine RANTES (regulated on activation normal T cell expressed and secreted)/CCL5 (69 residues, two disulfide bridges), which had been synthesized using standard approaches and characterized pharmacologically in an earlier study. Although, as expected, the multiplex method generated chemokine analogs of lower purity than those produced in the original study, it was nonetheless possible to closely match the pharmacological attributes (anti-HIV potency, capacity to elicit G protein signaling, and capacity to elicit intracellular receptor sequestration) of each chemokine analog to reference data from the earlier study. This rapid, low-cost approach has the potential to support discovery and optimization campaigns based on analogs of other chemokines as well as those of other complex peptide and small protein targets of a similar size.	[Paolini-Bertrand, Marianne; Cerini, Fabrice; Martins, Elsa; Scurci, Ilaria; Hartley, Oliver] Univ Geneva, Fac Med, Dept Pathol & Immunol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland	University of Geneva	Hartley, O (corresponding author), Univ Geneva, Fac Med, Dept Pathol & Immunol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	oliver.hartley@unige.ch		hartley, oliver/0000-0002-2283-8379	Swiss National Science Foundation [310030_163085]; Orion Biotechnology Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Orion Biotechnology Switzerland	We acknowledge support from the Swiss National Science Foundation (grant 310030_163085 to O. H). O. H. is the inventor of the chemokine analogs described in this study and a shareholder of Orion Biotechnology Switzerland, to whom the rights to the invention have been assigned.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; Bang D, 2004, ANGEW CHEM INT EDIT, V43, P2534, DOI 10.1002/anie.200353540; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bonsch C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125396; Breitling F, 2009, MOL BIOSYST, V5, P224, DOI 10.1039/b819850k; Cerini F, 2008, JAIDS-J ACQ IMM DEF, V49, P472, DOI 10.1097/QAI.0b013e31818c953f; Cerini F, 2017, AIDS RES HUM RETROV, V33, P768, DOI [10.1089/aid.2016.0199, 10.1089/AID.2016.0199]; Cerini F, 2016, PROTEIN EXPRES PURIF, V119, P1, DOI 10.1016/j.pep.2015.10.011; Chevigne A, 2011, BIOCHEM PHARMACOL, V82, P1438, DOI 10.1016/j.bcp.2011.07.091; ClarkLewis I, 1997, METHOD ENZYMOL, V287, P233; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Colin P, 2013, P NATL ACAD SCI USA, V110, P9475, DOI 10.1073/pnas.1222205110; Dawson PE, 1997, METHOD ENZYMOL, V287, P34; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dorgham K, 2016, METHOD ENZYMOL, V570, P47, DOI 10.1016/bs.mie.2015.09.014; Engelhard M, 2016, J PEPT SCI, V22, P246, DOI 10.1002/psc.2880; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Gaertner H, 2008, PROTEIN ENG DES SEL, V21, P65, DOI 10.1093/protein/gzm079; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Hartley O, 2005, CURR PROTEIN PEPT SC, V6, P207, DOI 10.2174/1389203054065400; Hartley O, 2004, P NATL ACAD SCI USA, V101, P16460, DOI 10.1073/pnas.0404802101; Hartley O, 2003, J VIROL, V77, P6637, DOI 10.1128/JVI.77.12.6637-6644.2003; Henninot A, 2018, J MED CHEM, V61, P1382, DOI 10.1021/acs.jmedchem.7b00318; Hesselgesser J, 1997, METHOD ENZYMOL, V287, P59; Horuk R, 1997, METHOD ENZYMOL, V287, P3; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Koehn Jim, 2009, V498, P1, DOI 10.1007/978-1-59745-196-3_1; Kufareva I, 2015, IMMUNOL CELL BIOL, V93, P372, DOI 10.1038/icb.2015.15; Lau JL, 2018, BIOORGAN MED CHEM, V26, P2700, DOI 10.1016/j.bmc.2017.06.052; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Loibl SF, 2016, CHEM SCI, V7, P6753, DOI 10.1039/c6sc01883a; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Ollivier N, 2010, ORG LETT, V12, P5238, DOI 10.1021/ol102273u; Pande J, 2010, BIOTECHNOL ADV, V28, P849, DOI 10.1016/j.biotechadv.2010.07.004; Pleskoff O, 1997, SCIENCE, V276, P1874, DOI 10.1126/science.276.5320.1874; Pluckthun A, 2012, METHODS MOL BIOL, V805, P3, DOI 10.1007/978-1-61779-379-0_1; Raibaut L, 2015, TOP CURR CHEM, V363, P103, DOI 10.1007/128_2014_609; Ramli S, 2009, PROTEIN PEPTIDE LETT, V16, P810, DOI 10.2174/092986609788681706; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Veazey RS, 2009, J INFECT DIS, V199, P1525, DOI 10.1086/598685; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wells TNC, 1996, J LEUKOCYTE BIOL, V59, P53, DOI 10.1002/jlb.59.1.53; Zheng Y, 2017, IMMUNITY, V46, P1005, DOI 10.1016/j.immuni.2017.05.002	48	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19092	19100		10.1074/jbc.RA118.004370	http://dx.doi.org/10.1074/jbc.RA118.004370			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30305389	Green Published, hybrid			2022-12-26	WOS:000458467400022
J	Murphy, K; Llewellyn, K; Wakser, S; Pontasch, J; Samanich, N; Flemer, M; Hensley, K; Kim, DS; Park, J				Murphy, Kelsey; Llewellyn, Killian; Wakser, Samuel; Pontasch, Josef; Samanich, Natasha; Flemer, Matthew; Hensley, Kenneth; Kim, Dong-Shik; Park, Joshua			Mini-GAGR, an intranasally applied polysaccharide, activates the neuronal Nrf2-mediated antioxidant defense system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; antioxidant; nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); polysaccharide; neurodegeneration; mini-GAGR; BBB-bypassing polysaccharide; antioxidant enzymes; amyloid; tau; oxidative stress	TRANSGENIC MOUSE MODEL; IMPROVES COGNITIVE IMPAIRMENT; PLACEBO-CONTROLLED PHASE-3; DISEASE-LIKE PATHOLOGY; REDUCES A-BETA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; AMYLOID-BETA; NEUROTROPHIC FACTOR; MEMORY DEFICITS	Oxidative stress triggers and exacerbates neurodegeneration in Alzheimer's disease (AD). Various antioxidants reduce oxidative stress, but these agents have little efficacy due to poor blood-brain barrier (BBB) permeability. Additionally, single-modal antioxidants are easily overwhelmed by global oxidative stress. Activating nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) and its downstream antioxidant system are considered very effective for reducing global oxidative stress. Thus far, only a few BBB-permeable agents activate the Nrf2-dependent antioxidant system. Here, we discovered a BBB-bypassing Nrf2-activating polysaccharide that may attenuate AD pathogenesis. Mini-GAGR, a 0.7-kDa cleavage product of low-acyl gellan gum, increased the levels and activities of Nrf2-dependent antioxidant enzymes, decreased reactive oxygen species (ROS) under oxidative stress in mouse cortical neurons, and robustly protected mitochondria from oxidative insults. Moreover, mini-GAGR increased the nuclear localization and transcriptional activity of Nrf2 similarly to known Nrf2 activators. Mechanistically, mini-GAGR increased the dissociation of Nrf2 from its inhibitor, Kelch-like ECH-associated protein 1 (Keap1), and induced phosphorylation and nuclear translocation of Nrf2 in a protein kinase C (PKC)- and fibroblast growth factor receptor (FGFR1)-dependent manner. Finally, 20-day intranasal treatment of 3xTg-AD mice with 100 nmol of mini-GAGR increased nuclear p-Nrf2 and growth-associated protein 43 (GAP43) levels in hippocampal neurons, reduced p-tau and -amyloid (A) peptide-stained neurons, and improved memory. The BBB-bypassing Nrf2-activating polysaccharide reported here may be effective in reducing oxidative stress and neurodegeneration in AD.	[Murphy, Kelsey; Llewellyn, Killian; Wakser, Samuel; Pontasch, Josef; Samanich, Natasha; Flemer, Matthew; Park, Joshua] Univ Toledo, Coll Med & Life Sci, Dept Neurosci, Toledo, OH 43614 USA; [Hensley, Kenneth] Univ Toledo, Coll Med & Life Sci, Dept Pathol, Toledo, OH 43614 USA; [Kim, Dong-Shik] Univ Toledo, Dept Chem Engn, Coll Engn, Toledo, OH 43607 USA; [Hensley, Kenneth] Arkansas Coll Osteopath Med ARCOM, Dept Biochem Mol & Cell Sci, 7000 Chad Colley Blvd, Ft Smith, AR 72916 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Park, J (corresponding author), Coll Med & Life Sci, Dept Neurosci, 3000 Arlington Ave, Toledo, OH 43614 USA.	joshua.park2@utoledo.edu		Kim, Dong-Shik/0000-0001-9242-385X	National Institutes of Health [5 R21 AG053590-02]; deArce-Koch Memorial Endowment Fund; University of Toledo Medical Research Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG053590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); deArce-Koch Memorial Endowment Fund; University of Toledo Medical Research Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant 5 R21 AG053590-02 and the deArce-Koch Memorial Endowment Fund. This work was also supported by the University of Toledo Medical Research Society and Donald and Gail Klise. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akagi M, 2015, J PHARMACOL SCI, V127, P155, DOI 10.1016/j.jphs.2014.12.015; ANDERSON DMW, 1988, FOOD ADDIT CONTAM, V5, P237, DOI 10.1080/02652038809373701; Banaceur S, 2013, BEHAV BRAIN RES, V240, P197, DOI 10.1016/j.bbr.2012.11.021; Barone E, 2016, FREE RADICAL BIO MED, V91, P127, DOI 10.1016/j.freeradbiomed.2015.12.012; Bell KFS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8066; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Blanchard J, 2010, ACTA NEUROPATHOL, V120, P605, DOI 10.1007/s00401-010-0734-6; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Carroll JC, 2010, BRAIN RES, V1366, P233, DOI 10.1016/j.brainres.2010.10.009; Christopher K, 2015, METHODSX, V2, P174, DOI 10.1016/j.mex.2015.03.006; Chuang JI, 2015, FREE RADICAL BIO MED, V89, P274, DOI 10.1016/j.freeradbiomed.2015.08.011; Ciesler J., 2013, OPEN J NEUROSCI, V3, P2; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; Cuadrado A, 2018, REDOX BIOL, V14, P522, DOI 10.1016/j.redox.2017.10.010; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Domanskyi A, 2015, HUM GENE THER, V26, P550, DOI 10.1089/hum.2015.065; Dore S, 1999, ANN NY ACAD SCI, V890, P167, DOI 10.1111/j.1749-6632.1999.tb07991.x; Dumont M, 2009, J NEUROCHEM, V109, P502, DOI 10.1111/j.1471-4159.2009.05970.x; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Fowler JH, 2018, J CEREBR BLOOD F MET, V38, P1354, DOI 10.1177/0271678X17713105; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Fragoulis A, 2017, REDOX BIOL, V12, P843, DOI 10.1016/j.redox.2017.04.024; Frazer ME, 2008, MOL THER, V16, P845, DOI 10.1038/mt.2008.39; Galindo MF, 2010, J NEUROCHEM, V114, P933, DOI 10.1111/j.1471-4159.2010.06814.x; Garcia P, 2010, J NEUROSCI, V30, P7516, DOI 10.1523/JNEUROSCI.4182-09.2010; Ghosh D, 2014, NEUROBIOL AGING, V35, P179, DOI 10.1016/j.neurobiolaging.2013.06.023; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Huang JY, 2010, FREE RADICAL BIO MED, V49, P1099, DOI 10.1016/j.freeradbiomed.2010.06.026; Iqbal K, 2011, ACTA NEUROPATHOL, V122, P543, DOI 10.1007/s00401-011-0878-z; IYANAGI T, 1970, BIOCHIM BIOPHYS ACTA, V216, P282, DOI 10.1016/0005-2728(70)90220-3; Jaworski T, 2011, NATURE, V480, pE4, DOI 10.1038/nature10615; Joshi G, 2015, NEUROBIOL AGING, V36, P664, DOI 10.1016/j.neurobiolaging.2014.09.004; Kanninen K, 2008, MOL CELL NEUROSCI, V39, P302, DOI 10.1016/j.mcn.2008.07.010; Kanninen K, 2009, P NATL ACAD SCI USA, V106, P16505, DOI 10.1073/pnas.0908397106; Kapitulnik J, 2009, TRENDS PHARMACOL SCI, V30, P129, DOI 10.1016/j.tips.2008.12.003; Katsouri L, 2015, NEUROBIOL AGING, V36, P821, DOI 10.1016/j.neurobiolaging.2014.10.004; Khan AR, 2017, J CONTROL RELEASE, V268, P364, DOI 10.1016/j.jconrel.2017.09.001; Kim TS, 2006, INT J GERIATR PSYCH, V21, P344, DOI 10.1002/gps.1469; Kiyota T, 2011, P NATL ACAD SCI USA, V108, pE1339, DOI 10.1073/pnas.1102349108; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; La Joie R, 2014, NEURON, V81, P1417, DOI 10.1016/j.neuron.2014.01.026; Leiros M, 2015, NEUROPHARMACOLOGY, V93, P285, DOI 10.1016/j.neuropharm.2015.02.015; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035122; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lipton SA, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.389; Liu YG, 2016, PHARMACOL BIOCHEM BE, V150, P207, DOI 10.1016/j.pbb.2016.11.002; Makani V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149715; MASLIAH E, 1992, BRAIN RES, V593, P323, DOI 10.1016/0006-8993(92)91329-D; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Moreira PI, 2006, J ALZHEIMERS DIS, V9, P101; Murphy KE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061168; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Mylroie H, 2015, CARDIOVASC RES, V106, P509, DOI 10.1093/cvr/cvv131; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nakajima A, 2015, BEHAV BRAIN RES, V289, P69, DOI 10.1016/j.bbr.2015.04.028; Neymotin A, 2011, FREE RADICAL BIO MED, V51, P88, DOI 10.1016/j.freeradbiomed.2011.03.027; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Pajares M, 2017, REDOX BIOL, V11, P543, DOI 10.1016/j.redox.2017.01.006; Park JJ, 2008, MOL ENDOCRINOL, V22, P989, DOI 10.1210/me.2007-0473; Peng Y, 2010, J NEUROSCI, V30, P8180, DOI 10.1523/JNEUROSCI.0340-10.2010; Pietropaolo S, 2008, BEHAV NEUROSCI, V122, P733, DOI 10.1037/a0012520; Quinti L, 2016, CELL CHEM BIOL, V23, P849, DOI 10.1016/j.chembiol.2016.05.015; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; Resende R, 2008, FREE RADICAL BIO MED, V44, P2051, DOI 10.1016/j.freeradbiomed.2008.03.012; Rosskothen-Kuhl N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092624; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Shailasree S, 2015, MOL NEUROBIOL, V51, P119, DOI 10.1007/s12035-014-8700-2; Shin MK, 2014, NEUROBIOL AGING, V35, P990, DOI 10.1016/j.neurobiolaging.2013.10.091; Stack C, 2010, FREE RADICAL BIO MED, V49, P147, DOI 10.1016/j.freeradbiomed.2010.03.017; Stover KR, 2015, BEHAV BRAIN RES, V289, P29, DOI 10.1016/j.bbr.2015.04.012; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Tiwari SK, 2014, CURR MED CHEM, V21, P2610, DOI 10.2174/0929867321666140217125857; Vargas MR, 2005, J BIOL CHEM, V280, P25571, DOI 10.1074/jbc.M501920200; Yacila G, 2014, CURR MED CHEM, V21, P3583, DOI 10.2174/0929867321666140601162710; Yenki P, 2013, J MOL NEUROSCI, V49, P262, DOI 10.1007/s12031-012-9837-y; Zenaro E, 2015, NAT MED, V21, P880, DOI 10.1038/nm.3913; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zhou YY, 2014, INT J NEUROPSYCHOPH, V17, P635, DOI 10.1017/S146114571300148X	88	21	22	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18242	18269		10.1074/jbc.RA117.001245	http://dx.doi.org/10.1074/jbc.RA117.001245			28	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30282635	Green Published, hybrid			2022-12-26	WOS:000451375200018
J	Barth, AIM; Kim, H; Riedel-Kruse, IH				Barth, Angela I. M.; Kim, Honesty; Riedel-Kruse, Ingmar H.			Regulation of epithelial migration by epithelial cell adhesion molecule requires its Claudin-7 interaction domain	PLOS ONE			English	Article							CONGENITAL TUFTING ENTEROPATHY; ADENOMATOUS POLYPOSIS-COLI; EP-CAM; TIGHT JUNCTION; ACTOMYOSIN CONTRACTILITY; SIGNALING PATHWAY; BETA-CATENIN; EPCAM; CANCER; ACTIVATION	Epithelial cell adhesion molecule (EpCAM) is a glycoprotein on the surface of epithelial cells that is essential for intestinal epithelial integrity and expressed at high levels in many epithelial derived cancers and circulating tumor cells. Here we show the effect of EpCAM levels on migration of Madin-Darby-Canine Kidney (MDCK) epithelial cells. MDCK cells depleted of EpCAM show increased activation of extracellular signal-regulated kinase (ERK) and of myosin, and increased cell spreading and epithelial sheet migration into a gap. In contrast, over-expression of EpCAM inhibits ERK and myosin activation, and slows epithelial sheet migration. Loss of EpCAM is rescued by EpCAM-YFP mutated in the extracellular domain required for cis-dimerization whereas EpCAM-YFP with a mutation that inhibits Claudin-7 interaction cannot rescue increased ERK, myosin activation, and increased migration in EpCAM-depleted cells. In summary, these results indicate that interaction of EpCAM and Claudin-7 at the cell surface negatively regulates epithelial migration by inhibiting ERK and actomyosin contractility.	[Barth, Angela I. M.; Kim, Honesty; Riedel-Kruse, Ingmar H.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University	Riedel-Kruse, IH (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	ingmar@stanford.edu		Riedel-Kruse, Ingmar/0000-0002-6068-5561	American Cancer Society [RSG-14-177-01]; Stanford Graduate Fellowship;  [NIH 1R21HD080553]	American Cancer Society(American Cancer Society); Stanford Graduate Fellowship(Stanford University); 	This work was supported by RSG-14-177-01 American Cancer Society: https://www.cancer.org/. AB, HK, IHRK received funding through this grant. HK received funding through the Stanford Graduate Fellowship. IHRK received funding through the grant NIH 1R21HD080553.	Allard WJ, 2005, TUMOR CELLS CIRCULAT, V10, P6897, DOI [10.1158/1078-0432.CCR-04-0378, 15501967, DOI 10.1158/1078-0432.CCR-04-0378]; Aoki K, 2017, DEV CELL, V43, P305, DOI 10.1016/j.devcel.2017.10.016; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Dukes JD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-43; Gaber A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31482-7; Garcia MA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029181; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Guerra E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049302; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; Lei ZL, 2012, DEV BIOL, V371, P136, DOI 10.1016/j.ydbio.2012.07.005; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Louie RK, 2004, J CELL SCI, V117, P1117, DOI 10.1242/jcs.00939; Lu HQ, 2013, DEV CELL, V24, P543, DOI 10.1016/j.devcel.2013.01.021; Lu Z, 2011, EXP CELL RES, V317, P1935, DOI 10.1016/j.yexcr.2011.05.019; Maghzal N, 2013, DEV CELL, V27, P263, DOI 10.1016/j.devcel.2013.10.003; Maghzal N, 2010, J CELL BIOL, V191, P645, DOI 10.1083/jcb.201004074; Martowicz A, 2016, HISTOL HISTOPATHOL, V31, P349, DOI 10.14670/HH-11-678; Matsubayashi Y, 2004, CURR BIOL, V14, P731, DOI 10.1016/j.cub.2004.03.060; Myung JH, 2010, LANGMUIR, V26, P8589, DOI 10.1021/la904678p; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Nubel T, 2009, MOL CANCER RES, V7, P285, DOI 10.1158/1541-7786.MCR-08-0200; Pandya P, 2017, CURR OPIN CELL BIOL, V48, P87, DOI 10.1016/j.ceb.2017.06.006; Pavsic M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5764; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917; Salomon J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13998; Sankpal NV, 2017, ONCOGENE, V36, P3706, DOI 10.1038/onc.2016.504; Sarrach S, 2018, SCI REP SPRINGER US, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Schnell U, 2013, HUM MOL GENET, V22, P2566, DOI 10.1093/hmg/ddt105; Sivagnanam M, 2008, GASTROENTEROLOGY, V135, P429, DOI 10.1053/j.gastro.2008.05.036; Tanimura S, 1998, ONCOGENE, V17, P57, DOI 10.1038/sj.onc.1201905; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Trebak M, 2001, J BIOL CHEM, V276, P2299, DOI 10.1074/jbc.M004770200; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Winter MJ, 2007, MOL CELL BIOCHEM, V302, P19, DOI 10.1007/s11010-007-9420-y; Winter MJ, 2003, EXP CELL RES, V285, P50, DOI 10.1016/S0014-4827(02)00045-9; Wu CJ, 2017, J CLIN INVEST, V127, P623, DOI 10.1172/JCI88428; Wu CJ, 2013, J BIOL CHEM, V288, P12253, DOI 10.1074/jbc.M113.457499; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304	46	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204957	10.1371/journal.pone.0204957	http://dx.doi.org/10.1371/journal.pone.0204957			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304739	Green Published, Green Submitted, gold			2022-12-26	WOS:000446921100068
J	El Sadik, A; Mohamed, E; El Zainy, A				El Sadik, Abir; Mohamed, Enas; El Zainy, Ahmed			Postnatal changes in the development of rat submandibular glands in offspring of diabetic mothers: Biochemical, histological and ultrastructural study	PLOS ONE			English	Article							SALIVARY-GLANDS; EXPRESSION; STREPTOZOTOCIN; CELLS; BAX; SECRETION; TRANSPORT; SERUM; MODEL; BCL-2	Development and maturation of submandibular salivary glands are influenced by intrauterine diabetic environment. Several studies investigated the effects of diabetes on the salivary glands. However, the effects of maternal diabetes on the submandibular glands of the offspring was not properly examined. Therefore, the present study was designed to describe the changes in the development of the submandibular glands of the offspring of diabetic mothers. The submandibular glands of the offspring of Streptozotocin (STZ)-induced diabetic female rats were examined at two and four weeks after birth. Detection of mRNA demonstrated that maternal diabetes affects the level of different indicators. The reduction of expression of epidermal growth factor (EGF); a protein mitogen, cytokeratin 5 (CK5); an epithelial cell progenitor, CK7 and aquaporin 5 (AQP5); differentiation markers and B cell lymphoma 2 (Bcl2); an antiapoptotic marker were found. Increase in Bcl2-associated X protein (Box); an apoptotic marker was detected. These changes indicate their effects on saliva secretion, glands tumorigenesis, growth of normal oral flora and oral microbes, with decreased protein synthesis and production of xerostomia and dental caries. Loss of normal glandular architecture, significant increase in fibrosis, by the detection of collagen fibers, and stagnation of secretory granules were found with atrophic changes in the acinar cells. Marked defect of polysaccharides in the acinar cells, denoting functional changes, was manifested by significant reduction of the intensity of periodic acid-Schiff (PAS) reaction. The positive immunoreactivity of caspase-3, denoting cellular apoptosis, and minimal reaction of alpha-smooth muscle actin (alpha SMA) and proliferating cell nuclear antigen (PCNA) were evident in the offspring of diabetic mothers. We conclude that maternal diabetes produces degenerative effects in the structure and function of the submandibular salivary glands of the offspring, reflecting possible influences on their secretory activity affecting oral and digestive health.	[El Sadik, Abir; Mohamed, Enas; El Zainy, Ahmed] Cairo Univ, Fac Med, Dept Anat & Embryol, Cairo, Egypt; [El Zainy, Ahmed] Qassim Univ, Qasim, Saudi Arabia; [El Sadik, Abir; Mohamed, Enas; El Zainy, Ahmed] Cairo Univ, Fac Med, Anat Dept, Kasralainy Hosp, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Qassim University; Egyptian Knowledge Bank (EKB); Cairo University	El Sadik, A (corresponding author), Cairo Univ, Fac Med, Dept Anat & Embryol, Cairo, Egypt.; El Sadik, A (corresponding author), Cairo Univ, Fac Med, Anat Dept, Kasralainy Hosp, Cairo, Egypt.	abeer.ouaida@kasralainy.edu.eg	Sadik, Abir El/AAE-4726-2021; Elzainy, Ahmed/AAI-4522-2020; , 叶叶叶/ABE-1619-2020	El Sadik, Abir/0000-0003-2098-2155; Elzainy, Ahmed/0000-0001-8912-7785				Abeeleh M.A., 2009, EUR J SCI RES, V32, P398; Abiko Yoshihiro, 2003, Medical Electron Microscopy, V36, P247, DOI 10.1007/s00795-003-0225-0; Akbarzadeh A, 2007, INDIAN J CLIN BIOCHE, V22, P60, DOI 10.1007/BF02913315; Armitage P., 2001, STAT METHODS MED RES; Bancroft J. D., 1994, MANUAL HISTOLOGICAL; Bancroft JD., 2013, THEORY PRACTICE HIST, V4; Benn A M L, 2014, N Z Dent J, V110, P92; Butterworth PJ, 2011, STARCH-STARKE, V63, P395, DOI 10.1002/star.201000150; Buyuk B, 2015, EURASIAN J MED, V47, P199, DOI 10.5152/eurasianjmed.2015.80; Caldeira EJ, 2005, ANAT REC PART A, V286A, P930, DOI 10.1002/ar.a.20236; Carpenter GH, 2013, ANNU REV FOOD SCI T, V4, P267, DOI 10.1146/annurev-food-030212-182700; Chavez EM, 2001, ORAL SURG ORAL MED O, V91, P166, DOI 10.1067/moe.2001.112054; Chu PGG, 2002, MODERN PATHOL, V15, P6, DOI 10.1038/modpathol.3880483; Dabelea D, 2011, DIABETES, V60, P1849, DOI 10.2337/db11-0400; de Rijk EPCT, 2003, TOXICOL PATHOL, V31, P1, DOI 10.1080/01926230390173798; El-Gamal DA, 2011, EGYPTIAN J HISTOLOGY, V34, P403, DOI 10.1126/science.1192046; El-Gusbi G. A. M., 2014, World Journal of Medical Sciences, V11, P210; EL-Kordy EA, 2014, J CYTOL HISTOL, V5, P252; Fedirko NV, 2006, BBA-MOL BASIS DIS, V1762, P294, DOI 10.1016/j.bbadis.2005.12.002; HAY DI, 1986, CALCIFIED TISSUE INT, V39, P151, DOI 10.1007/BF02555111; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Hussain QA, 2014, J BAGH COLL DENT, V26, P112; Kaur SG, 2016, J DENT SCI RRJDS, V4, P2; Kawedia JD, 2007, P NATL ACAD SCI USA, V104, P3621, DOI 10.1073/pnas.0608384104; Keirnan J., 2015, HISTOLOGICAL HISTOCH, P184; Klein RM, 2002, DEV STRUCTURE FUNCTI; Knas M, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4583742; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Kulkarni Chetan P., 2012, Diabetologia Croatica, V41, P29; Ladgotra A, 2016, J CLIN DIAGN RES, V10, pZC56, DOI 10.7860/JCDR/2016/19135.7995; Larsen HS, 2011, J MOL HISTOL, V42, P71, DOI 10.1007/s10735-010-9308-0; Lasisi T J, 2012, Niger J Physiol Sci, V27, P79; Lilliu MA, 2015, J ORAL PATHOL MED, V44, P291, DOI 10.1111/jop.12238; LINDEBERG H, 1987, ARCH OTO-RHINO-LARYN, V244, P100, DOI 10.1007/BF00458557; Mandel AL, 2012, J NUTR, V142, P853, DOI 10.3945/jn.111.156984; Maruo Y, 2001, J ORAL REHABIL, V28, P393, DOI 10.1046/j.1365-2842.2001.00674.x; Masago R, 2001, ARTHRITIS RHEUM, V44, P693, DOI 10.1002/1529-0131(200103)44:3<693::AID-ANR119>3.0.CO;2-7; Mitani Y, 2011, AM J PATHOL, V179, P391, DOI 10.1016/j.ajpath.2011.03.037; Mravak-Stipetic M, 2012, MED SCI, V38, P69; Murakami M, 2006, J MEMBRANE BIOL, V210, P91, DOI 10.1007/s00232-005-0848-2; Naudi A, 2012, EXP DIABETES RES, DOI 10.1155/2012/696215; Nelson DA, 2013, BIOL OPEN, V2, P439, DOI 10.1242/bio.20134309; Nicolau Jose, 2005, J Oral Sci, V47, P111, DOI 10.2334/josnusd.47.111; Rego MJBM, 2011, INT J MORPHOL, V29, P604, DOI 10.4067/S0717-95022011000200051; Sabino-Silva R, 2009, J MEMBRANE BIOL, V228, P63, DOI 10.1007/s00232-009-9159-3; Scott BJJ, 1998, J ORAL REHABIL, V25, P28; Takahashi S, 2008, INT J EXP PATHOL, V89, P303, DOI 10.1111/j.1365-2613.2008.00613.x; Tandler B, 2000, EUR J MORPHOL, V38, P233, DOI 10.1076/0924-3860(200010)38:4;1-O;FT233; Tano T, 2013, NEOPLASIA, V15, P305, DOI 10.1593/neo.121528; Van Assche FA, 2001, BRIT MED BULL, V60, P173, DOI 10.1093/bmb/60.1.173; Viana M, 2000, FREE RADICAL BIO MED, V29, P1115, DOI 10.1016/S0891-5849(00)00397-X; Vital P, 2006, J ENDOCRINOL, V190, P425, DOI 10.1677/joe.1.06596; Wang D, 2011, BBA-GEN SUBJECTS, V1810, P543, DOI 10.1016/j.bbagen.2011.01.013; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yao CJ, 2010, AM J PATHOL, V177, P724, DOI 10.2353/ajpath.2010.090282; Yuan J, 2011, CELL STRESS CHAPERON, V16, P689, DOI 10.1007/s12192-011-0281-7; Zhang NN, 2013, INT J CLIN EXP PATHO, V6, P2039	57	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205372	10.1371/journal.pone.0205372	http://dx.doi.org/10.1371/journal.pone.0205372			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304036	Green Published, Green Submitted, gold			2022-12-26	WOS:000446921100086
J	Lau, JTF; Ng, CSM; Wu, AMS; Ma, YL; Lau, MMC				Lau, Joseph T. F.; Ng, Catalina S. M.; Wu, Anise M. S.; Ma, Yee Ling; Lau, Mason M. C.			Low coverage of influenza vaccination among Chinese children aged 12-23 months: Prevalence and associated factors	PLOS ONE			English	Article							PARENTAL PERSPECTIVES; IMMUNIZATION; POPULATION	This study aimed to investigate prevalence and associated factors of influenza vaccination (IV) among children aged 12-23 months. Our cross-sectional survey interviewed 489 parents of children aged 12-23 months anonymously at twelve maternal and child health centers in Hong Kong. Results showed that only 11.5% of the children had ever received IV (64.3% being subsidized). Adjusted for the child's age, significant factors of the children's IV included parental knowledge about governmental policy/recommendation (Adjusted odds ratio [AOR] = 2.64, 95%CI = 1.09,6.40), knowledge about annual IV requirement (AOR = 2.30, 95%CI = 1.21,4.38), perceived safety-related barrier (AOR >= 0.14, 95%CI = 0.06,0.33), cue to action (AOR = 7.79, 95%CI = 3.45,17.58), and subjective norm (AOR = 4.59, 95%CI = 2.34,9.00). IV prevalence of children aged 12-23 months remained low despite a subsidization scheme. The higher IV prevalence of older children reported by other studies suggested that parents postponed action. Promotion campaigns should shift emphases from cost reduction and mass media approaches to dissemination of knowledge about IV policy and safety, enhancement of health professionals' advice, and creation of supportive subjective norm.	[Lau, Joseph T. F.; Ma, Yee Ling; Lau, Mason M. C.] Chinese Univ Hong Kong, Fac Med, Ctr Hlth Behav Res, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Ng, Catalina S. M.] Educ Univ Hong Kong, Dept Early Childhood Educ, Tai Po, Hong Kong, Peoples R China; [Wu, Anise M. S.] Univ Macau, Fac Social Sci, Dept Psychol, Macau, Peoples R China	Chinese University of Hong Kong; Education University of Hong Kong (EdUHK); University of Macau	Lau, JTF (corresponding author), Chinese Univ Hong Kong, Fac Med, Ctr Hlth Behav Res, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	jlau@cuhk.edu.hk	Wu, Anise M.S./AAJ-4293-2020	Wu, Anise M.S./0000-0001-8174-6581; NG, Sau Man Catalina/0000-0002-3096-4877	Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Hong Kong Special Administrative Region [09080362]	Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Hong Kong Special Administrative Region	This work was supported by the Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Hong Kong Special Administrative Region (Project Ref.: #09080362 https://rfs1.fhb.gov.hk/english/funds/funds_hmrf/funds_hmrf_abt/funds_hmrf_abt.html). The funder had no role in the entire research, writing, and submission or publication process. The authors declared no financial interests.	Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Bone A, 2010, VACCINE, V28, P8157, DOI 10.1016/j.vaccine.2010.09.096; Centers for Disease Control and Prevention, 2017, CHILDR FLU FLU VACC; Chen MF, 2011, J COMMUN HEALTH NURS, V28, P29, DOI 10.1080/07370016.2011.539087; Corace K, 2013, AM J INFECT CONTROL, V41, P679, DOI 10.1016/j.ajic.2013.01.014; Education Bureau, 2015, COMPR CHILD DEV SERV; Fabry P, 2011, VACCINE, V29, P1824, DOI 10.1016/j.vaccine.2010.12.109; Fishbein M., 2011, PREDICTING CHANGING, DOI [10.4324/9780203838020, DOI 10.4324/9780203838020]; Flood EM, 2010, CLIN THER, V32, P1448, DOI 10.1016/j.clinthera.2010.06.020; Gnanasekaran SK, 2006, PUBLIC HEALTH REP, V121, P181, DOI 10.1177/003335490612100213; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hofstetter AM, 2013, PREV MED, V56, P165, DOI 10.1016/j.ypmed.2012.11.018; Home Affairs Department, 2018, DEM ETHN GROUPS; Keenan H, 2007, BRIT J GEN PRACT, V57, P359; Kuchar E, 2013, ADV EXP MED BIOL, V755, P243, DOI 10.1007/978-94-007-4546-9_31; Lau JTF, 2010, INFECTION, V38, P275, DOI 10.1007/s15010-010-0034-z; Lau JTF, 2007, VACCINE, V25, P8279, DOI 10.1016/j.vaccine.2007.09.047; Lau JTF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1026; Lau JTF, 2012, AM J INFECT CONTROL, V40, pE225, DOI 10.1016/j.ajic.2012.01.036; Lau JTF, 2010, VACCINE, V28, P5389, DOI 10.1016/j.vaccine.2010.05.071; Lau JTF, 2006, VACCINE, V24, P5526, DOI 10.1016/j.vaccine.2006.04.014; Lau JTF, 2005, PREV MED, V41, P454, DOI 10.1016/j.ypmed.2004.11.023; Ma KK, 2006, PEDIATRICS, V117, pE157, DOI 10.1542/peds.2005-1079; Mereckiene J, 2014, EURO SURVEILL, V19; New South Wales Government, 2016, SEAS INFL VACC 2015; Ng S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-230; Nowalk MP, 2005, AM J PREV MED, V29, P210, DOI 10.1016/j.amepre.2005.05.010; Pabst L. J., 2010, Morbidity and Mortality Weekly Report, V59, P1266; Pabst LJ, 2013, VACCINE, V31, P3116, DOI 10.1016/j.vaccine.2013.04.080; Public Health England, 2015, NAT CHILDH FLU IMM P; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Santibanez T. A., 2007, Morbidity and Mortality Weekly Report, V56, P959; Smith LE, 2017, VACCINE, V35, P1936, DOI 10.1016/j.vaccine.2017.02.031; del Pozo SVF, 2007, J INFECTION, V54, P483, DOI 10.1016/j.jinf.2006.09.001; Wu AMS, 2015, VACCINE, V33, P3556, DOI 10.1016/j.vaccine.2015.05.039	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205561	10.1371/journal.pone.0205561	http://dx.doi.org/10.1371/journal.pone.0205561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304015	Green Published, Green Submitted, gold			2022-12-26	WOS:000446921100108
J	Mahmoud, AI; Galdos, FX; Dinan, KA; Jedrychowski, MP; Davis, JC; Vujic, A; Rachmin, I; Shigley, C; Pancoast, JR; Lee, S; Hollister-Lock, J; MacGillivray, CM; Gygi, SP; Melton, DA; Weir, GC; Lee, RT				Mahmoud, Ahmed, I; Galdos, Francisco X.; Dinan, Katherine A.; Jedrychowski, Mark P.; Davis, Jeffrey C.; Vujic, Ana; Rachmin, Inbal; Shigley, Christian; Pancoast, James R.; Lee, Samuel; Hollister-Lock, Jennifer; MacGillivray, Catherine M.; Gygi, Steven P.; Melton, Douglas A.; Weir, Gordon C.; Lee, Richard T.			Apolipoprotein E is a pancreatic extracellular factor that maintains mature beta-cell gene expression	PLOS ONE			English	Article							INSULIN-SECRETION; ISLET TRANSPLANTATION; MATRIX INTERACTIONS; FRESH ISLETS; RAT; DEDIFFERENTIATION; MAINTENANCE; CULTURE; GLUCOSE; MICE	The in vivo microenvironment of tissues provides myriad unique signals to cells. Thus, following isolation, many cell types change in culture, often preserving some but not all of their in vivo characteristics in culture. At least some of the in vivo microenvironment may be mimicked by providing specific cues to cultured cells. Here, we show that after isolation and during maintenance in culture, adherent rat islets reduce expression of key beta-cell transcription factors necessary for beta-cell function and that soluble pancreatic decellularized matrix (DCM) can enhance beta-cell gene expression. Following chromatographic fractionation of pancreatic DCM, we performed proteomics to identify soluble factors that can maintain beta-cell stability and function. We identified Apolipoprotein E (ApoE) as an extracellular protein that significantly increased the expression of key beta-cell genes. The ApoE effect on beta cells was mediated at least in part through the JAK/STAT signaling pathway. Together, these results reveal a role for ApoE as an extracellular factor that can maintain the mature beta-cell gene expression profile.	[Mahmoud, Ahmed, I; Galdos, Francisco X.; Dinan, Katherine A.; Davis, Jeffrey C.; Vujic, Ana; Rachmin, Inbal; Shigley, Christian; Pancoast, James R.; Lee, Samuel; MacGillivray, Catherine M.; Melton, Douglas A.; Lee, Richard T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Mahmoud, Ahmed, I; Galdos, Francisco X.; Dinan, Katherine A.; Davis, Jeffrey C.; Vujic, Ana; Rachmin, Inbal; Shigley, Christian; Pancoast, James R.; Lee, Samuel; MacGillivray, Catherine M.; Melton, Douglas A.; Lee, Richard T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Jedrychowski, Mark P.; Gygi, Steven P.] Harvard Med Sch, Dept Cell Biol, Boston, MA USA; [Hollister-Lock, Jennifer; Weir, Gordon C.] Harvard Med Sch, Harvard Stem Cell Inst, Joslin Diabet Ctr, Islet Cell & Regenerat Biol Sect, Boston, MA USA	Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Lee, RT (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Lee, RT (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	Richard_Lee@harvard.edu	Young, Richard A/F-6495-2012; Vujic, Ana/GYJ-6199-2022; Vujic, Ana/AAQ-8417-2020	Young, Richard A/0000-0001-8855-8647; Vujic, Ana/0000-0002-0559-5299; Galdos, Francisco/0000-0002-7985-4521; Shigley, Christian/0000-0003-0870-5681; Lee, Richard/0000-0003-4687-1381; Lee, Samuel/0000-0001-6768-7079; Mahmoud, Ahmed/0000-0003-1528-7393	American Heart Association [15POST21870000]; NIH [DK107396, HL117986]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK107396] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an American Heart Association Postdoctoral fellowship (15POST21870000) to A.I.M. and NIH grants (DK107396) and (HL117986) to R.T.L.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Cinti F, 2016, J CLIN ENDOCR METAB, V101, P1044, DOI 10.1210/jc.2015-2860; Futamura M, 2005, J BIOL CHEM, V280, P5414, DOI 10.1074/jbc.M411719200; Gaber AO, 2004, CELL BIOCHEM BIOPHYS, P49; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Geoffrey R, 2006, J IMMUNOL, V177, P7275, DOI 10.4049/jimmunol.177.10.7275; GOTOH M, 1987, ENDOCRINOL JAPON, V34, P843; Halban PA, 2014, J CLIN ENDOCR METAB, V99, P1983, DOI 10.1210/jc.2014-1425; Hammar E, 2004, DIABETES, V53, P2034, DOI 10.2337/diabetes.53.8.2034; Hammar EB, 2005, J BIOL CHEM, V280, P30630, DOI 10.1074/jbc.M502493200; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; KAISER N, 1988, ENDOCRINOLOGY, V123, P834, DOI 10.1210/endo-123-2-834; Kilkenny DM, 2008, MOL ENDOCRINOL, V22, P196, DOI 10.1210/me.2007-0241; King A, 2005, DIABETOLOGIA, V48, P2074, DOI 10.1007/s00125-005-1922-0; Kruit JK, 2010, DIABETOLOGIA, V53, P1110, DOI 10.1007/s00125-010-1691-2; Li W, 2013, SCI REP-UK, V3, DOI 10.1038/srep02863; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Lukjanenko L, 2016, NAT MED, V22, P897, DOI 10.1038/nm.4126; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Nagata N, 2002, J BIOMAT SCI-POLYM E, V13, P579, DOI 10.1163/15685620260178418; Noguchi H, 2012, CELL TRANSPLANT, V21, P517, DOI 10.3727/096368911X605439; Ogihara T, 2010, J BIOL CHEM, V285, P5392, DOI 10.1074/jbc.M109.064659; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Ranga A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5324; Ribaux P, 2007, ENDOCRINOLOGY, V148, P5582, DOI 10.1210/en.2007-0325; Scattolini V, 2016, DIABETES THER, V7, P679, DOI 10.1007/s13300-016-0210-y; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shi XM, 2015, ONCOL LETT, V10, P1309, DOI 10.3892/ol.2015.3447; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; Szabat M, 2012, DIABETES, V61, P1365, DOI 10.2337/db11-1361; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; THIVOLET CH, 1985, EXP CELL RES, V159, P313, DOI 10.1016/S0014-4827(85)80005-7; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; van der Meulen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052181; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Weber LM, 2008, MATRIX BIOL, V27, P667, DOI 10.1016/j.matbio.2008.08.001; Weber LM, 2008, TISSUE ENG PT A, V14, P1959, DOI 10.1089/ten.tea.2007.0238; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	45	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204595	10.1371/journal.pone.0204595	http://dx.doi.org/10.1371/journal.pone.0204595			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303984	Green Published, Green Submitted, gold			2022-12-26	WOS:000446921100056
J	Wolf, H; Wittlinger, M; Pfeffer, SE				Wolf, Harald; Wittlinger, Matthias; Pfeffer, Sarah E.			Two distance memories in desert ants-Modes of interaction	PLOS ONE			English	Article							CATAGLYPHIS-FORTIS; PATH-INTEGRATION; OPTIC FLOW; INSECT NAVIGATION; WALKING BEHAVIOR; HOMING DISTANCE; SUN COMPASS; POLARIZATION; SKY; ORIENTATION	Navigation plays an essential role for many animals leading a mobile mode of life, and for central place foragers in particular. One important prerequisite for navigation is the ability to estimate distances covered during locomotion. It has been shown that Cataglyphis desert ants, well-established model organisms in insect navigation, use two odometer mechanisms, namely, stride and optic flow integration. Although both mechanisms are well established, their mode of interaction to build one odometer output remains enigmatic. We tackle this problem by selectively covering the ventral eye parts in Cataglyphis fortis foragers, the eye regions responsible for optic flow input in odometry. Exclusion of optic flow cues was implemented during different sections of outbound and inbound travel. This demonstrated that the two odometers have separate distance memories that interact in determining homing distance. Possible interpretations posit that the two odometer memories (i) take on different relative weights according to context or (ii) compete in a winner-take-all mode. Explanatory values and implications of such interpretations are discussed. We are able to provide a rough quantitative assessment of odometer cue interaction. An understanding of the interaction of different odometer mechanisms appears valuable not only for animal navigation research but may inform discussions on sensor fusion in both behavioural contexts and potential technical applications.	[Wolf, Harald; Pfeffer, Sarah E.] Univ Ulm, Inst Neurobiol, Ulm, Germany; [Wittlinger, Matthias] Univ Freiburg, Inst Biol Neurobiol & Behav 1, Freiburg, Germany; [Wolf, Harald] Stellenbosch Univ, Wallenberg Res Ctr, Stellenbosch Inst Adv Study STIAS, Stellenbosch, South Africa	Ulm University; University of Freiburg; Stellenbosch University	Wolf, H (corresponding author), Univ Ulm, Inst Neurobiol, Ulm, Germany.; Wolf, H (corresponding author), Stellenbosch Univ, Wallenberg Res Ctr, Stellenbosch Inst Adv Study STIAS, Stellenbosch, South Africa.	harald.wolf@uni-ulm.de		Pfeffer, Sarah/0000-0003-1470-5055; Wolf, Harald/0000-0003-2715-3376				AGOSTI D, 1990, J NAT HIST, V24, P1457, DOI 10.1080/00222939000770851; Andel D, 2004, P ROY SOC B-BIOL SCI, V271, P1485, DOI 10.1098/rspb.2004.2749; Axenie C, 2015, ROBOT AUTON SYST, V71, P69, DOI 10.1016/j.robot.2014.11.019; Bolek S, 2012, THESIS; Bregy P, 2008, J EXP BIOL, V211, P1868, DOI 10.1242/jeb.018036; Buhlmann C, 2011, J EXP BIOL, V214, P2845, DOI 10.1242/jeb.054601; Cheng K, 2007, PSYCHOL BULL, V133, P625, DOI 10.1037/0033-2909.133.4.625; Cheng Ken, 2006, P189; Cheng K, 2014, BEHAV PROCESS, V102, P51, DOI 10.1016/j.beproc.2013.10.001; Cruse H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002009; Dacke M, 2008, J EXP BIOL, V211, P3281, DOI 10.1242/jeb.021022; Durrant-Whyte H. F., 2008, HDB ROBOTICS, P585, DOI DOI 10.1007/978-3-540-30301-5_26; Egelhaaf M, 2002, CURR OPIN NEUROBIOL, V12, P699, DOI 10.1016/S0959-4388(02)00390-2; Egelhaaf M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00108; el Jundi B, 2014, J COMP PHYSIOL A, V200, P575, DOI 10.1007/s00359-014-0890-6; Graham P, 2009, CURR BIOL, V19, pR935, DOI 10.1016/j.cub.2009.08.015; Hoinville T, 2018, P NATL ACAD SCI USA, V115, P2824, DOI 10.1073/pnas.1721668115; Homberg U, 2011, PHILOS T R SOC B, V366, P680, DOI 10.1098/rstb.2010.0199; Huber R, 2015, J COMP PHYSIOL A, V201, P609, DOI 10.1007/s00359-015-0998-3; Jeffery K.J., 2003, NEUROBIOLOGY SPATIAL; Lebhardt F, 2015, J COMP PHYSIOL A, V201, P599, DOI 10.1007/s00359-014-0928-9; Lebhardt F, 2014, J COMP PHYSIOL A, V200, P711, DOI 10.1007/s00359-013-0871-1; Legge ELG, 2014, J EXP BIOL, V217, P4159, DOI 10.1242/jeb.107862; Lenoir Alain, 2010, Israel Journal of Entomology, V39, P1; Lorenz K, 1937, NATURWISSENSCHAFTEN, V25, P289, DOI 10.1007/BF01492648; LORENZ KZ, 1950, SYM SOC EXP BIOL, V4, P221; Muller M, 2007, NATURWISSENSCHAFTEN, V94, P589, DOI 10.1007/s00114-007-0232-4; Muller M, 2010, CURR BIOL, V20, P1368, DOI 10.1016/j.cub.2010.06.035; MULLER M, 1994, J COMP PHYSIOL A, V175, P525, DOI 10.1007/BF00199474; Parsons MM, 2010, CURR BIOL, V20, P624, DOI 10.1016/j.cub.2010.01.064; Pfeffer SE, 2016, SCIENCE, V353, P1155, DOI 10.1126/science.aaf9754; Ronacher B, 2000, J EXP BIOL, V203, P1113; RONACHER B, 1995, J COMP PHYSIOL A, V177, P21; Seelig JD, 2015, NATURE, V521, P186, DOI 10.1038/nature14446; Seidl T, 2006, J COMP PHYSIOL A, V192, P1125, DOI 10.1007/s00359-006-0148-z; Sommer S, 2004, J COMP PHYSIOL A, V190, P1, DOI 10.1007/s00359-003-0465-4; Steck K, 2009, J EXP BIOL, V212, P2893, DOI 10.1242/jeb.030403; Stone T, 2017, CURR BIOL, V27, P3069, DOI 10.1016/j.cub.2017.08.052; Taylor Robert W., 2007, Memoirs of the American Entomological Institute (Gainesville), V80, P580; Thielin-Bescond M, 2005, NATURWISSENSCHAFTEN, V92, P193, DOI 10.1007/s00114-005-0609-1; Wehner R., 1983, Senckenbergiana Biologica, V64, P89; WEHNER R, 1981, J COMP PHYSIOL, V142, P315, DOI 10.1007/BF00605445; Wehner R., 1982, NEUJAHRSBL NATURFORS, V184, P1; Wehner R, 2016, J COMP PHYSIOL A, V202, P459, DOI 10.1007/s00359-016-1094-z; Wehner R, 2011, PHYSIOL ENTOMOL, V36, P271, DOI 10.1111/j.1365-3032.2011.00795.x; Wehner R, 2009, MYRMECOL NEWS, V12, P85; Wittlinger M, 2006, SCIENCE, V312, P1965, DOI 10.1126/science.1126912; Wittlinger M, 2007, J EXP BIOL, V210, P198, DOI 10.1242/jeb.02657; Wittlinger M, 2013, J PHYSIOL-PARIS, V107, P130, DOI 10.1016/j.jphysparis.2012.08.002; Wolf H, 2000, J EXP BIOL, V203, P857; Wolf H, 2011, J EXP BIOL, V214, P1629, DOI 10.1242/jeb.038570; Wystrach A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1484; Ziegler PE, 1997, J COMP PHYSIOL A, V181, P13, DOI 10.1007/s003590050088	53	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204664	10.1371/journal.pone.0204664	http://dx.doi.org/10.1371/journal.pone.0204664			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304010	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100062
J	Fujiwara, N; Wagatsuma, M; Oba, N; Yoshihara, D; Tokuda, E; Sakiyama, H; Eguchi, H; Ichihashi, M; Furukawa, Y; Inoue, T; Suzuki, K				Fujiwara, Noriko; Wagatsuma, Michiru; Oba, Naoto; Yoshihara, Daisaku; Tokuda, Eiichi; Sakiyama, Haruhiko; Eguchi, Hironobu; Ichihashi, Motoko; Furukawa, Yoshiaki; Inoue, Tadashi; Suzuki, Keiichiro			Cu/Zn-superoxide dismutase forms fibrillar hydrogels in a pH-dependent manner via a water-rich extended intermediate state	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; QUARTZ-CRYSTAL MICROBALANCE; MOTOR-NEURON DEGENERATION; BETA-LACTOGLOBULIN GELS; TRANSGENIC MICE; WILD-TYPE; HYDROPHOBIC INTERACTIONS; AQUEOUS-SOLUTION; PROTEINS; AGGREGATION	Under certain conditions, amyloid-like fibrils can develop into three-dimensional networks and form hydrogels by a self-assembly process. When Cu/Zn superoxide dismutase (SOD1), an anti-oxidative enzyme, undergoes misfolding, fibrillar aggregates are formed, which are a hallmark of a certain form of familial amyotrophic lateral sclerosis (ALS). However, the issue of whether SOD1 fibrils can be assembled into hydrogels remains to be tested. Here, we show that the SOD1 polypeptides undergo hydrogelation accompanied by the formation of thioflavin T-positive fibrils at pH 3.0 and 4.0, but not at pH 5.0 where precipitates are formed. The results of viscoelastic analyses indicate that the properties of SOD1 hydrogels (2%) were similar to and slightly more fragile than a 0.25% agarose gel. In addition, monitoring by a quartz crystal microbalance with admittance analysis showed that the denaturing of immobilized SOD1 on a sensor under the hydrogelation conditions at pH 3.0 and 4.0 resulted in an increase in the effective acoustic thickness from similar to 3.3 nm (a folded rigid form) to similar to 50 and similar to 100 nm (an extended water-rich state), respectively. In contrast, when SOD1 was denatured under the same conditions at pH 5.0, a compact water-poor state with an effective acoustic thickness of similar to 10 nm was formed. The addition of physiological concentrations of NaCl to the pH 4.0 sample induced a further extension of the SOD1 with larger amounts of water molecules (with an effective acoustic thickness of similar to 200 nm) but suppressed hydrogel formation. These results suggest that different denatured intermediate states of the protein before self-assembly play a major role in determining the characteristics of the resulting aggregates and that a conformational change to a suitable level of extended water-rich intermediate state before and/or during intermolecular assembling is required for fibrillation and hydrogelation in the case of globular proteins.	[Fujiwara, Noriko; Yoshihara, Daisaku; Sakiyama, Haruhiko; Eguchi, Hironobu; Suzuki, Keiichiro] Hyogo Coll Med, Dept Biochem, Nishinomiya, Hyogo, Japan; [Wagatsuma, Michiru; Ichihashi, Motoko] ULVAC, Res & Dev, Chigasaki, Kanagawa, Japan; [Oba, Naoto; Inoue, Tadashi] Osaka Univ, Grad Sch Sci, Dept Macromol Sci, Toyonaka, Osaka, Japan; [Tokuda, Eiichi; Furukawa, Yoshiaki] Keio Univ, Dept Chem, Yokohama, Kanagawa, Japan	Hyogo College of Medicine; Osaka University; Keio University	Fujiwara, N (corresponding author), Hyogo Coll Med, Dept Biochem, Nishinomiya, Hyogo, Japan.	noriko-f@hyo-med.ac.jp	Tokuda, Eiichi/GXF-7231-2022; Furukawa, Yoshiaki/F-2871-2014; Yoshihara, Daisaku/L-6664-2019; INOUE, Tadashi/B-5581-2014	Furukawa, Yoshiaki/0000-0002-1918-372X; Tokuda, Eiichi/0000-0002-7690-3025; INOUE, Tadashi/0000-0002-9934-1299	Hyogo College of Medicine; JSPS [16K13060]	Hyogo College of Medicine; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Researchers, Hyogo College of Medicine, 2015 and JSPS KAKENHI (Grant Number 16K13060).	Abelein A, 2016, J AM CHEM SOC, V138, P6893, DOI 10.1021/jacs.6b04511; Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0; [Anonymous], 2009, MOR SOL STICK PROBL, P79; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Baler K, 2014, BIOMACROMOLECULES, V15, P3625, DOI 10.1021/bm500883h; Bhak G, 2010, BIOMATERIALS, V31, P5986, DOI 10.1016/j.biomaterials.2010.03.080; Bowerman CJ, 2010, J AM CHEM SOC, V132, P9526, DOI 10.1021/ja1025535; Chan PK, 2013, P NATL ACAD SCI USA, V110, P10934, DOI 10.1073/pnas.1309613110; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Foegeding EA, 2006, FOOD BIOPHYS, V1, P41, DOI 10.1007/s11483-005-9003-y; Fujiwara N, 2005, J BIOL CHEM, V280, P5061, DOI 10.1074/jbc.M406106200; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furusawa H, 2009, ANAL CHEM, V81, P2268, DOI 10.1021/ac802412t; Gosal WS, 2004, BIOMACROMOLECULES, V5, P2408, DOI 10.1021/bm049659d; Gosal WS, 2004, BIOMACROMOLECULES, V5, P2420, DOI 10.1021/bm049660c; Goto Yuji, 2018, Biophys Rev, V10, P493, DOI 10.1007/s12551-017-0370-7; Groot CCM, 2016, J PHYS CHEM LETT, V7, P1800, DOI 10.1021/acs.jpclett.6b00708; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3; Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501; Hovgaard MB, 2007, BIOPHYS J, V93, P2162, DOI 10.1529/biophysj.107.109686; Ihara K, 2012, BIOSCIENCE REP, V32, P539, DOI 10.1042/BSR20120029; Itoh A, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/1/015402; Jean L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32124; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kato S, 1999, HISTOL HISTOPATHOL, V14, P973, DOI 10.14670/HH-14.973; Krebs MRH, 2004, P NATL ACAD SCI USA, V101, P14420, DOI 10.1073/pnas.0405933101; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Manno M, 2010, LANGMUIR, V26, P1424, DOI 10.1021/la903340v; Miller AF, 2005, MACROMOL SY, V222, P109, DOI 10.1002/masy.200550412; MIURA N, 1994, BIOPOLYMERS, V34, P357, DOI 10.1002/bip.360340307; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSSMURPHY SB, 1992, POLYMER, V33, P2622, DOI 10.1016/0032-3861(92)91146-S; Sakiyama H, 2016, FREE RADICAL RES, V50, P666, DOI 10.3109/10715762.2016.1164856; Sathaye S, 2014, BIOMACROMOLECULES, V15, P3891, DOI 10.1021/bm500874t; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Takeuchi S, 2010, J NEUROPATH EXP NEUR, V69, P1044, DOI 10.1097/NEN.0b013e3181f4a90a; Thirumalai D, 2012, ACCOUNTS CHEM RES, V45, P83, DOI 10.1021/ar2000869; Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Walters RH, 2012, J MOL BIOL, V421, P329, DOI 10.1016/j.jmb.2012.03.017; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Woodard D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094789; Yan H, 2006, BIOMACROMOLECULES, V7, P2776, DOI 10.1021/bm0605560; Yoshihara D, 2016, FREE RADICAL RES, V50, P1245, DOI 10.1080/10715762.2016.1234048	51	4	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205090	10.1371/journal.pone.0205090	http://dx.doi.org/10.1371/journal.pone.0205090			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289953	Green Published, Green Submitted, gold			2022-12-26	WOS:000446545500047
J	Huang, DL; Wang, L; Talbot, NC; Huang, C; Pu, LP; Zhao, XL; Tian, XC; Zhang, M; Tang, Y				Huang, Delun; Wang, Ling; Talbot, Neil C.; Huang, Chang; Pu, Liping; Zhao, Xiuling; Tian, Xiuchun; Zhang, Ming; Tang, Young			Analyzing bovine OCT4 and NANOG enhancer activity in pluripotent stem cells using fluorescent protein reporters	PLOS ONE			English	Article							MOUSE EPIBLAST; GROUND-STATE; SELF-RENEWAL; GENERATION; LINES; MAINTENANCE; EXPRESSION; DERIVATION; INDUCTION; NAIVE	Green fluorescent protein (GFP) reporters controlled by the regulatory region of OCT4 and NANOG-two master regulators for pluripotency are widely used in studies of pluripotent stem cell establishment and embryo development. Alongside the challenge in establishing bovine pluripotent stem cells, the application of bovine-specific gene reporters has rarely been explored. Using lentivirus-based GFP reporter, we investigated the upstream regulatory regions of bovine OCT4 and NANOG. These reporters show activity in both naive- and primed-state pluripotency when infected into mouse and human embryonic stem cells (ESCs), respectively. Consistent with what is found in humans and mice, the bovine OCT4-distal enhancer (bOCT4-DE) but not the proximal enhancer (bOCT4-PE) region is preferentially activated in naive-state pluripotency. Furthermore, the bOCT4-DE region is silenced upon conversion of naive-state ESCs into primed-state epiblast stem cells (EpiSCs). Co-infection of mouse fibroblasts with the reprograming factors for induced pluripotent stem cell (iPSC) induction leads to the generation of GFP positive colonies, demonstrating that these GFP reporters can serve as live indicators for induced pluripotent cell establishment. We further proved that the bovine OCT4 distal enhancer is active in bovine blastocysts. We established the lentiviral-based fluorescent reporters controlled by bovine OCT4 and NANOG enhancer sequences. These reporter constructs show activity in naive- and primed-pluripotent states. These reporters may serve as versatile tools for bovine ESC/iPSC generation and identification, as well as for developmental studies of bovine embryos.	[Huang, Delun; Pu, Liping; Zhao, Xiuling; Zhang, Ming] Guangxi Univ, Anim Reprod Inst, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China; [Huang, Delun; Wang, Ling; Huang, Chang; Tian, Xiuchun; Tang, Young] Univ Connecticut, Inst Syst Genom, Dept Anim Sci, Storrs, CT 06269 USA; [Talbot, Neil C.] ARS, USDA, Anim Biosci & Biotechnol Lab, Beltsville, MD USA	Guangxi University; University of Connecticut; United States Department of Agriculture (USDA)	Zhang, M (corresponding author), Guangxi Univ, Anim Reprod Inst, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China.; Tang, Y (corresponding author), Univ Connecticut, Inst Syst Genom, Dept Anim Sci, Storrs, CT 06269 USA.	mingzhang@gxu.edu.cn; yong.tang@uconn.edu	Tang, Young/GXF-6129-2022	Huang, Delun/0000-0002-7449-0386; Wang, Ling/0000-0002-0787-3352; Huang, Chang/0000-0002-9836-8166	United States Department of Agriculture (USDA) [W2171]; Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2016-67016-24894]; Chinese Scholarship Council	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; Chinese Scholarship Council(China Scholarship Council)	This work was supported by the United States Department of Agriculture (USDA) W2171 regional project to Y.T., the Agriculture and Food Research Initiative Competitive Grant no. 2016-67016-24894 to Y.T. from the USDA National Institute of Food and Agriculture (https://nifa.usda.gov/), and the Chinese Scholarship Council for Study Abroad for D.H. and M.Z. (https://www.csc.edu.cn/chuguo).	Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Cacchiarelli D, 2015, CELL, V162, P412, DOI 10.1016/j.cell.2015.06.016; Deng YF, 2012, STEM CELLS DEV, V21, P2485, DOI 10.1089/scd.2012.0018; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Han XP, 2011, CELL RES, V21, P1509, DOI 10.1038/cr.2011.125; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Huang YL, 2018, THERIOGENOLOGY, V110, P1, DOI 10.1016/j.theriogenology.2017.12.040; Kawaguchi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135403; Lei L, 2013, MOL REPROD DEV, V80, P193, DOI 10.1002/mrd.22147; Maruotti J, 2012, MOL REPROD DEV, V79, P461, DOI 10.1002/mrd.22051; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Neely MD, 2011, NEUROMETHODS, V56, P27, DOI 10.1007/978-1-61779-077-5_2; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Stice SL, 1996, BIOL REPROD, V54, P100, DOI 10.1095/biolreprod54.1.100; Sumer H, 2011, J ANIM SCI, V89, P2708, DOI 10.2527/jas.2010-3666; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talbot NC, 2017, MOL REPROD DEV, V84, P468, DOI 10.1002/mrd.22797; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van Eijk MJT, 1999, BIOL REPROD, V60, P1093, DOI 10.1095/biolreprod60.5.1093; Wu J, 2017, CELL, V168, P473, DOI 10.1016/j.cell.2016.12.036; Wu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep28343; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	41	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203923	10.1371/journal.pone.0203923	http://dx.doi.org/10.1371/journal.pone.0203923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289916	Green Published, Green Submitted, gold			2022-12-26	WOS:000446545500008
J	Agbana, TE; Diehl, JC; van Pul, F; Khan, SM; Patlan, V; Verhaegen, M; Vdovin, G				Agbana, Temitope E.; Diehl, Jan-Carel; van Pul, Fiona; Khan, Shahid M.; Patlan, Vsevolod; Verhaegen, Michel; Vdovin, Gleb			Imaging & identification of malaria parasites using cellphone microscope with a ball lens	PLOS ONE			English	Article							DIAGNOSIS	We have optimized the design and imaging procedures, to clearly resolve the malaria parasite in Giemsa-stained thin blood smears, using simple low-cost cellphone-based microscopy with oil immersion. The microscope uses a glass ball as the objective and the phone camera as the tube lens. Our optimization includes the optimal choice of the ball lens diameter, the size and the position of the aperture diaphragm, and proper application of immersion, to achieve diagnostic capacity in a wide field of view. The resulting system is potentially applicable to low-cost in-the-field optical diagnostics of malaria as it clearly resolves micron-sized features and allows for analysis of parasite morphology in the field of 50 x 50 mu m, and parasite detection in the field of at least 150 x 150 mu m.	[Agbana, Temitope E.; Verhaegen, Michel; Vdovin, Gleb] Delft Univ Technol, Delft Ctr Syst & Controls, Delft, Netherlands; [Diehl, Jan-Carel] Delft Univ Technol, Design Sustainabil, Ind Design Engn, Delft, Netherlands; [van Pul, Fiona; Khan, Shahid M.] Leiden Univ, Med Ctr, Parasitol & Immunologyparasitol Grp, Leiden, Netherlands; [Patlan, Vsevolod; Vdovin, Gleb] Flexible Opt BV, Rijswijk, Netherlands; [Verhaegen, Michel] Delft Univ Technol, Fac 3ME, Delft Ctr Syst & Control, Delft, Netherlands; [Vdovin, Gleb] Delft Univ Technol, Fac 3ME, Precis & Microsyst Engn, Delft, Netherlands	Delft University of Technology; Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology; Delft University of Technology	Agbana, TE (corresponding author), Delft Univ Technol, Delft Ctr Syst & Controls, Delft, Netherlands.	t.e.agbana@tudelft.nl	Diehl, Jan Carel/L-6621-2013	Diehl, Jan Carel/0000-0002-4007-2282; Khan, Shahid/0000-0002-0533-4670	Delft Global Initiative of TU Delft [P70370]; European Research Council under the European Union [339681]; Russian Ministry of Education; Flexible Optical B.V.	Delft Global Initiative of TU Delft; European Research Council under the European Union(European Research Council (ERC)); Russian Ministry of Education(Ministry of Education and Science, Russian Federation); Flexible Optical B.V.	The research leading to these results has received funding from Delft Global Initiative of TU Delft (P70370), http://globalstories.tudelft.nl/. Michel Verhaegen's work is funded by the European Research Council (https://erc.europa.eu/) under the European Unions Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement n. 339681. The work of G. Vdovin is partially funded by the program 5 in 100 of the Russian Ministry of Education (en.russia.edu.ru/), and by Flexible Optical B.V. (www.okotech.com/). The funders provided support in the form of salaries for authors [Temitope Agbana & Gleb Vdovin], but did not have any additional role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbana TE, 2017, OPT LETT, V42, P2271, DOI 10.1364/OL.42.002271; Bell S., 2010, INTRO MICROSCOPY; Bogoch II, 2017, AM J TROP MED HYG, V96, P1468, DOI 10.4269/ajtmh.16-0912; Bogoch II, 2013, AM J TROP MED HYG, V88, P626, DOI 10.4269/ajtmh.12-0742; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Butykai A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01431; Dendere R, 2015, J MICROSC-OXFORD, V260, P248, DOI 10.1111/jmi.12307; GOLDBERG O, 1980, MICROSCOPE, V28, P15; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; KAWAMOTO F, 1991, LANCET, V337, P200, DOI 10.1016/0140-6736(91)92159-Y; Kobori Y, 2016, FERTIL STERIL, V106, P574, DOI 10.1016/j.fertnstert.2016.05.027; Koydemir HC, 2015, LAB CHIP, V15, P1284, DOI 10.1039/c4lc01358a; Mogollon CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168362; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Mudanyali O, 2010, LAB CHIP, V10, P2419, DOI 10.1039/c004829a; Pirnstill CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13368; Seo S, 2009, LAB CHIP, V9, P777, DOI 10.1039/b813943a; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Switz NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095330; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; WHO, 2010, BAS MAL MICR; World Health Organisation, MAL FACTSH 2016; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524	25	21	22	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205020	10.1371/journal.pone.0205020	http://dx.doi.org/10.1371/journal.pone.0205020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286150	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500076
J	Koohkanzade, M; Zakiaghl, M; Dhami, MK; Fekrat, L; Namaghi, HS				Koohkanzade, Marzieh; Zakiaghl, Mohammad; Dhami, Manpreet K.; Fekrat, Lida; Namaghi, Hussein Sadeghi			Rapid identification of Bactrocera zonata (Dip.: Tephritidae) using TaqMan real-time PCR assay	PLOS ONE			English	Article							FRUIT-FLIES DIPTERA; MOLECULAR-IDENTIFICATION; MICROSATELLITE MARKERS; PEST; SEQUENCES; FLY; INFORMATION; PHYLOGENY; SELECTION; RFLP	Tephritid fruit flies are ranked as one of the most damaging groups of insect pests. Morphological identification of fruit flies is mainly performed on adults due to the lack of adequate identification keys for immature stages. The peach fruit fly, Bactrocera zonata (Saunders), infests some of the principal commercial fruits and vegetables. It is, therefore important to avert its global dispersal, particularly by accurately identifying this species at ports of entry. In this study, a TaqMan real-time polymerase chain reaction (PCR) was developed for the accurate identification and sensitive detection of the peach fruit fly. A novel set of primers and probe were designed to specifically identify the mitochondrial cytochrome oxidase I (COI) gene. All specimens of peach fruit fly (including various life stages) were detected, and no cross reactivity with other tested tephritids were observed. Since this assay performed equally well with crushed insects and purified DNA, we note added efficiency by eliminating DNA extraction step. Considering the speed, specificity as well as sensitivity of the assay, Taqman real-time PCR can be used as a swift and specific method for pest species at ports of entry.	[Koohkanzade, Marzieh; Zakiaghl, Mohammad; Fekrat, Lida; Namaghi, Hussein Sadeghi] Ferdowsi Univ Mashhad, Dept Plant Protect, Fac Agr, Mashhad, Iran; [Dhami, Manpreet K.] Manaaki Whenua Landcare Res, Biodivers & Conservat, Lincoln, New Zealand	Ferdowsi University Mashhad; Landcare Research - New Zealand	Fekrat, L (corresponding author), Ferdowsi Univ Mashhad, Dept Plant Protect, Fac Agr, Mashhad, Iran.	fekrat@ferdowsi.um.ac.ir	namaghi, hussein sadeghi/M-6394-2018; fekrat, Lida/A-2693-2016; zakiaghl, mohammad/AAC-7177-2022	fekrat, Lida/0000-0002-5189-9488; , mohammad/0000-0001-5032-8344	Ferdowsi University of Mashhad [3/40358]	Ferdowsi University of Mashhad	This work was supported by Ferdowsi University of Mashhad [grant number 3/40358].	[Anonymous], 1992, FRUIT FLIES EC SIGNI; Armstrong K, 1997, P NZ PLANT PROT C; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Asokan R, 2011, FLA ENTOMOL, V94, P1026, DOI 10.1653/024.094.0441; Barr NB, 2012, ANN ENTOMOL SOC AM, V105, P339, DOI 10.1603/AN11100; Barr NB, 2011, J ECON ENTOMOL, V104, P1706, DOI 10.1603/EC11093; Blacket MJ, 2012, MOL ECOL RESOUR, V12, P428, DOI 10.1111/j.1755-0998.2012.03124.x; Bonants P., 2013, Bulletin OEPP, V43, P211, DOI 10.1111/epp.12030; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Choudhary JS, 2018, MITOCHONDRIAL DNA A, V29, P727, DOI 10.1080/24701394.2017.1350952; Chua TH, 2010, PEST MANAG SCI, V66, P379, DOI 10.1002/ps.1886; Dai SM, 2004, MOL ECOL NOTES, V4, P629, DOI 10.1111/j.1471-8286.2004.00732.x; Delatte H, 2014, CONSERV GENET RESOUR, V6, P9, DOI 10.1007/s12686-013-0026-2; Dhami MK, 2016, J APPL ENTOMOL, V140, P536, DOI 10.1111/jen.12286; Dhami MK, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00005; Dhami MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098934; Diamantidis AD, 2008, J APPL ENTOMOL, V132, P695, DOI 10.1111/j.1439-0418.2008.01325.x; Gilligan TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142912; Huang KS, 2010, BIOL LETTERS, V6, P555, DOI 10.1098/rsbl.2009.1060; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Kadirvel P, 2013, J ECON ENTOMOL, V106, P408, DOI 10.1603/EC12119; Leblanc L, 2015, ZOOKEYS, P339, DOI 10.3897/zookeys.540.9786; Ledezma LA, 2016, J ECON ENTOMOL, V109, P1957, DOI 10.1093/jee/tow111; Li D, 2019, B ENTOMOL RES, V109, P102, DOI 10.1017/S0007485318000251; Logan JMJ, 2004, REAL TIME PCR ESSENT; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Naaum AM, 2014, J APPL ENTOMOL, V138, P485, DOI 10.1111/jen.12114; Naaum AM, 2012, J APPL ENTOMOL, V136, P704, DOI 10.1111/j.1439-0418.2012.01706.x; Onah IE, 2015, AFR ENTOMOL, V23, P342, DOI 10.4001/003.023.0225; Parubrub A, 2015, J ECON ENTOMOL, V108, P301, DOI 10.1093/jee/tou027; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Shearman DCA, 2006, MOL ECOL NOTES, V6, P4, DOI 10.1111/j.1471-8286.2006.01024.x; Smit J, 2013, ZOOKEYS, P279, DOI 10.3897/zookeys.365.5819; Stonehouse J, 2002, CROP PROT, V21, P651, DOI 10.1016/S0261-2194(02)00019-4; Vargas RI, 2008, AREAWIDE PEST MANAGEMENT: THEORY AND IMPLEMENTATION, P300, DOI 10.1079/9781845933722.0300; Vargas RI, 2015, INSECTS, V6, P297, DOI 10.3390/insects6020297; Walsh K, 2005, J APPL ENTOMOL, V129, P272, DOI 10.1111/j.1439-0418.2005.00960.x; Yu DJ, 2005, RAFFLES B ZOOL, V53, P73; Yu DJ, 2004, J APPL ENTOMOL, V128, P670, DOI 10.1111/j.1439-0418.2004.00907.x; Zhang B, 2010, FLA ENTOMOL, V93, P369, DOI 10.1653/024.093.0308; Zhang QL, 2016, SCI REP-UK, V6, DOI 10.1038/srep37549	43	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205136	10.1371/journal.pone.0205136	http://dx.doi.org/10.1371/journal.pone.0205136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286152	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500091
J	Luna-Pineda, VM; Ochoa, SA; Cruz-Cordova, A; Cazares-Dominguez, V; Reyes-Grajeda, JP; Flores-Oropeza, MA; Arellano-Galindo, J; Castro-Hernandez, R; Flores-Encarnacion, M; Ramirez-Vargas, A; Flores-Garcia, HJ; Moreno-Fierros, L; Xicohtencatl-Cortes, J				Luna-Pineda, Victor M.; Ochoa, Sara A.; Cruz-Cordova, Ariadnna; Cazares-Dominguez, Vicenta; Reyes-Grajeda, Juan P.; Flores-Oropeza, Marco A.; Arellano-Galindo, Jose; Castro-Hernandez, Rigoberto; Flores-Encarnacion, Marcos; Ramirez-Vargas, Adriana; Flores-Garcia, Hector J.; Moreno-Fierros, Leticia; Xicohtencatl-Cortes, Juan			Features of urinary Escherichia coli isolated from children with complicated and uncomplicated urinary tract infections in Mexico	PLOS ONE			English	Article							VIRULENCE GENES; PATHOGENICITY ISLAND; PHYLOGENETIC GROUPS; ERIC-PCR; STRAINS; EPIDEMIOLOGY; RESISTANCE; CYSTITIS; CLONE; BACTERIURIA	The Hospital Infantil de Mexico Federico Gomez (HIMFG) is a tertiary care hospital in Mexico City where Escherichia coli is frequently isolated from the urine samples of pediatric patients with urinary tract infections. A collection of 178 urinary Escherichia coli (UEc) isolates associated with complicated and uncomplicated urinary tract infections were evaluated in this study. The patterns of resistance to 9 antibiotic classes showed that 60.7% of the UEc isolates had a highly multidrug-resistant (MDR) profile. Genetic diversity analyses of the UEc isolates showed a high variability and revealed 16 clusters associated with four phylogenetic groups, namely, groups A, B1, B2, and D. Phylogenetic group B2 was widely associated with the 16 clusters as well as with virulence and fitness genes. The virulence and fitness genes in the UEc isolates, which included fimbriae-, siderophore-, toxin-, and mobility-associated genes, were grouped as occurring at a low, variable, or high frequency. Interestingly, only the papF gene could be amplified from some UEc isolates, and the sequence analysis of the pap operon identified an insertion sequence (IS) element and gene loss. These data suggested pathoadaptability and the development of immune system evasion, which was confirmed by the loss of P fimbriae-associated agglutination in the UEc isolates. E. coli clone O25-ST131 had a prevalence of 20.2% among the UEc isolates; these isolates displayed both a highly MDR profile and the presence of the papGII, fimH, papGIII, iutD, sat, hlyA, and motA genes. In conclusion, the UEc isolates from complicated urinary tract infection (cUTI) were characterized as being MDR, highly genetically diverse, and associated with phylogenetic group B2 and many virulence and fitness genes. Additionally, gene loss and IS elements were identified in some UEc isolates identified as clone O25-ST131.	[Luna-Pineda, Victor M.; Ochoa, Sara A.; Cruz-Cordova, Ariadnna; Cazares-Dominguez, Vicenta; Flores-Oropeza, Marco A.; Xicohtencatl-Cortes, Juan] Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Bacteriol Intestinal, Mexico City, DF, Mexico; [Luna-Pineda, Victor M.; Moreno-Fierros, Leticia] Univ Nacl Autonoma Mexico, Lab Inmunidad Mucosas, Unidad Biomed, Fac Estudios Super Iztacala, Tlalnepantla, Estado De Mexic, Mexico; [Reyes-Grajeda, Juan P.] Inst Nacl Med Genom, Mexico City, DF, Mexico; [Arellano-Galindo, Jose] Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Mexico City, DF, Mexico; [Castro-Hernandez, Rigoberto] Hosp Gen Dr Manuel Gea Gonzalez, Dept Ecol Agentes Patogenos, Mexico City, DF, Mexico; [Flores-Encarnacion, Marcos] Benemerita Univ Autonoma Puebla, Fac Med, Puebla, Mexico; [Ramirez-Vargas, Adriana; Flores-Garcia, Hector J.] Benemerita Univ Autonoma Puebla, Fac Biol, Puebla, Mexico	Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Hospital Infantil de Mexico Federico Gomez; Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla	Xicohtencatl-Cortes, J (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Bacteriol Intestinal, Mexico City, DF, Mexico.	juanxico@yahoo.com	Córdova, Ariadnna Cruz/AAF-9654-2021; Moreno-Fierros, Leticia/A-6208-2014; Xicohtencatl-Cortes, Juan/ABD-5463-2020	Moreno-Fierros, Leticia/0000-0002-2786-885X; Luna-Pineda, Victor Manuel/0000-0002-3078-9423; Reyes, Juan Pablo/0000-0001-6498-3286	Public Federal Funds from the HIMFG [HIM/2017/002 SSA.1298, HIM/2017/136 SSA.1456, HIM 2017-107 FF SSA.1421]; Consejo Nacional de Ciencia y Tecnologia (CONACYT); Direccion General de Asuntos del Personal Academico (DGAPA) at the Universidad Nacional Autonoma de Mexico (UNAM); Fundacion Alberto y Dolores Andrade, Mexico City	Public Federal Funds from the HIMFG; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico (DGAPA) at the Universidad Nacional Autonoma de Mexico (UNAM); Fundacion Alberto y Dolores Andrade, Mexico City	This work was supported by Public Federal Funds grant with the numbers HIM/2017/002 SSA.1298, HIM/2017/136 SSA.1456 and HIM 2017-107 FF SSA.1421 from the HIMFG (http://himfg.com.mx/interior/dir_investiga.html). This work also was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT, https://www.conacyt.gob.mx/index.php/sni/convocatorias-conacyt/convocatorias-apn) at Attention to National Problems with the under account number 1764.; We thank Alfonso Hernandez-Cardena, Israel Parra-Ortega, and Virginia Alcazar-Lopez for their technical assistance. Victor M. Luna-Pineda was supported by a postdoctoral fellowship from Direccion General de Asuntos del Personal Academico (DGAPA) at the Universidad Nacional Autonoma de Mexico (UNAM) under the direction of the Dra. Moreno-Fierro in Facultad de Estudios Superiores Iztacala-UNAM, as well as by a scholarship from Fundacion Alberto y Dolores Andrade, Mexico City.	Ardakani Maryam Afkhami, 2016, Electron Physician, V8, P2291, DOI 10.19082/2291; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; Derakhshandeh A, 2015, LETT APPL MICROBIOL, V60, P148, DOI 10.1111/lam.12349; Doi Y, 2009, ANTIMICROB AGENTS CH, V53, P3159, DOI 10.1128/AAC.00133-09; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2014, INFECT DIS CLIN N AM, V28, P1, DOI 10.1016/j.idc.2013.09.003; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Guimares AD, 2011, VET MICROBIOL, V153, P299, DOI 10.1016/j.vetmic.2011.06.002; Guyer DM, 1998, INFECT IMMUN, V66, P4411; Hadifar S, 2017, JPN J INFECT DIS, V70, P19, DOI 10.7883/yoken.JJID.2015.652; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Johnson JR, 2017, CLIN INFECT DIS, V64, P390, DOI 10.1093/cid/ciw712; Kidd TJ, 2011, J CLIN MICROBIOL, V49, P263, DOI 10.1128/JCM.01421-10; Lee JH, 2016, LETT APPL MICROBIOL, V62, P84, DOI 10.1111/lam.12517; Lichtenberger Paola, 2008, Curr Infect Dis Rep, V10, P499, DOI 10.1007/s11908-008-0081-0; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; Lo Y, 2015, INFECT GENET EVOL, V34, P244, DOI 10.1016/j.meegid.2015.06.023; Lopez-Banda DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/959206; López-Martínez Briceida, 2013, Bol. Med. Hosp. Infant. Mex., V70, P222; Lu ST, 2011, J BACTERIOL, V193, P7005, DOI 10.1128/JB.06284-11; Luna-Pineda VM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00135; Macedo NR, 2011, VET J, V188, P362, DOI 10.1016/j.tvjl.2010.05.024; Manning SD, 2001, CLIN DIAGN LAB IMMUN, V8, P637, DOI 10.1128/CDLI.8.3.637-640.2001; Luna-Pineda VM, 2018, B MED HOSP INFANT M, V75, P67, DOI [10.24875/BMHIM.M18000011, 10.24875/bmhim.m18000011]; Molina-Lopez J, 2011, J INFECT DEV COUNTR, V5, P840, DOI 10.3855/jidc.1703; Mosquito S., 2015, SCI WORLD J, V2015, DOI [10.1155/2015/610403, DOI 10.1155/2015/610403]; Munkhdelger Y, 2017, J INFECT DEV COUNTR, V11, P51, DOI 10.3855/jidc.7903; Nath G, 2010, INFECT GENET EVOL, V10, P530, DOI 10.1016/j.meegid.2010.02.004; Neal DE, 2008, UROL CLIN N AM, V35, P13, DOI 10.1016/j.ucl.2007.09.010; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Norinder BS, 2012, MICROB PATHOGENESIS, V52, P10, DOI 10.1016/j.micpath.2011.08.005; Ochoa SA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02042; Parham NJ, 2005, J CLIN MICROBIOL, V43, P2425, DOI 10.1128/JCM.43.5.2425-2434.2005; Pietrucha-Dilanchian P, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0021-2015; RIVERA IG, 1995, APPL ENVIRON MICROB, V61, P2898, DOI 10.1128/AEM.61.8.2898-2904.1995; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V42, P935; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Rushton HG, 1997, PEDIATR CLIN N AM, V44, P1133, DOI 10.1016/S0031-3955(05)70551-4; Sakellaris H, 2000, INFECT IMMUN, V68, P3780, DOI 10.1128/IAI.68.6.3780-3783.2000; Schlager TA, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0022-2016; Schwartz DJ, 2013, P NATL ACAD SCI USA, V110, P15530, DOI 10.1073/pnas.1315203110; Secretaria de Salud, 2015, PAN EP INF VIAS UR M; Secretaria de Salud, 2016, AN MORB 1984 2016; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; Sokurenko E, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0020-2015; Stamm WE, 2001, J INFECT DIS, V183, pS1, DOI 10.1086/318850; Takahashi A, 2006, J CLIN MICROBIOL, V44, P4589, DOI 10.1128/JCM.02070-06; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Valdes I, 2009, J FISH DIS, V32, P351, DOI 10.1111/j.1365-2761.2008.01014.x; VALVANO MA, 1986, INFECT IMMUN, V52, P192, DOI 10.1128/IAI.52.1.192-199.1986; Vigil PD, 2011, MBIO, V2, DOI 10.1128/mBio.00066-11; Vila J, 2002, J INFECT DIS, V186, P1039, DOI 10.1086/342955	55	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204934	10.1371/journal.pone.0204934	http://dx.doi.org/10.1371/journal.pone.0204934			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286185	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500063
J	Sesser, KA; Iglecia, M; Reiter, ME; Strum, KM; Hickey, CM; Kelsey, R; Skalos, DA				Sesser, Kristin A.; Iglecia, Monica; Reiter, Matthew E.; Strum, Khara M.; Hickey, Catherine M.; Kelsey, Rodd; Skalos, Daniel A.			Waterbird response to variable-timing of drawdown in rice fields after winter-flooding	PLOS ONE			English	Article							MANAGED WETLANDS; CENTRAL VALLEY; HABITAT; WATERFOWL; COMMUNITIES; GEESE; BIRDS	Wetland loss and degradation have been extensive across the world, especially in California's Central Valley where over 90% of the natural wetlands have been converted to agricultural and urban uses. In the Central Valley today, a much smaller network of managed wetlands and flooded agricultural fields supports almost five million waterfowl and half a million shorebirds. Over 50% of waterbird habitat in the Central Valley is provided by flooded agricultural land, primarily rice (Oryza sativa). Each year non-breeding waterbird habitat decreases in the late winter as flooded agricultural fields are drained after waterfowl hunting season in late-January to prepare for the next crop. This study evaluated a practice called 'variable drawdown' that involves delaying the removal of water from rice fields by 1, 2, and 3 weeks to extend the availability of flooded habitat later into February and March. We studied waterbird response to variable drawdown in 2012 and 2013 at twenty rice farms throughout the northern half of the Central Valley. The staggered drawdown created a mosaic of water depths throughout the six-week study period. The 3-week delay in drawdown supported more dabbling ducks than earlier drawdowns in the first half of the study and more shorebirds and long-legged wading birds during the second half of the study. The timing of highest use of each drawdown treatment differed for each waterbird guild; dabbling ducks, geese and swans benefited at the beginning, then long-legged wading birds, followed by shorebirds. Despite the presence of appropriate water depths for shorebirds across the treatments during the entire study period, shorebird densities were highest near the end of the study when the 3-week-delayed drawdown was providing the majority of the habitat on the landscape. This suggests that shorebirds may have concentrated in our study fields due to decreasing availability of shallow water habitat elsewhere. The practice of variable drawdown successfully extended the availability of waterbird habitat provided by post-harvest flooded rice fields later into winter.	[Sesser, Kristin A.; Reiter, Matthew E.; Strum, Khara M.; Hickey, Catherine M.; Skalos, Daniel A.] Point Blue Conservat Sci, Petaluma, CA 94954 USA; [Iglecia, Monica; Strum, Khara M.; Kelsey, Rodd] Audubon Calif, Sacramento, CA USA; [Iglecia, Monica] Manomet, Plymouth, MA USA; [Kelsey, Rodd] Nature Conservancy, Sacramento, CA USA; [Skalos, Daniel A.] Calif Dept Fish & Wildlife, Sacramento, CA USA	Nature Conservancy	Sesser, KA (corresponding author), Point Blue Conservat Sci, Petaluma, CA 94954 USA.	ksesser@pointblue.org		Kelsey III, Thomas Rodd/0000-0002-3187-1971; Sesser, Kristin/0000-0003-2761-7388	S. D. Bechtel, Jr. Foundation; U.S. Department of Agriculture Natural Resources Conservation Service [NRCS 68-9104-5-265]; NRCS	S. D. Bechtel, Jr. Foundation; U.S. Department of Agriculture Natural Resources Conservation Service(United States Department of Agriculture (USDA)); NRCS	Funding for this research was provided to the Migratory Bird Conservation Partnership (Point Blue Conservation Science, Audubon California, The Nature Conservancy) by the S. D. Bechtel, Jr. Foundation http://sdbjrfoundation.org/ and by a U.S. Department of Agriculture Natural Resources Conservation Service http://www.nrcs.usda.gov Regional Conservation Partnership Program grant (NRCS 68-9104-5-265). The funding sources had no additional role in study design, data collection and analysis, in the decision to submit the article for publication, or in the preparation of the manuscript.; This study would not have been possible without the participation and support of the U.S. Department of Agriculture Natural Resources Conservation Service and our rice farming partners: Don Bransford, Sean Doherty, Chris and Anna O'Sullivan, John Brennan, Mark Galentine, Montna Farms, Brett Perry, Robbins Rice Company, and six anonymous rice growers. We are also grateful for the support of Paul Buttner at the California Rice Commission. Jennifer Dhundale, Corey Shake, Karen Velas, and Brent Campos provided essential field support. B. Campos provided help with data analysis and interpretation. Tom Gardali and B. Campos provided valuable comments on earlier drafts. Funding was provided by the S. D. Bechtel, Jr. Foundation with some assistance for writing and analysis by a NRCS Regional Conservation Partnership Program grant. This is contribution No. 2203 of Point Blue Conservation Science.	Ackerman JT, 2006, J WILDLIFE MANAGE, V70, P965, DOI 10.2193/0022-541X(2006)70[965:SUBWGW]2.0.CO;2; Amano T, 2008, BIOL CONSERV, V141, P1704, DOI 10.1016/j.biocon.2008.04.012; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Barbaree BA, 2018, LANDSCAPE ECOL, DOI [10.1007/s10980-017-0605-9, DOI 10.1007/S10980-017-0605-9]; Barbaree BA, 2015, WATERBIRDS, V38, P40, DOI 10.1675/063.038.0106; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bety J, 2003, AM NAT, V162, P110, DOI 10.1086/375680; Bird JA, 2000, J APPL ECOL, V37, P728, DOI 10.1046/j.1365-2664.2000.00539.x; Burnham KP, 2002, MODEL SELECTION MULT, DOI [10.1007/978-3-319-02868-2_3, DOI 10.1007/978-3-319-02868-2_3]; Central Valley Joint Venture, 2006, CENTRAL VALLEY JOINT; Colwell MA, 2000, WATERBIRDS, V23, P45; Corline NJ, 2017, WETL ECOL MANAG, V25, P533, DOI 10.1007/s11273-017-9534-2; Dahl T. E., 1990, WETLANDS LOSSES US 1, V53, DOI [10.2144/000113917, DOI 10.2144/000113917]; Day JH, 1998, COLON WATERBIRD, V21, P185, DOI 10.2307/1521905; Dybala Kristen E., 2017, San Francisco Estuary & Watershed Science, V15, P2; Eadie J.M., 2008, CONSERVATION RICELAN, P7; Elphick CS, 2008, WATERBIRDS, V31, P62, DOI 10.1675/1524-4695(2008)31[62:LEOWDI]2.0.CO;2; Elphick CS, 2010, WATERBIRDS, V33, P181, DOI 10.1675/063.033.s114; Elphick CS, 1998, J APPL ECOL, V35, P95, DOI 10.1046/j.1365-2664.1998.00274.x; Elphick CS, 2000, CONSERV BIOL, V14, P181, DOI 10.1046/j.1523-1739.2000.98314.x; ESRI, 2014, ARCGIS DESKTOP RELEA; Fleskes JP, 2005, CALIF FISH GAME, V91, P207; Frayer WE, 1989, WETLANDS OF THE CALI; Garr JD, 2014, THE STATUS OF RICE F; Golet GH, 2018, ECOL APPL, V28, P409, DOI 10.1002/eap.1658; Gosselink J.G., 2000, WETLANDS; Isola CR, 2000, WATERBIRDS, V23, P196; Johnston A, 2015, ECOL APPL, V25, P1749, DOI 10.1890/14-1826.1; King S, 2010, WATERBIRDS, V33, P151, DOI 10.1675/063.033.s111; Lourenco PM, 2009, IBIS, V151, P196, DOI 10.1111/j.1474-919X.2008.00881.x; MCNEIL R, 1992, BIOL REV, V67, P381, DOI 10.1111/j.1469-185X.1992.tb01188.x; Miller MR, 2010, WETLANDS, V30, P939, DOI 10.1007/s13157-010-0090-2; Moser M., 1996, P 6 M C CONTR PART B, P21; Nam HK, 2015, WATERBIRDS, V38, P173, DOI 10.1675/063.038.0206; Nolet BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147340; Olson S.M., 2014, PACIFIC FLYWAY DATA; Pernollet CA, 2017, J WILDLIFE MANAGE, V81, P96, DOI 10.1002/jwmg.21167; Pernollet CA, 2015, AGR ECOSYST ENVIRON, V214, P118, DOI 10.1016/j.agee.2015.08.018; Petrie MJ, 2016, J FISH WILDL MANAG, V7, P408, DOI 10.3996/082015-JFWM-082; R Development Core Team, 2011, R A LANGUAGE AND ENV; Reiter ME, 2018, PEERJ, V6, DOI 10.7717/peerj.5147; Reiter ME, 2015, J FISH WILDL MANAG, V6, P29, DOI [10.3996/012014-JFWM-003, 1]; Schaffer-Smith D, 2017, REMOTE SENS ENVIRON, V193, P180, DOI 10.1016/j.rse.2017.02.016; Sesser KA, 2016, BIOL CONSERV, V197, P69, DOI 10.1016/j.biocon.2016.02.021; Shaskey L., 2012, LOCAL AND LANDSCAPE; Shuford WD, 1998, CONDOR, V100, P227, DOI 10.2307/1370264; Stafford JD, 2010, WATERBIRDS, V33, P133, DOI 10.1675/063.033.s110; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stralberg D, 2011, BIODIVERS CONSERV, V20, P19, DOI 10.1007/s10531-010-9943-5; Strum KM, 2013, AGR ECOSYST ENVIRON, V179, P116, DOI 10.1016/j.agee.2013.08.003; Taft OW, 2006, LANDSCAPE ECOL, V21, P169, DOI 10.1007/s10980-005-0146-5; Tajiri H, 2013, ORNITHOL SCI, V12, P127, DOI 10.2326/osj.12.127; Taylor IR, 2010, WATERBIRDS, V33, P71, DOI 10.1675/063.033.s105; Toral GM, 2011, IBIS, V153, P684, DOI 10.1111/j.1474-919X.2011.01147.x; Wald A, 1942, ANN MATH STAT, V13, P127, DOI 10.1214/aoms/1177731601; WHSRN, 2016, WESTERN HEMISPHERE S; Zuur Alain F., 2009, P1	57	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204800	10.1371/journal.pone.0204800	http://dx.doi.org/10.1371/journal.pone.0204800			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286116	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500045
J	Baltazar, CS; Rafael, F; Langa, JPM; Chicumbe, S; Cavailler, P; Gessner, BD; Pezzoli, L; Barata, A; Zaina, D; Inguane, DL; Mengel, MA; Munier, A				Baltazar, Cynthia Sema; Rafael, Florentina; Langa, Jose Paulo M.; Chicumbe, Sergio; Cavailler, Philippe; Gessner, Bradford D.; Pezzoli, Lorenzo; Barata, Americo; Zaina, Dores; Inguane, Dorteia L.; Mengel, Martin A.; Munier, Aline			Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique	PLOS ONE			English	Article							MALAWI	Background In addition to improving water, sanitation and hygiene (WASH) measures and optimal case management, the introduction of Oral cholera vaccine (OCV) is a complementary strategy for cholera prevention and control for vulnerable population groups. In October 2016, the Mozambique Ministry of Health implemented a mass vaccination campaign using a two-dose regimen of the Shanchol (TM) OCV in six high-risk neighborhoods of Nampula city, in Northern Mozambique. Overall 193,403 people were targeted by the campaign, which used a door-to-door strategy. During campaign follow-up, a population survey was conducted to assess: (1) OCV coverage; (2) frequency of adverse events following immunization; (3) vaccine acceptability and (4) reasons for non-vaccination. Methodology/Principal findings In the absence of a household listing and clear administrative neighborhood delimitations, we used geospatial technology to select households from satellite images and used the support of community leaders. One person per household was randomly selected for interview. In total, 636 individuals were enrolled in the survey. The overall vaccination coverage with at least one dose (including card and oral reporting) was 69.5% (95%CI: 51.2-88.2) and the two-dose coverage was 51.2% (95%CI: 37.9-64.3). The campaign was well accepted. Among the 185 non-vaccinated individuals, 83 (44.6%) did not take the vaccine because they were absent when the vaccination team visited their houses. Among the 451 vaccinated individuals, 47 (10%) reported minor and non-specific complaints, and 78 (17.3%) mentioned they did not receive any information before the campaign. Conclusions/Significance In spite of overall coverage being slightly lower than expected, the use of a mobile door-to-door strategy remains a viable option even in densely-populated urban settings. Our results suggest that campaigns can be successfully implemented and well accepted in Mozambique in non-emergency contexts in order to prevent cholera outbreaks. These findings are encouraging and complement the previous Mozambican experience related to OCV.	[Baltazar, Cynthia Sema; Langa, Jose Paulo M.; Chicumbe, Sergio; Inguane, Dorteia L.] Minist Hlth, Inst Nacl Saude, Maputo, Mozambique; [Rafael, Florentina] Agence Med Prevent, Abidjan, Cote Ivoire; [Cavailler, Philippe] Agence Med Prevent, Ferney Voltaire, France; [Gessner, Bradford D.; Mengel, Martin A.; Munier, Aline] Agence Med Prevent, Paris, France; [Pezzoli, Lorenzo] WHO, Geneva, Switzerland; [Barata, Americo] Minist Hlth, Direccao Prov Saude, Nampula, Mozambique; [Zaina, Dores] Minist Hlth, Direccao Saude Cidade, Nampula, Mozambique	Agence de Medecine Preventive; Agence de Medecine Preventive; World Health Organization	Rafael, F (corresponding author), Agence Med Prevent, Abidjan, Cote Ivoire.	florentina.rafael@hotmail.fr	Pezzoli, Lorenzo/AAA-9894-2019; Chicumbe, Sergio Antonio Rodrigues/GXA-1921-2022	Chicumbe, Sergio Antonio Rodrigues/0000-0002-2498-9373; Sema Baltazar, Cynthia/0000-0001-8901-2240	Bill & Melinda Gates Foundation [OPP 1106078]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org) through the project "Cholera Targeted Investments to Answer Endemic Use" (OPP 1106078), which granted funding to reinforce control and prevention of cholera in Africa by assessing the use of oral cholera vaccines and potentially integrating it into the list of measures used in endemic countries. The funding source had no role in study design, data collection, analysis or interpretation, or in the preparation of the manuscript and the decision to submit the paper for publication.	Abubakar A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001901; Admiraal R, 2014, J WATER SANIT HYG DE, V4, P410, DOI 10.2166/washdev.2014.145; Ali M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002120; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Cavailler P, 2006, VACCINE, V24, P4890, DOI 10.1016/j.vaccine.2005.10.006; Ciglenecki I, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001512; Desai SN, 2016, LANCET GLOB HEALTH, V4, pE223, DOI 10.1016/S2214-109X(16)00037-1; Desai SN, 2016, HUM VACCINES IMMUNOT; Dimitrov DT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003343; Gujral L, 2013, J INFECT DIS, V208, pS107, DOI 10.1093/infdis/jit212; Ivers LC, 2013, AM J TROP MED HYG, V89, P617, DOI 10.4269/ajtmh.13-0183; Lam E, 2017, EMERG INFECT DIS, V23, P38, DOI 10.3201/eid2301.160881; Langa JP, 2015, J INFECT DEV COUNTR, V9, P635, DOI 10.3855/jidc.6943; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; Luquero FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002465; Mengel MA, 2014, T ROY SOC TROP MED H, V108, P391, DOI 10.1093/trstmh/tru077; Msyamboza Kelias Phiri, 2016, Pan Afr Med J, V23, P203, DOI 10.11604/pamj.2016.23.203.8346; Msyamboza KP, 2014, J INFECT DEV COUNTR, V8, P720, DOI 10.3855/jidc.3506; Ngwa MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005105; Phares CR, 2016, VACCINE, V34, P128, DOI 10.1016/j.vaccine.2015.10.112; Rafael F, 2017, VACCINE, V35, P6041, DOI 10.1016/j.vaccine.2017.07.033; Sauvageot D, 2017, VACCINE, V35, P5194, DOI 10.1016/j.vaccine.2017.07.104; Schaetti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041527; Verma R, 2012, HUM VACC IMMUNOTHER, V8, P682, DOI 10.4161/hv.19083; WHO, 2017, 92 WHO, P477	26	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0198592	10.1371/journal.pone.0198592	http://dx.doi.org/10.1371/journal.pone.0198592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281604	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400003
J	Bartlow, CM; Mann, KA; Damron, TA; Oest, ME				Bartlow, Christopher M.; Mann, Kenneth A.; Damron, Timothy A.; Oest, Megan E.			Limited field radiation therapy results in decreased bone fracture toughness in a murine model	PLOS ONE			English	Article							HUMAN CORTICAL BONE; GLYCATION END-PRODUCTS; COLLAGEN CROSS-LINKS; SOFT-TISSUE SARCOMA; AGE-RELATED-CHANGES; X-RAY-IRRADIATION; BIOMECHANICAL PROPERTIES; NONENZYMATIC GLYCATION; IONIZING-RADIATION; GAMMA-IRRADIATION	Fragility fractures are a well-known complication following oncologic radiotherapy, and it is suspected that radiation-induced embrittlement of bone within the treatment field may contribute to fracture risk. To explore this phenomenon, a mouse model (BALB/cJ) of fractionated, limited field, bilateral hindlimb irradiation (4x5 Gy) was used. The effects of radiation on femoral (cortical) bone fracture toughness, morphology, and biochemistry-including advanced glycation end products (AGEs)-were quantified and compared to Sham group samples prior to irradiation and at 0, 4, 8, and 12 weeks post-irradiation. Additionally, alterations to bone fracture toughness mediated directly by radiation (independent of cellular mechanisms) were determined using devitalized mouse cadaver femurs. Finally, the contribution of AGEs to reduced fracture toughness was examined by artificially ribosylating mouse femurs ex vivo. These data demonstrate that in vivo irradiation results in an immediate (-42% at 0 weeks, p < 0.001) and sustained (-28% at 12 weeks, p < 0.001) decrease in fracture toughness with small changes in morphology (-5% in cortical area at 12 weeks), and minimal changes in bone composition (tissue mineral density, mineral:matrix ratio, and AGE content). Irradiation of devitalized femurs also reduced fracture toughness (-29%, p < 0.001), but to a lesser extent than was seen in vivo. While artificial ribosylation decreased fracture toughness with time, the extent of glycation needed to induce this effect exceeded the AGE accumulation that occurred in vivo. Overall, hindlimb irradiation induced a substantial and sustained decrease in bone fracture toughness. Approximately half of this decrease in fracture toughness is due to direct radiation damage, independent of cellular remodeling. Collagen glycation in vivo was not substantially altered, suggesting other matrix changes may contribute to post-radiotherapy bone embrittlement.	[Bartlow, Christopher M.; Mann, Kenneth A.; Damron, Timothy A.; Oest, Megan E.] SUNY Upstate Med Univ, Dept Orthoped Surg, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Oest, ME (corresponding author), SUNY Upstate Med Univ, Dept Orthoped Surg, Syracuse, NY 13210 USA.	oestm@upstate.edu	Damron, Timothy A./AAE-5816-2020		National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR065419, R01AR070142]; David G. Murray Endowment; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070142, R01AR065419] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); David G. Murray Endowment; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under awards R01AR065419 (TAD) & R01AR070142 (MEO), and by the David G. Murray Endowment (TAD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funding agency URLS: https://www.niams.nih.gov David G. Murray endowment has no url The funders had no role in study design, data, collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo C, 2018, NAT BIOMED ENG, V2, P62, DOI 10.1038/s41551-017-0183-9; Akkus O, 2001, J ORTHOP RES, V19, P927, DOI 10.1016/S0736-0266(01)00004-3; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Bandstra ER, 2008, RADIAT RES, V169, P607, DOI 10.1667/RR1310.1; Barth HD, 2011, BIOMATERIALS, V32, P8892, DOI 10.1016/j.biomaterials.2011.08.013; Barth HD, 2010, BONE, V46, P1475, DOI 10.1016/j.bone.2010.02.025; Baxter NN, 2005, JAMA-J AM MED ASSOC, V294, P2587, DOI 10.1001/jama.294.20.2587; Bierhaus A, 1998, CARDIOVASC RES, V37, P586, DOI 10.1016/S0008-6363(97)00233-2; Burr DB, 2002, BONE, V31, P8, DOI 10.1016/S8756-3282(02)00815-3; Burton B, 2014, BONE, V61, P71, DOI 10.1016/j.bone.2014.01.006; Carriero A, 2014, J MECH BEHAV BIOMED, V39, P38, DOI 10.1016/j.jmbbm.2014.06.017; Chandra A, 2015, J BIOL CHEM, V290, P157, DOI 10.1074/jbc.M114.608158; Chandra A, 2013, BONE, V55, P449, DOI 10.1016/j.bone.2013.02.023; Chen HHW, 2002, RADIOTHER ONCOL, V62, P239, DOI 10.1016/S0167-8140(02)00002-6; Currey JD, 1997, J ORTHOP RES, V15, P111, DOI 10.1002/jor.1100150116; DARLEYUSMAR VM, 1992, FREE RADICAL RES COM, V17, P9, DOI 10.3109/10715769209061085; Dhakal S, 2011, INT J RADIAT ONCOL, V80, P1158, DOI 10.1016/j.ijrobp.2010.04.012; Dickie CI, 2009, INT J RADIAT ONCOL, V75, P1119, DOI 10.1016/j.ijrobp.2008.12.006; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; FIDELER BM, 1995, AM J SPORT MED, V23, P643, DOI 10.1177/036354659502300521; Garnero P, 2006, BONE, V38, P300, DOI 10.1016/j.bone.2005.09.014; GIBBONS MJ, 1991, J ORTHOPAED RES, V9, P209, DOI 10.1002/jor.1100090209; Gong B, 2013, BONE, V57, P252, DOI 10.1016/j.bone.2013.08.014; Gortzak Y, 2010, CANCER-AM CANCER SOC, V116, P1553, DOI 10.1002/cncr.24949; Green DE, 2014, BONE, V63, P87, DOI 10.1016/j.bone.2014.02.018; Green DE, 2012, J BONE MINER RES, V27, P749, DOI 10.1002/jbmr.1505; Guise TA, 2006, ONCOLOGIST, V11, P1121, DOI 10.1634/theoncologist.11-10-1121; Hamer AJ, 1999, J BONE JOINT SURG BR, V81B, P342, DOI 10.1302/0301-620X.81B2.9083; Hamer AJ, 1996, J BONE JOINT SURG BR, V78B, P363, DOI 10.1302/0301-620X.78B3.0780363; Hernandez CJ, 2006, BONE, V39, P1173, DOI 10.1016/j.bone.2006.06.001; Hernandez CJ, 2005, BONE, V37, P825, DOI 10.1016/j.bone.2005.07.019; Inoue Yasuhiro, 2003, Int J Clin Oncol, V8, P336, DOI 10.1007/s10147-003-0340-x; Katsamenis OL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055641; Kondo H, 2010, J APPL PHYSIOL, V108, P152, DOI 10.1152/japplphysiol.00294.2009; Kondo H, 2009, RADIAT RES, V171, P283, DOI 10.1667/RR1463.1; Konski A, 1996, INT J RADIAT ONCOL, V35, P361, DOI 10.1016/0360-3016(95)02139-6; Kwon JW, 2008, AM J ROENTGENOL, V191, P987, DOI 10.2214/AJR.07.3634; McCormack J, 2012, BONE, V50, P1275, DOI 10.1016/j.bone.2012.02.018; Morales A, 1998, INT J RADIAT ONCOL, V42, P191, DOI 10.1016/S0360-3016(98)00185-0; Nalla RK, 2005, J BIOMECH, V38, P1517, DOI 10.1016/j.jbiomech.2004.07.010; NEUMAN RE, 1950, J BIOL CHEM, V184, P299; Nyaruba MM, 1998, ACTA RADIOL, V39, P43; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Oest ME, 2018, J BONE MINER RES, V33, P99, DOI 10.1002/jbmr.3289; Oest ME, 2016, CALCIFIED TISSUE INT, V98, P619, DOI 10.1007/s00223-016-0111-0; Oest ME, 2016, BONE, V86, P91, DOI 10.1016/j.bone.2016.03.003; Oest ME, 2015, J ORTHOP RES, V33, P334, DOI 10.1002/jor.22761; Oest ME, 2014, RADIAT RES, V181, P439, DOI 10.1667/RR13451.1; Oh D, 2008, INT J RADIAT ONCOL, V70, P1183, DOI 10.1016/j.ijrobp.2007.08.005; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Park SH, 2011, RADIAT ONCOL J, V29, P269, DOI 10.3857/roj.2011.29.4.269; Paschalis EP, 2004, J BONE MINER RES, V19, P2000, DOI 10.1359/JBMR.040820; Paulino AC, 2004, INT J RADIAT ONCOL, V60, P265, DOI 10.1016/j.ijrobp.2004.02.001; Poundarik AA, 2015, J MECH BEHAV BIOMED, V50, P82, DOI 10.1016/j.jmbbm.2015.05.025; Poundarik AA, 2015, J MECH BEHAV BIOMED, V52, P120, DOI 10.1016/j.jmbbm.2015.08.012; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Reisz JA, 2014, ANTIOXID REDOX SIGN, V21, P260, DOI 10.1089/ars.2013.5489; Ritchie RO, 2008, BONE, V43, P798, DOI 10.1016/j.bone.2008.04.027; Saito M, 2011, CALCIFIED TISSUE INT, V88, P314, DOI 10.1007/s00223-011-9472-6; Salehpour A, 1995, J ORTHOP RES, V13, P898, DOI 10.1002/jor.1100130614; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SINGH A, 1983, PROG BIOPHYS MOL BIO, V39, P69, DOI 10.1016/0079-6107(83)90014-7; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Sroga GE, 2012, CURR OSTEOPOROS REP, V10, P141, DOI 10.1007/s11914-012-0103-6; Sternheim A, 2013, BONE JOINT J, V95B, P1144, DOI [10.1302/0301-620X.9588.31832, 10.1302/0301-620X.95B8.31832]; Tang SY, 2007, BONE, V40, P1144, DOI 10.1016/j.bone.2006.12.056; Tang SY, 2011, J BIOMECH, V44, P330, DOI 10.1016/j.jbiomech.2010.10.016; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; Wernle JD, 2010, J BIOMECH, V43, P2738, DOI 10.1016/j.jbiomech.2010.06.017; Willey JS, 2008, RADIAT RES, V170, P388, DOI 10.1667/RR1388.1; Willey JS, 2010, BONE, V46, P101, DOI 10.1016/j.bone.2009.09.002; Wright LE, 2015, J BONE MINER RES, V30, P1268, DOI 10.1002/jbmr.2458; Yumoto K, 2010, RADIAT RES, V173, P494, DOI 10.1667/RR1754.1; Zimmermann EA, 2011, P NATL ACAD SCI USA, V108, P14416, DOI 10.1073/pnas.1107966108; Zioupos P, 2001, J BIOMATER APPL, V15, P187, DOI 10.1106/5JUJ-TFJ3-JVVA-3RJ0; Zou Q, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-015-0339-9	78	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204928	10.1371/journal.pone.0204928	http://dx.doi.org/10.1371/journal.pone.0204928			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281657	gold, Green Submitted, Green Published			2022-12-26	WOS:000446342400068
J	Kahle, P; Ludolphy, C; Kierdorf, H; Kierdorf, U				Kahle, Patricia; Ludolphy, Catharina; Kierdorf, Horst; Kierdorf, Uwe			Dental anomalies and lesions in Eastern Atlantic harbor seals, Phoca vitulina vitulina (Carnivora, Phocidae), from the German North Sea	PLOS ONE			English	Article							TEMPOROMANDIBULAR-JOINT PATHOLOGY; HYPOHIDROTIC ECTODERMAL DYSPLASIA; CANINE-DISTEMPER VIRUS; CALLORHINUS-URSINUS; ENAMEL HYPOPLASIA; SKULL LESIONS; MARION ISLAND; FERAL CATS; DENTITION; TEETH	Skulls of 1,901 Eastern Atlantic harbor seals (Phoca vitulina vitulina) were systematically studied for externally visible dental anomalies and lesions. The sample comprised 927 males and 974 female individuals, with age at death ranging between 1 week and 25 years. Most of the skulls originated from animals collected in 1988, when the population suffered from a mass mortality event caused by the phocine distemper virus (PDV). Mean age (+/- SD) of females (6.7 +/- 6.4 years) was higher (p = 0.002) than that of males (5.9 +/- 5.2 years). In 264 individuals, one or more teeth were missing either congenitally (n = 26 animals, 1.4%) or due to intravital loss (n = 238 animals, 12.5%). One male exhibited congenital absence of all teeth (anodontia). As this animal had been reported to be almost hairless, the condition was tentatively diagnosed as a case of hypohidrotic ectodermal dysplasia. Males were more frequently (p = 0.002) affected by intravital tooth loss (15.0%) than females (10.2%). Supernumerary teeth were found in 3.4% of the skulls, with females (4.7%) showing hyperodontia more frequently (p < 0.001) than males (1.9%). Fifty-nine individuals (3.1%; 28 males, 31 females, p = 0.84) exhibited abnormal tooth morphology. Tooth fractures were noted in 40 seals (2.1%), with males being more frequently affected than females (p = 0.017). Periapical lesions were diagnosed in 143 skulls, with a tendency (p = 0.05) for males (8.7%) to be more frequently affected than females (6.4%). Enamel hypoplasia was not observed in the study sample. Analyzing the occurrence of dental anomalies and lesions in wild mammals can substantially contribute to an assessment of population health and thereby broaden the basis for effective species conservation and informed management decisions.	[Kahle, Patricia; Ludolphy, Catharina; Kierdorf, Horst; Kierdorf, Uwe] Univ Hildesheim, Dept Biol, Hildesheim, Germany	University of Hildesheim	Kierdorf, U (corresponding author), Univ Hildesheim, Dept Biol, Hildesheim, Germany.	uwe.kierdorf@uni-hildesheim.de	Kierdorf, Uwe/F-2539-2012	Kierdorf, Uwe/0000-0003-0531-2460; Kahle, Patricia/0000-0001-7012-7507; Kierdorf, Horst/0000-0001-6411-9631	Volkswagen Foundation [Az. 89911, AZ 89 911]	Volkswagen Foundation(Volkswagen)	This study was funded by the Volkswagen Foundation (https://www.volkswagenstiftung.de/; grant number Az. 89911) within the program "Research in museums". The funder is supportive of publication, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to express their sincere thanks to Prof. Dr. Gunther B. Hartl and Mrs. Renate Lucht (Zoological Institute of Kiel University) for making the harbor seal skeletal collection available for this study. Renate is also thanked for her kind hospitality during our stays at the Institute in Kiel. We are much indebted to the two reviewers for their valuable comments and suggestions that helped to improve the manuscript. We further gratefully acknowledge the financial support of our study by the Volkswagen Foundation (AZ 89 911) within the framework of the program "Research in Museums".	Aalderink MT, 2015, J COMP PATHOL, V152, P325, DOI 10.1016/j.jcpa.2015.02.002; Aalderink MT, 2015, J COMP PATHOL, V152, P335, DOI 10.1016/j.jcpa.2015.02.003; Abbott C, 2005, J COMP PATHOL, V132, P169, DOI 10.1016/j.jcpa.2004.09.007; Abt KF, 2002, THESIS; Aghashani A, 2016, J COMP PATHOL, V154, P329, DOI 10.1016/j.jcpa.2016.03.001; AVDC (American Veterinary Dental College), 2015, DENT FRACT CLASS; Beineke A, 2015, ONE HEALTH, V1, P49, DOI 10.1016/j.onehlt.2015.09.002; Bhat M, 1989, Adv Dent Res, V3, P132; Bjorge A, 2010, NAMMCO SCI PUBLICATI, V8, P7, DOI [DOI 10.7557/3.2668, 10.7557/3.2668]; BODINGBAUER J, 1949, Schweiz Arch Tierheilkd, V91, P84; BRIGGS KT, 1974, J MAMMAL, V55, P158, DOI 10.2307/1379264; Brook AH, 2014, AUST DENT J, V59, P131, DOI 10.1111/adj.12160; Burns JJ, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P533; Casal ML, 1997, J HERED, V88, P513, DOI 10.1093/oxfordjournals.jhered.a023146; Clark EJ, 2017, J COMP PATHOL, V156, P240, DOI 10.1016/j.jcpa.2016.11.267; Cowan DF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P836; Cruwys L, 2006, POLAR REC, V42, P83, DOI 10.1017/S0032247405004869; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; Doring S, 2018, J COMP PATHOL, V160, P56, DOI 10.1016/j.jcpa.2018.03.001; Drehmer Cesar Jaeger, 2004, Latin American Journal of Aquatic Mammals, V3, P7; Drehmer CJ, 2015, ZOOMORPHOLOGY, V134, P325, DOI 10.1007/s00435-015-0255-x; Drogemuller C, 2003, GENET SEL EVOL, V35, pS137, DOI 10.1051/gse:2003022; Drogemuller C, 2002, VET DERMATOL, V13, P307, DOI 10.1046/j.1365-3164.2002.00313.x; DUBIELZIG RR, 1981, VET PATHOL, V18, P684, DOI 10.1177/030098588101800513; DUBIELZIG RR, 1979, VET PATHOL, V16, P268, DOI 10.1177/030098587901600216; Duguy R, 1992, HDB SAUGETIERE EUROP, V6, P18; Duignan PJ, 2014, VIRUSES-BASEL, V6, P5093, DOI 10.3390/v6125093; Ehlers K., 1962, Zeitschrift fuer Saugietierkunde, V27, P184; Evenhuis JV, 2018, J COMP PATHOL, V158, P39, DOI 10.1016/j.jcpa.2017.11.002; Galatius A, 2017, ANN REPORT; Garrott RA, 2002, ECOSYSTEMS, V5, P659, DOI 10.1007/s10021-002-0211-8; Gelberg H. B., 2001, THOMSONS SPECIAL VET, P1; GOODMAN AH, 1990, YEARB PHYS ANTHROPOL, V33, P59; HARKONEN T, 1990, OPHELIA, V32, P211; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; Higashino T, 2017, EXPERT OPIN ORPHAN D, V5, P967, DOI 10.1080/21678707.2017.1405806; Hillson S, 2014, TOOTH DEVELOPMENT IN HUMAN EVOLUTION AND BIOARCHAEOLOGY, P1, DOI 10.1017/CBO9780511894916; Hillson S., 2005, TEETH; Hillson S., 2010, BIOL ANTHR HUMAN SKE, P301; Janssens L, 2016, J MAMMAL, V97, P1111, DOI 10.1093/jmammal/gyw058; Jo WK, 2018, CURR OPIN VIROL, V28, P133, DOI 10.1016/j.coviro.2017.12.005; Kierdorf H, 2012, J ANAT, V220, P484, DOI 10.1111/j.1469-7580.2012.01482.x; Kierdorf H, 1997, CELL TISSUE RES, V289, P125, DOI 10.1007/s004410050858; Klein OD, 2013, AM J MED GENET C, V163, P318, DOI 10.1002/ajmg.c.31382; Konemann S, 1997, Z SAUGETIERKD, V62, P71; KUBOTA K, 1964, ANAT REC, V150, P487, DOI 10.1002/ar.1091500417; KUBOTA K, 1970, J DENT RES, V49, P325, DOI 10.1177/00220345700490022201; Lan Y, 2014, SEMIN CELL DEV BIOL, V25, P61, DOI 10.1016/j.semcdb.2013.12.003; Loch C, 2010, ZOOLOGIA-CURITIBA, V27, P477, DOI 10.1590/S1984-46702010005000001; Lowry L., IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-1.RLTS.T17013A45229114.en, DOI 10.2305/IUCN.UK.2016-1.RLTS.T17013A45229114.EN]; Ludolphy C, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1473-5; Matzke T, 2001, THESIS; Mauldin E.A., 2016, JUBB KENNEDY PALMERS, V6, P509, DOI DOI 10.1016/B978-0-7020-5317-7.00006-0; Merrick R, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P368; Meyer W, 2004, MAMM BIOL, V69, P401, DOI 10.1078/1616-5047-00162; Miles AEW, 1990, COLYERS VARIATIONS D; MORTENSEN P, 1992, AMBIO, V21, P520; NLWKN (Niedersachsischer Landesbetrieb fur Wasserwirtschaft Kusten-und Naturschutz), 2011, VOLLZ SCH SAUG NIED; POHLMEYER G, 1993, J COMP PATHOL, V109, P57, DOI 10.1016/S0021-9975(08)80240-X; Reeves R. R., 2002, SEA MAMMALS WORLD CO; Reijnders PJH, 1992, HDB SAUGETIERE EUROP, V6, P120; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Sadier A, 2014, TRENDS GENET, V30, P24, DOI 10.1016/j.tig.2013.08.006; Sasaki H, 2012, SELTZER AND BENDER'S DENTAL PULP, SECOND EDITION, P277; Schandorff S, 1997, ANN ZOOL FENN, V34, P151; SCHROEDER HE, 1991, PATHOBIOLOGIE ORALER; Schumacher G.H., 1990, ANATOMIE BIOCHEMIE Z; SEOW WK, 1991, J DENT CHILD, V58, P441; Sinai NL, 2014, J COMP PATHOL, V151, P113, DOI 10.1016/j.jcpa.2014.02.004; Siqueira JF, 2012, SELTZER AND BENDER'S DENTAL PULP, SECOND EDITION, P205; Slootweg, 2013, DENT PATHOLOGY PRACT; Starck D., 1995, LEHRBUCH SPEZIELLE 5, V2, P848; Suzuki M., 1990, Japanese Journal of Oral Biology, V32, P323; Thenius, 1989, HDB ZOOLOGIE, V8; Trzeciak WH, 2016, J APPL GENET, V57, P51, DOI 10.1007/s13353-015-0307-4; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; Van Valkenburgh B, 2009, BIOL J LINN SOC, V96, P68, DOI 10.1111/j.1095-8312.2008.01108.x; Verstraete FJM, 1996, J COMP PATHOL, V115, P265, DOI 10.1016/S0021-9975(96)80084-3; Verstraete FJM, 1996, J COMP PATHOL, V115, P283, DOI 10.1016/S0021-9975(96)80085-5; Winer JN, 2016, J COMP PATHOL, V155, P231, DOI 10.1016/j.jcpa.2016.07.004; Winer JN, 2016, J COMP PATHOL, V155, P242, DOI 10.1016/j.jcpa.2016.07.005; WOLSAN M, 1984, ACTA THERIOL, V29, P128, DOI 10.4098/AT.arch.84-11; Xu MG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15397	84	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204079	10.1371/journal.pone.0204079	http://dx.doi.org/10.1371/journal.pone.0204079			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281623	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400040
J	Chong, PSY; Zhou, JB; Chooi, JY; Chan, ZL; Toh, SHM; Tan, TZ; Wee, S; Gunaratne, J; Zeng, Q; Chng, WJ				Chong, Phyllis S. Y.; Zhou, Jianbiao; Chooi, Jing-Yuan; Chan, Zit-Liang; Toh, Sabrina Hui Min; Tan, Tuan Zea; Wee, Sheena; Gunaratne, Jayantha; Zeng, Qi; Chng, Wee-Joo			Non-canonical activation of beta-catenin by PRL-3 phosphatase in acute myeloid leukemia	ONCOGENE			English	Article							SIGNALING PATHWAY; ASSOCIATION	Aberrant activation of Wnt/beta-catenin signaling pathway is essential for the development of AML; however, the mechanistic basis for this dysregulation is unclear. PRL-3 is an oncogenic phosphatase implicated in the development of LSCs. Here, we identified Leo1 as a direct and specific substrate of PRL-3. Serine-dephosphorylated form of Leo1 binds directly to beta-catenin, promoting the nuclear accumulation of beta-catenin and transactivation of TCF/LEF downstream target genes such as cyclin D1 and c-myc. Importantly, overexpression of PRL-3 in AML cells displayed enhanced sensitivity towards beta-catenin inhibition in vitro and in vivo, suggesting that these cells are addicted to beta-catenin signaling. Altogether, our study revealed a novel regulatory role of PRL-3 in the sustenance of aberrant beta-catenin signaling in AML. PRL-3 may serve as a biomarker to select for the subset of AML patients who are likely to benefit from treatment with beta-catenin inhibitors. Our study presents a new avenue of cancer inhibition driven by PRL-3 overexpression or beta-catenin hyperactivation.	[Chong, Phyllis S. Y.; Zhou, Jianbiao; Chan, Zit-Liang; Toh, Sabrina Hui Min; Tan, Tuan Zea; Chng, Wee-Joo] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Zhou, Jianbiao; Chooi, Jing-Yuan; Chng, Wee-Joo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Wee, Sheena; Gunaratne, Jayantha; Zeng, Qi] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Gunaratne, Jayantha] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore, Singapore; [Chng, Wee-Joo] Natl Univ Hlth Syst, Dept Haematol Oncol, Natl Univ Canc Inst, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore	Chng, WJ (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore.; Chng, WJ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.; Chng, WJ (corresponding author), Natl Univ Hlth Syst, Dept Haematol Oncol, Natl Univ Canc Inst, Singapore, Singapore.	mdccwj@nus.edu.sg	Tan, Tuan Zea/I-9227-2019	Tan, Tuan Zea/0000-0001-6624-1593	Singapore National Research Foundation; Ministry of Education under the Research Center of Excellence Program; NMRC Clinician-Scientist IRG [CNIG11nov38]; NMRC Singapore Translational Research (STaR) Investigatorship; National Research Foundation Singapore; Singapore Ministry of Education under the Research Centers of Excellence initiative; RNA Biology Center at the Cancer Science Institute of Singapore, NUS under the Singapore Ministry of Education's Tier 3 grants [MOE2014-T3-1-006]	Singapore National Research Foundation(National Research Foundation, Singapore); Ministry of Education under the Research Center of Excellence Program; NMRC Clinician-Scientist IRG(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NMRC Singapore Translational Research (STaR) Investigatorship(National Medical Research Council, Singapore); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under the Research Centers of Excellence initiative(Ministry of Education, Singapore); RNA Biology Center at the Cancer Science Institute of Singapore, NUS under the Singapore Ministry of Education's Tier 3 grants(Ministry of Education, SingaporeNational University of Singapore)	This work was supported by the Singapore National Research Foundation and the Ministry of Education under the Research Center of Excellence Program to WJ Chng and NMRC Clinician-Scientist IRG Grant CNIG11nov38 to Zhou J. WJ Chng is supported by NMRC Singapore Translational Research (STaR) Investigatorship. This research is partly supported by the National Research Foundation Singapore and the Singapore Ministry of Education under the Research Centers of Excellence initiative as well as the RNA Biology Center at the Cancer Science Institute of Singapore, NUS, as part of funding under the Singapore Ministry of Education's Tier 3 grants, grant number MOE2014-T3-1-006. No potential conflicts of interest were disclosed. We would also like to thank Prof Phil Koeffler, Prof Dan Tenen, Prof Toshio Suda, and Dr Motomi Osato for helpful discussions and critical reading of the manuscript.	Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Beekman R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026537; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Chong PSY, 2014, CANCER RES, V74, P3043, DOI 10.1158/0008-5472.CAN-13-2321; Chung EJ, 2002, BLOOD, V100, P982, DOI 10.1182/blood.V100.3.982; Gandillet A, 2011, LEUKEMIA, V25, P770, DOI 10.1038/leu.2011.17; Gilliland DG, 2002, SEMIN HEMATOL, V39, P6, DOI 10.1053/shem.2002.36921; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Luu HH, 2004, CURR CANCER DRUG TAR, V4, P653, DOI 10.2174/1568009043332709; McParland V, 2011, BIOCHEMISTRY-US, V50, P7579, DOI 10.1021/bi201095z; Mikesch JH, 2007, LEUKEMIA, V21, P1638, DOI 10.1038/sj.leu.2404732; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; Park JE, 2013, EMBO MOL MED, V5, P1351, DOI 10.1002/emmm.201202183; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Reindl C, 2006, BLOOD, V107, P3700, DOI 10.1182/blood-2005-06-2596; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Ysebaert L, 2006, LEUKEMIA, V20, P1211, DOI 10.1038/sj.leu.2404239; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zeng Q, 2003, CANCER RES, V63, P2716; Zhou JX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019798, 10.1371/journal.pone.0014752, 10.1371/journal.pone.0024340]	26	14	16	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2019	38	9					1508	1519		10.1038/s41388-018-0526-3	http://dx.doi.org/10.1038/s41388-018-0526-3			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN1KL	30305722				2022-12-26	WOS:000459945800010
J	Todaro, DR; Augustus-Wallace, AC; Klein, JM; Haas, AL				Todaro, Dustin R.; Augustus-Wallace, Allison C.; Klein, Jennifer M.; Haas, Arthur L.			Oligomerization of the HECT ubiquitin ligase NEDD4-2/NEDD4L is essential for polyubiquitin chain assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E2; E3; ubiquitin; ubiquitin ligase; enzyme mechanism; enzyme kinetics; protein complex; protein degradation; protein-protein interactions; HECT ligase; HECT domain; linkage specificity; transthiolation; oligomer	EPITHELIAL NA+ CHANNEL; GATED SODIUM-CHANNELS; PROTEIN; MECHANISMS; DOMAIN; DEGRADATION; SUBSTRATE; REVEALS; NEDD4; THIOL	The NEDD4-2 (neural precursor cell-expressed developmentally down-regulated 4-2) HECT ligase catalyzes polyubiquitin chain assembly by an ordered two-step mechanism requiring two functionally distinct E2 approximate to ubiquitin-binding sites, analogous to the trimeric E6AP/UBE3A HECT ligase. This conserved catalytic mechanism suggests that NEDD4-2, and presumably all HECT ligases, requires oligomerization to catalyze polyubiquitin chain assembly. To explore this hypothesis, we examined the catalytic mechanism of NEDD4-2 through the use of biochemically defined kinetic assays examining rates of I-125-labeled polyubiquitin chain assembly and biophysical techniques. The results from gel filtration chromatography and dynamic light-scattering analyses demonstrate for the first time that active NEDD4-2 is a trimer. Homology modeling to E6AP revealed that the predicted intersubunit interface has an absolutely conserved Phe-823, substitution of which destabilized the trimer and resulted in a 10(4)-fold decrease in k(cat) for polyubiquitin chain assembly. The small-molecule Phe-823 mimic, N-acetylphenylalanyl-amide, acted as a noncompetitive inhibitor (K-i = 8 +/- 1.2 mm) of polyubiquitin chain elongation by destabilizing the active trimer, suggesting a mechanism for therapeutically targeting HECT ligases. Additional kinetic experiments indicated that monomeric NEDD4-2 catalyzes only HECT approximate to ubiquitin thioester formation and monoubiquitination, whereas polyubiquitin chain assembly requires NEDD4-2 oligomerization. These results provide evidence that the previously identified sites 1 and 2 of NEDD4-2 function in trans to support chain elongation, explicating the requirement for oligomerization. Finally, we identified a conserved catalytic ensemble comprising Glu-646 and Arg-604 that supports HECT-ubiquitin thioester exchange and isopeptide bond formation at the active-site Cys-922 of NEDD4-2.	[Todaro, Dustin R.; Augustus-Wallace, Allison C.; Klein, Jennifer M.; Haas, Arthur L.] Louisiana State Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Sch Med, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University System	Haas, AL (corresponding author), LSU Hlth Sci Ctr, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu			National Institutes of Health [R01 GM034009, P30 GM106392]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009, P30GM106392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM034009 (to A.L.H.) and P30 GM106392 (to Daniel R. Kapusta) and an appropriation from the Louisiana State University School of Medicine, New Orleans. The authors declare that they have no conflicts of interest with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Bailey CC, 2013, J BIOL CHEM, V288, P32184, DOI 10.1074/jbc.M113.514356; Bracher PJ, 2011, ORIGINS LIFE EVOL B, V41, P399, DOI 10.1007/s11084-011-9243-4; Brooks WS, 2008, J BIOL CHEM, V283, P22304, DOI 10.1074/jbc.M803238200; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Castro EA, 1999, CHEM REV, V99, P3505, DOI 10.1021/cr990001d; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Edwards DJ, 2014, J BIOL CHEM, V289, P34114, DOI 10.1074/jbc.M114.609164; FEDOR LR, 1965, J AM CHEM SOC, V87, P4138, DOI 10.1021/ja01096a024; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Freed EO, 2002, J VIROL, V76, P4679, DOI 10.1128/JVI.76.10.4679-4687.2002; Goel P, 2015, GENE, V557, P1, DOI 10.1016/j.gene.2014.11.051; Gong TWL, 2003, GENOMICS, V82, P143, DOI 10.1016/S0888-7543(03)00111-3; Gong W, 2015, ACTA CRYSTALLOGR F, V71, P1251, DOI 10.1107/S2053230X1501554X; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Grau-Bove X, 2013, GENOME BIOL EVOL, V5, P833, DOI 10.1093/gbe/evt052; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haas Arthur L., 2005, V301, P23; Han ZY, 2016, J VIROL, V90, P9163, DOI 10.1128/JVI.01078-16; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kim HT, 2012, METHODS MOL BIOL, V832, P653, DOI 10.1007/978-1-61779-474-2_46; Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108; Laedermann Cedric J, 2014, Handb Exp Pharmacol, V221, P231, DOI 10.1007/978-3-642-41588-3_11; Laedermann CJ, 2013, J CLIN INVEST, V123, P3002, DOI 10.1172/JCI68996; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lorenz S, 2018, BIOL CHEM, V399, P127, DOI 10.1515/hsz-2017-0184; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Mari S, 2014, STRUCTURE, V22, P1639, DOI 10.1016/j.str.2014.09.006; Marin I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-56; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Ronchi VP, 2017, J BIOL CHEM, V292, P18006, DOI 10.1074/jbc.M117.813477; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Ronchi VP, 2012, METHODS MOL BIOL, V832, P197, DOI 10.1007/978-1-61779-474-2_14; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Segel I.H., 1975, ENZYME KINETICS; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Todaro DR, 2017, J BIOL CHEM, V292, P19521, DOI 10.1074/jbc.M117.817882; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Uchiki T, 2009, J BIOL CHEM, V284, P12622, DOI 10.1074/jbc.M900556200; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wu LW, 2015, PHYSIOL BEHAV, V143, P104, DOI 10.1016/j.physbeh.2015.02.026; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	62	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18192	18206		10.1074/jbc.RA118.003716	http://dx.doi.org/10.1074/jbc.RA118.003716			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30287686	Green Published, hybrid			2022-12-26	WOS:000451375200014
J	Lesne, E; Coutte, L; Solans, L; Slupek, S; Debrie, AS; Dhennin, V; Froguel, P; Hot, D; Locht, C; Antoine, R; Jacob-Dubuisson, F				Lesne, Elodie; Coutte, Loic; Solans, Luis; Slupek, Stephanie; Debrie, Anne-Sophie; Dhennin, Veronique; Froguel, Philippe; Hot, David; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise			Distinct virulence ranges for infection of mice by Bordetella pertussis revealed by engineering of the sensor-kinase BvgS	PLOS ONE			English	Article							INTERMEDIATE PHASE; VENUS FLYTRAP; GENE; TRANSDUCTION; ACTIVATION; MUTATIONS; RECEPTORS; DISEASE; COMPLEX; REGULON	The whooping cough agent Bordetella pertussis coordinately regulates the expression of its virulence factors with the two-component system BvgAS. In laboratory conditions, specific chemical modulators are used to trigger phenotypic modulation of B. pertussis from its default virulent Bvg(+) phase to avirulent Bvg(-) or intermediate Bvg(i) phases, in which no virulence factors or only a subset of them are produced, respectively. Whether phenotypic modulation occurs in the host remains unknown. In this work, recombinant B. pertussis strains harboring BvgS variants were tested in a mouse model of infection and analyzed using transcriptomic approaches. Recombinant BP-Bvg(Delta 65), which is in the Bvg(i) phase by default and can be up-modulated to the Bvg(+) phase in vitro, could colonize the mouse nose but was rapidly cleared from the lungs, while Bvg(+)-phase strains colonized both organs for up to four weeks. These results indicated that phenotypic modulation, which might have restored the full virulence capability of BP-Bvg(Delta 65), does not occur in mice or is temporally or spatially restricted and has no effect in those conditions. Transcriptomic analyses of this and other recombinant Bvg(i) and Bvg(+)-phase strains revealed that two distinct ranges of virulence gene expression allow colonization of the mouse nose and lungs, respectively. We also showed that a recombinant strain expressing moderately lower levels of the virulence genes than its wild type parent was as efficient at colonizing both organs. Altogether, genetic modifications of BvgS generate a range of phenotypic phases, which are useful tools to decipher host-pathogen interactions.	[Lesne, Elodie; Coutte, Loic; Solans, Luis; Slupek, Stephanie; Debrie, Anne-Sophie; Dhennin, Veronique; Froguel, Philippe; Hot, David; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] Univ Lille, Lille, France; [Lesne, Elodie; Coutte, Loic; Solans, Luis; Slupek, Stephanie; Debrie, Anne-Sophie; Hot, David; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] CNRS, UMR 8204, Lille, France; [Lesne, Elodie; Coutte, Loic; Solans, Luis; Slupek, Stephanie; Debrie, Anne-Sophie; Hot, David; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] INSERM, U1019, Lille, France; [Lesne, Elodie; Coutte, Loic; Solans, Luis; Slupek, Stephanie; Debrie, Anne-Sophie; Hot, David; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] CHU Lille, Lille, France; [Lesne, Elodie; Coutte, Loic; Solans, Luis; Slupek, Stephanie; Debrie, Anne-Sophie; Hot, David; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] Inst Pasteur, Ctr Infect & Immunite Lille, Lille, France; [Dhennin, Veronique; Froguel, Philippe] CNRS, UMR 8199, European Genom Inst Diabet, Lille, France; [Lesne, Elodie] Publ Hlth England, Salisbury, Wilts, England	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Public Health England	Locht, C; Antoine, R (corresponding author), Univ Lille, Lille, France.; Locht, C; Antoine, R (corresponding author), CNRS, UMR 8204, Lille, France.; Locht, C; Antoine, R (corresponding author), INSERM, U1019, Lille, France.; Locht, C; Antoine, R (corresponding author), CHU Lille, Lille, France.; Locht, C; Antoine, R (corresponding author), Inst Pasteur, Ctr Infect & Immunite Lille, Lille, France.	rudy.antoine@inserm.fr; francoise.jacob@ibl.cnrs.fr	Antoine, Rudy/CAH-6653-2022; Antoine, Rudy/L-1630-2018; Coutte, Loïc/G-4379-2012; Locht, Camille/L-3516-2018; FROGUEL, Philippe/O-6799-2017; coutte, loic/B-2566-2019; Hot, David/M-6775-2016	Antoine, Rudy/0000-0002-7369-0626; Antoine, Rudy/0000-0002-7369-0626; Coutte, Loïc/0000-0002-8626-8109; FROGUEL, Philippe/0000-0003-2972-0784; coutte, loic/0000-0002-8626-8109; Hot, David/0000-0002-2361-0616; Locht, Camille/0000-0001-7295-7336	Agence Nationale de la Recherche [ANR-13-BSV8-0002-01]; Inserm, Lille University; Region Nord-Pas-de-Calais; Inserm; ANR Equipex 2010 session [ANR-10-EQPX-07-01]; FEDER; Region Nord-Pas-de-Calais-Picardie	Agence Nationale de la Recherche(French National Research Agency (ANR)); Inserm, Lille University; Region Nord-Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR Equipex 2010 session(French National Research Agency (ANR)); FEDER(European Commission); Region Nord-Pas-de-Calais-Picardie(Region Hauts-de-France)	This work was supported by the Agence Nationale de la Recherche (grant ANR-13-BSV8-0002-01) to F.J.-D and recurrent funding of the laboratory (Inserm, Lille University). E. L. received a fellowship form the Region Nord-Pas-de-Calais and Inserm. The authors also thank the UMR 8199 LIGAN-PM Genomics platform (Lille, France) which belongs to the 'Federation de Recherche' 3508 Labex EGID (European Genomics Institute for Diabetes; ANR-10-LABX-46) and was supported by the ANR Equipex 2010 session (ANR-10-EQPX-07-01; 'LIGAN-PM'). The LIGAN-PM Genomics platform (Lille, France) is also supported by the FEDER and the 6Region Nord-Pas-de-Calais-Picardie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bone MA, 2017, P NATL ACAD SCI USA, V114, pE1519, DOI 10.1073/pnas.1609565114; Bouchez V, 2015, VACCINES-BASEL, V3, P751, DOI 10.3390/vaccines3030751; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; Coutte L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32774; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; de Gouw D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084523; de Tejada GM, 1998, INFECT IMMUN, V66, P2762, DOI 10.1128/IAI.66.6.2762-2768.1998; Deora R, 2002, J BACTERIOL, V184, P6942, DOI 10.1128/JB.184.24.6942-6951.2002; Deora R, 2001, MOL MICROBIOL, V40, P669, DOI 10.1046/j.1365-2958.2001.02415.x; Dupre E, 2015, J BIOL CHEM, V290, P23307, DOI 10.1074/jbc.M115.655720; Dupre E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004700; Felder CB, 1999, AAPS PHARMSCI, V1; Herrou J, 2010, P NATL ACAD SCI USA, V107, P17351, DOI 10.1073/pnas.1006267107; Herrou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006996; Jacob-Dubuisson F, 2012, TWO-COMPONENT SYSTEMS IN BACTERIA, P57; Jones AM, 2005, MOL MICROBIOL, V58, P700, DOI 10.1111/j.1365-2958.2005.04875.x; Karataev GI, 2016, RUSS J GENET+, V52, P370, DOI 10.1134/S102279541603008X; Lam C, 2014, EMERG INFECT DIS, V20, P626, DOI 10.3201/eid2004.131478; Lamberti Y, 2016, J PROTEOMICS, V136, P55, DOI 10.1016/j.jprot.2016.02.002; Lesne E, 2016, MBIO, V7, DOI 10.1128/mBio.02089-15; Lesne E, 2018, MBIO, V9, DOI 10.1128/mBio.02052-17; Lesne E, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00114-17; Locht C, 2001, CURR OPIN MICROBIOL, V4, P82, DOI 10.1016/S1369-5274(00)00169-7; Locht C, 2017, J INFECT DIS, V216, P117, DOI 10.1093/infdis/jix254; MANETTI R, 1994, GENE, V150, P123, DOI 10.1016/0378-1119(94)90870-2; Martin SW, 2015, CLIN INFECT DIS, V60, P223, DOI 10.1093/cid/ciu788; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; MILLER JF, 1992, J BACTERIOL, V174, P970, DOI 10.1128/jb.174.3.970-979.1992; Moon K, 2017, MBIO, V8, DOI 10.1128/mBio.01526-17; Nakamura MM, 2006, INFECT IMMUN, V74, P5537, DOI 10.1128/IAI.00781-06; OH BH, 1993, J BIOL CHEM, V268, P11348; Pawloski LC, 2014, CLIN VACCINE IMMUNOL, V21, P119, DOI 10.1128/CVI.00717-13; Pinto MV, 2017, J INFECTION, V74, pS114, DOI 10.1016/S0163-4453(17)30201-3; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; SCARLATO V, 1991, EMBO J, V10, P3971, DOI 10.1002/j.1460-2075.1991.tb04967.x; Seydlova G, 2017, J BIOL CHEM, V292, P8048, DOI 10.1074/jbc.M117.781559; Stibitz S, 2007, BORDETELLA MOL MICRO, P47; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Taylor-Mulneix DL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000420; Thorstensson R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083449; Uhl MA, 1996, J BIOL CHEM, V271, P33176, DOI 10.1074/jbc.271.52.33176; van Beek LF, 2018, J INFECT DIS, V217, P1987, DOI 10.1093/infdis/jiy125; Veal-Carr WL, 2005, MOL MICROBIOL, V55, P788, DOI 10.1111/j.1365-2958.2004.04418.x; Vergara-Irigaray N, 2005, INFECT IMMUN, V73, P748, DOI 10.1128/IAI.73.2.748-760.2005	44	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204861	10.1371/journal.pone.0204861	http://dx.doi.org/10.1371/journal.pone.0204861			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307950	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500030
J	Arimide, DA; Abebe, A; Kebede, Y; Adugna, F; Tilahun, T; Kassa, D; Assefa, Y; Balcha, TT; Bjorkman, P; Medstrand, PK				Arimide, Dawit Assefa; Abebe, Almaz; Kebede, Yenew; Adugna, Fekadu; Tilahun, Tesfaye; Kassa, Desta; Assefa, Yibeltal; Balcha, Taye Tolera; Bjorkman, Per; Medstrand, Patri K.			HIV-genetic diversity and drug resistance transmission clusters in Gondar, Northern Ethiopia, 2003-2013	PLOS ONE			English	Article							ANTIRETROVIRAL-NAIVE INDIVIDUALS; SUB-SAHARAN AFRICA; TYPE-1 SUBTYPE-C; MOLECULAR EPIDEMIOLOGY; ADDIS-ABABA; MUTATIONS; SURVEILLANCE; THERAPY; RECOMBINATION; PERFORMANCE	Background The HIV-1 epidemic in Ethiopia has been shown to be dominated by two phylogenetically distinct subtype C clades, the Ethiopian (C'-ET) and East African (C-EA) clades, however, little is known about the temporal dynamics of the HIV epidemic with respect to subtypes and distinct clades. Moreover, there is only limited information concerning transmission of HIV-1 drug resistance (TDR) in the country. Methods A cross-sectional survey was conducted among young antiretroviral therapy (ART)-naive individuals recently diagnosed with HIV infection, in Gondar, Ethiopia, 2011-2013 using the WHO recommended threshold survey. A total of 84 study participants with a median age of 22 years were enrolled. HIV-1 genotyping was performed and investigated for drug resistance in 67 individuals. Phylogenetic analyses were performed on all available HIV sequences obtained from Gondar (n = 301) which were used to define subtype C clades, temporal trends and local transmission clusters. Dating of transmission clusters was performed using BEAST. Result Four of 67 individuals (6.0%) carried a HIV drug resistance mutation strain, all associated with non-nucleoside reverse transcriptase inhibitors (NNRTI). Strains of the C-EA Glade were most prevalent as we found no evidence of temporal changes during this time period. However, strains of the C-SA Glade, prevalent in Southern Africa, have been introduced in Ethiopia, and became more abundant during the study period. The oldest Gondar transmission clusters dated back to 1980 (C-EA), 1983 (C-SA) and 1990 (C'-ET) indicating the presence of strains of different subtype C clades at about the same time point in Gondar. Moreover, some of the larger clusters dated back to the 1980s but transmissions within clusters have been ongoing up till end of the study period. Besides being associated with more sequences and larger clusters, the C-EA Glade sequences were also associated with clustering of HIVDR sequences. One cluster was associated with the G190A mutation and showed onward transmissions at high rate. Conclusion TDR was detected in 6.0% of the sequenced samples and confirmed pervious reports that the two subtype C clades, C-EA and C'-ET, are common in Ethiopia. Moreover, the findings indicated an increased diversity in the epidemic as well as differences in transmission clusters sizes of the different clades and association with resistance mutations. These findings provide epidemiological insights not directly available using standard surveillance and may inform the adjustment of public health strategies in HIV prevention in Ethiopia.	[Arimide, Dawit Assefa; Bjorkman, Per; Medstrand, Patri K.] Lund Univ, Dept Translat Med, Malmo, Sweden; [Arimide, Dawit Assefa; Abebe, Almaz; Tilahun, Tesfaye; Kassa, Desta] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Kebede, Yenew] Ctr Dis Control & Prevent CDC Ethiopia, Addis Ababa, Ethiopia; [Adugna, Fekadu] World Hlth Org WHO Ethiopia, Addis Ababa, Ethiopia; [Assefa, Yibeltal] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Balcha, Taye Tolera] AHRI, Addis Ababa, Ethiopia	Lund University; World Health Organization; University of Queensland	Medstrand, PK (corresponding author), Lund Univ, Dept Translat Med, Malmo, Sweden.	patrik.medstrand@med.lu.se	Assefa, Yibeltal/N-5984-2016; Assefa, Yibeltal/ABI-8057-2020; Arimide, Dawit/AAR-9182-2021	Assefa, Yibeltal/0000-0003-2393-1492; Assefa, Yibeltal/0000-0003-2393-1492; Arimide, Dawit/0000-0001-9702-0216	CDC-Ethiopia; WHO-Ethiopia; Vetenskapsradet, Sweden [2015-05842]; Medical Faculty, Lund University, Sweden	CDC-Ethiopia; WHO-Ethiopia; Vetenskapsradet, Sweden(Swedish Research Council); Medical Faculty, Lund University, Sweden	This work received support from Grant number: NA; CDC-Ethiopia: https://www.cdc.gov/globalhealth/countries/ethiopia/; Grant number: NA; WHO-Ethiopia: http://www.afro.who.int/countries/ethiopia; Grant number: 2015-05842; Vetenskapsradet, Sweden: https://www.vr.se/; and Grant number: NA; Medical Faculty, Lund University, Sweden: https://www.med.lu.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe A, 1997, AIDS RES HUM RETROV, V13, P1071, DOI 10.1089/aid.1997.13.1071; Abebe A, 2000, AIDS RES HUM RETROV, V16, P1909, DOI 10.1089/08892220050195865; Abegaz WE, 2008, ANTIVIR THER, V13, P89; Aghokeng AF, 2011, AIDS, V25, P2183, DOI 10.1097/QAD.0b013e32834bbbe9; Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; Patino-Galindo JA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10286-1; Ayele W, 2010, AIDS RES HUM RETROV, V26, P805, DOI 10.1089/aid.2009.0152; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Beyrer C, 2017, NEW ENGL J MED, V377, P1605, DOI 10.1056/NEJMp1710608; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Bruhn CAW, 2014, AIDS, V28, P1031, DOI 10.1097/QAD.0000000000000198; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Castro H, 2013, J INFECT DIS, V208, P1459, DOI 10.1093/infdis/jit345; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; Delatorre EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041904; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Esbjornsson J, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew010; Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hamers RL, 2013, CURR OPIN HIV AIDS, V8, P19, DOI 10.1097/COH.0b013e32835b7f94; Hamers RL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4159; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hassan AS, 2017, AIDS, V31, P1211, DOI 10.1097/QAD.0000000000001470; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Huruy K, 2015, J MED VIROL, V87, P978, DOI 10.1002/jmv.24110; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kasang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023091; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kassu A, 2007, AIDS RES HUM RETROV, V23, P564, DOI 10.1089/aid.2006.0270; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Kiguoya MW, 2017, J VIROL, V91, DOI 10.1128/JVI.00253-17; Kityo C, 2017, JAIDS-J ACQ IMM DEF, V75, pE45, DOI [10.1097/QAI.0000000000001285, 10.1097/qai.0000000000001285]; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; LESTER FT, 1988, ETHIOPIAN MED J, V26, P139; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Ministry of Health Ethiopia, 2005, GUID IMPL ANT THER E; Mulu A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-158; Myatt M, 2008, ANTIVIR THER, V13, P37; Nazziwa J, 2013, AIDS RES HUM RETROV, V29, P788, DOI [10.1089/aid.2012.0123, 10.1089/AID.2012.0123]; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Pollakis G, 2003, AIDS RES HUM RETROV, V19, P999, DOI 10.1089/088922203322588350; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390; Sallam M, 2017, INFECT GENET EVOL, V49, P157, DOI 10.1016/j.meegid.2017.01.004; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Sigaloff KCE, 2012, AIDS RES HUM RETROV, V28, P171, DOI 10.1089/aid.2011.0136; Silverman RA, 2017, J INFECT DIS, V216, P1569, DOI 10.1093/infdis/jix544; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Telele NF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25888-6; The Ethiopian Public Health Institute, 2015, REP 2014 ROUND ANT C; Thomson MM, 2011, VIROLOGY, V415, P30, DOI 10.1016/j.virol.2011.03.021; Tilghman MW, 2014, HIV MED, V15, P339, DOI 10.1111/hiv.12122; TSEGA E, 1988, ETHIOPIAN MED J, V26, P179; Tully DC, 2010, AIDS, V24, P1577, DOI 10.1097/QAD.0b013e32833999e1; Van Blerk L, 2007, AIDS CARE, V19, P79, DOI 10.1080/09540120600805091; van Zyl GU, 2011, J MED VIROL, V83, P1764, DOI 10.1002/jmv.22189; Vermund SH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007195; Wallis CL, 2017, J INFECT DIS, V216, pS851, DOI 10.1093/infdis/jix409; Wertheim JO, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex008; Wilkinson E, 2016, INFECT GENET EVOL, V46, P200, DOI 10.1016/j.meegid.2016.07.008; Winand R, 2015, AIDS, V29, P2045, DOI 10.1097/QAD.0000000000000811; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11; World Health Organisation (WHO), 2017, HIV DRUG RES REP 201; World Health Organization, CONS GUID US ANT DRU; Yang WL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004722; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad; Zeh C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147436; Zhou ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028184	82	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205446	10.1371/journal.pone.0205446	http://dx.doi.org/10.1371/journal.pone.0205446			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304061	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100093
J	Dawson, DE; Keung, JH; Napoles, MG; Vella, MR; Chen, S; Sanderson, MW; Lanzas, C				Dawson, Daniel E.; Keung, Jocelyn H.; Napoles, Monica G.; Vella, Michael R.; Chen, Shi; Sanderson, Michael W.; Lanzas, Cristina			Investigating behavioral drivers of seasonal Shiga-Toxigenic Escherichia Coli (STEC) patterns in grazing cattle using an agent-based model	PLOS ONE			English	Article							COLI O157-H7; BEEF-CATTLE; INFECTIOUS-DISEASES; TEMPERATURE-DEPENDENCE; CLIMATE-CHANGE; HEAT-STRESS; PREVALENCE; TRANSMISSION; SURVIVAL; O157H7	The causes of seasonal variability in pathogen transmission are not well understood, and have not been comprehensively investigated. In an example for enteric pathogens, incidence of Escherichia coli O157 (STEC) colonization in cattle is consistently higher during warmer months compared to cooler months in various cattle production systems. However, actual mechanisms for this seasonality remain elusive. In addition, the influence of host (cattle) behavior on this pattern has not been thoroughly considered. To that end, we constructed a spatially explicit agent-based model that accounted for the effect of temperature fluctuations on cattle behavior (direct contact among cattle and indirect between cattle and environment), as well as its effect on pathogen survival in the environment. We then simulated the model in a factorial approach to evaluate the hypothesis that temperature fluctuations can lead to seasonal STEC transmission dynamics by influencing cattle aggregation, grazing, and drinking behaviors. Simulation results showed that higher temperatures increased the frequency at which cattle aggregated under shade in pasture, resulting in increased direct contact and transmission of STEC between individual cattle, and hence higher incidence over model simulations in the warm season. In contrast, increased drinking behavior during warm season was not an important transmission pathway. Although sensitivity analyses suggested that the relative importance of direct vs. indirect (environmental) pathways depend to upon model parameterization, model simulations indicated that factors influencing cattle aggregation, such as temperature, were likely strong drivers of transmission dynamics of enteric pathogens.	[Dawson, Daniel E.; Chen, Shi; Lanzas, Cristina] North Carolina State Univ, Coll Vet Med, Dept Pathobiol & Populat Hlth, Raleigh, NC 27695 USA; [Keung, Jocelyn H.; Napoles, Monica G.; Vella, Michael R.] Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN USA; [Chen, Shi] Univ North Carolina Charlotte, Coll Hlth & Human Serv, Dept Publ Hlth Sci, Charlotte, NC USA; [Sanderson, Michael W.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Ctr Outcomes Res & Epidemiol, Manhattan, KS 66506 USA	University of North Carolina; North Carolina State University; University of Tennessee System; University of Tennessee Knoxville; University of North Carolina; University of North Carolina Charlotte; Kansas State University	Dawson, DE (corresponding author), North Carolina State Univ, Coll Vet Med, Dept Pathobiol & Populat Hlth, Raleigh, NC 27695 USA.	dedawson@ncsu.edu		Dawson, Daniel/0000-0001-9622-4495; Lanzas, Cristina/0000-0002-4039-0336	National Institute for Mathematical and Biological Synthesis - National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF Award [EF-0832858]; University of Tennessee, Knoxville; U.S. National Institutes of Health (NIH) as part of the joint National Science Foundation (NSF)-NIH-United States Department of Agriculture (USDA) Ecology and Evolution of Infectious Diseases program [R01GM117618]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117618] Funding Source: NIH RePORTER	National Institute for Mathematical and Biological Synthesis - National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF Award; University of Tennessee, Knoxville; U.S. National Institutes of Health (NIH) as part of the joint National Science Foundation (NSF)-NIH-United States Department of Agriculture (USDA) Ecology and Evolution of Infectious Diseases program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was conducted with support to CL, SC, JK, MN, and MV from the National Institute for Mathematical and Biological Synthesis, an institute sponsored by the National Science Foundation (https://www.nsf.gov/), the U.S. Department of Homeland Security(https://www.dhs.gov/), and the U.S. Department of Agriculture through NSF Award #EF-0832858 (https://www.usda.gov/). Additional support was provided by The University of Tennessee, Knoxville (https://www.utk.edu/) and to CL by the U.S. National Institutes of Health (NIH) (https://www.nih.gov/) grant R01GM117618 as part of the joint National Science Foundation (NSF)-NIH-United States Department of Agriculture (USDA) Ecology and Evolution of Infectious Diseases program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MJ, 2006, J FOOD PROTECT, V69, P3018, DOI 10.4315/0362-028X-69.12.3018; Alam MJ, 2004, APPL ENVIRON MICROB, V70, P7578, DOI 10.1128/AEM.70.12.7578-7580.2004; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Armstrong GL, 1996, EPIDEMIOL REV, V18, P29, DOI 10.1093/oxfordjournals.epirev.a017914; Barkocy-Gallagher GA, 2004, J FOOD PROTECT, V67, P993, DOI 10.4315/0362-028X-67.5.993; Barkocy-Gallagher GA, 2003, J FOOD PROTECT, V66, P1978, DOI 10.4315/0362-028X-66.11.1978; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Berry ED, 2010, ADV FOOD NUTR RES, V60, P67, DOI 10.1016/S1043-4526(10)60004-6; Besser TE, 2001, EPIDEMIOL INFECT, V127, P555, DOI 10.1017/S095026880100615X; Besser TE, 1997, J INFECT DIS, V175, P726, DOI 10.1093/infdis/175.3.726; BLACKSHAW JK, 1994, AUST J EXP AGR, V34, P285, DOI 10.1071/EA9940285; Blaustein RA, 2013, WATER RES, V47, P569, DOI 10.1016/j.watres.2012.10.027; Bonnell TR, 2010, ECOL MODEL, V221, P2491, DOI 10.1016/j.ecolmodel.2010.07.020; BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608; Brouwer AF, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005481; Brown CA, 1997, APPL ENVIRON MICROB, V63, P27, DOI 10.1128/AEM.63.1.27-32.1997; Chen S, 2013, PREV VET MED, V109, P47, DOI 10.1016/j.prevetmed.2012.09.012; Chen S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03112; Cobbold RN, 2004, APPL ENVIRON MICROB, V70, P4375, DOI 10.1128/AEM.70.7.4375-4378.2004; Cortez MH, 2013, AM NAT, V181, pE43, DOI 10.1086/668826; CRAY WC, 1995, APPL ENVIRON MICROB, V61, P1586, DOI 10.1128/AEM.61.4.1586-1590.1995; Dion E, 2011, ECOL MODEL, V222, P2059, DOI 10.1016/j.ecolmodel.2011.03.026; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Edrington TS, 2006, FOODBORNE PATHOG DIS, V3, P413, DOI 10.1089/fpd.2006.3.413; Ekong PS, 2015, PREV VET MED, V121, P74, DOI 10.1016/j.prevetmed.2015.06.019; Fegan N, 2004, J APPL MICROBIOL, V97, P362, DOI 10.1111/j.1365-2672.2004.02300.x; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; *Flack S., 2016, ART SCI GRAZING; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Fremaux B, 2008, VET MICROBIOL, V132, P1, DOI 10.1016/j.vetmic.2008.05.015; Fremaux B, 2007, J APPL MICROBIOL, V102, P89, DOI 10.1111/j.1365-2672.2006.03059.x; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hahn GL, 1999, J ANIM SCI, V77, P10; Hamilton SA, 2015, MANAGING PASTURE YIE; Hancock DD, 1997, EPIDEMIOL INFECT, V118, P193, DOI 10.1017/S0950268896007212; Hoffmann I, 2010, ANIM GENET, V41, P32, DOI 10.1111/j.1365-2052.2010.02043.x; Khaitsa ML, 2006, J FOOD PROTECT, V69, P1154, DOI 10.4315/0362-028X-69.5.1154; Kulow MJ, 2012, APPL ENVIRON MICROB, V78, P8045, DOI 10.1128/AEM.02363-12; Lal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031883; Lanzas C, 2015, PREV VET MED, V118, P207, DOI 10.1016/j.prevetmed.2014.09.012; Le Cadre E, 2009, ENVIRON MODEL ASSESS, V14, P539, DOI 10.1007/s10666-008-9155-5; Lyons R. K., 2002, LIVESTOCK GRAZING DI; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Martinez G, 2013, ENVIRON INT, V54, P1, DOI 10.1016/j.envint.2012.12.013; McGee P, 2004, J FOOD PROTECT, V67, P2651, DOI 10.4315/0362-028X-67.12.2651; McGee P, 2002, J APPL MICROBIOL, V93, P706, DOI 10.1046/j.1365-2672.2002.01752.x; Mellor JE, 2016, SCI TOTAL ENVIRON, V548, P82, DOI 10.1016/j.scitotenv.2015.12.087; Mir RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148518; Mir RA, 2015, VET MICROBIOL, V175, P325, DOI 10.1016/j.vetmic.2014.12.016; Morrill JC, 2005, J ENVIRON ENG, V131, P139, DOI 10.1061/(ASCE)0733-9372(2005)131:1(139); Muirhead RW, 2009, SOIL USE MANAGE, V25, P389, DOI 10.1111/j.1475-2743.2009.00239.x; Nennich TD, 2005, J DAIRY SCI, V88, P3721, DOI 10.3168/jds.S0022-0302(05)73058-7; Ogden ID, 2004, FEMS MICROBIOL LETT, V233, P297, DOI 10.1111/j.1574-6968.2004.tb09495.x; Oliver DM, 2010, ENVIRON INT, V36, P1, DOI 10.1016/j.envint.2009.08.006; Pachepsky YA, 2006, AGR WATER MANAGE, V86, P81, DOI 10.1016/j.agwat.2006.06.010; Parish J, 2008, BEEF CATTLE WATER RE, P1; Pascual M, 2005, PLOS MED, V2, P18, DOI 10.1371/journal.pmed.0020005; Phillips C., 2002, CATTLE BEHAV WELFARE, P84; Pratt M., 2001, DETERMINING YOUR STO; Railsback S., 2012, AGENT BASED INDIVIDU; Rasmussen MA, 2001, CRIT REV MICROBIOL, V27, P57, DOI 10.1080/20014091096701; Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003; Renaudeau D, 2012, ANIMAL, V6, P707, DOI 10.1017/S1751731111002448; Rhoades JR, 2009, FOOD MICROBIOL, V26, P357, DOI 10.1016/j.fm.2008.10.012; Rind MI, 1999, ANIM SCI, V68, P589, DOI 10.1017/S135772980005061X; Rosselle L, 2013, J ANIM SCI, V91, P943, DOI 10.2527/jas.2012-5415; SATO S, 1991, APPL ANIM BEHAV SCI, V32, P3, DOI 10.1016/S0168-1591(05)80158-3; Smith RP, 2016, EPIDEMIOL INFECT, V144, P1818, DOI 10.1017/S095026881600008X; Spencer SEF, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0446; Synge BA, 2003, EPIDEMIOL INFECT, V130, P301, DOI 10.1017/S0950268802008208; Thiele JC, 2014, J STAT SOFTW, V58, P1; Van Donkersgoed J, 1999, CAN VET J, V40, P332; Wang GD, 1998, J FOOD PROTECT, V61, P662, DOI 10.4315/0362-028X-61.6.662; Williams MS, 2012, FOOD CONTROL, V27, P73, DOI 10.1016/j.foodcont.2012.03.007; Zuo HT, 2004, J RANGE MANAGE, V57, P426, DOI 10.2307/4003970; Zuur A, 2009, MIXED EFFECTS MODELS	79	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205418	10.1371/journal.pone.0205418	http://dx.doi.org/10.1371/journal.pone.0205418			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304002	gold, Green Published, Green Submitted			2022-12-26	WOS:000446921100089
J	Huebinger, J				Huebinger, Jan			Modification of cellular membranes conveys cryoprotection to cells during rapid, non-equilibrium cryopreservation	PLOS ONE			English	Article							VITRIFICATION; CHOLESTEROL; PRINCIPLES; RECOVERY; OOCYTES; EMBRYOS	Rapid cooling and re-warming has been shown promising to cryopreserve living cells, which cannot be preserved by conventional slow freezing methods. However, success is limited by the cytotoxicity of highly concentrated cryoprotective agents. Recent results have shown that cryoprotective agents do not need to suppress intracellular ice crystals completely to allow for survival after cryopreservation. Cryoprotective agents like DMSO or ethylene glycol can also lead to a tolerance of cells towards intracellular ice. It is however unclear by which mechanism this tolerance is achieved. These substances are also known to modulate properties of cellular membranes. It is shown here that cryoprotective DMSO and ethylene glycol have a clear influence on the mobility of lipids in the plasma membrane of HeLa cells. To isolate changes of the properties of plasma membranes from effects on ice formation, the membrane properties were modulated in absence of cryoprotective agents. This was achieved by changing their sterol content. In cells with elevated sterol content, an immobile lipid fraction was present, similar to cells treated with DMSO and ethylene glycol. These cells showed also significantly increased plasma membrane integrity after rapid freezing and thawing in the absence of classical cryoprotective agents. However, their intracellular lysosomes, which cannot be enriched with sterols, still got ruptured. These results clearly indicate that a modulation of membrane properties can convey cryoprotection. Upon slow cooling, elevated sterol content had actually an adverse effect on the plasma membranes, which shows that this effect is specific for rapid, non-equilibrium cooling processes. Unraveling this alternative mode of action of cryoprotection should help in the directed design of novel cryoprotective agents, which might be less cytotoxic than classical, empirically-found cryoprotective agents.	[Huebinger, Jan] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, Dortmund, Germany	Max Planck Society	Huebinger, J (corresponding author), Max Planck Inst Mol Physiol, Dept Syst Cell Biol, Dortmund, Germany.	jan.huebinger@mpi-dortmund.mpg.de		Huebinger, Jan/0000-0002-0225-4472				Akhoondi M, 2012, MOL MEMBR BIOL, V29, P197, DOI 10.3109/09687688.2012.699106; Akhoondi M, 2011, BBA-BIOMEMBRANES, V1808, P642, DOI 10.1016/j.bbamem.2010.11.021; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Best BP, 2015, REJUV RES, V18, P422, DOI 10.1089/rej.2014.1656; Bischof JC, 2002, CRYOBIOLOGY, V45, P22, DOI 10.1016/S0011-2240(02)00103-7; Christmann J, 2016, J PHYSIOL-LONDON, V594, P1663, DOI 10.1113/JP271245; Dabkowska AP, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3658382; DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413; Dubochet J, 2007, METHOD CELL BIOL, V79, P385, DOI 10.1016/S0091-679X(06)79015-X; Edgar DH, 2012, HUM REPROD UPDATE, V18, P536, DOI 10.1093/humupd/dms016; Elliott GD, 2017, CRYOBIOLOGY, V76, P74, DOI 10.1016/j.cryobiol.2017.04.004; Fahy GM, 2015, METHODS MOL BIOL, V1257, P21, DOI 10.1007/978-1-4939-2193-5_2; He XM, 2008, CRYOBIOLOGY, V56, P223, DOI 10.1016/j.cryobiol.2008.03.005; Horvath G, 2006, THERIOGENOLOGY, V66, P1026, DOI 10.1016/j.theriogenology.2006.03.004; Huebinger J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164270; Huebinger J, 2016, BIOPHYS J, V110, P840, DOI 10.1016/j.bpj.2015.09.029; LANGE Y, 1991, J LIPID RES, V32, P329; Moce E, 2010, REPROD DOMEST ANIM, V45, P57, DOI 10.1111/j.1439-0531.2010.01635.x; PARKS JE, 1987, BIOL REPROD, V37, P1249, DOI 10.1095/biolreprod37.5.1249; Pegg DE, 2015, METHODS MOL BIOL, V1257, P3, DOI 10.1007/978-1-4939-2193-5_1; Pierzynska-Mach A, 2014, CYTOM PART A, V85A, P729, DOI 10.1002/cyto.a.22495; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V; Wakelam MJO, 2007, METHOD ENZYMOL, V432, P233, DOI 10.1016/S0076-6879(07)32010-7; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	25	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205520	10.1371/journal.pone.0205520	http://dx.doi.org/10.1371/journal.pone.0205520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304023	Green Published, Green Submitted, gold			2022-12-26	WOS:000446921100102
J	Madsen, MD; Svejcar, L; Radke, J; Hulet, A				Madsen, Matthew D.; Svejcar, Lauren; Radke, Janae; Hulet, April			Inducing rapid seed germination of native cool season grasses with solid matrix priming and seed extrusion technology	PLOS ONE			English	Article							PERENNIAL GRASSES; GREAT-BASIN; RESTORATION; INCREASE; ENHANCEMENT; RECRUITMENT; DEMOGRAPHY; INVASIONS; DORMANCY	There is a need to develop effective techniques for establishing native vegetation in dryland ecosystems. We developed a novel treatment that primes (hydrates) seeds in a matrix of absorbent materials and bio-stimulants and then forms the mixture into pods for planting. In the development process, we determined optimal conditions for priming seeds and then compared seedling emergence from non-treated seeds, non-primed-seed pods, and primed-seed pods. Emergence trials were conducted on soils collected from a hillslope and ridgetop location on the Kaibab Plateau, Arizona, USA. Poa fendleriana and Pseudoroegneria spicata were used as test species. Seeds were primed from -0.5 to -2.5 MPa for up to 12 d. Seeds primed under drier conditions (-1.5 to -2.5 MPa) tended to have quicker germination. Days to 50% emergence for primed-seed pods was between 66.2 to 82.4% faster (5.2 to 14.5 d fewer) than non-treated seeds. Seedling emergence from primed-seed pods for P. fendleriana was 3.8-fold higher than non-treated seeds on the ridgetop soil, but no difference was found on the other soil. Final density of P. spicata primed-seed pods were 2.9 to 3.8-fold higher than non-treated seeds. Overall, primed-seed pods show promise for enhancing germination and seedling emergence, which could aid in native plant establishment.	[Madsen, Matthew D.; Svejcar, Lauren; Hulet, April] Eastern Oregon Agr Res Ctr, Burns, OR 97720 USA; [Madsen, Matthew D.; Radke, Janae] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [Svejcar, Lauren] Biodivers Conservat Ctr, Kings Pk & Bot Garden, Kings Park, WA, Australia; [Svejcar, Lauren] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia; [Hulet, April] Univ Idaho, Dept Forest Rangeland & Fire Sci, Moscow, ID 83843 USA	Brigham Young University; Murdoch University; Idaho; University of Idaho	Madsen, MD (corresponding author), Eastern Oregon Agr Res Ctr, Burns, OR 97720 USA.; Madsen, MD (corresponding author), Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA.	matthew.madsen@byu.edu	Madsen, Matthew/AAV-7493-2020	Madsen, Matthew/0000-0003-1398-8655	Kane and Two Mile Research and Stewardship Partnership; Oregon Department of Fish and Wildlife, US Fish and Wildlife Service - Wildlife and Sport Fish Restoration Program; USDA Agriculture Research Service; Brigham Young University	Kane and Two Mile Research and Stewardship Partnership; Oregon Department of Fish and Wildlife, US Fish and Wildlife Service - Wildlife and Sport Fish Restoration Program; USDA Agriculture Research Service(United States Department of Agriculture (USDA)); Brigham Young University	Funding for this research was provided by Kane and Two Mile Research and Stewardship Partnership; Oregon Department of Fish and Wildlife, US Fish and Wildlife Service - Wildlife and Sport Fish Restoration Program; USDA Agriculture Research Service; and Brigham Young University.	Bernstein EJ, 2014, RESTOR ECOL, V22, P57, DOI 10.1111/rec.12023; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Boyd CS, 2013, RANGELAND ECOL MANAG, V66, P117, DOI 10.2111/REM-D-11-00217.1; BRADFORD KJ, 1986, HORTSCIENCE, V21, P1105; Cassel D.K., 1986, METHODS SOIL ANAL 1; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davies KW, 2011, BIOL CONSERV, V144, P2573, DOI 10.1016/j.biocon.2011.07.016; Erickson TE, 2016, RESTOR ECOL, V24, pS64, DOI 10.1111/rec.12357; Gornish ES, 2015, OECOLOGIA, V177, P595, DOI 10.1007/s00442-014-3180-7; Guzzomi AL, 2016, RESTOR ECOL, V24, pS98, DOI 10.1111/rec.12386; Halmer P, 2008, ACTA HORTIC, P17, DOI 10.17660/ActaHortic.2008.771.1; HARDEGREE SP, 1992, J EXP BOT, V43, P233, DOI 10.1093/jxb/43.2.233; Hardegree SP, 1996, J RANGE MANAGE, V49, P87, DOI 10.2307/4002731; HARDEGREE SP, 1994, AGRON J, V86, P289, DOI 10.2134/agronj1994.00021962008600020015x; Hardegree SP, 2002, ANN BOT-LONDON, V89, P311, DOI 10.1093/aob/mcf043; Hardegree SP, 2016, RANGELAND ECOL MANAG, V69, P237, DOI 10.1016/j.rama.2016.04.007; Hardegree SP, 2010, ENVIRON EXP BOT, V69, P320, DOI 10.1016/j.envexpbot.2010.04.012; HARMAN GE, 1988, PHYTOPATHOLOGY, V78, P520, DOI 10.1094/Phyto-78-520; James JJ, 2011, J APPL ECOL, V48, P961, DOI 10.1111/j.1365-2664.2011.02009.x; MACK RN, 1983, J ECOL, V71, P69, DOI 10.2307/2259964; Madsen M. D., 2016, U.S. Patent No. US, Patent No. 9326451; Madsen MD, 2016, HORTTECHNOLOGY, V26, P379, DOI 10.21273/HORTTECH.26.4.379; Madsen MD, 2016, RESTOR ECOL, V24, pS77, DOI 10.1111/rec.12332; Madsen MD, 2014, AM SOC TEST MATER, V1569, P44, DOI 10.1520/STP156920120181; Madsen MD, 2016, NATIV PLANTS J, V17, P230, DOI [DOI 10.3368/NPJ.17.3.230, 10.3368/npj.17.3.230, DOI 10.3368/npj.17.3.230]; Madsen MD, 2016, U. S Patent Application, Patent No. [14/039,873, 14039873]; Nelleman C, 2010, DEAD PLANET LIVING P; Noda Chie, PATENT PUBLICATION; Pyke D. A., 2017, 1426 US GEOL SURV, DOI [10. 3133/cir1426, DOI 10.3133/CIR1426]; St Clair SB, 2016, ECOLOGY, V97, P1700, DOI 10.1002/ecy.1391; Svejcar T, 2017, PLANT ECOL, V218, P81, DOI 10.1007/s11258-016-0648-z; TARQUIS AM, 1992, J EXP BOT, V43, P307, DOI 10.1093/jxb/43.3.307; Taylor AG, 1998, SEED SCI RES, V8, P245, DOI 10.1017/S0960258500004141; TAYLOR AG, 1988, SCI HORTIC-AMSTERDAM, V37, P1, DOI 10.1016/0304-4238(88)90146-X; USDA, 1991, TERR EC SURV KAIB NA, P84; Vaughn KJ, 2015, ECOL APPL, V25, P791, DOI 10.1890/14-0922.1	36	16	16	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204380	10.1371/journal.pone.0204380	http://dx.doi.org/10.1371/journal.pone.0204380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303990	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100047
J	Malik, A; Khan, JM; Alamery, SF; Fouad, D; Labrou, NE; Daoud, MS; Abdelkader, MO; Ataya, FS				Malik, Ajamaluddin; Khan, Javed M.; Alamery, Selman F.; Fouad, Dalia; Labrou, Nikolaos E.; Daoud, Mohamed S.; Abdelkader, Mohamed O.; Ataya, Farid S.			Monomeric Camelus dromedarius GSTM1 at low pH is structurally more thermostable than its native dimeric form	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; CONFORMATIONAL STABILITY; THERMODYNAMIC PROPERTIES; CELL-PROLIFERATION; SIGNALING PATHWAYS; CRYSTAL-STRUCTURES; SUBUNIT INTERFACE; SUPERGENE FAMILY; EQUILIBRIUM; AGGREGATION	Glutathione S-transferases (GSTs) are multifunctional enzymes that play an important role in detoxification, cellular signalling, and the stress response. Camelus dromedarius is well-adapted to survive in extreme desert climate and it has GSTs, for which limited information is available. This study investigated the structure-function and thermodynamic properties of a mu-class camel GST (CdGSTM1) at different pH. Recombinant CdGSTM1 (25.7 kDa) was expressed in E. coli and purified to homogeneity. Dimeric CdGSTM1 dissociated into stable but inactive monomeric subunits at low pH. Conformational and thermodynamic changes during the thermal unfolding pathway of dimeric and monomeric CdGSTM1 were characterised via a thermal shift assay and dynamic multimode spectroscopy (DMS). The thermal shift assay based on intrinsic tryptophan fluorescence revealed that CdGSTM1 underwent a two-state unfolding pathway at pH 1.0-10.0. Its Tm value varied with varying pH. Another orthogonal technique based on far-UV CD also exhibited two-state unfolding in the dimeric and monomeric states. Generally, proteins tend to lose structural integrity and stability at low pH; however, monomeric CdGSTM1 at pH 2.0 was thermally more stable and unfolded with lower van't Hoff enthalpy. The present findings provide essential information regarding the structural, functional, and thermodynamic properties of CdGSTM1 at pH 1.0-10.0.	[Malik, Ajamaluddin; Alamery, Selman F.; Daoud, Mohamed S.; Abdelkader, Mohamed O.; Ataya, Farid S.] King Saud Univ, Coll Sci, Dept Biochem, Prot Res Chair, Riyadh, Saudi Arabia; [Khan, Javed M.] King Saud Univ, Fac Food & Agr Sci, Dept Food Sci & Nutr, Riyadh, Saudi Arabia; [Fouad, Dalia] King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia; [Fouad, Dalia] Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt; [Labrou, Nikolaos E.] Agr Univ Athens, Sch Food Biotechnol & Dev, Dept Biotechnol, Lab Enzyme Technol, Athens, Greece; [Daoud, Mohamed S.] Cairo Univ, King Fahd Unit Lab, Dept Clin & Chem Pathol, Kasr Al Ainy Univ Hosp, Cairo, Egypt; [Ataya, Farid S.] Natl Res Ctr, Mol Biol Dept, Genet Engn Div, Giza, Egypt	King Saud University; King Saud University; King Saud University; Egyptian Knowledge Bank (EKB); Helwan University; Agricultural University of Athens; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Malik, A (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Prot Res Chair, Riyadh, Saudi Arabia.	amalik@ksu.edu.sa	Labrou, Nikolaos/B-1089-2011; khan, Javed Masood/AAZ-8079-2021; Malik, Ajamaluddin/GYJ-1204-2022; Ataya, Farid Shokry/O-6570-2019; Fouad, Dalia/GQZ-4155-2022	Labrou, Nikolaos/0000-0003-1925-9867; khan, Javed Masood/0000-0003-0567-5712; Malik, Ajamaluddin/0000-0002-5578-0652; Ataya, Farid Shokry/0000-0002-0981-7805; Fouad, Dalia/0000-0002-8191-0895; Ataya, Farid/0000-0002-0247-5742	Deanship of Scientific Research at King Saud University [RGP-VPP-173]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through research group project number RGP-VPP-173.	ACETO A, 1992, BIOCHEM J, V285, P241, DOI 10.1042/bj2850241; Allocati N, 2006, BIOCHEM J, V394, P11, DOI 10.1042/BJ20051367; ARMSTRONG RN, 1991, CHEM RES TOXICOL, V4, P131, DOI 10.1021/tx00020a001; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Atkinson HJ, 2009, BIOCHEMISTRY-US, V48, P11108, DOI 10.1021/bi901180v; Bloom JD, 2007, GENETICS, V175, P255, DOI 10.1534/genetics.106.061754; Boscolo B, 2009, BBA-PROTEINS PROTEOM, V1794, P1041, DOI 10.1016/j.bbapap.2009.03.003; Bresell A, 2005, FEBS J, V272, P1688, DOI 10.1111/j.1742-4658.2005.04596.x; Codreanu SG, 2005, BIOCHEMISTRY-US, V44, P10605, DOI 10.1021/bi050836k; Cummins I, 2011, DRUG METAB REV, V43, P266, DOI 10.3109/03602532.2011.552910; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; DIRR HW, 1991, BIOCHEM BIOPH RES CO, V180, P294, DOI 10.1016/S0006-291X(05)81291-4; Dragani B, 2000, INT J BIOCHEM CELL B, V32, P725, DOI 10.1016/S1357-2725(00)00018-2; ENGELHARD M, 1995, PROTEIN SCI, V4, P1553, DOI 10.1002/pro.5560040813; ERHARDT J, 1995, EUR J BIOCHEM, V230, P614; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harper Sandra, 2008, Curr Protoc Protein Sci, VChapter 6, DOI 10.1002/0471140864.ps0606s52; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; He G, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01325; Hornby JAT, 2000, BIOCHEMISTRY-US, V39, P12336, DOI 10.1021/bi000176d; Hornby JAT, 2002, BIOCHEMISTRY-US, V41, P14238, DOI 10.1021/bi020548d; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; Johansson AS, 1998, J MOL BIOL, V278, P687, DOI 10.1006/jmbi.1998.1708; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kalita J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17678-3; Kaplan W, 1997, PROTEIN SCI, V6, P399; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khan JM, 2016, BIOCHEMISTRY-US, V55, P3920, DOI 10.1021/acs.biochem.5b01343; Khan JM, 2014, PHYS CHEM CHEM PHYS, V16, P5150, DOI 10.1039/c3cp54941k; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Lackowicz JR, 2004, PRINCIPLES FLUORESCE, DOI [10.1038/cdd.2010.80, DOI 10.1038/CDD.2010.80]; Liang Y, 2003, J BIOL CHEM, V278, P30098, DOI 10.1074/jbc.M304050200; Liu YJ, 2013, PLANT PHYSIOL, V161, P773, DOI 10.1104/pp.112.205815; LLC. Schrodinger, PYMOL MOL GRAPH SYST; Luo JK, 2002, PROTEIN SCI, V11, P2208, DOI 10.1110/ps.0208002; Malik A, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0744-3; Malik A, 2017, INT J BIOL MACROMOL, V102, P1052, DOI 10.1016/j.ijbiomac.2017.04.101; Malik A, 2016, INT J BIOL MACROMOL, V88, P313, DOI 10.1016/j.ijbiomac.2016.03.065; Malik A, 2015, EUR BIOPHYS J BIOPHY, V44, P17, DOI 10.1007/s00249-014-0997-2; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Nebert Daniel W., 2004, Human Genomics, V1, P460; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Oakley AJ, 2005, CURR OPIN STRUC BIOL, V15, P716, DOI 10.1016/j.sbi.2005.10.005; Oakley AJ, 2001, PROTEIN SCI, V10, P2176, DOI 10.1110/ps.21201; Perbandt M, 2004, J BIOL CHEM, V279, P1336, DOI 10.1074/jbc.M309663200; Sacchetta P, 1999, ARCH BIOCHEM BIOPHYS, V369, P100, DOI 10.1006/abbi.1999.1324; Salinas AE, 1999, CURR MED CHEM, V6, P279; Sayed Y, 2000, FEBS LETT, V465, P169, DOI 10.1016/S0014-5793(99)01747-0; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Singh S, 2015, CANCER CHEMOTH PHARM, V75, P1, DOI 10.1007/s00280-014-2566-x; SluisCremer N, 1996, EUR J BIOCHEM, V241, P484, DOI 10.1111/j.1432-1033.1996.00484.x; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stevens JM, 1998, BIOCHEMISTRY-US, V37, P15534, DOI 10.1021/bi981044b; Tew KD, 2011, FREE RADICAL BIO MED, V51, P299, DOI 10.1016/j.freeradbiomed.2011.04.013; Thompson LC, 2006, BIOCHEMISTRY-US, V45, P2267, DOI 10.1021/bi0519506; Vetri V, 2005, BIOPHYS CHEM, V113, P83, DOI 10.1016/j.bpc.2004.07.042; Wallace LA, 1998, BIOCHEMISTRY-US, V37, P5320, DOI 10.1021/bi972936z; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Watson EE, 2016, HUM ECOL, V44, P701, DOI 10.1007/s10745-016-9858-1; Winayanuwattikun P, 2004, BIOCHEM J, V382, P751, DOI 10.1042/BJ20040697; Wongsantichon J, 2006, BIOCHEM J, V394, P135, DOI 10.1042/BJ20050915; Wu HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5515; Zhu ZY, 1996, P NATL ACAD SCI USA, V93, P8350, DOI 10.1073/pnas.93.16.8350	69	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205274	10.1371/journal.pone.0205274	http://dx.doi.org/10.1371/journal.pone.0205274			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303997	gold, Green Published, Green Submitted			2022-12-26	WOS:000446921100075
J	Nishida, K; Hotta, K				Nishida, Kenshiro; Hotta, Kazuhiro			Robust cell particle detection to dense regions and subjective training samples based on prediction of particle center using convolutional neural network	PLOS ONE			English	Article								In recent years, finding the cause of pathogenesis is expected by observing the cell images. In this paper, we propose a cell particle detection method in cell images. However, there are mainly two kinds of problems in particle detection in cell image. The first is the different properties between cell images and standard images used in computer vision researches. Edges of cell particles are ambiguous, and overlaps between cell particles are often occurred in dense regions. It is difficult to detect cell particles by simple detection method using a binary classifier. The second is the ground truth made by cell biologists. The number of training samples for training a classifier is limited, and incorrect samples are included by the subjectivity of observers. From the background, we propose a cell particle detection method to address those problems. In our proposed method, we predict the center of a cell particle from the peripheral regions by convolutional neural network, and the prediction results are voted. By using the obvious peripheral edges, we can robustly detect overlapped cell particles because all edges of overlapping cell particles are not ambiguous. In addition, voting from peripheral views enables reliable detection. Moreover, our method is useful in practical applications because we can prepare many training samples from a cell particle. In experiments, we evaluate our detection methods on two kinds of cell detection datasets. One is challenging dataset for synthetic cells, and our method achieved the state-of-the-art performance. The other is real dataset of lipid droplets, and our method outperformed the conventional detector using CNN with binary outputs for particles and non-particles classification.	[Nishida, Kenshiro] Univ Meijo, Dept Elect & Elect Engn, Grad Sch Sci & Technol, Nagoya, Aichi, Japan; [Hotta, Kazuhiro] Univ Meijo, Dept Elect & Elect Engn, Fac Sci & Technol, Nagoya, Aichi, Japan		Nishida, K (corresponding author), Univ Meijo, Dept Elect & Elect Engn, Grad Sch Sci & Technol, Nagoya, Aichi, Japan.	110433076@ccmailg.meijo-u.ac.jp			MEXT/JSPS KAKENHI [16H01435]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT/JSPS KAKENHI Grant Number 16H01435 "Resonance Bio," https://reso.m.ehime-u.ac.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahmed E., 2015, PROC CVPR IEEE, DOI [10.1109/cvpr.2015.7299016, DOI 10.1109/CVPR.2015.7299016]; Anupama Kumar S., 2012, Proceedings of the 2012 International Conference on Recent Advances in Computing and Software Systems (RACSS), P67, DOI 10.1109/RACSS.2012.6212699; Arteta C, 2013, PROC CVPR IEEE, P3230, DOI 10.1109/CVPR.2013.415; Badrinarayanan V., 2015, IEEE T PATTERN ANAL, DOI [DOI 10.1109/TPAMI.2016.2644615, DOI 10.1103/PHYSREVX.5.041024]; Bertasius G, 2015, PROC CVPR IEEE, P4380, DOI 10.1109/CVPR.2015.7299067; Gall J, 2013, DECISION FORESTCOM, DOI [10.1007/978-1-4471-4929-3_11, DOI 10.1007/978-1-4471-4929-3_11]; Girshick R, 2014, P IEEE C COMP VIS PA, DOI [DOI 10.1109/CVPR.2014.81, 10.1109/CVPR.2014.81]; He KM, 2014, LECT NOTES COMPUT SC, V8691, P346, DOI 10.1007/978-3-319-10578-9_23; Karpathy A, 2014, PROC CVPR IEEE, P1725, DOI 10.1109/CVPR.2014.223; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Leibe B., 2004, ECCV WORKSH STAT LEA, P17, DOI DOI 10.1007/11957959_26; Lempitsky V., 2010, NIPS, P1324; Lin H., 2015, PROC CVPR IEEE, DOI [10.1109/CVPR.2015.7299170, DOI 10.1109/CVPR.2015.7299170]; Lin M, 2014, PUBLIC HEALTH NUTR, V17, P2029, DOI [10.1017/S1368980013002176, 10.1109/PLASMA.2013.6634954]; LIU S, 2015, PROC CVPR IEEE, P1419, DOI DOI 10.1109/CVPR.2015.7298748; Ma Z, 2015, PROC CVPR IEEE, P3689, DOI 10.1109/CVPR.2015.7298992; Onoro-Rubio D, 2016, LECT NOTES COMPUT SC, V9911, P615, DOI 10.1007/978-3-319-46478-7_38; Sirinukunwattana K, 2016, IEEE T MED IMAGING, V35, P1196, DOI 10.1109/TMI.2016.2525803; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Wollmann T, 2017, I S BIOMED IMAGING, P341, DOI 10.1109/ISBI.2017.7950533; Xie YP, 2015, LECT NOTES COMPUT SC, V9351, P374, DOI 10.1007/978-3-319-24574-4_45; Zhang N, 2014, PROC CVPR IEEE, P1637, DOI 10.1109/CVPR.2014.212	23	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0203646	10.1371/journal.pone.0203646	http://dx.doi.org/10.1371/journal.pone.0203646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303957	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100016
J	Ali, E; Orfi, J; Najib, A; Saleh, J				Ali, Emad; Orfi, Jamel; Najib, Abdullah; Saleh, Jehad			Enhancement of brackish water desalination using hybrid membrane distillation and reverse osmosis	PLOS ONE			English	Article							INTEGRATED MEMBRANE; THERMAL EFFICIENCY; GROUNDWATER; ENERGY	Desalination of geothermal brackish water by membrane distillation (MD) provides a low recovery rate, but integrating MD with reverse osmosis (RO) can maximize the production rate. In this study, different design configurations of a hybrid system involving brine recycling and cascading are studied via simulations, and the performance improvement due to the process integration is substantiated via the increased recovery rate and reduced specific energy consumption. Brine recycling is also found to improve the recovery rate considerably to 40% at an energy cost of 0.9 $/m(3). However, this achievement is only valid when the final brine is recycled to the RO feed: when the final brine is recycled to the MD feed, the overall performance degrades because the recycled brine cools the feed and causes a serious reduction in the driving force and the consequent production rate. Configuring the hybrid system in multiple stages connected in series increases the recovery rate to 90% and reduces the specific energy consumption to 0.9 MJ/kg. Although the specific energy cost increases dramatically because external inter-stage heating is implemented, using a free energy source (such as a geothermal or waste-energy source) for inter-stage heating could provide the optimum configuration.	[Ali, Emad; Saleh, Jehad] King Saud Univ, Dept Chem Engn, Riyadh, Saudi Arabia; [Orfi, Jamel; Najib, Abdullah] King Saud Univ, Dept Mech Engn, Riyadh, Saudi Arabia	King Saud University; King Saud University	Ali, E (corresponding author), King Saud Univ, Dept Chem Engn, Riyadh, Saudi Arabia.	amkamal@ksu.edu.sa	Orfi, Jamel/AAT-4595-2020	Orfi, Jamel/0000-0001-8537-5810; Emad, Ali Farid/0000-0003-1398-9914; Ali, Emadadeen/0000-0003-0657-2379	deanship of scientific research at King Saud University [1438-93]	deanship of scientific research at King Saud University(King Saud University)	The research is funded by the deanship of scientific research at King Saud University through the research group program number 1438-93. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alharbi M., 2014, THESIS; Ali E, 2018, DESALIN WATER TREAT, V116, P1, DOI 10.5004/dwt.2018.22471; Ali E, 2018, ARAB J SCI ENG, V43, P2413, DOI 10.1007/s13369-017-2831-5; Ali MI, 2012, DESALINATION, V306, P60, DOI 10.1016/j.desal.2012.07.043; Choi YJ, 2016, DESALIN WATER TREAT, V57, P24662, DOI 10.1080/19443994.2016.1152648; Criscuoli A, 1999, DESALINATION, V124, P243, DOI 10.1016/S0011-9164(99)00109-5; Davies PA, 2014, WATER-SUI, V6, P3409, DOI 10.3390/w6113409; Demirbas A, 2016, ENERG SOURCE PART A, V38, P2238, DOI 10.1080/15567036.2015.1045999; Drioli E, 2015, DESALINATION, V356, P56, DOI 10.1016/j.desal.2014.10.028; El-Bourawi MS, 2006, J MEMBRANE SCI, V285, P4, DOI 10.1016/j.memsci.2006.08.002; El-Zanati E, 2007, DESALINATION, V205, P15, DOI 10.1016/j.desal.2006.03.548; Guan GQ, 2015, DESALINATION, V366, P80, DOI 10.1016/j.desal.2015.01.013; Gude VG, 2016, RENEW SUST ENERG REV, V57, P1038, DOI 10.1016/j.rser.2015.12.186; Guillen E, 2011, DESALIN WATER TREAT, V31, P226, DOI 10.5004/dwt.2011.2395; Hamed OA, 2005, DESALINATION, V186, P207, DOI 10.1016/j.desal.2005.03.095; Lund JW, 2016, GEOTHERMICS, V60, P66, DOI 10.1016/j.geothermics.2015.11.004; Macedonio F, 2008, DESALINATION, V223, P396, DOI 10.1016/j.desal.2007.01.200; Manna AK, 2010, ENVIRON POLLUT, V158, P805, DOI 10.1016/j.envpol.2009.10.002; Mericq JP, 2010, WATER RES, V44, P5260, DOI 10.1016/j.watres.2010.06.052; Pangarkar B.L., 2011, ISRN MAT SCI, V2011, P1; Qtaishat MR, 2013, DESALINATION, V308, P186, DOI 10.1016/j.desal.2012.01.021; Summers EK, 2012, DESALINATION, V290, P54, DOI 10.1016/j.desal.2012.01.004; Swaminathan J., 2016, DESALIN WATER TREAT, V57, P1; Turton R., 2008, SYNTHESIS ANAL DESIG; Winter D, 2012, J MEMBRANE SCI, V423, P215, DOI 10.1016/j.memsci.2012.08.018; Zhang YG, 2015, DESALINATION, V367, P223, DOI 10.1016/j.desal.2015.04.013	26	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205012	10.1371/journal.pone.0205012	http://dx.doi.org/10.1371/journal.pone.0205012			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300370	Green Submitted, Green Published, gold			2022-12-26	WOS:000446897200030
J	Hsieh, JL; Jou, IM; Wu, CL; Wu, PT; Shiau, AL; Chong, HE; Lo, YT; Shen, PC; Chen, SY				Hsieh, Jeng-Long; Jou, I-Ming; Wu, Chao-Liang; Wu, Po-Ting; Shiau, Ai-Li; Chong, Hao-Earn; Lo, Yu-Ting; Shen, Po-Chuan; Chen, Shih-Yao			Estrogen and mechanical loading-related regulation of estrogen receptor-beta and apoptosis in tendinopathy	PLOS ONE			English	Article							CARPAL-TUNNEL-SYNDROME; HUMAN TENOCYTES; RISK-FACTORS; EXPRESSION; ACHILLES; STRAIN; GROWTH; INJURY; ALPHA; WOMEN	Female-dominant tendinopathies are musculoskeletal disorders caused by repetitive hand posture and motion; they are considered overuse syndromes. Both external mechanical stress and changes in hormone levels might affect disease progression. We have previously reported that estrogen receptor-beta (ER)-beta expression was associated with the pathogenesis of de Quervain's disease. To study the underlying mechanisms, a cyclic stretching culture system was applied to tendon tissue from ovariectomized (OVX) rats. Furthermore, a collagenase I-induced rat tendinopathy model was established to examine the association of ER-beta with disease progression. Our results showed that ER-beta expression and the number of apoptotic cells were higher and associated with disease severity in rats with tendinopathy. Mechanical stress altered the morphology of primary tenocytes and collagen fiber alignment in tendons, and up-regulated the expression of matrix metalloproteinase-9, ER-beta, and interleukin-1 beta, as well as induced apoptosis in tenocytes and tendon tissue from OVX rats. This is the first report on the effects of ER-beta and mechanical stress in tendinopathy. We hope these findings contribute to new pharmacological therapies targeting ER-beta signaling pathways to treat tendon-related diseases.	[Hsieh, Jeng-Long; Chong, Hao-Earn] Chung Hwa Univ Med Technol, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Jou, I-Ming] E DA Hosp, Dept Orthoped, Kaohsiung, Taiwan; [Wu, Chao-Liang] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan; [Wu, Po-Ting] Natl Cheng Kung Univ, Coll Med, Dept Orthoped, Tainan, Taiwan; [Shiau, Ai-Li; Lo, Yu-Ting] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan, Taiwan; [Shen, Po-Chuan] Tainan Hosp, Dept Orthoped, Minist Hlth & Welf, Tainan, Taiwan; [Shen, Po-Chuan; Chen, Shih-Yao] Chung Hwa Univ Med Technol, Dept Nursing, Tainan, Taiwan; [Chen, Shih-Yao] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan, Taiwan; [Chen, Shih-Yao] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan	Chung Hua University; E-Da Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Chung Hua University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Shen, PC (corresponding author), Tainan Hosp, Dept Orthoped, Minist Hlth & Welf, Tainan, Taiwan.; Shen, PC; Chen, SY (corresponding author), Chung Hwa Univ Med Technol, Dept Nursing, Tainan, Taiwan.; Chen, SY (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan, Taiwan.; Chen, SY (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan.	bcshen58@yahoo.com.tw; leonlai50@gmail.com	Chen, Shih-Yao/GXM-5182-2022	Chen, Shih-Yao/0000-0003-4929-855X; Wu, Po-Ting/0000-0001-5534-8993	Ministry of Science and Technology, Taiwan [MOST-105-2314-B-273-001-MY3, MOST-106-2320-B-006-074]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by MOST-105-2314-B-273-001-MY3 and MOST-106-2320-B-006-074, from the Ministry of Science and Technology, Taiwan.	[Anonymous], 2010, Harv Womens Health Watch, V17, P4; Bearoff F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117993; Borjesson AE, 2013, CELL MOL LIFE SCI, V70, P4023, DOI 10.1007/s00018-013-1317-1; Chagin AS, 2004, J BONE MINER RES, V19, P72, DOI 10.1359/JBMR.0301203; Chen J, 2014, OSTEOARTHR CARTILAGE, V22, P1861, DOI 10.1016/j.joca.2014.07.003; Clegg DJ, 2012, MOL ENDOCRINOL, V26, P1957, DOI 10.1210/me.2012-1284; Dale AM, 2015, AM J EPIDEMIOL, V181, P431, DOI 10.1093/aje/kwu286; Dey P, 2014, ONCOGENE, V33, P4213, DOI 10.1038/onc.2013.384; Heilskov-Hansen T, 2016, OCCUP ENVIRON MED, V73, P401, DOI 10.1136/oemed-2015-103298; Huttunen TT, 2014, AM J SPORT MED, V42, P2419, DOI 10.1177/0363546514540599; Jones ER, 2013, BBA-MOL CELL RES, V1833, P2596, DOI 10.1016/j.bbamcr.2013.06.019; Kato M, 2010, OSTEOARTHR CARTILAGE, V18, P934, DOI 10.1016/j.joca.2010.03.008; Kim JK, 2010, J ORTHOP RES, V28, P1469, DOI 10.1002/jor.21160; Kovacs WJ, 2011, NAT REV RHEUMATOL, V7, P307, DOI 10.1038/nrrheum.2010.231; Laoopugsin N, 2012, J HAND SURG-ASIAN-PA, V17, P205, DOI 10.1142/S0218810412500207; Le Manac'h AP, 2011, SCAND J WORK ENV HEA, V37, P394, DOI 10.5271/sjweh.3160; Lee SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05466-y; De la Parra-Marquez ML, 2008, CIR CIR, V76, P317; Lian O, 2007, AM J SPORT MED, V35, P605, DOI 10.1177/0363546506295702; Oshiro W, 2003, J HAND SURG-AM, V28A, P814, DOI 10.1016/S0363-5023(03)00366-6; PASCUAL E, 1991, BRIT J RHEUMATOL, V30, P60; Pavao M, 2001, STEROIDS, V66, P1, DOI 10.1016/S0039-128X(00)00143-4; Pearce CJ, 2009, AM J SPORT MED, V37, P2440, DOI 10.1177/0363546509340264; Rosenzweig DH, 2014, INT J MOL SCI, V15, P14427, DOI 10.3390/ijms150814427; Scott A, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.015164; Shakibaei M, 2011, HISTOL HISTOPATHOL, V26, P1173, DOI 10.14670/HH-26.1173; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Shen PC, 2015, INT J MOL SCI, V16, P26452, DOI 10.3390/ijms161125968; Spoendlin J, 2016, J DIABETES COMPLICAT, V30, P903, DOI 10.1016/j.jdiacomp.2016.02.017; Wise BL, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.05.027; Wu PT, 2017, SCI REP-UK, V7, DOI 10.1038/srep40840; Wu PT, 2014, J SHOULDER ELB SURG, V23, P1099, DOI 10.1016/j.jse.2013.11.013; Yasui Y, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7021862; Yuan J, 2002, J ORTHOP RES, V20, P1372, DOI 10.1016/S0736-0266(02)00075-X; Zhang KR, 2015, BIOCHEM BIOPH RES CO, V463, P667, DOI 10.1016/j.bbrc.2015.05.122	35	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0204603	10.1371/journal.pone.0204603	http://dx.doi.org/10.1371/journal.pone.0204603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296306	Green Published, Green Submitted, gold			2022-12-26	WOS:000446632700013
J	Mobley, MW; Gegear, RJ				Mobley, Melissa W.; Gegear, Robert J.			One size does not fit all: Caste and sex differences in the response of bumblebees (Bombus impatiens) to chronic oral neonicotinoid exposure	PLOS ONE			English	Article							ENVIRONMENTAL FATE; OSMIA-LIGNARIA; BEES BOMBUS; CLOTHIANIDIN; HYMENOPTERA; PESTICIDES; DECLINE; INSECTICIDES; APIDAE; CONSERVATION	Neonicotinoid insecticides have been implicated in the rapid global decline of bumblebees over recent years, particularly in agricultural and urban areas. While there is much known about neonicotinoid toxicity effects at the colony stage of the bumblebee annual cycle, far less is known about such effects at other stages critical for the maintenance of wild populations. In the present work, individual-based feeding assays were used to show that chronic consumption of the widely used neonicotinoid clothianidin at a field-realistic average rate of 3.6 and 4.0 ng/g.bee/day reduces survival of queen and male bumblebees, respectively, within a 7-day period. In contrast, worker survival was unaffected at a similar consumption rate of 3.9 ng/g.bee/day. To test the hypothesis that males have a lower tolerance for oral clothianidin exposure than workers due to their haploid genetic status, RNAseq analysis was used to compare the transcriptomic responses of workers and males to chronic intake of clothianidin at a sub-lethal dose of 0.37ng/bee/day for 5 days. Surprisingly, clothianidin consumption only altered the expression of 19 putative detoxification genes in a sex-specific manner, with 11/19 genes showing increased expression in workers. Sub-lethal clothianidin exposure also altered the expression of 40 genes associated with other major biological functions, including locomotion, reproduction, and immunity. Collectively, these results suggest that chronic oral toxicity effects of neonicotinoids are greatest during mating and nest establishment phases of the bumblebee life cycle. Chronic oral toxicity testing on males and queens is therefore required in order to fully assess the impact of neonicotinoids on wild bumblebee populations.	[Mobley, Melissa W.; Gegear, Robert J.] Worcester Polytech Inst, Dept Biol & Biotechnol, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Gegear, RJ (corresponding author), Worcester Polytech Inst, Dept Biol & Biotechnol, Worcester, MA 01609 USA.	rgegear@wpi.edu		Gegear, Robert/0000-0001-9886-1324	National Science Foundation [1501737]	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation (grant #1501737). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott VA, 2008, J ECON ENTOMOL, V101, P784, DOI 10.1603/0022-0493(2008)101[784:LASEOI]2.0.CO;2; Alkassab AT, 2016, ECOTOXICOLOGY, V25, P1000, DOI 10.1007/s10646-016-1657-3; Arce AN, 2017, J APPL ECOL, V54, P1199, DOI 10.1111/1365-2664.12792; Arena M, 2014, ECOTOXICOLOGY, V23, P324, DOI 10.1007/s10646-014-1190-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Cabrera AR, 2016, INTEGR ENVIRON ASSES, V12, P222, DOI 10.1002/ieam.1675; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chaimanee V, 2016, J INSECT PHYSIOL, V89, P1, DOI 10.1016/j.jinsphys.2016.03.004; Colla SR, 2008, BIODIVERS CONSERV, V17, P1379, DOI 10.1007/s10531-008-9340-5; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; David A, 2016, ENVIRON INT, V88, P169, DOI 10.1016/j.envint.2015.12.011; de Perre C, 2015, ENVIRON TOXICOL CHEM, V34, P258, DOI 10.1002/etc.2800; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Devillers J, 2003, SAR QSAR ENVIRON RES, V14, P389, DOI 10.1080/10629360310001623980; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Fauser-Misslin A, 2014, J APPL ECOL, V51, P450, DOI 10.1111/1365-2664.12188; Gels JA, 2002, J ECON ENTOMOL, V95, P722, DOI 10.1603/0022-0493-95.4.722; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; HEINRICH B, 1983, PHYSIOL ZOOL, V56, P552, DOI 10.1086/physzool.56.4.30155878; Heinrich B., 1979, BUMBLEBEE EC; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; de Oliveira IM, 2010, TOXICOL LETT, V192, P294, DOI 10.1016/j.toxlet.2009.11.005; Main AR, 2016, AGR ECOSYST ENVIRON, V215, P76, DOI 10.1016/j.agee.2015.09.011; Manjon C, 2018, CURR BIOL, V28, P1137, DOI 10.1016/j.cub.2018.02.045; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; O'Donnell S, 2004, P ROY SOC B-BIOL SCI, V271, P979, DOI 10.1098/rspb.2004.2685; Pecenka JR, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-015-1270-y; Rabhi KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114411; Sadd BM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0623-3; Schroder P, 2002, INT J PHYTOREMEDIAT, V4, P247, DOI 10.1080/15226510208500086; Scott-Dupree CD, 2009, J ECON ENTOMOL, V102, P177, DOI 10.1603/029.102.0125; Sheets LP, 2016, CRIT REV TOXICOL, V46, P153, DOI 10.3109/10408444.2015.1090948; Spurgeon D., 2016, EFSA SUPPORT PUBL, V13, P66, DOI [10.2903/sp.efsa.2016.EN-1076, DOI 10.2903/SP.EFSA.2016.EN-1076]; Thompson HM, 2015, PEST MANAG SCI, V71, P946, DOI 10.1002/ps.3868; Whiting SA, 2014, SCI TOTAL ENVIRON, V497, P534, DOI 10.1016/j.scitotenv.2014.07.115; Wood TJ, 2017, ENVIRON SCI POLLUT R, V24, P17285, DOI 10.1007/s11356-017-9240-x; Woodard SH, 2015, MOL ECOL, V24, P2916, DOI 10.1111/mec.13198; Wu JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016521; Xu JH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-874	46	13	13	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0200041	10.1371/journal.pone.0200041	http://dx.doi.org/10.1371/journal.pone.0200041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296261	Green Published, Green Submitted, gold			2022-12-26	WOS:000446632700003
J	Beckmann, N; Pugh, AM; Caldwell, CC				Beckmann, Nadine; Pugh, Amanda M.; Caldwell, Charles C.			Burn injury alters the intestinal microbiome's taxonomic composition and functional gene expression	PLOS ONE			English	Article							BACTERIAL TRANSLOCATION; GUT; MICROFLORA; INFECTION; ALIGNMENT; SCALD; ACID	Burn patients have a high risk of sepsis-related mortality even after surviving the initial injury. Immunosuppression increases the risk of sepsis after burn injury, as does the disruption of the intestinal epithelial barrier, which allows the translocation of bacteria and bacterial products into the circulation. The integrity of the intestinal epithelial barrier is largely maintained by the intestinal microbiota. Burn injury has been reported to result in significant changes in the intestinal microbiome composition. In this mouse study, we confirm these taxonomic differences in a full-thickness scald injury model using CF-1 mice. For the first time, we also address alterations in functional gene expression of the intestinal microbiota after burn injury to assess the microbiome's physiological capabilities for overgrowth and pathogenic invasion: 38 pathways were differentially abundant between the sham and burn injury mice, including bacterial invasion of epithelial cells and gap- and adherens junction pathways.	[Beckmann, Nadine; Pugh, Amanda M.; Caldwell, Charles C.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [Caldwell, Charles C.] Shriners Hosp Children, Div Res, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati	Caldwell, CC (corresponding author), Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA.; Caldwell, CC (corresponding author), Shriners Hosp Children, Div Res, Cincinnati, OH 45229 USA.	Charles.caldwell@uc.edu		Caldwell, Charles/0000-0003-1692-4550	Shriner's of North America - Cincinnati	Shriner's of North America - Cincinnati	This study was supported by the Hardisty Pilot Grant from the Shriner's of North America - Cincinnati awarded to Charles C. Caldwell (https://www.shrinershospitalsforchildren.org/shc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awadel-Kariem FM, 2010, ANAEROBE, V16, P223, DOI 10.1016/j.anaerobe.2010.01.001; Bar K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-145; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Bien J, 2013, THER ADV GASTROENTER, V6, P53, DOI 10.1177/1756283X12454590; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Cummings JH, 1997, NUTRITION, V13, P476, DOI 10.1016/S0899-9007(97)00114-7; d'Hennezel E, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00046-17; Earley ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129996; Faunce DE, 1999, BURNS, V25, P403, DOI 10.1016/S0305-4179(99)00014-5; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hanschen M, 2011, SHOCK, V35, P252, DOI 10.1097/SHK.0b013e3181f489c5; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kuethe JW, 2016, SHOCK, V45, P647, DOI 10.1097/SHK.0000000000000551; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsen PE, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0084-3; Lichtman SM, 2001, J PEDIATR GASTR NUTR, V33, P1, DOI 10.1097/00005176-200107000-00001; MacConmara MP, 2011, J LEUKOCYTE BIOL, V89, P137, DOI 10.1189/jlb.0210082; MacFie J, 1999, GUT, V45, P223, DOI 10.1136/gut.45.2.223; Magnotti LJ, 2005, J BURN CARE REHABIL, V26, P383, DOI 10.1097/01.bcr.0000176878.79267.e8; MOSS NM, 1988, SURGERY, V104, P882; Namazi MR, 2004, AUTOIMMUNITY, V37, P73, DOI 10.1080/08916930310001637968; Nothaft H, 2013, J BIOL CHEM, V288, P6912, DOI 10.1074/jbc.R112.417857; Rice TC, 2017, CELL IMMUNOL, V313, P25, DOI 10.1016/j.cellimm.2016.12.004; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sydenham TV, 2014, J CLIN MICROBIOL, V52, P1304, DOI 10.1128/JCM.03128-13; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Tschop J, 2009, SHOCK, V31, P157, DOI 10.1097/SHK.0b013e31817fbf4d; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	36	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205307	10.1371/journal.pone.0205307	http://dx.doi.org/10.1371/journal.pone.0205307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289947	Green Submitted, Green Published, gold			2022-12-26	WOS:000446545500064
J	Feiner, ZS; Foley, CJ; Bootsma, HA; Czesny, SJ; Janssen, J; Rinchard, J; Hook, TO				Feiner, Zachary S.; Foley, Carolyn J.; Bootsma, Harvey A.; Czesny, Sergiusz J.; Janssen, John; Rinchard, Jacques; Hook, Tomas O.			Species identity matters when interpreting trophic markers in aquatic food webs	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; STABLE-ISOTOPES; NEOGOBIUS-MELANOSTOMUS; LAKE-MICHIGAN; ROUND GOBY; FUNCTIONAL-CHARACTERIZATION; PREY FISH; DIET; MARINE; CARBON	In aquatic systems, food web linkages are often assessed using diet contents, stable isotope ratios, and, increasingly, fatty acid composition of organisms. Some correlations between different trophic metrics are assumed to be well-supported; for example, particular stable isotope ratios and fatty acids seem to reflect reliance on benthic or pelagic energy pathways. However, understanding whether the assumed correlations between different trophic metrics are coherent and consistent across species represents a key step toward their effective use in food web studies. To assess links among trophic markers, we compared relationships between major diet components, fatty acids, and stable isotope ratios in three fishes: yellow perch (Perca flavescens), round goby (Neogobius melanostomus), and spottail shiner (Notropis hudsonius) collected from nearshore Lake Michigan. Yellow perch and spottail shiner are native in this system, while round goby are a relatively recent invader. We found some evidence for agreement between different trophic metrics, especially between diet components, n-3:n-6 fatty acid ratios, and stable isotope ratios (delta C-13 and delta N-15). However, we also observed significant variation in observed relationships among markers and species, potentially due to taxonomic variation in the specific diet items consumed (e.g., chydorid microcrustaceans and Dreissena mussels) and species-specific biochemical processes. In many of these latter cases, the invasive species differed from the native species. Understanding the effects of taxonomic variation on prey and predator signatures could significantly improve the usefulness of fatty acids in food web studies, whereas diet contents and stable isotopes appear to be reliable indicators of trophic niche in aquatic food webs.	[Feiner, Zachary S.; Foley, Carolyn J.; Hook, Tomas O.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Foley, Carolyn J.; Hook, Tomas O.] Purdue Univ, Illinois Indiana Sea Grant, W Lafayette, IN 47907 USA; [Bootsma, Harvey A.; Janssen, John] Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53201 USA; [Czesny, Sergiusz J.] Univ Illinois, Lake Michigan Biol Stn, Illinois Nat Hist Survey, Zion, IL USA; [Rinchard, Jacques] SUNY Coll Brockport, Dept Environm Sci & Ecol, Brockport, NY 14420 USA; [Feiner, Zachary S.] Wisconsin Dept Nat Resources, Sci Operat Ctr, Off Appl Sci, Madison, WI USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Wisconsin System; University of Wisconsin Milwaukee; Illinois Natural History Survey; University of Illinois System; State University of New York (SUNY) System	Foley, CJ (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.; Foley, CJ (corresponding author), Purdue Univ, Illinois Indiana Sea Grant, W Lafayette, IN 47907 USA.	cfoley@purdue.edu	Feiner, Zachary S/A-2117-2009	Feiner, Zachary S/0000-0001-7880-0778	NOAA Sea Grant State Programs Illinois-Indiana Sea Grant [NA10OAR4170068]; Michigan Sea Grant [NA05OAR4171045]; Wisconsin Sea Grant [R/RegHCE-4]; US Environmental Protection Agency Great Lakes National Program Office through the Great Lakes Restoration Initiative [EPA GL-00E00720]; National Park Service; Purdue University Department of Forestry and Natural Resources	NOAA Sea Grant State Programs Illinois-Indiana Sea Grant; Michigan Sea Grant; Wisconsin Sea Grant; US Environmental Protection Agency Great Lakes National Program Office through the Great Lakes Restoration Initiative; National Park Service; Purdue University Department of Forestry and Natural Resources	Funding for this project was provided by NOAA Sea Grant State Programs Illinois-Indiana Sea Grant (www.iiseagrant.org grant no. NA10OAR4170068), Michigan Sea Grant (www.miseagrant.umich.edu/ grant no. NA05OAR4171045), Wisconsin Sea Grant (www.seagrant.wisc.edu/ grant no. R/RegHCE-4), the US Environmental Protection Agency Great Lakes National Program Office through the Great Lakes Restoration Initiative (https://www.glri.us/ grant no. EPA GL-00E00720), the National Park Service (www.nps.gov), and the Purdue University Department of Forestry and Natural Resources (www.ag.purdue.edu/fnr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Ayad SMEA, 2000, FISH PHYSIOL BIOCHEM, V23, P233, DOI 10.1023/A:1007891922182; Ahlgren G, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P147, DOI 10.1007/978-0-387-89366-2_7; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; BELL MV, 1986, COMP BIOCHEM PHYS B, V83, P711, DOI 10.1016/0305-0491(86)90135-5; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Brush JM, 2012, CAN J FISH AQUAT SCI, V69, P573, DOI 10.1139/F2012-001; Budge SM, 2006, MAR MAMMAL SCI, V22, P759, DOI 10.1111/j.1748-7692.2006.00079.x; Corkum LD, 2004, BIOL INVASIONS, V6, P173, DOI 10.1023/B:BINV.0000022136.43502.db; Czesny S, 1999, AQUACULTURE, V178, P103, DOI 10.1016/S0044-8486(99)00120-9; Czesny SJ, 2011, CAN J FISH AQUAT SCI, V68, P1211, DOI 10.1139/F2011-048; Dethier MN, 2013, MAR ECOL PROG SER, V478, P1, DOI 10.3354/meps10310; Foley C.J., 2017, FOOD WEBS, V10, P26, DOI [10.1016/j.fooweb.2016.10.001, DOI 10.1016/J.FOOWEB.2016.10.001]; Fry B., 2006, STABLE ISOTOPE ECOLO; Galvan DE, 2012, OECOLOGIA, V169, P1083, DOI 10.1007/s00442-012-2273-4; Ghioni C, 1996, COMP BIOCHEM PHYS B, V114, P161, DOI 10.1016/0305-0491(96)00019-3; Ghomi MR, 2014, J APPL ICHTHYOL, V30, P527, DOI 10.1111/jai.12312; Gu B, 1996, J FISH BIOL, V49, P1233, DOI 10.1111/j.1095-8649.1996.tb01792.x; Hanson CE, 2010, AQUAT BOT, V93, P114, DOI 10.1016/j.aquabot.2010.04.004; Happel A, 2016, CAN J FISH AQUAT SCI, V73, P1222, DOI 10.1139/cjfas-2015-0328; Happel A, 2015, J GREAT LAKES RES, V41, P172, DOI 10.1016/j.jglr.2015.03.025; Happel A, 2015, J GREAT LAKES RES, V41, P179, DOI 10.1016/j.jglr.2015.04.013; Hecky RE, 1995, J N AM BENTHOL SOC, V14, P631, DOI 10.2307/1467546; Henderson RJ, 1996, ARCH ANIM NUTR, V49, P5, DOI 10.1080/17450399609381859; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Kelly JR, 2012, MAR ECOL PROG SER, V446, P1, DOI 10.3354/meps09559; Kirsch PE, 1998, CAN J FISH AQUAT SCI, V55, P1378, DOI 10.1139/cjfas-55-6-1378; Li CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199713; Masclaux H, 2014, AQUAT SCI, V76, P73, DOI 10.1007/s00027-013-0314-7; McMeans BC, 2016, ECOL MONOGR, V86, P4, DOI 10.1890/15-0288.1; Moles MD, 2008, CAN J FISH AQUAT SCI, V65, P600, DOI 10.1139/F07-186; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Nakano S, 1999, ECOLOGY, V80, P2435; Napolitano GE, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P21; Nielsen JM, 2018, METHODS ECOL EVOL, V9, P278, DOI 10.1111/2041-210X.12869; Paterson G, 2014, FRESHWATER BIOL, V59, P2150, DOI 10.1111/fwb.12418; Perga ME, 2005, OECOLOGIA, V144, P598, DOI 10.1007/s00442-005-0069-5; Persson J, 2006, FRESHWATER BIOL, V51, P887, DOI 10.1111/j.1365-2427.2006.01540.x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; PIERCE GJ, 1991, OCEANOGR MAR BIOL, V29, P409; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Roswell CR, 2013, ECOL FRESHW FISH, V22, P479, DOI 10.1111/eff.12041; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Smyntek PM, 2008, FRESHWATER BIOL, V53, P1768, DOI 10.1111/j.1365-2427.2008.02001.x; Tocher DR, 2006, LIPIDS, V41, P1003, DOI 10.1007/s11745-006-5051-4; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Torres-Ruiz M, 2007, J N AM BENTHOL SOC, V26, P509, DOI 10.1899/06-070.1; Turschak BA, 2014, ECOLOGY, V95, P1243, DOI 10.1890/13-0329.1; Vander Zanden MJ, 2006, CAN J FISH AQUAT SCI, V63, P2608, DOI 10.1139/F06-148; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; Vanderploeg HA, 2010, J GREAT LAKES RES, V36, P50, DOI 10.1016/j.jglr.2010.04.005; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; West JM, 2003, ENVIRON BIOL FISH, V67, P297, DOI 10.1023/A:1025843300415; Wiegand MD, 2004, CAN J FISH AQUAT SCI, V61, P110, DOI 10.1139/F03-146	62	3	3	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204767	10.1371/journal.pone.0204767	http://dx.doi.org/10.1371/journal.pone.0204767			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289888	Green Published, Green Submitted, gold			2022-12-26	WOS:000446545500023
J	Morellato, J; Chik, W; Barry, MA; Lu, JT; Thiagalingam, A; Kovoor, P; Pouliopoulos, J				Morellato, John; Chik, William; Barry, M. A.; Lu, Juntang; Thiagalingam, Aravinda; Kovoor, Pramesh; Pouliopoulos, Jim			Quantitative spectral assessment of intracardiac electrogram characteristics associated with post infarct fibrosis and ventricular tachycardia	PLOS ONE			English	Article							SIGNAL-AVERAGED ELECTROCARDIOGRAMS; MYOCARDIAL-INFARCTION; OVINE MODEL; FRACTIONATED ELECTROGRAMS; ARRHYTHMOGENIC SUBSTRATE; PROGNOSTIC-SIGNIFICANCE; RECORDING TECHNIQUES; ELECTRICAL-ACTIVITY; TRANSFORM ANALYSIS; CATHETER ABLATION	Background Post-myocardial infarction (MI) remodeling contributes to increased electrophysiological and structural heterogeneity and arrhythmogenesis. Utilising the post-infarct ovine model our aim was to determine unipolar electrogram frequency characteristics consequent to this remodeling and the development of Ventricular Tachycardia (VT). Methods and results Mapping studies were performed on 14 sheep at > 1 month post-MI induction. Sheep were divided into VT inducible (n = 7) and non-inducible (n = 7) groups. Multielectrode needles (n = 20) were deployed within and surrounding ventricular scar for electrophysiological assessment of electrogram amplitude and width. Spectral analysis of electrograms was undertaken using wavelet and fast fourier transformations (WFFT) to calculate root mean square (RMS) power intervals spanning 0-300Hz in 20Hz intervals. Quantitative assessment between electrophysiological and histological parameters including collagen density, and structural organization of the myocardium was performed. Increasing myocardial scar density resulted in attenuation of electrogram amplitude and RMS values. (all p<0.01). Between groups there were no differences in electrogram amplitude (p = 0.37), however WFFT analysis revealed significantly higher RMS values in the VT group (p<0.05) in association with high frequency fractional components of the electrogram. As scar density increased, greater between-group differences in RMS were observed spanning this high frequency (200-280Hz) spectrum and which were proportionally dependent on the degree of structural disorganisation of the myocardium (p<0.001) and number of extrastimuli required to induce VT (p<0.05). Conclusion High frequency unipolar electrogram spectral characteristics were quantitatively co-influenced by the presence of fibrosis and degree of myocardial structural dissorganisation and were associated with the propensity for development of VT.	[Morellato, John; Chik, William; Thiagalingam, Aravinda; Kovoor, Pramesh; Pouliopoulos, Jim] Univ Sydney, Sydney, NSW, Australia; [Chik, William; Barry, M. A.; Lu, Juntang; Thiagalingam, Aravinda; Kovoor, Pramesh; Pouliopoulos, Jim] Westmead Hosp, Dept Cardiol, Sydney, NSW, Australia	University of Sydney; University of Sydney	Pouliopoulos, J (corresponding author), Univ Sydney, Sydney, NSW, Australia.; Pouliopoulos, J (corresponding author), Westmead Hosp, Dept Cardiol, Sydney, NSW, Australia.	jim.pouliopoulos@gmail.com		Pouliopoulos, Jim/0000-0002-9160-8630	Sydney Medical School - Early Career Researcher Grant; University of Sydney; National Health and Medical Research Council, Australia [402669]	Sydney Medical School - Early Career Researcher Grant; University of Sydney(University of Sydney); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a project grant from a Sydney Medical School - Early Career Researcher Grant, the University of Sydney [J.P], and The National Health and Medical Research Council, Australia [grant #402669 to P.K].	AbdelWahab A, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1181, DOI 10.1161/CIRCEP.115.002940; Aliot EM, 2009, HEART RHYTHM, V6, P886, DOI 10.1016/j.hrthm.2009.04.030; Bogun F, 2005, J AM COLL CARDIOL, V46, P667, DOI 10.1016/j.jacc.2005.01.064; BOURKE JP, 1995, AM J CARDIOL, V75, P431, DOI 10.1016/S0002-9149(99)80576-1; CABO C, 1990, IEEE T BIO-MED ENG, V37, P500, DOI 10.1109/10.55640; CAIN ME, 1984, CIRCULATION, V69, P711, DOI 10.1161/01.CIR.69.4.711; Campos B, 2015, HEART RHYTHM, V12, P95, DOI 10.1016/j.hrthm.2014.10.002; Chen LS, 2007, J CARDIOVASC ELECTR, V18, P123, DOI 10.1111/j.1540-8167.2006.00590.x; DEBAKKER JMT, 1988, CIRCULATION, V77, P589, DOI 10.1161/01.CIR.77.3.589; DEBAKKER JMT, 1993, CIRCULATION, V88, P915, DOI 10.1161/01.CIR.88.3.915; DENNISS AR, 1986, CIRCULATION, V74, P731, DOI 10.1161/01.CIR.74.4.731; ELLIS WS, 1995, CIRCULATION, V92, P1619, DOI 10.1161/01.CIR.92.6.1619; GARAN H, 1987, CIRC RES, V60, P879, DOI 10.1161/01.RES.60.6.879; GARDNER PI, 1985, CIRCULATION, V72, P596, DOI 10.1161/01.CIR.72.3.596; Hsieh CH, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1010, DOI 10.1161/CIRCEP.113.000348; IDEKER RE, 1983, PACE, V6, P908, DOI 10.1111/j.1540-8159.1983.tb04412.x; JOSEPHSON ME, 1978, CIRCULATION, V57, P659, DOI 10.1161/01.CIR.57.4.659; Kapela A, 2004, IEEE T BIO-MED ENG, V51, P1915, DOI 10.1109/TBME.2004.834277; Klein HU, 2005, J AM COLL CARDIOL, V46, P675, DOI 10.1016/j.jacc.2005.05.026; Kovoor P, 2003, PACE, V26, P1979, DOI 10.1046/j.1460-9592.2003.00305.x; Kucera JP, 1998, CIRC RES, V83, P795, DOI 10.1161/01.RES.83.8.795; Mekkaoui C, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-70; Popescu M, 1998, PHYSIOL MEAS, V19, P77, DOI 10.1088/0967-3334/19/1/007; Pouliopoulos J, 2010, EUROPACE, V12, P881, DOI 10.1093/europace/euq098; Reek S, 1999, PACE, V22, P605, DOI 10.1111/j.1540-8159.1999.tb00502.x; RICHARDS DAB, 1991, CIRCULATION, V83, P756, DOI 10.1161/01.CIR.83.3.756; Sasaki T, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1081, DOI 10.1161/CIRCEP.112.970699; SENHADJI L, 1995, IEEE ENG MED BIOL, V14, P167, DOI 10.1109/51.376755; SPACH MS, 1990, ANN NY ACAD SCI, V591, P62; SPACH MS, 1985, INT J CARDIOL, V7, P167, DOI 10.1016/0167-5273(85)90361-4; Stevenson WG, 2005, J CARDIOVASC ELECTR, V16, P1017, DOI 10.1111/j.1540-8167.2005.50155.x; Takayama H, 2006, CIRC J, V70, P69, DOI 10.1253/circj.70.69; Takayama H, 1997, J ELECTROCARDIOL, V30, P145, DOI 10.1016/S0022-0736(98)80062-9; Tsiachris D, 2015, CIRC-ARRHYTHMIA ELEC, V8, P863, DOI 10.1161/CIRCEP.114.002551; Turner I, 2005, J CARDIOVASC ELECTR, V16, P151, DOI 10.1046/j.1540-8167.2005.30490.x; WAXMAN HL, 1980, CIRCULATION, V62, P1349, DOI 10.1161/01.CIR.62.6.1349; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; WITKOWSKI FX, 1993, CIRC RES, V72, P424, DOI 10.1161/01.RES.72.2.424; Yao JA, 2003, CIRC RES, V92, P437, DOI 10.1161/01.RES.0000059301.81035.06; Zaman S, 2012, J WORKING GROUPS CAR	40	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204997	10.1371/journal.pone.0204997	http://dx.doi.org/10.1371/journal.pone.0204997			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289934	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500036
J	Al-Bashiri, H; Abdulgabber, MA; Romli, A; Kahtan, H				Al-Bashiri, Hael; Abdulgabber, Mansoor Abdullateef; Romli, Awanis; Kahtan, Hasan			An improved memory-based collaborative filtering method based on the TOPSIS technique	PLOS ONE			English	Article							RECOMMENDER SYSTEMS; SIMILARITY MEASURE; PERFORMANCE; ACCURACY	This paper describes an approach for improving the accuracy of memory-based collaborative filtering, based on the technique for order of preference by similarity to ideal solution (TOPSIS) method. Recommender systems are used to filter the huge amount of data available online based on user-defined preferences. Collaborative filtering (CF) is a commonly used recommendation approach that generates recommendations based on correlations among user preferences. Although several enhancements have increased the accuracy of memory-based CF through the development of improved similarity measures for finding successful neighbors, there has been less investigation into prediction score methods, in which rating/preference scores are assigned to items that have not yet been selected by a user. A TOPSIS solution for evaluating multiple alternatives based on more than one criterion is proposed as an alternative to prediction score methods for evaluating and ranking items based on the results from similar users. The recommendation accuracy of the proposed TOPSIS technique is evaluated by applying it to various common CF baseline methods, which are then used to analyze the MovieLens 100K and 1M benchmark datasets. The results show that CF based on the TOPSIS method is more accurate than baseline CF methods across a number of common evaluation metrics.	[Al-Bashiri, Hael; Abdulgabber, Mansoor Abdullateef; Romli, Awanis; Kahtan, Hasan] Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Kuantan, Pahang, Malaysia	Universiti Malaysia Pahang	Al-Bashiri, H (corresponding author), Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Kuantan, Pahang, Malaysia.	hailealbashiri1@gmail.com	al-bashiri, hael abdullah hussein/J-6729-2019; romli, awanis/T-2707-2019; Kahtan, Hasan/AAC-5991-2020; Kahtan, Hasan/L-8500-2016	al-bashiri, hael abdullah hussein/0000-0002-2973-1638; Kahtan, Hasan/0000-0001-6521-7081; Kahtan, Hasan/0000-0001-6521-7081	Department of Research and Innovation of University Malaysia Pahang [RDU170318]; Fundamental Research Grant Scheme (FRGS) [RDU170102]	Department of Research and Innovation of University Malaysia Pahang; Fundamental Research Grant Scheme (FRGS)	This research is supported by the Department of Research and Innovation of University Malaysia Pahang under RDU170318 to MAA and Fundamental Research Grant Scheme (FRGS) RDU170102 to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achakulvisut T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158423; Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Aggarwal C. C., 2016, CONTENT BASED RECOMM, P139, DOI DOI 10.1007/978-3-319-29659-3_4; Ahn HJ, 2008, INFORM SCIENCES, V178, P37, DOI 10.1016/j.ins.2007.07.024; Al-bashiri H, 2017, P INT C ADV IM PROC, DOI [10.1166/asl.2017.10020, DOI 10.1166/ASL.2017.10020]; Al-bashiri H, 2018, INT J ADV COMPUT SC, V9, P135; Al-Bashiri H, 2017, ADV SCI LETT, V23, P9045, DOI 10.1166/asl.2017.10020; Alper B., 2017, ANADOLU U J SCI TECH, V18, P225; BAEZAYATES R, 1999, MODERN INFORMATION R; Basu C., 1998, RECOMMENDATION CLASS; Bobadilla J, 2013, KNOWL-BASED SYST, V46, P109, DOI 10.1016/j.knosys.2013.03.012; Bobadilla J, 2010, KNOWL-BASED SYST, V23, P520, DOI 10.1016/j.knosys.2010.03.009; Bobadilla J, 2012, INFORM PROCESS MANAG, V48, P204, DOI 10.1016/j.ipm.2011.03.007; Bobadilla J, 2011, EXPERT SYST APPL, V38, P14609, DOI 10.1016/j.eswa.2011.05.021; Breese J S, 1998, P 14 C UNC ART INT; BURKE R, 2007, ADAPTIVE WEB, P377, DOI DOI 10.1007/978-3-540-72079-9_12; Cai G, 2014, DATA MINING WORKSHOP; Cantador I., 2011, 2 WORKSH INF HET FUS; Chen L, 2015, USER MODEL USER-ADAP, V25, P99, DOI 10.1007/s11257-015-9155-5; Cheng WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155739; Choi K, 2013, KNOWL-BASED SYST, V37, P146, DOI 10.1016/j.knosys.2012.07.019; Ekstrand Michael D., 2010, Foundations and Trends in Human-Computer Interaction, V4, P81, DOI 10.1561/1100000009; Gan MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114662; GOLDBERG D, 1992, COMMUN ACM, V35, P61, DOI 10.1145/138859.138867; Guo G, 2013, INT JOINT C ART INT; Han J, 2012, MOR KAUF D, P1; Haruna K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184516; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Herlocker JL, 1999, PROCEEDINGS OF THE 2; Hill W., 1995, P SIGCHI C HUM FACT; Huang BH, 2015, IEEE INT CONF MOB DA, P104, DOI 10.1109/MDM.2015.43; Hwang C.L., 2012, MULTIPLE ATTRIBUTE D, V186; Hwang C.L., 1981, MULTIPLE ATTRIBUTE D, DOI [DOI 10.1007/978-3-642-48318, 10.1007/978-3-642-48318-9, DOI 10.1007/978-3-642-48318-9]; Ic YT, 2010, EXPERT SYST APPL, V37, P567, DOI 10.1016/j.eswa.2009.05.038; Iijima J, 2007, ELECTRON COMMER R A, V6, P139, DOI 10.1016/j.elerap.2006.11.002; Ishizaka A., 2013, MULTICRITERIA DECISI, P1; Jamali M., 2009, P 15 ACM SIGKDD INT, P394, DOI 10.1145/1557019.1557067; Kahraman C, 2008, SPRINGER SER OPTIM A, V16, P1; Kim HN, 2010, ELECTRON COMMER R A, V9, P73, DOI 10.1016/j.elerap.2009.08.004; Konstan J. A., 1998, REC SYST 1998 WORKSH; Konstan JA, 1997, COMMUN ACM, V40, P77, DOI 10.1145/245108.245126; Koohi H, 2017, EXPERT SYST APPL, V83, P30, DOI 10.1016/j.eswa.2017.04.027; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Koutrika G, 2009, ACM SIGMOD/PODS 2009 CONFERENCE, P745; Liao CL, 2016, ELECTRON COMMER R A, V18, P1, DOI 10.1016/j.elerap.2016.05.001; Liu HF, 2014, KNOWL-BASED SYST, V56, P156, DOI 10.1016/j.knosys.2013.11.006; Liu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113457; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Mooney R. J., 2000, ACM 2000. Digital Libraries. Proceedings of the Fifth ACM Conference on Digital Libraries, P195, DOI 10.1145/336597.336662; Murti YR, 2016, ADV SCI LETT, V22, P1892, DOI 10.1166/asl.2016.7770; Olson DL, 2004, MATH COMPUT MODEL, V40, P721, DOI 10.1016/j.mcm.2004.10.003; Parkan C, 1997, INT J PROD RES, V35, P2963, DOI 10.1080/002075497194246; Patra BK, 2015, KNOWL-BASED SYST, V82, P163, DOI 10.1016/j.knosys.2015.03.001; Pazzani M. J., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P325; Polatidis N, 2016, EXPERT SYST APPL, V48, P100, DOI 10.1016/j.eswa.2015.11.023; Resnick P., 1994, Transcending Boundaries, CSCW '94. Proceedings of the Conference on Computer Supported Cooperative Work, P175, DOI 10.1145/192844.192905; Ricci F., 2011, INTRO RECOMMENDER SY; Salton G., 1986, INTRO MODERN INFORM; Saranya KG, 2017, APPL MATH INFORM SCI, V11, P317, DOI [DOI 10.18576/AMIS/110137, 10.18576/amis/110137]; Sarwar B., 2001, PROC 10 INT WORLD WI, P285, DOI 10.1145/371920.372071; Sarwar B., 2000, P ACM E COMM EC 2000, DOI DOI 10.1145/352871.352887; Sarwar B., 2000, ACM WEBKDD 2000 WORK; Schafer J. B., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P291; Shardanand U., 1995, Human Factors in Computing Systems. CHI'95 Conference Proceedings, P210, DOI 10.1145/223904.223931; Sharma L., 2013, INT J ENG TRENDS TEC, V4, P1989; Shen L, 2010, COMP MOD SIM 2010 IC; Shih HS, 2007, MATH COMPUT MODEL, V45, P801, DOI 10.1016/j.mcm.2006.03.023; Su X., 2009, ADV ARTIF INTELL, V2009, P19, DOI [10.1155/2009/421425, DOI 10.1155/2009/421425]; Suryakant, 2016, PROCEDIA COMPUT SCI, V89, P450, DOI 10.1016/j.procs.2016.06.099; Ungar LH, 1998, AAAI WORKSHOP ON REC; Van Den Oord Aaron, 2013, NEURAL INFORM PROCES, V26; Xu L, 2001, INTRO MULTICRITERIA, P1; Yang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049126; Yang XW, 2014, COMPUT COMMUN, V41, P1, DOI 10.1016/j.comcom.2013.06.009; Zang X, 2016, NEW WEIGHTED SIMILAR; Zeng W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111005; Zha Y, 2013, INF SCI CLOUD COMP C; Zhang R, 2014, ADV CLOUD BIG DAT CB	81	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204434	10.1371/journal.pone.0204434	http://dx.doi.org/10.1371/journal.pone.0204434			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286123	gold, Green Submitted, Green Published			2022-12-26	WOS:000446383500020
J	Debniak, T; Scott, RJ; Gorski, B; Masojc, B; Kram, A; Maleszka, R; Cybulski, C; Paszkowska-Szczur, K; Kashyap, A; Murawa, D; Malinska, K; Kiedrowicz, M; Rogoza-Janiszewska, E; Rudnicka, H; Deptula, J; Domagala, P; Kluzniak, W; Lener, MR; Lubinski, J				Debniak, Tadeusz; Scott, Rodney J.; Gorski, Bohdan; Masojc, Bartlomiej; Kram, Andrzej; Maleszka, Romuald; Cybulski, Cezary; Paszkowska-Szczur, Katarzyna; Kashyap, Aniruddh; Murawa, Dawid; Malinska, Karolina; Kiedrowicz, Magdalena; Rogoza-Janiszewska, Emilia; Rudnicka, Helena; Deptula, Jakub; Domagala, Pawel; Kluzniak, Wojciech; Lener, Marcin R.; Lubinski, Jan			BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population	PLOS ONE			English	Article							BREAST-CANCER RISK; CUTANEOUS MELANOMA; PROSTATE-CANCER; MC1R VARIANTS; FOUNDER BRCA1; REPAIR GENES; CARRIERS; FAMILIES; SUSCEPTIBILITY; CARCINOMA	The association of BRCA1/2 mutations with melanoma is not completely determined; the interpretation of variants of unknown significance is also problematic. To evaluate these issues we explored the molecular basis of melanoma risk by performing whole-exome sequencing on a cohort of 96 unrelated Polish early-onset melanoma patients and targeted sequencing of BRCA1/2 genes on additional 30 melanoma patients with familial aggregation of breast and other cancers. Sequencing was performed on peripheral blood. We evaluated Mutation Taster, Polyphen2, SIFT, PROVEAN algorithms, analyzed segregation with cancer disease (in both families with identified BRCA2 variants) and in one family performed LOH (based on 2 primary tumors). We found neither pathogenic mutations nor variants of unknown significance within BRCA1. We identified two BRCA2 variants of unknown significance: c.9334G>A and c.4534 C>T. Disease allele frequency was evaluated by genotyping of 1230 consecutive melanoma cases, 5000 breast cancer patients, 3500 prostate cancers and 9900 controls. Both variants were found to be absent among unselected cancer patients and healthy controls. The Mutation Taster, Polyphen2 and SIFT algorithms indicate that c.9334G>A is a damaging variant. Due to lack of tumour tissue LOH analysis could not be performed for this variant. The variant segregated with the disease. The c.4534 C>T variant did not segregate with disease, there was no LOH of the variant. The c.9334G>A variant, classified as a rare variant of unknown significance, on current evidence may predisposes to cancers of the breast, prostate and melanoma. Functional studies to describe how the DNA change affects the protein function and a large multi-center study to evaluate its penetrance are required.	[Debniak, Tadeusz; Gorski, Bohdan; Cybulski, Cezary; Paszkowska-Szczur, Katarzyna; Kashyap, Aniruddh; Malinska, Karolina; Rogoza-Janiszewska, Emilia; Rudnicka, Helena; Deptula, Jakub; Kluzniak, Wojciech; Lener, Marcin R.; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathomorphol, Szczecin, Poland; [Scott, Rodney J.] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Newcastle, NSW, Australia; [Scott, Rodney J.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Masojc, Bartlomiej; Kram, Andrzej] West Pomeranian Oncol Ctr, Szczecin, Poland; [Maleszka, Romuald; Kiedrowicz, Magdalena] Dept Skin Dis & Venerol PUM, Police, Poland; [Murawa, Dawid] Greater Poland Canc Ctr, Dept Oncol & Gen Surg 1, Poznan, Poland; [Domagala, Pawel] Pomeranian Med Univ, Dept Pathol, Szczecin, Poland	Pomeranian Medical University; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Wielkopolskie Centrum Onkologii; Pomeranian Medical University	Debniak, T (corresponding author), Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathomorphol, Szczecin, Poland.	debniak@pum.edu.pl	Domagala, Pawel/AAW-2296-2021; Maleszka, Romuald/C-3157-2017; Kashyap, Aniruddh/AAE-5053-2022; Scott, Rodney/B-2827-2013	Domagala, Pawel/0000-0002-7810-5289; Maleszka, Romuald/0000-0001-5975-2045; Lubinski, Jan/0000-0003-2931-3003; Kashyap, Aniruddh/0000-0001-7374-7912; Kram, Andrzej/0000-0003-0621-0204; Scott, Rodney/0000-0001-7724-3404	Polish National Science Centre [2014/13/B/NZ2/03888]	Polish National Science Centre	This research was supported by the Polish National Science Centre grant number 2014/13/B/NZ2/03888 to TD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akbari MR, 2008, ONCOGENE, V27, P1290, DOI 10.1038/sj.onc.1210739; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Crew KD, 2007, CANCER EPIDEM BIOMAR, V16, P2033, DOI 10.1158/1055-9965.EPI-07-0096; Debniak T, 2008, EUR J CANCER, V44, P110, DOI 10.1016/j.ejca.2007.10.006; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Gerstenblith MR, 2007, HUM MUTAT, V28, P495, DOI 10.1002/humu.20476; Goldstein AM, 2005, CANCER EPIDEM BIOMAR, V14, P2208, DOI 10.1158/1055-9965.EPI-05-0321; Gorski B, 2004, INT J CANCER, V110, P683, DOI 10.1002/ijc.20162; Gumaste PV, 2015, BRIT J DERMATOL, V172, P1498, DOI 10.1111/bjd.13626; Hou W, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0163-6; Iqbal J, 2016, BRIT J CANCER, V114, P1160, DOI 10.1038/bjc.2016.58; Johannsson O, 1999, EUR J CANCER, V35, P1248, DOI 10.1016/S0959-8049(99)00135-5; Kadouri L, 2009, FAM CANCER, V8, P29, DOI 10.1007/s10689-008-9206-8; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Kirchhoff T, 2004, CLIN CANCER RES, V10, P2918, DOI 10.1158/1078-0432.CCR-03-0604; Kote-Jarai Z, 2011, BRIT J CANCER, V105, P1230, DOI 10.1038/bjc.2011.383; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landi MT, 2004, J MED GENET, V41, P557, DOI 10.1136/jmg.2003.016907; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin ST, 2005, ONCOGENE, V24, P3652, DOI 10.1038/sj.onc.1208411; Mersch J, 2015, CANCER-AM CANCER SOC, V121, P269, DOI 10.1002/cncr.29041; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Monnerat C, 2007, FAM CANCER, V6, P453, DOI 10.1007/s10689-007-9143-y; Moran A, 2012, FAM CANCER, V11, P235, DOI 10.1007/s10689-011-9506-2; Mucci LA, 2016, JAMA-J AM MED ASSOC, V315, P68, DOI 10.1001/jama.2015.17703; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Potrony M, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.08.11; Read J, 2016, J MED GENET, V53, P1, DOI 10.1136/jmedgenet-2015-103150; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Shi JX, 2014, NAT GENET, V46, P482, DOI 10.1038/ng.2941; Tai YC, 2007, J NATL CANCER I, V99, P1811, DOI 10.1093/jnci/djm203; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Tuominen R, 2016, GENE CHROMOSOME CANC, V55, P601, DOI 10.1002/gcc.22363; van Asperen CJ, 2005, J MED GENET, V42, P711, DOI 10.1136/jmg.2004.028829; Wang Y, 2017, NAT GENET, V49, P651, DOI 10.1038/ng0417-651a; Warden CD, 2014, PEERJ, V2, DOI 10.7717/peerj.600; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yin JY, 2015, J INVEST DERMATOL, V135, P542, DOI 10.1038/jid.2014.416	43	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204768	10.1371/journal.pone.0204768	http://dx.doi.org/10.1371/journal.pone.0204768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286154	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500038
J	Mudrak, J; Slepicka, P; Slepickova, I				Mudrak, Jiri; Slepicka, Pavel; Slepickova, Irena			Sport motivation and doping in adolescent athletes	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; ANABOLIC-ANDROGENIC STEROIDS; DRUG-CONTROL MODEL; INTRINSIC MOTIVATION; EGO ORIENTATION; EXTRINSIC MOTIVATION; FIT INDEXES; ATTITUDES; ACHIEVEMENT; PERFORMANCE	Background Although performance-enhancing drugs appear to be prevalent in adolescent sports, relatively little attention has been paid to why adolescent athletes decide to use these drugs. In this study, we examine doping among adolescents from a motivational perspective and explore how motivational variables, such as achievement goal orientations and the perceived self-determination of sports activities, may be related to moral attitudes, doping intentions and doping behavior in adolescents who participate in competitive sports. Methodology The study included 1035 adolescents participating in competitive sports from all regions of the Czech Republic (mean age = 16.3 years). The respondents completed a battery of questionnaires assessing their achievement goal orientations (task, ego), sports motivation at various levels of self-determination (intrinsic motivation, external regulation, amotivation), moral attitudes toward sport competition (acceptance of cheating, keeping winning in proportion, attitudes toward doping), doping intentions and doping behavior. A structural equation model was used to test the relations among motivational variables, attitudes, intentions and doping behavior. Principal results Our analyses indicated a good fit with the proposed model, which explained 59% of the variance in doping intentions and 17.6% of the variance in doping behavior. Within the model, task orientation was positively associated with intrinsic motivation and lower amotivation, whereas ego orientation was positively associated with extrinsic regulation and amotivation. Furthermore, intrinsic motivation was positively associated with keeping winning in proportion and negatively associated with acceptance of cheating and attitudes toward doping; the less self-determined forms of motivation showed opposite relationships. However, only the acceptance of cheating and attitudes toward doping were related to doping intention, which subsequently predicted doping behavior. Conclusions/Significance The results provide further evidence that sports motivation represents a psychological variable that should be considered in anti-doping policies, programs, and interventions aimed at the adolescent population because motivation was linked to the doping-related attitudinal variables and also partially mediated the effect of achievement goal orientations in this regard. On the basis of these results, we may argue that the focus on intrinsic enjoyment, self-referenced criteria of success and self-improvement may be related to more negative attitudes toward doping and cheating, lower doping intentions and less frequent doping behavior, whereas the emphasis on competition, comparison with others and external motivation appear to be related to the opposite outcomes.	[Mudrak, Jiri; Slepicka, Pavel] Charles Univ Prague, Fac Phys Educ & Sport, Dept Pedag Psychol & Didact, Prague, Czech Republic; [Slepickova, Irena] Charles Univ Prague, Fac Phys Educ & Sport, Dept Kinanthropol & Humanities, Prague, Czech Republic	Charles University Prague; Charles University Prague	Mudrak, J (corresponding author), Charles Univ Prague, Fac Phys Educ & Sport, Dept Pedag Psychol & Didact, Prague, Czech Republic.	mudrak@ftvs.cuni.cz	Mudrak, Jiri/I-9956-2016	Mudrak, Jiri/0000-0002-9457-566X	World Anti-Doping Agency; PROGRES Q19 program	World Anti-Doping Agency; PROGRES Q19 program	The article was written with the support of a research grant from the World Anti-Doping Agency and the PROGRES Q19 program.	Alderman M. Kay, 2013, MOTIVATION ACHIEVEME; Allen J, 2015, J SPORT SCI, V33, P899, DOI 10.1080/02640414.2014.976588; Anderson SJ, 1997, PEDIATRICS, V99, P904; [Anonymous], 2015, 2015 PROH LIST; Barkoukis V, 2013, SCAND J MED SCI SPOR, V23, pE330, DOI 10.1111/sms.12068; Barkoukis V, 2011, PSYCHOL SPORT EXERC, V12, P205, DOI 10.1016/j.psychsport.2010.10.003; Blatny A M, 2006, CESK PSYCHOL, V50, P297; Chan DKC, 2015, J SCI MED SPORT, V18, P315, DOI 10.1016/j.jsams.2014.04.001; Chan DKC, 2015, J SPORT EXERCISE PSY, V37, P199, DOI 10.1123/jsep.2014-0250; Coakley J. J., 1997, SPORT SOC ISSUES CON; Czech Anti-doping Comittee, 2017, EDUCATION; Derenne JL, 2006, ACAD PSYCHIATR, V30, P257, DOI 10.1176/appi.ap.30.3.257; DUDA JL, 1995, INT J SPORT PSYCHOL, V26, P40; DUDA JL, 1991, RES Q EXERCISE SPORT, V62, P79, DOI 10.1080/02701367.1991.10607522; Dweck C. S., 2006, MINDSET NEW PSYCHOL; Ehrnborg C, 2009, GROWTH HORM IGF RES, V19, P285, DOI 10.1016/j.ghir.2009.04.003; Fishbein M, 2008, MED DECIS MAKING, V28, P834, DOI 10.1177/0272989X08326092; Fishbein M, 2006, J COMMUN, V56, pS1, DOI 10.1111/j.1460-2466.2006.00280.x; Gucciardi DF, 2011, J SCI MED SPORT, V14, P469, DOI 10.1016/j.jsams.2011.03.009; Hodge K, 2013, J SPORT EXERCISE PSY, V35, P419, DOI 10.1123/jsep.35.4.419; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Irving LM, 2002, J ADOLESCENT HEALTH, V30, P243, DOI 10.1016/S1054-139X(01)00414-1; Jalleh G, 2014, J SCI MED SPORT, V17, P574, DOI 10.1016/j.jsams.2013.10.249; JOHNSON MD, 1989, PEDIATRICS, V83, P921; Kanayama G, 2008, DRUG ALCOHOL DEPEN, V98, P1, DOI 10.1016/j.drugalcdep.2008.05.004; Kavussanu M, 2003, J SPORT EXERCISE PSY, V25, P501, DOI 10.1123/jsep.25.4.501; Kindlundh AMS, 1998, SCAND J SOC MED, V26, P71, DOI 10.1177/14034948980260010201; Kindlundh AMS, 2001, EUR J PUBLIC HEALTH, V11, P322, DOI 10.1093/eurpub/11.3.322; Knop PD., 1996, EUR J PHYS ED, V1, P36, DOI [10.1080/1740898960010104, DOI 10.1080/1740898960010104]; Laure P, 2007, BRIT J SPORT MED, V41, P660, DOI 10.1136/bjsm.2007.035733; Lazuras L, 2015, J SPORT EXERCISE PSY, V37, P37, DOI 10.1123/jsep.2013-0232; Lee MJ, 2007, PSYCHOL SPORT EXERC, V8, P369, DOI 10.1016/j.psychsport.2006.12.002; Lentillon-Kaestner V, 2010, SCAND J MED SCI SPOR, V20, P336, DOI 10.1111/j.1600-0838.2009.00885.x; Lucidi F, 2008, J SPORT SCI, V26, P447, DOI 10.1080/02640410701579370; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Mallett C, 2007, PSYCHOL SPORT EXERC, V8, P600, DOI 10.1016/j.psychsport.2006.12.005; Maravelias C, 2005, TOXICOL LETT, V158, P167, DOI 10.1016/j.toxlet.2005.06.005; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; Morente-Sanchez J, 2013, SPORTS MED, V43, P395, DOI 10.1007/s40279-013-0037-x; NICHOLLS JG, 1984, PSYCHOL REV, V91, P328, DOI 10.1037/0033-295X.91.3.328; Ntoumanis N, 2001, J SPORT SCI, V19, P397, DOI 10.1080/026404101300149357; Ntoumanis N, 2009, J APPL SPORT PSYCHOL, V21, P365, DOI 10.1080/10413200903036040; Ntoumanis N, 2014, SPORTS MED, V44, P1603, DOI 10.1007/s40279-014-0240-4; Pedersen W, 2001, J INTERPERS VIOLENCE, V16, P808, DOI 10.1177/088626001016008005; Pedersen W, 2001, J DRUG ISSUES, V31, P517, DOI 10.1177/002204260103100208; PELLETIER LG, 1995, J SPORT EXERCISE PSY, V17, P35, DOI 10.1123/jsep.17.1.35; Petroczi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010457; Petroczi A, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-34; Petroczi A, 2009, PSYCHOL SPORT EXERC, V10, P390, DOI 10.1016/j.psychsport.2008.11.001; Pintrich PR, 2000, J EDUC PSYCHOL, V92, P544, DOI 10.1037/0022-0663.92.3.544; Pluim B, 2008, BRIT J SPORT MED, V42, P549; R Development Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1080/10705519909540118, DOI 10.1080/10705519909540118]; Roberts GC, 1998, J SPORT SCI, V16, P337, DOI 10.1080/02640419808559362; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sas-Nowosielski K, 2008, INT J SPORTS MED, V29, P607, DOI 10.1055/s-2007-965817; Sas-Nowosielski K, 2006, BIOL SPORT, V23, P225; Slepicka P., 1996, ACTA U CAROLINAE KIN, V32, P23; Standage M, 2003, J EDUC PSYCHOL, V95, P97, DOI 10.1037/0022-0663.95.1.97; Vallerand RJ, 1999, J APPL SPORT PSYCHOL, V11, P142, DOI 10.1080/10413209908402956; Vealey RS, 1998, J SPORT EXERCISE PSY, V20, P54, DOI 10.1123/jsep.20.1.54; World Anti-Doping Agency, 2014, 2014 ANT TEST FIG RE; World Anti-Doping Agency, 2017, DANG DOP GET FACTS; Yesalis CE, 2000, BEST PRACT RES CL EN, V14, P25, DOI 10.1053/beem.2000.0051; Zelli A, 2010, PSYCHOL SPORT EXERC, V11, P304, DOI 10.1016/j.psychsport.2010.02.008; Zucchetti G, 2015, INT J DRUG POLICY, V26, P162, DOI 10.1016/j.drugpo.2014.07.021	66	21	22	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205222	10.1371/journal.pone.0205222	http://dx.doi.org/10.1371/journal.pone.0205222			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286200	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500098
J	Bover, O; Justo, T; Pereira, PNG; Facucho-Oliveira, J; Inacio, JM; Ramalho, JS; Domian, IJ; Belo, JA				Bover, Oriol; Justo, Tiago; Pereira, Paulo N. G.; Facucho-Oliveira, Joao; Inacio, Jose M.; Ramalho, Jose S.; Domian, Ibrahim J.; Belo, Jose Antonio			Loss of Ccbe1 affects cardiac-specification and cardiomyocyte differentiation in mouse embryonic stem cells	PLOS ONE			English	Article							CCBE1; LYMPHANGIOGENESIS; PROGENITORS; INDUCTION; MUTATIONS; DYSPLASIA; LINEAGES; VEGFC	Understanding the molecular pathways regulating cardiogenesis is crucial for the early diagnosis of heart diseases and improvement of cardiovascular disease. During normal mammalian cardiac development, collagen and calcium-binding EGF domain-1 (Ccbe1) is expressed in the first and second heart field progenitors as well as in the proepicardium, but its role in early cardiac commitment remains unknown. Here we demonstrate that during mouse embryonic stem cell (ESC) differentiation Ccbe1 is upregulated upon emergence of Isl1- and Nkx2.5- positive cardiac progenitors. Ccbe1 is markedly enriched in Isl1-positive cardiac progenitors isolated from ESCs differentiating in vitro or embryonic hearts developing in vivo. Disruption of Ccbe1 activity by shRNA knockdown or blockade with a neutralizing antibody results in impaired differentiation of embryonic stem cells along the cardiac mesoderm lineage resulting in a decreased expression of mature cardiomyocyte markers. In addition, knockdown of Ccbe1 leads to smaller embryoid bodies. Collectively, our results show that CCBE1 is essential for the commitment of cardiac mesoderm and consequently, for the formation of cardiac myocytes in differentiating mouse ESCs.	[Bover, Oriol; Justo, Tiago; Pereira, Paulo N. G.; Inacio, Jose M.; Belo, Jose Antonio] Univ NOVA Lisboa, Fac Ciencias Med, NOVA Med Sch, Stem Cells & Dev Lab,CEDOC,Chron Dis Res Ctr, Lisbon, Portugal; [Justo, Tiago; Facucho-Oliveira, Joao] Univ Algarve, Ctr Biomed Res, Campus Gambelas, Faro, Portugal; [Ramalho, Jose S.] Univ NOVA Lisboa, Fac Ciencias Med, NOVA Med Sch, CEDOC,Chron Dis Res Ctr, Lisbon, Portugal; [Domian, Ibrahim J.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Domian, Ibrahim J.] Harvard Stem Cell Inst, Cambridge, MA USA	Universidade Nova de Lisboa; Universidade do Algarve; Universidade Nova de Lisboa; Harvard University; Massachusetts General Hospital; Harvard University	Belo, JA (corresponding author), Univ NOVA Lisboa, Fac Ciencias Med, NOVA Med Sch, Stem Cells & Dev Lab,CEDOC,Chron Dis Res Ctr, Lisbon, Portugal.	jose.belo@nms.unl.pt	Pereira, Paulo/AAD-8375-2022; Inacio, Jose M/O-1455-2018; Belo, José A. A/F-4444-2012; Ramalho, Jose/M-6415-2015	Pereira, Paulo/0000-0002-9908-2290; Inacio, Jose M/0000-0002-9790-8335; Belo, José A. A/0000-0001-7384-0949; Facucho-Oliveira, Joao/0000-0003-2940-7915; Ramalho, Jose/0000-0002-1927-164X; Pereira, Paulo N G/0000-0002-0930-0902	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/82280/2011]; FCT [SFRH/BPD/46506/2008, CEDOC/2015/36/iNOVA4Health/Multi/04462, SFRH/BPD/87114/2012, PTDC/SAU-ENB/121095/2010, HMSP-ICT/0039/2013]; Fundacao para a Ciencia e Tecnologia / Ministerio da Educacao e Ciencia [UID/Multi/04462/2013]; FEDER under the PT2020 Partnership Agreement; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130391] Funding Source: NIH RePORTER; Fundação para a Ciência e a Tecnologia [HMSP-ICT/0039/2013, PTDC/SAU-ENB/121095/2010] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e Tecnologia / Ministerio da Educacao e Ciencia; FEDER under the PT2020 Partnership Agreement; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fundação para a Ciência e a Tecnologia	TJ was a pre-doctoral fellow of Fundacao para a Ciencia e Tecnologia (FCT; SFRH/BD/82280/2011), JFO (SFRH/BPD/46506/2008), JI (CEDOC/2015/36/iNOVA4Health/Multi/04462) and PNGP (SFRH/BPD/87114/2012) are FCT post-doctoral fellows. This work was supported by FCT grants (PTDC/SAU-ENB/121095/2010 and HMSP-ICT/0039/2013) to JA Belo. iNOVA4Health - UID/Multi/04462/2013, a program financially supported by Fundacao para a Ciencia e Tecnologia / Ministerio da Educacao e Ciencia, through national funds and co-funded by FEDER under the PT2020 Partnership Agreement is acknowledged.	Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; Astin JW, 2014, DEVELOPMENT, V141, P2680, DOI 10.1242/dev.106591; Bento M, 2011, GENE EXPR PATTERNS, V11, P437, DOI 10.1016/j.gep.2011.07.002; Bos FL, 2011, CIRC RES, V109, P486, DOI 10.1161/CIRCRESAHA.111.250738; Bratt-Leal AM, 2009, BIOTECHNOL PROGR, V25, P43, DOI 10.1002/btpr.139; Burger NB, 2015, PRENATAL DIAG, V35, P1278, DOI 10.1002/pd.4687; Connell FC, 2012, CLIN GENET, V81, P191, DOI 10.1111/j.1399-0004.2011.01731.x; Connell F, 2010, HUM GENET, V127, P231, DOI 10.1007/s00439-009-0766-y; Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Facucho-Oliveira J, 2011, INT J DEV BIOL, V55, P1007, DOI 10.1387/ijdb.113394jf; Furtado J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115481; Goh SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061856; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Higuchi S, 2013, J BIOSCI BIOENG, V115, P320, DOI 10.1016/j.jbiosc.2012.10.004; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Jakus Z, 2014, J EXP MED, V211, P815, DOI 10.1084/jem.20132308; Jeltsch M, 2014, CIRCULATION, V129, P1962, DOI 10.1161/CIRCULATIONAHA.113.002779; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Le Guen L, 2014, DEVELOPMENT, V141, P1239, DOI 10.1242/dev.100495; Liersch R, 2006, BLOOD, V107, P1214, DOI 10.1182/blood-2005-08-3400; Mishima K, 2007, MOL BIOL CELL, V18, P1421, DOI 10.1091/mbc.E06-09-0780; Mommersteeg MTM, 2010, CARDIOVASC RES, V87, P92, DOI 10.1093/cvr/cvq033; Roukens MG, 2015, CIRC RES, V116, P1660, DOI 10.1161/CIRCRESAHA.116.304949; Taylor-Weiner H, 2013, STEM CELLS, V31, P2084, DOI 10.1002/stem.1453; Zeng D, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-5; Zhou B, 2008, BIOCHEM BIOPH RES CO, V375, P450, DOI 10.1016/j.bbrc.2008.08.044	28	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205108	10.1371/journal.pone.0205108	http://dx.doi.org/10.1371/journal.pone.0205108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281646	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400083
J	Greenberg, DM; Baron-Cohen, S; Rosenberg, N; Fonagy, P; Rentfrow, PJ				Greenberg, David M.; Baron-Cohen, Simon; Rosenberg, Nora; Fonagy, Peter; Rentfrow, Peter J.			Elevated empathy in adults following childhood trauma	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MECHANICAL TURK; QUOTIENT; GROWTH	Traumatic events increase the risk of depression, but there is also evidence that adversity can lead to posttraumatic growth, including increased compassion and prosocial behavior. To date there is no empirical research pinpointing childhood trauma to an increase in trait empathy in adulthood. Although somewhat counter-intuitive, this might be predicted if trauma not only increases fear of future threat but also renders the individual more sensitive to suffering in others. We explored this possible link using multiple studies, self-report measures, and non-clinical samples. Results across samples and measures showed that, on average, adults who reported experiencing a traumatic event in childhood had elevated empathy levels compared to adults who did not experience a traumatic event. Further, the severity of the trauma correlated positively with various components of empathy. These findings suggest that the experience of a childhood trauma increases a person's ability to take the perspective of another and to understand their mental and emotional states, and that this impact is long-standing. Future research needs to test if this is seen on performance measures, and how these findings extend to clinical populations.	[Greenberg, David M.] CUNY City Coll, New York, NY 10031 USA; [Greenberg, David M.] CUNY, Grad Ctr, New York, NY 10016 USA; [Greenberg, David M.; Baron-Cohen, Simon] Univ Cambridge, Autism Res Ctr, Dept Psychiat, Cambridge, England; [Rosenberg, Nora; Rentfrow, Peter J.] Univ Cambridge, Dept Psychol, Cambridge, England; [Fonagy, Peter] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Fonagy, Peter] Anna Freud Ctr, London, England	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; University of Cambridge; University of Cambridge; University of London; University College London; The Anna Freud Centre	Greenberg, DM (corresponding author), CUNY City Coll, New York, NY 10031 USA.; Greenberg, DM (corresponding author), CUNY, Grad Ctr, New York, NY 10016 USA.; Greenberg, DM (corresponding author), Univ Cambridge, Autism Res Ctr, Dept Psychiat, Cambridge, England.	dmg39@cam.ac.uk	Rentfrow, Peter Jason/ABB-9257-2021	Rentfrow, Peter Jason/0000-0002-9068-2118; Baron-Cohen, Simon/0000-0001-9217-2544; Fonagy, Peter/0000-0003-0229-0091; Greenberg, David/0000-0003-1560-1418	Cambridge Commonwealth, European and International Trust; Medical Research Council UK; Autism Research Trust; MRC [G0600977] Funding Source: UKRI	Cambridge Commonwealth, European and International Trust; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Autism Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DMG was funded by the Cambridge Commonwealth, European and International Trust during this period of work. SBC was supported by the Medical Research Council UK and the Autism Research Trust during the period of this work.	Allison C, 2011, PERS INDIV DIFFER, V51, P829, DOI 10.1016/j.paid.2011.07.005; [Anonymous], 1999, POSTTRAUMATIC STRESS; Arseneault L, 2011, AM J PSYCHIAT, V168, P65, DOI 10.1176/appi.ajp.2010.10040567; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 1995, MINDBLINDNESS ESSAY, DOI [10.1027//0269-8803.13.1.57, DOI 10.1027//0269-8803.13.1.57]; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Berthelot N, 2015, INFANT MENT HEALTH J, V36, P200, DOI 10.1002/imhj.21499; Bevilacqua L, 2012, ARCH GEN PSYCHIAT, V69, P62, DOI 10.1001/archgenpsychiatry.2011.152; Bonanno GA, 2002, PERS SOC PSYCHOL B, V28, P184, DOI 10.1177/0146167202282005; Bonanno GA, 2001, AM BEHAV SCI, V44, P798, DOI 10.1177/00027640121956502; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Borderline Krohn A., 1974, INT J PSYCHOANAL PSY, DOI [10.1017/S003329170900600X, DOI 10.1017/S003329170900600X]; Brockhouse R, 2011, J TRAUMA STRESS, V24, P735, DOI 10.1002/jts.20704; Brodsky BS, 2001, AM J PSYCHIAT, V158, P1871, DOI 10.1176/appi.ajp.158.11.1871; Brune M, 2016, COMPR PSYCHIAT, V64, P29, DOI 10.1016/j.comppsych.2015.08.003; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Bussey M.C., 2007, TRAUMA TRANSFORMED E; Calhoun LG, 2000, J TRAUMA STRESS, V13, P521, DOI 10.1023/A:1007745627077; Daniels JK, 2012, J CLIN PSYCHIAT, V73, P327, DOI 10.4088/JCP.10m06293; Davis MH, 1980, CAT SEL DOC PSYCHOL; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; Dziobek I, 2006, J AUTISM DEV DISORD, V36, P623, DOI 10.1007/s10803-006-0107-0; Ensink K, 2015, BRIT J DEV PSYCHOL, V33, P203, DOI 10.1111/bjdp.12074; Etain B, 2013, J CLIN PSYCHIAT, V74, P991, DOI 10.4088/JCP.13m08353; Fonagy P, 2004, ANN NY ACAD SCI, V1036, P181, DOI 10.1196/annals.1330.012; FONAGY P, 1994, J CHILD PSYCHOL PSYC, V35, P231, DOI 10.1111/j.1469-7610.1994.tb01160.x; Fonagy P., 2002, AFFECT REGULATION ME; Fonagy P, 2017, BORDER PERS DIS EMOT, V4, DOI 10.1186/s40479-017-0062-8; Fonagy P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158678; Fonagy P, 2009, DEV PSYCHOPATHOL, V21, P1355, DOI 10.1017/S0954579409990198; Franzen N, 2011, PSYCHIAT RES, V187, P224, DOI 10.1016/j.psychres.2010.11.012; Frazzetto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000486; Freeman JB, 2000, J CLIN CHILD PSYCHOL, V29, P245, DOI 10.1207/S15374424jccp2902_10; Harari H, 2010, PSYCHIAT RES, V175, P277, DOI 10.1016/j.psychres.2009.03.002; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lim D, 2016, EMOTION, V16, P175, DOI 10.1037/emo0000144; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Lynch TR, 2006, EMOTION, V6, P647, DOI 10.1037/1528-3542.6.4.647; McNally RJ, 2006, TRENDS COGN SCI, V10, P271, DOI 10.1016/j.tics.2006.04.007; Muncer SJ, 2006, PERS INDIV DIFFER, V40, P1111, DOI 10.1016/j.paid.2005.09.020; OGATA SN, 1990, AM J PSYCHIAT, V147, P1008; Outcalt J, 2016, COMPR PSYCHIAT, V64, P22, DOI 10.1016/j.comppsych.2015.10.002; PENNEBAKER JW, 1988, SOC SCI MED, V26, P327, DOI 10.1016/0277-9536(88)90397-8; Perroud N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.60; Pessoa Luiz, 2004, Prog Brain Res, V144, P171; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; Shapiro DN, 2013, CLIN PSYCHOL SCI, V1, P213, DOI 10.1177/2167702612469015; Sharp C., 2015, J INFANT CHILD ADOLE, V14, P33, DOI [10.1080/15289168.2015.1004890, DOI 10.1080/15289168.2015.1004890]; Sharp C, 2016, COMPR PSYCHIAT, V64, P4, DOI 10.1016/j.comppsych.2015.07.008; Sharp C, 2013, J PERS DISORD, V27, P3, DOI 10.1521/pedi.2013.27.1.3; Vollhardt JR, 2011, AM J ORTHOPSYCHIAT, V81, P307, DOI 10.1111/j.1939-0025.2011.01099.x; Vollhardt JR, 2009, SOC JUSTICE RES, V22, P53, DOI 10.1007/s11211-009-0088-1; Vuilleumier P, 2005, J COGNITIVE NEUROSCI, V17, P1245, DOI 10.1162/0898929055002409; Vythilingam M, 2007, PSYCHOL MED, V37, P1445, DOI 10.1017/S003329170700092X; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Whitelock CF, 2013, CLIN PSYCHOL SCI, V1, P351, DOI 10.1177/2167702613480136; Wiersma JE, 2009, J CLIN PSYCHIAT, V70, P983, DOI 10.4088/JCP.08m04521; Wilson J., 2004, EMPATHY TREATMENT TR; Zanarini MC, 1997, AM J PSYCHIAT, V154, P1101; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	62	48	48	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203886	10.1371/journal.pone.0203886	http://dx.doi.org/10.1371/journal.pone.0203886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281628	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400032
J	Gregori, J; Soria, ME; Gallego, I; Guerrero-Murillo, M; Esteban, JI; Quer, J; Perales, C; Domingo, E				Gregori, Josep; Soria, Maria Eugenia; Gallego, Isabel; Guerrero-Murillo, Mercedes; Esteban, Juan Ignacio; Quer, Josep; Perales, Celia; Domingo, Esteban			Rare haplotype load as marker for lethal mutagenesis	PLOS ONE			English	Article							HEPATITIS-C VIRUS; FAVIPIRAVIR T-705; CELL-CULTURE; VIRAL-RNA; FITNESS; RIBAVIRIN; REPLICATION; MUTATIONS; SPECTRUM; INFECTIVITY	RNA viruses replicate with a template-copying fidelity, which lies close to an extinction threshold. Increases of mutation rate by nucleotide analogues can drive viruses towards extinction. This transition is the basis of an antiviral strategy termed lethal mutagenesis. We have introduced a new diversity index, the rare haplotype load (RHL), to describe NS5B (polymerase) mutant spectra of hepatitis C virus (HCV) populations passaged in absence or presence of the mutagenic agents favipiravir or ribavirin. The increase in RHL is more prominent in mutant spectra whose expansions were due to nucleotide analogues than to multiple passages in absence of mutagens. Statistical tests for paired mutagenized versus non-mutagenized samples with 14 diversity indices show that RHL provides consistently the highest standardized effect of mutagenic treatment difference for ribavirin and favipiravir. The results indicate that the enrichment of viral quasispecies in very low frequency minority genomes can serve as a robust marker for lethal mutagenesis. The diagnostic value of RHL from deep sequencing data is relevant to experimental studies on enhanced mutagenesis of viruses, and to pharmacological evaluations of inhibitors suspected to have a mutagenic activity.	[Gregori, Josep; Soria, Maria Eugenia; Guerrero-Murillo, Mercedes; Esteban, Juan Ignacio; Quer, Josep; Perales, Celia] Hosp Univ Vall dHebron HUVH, VHIR, Internal Med Dept, Liver Dis Lab Viral Hepatitis,Liver Unit, Barcelona, Spain; [Gregori, Josep; Gallego, Isabel; Esteban, Juan Ignacio; Quer, Josep; Perales, Celia; Domingo, Esteban] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [Gregori, Josep] Roche Diagnost SL, Barcelona, Spain; [Gallego, Isabel; Perales, Celia; Domingo, Esteban] CSIC, Ctr Biol Mol Severo Ochoa CSIC UAM, Campus Cantoblanco, Madrid, Spain; [Esteban, Juan Ignacio; Quer, Josep] Univ Autonoma Barcelona, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Roche Holding; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Barcelona	Quer, J; Perales, C (corresponding author), Hosp Univ Vall dHebron HUVH, VHIR, Internal Med Dept, Liver Dis Lab Viral Hepatitis,Liver Unit, Barcelona, Spain.; Quer, J; Perales, C (corresponding author), Inst Salud Carlos III, CIBERehd, Madrid, Spain.; Perales, C (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa CSIC UAM, Campus Cantoblanco, Madrid, Spain.; Quer, J (corresponding author), Univ Autonoma Barcelona, Barcelona, Spain.	josep.quer@vhir.org; celia.perales@vhir.org	Quer, Josep/A-6741-2012; Gregori, Josep/J-2586-2015; Domingo, Esteban/K-3937-2014	Quer, Josep/0000-0003-0014-084X; Gregori, Josep/0000-0002-4253-8015; Domingo, Esteban/0000-0002-0573-1676; GALLEGO, ISABEL/0000-0002-7338-1778; Guerrero Murillo, Mercedes/0000-0002-5556-2460; Perales Viejo, Celia Belen/0000-0003-1618-1937; Soria Benito, Maria Eugenia/0000-0002-4719-3351	Instituto de Salud Carlos III; European Regional Development Fund (ERDF) [PI13/00456, PI15/00829, PI16/00337]; CDTI (Centro para el Desarrollo Tecnologico Industrial), Spanish Ministry of Economics and Competitiveness (MINECO) [IDI-20151125]; Miguel Servet program of the Instituto de Salud Carlos III - European Regional Development Fund (ERDF) [CP14/00121]; Spanish Ministry of Economics and Competitiveness (MINECO) [BFU-2011-23604, SAF2014-52400-R, SAF2017-87846-R, S2013/ABI-2906]; Fundacion Ramon Areces; Banco Santander	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission); CDTI (Centro para el Desarrollo Tecnologico Industrial), Spanish Ministry of Economics and Competitiveness (MINECO); Miguel Servet program of the Instituto de Salud Carlos III - European Regional Development Fund (ERDF); Spanish Ministry of Economics and Competitiveness (MINECO); Fundacion Ramon Areces; Banco Santander	Work in Barcelona was funded by Instituto de Salud Carlos III; by grants PI13/00456, PI15/00829, and PI16/00337 cofinanced by the European Regional Development Fund (ERDF); and by CDTI (Centro para el Desarrollo Tecnologico Industrial), Spanish Ministry of Economics and Competitiveness (MINECO), IDI-20151125. CP is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CP14/00121) cofinanced by the European Regional Development Fund (ERDF). CIBERehd (Centro de Investigacion en Red de Enfermedades Hepaticas y Digestivas) is funded by Instituto de Salud Carlos III. The work in Madrid was supported by Spanish Ministry of Economics and Competitiveness (MINECO) grants number BFU-2011-23604, SAF2014-52400-R, SAF2017-87846-R and S2013/ABI-2906 (PLATESA from Comunidad de Madrid/FEDER). Institutional grants from the Fundacion Ramon Areces and Banco Santander to the CBMSO are also acknowledged.	Abdelnabi R, 2017, J VIROL, V91, DOI 10.1128/JVI.00487-17; Agol VI, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00067-17; Arias A, 2014, ELIFE, V3, DOI 10.7554/eLife.03679; Arias A, 2013, J GEN VIROL, V94, P817, DOI 10.1099/vir.0.049171-0; Arribas M, 2016, VIROLOGY, V497, P163, DOI 10.1016/j.virol.2016.07.007; Baranovich T, 2013, J VIROL, V87, P3741, DOI 10.1128/JVI.02346-12; Beaucourt S, 2014, CURR OPIN VIROL, V8, P10, DOI 10.1016/j.coviro.2014.04.011; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Borderia AV, 2016, CURR TOP MICROBIOL, V392, P303, DOI 10.1007/82_2015_483; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Crowder S, 2005, NAT GENET, V37, P701, DOI 10.1038/ng1583; de Avilla AI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164691; Delang L, 2018, ANTIVIR RES, V153, P85, DOI 10.1016/j.antiviral.2018.03.003; Delang L, 2014, J ANTIMICROB CHEMOTH, V69, P2770, DOI 10.1093/jac/dku209; DELATORRE JC, 1990, J VIROL, V64, P6278, DOI 10.1128/JVI.64.12.6278-6281.1990; Diaz-Martinez L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19829-6; Domingo E, 2018, EUR BIOPHYS J; Domingo E, 2016, QUASISPECIES THEORY; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Eigen M, 1979, THE HYPERCYCLE, P60; Escribano-Romero E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01400-17, 10.1128/AAC.01400-17]; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Furuta Y, 2017, P JPN ACAD B-PHYS, V93, P449, DOI 10.2183/pjab.93.027; Gallego I, 2016, ANTIMICROB AGENTS CH, V60, P3786, DOI 10.1128/AAC.00581-16; Gonzalez-Lopez C, 2004, J VIROL, V78, P3319, DOI 10.1128/JVI.78.7.3319-3324.2004; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Grande-Perez A, 2005, J VIROL, V79, P10451, DOI 10.1128/JVI.79.16.10451-10459.2005; Grande-Perez A, 2005, P NATL ACAD SCI USA, V102, P4448, DOI 10.1073/pnas.0408871102; Gregori J, 2016, VIROLOGY, V493, P227, DOI 10.1016/j.virol.2016.03.017; Gregori J, 2014, BIOINFORMATICS, V30, P1104, DOI 10.1093/bioinformatics/btt768; Gregori J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083361; Gregory MT, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv915; Guedj J, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002535; Hastie T., 2009, UNSUPERVISED LEARNIN; HOLLAND JJ, 1990, J VIROL, V64, P3960, DOI 10.1128/JVI.64.8.3960-3962.1990; Iranzo J, 2011, P NATL ACAD SCI USA, V108, P16008, DOI 10.1073/pnas.1110489108; de Avila AI, 2017, VIRUS RES, V233, P105, DOI 10.1016/j.virusres.2017.03.014; Jee J, 2016, NATURE, V534, P693, DOI 10.1038/nature18313; Jin ZN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068347; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Moreno E, 2017, J VIROL, V91, DOI 10.1128/JVI.02505-16; Moreno H, 2012, VIRUSES-BASEL, V4, P2786, DOI 10.3390/v4112786; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Mullins JGL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020973; NOVELLA IS, 1995, P NATL ACAD SCI USA, V92, P5841, DOI 10.1073/pnas.92.13.5841; Ortega-Prieto AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071039; Pages H, BIOSTRINGS STRING OB; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perales C, 2007, J MOL BIOL, V369, P985, DOI 10.1016/j.jmb.2007.03.074; Perales C, 2016, CURR TOP MICROBIOL, V392, P323, DOI 10.1007/82_2015_459; Perales C, 2013, J VIROL, V87, P7593, DOI 10.1128/JVI.02824-12; Perales C, 2012, TRENDS MICROBIOL, V20, P595, DOI 10.1016/j.tim.2012.08.010; Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658; Qiu L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006421; R Core Team, 2017, R LANGUAGE ENV STAT; Ramirez C, 2013, ANTIVIR RES, V98, P273, DOI 10.1016/j.antiviral.2013.03.007; Rawson JMO, 2015, ANTIMICROB AGENTS CH, V59, P6834, DOI 10.1128/AAC.01644-15; Schuster P, 2016, CURR TOP MICROBIOL, V392, P61, DOI 10.1007/82_2015_469; Seifert D, 2016, CURR TOP MICROBIOL, V392, P181, DOI 10.1007/82_2015_462; Sheldon J, 2014, J VIROL, V88, P12098, DOI 10.1128/JVI.01860-14; Sidwell OW, 1974, PROG CHEMOTHERAPY, V2, P889; Smith R. A., 1980, RIBAVIRIN BROAD SPEC	69	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204877	10.1371/journal.pone.0204877	http://dx.doi.org/10.1371/journal.pone.0204877			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281674	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400062
J	Ingrand, I; Paccalin, M; Liuu, E; Gil, R; Ingrand, P				Ingrand, Isabelle; Paccalin, Marc; Liuu, Evelyne; Gil, Roger; Ingrand, Pierre			Positive perception of aging is a key predictor of quality-of-life in aging people	PLOS ONE			English	Article							SELF-PERCEPTIONS; DEPRESSIVE SYMPTOMS; SOCIAL SUPPORT; OLD-AGE; HEALTH; MODEL; SATISFACTION; INDIVIDUALS	Objective We conducted a cross-sectional survey in France in a cohort over 55 years of age to characterize the impact of psychological dimensions on quality-of-life (QoL). Methods The predictors of QoL in relation with aging were studied using an adapted quality-of-life model, based on emotional, cognitive and physical symptoms, functional status, and general health perception. Adding psychological dimensions such as self-esteem, psychological distress, perceptions of ageing and coping, was hypothesized to improve the QoL model. Responses were analyzed using structural equation modeling and path analysis. Results The study involved 258 participants, mean age 66.9 +/- 7.9 years. Psychological distress and positive perception of aging exhibited the strongest direct impact on QoL (p<0.0001). Psychological distress also appeared to be mediator on QoL for perceived health status, self-esteem and negative perception of aging. Coping centred on emotion exhibited direct impact on self-esteem and so, indirect impact on QoL (p = 0.0002). Perception of personal financial situation (p = 0.0007) and coping centred on social support (p = 0.02) appeared as direct mediators influencing QoL. Conclusions Psychological dimensions are predictors of QOL and have to be taken into account to maximize the resources with a view to successful aging. Further interventions targeting successful aging should focus on positive perception aging.	[Ingrand, Isabelle; Ingrand, Pierre] Univ Poitiers, CHU Poitiers, Pharm & Sante Publ, Pole Biol, Poitiers, France; [Ingrand, Isabelle; Paccalin, Marc; Liuu, Evelyne; Ingrand, Pierre] Univ Poitiers, INSERM, CHU Poitiers, CIC 1402, Poitiers, France; [Paccalin, Marc] Univ Poitiers, Mol Targets & Therapeut Alzheimers Dis EA3808, Poitiers, France; [Paccalin, Marc; Liuu, Evelyne] Univ Poitiers, CHU Poitiers, Pole Geriatrie, Poitiers, France; [Paccalin, Marc; Gil, Roger] Univ Poitiers, CHU Poitiers, Ctr Memoire Ressources & Rech, Poitiers, France	CHU Poitiers; Universite de Poitiers; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Paccalin, M (corresponding author), Univ Poitiers, INSERM, CHU Poitiers, CIC 1402, Poitiers, France.; Paccalin, M (corresponding author), Univ Poitiers, Mol Targets & Therapeut Alzheimers Dis EA3808, Poitiers, France.; Paccalin, M (corresponding author), Univ Poitiers, CHU Poitiers, Pole Geriatrie, Poitiers, France.; Paccalin, M (corresponding author), Univ Poitiers, CHU Poitiers, Ctr Memoire Ressources & Rech, Poitiers, France.	marc.paccalin@chu-poitiers.fr			French Ministry of Research; Poitou-Charentes Region (CPER funding)	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Poitou-Charentes Region (CPER funding)	This work was sponsored by the French Ministry of Research and the Poitou-Charentes Region (CPER funding).	Bakas T, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-134; Barker M., 2007, BMC GERIATR, V7, P9, DOI [10.1186/1471-2318-7-9, DOI 10.1186/1471-2318-7-9]; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Bilotta C, 2012, HEALTH SOC CARE COMM, V20, P32, DOI 10.1111/j.1365-2524.2011.01011.x; Blazer DG, 2008, GERONTOLOGIST, V48, P415, DOI 10.1093/geront/48.4.415; Bollen KA, 1989, STRUCTURAL EQUATIONS; Bowling A., 2005, AGEING WELL QUALITY; Bowling A, 2006, AGE AGEING, V35, P607, DOI 10.1093/ageing/afl100; Bowling A, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-13; Cantarero R, 2014, INT J AGING HUM DEV, V78, P299, DOI 10.2190/AG.78.4.a; Melendez JC, 2009, ARCH GERONTOL GERIAT, V48, P291, DOI 10.1016/j.archger.2008.02.008; Carver LF, 2016, CLIN INTERV AGING, V11, P1623, DOI 10.2147/CIA.S117202; Dragomirecka E, 2008, CLIN PSYCHOL PSYCHOT, V15, P193, DOI 10.1002/cpp.571; European Commission, 2014, POP AG EUR FACTS IMP; Feeney BC, 2015, PERS SOC PSYCHOL REV, V19, P113, DOI 10.1177/1088868314544222; Fernandez-Ballesteros R, 2001, AGEING SOC, V21, P25, DOI 10.1017/S0144686X01008078; Fernandez-Ballesteros R, 2015, EXP AGING RES, V41, P410, DOI 10.1080/0361073X.2015.1053757; Garin Noe, 2014, Clin Pract Epidemiol Ment Health, V10, P103, DOI 10.2174/1745017901410010103; Hickey A, 2010, IRISH J PSYCHOL, V31, P135, DOI [10.1080/03033910.2010.10446331, DOI 10.1080/03033910.2010.10446331]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyde M, 2003, AGING MENT HEALTH, V7, P186, DOI 10.1080/1360786031000101157; Ingrand I, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-17; Koher-Gruhn D, 2012, J GERONTOL B-PSYCHOL, V67, P563, DOI 10.1093/geronb/gbr153; KOP JL, 1993, EUR REV APPL PSYCHOL, V43, P271; Kunzmann U, 2002, J GERONTOL B-PSYCHOL, V57, pP484, DOI 10.1093/geronb/57.6.P484; Lazarus R. S., 1984, STRESS APPRAISAL COP; Levy BR, 2014, PSYCHOL SCI, V25, P2127, DOI 10.1177/0956797614551970; Levy BR, 2002, J PERS SOC PSYCHOL, V83, P261, DOI 10.1037//0022-3514.83.2.261; Low G, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-146; Meeks S, 2001, J AGING HEALTH, V13, P92, DOI 10.1177/089826430101300105; Melchior M, 2003, SOC SCI MED, V56, P1817, DOI 10.1016/S0277-9536(02)00181-8; Netuveli G, 2006, J EPIDEMIOL COMMUN H, V60, P357, DOI 10.1136/jech.2005.040071; Netuveli G, 2008, BRIT MED BULL, V85, P113, DOI 10.1093/bmb/ldn003; O'Shea DM, 2017, INT J GERIATR PSYCH, V32, P1217, DOI 10.1002/gps.4584; Pinquart M, 2002, EXP AGING RES, V28, P317, DOI 10.1080/03610730290080353; Reichstadt J, 2010, AM J GERIAT PSYCHIAT, V18, P567, DOI 10.1097/JGP.0b013e3181e040bb; Sorokowski P, 2017, J GERONTOL B-PSYCHOL, V72, P561, DOI 10.1093/geronb/gbv080; Tarlow EM, 1996, J RES PERS, V30, P120, DOI 10.1006/jrpe.1996.0008; Thomas PA, 2010, J GERONTOL B-PSYCHOL, V65, P351, DOI 10.1093/geronb/gbp113; Tkatch Rifky, 2016, Gerontol Geriatr Med, V2, p2333721416667877, DOI 10.1177/2333721416667877; Tkatch R, 2017, GERIATR NURS, V38, P485, DOI 10.1016/j.gerinurse.2017.02.009; Tyrovolas S, 2015, J AGING HEALTH, V27, P1375, DOI 10.1177/0898264315583053; VALLIERES EF, 1990, INT J PSYCHOL, V25, P305, DOI 10.1080/00207599008247865; Wiggins RD, 2004, AGEING SOC, V24, P693, DOI 10.1017/S0144686X04002284; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	37	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204044	10.1371/journal.pone.0204044	http://dx.doi.org/10.1371/journal.pone.0204044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281672	gold, Green Published, Green Submitted			2022-12-26	WOS:000446342400039
J	Maurer, T; Stoffel, MH; Belyaev, Y; Stiefel, NG; Vidondo, B; Kuker, S; Mogel, H; Schafer, B; Balmer, J				Maurer, Thimo; Stoffel, Michael H.; Belyaev, Yury; Stiefel, Niklaus G.; Vidondo, Beatriz; Kueker, Susanne; Mogel, Helga; Schaefer, Birgit; Balmer, Jasmin			Structural characterization of four different naturally occurring porcine collagen membranes suitable for medical applications	PLOS ONE			English	Article							DIAPHRAGMATIC CENTRAL TENDON; EXTRACELLULAR-MATRIX; ELECTRON-MICROSCOPY; FIBER ARCHITECTURE; SCANNING ELECTRON; FIBRIL STRUCTURE; 3-DIMENSIONAL ORGANIZATION; TISSUE RECONSTRUCTION; INTESTINAL SUBMUCOSA; PARIETAL PERICARDIUM	Collagen is the main structural element of connective tissues, and its favorable properties make it an ideal biomaterial for regenerative medicine. In dental medicine, collagen barrier membranes fabricated from naturally occurring tissues are used for guided bone regeneration. Since the morphological characteristics of collagen membranes play a crucial role in their mechanical properties and affect the cellular behavior at the defect site, in-depth knowledge of the structure is key. As a base for the development of novel collagen membranes, an extensive morphological analysis of four porcine membranes, including centrum tendineum, pericardium, plica venae cavae and small intestinal submucosa, was performed. Native membranes were analyzed in terms of their thickness. Second harmonic generation and two-photon excitation microscopy of the native membranes showed the 3D architecture of the collagen and elastic fibers, as well as a volumetric index of these two membrane components. The surface morphology, fiber arrangement, collagen fibril diameter and Dperiodicity of decellularized membranes were investigated by scanning electron microscopy. All the membrane types showed significant differences in thickness. In general, undulating collagen fibers were arranged in stacked layers, which were parallel to the membrane surface. Multiphoton microscopy revealed a conspicuous superficial elastic fiber network, while the elastin content in deeper layers varied. The elastin/collagen volumetric index was very similar in the investigated membranes and indicated that the collagen content was clearly higher than the elastin content. The surface of both the pericardium and plica venae cavae and the cranial surface of the centrum tendineum revealed a smooth, tightly arranged and crumpled morphology. On the caudal face of the centrum tendineum, a compact collagen arrangement was interrupted by clusters of circular discontinuities. In contrast, both surfaces of the small intestinal submucosa were fibrous, fuzzy and irregular. All the membranes consisted of largely uniform fibrils displaying the characteristic D-banding. This study reveals similarities and relevant differences among the investigated porcine membranes, suggesting that each membrane represents a unique biomaterial suitable for specific applications.	[Maurer, Thimo; Stoffel, Michael H.; Belyaev, Yury; Mogel, Helga; Balmer, Jasmin] Univ Bern, Vetsuisse Fac, Div Vet Anat, Bern, Switzerland; [Stiefel, Niklaus G.; Schaefer, Birgit] Geistlich Pharma AG, Wolhusen, Switzerland; [Vidondo, Beatriz; Kueker, Susanne] Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Bern, Switzerland	University of Bern; University of Bern	Balmer, J (corresponding author), Univ Bern, Vetsuisse Fac, Div Vet Anat, Bern, Switzerland.	jasmin.balmer@vetsuisse.unibe.ch	Stoffel, Michael Hubert/I-6939-2015	Stoffel, Michael Hubert/0000-0002-4699-5125; Belyaev, Yury/0000-0001-8318-2951	Geistlich Pharma AG, Wolhusen, Switzerland; Geistlich Pharma AG	Geistlich Pharma AG, Wolhusen, Switzerland; Geistlich Pharma AG	This study was partly funded by Geistlich Pharma AG, Wolhusen, Switzerland. The funding company had a role as well in data analysis and manuscript proofreading. Geistlich Pharma AG provided the salary of TM and covered the costs related to 2-photonmicroscopy. Geistlich (BS, NS) was further involved in the experimental design, data analysis, decision to publish and in the preparation of the manuscript. Internal institutional resources (government funding) covered personnel costs (JB, MHS, HM, BV, SK) as well as the expenses for laboratory consumables and scanning electron microscopy. There was no additional external funding received for this study.	Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016; Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Baldwin SJ, 2014, BIOPHYS J, V107, P1794, DOI 10.1016/j.bpj.2014.09.003; Bear RS, 1944, J AM CHEM SOC, V66, P1297, DOI 10.1021/ja01236a027; Bianchini P, 2008, J BIOPHOTONICS, V1, P443, DOI 10.1002/jbio.200810060; Bottino MC, 2012, DENT MATER, V28, P703, DOI 10.1016/j.dental.2012.04.022; Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215; CHUONG CJ, 1991, J BIOMECH, V24, P563, DOI 10.1016/0021-9290(91)90289-Y; Cicchi R, 2013, J BIOPHOTONICS, V6, P129, DOI 10.1002/jbio.201200092; Deeken CR, 2011, J BIOMED MATER RES B, V96B, P199, DOI 10.1002/jbm.b.31753; Deeken CR, 2012, J MATER SCI-MATER M, V23, P537, DOI 10.1007/s10856-011-4486-1; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Erisken C, 2013, TISSUE ENG PT A, V19, P519, DOI 10.1089/ten.tea.2012.0072; FENTIE IH, 1986, J SUBMICR CYTOL PATH, V18, P53; Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gauvin R, 2013, J BIOMATER APPL, V28, P552, DOI 10.1177/0885328212465482; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Halper J, 2014, ADV EXP MED BIOL, V802, P31, DOI 10.1007/978-94-007-7893-1_3; Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T; Hodde J, 2006, ANZ J SURG, V76, P1096, DOI 10.1111/j.1445-2197.2006.03948.x; Hoit BD, 2017, CARDIOL CLIN, V35, P481, DOI 10.1016/j.ccl.2017.07.002; Holmes DF, 2001, MICRON, V32, P273, DOI 10.1016/S0968-4328(00)00040-8; ISHIHARA T, 1981, J THORAC CARDIOV SUR, V81, P747; Kielty CM, 2002, J CELL SCI, V115, P2817; KNUDSEN PJT, 1991, J ANAT, V177, P41; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Lee CH, 2001, INT J PHARMACEUT, V221, P1, DOI 10.1016/S0378-5173(01)00691-3; LI JC, 1991, ACTA ANAT, V141, P26; Liu ZZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37089; Luo JC, 2011, BIOMATERIALS, V32, P706, DOI 10.1016/j.biomaterials.2010.09.017; MARCHINI M, 1986, CONNECT TISSUE RES, V15, P269, DOI 10.3109/03008208609001985; Megerle K, 2016, PLAST RECONSTR SURG, V138, p630E, DOI 10.1097/PRS.0000000000002459; Michailova K, 1999, ANN ANAT, V181, P253, DOI 10.1016/S0940-9602(99)80040-5; Mienaltowski MJ, 2014, ADV EXP MED BIOL, V802, P5, DOI 10.1007/978-94-007-7893-1_2; Mirnajafi A, 2005, BIOMATERIALS, V26, P795, DOI 10.1016/j.biomaterials.2004.03.004; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Miura T, 2000, J THORAC CARDIOV SUR, V120, P437, DOI 10.1067/mtc.2000.108906; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Murali R, 2010, SEMIN RESP CRIT CARE, V31, P649, DOI 10.1055/s-0030-1269826; Naik Ronak, 2017, Cardiol Young, P1, DOI 10.1017/S1047951117000646; Nakatani T, 1996, ANAT REC, V244, P529, DOI 10.1002/(SICI)1097-0185(199604)244:4<529::AID-AR11>3.0.CO;2-R; OHTANI O, 1987, ARCH HISTOL CYTOL, V50, P557, DOI 10.1679/aohc.50.557; ORBERG JW, 1982, CONNECT TISSUE RES, V9, P187, DOI 10.3109/03008208209160260; Ortolani E, 2015, ANN I SUPER SANITA, V51, P229, DOI 10.4415/ANN_15_03_11; Ottani V, 2001, MICRON, V32, P251, DOI 10.1016/S0968-4328(00)00042-1; Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N; Parry DA, 1984, ULTRASTRUCTURE CONNE, P34; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Pattabhi SR, 2014, DIFFERENTIATION, V88, P131, DOI 10.1016/j.diff.2014.12.005; POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871; Provenzano PP, 2006, MATRIX BIOL, V25, P71, DOI 10.1016/j.matbio.2005.09.005; Rao RAR, 2009, OPT LETT, V34, P3779, DOI 10.1364/OL.34.003779; Raspanti M, 2007, BIOMACROMOLECULES, V8, P2087, DOI 10.1021/bm070091t; Raspanti M, 2018, INT J BIOL MACROMOL, V107, P1668, DOI 10.1016/j.ijbiomac.2017.10.037; Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P567, DOI 10.1111/j.1600-0501.2010.01922.x; Braga-Vilela AS, 2008, J MEMBRANE BIOL, V221, P15, DOI 10.1007/s00232-007-9081-5; Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7; SACKS MS, 1992, J BIOMECH ENG-T ASME, V114, P183, DOI 10.1115/1.2891370; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sheikh Z., 2017, BIOMATER RES, V21, P9, DOI [10.1186/s40824-017-0095-5 28593053, DOI 10.1186/S40824-017-0095-5]; Sizeland KH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/189197; Starborg T, 2008, METHOD CELL BIOL, V88, P319, DOI 10.1016/S0091-679X(08)00417-2; Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001; Tilbury K, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086014; Toshima M, 2004, ARCH HISTOL CYTOL, V67, P31, DOI 10.1679/aohc.67.31; Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109; Wang ZB, 2010, ANAT REC, V293, P754, DOI 10.1002/ar.21101; Yamamoto S, 2000, ARCH HISTOL CYTOL, V63, P127, DOI 10.1679/aohc.63.127	70	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205027	10.1371/journal.pone.0205027	http://dx.doi.org/10.1371/journal.pone.0205027			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281664	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400077
J	Radford, CA; Putland, RL; Mensinger, AF				Radford, Craig A.; Putland, Rosalyn L.; Mensinger, Allen F.			Barking mad: The vocalisation of the John Dory, Zeus faber	PLOS ONE			English	Article							ACOUSTIC-SIGNALS; SOUNDS; AMPLITUDE; TOADFISH; DEFENSE; SONG	Studies on the behavioural function of sounds are very rare within heterospecific interactions. John Dory (Zeus faber) is a solitary, predatory fish that produces sound when captured, but has not been documented to vocalize under natural conditions (i.e. in the wild). The present study provides the first in-situ recordings of John Dory vocalisations and correlates them to behavioural response of snapper (Pagrus auratus) a common species found through New Zealand. Vocalisations or 'barks', ranged between 200-600 Hz, with a peak frequency of 312 +/- 10 Hz and averaged 139 +/- 4 milliseconds in length. Baited underwater video (BUV) equipped with hydrophones determined that under natural conditions a John Dory vocalization induced an escape response in snapper present, causing them to exit the area opposite to the position of the John Dory. We speculate that the John Dory vocalisation may be used for territorial display towards both conspecifics and heterospecifics, asserting dominance in the area or heightening predatory status.	[Radford, Craig A.; Putland, Rosalyn L.; Mensinger, Allen F.] Univ Auckland, Inst Marine Sci, Leigh Marine Lab, Warkworth, New Zealand; [Mensinger, Allen F.] Univ Minnesota, Biol Dept, Duluth, MN 55812 USA	University of Auckland; University of Minnesota System; University of Minnesota Duluth	Radford, CA (corresponding author), Univ Auckland, Inst Marine Sci, Leigh Marine Lab, Warkworth, New Zealand.	c.radford@auckland.ac.nz		Radford, Craig/0000-0001-7949-9497	Rutherford Discovery Fellowship from the Royal Society of New Zealand [RDF-UOA1302]; NSF [IOS-1354745 NSF]; University of Minnesota travel grant; University of Minnesota Duluth Biology Department grant	Rutherford Discovery Fellowship from the Royal Society of New Zealand(Royal Society of New Zealand); NSF(National Science Foundation (NSF)); University of Minnesota travel grant; University of Minnesota Duluth Biology Department grant	CAR is funded by a Rutherford Discovery Fellowship from the Royal Society of New Zealand (RDF-UOA1302). RLP is funded by a PhD scholarship from the above mentioned funding. Funding for AFM was provided by a NSF grant IOS-1354745 NSF grant, a University of Minnesota travel grant and aUniversity of Minnesota Duluth Biology Department grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Amorim MCP, 2010, J EXP BIOL, V213, P2997, DOI 10.1242/jeb.044586; Amorim Maria Clara P., 2006, P71; Bradbury Jack W., 1998, pi; Chabert T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15547; CHOAT JH, 1982, J EXP MAR BIOL ECOL, V60, P129, DOI 10.1016/0022-0981(82)90155-1; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; Conti C, 2015, J EXP BIOL, V218, P893, DOI 10.1242/jeb.116673; Davies NB, 1978, DEEP CROAKS FIGHTING; Krebs J, 1978, SONG REPERTOIRES TER; LADICH F, 1992, ETHOLOGY, V90, P307; Ladich F, 1998, ETHOLOGY, V104, P517; Ladich F., 2006, COMMUNICATION FISHES, P122; Maravelias CD, 2007, ESTUAR COAST SHELF S, V72, P703, DOI 10.1016/j.ecss.2006.12.002; Mensinger AF., 2016, P M AC, V27, DOI [10.1121/2.0000234, DOI 10.1121/2.0000234]; Mirjany M, 2011, J EXP BIOL, V214, P3358, DOI 10.1242/jeb.052894; Myrberg AA, 1997, B MAR SCI, V60, P1017; NISSANOV J, 1990, BRAIN RES, V517, P88, DOI 10.1016/0006-8993(90)91012-6; Onuki A, 2004, J MAR BIOL ASSOC UK, V84, P843, DOI 10.1017/S0025315404010045h; Parvulescu A., 1963, MARINE BIOACOUSTICS, P413; Pereira R, 2014, ETHOLOGY, V120, P53, DOI 10.1111/eth.12180; Raffinger E, 2009, J ETHOL, V27, P239, DOI 10.1007/s10164-008-0109-9; Reichard DG, 2015, ANIM BEHAV, V105, P253, DOI 10.1016/j.anbehav.2015.04.017; Searcy WA, 2009, ANIM BEHAV, V78, P1281, DOI 10.1016/j.anbehav.2009.08.011; Slabbekoorn Hans, 2004, P178, DOI 10.1016/B978-012473070-0/50009-8; Thorson RF, 2002, ENVIRON BIOL FISH, V63, P321, DOI 10.1023/A:1014334425821; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; Wyman MT, 2008, ANIM BEHAV, V76, P1625, DOI 10.1016/j.anbehav.2008.05.032	28	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204647	10.1371/journal.pone.0204647	http://dx.doi.org/10.1371/journal.pone.0204647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281630	gold, Green Published, Green Submitted			2022-12-26	WOS:000446342400052
J	Shimizu, M; Tanaka, N				Shimizu, Masahiro; Tanaka, Nobuyuki			IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells	ONCOGENE			English	Article							GLUCOSE-METABOLISM; HIGH EXPRESSION; TUMORIGENESIS; INTERLEUKIN-8; GLCNACYLATION; TRANSCRIPTION; MECHANISMS; PATHWAY; SOX2; PHOSPHORYLATION	Interleukin-8 (IL-8) is a pro-inflammatory chemokine that is associated with induction of chemotaxis and degranulation of neutrophils. IL-8 is overexpressed in many tumors, including colon and lung cancer, and recent studies demonstrated essential roles for IL-8 in tumor progression within the tumor microenvironment. However, the molecular mechanism underlying the functions of IL-8 in tumor progression is unclear. In this study, we found that IL-8 is overexpressed in colon and lung cancer cells with cancer stem cell (CSC)-like characteristics and is required for CSC properties, including tumor-initiating abilities. These findings suggest that IL-8 plays an essential role in the development of CSCs. We also showed that IL-8 stimulation of colon and lung cancer cells-induced glucose uptake and expressions of glucose transporter 3 (GLUT3) and glucosamine fructose-6-phosphate aminotransferase (GFAT), a regulator of glucose flux to the hexosamine biosynthetic pathway, resulting in enhancement of protein O-GlcNAcylation. We demonstrated that these events are required for the generation and maintenance CSC-like characteristics of colon and lung cancer cells. Moreover, an O-GlcNAcylation inhibitor, OSMI1, reduced CSC number and tumor development in vivo. Together, these results reveal that IL-8-induced O-GlcNAcylation is required for generation and maintenance of CSCs of colon and lung cancer cells and suggests this regulatory pathway as a candidate therapeutic target of CSCs.	[Shimizu, Masahiro; Tanaka, Nobuyuki] Nippon Med Sch, Inst Adv Med Sci, Dept Mol Oncol, Kawasaki, Kanagawa, Japan	Nippon Medical School	Tanaka, N (corresponding author), Nippon Med Sch, Inst Adv Med Sci, Dept Mol Oncol, Kawasaki, Kanagawa, Japan.	nobuta@nms.ac.jp		Tanaka, Nobuyuki/0000-0002-6373-2220	Ministry of Education, Science, Sports, and Culture of Japan (MEXT/JSPS KAKEN) [17H04554]	Ministry of Education, Science, Sports, and Culture of Japan (MEXT/JSPS KAKEN)	We thank Y. Abe. Y. Nakajima, A. Tanimura, and I. Uehara for discussion, and Y. Asano, M. Kawagoe and T. Takatera for technical support. This work was supported by Grants-in-Aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT/JSPS KAKEN Grant Number 17H04554). We thank Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript.	Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Alfaro C, 2017, CANCER TREAT REV, V60, P24, DOI 10.1016/j.ctrv.2017.08.004; Allison DF, 2012, P NATL ACAD SCI USA, V109, P16888, DOI 10.1073/pnas.1208468109; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Bareiss PM, 2013, CANCER RES, V73, P5544, DOI 10.1158/0008-5472.CAN-12-4177; Batlle E, 2017, NAT MED, V23, P1124, DOI 10.1038/nm.4409; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Corbet C, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00958; David JM, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4030022; Dong TY, 2016, TUMOR BIOL, V37, P8159, DOI 10.1007/s13277-015-4729-8; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Guo HB, 2017, J BIOL CHEM, V292, P4123, DOI 10.1074/jbc.M116.763201; Ha H, 2017, THERANOSTICS, V7, P1543, DOI 10.7150/thno.15625; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; King JB, 2009, J BIOL CHEM, V284, P9059, DOI 10.1074/jbc.M809608200; Kuang R, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88815; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li LL, 2017, ONCOTARGET, V8, P19205, DOI 10.18632/oncotarget.15164; Liu BQ, 2011, EXP MOL MED, V43, P487, DOI 10.3858/emm.2011.43.9.055; Liu Q, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0597-1; Liu Q, 2016, CYTOKINE GROWTH F R, V31, P61, DOI 10.1016/j.cytogfr.2016.08.002; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Mo L, 2016, INT J CLIN EXP PATHO, V9, P9555; Nakajima W, 2016, ONCOTARGET, V7, P36353, DOI 10.18632/oncotarget.9217; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Oikari S, 2016, GLYCOBIOLOGY, V26, P710, DOI 10.1093/glycob/cww019; Ortiz-Meoz RF, 2015, ACS CHEM BIOL, V10, P1392, DOI 10.1021/acschembio.5b00004; Rodrigues-Ferreira C, 2012, J BIOENERG BIOMEMBR, V44, P39, DOI 10.1007/s10863-012-9413-8; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Shahzad Aamir, 2010, Int Arch Med, V3, P11, DOI 10.1186/1755-7682-3-11; Shi L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-70; Singh JP, 2015, CANCER LETT, V356, P244, DOI 10.1016/j.canlet.2014.04.014; Singh S, 2011, MICROVASC RES, V82, P318, DOI 10.1016/j.mvr.2011.06.011; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; STANDIFORD TJ, 1990, J CLIN INVEST, V86, P1945, DOI 10.1172/JCI114928; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visciano C, 2015, ONCOGENE, V34, P5175, DOI 10.1038/onc.2014.441; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang JC, 2015, ONCOTARGET, V6, P42825, DOI 10.18632/oncotarget.5739; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zhang YB, 2015, ONCOL LETT, V9, P2809, DOI 10.3892/ol.2015.3075; Zheng JH, 2017, ONCOTARGET, V8, P98635, DOI 10.18632/oncotarget.21709; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	54	41	44	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2019	38	9					1520	1533		10.1038/s41388-018-0533-4	http://dx.doi.org/10.1038/s41388-018-0533-4			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN1KL	30305725				2022-12-26	WOS:000459945800011
J	Meyer, SK; Dunn, M; Vidler, DS; Porter, A; Blain, PG; Jowsey, PA				Meyer, Stephanie K.; Dunn, Michael; Vidler, Daniel S.; Porter, Andrew; Blain, Peter G.; Jowsey, Paul A.			Phosphorylation of MCPH1 isoforms during mitosis followed by isoform-specific degradation by APC/C-CDH1	FASEB JOURNAL			English	Article						cell cycle regulation; cyclin-dependent kinase-1; microcephalin-1; anaphase; promoting complex; cyclosome	DNA-DAMAGE RESPONSE; ANAPHASE-PROMOTING COMPLEX; MITOTIC ENTRY; CHROMOSOME CONDENSATION; MICROCEPHALIN; PROTEIN; STABILITY; PATHWAY; CYCLE	Microcephalin-1 (MCPH1) exists as 2 isoforms that regulate cyclin-dependent kinase-1 activation and chromosome condensation during mitosis, with MCPH1 mutations causing primary microcephaly. MCPH1 is also a tumor suppressor protein, with roles in DNA damage repair/checkpoints. Despite these important roles, there is little information on the cellular regulation of MCPH1. We show that both MCPH1 isoforms are phosphorylated in a cyclin-dependent kinase-1-dependent manner in mitosis and identify several novel phosphorylation sites. Upon mitotic exit, MCPH1 isoforms were degraded by the anaphase-promoting complex/cyclosome-CDH1 E3 ligase complex. Anaphase-promoting complex/cyclosome-CDH1 target proteins generally have D-Box or KEN-Box degron sequences. We found that MCPH1 isoforms are degraded independently, with the long isoform degradation being D-Box dependent, whereas the short isoform was KEN-Box dependent. Our research identifies several novel mechanisms regulating MCPH1 and also highlights important issues with several commercial MCPH1 antibodies, with potential relevance to previously published data.Meyer, S. K., Dunn, M., Vidler, D. S., Porter, A., Blain, P. G., Jowsey, P. A. Phosphorylation of MCPH1 isoforms during mitosis followed by isoform-specific degradation by APC/C-CDH1.	[Meyer, Stephanie K.; Dunn, Michael; Vidler, Daniel S.; Blain, Peter G.; Jowsey, Paul A.] Newcastle Univ, Inst Cellular Med, NIHR, Hlth Protect Res Unit Chem & Radiat Threats & Haz, Wolfson Bldg, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; [Porter, Andrew] Newcastle Univ, Newcastle Univ Prot & Proteome Anal, Newcastle Upon Tyne, Tyne & Wear, England; [Vidler, Daniel S.] Univ Liverpool, Ctr Genom Res, GeneMill, Liverpool, Merseyside, England	Newcastle University - UK; Newcastle University - UK; University of Liverpool	Jowsey, PA (corresponding author), Newcastle Univ, Inst Cellular Med, NIHR, Hlth Protect Res Unit Chem & Radiat Threats & Haz, Wolfson Bldg, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.	paul.jowsey@newcastle.ac.uk		Jowsey, Paul/0000-0003-2867-6857	National Institute for Health Research (NIHR) Health Protection Research Unit for Chemical and Radiation Threats and Hazards at Newcastle University [HPRU-2012-10076]; Public Health England; Newcastle University via the Wellcome Trust Institutional Strategic Support Fund	National Institute for Health Research (NIHR) Health Protection Research Unit for Chemical and Radiation Threats and Hazards at Newcastle University; Public Health England; Newcastle University via the Wellcome Trust Institutional Strategic Support Fund	P.A.J., S.K.M., M.D., and P.G.B. are affiliated with the National Institute for Health Research (NIHR) Health Protection Research Unit for Chemical and Radiation Threats and Hazards at Newcastle University (Grant HPRU-2012-10076) in partnership with Public Health England. Funding was provided by Newcastle University via the Wellcome Trust Institutional Strategic Support Fund. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, the Department of Health, or Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Arroyo M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12793-7; Chang LF, 2014, CURR OPIN STRUC BIOL, V29, P1, DOI 10.1016/j.sbi.2014.08.003; Cotto-Rios XM, 2011, J CELL BIOL, V194, P177, DOI 10.1083/jcb.201101062; de Boer HR, 2016, CELL MOL LIFE SCI, V73, P2985, DOI 10.1007/s00018-016-2279-x; Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4; Gavvovidis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040387; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Ha K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15751; Hainline SG, 2014, BIOL OPEN, V3, P669, DOI 10.1242/bio.20148318; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jo YS, 2017, INT J COLORECTAL DIS, V32, P161, DOI 10.1007/s00384-016-2675-6; Kucharski TJ, 2017, CELL REP, V18, P1982, DOI 10.1016/j.celrep.2017.01.080; Lafranchi L, 2014, EMBO J, V33, P2860, DOI 10.15252/embj.201489017; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Liu XQ, 2017, EMBO J, V36, P3666, DOI 10.15252/embj.201694443; Liu XQ, 2016, ACTA BIOCH BIOPH SIN, V48, P678, DOI 10.1093/abbs/gmw048; Mantere T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005816; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Richardson J, 2011, BREAST CANCER RES TR, V127, P639, DOI 10.1007/s10549-010-1019-4; Sivakumar S, 2015, NAT REV MOL CELL BIO, V16, P82, DOI 10.1038/nrm3934; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Trimborn M, 2006, CELL CYCLE, V5, P322, DOI 10.4161/cc.5.3.2412; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Wu XL, 2009, CANCER RES, V69, P5531, DOI 10.1158/0008-5472.CAN-08-4834; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yamashita D, 2011, J CELL BIOL, V194, P841, DOI 10.1083/jcb.201106141	29	3	3	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2796	2808		10.1096/fj.201801353R	http://dx.doi.org/10.1096/fj.201801353R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303738	Green Accepted, Green Published			2022-12-26	WOS:000457296600101
J	Liou, G; Chiang, YC; Wang, Y; Weng, JK				Liou, Geoffrey; Chiang, Ying-Chih; Wang, Yi; Weng, Jing-Ke			Mechanistic basis for the evolution of chalcone synthase catalytic cysteine reactivity in land plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAR CONSTRAINT SOLVER; MOLECULAR-DYNAMICS; MODEL; PROTEINS; GENETICS; PK(A); LINCS	Flavonoids are important polyphenolic natural products, ubiquitous in land plants, that play diverse functions in plants' survival in their ecological niches, including UV protection, pigmentation for attracting pollinators, symbiotic nitrogen fixation, and defense against herbivores. Chalcone synthase (CHS) catalyzes the first committed step in plant flavonoid biosynthesis and is highly conserved in all land plants. In several previously reported crystal structures of CHSs from flowering plants, the catalytic cysteine is oxidized to sulfinic acid, indicating enhanced nucleophilicity in this residue associated with its increased susceptibility to oxidation. In this study, we report a set of new crystal structures of CHSs representing all five major lineages of land plants (bryophytes, lycophytes, monilophytes, gymnosperms, and angiosperms), spanning 500 million years of evolution. We reveal that the structures of CHS from a lycophyte and a moss species preserve the catalytic cysteine in a reduced state, in contrast to the cysteine sulfinic acid seen in all euphyl-lophyte CHS structures. In vivo complementation, in vitro biochemical and mutagenesis analyses, and molecular dynamics simulations identified a set of residues that differ between basal-plant and euphyllophyte CHSs and modulate catalytic cysteine reactivity. We propose that the CHS active-site environment has evolved in euphyllophytes to further enhance the nucleophilicity of the catalytic cysteine since the divergence of euphyllophytes from other vascular plant lineages 400 million years ago. These changes in CHS could have contributed to the diversification of flavonoid biosynthesis in euphyllophytes, which in turn contributed to their dominance in terrestrial ecosystems.	[Liou, Geoffrey; Weng, Jing-Ke] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Liou, Geoffrey; Weng, Jing-Ke] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Chiang, Ying-Chih; Wang, Yi] Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Chinese University of Hong Kong	Weng, JK (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	wengj@wi.mit.edu	Weng, Jing-Ke/V-5934-2019	Weng, Jing-Ke/0000-0003-3059-0075; Liou, Geoffrey/0000-0003-4712-9023; Chiang, Ying-Chih/0000-0002-1585-7213	Howard Hughes Medical Institute, National Science Foundation [CHE-1709616]; Pew Scholars Program in the Biomedical Sciences Grant [27345]; Searle Scholars Program of the Kinship Foundation Grant [15-SSP-162]; Chinese University of Hong Kong; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, National Science Foundation; Pew Scholars Program in the Biomedical Sciences Grant; Searle Scholars Program of the Kinship Foundation Grant; Chinese University of Hong Kong(Chinese University of Hong Kong); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute, National Science Foundation Grant CHE-1709616 (to J. K. W.), Pew Scholars Program in the Biomedical Sciences Grant 27345 (to J. K. W.), Searle Scholars Program of the Kinship Foundation Grant 15-SSP-162 (to J. K. W.), and direct grants from the Chinese University of Hong Kong (to Y. W.). J. K. W. is a co-founder, a member of the Scientific Advisory Board, and a shareholder of DoubleRainbow Biosciences, which develops biotechnologies related to natural products. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L, 2016, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Jez JM, 2000, J BIOL CHEM, V275, P39640, DOI 10.1074/jbc.M008569200; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Matasci N, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-17; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Oliveira SHP, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-197; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peralta D, 2015, NAT CHEM BIOL, V11, P156, DOI [10.1038/NCHEMBIO.1720, 10.1038/nchembio.1720]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rausher MD., 2006, SCI FLAVONOIDS, P175, DOI [10.1007/978-0-387-28822-2_7, DOI 10.1007/978-0-387-28822-2_7]; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P3538, DOI 10.1021/bi9723055; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; STORER AC, 1994, METHOD ENZYMOL, V244, P486; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Weigel D., 2002, ARABIDOPSIS LAB MANU; Weng JK, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00119; Weng JK, 2012, METHOD ENZYMOL, V515, P317, DOI [10.1016/B978-0-12-394290-6.00015-X, 10.1016/B978-0-12-394290-6.00014-8]; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7	44	20	22	3	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18601	18612		10.1074/jbc.RA118.005695	http://dx.doi.org/10.1074/jbc.RA118.005695			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30291143	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000458467300015
J	Pan, J; Di, YQ; Li, YB; Chen, CH; Wang, JX; Zhao, XF				Pan, Jing; Di, Yu-Qin; Li, Yong-Bo; Chen, Cai-Hua; Wang, Jin-Xing; Zhao, Xiao-Fan			Insulin and 20-hydroxyecdysone oppose each other in the regulation of phosphoinositide-dependent kinase-1 expression during insect pupation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; DOUBLE-STRANDED-RNA; ECDYSONE RECEPTOR; PROTHORACICOTROPIC HORMONE; LARVAL MIDGUT; DROSOPHILA; GROWTH; APOPTOSIS; AUTOPHAGY; FOXO	Insulin promotes larval growth of insects by stimulating the synthesis of the steroid hormone 20-hydroxyecdysone (20E), which induces pupation and apoptosis. However, the mechanism underlying the coordinate regulation of insect pupation and apoptosis by these two functionally opposing hormones is still unclear. Here, using the lepidopteran insect and serious agricultural pest Helicoverpa armigera (cotton bollworm) as a model, we report that phosphoinositide- dependent kinase-1 (PDK1) and forkhead box O (FoxO) play key roles in these processes. We found that the transcript levels of the PDK1 gene are increased during the larval feeding stages. Moreover, PDK1 expression was increased by insulin, but repressed by 20E. dsRNA-mediated PDK1 knockdown in the H. armigera larvae delayed pupation and resulted in small pupae and also decreased Akt/protein kinase B expression and increased FoxO expression. Furthermore, thePDK1knockdown blocked midgut remodeling and decreased 20E levels in the larvae. Of note, injecting larvae with 20E overcame the effect of the PDK1 knockdown and restored midgut remodeling. FoxO overexpression in an H. armigera epidermal cell line (HaEpi) did not induce apoptosis, but promoted autophagy and repressed cell proliferation. These results reveal cross-talk between insulin and 20E and that both hormones oppose each other's activities in the regulation of insect pupation and apoptosis by controlling PDK1 expression and, in turn, FoxO expression. We conclude that sufficiently high 20E levels are a key factor for inducing apoptosis during insect pupation.	[Pan, Jing; Di, Yu-Qin; Li, Yong-Bo; Chen, Cai-Hua; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Shandong Prov Key Lab Anim Cells & Dev Biol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Shandong Prov Key Lab Anim Cells & Dev Biol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	xfzhao@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021; Zhao, Xiao-Fan/AGW-9886-2022	Chen, Cai-Hua/0000-0002-2900-9530; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31730083, 31572328]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31730083 and 31572328. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; BALDWIN KM, 1991, TISSUE CELL, V23, P411, DOI 10.1016/0040-8166(91)90058-2; Battiprolu PK., 2010, DRUG DISCOV TODAY DI, V7, pE135, DOI [10.1016/j.ddmec.2010.08.001, DOI 10.1016/J.DDMEC.2010.08.001]; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Cai MJ, 2016, DEVELOPMENT, V143, P1005, DOI 10.1242/dev.128694; Chen CH, 2017, P NATL ACAD SCI USA, V114, pE7121, DOI 10.1073/pnas.1704999114; Cho KS, 2001, P NATL ACAD SCI USA, V98, P6144, DOI 10.1073/pnas.101596998; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; Hossain MS, 2013, INSECT BIOCHEM MOLEC, V43, P829, DOI 10.1016/j.ibmb.2013.06.007; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Kasprzak A, 2017, MUTAT RES-REV MUTAT, V772, P78, DOI 10.1016/j.mrrev.2016.08.007; Keshan B, 2017, GEN COMP ENDOCR, V241, P108, DOI 10.1016/j.ygcen.2016.06.022; Kondo H, 1996, J MOL BIOL, V259, P926, DOI 10.1006/jmbi.1996.0370; Koyama T, 2014, ELIFE, V3, DOI 10.7554/eLife.03091; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kumar D, 2008, EUR J ENTOMOL, V105, P591, DOI 10.14411/eje.2008.079; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Lapierre LR, 2015, AUTOPHAGY, V11, P867, DOI 10.1080/15548627.2015.1034410; Li YB, 2017, CELL CALCIUM, V68, P24, DOI 10.1016/j.ceca.2017.10.004; Li YB, 2016, INSECT BIOCHEM MOLEC, V79, P73, DOI 10.1016/j.ibmb.2016.10.004; Lin X., 2018, PEPTIDES, DOI 10.1016/j.peptides.2018.02.001; Liu CY, 2015, CELL CYCLE, V14, P3045, DOI 10.1080/15384101.2015.1053664; Liu CY, 2013, APOPTOSIS, V18, P171, DOI 10.1007/s10495-012-0784-4; Liu W, 2014, J BIOL CHEM, V289, P13026, DOI 10.1074/jbc.M113.547018; Matsui H, 2012, J INSECT PHYSIOL, V58, P1575, DOI 10.1016/j.jinsphys.2012.09.012; Matsuzaki Y, 2003, J INVEST DERMATOL, V120, P308, DOI 10.1046/j.1523-1747.2003.12044.x; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Mizoguchi A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00217; NAGASAWA H, 1984, SCIENCE, V226, P1344, DOI 10.1126/science.226.4680.1344; Nassel DR, 2016, CELL MOL LIFE SCI, V73, P271, DOI 10.1007/s00018-015-2063-3; Orme MH, 2005, CELL METAB, V2, P277, DOI 10.1016/j.cmet.2005.10.005; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Sonksen P, 2000, BRIT J ANAESTH, V85, P69, DOI 10.1093/bja/85.1.69; Sui YP, 2009, INSECT MOL BIOL, V18, P443, DOI 10.1111/j.1365-2583.2009.00884.x; Tavallai S, 2014, CANCER BIOL THER, V15, P578, DOI 10.4161/cbt.28163; Tettamanti G, 2007, AUTOPHAGY, V3, P630, DOI 10.4161/auto.4908; Tettamanti G, 2007, CELL TISSUE RES, V330, P345, DOI 10.1007/s00441-007-0449-8; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Tian L, 2013, AUTOPHAGY, V9, P1172, DOI 10.4161/auto.24731; Umezaki Y, 2018, CURR BIOL, V28, P779, DOI 10.1016/j.cub.2018.01.060; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Vilaplana L, 2007, INSECT BIOCHEM MOLEC, V37, P1241, DOI 10.1016/j.ibmb.2007.07.013; Wang D, 2016, CELL CALCIUM, V60, P1, DOI 10.1016/j.ceca.2016.05.003; Wang JL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-76; Xiao YJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12271; Xie K, 2016, AUTOPHAGY, V12, P381, DOI 10.1080/15548627.2015.1134079; Xu J, 2016, GENES-BASEL, V7, DOI 10.3390/genes7100088; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Yun HM, 2017, SCI REP-UK, V7, DOI 10.1038/srep44724; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhao WL, 2014, J MOL ENDOCRINOL, V53, P93, DOI 10.1530/JME-14-0019; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0; Zhou XF, 2002, DEVELOPMENT, V129, P2259; Zhou Z, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev102	66	17	21	5	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18613	18623		10.1074/jbc.RA118.004891	http://dx.doi.org/10.1074/jbc.RA118.004891			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30305395	Green Published, hybrid			2022-12-26	WOS:000458467300016
J	Macdonald, R; Cascio, D; Collazo, MJ; Phillips, M; Clubb, RT				Macdonald, Ramsay; Cascio, Duilio; Collazo, Michael J.; Phillips, Martin; Clubb, Robert T.			The Streptococcus pyogenes Shr protein captures human hemoglobin using two structurally unique binding domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Streptococcus pyogenes (S; pyogenes); hemoglobin; X-ray crystallography; nuclear magnetic resonance (NMR); isothermal titration calorimetry (ITC); receptor; bacterial pathogen; DUF1533; Shr	CELL-SURFACE PROTEIN; STAPHYLOCOCCUS-AUREUS USES; HEME-BINDING; IRON ACQUISITION; NEAT DOMAIN; TRANSPORTER DOMAINS; CRYSTAL-STRUCTURE; RECEPTOR; ISDB; HTSA	In order to proliferate and mount an infection, many bacterial pathogens need to acquire iron from their host. The most abundant iron source in the body is the oxygen transporter hemoglobin (Hb). Streptococcus pyogenes, a potentially lethal human pathogen, uses the Shr protein to capture Hb on the cell surface. Shr is an important virulence factor, yet the mechanism by which it captures Hb and acquires its heme is not well-understood. Here, we show using NMR and biochemical methods that Shr binds Hb using two related modules that were previously defined as domains of unknown function (DUF1533). These hemoglobin-interacting domains (HIDs), called HID1 and HID2, are autonomously folded and independently bind Hb. The 1.5 resolution crystal structure of HID2 revealed that it is a structurally unique Hb-binding domain. Mutagenesis studies revealed a conserved tyrosine in both HIDs that is essential for Hb binding. Our biochemical studies indicate that HID2 binds Hb with higher affinity than HID1 and that the Hb tetramer is engaged by two Shr receptors. NMR studies reveal the presence of a third autonomously folded domain between HID2 and a heme-binding NEAT1 domain, suggesting that this linker domain may position NEAT1 near Hb for heme capture.	[Macdonald, Ramsay; Phillips, Martin; Clubb, Robert T.] UCLA, Dept Chem & Biochem, 602 Boyer Hall,611 Charles Young Dr East, Los Angeles, CA 90025 USA; [Macdonald, Ramsay; Cascio, Duilio; Collazo, Michael J.; Clubb, Robert T.] UCLA, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Clubb, Robert T.] UCLA, Mol Biol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clubb, RT (corresponding author), UCLA, Dept Chem & Biochem, 602 Boyer Hall,611 Charles Young Dr East, Los Angeles, CA 90025 USA.	rclubb@mbi.ucla.edu			National Institutes of Health Equipment Grant [S10OD016336]; National Institutes of Health from NIGMS [P41 GM103403]; National Institutes of Health-ORIP HEI Grant [S10 RR029205]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016336] Funding Source: NIH RePORTER	National Institutes of Health Equipment Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health-ORIP HEI Grant; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Robert Peterson for assistance with NMR experiments. We also thank Dr. Brendan R. Amer and Orlando Martinez for assistance with the SEC-MALS experiments and Dr. William Silkworth for assistance with ITC experiments. We are grateful for useful discussions with Dr. Megan Sjodt, as well as members of the Clubb laboratory. We thank Professors Zehava Eichenbaum and John Olson for providing useful reagents. NMR equipment used in this research was purchased using funds from shared National Institutes of Health Equipment Grant S10OD016336. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines that are funded by National Institutes of Health Grant P41 GM103403 from NIGMS. The Pilatus 6M detector on 24-ID-C beam line is funded by National Institutes of Health-ORIP HEI Grant S10 RR029205. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrade MA, 2002, GENOME BIOL, V3; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; Balderas MA, 2012, J BACTERIOL, V194, P5513, DOI 10.1128/JB.00685-12; Bates CS, 2003, INFECT IMMUN, V71, P1042, DOI 10.1128/IAI.71.3.1042-1055.2003; Bowden CFM, 2018, J BIOL CHEM, V293, P177, DOI 10.1074/jbc.M117.806562; Bowden CFM, 2014, BIOCHEMISTRY-US, V53, P2286, DOI 10.1021/bi500230f; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cobessi D, 2010, PROTEINS, V78, P286, DOI 10.1002/prot.22539; Dahesh S, 2012, VIRULENCE, V3, P566, DOI 10.4161/viru.21933; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2004, PYMOL USERS GUIDE VE; Dickson CF, 2015, ACTA CRYSTALLOGR D, V71, P1295, DOI 10.1107/S1399004715005817; Dickson CF, 2014, J BIOL CHEM, V289, P6728, DOI 10.1074/jbc.M113.545566; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Fisher M, 2008, INFECT IMMUN, V76, P5006, DOI 10.1128/IAI.00300-08; Fonner BA, 2014, BIOCHEMISTRY-US, V53, P3922, DOI 10.1021/bi5005188; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Ge RG, 2014, METALLOMICS, V6, P996, DOI 10.1039/c4mt00011k; GODDARD TD, 2006, SPARKY3; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Hare SA, 2017, BBA-PROTEINS PROTEOM, V1865, P422, DOI 10.1016/j.bbapap.2017.01.006; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Hoshino M, 2017, BIOCHEM BIOPH RES CO, V493, P1109, DOI 10.1016/j.bbrc.2017.09.055; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Keller R., 2004, COMPUTER AIDED RESON, V1; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Lei Benfang, 2010, World J Biol Chem, V1, P286, DOI 10.4331/wjbc.v1.i9.286; Lei BF, 2002, INFECT IMMUN, V70, P4494, DOI 10.1128/IAI.70.8.4494-4500.2002; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Liu MY, 2005, INFECT IMMUN, V73, P5086, DOI 10.1128/IAI.73.8.5086-5092.2005; LOOKER D, 1994, METHOD ENZYMOL, V231, P364; LOOKER D, 1992, NATURE, V356, P258, DOI 10.1038/356258a0; Lu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037556; Malmirchegini GR, 2014, J BIOL CHEM, V289, P34886, DOI 10.1074/jbc.M114.583013; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Moriwaki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145125; Moriwaki Y, 2013, BIOCHEMISTRY-US, V52, P8866, DOI 10.1021/bi4008325; NMR Software Department, 2016, TOPSPIN NMRDATA PUBL; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Ouattara M, 2013, ARCH BIOCHEM BIOPHYS, V538, P71, DOI 10.1016/j.abb.2013.08.009; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pishchany G, 2014, J INFECT DIS, V209, P1764, DOI 10.1093/infdis/jit817; Pishchany G, 2009, INFECT IMMUN, V77, P2624, DOI 10.1128/IAI.01531-08; Pluym M, 2008, J INORG BIOCHEM, V102, P480, DOI 10.1016/j.jinorgbio.2007.11.011; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Ran YC, 2007, J BIOL CHEM, V282, P31380, DOI 10.1074/jbc.M705967200; Ran YC, 2013, BIOCHEMISTRY-US, V52, P6537, DOI 10.1021/bi400965u; Ran YC, 2010, BIOCHEMISTRY-US, V49, P2834, DOI 10.1021/bi901987h; Saederup KL, 2016, J BIOL CHEM, V291, P23989, DOI 10.1074/jbc.M116.755934; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sjodt M, 2018, J BIOL CHEM, V293, P6942, DOI 10.1074/jbc.RA117.000803; Sjodt M, 2016, J MOL BIOL, V428, P1107, DOI 10.1016/j.jmb.2015.02.008; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Spirig T, 2013, J BIOL CHEM, V288, P1065, DOI 10.1074/jbc.M112.419119; STEVENS DL, 1995, EMERG INFECT DIS, V1, P69, DOI 10.3201/eid0103.950301; Stodkilde K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6487; Tsatsaronis JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004266; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Vicente JJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-1; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Vu NT, 2013, PROTEIN SCI, V22, P942, DOI 10.1002/pro.2276; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Wong CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10172; Zhu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100744; Zhu LC, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00460-17	83	4	4	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18365	18377		10.1074/jbc.RA118.005261	http://dx.doi.org/10.1074/jbc.RA118.005261			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30301765	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000451375200027
J	Miskinyte, G; Hansen, MG; Monni, E; Lam, M; Bengzon, J; Lindvall, O; Ahlenius, H; Kokaia, Z				Miskinyte, Giedre; Hansen, Marita Gronning; Monni, Emanuela; Lam, Matti; Bengzon, Johan; Lindvall, Olle; Ahlenius, Henrik; Kokaia, Zaal			Transcription factor programming of human ES cells generates functional neurons expressing both upper and deep layer cortical markers	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DEVELOPING CEREBRAL-CORTEX; NEOCORTICAL PROJECTION NEURONS; IN-VIVO; PYRAMIDAL NEURONS; DENDRITIC MORPHOLOGY; SPECIFICATION; SATB2; PROGENITOR; CALLOSAL	Human neurodegenerative disorders affect specific types of cortical neurons. Efficient protocols for the generation of such neurons for cell replacement, disease modeling and drug screening are highly warranted. Current methods for the production of cortical neurons from human embryonic stem (ES) cells are often time-consuming and inefficient, and the functional properties of the generated cells have been incompletely characterized. Here we have used transcription factor (TF) programming with the aim to induce rapid differentiation of human ES cells to layer-specific cortical neurons (hES-iNs). Three different combinations of TFs, NEUROGENIN 2 (NGN2) only, NGN2 plus Forebrain Embryonic Zinc Finger-Like Protein 2 (FEZF2), and NGN2 plus Special AT-Rich Sequence-Binding Protein 2 (SATB2), were delivered to human ES cells by lentiviral vectors. We observed only subtle differences between the TF combinations, which all gave rise to the formation of pyramidal-shaped cells, morphologically resembling adult human cortical neurons expressing cortical projection neuron (PN) markers and with mature electrophysiological properties. Using ex vivo transplantation to human organotypic cultures, we found that the hES-iNs could integrate into adult human cortical networks. We obtained no evidence that the hES-iNs had acquired a distinct cortical layer phenotype. Instead, our single-cell data showed that the hES-iNs, similar to fetal human cortical neurons, expressed both upper and deep layer cortical neuronal markers. Taken together, our findings provide evidence that TF programming can direct human ES cells towards cortical neurons but that the generated cells are transcriptionally profiled to generate both upper and deep layer cortical neurons. Therefore, most likely additional cues will be needed if these cells should adopt a specific cortical layer and area identity.	[Miskinyte, Giedre; Monni, Emanuela; Lindvall, Olle; Kokaia, Zaal] Univ Hosp, Lab Stem Cells & Restorat Neurol, Lund, Sweden; [Miskinyte, Giedre; Hansen, Marita Gronning; Monni, Emanuela; Lam, Matti; Bengzon, Johan; Lindvall, Olle; Ahlenius, Henrik; Kokaia, Zaal] Lund Univ, Lund Stem Cell Ctr, Lund, Sweden; [Lam, Matti; Ahlenius, Henrik] Univ Hosp, Stem Cells Aging & Neurodegenerat Grp, Lund, Sweden; [Bengzon, Johan] Univ Hosp, Dept Clin Sci Lund, Div Neurosurg, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Kokaia, Z (corresponding author), Univ Hosp, Lab Stem Cells & Restorat Neurol, Lund, Sweden.; Kokaia, Z (corresponding author), Lund Univ, Lund Stem Cell Ctr, Lund, Sweden.	zaal.kokaia@med.lu.se	Lam, Matti/GWZ-4185-2022; Ahlenius, Henrik/GPG-1120-2022; Ahlenius, Henrik/L-8660-2015; Kokaia, Zaal/AAL-6009-2020	Ahlenius, Henrik/0000-0001-8958-6148; Ahlenius, Henrik/0000-0001-8958-6148; Kokaia, Zaal/0000-0003-2296-2449	Swedish Research Council; Swedish Brain Foundation; Torsten Soderberg Foundation; Ragnar Soderberg Foundation; Region Skane; Sparbanksstiftelsen Fars Frosta; Swedish Government Initiative for Strategic Research Areas (StemTherapy); King Gustav V's and Queen Victorias Free Mason foundation; Crafoord foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Torsten Soderberg Foundation; Ragnar Soderberg Foundation; Region Skane; Sparbanksstiftelsen Fars Frosta; Swedish Government Initiative for Strategic Research Areas (StemTherapy); King Gustav V's and Queen Victorias Free Mason foundation; Crafoord foundation	This work was supported by the Swedish Research Council, Swedish Brain Foundation, Torsten and Ragnar Soderberg Foundations, Region Skane, Sparbanksstiftelsen Fars & Frosta, Swedish Government Initiative for Strategic Research Areas (StemTherapy), King Gustav V's and Queen Victorias Free Mason foundation, Crafoord foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Berninger B, 2007, EUR J NEUROSCI, V25, P2581, DOI 10.1111/j.1460-9568.2007.05509.x; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Cusulin C, 2012, STEM CELLS, V30, P2657, DOI 10.1002/stem.1227; De la Rossa A, 2013, NAT NEUROSCI, V16, P193, DOI 10.1038/nn.3299; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eckler MJ, 2015, NEURON, V86, P1100, DOI 10.1016/j.neuron.2015.04.020; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fame RM, 2017, CEREB CORTEX, V27, P1817, DOI 10.1093/cercor/bhw023; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; Grade S, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0033-0; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Guo C, 2013, NEURON, V80, P1167, DOI 10.1016/j.neuron.2013.09.037; Haggarty SJ, 2016, MOL CELL NEUROSCI, V73, P104, DOI 10.1016/j.mcn.2016.01.011; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Leone DP, 2015, CEREB CORTEX, V25, P3406, DOI 10.1093/cercor/bhu156; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; McKenna WL, 2015, P NATL ACAD SCI USA, V112, P11702, DOI 10.1073/pnas.1504144112; Miskinyte G, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0658-3; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Molyneaux BJ, 2015, NEURON, V85, P275, DOI 10.1016/j.neuron.2014.12.024; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Rouaux C, 2013, NAT CELL BIOL, V15, P214, DOI 10.1038/ncb2660; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Tiberi L, 2012, CURR OPIN CELL BIOL, V24, P269, DOI 10.1016/j.ceb.2012.01.010; van den Ameele J, 2014, TRENDS NEUROSCI, V37, P334, DOI 10.1016/j.tins.2014.03.005; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Yang N, 2017, NAT METHODS, V14, P621, DOI [10.1038/NMETH.4291, 10.1038/nmeth.4291]; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zahr SK, 2018, NEURON, V97, P520, DOI 10.1016/j.neuron.2017.12.045; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zhu XQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28572	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204688	10.1371/journal.pone.0204688	http://dx.doi.org/10.1371/journal.pone.0204688			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307948	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500022
J	Guenard, B; Dumont, F; Frechette, B; Francoeur, A; Lucas, E				Guenard, Benoit; Dumont, Francois; Frechette, Bruno; Francoeur, Andre; Lucas, Eric			May furtive predation provide enemy free space in ant-tended aphid colonies?	PLOS ONE			English	Article							INTRAGUILD PREDATION; CHEMICAL MIMICRY; PREY ABUNDANCE; PARASITOIDS; FORMICIDAE; MUTUALISM; DIPTERA; ASSOCIATION; POPULATIONS; COLEOPTERA	In furtive predation, a predator is able to exploit its prey without generating significant defensive behaviors from them. However, in aphidophagous guild, if furtive predator can benefit from dilution effects generated by the aphids, they also suffer from intraguild predation from more mobile and active-searching predators. In this context ant-tended aphid colonies might not only represent an important food source but also potentially an enemy-free space for furtive predators if they remain unharmed by ants while other active predators are being repelled. Here we use the furtive predator Aphidoletes aphidimyza and two distinct instars of an active-searching predator, the Asian ladybeetle Harmonia axyridis, to test hypotheses related to predator persistence within aphid colonies in presence of ants. Our results show that persistence rate over time of the furtive predator was not affected by ant presence while it was strongly reduced for both instars of the active-searching predator. Furthermore, when ran in paired trials within ant-tended aphid colonies, furtive predator persistence rate was significantly higher than for active-searching predators, with these latter always leaving the plants quicker. Finally, we tested the importance of predator mobility in detection susceptibility and aggressive responses in ants using mobile and immobile active-searching predators. While the number of antennal palpations was similar for both treatments indicating similar detection rate, the number of ant attacks was significantly higher on mobile individuals highlighting the importance of movement in triggering aggressive responses in ants. Overall our results indicate that furtive predation represents an efficient strategy to limit ant aggressions, while the exclusion of active-searching predators might create an enemy-free space for furtive predators within ant-tended aphid colonies.	[Guenard, Benoit; Dumont, Francois; Frechette, Bruno; Lucas, Eric] Univ Quebec Montreal, Dept Sci Biol, Montreal, PQ, Canada; [Guenard, Benoit] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Francoeur, Andre] Univ Quebec Chicoutimi, Chicoutimi, PQ, Canada	University of Quebec; University of Quebec Montreal; University of Hong Kong; University of Quebec; University of Quebec Chicoutimi	Dumont, F (corresponding author), Univ Quebec Montreal, Dept Sci Biol, Montreal, PQ, Canada.	dumont.francois.3@courrier.uqam.ca		Guenard, Benoit/0000-0002-7144-1175	NSERC (Canada) [NIP: 144485]; FQRNT (Quebec) [2004-EN-102690]	NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); FQRNT (Quebec)(FQRNT)	This work was funded by grants from NSERC (Canada) (grant number: [Discovery 2003-2007 NIP: 144485]) and FQRNT (Quebec) (grant number: [2004-EN-102690]) to E.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; ATSATT PR, 1981, AM NAT, V118, P638, DOI 10.1086/283859; BANKS CJ, 1958, J EXP BIOL, V35, P703; Bishop DB, 2001, ANN ENTOMOL SOC AM, V94, P33, DOI 10.1603/0013-8746(2001)094[0033:EOAMAH]2.0.CO;2; BOUCHARD D, 1981, Annales de la Societe Entomologique du Quebec, V26, P119; BOUCHARD D, 1982, Annales de la Societe Entomologique du Quebec, V27, P80; BRISTOW CM, 1991, ANT - PLANT INTERACTIONS, P104; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Brown MW, 2004, BIOL CONTROL, V29, P189, DOI 10.1016/S1049-9644(03)00153-1; BUCKLEY R, 1987, ADV ECOL RES, V16, P53; Cushing P. E., 2012, PSYCHE-J ENTOMOL, V2012, P1, DOI DOI 10.1155/2012/151989; DEJEAN A, 1985, INSECT SOC, V32, P23, DOI 10.1007/BF02233224; DEJEAN A, 1990, BEHAVIOUR, V115, P175, DOI 10.1163/156853990X00563; Delabie Jacques H. C., 2001, Neotropical Entomology, V30, P501, DOI 10.1590/S1519-566X2001000400001; DETTNER K, 1994, ANNU REV ENTOMOL, V39, P129, DOI 10.1146/annurev.en.39.010194.001021; Dumont F, 2015, BEHAV ECOL SOCIOBIOL, V69, P971, DOI 10.1007/s00265-015-1909-x; EL-ZIADY S., 1956, Proceedings of the Royal Entomological Society of London, V31, P61; Fischer MK, 2001, OIKOS, V92, P531, DOI 10.1034/j.1600-0706.2001.920314.x; Frechette B, 2008, EUR J ENTOMOL, V105, P399, DOI 10.14411/eje.2008.050; FRYER G, 1986, BIOL J LINN SOC, V27, P287, DOI 10.1111/j.1095-8312.1986.tb01738.x; Gardiner MM, 2007, BIOL CONTROL, V40, P386, DOI 10.1016/j.biocontrol.2006.11.005; Hindayana D, 2001, BIOL CONTROL, V20, P236, DOI 10.1006/bcon.2000.0895; Holldobler B., 1990, pi; JANZEN DH, 1975, SCIENCE, V188, P936, DOI 10.1126/science.188.4191.936; JEFFRIES MJ, 1984, BIOL J LINN SOC, V23, P269, DOI 10.1111/j.1095-8312.1984.tb00145.x; Koch R L, 2003, J Insect Sci, V3, P32; LEDOUX ANDRE, 1952, ANN SCI NAT ZOOL 11E SE R, V14, P231; Liepert C, 1996, J CHEM ECOL, V22, P695, DOI 10.1007/BF02033579; LIEPERT C, 1993, J CHEM ECOL, V19, P2143, DOI 10.1007/BF00979653; Lucas E, 1999, ENVIRON ENTOMOL, V28, P622, DOI 10.1093/ee/28.4.622; Lucas E, 1998, ECOLOGY, V79, P1084, DOI 10.1890/0012-9658(1998)079[1084:IPAAPC]2.0.CO;2; Lucas E, 2001, ECOLOGY, V82, P3246, DOI 10.1890/0012-9658(2001)082[3246:AFISSC]2.0.CO;2; MANSOUR M H, 1976, Entomophaga, V21, P281, DOI 10.1007/BF02371763; MESSINA FJ, 1981, ECOLOGY, V62, P1433, DOI 10.2307/1941499; MILBRATH LR, 1993, ECOLOGY, V74, P1384, DOI 10.2307/1940068; Minarro M, 2005, BIOCONTROL, V50, P403, DOI 10.1007/s10526-004-5527-1; NAULT LR, 1976, SCIENCE, V192, P1349, DOI 10.1126/science.1273595; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; Sentis A, 2012, J INSECT BEHAV, V25, P529, DOI 10.1007/s10905-012-9320-1; Silva EN, 2013, SOCIOBIOLOGY, V60, P259; Stadler B, 2001, OIKOS, V92, P467, DOI 10.1034/j.1600-0706.2001.920308.x; Sudd JH, 1967, INTRO BEHAV ANTS; Vantaux Amelie, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/591570; VOLKL W, 1995, J INSECT BEHAV, V8, P653, DOI 10.1007/BF01997236; VOLKL W, 1993, J INSECT BEHAV, V6, P301, DOI 10.1007/BF01048111; VOLKL W, 1992, J ANIM ECOL, V61, P273, DOI 10.2307/5320; Volkl W, 2001, BEHAV ECOL SOCIOBIOL, V49, P135, DOI 10.1007/s002650000285; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; Yu DW, 2001, BIOL J LINN SOC, V72, P529, DOI [10.1006/bijl.2000.0514, 10.1111/j.1095-8312.2001.tb01336.x]	50	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204019	10.1371/journal.pone.0204019	http://dx.doi.org/10.1371/journal.pone.0204019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303985	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100029
J	Alfaress, S; Brodersen, CR; Ammar, ED; Rogers, ME; Killiny, N				Alfaress, Serine; Brodersen, Craig R.; Ammar, El-Desouky; Rogers, Michael E.; Killiny, Nabil			Laser surgery reveals the biomechanical and chemical signaling functions of aphid siphunculi (cornicles)	PLOS ONE			English	Article							ALARM PHEROMONE; PEA APHID; ACYRTHOSIPHON-PISUM; FORAGING PREDATORS; INCLUSIVE FITNESS; RISK; SECRETION; ONTOGENY; BEHAVIOR; LENGTH	Aphids are an attractive food source to many predators and parasitoids because of their small size, soft bodies and slow movement. To combat predation, aphids evolved both behavioral and chemical defensive mechanisms that are operated via siphunculi (cornicles), differently developed structures that more or less extend from their abdomen. Although both direct and indirect linkages between siphunculi and their defensive mechanisms have been explored, their ultimate effects on aphid fitness are still broadly debated. To explicitly test the influence of siphunculi on brown citrus aphid, Aphis (Toxoptera) citricida (Kirkaldy), fitness, we razor-cut and laser-sealed the siphunculi. Siphunculi removal resulted in two distinct behavior modifications, (false aggregation and increased drop-off rates) that led to decreased survival and the loss of the ability to right themselves from an inverted position. These results together indicate that siphunculi play an important role in survival, and removal of these organs will have negative effect on aphid fitness. Furthermore, results suggested that released alarm pheromone may play an important role in communication among aphid clone-mate, and omitting it results in miscommunication and competition among clonemates. These findings will help in better understanding the aphid biology.	[Alfaress, Serine; Rogers, Michael E.; Killiny, Nabil] Univ Florida, Citrus Res & Educ Ctr, IFAS, Lake Alfred, FL 33850 USA; [Brodersen, Craig R.] Yale Univ, Sch Forestry & Environm Studies, 195 Prospect, New Haven, CT 06511 USA; [Ammar, El-Desouky] ARS, USDA, US Hort Res Lab, Ft Pierce, FL USA	State University System of Florida; University of Florida; Yale University; United States Department of Agriculture (USDA)	Killiny, N (corresponding author), Univ Florida, Citrus Res & Educ Ctr, IFAS, Lake Alfred, FL 33850 USA.	nabilkilliny@ufl.edu	Brodersen, Craig/AAN-8404-2020	Brodersen, Craig/0000-0002-0924-2570; Killiny, Nabil/0000-0002-3895-6943				Alfaress S, 2014, 62 ANN M NOV PORTL O; Bahlai CA, 2013, ECOL MODEL, V254, P54, DOI 10.1016/j.ecolmodel.2013.01.014; BOWERS WS, 1972, SCIENCE, V177, P1121, DOI 10.1126/science.177.4054.1121; Brodersen CR, 2011, NEW PHYTOL, V191, P1168, DOI 10.1111/j.1469-8137.2011.03754.x; Byers JA, 2005, NATURWISSENSCHAFTEN, V92, P69, DOI 10.1007/s00114-004-0592-y; CALLOW RK, 1973, J INSECT PHYSIOL, V19, P737, DOI 10.1016/0022-1910(73)90146-7; CHEN SW, 1972, Z ZELLFORSCH MIK ANA, V130, P312, DOI 10.1007/BF00306945; CUTLER B, 1972, Journal of the Kansas Entomological Society, V45, P275; de Vos M, 2010, P NATL ACAD SCI USA, V107, P14673, DOI 10.1073/pnas.1001539107; DILL LM, 1990, OECOLOGIA, V83, P473, DOI 10.1007/BF00317197; DIXON A. F. G., 1958, TRANS ROY ENTOMOL SOC LONDON, V110, P319; DIXON AFG, 1975, J ZOOL, V175, P279, DOI 10.1111/j.1469-7998.1975.tb01402.x; EDWARDS JS, 1966, NATURE, V211, P73, DOI 10.1038/211073a0; Hatano E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011188; KISLOW CJ, 1972, NATURE, V235, P108, DOI 10.1038/235108a0; Losey JE, 1998, ECOL ENTOMOL, V23, P53, DOI 10.1046/j.1365-2311.1998.00102.x; Losey JE, 1998, OECOLOGIA, V115, P245, DOI 10.1007/s004420050513; Micha SG, 1996, CHEMOECOLOGY, V7, P132, DOI 10.1007/BF01245965; Mondor EB, 2007, J EVOLUTION BIOL, V20, P807, DOI 10.1111/j.1420-9101.2006.01271.x; Mondor EB, 2004, P ROY SOC B-BIOL SCI, V271, pS341, DOI 10.1098/rsbl.2004.0179; Mondor EB, 2003, CAN J ZOOL, V81, P757, DOI [10.1139/z03-053, 10.1139/Z03-053]; Mondor EB, 2002, CAN J ZOOL, V80, P2131, DOI 10.1139/Z02-209; Mondor EB, 2002, ECOL ENTOMOL, V27, P758, DOI 10.1046/j.1365-2311.2002.00470.x; Mondor EB, 2000, J CHEM ECOL, V26, P2875, DOI 10.1023/A:1026402229440; NAULT L R, 1973, Environmental Entomology, V2, P101, DOI 10.1093/ee/2.1.101; Nault L.R., 1984, P237; STRONG FE, 1967, ANN ENTOMOL SOC AM, V60, P668, DOI 10.1093/aesa/60.3.668; TURCHIN P, 1989, ECOLOGY, V70, P1008, DOI 10.2307/1941369; Vandermoten S, 2012, INSECT BIOCHEM MOLEC, V42, P155, DOI 10.1016/j.ibmb.2011.11.008; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; Wu GM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-19; Yokomi RK, 2009, OPTIONS MEDITERRANEE, V65, P35	32	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0204984	10.1371/journal.pone.0204984	http://dx.doi.org/10.1371/journal.pone.0204984			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296296	Green Submitted, gold, Green Published			2022-12-26	WOS:000446632700017
J	Atsri, HK; Konko, Y; Cuni-Sanchez, A; Abotsi, KE; Kokou, K				Atsri, Honam Komina; Konko, Yawo; Cuni-Sanchez, Aida; Abotsi, Komla Elikplim; Kokou, Kouami			Changes in the West African forest-savanna mosaic, insights from central Togo	PLOS ONE			English	Article							DYNAMICS; FRAGMENTATION; BIODIVERSITY; INDICATORS; RESERVE; AREA	The West African forest-savanna mosaic, an important habitat for biodiversity and humans, is severely degraded, fragmented and modified by human activities. However, few studies have quantified the land cover changes observed over time and/or analysed the drivers of change. This study focused on Fazao-Malfakassa National Park, the largest in Togo, uses a combination of remote sensing, ground surveys and questionnaires to: (i) quantify vegetation changes, (ii) determine the drivers of change, (iii) compare results with findings elsewhere in the region and (iv) suggest management interventions. The images used were Landsat 5 TM, Landsat 7 ETM and Sentinel-2. Different vegetation indices were computed including: number of fragments, index of dominance, mean area of a vegetation type and mean annual expansion rate. In total, 300 people (including park staff and local populations) were interviewed using a semi-structured questionnaire. Results indicate that between 1987 and 2015 closed-canopy forest and tree-savanna became severely degraded and fragmented, following trends in other parts of the West African forest-savanna mosaic. The main drivers of change were agricultural expansion, bush fires and timber extraction. Observed changes and drivers altered with time: e.g. agricultural expansion was greatest during 1987-2001 (linked with political instability) while illegal timber extraction augmented during 2001-2015 (following increased timber value). Park staff and local populations' perceptions on drivers of change did not differ. Our study highlights that action is urgently needed if we are to preserve this important habitat, the biodiversity it hosts and the services it provides to humans. We suggest several management interventions, learning from successful interventions elsewhere in the region.	[Atsri, Honam Komina; Abotsi, Komla Elikplim; Kokou, Kouami] Univ Lome Togo, Fac Sci, Lab Rech Forestiere, Lome, Togo; [Konko, Yawo] Minist Environm & Ressources Forestieres Togo, Agence Natl Gest Environm, Lome, Togo; [Cuni-Sanchez, Aida] Univ York, Environm Dept, York, N Yorkshire, England	University of York - UK	Atsri, HK (corresponding author), Univ Lome Togo, Fac Sci, Lab Rech Forestiere, Lome, Togo.	atsri.honam@yahoo.com	Atsri, Honam/Q-8052-2019	Atsri, Honam/0000-0001-5594-316X				Achard F, 1990, APPORTS TELEDETECTIO, P1; Adjonou K., 2010, BOIS FOR TROP, V306, P33; Adjoussi P., 2000, CHANGEMENT CLIMATIQU; Amori G, 2016, ZOOSYSTEMA, V38, P201, DOI 10.5252/z2016n2a3; Arouna O., 2012, CARTOGRAPHIE MODELIS; Aubreville A., 1957, Bois et Forets des Tropiques, P23; Banque mondiale, 2014, POPULATION TOTAL BAN; Barima Y.S.S., 2010, T L D TECTION, V9, P129; Barima YSS, 2010, BIOTECHNOL AGRON SOC, V14, P617; Belle EMS, 2016, SUMMARY MAIN OUTPUTS; Blanc-Pamard C., 1984, DEV RURAL QUESTION, V106, P55; BLOT A, 1988, J AFR EARTH SCI, V7, P159, DOI 10.1016/0899-5362(88)90062-0; Bogaert J, 2003, CONSERV ECOL, V7; Bouko BS, 2016, EUR SCI J ESJ, V12; CALOZ R., 1993, TELEDETECTION CARTOG, P17; Camara AA, 2012, CYBERGEO; Campbell G, 2005, PRIMATE BIRD DIVERSI; Carr JA, 2014, EVALUATION VULNERABI; CIBIEN C, 2000, RESERVES BIOSPHERE T; Cibien C, 2008, DEMARCHE MAB VOIE OP; Cochrane MA, 2001, CONSERV BIOL, V15, P1515, DOI 10.1046/j.1523-1739.2001.01091.x; Commission allemande pour l'UNESCO, 2015, GUID GEST RES UNESCO; Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6; Davidson C, 1998, WILDLIFE SOC B, V26, P32; Denis G., 2015, EUR SCI J ESJ, V11; Diallo Hady, 2011, Secheresse (Montrouge), V22, P97, DOI 10.1684/sec.2011.0306; DibiN'Da H., 2008, TELEDETECTION, V8, P17; Dimobe K, 2015, GLOB ECOL CONSERV, V4, P559, DOI 10.1016/j.gecco.2015.10.006; Diwediga B, 2017, J GEOGR SCI, V27, P579, DOI 10.1007/s11442-017-1394-4; Djibu K.J.-P., 2008, ANN FS AGRON LUNIVER, V1, P12; Djiwa O, 2008, DYNAMIQUE FOERESTIER; Dourma M, 2012, BOIS FOR TROP, V313; FFW, 2013, ET EC INV FOR FAUN E; Gautestad AO, 2010, ECOL MODEL, V221, P2741, DOI 10.1016/j.ecolmodel.2010.08.014; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; GUELLY KA, 2013, ANAL COMPRE HENSION, P88; Heilig GK, 2012, DEP EC SOC AFF DESA; Idbraim S., 2009, THESIS; Inoussa Maman Maarouhi, 2011, Secheresse (Montrouge), V22, P108, DOI 10.1684/sec.2011.0305; IUCN/PACO, 2008, EV EFF GEST AIR PROT; James R, 2013, CLIMATIC CHANGE, V117, P859, DOI 10.1007/s10584-012-0581-7; Jenkins MD, 2002, WORLD ATLAS BIODIVER; Johns Andrew Grieser, 1995, Oryx, V29, P205, DOI 10.1017/S0030605300021141; Kaiser J., 2001, BIOINDICATORS BIOMAR; Kemavo A., 2012, CONTRIBUTION TECHNOL; Kokou K, 2006, PHYTOCOENOLOGIA, V36, P403, DOI 10.1127/0340-269X/2006/0036-0403; Kone M, 2007, REV TELEDETECTION, V7, P3; Kouami K, 2009, SCI RES ESSAYS, V4, P881; Kurtz C., 2009, ANAL MULTIRESOLUTION; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lerman SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043497; Levine J.S., 1999, WILDLAND FIRES ENV G; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lugo E., 2008, J LAND USE ENV LAW, V23, P243; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Masumbuko B, 2014, ANAL LINKS CLIMATE C; McGarigal K., 1994, FRAGSTATS SPATIAL PA, V2, P128; Ministere de l'Environnement et des Ressources Forestieres, 2016, PLAN NAT AD AUX CHAN, P117; MPTHU, 2001, COMSTABEX9194 MPTHU; Niemi GJ, 2004, ANNU REV ECOL EVOL S, V35, P89, DOI 10.1146/annurev.ecolsys.35.112202.130132; Oloukoi J, 2007, TELEDETECTION, V6, P305; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Osseni Inoussa A., 2009, CONTRIBUTION GESTION; Otto H-J, 1998, ECOLOGIE FORESTIERE; PACO/UICN I, 2012, PAPACO STUD; PNUD, 2016, RAPP DEV HUM AFR 201; Poilecot P, 2009, BOIS FOR TROP, P51; Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a; Prudent P, 2008, 742 ACP RPR; Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3; Rabeil T., 2003, DISTRIBUTION POTENTI; RGPH4, 2011, DIR GEN STAT COMPT N; Robin A, 2007, THESIS; Sambieni K, 2015, VERTIGO REV ELECT SC, V15; Sawadogo L, 2007, ADAPTER APPROCHES AM; Schulz JJ, 2010, APPL GEOGR, V30, P436, DOI 10.1016/j.apgeog.2009.12.003; Sinsin B, 2010, ATLAS BIODIVERSITE A, VI; Smyth RL, 2007, ENVIRON MANAGE, V39, P301, DOI 10.1007/s00267-005-0282-3; Tankoano B., 2015, International Journal of Biological and Chemical Sciences, V9, P1983, DOI 10.4314/ijbcs.v9i4.23; Tchamie T. T. K., 1994, UNASYLVA, V45, P22; Toko Mouhamadou I, 2012, VERTIGO REV ELECT SC, V12; Vergara PM, 2015, ECOL MODEL, V300, P114, DOI 10.1016/j.ecolmodel.2015.01.006; Woegan Y. A., 2013, International Journal of Biological and Chemical Sciences, V7, P1951, DOI 10.4314/ijbcs.v7i5.14; Woegan YA, 2011, ACTA BOT GALLICA, V158, P444	84	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203999	10.1371/journal.pone.0203999	http://dx.doi.org/10.1371/journal.pone.0203999			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289922	Green Published, Green Submitted, gold			2022-12-26	WOS:000446545500012
J	Sacreas, A; Yang, JYC; Vanaudenaerde, BM; Sigdel, TK; Liberto, JM; Damm, I; Verleden, GM; Vos, R; Verleden, SE; Sarwal, MM				Sacreas, Annelore; Yang, Joshua Y. C.; Vanaudenaerde, Bart M.; Sigdel, Tara K.; Liberto, Juliane M.; Damm, Izabella; Verleden, Geert M.; Vos, Robin; Verleden, Stijn E.; Sarwal, Minnie M.			The common rejection module in chronic rejection post lung transplantation	PLOS ONE			English	Article							BRONCHIOLITIS OBLITERANS SYNDROME; ALLOGRAFT DYSFUNCTION; EXPRESSION; BIOPSIES	Rationale Recent studies suggest that similar injury mechanisms are in place across different solid organ transplants, resulting in the identification of a common rejection module (CRM), consisting of 11 genes that are overexpressed during acute and, to a lesser extent, chronic allograft rejection. Objectives We wanted to evaluate the usefulness of the CRM module in identifying acute rejection (AR) and different phenotypes of chronic lung transplant rejection (CLAD), i.e., bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS), using transbronchial brushings, broncho-alveolar lavage (BAL) samples, and explant tissue. Methods Gene expression measurements for the 11 CRM genes (CD6, TAP1, CXCL10, CXCL9, INPP5D, ISG20, LCK, NKG7, PSMB9, RUNX3, and BASP1) were performed via qRT-PCR in 14 transbronchial brushings (AR, n = 4; no AR, n = 10), 32 BAL samples (stable, n = 13; AR, n = 8; BOS, n = 9; RAS, n = 10), and 44 tissue specimens (unused donor lungs, n = 15; BOS, n = 13; RAS, n = 16). A geometric mean score was calculated to quantitate overall burden of immune injury and a new computational model was built for the most significant genes in lung transplant injury. Results Acute rejection showed a significant difference in almost every gene analysed, validating previous observations from microarray analysis. RAS tissue demonstrated a higher geometric mean score (6.35) compared to donor tissue (4.09, p = 0.018). Analysis of individual CRM genes showed an increased expression of ISG20, CXCL10 and CXCL9 in RAS. In BAL samples, no differences were detected in gene expression or geometric mean scores between the various groups (stable, 5.15; AR, 5.81; BOS, 5.62; RAS, 7.31). A newly modelled 2-gene tissue CRM score did not demonstrate any difference between BOS and RAS (p>0.05). However, the model was able to discriminate RAS from BOS tissue (AUC = 0.75, 95% CI = 0.55-0.94, p = 0.025). Conclusion Transcriptional tissue analysis for CRM genes in CLAD can identify acute rejection and distinguish RAS from BOS. The immune activation in RAS seems similar to acute rejection after kidney/liver/heart transplantation.	[Sacreas, Annelore; Vanaudenaerde, Bart M.; Verleden, Geert M.; Vos, Robin; Verleden, Stijn E.] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing CHROMETA, Leuven Lung Transplant Unit, Leuven, Belgium; [Yang, Joshua Y. C.; Sigdel, Tara K.; Liberto, Juliane M.; Damm, Izabella; Sarwal, Minnie M.] Univ Calif San Francisco, Dept Surg, Div Transplant Surg, San Francisco, CA 94143 USA	KU Leuven; University of California System; University of California San Francisco	Verleden, SE (corresponding author), Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing CHROMETA, Leuven Lung Transplant Unit, Leuven, Belgium.; Sarwal, MM (corresponding author), Univ Calif San Francisco, Dept Surg, Div Transplant Surg, San Francisco, CA 94143 USA.	stijn.verleden@kuleuven.be; minnie.sarwal@ucsf.edu	Liberto, Juliane M/ABA-9675-2020; Yang, Joshua Young Cynming/P-6447-2018; Sigdel, Tara/AAV-5886-2020	Liberto, Juliane M/0000-0003-1927-5058; Yang, Joshua Young Cynming/0000-0003-2410-7817; Sigdel, Tara/0000-0001-8448-0328; Verleden, Stijn/0000-0002-9656-5844; Vanaudenaerde, Bart/0000-0001-6435-6901	Reaseach Foundation - Flanders (FWO) [12G8715N, 1500617N]; UZ Leuven [STG/15/023]; KU Leuven research funding [C24/15/030]; NIH (NIAID); NIH (NIDDK)	Reaseach Foundation - Flanders (FWO); UZ Leuven(KU Leuven); KU Leuven research funding; NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Authors of this work were supported by several funding resources. RV and SEV are senior clinical research fellows sponsored by Reaseach Foundation - Flanders (FWO: 12G8715N and 1500617N). RV is supported by UZ Leuven (STG/15/023). GMV and BMV are supported by KU Leuven research funding C24/15/030. MMS and TKS have research support from the NIH (NIAID and NIDDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angaswamy N, 2013, HUM IMMUNOL, V74, P1478, DOI 10.1016/j.humimm.2013.07.002; Bollmann BA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01844-2016; Davis WA, 2012, AM J TRANSPLANT, V12, P745, DOI 10.1111/j.1600-6143.2011.03849.x; Einecke G, 2010, J CLIN INVEST, V120, P1862, DOI 10.1172/JCI41789; Espert L, 2003, J BIOL CHEM, V278, P16151, DOI 10.1074/jbc.M209628200; Halloran PF, 2017, J HEART LUNG TRANSPL, V36, P1192, DOI 10.1016/j.healun.2017.05.029; Halloran PF, 2016, NAT REV NEPHROL, V12, P534, DOI 10.1038/nrneph.2016.85; Kennedy VE, 2013, AM J TRANSPLANT, V13, P552, DOI 10.1111/ajt.12091; Keslar KS, 2013, AM J TRANSPLANT, V13, P1891, DOI 10.1111/ajt.12284; Khatri P, 2013, J EXP MED, V210, P2205, DOI 10.1084/jem.20122709; Mengual Lourdes, 2008, BMC Res Notes, V1, P21, DOI 10.1186/1756-0500-1-21; Meyer KC, 2014, EUR RESPIR J, V44, P1479, DOI 10.1183/09031936.00107514; Royer PJ, 2016, TRANSPLANTATION, V100, P1803, DOI 10.1097/TP.0000000000001215; Sato M, 2011, J HEART LUNG TRANSPL, V30, P735, DOI 10.1016/j.healun.2011.01.712; Shino MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180281; Shino MY, 2013, AM J RESP CRIT CARE, V188, P1117, DOI 10.1164/rccm.201305-0861OC; Sigdel T, 2017, AM J TRANSPLANT, V17, DOI [10.1371/journal.pone.0138133, DOI 10.1371/JOURNAL.PONE.0138133]; Sigdel TK, 2018, KIDNEY INT REP, V3, P722, DOI 10.1016/j.ekir.2018.01.014; Sigdel TK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138133; Verleden GM, 2014, J HEART LUNG TRANSPL, V33, P127, DOI 10.1016/j.healun.2013.10.022; Verleden SE, 2015, J HEART LUNG TRANSPL, V34, P625, DOI 10.1016/j.healun.2014.11.007; Verleden SE, 2015, TRANSPLANTATION, V99, P86, DOI 10.1097/TP.0000000000000269; Verleden SE, 2014, AM J RESP CRIT CARE, V189, P292, DOI 10.1164/rccm.201310-1894OC; Yang JYC, 2017, NAT REV GENET, V18, P309, DOI 10.1038/nrg.2017.12; Yusen RD, 2016, J HEART LUNG TRANSPL, V35, P1170, DOI 10.1016/j.healun.2016.09.001; Zheng ZW, 2017, INTRACTABLE RARE DIS, V6, P35, DOI 10.5582/irdr.2017.01004	26	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205107	10.1371/journal.pone.0205107	http://dx.doi.org/10.1371/journal.pone.0205107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289917	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000446545500049
J	Chakravorty, D; Patra, S				Chakravorty, Debamitra; Patra, Sanjukta			RankProt: A multi criteria-ranking platform to attain protein thermostabilizing mutations and its in vitro applications - Attribute based prediction method on the principles of Analytical Hierarchical Process	PLOS ONE			English	Article							STABILITY CHANGES; EVOLUTION; SEQUENCE	Attaining recombinant thermostable proteins is still a challenge for protein engineering. The complexity is the length of time and enormous efforts required to achieve the desired results. Present work proposes a novel and economic strategy of attaining protein thermostability by predicting site-specific mutations at the shortest possible time. The success of the approach can be attributed to Analytical Hierarchical Process and the outcome was a rationalized thermostable mutation(s) prediction tool- RankProt. Briefly the method involved ranking of 17 biophysical protein features as class predictors, derived from 127 pairs of thermostable and mesostable proteins. Among the 17 predictors, ionic interactions and main-chain to main-chain hydrogen bonds were the highest ranked features with eigen value of 0.091. The success of the tool was judged by multi-fold in silico validation tests and it achieved the prediction accuracy of 91% with AUC 0.927. Further, in vitro validation was carried out by predicting thermostabilizing mutations for mesostable Bacillus subtilis lipase and performing the predicted mutations by multi-site directed mutagenesis. The rationalized method was successful to render the lipase thermostable with optimum temperature stability and T m increase by 20 degrees C and 7 degrees C respectively. Conclusively it can be said that it was the minimum number of mutations in comparison to the number of mutations incorporated to render Bacillus subtilis lipase thermostable, by directed evolution techniques. The present work shows that protein stabilizing mutations can be rationally designed by balancing the biophysical pleiotropy of proteins, in accordance to the selection pressure.	[Chakravorty, Debamitra; Patra, Sanjukta] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Patra, S (corresponding author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati, Assam, India.	sanjukta@iitg.ernet.in	Chakravorty, Debamitra/AAO-3550-2020		Department of Biotechnology, Government of India [BT/535/NE/TBP/2013]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The study was supported by The Department of Biotechnology, Government of India, is acknowledged for funding the project BT/535/NE/TBP/2013 to SP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2004, J MOL BIOL, V341, P1271, DOI 10.1016/j.jmb.2004.06.059; Akanuma S, 2017, LIFE-BASEL, V7, DOI 10.3390/life7030033; Bednar D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004556; Bhardwaj A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011347; Bikadi Z, 2007, ARCH BIOCHEM BIOPHYS, V461, P225, DOI 10.1016/j.abb.2007.02.020; Bommarius AS, 2013, CHEM SOC REV, V42, P6534, DOI 10.1039/c3cs60137d; Cang ZX, 2017, BIOINFORMATICS, V33, P3549, DOI 10.1093/bioinformatics/btx460; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chakravorty D, 2015, CURRENT BIOTECHNOL, V61, P39; Chakravorty D, 2011, EXTREMOPHILES, V15, P89, DOI 10.1007/s00792-010-0337-0; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; EIJSINK VGH, 1992, BIOCHEM J, V285, P625, DOI 10.1042/bj2850625; Folkman L, 2016, J MOL BIOL, V428, P1394, DOI 10.1016/j.jmb.2016.01.012; Glogauer A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-54; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Huang W, 2013, ECOL INDIC, V25, P180, DOI 10.1016/j.ecolind.2012.09.017; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Ivanov A, 2012, INT CONF ACOUST SPEE, P5125, DOI 10.1109/ICASSP.2012.6289074; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; KOLLMAN PA, 1972, CHEM REV, V72, P283, DOI 10.1021/cr60277a004; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Leuenberger P, 2017, SCIENCE, V355, DOI 10.1126/science.aai7825; Levner I, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-68; Li YQ, 2012, PROTEINS, V80, P81, DOI 10.1002/prot.23163; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Murakami S, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4931814; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Notomista E, 2001, BIOCHEMISTRY-US, V40, P9097, DOI 10.1021/bi010741s; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Porebski BT, 2016, PROTEIN ENG DES SEL, V29, P245, DOI 10.1093/protein/gzw015; Pucci F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091659; Quan LJ, 2016, BIOINFORMATICS, V32, P2936, DOI 10.1093/bioinformatics/btw361; Rathi PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130289; Reetz MT, 2009, BIOTECHNOL BIOENG, V102, P1712, DOI 10.1002/bit.22202; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Russell RJM, 1997, BIOCHEMISTRY-US, V36, P9983, DOI 10.1021/bi9705321; Saaty TL, 2000, INT J SERVICES SCI, V11, P83; Sadeghi M, 2006, BIOPHYS CHEM, V119, P256, DOI 10.1016/j.bpc.2005.09.018; Schmidt K, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0234-7; Shin DS, 2009, J MOL BIOL, V385, P1534, DOI 10.1016/j.jmb.2008.11.031; Sikosek T, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0419; Socha RD, 2013, FEBS J, V280, P5582, DOI 10.1111/febs.12354; Srinivasu P, 2012, ADV INTELLIGENT SOFT, V132; Srivastava A, 2014, PLOS ONE, V98; Su Q, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1645619; Subrahmanyam K., 2013, IOSR J COMPUT ENG, V133, P70; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Torrez M, 2003, BIOPHYS J, V85, P2845, DOI 10.1016/S0006-3495(03)74707-9; Vehlow C, 2011, BIOINFORMATICS, V27, P1573, DOI 10.1093/bioinformatics/btr163; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wang ZY, 2013, BIOINFORMATICS, V29, P266, DOI 10.1093/bioinformatics/btt211; Wijma HJ, 2014, PROTEIN ENG DES SEL, V27, P49, DOI 10.1093/protein/gzt061; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Yin S, 2007, MODELING BACKBONE FL, V1512, P1567; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yu JS, 2005, BIOINFORMATICS, V21, P2200, DOI 10.1093/bioinformatics/bti370; Zhu W., 2010, P NESUG P HLTH CAR L, V19, P67	64	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203036	10.1371/journal.pone.0203036	http://dx.doi.org/10.1371/journal.pone.0203036			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286107	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500004
J	Sogawa, Y; Nagasu, H; Itano, S; Kidokoro, K; Taniguchi, S; Takahashi, M; Kadoya, H; Satoh, M; Sasaki, T; Kashihara, N				Sogawa, Yuji; Nagasu, Hajime; Itano, Seiji; Kidokoro, Kengo; Taniguchi, Shun'ichiro; Takahashi, Masafumi; Kadoya, Hiroyuki; Satoh, Minoru; Sasaki, Tamaki; Kashihara, Naoki			The eNOS-NO pathway attenuates kidney dysfunction via suppression of inflammasome activation in aldosterone-induced renal injury model mice	PLOS ONE			English	Article							NITRIC-OXIDE; BLOOD-PRESSURE; DISEASE; PROMOTES; RISK; MACROPHAGES; SUPEROXIDE; DEFICIENCY; DAMAGE; CELLS	Hypertension causes vascular complications, such as stroke, cardiovascular disease, and chronic kidney disease (CKD). The relationship between endothelial dysfunction and progression of kidney disease is well known. However, the relationship between the eNOS-NO pathway and chronic inflammation, which is a common pathway for the progression of kidney disease, remains unexplored. We performed in vivo experiments to determine the role of the eNOS-NO pathway by using eNOS-deficient mice in a hypertensive kidney disease model. All mice were unilateral nephrectomized (Nx). One week after Nx, the mice were randomly divided into two groups: the aldosterone infusion groups and the vehicle groups. All mice also received a 1% NaCl solution instead of drinking water. The aldosterone infusion groups were treated with hydralazine to correct blood pressure differences. After four weeks of drug administration, all mice were euthanized, and blood and kidney tissue samples were collected. In the results, NLRP3 inflammasome activation was elevated in the kidneys of the eNOS-deficient mice, and tubulointerstitial fibrosis was accelerated. Suppression of inflammasome activation by knocking out ASC prevented tubulointerstitial injury in the eNOS knockout mice, indicating that the eNOS-NO pathway is involved in the development of kidney dysfunction through acceleration of NLRP3 inflammasome in macrophages. We revealed that endothelial function, particularly the eNOS-NO pathway, attenuates the progression of renal tubulointerstitial injury via suppression of inflammasome activation. Clinically, patients who develop vascular endothelial dysfunction have lifestyle diseases, such as hypertension or diabetes, and are known to be at risk for CKD. Our study suggests that the eNOS-NO pathway could be a therapeutic target for the treatment of chronic kidney disease associated with endothelial dysfunction.	[Sogawa, Yuji; Nagasu, Hajime; Itano, Seiji; Kidokoro, Kengo; Kadoya, Hiroyuki; Satoh, Minoru; Sasaki, Tamaki; Kashihara, Naoki] Kawasaki Med Sch, Dept Nephrol & Hypertens, Kurashiki, Okayama, Japan; [Taniguchi, Shun'ichiro] Shinshu Univ, Dept Mol Oncol, Grad Sch Med, Matsumoto, Nagano, Japan; [Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi, Japan	Kawasaki Medical School; Shinshu University; Jichi Medical University	Nagasu, H (corresponding author), Kawasaki Med Sch, Dept Nephrol & Hypertens, Kurashiki, Okayama, Japan.	hajimenagasu@med.kawasaki-m.ac.jp		Nagasu, Hajime/0000-0003-2549-4126	Japan Society of The Promotion for Science KAKENHI [24591220]; JSPS KAKENHI [24591220, 18H02828]	Japan Society of The Promotion for Science KAKENHI; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society of The Promotion for Science (http://www.jsps.go.jp/index.html) KAKENHI grant (No. 24591220 to HN).; We thank Etsuko Yorimasa, Yuriko Katayama, and Ayano Higashi for providing animal care, as well as Satomi Hanada, Keiko Shirakiya, and Keiko Satoh for assisting with the in vitro assays. This work was supported in part by a JSPS KAKENHI grant (No. 24591220 to HN and No.18H02828 to NK).	Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Aramoto H, 2004, AM J PHYSIOL-HEART C, V287, pH1590, DOI 10.1152/ajpheart.00767.2003; Cao Q, 2015, J AM SOC NEPHROL, V26, P349, DOI 10.1681/ASN.2013121336; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Friebe A, 2009, NITRIC OXIDE-BIOL CH, V21, P149, DOI 10.1016/j.niox.2009.07.004; Fujimoto S, 2008, HYPERTENS RES, V31, P305, DOI 10.1291/hypres.31.305; Fukumura D, 1997, AM J PATHOL, V150, P713; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Ikeda A, 2009, AM J HYPERTENS, V22, P273, DOI 10.1038/ajh.2008.356; Kadoya H, 2015, FASEB J, V29, P3899, DOI 10.1096/fj.15-271734; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; Luther JM, 2012, KIDNEY INT, V82, P643, DOI 10.1038/ki.2012.170; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; McMaster WG, 2015, CIRC RES, V116, P1022, DOI 10.1161/CIRCRESAHA.116.303697; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nagasu H, 2016, LAB INVEST, V96, P25, DOI 10.1038/labinvest.2015.128; Nagasu H, 2012, AM J PHYSIOL-RENAL, V302, pF1402, DOI 10.1152/ajprenal.00459.2011; Nakayama T, 2009, AM J PHYSIOL-RENAL, V296, pF317, DOI 10.1152/ajprenal.90450.2008; Nishi Y, 2013, KIDNEY INT, V83, P662, DOI 10.1038/ki.2012.475; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; Pushpakumar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06484-6; Pyriochou A, 2006, J PHARMACOL EXP THER, V319, P663, DOI 10.1124/jpet.106.108878; Ross R, 2001, INT IMMUNOPHARMACOL, V1, P1469, DOI 10.1016/S1567-5769(01)00091-1; Satoh M, 2005, AM J PHYSIOL-RENAL, V288, pF1144, DOI 10.1152/ajprenal.00221.2004; Satoh M, 2010, HYPERTENS RES, V33, P135, DOI 10.1038/hr.2009.190; Seliger SL, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0303-x; Sogawa Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08054-2; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; Wassertheil-Smoller S, 2004, JAMA-J AM MED ASSOC, V292, P2849, DOI 10.1001/jama.292.23.2849; Weisheit CK, 2015, CLIN J AM SOC NEPHRO, V10, P1841, DOI 10.2215/CJN.07100714; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111	36	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203823	10.1371/journal.pone.0203823	http://dx.doi.org/10.1371/journal.pone.0203823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281670	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400030
J	Xu, JY; Chang, NB; Rong, ZH; Li, T; Xiao, L; Yao, QP; Jiang, R; Jiang, J				Xu, Jia-Ying; Chang, Neng-Bin; Rong, Zhi-Hua; Li, Tao; Xiao, Ling; Yao, Qing-Ping; Jiang, Rui; Jiang, Jun			circDiaph3 regulates rat vascular smooth muscle cell differentiation, proliferation, and migration	FASEB JOURNAL			English	Article						intimal hyperplasia; vascular injury; vascular remodeling; VSMC; noncoding RNA	NONCODING RNA; BALLOON ANGIOPLASTY; CIRCULAR RNAS; EXPRESSION; ATHEROSCLEROSIS; APOPTOSIS; MICRORNA; DISEASE; MIRNAS; STENTS	Intimal hyperplasia is a reaction to vascular injury, which is the primary reason for vascular restenosis caused by the diagnostic or therapeutic procedure for cardiovascular diseases. Circular RNAs (circRNAs) are known to be associated with several cardiovascular conditions, but the expression of circRNAs in the neointima has not been reported in detail. In this study, we established the balloon-injured rat carotid artery model and detected the expression of circRNAs in the carotid arteries with a microarray. We found that the circRNA expression profile of the healthy carotid arteries and the injured arteries were significantly different. We investigated the role of rno-circ_005717 (circDiaph3) in the differentiation of rat vascular smooth muscle cells (VSMCs). We found that knockdown of circDiaph3 up-regulated the level of diaphanous-related formin-3 and promoted the differentiation of VSMCs to contractile type. In addition, circDiaph3 up-regulated the transcription of Igf1r and supported the proliferation and migration of VSMCs. circDiaph3 could be a molecular target to combat intimal hyperplasia.Xu, J.-Y., Chang, N.-B., Rong, Z.-H., Li, T., Xiao, L., Yao, Q.-P., Jiang, R., Jiang, J. circDiaph3 regulates rat vascular smooth muscle cell differentiation, proliferation, and migration.	[Xu, Jia-Ying; Rong, Zhi-Hua; Jiang, Rui; Jiang, Jun] Southwest Med Univ, Affiliated Hosp, Dept Surg, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China; [Chang, Neng-Bin] Southwest Med Univ, Inst Cardiovasc Res, Collaborat Innovat Ctr Prevent & Treatment Cardio, Dept Anat,Minist Educ, Luzhou, Peoples R China; [Li, Tao] Southwest Med Univ, Inst Cardiovasc Res, Collaborat Innovat Ctr Prevent & Treatment Cardio, Key Lab Med Electrophysiol,Minist Educ, Luzhou, Peoples R China; [Xiao, Ling] Emergency Med Ctr Chongqing, Chongqing, Peoples R China; [Yao, Qing-Ping] Shanghai Jiao Tong Univ, Inst Mechanobiol & Med Engn, Sch Life Sci & Biotechnol, Shanghai, Peoples R China	Southwest Medical University; Southwest Medical University; Southwest Medical University; Shanghai Jiao Tong University	Jiang, R; Jiang, J (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Surg, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China.	jiangrui@126.com; john978@163.com	xu, jia/GSD-6347-2022		Science and Technology-Department of Sichuan Province [2016JY0066]; Office of Science and Technology and Intellectual Property of Luzhou [14JC0176]; Institute of Cardiovascular Research, Southwest Medical University; Southwest Medical University/Affiliated Hospital of Southwest Medical University	Science and Technology-Department of Sichuan Province; Office of Science and Technology and Intellectual Property of Luzhou; Institute of Cardiovascular Research, Southwest Medical University; Southwest Medical University/Affiliated Hospital of Southwest Medical University	This research was supported by Science and Technology-Department of Sichuan Province Grant 2016JY0066; Office of Science and Technology and Intellectual Property of Luzhou Grant 14JC0176; the Institute of Cardiovascular Research, Southwest Medical University; and by the Southwest Medical University/Affiliated Hospital of Southwest Medical University. The authors declare no conflicts of interest.	Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Ballantyne MD, 2016, CIRCULATION, V133, P2050, DOI 10.1161/CIRCULATIONAHA.115.021019; Boeckel JN, 2015, CIRC RES, V117, P884, DOI 10.1161/CIRCRESAHA.115.306319; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Deng L, 2016, CURR OPIN LIPIDOL, V27, P439, DOI 10.1097/MOL.0000000000000336; Gareri C, 2016, CIRC RES, V118, P1170, DOI 10.1161/CIRCRESAHA.115.308237; Geng HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151753; Grant MB, 1999, REGUL PEPTIDES, V79, P47, DOI 10.1016/S0167-0115(98)00027-5; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hentze MW, 2013, EMBO J, V32, P923, DOI 10.1038/emboj.2013.53; Holdt LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12429; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Katsanos K, 2016, J ENDOVASC THER, V23, P851, DOI 10.1177/1526602816671740; Lv JY, 2018, BIOCHEM BIOPH RES CO, V497, P1154, DOI 10.1016/j.bbrc.2017.01.011; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Polimeni A, 2013, TRENDS CARDIOVAS MED, V23, P9, DOI 10.1016/j.tcm.2012.08.004; Schillinger M, 2006, NEW ENGL J MED, V354, P1879, DOI 10.1056/NEJMoa051303; Shan K, 2017, CIRCULATION, V136, P1629, DOI 10.1161/CIRCULATIONAHA.117.029004; Song XW, 2014, SCI CHINA LIFE SCI, V57, P826, DOI 10.1007/s11427-014-4698-y; Staus DP, 2007, ARTERIOSCL THROM VAS, V27, P478, DOI 10.1161/01.ATV.0000255559.77687.c1; Staus DP, 2014, AM J PHYSIOL-HEART C, V307, pH379, DOI 10.1152/ajpheart.01002.2013; Staus DP, 2011, BIOCHEM J, V439, P57, DOI 10.1042/BJ20101700; Tang CY, 2017, SPR SER POLYM COMPOS, P1, DOI 10.1007/978-3-319-46458-9_1; Vausort M, 2016, J AM COLL CARDIOL, V68, P1247, DOI 10.1016/j.jacc.2016.06.040; Viereck J, 2017, CIRC RES, V120, P381, DOI 10.1161/CIRCRESAHA.116.308434; Wang K, 2016, EUR HEART J, V37, P2602, DOI 10.1093/eurheartj/ehv713; Weise-Cross L, 2015, ARTERIOSCL THROM VAS, V35, P2374, DOI 10.1161/ATVBAHA.115.305879; Wilusz JE, 2013, SCIENCE, V340, P440, DOI 10.1126/science.1238522; Wu GZ, 2014, CIRCULATION, V130, P1452, DOI 10.1161/CIRCULATIONAHA.114.011675; Zhao ZZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep39918; Zheng CF, 2015, MOL MED REP, V12, P6656, DOI 10.3892/mmr.2015.4264	32	32	35	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2659	2668		10.1096/fj.201800243RRR	http://dx.doi.org/10.1096/fj.201800243RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307766				2022-12-26	WOS:000457296600090
J	Kuhn, P; Kalariya, HM; Poulev, A; Ribnicky, DM; Jaja-Chimedza, A; Roopchand, DE; Raskin, I				Kuhn, Peter; Kalariya, Hetalben M.; Poulev, Alexander; Ribnicky, David M.; Jaja-Chimedza, Asha; Roopchand, Diana E.; Raskin, Ilya			Grape polyphenols reduce gut-localized reactive oxygen species associated with the development of metabolic syndrome in mice	PLOS ONE			English	Article							AKKERMANSIA-MUCINIPHILA; OXIDATIVE STRESS; GASTROINTESTINAL-TRACT; INSULIN SENSITIVITY; PROANTHOCYANIDINS; OBESITY; KINASE; BIOAVAILABILITY; HYPERGLYCEMIA; INFLAMMATION	High-fat diet (HFD)-induced leaky gut syndrome combined with low-grade inflammation increase reactive oxygen species (ROS) in the intestine and may contribute to dysbiosis and metabolic syndrome (MetS). Poorly bioavailable and only partially metabolizable dietary polyphenols, such as proanthocyanidins (PACs), may exert their beneficial effects on metabolic health by scavenging intestinal ROS. To test this hypothesis, we developed and validated a novel, noninvasive, in situ method for visualizing intestinal ROS using orally administered ROS-sensitive indocyanine green (ICG) dye. C57BLJ6J mice fed HFD for 10 weeks accumulated high levels of intestinal ROS compared to mice fed low-fat diet (LFD). Oral administration of poorly bioavailable grape polyphenol extract (GPE) and beta-carotene decreased HFD-induced ROS in the gut to levels comparable to LFD-fed mice, while administration of more bioavailable dietary antioxidants (alpha-lipoic acid, vitamin C, vitamin E) did not. Forty percent of administered GPE antioxidant activity was measured in feces collected over 24 h, confirming poor bioavailability and persistence in the gut. The bloom of beneficial anaerobic gut bacteria, such as Akkermansia muciniphila, associated with improved metabolic status in rodents and humans may be directly linked to protective antioxidant activity of some dietary components. These findings suggest a possible mechanistic explanation for the beneficial effects of poorly bioavailable polyphenols on metabolic health.	[Kuhn, Peter; Kalariya, Hetalben M.; Poulev, Alexander; Ribnicky, David M.; Jaja-Chimedza, Asha; Raskin, Ilya] Rutgers State Univ, Dept Plant Biol, Foran Hall, New Brunswick, NJ 08901 USA; [Roopchand, Diana E.] Rutgers State Univ, Dept Food Sci, Inst Food Nutr & Hlth, Ctr Digest Hlth, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Raskin, I (corresponding author), Rutgers State Univ, Dept Plant Biol, Foran Hall, New Brunswick, NJ 08901 USA.	raskin@rutgers.edu		Poulev, Alexander/0000-0003-0939-0642; Raskin, Ilya/0000-0002-3025-8112	National Center for Complementary and Alternative Medicine [R01-AT-008618-01, 1 T32 AT004094]; Office of Dietary Supplements (ODS); NCCIH / ODS [P50-AT-002776-01, K01-AT008829]; National Center for Complementary & Integrative Health [P50AT002776, R01AT008618, K01AT008829] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCIH / ODS; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by R01-AT-008618-01 and 1 T32 AT004094 from the National Center for Complementary and Alternative Medicine to IR and by the Office of Dietary Supplements (ODS); DMR is funded by P50-AT-002776-01 from NCCIH / ODS; DER is funded by K01-AT008829 from NCCIH / ODS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abia R, 2001, J SCI FOOD AGR, V81, P1156, DOI 10.1002/jsfa.924; Anhe FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142; Bertoia ML, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i17; Burton LJ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-97; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Choy YY, 2013, J AGR FOOD CHEM, V61, P121, DOI 10.1021/jf301939e; Czank C, 2013, AM J CLIN NUTR, V97, P995, DOI 10.3945/ajcn.112.049247; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; DAWSON AM, 1965, NATURE, V206, P943, DOI 10.1038/206943b0; de Kort S, 2011, OBES REV, V12, P449, DOI 10.1111/j.1467-789X.2010.00845.x; Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Felgines C, 2010, BRIT J NUTR, V103, P1738, DOI 10.1017/S0007114510000061; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Geurts L, 2014, BENEF MICROBES, V5, P3, DOI 10.3920/BM2012.0065; Gonzalez-Sarrias A, 2017, TRENDS FOOD SCI TECH, V69, P281, DOI 10.1016/j.tifs.2017.07.010; Guariguata L, 2014, DIABETES, V63, pA391; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HAUSER CJ, 1988, J LAB CLIN MED, V112, P68; He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; KESHAVARZIAN A, 1992, GASTROENTEROLOGY, V103, P177, DOI 10.1016/0016-5085(92)91111-G; Kundu K, 2009, ABSTR PAP AM CHEM S, V238, P1; Liang ZC, 2012, J AGR FOOD CHEM, V60, P1291, DOI 10.1021/jf2046637; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Magalotti S, 2013, MOL IMAGING BIOL, V15, P423, DOI 10.1007/s11307-013-0614-2; Masumoto S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31208; Mu QH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00598; Ottman N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01157; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Prior RL, 2010, J SCI FOOD AGR, V90, P1473, DOI 10.1002/jsfa.3966; Prunty MC, 2015, INVEST OPHTH VIS SCI, V56, P5862, DOI 10.1167/iovs.15-16810; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Roopchand DE, 2015, DIABETES, V64, P2847, DOI 10.2337/db14-1916; Roopchand DE, 2013, PHARMACOL RES, V68, P59, DOI 10.1016/j.phrs.2012.11.008; Roopchand DE, 2012, J AGR FOOD CHEM, V60, P8860, DOI 10.1021/jf300232h; Sadlowski CM, 2017, MOL SYST DES ENG, V2, P191, DOI 10.1039/c7me00014f; Saura-Calixto F, 2007, FOOD CHEM, V101, P492, DOI 10.1016/j.foodchem.2006.02.006; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Selvam S, 2011, BIOMATERIALS, V32, P7785, DOI 10.1016/j.biomaterials.2011.07.020; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Stull AJ, 2010, J NUTR, V140, P1764, DOI 10.3945/jn.110.125336; Swanson PA, 2011, P NATL ACAD SCI USA, V108, P8803, DOI 10.1073/pnas.1010042108; Takikawa M, 2010, J NUTR, V140, P527, DOI 10.3945/jn.109.118216; Teixeira TFS, 2012, NUTR RES, V32, P637, DOI 10.1016/j.nutres.2012.07.003; Tresserra-Rimbau A, 2016, J NUTR, V146, P767, DOI 10.3945/jn.115.223610; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; Wentworth CC, 2011, J BIOL CHEM, V286, P38448, DOI 10.1074/jbc.M111.268938; Xu YP, 2011, J AGR FOOD CHEM, V59, P10586, DOI 10.1021/jf202438d; Zhang L, 2018, J NUTR BIOCH	54	30	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0198716	10.1371/journal.pone.0198716	http://dx.doi.org/10.1371/journal.pone.0198716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308002	gold, Green Published, Green Submitted			2022-12-26	WOS:000447173500001
J	Lin, PY; Chang, YJ; Chen, YC; Lin, CH; Erkekoglu, P; Chao, MW; Tseng, CY				Lin, Pei-Ying; Chang, Yu-Jung; Chen, Yu-Chen; Lin, Chin-Hung; Erkekoglu, Pinar; Chao, Ming-Wei; Tseng, Chia-Yi			Anti-cancer effects of 3,5-dimethylaminophenol in A549 lung cancer cells	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; CELLULAR-RESPONSE; RISK-FACTORS; STRESS; APOPTOSIS; SMOKING; P53; EPIDEMIOLOGY; GENOTOXICITY; METASTASIS	Exposure to 3,5-dimethylaminophenol (3,5-DMAP), the metabolite of the 3-5-dimethylaniline, was shown to cause high levels of oxidative stress in different cells. The aim of the present work was to observe whether this metabolite can lead to cytotoxicity, oxidative stress, DNA damage and cell cycle changes in non-small cell lung cancer A549 cells. 3,5-DMAP caused a dose-dependent increase in cytotoxicity, generation of superoxide (O-2(-center dot)), inductions in the enzyme activities orchestrating cellular antioxidant balance, increases in lipid peroxidation as well as DNA damage. However, 3,5-DMAP showed significantly lower cytotoxicity towards human lung fibroblast (HLF) cells. 3,5-DMAP also led to molecular events, like inducing apoptotic markers (ie. p53, Bad, Box and cytochrome c); decreasing anti-apoptotic proteins (Bcl-2) and alterations in cell cycle. Our findings indicate that the cytotoxicity caused by this particular alkylaniline metabolite led to initiation of caspase 3-mediated apoptosis. Furthermore, 3,5-DMAP attenuated carcinogenic properties like migration capacity of A549 cells and eventually inhibited growth of A549 cells in an in vivo mouse model. Tumor sections showed that 3,5-DMAP down-regulated c-Myc expression but up-regulated p53 and cytochrome c, all of which might result in tumor growth arrest. Co-treatment with N-acetylcysteine provided reductions in cytotoxicity and positively modulated genetic events induced by 3,5-DMAP in A549 cells. In conclusion, our findings demonstrate 3,5-DMAP may be a potential anti-cancer drug in cancer, due to its self redox cycling properties.	[Lin, Pei-Ying; Chang, Yu-Jung; Lin, Chin-Hung; Chao, Ming-Wei] Chung Yuan Christian Univ, Coll Sci, Dept Biosci Technol, Taoyuan, Taiwan; [Chen, Yu-Chen] Taoyuan Gen Hosp, Dept Radiol, Taoyuan, Taiwan; [Erkekoglu, Pinar] Hacettepe Univ, Fac Pharm, Dept Toxicol, Ankara, Turkey; [Chao, Ming-Wei; Tseng, Chia-Yi] Chung Yuan Christian Univ, Ctr Nanotechnol, Taoyuan, Taiwan; [Tseng, Chia-Yi] Chung Yuan Christian Univ, Coll Engn, Dept Biomed Engn, Taoyuan, Taiwan	Chung Yuan Christian University; Hacettepe University; Chung Yuan Christian University; Chung Yuan Christian University	Tseng, CY (corresponding author), Chung Yuan Christian Univ, Ctr Nanotechnol, Taoyuan, Taiwan.; Tseng, CY (corresponding author), Chung Yuan Christian Univ, Coll Engn, Dept Biomed Engn, Taoyuan, Taiwan.	cytseng@cycu.edu.tw		Chao, Ming-Wei/0000-0002-1574-6425	Ministry of Science and Technology [NSC-102-2320-B-033-001-MY3, NSC-101-2320-B-033-004, MOST-106-2314-B-033-001]; Taoyuan General Hospital in Taiwan [PTH10531]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taoyuan General Hospital in Taiwan	This work was supported by grants from Ministry of Science and Technology (NSC-102-2320-B-033-001-MY3, NSC-101-2320-B-033-004 and MOST-106-2314-B-033-001) and Taoyuan General Hospital (PTH10531) in Taiwan.	Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Aslani BA, 2016, LIFE SCI, V146, P163, DOI 10.1016/j.lfs.2016.01.014; Chao MW, 2015, J APPL TOXICOL, V35, P466, DOI 10.1002/jat.3046; Chao MW, 2014, TOXICOL SCI, V141, P300, DOI 10.1093/toxsci/kfu127; Chao MW, 2012, TOXICOL SCI, V130, P48, DOI 10.1093/toxsci/kfs229; Chen JH, 2008, TOXICOL SCI, V106, P364, DOI 10.1093/toxsci/kfn195; Cheng XH, 2014, ONCOTARGETS THER, V7, P1689, DOI 10.2147/OTT.S66502; Chou KJ, 2015, EUR ARCH PSY CLIN N, V265, P249, DOI 10.1007/s00406-014-0515-7; Collins LG, 2007, AM FAM PHYSICIAN, V75, P56; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Erkekoglu P, 2014, FOOD CHEM TOXICOL, V72, P98, DOI 10.1016/j.fct.2014.06.031; Evans P, 2001, BRIT J NUTR, V85, pS67, DOI 10.1079/BJN2000296; Fidler IJ, 2002, DIFFERENTIATION, V70, P498, DOI 10.1046/j.1432-0436.2002.700904.x; Gan JP, 2004, JNCI-J NATL CANCER I, V96, P1425, DOI 10.1093/jnci/djh274; Gao YT, 1996, LUNG CANCER-J IASLC, V14, pS39, DOI 10.1016/S0169-5002(96)90209-3; Gros L, 2002, ONCOGENE, V21, P8905, DOI 10.1038/sj.onc.1206005; Gustavsson P, 2002, AM J EPIDEMIOL, V155, P1016, DOI 10.1093/aje/155.11.1016; Hamilton W, 2005, THORAX, V60, P1059, DOI 10.1136/thx.2005.045880; Hauptmann M, 2002, AM J IND MED, V41, P89, DOI 10.1002/ajim.10020; Hengstler JG, 2008, ARCH TOXICOL, V82, P271, DOI 10.1007/s00204-008-0305-y; Iyengar P, 2002, SURG ONCOL, V11, P167, DOI 10.1016/S0960-7404(02)00047-6; Kang SW, 2015, INT J CLIN EXP MED, V8, P14647; KASTAN MB, 1991, CANCER RES, V51, P6304; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Langer CJ, 2010, J CLIN ONCOL, V28, P5311, DOI 10.1200/JCO.2010.28.8126; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Mates JM, 2008, ARCH TOXICOL, V82, P273, DOI 10.1007/s00204-008-0304-z; Mates JM, 2012, ARCH TOXICOL, V86, P1649, DOI 10.1007/s00204-012-0906-3; Melis JPM, 2013, ANTIOXID REDOX SIGN, V18, P2409, DOI 10.1089/ars.2012.5036; Minna J, 2008, LIB J, V133; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Murata M, 2004, CHEM RES TOXICOL, V17, P1750, DOI 10.1021/tx0497550; Murphy KM, 2000, CELL DEATH DIFFER, V7, P102, DOI 10.1038/sj.cdd.4400597; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Oral D, 2016, J ENVIRON PATHOL TOX, V35, P43, DOI 10.1615/JEnvironPatholToxicolOncol.2016014200; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Program, 2009, CHEM INF PROF ALK; RICHARD MJ, 1992, CLIN CHEM, V38, P704; Risom L, 2005, MUTAT RES-FUND MOL M, V592, P119, DOI 10.1016/j.mrfmmm.2005.06.012; Sanchez-Perez Y, 2009, CANCER LETT, V278, P192, DOI 10.1016/j.canlet.2009.01.010; Skipper PL, 2010, CARCINOGENESIS, V31, P50, DOI 10.1093/carcin/bgp267; Spaans JN, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00190; Spiro SG, 2005, AM J RESP CRIT CARE, V172, P523, DOI 10.1164/rccm.200504-531OE; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang TJ, 1996, LUNG CANCER-J IASLC, V14, pS93, DOI 10.1016/S0169-5002(96)90214-7; Ye WJ, 2012, CHEM RES TOXICOL, V25, P2627, DOI 10.1021/tx3004517; Zarogoulidis K, 2013, J THORAC DIS, V5, pS389, DOI 10.3978/j.issn.2072-1439.2013.07.10	50	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205249	10.1371/journal.pone.0205249	http://dx.doi.org/10.1371/journal.pone.0205249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307971	gold, Green Submitted, Green Published			2022-12-26	WOS:000447173500051
J	Maharani, A; Dawes, P; Nazroo, J; Tampubolon, G; Pendleton, N				Maharani, Asri; Dawes, Piers; Nazroo, James; Tampubolon, Gindo; Pendleton, Neil		SENSE-Cog WP1 Grp	Cataract surgery and age-related cognitive decline: A 13-year follow-up of the English Longitudinal Study of Ageing	PLOS ONE			English	Article							HEARING IMPAIRMENT; ASSOCIATION; DEMENTIA; VISION; IMPACT	Background Visual impairment has been associated with lower cognitive ability among older adults, yet little is known about whether improving visual function with cataract surgery would be associated with slower cognitive decline. This study aimed to assess whether trajectories of cognitive decline differed before and after cataract surgery and compare those trajectories between older adults with cataract surgery and without cataract. Methods and findings Data were drawn from the English Longitudinal Study of Ageing (ELSA) Wave 1 (2002/03) until Wave 7 (2014/15). The study population consisted of 2,068 individuals who underwent cataract surgery between Wave 2 and Wave 6 as the treatment group and 3,636 individuals with no cataract as the control group. We included only respondents who took part in a minimum three waves. Propensity score matching method was used to match the individuals in the treatment group with those in the control group. After we put an "artificial" intervention point for the individuals in the control group at the point that the matched person has cataract surgery, spline method was used to identify differences in cognitive trajectories pre- and post-cataract surgery. In the treatment group, we found that cataract surgery was positively associated with episodic memory scores after controlling for the potential covariates (beta = 4.23, p<0.001). Episodic memory scores declined with older age, but the decline in episodic memory scores was slower after cataract surgery (beta = -0.05, p<0.001) than before cataract surgery (beta = -0.1, p<0.001). Although the episodic memory among respondents in the control group before intervention (beta = -0.08, p<0.001) declined slower than those in the intervention group (beta = -0.1, p<0.001), the declines in episodic memory scores were similar in both groups after the intervention (control: beta = -0.05, p<0.001; intervention: beta = -0.05, p<0.001). Conclusions Cataract surgery may have a positive impact on trajectories of cognitive decline in later life. Further research is required to identify the mechanism to explain the association between cataract surgery and cognitive ageing, and whether early intervention towards vision correction results in a reduction in dementia risk.	[Maharani, Asri; Pendleton, Neil] Univ Manchester, Div Neurosci & Expt Psychol, Manchester, Lancs, England; [Dawes, Piers] Univ Manchester, Div Human Commun Dev & Hearing, Manchester, Lancs, England; [Nazroo, James; Tampubolon, Gindo] Univ Manchester, Cathie Marsh Inst Social Res, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Maharani, A (corresponding author), Univ Manchester, Div Neurosci & Expt Psychol, Manchester, Lancs, England.	asri.maharani@manchester.ac.uk	Pendleton, Neil/F-2333-2015; Maharani, Asri/U-7663-2017	Pendleton, Neil/0000-0003-0794-2386; Dawes, Piers/0000-0003-3180-9884; Tampubolon, Gindo/0000-0002-9081-2349; Maharani, Asri/0000-0002-5931-8692	SENSE-Cog project; European Union's Horizon 2020 research and innovation programme [668648]; NATIONAL INSTITUTE ON AGING [R01AG017644] Funding Source: NIH RePORTER	SENSE-Cog project; European Union's Horizon 2020 research and innovation programme; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by SENSE-Cog project. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 668648. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2006, J INT NEUROPSYCH SOC, V12, P632, DOI 10.1017/S1355617706060954; Artistico D, 2011, PSYCHOL FUNCTIONING; Banks J, 2011, LONGITUD LIFE COURSE, V2, P101, DOI 10.14301/llcs.v2i2.115; Bilbao A, 2009, OPHTHALMOLOGY, V116, P418, DOI 10.1016/j.ophtha.2008.11.020; Birren JE, 1964, PSYCHOL AGING; Bonsang E, 2012, J HEALTH ECON, V31, P490, DOI 10.1016/j.jhealeco.2012.03.005; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Butters MA, 2004, ARCH GEN PSYCHIAT, V61, P587, DOI 10.1001/archpsyc.61.6.587; Cook G, 2006, INT J OLDER PEOPLE N, V1, P216, DOI 10.1111/j.1748-3743.2006.00034.x; Davies HR, 2017, J AM GERIATR SOC, V65, P2074, DOI 10.1111/jgs.14986; Dawes P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119616; Freeman EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063315; Gray CS, 2006, J CATARACT REFR SURG, V32, P60, DOI 10.1016/j.jcrs.2005.07.040; Grodstein F, 2003, EPIDEMIOLOGY, V14, P493, DOI 10.1097/01.ede.0000083503.34133.8c; Hong T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147646; Inst Med, 2015, COGNITIVE AGING: PROGRESS IN UNDERSTANDING AND OPPORTUNITIES FOR ACTION, P1; Ishii K, 2008, AM J OPHTHALMOL, V146, P404, DOI 10.1016/j.ajo.2008.05.014; Jefferis JM, 2015, J CATARACT REFR SURG, V41, P1241, DOI 10.1016/j.jcrs.2014.09.044; Lin FR, 2014, NEUROIMAGE, V90, P84, DOI 10.1016/j.neuroimage.2013.12.059; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Maharani A, 2017, AGE AGEING; Marmot M, 2017, ENGLISH LONGITUDINAL; McArdle J., 2009, COGNITION EC OUTCOME; Miyata K, 2016, REJUV RES, V19, P239, DOI 10.1089/rej.2015.1718; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rogers MAM, 2010, AM J EPIDEMIOL, V171, P728, DOI 10.1093/aje/kwp453; SALIVE ME, 1994, J AM GERIATR SOC, V42, P287, DOI 10.1111/j.1532-5415.1994.tb01753.x; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Sare RM, 2016, J NEUROSCI, V36, P1051, DOI 10.1523/JNEUROSCI.4014-15.2016; Tampubolon G, 2017, EUR GERIATR MED, V8, P454, DOI 10.1016/j.eurger.2017.08.001; Tampubolon G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144907; Tamura H, 2004, J CATARACT REFR SURG, V30, P598, DOI 10.1016/j.jcrs.2003.10.019; Twamley EW, 2006, J INT NEUROPSYCH SOC, V12, P707, DOI 10.1017/S1355617706060863; Valentijn SAM, 2005, J AM GERIATR SOC, V53, P374, DOI 10.1111/j.1532-5415.2005.53152.x; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P234, DOI 10.1001/archpsyc.64.2.234	38	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204833	10.1371/journal.pone.0204833	http://dx.doi.org/10.1371/journal.pone.0204833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW7TO	30307960	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500027
J	Lucas, M; Balbin-Suarez, A; Smalla, K; Vetterlein, D				Lucas, Maik; Balbin-Suarez, Alicia; Smalla, Kornelia; Vetterlein, Doris			Root growth, function and rhizosphere microbiome analyses show local rather than systemic effects in apple plant response to replant disease soil	PLOS ONE			English	Article							ACCUMULATING POTATO PLANTS; ARTIFICIAL SOILS; COMMUNITIES; COLONIZATION; RELEASE; COMPLEX	Apple replant disease (ARD) is the phenomenon of soil decline occurring after repeated planting of apple trees at the same site. This study aimed to elucidate whether ARD is systemic, i.e. whether the contact of parts of the root system with ARD soil causes the whole plant to show poor shoot and root growth. A split-root experiment was conducted with seedlings of 'M26', offering the same plant for its root system the choice between the substrates ARD soil (+ARD), gamma-sterilized ARD soil (-ARD) or soil from a grass parcel (Control) with the following combinations: +ARD/+ARD, -ARD/-ARD; +ARD/-ARD; +ARD/Control. Root growth was analysed throughout the 34-day growing period. Samples from bulk, rhizosphere and rhizoplane soil were collected separately for each compartment, and analysed by fingerprints of 16S rRNA gene or ITS fragments amplified from total community (TC) DNA. The response of the plant to +ARD was not systemic as root growth in -ARD compartment was always superior to root growth in +ARD soil. Crosswise N-15-labelling of the N-fertilizer applied to the split-root compartments showed that nitrate-N uptake efficiency was higher for roots in -ARD soil compared to those in +ARD. Bacterial and fungal community composition in the rhizoplane and rhizosphere of the same plants differed significantly between the compartments containing +ARD/-ARD or +ARD/Control. The strongest differences between the bacterial fingerprints were observed in the rhizoplane and rhizosphere. Bacterial genera with increased abundance in response to ARD were mainly Streptomyces but also Sphingobium, Novosphingobium, Rhizobium, Lysobacter and Variovorax. The strongest differences between the fungal fingerprints were observed in bulk soil. Our data showed that the response of the apple plant to ARD soil is local and not systemic.	[Lucas, Maik; Vetterlein, Doris] UFZ Helmholtz Ctr Environm Res, Dept Soil Syst Sci, Halle, Germany; [Lucas, Maik; Vetterlein, Doris] Martin Luther Univ Halle Wittenberg, Soil Sci, Von Seckendorff Pl 3, Halle, Germany; [Balbin-Suarez, Alicia; Smalla, Kornelia] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants JKI, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Martin Luther University Halle Wittenberg; Julius Kuhn-Institut	Vetterlein, D (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Syst Sci, Halle, Germany.; Vetterlein, D (corresponding author), Martin Luther Univ Halle Wittenberg, Soil Sci, Von Seckendorff Pl 3, Halle, Germany.	doris.vetterlein@ufz.de	Lucas, Maik/AFV-2583-2022	Lucas, Maik/0000-0002-4287-7666	BMBF FZK [031B0025G, 031B0025A]	BMBF FZK	This study was supported by BMBF FZK 031B0025G, BMBF FZK 031B0025A.	Babin D, 2013, FEMS MICROBIOL ECOL, V86, P3, DOI 10.1111/1574-6941.12058; Berg G, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix050; Boukcim H, 2006, J PLANT PHYSIOL, V163, P1293, DOI 10.1016/j.jplph.2005.08.011; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Catford JG, 2003, J EXP BOT, V54, P1481, DOI 10.1093/jxb/erg156; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; Emmett B, 2014, PLANTA, V239, P325, DOI 10.1007/s00425-013-1989-7; Franke-Whittle IH, 2015, PLANT SOIL, V395, P317, DOI 10.1007/s11104-015-2562-x; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Cabanas CGL, 2017, PLANT SOIL, V417, P433, DOI 10.1007/s11104-017-3269-y; Gosch C, 2010, PHYTOCHEMISTRY, V71, P838, DOI 10.1016/j.phytochem.2010.03.003; Gschwendtner S, 2010, PLANT SOIL, V335, P413, DOI 10.1007/s11104-010-0430-2; Henfrey JL, 2015, SCI HORTIC-AMSTERDAM, V194, P111, DOI 10.1016/j.scienta.2015.07.034; Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177; Heuer H, 2002, APPL ENVIRON MICROB, V68, P1325, DOI 10.1128/AEM.68.3.1325-1335.2002; Hoestra H., 1968, THESIS; Hofmann A, 2009, J APPL BOT FOOD QUAL, V82, P193; JAFFEE BA, 1982, PLANT DIS, V66, P942, DOI 10.1094/PD-66-942; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Lapsansky ER, 2016, CURR OPIN BIOTECH, V38, P137, DOI 10.1016/j.copbio.2016.01.014; MAI WF, 1978, PHYTOPATHOLOGY, V68, P1540, DOI 10.1094/Phyto-68-1540; Manici LM, 2013, APPL SOIL ECOL, V72, P207, DOI 10.1016/j.apsoil.2013.07.011; Manici LM, 2003, PLANT SOIL, V256, P315, DOI 10.1023/A:1026103001592; Manici LM, 2010, EUR J AGRON, V33, P188, DOI 10.1016/j.eja.2010.05.005; Mazzola M, 1999, PHYTOPATHOLOGY, V89, P920, DOI 10.1094/PHYTO.1999.89.10.920; Mazzola M, 1998, PHYTOPATHOLOGY, V88, P930, DOI 10.1094/PHYTO.1998.88.9.930; Mazzola M, 2012, ANNU REV PHYTOPATHOL, V50, P45, DOI 10.1146/annurev-phyto-081211-173005; McNamara NP, 2003, APPL SOIL ECOL, V24, P117, DOI 10.1016/S0929-1393(03)00073-8; Politycka B, 2003, POL J ENVIRON STUD, V12, P95; Polverigiani S, 2014, PLANT ROOT, V8, P55, DOI 10.3117/plantroot.8.55; Rumberger A, 2007, SOIL BIOL BIOCHEM, V39, P1645, DOI 10.1016/j.soilbio.2007.01.023; Shin SB, 2016, PHYSIOL MOL PLANT P, V94, P16, DOI 10.1016/j.pmpp.2016.03.003; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Spath M, 2015, J PHYTOPATHOL, V163, P287, DOI 10.1111/jph.12318; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Tewoldemedhin YT, 2011, SOIL BIOL BIOCHEM, V43, P1917, DOI 10.1016/j.soilbio.2011.05.014; van Schoor L, 2009, SCI HORTIC-AMSTERDAM, V119, P153, DOI 10.1016/j.scienta.2008.07.032; Vogel C, 2014, SOIL BIOL BIOCHEM, V79, P57, DOI 10.1016/j.soilbio.2014.07.012; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Weiss S, 2017, PLANT MOL BIOL, V94, P303, DOI 10.1007/s11103-017-0608-6; WESTCOTT SW, 1987, PHYTOPATHOLOGY, V77, P1071, DOI 10.1094/Phyto-77-1071; Working Group WRB I, 2015, WORLD REF BAS SOIL R; Yao SR, 2006, SOIL BIOL BIOCHEM, V38, P587, DOI 10.1016/j.soilbio.2005.06.026; Yim B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01224; Yim B, 2013, PLANT SOIL, V366, P617, DOI 10.1007/s11104-012-1454-6; Yin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167347	46	20	20	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0204922	10.1371/journal.pone.0204922	http://dx.doi.org/10.1371/journal.pone.0204922			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296282	Green Submitted, Green Published, gold			2022-12-26	WOS:000446632700015
J	Toraih, EA; Alghamdi, SA; El-Wazir, A; Hosny, MM; Hussein, MH; Khashana, MS; Fawzy, MS				Toraih, Eman A.; Alghamdi, Saleh Ali; El-Wazir, Aya; Hosny, Marwa M.; Hussein, Mohammad H.; Khashana, Moataz S.; Fawzy, Manal S.			Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; BREAST-CANCER CELLS; GROWTH ARREST; LNCRNA GAS5; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; PROSTATE-CANCER; EXPRESSION; MIR-34A; SUPPRESSES	Accumulating evidence indicates that non-coding RNAs including microRNAs (miRs) and long non-coding RNAs (lncRNAs) are aberrantly expressed in cancer, providing promising biomarkers for diagnosis, prognosis and/or therapeutic targets. We aimed in the current work to quantify the expression profile of miR-34a and one of its bioinformatically selected partner lncRNA growth arrest-specific 5 (GAS5) in a sample of Egyptian cancer patients, including three prevalent types of cancer in our region; renal cell carcinoma (RCC), glioblastoma (GB), and hepatocellular carcinoma (HCC) as well as to correlate these expression profiles with the available clinicopathological data in an attempt to clarify their roles in cancer. Quantitative real-time polymerase chain reaction analysis was applied. Different bioinformatics databases were searched to confirm the potential miRNAs-lncRNA interactions of the selected ncRNAs in cancer pathogenesis. The tumor suppressor lncRNA GAS5 was significantly under-expressed in the three types of cancer [0.08 (0.006-0.38) in RCC, p <0.001; 0.10 (0.003-0.89) in GB, p < 0.001; and 0.12 (0.015-0.74) in HCC, p < 0.001]. However, levels of miR-34a greatly varied according to the tumor type; it displayed an increased expression in RCC [4.05 (1.003-22.69), p <0.001] and a decreased expression in GB [0.35 (0.04-0.95), p <0.001]. Consistent to the computationally predicted miRNA-lncRNA interaction, negative correlations were observed between levels of GAS5 and miR-34a in RCC samples (r = -0.949, p < 0.001), GB (r = -0.518, p < 0.001) and HCC (r = -0.455, p = 0.013). Kaplan-Meier curve analysis revealed that RCC patients with down-regulated miR-34a levels had significantly poor overall survival than their corresponding (p < 0.05). Hierarchical clustering analysis showed RCC patients could be clustered by GAS5 and miR-34a co-expression profile. Our results suggest potential applicability of GAS5 and miR-34a with other conventional markers for various types of cancer. Further functional validation studies are warranted to confirm miR-34a/GAS5 interplay in cancer.	[Toraih, Eman A.; El-Wazir, Aya] Suez Canal Univ, Fac Med, Dept Histol & Cell Biol, Genet Unit, Ismailia, Egypt; [Toraih, Eman A.; El-Wazir, Aya] Suez Canal Univ, Ctr Excellence Mol & Cellular Med, Ismailia, Egypt; [Alghamdi, Saleh Ali] Taif Univ, Coll Appl Med Sci, Clin Lab Dept, Med Genet, At Taif, Saudi Arabia; [Hosny, Marwa M.; Fawzy, Manal S.] Suez Canal Univ, Fac Med, Dept Med Biochem & Mol Biol, Ismailia, Egypt; [Hussein, Mohammad H.] Minist Hlth & Populat, Cairo, Egypt; [Khashana, Moataz S.] Suez Canal Univ, Fac Med, Ismailia, Egypt; [Fawzy, Manal S.] Northern Border Univ, Fac Med, Dept Biochem, Ar Ar, Saudi Arabia	Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Suez Canal University; Taif University; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); Suez Canal University; Northern Borders University	Toraih, EA (corresponding author), Suez Canal Univ, Fac Med, Dept Histol & Cell Biol, Genet Unit, Ismailia, Egypt.; Toraih, EA (corresponding author), Suez Canal Univ, Ctr Excellence Mol & Cellular Med, Ismailia, Egypt.; Fawzy, MS (corresponding author), Suez Canal Univ, Fac Med, Dept Med Biochem & Mol Biol, Ismailia, Egypt.; Fawzy, MS (corresponding author), Northern Border Univ, Fac Med, Dept Biochem, Ar Ar, Saudi Arabia.	emantoraih@gmail.com; manal2_khashana@ymail.com	Fawzy, Manal S./L-1516-2016; Elwazir, Aya/AAE-4673-2019; Toraih, Eman/I-3024-2019; Hosny, Marwa/W-3146-2017	Fawzy, Manal S./0000-0003-1252-8403; Toraih, Eman/0000-0001-9267-3787; Hosny, Marwa/0000-0003-4287-9618; Khashana, Motaz/0000-0001-6616-8779; Elwazir, Aya/0000-0002-2766-3854				Aithal Madhuri G S, 2015, Brain Tumor Res Treat, V3, P24, DOI 10.14791/btrt.2015.3.1.24; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2017, TUMOUR BIOL, DOI [10.1177/1010428317726842, DOI 10.1177/1010428317726842]; [Anonymous], 2015, PC ORD MULTIVARIATE; Bai XY, 2011, J AM SOC NEPHROL, V22, P1252, DOI 10.1681/ASN.2010040367; Bartonicek N, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0530-6; Bhatt K, 2010, MOL MED, V16, P409, DOI 10.2119/molmed.2010.00002; Borrell B, 2010, NATURE, V463, P858, DOI 10.1038/463858a; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao QF, 2016, MOL MED REP, V13, P27, DOI 10.3892/mmr.2015.4503; Chang L, 2016, MOL MED REP, V13, P1541, DOI 10.3892/mmr.2015.4716; Cheng TT, 2013, ONCOL LETT, V6, P769, DOI 10.3892/ol.2013.1460; Chim CS, 2010, CARCINOGENESIS, V31, P745, DOI 10.1093/carcin/bgq033; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; COCCIA EM, 1992, MOL CELL BIOL, V12, P3514, DOI 10.1128/MCB.12.8.3514; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Dominguez-Monzon G, 2009, INT J DEV NEUROSCI, V27, P305, DOI 10.1016/j.ijdevneu.2009.03.009; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Faghihi MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r56; Fritz HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135991; Grander D, 1998, MED ONCOL, V15, P20, DOI 10.1007/BF02787340; Guo C, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0213-4; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hu LT, 2016, TUMOR BIOL, V37, P2691, DOI 10.1007/s13277-015-4111-x; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kato M, 2009, ONCOGENE, V28, P2419, DOI 10.1038/onc.2009.106; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Leucci E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02535; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liang WJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004608; Liu F, 2017, ONCOTARGET, V8, P62927, DOI 10.18632/oncotarget.17757; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llovet Josep M, 2004, Liver Transpl, V10, pS115, DOI 10.1002/lt.20034; Lo PK, 2016, BRIEF FUNCT GENOMICS, V15, P200, DOI 10.1093/bfgp/elv055; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lu XX, 2013, CELL TISSUE RES, V354, P891, DOI 10.1007/s00441-013-1711-x; Ma YF, 2013, BIOCHEM BIOPH RES CO, V441, P958, DOI 10.1016/j.bbrc.2013.11.010; Maden BEH, 1997, CHROMOSOMA, V105, P391, DOI 10.1007/s004120050200; Mannoor K, 2012, BBA-REV CANCER, V1826, P121, DOI 10.1016/j.bbcan.2012.03.005; Marsh EE, 2008, FERTIL STERIL, V89, P1771, DOI 10.1016/j.fertnstert.2007.05.074; Moller HG, 2013, MOL NEUROBIOL, V47, P131, DOI 10.1007/s12035-012-8349-7; Munari E, 2014, HUM PATHOL, V45, P1130, DOI 10.1016/j.humpath.2014.01.013; Nakamura Y, 2008, CANCER GENET CYTOGEN, V182, P144, DOI 10.1016/j.cancergencyto.2008.01.013; Ng KW, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0491-9; Paraskevopoulou MD, 2016, METHODS MOL BIOL, V1402, P271, DOI 10.1007/978-1-4939-3378-5_21; Pickard MR, 2014, BREAST CANCER RES TR, V145, P359, DOI 10.1007/s10549-014-2974-y; Qiao HP, 2013, ASIAN PAC J CANCER P, V14, P1077, DOI 10.7314/APJCP.2013.14.2.1077; Raho G, 2000, GENE, V256, P13, DOI 10.1016/S0378-1119(00)00363-2; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Shehata Rasha H, 2017, Asian Pac J Cancer Prev, V18, P2395, DOI 10.22034/APJCP.2017.18.9.2395; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Tao RY, 2015, CARCINOGENESIS, V36, P1136, DOI 10.1093/carcin/bgv099; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Toraih EA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3269379; Toraih EA, 2016, MOL DIAGN THER, V20, P559, DOI 10.1007/s40291-016-0223-2; Toraih EA, 2016, MOL MED, V22, P653, DOI 10.2119/molmed.2016.00096; Toraih EA, 2015, MOL DIAGN THER, V19, P179, DOI 10.1007/s40291-015-0143-6; Tu ZQ, 2014, INT J CLIN EXP PATHO, V7, P4303; Valente V, 2014, ANN NEUROSCI, V21, P62, DOI 10.5214/ans.0972.7531.210207; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Weng WH, 2014, ONCOL REP, V31, P1921, DOI 10.3892/or.2014.3005; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; World Health Organization, CANC; Xue D, 2016, TUMOR BIOL, V37, P16187, DOI 10.1007/s13277-016-5429-8; Yacqub-Usman K, 2015, PROSTATE, V75, P693, DOI 10.1002/pros.22952; Yadav S, 2017, UROLOGY, V104, P65, DOI 10.1016/j.urology.2017.03.013; Yamamura S, 2012, CARCINOGENESIS, V33, P294, DOI 10.1093/carcin/bgr286; Yamashita R, 2008, NUCLEIC ACIDS RES, V36, P3707, DOI 10.1093/nar/gkn248; Yang WW, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317711315; Ye KS, 2017, J CELL BIOCHEM, V118, P4772, DOI 10.1002/jcb.26145; Yin DD, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0253-8; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Yu FJ, 2015, J BIOL CHEM, V290, P28286, DOI 10.1074/jbc.M115.683813; Yu G, 2014, J UROLOGY, V192, P1229, DOI 10.1016/j.juro.2014.05.094; Zhang EB, 2014, ONCOTARGET, V5, P2276, DOI 10.18632/oncotarget.1902; Zhang XQ, 2013, NEUROBIOL DIS, V58, P123, DOI 10.1016/j.nbd.2013.05.011; Zhang Z, 2013, CELL DEATH DIFFER, V20, P1558, DOI 10.1038/cdd.2013.110; Zhao XH, 2017, BBA-MOL CELL RES, V1864, P1605, DOI 10.1016/j.bbamcr.2017.06.020; Zhao XH, 2015, MOL THER, V23, P1899, DOI 10.1038/mt.2015.170; Zhou Y, 2014, J CELL SCI, V127, P4494, DOI 10.1242/jcs.155523	85	34	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0198231	10.1371/journal.pone.0198231	http://dx.doi.org/10.1371/journal.pone.0198231			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289954	Green Published, Green Submitted, gold			2022-12-26	WOS:000446545500001
J	Chen, YY; Lin, KH; Huang, HK; Chang, H; Lee, SC; Huang, TW				Chen, Ying-Yi; Lin, Kuan-Hsun; Huang, Hsu-Kai; Chang, Hung; Lee, Shih-Chun; Huang, Tsai-Wang			The beneficial application of preoperative 3D printing for surgical stabilization of rib fractures	PLOS ONE			English	Article							FLAIL CHEST; FIXATION; INJURY; TRAUMA	Objectives The beneficial application of three-dimensional (3D) printing for surgical stabilization of rib fractures (SSRF) has never been proposed in the literature before. The aim of this study was to verify patients' surgical outcomes when utilizing preoperative three-dimensional printing for SSRF. Methods We retrospectively reviewed the records of all consecutive patients who were treated at our hospital for SSRF from July 2015 to December 2017. The patients were divided into two groups according to whether or not 3D printing was utilized. Results Forty-eight patients who underwent SSRF at our hospital were enrolled. Of them, three patients underwent bilateral surgeries. The patients with application of preoperative 3D printing for SSRF had statistically significant associations with shorter operation time per fixed plate (p < 0.001), and a smaller incision length (p < 0.001). Conclusions We present an useful technique involving 3D printing for promoting SSRF significantly with shorter operation time and an appropriate incision length.	[Chen, Ying-Yi; Lin, Kuan-Hsun; Huang, Hsu-Kai; Chang, Hung; Lee, Shih-Chun; Huang, Tsai-Wang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan; [Chen, Ying-Yi; Huang, Tsai-Wang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Huang, TW (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan.; Huang, TW (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	chi-wang@yahoo.com.tw	Chen, Ying Yi/AAF-6765-2022; Chen, Ying Yi/AFJ-9705-2022; Chen, Ying-Yi/AAN-7880-2020	Chen, Ying Yi/0000-0003-3753-4877; Chen, Ying Yi/0000-0003-3753-4877; 				Althausen PL, 2011, J ORTHOP TRAUMA, V25, P641, DOI 10.1097/BOT.0b013e318234d479; Baskaran V, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00069; BEAL SL, 1985, AM J SURG, V150, P324, DOI 10.1016/0002-9610(85)90071-6; Berman B, 2012, BUS HORIZONS, V55, P155, DOI 10.1016/j.bushor.2011.11.003; Bhatnagar A, 2012, J AM COLL SURGEONS, V215, P201, DOI 10.1016/j.jamcollsurg.2012.02.023; Liman ST, 2003, EUR J CARDIO-THORAC, V23, P374, DOI 10.1016/S1010-7940(02)00813-8; Majercik S, 2014, AM J SURG, V208, P88, DOI 10.1016/j.amjsurg.2013.08.051; Marasco SF, 2013, J AM COLL SURGEONS, V216, P924, DOI 10.1016/j.jamcollsurg.2012.12.024; McMenamin PG, 2014, ANAT SCI EDUC, V7, P479, DOI 10.1002/ase.1475; Nickerson TP, 2015, WORLD J SURG, V39, P789, DOI 10.1007/s00268-014-2862-y; Nirula R, 2006, AM SURGEON, V72, P307; Schots JPM, 2017, ANN THORAC SURG, V103, P940, DOI 10.1016/j.athoracsur.2016.09.036; Tanaka H, 2002, J TRAUMA, V52, P727, DOI 10.1097/00005373-200204000-00020; Tarng YW, 2016, SURG ENDOSC, V30, P388, DOI 10.1007/s00464-015-4207-9	14	7	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204652	10.1371/journal.pone.0204652	http://dx.doi.org/10.1371/journal.pone.0204652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286120	gold, Green Submitted, Green Published			2022-12-26	WOS:000446383500032
J	Dey, A; Hay, K; Afroz, B; Chandurkar, D; Singh, K; Dehingia, N; Raj, A; Silverman, JG				Dey, Arnab; Hay, Katherine; Afroz, Bilal; Chandurkar, Dharmendra; Singh, Kultar; Dehingia, Nabamallika; Raj, Anita; Silverman, Jay G.			Understanding intersections of social determinants of maternal healthcare utilization in Uttar Pradesh, India	PLOS ONE			English	Article							INEQUALITIES	Objective To explore intersections of social determinants of maternal healthcare utilization using the Classification and Regression Trees (CART) algorithm which is a machine-learning method used to construct prediction models. Methods Institutional review board approval for this study was granted from Public Health Service- Ethical Review Board (PHS-ERB) and from the Health Ministry Screening Committee (HMSC) facilitated by Indian Council for Medical Research (ICMR). IRB review and approval for the current analyses was obtained from University of California, San Diego. Cross-sectional data were collected from women with children aged 0-11 months (n = 5,565) from rural households in 25 districts of Uttar Pradesh, India. Participants were surveyed on maternal healthcare utilization including registration of pregnancy (model-1), receipt of antenatal care (ANC) during pregnancy (model-2), and delivery at health facilities (model -3). Social determinants of health including wealth, social group, literacy, religion, and early age at marriage were captured during the survey. The Classification and Regression Tree (CART) algorithm was used to explore intersections of social determinants of healthcare utilization. Results CART analyses highlight the intersections, particularly of wealth and literacy, in maternal healthcare utilization in Uttar Pradesh. Model-1 documents that women who are poorer, illiterate and Muslim are less likely to have their pregnancies registered (71.4% vs. 86.0% in the overall sample). Model-2 documents that poorer, illiterate women had the lowest ANC coverage (37.7% vs 45% in the overall sample). Model-3, developed for deliveries at health facilities, highlighted that illiterate and poor women have the lowest representation among facility deliveries (59.6% vs. 69% in the overall sample). Conclusion This paper explores the interactions between determinants of maternal healthcare utilization indicators. The findings in this paper highlights that the interaction of wealth and literacy can play a very strong role in accentuating or diminishing healthcare utilization among women. The study also reveals that religion and women's age at marriage also interact with wealth and literacy to create substantial disparities in utilization. The study provides insights into the effect of intersections of determinants, and highlights the importance of using a more nuanced understanding of the impact of co-occurring forms of marginalization to effectively tackle inequities in healthcare utilization.	[Dey, Arnab; Afroz, Bilal; Chandurkar, Dharmendra; Singh, Kultar; Dehingia, Nabamallika] Sambodhi Res & Commun Pvt Ltd, Noida, India; [Hay, Katherine] Bill & Melinda Gates Fdn, Seattle, WA USA; [Raj, Anita; Silverman, Jay G.] Univ Calif San Diego, Sch Med, Div Global Publ Hlth, Ctr Gender Equ & Hlth, La Jolla, CA 92093 USA	Bill & Melinda Gates Foundation; University of California System; University of California San Diego	Dey, A (corresponding author), Sambodhi Res & Commun Pvt Ltd, Noida, India.	arnab@sambodhi.co.in	Dehingia, Nabamallika/AAY-5588-2021; Dehingia, Nabamallika/AAF-1639-2021; Hay, Katherine/ABB-7795-2021	Dehingia, Nabamallika/0000-0003-1787-9050; Dey, Arnab K./0000-0003-4585-3130	Bill and Melinda Gates Foundation [OPP1083531]; Sambodhi Research and Communications Pvt. Ltd.	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Sambodhi Research and Communications Pvt. Ltd.	This study was funded by the Bill and Melinda Gates Foundation (https://www.gatesfoundation.org/) Grant No. OPP1083531. Sambodhi Research and Communications Pvt. Ltd. provided support in the form of salaries for authors AD, BA, DC, KS and ND but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Breiman L., 2017, CLASSIFICATION REGRE; CALDWELL JC, 1993, SOC SCI MED, V36, P125, DOI 10.1016/0277-9536(93)90204-H; Census of India, 2011, MMR B 2011 2013; Census of India, PRIM CENS ABSTR 2011; Census of India, UTT PRAD REL CENS 20; International Institute of Population Sciences, 2014, NAT FAM HLTH SURV IN; Iyer A, 2008, Glob Public Health, V3 Suppl 1, P13, DOI 10.1080/17441690801892174; Joe W, 2015, MATERNAL MORTALITY I; Joe W, 2015, HEALTH POLICY PLANN, V30, P407, DOI 10.1093/heapol/czu023; Kapilashrami A, 2015, SOC THEOR HEALTH, V13, P288, DOI 10.1057/sth.2015.16; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Montgomery AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083331; Open Working Group, OP WORK GROUP PROP S; Ostlin P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001115; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sanneving L, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19145; Sciences IIfP, 2007, IND NAT FAM HLTH SUR; Sen G, 2009, J HUM DEV CAPABIL, V10, P397, DOI 10.1080/19452820903048894; Seth A, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0538-6; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031666; Sridharan S, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1287493; SUBBARAO K, 1995, ECON DEV CULT CHANGE, V44, P105, DOI 10.1086/452202; Tan P.-N., 2006, INTRO DATA MINING, P145; UNICEF WHO and the World Bank Group, 2020, LEVELS TRENDS CHILD; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Weber L, 2003, ADV GEND RES, V7, P181	27	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204810	10.1371/journal.pone.0204810	http://dx.doi.org/10.1371/journal.pone.0204810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286134	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500046
J	Favre, B; Begre, N; Bouameur, JE; Lingasamy, P; Conover, GM; Fontao, L; Borradori, L				Favre, Bertrand; Begre, Nadja; Bouameur, Jamal-Eddine; Lingasamy, Prakash; Conover, Gloria M.; Fontao, Lionel; Borradori, Luca			Desmoplakin interacts with the coil 1 of different types of intermediate filament proteins and displays high affinity for assembled intermediate filaments	PLOS ONE			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; DESMOSOMAL PROTEINS; HUMAN VIMENTIN; KERATIN; DOMAINS; BINDING; PLECTIN; CELLS; HEART; SKIN	The interaction of intermediate filaments (IFs) with the cell-cell adhesion complexes desmosomes is crucial for cytoskeletal organization and cell resilience in the epidermis and heart. The intracellular desmosomal protein desmoplakin anchors IFs to the cell adhesion complexes predominantly via its four last carboxy-terminal domains (C-terminus). However, it remains unclear why the C-terminus of desmoplakin interacts with different IF types or if there are different binding affinities for each type of IFs that may influence the stability of cell-specific adhesion complexes. By yeast three-hybrid and fluorescence binding assays, we found that the coiled-coil 1 of the conserved central rod domain of the heterodimeric cyto-keratins (Ks) 5 and 14 (K5/K14) was required for their interaction with the C-terminus of desmoplakin, while their unique amino head- and C-tail domains were dispensable. Similar findings were obtained in vitro with K1/K10, and the type III IF proteins desmin and vimentin. Binding assays testing the C-terminus of desmoplakin with assembled K5/K14 and desmin IFs yielded an apparent affinity in the nM range. Our findings reveal that the same conserved domain of IF proteins binds to the C-terminus of desmoplakin, which may help explain the previously reported broad binding IF-specificity to desmoplakin. Our data suggest that desmoplakin high-affinity binding to diverse IF proteins ensures robust linkages of IF cytoskeleton and desmosomes that maintain the structural integrity of cellular adhesion complexes. In summary, our results give new insights into the molecular basis of the IF-desmosome association.	[Favre, Bertrand; Begre, Nadja; Bouameur, Jamal-Eddine; Lingasamy, Prakash; Borradori, Luca] Bern Univ Hosp, Dept Dermatol, Inselspital, Bern, Switzerland; [Favre, Bertrand; Begre, Nadja; Bouameur, Jamal-Eddine; Lingasamy, Prakash] Univ Bern, Dept Biomed Res, Bern, Switzerland; [Conover, Gloria M.] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA; [Fontao, Lionel] Geneva Univ Hosp, Dept Dermatol, Geneva, Switzerland; [Bouameur, Jamal-Eddine] Univ Leipzig, SIKT, Leipzig, Germany; [Bouameur, Jamal-Eddine] Univ Leipzig, Inst Biol, Leipzig, Germany; [Lingasamy, Prakash] Univ Tartu, Inst Biomed & Translat Med, Lab Canc Biol, Tartu, Estonia	University of Bern; University Hospital of Bern; University of Bern; Texas A&M University System; Texas A&M University College Station; University of Geneva; Leipzig University; Leipzig University; University of Tartu	Borradori, L (corresponding author), Bern Univ Hosp, Dept Dermatol, Inselspital, Bern, Switzerland.	Luca.Borradori@insel.ch	Lionel, Fontao/AGN-3640-2022; Lingasamy, Prakash/H-5010-2013; Conover, Gloria M/L-2279-2019	Lingasamy, Prakash/0000-0002-8826-4531; Fontao, Lionel/0000-0002-5950-564X; Conover, Gloria/0000-0001-7129-4403	Swiss National Foundation for Research [3100A0-121966]; Swiss Foundation for Research on Muscle Diseases; University of Bern	Swiss National Foundation for Research(Swiss National Science Foundation (SNSF)); Swiss Foundation for Research on Muscle Diseases; University of Bern	This work was supported by the Swiss National Foundation for Research (3100A0-121966 to L.B.), www.snf.ch; the Swiss Foundation for Research on Muscle Diseases (to L.B.), www.fsrmm.ch; and University of Bern (to L.B.), www.unibe.ch.	Akat K, 2003, ACTA NEUROPATHOL, V106, P337, DOI 10.1007/s00401-003-0736-8; Albrecht LV, 2015, J CELL BIOL, V208, P597, DOI 10.1083/jcb.201406020; Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068; Block J, 2015, BBA-MOL CELL RES, V1853, P3053, DOI 10.1016/j.bbamcr.2015.05.009; Bouameur JE, 2017, SUBCELL BIOCHEM, V82, P171, DOI 10.1007/978-3-319-49674-0_7; Bouameur JE, 2014, J INVEST DERMATOL, V134, P2776, DOI 10.1038/jid.2014.255; Bouameur JE, 2014, J INVEST DERMATOL, V134, P885, DOI 10.1038/jid.2013.498; Bouameur JE, 2013, J CELL SCI, V126, P4195, DOI 10.1242/jcs.127779; Choi HJ, 2002, NAT STRUCT BIOL, V9, P612, DOI 10.1038/nsb818; Christensen AH, 2010, J MED GENET, V47, P736, DOI 10.1136/jmg.2010.077891; Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; Coulombe PA, 2012, J INVEST DERMATOL, V132, P763, DOI 10.1038/jid.2011.450; Coulombe PA, 2009, J CLIN INVEST, V119, P1784, DOI 10.1172/JCI38177; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Favre B, 2018, BRIT J DERMATOL, V179, P797, DOI 10.1111/bjd.16832; Favre B, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002241; Favre B, 2016, METHOD ENZYMOL, V569, P117, DOI 10.1016/bs.mie.2015.06.017; Favre B, 2011, EUR J CELL BIOL, V90, P390, DOI 10.1016/j.ejcb.2010.11.013; Fogl C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10827; Fontao L, 2003, MOL BIOL CELL, V14, P1978, DOI 10.1091/mbc.e02-08-0548; Franke WW, 2006, EUR J CELL BIOL, V85, P69, DOI 10.1016/j.ejcb.2005.11.003; Gallicano GI, 2001, DEVELOPMENT, V128, P929; GREEN KJ, 1988, P NATL ACAD SCI USA, V85, P2613, DOI 10.1073/pnas.85.8.2613; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hudson TY, 2004, METHOD CELL BIOL, V78, P757; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; KARTENBECK J, 1983, EMBO J, V2, P735, DOI 10.1002/j.1460-2075.1983.tb01493.x; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; KOUKLIS PD, 1994, J CELL BIOL, V127, P1049, DOI 10.1083/jcb.127.4.1049; Kowalczyk AP, 1999, J BIOL CHEM, V274, P18145, DOI 10.1074/jbc.274.26.18145; Lapouge K, 2006, J CELL SCI, V119, P4974, DOI 10.1242/jcs.03255; Lichtenstern T, 2012, J STRUCT BIOL, V177, P54, DOI 10.1016/j.jsb.2011.11.003; Meng JJ, 1997, J BIOL CHEM, V272, P21495, DOI 10.1074/jbc.272.34.21495; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Nikolic B, 1996, J CELL BIOL, V134, P1455, DOI 10.1083/jcb.134.6.1455; Panagopoulou P, 2008, J CELL BIOL, V181, P761, DOI 10.1083/jcb.200710049; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Portet S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121090; Puzzi L, 2018, MICRON, V106, P27, DOI 10.1016/j.micron.2017.12.005; QUINLAN RA, 1986, J MOL BIOL, V192, P337, DOI 10.1016/0022-2836(86)90369-4; Ramms L, 2013, P NATL ACAD SCI USA, V110, P18513, DOI 10.1073/pnas.1313491110; Robert A, 2015, P NATL ACAD SCI USA, V112, pE3505, DOI 10.1073/pnas.1505303112; Rogers KR, 1996, J STRUCT BIOL, V117, P55, DOI 10.1006/jsbi.1996.0069; Sakiyama T, 2016, J DERMATOL, V43, P264, DOI 10.1111/1346-8138.13219; Samuelov L, 2015, CELL TISSUE RES, V360, P457, DOI 10.1007/s00441-014-2062-y; Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; STAPPENBECK TS, 1993, J CELL BIOL, V123, P691, DOI 10.1083/jcb.123.3.691; Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442	54	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205038	10.1371/journal.pone.0205038	http://dx.doi.org/10.1371/journal.pone.0205038			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286183	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500080
J	Naruse, M; Yamamoto, E; Nakao, T; Akimoto, T; Saigo, H; Okamura, K; Ojima, I; Northoff, G; Hori, H				Naruse, Makoto; Yamamoto, Eiji; Nakao, Takashi; Akimoto, Takuma; Saigo, Hayato; Okamura, Kazuya; Ojima, Izumi; Northoff, Georg; Hori, Hirokazu			Why is the environment important for decision making? Local reservoir model for choice-based learning	PLOS ONE			English	Article							SINGLE-PHOTON; DISSONANCE; BRAIN; SELF	Decision making based on behavioral and neural observations of living systems has been extensively studied in brain science, psychology, neuroeconomics, and other disciplines. Decision-making mechanisms have also been experimentally implemented in physical processes, such as single photons and chaotic lasers. The findings of these experiments suggest that there is a certain common basis in describing decision making, regardless of its physical realizations. In this study, we propose a local reservoir model to account for choice-based learning (CBL). CBL describes decision consistency as a phenomenon where making a certain decision increases the possibility of making that same decision again later. This phenomenon has been intensively investigated in neuroscience, psychology, and other related fields. Our proposed model is inspired by the viewpoint that a decision is affected by its local environment, which is referred to as a local reservoir. If the size of the local reservoir is large enough, consecutive decision making will not be affected by previous decisions, thus showing lower degrees of decision consistency in CBL. In contrast, if the size of the local reservoir decreases, a biased distribution occurs within it, which leads to higher degrees of decision consistency in CBL. In this study, an analytical approach for characterizing local reservoirs is presented, as well as several numerical demonstrations. Furthermore, a physical architecture for CBL based on single photons is discussed, and the effects of local reservoirs are numerically demonstrated. Decision consistency in human decision-making tasks and in recruiting empirical data is evaluated based on the local reservoir. This foundation based on a local reservoir offers further insights into the understanding and design of decision making.	[Naruse, Makoto] Natl Inst Informat & Commun Technol, Network Syst Res Inst, Koganei, Tokyo, Japan; [Yamamoto, Eiji] Keio Univ, Dept Syst Design Engn, Yokohama, Kanagawa, Japan; [Nakao, Takashi] Hiroshima Univ, Grad Sch Educ, Dept Psychol, Hiroshima, Japan; [Akimoto, Takuma] Tokyo Univ Sci, Fac Sci & Technol, Dept Phys, Noda, Chiba, Japan; [Saigo, Hayato] Nagahama Insitute Biosci & Technol, Nagahama, Shiga, Japan; [Okamura, Kazuya] Nagoya Univ, Grad Sch Informat, Nagoya, Aichi, Japan; [Northoff, Georg] Univ Ottawa, Royals Inst Mental Hlth Res, Mind Brain Imaging & Neuroeth Res Unit, Ottawa, ON, Canada; [Hori, Hirokazu] Univ Yamanashi, Interdisciplinary Grad Sch, Kofu, Yamanashi, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Keio University; Hiroshima University; Tokyo University of Science; Nagoya University; University of Ottawa; University of Yamanashi	Naruse, M (corresponding author), Natl Inst Informat & Commun Technol, Network Syst Res Inst, Koganei, Tokyo, Japan.	naruse@nict.go.jp	nakao, takashi/U-7188-2017; Okamura, Kazuya/GNM-8339-2022; Yamamoto, Eiji/E-4926-2013; Naruse, Makoto/F-7400-2014	nakao, takashi/0000-0002-2227-4526; Okamura, Kazuya/0000-0001-9223-5920; Naruse, Makoto/0000-0001-8982-9824; Yamamoto, Eiji/0000-0002-8813-5297; akimoto, takuma/0000-0002-7647-2309	CREST program from Japan Science and Technology Agency; Core-to-Core Program A. Advanced Research Networks; Japan Society for the Promotion of Science [JP17H01277]; MEXT (Ministry of Education, Culture, Sports, Science and Technology); CREST from the Japan Science and Technology Agency [JPMJCR17N2]	CREST program from Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Core-to-Core Program A. Advanced Research Networks; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by the CREST program from Japan Science and Technology Agency and the Core-to-Core Program A. Advanced Research Networks and the Grants-in-Aid for Scientific Research (A) (JP17H01277) from the Japan Society for the Promotion of Science. E. Y. were supported by MEXT (Ministry of Education, Culture, Sports, Science and Technology) Grant-in-Aid for the "Building of Consortia for the Development of Human Resources in Science and Technology".; This work was supported in part by the CREST (JPMJCR17N2) from the Japan Science and Technology Agency, and by the Core-to-Core Program A. Advanced Research Networks and Grants-in-Aid for Scientific Research (A) (JP17H01277) from the Japan Society for the Promotion of Science. E.Y. received support from MEXT (Ministry of Education, Culture, Sports, Science and Technology) Grant-in-Aid for the "Building of Consortia for the Development of Human Resources in Science and Technology".	Akaishi R, 2014, NEURON, V81, P195, DOI 10.1016/j.neuron.2013.10.018; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Deco G, 2013, PROG NEUROBIOL, V103, P194, DOI 10.1016/j.pneurobio.2012.01.010; Flood TF, 2013, NATURE, V499, P83, DOI 10.1038/nature12208; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Iversen B., 2012, COHOMOLOGY SHEAVES; Izuma K, 2010, P NATL ACAD SCI USA, V107, P22014, DOI 10.1073/pnas.1011879108; Kitayama S, 2013, NEUROIMAGE, V69, P206, DOI 10.1016/j.neuroimage.2012.11.034; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Martino M, 2016, P NATL ACAD SCI USA, V113, P4824, DOI 10.1073/pnas.1517558113; Mihana T, 2018, COMPLEXITY, DOI 10.1155/2018/4318127; Miyagi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180041; Nakamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072071; Nakao T, 2016, SCI REP-UK, V6, DOI 10.1038/srep32477; Nakao T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00031; Naruse M, 2018, INT J INF TECH DECIS, V17, P1305, DOI 10.1142/S0219622018500268; Naruse M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08585-8; Naruse M, 2016, ACS PHOTONICS, V3, P2505, DOI 10.1021/acsphotonics.6b00742; Naruse M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13253; Northoff, 2014, UNLOCKING BRAIN, DOI 10.1093/ACPROF:OSO/9780199826988.001.0001; Northoff G., 2014, UNLOCKING BRAIN; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Northoff G, 2017, NEUROSCI BIOBEHAV R, V80, P630, DOI 10.1016/j.neubiorev.2017.07.013; O'Doherty JP, 2017, ANNU REV PSYCHOL, V68, P73, DOI 10.1146/annurev-psych-010416-044216; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Urayama J, 2001, PHYS REV LETT, V86, P4930, DOI 10.1103/PhysRevLett.86.4930	29	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205161	10.1371/journal.pone.0205161	http://dx.doi.org/10.1371/journal.pone.0205161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286186	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500093
J	Madan, C; Chopra, KK; Satyanarayana, S; Surie, D; Chadha, V; Sachdeva, KS; Khanna, A; Deshmukh, R; Dutte, L; Namdeo, A; Shukla, A; Sagili, K; Chauhan, LS				Madan, Chandravali; Chopra, Kamal Kishore; Satyanarayana, Srinath; Surie, Diya; Chadha, Vineet; Sachdeva, Kuldeep Singh; Khanna, Ashwani; Deshmukh, Rajesh; Dutte, Lopamudra; Namdeo, Amit; Shukla, Ajay; Sagili, Karuna; Chauhan, Lakhbir Singh			Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India	PLOS ONE			English	Article							HIV; CARE	Background Tuberculosis (TB) patients with human immunodeficiency virus (HIV) co-infection have worse TB treatment outcomes compared to patients with TB alone. The distribution of unfavourable treatment outcomes differs by socio-demographic and clinical characteristics, allowing for early identification of patients at risk. Objective To develop a statistical model that can provide individual probabilities of unfavourable outcomes based on demographic and clinical characteristics of TB-HIV co-infected patients. Methodology We used data from all TB patients with known HIV-positive test results (aged >15 years) registered for first-line anti-TB treatment (ATT) in 2015 under the Revised National TB Control Programme (RNTCP) in Delhi, India. We included variables on demographics and pretreatment clinical characteristics routinely recorded and reported to RNTCP and the National AIDS Control Organization. Binomial logistic regression was used to develop a statistical model to estimate probabilities of unfavourable TB treatment outcomes (i.e., death, loss to follow-up, treatment failure, transfer out of program, and a switch to drug-resistant regimen). Results Of 55,260 TB patients registered for ATT in 2015 in Delhi, 928 (2%) had known HIV-positive test results. Of these, 816 (88%) had drug-sensitive TB and were >= 15 years. Among 816 TB-HIV patients included, 157 (19%) had unfavourable TB treatment outcomes. We developed a model for predicting unfavourable outcomes using age, sex, disease classification (pulmonary versus extra-pulmonary), TB treatment category (new or previously treated case), sputum smear grade, known HIV status at TB diagnosis, antiretroviral treatment at TB diagnosis, and CD4 cell count at ATT initiation. The chi-square p-value for model calibration assessed using the Hosmer-Lemeshow test was 0.15. The model discrimination, measured as the area under the receiver operator characteristic (ROC) curve, was 0.78. Conclusion The model had good internal validity, but should be validated with an independent cohort of TB HIV co-infected patients to assess its performance before clinical or programmatic use.	[Madan, Chandravali] Evidence Act Deworm World Initiat, New Delhi, India; [Chopra, Kamal Kishore] New Delhi TB Ctr, New Delhi, India; [Satyanarayana, Srinath; Sagili, Karuna] Int Union TB & Lung Dis, New Delhi, India; [Surie, Diya] Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA; [Chadha, Vineet] Natl TB Inst, Bangalore, Karnataka, India; [Sachdeva, Kuldeep Singh; Deshmukh, Rajesh] Natl AIDS Control Org, New Delhi, India; [Khanna, Ashwani] Lok Nayak Chest Clin, New Delhi, India; [Dutte, Lopamudra; Namdeo, Amit] United Nat Childrens Fund UNICEF, New Delhi, India; [Shukla, Ajay] Uttar Pradesh State AIDS Control Soc, Lucknow, Uttar Pradesh, India; [Chauhan, Lakhbir Singh] TB Assoc India, New Delhi, India	Centers for Disease Control & Prevention - USA	Madan, C (corresponding author), Evidence Act Deworm World Initiat, New Delhi, India.	madan.chandravali@gmail.com		Chadha, Vineet/0000-0003-4457-4842; Satyanarayana, Srinath/0000-0002-5420-2551	Tuberculosis Association of India [TAI/ORP/2016]; President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC)	Tuberculosis Association of India; President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC)	This work was supported by Tuberculosis Association of India (Grant number- TAI/ORP/2016). This research has also been supported in part by the President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Ambadekar NN, 2015, PUBLIC HEALTH, V129, P783, DOI 10.1016/j.puhe.2015.03.006; [Anonymous], 2010, TREATM TUB GUID; Bastanlar Y, 2014, METHODS MOL BIOL, V1107, P105, DOI 10.1007/978-1-62703-748-8_7; Central TB Division, 2013, J CHEM INF MODEL, V53, P1689, DOI DOI 10.1021/CI400128M; Central TB Division, 2016, TB IND 2016 ANN REP; Central TB Division, 2012, SUP MON STRAT REV NA; Gupta S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004007; India [Internet]. Ministry of Health & Family Welfare Government of India, 2016, REV NAT TB CONTR PRO; Isaakidis P, 2015, INT J TUBERC LUNG D, V19, P969, DOI 10.5588/ijtld.15.0123; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Parchure R, 2016, INT J TUBERC LUNG D, V20, P1348, DOI 10.5588/ijtld.16.0098; Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868; Reddy Satti Siva Balaji, 2016, Indian J Community Med, V41, P120, DOI 10.4103/0970-0218.177529; Sachdeva KS, 2015, POTENTIAL IMPACT UP, P1; Satyanarayana S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024160; Sharma SK, 2014, INDIAN J MED RES, V139, P154; Shastri S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-838; Subbaraman R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002149; Sudharsan Bharath, 2015, J Diabetes Sci Technol, V9, P86, DOI 10.1177/1932296814554260; *WHO, INT POL COLL TB HIV; World Health Organization, 2016, GLOB REP DIAB 2016; World Health Organization (WHO), 2015, GUID MON EV COLL TB	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204982	10.1371/journal.pone.0204982	http://dx.doi.org/10.1371/journal.pone.0204982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281679	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400073
J	Moffett, BS; Morris, J; Kam, C; Galati, M; Dutta, A; Akcan-Arikan, A				Moffett, Brady S.; Morris, Jennifer; Kam, Charissa; Galati, Marianne; Dutta, Ankhi; Akcan-Arikan, Ayse			Vancomycin associated acute kidney injury in pediatric patients	PLOS ONE			English	Article							LOW-DOSE DOPAMINE; SERUM TROUGH CONCENTRATIONS; PIPERACILLIN-TAZOBACTAM; CRITICALLY-ILL; HOSPITALIZED CHILDREN; RETROSPECTIVE COHORT; RENAL DYSFUNCTION; RISK-FACTORS; NEPHROTOXICITY; METAANALYSIS	Introduction Vancomycin associated acute kidney injury (vAKI) is a well known complication in pediatric patients. Identification and characterization of the incidence and risk factors for vAKI in the pediatric population would assist clinicians in potentially preventing or mitigating vAKI. Methods and materials A 6 year retrospective cohort study was designed. Patients were included if they were < 19 years of age, received vancomycin as inpatients, and had a baseline SCr and one other SCr drawn during and up to 72 hours after the discontinuation of vancomycin. Data collection included patient demographics, vancomycin doses and length of therapy, vancomycin serum concentrations, and concomitant medications. The Kidney Disease Improving Global Outcomes (KDIGO) criteria were used to characterize acute kidney injury. Descriptive statistical methods were used and ordinal logistic regression was employed to determine variables significantly associated with vAKI. Results A total of 7,095 patients met study criteria (55.4% male, median age 4.1 years (IQR 0.671-1.2 years)). Mechanical ventilation was used in 7.9% (n = 563) and mortality was 4.9% (n = 344). A total of 153 concomitant medications were identified. A median of 5 (IQR 3-7) SCr values were obtained and median SCr prior to vancomycin was 0.39 (IQR 0.28-0.57) mg/dL (CrCl 134 +/- 58 mL/min/1.73m(2)). Vancomycin was administered for a median of 2 (IQR 1-3) days (14.9 +/- 1.6 mg/kg/dose). vAKI was present in 12.2% (n = 862: KDIGO stage 1 (8.30%, n = 589), KDIGO stage 2 (1.94%, n = 138) KDIGO stage 3 (1.89%, n = 134)). Mean vancomycin serum concentration at 6-8 hours after a dose for patients with vAKI (10.7 +/- 8.9 mg/L) was significantly, but not clinically different for patients with no vAKI (7.5 +/- 6.3 mg/L). (p<0.05) Ordinal logistic regression identified total dose of vancomycin, vancomycin administration in the intensive care unit, and concomitant medication administration as significant for vAKI. In particular, concomitant administration of several different medications, including nafcillin, clindamycin, and acetazolamide, were noted for strong associations with vAKI. (p<0.05) Conclusions Moderate to severe acute kidney injury due to vancomycin is infrequent in children and associated with concomitant medication use and total dose of vancomycin. Serum vancomycin concentrations are not useful predictors of vAKI in the pediatric population.	[Moffett, Brady S.; Morris, Jennifer; Kam, Charissa; Dutta, Ankhi; Akcan-Arikan, Ayse] Texas Childrens Hosp, Dept Pharm, Houston, TX 77030 USA; [Moffett, Brady S.; Morris, Jennifer; Kam, Charissa; Dutta, Ankhi; Akcan-Arikan, Ayse] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Galati, Marianne] Texas Med Ctr Lib, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Moffett, BS (corresponding author), Texas Childrens Hosp, Dept Pharm, Houston, TX 77030 USA.; Moffett, BS (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	bsmoffet@texaschildrens.org	Kam, Charissa/AAE-1980-2021	Akcan Arikan, Ayse/0000-0002-5123-6713				Bamgbola O, 2016, THER ADV ENDOCRINOL, V7, P136, DOI 10.1177/2042018816638223; Bellomo R, 2000, LANCET, V356, P2139; Benefield Emily C, 2016, J Pediatr Pharmacol Ther, V21, P66, DOI 10.5863/1551-6776-21.1.66; Bennett WM, 2016, AM J NEPHROL, V44, P454, DOI 10.1159/000452430; Bonazza Sarah, 2016, J Pediatr Pharmacol Ther, V21, P486, DOI 10.5863/1551-6776-21.6.486; Constance JE, 2016, ARCH DIS CHILD-FETAL, V101, pF236, DOI 10.1136/archdischild-2015-308459; Davies SW, 2015, SURG INFECT, V16, P684, DOI 10.1089/sur.2014.198; Downes KJ, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.3219; Filippone EJ, 2017, CLIN PHARMACOL THER, V102, P459, DOI 10.1002/cpt.726; Fisher BT, 2010, PEDIATR BLOOD CANCER, V55, P655, DOI 10.1002/pbc.22601; Friedrich JO, 2005, ANN INTERN MED, V142, P510, DOI 10.7326/0003-4819-142-7-200504050-00010; Gupta A, 2011, NETH J MED, V69, P379; Hammoud K, 2016, AM J NEPHROL, V44, P456, DOI 10.1159/000452427; Hanrahan TP, 2015, ANAESTH INTENS CARE, V43, P594, DOI 10.1177/0310057X1504300507; Hanrahan TP, 2014, CRIT CARE MED, V42, P2527, DOI 10.1097/CCM.0000000000000514; Heble DE, 2016, AM J THER, V23, pE1469, DOI 10.1097/MJT.0000000000000147; Ibach Bethany W, 2016, J Pediatr Pharmacol Ther, V21, P169, DOI 10.5863/1551-6776-21.2.169; Jeon N, 2017, INT J ANTIMICROB AG, V50, P63, DOI 10.1016/j.ijantimicag.2017.02.023; Kaddourah A, 2017, NEW ENGL J MED, V376, P11, DOI 10.1056/NEJMoa1611391; Kane-Gill SL, 2015, AM J KIDNEY DIS, V65, P860, DOI 10.1053/j.ajkd.2014.10.018; Knoderer CA, 2015, ANN PHARMACOTHER, V49, P1113, DOI 10.1177/1060028015594190; Knoderer CA, 2014, J PEDIATR INFECT DIS, V3, P127, DOI 10.1093/jpids/pit076; Le J, 2013, PEDIATR INFECT DIS J, V32, pE155, DOI 10.1097/INF.0b013e318286378e; LeCleir LK, 2017, PEDIATR PULM, V52, P1000, DOI 10.1002/ppul.23718; Luther MK, 2018, CRIT CARE MED, V46, P12, DOI 10.1097/CCM.0000000000002769; Marik PE, 2002, INTENS CARE MED, V28, P877, DOI 10.1007/s00134-002-1346-y; McGregor TL, 2016, AM J KIDNEY DIS, V67, P384, DOI 10.1053/j.ajkd.2015.07.019; McKamy S, 2011, J PEDIATR-US, V158, P422, DOI 10.1016/j.jpeds.2010.08.019; McNeil JC, 2016, PEDIATR INFECT DIS J, V35, P263, DOI 10.1097/INF.0000000000000991; Moffett BS, 2008, PEDIATR CRIT CARE ME, V9, P403, DOI 10.1097/PCC.0b013e3181728c25; Moffett BS, 2015, CONGENIT HEART DIS, V10, pE6, DOI 10.1111/chd.12187; Moffett BS, 2011, CLIN PEDIATR, V50, P442, DOI 10.1177/0009922810393500; Moffett BS, 2011, J PEDIATR-US, V158, P865, DOI 10.1016/j.jpeds.2010.12.018; Moffett BS, 2011, CLIN J AM SOC NEPHRO, V6, P856, DOI 10.2215/CJN.08110910; Nolin TD, 2016, CLIN J AM SOC NEPHRO, V11, P2101, DOI 10.2215/CJN.11011016; O'Donnell JN, 2018, INT J ANTIMICROB AG, V51, P239, DOI 10.1016/j.ijantimicag.2017.08.012; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Patel A, 2015, PEDIATR INFECT DIS J, V34, P849, DOI 10.1097/INF.0000000000000748; Prabaker KK, 2012, J HOSP MED, V7, P91, DOI 10.1002/jhm.946; Pritchard L, 2010, AM J MED, V123, P1143, DOI 10.1016/j.amjmed.2010.07.025; RYBAK MJ, 1990, J ANTIMICROB CHEMOTH, V25, P679, DOI 10.1093/jac/25.4.679; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Sinclair EA, 2014, ANN PHARMACOTHER, V48, P1555, DOI 10.1177/1060028014549185; Slater MB, 2017, PEDIATR DRUGS, V19, P59, DOI 10.1007/s40272-016-0205-1; Sutherland SM, 2015, CLIN J AM SOC NEPHRO, V10, P554, DOI 10.2215/CJN.01900214; van Hal SJ, 2013, ANTIMICROB AGENTS CH, V57, P734, DOI 10.1128/AAC.01568-12; Zappitelli M, 2008, CLIN J AM SOC NEPHRO, V3, P948, DOI 10.2215/CJN.05431207	47	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202439	10.1371/journal.pone.0202439	http://dx.doi.org/10.1371/journal.pone.0202439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281600	gold, Green Published, Green Submitted			2022-12-26	WOS:000446342400012
J	Sun, JZ; Vu, H; Ellerbroek, J; Hoekstra, JM				Sun, Junzi; Vu, Huy; Ellerbroek, Joost; Hoekstra, Jacco M.			Weather field reconstruction using aircraft surveillance data and a novel meteo-particle model	PLOS ONE			English	Article								Wind and temperature data are important parameters in aircraft performance studies. The lack of accurate measurements of these parameters forces researchers to rely on numerical weather prediction models, which are often filtered for a larger area with decreased local accuracy. Aircraft, however, also transmit information related to weather conditions, in response to interrogation by air traffic controller surveillance radars. Although not intended for this purpose, aircraft surveillance data contains information that can be used for weather models. This paper presents a method that can be used to reconstruct a weather field from surveillance data that can be received with a simple 1090 MHz receiver. Throughout the paper, we answer two main research questions: how to accurately infer wind and temperature from aircraft surveillance data, and how to reconstruct a real-time weather grid efficiently. We consider aircraft as moving sensors that measure wind and temperature conditions indirectly at different locations and flight levels. To address the first question, aircraft barometric altitude, ground velocity, and airspeed are decoded from down-linked surveillance data. Then, temperature and wind observations are computed based on aeronautical speed conversion equations. To address the second question, we propose a novel Meteo-Particle (MP) model for constructing the wind and temperature fields. Short-term local prediction is also possible by employing a predictor layer. Using an unseen observation test dataset, we are able to validate that the mean absolute errors of inferred wind and temperature using MP model are 67% and 26% less than using the interpolated model based on GFS reanalysis data.	[Sun, Junzi; Vu, Huy; Ellerbroek, Joost; Hoekstra, Jacco M.] Delft Univ Technol, Fac Aerosp Engn, Control & Simulat, Kluyverweg 1, NL-2629 HS Delft, Netherlands	Delft University of Technology	Sun, JZ (corresponding author), Delft Univ Technol, Fac Aerosp Engn, Control & Simulat, Kluyverweg 1, NL-2629 HS Delft, Netherlands.	j.sun-1@tudelft.nl		Ellerbroek, Joost/0000-0002-2232-8299; Vu, Huy/0000-0001-6707-3595; Sun, Junzi/0000-0003-3888-1192				Barker DM, 2004, MON WEATHER REV, V132, P897, DOI 10.1175/1520-0493(2004)132<0897:ATVDAS>2.0.CO;2; Dalmau R, 2017, DIG AV SYST C DASC 2, P1; de Haan S, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015264; de Haan S., 2014, 201401 KNMI IR; de Jong PMA, 2014, J AIRCRAFT, V51, P1852, DOI 10.2514/1.C032550; de Leege AMP, 2013, J AIRCRAFT, V50, P249, DOI 10.2514/1.C031901; Delahaye D, 2009, DIG AV SYST C 2009 D, P2; Delahaye D, 2003, DIG AV SYST C 2003 D, V1, P5; Delahaye D, 2008, 2008 10TH INTERNATIONAL CONFERENCE ON CONTROL AUTOMATION ROBOTICS & VISION: ICARV 2008, VOLS 1-4, P1033, DOI 10.1109/ICARCV.2008.4795661; Hollister W. M., 1989, Lincoln Laboratory Journal, V2, P555; Houtekamer PL, 1998, MON WEATHER REV, V126, P796, DOI 10.1175/1520-0493(1998)126<0796:DAUAEK>2.0.CO;2; Hrastovec M, 2013, IEEE AERO EL SYS MAG, V28, P12, DOI 10.1109/MAES.2013.6693664; Hurter C, 2014, COMPUT ENVIRON URBAN, V47, P28, DOI 10.1016/j.compenvurbsys.2014.01.005; Kanamitsu M, 1989, WEA FORECASTING, p[4, 335], DOI [10.1175/1520-0434(1989)004&LT;0335:DOTNGD&GT;2.0.CO;2, DOI 10.1175/1520-0434(1989)004<0335:D0TNGD>2.0.C0;2, 10.1175/1520-0434(1989)0042.0.CO;2]; Kapoor A, 2014, PROCEEDINGS OF THE 13TH INTERNATIONAL SYMPOSIUM ON INFORMATION PROCESSING IN SENSOR NETWORKS (IPSN' 14), P25, DOI 10.1109/IPSN.2014.6846738; Lin J, 2013, LAGRANGIAN MODELING, V200; Moninger WR, 2003, B AM METEOROL SOC, V84, P203, DOI 10.1175/BAMS-84-2-203; Moradkhani H, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003604; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rasmussen CE, 2004, LECT NOTES ARTIF INT, V3176, P63, DOI 10.1007/978-3-540-28650-9_4; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Sondij J., 2013, TR336 KNMI; Stone EK, 2015, J ATMOS OCEAN TECH, V32, P736, DOI 10.1175/JTECH-D-14-00192.1; Sun J, 2018, JUNZI PYMODES PYTHON, DOI [10.5281/zenodo.894419, DOI 10.5281/ZENODO.894419]; Sun J., 2018, SUPPLEMENTAL DATASET, DOI [10.6084/m9.figshare.6970403, DOI 10.6084/M9.FIGSHARE.6970403]; Sun J, 2018, 8 INT C RES AIR TRAN; Sun J, 2018, JUNZIS METEOPARTICLE, DOI [10.5281/zenodo.1319564, DOI 10.5281/ZENODO.1319564]; Williams CKI, 1998, NATO ADV SCI I D-BEH, V89, P599	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205029	10.1371/journal.pone.0205029	http://dx.doi.org/10.1371/journal.pone.0205029			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281667	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400078
J	Mouzannar, K; Fusil, F; Lacombe, B; Ollivier, A; Menard, C; Lotteau, V; Cosset, FL; Ramiere, C; Andre, P				Mouzannar, Karim; Fusil, Floriane; Lacombe, Benoit; Ollivier, Anais; Menard, Camille; Lotteau, Vincent; Cosset, Francois-Loic; Ramiere, Christophe; Andre, Patrice			Farnesoid X receptor- is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo	FASEB JOURNAL			English	Article						bile acids; mouse model; rAAV-HBV; HBx; agonist	CLOSED-CIRCULAR DNA; BILE-ACIDS; EPIGENETIC REGULATION; FEEDBACK-REGULATION; HEPARG CELLS; HBV; CCCDNA; MICE; REPLICATION; TRANSCRIPTION	Hepatitis B virus (HBV) infection and bile acid (BA) metabolism are interdependent: infection modifies the expression of the BA nuclear receptor farnesoid X receptor (FXR)-, and modulation of FXR activity by ligands alters HBV replication. Mechanisms of HBV control by FXR remain to be unveiled. FXR silencing in HBV-infected HepaRG cells decreased the viral covalently closed circular (ccc)DNA pool size and transcriptional activity. Treatment with the FXR agonist GW4064 inhibited FXR proviral effect on cccDNA similarly for wild-type and hepatitis B viral X protein (HBx)-deficient virus, whereas agonist-induced inhibition of pregenomic and precore RNA transcription and viral DNA secretion was HBx dependent. These data indicated that FXR acts as a proviral factor by 2 different mechanisms, which are abolished by FXR stimulation. Finally, infection of C3H/HeN mice by a recombinant adeno-associated virus-2/8-HBV vector induced a sustained HBV replication in young mice in contrast with the transient decline in adult mice. Four-week GW4064 treatment of infected C3H/HeN mice decreased secretion of HBV DNA and HB surface antigen in adult mice only. These results suggest that the physiologic balance of FXR expression and activation by bile acid is a key host metabolic pathway in the regulation of HBV infection and that FXR can be envisioned as a target for HBV treatment.Mouzannar, K., Fusil, F., Lacombe, B., Ollivier, A., Menard, C., Lotteau, V., Cosset, F.-L., Ramiere, C., Andre, P. Farnesoid X receptor is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo.	[Mouzannar, Karim; Fusil, Floriane; Lacombe, Benoit; Ollivier, Anais; Menard, Camille; Lotteau, Vincent; Cosset, Francois-Loic; Ramiere, Christophe; Andre, Patrice] Univ Claude Bernard Lyon 1, CIRI, Univ Lyon,Ecole Normale Super ENS Lyon, INSERM,Unite 1111,CNRS,Unite Mixte Rech UMR 5308, Lyon, France; [Ramiere, Christophe] Hosp Civils Lyon, Lab Virol, Hop Croix Rousse, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Andre, P (corresponding author), Univ Claude Bernard Lyon 1, CIRI, Univ Lyon, 21 Ave Tony Garnier, F-69007 Lyon, France.	patrice.andre@inserm.fr	Cosset, François-Loïc/M-5862-2019; Sharma, Ashwani/AAK-3879-2020; André, Patrice/M-8139-2014; Ramière, Christophe/M-8083-2014	Cosset, François-Loïc/0000-0001-8842-3726; Sharma, Ashwani/0000-0001-9835-1973; André, Patrice/0000-0002-5834-7395; Ramière, Christophe/0000-0002-1981-7155; FUSIL, Floriane/0000-0002-1619-7333; Ollivier, Anais/0000-0003-1411-2348; Lotteau, Vincent/0000-0003-0997-3282	Biosafety Level-3 Laboratory of Structure Federative de Recherche (SFR) Biosciences (Gerland-Lyon Sud, France) [AMS3444/US8AniRA]; French Agence Nationale de la Recherche (ANR) sur le sida et les Hepatites Virales (ANRS); Universite de Lyon [ANR-11-LABX-0048LabEx Ecofect, ANR-11-IDEX-0007]; INSERM; EnyoPharma	Biosafety Level-3 Laboratory of Structure Federative de Recherche (SFR) Biosciences (Gerland-Lyon Sud, France); French Agence Nationale de la Recherche (ANR) sur le sida et les Hepatites Virales (ANRS); Universite de Lyon; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); EnyoPharma	The authors acknowledge Grant AMS3444/US8AniRA from the Biosafety Level-3 Laboratory of Structure Federative de Recherche (SFR) Biosciences (Gerland-Lyon Sud, France). This work was supported by the French Agence Nationale de la Recherche (ANR) sur le sida et les Hepatites Virales (ANRS; to P.A. and F.L.-C.), and Grant ANR-11-LABX-0048LabEx Ecofect from the Universite de Lyon, within the "Investissements d'Avenir" (ANR-11-IDEX-0007) Program, operated by the ANR (to P.A. and F.L.-C.). P.A. and V.L. are cofounders and consultants for EnyoPharma. The wages of B.L. and C.M. are supported by a collaboration contract between INSERM and EnyoPharma. The remaining authors declare no conflicts of interest.	BELLE RCD, 1979, J PEDIATR-US, V94, P472, DOI 10.1016/S0022-3476(79)80604-6; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Bourlieu C, 2014, CRIT REV FOOD SCI, V54, P1427, DOI 10.1080/10408398.2011.640757; Chou HH, 2015, P NATL ACAD SCI USA, V112, P2175, DOI 10.1073/pnas.1424775112; Curtil C, 2014, FASEB J, V28, P1454, DOI 10.1096/fj.13-236372; Dion S, 2013, J VIROL, V87, P5554, DOI 10.1128/JVI.03134-12; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003; Hantz O, 2009, J GEN VIROL, V90, P127, DOI 10.1099/vir.0.004861-0; Hong XP, 2017, HEPATOLOGY, V66, P2066, DOI 10.1002/hep.29479; Izhar L, 2015, CELL REP, V11, P1486, DOI 10.1016/j.celrep.2015.04.053; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lucifora J, 2017, ANTIVIR RES, V145, P14, DOI 10.1016/j.antiviral.2017.07.006; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Nakai H, 2000, J VIROL, V74, P9451, DOI 10.1128/JVI.74.20.9451-9463.2000; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; Naugler WE, 2015, GASTROENTEROLOGY, V149, P728, DOI 10.1053/j.gastro.2015.05.043; Niu YD, 2017, HEPATOLOGY, V65, P893, DOI 10.1002/hep.28924; Oehler N, 2014, HEPATOLOGY, V60, P1483, DOI 10.1002/hep.27159; Protzer U, 2017, NAT REV GASTRO HEPAT, V14, P327, DOI 10.1038/nrgastro.2017.44; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; Radreau P, 2016, FASEB J, V30, P3146, DOI 10.1096/fj.201500134; Ramiere C, 2008, J VIROL, V82, P10832, DOI 10.1128/JVI.00883-08; Reese VC, 2012, J VIROL, V86, P2760, DOI 10.1128/JVI.06742-11; Ren J.-H., 2018, HEPATOLOGY; Riviere L, 2015, J HEPATOL, V63, P1093, DOI 10.1016/j.jhep.2015.06.023; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shao JB, 2003, J VIROL METHODS, V112, P45, DOI 10.1016/S0166-0934(03)00190-3; Slijepcevic D, 2015, HEPATOLOGY, V62, P207, DOI 10.1002/hep.27694; Song M, 2018, J VIROL, V92, DOI 10.1128/JVI.01771-17; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; WATKINS JB, 1973, NEW ENGL J MED, V288, P431, DOI 10.1056/NEJM197303012880902; Yan H, 2014, J VIROL, V88, P3273, DOI 10.1128/JVI.03478-13; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yu XM, 1997, J VIROL, V71, P9366, DOI 10.1128/JVI.71.12.9366-9374.1997	41	22	22	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2472	2483		10.1096/fj.201801181R	http://dx.doi.org/10.1096/fj.201801181R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307769				2022-12-26	WOS:000457296600075
J	Xu, XH; Wang, L; Liu, BF; Xie, W; Chen, YG				Xu, Xuanhao; Wang, Lu; Liu, Bofeng; Xie, Wei; Chen, Ye-Guang			Activin/Smad2 and Wnt/beta-catenin up-regulate HAS2 and ALDH3A2 to facilitate mesendoderm differentiation of human embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; PRIMITIVE STREAK; RETINOIC ACID; SELF-RENEWAL; CHROMATIN; HYALURONAN; SMADS; FATE; WNT; TRANSCRIPTION	Activin and Wnt signaling are necessary and sufficient for mesendoderm (ME) differentiation of human embryonic stem cells (ESCs). In this study, we report that during ME differentiation induced by Activin and Wnt, Activin/Smad2 induces a decrease of the repressive histone modification ofH3K27me3by promoting the proteasome-dependent degradation of enhancer of zeste 2 polycomb (EZH2)-repressive complex 2 subunit. As a result, recruitment of the forkhead protein FOXH1 on open chromatin regions integrates the signals of Activin/Smad2 and Wnt/beta-catenin to activate the expression of the ME genes including HAS2 and ALDH3A2. Consistently, H3K27me3 decrease is enriched on open chromatin around regulatory regions. Furthermore, knockdown ofHAS2orALDH3A2greatly attenuates ME differentiation. These findings unveil a pathway from extracellular signals to epigenetic modification-mediated gene activation during ME commitment.	[Xu, Xuanhao; Wang, Lu; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Liu, Bofeng; Xie, Wei] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Chen, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019		National Natural Science Foundation of China [31730056]; National Key Research and Development Program of China [2017YFA0103601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by National Natural Science Foundation of China Grant 31730056 and National Key Research and Development Program of China Grant 2017YFA0103601 (to Y. G. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Attisano L, 2001, MOL CELL ENDOCRINOL, V180, P3, DOI 10.1016/S0303-7207(01)00524-X; Bertero A, 2015, GENE DEV, V29, P702, DOI 10.1101/gad.255984.114; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; CHEN M, 1994, MOL PHARMACOL, V46, P88; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Choudhary M, 2007, STEM CELLS, V25, P3045, DOI 10.1634/stemcells.2007-0296; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Collinson A, 2016, CELL REP, V17, P2700, DOI 10.1016/j.celrep.2016.11.032; Davenport C, 2016, STEM CELLS, V34, P2635, DOI 10.1002/stem.2428; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Estaras C, 2015, MOL CELL, V58, P780, DOI 10.1016/j.molcel.2015.04.001; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Funa NS, 2015, CELL STEM CELL, V16, P639, DOI 10.1016/j.stem.2015.03.008; Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hill CS, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022079; Hoodless PA, 2001, GENE DEV, V15, P1257, DOI 10.1101/gad.881501; Huang W, 2014, DEV BIOL, V394, P83, DOI 10.1016/j.ydbio.2014.07.021; Itoh F, 2014, SEMIN CELL DEV BIOL, V32, P98, DOI 10.1016/j.semcdb.2014.05.017; Jiang W, 2013, CELL RES, V23, P122, DOI 10.1038/cr.2012.119; Keller MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5439; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Kimura H, 2013, J HUM GENET, V58, P439, DOI 10.1038/jhg.2013.66; Kunwar PS, 2003, DEVELOPMENT, V130, P5589, DOI 10.1242/dev.00803; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Li M, 2012, NAT REV MOL CELL BIO, V13, P524, DOI 10.1038/nrm3393; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Liu YT, 2015, INT J CLIN EXP MED, V8, P17601; Loh KM, 2016, CELL, V166, P451, DOI 10.1016/j.cell.2016.06.011; Lolas M, 2014, P NATL ACAD SCI USA, V111, P4478, DOI 10.1073/pnas.1402612111; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Munoz-Descalzo S, 2015, SEMIN CELL DEV BIOL, V47-48, P101, DOI 10.1016/j.semcdb.2015.08.011; Pan MR, 2018, CELL MOL LIFE SCI, V75, P209, DOI 10.1007/s00018-017-2596-8; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang L, 2017, J BIOL CHEM, V292, P1339, DOI 10.1074/jbc.M116.766949; Wang L, 2016, J MOL BIOL, V428, P1409, DOI 10.1016/j.jmb.2015.06.013; Wang Q, 2017, CELL STEM CELL, V20, P70, DOI 10.1016/j.stem.2016.10.002; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu YL, 2013, EMBO MOL MED, V5, P531, DOI 10.1002/emmm.201201783; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3	49	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18444	18453		10.1074/jbc.RA118.003688	http://dx.doi.org/10.1074/jbc.RA118.003688			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30282636	hybrid, Green Published			2022-12-26	WOS:000458467300003
J	Nadeem, MA; Habyarimana, E; Ciftci, V; Nawaz, MA; Karakoy, T; Comertpay, G; Shahid, MQ; Hatipoglu, R; Yeken, MZ; Ali, F; Ercisli, S; Chung, G; Baloch, FS				Nadeem, Muhammad Azhar; Habyarimana, Ephrem; Ciftci, Vandettin; Nawaz, Muhammad Amjad; Karakoy, Tolga; Comertpay, Gonul; Shahid, Muhammad Qasim; Hatipoglu, Rustu; Yeken, Mehmet Zahit; Ali, Fawad; Ercisli, Sezai; Chung, Gyuhwa; Baloch, Faheem Shehzad			Characterization of genetic diversity in Turkish common bean gene pool using phenotypic and whole-genome DArTseq-generated silicoDArT marker information	PLOS ONE			English	Article							PHASEOLUS-VULGARIS L.; POPULATION-STRUCTURE; DISSEMINATION PATHWAYS; LANDRACES; GERMPLASM; ORIGIN; DIFFERENTIATION; DOMESTICATION; MESOAMERICAN; TOLERANCE	Turkey presents a great diversity of common bean landraces in farmers' fields. We collected 183 common bean accessions from 19 different Turkish geographic regions and 5 scarlet runner bean accessions to investigate their genetic diversity and population structure using phenotypic information (growth habit, and seed weight, flower color, bracteole shape and size, pod shape and leaf shape and color), geographic provenance and 12,557 silicoDArT markers. A total of 24.14% markers were found novel. For the entire population (188 accessions), the expected heterozygosity was 0.078 and overall gene diversity, Fst and Fis were 0.14, 0.55 and 1, respectively. Using marker information, model-based structure, principal coordinate analysis (PCoA) and unweighted pair-group method with arithmetic means (UPGMA) algorithms clustered the 188 accessions into two main populations A (predominant) and B, and 5 unclassified genotypes, representing 3 meaningful heterotic groups for breeding purposes. Phenotypic information clearly distinguished these populations; population A and B, respectively, were bigger (>40g/100 seeds) and smaller (<40g/100 seeds) seed-sized. The unclassified population was pure and only contained climbing genotypes with 100 seed weight 2-3 times greater than populations A and B. Clustering was mainly based on A: seed weight, B: growth habit, C: geographical provinces and D: flower color. Mean kinship was generally low, but population B was more diverse than population A. Overall, a useful level of gene and genotypic diversity was observed in this work and can be used by the scientific community in breeding efforts to develop superior common bean strains.	[Nadeem, Muhammad Azhar; Ciftci, Vandettin; Yeken, Mehmet Zahit; Ali, Fawad; Baloch, Faheem Shehzad] Abant Izzet Baysal Univ, Fac Agr & Nat Sci, Dept Field Crops, Bolu, Turkey; [Habyarimana, Ephrem] Consiglio Ric Agr & Anal Econ Agr, Ctr Ric Cerealicoltura & Colture Ind, Bologna, Italy; [Nawaz, Muhammad Amjad; Chung, Gyuhwa] Chonnam Natl Univ, Dept Biotechnol, Chungnam, South Korea; [Karakoy, Tolga] Univ Cumhuriyet, Vocat Sch Sivas, Organ Agr Program, Sivas, Turkey; [Comertpay, Gonul] Eastern Mediterranean Agr Res Inst, Adana, Turkey; [Shahid, Muhammad Qasim] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Hatipoglu, Rustu] Univ Cukurova, Fac Agr, Dept Field Crops, Adana, Turkey; [Ercisli, Sezai] Ataturk Univ, Fac Agr, Dept Hort, Erzurum, Turkey	Abant Izzet Baysal University; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Chonnam National University; Cumhuriyet University; Ministry of Food, Agriculture & Livestock - Turkey; South China Agricultural University; Cukurova University; Ataturk University	Baloch, FS (corresponding author), Abant Izzet Baysal Univ, Fac Agr & Nat Sci, Dept Field Crops, Bolu, Turkey.; Chung, G (corresponding author), Chonnam Natl Univ, Dept Biotechnol, Chungnam, South Korea.	chung@chonnam.ac.kr; balochfaheem13@gmail.com	KARAKÖY, Tolga/AAG-9837-2021; Baloch, Faheem Shehzad/ABG-8788-2020; Shahid, Muhammad Qasim/F-2908-2013; Habyarimana, Ephrem/AAK-3957-2020; Shahid, Muhammad Qasim/K-2304-2019; YEKEN, Mehmet Zahit/AAT-2290-2020; Nawaz, Muhammad Amjad/L-9934-2018; COMERTPAY, GONUL/GYE-0278-2022; Azhar Nadeem, Muhammad/AAE-2747-2020	KARAKÖY, Tolga/0000-0002-5428-1907; Baloch, Faheem Shehzad/0000-0002-7470-0080; Shahid, Muhammad Qasim/0000-0002-6767-4355; Habyarimana, Ephrem/0000-0003-2731-2744; Shahid, Muhammad Qasim/0000-0002-6767-4355; YEKEN, Mehmet Zahit/0000-0003-0490-371X; Amjad Nawaz, Muhammad/0000-0001-9901-7555; COMERTPAY, GONUL/0000-0002-6522-4596; Azhar Nadeem, Muhammad/0000-0002-0637-9619	Scientific and Technological Research Council of Turkey (TUBITAK) [TOVAG-2015O630, 2216]; Abant Izzet Baysal University, Bolu, Turkey [2017.10.07.1208]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Abant Izzet Baysal University, Bolu, Turkey(Abant Izzet Baysal University)	The authors express their gratitude to Scientific and Technological Research Council of Turkey (TUBITAK) (TOVAG-2015O630 to FSB and 2216 research fellowship to FA) and Scientific research unit, Abant Izzet Baysal University, Bolu, Turkey (BAP project: 2017.10.07.1208 to FSB) for providing research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andeden EE, 2015, PLANT BREEDING, V134, P589, DOI 10.1111/pbr.12296; Angioi SA, 2010, THEOR APPL GENET, V121, P829, DOI 10.1007/s00122-010-1353-2; Baloch FS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167821; Baloch FS, 2016, TURK J AGRIC FOR, V40, P352, DOI 10.3906/tar-1508-27; Bitocchi E, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00722; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Blair MW, 2006, THEOR APPL GENET, V113, P100, DOI 10.1007/s00122-006-0276-4; Blair MW, 2013, THEOR APPL GENET, V126, P535, DOI 10.1007/s00122-012-1999-z; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Bouchet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033470; Burle ML, 2010, THEOR APPL GENET, V121, P801, DOI 10.1007/s00122-010-1350-5; Carovic-Stanko K, 2017, FRONT PLANT SCI, V8, DOI [10.3339/fpls.2017.00604, 10.3389/fpls.2017.00604]; Ceylan A, 2014, BIOCHEM SYST ECOL, V54, P219, DOI 10.1016/j.bse.2014.01.014; Chacon MI, 2005, THEOR APPL GENET, V110, P432, DOI 10.1007/s00122-004-1842-2; Chavez-Servia J.L., 2016, GRAIN LEGUMES, P1; Cichy KA, 2014, MOL BREEDING, V33, P139, DOI 10.1007/s11032-013-9940-y; Comertpay G, 2012, PLANT MOL BIOL REP, V30, P261, DOI 10.1007/s11105-011-0332-3; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dwivedi SL, 2016, TRENDS PLANT SCI, V21, P31, DOI 10.1016/j.tplants.2015.10.012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Food and Agriculture Organization of the United Nations (FAO), 2014, FOOD AGR COMM; GEPTS P, 1988, ECON BOT, V42, P86, DOI 10.1007/BF02859038; Gioia T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075974; Goudet J, 1996, GENETICS, V144, P1933; Govindaraj M, 2015, GENET RES INT, V2015, DOI 10.1155/2015/431487; Gross BL, 2010, TRENDS PLANT SCI, V15, P529, DOI 10.1016/j.tplants.2010.05.008; Habyarimana E., 2016, Australian Journal of Crop Science, V10, P127; Habyarimana E, 2017, PLANT BREEDING, V136, P245, DOI 10.1111/pbr.12461; IBPGR, 1982, INT BOARD PLANT GEN; Khaidizar MI, 2012, TURK J FIELD CROPS, V17, P145; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Kumar V, 2008, SCI HORTIC-AMSTERDAM, V116, P138, DOI 10.1016/j.scienta.2007.12.001; Kwak M, 2009, THEOR APPL GENET, V118, P979, DOI 10.1007/s00122-008-0955-4; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li HH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1424-5; Lombardi M, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0150-3; Mamidi S, 2011, FUNCT PLANT BIOL, V38, P953, DOI 10.1071/FP11124; Maras M, 2013, J AM SOC HORTIC SCI, V138, P297, DOI 10.21273/JASHS.138.4.297; McClean PE, 2012, GENET RESOUR CROP EV, V59, P499, DOI 10.1007/s10722-011-9699-0; Mickelbart MV, 2015, NAT REV GENET, V16, P237, DOI 10.1038/nrg3901; Mukeshimana G, 2014, CROP SCI, V54, P923, DOI 10.2135/cropsci2013.06.0427; Nadeem MA, 2018, BIOTECHNOL BIOTEC EQ, V32, P261, DOI 10.1080/13102818.2017.1400401; Nawaz MA, 2013, INT J AGRIC BIOL, V15, P362; Nemli S, 2017, TURK J AGRIC FOR, V41, P389, DOI 10.3906/tar-1707-89; Nemli S, 2015, TURK J AGRIC FOR, V39, P940, DOI 10.3906/tar-1505-59; Newell MA, 2013, ANN APPL STAT, V7, P1898, DOI 10.1214/13-AOAS671; Petry N, 2015, NUTRIENTS, V7, P1144, DOI 10.3390/nu7021144; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Raman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101673; Rodino AP, 2006, CROP SCI, V46, P2540, DOI 10.2135/cropsci2006.02.0104; Rodriguez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057337; Rodriguez M, 2016, NEW PHYTOL, V209, P1781, DOI 10.1111/nph.13713; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Salinas AD, 1988, VARIATION TAXONOMY D, P441; Santalla M, 2004, EUPHYTICA, V135, P205, DOI 10.1023/B:EUPH.0000014912.07993.e7; Sarikamis G, 2009, GENET MOL RES, V8, P880, DOI 10.4238/vol8-3gmr605; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schroder S, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-015-0431-1; Sehirali S., 1988, YEMEKLIK DANE BAKLAG; SINGH SP, 1991, ECON BOT, V45, P379, DOI 10.1007/BF02887079; SINGH SP, 1991, CROP SCI, V31, P23, DOI 10.2135/cropsci1991.0011183X003100010005x; Spataro G, 2011, THEOR APPL GENET, V122, P1281, DOI 10.1007/s00122-011-1530-y; Tan A, 1988, INT S SIT CONS PLANT, P5; Valdisser PAMR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3805-4; Valdisser PAMR, 2016, MOL GENET GENOMICS, V291, P1277, DOI 10.1007/s00438-016-1182-3; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wani AB., 2017, J PHARMACOGN PHYTOCH, V6, P343, DOI DOI 10.6084/M9.FIGSHARE.12639305; Yang RC, 1998, EVOLUTION, V52, P950, DOI 10.1111/j.1558-5646.1998.tb01824.x	70	36	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205363	10.1371/journal.pone.0205363	http://dx.doi.org/10.1371/journal.pone.0205363			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308006	gold, Green Published, Green Submitted			2022-12-26	WOS:000447173500064
J	Thakur, M; Fernandes, M; Sathyakumar, S; Singh, SK; Vijh, RK; Han, JL; Wu, DD; Zhang, YP				Thakur, Mukesh; Fernandes, Merwyn; Sathyakumar, Sambandam; Singh, Sujeet K.; Vijh, Ramesh Kumar; Han, Jianlin; Wu, Dong-Dong; Zhang, Ya-Ping			Understanding the cryptic introgression and mixed ancestry of Red Junglefowl in India	PLOS ONE			English	Article							POPULATION-STRUCTURE; STATISTICAL TESTS; DNA POLYMORPHISM; GALLUS-GALLUS; HYBRIDIZATION; CHICKENS; SOFTWARE; ORIGIN; NEUTRALITY; MUTATIONS	Red Junglefowls (RJFs), the wild progenitor of modern day chickens (DCs), are believed to be in genetic endangerment due to introgression of domestic genes through opportunistic matings with domestic or feral chickens. Previous studies from India reported rare hybridization of RJFs in the wild. However, RJF population genetic structure, pattern of gene flow and their admixture with DC populations are poorly understood at the landscape level. We conducted this study with a large sample size, covering the predicted natural distribution range of RJFs in India. We documented strong evidence of directional gene flow from DCs to free-ranging wild RJFs, with the Northeastern RJF population exhibiting the most genetic variants in their nuclear and mitochondrial genomes, indicating it to be the ancestral population from which early radiation may have occurred. The results provide evidence that landscape features do not act as a barrier to gene flow and the distribution pattern could not be explored due to physical sharing or exchange of wild birds in the past when forests were continuous across RJF range in India.	[Thakur, Mukesh; Fernandes, Merwyn; Sathyakumar, Sambandam; Singh, Sujeet K.] Wildlife Inst India, Dehra Dun, Uttarakhand, India; [Thakur, Mukesh; Wu, Dong-Dong; Zhang, Ya-Ping] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Thakur, Mukesh; Wu, Dong-Dong; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, Yunnan Lab Mol Biol Domest Anim, Kunming, Yunnan, Peoples R China; [Vijh, Ramesh Kumar] ICAR Natl Bur Anim Genet Resources NBAGR, GT Rd Bye Pass, Kernal, Haryana, India; [Han, Jianlin] Chinese Acad Agr Sci, Inst Anim Sci, CAAS ILRI Joint Lab Livestock & Forage Genet Reso, Beijing, Peoples R China; [Han, Jianlin] ILRI, Nairobi, Kenya; [Thakur, Mukesh] Zool Survey India, Kolkata, W Bengal, India; [Fernandes, Merwyn] WWF India Secretariat, TRAFFIC, 172-B Lodhi Estate, New Delhi, India	Wildlife Institute of India; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources; CGIAR; International Livestock Research Institute (ILRI); Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; CGIAR; International Livestock Research Institute (ILRI); Zoological survey of India	Thakur, M; Sathyakumar, S (corresponding author), Wildlife Inst India, Dehra Dun, Uttarakhand, India.; Thakur, M (corresponding author), Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.; Thakur, M (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Yunnan Lab Mol Biol Domest Anim, Kunming, Yunnan, Peoples R China.; Thakur, M (corresponding author), Zool Survey India, Kolkata, W Bengal, India.	thamukesh@gmail.com; ssk@wii.gov.in	Singh, Sujeet Kumar/ABC-2594-2020; Thakur, Mukesh/F-6516-2011; Wu, Dong-Dong/AAR-5615-2020	Singh, Sujeet Kumar/0000-0002-3671-1328; Thakur, Mukesh/0000-0003-2609-7579; 	Wildlife Institute of India, Dehradun	Wildlife Institute of India, Dehradun	The project was funded through the grant in aid scheme of Wildlife Institute of India, Dehradun. Funds were raised by Dr. S. Sathyakumar.; We thank all the State Forest / Wildlife Departments, Principal Chief Conservator of Forests and Chief Wildlife Wardens for granting permission for live-trapping and collection of RJF samples in the wild and the logistics provided during field surveys. We are thankful to Director, Dean, Research Coordinator and faculties of Wildlife Institute of India, Dehradun for their encouragement and support. This study was funded by the in-house research grant of Wildlife Institute of India, Dehradun. We acknowledge Dr William J. McShea (Smithsonian Conservation Biology Institute, Virginia) for editing manuscript and two reviewers for helping in improving the contents of the present manuscript.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berthouly C, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-1; Brisbin IL, 2007, ANIM CONSERV, V10, P429, DOI 10.1111/j.1469-1795.2007.00112.x; Brisbin I. Lehr Jr., 2002, Journal of the Bombay Natural History Society, V99, P217; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2011, AN PROD HLTH GUID, V9; FAO/MoDAD, 2004, SEC GUID MEAS DOM AN; Flamand JRB, 2003, ANIM CONSERV, V6, P265, DOI 10.1017/S1367943003003329; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Fuller R., 2000, PHEASANTS STATUS SUR, DOI [10.1007/978-1-4939-2365-6, DOI 10.1007/978-1-4939-2365-6]; Fumihito A, 1996, P NATL ACAD SCI USA, V93, P6792, DOI 10.1073/pnas.93.13.6792; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; Gering E, 2015, MOL ECOL, V24, P2112, DOI 10.1111/mec.13096; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Johnsingh AT, 2003, BIOL CONSERV, V111, P385, DOI 10.1016/S0006-3207(02)00307-5; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kanginakudru S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-174; Komiyama T, 2003, GENE, V317, P195, DOI 10.1016/S0378-1119(03)00703-0; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Mackey K, 1996, BIOMED PROD S, P13; Miao YW, 2013, HEREDITY, V110, P277, DOI 10.1038/hdy.2012.83; Mukesh, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132005; Mukesh, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117069; Mukesh, 2013, ZOO BIOL, V32, P476, DOI 10.1002/zoo.21081; Mukesh, 2011, Asian Journal of Biotechnology, V3, P293, DOI 10.3923/ajbkr.2011.293.301; Mwacharo JM, 2013, MOL ECOL, V22, P2683, DOI 10.1111/mec.12294; Nishibori M, 2005, ANIM GENET, V36, P367, DOI 10.1111/j.1365-2052.2005.01318.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peterson A.T., 1999, BIRD CONSERV INT, V9, P387; Pritchard JK, 2000, GENETICS, V155, P945; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sathyakumar S, 2012, FOR MIGR GLOB ENV CH; Sprem N, 2014, LIVEST SCI, V162, P1, DOI 10.1016/j.livsci.2013.12.010; Statham MJ, 2011, BIOL J LINN SOC, V103, P168, DOI 10.1111/j.1095-8312.2011.01629.x; TAJIMA F, 1989, GENETICS, V123, P585; Thakur M, 2014, GEFLUGEL TIERWELT; Torres RT, 2017, MAMM BIOL, V86, P70, DOI 10.1016/j.mambio.2017.05.001; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	48	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204351	10.1371/journal.pone.0204351	http://dx.doi.org/10.1371/journal.pone.0204351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307994	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500014
J	Hansen, SV; Traynor, S; Ditzel, HJ; Gjerstorff, MF				Hansen, Simone Valentin; Traynor, Sofie; Ditzel, Henrik Jorn; Gjerstorff, Morten Frier			Human DREF/ZBED1 is a nuclear protein widely expressed in multiple cell types derived from all three primary germ layers	PLOS ONE			English	Article							REPLICATION-RELATED ELEMENT; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; DRE/DREF SYSTEM; DREF PATHWAY; DROSOPHILA; DNA; PROMOTER; PROLIFERATION; CHROMATIN	Drosophila DNA replication-related element binding factor (DREF) is a transcription regulatory factor that binds the promoters of many genes involved in replication and cell proliferation and is required for normal cell cycle progression. Human DREF/zinc finger BED domain-containing protein 1 (ZBED1), an orthologue of Drosophila DREF, also has DNA binding activity, but its cellular functions remain largely uncharacterized. Herein, we show that ZBED1 is a chromatin-associated nuclear protein with a wide expression profile in human tissues from all three primary germ layers. For instance, ZBED1 was expressed in mesodermal-derived epithelial cells of the reproductive system and urinary tract, in endodermal-derived epithelial cells throughout the gastrointestinal tract, and in epidermal epithelium from the ectoderm. ZBED1 was also expressed in connective tissue and smooth muscle cells of multiple organs. To investigate whether ZBED1 is implicated in cell proliferation, similar to Drosophila DREF, we compared the tissue distribution of ZBED1 to that of the proliferation marker Ki-67. ZBED1 and Ki-67 were co-expressed in many epithelial tissues, but ZBED1 expression extended widely beyond that of Ki-67-positive cells. In other tissues, ZBED1 expression was more restricted than Ki-67 expression. These results suggest that ZBED1 is not a cell proliferation-associated factor such as Drosophila DREF, and our study adds to the cumulative understanding of the functions of ZBED1 in human cells and tissues.	[Hansen, Simone Valentin; Traynor, Sofie; Ditzel, Henrik Jorn; Gjerstorff, Morten Frier] Univ Southern Denmark, Inst Mol Med, Dept Canc & Inflammat Res, Odense, Denmark; [Ditzel, Henrik Jorn] Odense Univ Hosp, Dept Oncol, Odense, Denmark; [Ditzel, Henrik Jorn; Gjerstorff, Morten Frier] Odense Univ Hosp, Acad Geriatr Canc Res AgeCare, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Gjerstorff, MF (corresponding author), Univ Southern Denmark, Inst Mol Med, Dept Canc & Inflammat Res, Odense, Denmark.; Gjerstorff, MF (corresponding author), Odense Univ Hosp, Acad Geriatr Canc Res AgeCare, Odense, Denmark.	mgjierstorff@health.sdu.dk		Ditzel, Henrik J./0000-0003-3927-5135; gjerstorff, morten/0000-0002-0845-1952; Traynor, Sofie/0000-0003-2565-5110	Velux Foundation; Danish Cancer Society; Academy of Geriatric Cancer Research (AgeCare); Danish Research Council for Independent Research	Velux Foundation(Velux Fonden); Danish Cancer Society(Danish Cancer Society); Academy of Geriatric Cancer Research (AgeCare); Danish Research Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was supported by the Velux Foundation, the Danish Cancer Society, Academy of Geriatric Cancer Research (AgeCare), and the Danish Research Council for Independent Research.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Bruckmann NH, 2018, MOL CANCER RES, V16, P417, DOI 10.1158/1541-7786.MCR-17-0477; Gjerstorff MF, 2006, BRIT J CANCER, V94, P1864, DOI 10.1038/sj.bjc.6603163; Hart CM, 1999, CHROMOSOMA, V108, P375, DOI 10.1007/s004120050389; Hirose F, 1996, J BIOL CHEM, V271, P3930; HIROSE F, 1993, J BIOL CHEM, V268, P2092; Hochheimer A, 2002, NATURE, V420, P439, DOI 10.1038/nature01167; Hyun JY, 2005, MOL CELL BIOL, V25, P5590, DOI 10.1128/MCB.25.13.5590-5598.2005; Kim S, 2018, GENES GENOM, V40, P475, DOI 10.1007/s13258-018-0649-5; Matsukage A, 2008, BBA-GENE REGUL MECH, V1779, P81, DOI 10.1016/j.bbagrm.2007.11.011; Nakamura K, 2008, NUCLEIC ACIDS RES, V36, P3905, DOI 10.1093/nar/gkn291; Tue NT, 2017, BBA-GENE REGUL MECH, V1860, P705, DOI 10.1016/j.bbagrm.2017.03.004; Ohno K, 1996, NUCLEIC ACIDS RES, V24, P3942, DOI 10.1093/nar/24.20.3942; Ohshima N, 2003, J BIOL CHEM, V278, P22928, DOI 10.1074/jbc.M303109200; Park SY, 2004, NUCLEIC ACIDS RES, V32, P1318, DOI 10.1093/nar/gkh302; Sawado T, 1998, J BIOL CHEM, V273, P26042, DOI 10.1074/jbc.273.40.26042; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seto H, 2006, GENES CELLS, V11, P499, DOI 10.1111/j.1365-2443.2006.00956.x; Takata K, 2002, NUCLEIC ACIDS RES, V30, P3795, DOI 10.1093/nar/gkf490; Thao DTP, 2006, EXP CELL RES, V312, P3641, DOI DOI 10.1016/J.YEXCR.2006.08.005; Tsuchiya A, 2007, FEBS J, V274, P1818, DOI 10.1111/j.1742-4658.2007.05730.x; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Valadez-Graham V, 2012, NUCLEIC ACIDS RES, V40, P1460, DOI 10.1093/nar/gkr865; Yamashita D, 2007, MOL CELL BIOL, V27, P2003, DOI 10.1128/MCB.01462-06; Yamashita D, 2007, J BIOL CHEM, V282, P7563, DOI 10.1074/jbc.M607180200; Yamashita D, 2016, J BIOL CHEM, V291, P11619, DOI 10.1074/jbc.M115.713370	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205461	10.1371/journal.pone.0205461	http://dx.doi.org/10.1371/journal.pone.0205461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304065	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100096
J	Ingendoh-Tsakmakidis, A; Nolte, L; Winkel, A; Meyer, H; Koroleva, A; Shpichka, A; Ripken, T; Heisterkamp, A; Stiesch, M				Ingendoh-Tsakmakidis, Alexandra; Nolte, Lena; Winkel, Andreas; Meyer, Heiko; Koroleva, Anastasia; Shpichka, Anastasia; Ripken, Tammo; Heisterkamp, Alexander; Stiesch, Meike			Time resolved 3D live-cell imaging on implants	PLOS ONE			English	Article							HUMAN GINGIVAL FIBROBLASTS; TITANIUM; MICROSCOPY; MODEL	It is estimated that two million new dental implants are inserted worldwide each year. Innovative implant materials are developed in order to minimize the risk of peri-implant inflammations. The broad range of material testing is conducted using standard 2D, terminal, and invasive methods. The methods that have been applied are not sufficient to monitor the whole implant surface and temporal progress. Therefore, we built a 3D peri-implant model using a cylindrical implant colonized by human gingival fibroblasts. In order to monitor the cell response over time, a non-toxic LIVE/DEAD staining was established and applied to the new 3D model. Our LIVE/DEAD staining method in combination with the time resolved 3D visualization using Scanning Laser Optical Tomography (SLOT), allowed us to monitor the cell death path along the implant in the 3D peri-implant model. The differentiation of living and dead gingival fibroblasts in response to toxicity was effectively supported by the LIVE/DEAD staining. Furthermore, it was possible to visualize the whole cell-colonized implant in 3D and up to 63 hours. This new methodology offers the opportunity to record the long-term cell response on external stress factors, along the dental implant and thus to evaluate the performance of novel materials/surfaces.	[Ingendoh-Tsakmakidis, Alexandra; Winkel, Andreas; Stiesch, Meike] Hannover Med Sch, Dept Prosthet Dent & Biomed Mat Sci, Hannover, Germany; [Nolte, Lena; Meyer, Heiko; Ripken, Tammo] Laser Zentrum Hannover eV, Ind & Biomed Opt Dept, Hannover, Germany; [Koroleva, Anastasia] Laser Zentrum Hannover eV, Nanotechnol Dept, Hannover, Germany; [Shpichka, Anastasia] Sechenov First Moscow State Med Univ, Inst Regenerat Med, Moscow, Russia; [Heisterkamp, Alexander] Leibniz Univ Hannover, Inst Quantum Opt, Hannover, Germany	Hannover Medical School; Sechenov First Moscow State Medical University; Leibniz University Hannover	Ingendoh-Tsakmakidis, A (corresponding author), Hannover Med Sch, Dept Prosthet Dent & Biomed Mat Sci, Hannover, Germany.	ingendoh-tsakmakidis.alexandra@mh-hannover.de	Ingendoh-Tsakmakidis, Alexandra/AAJ-3983-2020; Shpichka, Anastasia/A-6658-2015	Ingendoh-Tsakmakidis, Alexandra/0000-0002-4665-8022; Shpichka, Anastasia/0000-0002-9918-9979; Ripken, Tammo/0000-0003-3512-9544	ministry of Lower Saxony; VolkswagenStiftung	ministry of Lower Saxony; VolkswagenStiftung(Volkswagen)	The BIOFABRICATION FOR NIFE Initiative is financially supported by the ministry of Lower Saxony and the VolkswagenStiftung (both BIOFABRICATION FOR NIFE: VWZN2860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko Yoshimitsu, 2004, J Oral Sci, V46, P19, DOI 10.2334/josnusd.46.19; Ahmed TAE, 2008, TISSUE ENG PART B-RE, V14, P199, DOI 10.1089/ten.teb.2007.0435; [Anonymous], 2013, J Periodontol, V84, P436, DOI 10.1902/jop.2013.134001; Attik GN, 2014, JOVE-J VIS EXP, DOI 10.3791/51949; Belibasakis GN, 2014, MOL ORAL MICROBIOL, V29, P174, DOI 10.1111/omi.12053; Belibasakis GN, 2014, ARCH ORAL BIOL, V59, P66, DOI 10.1016/j.archoralbio.2013.09.013; Chai WL, 2013, J PERIODONTAL RES, V48, P663, DOI 10.1111/jre.12062; Chai WL, 2010, J PERIODONTOL, V81, P1187, DOI 10.1902/jop.2010.090648; Contaldo M, 2014, ODONTOLOGY, V102, P325, DOI 10.1007/s10266-013-0110-9; Doll K, 2017, ACS APPL MATER INTER, V9, P9359, DOI 10.1021/acsami.6b16159; Dreyer H, 2018, J PERIODONTAL RES; Eberhard J, 2014, J CLIN PERIODONTOL, V41, P321, DOI 10.1111/jcpe.12227; Fernandes LO, 2017, J BIOPHOTONICS, V10, P862, DOI 10.1002/jbio.201600082; Gomez-Florit M, 2014, J DENT, V42, P30, DOI 10.1016/j.jdent.2013.11.003; Grassia V, 2016, ULTRASTRUCT PATHOL, V40, P317, DOI 10.1080/01913123.2016.1237603; Groeger SE, 2015, PERIODONTOL 2000, V69, P46, DOI 10.1111/prd.12094; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Heidrich M, 2011, BIOMED OPT EXPRESS, V2, P2982, DOI 10.1364/BOE.2.002982; Koroleva A., 2016, BIONANOMATERIALS, V17, P19, DOI DOI 10.1515/BNM-2015-0026; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lau SL, 2016, IMPLANT DENT, V25, P619, DOI 10.1097/ID.0000000000000437; Lorbeer RA, 2011, OPT EXPRESS, V19, P5419, DOI 10.1364/OE.19.005419; Machtei EE, 2008, CLIN ORAL IMPLAN RES, V19, P259, DOI 10.1111/j.1600-0501.2007.01466.x; McLean JS, 2008, ISME J, V2, P121, DOI 10.1038/ismej.2007.107; Nolte L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175431; Palaiologou AA, 2001, J PERIODONTOL, V72, P798, DOI 10.1902/jop.2001.72.6.798; Pfaffenroth C, 2011, MACROMOL BIOSCI, V11, P1515, DOI 10.1002/mabi.201100124; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stavroullakis A, 2015, J BIOMED MATER RES A, V103, P1131, DOI 10.1002/jbm.a.35262; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Tzach-Nahman R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11771-3; Wang YL, 2016, CLIN ORAL INVEST, V20, P685, DOI 10.1007/s00784-015-1558-5; Wassmann M, 2016, J BIOMAT SCI-POLYM E, V27, P1507, DOI 10.1080/09205063.2016.1214001; Winkel A, 2015, INT J MOL SCI, V16, P4327, DOI 10.3390/ijms16024327	35	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205411	10.1371/journal.pone.0205411	http://dx.doi.org/10.1371/journal.pone.0205411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304039	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100088
J	Lin, YP; Lee, YL; Hung, CY; Chang, CF; Chen, Y				Lin, Yen-Ping; Lee, Ying-Lin; Hung, Chien-Ya; Chang, Chuan-Fa; Chen, Yi			Detection of adulterated drugs in traditional Chinese medicine and dietary supplements using hydrogen as a carrier gas	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; HERBAL MEDICINES; LIQUID-CHROMATOGRAPHY; GC-MS; PATENT MEDICINES; SYNTHETIC DRUGS; WEIGHT-LOSS; SIBUTRAMINE; IDENTIFICATION; CONFIRMATION	Helium, a minor component of natural gas and radioactive minerals, is most commonly used as a carrier in gas chromatography-mass spectrometry (GC-MS). Its scarcity leads to limited availability and higher costs. In this experiment, hydrogen from a safe source of a hydrogen generator was tested as a substitutive carrier gas for the detection of adulterant in traditional Chinese medicine (TCM) and food supplements by GC-MS analysis. We found that the limits of detection (LODs) of using hydrogen were from 10 to 1000 mu g/g. The levels of LODs tested among 170 drugs remain the same whether hydrogen or helium was used as a carrier gas with the exception of 7 drugs-benzbromarone, estradiol benzoate, bezafibrate, mefenamic acid, oxymetholone, piperidenafil and cetilistat. The real sample analysis results using hydrogen were as satisfactory as those using helium. In addition, the retention time was shortened after the chromatographic performance was optimized. In summary, it is worth considering hydrogen as a carrier gas due to its affordable costs, energy efficiency, carbon reduction and chromatographic advantages to detect adulterated drugs in TCM and dietary supplement using GC-MS.	[Lin, Yen-Ping; Lee, Ying-Lin; Hung, Chien-Ya; Chen, Yi] Tainan City Govt, Publ Hlth Bur, Tainan, Taiwan; [Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan	National Cheng Kung University	Lin, YP; Lee, YL (corresponding author), Tainan City Govt, Publ Hlth Bur, Tainan, Taiwan.; Chang, CF (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.	lab17@tncghb.gov.tw; lab01@tncghb.gov.tw; affa@mail.ncku.edu.tw	Chang, Chuan-Fa/F-8660-2011	Chang, Chuan-Fa/0000-0003-2404-1248	Tainan City Government	Tainan City Government	This work was supported by the Tainan City Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, METHOD TEST ADULTERA; Ariburnu E, 2012, J PHARMACEUT BIOMED, V64-65, P77, DOI 10.1016/j.jpba.2012.02.004; Au AM, 2000, B ENVIRON CONTAM TOX, V65, P112, DOI 10.1007/s001280000102; Avivanalytical, HEL SHORT HYDR CARR; Bartram RJ, 2010, LC GC N AM, V28, P890; Bodeker G, 2002, AM J PUBLIC HEALTH, V92, P1582, DOI 10.2105/AJPH.92.10.1582; Champagne AB, 2011, VIB SPECTROSC, V55, P216, DOI 10.1016/j.vibspec.2010.11.009; Cheng HL, 2001, RAPID COMMUN MASS SP, V15, P1473, DOI 10.1002/rcm.396; Connor E, USING HYDROGEN CARRI; Ernst E, 2002, J INTERN MED, V252, P107, DOI 10.1046/j.1365-2796.2002.00999.x; Gregori A, 2013, SCI JUSTICE, V53, P286, DOI 10.1016/j.scijus.2012.10.002; Haneef J, 2013, DRUG TEST ANAL, V5, P607, DOI 10.1002/dta.1482; Impens S, 2001, RAPID COMMUN MASS SP, V15, P2409, DOI 10.1002/rcm.515; Khazan M, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.15344; Kim SH, 2009, BIOMED CHROMATOGR, V23, P1259, DOI 10.1002/bmc.1248; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Ko RJ, 1998, NEW ENGL J MED, V339, P847, DOI 10.1056/NEJM199809173391214; Lin MC, 2001, J FOOD DRUG ANAL, V9, P139; Liu ZZ, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0002-5; Marcus DM, 2002, NEW ENGL J MED, V347, P2073, DOI 10.1056/NEJMsb022858; Mokhtar SU, 2016, J PHARMACEUT BIOMED, V121, P188, DOI 10.1016/j.jpba.2016.01.034; Munoz-Guerra JA, 2011, J CHROMATOGR A, V1218, P7365, DOI 10.1016/j.chroma.2011.08.009; Nnaji CN, 2015, SCI JUSTICE, V55, P162, DOI 10.1016/j.scijus.2015.01.003; OLIVER BM, 1984, GEOCHIM COSMOCHIM AC, V48, P1759, DOI 10.1016/0016-7037(84)90030-9; Phattanawasin P, 2012, FORENSIC SCI INT, V219, P96, DOI 10.1016/j.forsciint.2011.12.004; Popescu AM, 2015, UNIV POLITEH BUCHAR, V77, P221; Shi F, 2014, J CHROMATOGR A, V1344, P91, DOI 10.1016/j.chroma.2013.12.030; Shimadzu, EV HYDR CARR GAS GAS; Song FH, 2014, J PHARMACEUT BIOMED, V88, P136, DOI 10.1016/j.jpba.2013.08.031; Stypulkowska K, 2011, J PHARMACEUT BIOMED, V56, P969, DOI 10.1016/j.jpba.2011.08.028; Tagami T, 2013, FOOD HYG SAFE SCI, V54, P232, DOI 10.3358/shokueishi.54.232; Tseng MC, 2000, J FOOD DRUG ANAL, V8, P315; Vaysse J, 2010, FOOD ADDIT CONTAM A, V27, P903, DOI 10.1080/19440041003705821; Watanabe A, 2016, ANAL CHEM, V88, P5462, DOI 10.1021/acs.analchem.6b00892; Zhao JC, 2006, CHIN J CHROMATOGR, V24, P660; Zhu QX, 2014, ANAL BIOANAL CHEM, V406, P1877, DOI 10.1007/s00216-013-7605-7	36	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205371	10.1371/journal.pone.0205371	http://dx.doi.org/10.1371/journal.pone.0205371			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304050	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100085
J	Myronycheva, O; Karlsson, O; Sehlstedt-Persson, M; Ohman, M; Sandberg, D				Myronycheva, Olena; Karlsson, Olov; Sehlstedt-Persson, Margot; Ohman, Micael; Sandberg, Dick			Distribution of low-molecular lipophilic extractives beneath the surface of air- and kiln-dried Scots pine sapwood boards	PLOS ONE			English	Article							WEAK BOUNDARY-LAYERS; SYLVESTRIS L; WOOD; CONSTITUENTS; DEGRADATION; PATHOGENS; HEARTWOOD; NITROGEN; FUNGI; ACIDS	During industrial wood drying, extractives migrate towards the wood surfaces and make the material more susceptible to photo/biodegradation. The present work provides information about the distribution, quantity and nature of lipophilic substances beneath the surface in air- and kiln-dried Scots pine (Pinus sylvestris L.) sapwood boards. Samples were taken from knot-free sapwood surfaces and the composition of lipophilic extractives, phenols and low-molecular fatty/resin acids layers at different nominal depths below the surface was studied gravimetrically, by UV-spectrometry and by gas chromatography-mass spectrometry (GC-MS). The concentration of total extractives was significantly higher in kiln-dried than in air-dried samples and was higher close to the surface than in the layers beneath. The scatter in the values for the lipophilic extractives was high in both drying types, being highest for linoleic acid and slightly lower for palmitic, oleic and stearic acids. The amount of fatty acids was low in kiln-dried boards, probably due to a stronger degradation due to the high temperature employed. The most abundant resin acid was dehydroabietic acid followed by pimaric, isopimaric, and abietic acids in both drying types. It is concluded that during kiln-drying a migration front is created at a depth of 0.25 mm with a thickness of about 0.5 mm.	[Myronycheva, Olena; Karlsson, Olov; Sehlstedt-Persson, Margot; Ohman, Micael; Sandberg, Dick] Lulea Univ Technol, Div Wood Sci & Engn, Skelleftea, Sweden	Lulea University of Technology	Karlsson, O (corresponding author), Lulea Univ Technol, Div Wood Sci & Engn, Skelleftea, Sweden.	olov.karlsson@ltu.se	Myronycheva, Olena/M-6357-2019; Myronycheva, Olena/A-4326-2016	Myronycheva, Olena/0000-0001-7864-8091; Myronycheva, Olena/0000-0001-7864-8091	Swedish Research Council for the Environment, Agricultural Sciences and Spatial Planning (FORMAS) project "Experimental studies of capillary phenomena in bio-based materials" [942-2016-64]; "Fungal growth on modified wood-based products under subarctic conditions" [2017-00419]; COST Action "ModWoodLife" project "Understanding wood modification through an integrated scientific and environmental impact approach" [FP1407]	Swedish Research Council for the Environment, Agricultural Sciences and Spatial Planning (FORMAS) project "Experimental studies of capillary phenomena in bio-based materials"; "Fungal growth on modified wood-based products under subarctic conditions"; COST Action "ModWoodLife" project "Understanding wood modification through an integrated scientific and environmental impact approach"	This work received support from the Swedish Research Council for the Environment, Agricultural Sciences and Spatial Planning (FORMAS) project "Experimental studies of capillary phenomena in bio-based materials" 942-2016-64, "Fungal growth on modified wood-based products under subarctic conditions" 2017-00419, PI-Dr. Olov Karlsson; COST Action FP1407 "ModWoodLife" project "Understanding wood modification through an integrated scientific and environmental impact approach" PI-Prof. Dick Sandberg.	Ahmed SA, 2012, HOLZFORSCHUNG, V66, P251, DOI 10.1515/HF.2011.126; [Anonymous], 2004, 131831 SSEN SIS; [Anonymous], 4903 SCAN CM PFI; Arshadi M, 2009, ANN OCCUP HYG, V53, P797, DOI 10.1093/annhyg/mep058; Bergstrom B, 2003, FORESTRY, V76, P45, DOI 10.1093/forestry/76.1.45; BIKERMAN JJ, 1967, IND ENG CHEM, V59, P40, DOI 10.1021/ie51403a010; CHOONG ET, 1991, WOOD FIBER SCI, V23, P185; Dorado J, 2000, BIORESOURCE TECHNOL, V71, P13, DOI 10.1016/S0960-8524(99)00060-7; Dorado J, 2001, WOOD SCI TECHNOL, V35, P117, DOI 10.1007/s002260000077; Ek M., 2009, WOOD CHEM WOOD BIOTE, V1, P1; Fengel D., 1984, WOOD CHEM ULTRASTRUC; FISCHER C, 1992, TREES-STRUCT FUNCT, V6, P147; Fromm J, 2013, PLANT CELL MONOGR, V20, P1, DOI 10.1007/978-3-642-36491-4; IBM, 2014, SPSS STAT; JULKUNENTIITTO R, 1985, J AGR FOOD CHEM, V33, P213, DOI 10.1021/jf00062a013; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Lai YZ, 1992, METHODS LIGNIN CHEM, P423, DOI DOI 10.1007/978-3-642-74065-7_28; Langenheim J.H., 2003, PLANT RESINS CHEM EV; McDonald AG, 2000, HOLZFORSCHUNG, V54, P12, DOI 10.1515/HF.2000.003; Nagy NE, 2006, TREE PHYSIOL, V26, P159, DOI 10.1093/treephys/26.2.159; Normark M, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-20; Piispanen R, 2002, TREE PHYSIOL, V22, P661, DOI 10.1093/treephys/22.9.661; Salehi AM, 2013, PROG ORG COAT, V76, P1068, DOI 10.1016/j.porgcoat.2013.03.002; Saranpaa P, 1987, TREES-STRUCT FUNCT, V1, P82, DOI 10.1007/BF00203575; Sehlstedt-Persson M., 2008, THESIS; Sehlstedt-Persson M, 2010, J WOOD SCI, V56, P25, DOI 10.1007/s10086-009-1066-9; Sjostrom E., 1993, WOOD CHEM, V2nd, P1, DOI [DOI 10.1016/B978-0-08-092589-9.50005-X, 10.1016/B978-0-08-092589-9.50005-X]; Sjostrom E, 1999, ANAL METHODS WOOD CH, DOI [10.1007/978-3-662-03898-7, DOI 10.1007/978-3-662-03898-7, 10.1007/978-3-662-03898- 7]; Song Haitong, 2012, IMPACT DRYING CONDIT; Steckel V, 2011, INT WOOD PROD J, V2, P75, DOI 10.1179/2042645311Y.0000000007; Stehr M, 2000, J ADHES SCI TECHNOL, V14, P1211, DOI 10.1163/156856100742168; Terziev N, 1997, SCAND J FOREST RES, V12, P216, DOI 10.1080/02827589709355403; Terziev N, 1998, WOOD FIBER SCI, V30, P360; Terziev N, 2009, INT J BIOL CHEM PHYS, V49, P565, DOI [10.1515/hfsg.1995.49.6.565, DOI 10.1515/HFSG.1995.49.6.565]; THEANDER O, 1993, WOOD SCI TECHNOL, V27, P381, DOI 10.1007/BF00192224; Uggla C, 2001, PLANT PHYSIOL, V125, P2029, DOI 10.1104/pp.125.4.2029; Wiberg P, 2000, DRY TECHNOL, V18, P1647, DOI 10.1080/07373930008917804; Willfor S, 2003, HOLZFORSCHUNG, V57, P359, DOI 10.1515/HF.2003.054; Witzell J, 2008, CAN J FOREST RES, V38, P2711, DOI 10.1139/X08-112	39	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204212	10.1371/journal.pone.0204212	http://dx.doi.org/10.1371/journal.pone.0204212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303988	gold, Green Published, Green Submitted			2022-12-26	WOS:000446921100033
J	Vita, GL; Polito, F; Oteri, R; Arrigo, R; Ciranni, AM; Musumeci, O; Messina, S; Rodolico, C; Di Giorgio, RM; Vita, G; Aguennouz, M				Vita, Gian Luca; Polito, Francesca; Oteri, Rosaria; Arrigo, Roberto; Ciranni, Anna Maria; Musumeci, Olimpia; Messina, Sonia; Rodolico, Carmelo; Di Giorgio, Rosa Maria; Vita, Giuseppe; Aguennouz, M'Hammed			Hippo signaling pathway is altered in Duchenne muscular dystrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; MDX MICE; ISOFLAVONE GENISTEIN; SATELLITE CELLS; YAP; SURVIVIN; MICRORNA; CANCER; GENE; MECHANOTRANSDUCTION	Hippo signaling pathway is considered a key regulator of tissue homeostasis, cell proliferation, apoptosis and it is involved in cancer development. In skeletal muscle, YAP, a downstream target of the Hippo pathway, is an important player in myoblast proliferation, atrophy/hypertrophy regulation, and in mechano-trasduction, transferring mechanical signals into transcriptional responses. We studied components of Hippo pathway in muscle specimens from patients with Duchenne muscular dystrophy (DMD), Becker muscular dystrophy, limbgirdle muscular dystrophy type 2A and type 2B and healthy subjects. Only DMD muscles had decreased YAP1 protein expression, increased LATS1/2 kinase activity, low Survivin mRNA expression and high miR-21 expression. In light of our novel results, a schematic model is postulated: low levels of YOD1 caused by increased inhibition by miR-21 lead to an increase of LATS1/2 activity which in turn augments phosphorylation of YAP. Reduced amount of active YAP, which is also a target of increased miR-21, causes decreased nuclear expression of YAP-mediated target genes. Since it is known that YAP has beneficial roles in promoting tissue repair and regeneration after injury so that its activation may be therapeutically useful, our results suggest that some components of Hippo pathway could become novel therapeutic targets for DMD treatment.	[Vita, Gian Luca; Messina, Sonia; Rodolico, Carmelo; Vita, Giuseppe] Nemo Sud Clin Ctr Neuromuscular Disorders, Messina, Italy; [Polito, Francesca; Oteri, Rosaria; Arrigo, Roberto; Ciranni, Anna Maria; Musumeci, Olimpia; Messina, Sonia; Rodolico, Carmelo; Di Giorgio, Rosa Maria; Vita, Giuseppe; Aguennouz, M'Hammed] Univ Messina, Dept Clin & Expt Med, Unit Neurol & Neuromuscular Dis, Messina, Italy	University of Messina	Vita, G (corresponding author), Nemo Sud Clin Ctr Neuromuscular Disorders, Messina, Italy.; Vita, G (corresponding author), Univ Messina, Dept Clin & Expt Med, Unit Neurol & Neuromuscular Dis, Messina, Italy.	vitag@unime.it	Vita, Gianluca/AAR-4587-2020; Aguennouz, M'hammed/O-9520-2019	Vita, Gianluca/0000-0003-4190-8042; Aguennouz, M'hammed/0000-0003-0440-0354; RODOLICO, Carmelo/0000-0003-2543-6356; Vita, Giuseppe/0000-0002-5204-7826				Aguennouz M, 2011, NEUROBIOL AGING, V32, P2190, DOI 10.1016/j.neurobiolaging.2010.01.008; Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; An F, 2017, ONCOL LETT, V14, P4684, DOI 10.3892/ol.2017.6746; [Anonymous], 2007, MUSCLE BIOPSY; Bai HB, 2012, HUM PATHOL, V43, P1376, DOI 10.1016/j.humpath.2011.12.001; Barton ER, 2006, AM J PHYSIOL-CELL PH, V290, pC411, DOI 10.1152/ajpcell.00192.2005; Bassat E, 2017, NATURE, V547, P179, DOI 10.1038/nature22978; Chakraborty S, 2017, CELL REP, V18, P2464, DOI 10.1016/j.celrep.2017.02.041; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dubowitz V., 1995, MUSCLE DISORDERS CHI; Fischer M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00041; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE41, DOI 10.1152/ajpendo.00389.2012; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Judson RN, 2012, J CELL SCI, V125, P6009, DOI 10.1242/jcs.109546; Kim JH, 2013, J MUSCLE RES CELL M, V34, P1, DOI 10.1007/s10974-012-9330-9; Kim W, 2018, BMB REP, V51, P106, DOI 10.5483/BMBRep.2018.51.3.022; Kim Y, 2017, P NATL ACAD SCI USA, V114, P4691, DOI 10.1073/pnas.1620306114; Kosek DJ, 2008, J APPL PHYSIOL, V104, P1476, DOI 10.1152/japplphysiol.00708.2007; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Messina S, 2015, BIOFACTORS, V41, P324, DOI 10.1002/biof.1226; Messina S, 2011, NEUROMUSCULAR DISORD, V21, P579, DOI 10.1016/j.nmd.2011.04.014; Messina S, 2009, EXP NEUROL, V220, P349, DOI 10.1016/j.expneurol.2009.09.015; Miyatake S, 2016, DRUG DES DEV THER, V10, P2745, DOI 10.2147/DDDT.S110163; Morikawa Y, 2017, NATURE, V547, P227, DOI 10.1038/nature22979; Morikawa Y, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005781; Murgia M, 2017, CELL REP, V19, P2396, DOI 10.1016/j.celrep.2017.05.054; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Peverelli L, 2015, NEUROLOGY, V85, P1886, DOI 10.1212/WNL.0000000000002147; Ross SA, 2011, ADV NUTR, V2, P472, DOI 10.3945/an.111.001206; Silahtaroglu A, 2010, ESSAYS BIOCHEM, V48, P165, DOI [10.1042/BSE0480165, 10.1042/bse0480165]; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Tremblay AM, 2014, CANCER CELL, V26, P273, DOI 10.1016/j.ccr.2014.05.029; Watt KI, 2018, EXERC SPORT SCI REV, V46, P92, DOI 10.1249/JES.0000000000000142; Watt KI, 2010, BIOCHEM BIOPH RES CO, V393, P619, DOI 10.1016/j.bbrc.2010.02.034; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; Wei B, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-12; Yang ZY, 2014, MOL CELL BIOL, V34, P1607, DOI 10.1128/MCB.01346-13; Yeung YT, 2018, CURR PHARM DESIGN, V24, P1449, DOI 10.2174/1381612824666180327165604; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	44	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205514	10.1371/journal.pone.0205514	http://dx.doi.org/10.1371/journal.pone.0205514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304034	gold, Green Submitted, Green Published			2022-12-26	WOS:000446921100101
J	Hwang, JK; Jeong, DS; Bin Gwag, H; Park, KM; Ahn, J; Carriere, K; Park, SJ; Kim, JS; On, YK				Hwang, Jin Kyung; Jeong, Dong Seop; Bin Gwag, Hye; Park, Kyoung-Min; Ahn, Joonghyun; Carriere, Keumhee; Park, Seung-Jung; Kim, June Soo; On, Young Keun			Staged hybrid procedure versus radiofrequency catheter ablation in the treatment of atrial fibrillation	PLOS ONE			English	Article							SURGICAL ABLATION; ESC GUIDELINES; FOLLOW-UP; PERSISTENT; MANAGEMENT; COLLABORATION; BIPOLAR	The treatment effect of the hybrid procedure, consisting of a thoracoscopic ablation followed by an endocardial radiofrequency catheter ablation (RFCA), is unclear. A total of 117 ablation-naive patients who underwent either the staged hybrid procedure (n = 72) or RFCA alone (n = 105) for drug-refractory, non-valvular persistent or long-standing persistent atrial fibrillation (AF) were enrolled. The primary outcome is occurrence of total atrial arrhythmia, defined as a composite of AF, sustained atrial tachycardia (AT), and atypical atrial flutter (AFL) after index procedure. The mean age was 52.7 years. Eighty-four percentage of the patients were male. Patients with prior history of stroke and long-standing persistent AF were more prevalent in the hybrid group than RFCA group. The left atrial volume index was larger in the hybrid group (P<0.001). During 2.1 years of median follow-up, the incidence of total atrial arrhythmia was not different between the two groups (32.5% vs. 35.7%; adjusted hazard ratio: 0.64; 95% confidence interval: 0.36-1.14; P = 0.13). The AF recurrence was significantly lower in the hybrid group than in the RFCA group (29.6% vs. 34.9%; adjusted HR: 0.53; 95% CI: 0.29-0.99; P = 0.046). The hospital stay was longer in the hybrid group than in the RFCA group (11 days vs. 4 days; P<0.001). A staged hybrid procedure may be an alternative choice for drug-refractory persistent AF, but it is no more effective than RFCA alone to eliminate atrial arrhythmias. Considering the long-length of stay and the morbidity, careful consideration should be given in selection of treatment strategy.	[Hwang, Jin Kyung] Vet Hlth Serv Med Ctr, Div Cardiol, Dept Med, Seoul, South Korea; [Jeong, Dong Seop] Sungkyunkwan Univ, Div Thorac Surg, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Bin Gwag, Hye; Park, Kyoung-Min; Park, Seung-Jung; Kim, June Soo; On, Young Keun] Sungkyunkwan Univ, Div Cardiol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea; [Ahn, Joonghyun; Carriere, Keumhee] Samsung Med Ctr, Res Inst Future Med, Biostat & Clin Epidemiol Ctr, Seoul, South Korea; [Carriere, Keumhee] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB, Canada	Veterans Health Service Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Alberta	On, YK (corresponding author), Sungkyunkwan Univ, Div Cardiol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea.	yk.on@samsung.com	Jeong, Dong Seop/F-4601-2014	Jeong, Dong Seop/0000-0002-6947-8403; Park, Kyoung-Min/0000-0002-5416-9691; Ahn, Joong Hyun/0000-0002-5768-5990	Samsung Biomedical Research Institute grant	Samsung Biomedical Research Institute grant(Samsung)	This study was supported by a Samsung Biomedical Research Institute grant.	Boersma LVA, 2012, CIRCULATION, V125, P23, DOI 10.1161/CIRCULATIONAHA.111.074047; Bugge E, 2005, EUR J CARDIO-THORAC, V28, P76, DOI 10.1016/j.ejcts.2005.02.028; Bulava A, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001754; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Camm AJ, 2012, EUR HEART J, V33; COX JL, 1991, J THORAC CARDIOV SUR, V101, P569, DOI 10.1016/s0022-5223(19)36684-x; Edgerton Z, 2016, J CARDIOVASC ELECTR, V27, P524, DOI 10.1111/jce.12926; Gerstenfeld EP, 2004, CIRCULATION, V110, P1351, DOI 10.1161/01.CIR.0000141369.50476.D3; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Krul SPJ, 2014, INT J CARDIOL, V173, P229, DOI 10.1016/j.ijcard.2014.02.043; Krul SPJ, 2011, CIRC-ARRHYTHMIA ELEC, V4, P262, DOI 10.1161/CIRCEP.111.961862; La Meir M, 2012, INTERACT CARDIOV TH, V14, P445, DOI 10.1093/icvts/ivr142; Lockwood D, 2009, HEART RHYTHM, V6, pS50, DOI 10.1016/j.hrthm.2009.09.010; Mahapatra S, 2011, ANN THORAC SURG, V91, P1890, DOI 10.1016/j.athoracsur.2011.02.045; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Nault I, 2010, EUR HEART J, V31, P1046, DOI 10.1093/eurheartj/ehq079; O'Neill MD, 2009, EUR HEART J, V30, P1105, DOI 10.1093/eurheartj/ehp063; On YK, 2015, ANN THORAC SURG, V100, P1595, DOI 10.1016/j.athoracsur.2015.04.127; Oral H, 2003, CIRCULATION, V108, P2355, DOI 10.1161/01.CIR.0000095796.45180.88; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Oral H, 2002, CIRCULATION, V105, P1077, DOI 10.1161/hc0902.104712; Pison L, 2012, J AM COLL CARDIOL, V60, P54, DOI 10.1016/j.jacc.2011.12.055; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Yilmaz A, 2010, EUR J CARDIO-THORAC, V38, P356, DOI 10.1016/j.ejcts.2010.01.058	25	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205431	10.1371/journal.pone.0205431	http://dx.doi.org/10.1371/journal.pone.0205431			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300413	Green Published, gold, Green Submitted			2022-12-26	WOS:000446897200063
J	Inceer, H; Garnatje, T; Hayirlioglu-Ayaz, S; Pascual-Diaz, JP; Valles, J; Garcia, S				Inceer, Huseyin; Garnatje, Teresa; Hayirlioglu-Ayaz, Sema; Pere Pascual-Diaz, Joan; Valles, Joan; Garcia, Sonia			A genome size and phylogenetic survey of Mediterranean Tripleurospermum and Matricaria (Anthemideae, Asteraceae)	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; EXTERNAL TRANSCRIBED SPACER; SCH BIP. ASTERACEAE; L. ASTERACEAE; COMPOSITAE-ANTHEMIDEAE; TAXONOMIC POSITION; ARTEMISIA L.; PLANTS; EVOLUTION; TURKEY	The study of genome size variation can contribute valuable information on species relationships as well as correlate to several morphological or ecological features, among others. Here we provide an extensive report on genome sizes on genus Tripleurospermum and its closely related genus Matricaria, which are two typically Mediterranean genera particularly widespread and diverse in Turkey, the origin of most of the populations here studied. We analyse and discuss genome size variation in the first relatively complete molecular phylogenetic framework of Tripleurospermum (based on ITS and ETS ribosomal DNA-rDNA-regions). We find cases of intraspecific genome size variation, which could be taxonomically significant. Genome downsizing is also detected as the typical response to polyploidisation in Tripleurospermum taxa, being most conspicuous at the tetraploid level. Several positive correlations with genome size, including those with pollen and stomatal size or cypsela length, among others, are also found. Remarkably, taxa presenting rhizomes tend to present higher genome sizes, confirming a trend to accumulate nuclear DNA in such species, which could be explained by the nutrient reserves availability in their storage organs, allowing genome expansion, or by the lower rates of sexual reproduction in rhizomatous taxa.	[Inceer, Huseyin; Hayirlioglu-Ayaz, Sema] Karadeniz Tech Univ, Fac Sci, Dept Biol, Trabzon, Turkey; [Garnatje, Teresa; Pere Pascual-Diaz, Joan; Garcia, Sonia] CSIC ICUB, IBB, Passeig Migdia S-N,Parc Montjuic, Barcelona, Catalonia, Spain; [Valles, Joan] Univ Barcelona, Fac Farm & Ciencies Alimentacio, Unitat Associada CSIC, Lab Bot UB, Barcelona, Catalonia, Spain	Karadeniz Technical University; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Botanic de Barcelona (ICUB); Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona	Garcia, S (corresponding author), CSIC ICUB, IBB, Passeig Migdia S-N,Parc Montjuic, Barcelona, Catalonia, Spain.	soniagarcia@ibb.csic.es	Garcia, Sònia/M-7460-2013; Inceer, Huseyin/AAW-3956-2020; Pascual-Díaz, Joan Pere/O-7240-2019; Hayırlıoğlu-Ayaz, Sema/AAJ-9914-2021; Garnatje, Teresa/L-3028-2014	Garcia, Sònia/0000-0002-3143-0527; Inceer, Huseyin/0000-0003-1344-8747; Pascual-Díaz, Joan Pere/0000-0002-5984-6815; Garnatje, Teresa/0000-0001-6295-6217	Direccion General de Investigacion Cientifica y Tecnica, Government of Spain [CGL2016-75694-P]; Generalitat de Catalunya, Government of Catalonia [2017SGR1116]; Scientific and Technological Research Council of Turkey (TUBITAK) [106T162]; Ramon y Cajal contract from the Government of Spain [RYC-2014-16608]; SYNTHESYS [GB-TAF1175]	Direccion General de Investigacion Cientifica y Tecnica, Government of Spain; Generalitat de Catalunya, Government of Catalonia; Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Ramon y Cajal contract from the Government of Spain; SYNTHESYS	This work was supported by the Direccion General de Investigacion Cientifica y Tecnica, Government of Spain (CGL2016-75694-P), the Generalitat de Catalunya, Government of Catalonia ("Ajuts a grups de recerca consolidats" 2017SGR1116) and the Scientific and Technological Research Council of Turkey (TUBITAK, project no. 106T162). SG benefited from a Ramon y Cajal contract from the Government of Spain (RYC-2014-16608). SYNTHESYS provided to HI the funding for the visit to the Royal Botanic Garden, Edinburgh (GB-TAF1175).	Abe T, 2008, SOIL SCI PLANT NUTR, V54, P566, DOI 10.1111/j.1747-0765.2008.00288.x; AKAIKE H, 1979, BIOMETRIKA, V66, P237, DOI 10.1093/biomet/66.2.237; Applequist WL, 2002, TAXON, V51, P757, DOI 10.2307/1555032; Ayaz FA, 2016, ROM BIOTECH LETT, V21, P11576; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; BENNETT MD, 1976, ENVIRON EXP BOT, V16, P93, DOI 10.1016/0098-8472(76)90001-0; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P109, DOI 10.1098/rspb.1972.0042; Biemont C, 2008, HEREDITY, V101, P297, DOI 10.1038/hdy.2008.80; Borchsenius F., FASTGAP 1 2; Bremer K., 1994, ASTERACEAE CLADISTIC; Bremer K., 1993, B NAT HIST MUS LOND, V23, P71; Ceccarelli M, 2011, GENOME, V54, P701, DOI [10.1139/G11-039, 10.1139/g11-039]; Certner M, 2017, ANN BOT-LONDON, V120, P303, DOI 10.1093/aob/mcx032; Ceter T, 2013, PLANT SYST EVOL, V299, P959, DOI 10.1007/s00606-013-0776-z; Colak N., 2017, INT J PHARM SCI RES, V8, P3265; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doyle J. J., 1987, PHYTOCHEM B, P11; Enayet Hossain ABM, 1975, FLORA TURKEY E AEGEA, P295; Garcia S, 2005, BIOL PLANTARUM, V49, P381, DOI 10.1007/s10535-005-0011-z; Garcia S, 2013, PLANT BIOSYST, V147, P1219, DOI 10.1080/11263504.2013.863811; Garnatje T, 2011, CYTOM PART A, V79A, P401, DOI 10.1002/cyto.a.21056; Grotkopp E, 2004, EVOLUTION, V58, P1705, DOI 10.1111/j.0014-3820.2004.tb00456.x; Guerra M, 2008, CYTOGENET GENOME RES, V120, P339, DOI 10.1159/000121083; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARLING GUNNAR, 1951, ACTA HORTI BERGIANI, V16, P73; Herben T, 2017, ANN BOT-LONDON, V120, P341, DOI 10.1093/aob/mcx009; Himmelreich S, 2008, PLANT SYST EVOL, V272, P131, DOI 10.1007/s00606-007-0634-y; Hodgson JG, 2010, ANN BOT-LONDON, V105, P573, DOI 10.1093/aob/mcq011; Inceer H, 2004, BOT J LINN SOC, V146, P427, DOI 10.1111/j.1095-8339.2004.00334.x; Inceer H., 2003, THESIS; Inceer H, 2015, PHYTOTAXA, V202, P214, DOI 10.11646/phytotaxa.202.3.5; Inceer H, 2014, ANN BOT FENN, V51, P49, DOI 10.5735/085.051.0106; Inceer H, 2012, PLANT SYST EVOL, V298, P845, DOI 10.1007/s00606-012-0596-6; Inceer H, 2011, PLANT SYST EVOL, V296, P205, DOI 10.1007/s00606-011-0487-2; Inceer H, 2011, ACTA BOT CROAT, V70, P109, DOI 10.2478/v10184-010-0005-6; Inceer H, 2010, PLANT SYST EVOL, V285, P149, DOI 10.1007/s00606-009-0266-5; Katoh K., 2017, BRIEFINGS BIOINFORMA; KAY QON, 1994, J ECOL, V82, P681, DOI 10.2307/2261275; Knight CA, 2005, ANN BOT-LONDON, V95, P177, DOI 10.1093/aob/mci011; Knight CA, 2002, ECOL LETT, V5, P66, DOI 10.1046/j.1461-0248.2002.00283.x; Knight CA, 2008, ANN BOT-LONDON, V101, P759, DOI 10.1093/aob/mcm321; Kovacik J, 2011, WATER AIR SOIL POLL, V218, P681, DOI 10.1007/s11270-010-0677-5; Kreitschitz A, 2007, FLORA, V202, P570, DOI 10.1016/j.flora.2006.12.003; Kreitschitz A, 2012, SEED SCI RES, V22, P177, DOI 10.1017/S0960258512000098; Kubesova M, 2010, PRESLIA, V82, P81; Leitch IJ, 2005, ANN BOT-LONDON, V95, P207, DOI 10.1093/aob/mci014; Leitch IJ, 2004, BIOL J LINN SOC, V82, P651, DOI 10.1111/j.1095-8312.2004.00349.x; Loureiro J, 2006, ANN BOT-LONDON, V98, P679, DOI 10.1093/aob/mcl141; LOVE A, 1967, Biologisches Zentralblatt, V86, P307; MARIE D, 1993, BIOL CELL, V78, P41, DOI 10.1016/0248-4900(93)90113-S; Markos S, 2001, SYST BOT, V26, P168; de Xaxars GM, 2016, ALPINE BOT, V126, P35, DOI 10.1007/s00035-015-0159-x; Mennan H, 2003, PAK J BOT, V35, P155; Morgan HD, 2005, ANN BOT-LONDON, V96, P1321, DOI 10.1093/aob/mci284; Morton J.K., 1993, OPERA BOT, V121, P159; Murray BG, 2005, ANN BOT-LONDON, V95, P119, DOI 10.1093/aob/mci007; NAGL W, 1974, PLANT SYST EVOL, V123, P35, DOI 10.1007/BF00983284; Oberprieler C, 2001, TAXON, V50, P745, DOI 10.2307/1223705; Oberprieler C., 2009, SYSTEMATICS EVOLUTIO, P631, DOI DOI 10.1006/MPEV.1999.0635; Oberprieler Christoph, 2007, Willdenowia, V37, P89, DOI 10.3372/wi.37.37104; Oberprieler Christoph, 2006, Willdenowia, V36, P329, DOI 10.3372/wi.36.36128; Olanj N, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0564-8; Pobedimova EG, 1995, FLORA SSSR, V26, P181; RAYBURN AL, 1990, THEOR APPL GENET, V79, P470, DOI 10.1007/BF00226155; REES H, 1967, HEREDITY, V22, P1, DOI 10.1038/hdy.1967.1; Rejmanek M., 2005, Invasive alien species: a new synthesis, P161; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Semple J. C., 2009, SYSTEMATICS EVOLUTIO, P21; Smarda P, 2010, PRESLIA, V82, P41; SOLTIS DE, 1991, AM J BOT, V78, P1091, DOI 10.2307/2444898; Sonboli A, 2012, BIOCHEM SYST ECOL, V45, P166, DOI 10.1016/j.bse.2012.06.026; Stupar RM, 2007, GENETICS, V176, P2055, DOI 10.1534/genetics.107.074286; SWIFT H, 1950, P NATL ACAD SCI USA, V36, P643, DOI 10.1073/pnas.36.11.643; Tank DC, 2015, NEW PHYTOL, V207, P454, DOI 10.1111/nph.13491; Valles J, 2013, CARYOLOGIA, V66, P221, DOI 10.1080/00087114.2013.829690; Vamosi JC, 2013, BOTANY, V91, P182, DOI 10.1139/cjb-2012-0177; Vesely P, 2013, ANN BOT-LONDON, V112, P1193, DOI 10.1093/aob/mct185; Vitales D, 2018, PHYTOTAXA, V349, P1, DOI 10.11646/phytotaxa.349.1.1; Vitales D, 2017, PLANT SYST EVOL, V303, P1115, DOI 10.1007/s00606-017-1440-9; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	80	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0203762	10.1371/journal.pone.0203762	http://dx.doi.org/10.1371/journal.pone.0203762			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300347	Green Published, Green Submitted, gold			2022-12-26	WOS:000446897200008
J	Yi, SS; Niu, JT; Wang, HL; Dong, GY; Guo, YB; Dong, H; Wang, K; Hu, GX				Yi, Shushuai; Niu, Jiangting; Wang, Hualei; Dong, Guoying; Guo, Yanbing; Dong, Hao; Wang, Kai; Hu, Guixue			Molecular characterization of feline astrovirus in domestic cats from Northeast China	PLOS ONE			English	Article							CANINE ASTROVIRUS; INFECTION; DIARRHEA; FECES; GASTROENTERITIS; ENCEPHALITIS; DIAGNOSIS; DIVERSITY; REVEALS; FLORIDA	Feline astrovirus (FeAstV) which belonged to the genus Mamastrovirus was first identified in the feces of kittens with diarrhea in the USA in 1981 by electron microscopy, and had been reported in many countries. Presently, there are no any reports of the circulation of FeAstV in mainland China. We performed this study to investigate the apparent prevalence and genetic variability of FeAstV infected in cats in mainland China for the first time. We tested fecal samples of 105 cats with diarrhea and 92 asymptomatic cats in five cities in northeast China by RT-PCR targeting RNA-dependent RNA polymerase (RdRp) gene of FeAstV, and analyzed sequences variability and phylogenetic evolution based on the complete capsid gene of FeAstV strains obtained from positive samples. The overall prevalence of FeAstV was 23.4% (46/197) of which 38 were tested in cats with diarrhea (36.2%, 38/105) and 8 were in asymptomatic cats (8.7%, 8/92). Mixed infection with other enteroviruses including feline parvovirus (FPV), feline bocavirus (FBoV) and feline kobuvirus (FeKoV) was found in 38 FeAstV-positive samples. Phylogenetic analysis based on the complete capsid gene revealed all FeAstV strains were divided into two different groups with a 0.454 +/- 0.016 of mean amino acid genetic distance between two groups, suggesting that FeAstVs should be classified into two different genotype species. This study provided the first molecular evidence that FeAstV with considerable genetic diversity was circulating in northeast China, and analyzed genetic variability and classification of FeAstVs for the first time.	[Yi, Shushuai; Niu, Jiangting; Guo, Yanbing; Wang, Kai; Hu, Guixue] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China; [Wang, Hualei] Acad Mil Med Sci, Mil Vet Res Inst, Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun, Jilin, Peoples R China; [Dong, Guoying] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing, Peoples R China; [Guo, Yanbing] Jilin Inst Anim Husb & Vet Sci, Changchun, Jilin, Peoples R China; [Dong, Hao] Jilin Agr Univ, Coll Life Sci & Technol, Changchun, Jilin, Peoples R China	Jilin Agricultural University; Beijing Normal University	Hu, GX (corresponding author), Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China.; Dong, H (corresponding author), Jilin Agr Univ, Coll Life Sci & Technol, Changchun, Jilin, Peoples R China.	13504466861@163.com; huguixue901103@163.com	Dong, Hao/G-5258-2019	Dong, Hao/0000-0001-5014-3438	National Key Research and Development Plan of China [2016YFD0501002]; National Key R&D Program of China [2017YFD0501703]	National Key Research and Development Plan of China; National Key R&D Program of China	This study was supported by the Research Project of the National Key Research and Development Plan of China [2016YFD0501002 to GH] and National Key R&D Program of China [2017YFD0501703 to KW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CF, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010015; Bass DM, 2000, J VIROL, V74, P1810, DOI 10.1128/JVI.74.4.1810-1814.2000; Blomstrom AL, 2010, J CLIN MICROBIOL, V48, P4392, DOI 10.1128/JCM.01040-10; Caddy SL, 2015, VET MICROBIOL, V177, P206, DOI 10.1016/j.vetmic.2015.03.011; Cai YH, 2016, VIROL J, V13, DOI 10.1186/s12985-015-0462-6; Cho YY, 2014, J FELINE MED SURG, V16, P679, DOI 10.1177/1098612X13511812; Cortez V, 2017, ANNU REV VIROL, V4, P327, DOI 10.1146/annurev-virology-101416-041742; Ernesto Mendez AM, 2012, ASTROVIRUS RES, P19; Geigenmuller U, 2002, J GEN VIROL, V83, P1691, DOI 10.1099/0022-1317-83-7-1691; HARBOUR DA, 1987, VET REC, V120, P555, DOI 10.1136/vr.120.23.555; HERBST W, 1989, TIJDSCHR DIERGENEESK, V114, P328; HOSHINO Y, 1981, ARCH VIROL, V70, P373, DOI 10.1007/BF01320252; Ito M, 2017, INFECT GENET EVOL, V50, P38, DOI 10.1016/j.meegid.2017.02.008; Lau SKP, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00708-13; Lawler PE, 2018, J VET DIAGN INVEST, V30, P275, DOI 10.1177/1040638717747322; MARSHALL JA, 1987, AUST VET J, V64, P100, DOI 10.1111/j.1751-0813.1987.tb09638.x; Moschidou P, 2011, J VET DIAGN INVEST, V23, P581, DOI 10.1177/1040638711404149; Naccache SN, 2015, CLIN INFECT DIS, V60, P919, DOI 10.1093/cid/ciu912; Ng TFF, 2014, VET MICROBIOL, V171, P102, DOI 10.1016/j.vetmic.2014.04.005; Sabshin SJ, 2012, JAVMA-J AM VET MED A, V241, P331, DOI 10.2460/javma.241.3.331; Sato M, 2016, J CLIN VIROL, V78, P66, DOI 10.1016/j.jcv.2016.03.010; Spinato MT, 2017, CAN VET J, V58, P607; Susana Guix AB, 2012, ASTROVIRUS RES, P97; Takano T, 2016, ARCH VIROL, V161, P2825, DOI 10.1007/s00705-016-2972-y; Takano T, 2015, ARCH VIROL, V160, P1549, DOI 10.1007/s00705-015-2405-3; Zaraket H, 2017, INFECT GENET EVOL, V53, P94, DOI 10.1016/j.meegid.2017.05.016; Zhu AL, 2011, ARCH VIROL, V156, P1671, DOI 10.1007/s00705-011-1022-z	27	21	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205441	10.1371/journal.pone.0205441	http://dx.doi.org/10.1371/journal.pone.0205441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300387	Green Published, Green Submitted, gold			2022-12-26	WOS:000446897200066
J	Callister, SJ; McCue, LA; Boaro, AA; LaMarche, B; White, RA; Brown, JM; Ahring, BK				Callister, Stephen J.; McCue, Lee Ann; Boaro, Amy A.; LaMarche, Brian; White, Richard A., III; Brown, Joseph M.; Ahring, Birgitte K.			Identification of metabolite and protein explanatory variables governing microbiome establishment and re-establishment within a cellulose-degrading anaerobic bioreactor	PLOS ONE			English	Article							MUNICIPAL SOLID-WASTE; COMMUNITY STRUCTURE; MIXING CONDITIONS; ESCHERICHIA-COLI; SEQUENCE DATA; DEGRADATION; ACETATE; ADAPTATION; PROPIONATE; PERFORMANCE	Proteins, metabolites, and 16S rRNA measurements were used to examine the community structure and functional relationships within a cellulose degrading anaerobic bioreactor. The bioreactor was seeded with bovine rumen fluid and operated with a 4 day hydraulic retention time on cellulose (avicel) as sole carbon and energy source. The reactor performance and microbial community structure was monitored during the establishment of the cellulose-degrading community. After stable operation was established in the bioreactor, the mixing intensity was increased in order to investigate the effect of a physical disruption of the microbial community structure. Finally, the original conditions were re-established to understand the stability of the microbial community after a perturbation. All factors measured were found to be inter-correlated during these three distinct phases of operation (establishment, perturbation and re-establishment). In particular, the return of community structure and function to pre-perturbed conditions suggests that propionate fermentation and acetate utilization were the explanatory factors for community establishment and re-establishment.	[Callister, Stephen J.; LaMarche, Brian; White, Richard A., III; Brown, Joseph M.] Pacific Northwest Natl Lab, Biol Sci Div, Richland, WA USA; [Callister, Stephen J.; Ahring, Birgitte K.] Washington State Univ, Dept Biol Syst Engn, Pullman, WA 99164 USA; [McCue, Lee Ann] Pacific Northwest Natl Lab, Environm Mol Sci Div, Richland, WA USA; [Boaro, Amy A.; Ahring, Birgitte K.] Washington State Univ Tri Cities, Bioprod Sci & Engn Lab, Richland, WA 99354 USA; [Ahring, Birgitte K.] Washington State Univ, Gene & Linda Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Washington State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Washington State University; Washington State University	Ahring, BK (corresponding author), Washington State Univ, Dept Biol Syst Engn, Pullman, WA 99164 USA.; Ahring, BK (corresponding author), Washington State Univ Tri Cities, Bioprod Sci & Engn Lab, Richland, WA 99354 USA.; Ahring, BK (corresponding author), Washington State Univ, Gene & Linda Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA.	bka@tricity.wsu.edu	White, Richard Allen/H-5142-2019	White III, Richard Allen/0000-0002-6292-5936	Microbial Communities Initiative (MCI); Microbiomes in Transition Initiative (MinT); Department of Energy Office of Biological and Environmental Research under the Pan-omics project; EMSL [grid.436923.9]; Office of Biological and Environmental Research	Microbial Communities Initiative (MCI); Microbiomes in Transition Initiative (MinT); Department of Energy Office of Biological and Environmental Research under the Pan-omics project(United States Department of Energy (DOE)); EMSL; Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Partial support for this research was provided by the Microbial Communities Initiative (MCI), Microbiomes in Transition Initiative (MinT), and by the Department of Energy Office of Biological and Environmental Research under the Pan-omics project. Research was performed at the Bioproducts, Sciences & Engineering Laboratory (BSEL) located on the campus of Washington State University Tri-cities, Richland, WA. And, a portion of this research was performed using EMSL (grid.436923.9), a DOE Office of Science User Facility sponsored by the Office of Biological and Environmental Research and located on the campus of Pacific Northwest National Laboratory (PNNL) in Richland, WA.	Ahn S, 2016, J BIOL CHEM, V291, P11928, DOI 10.1074/jbc.M115.708149; AHRING BK, 1995, APPL MICROBIOL BIOT, V43, P559, DOI 10.1007/BF00218466; ANGELIDAKI I, 1990, APPL MICROBIOL BIOT, V33, P469, DOI 10.1007/BF00176668; Ayala-del-Rio HL, 2004, APPL ENVIRON MICROB, V70, P4950, DOI 10.1128/AEM.70.8.4950-4960.2004; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Boaro AA, 2014, FEMS MICROBIOL ECOL, V90, P802, DOI 10.1111/1574-6941.12435; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Callister SJ, 2006, J PROTEOME RES, V5, P1940, DOI 10.1021/pr060050o; Chang D-H, 2015, GENOME ANNOUNC, V3, P1; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EPA US, 2001, 1684 EPA US; FUKUZAKI S, 1990, APPL ENVIRON MICROB, V56, P719, DOI 10.1128/AEM.56.3.719-723.1990; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; GORRIS LGM, 1989, BIOTECHNOL LETT, V11, P61, DOI 10.1007/BF01026788; Guieysse B, 2001, APPL MICROBIOL BIOT, V56, P780, DOI 10.1007/s002530100676; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HILL DT, 1989, BIOL WASTE, V28, P33, DOI 10.1016/0269-7483(89)90047-5; HILL DT, 1988, BIOL WASTE, V23, P195, DOI 10.1016/0269-7483(88)90034-1; Hoffmann RA, 2008, BIOTECHNOL BIOENG, V100, P38, DOI 10.1002/bit.21730; HOLMS WH, 1971, J GEN MICROBIOL, V65, P57, DOI 10.1099/00221287-65-1-57; Ishii S, 2005, APPL ENVIRON MICROB, V71, P7838, DOI 10.1128/AEM.71.12.7838-7845.2005; Jumas-Bilak E, 2007, INT J SYST EVOL MICR, V57, P2314, DOI 10.1099/ijs.0.64883-0; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Konwar KM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-202; Krumholz LR, 2015, APPL ENVIRON MICROB, V81, P2339, DOI 10.1128/AEM.03358-14; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Maharjan RP, 2005, RES MICROBIOL, V156, P178, DOI 10.1016/j.resmic.2004.09.004; Mao SY, 2013, ANAEROBE, V24, P12, DOI 10.1016/j.anaerobe.2013.08.003; MAWSON AJ, 1991, WATER RES, V25, P1549, DOI 10.1016/0043-1354(91)90187-U; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McMahon KD, 2001, WATER RES, V35, P1817, DOI 10.1016/S0043-1354(00)00438-3; MUCHA H, 1988, APPL MICROBIOL BIOT, V27, P581, DOI 10.1007/BF00451636; NOIKE T, 1985, BIOTECHNOL BIOENG, V27, P1482, DOI 10.1002/bit.260271013; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; PAVLOSTATHIS SG, 1991, CRIT REV ENV CONTR, V21, P411, DOI 10.1080/10643389109388424; PAVLOSTATHIS SG, 1991, WATER SCI TECHNOL, V24, P35, DOI 10.2166/wst.1991.0217; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Robidart J, 2013, ENVIRON SCI TECHNOL, V47, P4399, DOI 10.1021/es3037302; Perez JAS, 2006, CHEM ENG J, V124, P1, DOI 10.1016/j.cej.2006.07.002; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seshan H, 2014, WATER RES, V53, P282, DOI 10.1016/j.watres.2014.01.015; Shimoyama T, 2009, SCIENCE, V323, P1574, DOI 10.1126/science.1170086; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Speece RE, 2006, WATER ENVIRON RES, V78, P460, DOI 10.2175/106143006X95492; Stroot PG, 2001, WATER RES, V35, P1804, DOI 10.1016/S0043-1354(00)00439-5; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Vanwonterghem I, 2014, ISME J, V8, P2015, DOI 10.1038/ismej.2014.50; Vavilin VA, 2005, BIOTECHNOL BIOENG, V89, P113, DOI 10.1002/bit.20323; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; White RA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00045-16; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wu YW, 2016, BIOINFORMATICS, V32, P605, DOI 10.1093/bioinformatics/btv638	57	0	0	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204831	10.1371/journal.pone.0204831	http://dx.doi.org/10.1371/journal.pone.0204831			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289885	Green Submitted, Green Published, gold			2022-12-26	WOS:000446545500025
J	Ghobrial, C; Mogahed, EA; El-Karaksy, H				Ghobrial, Carolyne; Mogahed, Engy Adel; El-Karaksy, Hanaa			Routine analysis of ascitic fluid for evidence of infection in children with chronic liver disease: Is it mandatory?	PLOS ONE			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; C-REACTIVE PROTEIN; RISK-FACTORS; DIAGNOSIS; CIRRHOSIS; PROFILE	Ascitic fluid infection is a major cause of morbidity and mortality in cirrhotic patients, requiring early diagnosis and therapy. We aimed to determine predictors of ascitic fluid infection in children with chronic liver disease. The study included 45 children with chronic liver disease and ascites who underwent 66 paracentesis procedures. Full history taking and clinical examination of all patients were obtained including fever, abdominal pain and tenderness and respiratory distress. Investigations included: complete blood count, C-reactive protein, full liver function tests, ascitic fluid biochemical analysis, cell count and culture. Our results showed that patients' ages ranged between 3 months to 12 years. Prevalence of ascitic fluid infection was 33.3%. Gram-positive bacteria were identified in six cases, and Gram-negative bacteria in five. Fever and abdominal pain were significantly more associated with infected ascites (p value = 0.004, 0.006). Patients with ascitic fluid infection had statistically significant elevated absolute neutrophilic count and C-reactive protein. Logistic regression analysis showed that fever, abdominal pain, elevated absolute neutrophilic count and positive C-reactive protein are independent predictors of ascitic fluid infection. Fever, elevated absolute neutrophilic count and positive C-reactive protein raise the probability of ascitic fluid infection by 3.88, 9.15 and 4.48 times respectively. The cut-off value for C-reactive protein for ascitic fluid infection was 7.2 with sensitivity 73% and specificity of 71%. In conclusion, prevalence of ascitic fluid infection in pediatric patients with chronic liver disease and ascites was 33.3%. Fever, abdominal pain, positive C-reactive protein and elevated absolute neutrophilic count are strong predictors of ascitic fluid infection. Therefore an empirical course of first-line antibiotics should be immediately started with presence of any of these predictors after performing ascitic fluid tapping for culture and sensitivity. In absence of these infection parameters, routine ascitic fluid analysis could be spared.	[Ghobrial, Carolyne; Mogahed, Engy Adel; El-Karaksy, Hanaa] Kasr Alainy Sch Med, Pediat Dept, Pediat Hepatol Unit, Cairo, Egypt		Mogahed, EA (corresponding author), Kasr Alainy Sch Med, Pediat Dept, Pediat Hepatol Unit, Cairo, Egypt.	engy.mogahed@kasralainy.edu.eg	El-Karaksy, Hanaa/ABG-6674-2020; Mogahed, Engy/ABD-2616-2021	El-Karaksy, Hanaa/0000-0002-8479-2847; 				ANDREU M, 1993, GASTROENTEROLOGY, V104, P1133, DOI 10.1016/0016-5085(93)90284-J; Bibi S, 2015, JCPSP-J COLL PHYSICI, V25, P95, DOI 02.2015/JCPSP.9599; Bruce BR, 2008, HARRISONS PRINCIPLES, P1979; Cadranel JF, 2013, WORLD J HEPATOL, V5, P104, DOI 10.4254/wjh.v5.i3.104; Caruntu Florin Alexandru, 2006, J Gastrointestin Liver Dis, V15, P51; Chinnock B, 2008, ANN EMERG MED, V52, P268, DOI 10.1016/j.annemergmed.2008.02.016; CROSSLEY IR, 1985, GUT, V26, P325, DOI 10.1136/gut.26.4.325; Dever JB, 2015, ALIMENT PHARM THER, V41, P1116, DOI 10.1111/apt.13172; Di Giorgio A, 2017, J PEDIATR GASTR NUTR, V64, P171, DOI 10.1097/MPG.0000000000001389; El-Shabrawi MHF, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-26; Evans LT, 2003, HEPATOLOGY, V37, P897, DOI 10.1053/jhep.2003.50119; Farahmand Fatemeh, 2013, Acta Med Iran, V51, P125; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; Haghighat M, 2006, WORLD J GASTROENTERO, V12, P5890, DOI 10.3748/wjg.v12.i36.5890; HOEFS JC, 1985, DM-DIS MON, V31, P1, DOI 10.1016/0011-5029(85)90002-1; Kalvandi G, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.38973; Karnsakul W, 2017, J PEDIATR GASTR NUTR, V64, P83, DOI 10.1097/MPG.0000000000001209; Koulaouzidis A, 2008, ANN HEPATOL, V7, P255, DOI 10.1016/S1665-2681(19)31857-5; Koulaouzidis A, 2009, WORLD J GASTROENTERO, V15, P1042, DOI 10.3748/wjg.15.1042; Lata J, 2009, WORLD J GASTROENTERO, V15, P5505, DOI 10.3748/wjg.15.5505; LLOVET JM, 1993, AM J GASTROENTEROL, V88, P388; Natarajan SK, 2007, J GASTROEN HEPATOL, V22, P177, DOI 10.1111/j.1440-1746.2006.04400.x; Navasa M, 2004, LIVER INT, V24, P277, DOI 10.1111/j.1478-3231.2004.0934.x; Parsi MA, 2004, CLEV CLIN J MED, V71, P569, DOI 10.3949/ccjm.71.7.569; Paul K, 2015, J CLIN DIAGN RES, V9, pOJ1, DOI 10.7860/JCDR/2015/14326.6391; Preto-Zamperlini M, 2014, J PEDIATR GASTR NUTR, V58, P96, DOI 10.1097/MPG.0000000000000177; Rerknimitr R, 2006, WORLD J GASTROENTERO, V12, P7183, DOI 10.3748/wjg.v12.i44.7183; Rimola A, 2000, J HEPATOL, V32, P142, DOI 10.1016/S0168-8278(00)80201-9; Runyon BA, 2012, PRACTICE GUIDELINE M; Song KH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-41; Srivastava A, 2017, J PEDIATR GASTR NUTR, V64, P194, DOI 10.1097/MPG.0000000000001348; Thanopoulou Anastasia C., 2002, Eur J Intern Med, V13, P194, DOI 10.1016/S0953-6205(02)00027-4; Vieira SMG, 2005, J PEDIATR GASTR NUTR, V40, P289, DOI 10.1097/01.MPG.0000154659.54735.1D; Wiesner RH, 2001, LIVER TRANSPLANT, V7, P567, DOI 10.1053/jlts.2001.25879; Yuan LY, 2013, ANN LAB MED, V33, P449, DOI 10.3343/alm.2013.33.6.449	35	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203808	10.1371/journal.pone.0203808	http://dx.doi.org/10.1371/journal.pone.0203808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289914	Green Published, Green Submitted, gold			2022-12-26	WOS:000446545500007
J	Koshio, K; Arai, K; Waku, T; Wilson, PW; Hagiwara, Y				Koshio, Kazuya; Arai, Kazuhide; Waku, Tomonori; Wilson, Peter W.; Hagiwara, Yoshimichi			Suppression of droplets freezing on glass surfaces on which antifreeze polypeptides are adhered by a silane coupling agent	PLOS ONE			English	Article							ICE ADHESION; ANTIICING COATINGS; WINTER FLOUNDER; WATER DROPLETS; ANTI-ICE; PROTEIN; WETTABILITY; PERFORMANCE; IONS	The development of ice-phobic, glass-substrate surfaces is important for many reasons such as poor visibility through the ice-covered windshields of vehicles. The present authors have developed new glass surfaces coated with a silane coupling agent and polypeptides whose amino-acid sequence is identical to a partial sequence of winter flounder antifreeze protein. We have conducted experiments on the freezing of sessile water droplets on the glass surfaces, and measured the droplet temperature, contact angle, contact area and surface roughness. The results show that the supercooling temperature decreased noticeably in the case where a higher concentration solution of polypeptide was used for the coating. The adhesion strength of frozen droplets was lowest in the same case. In addition, we observed many nanoscale humps on the coated surface, which were formed by polypeptide aggregates in the solution. We argue that the combination of the hydrophilic humps and the hydrophobic base surfaces causes water molecules adjacent to the surfaces to have a variety of orientations in that plane, even after the ice layer started to grow. This then induces a misfit of water-molecule spacing in the ice layers and consequent formation of fragile polycrystalline structure. This explains the lower values of ice adhesion strength and supercooling enhancement in the cases of the polypeptide-coated glass plates.	[Koshio, Kazuya; Arai, Kazuhide] Kyoto Inst Technol, Grad Sch Sci & Technol, Div Mechanophys, Sakyo Ku, Kyoto, Japan; [Waku, Tomonori] Kyoto Inst Technol, Fac Mol Chem & Engn, Sakyo Ku, Kyoto, Japan; [Wilson, Peter W.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Wilson, Peter W.] Univ S Florida, Honors Coll, Tampa, FL USA; [Hagiwara, Yoshimichi] Kyoto Inst Technol, Fac Mech Engn, Sakyo Ku, Kyoto, Japan	Kyoto Institute of Technology; Kyoto Institute of Technology; University of Tasmania; State University System of Florida; University of South Florida; Kyoto Institute of Technology	Hagiwara, Y (corresponding author), Kyoto Inst Technol, Fac Mech Engn, Sakyo Ku, Kyoto, Japan.	yoshi@kit.ac.ip	Wilson, Peter/AAT-6428-2020	Wilson, Peter/0000-0002-1535-6398; Hagiwara, Yoshimichi/0000-0002-1425-2431	Japan Society for the Promotion of Science [15H02220]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	YH acknowledges the financial support of the Japan Society for the Promotion of Science through the Grant-in-Aid for Scientific Research (A) (No. 15H02220). https://www.jsps.go.jp/, https://www.jsps.go.jp/english/index.html.	Agui H, FROST FORMATIO UNPUB; Charpentier TVJ, 2013, J BIONIC ENG, V10, P139, DOI 10.1016/S1672-6529(13)60208-5; Chaudhary G, 2014, EXP THERM FLUID SCI, V57, P86, DOI 10.1016/j.expthermflusci.2014.04.007; Chen J, 2014, SMALL, V10, P4693, DOI 10.1002/smll.201401557; Chen J, 2013, ACS APPL MATER INTER, V5, P4026, DOI 10.1021/am401004t; Chernyy S, 2014, ACS APPL MATER INTER, V6, P6487, DOI 10.1021/am500046d; Eberle P, 2014, NANOSCALE, V6, P4874, DOI 10.1039/c3nr06644d; Esser-Kahn AP, 2010, J AM CHEM SOC, V132, P13264, DOI 10.1021/ja103038p; Evans RP, 2001, BBA-PROTEIN STRUCT M, V1547, P235, DOI 10.1016/S0167-4838(01)00190-X; Graeber G, 2017, P NATL ACAD SCI USA, V114, P11040, DOI 10.1073/pnas.1705952114; Gwak Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12019; Hayakari K, 2012, MOL SIMULAT, V38, P26, DOI 10.1080/08927022.2011.600759; Jung S, 2011, LANGMUIR, V27, P3059, DOI 10.1021/la104762g; Kim M., 2017, MAR DRUGS, V15; Kim P, 2012, ACS NANO, V6, P6569, DOI 10.1021/nn302310q; Kreder MJ, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2015.3; Kun H, 2007, BIOPOLYMERS, V88, P807, DOI 10.1002/bip.20844; Marshall CB, 2005, J BIOL CHEM, V280, P17920, DOI 10.1074/jbc.M500622200; Matsumoto K, 2007, INT J REFRIG, V30, P851, DOI 10.1016/j.ijrefrig.2006.11.009; Meuler AJ, 2010, ACS APPL MATER INTER, V2, P3100, DOI 10.1021/am1006035; Miyamoto T, 2018, HEAT MASS TRANSFER, V54, P2415, DOI 10.1007/s00231-018-2315-5; NAKAMURA M, 1986, NIPPON SERAM KYO GAK, V94, P1239; Nishi N., 2016, THESIS; Nishi N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154782; Oberli L, 2014, ADV COLLOID INTERFAC, V210, P47, DOI 10.1016/j.cis.2013.10.018; Pentelute BL, 2008, J AM CHEM SOC, V130, P9695, DOI 10.1021/ja8013538; Petrenko VF, 2003, CAN J PHYS, V81, P387, DOI 10.1139/P03-014; Sonnichsen FD, 1996, STRUCTURE, V4, P1325, DOI 10.1016/S0969-2126(96)00140-2; Subramanyam SB, 2013, LANGMUIR, V29, P13414, DOI 10.1021/la402456c; Wang CY, 2014, LANGMUIR, V30, P12819, DOI 10.1021/la5030444; Wang YL, 2015, SCI CHINA MATER, V58, P559, DOI 10.1007/s40843-015-0069-7; Wang YY, 2013, ACS APPL MATER INTER, V5, P3370, DOI 10.1021/am400429q; Wilson PW, 2013, PHYS CHEM CHEM PHYS, V15, P581, DOI 10.1039/c2cp43586a; Yin XY, 2015, ADV FUNCT MATER, V25, P4237, DOI 10.1002/adfm.201501101	34	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204686	10.1371/journal.pone.0204686	http://dx.doi.org/10.1371/journal.pone.0204686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289883	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000446545500022
J	Dirbaba, NB; Li, S; Wu, HJ; Yan, X; Wang, J				Dirbaba, Niguse Bekele; Li, Sen; Wu, Hongjuan; Yan, Xue; Wang, Jun			Organochlorine pesticides, polybrominated diphenyl ethers and polychlorinated biphenyls in surficial sediments of the Awash River Basin, Ethiopia	PLOS ONE			English	Article							RISK-ASSESSMENT; SURFACE SEDIMENTS; HONG-KONG; PERFLUOROALKYL SUBSTANCES; QUALITY GUIDELINES; SOUTH CHINA; EAST CHINA; BALTIC SEA; PCBS; RESIDUES	This study was initiated to document information on the levels of sediment contamination with organochlorine pesticides (OCPs), polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs). Moreover, it was intended to identify compounds which impose major ecological risks to aquatic organisms. Surficial sediments were collected from 46 locations within the streams and rivers of the Awash River Basin. In total 30 compounds were included in this study: 16 OCPs, 7 PCBs and 7 PBDEs. The total concentrations of OCPs, PCBs, and PBDEs ranged from 6.63 to 206.13 ng g(-1)-dry weight (dw), 0.85 to 26.56 ng g(-1)-dw and 3.71 to 18.95 ng g(-1)-dw respectively. Out of all the tested OCPs, heptachlor, heptachlor epoxide, p,p'-dichlorodiphenyltrichloroethane (p,p'-DDT) and 8-hexachlorocyclohexane ((3-HCH) were the most abundant in the study area. The ratio of ((3-HCH/ZHCHs) indicated that HCHs were originally from earlier usage of HCH in the area whereas the ratio of (p,p'-DDT/p,p'-DDE) showed that the majority of DDT components were recently introduced into most of the sampling locations. Even though there were relatively low concentrations of PBDEs and PCBs across the sampling sites, substantial amounts of PCBs were observed in Addis Ababa City. According to the established ecological risk indices, p,p'DDT and y-HCH are the major concerns for potential adverse ecological impacts. This study provided the first comprehensive information on organohalogenated compounds' (OCs') occurrences, spatial distributions, and ecological risks in sediments of the Awash River Basin. Thus, the report will be very useful background information for further studies on sediment contamination with OCs' in the region. It also adds important first-hand data to the field of fresh water ecology and provides useful empirical evidence for setting pollution control priorities for an ecologically important, yet largely understudied region.	[Dirbaba, Niguse Bekele; Li, Sen; Wu, Hongjuan] Huazhong Univ Sci & Technol, Sch Environm & Sci & Engn, Wuhan, Hubei, Peoples R China; [Dirbaba, Niguse Bekele; Yan, Xue; Wang, Jun] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei, Peoples R China; [Yan, Xue; Wang, Jun] Chinese Acad Sci, Sinoafrica Joint Res Ctr, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences	Wu, HJ (corresponding author), Huazhong Univ Sci & Technol, Sch Environm & Sci & Engn, Wuhan, Hubei, Peoples R China.; Yan, X; Wang, J (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei, Peoples R China.; Yan, X; Wang, J (corresponding author), Chinese Acad Sci, Sinoafrica Joint Res Ctr, Wuhan, Hubei, Peoples R China.	hongjuanwu@mail.hust.edu.cn; yanx@wbgcas.cn; wangjun@wbgcas.cn	Wang, Jun/AAN-4446-2021	Wang, Jun/0000-0002-7574-9468; Li, Sen/0000-0002-1177-7339; Yan, Xue/0000-0003-4460-8117	Sino-Africa Joint Research Center; Chinese Academy of Sciences [Y623321K01]; Hundred Talents Program of the Chinese Academy of Sciences [Y329671K01]; Natural Science Key Foundation of Hubei Province of China; Sino-Africa Joint Research Center, Chinese Academy of Sciences [Y623321K01]	Sino-Africa Joint Research Center; Chinese Academy of Sciences(Chinese Academy of Sciences); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Key Foundation of Hubei Province of China; Sino-Africa Joint Research Center, Chinese Academy of Sciences	This work was supported by Funding Project of Sino-Africa Joint Research Center (JW), Chinese Academy of Sciences (Y623321K01); the Hundred Talents Program of the Chinese Academy of Sciences (Y329671K01) (JW).; The authors are grateful to Natural Science Key Foundation of Hubei Province of China, Funding Project of Sino-Africa Joint Research Center, Chinese Academy of Sciences (Y623321K01), and the Hundred Talents Program of the Chinese Academy of Sciences (Y329671K01).	Aamir M, 2016, ECOTOX ENVIRON SAFE, V125, P128, DOI 10.1016/j.ecoenv.2015.12.005; Ali U, 2015, CHEMOSPHERE, V134, P172, DOI 10.1016/j.chemosphere.2015.03.020; Asante KA, 2011, ENVIRON INT, V37, P921, DOI 10.1016/j.envint.2011.03.011; Bai JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17624; Barakat AO, 2002, MAR POLLUT BULL, V44, P1426, DOI 10.1016/S0025-326X(02)00313-2; Bian CW, 2010, CONT SHELF RES, V30, P1189, DOI 10.1016/j.csr.2010.03.008; Binelli A, 2008, CHEMOSPHERE, V73, P1129, DOI 10.1016/j.chemosphere.2008.07.019; Binelli A, 2007, MAR POLLUT BULL, V54, P1220, DOI 10.1016/j.marpolbul.2007.03.021; Breivik K, 2002, SCI TOTAL ENVIRON, V290, P181, DOI 10.1016/S0048-9697(01)01075-0; Carriger JF, 2011, ARCH ENVIRON CON TOX, V60, P281, DOI 10.1007/s00244-010-9623-1; Chen LG, 2009, CHEMOSPHERE, V76, P226, DOI 10.1016/j.chemosphere.2009.03.033; De Roma A, 2017, J VET DIAGN INVEST, V29, P122, DOI 10.1177/1040638716681389; Deribe E, 2011, SCI TOTAL ENVIRON, V410, P136, DOI 10.1016/j.scitotenv.2011.09.008; Doong RA, 2002, MAR POLLUT BULL, V45, P246, DOI 10.1016/S0025-326X(02)00102-9; Eljarrat E, 2004, ENVIRON SCI TECHNOL, V38, P2603, DOI 10.1021/es0301424; Environmental Protection Authority (EPA), 2004, DRAFT ENV IMP ASS GU; FAO, 2013, AWASH RIV BAS WAT AU; Forstner U., 1989, CONTAMINATED SEDIMEN; Gakuba E, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4790-1; Gao J, 2013, SCI TOTAL ENVIRON, V443, P7, DOI 10.1016/j.scitotenv.2012.10.086; Hallare AV, 2005, SCI TOTAL ENVIRON, V347, P254, DOI 10.1016/j.scitotenv.2004.12.002; Haylamicheal ID, 2009, ENVIRON INT, V35, P667, DOI 10.1016/j.envint.2008.11.004; HITCH RK, 1992, B ENVIRON CONTAM TOX, V48, P259, DOI 10.1007/BF00194381; Hong HS, 1999, MAR POLLUT BULL, V39, P376, DOI 10.1016/S0025-326X(99)00081-8; Hong SH, 2003, MAR POLLUT BULL, V46, P244, DOI 10.1016/S0025-326X(02)00399-5; Iwata H., 1995, ENVIRON SCI TECHNOL, V29, P272, DOI DOI 10.1021/ES00001A036; Kanzari F, 2014, SCI TOTAL ENVIRON, V478, P141, DOI 10.1016/j.scitotenv.2014.01.065; KOOPMANESSEBOOM C, 1994, PEDIATR RES, V36, P468, DOI 10.1203/00006450-199410000-00009; Lammel G, 2011, J ENVIRON MONITOR, V13, P3358, DOI 10.1039/c1em10479a; Li JP, 2016, APPL MATER TODAY, V3, P63, DOI 10.1016/j.apmt.2016.03.003; Li QZ, 2011, B ENVIRON CONTAM TOX, V87, P372, DOI 10.1007/s00128-011-0385-x; Liu RX, 2015, ENVIRON EARTH SCI, V73, P5007, DOI 10.1007/s12665-015-4317-7; Liu Y, 2005, MAR POLLUT BULL, V50, P1173, DOI 10.1016/j.marpolbul.2005.04.025; Long E.R., 1991, 52 NOAA NOS OMA; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Long ER, 2000, ECOL APPL, V10, P338, DOI 10.1890/1051-0761(2000)010[0338:DSQIUS]2.0.CO;2; MacDonald DD, 1996, ECOTOXICOLOGY, V5, P253, DOI 10.1007/BF00118995; MacDonald DD, 1994, DEV EVALUATION APPRO, V3; Mai BX, 2005, ENVIRON SCI TECHNOL, V39, P3521; Malik RN, 2014, SCI TOTAL ENVIRON, V481, P343, DOI 10.1016/j.scitotenv.2014.02.042; Manirakiza P, 2003, ARCH ENVIRON CON TOX, V44, P171, DOI 10.1007/s00244-002-2006-5; Mansour SA, 2009, HUM EXP TOXICOL, V28, P531, DOI 10.1177/0960327109347048; Meng J, 2014, J ENVIRON SCI-CHINA, V26, P2198, DOI 10.1016/j.jes.2014.09.002; Miglioranza KSB, 1999, ENVIRON POLLUT, V105, P91, DOI 10.1016/S0269-7491(98)00200-0; Ministry of Agriculture (MoA), 2007, REP 12 YEARS PEST IM; Newman MC, 2010, FUNDAMENTALS ECOTOXI, P5; Niu LL, 2013, ENVIRON SCI TECHNOL, V47, P12140, DOI 10.1021/es401630w; Omar WA, 2017, ENVIRON GEOCHEM HLTH, V39, P125, DOI 10.1007/s10653-016-9814-4; Parker H., 2016, THIRSTY FUTURE WATER; Perez F, 2014, ENVIRON RES, V135, P181, DOI 10.1016/j.envres.2014.08.004; Rajendran RB, 2005, ENVIRON INT, V31, P503, DOI 10.1016/j.envint.2004.10.009; Salo S, 2008, CHEMOSPHERE, V73, P1675, DOI 10.1016/j.chemosphere.2008.07.085; Samara F, 2006, ENVIRON POLLUT, V139, P489, DOI 10.1016/j.envpol.2005.06.001; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Sikrbic BD, 2017, ENVIRON SCI POLLUT R, V25, P260; Song WL, 2004, ENVIRON SCI TECHNOL, V38, P3286, DOI 10.1021/es035297q; Strandberg B, 1998, ENVIRON SCI TECHNOL, V32, P1754, DOI 10.1021/es970789m; Sun HW, 2016, ENVIRON POLLUT, V209, P177, DOI 10.1016/j.envpol.2015.11.040; [孙剑辉 SUN Jianhui], 2008, [环境科学学报, Acta Scientiae Circumstantiae], V28, P342; Taddese G, 2004, WATER AWASH RIVER BA; Tan L, 2009, ESTUAR COAST SHELF S, V84, P119, DOI 10.1016/j.ecss.2009.06.013; Teklu BM, 2016, CHEMOSPHERE, V161, P280, DOI 10.1016/j.chemosphere.2016.07.031; Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236; UN University/ StEP Initiative, 2013, SOLV E WAST PROBL ST; Wang W, 2017, ENVIRON POLLUT, V230, P1062, DOI 10.1016/j.envpol.2017.06.068; Westbom R, 2008, CHEMOSPHERE, V72, P1181, DOI 10.1016/j.chemosphere.2008.03.041; Willett KL, 1998, ENVIRON SCI TECHNOL, V32, P2197, DOI 10.1021/es9708530; Wu CW, 2013, CHEMOSPHERE, V90, P2341, DOI 10.1016/j.chemosphere.2012.10.023; Wu YL, 2016, ENVIRON POLLUT, V219, P519, DOI 10.1016/j.envpol.2016.05.081; Yang RQ, 2005, CHEMOSPHERE, V61, P347, DOI 10.1016/j.chemosphere.2005.02.091; Yun XY, 2015, ECOTOXICOLOGY, V24, P172, DOI 10.1007/s10646-014-1370-z; Zacharewski T, 1998, ENVIRON HEALTH PERSP, V106, P577, DOI 10.2307/3433808; Zhang G, 2002, ENVIRON SCI TECHNOL, V36, P3671, DOI 10.1021/es0102888; Zhang HB, 2006, CHEMOSPHERE, V63, P633, DOI 10.1016/j.chemosphere.2005.08.006; Zhang ZL, 2004, ENVIRON POLLUT, V130, P249, DOI 10.1016/j.envpol.2003.12.002; Zhou HY, 1999, ARCH ENVIRON CON TOX, V36, P424, DOI 10.1007/PL00006615; Zhou RB, 2006, J HAZARD MATER, V137, P68, DOI 10.1016/j.jhazmat.2006.02.005; Zhou SS, 2014, CHEMOSPHERE, V114, P26, DOI 10.1016/j.chemosphere.2014.03.100	78	21	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205026	10.1371/journal.pone.0205026	http://dx.doi.org/10.1371/journal.pone.0205026			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286178	Green Submitted, gold, Green Published			2022-12-26	WOS:000446383500078
J	Shim, JS; Park, DS; Baek, DH; Jha, N; Park, SI; Yun, HJ; Kim, WJ; Ryu, JJ				Shim, Ji Suk; Park, Dong-sik; Baek, Dong-Heon; Jha, Nayansi; Park, Serk In; Yun, Hyoung Jin; Kim, Won Jong; Ryu, Jae Jun			Antimicrobial activity of NO-releasing compounds against periodontal pathogens	PLOS ONE			English	Article							NITRIC-OXIDE; POTENTIAL APPLICATION; ANTIBACTERIAL AGENTS; DELIVERY; DISEASES; NANOPARTICLES; TETRACYCLINE; DENDRIMERS; EFFICACY	This study describes the successful synthesis of nitric oxide (NO)-releasing compounds with biodegradable and injectable properties and demonstrates that the kinetics of NO release vary according to the type of NO donor. The antimicrobial activity of NO-releasing compounds against three common periodontal pathogens, i.e., Aggregatibacter actinomy-cetemcomitans, Porphyromonas gingivalis, and Actinomyces israelii, was investigated using a susceptibility assay. Human gingival fibroblasts were treated with NO-releasing compounds at the minimum concentrations required for bacterial growth and cytotoxicity was evaluated using the MTT cell proliferation assay. Our results suggest that NO-releasing compounds can be used topically to treat both gram-negative and gram-positive periodontal pathogens. Comparison of the antimicrobial activity and cytotoxicity assay results between the NO-releasing compounds revealed that an NO donor comprising a macromolecule without surface charge, a lower instantaneous NO concentration, and an adequate supply of NO were associated with a strong bactericidal effect and low cytotoxicity. NO-releasing compounds with these properties may be suitable for treatment of periodontitis.	[Shim, Ji Suk] Korea Univ, Dept Dent, Ansan Hosp, Ansan, South Korea; [Park, Dong-sik; Kim, Won Jong] Pohang Univ Sci & Technol POSTECH, Dept Chem, Pohang, South Korea; [Baek, Dong-Heon; Yun, Hyoung Jin] Dankook Univ, Dept Oral Microbiol & Immunol, Coll Dent, Cheonan, South Korea; [Jha, Nayansi] Korea Univ, Grad Sch, Seoul, South Korea; [Park, Serk In] Korea Univ, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea; [Ryu, Jae Jun] Korea Univ, Dept Dent, Anam Hosp, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Pohang University of Science & Technology (POSTECH); Dankook University; Korea University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, WJ (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Chem, Pohang, South Korea.; Ryu, JJ (corresponding author), Korea Univ, Dept Dent, Anam Hosp, Seoul, South Korea.	wkim@postech.ac.kr; koprosth@unitel.co.kr	Park, Serk In/D-2840-2011; Ryu, Jae-Jun/AAL-6362-2020	Park, Serk In/0000-0001-8643-5096; Ryu, Jae-Jun/0000-0001-6903-5955; Shim, Ji Suk/0000-0002-4112-6051	National Research Foundation of Korea(NRF) grant - Korea government(MSIP; Ministry of Science, ICT & Future Planning) [2017R1D1A1B03036033]	National Research Foundation of Korea(NRF) grant - Korea government(MSIP; Ministry of Science, ICT & Future Planning)	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIP; Ministry of Science, ICT & Future Planning) (No. 2017R1D1A1B03036033).	Al-Ani B, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000025; Azevedo MM, 2014, J MED MICROBIOL, V63, P1167, DOI 10.1099/jmm.0.069609-0; Backlund CJ, 2015, J DENT RES, V94, P1092, DOI 10.1177/0022034515589314; Backlund CJ, 2014, J DENT RES, V93, P1089, DOI 10.1177/0022034514529974; Backlund CJ, 2016, ACTA BIOMATER, V29, P198, DOI 10.1016/j.actbio.2015.10.021; Cha MH, 2011, J COLLOID INTERF SCI, V360, P78, DOI 10.1016/j.jcis.2011.04.041; Da Rocha Huberth Alexandre Junior, 2015, J Int Acad Periodontol, V17, P82; De Ceulaer J, 2014, EUR J CLIN MICROBIOL, V33, P1873, DOI 10.1007/s10096-014-2160-5; De Colli M, 2015, CLIN ORAL INVEST, V19, P1269, DOI 10.1007/s00784-014-1344-9; Emtiazi Giti, 1994, Biodegradation, V5, P83, DOI 10.1007/BF00700633; Esposito E, 1997, J MICROENCAPSUL, V14, P175, DOI 10.3109/02652049709015331; Fukada SY, 2008, J DENT RES, V87, P1155, DOI 10.1177/154405910808701207; GENCO RJ, 1981, J PERIODONTOL, V52, P545, DOI 10.1902/jop.1981.52.9.545; Ghaffari A, 2006, NITRIC OXIDE-BIOL CH, V14, P21, DOI 10.1016/j.niox.2005.08.003; GOODSON JM, 1983, J PERIODONTOL, V54, P575, DOI 10.1902/jop.1983.54.10.575; Hecht DW, 2007, METHODS ANTIMICROBIA; Hetrick EM, 2008, ACS NANO, V2, P235, DOI 10.1021/nn700191f; HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030; Jain N, 2008, DRUG DISCOV TODAY, V13, P932, DOI 10.1016/j.drudis.2008.07.010; Jones ML, 2010, APPL MICROBIOL BIOT, V88, P401, DOI 10.1007/s00253-010-2733-x; Kang Y, 2015, J CONTROL RELEASE, V220, P624, DOI 10.1016/j.jconrel.2015.08.057; Kaplish V, 2013, PHARMACOPHORE, V4, P39; Katsarelis H, 2015, J DENT RES, V94, P534, DOI 10.1177/0022034515572021; Kim J, 2014, J MATER CHEM B, V2, P341, DOI 10.1039/c3tb21259a; Lu Y, 2015, ACTA BIOMATER, V12, P62, DOI 10.1016/j.actbio.2014.10.028; MARLETTA M A, 1990, Biofactors, V2, P219; Mastiholimath V. S., 2006, Indian Journal of Pharmaceutical Sciences, V68, P68; Morbidelli L, 1996, AM J PHYSIOL-HEART C, V270, pH411, DOI 10.1152/ajpheart.1996.270.1.H411; NI PH, 1995, J MEMBRANE SCI, V103, P51; Park JS, 2013, SUPERLATTICE MICROST, V64, P7, DOI 10.1016/j.spmi.2013.09.019; Rams TE, 2014, J PERIODONTOL, V85, P160, DOI 10.1902/jop.2013.130142; Soskolne WA, 1997, CRIT REV ORAL BIOL M, V8, P164, DOI 10.1177/10454411970080020501; Sun B, 2012, BIOMACROMOLECULES, V13, P3343, DOI 10.1021/bm301109c; Tomasi C, 2004, J CLIN PERIODONTOL, V31, P589, DOI 10.1111/j.1600-051X.2004.00524.x; Vyas SP, 2000, J CLIN PHARM THER, V25, P21, DOI 10.1046/j.1365-2710.2000.00261.x; Yang L, 2018, BIOCONJUGATE CHEM, V29, P35, DOI 10.1021/acs.bioconjchem.7b00537; Zhou ZR, 2006, BIOMACROMOLECULES, V7, P2565, DOI 10.1021/bm060361s	37	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0199998	10.1371/journal.pone.0199998	http://dx.doi.org/10.1371/journal.pone.0199998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286117	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500002
J	Dancak, M; Hrones, M; Sochor, M; Sochorova, Z				Dancak, Martin; Hrones, Michal; Sochor, Michal; Sochorova, Zuzana			Thismia kelabitiana (Thismiaceae), a new unique Fairy Lantern from Borneo potentially threatened by commercial logging	PLOS ONE			English	Article							TRIURIDACEAE; KALIMANTAN	Thismia kelabitiana, a new unique species from the Sarawak state of Malaysia in the island of Borneo is described and illustrated. This new species is not similar to any species of Thismia described so far especially by having a unique form of mitre and outer perianth lobes deeply divided into 8-10 acute lobes and forming striking fringe around perianth tube opening. The species appears to be critically endangered due to ongoing logging activities in the region. It may potentially become a surrogate species for lower montane forests of the region and thus help protect them against further destruction.	[Dancak, Martin] PalackY Univ, Dept Ecol & Environm Sci, Olomouc, Czech Republic; [Hrones, Michal; Sochorova, Zuzana] Palacky Univ, Dept Bot, Olomouc, Czech Republic; [Sochor, Michal] Crop Res Inst, Dept Genet Resources Vegetables Med & Special Pla, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Czech Crop Research Institute (CRI)	Dancak, M (corresponding author), PalackY Univ, Dept Ecol & Environm Sci, Olomouc, Czech Republic.	martin.dancak@upol.cz	Sochor, Michal/AAF-7666-2020; Sochor, Michal/G-7270-2016; Dančák, Martin/AAB-9537-2019; Sochor, Michal/AAE-2042-2022; Sochorová, Zuzana/ABG-7697-2020	Dančák, Martin/0000-0002-3851-4969; Sochor, Michal/0000-0002-6525-1295; Sochorová, Zuzana/0000-0003-0022-9780; Hrones, Michal/0000-0002-0380-929X	Internal Grant Agency of the Palacky University [IGA PrF-2018-001]; (Sustainable development of research in the Centre of the Region Hana) from the National Program of Sustainability I, MEYS [LO1204]; Ministry of Education, Youth and Sports of the Czech Republic [INTER-TRANSFER LTT17017]	Internal Grant Agency of the Palacky University; (Sustainable development of research in the Centre of the Region Hana) from the National Program of Sustainability I, MEYS; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Michal Hrones was supported by the project no. IGA PrF-2018-001 from the Internal Grant Agency of the Palacky University. Michal Sochor was supported by grant No. LO1204 (Sustainable development of research in the Centre of the Region Hana) from the National Program of Sustainability I, MEYS. Martin Dancak was supported by a grant from the Ministry of Education, Youth and Sports of the Czech Republic (grant number: INTER-TRANSFER LTT17017). Zuzana Sochorova was supported by the project no. IGA PrF-2018-001 from the Internal Grant Agency of the Palacky University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Berger J, 1997, CONSERV BIOL, V11, P69, DOI 10.1046/j.1523-1739.1997.95481.x; Budiharta S, 2011, ORYX, V45, P172, DOI 10.1017/S0030605310001092; Caro T. M, 2010, CONSERVATION PROXY I; Fleishman E, 2000, ECOL APPL, V10, P569, DOI 10.1890/1051-0761(2000)010[0569:ANMFSO]2.0.CO;2; Gaveau DLA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32017; Global Forest Watch, 2010, SAR LOGG CONC 2010 2; Hrones M, 2018, PLANT ECOL EVOL, V151, P110, DOI 10.5091/plecevo.2018.1387; Hrones M, 2015, PHYTOTAXA, V234, P172; Jonker F. P., 1948, FLORA MALESIANA 1, P13; Jonker FP., 1938, MEDEDEELINGEN BOT MU, V51, P1; Kiew Ruth, 1999, Gardens' Bulletin (Singapore), V51, P179; Kumar P, 2017, PHYTOTAXA, V319, P225, DOI 10.11646/phytotaxa.319.3.2; Lhota S, 2012, AM J PRIMATOL, V74, P193, DOI 10.1002/ajp.21983; Luu HT, 2014, PHYTOTAXA, V164, P190; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Smets EF, 2013, MYCOHETEROTROPHY BIO, P103, DOI DOI 10.1007/978-1-4614-5209-63; Sochor M, 2018, PLANT SYST EVOL, V304, P699, DOI 10.1007/s00606-018-1504-5; Sochor M, 2017, PHYTOTAXA, V295, P263, DOI 10.11646/phytotaxa.295.3.7; Thiele K, 2012, TELOPEA, V9, P765; Tsukaya H, 2016, PHYTOTAXA, V266, P146, DOI 10.11646/phytotaxa.266.2.9; Tsukaya H, 2014, PHYTOTAXA, V170, P283, DOI 10.11646/phytotaxa.170.4.6; Tsukaya H, 2013, SYST BOT, V38, P600, DOI 10.1600/036364413X670476; Tsukaya H, 2012, SYST BOT, V37, P53, DOI 10.1600/036364412X616639	25	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203443	10.1371/journal.pone.0203443	http://dx.doi.org/10.1371/journal.pone.0203443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281609	Green Submitted, Green Published, gold			2022-12-26	WOS:000446342400021
J	Gibbs, A; Jewkes, R; Willan, S; Washington, L				Gibbs, Andrew; Jewkes, Rachel; Willan, Samantha; Washington, Laura			Associations between poverty, mental health and substance use, gender power, and intimate partner violence amongst young (18-30) women and men in urban informal settlements in South Africa: A cross-sectional study and structural equation model	PLOS ONE			English	Article							PREVALENCE; MULTICOUNTRY; PERPETRATION; INCOME; RISK; ASIA	Research suggests that poverty is a key driver of intimate partner violence (IPV), however detailed analysis suggests that this relationship is not clear, either for women's experience or men's perpetration of IPV. We explored associations between poverty and IPV using cross-sectional data from the Stepping Stones and Creating Futures cluster randomized control trial, in urban informal settlements in Durban, South Africa, with young (18-30) people. Using logistic regression and structural equation modelling we assess associations between poverty and women's experience and men's perpetration of physical and/or sexual IPV in the past 12 months. 680 women and 677 men were recruited into the study between September 2015 and September 2016. The analyses highlight how specific forms or measures of poverty intersecting with gender identities shape IPV. For men we found indicators of economic provision were associated with IPV perpetration, while for women food-insecurity was key to IPV experience. We also found similarities between women and men. First, food-insecurity and childhood traumas shaped pathways to substance misuse and poor mental health that increased IPV. Second, there was a resilience pathway in both models, whereby those with more education had increased gender equitable attitudes and fewer controlling behaviours, which reduced IPV. Interventions to reduce IPV need to work to reduce household food insecurity, but these need to be combined with gender transformative interventions. Interventions should also focus on reducing the impact of mental health and substance misuse. Finally, working to increase educational attainment is a long-term critical intervention to reduce IPV.	[Gibbs, Andrew] Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa; [Gibbs, Andrew; Jewkes, Rachel; Willan, Samantha] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Washington, Laura] Project Empower, Durban, South Africa	University of Kwazulu Natal; South African Medical Research Council	Gibbs, A (corresponding author), Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa.; Gibbs, A (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa.	andrew.gibbs@mrc.ac.za		Jewkes, Rachel/0000-0002-4330-6267; Gibbs, Andrew/0000-0003-2812-5377	What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) - UK Government's Department for International Development (DFID); South African Medical Research Council	What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) - UK Government's Department for International Development (DFID); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research is funded through the What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) funded by the UK Government's Department for International Development (DFID). However, the views expressed do not necessarily reflect the department's official policies and the funders had no role in study design; collection, management, analysis, and interpretation of data; writing of the report; and the decision to submit the paper for publication. Funding was managed by the South African Medical Research Council.	Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; [Anonymous], 2011, WORKING PAPER; [Anonymous], 2015, 22 UN HAB; Bhatla N, 2010, SOCIAL PROTECTION AS DEVELOPMENT POLICY: ASIAN PERSPECTIVES, P219; Bingham N.H., 2010, REGRESSION LINEAR MO; Buller AM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3129-3; Decker MR, 2014, J ADOLESCENT HEALTH, V55, pS58, DOI 10.1016/j.jadohealth.2014.08.022; Deitchler M., 2010, VALIDATION MEASURE H; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Fleming PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118639; Fong S, 2016, INT J GYNECOLOGY OBS; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gibbs A, 2017, GLOB HLTH ACTION, P1; Gibbs A, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23676; Gibbs A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4223-x; Gibbs A, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17362; Groes-Green C., 2009, NORDIC J AFRICAN STU, V18, P286; HDA, 2012, KWAZULU NAT INF SETT; Heise LL, 2015, LANCET GLOB HEALTH, V3, pE332, DOI 10.1016/S2214-109X(15)00013-3; Hidrobo M, 2013, EFFECT CASH VOUCHERS; Huchzermeyer M, 2006, INFORMAL SETTLEMENTS; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; Jewkes R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002381; Jewkes R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1325; Jewkes R, 2013, LANCET GLOB HEALTH, V1, pE208, DOI 10.1016/S2214-109X(13)70069-X; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029590; Johnson M.P., 2010, TYPOLOGY DOMESTIC VI; Krishnan S, 2008, ANN NY ACAD SCI, V1136, P101, DOI 10.1196/annals.1425.013; Lagdon S, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.24794; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; Machisa MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175240; Machisa MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150986; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Patel V, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002257; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peterman A, 2017, AM J PUBLIC HEALTH, V107, P747, DOI 10.2105/AJPH.2017.303694; Pulerwitz J, 2008, MEN MASC, V10, P322, DOI 10.1177/1097184X06298778; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ricks JL, 2016, PUBLIC HEALTH NUTR, V19, P914, DOI 10.1017/S1368980015001986; Tsai AC, 2012, SOCIAL SCI MED, V74; Vyas S, 2009, J INT DEV, V21, P577, DOI 10.1002/jid.1500; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	46	72	72	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204956	10.1371/journal.pone.0204956	http://dx.doi.org/10.1371/journal.pone.0204956			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281677	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400071
J	Rock, CG; Wurdeman, SR; Stergiou, N; Takahashi, KZ				Rock, Chase G.; Wurdeman, Shane R.; Stergiou, Nicholas; Takahashi, Kota Z.			Stride-to-stride fluctuations in transtibial amputees are not affected by changes in push-off mechanics from using different prostheses	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; NONLINEAR DYNAMICS; ENERGY PROFILES; HUMAN GAIT; WALKING; VARIABILITY; FOOT; STABILITY; INTERVAL; SYSTEM	Stride-to-stride fluctuations of joint kinematics during walking reflect a highly structured organization that is characteristic of healthy gait. The organization of stride-to-stride fluctuations is disturbed in lower-limb prosthesis users, yet the factors contributing to this difference are unclear. One potential contributor to the changes in stride-to-stride fluctuations is the altered push-off mechanics experienced by passive prosthesis users. The purpose of our study was to determine if changes in push-off mechanics affect stride-to-stride fluctuations in transtibial amputees. Twenty-two unilateral transtibial amputees were enrolled in the 6-week cross-over study, where High and Low Activity (based on the Medicare Functional Classification System) prostheses were worn for three weeks each. Data collection took place at the end of the third week. Participants walked on a treadmill in a motion capture laboratory to quantify stride-to-stride fluctuations of the lower extremity joint angle trajectories using the largest Lyapunov Exponent, and over floor-embedded force platforms to enable calculating push-off work from the prosthesis and the sound limb. Push-off work was 140% greater in the High Activity prosthesis compared to the Low Activity prosthesis (p < 0.001), however no significant change was observed in stride-to-stride fluctuations of the ankle between the two prosthesis types (p = 0.576). There was no significant correlation between changes in prosthesis push-off work and the largest Lyapunov exponent. Though differences in push-off work were observed between the two prosthesis types, stride-to-stride fluctuations remained similar, indicating that prosthesis propulsion mechanics may not be a strong determinant of stride-to-stride fluctuations in unpowered transtibial prosthesis users.	[Rock, Chase G.; Stergiou, Nicholas; Takahashi, Kota Z.] Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA; [Wurdeman, Shane R.] Hanger Clin, Dept Clin & Sci Affairs, Houston, TX USA; [Stergiou, Nicholas] Univ Nebraska Med Ctr, Dept Environm Agr & Occupat Hlth, Omaha, NE USA	University of Nebraska System; University of Nebraska System; University of Nebraska Medical Center	Takahashi, KZ (corresponding author), Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA.	ktakahashi@unomaha.edu	Rock, Chase G/AAG-9072-2019	Rock, Chase/0000-0001-7598-759X	Center for Research in Human Movement Variability; National Institute of Health [P20GM109090, R15HD086828]; Office of Research and Creative Activity at the University of Nebraska at Omaha; NASA Nebraska Space Grant Fellowship; NIH [P20GM109090, R15HD086828]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109090] Funding Source: NIH RePORTER	Center for Research in Human Movement Variability; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Creative Activity at the University of Nebraska at Omaha; NASA Nebraska Space Grant Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by the Center for Research in Human Movement Variability and the National Institute of Health (P20GM109090 and R15HD086828), the Office of Research and Creative Activity at the University of Nebraska at Omaha, and the NASA Nebraska Space Grant Fellowship.; This work has been supported by the Center for Research in Human Movement Variability and the NIH (P20GM109090 and R15HD086828), the Office of Research and Creative Activity at the University of Nebraska at Omaha, and the NASA Nebraska Space Grant Fellowship.	Adamczyk PG, 2015, IEEE T NEUR SYS REH, V23, P776, DOI 10.1109/TNSRE.2014.2356722; BARR AE, 1992, PHYS THER, V72, P344, DOI 10.1093/ptj/72.5.344; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Cignetti F, 2012, ANN BIOMED ENG, V40, P1122, DOI 10.1007/s10439-011-0474-3; D'Alonzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050756; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; Franz JR, 2016, EXERC SPORT SCI REV, V44, P129, DOI 10.1249/JES.0000000000000086; Franz JR, 2013, J BIOMECH, V46, P535, DOI 10.1016/j.jbiomech.2012.09.032; Goldberg EJ, 2008, J BIOMECH, V41, P1805, DOI 10.1016/j.jbiomech.2008.03.009; Hafner BJ, 2002, J REHABIL RES DEV, V39, P1; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Herr HM, 2012, P ROY SOC B-BIOL SCI, V279, P457, DOI 10.1098/rspb.2011.1194; Kararizou E, 2006, INT J NEUROSCI, V116, P629, DOI 10.1080/00207450600592180; Kurz MJ, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-30; Lee MY, 2007, IEEE SYS MAN CYBERN, P2909; LEHMANN JF, 1993, ARCH PHYS MED REHAB, V74, P853, DOI 10.1016/0003-9993(93)90013-Z; Look N, 2013, CHAOS, V23, DOI 10.1063/1.4837095; Malcolm P, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0014-8; Myers SA, 2009, J VASC SURG, V49, P924, DOI 10.1016/j.jvs.2008.11.020; Nishikawa K, 2007, INTEGR COMP BIOL, V47, P16, DOI 10.1093/icb/icm024; Plauche A, 2016, IEEE T HAPTICS, V9, P421, DOI 10.1109/TOH.2016.2580507; Prince F, 1997, GAIT POSTURE, V5, P128, DOI 10.1016/S0966-6362(97)01118-1; Quesada RE, 2016, J BIOMECH, V49, P3452, DOI 10.1016/j.jbiomech.2016.09.015; Scott-Okafor HR, 2001, ANGIOLOGY, V52, P7, DOI 10.1177/000331970105200102; Shull PB, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0055-z; Silverman AK, 2012, J BIOMECH, V45, P2271, DOI 10.1016/j.jbiomech.2012.06.008; Stergiou N., 2016, NONLINEAR ANAL HUMAN; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Stergiou UH, 2004, INNOVATIVE ANAL HUMA, P63; Takahashi KZ, 2015, PROSTHET ORTHOT INT, V39, P150, DOI 10.1177/0309364613513298; Takahashi KZ, 2013, GAIT POSTURE, V38, P818, DOI 10.1016/j.gaitpost.2013.04.002; Takahashi KZ, 2012, J BIOMECH, V45, P2662, DOI 10.1016/j.jbiomech.2012.08.017; WINTER DA, 1988, J BIOMECH, V21, P361, DOI 10.1016/0021-9290(88)90142-X; WINTER DA, 1984, HUM MOVEMENT SCI, V3, P51, DOI 10.1016/0167-9457(84)90005-8; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Wurdeman SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100125; Wurdeman SR, 2013, J REHABIL RES DEV, V50, P671, DOI 10.1682/JRRD.2012.06.0104; Wurdeman SR, 2013, ANN BIOMED ENG, V41, P806, DOI 10.1007/s10439-012-0705-2; Wurdeman SR, 2012, MED ENG PHYS, V34, P1421, DOI 10.1016/j.medengphy.2012.01.004; Zelik KE, 2016, J EXP BIOL, V219, P3676, DOI 10.1242/jeb.140376	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205098	10.1371/journal.pone.0205098	http://dx.doi.org/10.1371/journal.pone.0205098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281652	gold, Green Published, Green Submitted			2022-12-26	WOS:000446342400082
J	Yonesaka, K; Takegawa, N; Watanabe, S; Haratani, K; Kawakami, H; Sakai, K; Chiba, Y; Maeda, N; Kagari, T; Hirotani, K; Nishio, K; Nakagawa, K				Yonesaka, Kimio; Takegawa, Naoki; Watanabe, Satomi; Haratani, Koji; Kawakami, Hisato; Sakai, Kazuko; Chiba, Yasutaka; Maeda, Naoyuki; Kagari, Takashi; Hirotani, Kenji; Nishio, Kazuto; Nakagawa, Kazuhiko			An HER3-targeting antibody-drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC	ONCOGENE			English	Article							CELL LUNG-CANCER; MONOCLONAL-ANTIBODY; HER3; GEFITINIB; AMPLIFICATION; EGFR(T790M); PATRITUMAB; SURVIVAL; C-ERBB-3; PROTEIN	EGFR tyrosine kinase inhibitors (TKIs) are standard therapy for EGFR-mutant non-small cell lung cancer (NSCLC); however, these tumours eventually acquire chemoresistance. U3-1402 is an anti-HER3 antibody-drug conjugate with a novel topoisomerase I inhibitor, DXd. In the current study, we evaluated the anticancer efficacy of U3-1402 in EGFR-mutant NSCLC cells with acquired resistance to EGFR-TKIs. HCC827GR5 and PC9AZDR7 are EGFR-TKI-resistant clones for gefitinib and osimertinib, respectively. U3-1402 alone or in combination with the EGFR-TKI erlotinib demonstrated potent anticancer efficacy in HCC827GR5 cells using an in vitro growth inhibition assay and in vivo xenograft mouse model. U3-1402 induced apoptosis in HCC827GR5 cells accompanying phosphorylation of histone H2A.X, a marker of DNA damage, but did not block HER3/PI3K/AKT signalling. Further, we found using flow cytometry that the cell surface HER3 expression level in HCC827GR5 cells was twice that found in HCC827 cells, indicating internalization of U3-1402 was increased in resistant cells. In addition, administration of U3-1402 notably repressed growth of EGFR-TKI osimertinib-resistant PC9AZDR7 xenograft tumours, and that PC9AZDR7 cells expressed five times greater cell surface HER3 than PC9 cells. Furthermore, using immunofluorescent microscopy, HER3 was observed predominantly in the nucleus of PC9 cells, but was localized in the cytoplasm of PC9AZDR7 cells. This finding indicates that altered trafficking of the HER3-U3-1402 complex may accelerate linker payload cleavage by cytoplasmic lysosomal enzymes, resulting in DNA damage. Our results indicate that administration of U3-1402 alone or in combination with an EGFR-TKI may have potential as a novel therapy for EGFR-TKI-resistant EGFR-mutant NSCLC.	[Yonesaka, Kimio; Takegawa, Naoki; Watanabe, Satomi; Haratani, Koji; Kawakami, Hisato; Nakagawa, Kazuhiko] Kindai Univ, Dept Med Oncol, Fac Med, Osaka, Japan; [Sakai, Kazuko; Nishio, Kazuto] Kindai Univ, Dept Genome Biol, Fac Med, Osaka, Japan; [Chiba, Yasutaka] Kindai Univ Hosp, Clin Res Ctr, Osaka, Japan; [Maeda, Naoyuki] Daiichi Sankyo Co Ltd, Biomarker Dept, Shinagawa Ku, Tokyo, Japan; [Kagari, Takashi] Daiichi Sankyo Co Ltd, Biol & Immunooncol Labs, Shinagawa Ku, Tokyo, Japan; [Hirotani, Kenji] Daiichi Sankyo Co Ltd, Oncol Clin Dev Dept, Shinagawa Ku, Tokyo, Japan	Kindai University (Kinki University); Kindai University (Kinki University); Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited	Yonesaka, K (corresponding author), Kindai Univ, Dept Med Oncol, Fac Med, Osaka, Japan.	yonesaka@med.kindai.ac.jp	Kawakami, Hisato/L-6845-2019; Watanabe, Satomi/HCI-6317-2022	Kawakami, Hisato/0000-0002-3280-4850; 	Daiichi Sankyo Co., Ltd. [U3-1402]	Daiichi Sankyo Co., Ltd.(Daiichi Sankyo Company Limited)	This study was financially supported by Daiichi Sankyo Co., Ltd. U3-1402 and patritumab were provided by Daiichi Sankyo Co., Ltd.	Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Cappuzzo F, 2005, BRIT J CANCER, V93, P1334, DOI 10.1038/sj.bjc.6602865; Chen R, 2015, MOL CANCER THER, V14, P1376, DOI 10.1158/1535-7163.MCT-15-0036; Doi T, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.108; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Jia Y, 2016, NATURE, V534, P129, DOI 10.1038/nature17960; Juric D, 2015, CLIN CANCER RES, V21, P2462, DOI 10.1158/1078-0432.CCR-14-2412; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Loganzo F, 2016, MOL CANCER THER, V15, P2825, DOI 10.1158/1535-7163.MCT-16-0408; Loganzo F, 2015, MOL CANCER THER, V14, P952, DOI 10.1158/1535-7163.MCT-14-0862; Mendell J, 2015, EBIOMEDICINE, V2, P264, DOI 10.1016/j.ebiom.2015.02.005; Meulendijks D, 2017, CLIN CANCER RES, V23, P5406, DOI 10.1158/1078-0432.CCR-17-0812; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; Ogitani Y, 2016, CLIN CANCER RES, V22, P5097, DOI 10.1158/1078-0432.CCR-15-2822; Reif R, 2016, J BIOL CHEM, V291, P3837, DOI 10.1074/jbc.M115.686782; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shimizu T, 2017, CANCER CHEMOTH PHARM, V79, P489, DOI 10.1007/s00280-016-3231-3; Takegawa N, 2017, INT J CANCER, V141, P1682, DOI 10.1002/ijc.30870; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Trocme E, 2012, INT J CANCER, V130, P1120, DOI 10.1002/ijc.26118; Ueno S, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-3092; Yi ES, 1997, MODERN PATHOL, V10, P142; Yonesaka K, 2016, ONCOGENE, V35, P878, DOI 10.1038/onc.2015.142; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zhou CC, 2016, J THORAC ONCOL, V11, P174, DOI 10.1016/j.jtho.2015.10.002	30	40	42	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2019	38	9					1398	1409		10.1038/s41388-018-0517-4	http://dx.doi.org/10.1038/s41388-018-0517-4			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN1KL	30302022				2022-12-26	WOS:000459945800003
J	Guo, LL; Huang, JB; Chen, ML; Piotrowski, E; Song, N; Zahner, G; Paust, HJ; Alawi, M; Geffers, R; Thaiss, F				Guo, Linlin; Huang, Jiabin; Chen, Meilan; Piotrowski, Eveline; Song, Ning; Zahner, Gunther; Paust, Hans-Joachim; Alawi, Malik; Geffers, Robert; Thaiss, Friedrich			T-lymphocyte-specific knockout of IKK-2 or NEMO induces T(h)17 cells in an experimental nephrotoxic nephritis mouse model	FASEB JOURNAL			English	Article						NTN; NF-B; transcription factors; canonical; noncanonical pathway; transcriptome	NF-KAPPA-B; TH17 CELLS; IMMUNE-RESPONSE; EXPRESSION; BETA; IMBALANCE; PROMOTES; DISEASE; INFLAMMATION; ACTIVATION	Experimental nephrotoxic serum nephritis (NTN) is a model for T-cell-mediated human rapid progressive glomerulonephritis. T-cell receptor stimulation involves intracellular signaling events that ultimately lead to the activation of transcription factors, such as NF-B. We explored the involvement of the NF-B components IKK-2 and NEMO in NTN, by using cell-specific knockouts of IKK-2 and NEMO in CD4(+) T lymphocytes. Our results demonstrate that although the course of disease was not grossly altered in CD4xIKK2 and CD4xNEMO animals, renal regulatory T cells were significantly reduced and T helper (T-h)1 and T(h)17 cells significantly increased in both knockout mouse groups. The expression of the renal cytokines and chemokines IL-1, CCL-2, and CCL-20 was also significantly altered in both knockout mice. Lymphocyte transcriptome analysis confirmed the increased expression of T(h)17-related cytokines in spleen CD4(+) T cells. Moreover, our array data demonstrate an interrupted canonical NF-B pathway and an increased expression of noncanonical NF-B pathway-related genes in nephritic CD4xNEMO mice, highlighting different downstream effects of deletion of IKK-2 or NEMO in T lymphocytes. We propose that better understanding of the role of IKK-2 and NEMO in nephritis is essential for the clinical application of kinase inhibitors in patients with glomerulonephritis.Guo, L., Huang, J., Chen, M., Piotrowski, E., Song, N., Zahner, G., Paust, H.-J., Alawi, M., Geffers, R., Thaiss, F. T-lymphocyte-specific knockout of IKK-2 or NEMO induces T(h)17 cells in an experimental nephrotoxic nephritis mouse model.	[Guo, Linlin; Chen, Meilan; Piotrowski, Eveline; Song, Ning; Zahner, Gunther; Paust, Hans-Joachim; Thaiss, Friedrich] Univ Med Ctr Hamburg Eppendorf, Dept Med 3, Martini St 52, D-20246 Hamburg, Germany; [Huang, Jiabin] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Alawi, Malik] Univ Med Ctr Hamburg Eppendorf, Bioinformat Serv Facil, Hamburg, Germany; [Alawi, Malik] Leibniz Inst Expt Virol, Heinrich Pette Inst, Virus Genom, Hamburg, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Genome Analyt, Braunschweig, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; Helmholtz Association; Helmholtz-Center for Infection Research	Thaiss, F (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med 3, Martini St 52, D-20246 Hamburg, Germany.	thaiss@uke.de		Huang, Jiabin/0000-0002-3480-7115; Thaiss, Friedrich/0000-0003-1202-0933; , Malik/0000-0002-5993-7709	FACS Unit at the UKE; German Research Foundation [DFG Th 343/12-2]	FACS Unit at the UKE; German Research Foundation(German Research Foundation (DFG))	The authors thank Dr. Anna Reinicke Vogt [University Medical Center Hamburg-Eppendorf (UKE)] for language editing. The authors acknowledge the technical support of the FACS Unit at the UKE. This study was supported by a grant from the German Research Foundation (Grant: DFG Th 343/12-2 to F.T.). The doctoral thesis of M.C. is part of this publication. The authors declare no conflicts of interest.	Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brahler S, 2012, AM J PHYSIOL-RENAL, V303, pF1473, DOI 10.1152/ajprenal.00031.2012; de Oliveira KAP, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0280-5; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Gasparini C, 2012, CURR PHARM DESIGN, V18, P5735, DOI 10.2174/138161212803530763; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gotot J, 2016, J AM SOC NEPHROL, V27, P1917, DOI 10.1681/ASN.2015060699; Gray CM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004557; Grinberg-Bleyer Y, 2018, J IMMUNOL, V200, P2362, DOI 10.4049/jimmunol.1800042; Guo L, 2016, AM J PHYSIOL-RENAL, V311, pF1005, DOI 10.1152/ajprenal.00242.2016; He ZH, 2017, J IMMUNOL, V199, P955, DOI 10.4049/jimmunol.1700457; Heuser C, 2017, CELL REP, V21, P578, DOI 10.1016/j.celrep.2017.09.082; Kitching AR, 2011, J AM SOC NEPHROL, V22, P235, DOI 10.1681/ASN.2010050536; Krebs CF, 2016, IMMUNITY, V45, P1078, DOI 10.1016/j.immuni.2016.10.020; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Kuttkat N, 2017, GUT, V66, P908, DOI 10.1136/gutjnl-2015-311119; Lee MJ, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0116-1; Li JH, 2018, J IMMUNOL, V200, P1325, DOI 10.4049/jimmunol.1701310; Li L, 2011, J EXP MED, V208, P787, DOI 10.1084/jem.20091346; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Ma CS, 2016, J EXP MED, V213, P1589, DOI 10.1084/jem.20151467; Malato Y, 2008, HEPATOLOGY, V47, P2036, DOI 10.1002/hep.22264; Mankan AK, 2011, P NATL ACAD SCI USA, V108, P6567, DOI 10.1073/pnas.1018331108; Oh H, 2017, IMMUNITY, V47, P450, DOI 10.1016/j.immuni.2017.08.010; Oh H, 2013, IMMUNOL REV, V252, P41, DOI 10.1111/imr.12033; Panzer U, 2009, AM J PHYSIOL-RENAL, V297, pF429, DOI 10.1152/ajprenal.90435.2008; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Riedel JH, 2016, J AM SOC NEPHROL, V27, P3666, DOI 10.1681/ASN.2015101077; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Sharma S, 2014, CURR PROTOC IMMUNOL, V105, DOI DOI 10.34.1-10.34.13; Silva GEB, 2011, DIS MARKERS, V31, P9, DOI [10.1155/2011/940827, 10.3233/DMA-2011-0795]; Sun NN, 2016, INFLAMMATION, V39, P2008, DOI 10.1007/s10753-016-0436-x; Talaat RM, 2015, CYTOKINE, V72, P146, DOI 10.1016/j.cyto.2014.12.027; Tipping PG, 2006, J AM SOC NEPHROL, V17, P1253, DOI 10.1681/ASN.2005091013; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vlantis K, 2016, IMMUNITY, V44, P553, DOI 10.1016/j.immuni.2016.02.020; Volchenkov R, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00698; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Wang K, 2012, CELL SIGNAL, V24, P1556, DOI 10.1016/j.cellsig.2012.03.022; Xiao X, 2016, IMMUNITY, V44, P1271, DOI 10.1016/j.immuni.2016.05.013; Yu JY, 2014, J IMMUNOL, V193, P422, DOI 10.4049/jimmunol.1303237; Zhang F, 2016, SCI REP-UK, V6, DOI 10.1038/srep21348	49	2	2	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2359	2371		10.1096/fj.201800485RR	http://dx.doi.org/10.1096/fj.201800485RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30285578				2022-12-26	WOS:000457296600066
J	Leng, F; Saxena, L; Hoang, N; Zhang, CX; Lee, L; Li, WJ; Gong, XS; Lu, F; Sun, H; Zhang, H				Leng, Feng; Saxena, Lovely; Hoang, Nam; Zhang, Chunxiao; Lee, Logan; Li, Wenjing; Gong, Xiaoshan; Lu, Fei; Sun, Hong; Zhang, Hui			Proliferating cell nuclear antigen interacts with the CRL4 ubiquitin ligase subunit CDT2 in DNA synthesis-induced degradation of CDT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE INHIBITOR XIC1; PROTEOLYSIS; PCNA; REPLICATION; PROTEINS; DESTRUCTION; CUL4-ROC1; COMPLEX	During DNA replication or repair, the DNA polymerase cofactor, proliferating cell nuclear antigen (PCNA), homotrimerizes and encircles the replicating DNA, thereby acting as a DNA clamp that promotes DNA polymerase processivity. The formation of the PCNA trimer is also essential for targeting the replication-licensing protein, chromatin-licensing, and DNA replication factor 1 (CDT1), for ubiquitin-dependent proteolysis to prevent chromosomal DNA re-replication. CDT1 uses its PCNA-interacting peptide box (PIP box) to interact with PCNA, and the CRL4 E3 ubiquitin ligase subunit CDT2 is recruited through the formation of PCNA-CDT1 complexes. However, it remains unclear how CDT1 and many other PIP box-containing proteins are marked for degradation by the CRL4(CDT2) ubiquitin ligase during DNA replication or damage. Here, using recombinant protein expression coupled with site-directed mutagenesis, we report that CDT2 and PCNA directly interact and this interaction depends on the presence of a highly conserved, C-terminal PIP box-like region in CDT2. Deletion or mutation of this region abolished the CDT2-PCNA interaction between CDT2 and PCNA both in vitro and in vivo. Moreover, PCNA-dependent CDT1 degradation in response to DNA damage and replication during the cell cycle requires an intact PIP box in CDT2. The requirement of the PIP boxes in both CDT2 and its substrate CDT1 suggests that the formation of the PCNA trimeric clamp around DNA during DNA replication and repair may bring together CDT1 and CRL4(CDT2) ubiquitin E3 ligase to target CDT1 for proteolysis in a DNA synthesis-dependent manner.	[Leng, Feng; Zhang, Chunxiao; Li, Wenjing; Lu, Fei] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Shenzhen 518055, Guangdong, Peoples R China; [Leng, Feng; Saxena, Lovely; Hoang, Nam; Zhang, Chunxiao; Lee, Logan; Li, Wenjing; Gong, Xiaoshan; Sun, Hong; Zhang, Hui] Univ Nevada, Dept Chem & Biochem, Las Vegas, NV 89154 USA	Peking University; University Town of Shenzhen; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Zhang, H (corresponding author), 4505 S Maryland Pkwy,SEB 4138, Las Vegas, NV 89154 USA.	hui.zhang@unlv.edu	zhang, chunxiao/AAH-3229-2019; Leng, Feng/AAP-7294-2020	Zhang, Chunxiao/0000-0001-5543-4509; Li, Wenjing/0000-0001-9151-9219; Zhang, Hui/0000-0001-6028-2554; Sun, Hong/0000-0003-2100-1451	National Institutes of Health [R15 NS096694, R15GM116087, R15GM131255]; Cancer Research Gift Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM116087, R15GM131255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS096694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Gift Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R15 NS096694 (to H. S.), R15GM116087 and R15GM131255 (to H. Z.) and the Cancer Research Gift Fund to the College of Sciences at University of Nevada, Las Vegas (to H. S. and H. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Chuang LC, 2005, J BIOL CHEM, V280, P35299, DOI 10.1074/jbc.M506429200; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; Havens CG, 2012, J BIOL CHEM, V287, P11410, DOI 10.1074/jbc.M111.337683; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Lu F, 2016, BIOL OPEN, V5, P1449, DOI 10.1242/bio.019729; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Pacaud R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04230; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Qin WH, 2011, NUCLEUS-PHILA, V2, P392, DOI 10.4161/nucl.2.5.17928; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Yin F, 2014, MOL CELL BIOL, V34, P158, DOI 10.1128/MCB.00631-13; Zhang CX, 2018, J BIOL CHEM, V293, P3663, DOI 10.1074/jbc.RA117.000342; Zhang XM, 2013, CELL REP, V5, P445, DOI 10.1016/j.celrep.2013.09.018	26	11	11	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18879	18889		10.1074/jbc.RA118.003049	http://dx.doi.org/10.1074/jbc.RA118.003049			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30301766	Green Published, hybrid			2022-12-26	WOS:000458467400006
J	Yap, CC; Digilio, L; Kruczek, K; Roszkowska, M; Fu, XQ; Liu, JS; Winckler, B				Yap, Chan Choo; Digilio, Laura; Kruczek, Kamil; Roszkowska, Matylda; Fu, Xiao-qin; Liu, Judy S.; Winckler, Bettina			A dominant dendrite phenotype caused by the disease-associated G253D mutation in doublecortin (DCX) is not due to its endocytosis defect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE; KINASE; NEUROFASCIN; MAINTENANCE; MIGRATION; INTERACTS; ADAPTER; DOMAIN	Doublecortin (DCX) is a protein needed for cortical development, and DCX mutations cause cortical malformations in humans. The microtubule-binding activity of DCX is well-described and is important for its function, such as supporting neuronal migration and dendrite growth during development. Previous work showed that microtubule binding is not sufficient for DCX-mediated promotion of dendrite growth and that domains in DCX's C terminus are also required. The more C-terminal regions of DCX bind several other proteins, including the adhesion receptor neurofascin and clathrin adaptors. We recently identified a role for DCX in endocytosis of neurofascin. The disease-associated DCX-G253D mutant protein is known to be deficient in binding neurofascin, and we now asked if disruption of neurofascin endocytosis underlies the DCX-G253D-associated pathology. We first demonstrated that DCX functions in endocytosis as a complex with both the clathrin adaptor AP-2 and neurofascin: disrupting either clathrin adaptor binding (DCX-ALPA) or neurofascin binding (DCX-G253D) decreased neurofascin endocytosis in primary neurons. We then investigated a known function for DCX, namely, increasing dendrite growth in cultured neurons. Surprisingly, we found that the DCX-ALPA and DCX-G253D mutants yield distinct dendrite phenotypes. Unlike DCX-ALPA, DCX-G253D caused a dominant-negative dendrite growth phenotype. The endocytosis defect of DCX-G253D thus was separable from its detrimental effects on dendrite growth. We recently identified Dcx-R59H as a dominant allele and can now classify Dcx-G253D as a second Dcx allele that acts dominantly to cause pathology, but does so via a different mechanism.	[Yap, Chan Choo; Digilio, Laura; Winckler, Bettina] Univ Virginia, Dept Cell Biol, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA; [Kruczek, Kamil] Jagiellonian Univ, Program Biotechnol, PL-31007 Krakow, Poland; [Roszkowska, Matylda] Jagiellonian Univ, Fac Biol & Earth Sci, PL-31007 Krakow, Poland; [Fu, Xiao-qin; Liu, Judy S.] Brown Univ, Dept Neurol, Providence, RI 02912 USA; [Kruczek, Kamil] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, 6 Ctr Dr, Bethesda, MD 20892 USA; [Roszkowska, Matylda] Polish Acad Sci, Nencki Inst Expt Biol, Lab Mol & Syst Neuromorphol, PL-02093 Warsaw, Poland; [Fu, Xiao-qin] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou 325027, Zhejiang, Peoples R China; [Fu, Xiao-qin] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Zhejiang, Peoples R China	University of Virginia; Jagiellonian University; Jagiellonian University; Brown University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Wenzhou Medical University; Wenzhou Medical University	Winckler, B (corresponding author), Univ Virginia, Dept Cell Biol, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	BWinckler@virginia.edu	Roszkowska, Matylda/HGC-4112-2022	Roszkowska, Matylda/0000-0001-9280-8063; Winckler, Bettina/0000-0002-7924-9313	National Institutes of Health [R01NS081674]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01NS081674 (to B. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bazelot M, 2012, EUR J NEUROSCI, V35, P244, DOI 10.1111/j.1460-9568.2011.07962.x; Bechstedt S, 2012, DEV CELL, V23, P181, DOI 10.1016/j.devcel.2012.05.006; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Cohen D, 2008, DEV NEUROSCI-BASEL, V30, P187, DOI 10.1159/000109862; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Dixon-Salazar TJ, 2010, ANN NY ACAD SCI, V1214, P156, DOI 10.1111/j.1749-6632.2010.05819.x; Ebel Julia, 2014, Adv Neurobiol, V8, P231; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Friocourt G, 2001, MOL CELL NEUROSCI, V18, P307, DOI 10.1006/mcne.2001.1022; Friocourt G, 2011, ACTA NEUROPATHOL, V121, P149, DOI 10.1007/s00401-010-0768-9; Fu XQ, 2013, J NEUROSCI, V33, P709, DOI 10.1523/JNEUROSCI.4603-12.2013; Gurevich VV, 2014, CURR OPIN CELL BIOL, V27, P1, DOI 10.1016/j.ceb.2013.10.007; Jean DC, 2012, HUM MOL GENET, V21, P5511, DOI 10.1093/hmg/dds395; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; Kizhatil K, 2002, J NEUROSCI, V22, P7948; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Kriebel M, 2011, J BIOL CHEM, V286, P24385, DOI 10.1074/jbc.M110.212191; Liu JS, 2012, MOL CELL, V47, P707, DOI 10.1016/j.molcel.2012.06.025; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Martineau FS, 2018, CEREB CORTEX, V28, P2976, DOI 10.1093/cercor/bhy113; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Reider A, 2011, J CELL SCI, V124, P1613, DOI 10.1242/jcs.073395; Sapir T, 2000, HUM MOL GENET, V9, P703, DOI 10.1093/hmg/9.5.703; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Tint I, 2009, J NEUROSCI, V29, P10995, DOI 10.1523/JNEUROSCI.3399-09.2009; Toriyama M, 2012, J BIOL CHEM, V287, P12691, DOI 10.1074/jbc.M111.316307; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; Tsukada M, 2003, MECH DEVELOP, V120, P1033, DOI 10.1016/S0925-4773(03)00177-1; Volkmer H, 1996, J CELL BIOL, V135, P1059, DOI 10.1083/jcb.135.4.1059; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Yap C. C., 2017, SCI REP, V7, P1, DOI 10.1038/s41598-017-07667-x; Yap CC, 2016, J BIOL CHEM, V291, P26613, DOI 10.1074/jbc.M116.760777; Yap CC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00119; Yap CC, 2012, J NEUROSCI, V32, P7439, DOI 10.1523/JNEUROSCI.5318-11.2012; Zonta B, 2011, NEURON, V69, P945, DOI 10.1016/j.neuron.2011.02.021	43	7	7	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18890	18902		10.1074/jbc.RA118.004462	http://dx.doi.org/10.1074/jbc.RA118.004462			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30291144	Green Published, hybrid			2022-12-26	WOS:000458467400007
J	Choi, E; Hwang, J				Choi, Eunsil; Hwang, Jihwan			The GTPase BipA expressed at low temperature in Escherichia coli assists ribosome assembly and has chaperone-like activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E. coli); ribosome assembly; GTPase; cyclic AMP (cAMP); chaperone; cold adaptation; CRP	CATABOLITE ACTIVATOR PROTEIN; EF-G; SHOCK RESPONSE; G-DOMAIN; IN-VIVO; GENE; TRANSCRIPTION; BINDING; PPGPP; RNA	BPI-inducible protein A (BipA) is a conserved ribosome-associated GTPase in bacteria that is structurally similar to other GTPases associated with protein translation, including IF2, EF-Tu, and EF-G. Its binding site on the ribosome appears to overlap those of these translational GTPases. Mutations in the bipA gene cause a variety of phenotypes, including cold and antibiotics sensitivities and decreased pathogenicity, implying that BipA may participate in diverse cellular processes by regulating translation. According to recent studies, a bipA-deletion strain of Escherichia coli displays a ribosome assembly defect at low temperature, suggesting that BipA might be involved in ribosome assembly. To further investigate BipA's role in ribosome biogenesis, here, we compared and analyzed the ribosomal protein compositions of MG1655 WT and bipA-deletion strains at 20 degrees C. Aberrant 50S ribosomal subunits (i.e. 44S particles) accumulated in the bipA-deletion strain at 20 degrees C, and the ribosomal protein L6 was absent in these 44S particles. Furthermore, bipA expression was significantly stimulated at 20 degrees C, suggesting that it encodes a cold shock-inducible GTPase. Moreover, the transcriptional regulator cAMP receptor protein (CRP) positively promoted bipA expression only at 20 degrees C. Importantly, GFP and -glucosidase refolding assays revealed that BipA has chaperone activity. Our findings indicate that BipA is a cold shock-inducible GTPase that participates in 50S ribosomal subunit assembly by incorporating the L6 ribosomal protein into the 44S particle during the assembly.	[Choi, Eunsil; Hwang, Jihwan] Pusan Natl Univ, Dept Microbiol, Busan 46241, South Korea	Pusan National University	Hwang, J (corresponding author), Pusan Natl Univ, Dept Microbiol, Busan 46241, South Korea.	hwangjh@pusan.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [NRF-2015R1A2A2A01005881]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by Ministry of Education, Science, and Technology Grant NRF-2015R1A2A2A01005881. The authors declare that they have no conflicts of interest with the contents of this article.	Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barria C, 2013, MICROBIOL-SGM, V159, P2437, DOI 10.1099/mic.0.052209-0; Beckering CL, 2002, J BACTERIOL, V184, P6395, DOI 10.1128/JB.184.22.6395-6402.2002; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOSL A, 1981, MOL GEN GENET, V182, P358, DOI 10.1007/BF00269684; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Caldas T, 2000, J BIOL CHEM, V275, P855, DOI 10.1074/jbc.275.2.855; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Canny G, 2002, P NATL ACAD SCI USA, V99, P3902, DOI 10.1073/pnas.052533799; Choi E, 2016, J BACTERIOL, V198, P2284, DOI 10.1128/JB.00384-16; Choudhury P, 2015, J BACTERIOL, V197, P1819, DOI 10.1128/JB.00023-15; Conrad J, 1998, J BIOL CHEM, V273, P18562, DOI 10.1074/jbc.273.29.18562; De Lay N, 2009, J BACTERIOL, V191, P461, DOI 10.1128/JB.01157-08; deLivron MA, 2008, J BACTERIOL, V190, P5944, DOI 10.1128/JB.00763-08; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; DONINI P, 1978, MOL BIOL REP, V4, P15, DOI 10.1007/BF00775174; Donovan GT, 2013, INFECT IMMUN, V81, P249, DOI 10.1128/IAI.00796-12; Elsbach P, 1998, J LEUKOCYTE BIOL, V64, P14, DOI 10.1002/jlb.64.1.14; Ero R, 2016, RNA BIOL, V13, P1258, DOI 10.1080/15476286.2016.1201627; Farris M, 1998, MOL MICROBIOL, V28, P265, DOI 10.1046/j.1365-2958.1998.00793.x; Feng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058829; Freestone P, 1998, J MOL BIOL, V279, P1045, DOI 10.1006/jmbi.1998.1836; GALLANT J, 1977, CELL, V11, P181, DOI 10.1016/0092-8674(77)90329-4; Gibbs MR, 2017, P NATL ACAD SCI USA, V114, P980, DOI 10.1073/pnas.1613665114; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Grant AJ, 2003, MOL MICROBIOL, V48, P507, DOI 10.1046/j.1365-2958.2003.t01-1-03447.x; Gulati M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004694; Gutierrez-Rios RM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-53; HAMEL E, 1976, EUR J BIOCHEM, V63, P431, DOI 10.1111/j.1432-1033.1976.tb10245.x; Handke LD, 2008, J BACTERIOL, V190, P798, DOI 10.1128/JB.01115-07; Hansen AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003403; Huang LX, 1998, BIOCHEMISTRY-US, V37, P15951, DOI 10.1021/bi981002n; Hwang J, 2008, J BACTERIOL, V190, P3236, DOI 10.1128/JB.01758-07; Hwang J, 2006, MOL MICROBIOL, V61, P1660, DOI 10.1111/j.1365-2958.2006.05348.x; IKEHARA K, 1984, J BIOCHEM-TOKYO, V95, P895, DOI 10.1093/oxfordjournals.jbchem.a134684; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; ISHIHAMA A, 1992, MOL MICROBIOL, V6, P3283, DOI 10.1111/j.1365-2958.1992.tb02196.x; Jackson DW, 2002, J BACTERIOL, V184, P3406, DOI 10.1128/JB.184.12.3406-3410.2002; Jones PG, 1996, MOL MICROBIOL, V21, P1207, DOI 10.1111/j.1365-2958.1996.tb02582.x; JONES PG, 1994, MOL MICROBIOL, V11, P811, DOI 10.1111/j.1365-2958.1994.tb00359.x; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kiss E, 2004, MOL PLANT MICROBE IN, V17, P235, DOI 10.1094/MPMI.2004.17.3.235; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Krishnan K, 2008, J BACTERIOL, V190, P7675, DOI 10.1128/JB.00835-08; Kumar V, 2016, J BIOL CHEM, V291, P12943, DOI 10.1074/jbc.M116.725945; Kumar V, 2015, P NATL ACAD SCI USA, V112, P10944, DOI 10.1073/pnas.1513216112; Landis L, 1999, GENE DEV, V13, P3081, DOI 10.1101/gad.13.23.3081; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macvanin M, 2000, MOL MICROBIOL, V37, P98, DOI 10.1046/j.1365-2958.2000.01967.x; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Mares RE, 2011, INT J MOL SCI, V12, P4625, DOI 10.3390/ijms12074625; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; Miller J. H., 1992, SHORT COURSE BACTERI, P263; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; Mitkevich VA, 2010, J MOL BIOL, V402, P838, DOI 10.1016/j.jmb.2010.08.016; Muller CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000303; Neidig A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-77; OSSWALD M, 1990, NUCLEIC ACIDS RES, V18, P6755; Pfennig PL, 2001, MOL GENET GENOMICS, V266, P313, DOI 10.1007/s004380100559; Phadtare S, 2005, J BACTERIOL, V187, P6584, DOI 10.1128/JB.187.18.6584-6589.2005; QI SY, 1995, MOL MICROBIOL, V17, P523, DOI 10.1111/j.1365-2958.1995.mmi_17030523.x; Reva ON, 2006, J BACTERIOL, V188, P4079, DOI 10.1128/JB.00101-06; ROJAS AM, 1984, MOL GEN GENET, V197, P36, DOI 10.1007/BF00327920; RON EZ, 1966, SCIENCE, V153, P1119, DOI 10.1126/science.153.3740.1119; Rowe S, 2000, J BACTERIOL, V182, P2741, DOI 10.1128/JB.182.10.2741-2745.2000; SARMIENTOS P, 1983, CELL, V32, P1337, DOI 10.1016/0092-8674(83)90314-8; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; SHAND RF, 1989, J BACTERIOL, V171, P737, DOI 10.1128/jb.171.2.737-743.1989; Shigeno Y, 2016, BIOCHEM BIOPH RES CO, V473, P237, DOI 10.1016/j.bbrc.2016.03.085; Shimizu K, 2014, METABOLITES, V4, P1, DOI 10.3390/metabo4010001; Starosta AL, 2014, FEMS MICROBIOL REV, V38, P1172, DOI 10.1111/1574-6976.12083; Uppal S, 2008, FEMS MICROBIOL LETT, V279, P83, DOI 10.1111/j.1574-6968.2007.01009.x; Uppal S, 2015, ARCH MICROBIOL, V197, P497, DOI 10.1007/s00203-015-1085-4; Uppal S, 2014, J BACTERIOL, V196, P1569, DOI 10.1128/JB.01476-13; Uppal S, 2011, J BACTERIOL, V193, P6142, DOI 10.1128/JB.05728-11; Wang F, 2008, PLANT CELL ENVIRON, V31, P982, DOI 10.1111/j.1365-3040.2008.01810.x; WEBER MJ, 1966, P NATL ACAD SCI USA, V55, P1224, DOI 10.1073/pnas.55.5.1224; YOSHIDA M, 1972, FEBS LETT, V23, P163, DOI 10.1016/0014-5793(72)80331-4; Zhang DD, 2012, NUCLEIC ACIDS RES, V40, P10851, DOI 10.1093/nar/gks833; Zhang ZG, 2005, J BACTERIOL, V187, P980, DOI 10.1128/JB.187.3.980-990.2005; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	87	15	16	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18404	18419		10.1074/jbc.RA118.002295	http://dx.doi.org/10.1074/jbc.RA118.002295			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30305394	Green Published, hybrid			2022-12-26	WOS:000451375200033
J	Hausberger, M; Boigne, A; Lesimple, C; Belin, L; Henry, L				Hausberger, Martine; Boigne, Anthony; Lesimple, Clemence; Belin, Laurine; Henry, Laurence			Wide-eyed glare scares raptors: From laboratory evidence to applied management	PLOS ONE			English	Article							NUCLEUS ROTUNDUS; LOOMING STIMULI; BIRD STRIKES; RESPONSES; EYESPOTS; BEHAVIOR; COLLISION; AIRCRAFT; PREDATOR; MIMICRY	Raptors are one of the most important causes of fatalities due to their collisions with aircrafts as well as being the main victims of collisions with constructions. They are difficult to deter because they are not influenced by other airspace users or ground predators. Because vision is the primary sensory mode of many diurnal raptors, we evaluated the reactions of captive raptors to a "superstimulus" (a "paradoxical effect whereby animals show greater responsiveness to an exaggerated stimulus than to the natural stimulus") that combined an "eye shape" stimulus (as many species have an aversion for this type of stimulus) and a looming movement (LE). This looming stimulus mimics an impending collision and induces avoidance in a wide range of species. In captivity, raptors showed a clear aversion for this LE stimulus. We then tested it in a real life setting: at an airport where raptors are abundant. This study is the first to show the efficiency of a visual non-invasive repellent system developed on the basis of both captive and field studies. This system deterred birds of prey and corvids through aversion, and did not induce habituation. These findings suggest applications for human security as well as bird conservation, and further research on avian visual perception and sensitivity to signals.	[Hausberger, Martine; Boigne, Anthony; Lesimple, Clemence; Belin, Laurine; Henry, Laurence] Univ Caen Normandie, Univ Rennes, Lab Ethol Anim & Humaine, CNRS,UMR 6552, Caen, France; [Boigne, Anthony] Soc Accelerat Transfert Technol SATT Ouest Valori, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Caen Normandie	Henry, L (corresponding author), Univ Caen Normandie, Univ Rennes, Lab Ethol Anim & Humaine, CNRS,UMR 6552, Caen, France.	laurence.henry@univ-rennes1.fr		/0000-0003-0664-1151	Airbus Group; CNRS; Rennes 1 University; SATT Ouest Valorisation	Airbus Group; CNRS(Centre National de la Recherche Scientifique (CNRS)); Rennes 1 University; SATT Ouest Valorisation	This study was jointly funded by Airbus Group, CNRS, Rennes 1 University and the SATT Ouest Valorisation. The funders had no role in the study design apart from providing and programming the technical equipment (screens) and obtaining the agreement from Lourdes-Tarbes-Pyrenees airport to be part of the study. They played no role in data collection and analyses, decision to publish or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Avery ML, 2002, J RAPTOR RES, V36, P45; BALL W, 1971, SCIENCE, V171, P818, DOI 10.1126/science.171.3973.818; BIELERT C, 1985, INT J PRIMATOL, V6, P377, DOI 10.1007/BF02736384; Brilot BO, 2009, APPL ANIM BEHAV SCI, V118, P182, DOI 10.1016/j.applanim.2009.02.015; Broom D. M, 1999, ADV VERTEBRATE PEST, P309; Carlile PA, 2006, ANIM BEHAV, V72, P553, DOI 10.1016/j.anbehav.2005.10.027; Davidson GL, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1077; Davis R.A, 1998, LGL REP AERODR SAF B, V3, P107; Direction Ge A ne A rale de L' Aviation civile. Le pe A ril animaler, 2007, LE PER AN; Dixon A, 2002, ATTACKS BIRDS PREY R; Dolbeer RA, 2000, WILDLIFE SOC B, V28, P372; Fernandez-Juricic Esteban, 2011, Human-Wildlife Interactions, V5, P224; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; FOX R, 1976, SCIENCE, V192, P263, DOI 10.1126/science.1257767; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; Frost B, 2003, ADV PSYCHOL SERIES, P13; GIBSON JJ, 1958, BRIT J PSYCHOL, V49, P182, DOI 10.1111/j.2044-8295.1958.tb00656.x; Ginati A, 2010, ESA BULL-EUR SPACE, P46; Guyomarc'h JC, 1995, ABREGE DETHOLOGIE; Howse PE, 2013, BIOL J LINN SOC, V109, P203, DOI 10.1111/bij.12027; Inglis IR, 1980, BIRD PROBLEMS AGR, P121; Martin GR, 2007, J ORNITHOL, V148, pS547, DOI 10.1007/s10336-007-0213-6; Martin GR, 2012, IBIS, V154, P626, DOI 10.1111/j.1474-919X.2012.01227.x; MCLENNAN JA, 1995, NEW ZEAL J CROP HORT, V23, P139, DOI 10.1080/01140671.1995.9513880; Nesic A, 2017, PROMET-ZAGREB, V29, P623, DOI 10.7307/ptt.v29i6.2448; Nomsen DE, 1989, PREVENTING WATERFOWL; Oliva D, 2007, J EXP BIOL, V210, P865, DOI 10.1242/jeb.02707; Philiben ST, 2005, BIRD STRIK COMM US C; R Core Team, 2020, R LANG ENV STAT COMP; REYMOND L, 1987, VISION RES, V27, P1859, DOI 10.1016/0042-6989(87)90114-3; REYMOND L, 1985, VISION RES, V25, P1477, DOI 10.1016/0042-6989(85)90226-3; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; SIEGEL S., 1956, NONPARAMETRIC STAT B; Sodhi NS, 2002, AUK, V119, P587, DOI 10.1642/0004-8038(2002)119[0587:CITABV]2.0.CO;2; Stevens M, 2008, BEHAV ECOL, V19, P525, DOI 10.1093/beheco/arm162; Stevens M, 2007, ANIM BEHAV, V74, P1215, DOI 10.1016/j.anbehav.2007.01.031; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Thorpe J., 2012, INT BIRD STRIKE COMM, P1; Tinbergen N., 1948, Wilson Bulletin, V60, P6; VALLORTIGARA G, 1988, ANIM LEARN BEHAV, V16, P359, DOI 10.3758/BF03209088; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0	42	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204802	10.1371/journal.pone.0204802	http://dx.doi.org/10.1371/journal.pone.0204802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307964	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500026
J	Munroe, SEM; Coates-Marnane, J; Burford, MA; Fry, B				Munroe, Samantha E. M.; Coates-Marnane, Jack; Burford, Michele A.; Fry, Brian			A benthic bioindicator reveals distinct land and ocean-Based influences in an urbanized coastal embayment	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; BARRIER-REEF LAGOON; STABLE-ISOTOPE; MORETON-BAY; ESTUARINE SEDIMENTS; METAL POLLUTION; EAST-COAST; SEAGRASS ECOSYSTEM; ANTIFOULING PAINT; PENAEUS-PLEBEJUS	Biogeochemical maps of coastal regions can be used to identify important influences and inputs that define nearshore environments and biota. Biogeochemical tracers can also track animal movement and their diet, monitor human coastal development, and evaluate the condition of habitats and species. However, the beneficial applications of spatial biogeochemical analysis are hindered by a limited understanding of how tracer distribution is affected by different land and ocean-based influences. To help address these knowledge gaps, we determined the spatial trends of three stable isotopes (delta C-13-carbon, delta N-15-nitrogen, delta S-34-sulfur) and 13 major and trace elements in an urbanized coastal embayment (Moreton Bay, Australia), as incorporated into the muscle tissue of a marine consumer, the eastern king prawn Melicertus plebejus. Results were used to identify unique biochemical regions within the bay and to discuss how spatial patterns in tracers could be used to indicate the relative importance of catchment, urban and offshore drivers in coastal bays. Discriminant analysis identified seven biogeochemical regions that were likely distinguished by variation in catchment, urban, and offshore input, and habitat type. delta C-13 and delta N-15 patterns suggested nearshore areas could be distinguished by increased sediment resuspension and higher wastewater inputs from catchments. High inshore lead (Pb) and copper (Cu) concentrations were likely the result of urban input. Arsenic (As) and cadmium (Cd) increased further from shore. This trend implied oceanic influences were a significant control over As and Cd bio-availability. Cobalt (Co) and rare earths were also used to differentiate some nearshore areas, but incongruent distribution patterns in Co suggested it may be less reliable. Overall, results indicated that delta N-15, delta C-13, Cd, Cu, Pb and rare earth elements were the most reliable tracers to differentiate nearshore and offshore environments, and catchment-based effects. We encourage future studies to consider using a similar multivariate approach in coastal spatial analysis, and to include unrelated tracers that reflect distinct coastal influences.	[Munroe, Samantha E. M.; Coates-Marnane, Jack; Burford, Michele A.; Fry, Brian] Griffith Univ, Sch Environm, Australian Rivers Inst, Nathan, Qld, Australia	Griffith University	Munroe, SEM (corresponding author), Griffith Univ, Sch Environm, Australian Rivers Inst, Nathan, Qld, Australia.	s.munroe@griffith.edu.au	Burford, Michele A/A-3138-2012; Burford, Michele/AAS-9084-2020	Burford, Michele A/0000-0002-1076-6144; Burford, Michele/0000-0002-1076-6144; Munroe, Samantha/0000-0001-7827-1028	Australian Research Council [DP150104006]	Australian Research Council(Australian Research Council)	This research was supported by the Australian Research Council (grant number DP150104006; http://www.arc.gov.au/discoveryprojects). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altabet MA, 2006, HANDB ENVIRON CHEM, V2, P251, DOI 10.1117/698_2_008; [Anonymous], 2018, EC HLTH MON PROGR; [Anonymous], 2017, HLTH WAT REP CARD 20; ARZUL G, 1990, MAR POLLUT BULL, V21, P431, DOI 10.1016/0025-326X(90)90762-W; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Barrio-Parra F, 2018, ENVIRON GEOCHEM HLTH, V40, P737, DOI 10.1007/s10653-017-0020-9; Barwick M, 2003, MAR ENVIRON RES, V56, P471, DOI 10.1016/S0141-1136(03)00028-X; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Blewett TA, 2017, ENVIRON POLLUT, V223, P311, DOI 10.1016/j.envpol.2017.01.028; Blewett TA, 2015, AQUAT TOXICOL, V164, P23, DOI 10.1016/j.aquatox.2015.04.010; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Bouillon S, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 7: FUNCTIONING OF ECOSYSTEMS AT THE LAND-OCEAN INTERFACE, P143; Brandes JA, 1997, GEOCHIM COSMOCHIM AC, V61, P1793, DOI 10.1016/S0016-7037(97)00041-0; Brett MT, 2014, MAR ECOL PROG SER, V514, P1, DOI 10.3354/meps11017; Buchwalter DB, 2005, ENVIRON SCI TECHNOL, V39, P498, DOI 10.1021/es0404421; Burford MA, 2012, AQUAT SCI, V74, P179, DOI 10.1007/s00027-011-0209-4; BYRD JT, 1988, MAR CHEM, V25, P383, DOI 10.1016/0304-4203(88)90118-1; Carson HS, 2008, MAR BIOL, V153, P327, DOI 10.1007/s00227-007-0808-8; Carter JF, 2015, FOOD CHEM, V170, P241, DOI 10.1016/j.foodchem.2014.08.037; CLAISSE D, 1993, MAR POLLUT BULL, V26, P395, DOI 10.1016/0025-326X(93)90188-P; Coates-Marnane J, 2016, SCI TOTAL ENVIRON, V569, P716, DOI 10.1016/j.scitotenv.2016.06.193; Connolly RM, 2005, OECOLOGIA, V144, P684, DOI 10.1007/s00442-005-0167-4; Connolly RM, 2004, OECOLOGIA, V138, P161, DOI 10.1007/s00442-003-1415-0; Connolly RM, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00243.1; Connolly RM, 2009, MAR BIOL RES, V5, P164, DOI 10.1080/17451000802266625; Costanzo SD, 2005, MAR POLLUT BULL, V51, P212, DOI 10.1016/j.marpolbul.2004.10.018; Costanzo SD, 2001, MAR POLLUT BULL, V42, P149, DOI 10.1016/S0025-326X(00)00125-9; Courtney A., 2012, HARVEST STRATEGY EVA; COURTNEY AJ, 1995, ESTUAR COAST SHELF S, V41, P377, DOI 10.1016/0272-7714(95)90000-4; Cox ME, 2005, GEOGR RES-AUST, V43, P173, DOI 10.1111/j.1745-5871.2005.00312.x; Cresswell T, 2017, ENVIRON SCI TECHNOL, V51, P4054, DOI 10.1021/acs.est.6b06471; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Dobson S, 2014, RISK ASSESSMENT CADM; ELDERFIELD H, 1990, GEOCHIM COSMOCHIM AC, V54, P971, DOI 10.1016/0016-7037(90)90432-K; Eyre B, 1998, ESTUAR COAST SHELF S, V47, P513, DOI 10.1006/ecss.1998.0371; Eyre BD, 2002, LIMNOL OCEANOGR, V47, P1043, DOI 10.4319/lo.2002.47.4.1043; Forrest BM, 2007, NEW ZEAL J MAR FRESH, V41, P13, DOI 10.1080/00288330709509892; FRY B, 1982, GEOCHIM COSMOCHIM AC, V46, P1121, DOI 10.1016/0016-7037(82)90063-1; FRY B, 1982, OECOLOGIA, V54, P200, DOI 10.1007/BF00378393; Fry B, 2003, ESTUARIES, V26, P82, DOI 10.1007/BF02691696; Fry B, 2016, ISOT ENVIRON HEALT S, V52, P619, DOI 10.1080/10256016.2016.1149481; Fry B, 2013, MAR ECOL PROG SER, V472, P1, DOI 10.3354/meps10168; Gamboa-Delgado J, 2011, J SHELLFISH RES, V30, P969, DOI 10.2983/035.030.0340; GLAISTER JP, 1990, AUST J MAR FRESH RES, V41, P175, DOI 10.1071/MF9900175; GLAISTER JP, 1987, AUST J MAR FRESH RES, V38, P225, DOI 10.1071/MF9870225; HAMILTON EI, 1994, SCI TOTAL ENVIRON, V150, P7, DOI 10.1016/0048-9697(94)90126-0; Hannigan R, 2010, CHEM GEOL, V272, P20, DOI 10.1016/j.chemgeo.2010.01.009; Hargreaves JC, 2008, AGR ECOSYST ENVIRON, V123, P1, DOI 10.1016/j.agee.2007.07.004; Herrmann H, 2016, ECOTOX ENVIRON SAFE, V124, P213, DOI 10.1016/j.ecoenv.2015.09.033; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Kirkegaard I, 1970, SYNOPSIS BIOL DATA E; KUSTIN K, 1983, STRUCT BOND, V53, P139; LAPOINTE BE, 1992, ESTUARIES, V15, P465, DOI 10.2307/1352391; Lawrence MG, 2006, AQUAT GEOCHEM, V12, P39, DOI 10.1007/s10498-005-4471-8; Lawrence MG, 2006, MAR CHEM, V100, P147, DOI 10.1016/j.marchem.2005.11.007; Lebrun JD, 2011, AQUAT TOXICOL, V104, P161, DOI 10.1016/j.aquatox.2011.04.011; Lewtas KLM, 2014, ENVIRON SCI POLLUT R, V21, P704, DOI 10.1007/s11356-013-1961-x; Liu YJ, 2016, ENVIRON GEOCHEM HLTH, V38, P111, DOI 10.1007/s10653-015-9689-9; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; MALLIN MA, 1993, MAR ECOL PROG SER, V93, P199, DOI 10.3354/meps093199; Markert B, 1999, J RADIOANAL NUCL CH, V240, P425, DOI 10.1007/BF02349387; Masel J. M., 2000, Proceedings of the Royal Society of Queensland, V109, P107; MIRAMAND P, 1981, J EXP MAR BIOL ECOL, V49, P267, DOI 10.1016/0022-0981(81)90076-9; Moermond CTA, 2001, ENVIRON TOXICOL CHEM, V20, P1916, DOI [10.1897/1551-5028(2001)020&lt;1916:DSABOL&gt;2.0.CO;2, 10.1002/etc.5620200909]; Monbet P, 2004, MAR POLLUT BULL, V48, P78, DOI 10.1016/S0025-326X(03)00327-8; Montgomery S.S., 1981, Australian Fisheries, V40, P13; MONTGOMERY SS, 1990, FISH RES, V9, P189, DOI 10.1016/S0165-7836(05)80001-3; MORIARTY DJW, 1977, AUST J MAR FRESH RES, V28, P113; Munksgaard NC, 2017, MAR POLLUT BULL, V123, P47, DOI 10.1016/j.marpolbul.2017.09.031; Munroe S, 2018, LIMNOL OCEANOGR-METH, V16, P444, DOI 10.1002/lom3.10258; Nascimento JR, 2017, MAR POLLUT BULL, V114, P1007, DOI 10.1016/j.marpolbul.2016.11.013; Neff JM, 1997, ENVIRON TOXICOL CHEM, V16, P917, DOI 10.1002/etc.5620160511; NEWELL RIE, 1995, MAR BIOL, V123, P595, DOI 10.1007/BF00349238; NIXON S W, 1986, Journal of the Limnological Society of Southern Africa, V12, P43; Nugegoda D, 1995, MAR POLLUT BULL, V31, P460, DOI 10.1016/0025-326X(95)00131-6; Nunez-Nogueira G, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1644-8; Oakes JM, 2004, J EXP MAR BIOL ECOL, V302, P153, DOI 10.1016/j.jembe.2003.10.011; Odate S, 2007, J CHEM ECOL, V33, P643, DOI 10.1007/s10886-007-9251-z; PAEZOSUNA F, 1995, ENVIRON POLLUT, V87, P243, DOI 10.1016/0269-7491(94)P2612-D; PAEZOSUNA F, 1995, ESTUAR COAST SHELF S, V40, P35, DOI 10.1016/0272-7714(95)90011-X; Parnell AC, SIAR STABLE ISOTOPE; Peterson BJ, 1999, ACTA OECOL, V20, P479, DOI 10.1016/S1146-609X(99)00120-4; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pitt KA, 2009, MAR POLLUT BULL, V58, P573, DOI 10.1016/j.marpolbul.2008.11.016; Pourang N, 2004, ECOTOXICOLOGY, V13, P519, DOI 10.1023/B:ECTX.0000037189.80775.9c; Prego R, 2012, CONT SHELF RES, V35, P75, DOI 10.1016/j.csr.2011.12.010; Price A, 2012, ENVIRON CHEM, V9, P77, DOI 10.1071/EN11105; PROSI F, 1989, SCI TOTAL ENVIRON, V79, P157, DOI 10.1016/0048-9697(89)90359-8; Racek A.A., 1959, PRAWN INVESTIGATIONS; Rainbow PS, 2007, ENVIRON INT, V33, P576, DOI 10.1016/j.envint.2006.05.007; Rainbow PS, 2000, AQUAT TOXICOL, V50, P189, DOI 10.1016/S0166-445X(99)00103-4; Rainbow PS, 2002, ENVIRON POLLUT, V120, P497, DOI 10.1016/S0269-7491(02)00238-5; Rainbow PS, 1997, ESTUAR COAST SHELF S, V44, P169, DOI 10.1006/ecss.1996.0208; RAINBOW PS, 1995, MAR POLLUT BULL, V31, P55, DOI 10.1016/0025-326X(95)00005-8; Ramesh R, 1999, HYDROBIOLOGIA, V397, P89, DOI 10.1023/A:1003646631589; RIEDEL GF, 1993, ESTUARIES, V16, P533, DOI 10.2307/1352600; Roelfsema C, 2013, ESTUAR COAST SHELF S, V133, P161, DOI 10.1016/j.ecss.2013.08.026; Rothlisberg PC, 1996, MAR FRESHWATER RES, V47, P157, DOI 10.1071/MF9960157; Rothlisberg PC, 2013, BIOPHYSICS MARINE LA, P235, DOI [10.1029/CE045p0235, DOI 10.1029/CE045P0235]; ROY PS, 1984, ESTUAR COAST SHELF S, V19, P341, DOI 10.1016/0272-7714(84)90030-1; Ruelas-Inzunza J, 2011, SCI TOTAL ENVIRON, V409, P3527, DOI 10.1016/j.scitotenv.2011.05.035; Ruello N, 1975, 1 AUSTR NAT PRAWN SE; RUELLO NV, 1975, AUST J MAR FRESH RES, V26, P343; SANDERS JG, 1980, ESTUAR COAST MAR SCI, V10, P555, DOI 10.1016/S0302-3524(80)80075-2; Savage C, 2004, LIMNOL OCEANOGR, V49, P1503, DOI 10.4319/lo.2004.49.5.1503; Savage C, 2005, AMBIO, V34, P145, DOI 10.1579/0044-7447-34.2.145; Schiff K, 2004, MAR POLLUT BULL, V48, P371, DOI 10.1016/j.marpolbul.2003.08.016; Shynu R, 2011, ESTUAR COAST SHELF S, V94, P355, DOI 10.1016/j.ecss.2011.07.013; Soto-Jimenez MF, 2008, MAR ENVIRON RES, V66, P451, DOI 10.1016/j.marenvres.2008.07.009; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stankovic S, 2014, ENVIRON CHEM LETT, V12, P63, DOI 10.1007/s10311-013-0430-6; STEPHENSON RL, 1982, OECOLOGIA, V55, P110, DOI 10.1007/BF00386725; SUTHERS IM, 1984, AUST J MAR FRESH RES, V35, P785, DOI 10.1071/MF9840785; Tchounwou P.B., 2012, EXP S, V101, P133, DOI [10.1007/978-3-7643-8340-4_6, 10.1007/978-3-7643-8340-4, DOI 10.1007/978-3-7643-8340-4_6]; Tukai R, 2002, MAR FRESHWATER RES, V53, P971, DOI 10.1071/MF01230; Turner A, 2010, MAR POLLUT BULL, V60, P159, DOI 10.1016/j.marpolbul.2009.12.004; UNSAL M, 1982, MAR POLLUT BULL, V13, P139, DOI 10.1016/0025-326X(82)90373-3; UNSAL M, 1983, MAR BIOL, V72, P279, DOI 10.1007/BF00396833; Viana IG, 2013, SCI TOTAL ENVIRON, V443, P887, DOI 10.1016/j.scitotenv.2012.11.065; Walther BD, 2015, ESTUAR COAST, V38, P754, DOI 10.1007/s12237-014-9881-7; Wang WX, 1999, SCI TOTAL ENVIRON, V238, P459; Wang Y, 2007, MAR FRESHWATER RES, V58, P778, DOI 10.1071/MF06148; WASSENBERG TJ, 1987, AUST J MAR FRESH RES, V38, P169, DOI 10.1071/MF9870169; Weihs C, 2005, ST CLASS DAT ANAL, P335; Xu SJ, 2015, MAR POLLUT BULL, V100, P562, DOI 10.1016/j.marpolbul.2015.08.031; YOUNG PC, 1978, AUST J MAR FRESH RES, V29, P55; Zhang W, 2013, ECOTOXICOLOGY, V22, P671, DOI 10.1007/s10646-013-1059-8; Zhou QF, 2008, ANAL CHIM ACTA, V606, P135, DOI 10.1016/j.aca.2007.11.018	129	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205408	10.1371/journal.pone.0205408	http://dx.doi.org/10.1371/journal.pone.0205408			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308010	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500070
J	Sari, E; Berraies, S; Knox, RE; Singh, AK; Ruan, YF; Cuthbert, RD; Pozniak, CJ; Henriquez, MA; Kumar, S; Burt, AJ; N'Diaye, A; Konkin, DJ; Cabral, AL; Campbell, HL; Wiebe, K; Condie, J; Lokuruge, P; Meyer, B; Fedak, G; Clarke, FR; Clarke, JM; Somers, DJ; Fobert, PR				Sari, Ehsan; Berraies, Samia; Knox, Ron E.; Singh, Asheesh K.; Ruan, Yuefeng; Cuthbert, Richard D.; Pozniak, Curtis J.; Henriquez, Maria Antonia; Kumar, Santosh; Burt, Andrew J.; N'Diaye, Amidou; Konkin, David J.; Cabral, Adrian L.; Campbell, Heather L.; Wiebe, Krystalee; Condie, Janet; Lokuruge, Prabhath; Meyer, Brad; Fedak, George; Clarke, Fran R.; Clarke, John M.; Somers, Daryl J.; Fobert, Pierre R.			High density genetic mapping of Fusarium head blight resistance QTL in tetraploid wheat	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; X TRITICUM-DURUM; WINTER-WHEAT; SPRING WHEAT; POPULATION; SELECTION; IDENTIFICATION; EMMER; DICOCCOIDES; SPREAD	Breeding for Fusarium head blight (FHB) resistance in durum wheat is complicated by the quantitative trait expression and narrow genetic diversity of available resources. High-density mapping of the FHB resistance quantitative trait loci (QTL), evaluation of their co-localization with plant height and maturity QTL and the interaction among the identified QTL are the objectives of this study. Two doubled haploid (DH) populations, one developed from crosses between Triticum turgidum ssp. durum lines DT707 and DT696 and the other between T. turgidum ssp. durum cv. Strongfield and T. turgidum ssp. carthlicum cv. Blackbird were genotyped using the 90K Infinium iSelect chip and evaluated phenotypically at multiple field FHB nurseries over years. A moderate broad-sense heritability indicated a genotype-by-environment interaction for the expression of FHB resistance in both populations. Resistance QTL were identified for the DT707 x DT696 population on chromosomes 1B, 2B, 5A (two loci) and 7A and for the Strongfield x Blackbird population on chromosomes 1A, 2A, 2B, 3A, 6A, 6B and 7B with the QTL on chromosome 1 A and those on chromosome 5A being more consistently expressed over environments. FHB resistance co-located with plant height and maturity QTL on chromosome 5A and with a maturity QTL on chromosome 7A for the DT707 x DT696 population. Resistance also co-located with plant height QTL on chromosomes 2A and 3A and with maturity QTL on chromosomes 1A and 7B for the Strongfield x Blackbird population. Additive x additive interactions were identified, for example between the two FHB resistance QTL on chromosome 5A for the DT707 x DT696 population and the FHB resistance QTL on chromosomes 1A and 7B for the Strongfield x Blackbird population. Application of the Single Nucleotide Polymorphic (SNP) markers associated with FHB resistance QTL identified in this study will accelerate combining genes from the two populations.	[Sari, Ehsan; Berraies, Samia; Knox, Ron E.; Singh, Asheesh K.; Ruan, Yuefeng; Cuthbert, Richard D.; Campbell, Heather L.; Lokuruge, Prabhath; Meyer, Brad; Clarke, Fran R.; Clarke, John M.] Agr & Agri Food Canada, Swift Current Res & Dev Ctr, Swift Current, SK, Canada; [Sari, Ehsan; Konkin, David J.; Cabral, Adrian L.; Condie, Janet; Lokuruge, Prabhath; Fobert, Pierre R.] Natl Res Council Canada, Aquat & Crop Resource Dev Ctr, Saskatoon, SK, Canada; [Pozniak, Curtis J.; N'Diaye, Amidou] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [Henriquez, Maria Antonia; Wiebe, Krystalee] Agr & Agri Food Canada, Morden Res & Dev Ctr, Morden, MB, Canada; [Kumar, Santosh; Burt, Andrew J.] Agr & Agri Food Canada, Brandon Res & Dev Ctr, Brandon, MB, Canada; [Fedak, George] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada; [Somers, Daryl J.] Vineland Res & Innovat Ctr, Vineland Stn, ON, Canada; [Singh, Asheesh K.] Iowa State Univ, Dept Agron, Ames, IA USA	Agriculture & Agri Food Canada; National Research Council Canada; University of Saskatchewan; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada; Iowa State University	Knox, RE (corresponding author), Agr & Agri Food Canada, Swift Current Res & Dev Ctr, Swift Current, SK, Canada.	ron.knox@canada.ca	CABRAL, ADRIAN L/E-6983-2011; Konkin, David/ABA-1737-2021	CABRAL, ADRIAN L/0000-0003-4550-7721; Cuthbert, Richard/0000-0002-1640-4929; N'Diaye, Amidou/0000-0001-7769-7801; Sari, Ehsan/0000-0002-8813-5465	Agriculture and Agri-Food Canada; Agriculture Development Fund (ADF) of the Government of Saskatchewan; Canadian Wheat Improvement Flaghip Program, as part of the National Research Council of Canada's	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Agriculture Development Fund (ADF) of the Government of Saskatchewan; Canadian Wheat Improvement Flaghip Program, as part of the National Research Council of Canada's	This work was supported by Agriculture and Agri-Food Canada, Agriculture Development Fund (ADF) of the Government of Saskatchewan, Canadian Wheat Improvement Flaghip Program, as part of the National Research Council of Canada's contribution to the Canadian Wheat Alliance.	Anderson JA, 2001, THEOR APPL GENET, V102, P1164, DOI 10.1007/s001220000509; Avni R, 2014, MOL BREEDING, V34, P1549, DOI 10.1007/s11032-014-0176-2; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Ball AD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-218; Bokore FE, 2017, CAN J PLANT SCI, V97, P65, DOI 10.1139/cjps-2016-0066; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buerstmayr H, 2002, THEOR APPL GENET, V104, P84, DOI 10.1007/s001220200009; Buerstmayr H, 2003, THEOR APPL GENET, V107, P503, DOI 10.1007/s00122-003-1272-6; Buerstmayr H, 2003, EUPHYTICA, V130, P17, DOI 10.1023/A:1022324727780; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Buerstmayr H, 2016, 5 INT S FUS HEAD BLI; Buerstmayr M, 2015, THEOR APPL GENET, V128, P1519, DOI 10.1007/s00122-015-2527-8; Buerstmayr M, 2013, THEOR APPL GENET, V126, P2825, DOI 10.1007/s00122-013-2174-x; Buerstmayr M, 2012, THEOR APPL GENET, V125, P1751, DOI 10.1007/s00122-012-1951-2; Buerstmayr M, 2011, THEOR APPL GENET, V123, P293, DOI 10.1007/s00122-011-1584-x; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chandra S, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0696-7; Chu CG, 2011, THEOR APPL GENET, V123, P1107, DOI 10.1007/s00122-011-1652-2; CHURCHILL GA, 1994, GENETICS, V138, P963; Clarke JM, 2009, CAN J PLANT SCI, V89, P505, DOI 10.4141/CJPS08168; Clarke JM, 2005, CAN J PLANT SCI, V85, P651, DOI 10.4141/P04-119; Cuthbert PA, 2007, THEOR APPL GENET, V114, P429, DOI 10.1007/s00122-006-0439-3; Engle JS, 2003, PLANT DIS, V87, P1530, DOI 10.1094/PDIS.2003.87.12.1530; Frisch M, 2005, GENETICS, V170, P909, DOI 10.1534/genetics.104.035451; Gladysz C, 2007, ISR J PLANT SCI, V55, P263, DOI 10.1560/IJPS.55.3-4.263; Handa H, 2008, MOL BREEDING, V22, P71, DOI 10.1007/s11032-008-9157-7; He XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162499; Holland J. B., 2003, Plant Breeding Reviews, V22, P9, DOI 10.1002/9780470650202.ch2; Huhn MR, 2012, CROP SCI, V52, P136, DOI 10.2135/cropsci2011.05.0263; Kong L, 2005, PLANT BREEDING, V124, P525, DOI 10.1111/j.1439-0523.2005.01139.x; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kumar S, 2007, PHYTOPATHOLOGY, V97, P592, DOI 10.1094/PHYTO-97-5-0592; Li XM, 2006, GENET MOL BIOL, V29, P166, DOI 10.1590/S1415-47572006000100030; Liu XM, 2005, THEOR APPL GENET, V111, P1308, DOI 10.1007/s00122-005-0059-3; Liu XM, 2005, THEOR APPL GENET, V110, P1473, DOI 10.1007/s00122-005-1982-z; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; Ma HX, 2006, PHYTOPATHOLOGY, V96, P534, DOI 10.1094/PHYTO-96-0534; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; McCartney CA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01542; Nicholson P, 2016, P 5 INT FUS HEAD BLI; Oliver RE, 2008, CROP SCI, V48, P213, DOI 10.2135/cropsci2007.03.0129; Oliver RE, 2007, CROP SCI, V47, P893, DOI 10.2135/cropsci2006.08.0531; Otto CD, 2002, PLANT MOL BIOL, V48, P625, DOI 10.1023/A:1014821929830; Prat N, 2017, THEOR APPL GENET, V130, P13, DOI 10.1007/s00122-016-2785-0; Randhawa HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005752; Ruan YF, 2012, GENOME, V55, P853, DOI 10.1139/gen-2012-0110; Singh AK, 2012, CAN J PLANT SCI, V92, P809, DOI 10.4141/cjps2011-255; Singh A.K, 2008, P 11 INT WHEAT GEN S P 11 INT WHEAT GEN S; Somers DJ, 2006, GENOME, V49, P1586, DOI 10.1139/G06-127; Stack RW, 2006, PLANT AN GEN 14 C SA; Steiner B, 2017, TROP PLANT PATHOL, V42, P165, DOI 10.1007/s40858-017-0127-7; Stepien L, 2010, WORLD MYCOTOXIN J, V3, P107, DOI 10.3920/WMJ2009.1193; Talas F, 2011, PLANT BREEDING, V130, P398, DOI 10.1111/j.1439-0523.2011.01867.x; Trebbi D, 2011, THEOR APPL GENET, V123, P555, DOI 10.1007/s00122-011-1607-7; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Verges VL, 2006, CROP SCI, V46, P1587, DOI 10.2135/cropsci2005.11-0412; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Waldron BL, 1999, CROP SCI, V39, P805, DOI 10.2135/cropsci1999.0011183X003900030032x; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Zhang QJ, 2014, MOL BREEDING, V34, P1677, DOI 10.1007/s11032-014-0180-6	61	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204362	10.1371/journal.pone.0204362	http://dx.doi.org/10.1371/journal.pone.0204362			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307951	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500015
J	Kaplan, JB; Mlynek, KD; Hettiarachchi, H; Alamneh, YA; Biggemann, L; Zurawski, DV; Black, CC; Bane, CE; Kim, RK; Granick, MS				Kaplan, Jeffrey B.; Mlynek, Kevin D.; Hettiarachchi, Hashani; Alamneh, Yonas A.; Biggemann, Lionel; Zurawski, Daniel, V; Black, Chad C.; Bane, Charles E.; Kim, Robert K.; Granick, Mark S.			Extracellular polymeric substance (EPS)-degrading enzymes reduce staphylococcal surface attachment and biocide resistance on pig skin in vivo	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; CARE-ASSOCIATED INFECTIONS; AUREUS BIOFILM FORMATION; EPIDERMIDIS BIOFILMS; BACTERIAL ADHESION; DISPERSIN-B; DNA; MODEL; COLONIZATION; MICROBIOTA	Staphylococcal extracellular polymeric substances (EPS) such as extracellular DNA (eDNA) and poly-N-acetylglucosamine surface polysaccharide (PNAG) mediate numerous virulence traits including host colonization and antimicrobial resistance. Previous studies showed that EPS-degrading enzymes increase staphylococcal biocide susceptibility in vitro and in vivo, and decrease virulence in animal models. In the present study we tested the effect of EPS-degrading enzymes on staphylococcal skin colonization and povidone iodine susceptibility using a novel in vivo pig model that enabled us to colonize and treat 96 isolated areas of skin on a single animal in vivo. To quantitate skin colonization, punch biopsies of colonized areas were homogenized, diluted, and plated on agar for colony forming unit enumeration. Skin was colonized with either Staphylococcus epidermidis or Staphylococcus aureus. Two EPS-degrading enzymes, DNase I and the PNAG-degrading enzyme dispersin B, were employed. Enzymes were tested for their ability to inhibit skin colonization and detach preattached bacteria. The effect of enzymes on the susceptibility of preattached S. aureus to killing by povidone iodine was also measured. We found that dispersin B significantly inhibited skin colonization by S. epidermidis and detached preattached S. epidermidis cells from skin. A cocktail of dispersin B and DNase I detached preattached S. aureus cells from skin and increased their susceptibility to killing by povidone iodine. These findings suggest that staphylococcal EPS components such as eDNA and PNAG contribute to skin colonization and biocide resistance in vivo. EPS-degrading enzymes may be a useful adjunct to conventional skin antisepsis procedures in order to further reduce skin bioburden.	[Kaplan, Jeffrey B.; Mlynek, Kevin D.; Hettiarachchi, Hashani] Amer Univ, Dept Biol, Washington, DC 20016 USA; [Alamneh, Yonas A.; Biggemann, Lionel; Zurawski, Daniel, V; Black, Chad C.; Bane, Charles E.; Kim, Robert K.] Walter Reed Army Inst Res, Wound Infect Dept, Silver Spring, MD USA; [Granick, Mark S.] Rutgers New Jersey Med Sch, Dept Surg, Newark, NJ USA; [Mlynek, Kevin D.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Hettiarachchi, Hashani] Sanaria Inc, Rockville, MD USA; [Biggemann, Lionel] Tufts Univ, Cummings Sch Vet Med, North Grafton, MA USA; [Bane, Charles E.] US Army Publ Hlth Act Ft Gordon, Ft Gordon, GA USA	American University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Rutgers State University New Brunswick; Rutgers State University Medical Center; Georgetown University; Sanaria Inc.; Tufts University; United States Department of Defense; United States Army	Kaplan, JB (corresponding author), Amer Univ, Dept Biol, Washington, DC 20016 USA.	kaplanjb@american.edu	Zurawski, Daniel/B-6578-2009	Zurawski, Daniel/0000-0002-7920-5601	National Institute of Allergy and Infectious Disease of the National Institutes of Health [AI097182]	National Institute of Allergy and Infectious Disease of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Disease of the National Institutes of Health under award number AI097182 (to J.B.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Buttner H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00014; Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y; Chokr A, 2006, INT J MED MICROBIOL, V296, P381, DOI 10.1016/j.ijmm.2006.02.018; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Costa AR, 2009, EUR J CLIN MICROBIOL, V28, P623, DOI 10.1007/s10096-008-0684-2; Cywes-Bentley C, 2013, P NATL ACAD SCI USA, V110, pE2209, DOI 10.1073/pnas.1303573110; Darouiche RO, 2009, J ANTIMICROB CHEMOTH, V64, P88, DOI 10.1093/jac/dkp158; Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332; Dengler V, 2015, J BACTERIOL, V197, P3779, DOI 10.1128/JB.00726-15; Foster T, 2016, EUR J CLIN MICROBIOL, V35, P1923, DOI 10.1007/s10096-016-2763-0; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Garrett TR, 2008, PROG NAT SCI-MATER, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001; Giacometti A, 2000, J CLIN MICROBIOL, V38, P918, DOI 10.1128/JCM.38.2.918-922.2000; Giotis ES, 2012, J APPL MICROBIOL, V113, P992, DOI 10.1111/j.1365-2672.2012.05397.x; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Hogan S, 2017, J HOSP INFECT, V96, P177, DOI 10.1016/j.jhin.2017.02.008; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Juarez-Verdayes MA, 2013, J MED MICROBIOL, V62, P1579, DOI 10.1099/jmm.0.055210-0; Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004; Kaplan JB, 2002, APPL ENVIRON MICROB, V68, P4943, DOI 10.1128/AEM.68.10.4943-4950.2002; Kaplan JB, 2012, J ANTIBIOT, V65, P73, DOI 10.1038/ja.2011.113; Krsko P, 2009, ACTA BIOMATER, V5, P589, DOI 10.1016/j.actbio.2008.08.025; Lee MJ, 2014, J BONE JOINT SURG AM, V96A, P1447, DOI 10.2106/JBJS.M.01474; Lin MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124216; Magill SS, 2012, INFECT CONT HOSP EP, V33, P283, DOI 10.1086/664048; McIntyre MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166176; Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051; O'Gara JP, 2017, ENVIRON MICROBIOL, V19, P3823, DOI 10.1111/1462-2920.13833; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Percival SL, 2015, J MED MICROBIOL, V64, P323, DOI 10.1099/jmm.0.000032; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Ravaioli S, 2011, INT J ARTIF ORGANS, V34, P840, DOI 10.5301/ijao.5000057; Sadovskaya I, 2006, FEMS IMMUNOL MED MIC, V47, P75, DOI 10.1111/j.1574-695X.2006.00068.x; Sanford JA, 2013, SEMIN IMMUNOL, V25, P370, DOI 10.1016/j.smim.2013.09.005; SERRERA A, 2007, 17 EUR C CLIN MICR I; Shanks RMQ, 2005, INFECT IMMUN, V73, P4596, DOI 10.1128/IAI.73.8.4596-4606.2005; Shopova I, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00141; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Surnmerfield A, 2015, MOL IMMUNOL, V66, P14, DOI 10.1016/j.molimm.2014.10.023; Swenson BR, 2009, INFECT CONT HOSP EP, V30, P964, DOI 10.1086/605926; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Wang Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep45070; Waryah CB, 2017, MICROB DRUG RESIST, V23, P384, DOI 10.1089/mdr.2016.0100; Zatorska B, 2017, CLIN ORTHOP RELAT R, V475, P2105, DOI 10.1007/s11999-017-5266-0	46	30	30	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205526	10.1371/journal.pone.0205526	http://dx.doi.org/10.1371/journal.pone.0205526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304066	Green Published, Green Submitted, gold			2022-12-26	WOS:000446921100104
J	Limpawattana, P; Theerakulpisut, D; Wirasorn, K; Sookprasert, A; Khuntikeo, N; Chindaprasirt, J				Limpawattana, Panita; Theerakulpisut, Daris; Wirasorn, Kosin; Sookprasert, Aumkhae; Khuntikeo, Narong; Chindaprasirt, Jarin			The impact of skeletal muscle mass on survival outcome in biliary tract cancer patients	PLOS ONE			English	Article							TO-LYMPHOCYTE RATIO; BODY-COMPOSITION; SARCOPENIA; METAANALYSIS; GEMCITABINE; CISPLATIN	Low skeletal muscle mass is frequently observed in cancer patients and is known to be a poor prognostic factor for survival outcomes. The purposes of our study were to determine the prevalence of sarcopenia and its relation to mortality in biliary tract cancer. Body composition measurements (skeletal muscle index, total fat mass, bone mineral content) were evaluated by using dual-energy x-ray absorptiometry in 75 biliary tract cancer patients before chemotherapy. Muscle strength was measured by handgrip strength and gait speed. Overall survival and its associated factors were determined. The mean appendicular muscle mass was 17.8 +/- 2.7 kg in men and 14.0 +/- 2.1 kg in women (p < 0.05). Sarcopenia was diagnosed in 46 patients (61.3%) and higher proportion of men was classified as sarcopenia than women (69.0% vs 35.3%, p < 0.05). Multivariable analysis adjusted for chemotherapy regimen and age revealed that high appendicular muscle mass independently predicted better survival outcomes (HR 0.40; 95% CI, 0.18 to 0.88; p = 0.023). Sarcopenia is common in biliary tract cancer patients and low appendicular muscle mass was associated with poor survival outcome.	[Limpawattana, Panita] Khon Kaen Univ, Fac Med, Dept Internal Med, Div Geriatr Med, Khon Kaen, Thailand; [Theerakulpisut, Daris] Khon Kaen Univ, Fac Med, Dept Radiol, Div Nucl Med, Khon Kaen, Thailand; [Wirasorn, Kosin; Sookprasert, Aumkhae; Chindaprasirt, Jarin] Khon Kaen Univ, Fac Med, Dept Internal Med, Med Oncol Unit, Khon Kaen, Thailand; [Khuntikeo, Narong] Khon Kaen Univ, Fac Med, Dept Surg, Div Hepatobiliary Surg, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Chindaprasirt, J (corresponding author), Khon Kaen Univ, Fac Med, Dept Internal Med, Med Oncol Unit, Khon Kaen, Thailand.	jarich@kku.ac.th	Theerakulpisut, Daris/F-4417-2015	Theerakulpisut, Daris/0000-0002-1338-511X; , Panita/0000-0003-3565-9342; Chindaprasirt, Jarin/0000-0002-0401-9812	Research Grant for New Scholar - Office of the Higher Education Commission; TRF; Khon Kaen University (KKU) [MRG-5980172]	Research Grant for New Scholar - Office of the Higher Education Commission; TRF(Thailand Research Fund (TRF)); Khon Kaen University (KKU)	This project was supported by the Research Grant for New Scholar co-funded by the Office of the Higher Education Commission, TRF and Khon Kaen University (KKU) (MRG-5980172 to JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banales JM, 2016, NAT REV GASTRO HEPAT, V13, P261, DOI 10.1038/nrgastro.2016.51; Cesari M, 2004, J GERONTOL A-BIOL, V59, P249; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chindapasirt Jarin, 2015, Asian Pac J Cancer Prev, V16, P8075; Choi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139749; Dalal S, 2012, J PAIN SYMPTOM MANAG, V44, P181, DOI 10.1016/j.jpainsymman.2011.09.010; Eckel F, 2007, BRIT J CANCER, V96, P896, DOI 10.1038/sj.bjc.6603648; Ethier JL, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-016-0794-1; Fukushima H, 2016, J UROLOGY, V195, P26, DOI 10.1016/j.juro.2015.08.071; Kang J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195118; Kelly CM, 2016, J ONCOL, V2016, DOI 10.1155/2016/6186543; Khuntikeo N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1475-7; Leal AD, 2018, LEUKEMIA LYMPHOMA, V59, P695, DOI 10.1080/10428194.2017.1347930; Lee JL, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2015.03.032; Lennon H, 2016, CURR ONCOL REP, V18, DOI 10.1007/s11912-016-0539-4; Ma JJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22425-3; Marosi C, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2015-000020; Martin L, 2015, J CLIN ONCOL, V33, P90, DOI 10.1200/JCO.2014.56.1894; Ninomiya G, 2017, INT J SURG, V39, P45, DOI 10.1016/j.ijsu.2017.01.075; Psutka SP, 2014, CANCER-AM CANCER SOC, V120, P2910, DOI 10.1002/cncr.28798; Shachar SS, 2016, EUR J CANCER, V57, P58, DOI 10.1016/j.ejca.2015.12.030; Tamandl D, 2016, EUR RADIOL, V26, P1359, DOI 10.1007/s00330-015-3963-1; Thoresen L, 2012, EUR J CANCER CARE, V21, P505, DOI 10.1111/j.1365-2354.2012.01327.x; Valle JW, 2014, ANN ONCOL, V25, P391, DOI 10.1093/annonc/mdt540; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; van Vledder MG, 2012, BRIT J SURG, V99, P550, DOI 10.1002/bjs.7823; Wirasorn K, 2016, Asian Pac J Cancer Prev, V17, P767; Wirasorn K, 2014, ASIAN PAC J CANCER P, V15, P8423, DOI 10.7314/APJCP.2014.15.19.8423; Xue TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096072	29	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204985	10.1371/journal.pone.0204985	http://dx.doi.org/10.1371/journal.pone.0204985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303998	gold, Green Submitted, Green Published			2022-12-26	WOS:000446921100070
J	Takahashi, T; Yoshihisa, A; Sugimoto, K; Yokokawa, T; Misaka, T; Kaneshiro, T; Oikawa, M; Kobayashi, A; Nakazato, K; Ishida, T; Takeishi, Y				Takahashi, Tomoko; Yoshihisa, Akiomi; Sugimoto, Koichi; Yokokawa, Tetsuro; Misaka, Tomofumi; Kaneshiro, Takashi; Oikawa, Masayoshi; Kobayashi, Atsushi; Nakazato, Kazuhiko; Ishida, Takafumi; Takeishi, Yasuchika			Associations between diabetes mellitus and pulmonary hypertension in chronic respiratory disease patients	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; INSULIN-RESISTANCE; GUIDELINES; SOCIETY; HEART	Background Pulmonary hypertension (PH) is a common complication of chronic respiratory disease. Recent studies have reported diabetes mellitus (DM) to be a poor prognostic factor in patients with chronic respiratory disease, including chronic obstructive pulmonary disease or interstitial pneumoniae. However, the association between DM and PH in chronic respiratory disease remains unclear. In this study, we aimed to investigate whether DM is a predictor of PH in patients with chronic respiratory disease. Methods We prospectively analyzed 386 patients in our hospital with chronic respiratory disease. An echocardiographic pressure gradient between the right atrium and the right ventricle of >= 40 mmHg was defined as PH. We compared the clinical characteristics and impact of DM between chronic respiratory disease patients with and those without PH. Results Of the 386 patients, 42 (10.9%) were diagnosed as having PH. The PH group had higher modified medical research council (mMRC) grade and complication rate of DM, but not hypertension and hyperlipidemia, when compared to the non-PH group. Multivariable logistic regression analysis revealed that mMRC scale (odds ratio 1.702, 95% confidence interval, 1.297 to 2.232, P < 0.001) and presence of DM (odd ratio 2.935, 95% confidence interval, 1.505 to 5.725, P = 0.002) were associated with PH in chronic respiratory disease patients. Conclusion DM is potentially associated with PH and is an independent factor for prediction of PH in patients with chronic respiratory disease.	[Takahashi, Tomoko] Fukushima Med Univ Hosp, Clin Res Ctr, Fukushima, Japan; [Yoshihisa, Akiomi; Misaka, Tomofumi] Fukushima Med Univ, Dept Adv Cardiac Therapeut, Fukushima, Japan; [Sugimoto, Koichi; Yokokawa, Tetsuro] Fukushima Med Univ, Dept Pulm Hypertens, Fukushima, Japan; [Kaneshiro, Takashi] Fukushima Med Univ, Dept Arrhythmia & Cardiac Pacing, Fukushima, Japan; [Oikawa, Masayoshi; Kobayashi, Atsushi; Nakazato, Kazuhiko; Ishida, Takafumi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiovasc Med, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University	Sugimoto, K (corresponding author), Fukushima Med Univ, Dept Pulm Hypertens, Fukushima, Japan.	ksugi@fmu.ac.jp			Acterion Pharmaceuticals Japan; Fukuda denshi; Biotronic Japan; Abbot Japan	Acterion Pharmaceuticals Japan; Fukuda denshi; Biotronic Japan; Abbot Japan	Acterion Pharmaceuticals Japan provided support in the form of salaries for authors [K.S., T. Y.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Fukuda denshi provided support in the form of salaries for authors [A.Y., T.M.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biotronic Japan and Abbot Japan provided support in the form of salaries for authors [T.K.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy AD, 2015, PULM CIRC, V5, P117, DOI 10.1086/679705; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Green DE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133391; Grinnan D, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2481659; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; Ho TW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175794; Hurdman J, 2012, EUR RESPIR J, V39, P945, DOI 10.1183/09031936.00078411; Hyldgaard C, 2014, RESP MED, V108, P647, DOI 10.1016/j.rmed.2014.01.008; Jo YS, 2017, INT J CHRONIC OBSTR, V12, P2433, DOI 10.2147/COPD.S136304; Makarevich AE, 2007, ADV MED SCI-POLAND, V52, P265; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Moral-Sanz J, 2012, EXP PHYSIOL, V97, P676, DOI 10.1113/expphysiol.2011.062257; Nakamura A, 2000, RESPIRATION, V67, P502, DOI 10.1159/000067463; Pan ML, 2017, PULM CIRC, V7, P175, DOI 10.1086/690206; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Perez T, 2015, INT J CHRONIC OBSTR, V10, P1663, DOI 10.2147/COPD.S82408; Pugh ME, 2011, J HEART LUNG TRANSPL, V30, P904, DOI 10.1016/j.healun.2011.02.016; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P517, DOI 10.5551/jat.15792; Weitzenblum E, 2009, SEMIN RESP CRIT CARE, V30, P458, DOI 10.1055/s-0029-1233315; West J, 2013, EUR RESPIR J, V41, P861, DOI 10.1183/09031936.00030312; Yoshihisa A, 2014, J CARDIOL, V64, P256, DOI 10.1016/j.jjcc.2014.02.003; Zamanian RT, 2009, EUR RESPIR J, V33, P318, DOI 10.1183/09031936.00000508; Zangiabadi A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/739674	27	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205008	10.1371/journal.pone.0205008	http://dx.doi.org/10.1371/journal.pone.0205008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300400	Green Submitted, Green Published, gold			2022-12-26	WOS:000446897200029
J	Llanaj, E; Adany, R; Lachat, C; D'Haese, M				Llanaj, Erand; Adany, Roza; Lachat, Carl; D'Haese, Marijke			Examining food intake and eating out of home patterns among university students	PLOS ONE			English	Article							DIETARY-INTAKE; ASSOCIATIONS; CONSUMPTION; ADOLESCENTS	Eating out of home (OH) is increasingly popular in Balkan countries, among them Albania. To date there is only anecdotal evidence regarding nutritional quality of food consumed OH and the contribution to diet. This study assessed intake of foods and drinks consumed OH and at home (AH), as well as their nutritional contribution to the daily diet of university students in Tirana, Albania. Using a single day Automated Multiple Pass Method (AMPM) 24-hour dietary recall, we examined food intake among 289 students aged 18-24 years old, from three major universities in Albania. Contribution of eating OH to total energy intake per day, as well as to daily consumption of macronutrients by eating OH intensity tertiles were assessed. Foods and drinks consumed OH contributed 46.9% [95% CI: 41.4-52.8] of total daily energy intake, representing, on average, 1169.1 kcal [95% CI: 1088.3-1249.9]. Sweets, soft drinks and meat products were more frequently consumed OH, while fruits and vegetables consumption was extremely low. The average quantity of sugars and dietary fats per day was higher AH, 76.9g [95% CI: 70.3-83.5] and 173.7g [95% CI: 163.2-184.2] respectively, compared to OH, 33.7g [95% CI: 30.4-37.0] and 142.0g [95% CI: 131.5-152.5] respectively. Dietary composition of AH intake was richer in sugars, total fats and proteins, while OH intake was richer in saturated fats. The overall diet appeared unhealthy, when nutrients were assessed as energy percentage against WHO proposed nutrient standards for sugar and saturated fats. Eating OH, even though was associated with lower fruits and vegetables intake, was not clearly associated with poor diet quality, as AH foods were also characterized by increased saturated fats and sugars intake as energy percentage. This study provides data on the first assessment of current dietary patterns of the studied population and can be used as baseline for designing and conducting future studies and interventions targeting malnutrition in all its forms.	[Llanaj, Erand; Adany, Roza] Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, Debrecen, Hungary; [Llanaj, Erand; Lachat, Carl] Univ Ghent, Fac Biosci Engn, Dept Food Technol Safety & Hlth, Ghent, Belgium; [Llanaj, Erand; D'Haese, Marijke] Univ Ghent, Fac Biosci Engn, Dept Agr Econ, Ghent, Belgium	University of Debrecen; Ghent University; Ghent University	Llanaj, E (corresponding author), Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, Debrecen, Hungary.; Llanaj, E (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Food Technol Safety & Hlth, Ghent, Belgium.; Llanaj, E (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Agr Econ, Ghent, Belgium.	erand.llanaj@sph.unideb.hu	Llanaj, Erand/B-8403-2018; lachat, carl/AAH-9764-2020	Llanaj, Erand/0000-0003-4300-0433; lachat, carl/0000-0002-1389-8855; D'Haese, Marijke/0000-0002-0544-3420	European Union under the European Social Fund [GINOP-2.3.2-15-2016-00005]; European Regional Development Fund	European Union under the European Social Fund; European Regional Development Fund(European Commission)	This work was supported by the GINOP-2.3.2-15-2016-00005 project cofinanced by the European Union under the European Social Fund and European Regional Development Fund. There was no additional external funding received for this study.	[Anonymous], 2007, NUTR COMP GREEK FOOD; [Anonymous], 2008, RUR INFR STR AGR IND; [Anonymous], 2017, GLOBAL NUTR REPORT 2; ASSEMBLY UNG, 2016, RES AD UN GEN ASS UN; Austin SB, 2005, AM J PUBLIC HEALTH, V95, P1575, DOI 10.2105/AJPH.2004.056341; Bezerra IN, 2015, PUBLIC HEALTH NUTR, V18, P1011, DOI 10.1017/S1368980014001189; Bucaj A, 2013, MEDITERR J NUTR META, V6, P39, DOI 10.1007/s12349-012-0114-y; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Citozi R, 2016, ARENA J PHYS ACTIVIT; Louzada MLD, 2015, PREV MED, V81, P9, DOI 10.1016/j.ypmed.2015.07.018; Deforche B, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0173-9; Djekic I, 2011, FOOD CONTROL, V22, P1736, DOI 10.1016/j.foodcont.2011.04.006; Fleischhacker SE, 2011, OBES REV, V12, pe460, DOI 10.1111/j.1467-789X.2010.00715.x; French SA, 2001, INT J OBESITY, V25, P1823, DOI 10.1038/sj.ijo.0801820; Hoefkens C, 2011, AM J CLIN NUTR, V94, P562, DOI 10.3945/ajcn.111.013417; [INSTAT (INSTAT) TIoS], 2017, INSTAT TIOS; Janssen HG, 2017, NUTR RES REV, P1; Jaupi A., 2015, Albanian Journal of Agricultural Sciences, V14, P59; Kant AK, 2015, INT J OBESITY, V39, P820, DOI 10.1038/ijo.2014.183; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Lachat C, 2012, OBES REV, V13, P329, DOI 10.1111/j.1467-789X.2011.00953.x; Lachat C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002036; Lachat C, 2011, APPETITE, V57, P649, DOI 10.1016/j.appet.2011.08.003; Lachat CK, 2009, PUBLIC HEALTH NUTR, V12, P122, DOI 10.1017/S1368980008002048; Langley-Evans SC, 2015, J HUM NUTR DIET, V28, P1, DOI 10.1111/jhn.12212; Magnani R., 1997, FOOD NUTR TECHNICAL; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Muzi G, 2016, ANGLISTICUM J ASS AN, V4, P78; Naska A, 2015, BRIT J NUTR, V113, P1951, DOI 10.1017/S0007114515000963; Neumark-Sztainer D, 2003, J AM DIET ASSOC, V103, P317, DOI 10.1053/jada.2003.50048; Rippin H, 2018, NATL NUTR SURVEYS EU, V62, DOI [10.29219/fnr.v62.1362, DOI 10.29219/FNR.V62.1362]; Roos E, 2004, PUBLIC HEALTH NUTR, V7, P53, DOI 10.1079/PHN2003511; Seguin RA, 2016, J ENV PUBLIC HLTH, V2016; Seow DY, 2015, AM J HYPERTENS, DOI [10.1017/S0007114515000963, DOI 10.1017/S0007114515000963]; Shabani Z, 2013, ACAD J INTERDISCIPLI, V2, P360; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; VANHORN LV, 1993, J AM DIET ASSOC, V93, P1396, DOI 10.1016/0002-8223(93)92241-O; Vepsalainen H, 2015, Int J Obes Suppl, V5, pS66, DOI 10.1038/ijosup.2015.22	38	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0197874	10.1371/journal.pone.0197874	http://dx.doi.org/10.1371/journal.pone.0197874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296258	Green Published, Green Submitted, gold			2022-12-26	WOS:000446632700001
J	Maharjan, M; Maeda, RK; Karch, F; Hart, CM				Maharjan, Mukesh; Maeda, Robert K.; Karch, Francois; Hart, Craig M.			Using a phiC31 "Disintegrase" to make new attP sites in the Drosophila genome at locations showing chromosomal position effects	PLOS ONE			English	Article							INTEGRASE; PHI-C31; RECOMBINATION; TRANSFORMATION; INSULATOR; ELEMENTS; DOMAINS	An engineered phiC31 "Disintegrase" able to make an attP site in Drosophila out of an attR-attL pair is described. This was used to generate attP sites at genomic locations where a mini-white (mini-w) transgene was subject to chromosomal position effects (CPE). The first step was random genomic integration of a P-element-based transposon with an insulated mini-w transgene. We then removed the upstream insulator using FLP recombinase to detect CPE. Next mini-w and the downstream insulator were "dis-integrated" leaving behind an attP site. The location is marked by a yellow(+) transgene that is flanked by loxP sites, so it can also be removed. Using this system, we generated 10 new attP landing platforms. Three of these showing strong activating CPE were selected for further analysis. We show that the attP sites are functional by integrating in plasmids with attB sites. The CPE is recapitulated and can be blocked by insulators. We show that a dimerized 215 bp fragment of the 500 bp BEAF-dependent scs' insulator containing a high affinity BEAF binding site blocks the CPE, while a monomer of the sequence is less effective. This indicates that two BEAF binding sites make a stronger insulator than a single site. This system could be useful for generating attP sites at prescreened sites for other purposes, such as studying CPE in embryos or other tissues or for use with "trapped" enhancers of interest.	[Maharjan, Mukesh; Hart, Craig M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Maeda, Robert K.; Karch, Francois] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland	Louisiana State University System; Louisiana State University; University of Geneva	Hart, CM (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	chart4@lsu.edu	Hart, Craig/B-4832-2016; Maharjan, Mukesh/AAL-3031-2021	Hart, Craig/0000-0002-9870-991X; Maharjan, Mukesh/0000-0002-8002-3311; karch, Francois/0000-0003-4722-5170	National Science Foundation [1244100]; State of Geneva; Swiss National Fund	National Science Foundation(National Science Foundation (NSF)); State of Geneva; Swiss National Fund(Swiss National Science Foundation (SNSF))	This work was supported by the National Science Foundation [1244100 to CMH]; the State of Geneva [FK and RM]; the Swiss National Fund [FK and RM]; and Donation Claraz [FK and RM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bier E, 2018, GENETICS, V208, P1, DOI 10.1534/genetics.117.1113; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Cuvier O, 1998, MOL CELL BIOL, V18, P7478, DOI 10.1128/MCB.18.12.7478; GAVIS ER, 1992, CELL, V71, P301, DOI 10.1016/0092-8674(92)90358-J; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Gilbert MK, 2006, GENETICS, V173, P1365, DOI 10.1534/genetics.106.056002; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Huang Audrey M, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5199; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Knapp JM, 2015, GENETICS, V199, P919, DOI 10.1534/genetics.114.173187; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Pirrotta V, 1988, Biotechnology, V10, P437; Potter CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010168; Rowley PA, 2008, NUCLEIC ACIDS RES, V36, P3879, DOI 10.1093/nar/gkn269; Roy S, 2007, GENETICS, V176, P801, DOI 10.1534/genetics.106.068056; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sigrist CJA, 1997, GENETICS, V147, P209; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X	24	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205538	10.1371/journal.pone.0205538	http://dx.doi.org/10.1371/journal.pone.0205538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296303	Green Submitted, Green Published, gold			2022-12-26	WOS:000446632700040
J	Vetreno, RP; Crews, FT				Vetreno, Ryan P.; Crews, Fulton T.			Adolescent binge ethanol-induced loss of basal forebrain cholinergic neurons and neuroimmune activation are prevented by exercise and indomethacin	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NF-KAPPA-B; POSTNATAL-DEVELOPMENT; GENE-EXPRESSION; CHRONIC NEUROINFLAMMATION; HIPPOCAMPAL-FORMATION; RAT HIPPOCAMPUS; NUCLEUS BASALIS; DIAGONAL BAND; ADULT	Basal forebrain cholinergic neurons mature in adolescence coinciding with development of adult cognitive function. Preclinical studies using the rodent model of adolescent intermittent ethanol (AIE; 5.0 g/kg, i.g., 2-days on/2-days off from postnatal day [P] 25 to P55) reveal persistent increases of brain neuroimmune genes that are associated with cognitive dysfunction. Adolescent intermittent ethanol exposure also reduces basal forebrain expression of choline acetyltransferase (ChAT), an enzyme critical for acetylcholine synthesis in cholinergic neurons similar to findings in the post-mortem human alcoholic basal forebrain. We report here that AIE decreases basal forebrain ChAT+IR neurons in both adult female and male Wistar rats following early or late adolescent ethanol exposure. In addition, we find reductions in ChAT+IR somal size as well as the expression of the high-affinity nerve growth factor (NGF) receptor tropomyosin receptor kinase A (TrkA) and the low-affinity NGF receptor p75(NTR), both of which are expressed on cholinergic neurons. The decrease in cholinergic neuron marker expression was accompanied by increased phosphorylation of NF-kappa B p65 (pNF-kappa B p65) consistent with increased neuroimmune signaling. Voluntary wheel running from P24 to P80 prevented AIE-induced cholinergic neuron shrinkage and loss of cholinergic neuron markers (i.e., ChAT, TrkA, and p75(NTR)) as well as the increase of pNF-kappa B p65 in the adult basal forebrain. Administration of the anti-inflammatory drug indomethacin (4.0 mg/kg, i.p prior to each ethanol exposure) during AIE also prevented the loss of basal forebrain cholinergic markers and the concomitant increase of pNF-kappa B p65. In contrast, treatment with the proinflammatory immune activator lipopolysaccharide (1.0 mg/kg, i.p. on P70) caused a loss of cholinergic neuron markers that was paralleled by increased pNF-kappa B p65 in the basal forebrain. These novel findings are consistent with AIE causing lasting activation of the neuroimmune system that contributes to the persistent loss of basal forebrain cholinergic neurons in adulthood.	[Vetreno, Ryan P.; Crews, Fulton T.] Univ North Carolina Chapel Hill, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Vetreno, RP (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA.	rvetreno@email.unc.edu	Crews, Fulton/T-1181-2019	Crews, Fulton/0000-0003-2393-4976; Vetreno, Ryan/0000-0003-0449-395X	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism [AA019767, AA011605, AA007573, AA021040]; Neurobiology of Adolescent Drinking in Adulthood (NADIA) [AA020023, AA020024, AA020022]; Bowles Center for Alcohol Studies; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U54AA019767, U01AA020023, U24AA020024, P60AA011605] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Neurobiology of Adolescent Drinking in Adulthood (NADIA); Bowles Center for Alcohol Studies; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (AA019767, AA011605, AA007573, and AA021040), the Neurobiology of Adolescent Drinking in Adulthood (NADIA [AA020023, AA020024, and AA020022]), and the Bowles Center for Alcohol Studies. The NIH, NIAAA, NADIA, and Bowles Center for Alcohol Studies had no further role in the study design, data collection, analysis, and interpretation of data, writing of the report, or decision to submit the article for publication.	Alfonso-Loeches S, 2011, CRIT REV CL LAB SCI, V48, P19, DOI 10.3109/10408363.2011.580567; Ang ET, 2004, NEUROSCIENCE, V129, P337, DOI 10.1016/j.neuroscience.2004.06.087; Ang ET, 2003, NEUROSCIENCE, V118, P335, DOI 10.1016/S0306-4522(02)00989-2; ARENDT T, 1995, NEUROSCIENCE, V65, P633, DOI 10.1016/0306-4522(94)00526-B; ARMSTRONG DM, 1987, J COMP NEUROL, V264, P421, DOI 10.1002/cne.902640309; Ballinger EC, 2016, NEURON, V91, P1199, DOI 10.1016/j.neuron.2016.09.006; Banuelos C, 2013, NEUROBIOL AGING, V34, P845, DOI 10.1016/j.neurobiolaging.2012.06.013; Baxter MG, 1999, CURR OPIN NEUROBIOL, V9, P178, DOI 10.1016/S0959-4388(99)80024-5; Blake MG, 2018, CURR TOP BEHAV NEURO, V37, P253, DOI 10.1007/7854_2016_467; Boissiere F, 1997, NEUROREPORT, V8, P2849, DOI 10.1097/00001756-199709080-00009; Boutros N, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu003; Broadwater M, 2013, BEHAV BRAIN RES, V256, P10, DOI 10.1016/j.bbr.2013.08.013; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Coleman LG, 2011, ALCOHOL CLIN EXP RES, V35, P671, DOI 10.1111/j.1530-0277.2010.01385.x; Crews FT, 2004, ALCOHOL CLIN EXP RES, V28, P350, DOI 10.1097/01.ALC.0000113416.65546.01; Crews FT, 2004, ALCOHOL, V33, P63, DOI 10.1016/j.alcohol.2004.04.005; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Crews F, 2006, ALCOHOL CLIN EXP RES, V30, P1938, DOI 10.1111/j.1530-0277.2006.00239.x; Crews FT, 2017, PSYCHOPHARMACOLOGY, V234, P1483, DOI 10.1007/s00213-017-4560-6; Crews FT, 2016, PHARMACOL REV, V68, P1074, DOI 10.1124/pr.115.012138; Crews FT, 2016, PSYCHOPHARMACOLOGY, V233, P1543, DOI 10.1007/s00213-015-3906-1; DINOPOULOS A, 1992, DEV BRAIN RES, V65, P65, DOI 10.1016/0165-3806(92)90009-L; Ehlers CL, 2011, NEUROSCIENCE, V199, P333, DOI 10.1016/j.neuroscience.2011.10.011; Fernandez GM, 2017, NEUROSCIENCE, V361, P129, DOI 10.1016/j.neuroscience.2017.08.013; Gibbs RB, 1998, EXP NEUROL, V151, P289, DOI 10.1006/exnr.1998.6789; GOULD E, 1989, DEV BRAIN RES, V46, P297, DOI 10.1016/0165-3806(89)90293-9; GOULD E, 1991, BRAIN RES BULL, V27, P767, DOI 10.1016/0361-9230(91)90209-3; Guan ZW, 2006, BRAIN BEHAV IMMUN, V20, P64, DOI 10.1016/j.bbi.2005.04.005; Guo KH, 2014, INT J DEV NEUROSCI, V35, P72, DOI 10.1016/j.ijdevneu.2014.03.004; Hall JM, 2016, EXP NEUROL, V278, P62, DOI 10.1016/j.expneurol.2016.01.018; HIGGINS GA, 1989, EXP NEUROL, V106, P222, DOI 10.1016/0014-4886(89)90155-6; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Isaev NK, 2017, BIOCHEMISTRY-MOSCOW+, V82, P291, DOI 10.1134/S0006297917030075; Johnston LD, 2013, MONITORING THE FUTUR; KORSCHING S, 1986, NEUROSCI LETT, V66, P175, DOI 10.1016/0304-3940(86)90186-2; Lazo OM, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-5; Leasure JL, 2009, HIPPOCAMPUS, V19, P907, DOI 10.1002/hipo.20563; LEHERICY S, 1993, J COMP NEUROL, V330, P15, DOI 10.1002/cne.903300103; LINKE R, 1993, J COMP NEUROL, V332, P69, DOI 10.1002/cne.903320106; MATTHEWS DA, 1974, DEV BIOL, V36, P130, DOI 10.1016/0012-1606(74)90196-1; MCMILLIAN M, 1995, BIOCHEM BIOPH RES CO, V215, P572, DOI 10.1006/bbrc.1995.2503; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Miller R, 2002, BRAIN RES, V950, P137, DOI 10.1016/S0006-8993(02)03014-7; Montesinos J, 2016, BRAIN BEHAV IMMUN, V53, P159, DOI 10.1016/j.bbi.2015.12.006; Mufson EJ, 1996, NEUROREPORT, V8, P25, DOI 10.1097/00001756-199612200-00006; NADLER JV, 1974, DEV BIOL, V36, P142, DOI 10.1016/0012-1606(74)90197-3; Nagahara AH, 2009, EXP NEUROL, V215, P153, DOI 10.1016/j.expneurol.2008.10.004; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peterson DA, 1999, J COMP NEUROL, V404, P1, DOI 10.1002/(SICI)1096-9861(19990201)404:1<1::AID-CNE1>3.0.CO;2-#; Richwine AF, 2008, PSYCHONEUROENDOCRINO, V33, P1369, DOI 10.1016/j.psyneuen.2008.08.003; SOBREVIELA T, 1994, J COMP NEUROL, V350, P587, DOI 10.1002/cne.903500407; Spear LP, 2009, BEHAV NEUROSCIENCE A; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Sung S, 2004, AM J PATHOL, V165, P2197, DOI 10.1016/S0002-9440(10)63269-5; Swartzwelder HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140042; ToliverKinsky T, 1997, J NEUROSCI RES, V48, P580, DOI 10.1002/(SICI)1097-4547(19970615)48:6<580::AID-JNR11>3.0.CO;2-Z; Unal CT, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00021; Vetreno RP, 2012, NEUROSCIENCE, V226, P475, DOI 10.1016/j.neuroscience.2012.08.046; Vetreno RP, FRONTIERS NEUROSCIEN; Vetreno RP, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00200; Vetreno RP, 2017, BRAIN BEHAV IMMUN, V60, P333, DOI 10.1016/j.bbi.2016.09.018; Vetreno RP, 2016, ADDICT BIOL, V21, P939, DOI 10.1111/adb.12232; Vetreno RP, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00035; Vetreno RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113421; Vetreno RP, 2013, NEUROBIOL DIS, V59, P52, DOI 10.1016/j.nbd.2013.07.002; Wenk GL, 2003, NEUROSCIENCE, V121, P719, DOI 10.1016/S0306-4522(03)00545-1; White AM, 2006, ALCOHOL CLIN EXP RES, V30, P1006, DOI 10.1111/j.1530-0277.2006.00122.x; Willard LB, 2000, EXP BRAIN RES, V134, P58, DOI 10.1007/s002210000446; Willard LB, 1999, NEUROSCIENCE, V88, P193; Wu CK, 2005, EXP NEUROL, V195, P484, DOI 10.1016/j.expneurol.2005.06.020; ZAHALKA EA, 1993, BRAIN RES, V601, P221, DOI 10.1016/0006-8993(93)91714-4	73	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0204500	10.1371/journal.pone.0204500	http://dx.doi.org/10.1371/journal.pone.0204500			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296276	Green Submitted, gold, Green Published			2022-12-26	WOS:000446632700012
J	Finsterwalder, R; Ganesan, MK; Leb, H; Habertheuer, A; Basilio, J; Lang, I; Krunic, M; Wiedemann, D; Petzelbauer, P				Finsterwalder, Richard; Ganesan, Minu Karthika; Leb, Heide; Habertheuer, Andreas; Basilio, Jose; Lang, Irene; Krunic, Milica; Wiedemann, Dominik; Petzelbauer, Peter			Hypoxia/reperfusion predisposes to atherosclerosis	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; GENE-EXPRESSION; MOUSE MODEL; CELL-PROLIFERATION; ORPHAN-RECEPTOR; MECHANISMS; INJURY; PATHOPHYSIOLOGY; POLYPLOIDY; MODULATION	Surgical interventions on blood vessels bear a risk for intimal hyperplasia and atherosclerosis as a consequence of injury. A specific feature of intimal hyperplasia is the loss of vascular smooth muscle cell (VSMC) differentiation gene expression. We hypothesized that immediate responses following injury induce vascular remodeling. To differentiate injury due to trauma, reperfusion and pressure changes we analyzed vascular responses to carotid artery bypass grafting in mice compared to transient ligation. As a control, the carotid artery was surgically laid open only. In both, bypass or ligation models, the inflammatory responses were transient, peaking after 6h, whereas the loss of VSMC differentiation gene expression persisted. Extended time kinetics showed that transient carotid artery ligation was sufficient to induce a persistent VSMC phenotype change throughout 28 days. Transient arterial ligation in ApoE knockout mice resulted in atherosclerosis in the transiently ligated vascular segment but not on the not-ligated contralateral side. The VSMC phenotype change could not be prevented by anti-TNF antibodies, Sorafenib, Cytosporone B or N-acetylcysteine treatment. Surgical interventions involving hypoxia/reperfusion are sufficient to induce VSMC phenotype changes and vascular remodeling. In situations of a perturbed lipid metabolism this bears the risk to precipitate atherosclerosis.	[Finsterwalder, Richard; Ganesan, Minu Karthika; Leb, Heide; Petzelbauer, Peter] Med Univ Vienna, Dept Dermatol, SERD, Vienna, Austria; [Habertheuer, Andreas] Hosp Univ Penn, Div Cardiovasc Surg, Perelman Sch Med, 3400 Spruce St, Philadelphia, PA 19104 USA; [Basilio, Jose] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Vienna, Austria; [Lang, Irene] Med Univ Vienna, Vienna Gen Hosp, Dept Internal Med 2, Div Cardiol, Vienna, Austria; [Krunic, Milica] Univ Vienna, Med Univ Vienna, Ctr Integrat Bioinformat Vienna, Max F Perutz Labs, Vienna, Austria; [Wiedemann, Dominik] Med Univ Vienna, Dept Cardiac Surg, Vienna, Austria	Medical University of Vienna; University of Pennsylvania; Pennsylvania Medicine; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna	Petzelbauer, P (corresponding author), Med Univ Vienna, Dept Dermatol, SERD, Vienna, Austria.	peter.petzelbauer@meduniwien.ac.at	Wiedemann, Dominik/AAH-2649-2020; petzelbauer, peter/GLU-3941-2022	Wiedemann, Dominik/0000-0002-2055-8293; Basilio, Jose/0000-0001-7380-2942; Lang, Irene/0000-0003-0485-2692; Habertheuer, Andreas/0000-0001-7310-8838; Petzelbauer, Peter/0000-0001-7080-5259	SFB grant Austrian Science Foundation [F 5408-B21, F 5411-B21]	SFB grant Austrian Science Foundation	This work was supported by SFB grant Austrian Science Foundation F 5408-B21 and F 5411-B21. www.fwf.ac.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Ali MS, 2013, J CEREBR BLOOD F MET, V33, P1564, DOI 10.1038/jcbfm.2013.109; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrienko TN, 2017, J MOL CELL CARDIOL, V110, P1, DOI 10.1016/j.yjmcc.2017.06.016; Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; Bonta PI, 2010, CARDIOVASC RES, V87, P561, DOI 10.1093/cvr/cvq064; Borel CO, 2003, STROKE, V34, P427, DOI 10.1161/01.STR.0000053848.06436.AB; Chang M, 2016, AM J CARDIOL, V118, P17, DOI 10.1016/j.amjcard.2016.04.009; Cui ML, 2016, HYPERTENSION, V67, P153, DOI 10.1161/HYPERTENSIONAHA.115.06114; Curcio A, 2011, CIRC J, V75, P1287, DOI 10.1253/circj.CJ-11-0366; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; de Vries MR, 2016, NAT REV CARDIOL, V13, P451, DOI 10.1038/nrcardio.2016.76; De Wilde D, 2016, J BIOMECH, V49, P2135, DOI 10.1016/j.jbiomech.2015.11.048; De Wilde D, 2015, MOL IMAGING, V14, DOI 10.2310/7290.2015.00009; Eltzschig HK, 2004, BRIT MED BULL, V70, P71, DOI 10.1093/bmb/ldh025; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fang H, 2014, EXP THER MED, V7, P970, DOI 10.3892/etm.2014.1510; Getz GS, 2016, J LIPID RES, V57, P758, DOI 10.1194/jlr.R067249; Gorla GR, 2001, J CELL SCI, V114, P2943; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Jeffery TK, 2002, PROG CARDIOVASC DIS, V45, P173, DOI 10.1053/pcad.2002.130041; Jia ZL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137782; Johnson JL, 2014, CARDIOVASC RES, V103, P452, DOI 10.1093/cvr/cvu171; Katsuumi G, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00018; Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282; Kijani S, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13334; Lacolley P, 2017, PHYSIOL REV, V97, P1555, DOI 10.1152/physrev.00003.2017; Lilly B, 2014, PHYSIOLOGY, V29, P234, DOI 10.1152/physiol.00047.2013; LINDNER V, 1993, CIRC RES, V73, P792, DOI 10.1161/01.RES.73.5.792; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Sasso G, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0901-1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu P, 2007, MAMM GENOME, V18, P617, DOI 10.1007/s00335-007-9048-y; Mccrann DJ, 2008, J CELL PHYSIOL, V215, P588, DOI 10.1002/jcp.21363; McCrann DJ, 2009, CELL CYCLE, V8, P902, DOI 10.4161/cc.8.6.7900; Mitra AK, 2006, IMMUNOL CELL BIOL, V84, P115, DOI 10.1111/j.1440-1711.2005.01407.x; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murgai M, 2017, NAT MED, V23, P1176, DOI 10.1038/nm.4400; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Roostalu U, 2018, DEV BIOL, V435, P109, DOI 10.1016/j.ydbio.2018.01.018; Shimamura N, 2014, TRANSL STROKE RES, V5, P357, DOI 10.1007/s12975-013-0310-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tange O., 2018, USENIX MAGAZINE, V36, P42; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yildiz G, 2007, ANN NY ACAD SCI, V1100, P353, DOI 10.1196/annals.1395.038; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163; Zimna A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/549412; Zou YP, 1998, AM J PATHOL, V153, P1301, DOI 10.1016/S0002-9440(10)65675-1	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205067	10.1371/journal.pone.0205067	http://dx.doi.org/10.1371/journal.pone.0205067			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289932	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500044
J	Cheng, YF; Yang, TH; Wu, CS; Huang, CC; Lin, HC				Cheng, Yen-Fu; Yang, Tzong-Han; Wu, Chuan-Song; Huang, Chung-Chien; Lin, Herng-Ching			Association between mitral valve prolapse and sudden sensorineural hearing loss: A case-control population-based study	PLOS ONE			English	Article							MARFAN-SYNDROME; DISEASE; GENES	This study aimed to evaluate the relationship between sudden sensorineural hearing loss (SSNHL) and MVP using a population-based dataset. Data for this case-control study were retrieved from the Taiwan Longitudinal Health Insurance Database. In total, 3399 cases of newly diagnosed SSNHL were identified. We used propensity score matching to select 3399 comparison patients (one for every case) from the same dataset. The selected matching variables included age, sex, monthly income, geographical location, urbanization level of the patient's residence, hypertension, diabetes, and hyperlipidemia. Chi-squared tests were used to compare differences in sociodemographic characteristics, while conditional logistic regression analyses were used to examine the association of SSNHL with previously diagnosed MVP. Of the 6798 sampled subjects, 131 (1.93%) patients had received a diagnosis of MVP prior to the index date. A significant difference in the prevalence of prior MVP between cases and controls (2.41% vs. 1.44%, p =0.004) was observed. The conditional logistic regression analysis conditioned on gender, age, monthly income, urbanization level, geographic region, hyperlipidemia, diabetes, and hypertension suggested that the odds ratio of prior MVP for cases was 1.69 (95% confidence interval (CI): 1.18-2.42) compared to controls. Our study found that patients with MVP had a 1.69-fold higher risk of getting SSNHL compared to patients without MVP.	[Cheng, Yen-Fu] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Cheng, Yen-Fu] Taipei Vet Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Cheng, Yen-Fu] Natl Yang Ming Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Cheng, Yen-Fu] Natl Taipei Univ Nursing & Hlth Sci, Dept Speech Language & Audiol, Taipei, Taiwan; [Cheng, Yen-Fu; Lin, Herng-Ching] Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan; [Yang, Tzong-Han; Wu, Chuan-Song] Taipei City Hosp, Dept Otolaryngol, Taipei, Taiwan; [Huang, Chung-Chien; Lin, Herng-Ching] Taipei Med Univ, Coll Management, Sch Hlth Care Adm, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS); Taipei Medical University; Taipei City Hospital; Taipei Medical University	Lin, HC (corresponding author), Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan.; Lin, HC (corresponding author), Taipei Med Univ, Coll Management, Sch Hlth Care Adm, Taipei, Taiwan.	henry11111@tmu.edu.tw	Huang, CC/AAX-5872-2021	Huang, CC/0000-0003-0818-7175; Cheng, Yen-Fu/0000-0003-1995-5854				Avierinos JF, 2003, STROKE, V34, P1339, DOI 10.1161/01.STR.0000072274.12041.FF; Calabrese V, 2010, NEUROCHEM RES, V35, P2208, DOI 10.1007/s11064-010-0304-2; CALTRIDER ND, 1980, AM J OPHTHALMOL, V90, P534, DOI 10.1016/S0002-9394(14)75024-X; Di Stadio A, 2017, J INT MED RES, V45, P1470, DOI 10.1177/0300060516688600; Freed LA, 1999, PREVALENCE CLIN OUTC; Graff J, 2005, SEMIN THROMB HEMOST, V31, P482, DOI 10.1055/s-2005-916685; Icli A, 2013, CLIN APPL THROMB-HEM, V19, P608, DOI 10.1177/1076029612461847; Le Tourneau T, 2018, HEART BRIT CARDIAC S, DOI [10.1136/heartjnl-2016-311028, DOI 10.1136/HEARTJNL-2016-311028]; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; Levine RA, 2015, NAT REV CARDIOL, V12, P689, DOI 10.1038/nrcardio.2015.161; MAYAHARA T, 1972, LARYNGOSCOPE, V82, P578, DOI 10.1288/00005537-197204000-00003; Moulonguet H, 1985, Ann Otolaryngol Chir Cervicofac, V102, P415; Murillo-Cuesta S, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3389/fnagi.2015.00032, 10.5589/fnagi.2015.00032]; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Olivetto E, 2015, HEARING RES, V327, P58, DOI 10.1016/j.heares.2015.05.004; PERLOFF JK, 1987, AM HEART J, V113, P1324, DOI 10.1016/0002-8703(87)90961-6; PERLOFF JK, 1989, CIRCULATION, V80, P710, DOI 10.1161/01.CIR.80.3.710; Solanellas J, 1996, Ann Otolaryngol Chir Cervicofac, V113, P430; VANRHEE F, 1991, BRIT J OPHTHALMOL, V75, P436, DOI 10.1136/bjo.75.7.436; Vazquez R, 2008, INT J CARDIOL, V124, P370, DOI 10.1016/j.ijcard.2006.11.240; WALSH PN, 1981, CIRCULATION, V63, P552, DOI 10.1161/01.CIR.63.3.552; Walsh T, 2010, AM J HUM GENET, V87, P101, DOI 10.1016/j.ajhg.2010.05.011; Yoshikawa S, 2004, AURIS NASUS LARYNX, V31, P361, DOI 10.1016/j.anl.2004.07.007	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205199	10.1371/journal.pone.0205199	http://dx.doi.org/10.1371/journal.pone.0205199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286192	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500097
J	Mano, S; Nishihama, R; Ishida, S; Hikino, K; Kondo, M; Nishimura, M; Yamato, KT; Kohchi, T; Nakagawa, T				Mano, Shoji; Nishihama, Ryuichi; Ishida, Sakiko; Hikino, Kazumi; Kondo, Maki; Nishimura, Mikio; Yamato, Katsuyuki T.; Kohchi, Takayuki; Nakagawa, Tsuyoshi			Novel gateway binary vectors for rapid tripartite DNA assembly and promoter analysis with various reporters and tags in the liverwort Marchantia polymorpha	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; GLYOXYSOMAL CITRATE SYNTHASE; GREEN FLUORESCENT PROTEIN; ARABIDOPSIS-THALIANA; GENE ORGANIZATION; PLASTID TRANSFORMATION; COMPLETE SEQUENCE; PLANT BIOLOGY; PEROXISOMES; CELLS	The liverwort Marchantia polymorpha is an emerging model species for basal lineage plant research. In this study, two Gateway cloning-compatible binary vector series, R4pMpGWB and R4L1pMpGWB, were generated to facilitate production of transgenic M. polymorpha. The R4pMpGWB series allows tripartite recombination of any promoter and any coding sequence with a specific reporter or tag. Reporters/tags for the R4pMpGWB series are GUS, ELuc(PEST), FLAG, 3xHA, 4xMyc, mRFP1, Citrine, mCitrine, ER-targeted mCitrine and nucleus-targeted mCitrine. The R4L1pMpGWB series is suitable for promoter analysis. R4L1 pMpGWB vector structure is the same as that of R4pMpGWB vectors, except that the attR2 site is replaced with attL1, enabling bipartite recombination of any promoter with a reporter or tag. Reporters/tags for the R4L1pMpGWB series are GUS, G3GFP-GUS, LUC, ELuc(PEST), Citrine, mCitrine, ER-targeted mCitrine and mCitrine-NLS. Both vector series were functional in M. polymorpha cells. These vectors will facilitate the design and assembly of plasmid constructs and generation of transgenic M. polymorpha.	[Mano, Shoji; Hikino, Kazumi; Nishimura, Mikio] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi, Japan; [Mano, Shoji] SOKENDAI Grad Univ Adv Studies, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi, Japan; [Nishihama, Ryuichi; Ishida, Sakiko; Kohchi, Takayuki] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Kondo, Maki] Natl Inst Basic Biol, Spectrog & Bioimaging Facil, NIBB Core Res Facil, Okazaki, Aichi, Japan; [Yamato, Katsuyuki T.] Kindai Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan; [Nakagawa, Tsuyoshi] Shimane Univ, Dept Mol & Funct Genom, Interdisciplinary Ctr Sci Res, Org Res, Matsue, Shimane, Japan; [Nishimura, Mikio] Konan Univ, Dept Biol, Fac Sci & Engn, Kobe, Hyogo, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Shimane University; Konan University	Mano, S (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi, Japan.; Mano, S (corresponding author), SOKENDAI Grad Univ Adv Studies, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi, Japan.	mano@nibb.ac.jp	YAMATO, Katsuyuki T/Q-7263-2016	YAMATO, Katsuyuki T/0000-0002-7130-0911; Mano, Shoji/0000-0003-1323-3308; Nishimura, Mikio/0000-0001-7960-9721	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [KAKENHI] [26440157, 17K07457]; Japan Agency for Medical Research and development, AMED; NIBB Research Project for the Development of New Model Organisms	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [KAKENHI](Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); NIBB Research Project for the Development of New Model Organisms	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) [KAKENHI Grant-in-Aid for Scientific Research (C) (grant Nos. 26440157 and 17K07457 to S.M), and Research Program on Hepatitis from Japan Agency for Medical Research and development, AMED, and NIBB Research Project for the Development of New Model Organisms.	Aboulela M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177889; Aboulela M, 2017, PLASMID, V92, P1, DOI 10.1016/j.plasmid.2017.05.001; Althoff F, 2014, TRANSGENIC RES, V23, P235, DOI 10.1007/s11248-013-9746-z; Bowman JL, 2017, CELL, V171, P287, DOI 10.1016/j.cell.2017.09.030; Bowman JL, 2016, PLANT CELL PHYSIOL, V57, P257, DOI 10.1093/pcp/pcv193; Chiyoda S, 2008, PLANT CELL REP, V27, P1467, DOI 10.1007/s00299-008-0570-5; Chiyoda S, 2007, TRANSGENIC RES, V16, P41, DOI 10.1007/s11248-006-9027-1; Chiyoda S, 2014, METHODS MOL BIOL, V1132, P439, DOI 10.1007/978-1-62703-995-6_30; Chytilova E, 1999, ANN BOT-LONDON, V83, P645, DOI 10.1006/anbo.1999.0866; Era A, 2009, PLANT CELL PHYSIOL, V50, P1041, DOI 10.1093/pcp/pcp055; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Goto S, 2011, PLANT CELL, V23, P1573, DOI 10.1105/tpc.110.080770; Goto-Yamada S, 2015, PLANT CELL PHYSIOL, V56, P1264, DOI 10.1093/pcp/pcv081; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Higo A, 2016, PLANT CELL PHYSIOL, V57, P325, DOI 10.1093/pcp/pcw005; Hino T, 2011, BIOSCI BIOTECH BIOCH, V75, P1848, DOI 10.1271/bbb.110331; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Ishizaki K, 2016, PLANT CELL PHYSIOL, V57, P262, DOI 10.1093/pcp/pcv097; Ishizaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138876; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kamada T, 2003, PLANT CELL PHYSIOL, V44, P1275, DOI 10.1093/pcp/pcg173; Kamigaki A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160717; KATO A, 1995, PLANT MOL BIOL, V27, P377, DOI 10.1007/BF00020191; Kato A, 1996, PLANT CELL, V8, P1601, DOI 10.1105/tpc.8.9.1601; Kubota A, 2013, BIOSCI BIOTECH BIOCH, V77, P167, DOI 10.1271/bbb.120700; Mano S, 2002, PLANT CELL PHYSIOL, V43, P331, DOI 10.1093/pcp/pcf037; Mano S, 2006, PLANT J, V47, P604, DOI 10.1111/j.1365-313X.2006.02809.x; Mano S, 2011, PLANT CELL PHYSIOL, V52, P2157, DOI 10.1093/pcp/pcr147; Nakagawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P624, DOI 10.1271/bbb.70678; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nakamura S, 2009, BIOSCI BIOTECH BIOCH, V73, P2556, DOI 10.1271/bbb.90720; Nishihama R, 2016, PLANT CELL PHYSIOL, V57, P271, DOI 10.1093/pcp/pcv102; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; Ogasawara Y, 2013, PLANT CELL ENVIRON, V36, P1520, DOI 10.1111/pce.12085; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Ridge RW, 1999, PLANT CELL PHYSIOL, V40, P1253, DOI 10.1093/oxfordjournals.pcp.a029513; Takenaka M, 2000, TRANSGENIC RES, V9, P179, DOI 10.1023/A:1008963410465; Tanaka D, 2016, PLANT CELL PHYSIOL, V57, P300, DOI 10.1093/pcp/pcv173; Tanaka Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1795, DOI 10.1271/bbb.130405; Tsuboyama S, 2014, PLANT CELL PHYSIOL, V55, P229, DOI 10.1093/pcp/pct168; Tsuboyama-Tanaka S, 2015, J PLANT RES, V128, P337, DOI 10.1007/s10265-014-0695-2; Yamato KT, 2007, P NATL ACAD SCI USA, V104, P6472, DOI 10.1073/pnas.0609054104	42	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204964	10.1371/journal.pone.0204964	http://dx.doi.org/10.1371/journal.pone.0204964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286137	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500067
J	Schifano, F; Chiappini, S				Schifano, Fabrizio; Chiappini, Stefania			Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports	PLOS ONE			English	Article							P-GLYCOPROTEIN; CARDIAC DYSRHYTHMIAS; ABUSE; MISUSE; DRUG; CARDIOMYOPATHY; INHIBITION; MEDICATION; TRENDS	Background Among over-the-counter (OTC) drugs, loperamide has recently emerged for its potential of misuse and cardiotoxicity issues. Hence, we aimed here at assessing the loperamiderelated cases being reported to the EMA's EudraVigilance (EV) database. Methods All spontaneous EV reports relating to loperamide misuse/abuse/dependence/withdrawal and cardiotoxicity issues were here retrieved, performing a descriptive analysis. Findings During the years 2005-2017, EV collected a number of 1,983 (out of a total of 7,895; 25.11%) loperamide-related misuse/abuse/dependence/withdrawal adverse drug reaction (ADR) reports, with a progressively increasing trend since 2014. Most cases were classified as drug use disorder (37.4%) or intentional overdose (25.4%). Loperamide was used on its own in 41.9% of cases; remaining, polydrug, cases included antidepressants; benzodiazepines; and other OTCs. Some 1,085 (1,085/7,895 = 13.7%) cardiovascular ADRs were reported, being conduction abnormalities and EKG alterations the most frequently identified. Conclusions EV data may support the levels of concern relating to loperamide potential of abuse and associated cardiotoxicity issues.	[Schifano, Fabrizio; Chiappini, Stefania] Univ Hertfordshire, Sch Life & Med Sci, Psychopharmacol Drug Misuse & Novel Psychoact Sub, Hatfield, Herts, England; [Chiappini, Stefania] Casa Cura Villa Rosa, Viterbo, VT, Italy	University of Hertfordshire	Chiappini, S (corresponding author), Univ Hertfordshire, Sch Life & Med Sci, Psychopharmacol Drug Misuse & Novel Psychoact Sub, Hatfield, Herts, England.; Chiappini, S (corresponding author), Casa Cura Villa Rosa, Viterbo, VT, Italy.	stefaniachiappini9@gmail.com	CHIAPPINI, STEFANIA/ABC-3831-2020	CHIAPPINI, STEFANIA/0000-0002-6810-1540; Schifano, Fabrizio/0000-0002-4178-5401				Akel T, 2018, ANN NONINVAS ELECTRO, V23, DOI 10.1111/anec.12505; Amin ML, 2013, DRUG TARGET INSIGHT, V7, P27, DOI 10.4137/DTI.S12519; [Anonymous], 2012, GREY PAGES MERITS HI; [Anonymous], 2016, NY TIMES; Baker DE, 2007, REV GASTROENTEROL DI, V7, pS11; Bhatti Z, 2017, CLIN TOXICOL, V55, P659, DOI 10.1080/15563650.2017.1304555; Bishop-Freeman SC, 2016, J ANAL TOXICOL, V40, P677, DOI 10.1093/jat/bkw069; Bluelight.org, LOP; Borron SW, 2017, J EMERG MED, V53, P73, DOI 10.1016/j.jemermed.2017.03.018; CHURCH J, 1994, MOL PHARMACOL, V45, P747; Cooper RJ, 2013, J SUBST USE, V18, P82, DOI 10.3109/14659891.2011.615002; Council of Europe, 2014, AG MED PROD MED DEV; Daniulaityte R, 2013, DRUG ALCOHOL DEPEN, V130, P241, DOI 10.1016/j.drugalcdep.2012.11.003; Drugs-forum, LOP; Eggleston W, 2016, MMWR-MORBID MORTAL W, V65, P1276, DOI 10.15585/mmwr.mm6545a7; Eggleston W, 2017, ANN EMERG MED, V69, P83, DOI 10.1016/j.annemergmed.2016.03.047; Eggleston W, 2015, CLIN TOXICOL, V53, P495, DOI 10.3109/15563650.2015.1026971; Eichenberg C, 2017, GESUNDHEITSWESEN, V79, P80, DOI 10.1055/s-0035-1549970; Enakpene EO, 2015, AM J MED, V128, P1083, DOI 10.1016/j.amjmed.2015.05.019; Erowid, 2016, LOP; Erowid, 2010, WOULDNT SAY THIS IS; Erowid, 2007, ABS AW LOP; Erowid, 2014, MY NEW FAV OTC HIGH; Erowid, 2012, REC WITHDR; EudraVigilance, EUR DAT SUSP ADV DRU; European Medicines Agency (EMA), 2015, BUYING MED ONL; Finch M., 2015, USE LOPERAMIDE OPIAT; Finkelstein Y, 2017, PEDIATR EMERG CARE, V33, P451, DOI 10.1097/PEC.0000000000000571; Food and Drug Administration, 2018, PUBL DASHB; Food and Drug Administration (FDA), 2016, IM LAB; Fox N, 2005, SOC SCI MED, V61, P1474, DOI 10.1016/j.socscimed.2005.03.011; Heads of Medicines Agencies (HMA) European Medicines Agency (EMA), 2017, GUID GOOD PHARM PRAC; JAFFE JH, 1980, CLIN PHARMACOL THER, V28, P812, DOI 10.1038/clpt.1980.239; Kang JS, 2016, N-S ARCH PHARMACOL, V389, P1133, DOI 10.1007/s00210-016-1286-7; Karami S., 2017, CLIN TOXICOL, V20, P1; Kozak PM, 2017, J ELECTROCARDIOL, V50, P355, DOI 10.1016/j.jelectrocard.2017.01.011; Lasoff DR, 2017, PHARMACOTHERAPY, V37, P249, DOI 10.1002/phar.1885; Le V.T., 2016, J AM COLL HEALTH, V16, P1; Leo RJ, 2017, J ADDICT MED, V11, P402, DOI 10.1097/ADM.0000000000000325; Levine DA, 2007, CURR OPIN PEDIATR, V19, P270, DOI 10.1097/MOP.0b013e32814b09cf; MacDonald R., 2015, BMJ CASE REP; Manchikanti Laxmaiah, 2006, Pain Physician, V9, P287; Marraffa JM, 2014, CLIN TOXICOL, V52, P952, DOI 10.3109/15563650.2014.969371; MedDRA, 2017, INTR GUID VERS 20 1; MedDRA, 2017, INTR GUID STAND MEDD; Medicines and Healthcare products Regulatory Agency (MHRA), 2018, YELL CARD SCHEM LOP; Miller H, 2017, J AM PHARM ASSOC, V57, pS45, DOI 10.1016/j.japh.2016.12.079; Mukarram O, 2016, CASE REP MED, V2016, DOI 10.1155/2016/4061980; National Association of Boards of Pharmacy (NABP), 2012, INT DRUG OUTL ID PRO; Nguyen L, 2016, PHARMACOL THERAPEUT, V159, P1, DOI 10.1016/j.pharmthera.2016.01.016; Nielsen S, 2017, CURR TOP BEHAV NEURO, V34, P59, DOI 10.1007/7854_2015_422; Nozaki-Taguchi N, 1999, ANESTHESIOLOGY, V90, P225, DOI 10.1097/00000542-199901000-00029; Rasla Somwail, 2017, R I Med J (2013), V100, P33; Reeves RR, 2015, SOUTH MED J, V108, P151, DOI 10.14423/SMJ.0000000000000256; Riaz IB, 2017, AM J THER; Rose B.J., 2016, PHARM TODAY, P34; Schifano F, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00239; Stanciu CN, 2017, J PSYCHOACTIVE DRUGS, V49, P18, DOI 10.1080/02791072.2016.1260188; Swank KA, 2017, J AM PHARM ASSOC, V57, pS63, DOI 10.1016/j.japh.2016.11.011; U.S. Food and Drug Administration, 2020, FDA WARNS SER PROBL; Upadhyay A, 2016, CASE REP CARDIOL, V2016, DOI 10.1155/2016/5040176; Vakkalanka JP, 2017, ANN EMERG MED, V69, P73, DOI 10.1016/j.annemergmed.2016.08.444; Vaughn P, 2016, J CARDIOVASC ELECTR, V27, P1230, DOI 10.1111/jce.13052; Wightman RS, 2016, CLIN TOXICOL, V54, P454, DOI 10.3109/15563650.2016.1159310; Wright J, 2016, J PUBLIC HEALTH-UK, V38, P793, DOI 10.1093/pubmed/fdv169; Wu PE, 2017, ANN EMERG MED, V70, P245, DOI 10.1016/j.annemergmed.2017.04.008; Zaprutko T, 2016, HEALTH POLICY, V120, P875, DOI 10.1016/j.healthpol.2016.06.008; Zhang Y, 2013, BIOMED PHARMACOTHER, V67, P757, DOI 10.1016/j.biopha.2013.04.012; Zhou SF, 2004, DRUG METAB REV, V36, P57, DOI 10.1081/DMR-120028427	69	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204443	10.1371/journal.pone.0204443	http://dx.doi.org/10.1371/journal.pone.0204443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286103	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500021
J	Bouzouggar, A; Humphrey, LT; Barton, N; Parfitt, SA; Balzan, LC; Schwenninger, JL; El Hajraoui, MA; Nespoulet, R; Bello, SM				Bouzouggar, Abdeljalil; Humphrey, Louise T.; Barton, Nick; Parfitt, Simon A.; Balzan, Laine Clark; Schwenninger, Jean-Luc; El Hajraoui, Mohammed Abdeljalil; Nespoulet, Roland; Bello, Silvia M.			90,000 year-old specialised bone technology in the Aterian Middle Stone Age of North Africa	PLOS ONE			English	Article							MODERN HUMAN-BEHAVIOR; EL HARHOURA 2; SOUTH-AFRICA; SHELL BEADS; BLOMBOS CAVE; SIBUDU CAVE; ADDITIONAL EVIDENCE; UPPER PLEISTOCENE; CUT-MARKS; MOROCCO	The question of cognitive complexity in early Homo sapiens in North Africa is intimately tied to the emergence of the Aterian culture (similar to 145 ka). One of the diagnostic indicators of cognitive complexity is the presence of specialised bone tools, however significant uncertainty remains over the manufacture and use of these artefacts within the Aterian techno-complex. In this paper we report on a bone artefact from Aterian Middle Stone Age (MSA) deposits in Dar es-Soltan 1 cave on the Atlantic coast of Morocco. It comes from a layer that can be securely dated to similar to 90 ka. The typological characteristics of this tool, which suggest its manufacture and use as a bone knife, are comparatively similar to other bone artefacts from dated Aterian levels at the nearby site of El Mnasra and significantly different from any other African MSA bone technology. The new find from Dar es-Soltan 1 cave combined with those from El Mnasra suggest the development of a bone technology unique to the Aterian.	[Bouzouggar, Abdeljalil; El Hajraoui, Mohammed Abdeljalil] Rabat Inst, Madinat Al Irfane, Inst Natl Sci Archeol Patrimoine, Origin & Evolut Homo Sapiens Morocco Res Grp, Rabat, Morocco; [Bouzouggar, Abdeljalil] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Humphrey, Louise T.; Parfitt, Simon A.; Bello, Silvia M.] Nat Hist Museum, Dept Earth Sci, London, England; [Barton, Nick] Univ Oxford, Inst Archaeol, Oxford, England; [Parfitt, Simon A.] UCL, Inst Archaeol, Gordon Sq, London, England; [Balzan, Laine Clark] Albert Ludwigs Univ Freiburg, Sedimentary Geol & Quaternary Res, Freiburg, Germany; [Schwenninger, Jean-Luc] Univ Oxford, Luminescence Dating Lab, Res Lab Archaeol & Hist Art, Oxford, England; [Nespoulet, Roland] Musee Homme Paris, Museum Natl Hist Nat, UMR 7194, HNHP, Paris, France	Max Planck Society; Natural History Museum London; University of Oxford; University of London; University College London; University of Freiburg; University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Bouzouggar, A (corresponding author), Rabat Inst, Madinat Al Irfane, Inst Natl Sci Archeol Patrimoine, Origin & Evolut Homo Sapiens Morocco Res Grp, Rabat, Morocco.; Bouzouggar, A (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.; Bello, SM (corresponding author), Nat Hist Museum, Dept Earth Sci, London, England.	abdeljalil_bouzouggar@eva.mpg.de; s.bello@nhm.ac.uk	Bello, Silvia/ABW-5535-2022; Bello, Silvia/GZK-9069-2022; Bouzouggar, Abdeljalil/AAD-3608-2022	Bouzouggar, Abdeljalil/0000-0002-4332-4385	University of Oxford; Calleva Foundation; Moroccan Institut National des Sciences de l'Archeologie et du Patrimoine; Oxford University; Institut National des Sciences de l'Archeologie et du Patrimoine, Rabat	University of Oxford; Calleva Foundation; Moroccan Institut National des Sciences de l'Archeologie et du Patrimoine; Oxford University; Institut National des Sciences de l'Archeologie et du Patrimoine, Rabat	Excavations at Dar es-Soltan were supported by Institut National des Sciences de l'Archeologie et du Patrimloine, Rabat, Morocco, University of Oxford (Fell Fund) and Calleva Foundation. The study of the bone tool was supported by the Calleva Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research program at Dar es-Soltan 1 cave is jointly conducted and supported by the Moroccan Institut National des Sciences de l'Archeologie et du Patrimoine, and the University of Oxford. We thank Simon Collcutt for his lithostratigraphic description and interpretation of the cave sediment taphonomy and Cath Price for her expert processing and sorting of the micro-vertebrate samples, Lu-Allington-Jones and Arianna Bernucci for preparation and conservation of the bone tool, Laura Buck for CT-scanning the bone tool, Shaymae Iken for providing fauna information, Michel Grenet for the lithic drawings and Julia Galway-Witham for assistance. Excavations at Dar es-Soltan and study of the bone tool were supported by the Calleva Foundation. Additional funding for the excavations came from Oxford University (Fell Fund) and the Institut National des Sciences de l'Archeologie et du Patrimoine, Rabat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS P, 1985, MAN, V20, P675, DOI 10.2307/2802756; Arrighi S, 2016, QUATERN INT, V423, P143, DOI 10.1016/j.quaint.2015.11.114; Backwell LR., 2014, ENCY GLOBAL ARCHAEOL, P950, DOI [10.1007/978-1-4419-0465-2_702, DOI 10.1007/978-1-4419-0465-2_702]; Backwell L, 2008, J ARCHAEOL SCI, V35, P1566, DOI 10.1016/j.jas.2007.11.006; Backwell L, 2016, VERTEBR PALEOBIOL PA, P15, DOI 10.1007/978-94-024-0899-7_2; Barton RNE, 2009, QUATERNARY SCI REV, V28, P1914, DOI 10.1016/j.quascirev.2009.03.010; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; BEHRENSMEYER AK, 1986, NATURE, V319, P768, DOI 10.1038/319768a0; Bello SM, 2013, J ARCHAEOL SCI, V40, P2464, DOI 10.1016/j.jas.2012.12.016; Bello SM, 2008, J ARCHAEOL SCI, V35, P1542, DOI 10.1016/j.jas.2007.10.018; Bello SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182127; Bello SM, 2006, AM J PHYS ANTHROPOL, V129, P24, DOI 10.1002/ajpa.20243; Boulestin B, 1999, BRIT ARCHAEOLOGICAL, V776, P398; Bouzouggar A., 2012, MODERN ORIGINS N AFR, P93; Bouzouggar A, 2007, P NATL ACAD SCI USA, V104, P9964, DOI 10.1073/pnas.0703877104; BROMAGE TG, 1984, AM J PHYS ANTHROPOL, V65, P359, DOI 10.1002/ajpa.1330650404; Campmas E, 2016, QUATERN INT, V413, P5, DOI 10.1016/j.quaint.2015.11.136; Campmas E, 2015, J HUM EVOL, V78, P122, DOI 10.1016/j.jhevol.2014.08.008; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F., 1993, OXFORD J ARCHAEOL, V12, P145; d'Errico F, 2008, J ARCHAEOL SCI, V35, P2675, DOI 10.1016/j.jas.2008.04.023; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; d'Errico F, 2012, P NATL ACAD SCI USA, V109, P13214, DOI 10.1073/pnas.1204213109; d'Errico F, 2012, J ARCHAEOL SCI, V39, P2479, DOI 10.1016/j.jas.2012.01.040; d'Errico F, 2009, P NATL ACAD SCI USA, V106, P16051, DOI 10.1073/pnas.0903532106; Debenath A, 2000, ANTHROPOLOGIE, V104, P131; Debenath A, 2012, PREHISTORIE REGION R, VIII, P179; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; El Hajraoui MA, 1994, PREHISTOIRE ANTHR ME, V3, P91; Greenfield HJ, 1999, J ARCHAEOL SCI, V26, P797, DOI 10.1006/jasc.1998.0348; Hallett-Desguez E, 2014, PALEOANTHROPOLOGY, pA10; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Hublin J.J., 2001, HUMAN ROOTS AFRICA A, P99; Idrissi NJ, 2012, QUATERNAIRE, V23, P25; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; MOREL J, 1974, ANTHROPOLOGIE, V78, P53; Oudouche H, 2012, VILLES SITES ARCHEOL, VIII, P191; Ruhlmann A., 1951, COLLECTION HESPERIS, P210; Schwenninger J.L., 2010, S E MEDITERRANEAN PE, P18; SHIPMAN P, 1981, ANN NY ACAD SCI, V376, P357, DOI 10.1111/j.1749-6632.1981.tb28179.x; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Soressi M, 2013, P NATL ACAD SCI USA, V110, P14186, DOI 10.1073/pnas.1302730110; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Wadley L, 2010, CURR ANTHROPOL, V51, pS111, DOI 10.1086/649836; White T.D., 1992, PREHISTORIC CANNIBAL; YELLEN JE, 1995, SCIENCE, V268, P553, DOI 10.1126/science.7725100; Zou Y, 2004, PHYS MED BIOL, V49, P2365, DOI 10.1088/0031-9155/49/11/017	49	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202021	10.1371/journal.pone.0202021	http://dx.doi.org/10.1371/journal.pone.0202021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281602	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400010
J	Starlard-Davenport, A; Allman, R; Dite, GS; Hopper, JL; Tuff, ES; Macleod, S; Kadlubar, S; Preston, M; Henry-Tillman, R				Starlard-Davenport, Athena; Allman, Richard; Dite, Gillian S.; Hopper, John L.; Tuff, Erika Spaeth; Macleod, Stewart; Kadlubar, Susan; Preston, Michael; Henry-Tillman, Ronda			Validation of a genetic risk score for Arkansas women of color	PLOS ONE			English	Article							BREAST-CANCER RISK; GENOME-WIDE ASSOCIATION; AFRICAN-AMERICAN; SUSCEPTIBILITY LOCI; PREDICTION; MODEL; GAIL; SUBTYPES; RACE	African American women in the state of Arkansas have high breast cancer mortality rates. Breast cancer risk assessment tools developed for African American underestimate breast cancer risk. Combining African American breast cancer associated single-nucleotide polymorphisms (SNPs) into breast cancer risk algorithms may improve individualized estimates of a woman's risk of developing breast cancer and enable improved recommendation of screening and chemoprevention for women at high risk. The goal of this study was to confirm with an independent dataset consisting of Arkansas women of color, whether a genetic risk score derived from common breast cancer susceptibility SNPs can be combined with a clinical risk estimate provided by the Breast Cancer Risk Assessment Tool (BCRAT) to produce a more accurate individualized breast cancer risk estimate. A population-based cohort of African American women representative of Arkansas consisted of 319 cases and 559 controls for this study. Five-year and lifetime risks from the BCRAT were measured and combined with a risk score based on 75 independent susceptibility SNPs in African American women. We used the odds ratio (OR) per adjusted standard deviation to evaluate the improvement in risk estimates produced by combining the polygenic risk score (PRS) with 5-year and lifetime risk scores estimated using BCRAT. For 5-year risk OR per standard deviation increased from 1.84 to 2.08 with the addition of the polygenic risk score and from 1.79 to 2.07 for the lifetime risk score. Reclassification analysis indicated that 13% of cases had their 5-year risk increased above the 1.66% guideline threshold (NRI = 0.020 (95% CI -0.040, 0.080)) and 6.3% of cases had their lifetime risk increased above the 20% guideline threshold by the addition of the polygenic risk score (NRI = 0.034 (95% CI 0.000, 0.070)). Our data confirmed that discriminatory accuracy of BCRAT is improved for African American women in Arkansas with the inclusion of specific SNP breast cancer risk alleles.	[Starlard-Davenport, Athena] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Genet Genom & Informat, Memphis, TN 38163 USA; [Allman, Richard] Genet Technol Ltd, Fitzroy, Vic, Australia; [Dite, Gillian S.; Hopper, John L.] Univ Melbourne, Ctr Epidemiol & Biostat, Parkville, Vic, Australia; [Tuff, Erika Spaeth] Phenogen Sci Inc, Charlotte, NC USA; [Macleod, Stewart] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Genom Core, Little Rock, AR 72205 USA; [Kadlubar, Susan] Univ Arkansas Med Sci, Div Med Genet, Little Rock, AR 72205 USA; [Preston, Michael] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Ctr Divers Affairs & Inclus, Little Rock, AR 72205 USA; [Henry-Tillman, Ronda] Univ Arkansas Med Sci, Coll Med, Dept Surg, Little Rock, AR 72205 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Melbourne; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Starlard-Davenport, A (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Genet Genom & Informat, Memphis, TN 38163 USA.	astarlar@uthsc.edu	Starlard-Davenport, Athena/Q-3866-2017	Starlard-Davenport, Athena/0000-0002-8938-237X; Spaeth, Erika/0000-0002-5397-3493; Allman, Richard/0000-0002-8635-5237	Genetic Technologies Ltd.	Genetic Technologies Ltd.	A. Starlard-Davenport and R. Henry-Tillman report receiving commercial research support from Genetic Technologies Ltd. who provided support in the form of salaries for author AS-D, but did not have any additional role in the study design, data collection and analysis, or decision to publish. Phenogen Sciences Inc. did not provide any financial support, but did have an additional role in preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams-Campbell LL, 2007, BREAST J, V13, P332, DOI 10.1111/j.1524-4741.2007.00439.x; Adams-Campbell LL, 2009, BREAST J, V15, pS72, DOI 10.1111/j.1524-4741.2009.00824.x; Allman R, 2015, BREAST CANCER RES TR, V154, P583, DOI 10.1007/s10549-015-3641-7; Bondurant KL, 2011, BREAST J, V17, P281, DOI 10.1111/j.1524-4741.2011.01082.x; Brentnall AR, 2013, J GENET SYNDR GENE T, V4, P202; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Comen E, 2011, BREAST CANCER RES TR, V127, P479, DOI 10.1007/s10549-010-1215-2; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Dite GS, 2016, CANCER EPIDEM BIOMAR, V25, P359, DOI 10.1158/1055-9965.EPI-15-0838; Dite GS, 2013, BREAST CANCER RES TR, V139, P887, DOI 10.1007/s10549-013-2610-2; Dite GS, 2003, J NATL CANCER I, V95, P448, DOI 10.1093/jnci/95.6.448; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Feng Y, 2017, CANCER EPIDEM BIOMAR, V26, P1016, DOI [10.1158/1055-9965.EPI-16-0567, 10.1158/1055-9965.epi-16-0567]; Feng Y, 2014, HUM MOL GENET, V23, P5518, DOI 10.1093/hmg/ddu252; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2007, J NATL CANCER I, V99, P1782, DOI 10.1093/jnci/djm223; Hopper JL, 2015, AM J EPIDEMIOL, V182, P863, DOI 10.1093/aje/kwv193; Maas P, 2016, JAMA ONCOL; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Mealiffe ME, 2010, JNCI-J NATL CANCER I, V102, P1618, DOI 10.1093/jnci/djq388; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Murphy ME, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0007-9; Palmer JR, 2013, CANCER EPIDEM BIOMAR, V22, P127, DOI 10.1158/1055-9965.EPI-12-0769; Perez CA, 2013, BREAST CANCER RES TR, V139, P497, DOI 10.1007/s10549-013-2550-x; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Society AC, 2016, CANC FACTS FIG FRIC; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; StataCorp, 2013, STAT REL 13; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204834	10.1371/journal.pone.0204834	http://dx.doi.org/10.1371/journal.pone.0204834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281645	Green Published, gold			2022-12-26	WOS:000446342400061
J	Engel, D; Malone, TW				Engel, David; Malone, Thomas W.			Integrated information as a metric for group interaction	PLOS ONE			English	Article							CONSCIOUSNESS; COMPLEXITY	Researchers in many disciplines have previously used a variety of mathematical techniques for analyzing group interactions. Here we use a new metric for this purpose, called "integrated information" or "phi." Phi was originally developed by neuroscientists as a measure of consciousness in brains, but it captures, in a single mathematical quantity, two properties that are important in many other kinds of groups as well: differentiated information and integration. Here we apply this metric to the activity of three types of groups that involve people and computers. First, we find that 4-person work groups with higher measured phi perform a wide range of tasks more effectively, as measured by their collective intelligence. Next, we find that groups of Wikipedia editors with higher measured phi create higher quality articles. Last, we find that the measured phi of the collection of people and computers communicating on the Internet increased over a recent six-year period. Together, these results suggest that integrated information can be a useful way of characterizing a certain kind of interactional complexity that, at least sometimes, predicts group performance. In this sense, phi can be viewed as a potential metric of effective group collaboration.	[Engel, David; Malone, Thomas W.] MIT, Ctr Collect Intelligence, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Engel, David; Malone, Thomas W.] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Engel, David] Google Inc, Zurich, Switzerland	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Google Incorporated	Malone, TW (corresponding author), MIT, Ctr Collect Intelligence, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Malone, TW (corresponding author), MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	malone@mit.edu		/0000-0002-7005-1482	National Science Foundation [IIS-0963285, ACI-1322254, IIS-0963451]; U.S. Army Research Office [56692-MA, 64079-NS, W911NF-15-1-0577, W911NF-13-1-0422]; Cisco Systems, Inc.; MIT Center for Collective Intelligence	National Science Foundation(National Science Foundation (NSF)); U.S. Army Research Office; Cisco Systems, Inc.; MIT Center for Collective Intelligence	This work was supported by grants to TWM from the National Science Foundation (www.nsf.gov; grant numbers IIS-0963285, ACI-1322254, and IIS-0963451), the U.S. Army Research Office (http://www.arl.army.mil/; grant numbers 56692-MA, 64079-NS, W911NF-15-1-0577, and W911NF-13-1-0422) and Cisco Systems, Inc. (www.cisco.com), through their sponsorship of the MIT Center for Collective Intelligence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albantakis L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003966; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; [Anonymous], 2014, VERS 1 0 ED TEAM ASS; Arrow KJ, 1954, ECONOMETRICA, V22, P265, DOI 10.2307/1907353; Bakeman R., 1997, OBSERVING INTERACTIO; Balduzzi D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000091; Balduzzi D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000462; Barrett AB, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001052; Binder A, AUTOMOTIVE IND; Browning TR, 2001, IEEE T ENG MANAGE, V48, P292, DOI 10.1109/17.946528; CAIDA, 2014, CAIDA UCSD AN INT TR; CAIDA, 2010, CAIDA UCSD AN INT TR; CAIDA, 2013, CAIDA UCSD AN INT TR; CAIDA, 2011, CAIDA UCSD AN INT TR; CAIDA, 2012, CAIDA UCSD AN INT TR; CAIDA, 2009, CAIDA UCSD AN INT TR; CAIDA, 2008, CAIDA UCSD AN INT TR; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Deary I. J., 2000, LOOKING HUMAN INTELL; Easley D, 2010, NETWORKS CROWDS MARK; Edlund JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002236; Engel D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115212; Eppinger SD, 2012, ENG SYST, P1; Gottman J.M., 1994, WHAT PREDICTS DIVORC; Hackman J. R, 1975, ADV EXPT SOCIAL PSYC, P1, DOI DOI 10.1016/S0065-2601(08)60248-8; Joshi NJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003111; Kim YJ, 2015, COLL INT C; King JR, 2013, CURR BIOL, V23, P1914, DOI 10.1016/j.cub.2013.07.075; Klinkner K, 2005, ADV NEURAL INFORM PR, P667; Koch C, 2013, CAN PHOTODIODE BE CO; LAWRENCE PR, 1967, ADMIN SCI QUART, V12, P1, DOI 10.2307/2391211; Leskovec J, 2006, P 12 ACM SIGKDD INT, P631; LLOYD S, 1988, ANN PHYS-NEW YORK, V188, P186, DOI 10.1016/0003-4916(88)90094-2; Oizumi M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004654; Oizumi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003588; PARKER KCH, 1988, J PERS SOC PSYCHOL, V54, P965, DOI 10.1037/0022-3514.54.6.965; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Simon H. A., 1996, SCI ARTIFICIAL, V3rd; Smith A., 1976, INQUIRY NATURE CAUSE; SOLOW RM, 1957, REV ECON STAT, V39, P312, DOI 10.2307/1926047; Suppes P., 1960, MARKOV LEARNING MODE; Tegmark M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005123; THOMAS EAC, 1979, PSYCHOL REV, V86, P331, DOI 10.1037/0033-295X.86.4.331; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Tononi G, 1998, NEUROIMAGE, V7, P133, DOI 10.1006/nimg.1997.0313; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Tononi G, 2015, PHILOS T R SOC B, V370, P117, DOI 10.1098/rstb.2014.0167; Tononi G, 2008, BIOL BULL-US, V215, P216, DOI 10.2307/25470707; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	52	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205335	10.1371/journal.pone.0205335	http://dx.doi.org/10.1371/journal.pone.0205335			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW7TO	30307973	Green Submitted, Green Published, gold			2022-12-26	WOS:000447173500061
J	Jones, GD; James, DC; Thacker, M; Green, DA				Jones, Gareth D.; James, Darren C.; Thacker, Michael; Green, David A.			Parameters that remain consistent independent of pausing before gait-initiation during normal rise-to-walk behaviour delineated by sit-to-walk and sit-to-stand-and-walk	PLOS ONE			English	Article							PARKINSONS-DISEASE; TASK; MOVEMENT; STABILITY; HEALTHY; STROKE; ADULTS; RELIABILITY; BALANCE; BODY	Background Rising-to-walk is an everyday transitional movement task rarely employed in gait rehabilitation. Sit-to-walk (STW) and sit-to-stand-and-walk (STSW), where a pause separates sit-to-stand and gait-initiation (GI) represent extremes of rising-to-walk behaviour. Delayed GI can indicate pathological impairment but is also observed in healthy individuals. We hypothesise that healthy subjects express consistent biomechanical parameters, among others that differ, during successful rising-to-walk task performance regardless of behaviour. This study therefore sought to identify if any parameters are consistent between STW and STSW in health because they represent normal rise-to-walk performance independent of pause, and also because they represent candidate parameters sensitive enough to monitor change in pathology. Methods Ten healthy volunteers performed 5 trials of STW and STSW. Event timing, ground-reaction-forces (GRFs), whole-body-centre-of-mass (BCoM) displacement, and centre-of-pressure (CoP) to extrapolated BCoM (xCoM) distance (indicator of positional stability) up to the 3rd step were compared between-tasks with paired t-tests. For consistent parameters; agreement between-tasks was assessed using Bland-Altman analyses and minimal-detectable-change (MDC) calculations. Results Mean vertical GRFs, peak forward momentum and fluidity during rising; CoP-xCoM separation at seat-off, upright, GI-onset, and steps1-2; and forward BCoM velocity were all significantly greater in STW. In contrast, peak BCoM vertical momentum, flexion-momentum time, and 3rd step stability were consistent between tasks and yielded acceptable reliability. Conclusion STW is a more challenging task due to the merging of rising with GI reflected by greater CoP-xCoM separation compared to STSW indicative of more positional instability. However, BCoM vertical momentum, flexion-momentum time, and step3 stability remained consistent in healthy individuals and are therefore candidates with which to monitor change in gait rehabilitation following pathology. Future studies should impose typical pause-durations observed in pathology upon healthy subjects to determine if the parameters we have identified remain consistent.	[Jones, Gareth D.; Thacker, Michael; Green, David A.] Kings Coll London, CHAPS, London, England; [Jones, Gareth D.] Guys & St Thomas NHS Fdn Trust, Physiotherapy Dept, London, England; [James, Darren C.] London South Bank Univ, Sport & Exercise Sci Res Ctr, London, England; [Thacker, Michael] London South Bank Univ, Sch Hlth & Social Care, London, England; [Green, David A.] European Space Agcy, Directorate Human Spaceflight & Robot Explorat Pr, European Astronaut Ctr, Cologne, Germany; [Green, David A.] KBRwyle GmbH, Cologne, Germany	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; London South Bank University; London South Bank University	Jones, GD (corresponding author), Kings Coll London, CHAPS, London, England.; Jones, GD (corresponding author), Guys & St Thomas NHS Fdn Trust, Physiotherapy Dept, London, England.	gareth.jones@gstt.nhs.uk	Jones, Gareth D/I-3250-2015; Jones, Gareth D/AAQ-5189-2020	Jones, Gareth D/0000-0001-5516-9418; James, Darren/0000-0001-6833-6019; Thacker, Michael/0000-0002-9034-1137				Abu-Arafeh A, 2016, BRIT J ANAESTH, V117, P569, DOI 10.1093/bja/aew320; Akram SB, 2011, J MOTOR BEHAV, V43, P147, DOI 10.1080/00222895.2011.552077; [Anonymous], 1996, GAIT POSTURE; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Buckley T, 2009, J BIOMECH, V42, P2318, DOI 10.1016/j.jbiomech.2009.06.023; Buckley TA, 2008, MOVEMENT DISORD, V23, P1274, DOI 10.1002/mds.22079; CARR JH, 1994, HUM MOVEMENT SCI, V13, P175, DOI 10.1016/0167-9457(94)90035-3; Dall PM, 2010, APPL ERGON, V41, P58, DOI 10.1016/j.apergo.2009.04.005; Dehail P, 2007, CLIN BIOMECH, V22, P1096, DOI 10.1016/j.clinbiomech.2007.07.015; Etnyre B, 2007, PHYS THER, V87, P1651, DOI 10.2522/ptj.20060378; Frykberg GE, 2009, ARCH PHYS MED REHAB, V90, P1009, DOI 10.1016/j.apmr.2008.12.023; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; HANKE TA, 1995, PHYS THER, V75, P105, DOI 10.1093/ptj/75.2.105; Hass CJ, 2005, ARCH PHYS MED REHAB, V86, P2172, DOI 10.1016/j.apmr.2005.05.013; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Jones GD, 2016, JOVE-J VIS EXP, DOI 10.3791/54323; Jones GD, 2016, GAIT POSTURE, V48, P226, DOI 10.1016/j.gaitpost.2016.06.005; Kerr A, 2004, CLIN BIOMECH, V19, P385, DOI 10.1016/j.clinbiomech.2003.12.012; Kerr A, 2013, GAIT POSTURE, V37, P598, DOI 10.1016/j.gaitpost.2012.09.026; Kerr A, 2017, GAIT POSTURE, V52, P233, DOI 10.1016/j.gaitpost.2016.11.046; Kouta M, 2006, J PHYS THER SCI, V18, P201, DOI [DOI 10.1589/JPTS.18.201, 10.1589/jpts.18.201]; Kwong PWH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/636530; Latash ML, 2012, EXP BRAIN RES, V217, P1, DOI 10.1007/s00221-012-3000-4; Malouin F, 2003, CLIN REHABIL, V17, P674, DOI 10.1191/0269215503cr663oa; Malouin F, 2001, CONTROL POSTURE GAIT, P671; Nakano W, 2015, GAIT POSTURE, V42, P158, DOI 10.1016/j.gaitpost.2015.05.004; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Song J, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/386962	31	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205346	10.1371/journal.pone.0205346	http://dx.doi.org/10.1371/journal.pone.0205346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4OW	30300414	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000446897200057
J	Joo, SW; Yoon, W; Shon, SH; Kim, H; Cha, S; Park, KJ; Lee, J				Joo, Sung Woo; Yoon, Woon; Shon, Seung-Hyun; Kim, Harin; Cha, Saetbyeol; Park, Kee Jeong; Lee, Jungsun			Altered white matter connectivity in patients with schizophrenia: An investigation using public neuroimaging data from SchizConnect	PLOS ONE			English	Article							MIDDLE LONGITUDINAL FASCICLE; RECENT-ONSET SCHIZOPHRENIA; RESEARCH NETWORK BIRN; WORKING-MEMORY; STRUCTURAL CONNECTIVITY; 1ST-EPISODE PSYCHOSIS; DIFFUSION ANISOTROPY; MULTIPLE-SCLEROSIS; SPATIAL STATISTICS; VISUAL-PERCEPTION	Several studies have produced extensive evidence on white matter abnormalities in schizophrenia (SZ). However, optimum consistency and reproducibility have not been achieved, and reported low white matter tract integrity in patients with SZ varies between studies. A whole-brain imaging study with a large sample size is needed. This study aimed to investigate white matter integrity in the corpus callosum and connections between regions of interests (ROIs) in the same hemisphere in 122 patients with SZ and 129 healthy controls with public neuroimaging data from SchizConnect. For each diffusion-weighted image (DWI), two-tensor full-brain tractography was performed; DWIs were parcellated by processing and registering T1 images with FreeSurfer and Advanced Normalization Tools. White matter query language was used to extract white matter fiber tracts. We evaluated group differences in means of diffusion measures between the patients and controls, and correlations of diffusion measures with the severity of clinical symptoms and cognitive impairment in the patients using the Positive and Negative Syndrome Scale (PANSS), a letter-number sequencing (LNS) test, vocabulary test, letter fluency test, category fluency test, and trail-making test, part A. To correct for multiple comparisons, a false discovery rate of q < 0.05 was applied. In patients with SZ, we observed significant radial diffusivity (RD) and trace (TR) increases in left thalamo-occipital tracts and the right uncinate fascicle, and a significant RD increase in the right middle longitudinal fascicle (MDLF) and the right superior longitudinal fascicle ii. Correlations were present between TR of left thalamo-occipital tracts, and the letter fluency test and the LNS test, and RD in the right MDLF and PANSS positive sub-scale score. However, these correlations were not significant after correction for multiple comparisons. These results indicated widespread white matter fiber tract abnormalities in patients with SZ, contributing to SZ pathophysiology.	[Joo, Sung Woo] Republ Korea Navy, Donghae, South Korea; [Yoon, Woon; Shon, Seung-Hyun; Cha, Saetbyeol; Park, Kee Jeong; Lee, Jungsun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Psychiat, Seoul, South Korea; [Kim, Harin] Korean Armed Forces Capital Hosp, Dept Psychiat, Seongnam, South Korea	University of Ulsan; Asan Medical Center	Lee, J (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Psychiat, Seoul, South Korea.	js_lee@amc.seoul.kr		Lee, JungSun/0000-0003-2171-2720; Yoon, Woon/0000-0002-7915-4402; Joo, Sung Woo/0000-0001-6555-9110	National Research Foundation of Korea [NRF-2017R1D1A1B03032707]; NIH [5P20RR021938, P20GM103472]; Department of Energy [DE-FG02-08ER64581]; NIMH [A R01 MH056584]	National Research Foundation of Korea(National Research Foundation of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The present study was supported by the National Research Foundation of Korea (NRF-2017R1D1A1B03032707) to Jungsun Lee (http://www.nrf.re.kr/eng/main). The respective SchizConnect samples were supported by the following grants: NIH grants 5P20RR021938 and P20GM103472 (COBRE) (https://www.nih.gov), the Department of Energy under Award Number DE-FG02-08ER64581 (MCIC) (https://www.energy.gov/), and NIMH grant A R01 MH056584 (NMorphCH) (https://www.nimh.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2012, SCHIZOPHR RES, V142, P77, DOI 10.1016/j.schres.2012.09.012; Alba-Ferrara LM, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00009; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Ambite JL, 2015, LECT N BIOINFORMAT, V9162, P37, DOI 10.1007/978-3-319-21843-4_4; Andreasen N., 1984, SCALE ASSESSMENT POS; Andreasen N. C., 1984, SCALE ASSESSMENT POS; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Asami T, 2013, SCHIZOPHR RES, V143, P253, DOI 10.1016/j.schres.2012.11.030; Aung Wint Yan, 2013, Imaging Med, V5, P427; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Balevich EC, 2015, PSYCHIAT RES-NEUROIM, V231, P244, DOI 10.1016/j.pscychresns.2014.12.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benton AL, 1984, MULTILINGUAL APHASIA; Benton AL, 1976, MULTILINGUAL APHASIA; Berry KJ, 2002, PSYCHOL REP, V90, P495, DOI 10.2466/PR0.90.2.495-502; Bowie Christopher R, 2006, Neuropsychiatr Dis Treat, V2, P531, DOI 10.2147/nedt.2006.2.4.531; Buchsbaum MS, 1998, NEUROREPORT, V9, P425, DOI 10.1097/00001756-199802160-00013; Butler PD, 2008, BIOL PSYCHIAT, V64, P40, DOI 10.1016/j.biopsych.2008.03.023; Butler PD, 2006, AM J PSYCHIAT, V163, P2011, DOI 10.1176/appi.ajp.163.11.2011; Canu E, 2015, SCHIZOPHR RES, V161, P19, DOI 10.1016/j.schres.2014.05.020; Cho KIK, 2016, SCHIZOPHRENIA BULL, V42, P723, DOI 10.1093/schbul/sbv169; Federspiel A, 2006, NEUROBIOL DIS, V22, P702, DOI 10.1016/j.nbd.2006.01.015; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fitzsimmons J, 2013, CURR OPIN PSYCHIATR, V26, P172, DOI 10.1097/YCO.0b013e32835d9e6a; Forbes NF, 2009, PSYCHOL MED, V39, P889, DOI 10.1017/S0033291708004558; Friedman L, 2008, HUM BRAIN MAPP, V29, P958, DOI 10.1002/hbm.20440; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Gollub RL, 2013, NEUROINFORMATICS, V11, P367, DOI 10.1007/s12021-013-9184-3; Green MF, 2006, J CLIN PSYCHIAT, V67, P3, DOI 10.4088/JCP.1006e12; Green MF, 2009, ARCH GEN PSYCHIAT, V66, P1295, DOI 10.1001/archgenpsychiatry.2009.132; Guo WB, 2012, NEUROSCI LETT, V531, P5, DOI 10.1016/j.neulet.2012.09.033; Helmer KG, 2011, J AM MED INFORM ASSN, V18, P416, DOI 10.1136/amiajnl-2010-000032; Henze R, 2014, J NEUROIMAGING, V24, P111, DOI 10.1111/j.1552-6569.2011.00668.x; Hothorn T, 2008, J STAT SOFTW, V28, P1; Javitt DC, 2015, AM J PSYCHIAT, V172, P17, DOI 10.1176/appi.ajp.2014.13121691; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Kaiser J, 2007, STATA J, V7, P402, DOI 10.1177/1536867X0700700307; Kawashima T, 2009, SCHIZOPHR RES, V110, P119, DOI 10.1016/j.schres.2009.01.014; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Kochunov P, 2013, BIOL PSYCHIAT, V73, P482, DOI 10.1016/j.biopsych.2012.10.002; Konrad A, 2008, SCHIZOPHRENIA BULL, V34, P72, DOI 10.1093/schbul/sbm034; Kubicki M, 2002, AM J PSYCHIAT, V159, P813, DOI 10.1176/appi.ajp.159.5.813; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Kubicki M, 2014, CURR OPIN PSYCHIATR, V27, P179, DOI 10.1097/YCO.0000000000000053; Lee SH, 2013, ANAL BIOCHEM, V437, P10, DOI 10.1016/j.ab.2013.01.023; Lener MS, 2015, SCHIZOPHRENIA BULL, V41, P300, DOI 10.1093/schbul/sbu093; Lett TA, 2014, BIOL PSYCHIAT, V75, P361, DOI 10.1016/j.biopsych.2013.07.026; Makris N, 2013, BRAIN STRUCT FUNCT, V218, P951, DOI 10.1007/s00429-012-0441-2; Makris N, 2017, BRAIN IMAGING BEHAV, V11, P1258, DOI 10.1007/s11682-016-9589-3; Makris N, 2009, CEREB CORTEX, V19, P777, DOI 10.1093/cercor/bhn124; Mandl RCW, 2013, HUM BRAIN MAPP, V34, P2353, DOI 10.1002/hbm.22075; Melonakos ED, 2011, PSYCHIAT RES-NEUROIM, V193, P65, DOI 10.1016/j.pscychresns.2011.01.009; Nakamura K, 2012, PSYCHIAT RES-NEUROIM, V202, P233, DOI 10.1016/j.pscychresns.2011.09.006; Nestor PG, 2008, NEUROPSYCHOLOGY, V22, P246, DOI 10.1037/0894-4105.22.2.246; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Ojeda N, 2010, J NERV MENT DIS, V198, P286, DOI 10.1097/NMD.0b013e3181d61748; Ozcelik-Eroglu E, 2014, PSYCHIAT RES-NEUROIM, V223, P226, DOI 10.1016/j.pscychresns.2014.06.001; Papadakis NG, 1999, MAGN RESON IMAGING, V17, P881, DOI 10.1016/S0730-725X(99)00029-6; Rathi Y, 2011, MAGN RESON IMAGING, V29, P507, DOI 10.1016/j.mri.2010.10.005; Reavis EA, 2017, SCHIZOPHR RES, V190, P102, DOI 10.1016/j.schres.2017.03.027; Samartzis L, 2014, J NEUROIMAGING, V24, P101, DOI 10.1111/j.1552-6569.2012.00779.x; Savadjiev P, 2014, CEREB CORTEX, V24, P1389, DOI 10.1093/cercor/bhs422; Schmitt A, 2011, EUR ARCH PSY CLIN N, V261, P150, DOI 10.1007/s00406-011-0242-2; Segal D, 2007, INT J NEUROPSYCHOPH, V10, P503, DOI 10.1017/S146114570600722X; Shenton Martha E, 2010, Dialogues Clin Neurosci, V12, P317; Silver H, 2003, AM J PSYCHIAT, V160, P1809, DOI 10.1176/appi.ajp.160.10.1809; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sommer IE, 2013, SCHIZOPHRENIA BULL, V39, P815, DOI 10.1093/schbul/sbs037; Sun HQ, 2015, JAMA PSYCHIAT, V72, P678, DOI 10.1001/jamapsychiatry.2015.0505; Szeszko PR, 2008, NEUROPSYCHOPHARMACOL, V33, P976, DOI 10.1038/sj.npp.1301480; Szeszko PR, 2014, NEUROPSYCHOPHARMACOL, V39, P1324, DOI 10.1038/npp.2013.288; Szoke A, 2008, BRIT J PSYCHIAT, V192, P248, DOI 10.1192/bjp.bp.106.029009; Twamley EW, 2006, SCHIZOPHR RES, V87, P185, DOI 10.1016/j.schres.2006.04.013; van Erp TGM, 2014, SCHIZOPHR RES, V152, P289, DOI 10.1016/j.schres.2013.11.013; Viher PV, 2016, NEUROIMAGE-CLIN, V12, P93, DOI 10.1016/j.nicl.2016.06.013; Vos SB, 2016, NEUROIMAGE, V129, P117, DOI 10.1016/j.neuroimage.2016.01.011; Walterfang M, 2011, EXPERT REV NEUROTHER, V11, P971, DOI [10.1586/ern.11.76, 10.1586/ERN.11.76]; Wang L, 2016, NEUROIMAGE, V124, P1155, DOI 10.1016/j.neuroimage.2015.06.065; Wang Q, 2013, PSYCHOL MED, V43, P2301, DOI 10.1017/S0033291713000238; Wang YB, 2013, CEREB CORTEX, V23, P2347, DOI 10.1093/cercor/bhs225; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1997, WECHSLER ADULT INTEL; Wheeler AL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00653; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Zhang YC, 2014, SCHIZOPHR RES, V153, P129, DOI 10.1016/j.schres.2014.01.023	98	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205369	10.1371/journal.pone.0205369	http://dx.doi.org/10.1371/journal.pone.0205369			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4OW	30300425	Green Submitted, Green Published, gold			2022-12-26	WOS:000446897200058
J	Yang, CJ; Cai, WF; Li, ZJ; Page, AT; Fang, Y				Yang, Caijun; Cai, Wenfang; Li, Zongjie; Page, Amy Theresa; Fang, Yu			The current status and effects of emergency drug shortages in China: Perceptions of emergency department physicians	PLOS ONE			English	Article							IMPACT; CHALLENGE; MEDICINES; HOSPITALS	Objectives The shortage of emergency drugs in China is severe. This study aimed to characterize emergency drug shortages in China and to measure their effects. Methods An online questionnaire based on a literature review was sent to emergency department physicians in Chinese secondary and tertiary hospitals from November 2016 to February 2017. The survey asked physicians questions about their experiences with emergency drug shortages. Results In total, 236 physicians from 29 provinces participated in the survey. According to their responses, 90.7% of the respondents experienced drug shortages during the last year. More than half of the physicians (65.7%) reported that drug shortages occurred at least once a month. Hospitals in the eastern and western regions of China had more emergency drugs in shortage than hospitals in central China, especially those with many inpatient beds (>= 800). In addition, the shortage situation was more serious in secondary hospitals than in tertiary hospitals. More respondents agreed that original medicines, injections, essential medicines, medicines without alternative agents and cheap medicines were more susceptible to shortages than generics, oral medicines, nonessential medicines, medicines with alternative agents and expensive medicines, respectively. Most respondents thought that drug shortages always, often or sometimes affected patients [delayed therapy (62.6%), longer rescue and recovery times (58.9%) and higher costs (58.7%)] and physicians [inconvenience (81.0%), higher pressure (76.5%) and harm to patient-doctor relationships (72%)] and compromised hospital reputations (55.1%). Conclusions The shortage of emergency drugs in China is serious, especially in secondary hospitals located in eastern and western China. Emergency drug shortages have significant effects on patients and physicians.	[Yang, Caijun; Cai, Wenfang; Li, Zongjie; Fang, Yu] Xi An Jiao Tong Univ, Sch Pharm, Dept Pharm Adm & Clin Pharm, Xian, Shaanxi, Peoples R China; [Yang, Caijun; Cai, Wenfang; Li, Zongjie; Fang, Yu] Xi An Jiao Tong Univ, Ctr Drug Safety & Policy Res, Xian, Shaanxi, Peoples R China; [Page, Amy Theresa] Univ Western Australia, Western Australian Ctr Hlth & Ageing, Perth, WA, Australia; [Page, Amy Theresa] Monash Univ, Ctr Med Use & Safety, Perth, WA, Australia	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Western Australia	Fang, Y (corresponding author), Xi An Jiao Tong Univ, Sch Pharm, Dept Pharm Adm & Clin Pharm, Xian, Shaanxi, Peoples R China.; Fang, Y (corresponding author), Xi An Jiao Tong Univ, Ctr Drug Safety & Policy Res, Xian, Shaanxi, Peoples R China.	yufang@mail.xjtu.edu.cn	Page, Amy/F-9424-2013	Page, Amy/0000-0002-2084-8469	National Natural Science Foundation of China [71503197, 71473192]; Department of Science and Technology of Shaanxi Province [2016SF-082]; China Medical Board Open Competition Research Program [14-196]; "Young Talent Support Plan" of Xian Jiaotong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Shaanxi Province; China Medical Board Open Competition Research Program; "Young Talent Support Plan" of Xian Jiaotong University	This work was supported by the National Natural Science Foundation of China (71503197 and 71473192), Department of Science and Technology of Shaanxi Province (2016SF-082), China Medical Board Open Competition Research Program (14-196), and "Young Talent Support Plan" of Xian Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 2016, MED SOC, V29, P45; [Anonymous], 2013, REP ISPE 2013 DRUG S; Assary G, 2013, DECCAN CHRONICLE; Becker DJ, 2013, J ONCOL PRACT, V9, pE122, DOI 10.1200/JOP.2012.000799; Bible JR, 2014, JPEN-PARENTER ENTER, V38, p65S, DOI 10.1177/0148607114550317; Cai W, 2016, CHINESE PHARM AFFAIR, V30, P1190; Casassus B, 2015, LANCET, V385, P1279, DOI 10.1016/S0140-6736(15)60667-5; Chabner BA, 2011, NEW ENGL J MED, V365, P2147, DOI 10.1056/NEJMp1112633; [陈慧 Chen Hui], 2014, [中国药房, China Pharmacy], V25, P1453; Costelloe EM, 2015, IRISH J MED SCI, V184, P435, DOI 10.1007/s11845-014-1139-7; De Weerdt E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174556; Dill S, 2014, EUR J CLIN PHARMACOL, V70, P1405, DOI 10.1007/s00228-014-1747-1; Ding, 2015, J TRADITIONAL CHINES, V23, P99; Eddleston M, 2005, LANCET, V366, P1452, DOI 10.1016/S0140-6736(05)67598-8; Fox ER, 2014, MAYO CLIN PROC, V89, P361, DOI 10.1016/j.mayocp.2013.11.014; Furlow B, 2017, LANCET RESP MED, V5, P469, DOI 10.1016/S2213-2600(17)30159-5; Gray A, 2012, B WORLD HEALTH ORGAN, V90, P158, DOI 10.2471/BLT.11.101303; Hawley KL, 2016, ACAD EMERG MED, V23, P63, DOI 10.1111/acem.12838; Hicks RW, 2006, J INFUS MURS, V29, P20, DOI 10.1097/00129804-200601000-00005; Ji JF, 2015, GENET MOL RES, V14, P9353, DOI 10.4238/2015.August.10.16; Kaakeh R, 2011, AM J HEALTH-SYST PH, V68, P1811, DOI 10.2146/ajhp110210; Kaiser J, 2011, SCIENCE, V332, P523, DOI 10.1126/science.332.6029.523; [刘敏豪 Liu Minhao], 2012, [中国药房, China Pharmacy], V23, P673; Liu X, 2015, CENTRAL S PHARM, P880; [马建春 Ma Jianchun], 2014, [中国医院药学杂志, Chinese Journal of Hospital Pharmacy], V34, P229; National Health and Family Planning Commission of the People's Republic of China, 2011, NOT ENS SUPPL EM MED; National Health and Family Planning Commission of the People's Republic of China, 2015, NOT ENS SUPPL EM MED; National Health and Family Planning Commission of the People's Republic of China, 2015, NOT SEL RUL MED LIST; Pauwels K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-438; Rosoff PM, 2012, AM J BIOETHICS, V12, P1, DOI 10.1080/15265161.2011.634483; Tran DT, 2008, COCHRANE DB SYST REV, V2; University of Utah Drug Information Service, DRUG SHORT STAT; WHO, 2001, TECHNICAL REPORT SER; Woodcock J, 2013, CLIN PHARMACOL THER, V93, P170, DOI 10.1038/clpt.2012.220; Wu L., 2016, CHIN PHARM AFF, V5, P458, DOI [10.16153/j.1002-7777.2016.05.009, DOI 10.16153/J.1002-7777.2016.05.009]; Yang CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165183; Yang LP, 2015, SOC SCI MED, V145, P201, DOI 10.1016/j.socscimed.2015.08.044	37	8	9	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205238	10.1371/journal.pone.0205238	http://dx.doi.org/10.1371/journal.pone.0205238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300412	gold, Green Published, Green Submitted			2022-12-26	WOS:000446897200047
J	Kaltdorf, KV; Theiss, M; Markert, SM; Zhen, M; Dandekar, T; Stigloher, C; Kollmannsberger, P				Kaltdorf, Kristin Verena; Theiss, Maria; Markert, Sebastian Matthias; Zhen, Mei; Dandekar, Thomas; Stigloher, Christian; Kollmannsberger, Philip			Automated classification of synaptic vesicles in electron tomograms of C. elegans using machine learning	PLOS ONE			English	Article							DENSE-CORE VESICLES; DAUER LARVA; ACTIVE ZONE; INSULIN; KISS; NEUROPEPTIDES; EXOCYTOSIS; PHEROMONE; MEMBER	Synaptic vesicles (SVs) are a key component of neuronal signaling and fulfil different roles depending on their composition. In electron micrograms of neurites, two types of vesicles can be distinguished by morphological criteria, the classical "clear core" vesicles (CCV) and the typically larger "dense core" vesicles (DCV), with differences in electron density due to their diverse cargos. Compared to CCVs, the precise function of DCVs is less defined. DCVs are known to store neuropeptides, which function as neuronal messengers and modulators [1]. In C. elegans, they play a role in locomotion, dauer formation, egg-laying, and mechano- and chemosensation [2]. Another type of DCVs, also referred to as granulated vesicles, are known to transport Bassoon, Piccolo and further constituents of the presynaptic density in the center of the active zone (AZ), and therefore are important for synaptogenesis [3]. To better understand the role of different types of SVs, we present here a new automated approach to classify vesicles. We combine machine learning with an extension of our previously developed vesicle segmentation workflow, the ImageJ macro 3D ART VeSElecT. With that we reliably distinguish CCVs and DCVs in electron tomograms of C. elegans NMJs using image-based features. Analysis of the underlying ground truth data shows an increased fraction of DCVs as well as a higher mean distance between DCVs and AZs in dauer larvae compared to young adult hermaphrodites. Our machine learning based tools are adaptable and can be applied to study properties of different synaptic vesicle pools in electron tomograms of diverse model organisms.	[Kaltdorf, Kristin Verena; Markert, Sebastian Matthias; Stigloher, Christian] Univ Wurzburg, Bioctr, Imaging Core Facil, Wurzburg, Germany; [Kaltdorf, Kristin Verena; Theiss, Maria; Dandekar, Thomas] Univ Wurzburg, Bioctr, Dept Bioinformat, Wurzburg, Germany; [Kaltdorf, Kristin Verena; Theiss, Maria; Kollmannsberger, Philip] Univ Wurzburg, Ctr Computat & Theoret Biol, Wurzburg, Germany; [Zhen, Mei] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Toronto	Stigloher, C (corresponding author), Univ Wurzburg, Bioctr, Imaging Core Facil, Wurzburg, Germany.; Dandekar, T (corresponding author), Univ Wurzburg, Bioctr, Dept Bioinformat, Wurzburg, Germany.; Kollmannsberger, P (corresponding author), Univ Wurzburg, Ctr Computat & Theoret Biol, Wurzburg, Germany.	dandekar@biozentrum.uni-wuerzburg.de; christian.stigloher@uni-wuerzburg.de; philip.kollmannsberger@uni-wuerzburg.de	Zhen, Mei/A-4967-2012; Kollmannsberger, Philip/D-7925-2011; Stigloher, Christian/E-4762-2015; Dandekar, Thomas/A-4431-2017	Zhen, Mei/0000-0003-0086-9622; Kollmannsberger, Philip/0000-0002-8049-6186; Stigloher, Christian/0000-0001-6941-2669; Markert, Sebastian/0000-0001-9069-156X; Theiss, Maria/0000-0002-7843-2351; Dandekar, Thomas/0000-0003-1886-7625	Deutsche Forschungsgemeinschaft [SFB688/A2]; Studienstiftung des Deutschen Volkes; German Research Foundation (DFG); University of Wuerzburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	K.V.K., T.D. acknowledge support by the Deutsche Forschungsgemeinschaft (grant SFB688/A2, http://gepris.dfg.de/gepris/projekt/14085162). S.M.M. was supported by a PhD grant from the Studienstiftung des Deutschen Volkes. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artalejo CR, 1998, CURR BIOL, V8, pR62, DOI 10.1016/S0960-9822(98)70036-3; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Cornils A, 2011, DEVELOPMENT, V138, P1183, DOI 10.1242/dev.060905; Erkut C, 2015, PLANTA, V242, P389, DOI 10.1007/s00425-015-2300-x; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Haueis P, 2017, PROG BRAIN RES, V233, P149, DOI 10.1016/bs.pbr.2017.05.002; Helmprobst F, 2015, J COMP NEUROL, V523, P1984, DOI 10.1002/cne.23775; Hope IA., 1999, C ELEGANS PRACTICAL; Hung WL, 2014, DEVELOPMENT, V141, P1767, DOI 10.1242/dev.103846; Kaltdorf KV, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005317; Kittelmann M, 2013, J CELL BIOL, V203, P849, DOI 10.1083/jcb.201302022; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lim MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19887; MARKUS EJ, 1987, DEV BRAIN RES, V35, P239, DOI 10.1016/0165-3806(87)90048-4; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McKinney W., 2010, 9 PYTHON SCI C, V445, P51; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Phillips MI, 2000, NEUROPEPTIDES REGULA, V90, P101, DOI DOI 10.1016/S0167-0115(00)00102-6; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Raschka S., 2015, PYTHON MACHINE LEARN; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; ROBERTSON JD, 1987, INT REV CYTOL, V100, P129; Rutter GA, 2004, NEUROREPORT, V15, P79, DOI 10.1097/00001756-200401190-00016; Salio C, 2007, DEV NEUROBIOL, V67, P326, DOI 10.1002/dneu.20358; Salio C, 2006, CELL TISSUE RES, V326, P583, DOI 10.1007/s00441-006-0268-3; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Shawe-Taylor J, 2004, KERNEL METHODS PATTE; Stigloher C, 2011, J NEUROSCI, V31, P4388, DOI 10.1523/JNEUROSCI.6164-10.2011; Tsuboi T, 2004, J BIOL CHEM, V279, P47115, DOI 10.1074/jbc.M408179200; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; WALCHSOLIMENA C, 1993, J NEUROSCI, V13, P3895; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zampighi GA, 2005, J STRUCT BIOL, V151, P263, DOI 10.1016/j.jsb.2005.05.008; Zampighi GA, 2008, J NEUROSCI, V28, P4151, DOI 10.1523/JNEUROSCI.4639-07.2008; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205348	10.1371/journal.pone.0205348	http://dx.doi.org/10.1371/journal.pone.0205348			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296290	gold, Green Published, Green Submitted			2022-12-26	WOS:000446632700034
J	Forcina, G; Guerrini, M; Khaliq, I; Khan, AA; Barbanera, F				Forcina, Giovanni; Guerrini, Monica; Khaliq, Imran; Khan, Aleem Ahmed; Barbanera, Filippo			Human-modified biogeographic patterns and conservation in game birds: The dilemma of the black francolin (Francolinus francolinus, Phasianidae) in Pakistan	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC DIVERSITY; BIOTIC HOMOGENIZATION; PASSERINE BIRDS; COMMON QUAIL; RAPD MARKERS; WILD; GALLIFORMES; HYBRIDIZATION; CONSEQUENCES	The ever-increasing human-mediated wildlife reshuffling is raising concern for the conservation of biodiversity. The loss of biological distinctiveness among regions lessens the genetic diversity and consequently the evolutionary potential of local biotas to tackle present-day global change and human disturbance. This process may be sometimes cryptic unless investigated by means of a molecular approach. In this respect, game birds are a paradigmatic case. The black francolin (Francolinus francolinus, Phasianidae) is a medium-sized galliform whose distribution range stretches from Cyprus to the Gulf of Bengal. Six morphologic subspecies are known, with three of which occurring in Pakistan, where the species is heavily hunted and used as pet for chirping competitions. We genotyped 98 samples (feathers) at both the entire mitochondrial DNA Control Region gene and nine microsatellite loci to get a deeper insight into the genetic diversity of the black francolin in Pakistan in order to offer cogent recommendations for its conservation management. We identified several mtDNA lineages that were consistent with the currently described subspecies/taxonomy whose pattern of co-occurrence is compatible with the geological history and the faunal movement routes of the region under study. However, the biparentally inherited micro-satellites returned a quite discordant picture of an extensive, sex-biased genetic mixing due to the intensive relocations of already overharvested male individuals for chirping competitions. Our results indicated that the genetic integrity of the black francolin in Pakistan could be seriously at risk and call for monitoring and limiting its trade other than enhancing the public awareness of the importance of local biodiversity resources.	[Forcina, Giovanni; Guerrini, Monica; Barbanera, Filippo] Univ Pisa, Dept Biol, Pisa, Italy; [Khaliq, Imran; Khan, Aleem Ahmed] Ghazi Univ, Dept Zool, Dera Ghazi Khan, Punjab, Pakistan; [Forcina, Giovanni; Guerrini, Monica; Barbanera, Filippo] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore	University of Pisa; National University of Singapore	Barbanera, F (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	filippo.barbaner@unipi.it	Forcina, Giovanni/O-5179-2017	Forcina, Giovanni/0000-0001-5727-7770				Ali S., 1983, HDB BIRDS INDIA PAKI; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Altaf M, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-018-0253-4; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Baker E. C. S., 1923, Journal of the Bombay Natural History Society, V29, P9; Baldacci Ugo, 1964, FRANCOLINO SUA REINT; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbanera F, 2005, BIOL CONSERV, V122, P275, DOI 10.1016/j.biocon.2004.07.017; Barbanera F, 2010, BIOL CONSERV, V143, P1259, DOI 10.1016/j.biocon.2010.02.035; Barbanera F, 2009, BIOL INVASIONS, V11, P333, DOI 10.1007/s10530-008-9251-0; Behbash R, 2010, AFR J BIOTECHNOL, V9, P3847; Bird Life International, 2004, BIRD LIF CONS SER, V12; Boivin N, 2017, HUMAN DISPERSAL AND SPECIES MOVEMENT: FROM PREHISTORY TO THE PRESENT, P1; BRENNAN LA, 1991, WILDLIFE SOC B, V19, P544; Casas F, 2012, BIOL INVASIONS, V14, P295, DOI 10.1007/s10530-011-0062-3; Champagnon J, 2012, J NAT CONSERV, V20, P231, DOI 10.1016/j.jnc.2012.02.002; Clements JF, 2007, CLEMENTS CHECKLIST B; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; Dementiev GP, 1952, BIRDS TURKMENISTAN, V1, DOI [10.1111/brv.12107, DOI 10.1111/BRV.12107]; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ericson PGP, 2002, MOL PHYLOGENET EVOL, V25, P53, DOI 10.1016/S1055-7903(02)00215-4; Ericson PGP, 2002, P ROY SOC B-BIOL SCI, V269, P235, DOI 10.1098/rspb.2001.1877; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Finlayson C., 2011, AVIAN SURVIVORS HIST; Flockhart DTT, 2017, WILDLIFE SOC B, V41, P231, DOI 10.1002/wsb.759; Forcina G, 2012, MOL PHYLOGENET EVOL, V65, P523, DOI 10.1016/j.ympev.2012.07.006; Forcina G, 2015, P NATL ACAD SCI USA, V112, P3296, DOI 10.1073/pnas.1500677112; Forcina G, 2014, J NAT CONSERV, V22, P15, DOI 10.1016/j.jnc.2013.07.004; Ford MJ, 2002, CONSERV BIOL, V16, P815, DOI 10.1046/j.1523-1739.2002.00257.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Fuller R.A., 2000, PARTRIDGES QUAILS FR, P63; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; Goudet J., 2002, FSTAT PROGRAM ESTIMA; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Guerrini M, 2009, BIOCHEM GENET, V47, P873, DOI 10.1007/s10528-009-9288-5; Gummer H, 2003, DEP CONSERVATION SCI, V150; HALL B. P., 1963, BRIT MUS [NAT HIST] ZOOL, V10, P105; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hufbauer RA, 2015, P NATL ACAD SCI USA, V112, P10557, DOI 10.1073/pnas.1504732112; Islam K., 1993, P131; ISLAM K, 1999, BIRDS N AM, P394; Itoh Yuichiro, 2007, Journal of Biology, V6, pUnpaginated, DOI 10.1186/jbiol53; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnsgard PA, 1988, QUAILS PARTRIDGES FR; Jonsson KA, 2012, P NATL ACAD SCI USA, V109, P6620, DOI 10.1073/pnas.1115835109; Karanth KP, 2003, CURR SCI INDIA, V85, P1276; Khan MF, 2015, J ANIM PLANT SCI, V25, P101; Khan WA, 2013, PAK J ZOOL, V45, P949; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Madge S., 2002, PHEASANTS PARTRIDGES; Mahmoud Sajid, 2010, Podoces, V5, P42; Mani MS., 1974, ECOLOGY BIOGEOGRAPHY, P698, DOI DOI 10.1007/978-94-010-2331-3_24; Mann M. Anwar, 2000, Pakistan Veterinary Journal, V20, P118; Ogawa A, 1997, CHROMOSOME RES, V5, P93, DOI 10.1023/A:1018461906913; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Oliveira R, 2008, CONSERV GENET, V9, P1, DOI 10.1007/s10592-007-9297-z; Perez T, 1998, MOL ECOL, V7, P1347, DOI 10.1046/j.1365-294x.1998.00484.x; PERGAMS ORW, 2009, PRINCETON GUIDE ECOL, P642; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Price TD, 2014, NATURE, V509, P222, DOI 10.1038/nature13272; Pritchard JK, 2000, GENETICS, V155, P945; Qureshi JI, 1972, PAK J AGR SCI, V12, P103; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Riaz M, 2011, PAK J ZOOL, V43, P889; Roberts T.J., 1992, BIRDS PAKISTAN, V1; Romagosa CM, 2009, CONSERV BIOL, V23, P1001, DOI 10.1111/j.1523-1739.2009.01194.x; RYMAN N, 1991, CONSERV BIOL, V5, P325, DOI 10.1111/j.1523-1739.1991.tb00144.x; Sanchez-Donoso I, 2018, ANIM BEHAV, V136, P107, DOI 10.1016/j.anbehav.2017.12.012; Sanchez-Donoso I, 2014, EVOL ECOL RES, V16, P493; Sanchez-Donoso Ines, 2014, Frontiers in Ecology and Evolution, V2, P15; Sclater PL, 1858, J P LINNEAN SOC ZOOL, V2, P130, DOI DOI 10.1111/J.1096-3642.1858.TB02549.X; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Soderquist P, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-017-1156-8; Templeton A.R., 1986, P105; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vazquez-Reyes LD, 2017, CONDOR, V119, P275, DOI 10.1650/CONDOR-16-116.1; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Whistler H., 1949, POPULAR HDB INDIAN B; Whiteley AR, 2015, TRENDS ECOL EVOL, V30, P42, DOI 10.1016/j.tree.2014.10.009; *WORLD PHEAS ASS I, 2009, GUID REINTR GALL CON; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450	90	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205059	10.1371/journal.pone.0205059	http://dx.doi.org/10.1371/journal.pone.0205059			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289901	Green Published, Green Submitted, gold			2022-12-26	WOS:000446545500042
J	Glaspie, CN; Seitz, RD				Glaspie, Cassandra N.; Seitz, Rochelle D.			Habitat complexity and benthic predator-prey interactions in Chesapeake Bay	PLOS ONE			English	Article							CALLINECTES-SAPIDUS RATHBUN; SOFT-SHELL CLAM; DENSITY-DEPENDENT PREDATION; MYA-ARENARIA L.; BLUE-CRAB; FUNCTIONAL-RESPONSES; FORAGING BEHAVIOR; HARD CLAMS; POPULATION; SIZE	In Chesapeake Bay, the soft-shell clam Mya arenaria (thin-shelled, deep-burrowing) exhibits population declines when predators are active, and it persists at low densities. In contrast, the hard clam Mercenaria mercenaria (thick-shelled, shallow-burrowing) has a stable population and age distribution. We examined the potential for habitat and predators to control densities and distributions of bivalves in a field caging experiment (Mya only) and laboratory mesocosm experiments (both species). In the field, clams exposed to predators experienced 76.3% greater mortality as compared to caged individuals, and blue crabs were likely responsible for most of the mortality of juvenile Mya. In mesocosm experiments, Mya had lower survival in sand and seagrass than in shell hash or oyster shell habitats. However, crabs often missed one or more prey items in seagrass, shell, and oyster shell habitats. Predator search times and encounter rates declined when prey were at low densities, likely due to the added cost of inefficient foraging; however, this effect was more pronounced for Mya than for Mercenaria. Mercenaria had higher survival than Mya in mesocosm experiments, likely because predators feeding on Mercenaria spent less time foraging than those feeding on Mya. Mya may retain a low-density refuge from predation even with the loss of structurally complex habitats, though a loss of habitat refuge may result in clam densities that are not sustainable. A better understanding of density-dependent predator-prey interactions is necessary to prevent loss of food-web integrity and to conserve marine resources.	[Glaspie, Cassandra N.; Seitz, Rochelle D.] Virginia Inst Marine Sci, Dept Biol Sci, Gloucester Point, VA 23062 USA; [Glaspie, Cassandra N.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	William & Mary; Virginia Institute of Marine Science; Louisiana State University System; Louisiana State University	Glaspie, CN (corresponding author), Virginia Inst Marine Sci, Dept Biol Sci, Gloucester Point, VA 23062 USA.; Glaspie, CN (corresponding author), Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	cglaspie1@lsu.edu			National Oceanic and Atmospheric Administration Chesapeake Bay Office [NA11NMF4570218]; Environmental Protection Agency EPA STAR Fellowship [FP91767501]; National Science Foundation Administration GK-12 program [DGE-0840804]	National Oceanic and Atmospheric Administration Chesapeake Bay Office(National Oceanic Atmospheric Admin (NOAA) - USA); Environmental Protection Agency EPA STAR Fellowship; National Science Foundation Administration GK-12 program	This material is based upon work supported by the National Oceanic and Atmospheric Administration Chesapeake Bay Office (https://chesapeakebay.noaa.gov/) grant number NA11NMF4570218 (RDS); the Environmental Protection Agency EPA STAR Fellowship (https://www.epa.gov/research-fellowships/science-achieve-results-star-graduate-fellowships) under grant number FP91767501 (CNG); and the National Science Foundation Administration GK-12 program (http://www.vims.edu/education/graduate/gk12/fellows/index.php) under grant number DGE-0840804 (CNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1982, AM NAT, V120, P382, DOI 10.1086/283996; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; ARNOLD WS, 1984, J EXP MAR BIOL ECOL, V80, P207, DOI 10.1016/0022-0981(84)90150-3; Beal BF, 2002, AQUACULTURE, V208, P81, DOI 10.1016/S0044-8486(01)00900-0; Beal BF, 2006, J EXP MAR BIOL ECOL, V336, P1, DOI 10.1016/j.jembe.2006.04.006; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Bellmore JR, 2015, ECOLOGY, V96, P274, DOI 10.1890/14-0733.1; BLUNDON JA, 1982, J EXP MAR BIOL ECOL, V65, P47, DOI 10.1016/0022-0981(82)90175-7; BLUNDON JA, 1982, J EXP MAR BIOL ECOL, V65, P67, DOI 10.1016/0022-0981(82)90176-9; Boukal DS, 2007, THEOR POPUL BIOL, V72, P136, DOI 10.1016/j.tpb.2006.12.003; CRONIN TW, 1988, J COMP PHYSIOL A, V162, P463, DOI 10.1007/BF00612512; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Duarte CM, 2008, ESTUAR COAST, V31, P233, DOI 10.1007/s12237-008-9038-7; Dungan CF, 2002, DIS AQUAT ORGAN, V50, P67, DOI 10.3354/dao050067; EGGLESTON DB, 1992, MAR ECOL PROG SER, V85, P55, DOI 10.3354/meps085055; Fisher R.A, 2010, LIFE HIST TROPHIC EC; Fisher RA, 2011, J SHELLFISH RES, V30, P187, DOI 10.2983/035.030.0126; GARRITY SD, 1981, ECOL MONOGR, V51, P267, DOI 10.2307/2937274; Gascoigne JC, 2004, J APPL ECOL, V41, P801, DOI 10.1111/j.0021-8901.2004.00944.x; Glaspie CN, 2018, MAR ECOL PROG SER, V603, P117, DOI 10.3354/meps12706; Glaspie CN, 2017, MAR ECOL PROG SER, V570, P113, DOI 10.3354/meps12103; Glaspie CN, 2017, J EXP MAR BIOL ECOL, V489, P58, DOI 10.1016/j.jembe.2016.11.010; Glaspie CN, 2017, KNOWLEDGE NETWORK BI; HASSELL MP, 1973, J ANIM ECOL, V42, P693, DOI 10.2307/3133; Hassell MP., 1978, DYNAMICS ARTHROPOD P; HINES AH, 1990, MAR ECOL PROG SER, V67, P105, DOI 10.3354/meps067105; Homer ML, 2011, ASSESSMENT CHESAPEAK; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hunsicker ME, 2011, ECOL LETT, V14, P1288, DOI 10.1111/j.1461-0248.2011.01696.x; Kramer AM, 2010, J ANIM ECOL, V79, P633, DOI 10.1111/j.1365-2656.2009.01657.x; LAURANCE WF, 1991, BIOL CONSERV, V55, P77, DOI 10.1016/0006-3207(91)90006-U; Lipcius RN, 1998, MAR FRESHWATER RES, V49, P807, DOI 10.1071/MF97094; LIPCIUS RN, 1986, ECOLOGY, V67, P1361, DOI 10.2307/1938692; Lipcius Romuald N., 2007, BLUE CRAB CALLINECTE, P535; Long WC, 2013, J EXP MAR BIOL ECOL, V449, P142, DOI 10.1016/j.jembe.2013.09.004; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Madadi H, 2011, J PEST SCI, V84, P447, DOI 10.1007/s10340-011-0387-9; Micheli F, 1997, ECOL MONOGR, V67, P203, DOI 10.1890/0012-9615(1997)067[0203:EOPFBO]2.0.CO;2; MURDOCH W W, 1975, P1; ORTH RJ, 1983, SCIENCE, V222, P51, DOI 10.1126/science.222.4619.51; Peterson CH, 2001, OECOLOGIA, V129, P349, DOI 10.1007/s004420100742; QUAMMEN ML, 1984, ECOLOGY, V65, P529, DOI 10.2307/1941415; RANDALL JE, 1961, ECOLOGY, V42, P812, DOI 10.2307/1933510; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; Seitz RD, 2001, ECOLOGY, V82, P2435, DOI 10.1890/0012-9658(2001)082[2435:DDPHVA]2.0.CO;2; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; Sinclair ARE, 2006, J ANIM ECOL, V75, P64, DOI 10.1111/j.1365-2656.2006.01036.x; SKILLETER GA, 1994, MAR ECOL PROG SER, V109, P29, DOI 10.3354/meps109029; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; SPONAUGLE S, 1990, MAR ECOL PROG SER, V67, P43, DOI 10.3354/meps067043; Stoner AW, 2009, J EXP MAR BIOL ECOL, V382, P54, DOI 10.1016/j.jembe.2009.10.003; Taylor DL, 2000, MAR ECOL PROG SER, V196, P221, DOI 10.3354/meps196221; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Uszko W, 2015, ECOLOGY, V96, P3243, DOI 10.1890/15-0055.1; Vermeij G.J, 1987, EVOLUTION ESCALATION; WHETSTONE JM, 1981, ESTUARIES, V4, P153, DOI 10.2307/1351680; WRIGHT LD, 1987, ESTUAR COAST SHELF S, V24, P765, DOI 10.1016/0272-7714(87)90151-X	58	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205162	10.1371/journal.pone.0205162	http://dx.doi.org/10.1371/journal.pone.0205162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289889	Green Published, Green Submitted, gold			2022-12-26	WOS:000446545500054
J	Huruy, K; Mulu, A; Liebert, UG; Melanie, M				Huruy, Kahsay; Mulu, Andargachew; Liebert, Uwe Gerd; Melanie, Maier			HIV-1 C proviral DNA for detection of drug resistance mutations	PLOS ONE			English	Article							GENOTYPIC RESISTANCE; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; CELLULAR RESERVOIRS; NAIVE INDIVIDUALS; PLASMA RNA; BLOOD DNA; EPIDEMIOLOGY; PREVALENCE; VARIANTS	Background Using HIV proviral DNA as a template may be suitable for initial detection of transmitted drug resistance mutations (TDRMs) as it is easy to handle and less expensive compared to RNA. However, existing literatures which are mainly focused on HIV-1B subtypes DNA extracted from PBMCs revealed controversial findings ranging from the detection of significantly lower or higher mutations in proviral DNA compared to historic viral RNA. Thus, to verify whether viral RNA or proviral DNA has improved sensitivity in detecting transmitted genotypic drug resistance mutations paired viral RNA and proviral DNA (which is directly extracted from stored whole blood) samples were tested from Ethiopian antiretroviral naive HIV-1C infected subjects. Methods In the present comparative study the frequency of TDR mutations was assessed in paired samples of viral RNA and proviral DNA (extracted directly from stored whole blood) of HIV1C infected treatment naive patients and interpreted using the 2009 WHO drug resistance surveillance mutation lists, Stanford University drug resistance data base and International Antiviral Society-USA mutation lists. Results High agreement in rate of TDR between the two compartments was observed using the WHO mutation lists. While mutations G190A and E138A were concurrently found in both compartments, others such as G735 on PR and A62V, M1841, M2301 on RT were identified in proviral DNA only. All signature mutations seen in viral RNA were not missed in proviral DNA. Conclusions The concordance of major genotype drug resistance mutation between RNA and proviral DNA in treatment naive patients suggests that proviral DNA might be an alternative approaches for an initial assessment of drug resistance prior to initiation of antiretroviral therapy using the WHO mutations lists in resource-limited countries. However, the clinical importance of TDRMs observed only in proviral DNA in terms of being a risk factor for virologic failure and whether they limit future treatment options needs additional investigation using more sensitive sequencing approaches such as Next Generation Sequencing (NGS).	[Huruy, Kahsay] Univ Gondar, Sch Biomed & Lab Sci, Dept Med Microbiol, Gondar, Ethiopia; [Mulu, Andargachew] AHRI, Addis Ababa, Ethiopia; [Liebert, Uwe Gerd; Melanie, Maier] Univ Leipzig, Inst Virol, Leipzig, Germany	University of Gondar; Leipzig University	Mulu, A (corresponding author), AHRI, Addis Ababa, Ethiopia.	andargachewmulu@yahoo.com	Mulu, Andargachew/GMW-4823-2022	Mulu, Andargachew/0000-0003-2862-0175				Abdissa A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-181; Abegaz WE, 2008, ANTIVIR THER, V13, P89; Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Banks Lauren, 2012, J AIDS Clin Res, V3, P141; Bansode V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-52; Bon I, 2007, J CLIN VIROL, V38, P313, DOI 10.1016/j.jcv.2006.12.018; Casabianca A, 2007, MOL CELL PROBE, V21, P368, DOI 10.1016/j.mcp.2007.05.005; Chew CB, 2005, J CLIN VIROL, V33, P206, DOI 10.1016/j.jcv.2004.11.006; d'Ettorre G, 2010, NEW MICROBIOL, V33, P1; Demetriou VL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010976; Derache A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117430; Fourati S, 2012, AIDS, V26, P1619, DOI 10.1097/QAD.0b013e3283560703; Frentz D, 2012, AIDS REV, V14, P17; Geretti AM, 2014, J ANTIMICROB CHEMOTH, V69, P1090, DOI 10.1093/jac/dkt474; Ghosn J, 2006, AIDS, V20, P159, DOI 10.1097/01.aids.0000199820.47703.a0; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Huruy K, 2015, J MED VIROL, V87, P978, DOI 10.1002/jmv.24110; Imaz A, 2011, AIDS REV, V13, P180; Kabamba-Mukadi B, 2010, HIV MED, V11, P483, DOI 10.1111/j.1468-1293.2009.00814.x; Kassu A, 2007, AIDS RES HUM RETROV, V23, P564, DOI 10.1089/aid.2006.0270; Leal-Klevezas DS, 2000, CLIN DIAGN LAB IMMUN, V7, P945, DOI 10.1128/CDLI.7.6.945-946.2000; Lee GQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046181; Mulu A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141318; Mulu A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-158; Noe A, 2005, J ANTIMICROB CHEMOTH, V55, P410, DOI 10.1093/jac/dki038; Parisi SG, 2007, J CLIN MICROBIOL, V45, P1783, DOI 10.1128/JCM.00056-07; Sanabani SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062552; Saracino A, 2008, J MED VIROL, V80, P1695, DOI 10.1002/jmv.21261; Shet A, 2006, JAIDS-J ACQ IMM DEF, V41, P439, DOI 10.1097/01.qai.0000219290.49152.6a; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turriziani O, 2010, CLIN MICROBIOL INFEC, V16, P1518, DOI 10.1111/j.1469-0691.2010.03329.x; Turriziani O, 2007, JAIDS-J ACQ IMM DEF, V44, P518, DOI 10.1097/QAI.0b013e3180315515; Venturi G, 2002, ANTIVIR THER, V7, P245; Vicenti I, 2007, CLIN INFECT DIS, V44, P1657, DOI 10.1086/518287; Wainberg MA, 2011, VIRUSES, V1, P2493; Wang YM, 2007, CURR HIV RES, V5, P235; Wensing AM, 2017, TOP ANTIVIR MED, V24; Yanik EL, 2012, JAIDS-J ACQ IMM DEF, V61, P258, DOI 10.1097/QAI.0b013e3182618f05; Yebra G, 2010, ANTIVIR RES, V85, P409, DOI 10.1016/j.antiviral.2009.11.010	39	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205119	10.1371/journal.pone.0205119	http://dx.doi.org/10.1371/journal.pone.0205119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286160	gold, Green Submitted, Green Published			2022-12-26	WOS:000446383500088
J	Schnell, G; Krishnan, P; Tripathi, R; Beyer, J; Reisch, T; Irvin, M; Dekhtyar, T; Lu, LJ; Ng, TI; Xie, WG; Pilot-Matias, T; Collins, C				Schnell, Gretja; Krishnan, Preethi; Tripathi, Rakesh; Beyer, Jill; Reisch, Thomas; Irvin, Michelle; Dekhtyar, Tatyana; Lu, Liangjun; Ng, Teresa I.; Xie, Wangang; Pilot-Matias, Tami; Collins, Christine			Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir	PLOS ONE			English	Article							VIVO ANTIVIRAL ACTIVITY; HISTORICAL EPIDEMIOLOGY; 6 INFECTION; SELECT COUNTRIES; GLOBAL EPIDEMIOLOGY; RESISTANCE PROFILE; HCV GENOTYPES; FULL-LENGTH; IN-VITRO; SOFOSBUVIR	Hepatitis C virus (HCV) is genetically diverse and includes 7 genotypes and 67 confirmed subtypes, and the global distribution of each HCV genotype (GT) varies by geographic region. In this report, we utilized a large dataset of NS3/4A and NS5A sequences isolated from 2348 HCV GT1-6-infected patients treated with the regimen containing glecaprevir/pibrentasvir (GLE/PIB) to assess genetic diversity within HCV subtypes by geographic region using phylogenetic analyses, and evaluated the prevalence of baseline amino acid polymorphisms in NS3 and NS5A by region/country and phylogenetic cluster. Among 2348 NS3/4A and NS5A sequences, phylogenetic analysis identified 6 genotypes and 44 subtypes, including 3 GT1, 8 GT2, 3 GT3, 13 GT4, 1 GT5, and 16 GT6 subtypes. Phylogenetic analysis of HCV subtype la confirmed the presence of two clades, which differed by geographic region distribution and NS3 080K prevalence. We detected phylogenetic clustering by country in HCV subtypes 1a, 1 b, 2a, 2b, and 5a, suggesting that genetically distinct virus lineages are circulating in different countries. In addition, two clades were detected in HCV GT4a and GT6e, and NS5A amino acid polymorphisms were differentially distributed between the 2 clades in each subtype. The prevalence of NS3 and NS5A baseline polymorphisms varied substantially by genotype and subtype; therefore, we also determined the activity of GLE or PIB against replicons containing NS3/4A or NS5A from HCV GT1-6 clinical samples representing 6 genotypes and 21 subtypes overall. GLE and PIB retained activity against the majority of HCV replicons containing NS3/4A or NS5A from HCV GT1-6 clinical samples, with a median EC50 of 0.29 nM for GLE and 1.1 pM for PIB in a transient replicon assay. The data presented in this report expands the available data on HCV epidemiology, subtype diversity by geographic region, and NS3 and NS5A baseline polymorphism prevalence.	[Schnell, Gretja; Krishnan, Preethi; Tripathi, Rakesh; Beyer, Jill; Reisch, Thomas; Irvin, Michelle; Dekhtyar, Tatyana; Lu, Liangjun; Ng, Teresa I.; Xie, Wangang; Pilot-Matias, Tami; Collins, Christine] AbbVie Inc, Res & Dev, N Chicago, IL 60064 USA	AbbVie	Schnell, G (corresponding author), AbbVie Inc, Res & Dev, N Chicago, IL 60064 USA.	gretja.schnell@abbvie.com	Irvin, Michelle/AAR-9177-2020; Zhou, Linjie/E-7874-2013	Irvin, Michelle/0000-0001-5712-1100; Zhou, Linjie/0000-0002-2792-2959; Ng, Teresa/0000-0001-8333-2446	AbbVie, Inc.; AbbVie	AbbVie, Inc.(AbbVie); AbbVie(AbbVie)	The study was funded by AbbVie, Inc. All authors are employees of AbbVie and may hold AbbVie stock or stock options. The design, study conduct, and financial support for these studies were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.	Abergel A, 2007, ALIMENT PHARM THER, V26, P1437, DOI 10.1111/j.1365-2036.2007.03530.x; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; [Anonymous], 2017, MAV GLEC PIBR PRESCR; [Anonymous], 2017, MAV GLEC PIBR; Asselah T, 2018, J HEPATOL, V68, pS39, DOI 10.1016/S0168-8278(18)30294-0; Asselah T, 2018, J HEPATOL, V68, P814, DOI 10.1016/j.jhep.2017.11.037; Asselah T, 2018, CLIN GASTROENTEROL H, V16, P417, DOI 10.1016/j.cgh.2017.09.027; Asselah T, 2018, LIVER INT, V38, P7, DOI 10.1111/liv.13673; Babatin MA, 2018, J CLIN GASTROENTEROL, V52, P452, DOI 10.1097/MCG.0000000000000896; Bourliere M, 2017, NEW ENGL J MED, V376, P2134, DOI 10.1056/NEJMoa1613512; Brown A, 2018, J VIRAL HEPATITIS, V25, P457, DOI 10.1111/jvh.12801; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; De Luca A, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv043; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Flisiak R, 2011, EUR J GASTROEN HEPAT, V23, P1213, DOI 10.1097/MEG.0b013e32834d173c; Forns X, 2017, LANCET INFECT DIS, V17, P1062, DOI 10.1016/S1473-3099(17)30496-6; Foster GR, 2015, NEW ENGL J MED, V373, P2608, DOI 10.1056/NEJMoa1512612; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Gane E, 2017, NEW ENGL J MED, V377, P1448, DOI 10.1056/NEJMoa1704053; Gane E, 2016, GASTROENTEROLOGY, V151, P651, DOI 10.1053/j.gastro.2016.07.020; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Harrington PR, 2018, HEPATOLOGY, V67, P2430, DOI 10.1002/hep.29693; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Henquell C, 2011, INFECT GENET EVOL, V11, P496, DOI 10.1016/j.meegid.2010.12.015; Kamal SM, 2008, HEPATOLOGY, V47, P1371, DOI 10.1002/hep.22127; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Krishnan P, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01249-18; Krishnan P, 2015, ANTIMICROB AGENTS CH, V59, P979, DOI 10.1128/AAC.04226-14; Kwo P, 2016, HEPATOLOGY, V64, P370, DOI 10.1002/hep.28467; Kwo PY, 2017, J HEPATOL, V67, P263, DOI 10.1016/j.jhep.2017.03.039; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lee YM, 2010, J MED VIROL, V82, P57, DOI 10.1002/jmv.21658; Liakina V, 2015, J VIRAL HEPATITIS, V22, P4, DOI 10.1111/jvh.12475; Lim SG, 2017, LANCET GASTROENTEROL, V2, P52, DOI 10.1016/S2468-1253(16)30080-2; Maaroufi A, 2017, J VIRAL HEPATITIS, V24, P8, DOI 10.1111/jvh.12762; McCloskey RM, 2015, J INFECT DIS, V211, P1288, DOI 10.1093/infdis/jiu613; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Murphy DG, 2015, J CLIN MICROBIOL, V53, P967, DOI 10.1128/JCM.02831-14; Ng TI, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01620-17; Ng TI, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02558-16, 10.1128/aac.02558-16]; Panasiuk Anatol, 2013, Przegl Epidemiol, V67, P11; Pham VH, 2011, JPN J INFECT DIS, V64, P537; Pickett BE, 2011, J VIRAL HEPATITIS, V18, P608, DOI 10.1111/j.1365-2893.2010.01342.x; Pilot-Matias T, 2015, ANTIMICROB AGENTS CH, V59, P988, DOI 10.1128/AAC.04227-14; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Rehman Irshad-Ur, 2011, Genet Vaccines Ther, V9, P2, DOI 10.1186/1479-0556-9-2; Rodrigo C, 2017, J VIRAL HEPATITIS, V24, P43, DOI 10.1111/jvh.12616; Rodrigo C, 2016, J INFECT DIS, V214, P1383, DOI 10.1093/infdis/jiw389; Sacks-Davis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047335; Santos AF, 2016, SCI REP-UK, V6, DOI 10.1038/srep31780; Saraswat V, 2015, J VIRAL HEPATITIS, V22, P6, DOI 10.1111/jvh.12350; Schnell G, 2018, J VIRAL HEPATITIS, V25, P1078, DOI 10.1111/jvh.12906; Schnell G, 2018, J MED VIROL, V90, P109, DOI 10.1002/jmv.24923; Schnell G, 2015, ANTIMICROB AGENTS CH, V59, P6807, DOI 10.1128/AAC.01229-15; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Tanaka Y, 2004, J MOL EVOL, V58, P191, DOI 10.1007/s00239-003-2541-3; Thrift AP, 2017, NAT REV GASTRO HEPAT, V14, P122, DOI 10.1038/nrgastro.2016.176; Verbeeck J, 2006, J VIROL, V80, P4220, DOI 10.1128/JVI.80.9.4220-4226.2006; Verbeeck J, 2010, EUR J CLIN MICROBIOL, V29, P1427, DOI 10.1007/s10096-010-1021-0; Thong VD, 2014, WORLD J GASTROENTERO, V20, P2927, DOI 10.3748/wjg.v20.i11.2927; Welzel TM, 2017, J HEPATOL, V67, P224, DOI 10.1016/j.jhep.2017.03.014; WHO, 2017, WHO PUBLISHES LIST B; Wyles D, 2018, HEPATOLOGY, V67, P514, DOI 10.1002/hep.29541; Wyles DL, 2017, CURR HIV-AIDS REP, V14, P229, DOI 10.1007/s11904-017-0369-5; Zeuzem S, 2018, NEW ENGL J MED, V378, P354, DOI 10.1056/NEJMoa1702417; Zeuzem S, 2015, ANN INTERN MED, V163, P1, DOI 10.7326/M15-0785; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	75	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205186	10.1371/journal.pone.0205186	http://dx.doi.org/10.1371/journal.pone.0205186			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286205	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500095
J	Su, TC; Chen, CY; Tsai, WC; Hsu, HT; Yen, HH; Sung, WW; Chen, CJ				Su, Tzu-Cheng; Chen, Chun-Yu; Tsai, Wen-Che; Hsu, Hui-Ting; Yen, Hsu-Heng; Sung, Wen-Wei; Chen, Chih-Jung			Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays	PLOS ONE			English	Article							ORIGINATED PROTEIN-KINASE; MITOTIC KINASE; PHOSPHATASE; METASTASIS; PHOSPHORYLATION	Objective PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) regulates components of the cell cycle, including cell growth, immune responses, DNA damage repair, apoptosis, and inflammation. PBK/TOPK may also accelerate tumorigenesis in colorectal cancer. Methods We investigated the impact of PBK/TOPK on the clinical outcome of colorectal cancer patients to further identify its role in colorectal cancer. PBK/TOPK immunoreactivity was analyzed by immunohistochemistry in 162 cancer specimens from primary colorectal cancer patients. Results The mean follow-up time after surgery was 5.4 years (medium: 3.9 years; range 0.01 to 13.1 years). The prognostic value of PBK/TOPK on overall survival was determined by Kaplan-Meier analysis and Cox proportional hazard models. PBK/TOPK was expressed in both the cytoplasm and nucleus. High PBK/TOPK expression in tumor cells was significantly associated with advanced T value. The 5-year survival rate was greater for patients with high total PBK/TOPK expression than with low PBK/TOPK expression (58.3% vs 34.4%, P = 0.005). Multivariate analyses showed that low-scoring cytoplasmic PBK/TOPK, negative nuclear PBK/TOPK, low total PBK/TOPK, and advanced tumor stage were correlated with poor overall patient survival. Conclusions We suggest that PBK/TOPK expression, detected by IHC staining, could be used as an independent prognostic marker for colorectal cancer patients.	[Su, Tzu-Cheng; Hsu, Hui-Ting; Chen, Chih-Jung] Changhua Christian Hosp, Dept Surg Pathol, Changhua, Taiwan; [Chen, Chun-Yu] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Tsai, Wen-Che] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Hsu, Hui-Ting; Yen, Hsu-Heng; Sung, Wen-Wei; Chen, Chih-Jung] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsu, Hui-Ting; Sung, Wen-Wei] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yen, Hsu-Heng] Changhua Christian Hosp, Dept Gastroenterol, Changhua, Taiwan; [Sung, Wen-Wei] Chung Shan Med Univ Hosp, Dept Urol, Taichung, Taiwan; [Chen, Chih-Jung] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan	Changhua Christian Hospital; National Taiwan University; National Taiwan University Hospital; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Chen, CJ (corresponding author), Changhua Christian Hosp, Dept Surg Pathol, Changhua, Taiwan.; Sung, WW; Chen, CJ (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Sung, WW (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Sung, WW (corresponding author), Chung Shan Med Univ Hosp, Dept Urol, Taichung, Taiwan.; Chen, CJ (corresponding author), Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan.	flutewayne@gmail.com; 132540@cch.org.tw	Sung, Wen-Wei/P-5053-2019	Sung, Wen-Wei/0000-0002-2375-0029	 [102-CCH-IRP-064];  [104-CCH-IRP-088]	; 	This work was jointly supported by grants from 102-CCH-IRP-064 and 104-CCH-IRP-088 (Dr. CJ Chen. Changhua Christian Hospital, Changhua, Taiwan). URL: http://www2.cch.org.tw/cch_english/.	Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; Abe Y, 2007, J MOL BIOL, V370, P231, DOI 10.1016/j.jmb.2007.04.067; Ayllon V, 2007, ONCOGENE, V26, P3451, DOI 10.1038/sj.onc.1210142; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bradbury J, 2001, LANCET, V358, P1245, DOI 10.1016/S0140-6736(01)06385-1; Chen TC, 2009, J PROTEOME RES, V8, P4943, DOI 10.1021/pr900325f; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; He FR, 2010, HUM PATHOL, V41, P415, DOI 10.1016/j.humpath.2009.05.016; Hewish M, 2010, NAT REV CLIN ONCOL, V7, P197, DOI 10.1038/nrclinonc.2010.18; Hu F, 2010, ONCOGENE, V29, P5464, DOI 10.1038/onc.2010.275; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin KT, 2012, ONCOL LETT, V3, P11, DOI 10.3892/ol.2011.432; Kim DJ, 2012, CANCER RES, V72, P3060, DOI 10.1158/0008-5472.CAN-11-3851; Layer G, 2008, RADIOLOGE, V48, P26, DOI 10.1007/s00117-007-1584-7; Matsumoto S, 2004, BIOCHEM BIOPH RES CO, V325, P997, DOI 10.1016/j.bbrc.2004.10.133; Onodera H, 2015, EBIOMEDICINE, V2, P495, DOI 10.1016/j.ebiom.2015.05.019; Park JH, 2010, CANCER SCI, V101, P403, DOI 10.1111/j.1349-7006.2009.01400.x; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Simons-Evelyn M, 2001, BLOOD CELL MOL DIS, V27, P825, DOI 10.1006/bcmd.2001.0452; Sung WW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-951; Sung WW, 2013, CLIN CANCER RES, V19, P4092, DOI 10.1158/1078-0432.CCR-12-3439; Sung WW, 2011, CLIN CANCER RES, V17, P5991, DOI 10.1158/1078-0432.CCR-11-0227; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Vlajnic T, 2011, MODERN PATHOL, V24, P1404, DOI 10.1038/modpathol.2011.96; Wang Z, 2015, BRIT J CANCER, V112, P572, DOI 10.1038/bjc.2014.598; Zhu F, 2007, GASTROENTEROLOGY, V133, P219, DOI 10.1053/j.gastro.2007.04.048; Zlobec I, 2010, BRIT J CANCER, V102, P151, DOI 10.1038/sj.bjc.6605452; Zykova TA, 2006, CLIN CANCER RES, V12, P6884, DOI 10.1158/1078-0432.CCR-06-0410	29	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204866	10.1371/journal.pone.0204866	http://dx.doi.org/10.1371/journal.pone.0204866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286126	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500054
J	Temiye, EO; Adeniyi, OF; Fajolu, IB; Ogbenna, AA; Ladapo, TA; Esezobor, CI; Akinsulie, AO; Mabogunje, CA				Temiye, Edamisan Olusoji; Adeniyi, Oluwafunmilayo Funke; Fajolu, Iretiola Bamikeolu; Ogbenna, Ann Abiola; Ladapo, Taiwo Augustine; Esezobor, Christopher Imokhuede; Akinsulie, Adebola Olumide; Mabogunje, Cecilia Abimbola			Human immunodeficiency virus status in malnourished children seen at Lagos	PLOS ONE			English	Article							PEDIATRIC HIV-INFECTION; HEMATOLOGICAL ABNORMALITIES; MALNUTRITION; HEALTH; IMPACT	Introduction Human immunodeficiency virus and protein energy malnutrition are still prevalent in Nigeria and the occurrence of the two conditions together confers a poor prognosis. The aim of this study was to determine the current categories of malnutrition amongst under-5 children in Lagos, document their HIV status and determine any peculiarities in the clinical features, haematological and some biochemical profile in these children. Methods The study was a cross-sectional study conducted at the Paediatric departments of the Lagos University Teaching Hospital and the Massey Street Children's Hospital, both in Lagos, over a 6-month period. All the subjects had anthropometry, HIV testing, full blood count and serum proteins done. The factors associated with HIV status were determined with the logistic regression analysis. Results Two hundred and fourteen (214) malnourished children <= 5 years, including 25 (11.7%) with HIV were recruited in the study. Among the study participants, 150 (70.1%) and 54 (29.9%) had moderate and severe malnutrition, respectively. Fever, cough and diarrhea were the most common symptoms in the study participants. The haematological indices were comparable in the two groups, the serum globulin levels though higher in the HIV infected group was not statistically significantly different from the non-infected group.(p = 0.66). None of the factors explored on multivariate analysis was able to predict the occurrence of the infection in this cohort. Conclusion Malnourished children remain a high risk group for HIV infection and the prevalence of the infection obtained in this group of children is still unacceptably high. Discriminatory features between malnutrition and HIV remains difficult. The presence of hyperglobulinaemia on laboratory analysis in a malnourished child may heighten the suspicion of possible underlying associated HIV infection. Screening of malnourished children for HIV infection and further longitudinal studies on malnourished children with HIV is advocated	[Temiye, Edamisan Olusoji; Adeniyi, Oluwafunmilayo Funke; Fajolu, Iretiola Bamikeolu; Ladapo, Taiwo Augustine; Esezobor, Christopher Imokhuede; Akinsulie, Adebola Olumide] Univ Lagos, Lagos Univ Teaching Hosp, Coll Med, Dept Paediat, Lagos, Nigeria; [Ogbenna, Ann Abiola] Univ Lagos, Lagos Univ Teaching Hosp, Coll Med, Dept Haematol, Lagos, Nigeria; [Mabogunje, Cecilia Abimbola] Massey St Childrens Hosp, Lagos, Nigeria	University of Lagos; University of Lagos	Adeniyi, OF (corresponding author), Univ Lagos, Lagos Univ Teaching Hosp, Coll Med, Dept Paediat, Lagos, Nigeria.	layo_funke@yahoo.co.uk	Fajolu, Iretiola Bamikeolu/P-5759-2019; Ogbenna, Ann A/D-1656-2015; Adeniyi, Oluwafunmilayo/CAF-6583-2022; Adeniyi, Oluwafunmilayo/ABA-2009-2020; Esezobor, Christopher Imokhuede/AAP-2230-2020	Fajolu, Iretiola Bamikeolu/0000-0003-3045-9616; Adeniyi, Oluwafunmilayo/0000-0003-2564-6118; Esezobor, Christopher Imokhuede/0000-0003-1736-4794; Ladapo, Taiwo/0000-0002-9969-6233; Akinsulie, Adebola/0000-0003-2543-5871	Central Research Committee of University of Lagos, Lagos, Nigeria [CRC. 2015/09]; Central research Committee of the University of Lagos	Central Research Committee of University of Lagos, Lagos, Nigeria; Central research Committee of the University of Lagos	This study received some funding from the Central Research Committee of University of Lagos, Lagos, Nigeria; Grant number: CRC.NO. 2015/09.; We acknowledge the contribution of the Central research Committee of the University of Lagos for the support for the study. We are also grateful to Mr Niyi and the resident doctors in the department of Paediatrics Lagos University Teaching Hospital who assisted with the recruitment of the subjects and the collection of the data for the study.	Achadi E, 2016, GLOBAL NUTR REPORT 2; Adeleke SI, 2004, NIGERIAN J PHARM MED, V1, P23; Adetifa IMO, 2006, ANN TROP PAEDIATR, V26, P121, DOI 10.1179/146532806X107467; Bachou H, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-27; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bugaje M. A., 2006, Annals of African Medicine, V5, P73; Chinkhumba J, 2008, T ROY SOC TROP MED H, V102, P639, DOI 10.1016/j.trstmh.2008.04.028; Emodi IJ, 1998, J TROP PEDIATRICS, V44, P73, DOI 10.1093/tropej/44.2.73; Ezeonwu BU, 2014, NIGER J CLIN PRACT, V17, P303, DOI 10.4103/1119-3077.130230; Fergusson P, 2009, T ROY SOC TROP MED H, V103, P541, DOI 10.1016/j.trstmh.2008.10.029; FISCHER GD, 1993, EPIDEMIOL INFECT, V110, P373, DOI 10.1017/S095026880006831X; Heikens GT, 2008, LANCET, V371, P1305, DOI 10.1016/S0140-6736(08)60565-6; Kessler L, 2000, ANN TROP PAEDIATR, V20, P50, DOI 10.1080/02724930092075; LESBORDES JL, 1986, LANCET, V2, P337; Madec Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022787; Merchant R H, 2001, Indian Pediatr, V38, P239; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Naing L, 2006, ARCH OROFAC SCI, V1, P9; Ogubosi BO, 2011, ITAL J PEDIATR, V37, P29, DOI [10.1186/1824-7288-37-29, DOI 10.1186/1824-7288-37-29]; Okonko, 2013, J MICROBIOL RES, V3, P107; Senbanjo Idowu O, 2016, Niger Med J, V57, P307, DOI 10.4103/0300-1652.193854; Sudawa A, 2013, WORLD J AIDS, V3, P350; Ticklay IMH, 1997, E AFR MED J, V74, P217; Tindyebwa D, 2006, INTRO HDB PAEDIAT AI; United Nations Children's Fund World Health Organization The World Bank, 2012, UNICEFWHO WORLD BANK; van Gend CL, 2003, J TROP PEDIATRICS, V49, P143, DOI 10.1093/tropej/49.3.143; Yeung S, 2000, J TROP PEDIATRICS, V46, P107, DOI 10.1093/tropej/46.2.107	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0200435	10.1371/journal.pone.0200435	http://dx.doi.org/10.1371/journal.pone.0200435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286087	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500003
J	Zhong, FL; Robinson, K; Teo, DET; Tan, KY; Lim, C; Harapas, CR; Yu, CH; Xie, WH; Sobota, RM; Au, VB; Hopkins, R; D'Osualdo, A; Reed, JC; Connolly, JE; Masters, SL; Reversade, B				Zhong, Franklin L.; Robinson, Kim; Teo, Daniel Eng Thiam; Tan, Kiat-Yi; Lim, Chrissie; Harapas, Cassandra R.; Yu, Chien-Hsiung; Xie, William H.; Sobota, Radoslaw M.; Au, Veonice Bijin; Hopkins, Richard; D'Osualdo, Andrea; Reed, John C.; Connolly, John E.; Masters, Seth L.; Reversade, Bruno			Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; INHIBITION; PHOSPHORYLATION; CASPASE-1; KERATINOCYTES; PYROPTOSIS; BACTERIAL; PATHWAYS; ASC	The inflammasome is a critical molecular complex that activates interleukin-1 driven inflammation in response to pathogen- and danger-associated signals. Germline mutations in the inflammasome sensor NLRP1 cause Mendelian systemic auto-immunity and skin cancer susceptibility, but its endogenous regulation remains less understood. Here we use a proteomics screen to uncover dipeptidyl dipeptidase DPP9 as a novel interacting partner with human NLRP1 and a related inflammasome regulator, CARD8. DPP9 functions as an endogenous inhibitor of NLRP1 inflammasome in diverse primary cell types from human and mice. DPP8/9 inhibition via small molecule drugs and CRISPR/Cas9-mediated genetic deletion specifically activate the human NLRP1 inflammasome, leading to ASC speck formation, pyroptotic cell death, and secretion of cleaved interleukin-1 beta. Mechanistically, DPP9 interacts with a unique auto-proteolytic domain (Function to Find Domain (FIIND)) found in NLRP1 and CARD8. This scaffolding function of DPP9 and its catalytic activity act synergistically to maintain NLRP1 in its inactive state and repress downstream inflammasome activation. We further identified a single patient-derived germline missense mutation in the NLRP1 FIIND domain that abrogates DPP9 binding, leading to inflammasome hyperactivation seen in the Mendelian autoinflammatory disease Autoinflammation with Arthritis and Dyskeratosis. These results unite recent findings on the regulation of murine Nlrp1b by Dpp8/9 and uncover a new regulatory mechanism for the NLRP1 inflammasome in primary human cells. Our results further suggest that DPP9 could be a multifunctional inflammasome regulator involved in human autoinflammatory diseases.	[Zhong, Franklin L.; Teo, Daniel Eng Thiam; Tan, Kiat-Yi; Lim, Chrissie; Sobota, Radoslaw M.; Au, Veonice Bijin; Hopkins, Richard; Connolly, John E.; Reversade, Bruno] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Zhong, Franklin L.; Robinson, Kim; Teo, Daniel Eng Thiam; Xie, William H.; Reversade, Bruno] ASTAR, Inst Med Biol, Singapore 138648, Singapore; [Zhong, Franklin L.; Robinson, Kim; Teo, Daniel Eng Thiam] Skin Res Inst Singapore, Singapore 138648, Singapore; [Harapas, Cassandra R.; Yu, Chien-Hsiung; Masters, Seth L.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic 3052, Australia; [Masters, Seth L.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Connolly, John E.] Baylor Univ, Inst Biomed Studies, Waco, TX 76712 USA; [Connolly, John E.] Natl Univ Singapore, Dept Microbiol & Immunol, Singapore 117545, Singapore; [D'Osualdo, Andrea] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, CH-4070 Basel, Switzerland; [Reed, John C.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Reversade, Bruno] Amsterdam UMC, Reprod Biol Lab, Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [Reversade, Bruno] Natl Univ Singapore, Dept Paediat, Singapore 119228, Singapore; [Reversade, Bruno] Koc Univ, Sch Med, Med Genet Dept, TR-34010 Istanbul, Turkey; [Zhong, Franklin L.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 636921, Singapore; [Reversade, Bruno] Branco Weiss Fdn, Zurich, Switzerland	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); Skin Research Institute of Singapore (SRIS); Walter & Eliza Hall Institute; University of Melbourne; Baylor University; National University of Singapore; Roche Holding; Sanford Burnham Prebys Medical Discovery Institute; University of Amsterdam; National University of Singapore; Koc University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zhong, FL; Reversade, B (corresponding author), ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore.; Zhong, FL; Reversade, B (corresponding author), ASTAR, Inst Med Biol, Singapore 138648, Singapore.; Zhong, FL (corresponding author), Skin Res Inst Singapore, Singapore 138648, Singapore.; Reversade, B (corresponding author), Amsterdam UMC, Reprod Biol Lab, Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands.; Reversade, B (corresponding author), Natl Univ Singapore, Dept Paediat, Singapore 119228, Singapore.; Reversade, B (corresponding author), Koc Univ, Sch Med, Med Genet Dept, TR-34010 Istanbul, Turkey.; Zhong, FL (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 636921, Singapore.; Reversade, B (corresponding author), Branco Weiss Fdn, Zurich, Switzerland.	franklin.zhong@reversade.com; bruno@reversade.com	Hopkins, Richard/AAI-5007-2020; Masters, Seth L/N-2886-2013	Masters, Seth L/0000-0003-4763-576X; Sobota, Radoslaw/0000-0002-2455-2526; Yu, Chien-Hsiung Alan/0000-0003-1744-3791; Xie, William Haowei/0000-0002-0376-7165; Zhong, Franklin/0000-0002-0516-6021; REVERSADE, Bruno/0000-0002-4070-7997; Au, Bijin/0000-0002-3670-4670	Institute of Molecular and Cell Biology (IMCB); Institute of Medical Biology (IMB) Strategic Positioning Fund (Biomedical Research Council (BMRC), A*STAR); Young Investigator Grant YIG 2015 (BMRC, A*STAR); National Medical Research Council MS-CETSA platform Grant [MOHIAFCAT2/004/2015]; National Medical Research Council Young Investigator Grant [NMRC/OFYIRG/0046/2017]; National Health and Medical Research Council [1142354, 1099262]; Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute-Wellcome International Research Scholarship; GlaxoSmithKline; National Research Foundation (NRF)	Institute of Molecular and Cell Biology (IMCB); Institute of Medical Biology (IMB) Strategic Positioning Fund (Biomedical Research Council (BMRC), A*STAR)(Agency for Science Technology & Research (A*STAR)); Young Investigator Grant YIG 2015 (BMRC, A*STAR); National Medical Research Council MS-CETSA platform Grant(National Medical Research Council, Singapore); National Medical Research Council Young Investigator Grant; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute-Wellcome International Research Scholarship; GlaxoSmithKline(GlaxoSmithKline); National Research Foundation (NRF)	This work was supported by core funding from the Institute of Molecular and Cell Biology (IMCB) and Institute of Medical Biology (IMB) Strategic Positioning Fund (Biomedical Research Council (BMRC), A*STAR) (to B. R. and R. M. S.), Young Investigator Grant YIG 2015 (BMRC, A*STAR) (to B. R. and R. M. S.), National Medical Research Council MS-CETSA platform Grant MOHIAFCAT2/004/2015 (to B. R. and R. M. S.), National Medical Research Council Young Investigator Grant NMRC/OFYIRG/0046/2017 (to F. L. Z.), National Health and Medical Research Council Grants 1142354 and 1099262 (to S. L. M.), funds from the Sylvia and Charles Viertel Foundation (to S. L. M.), a Howard Hughes Medical Institute-Wellcome International Research Scholarship (to S. L. M.), and funds from GlaxoSmithKline (to S. L. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Fellow of the Branco Weiss Foundation. Recipient of the A*STAR Investigatorship and Senior National Research Foundation (NRF) fellowship. EMBO Young Investigator.	Adams S, 2004, CANCER RES, V64, P5471, DOI 10.1158/0008-5472.CAN-04-0447; Agudelo D, 2017, NAT METHODS, V14, P615, DOI [10.1038/NMETH.4265, 10.1038/nmeth.4265]; Bachovchin D, 2018, BIORXIV, DOI [10.1101/317826, DOI 10.1101/317826]; Chang MX, 2010, DEV COMP IMMUNOL, V34, P1, DOI 10.1016/j.dci.2009.08.002; Chavarria-Smith J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003452; Cirelli KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003927; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Ewald SE, 2014, INFECT IMMUN, V82, P460, DOI 10.1128/IAI.01170-13; Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323; Gall MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078378; Grandemange S, 2017, ANN RHEUM DIS, V76, P1191, DOI 10.1136/annrheumdis-2016-210021; Guo CS, 2016, IMMUNITY, V45, P802, DOI 10.1016/j.immuni.2016.09.008; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Johnson DC, 2018, NAT MED, V24, P1151, DOI 10.1038/s41591-018-0082-y; Justa-Schuch D, 2016, ELIFE, V5, DOI [10.7554/eLife.16370, 10.7554/elife.16370]; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim ML, 2015, J EXP MED, V212, P927, DOI 10.1084/jem.20142384; Kim M, 2017, DEV BIOL, V431, P297, DOI 10.1016/j.ydbio.2017.09.001; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Lamkanfi M, 2011, J IMMUNOL, V187, P597, DOI 10.4049/jimmunol.1100229; Liston A, 2017, NAT REV IMMUNOL, V17, P208, DOI 10.1038/nri.2016.151; Mao LM, 2018, J CLIN INVEST, V128, P1793, DOI 10.1172/JCI98642; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Moghaddas F, 2015, CYTOKINE, V74, P237, DOI 10.1016/j.cyto.2015.02.012; Okondo MC, 2018, CELL CHEM BIOL, V25, P262, DOI 10.1016/j.chembiol.2017.12.013; Okondo MC, 2017, NAT CHEM BIOL, V13, P46, DOI [10.1038/NCHEMBIO.2229, 10.1038/nchembio.2229]; Pratley RE, 2007, CURR MED RES OPIN, V23, P919, DOI 10.1185/030079906X162746; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Sand J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0009-4; Schott WH, 2004, DIABETES, V53, P99, DOI 10.2337/diabetes.53.1.99; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Spalinger MR, 2016, J CLIN INVEST, V126, P1783, DOI 10.1172/JCI83669; Stutz A, 2017, J EXP MED, V214, P1725, DOI 10.1084/jem.20160933; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003; Zhong FL, 2016, CELL, V167, P187, DOI 10.1016/j.cell.2016.09.001	47	93	94	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18864	18878		10.1074/jbc.RA118.004350	http://dx.doi.org/10.1074/jbc.RA118.004350			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30291141	Green Published, hybrid			2022-12-26	WOS:000458467400005
J	Yu, G; Liu, YA; Qin, J; Wang, ZJ; Hu, YS; Wang, F; Li, YB; Chakrabarti, S; Chen, QY; Wang, QK				Yu, Gang; Liu, Yinan; Qin, Jun; Wang, Zhijie; Hu, Yushuang; Wang, Fan; Li, Yabo; Chakrabarti, Susmita; Chen, Qiuyun; Wang, Qing Kenneth			Mechanistic insights into the interaction of the MOG1 protein with the cardiac sodium channel Na(v)1.5 clarify the molecular basis of Brugada syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiovascular disease; sodium channel; protein-protein interaction; membrane trafficking; molecular modeling; Brugada syndrome (BrS); MOG1; Nav1; 5 sodium channel; SCN5A; trafficking; genetic disorder; cardiac disease; arrhythmia; myocardial ischemia	SCN5A MUTATION; RAN; IDENTIFICATION; GENE; SUSCEPTIBILITY; BINDING; DEATH; N1325S	Na(v)1.5 is the -subunit of the cardiac sodium channel complex. Abnormal expression of Na(v)1.5 on the cell surface because of mutations that disrupt Na(v)1.5 trafficking causes Brugada syndrome (BrS), sick sinus syndrome (SSS), cardiac conduction disease, dilated cardiomyopathy, and sudden infant death syndrome. We and others previously reported that Ran-binding protein MOG1 (MOG1), a small protein that interacts with Na(v)1.5, promotes Na(v)1.5 intracellular trafficking to plasma membranes and that a substitution in MOG1, E83D, causes BrS. However, the molecular basis for the MOG1/Nav1.5 interaction and how the E83D substitution causes BrS remains unknown. Here, we assessed the effects of defined MOG1 deletions and alanine-scanning substitutions on MOG1's interaction with Na(v)1.5. Large deletion analysis mapped the MOG1 domain required for the interaction with Na(v)1.5 to the region spanning amino acids 146-174, and a refined deletion analysis further narrowed this domain to amino acids 146-155. Site-directed mutagenesis further revealed that Asp-148, Arg-150, and Ser-151 cluster in a peptide loop essential for binding to Na(v)1.5. GST pulldown and electrophysiological analyses disclosed that the substitutions E83D, D148Q, R150Q, and S151Q disrupt MOG1's interaction with Na(v)1.5 and significantly reduce its trafficking to the cell surface. Examination of MOG1's 3D structure revealed that Glu-83 and the loop containing Asp-148, Arg-150, and Ser-151 are spatially proximal, suggesting that these residues form a critical binding site for Na(v)1.5. In conclusion, our findings identify the structural elements in MOG1 that are crucial for its interaction with Na(v)1.5 and improve our understanding of how the E83D substitution causes BrS.	[Yu, Gang; Liu, Yinan; Wang, Zhijie; Hu, Yushuang; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, CardioX Ctr, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Peoples R China; [Yu, Gang; Liu, Yinan; Wang, Zhijie; Hu, Yushuang; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China; [Yu, Gang; Qin, Jun; Wang, Zhijie; Wang, Fan; Li, Yabo; Chakrabarti, Susmita; Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Cleveland Clin, Dept Mol Cardiol, Ctr Cardiovasc Genet,Lerner Res Inst, Cleveland, OH 44195 USA; [Yu, Gang; Qin, Jun; Wang, Zhijie; Wang, Fan; Li, Yabo; Chakrabarti, Susmita; Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA; [Li, Yabo] Lanzhou Univ, Coll Life Sci, Lanzhou, Gansu, Peoples R China; [Wang, Qing Kenneth] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Lanzhou University; Case Western Reserve University	Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, CardioX Ctr, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Peoples R China.; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China.; Wang, QK (corresponding author), Case Western Reserve Univ, Cleveland Clin, Dept Mol Cardiol, Ctr Cardiovasc Genet,Lerner Res Inst, Cleveland, OH 44195 USA.; Wang, QK (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA.; Wang, QK (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.; Chen, QY (corresponding author), 9500 Euclid Ave, Cleveland, OH 44195 USA.	chenq3@ccf.org; qkwang@hust.edu.cn	Chakrabarti, Susmita/CAH-2331-2022	Chakrabarti, Susmita/0000-0003-1197-2780; Wang, Qing Kenneth/0000-0002-2235-6572; Wang, Qing/0000-0002-5639-8519; Qin, Jun/0000-0002-2647-9270; Wang, Zhijie/0000-0003-4619-0543; WANG, FAN/0000-0001-9806-5037	NHLBI, National Institutes of Health [R01 HL121358, R01 HL126729]; National Natural Science Foundation of China [81630002, 31430047, 91439129]; Hubei Province's Innovative Team Grant; 2016 Top-Notch Innovative Talent Development Project from the Bureau of Human Resources and Social Security of Wuhan City; Hubei Province Natural Science Programs [2016CFB224, 2014CFA074]; Chinese National Basic Research Programs (973 Programs) [2013CB531101, 2012CB517801]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121358, R01HL126729] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province's Innovative Team Grant; 2016 Top-Notch Innovative Talent Development Project from the Bureau of Human Resources and Social Security of Wuhan City; Hubei Province Natural Science Programs; Chinese National Basic Research Programs (973 Programs)(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NHLBI, National Institutes of Health Grants R01 HL121358 and R01 HL126729; the National Natural Science Foundation of China Grants 81630002, 31430047, and 91439129; Hubei Province's Innovative Team Grant, 2016 Top-Notch Innovative Talent Development Project from the Bureau of Human Resources and Social Security of Wuhan City, Hubei Province Natural Science Programs 2016CFB224 and 2014CFA074; and Chinese National Basic Research Programs (973 Programs) 2013CB531101 and 2012CB517801. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker RP, 2001, J BIOL CHEM, V276, P41255, DOI 10.1074/jbc.M106060200; Baker RP, 2000, ACTA CRYSTALLOGR D, V56, P229, DOI 10.1107/S0907444999016856; Bao XL, 2018, J MOL CELL BIOL, V10, P18, DOI 10.1093/jmcb/mjx045; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Chakrabarti S, 2013, CIRC-ARRHYTHMIA ELEC, V6, P392, DOI 10.1161/CIRCEP.111.000206; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Gui JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010985; Kattygnarath D, 2011, CIRC-CARDIOVASC GENE, V4, P261, DOI 10.1161/CIRCGENETICS.110.959130; Marfatia KA, 2001, GENE, V266, P45, DOI 10.1016/S0378-1119(01)00364-X; Oki M, 1998, P NATL ACAD SCI USA, V95, P15388, DOI 10.1073/pnas.95.26.15388; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Otagiri T, 2008, PEDIATR RES, V64, P482, DOI 10.1203/PDR.0b013e3181841eca; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Steggerda SM, 2000, J BIOL CHEM, V275, P23175, DOI 10.1074/jbc.C000252200; Steggerda SM, 2001, TRAFFIC, V2, P804, DOI 10.1034/j.1600-0854.2001.21109.x; Stewart M, 2000, J MOL BIOL, V299, P213, DOI 10.1006/jmbi.2000.3733; Tian XL, 2004, CARDIOVASC RES, V61, P256, DOI 10.1016/j.cardiores.2003.11.007; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Wang Zhan-shan, 2018, Huanjing Kexue, V39, P1, DOI 10.13227/j.hjkx.201705276; WILLICH SN, 1987, AM J CARDIOL, V60, P801, DOI 10.1016/0002-9149(87)91027-7; Wu L, 2008, J BIOL CHEM, V283, P6968, DOI 10.1074/jbc.M709721200; Yong SRL, 2007, BIOCHEM BIOPH RES CO, V352, P378, DOI 10.1016/j.bbrc.2006.11.019; Zhang T, 2007, BIOCHEM BIOPH RES CO, V355, P444, DOI 10.1016/j.bbrc.2007.01.170	26	14	14	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18207	18217		10.1074/jbc.RA118.003997	http://dx.doi.org/10.1074/jbc.RA118.003997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30282806	Green Published, hybrid			2022-12-26	WOS:000451375200015
J	Bielecka, M; Obuchowicz, R; Korkosz, M				Bielecka, Marzena; Obuchowicz, Rafal; Korkosz, Mariusz			The shape language in application to the diagnosis of cervical vertebrae pathology	PLOS ONE			English	Article							X-RAY IMAGES; JOINT SPACE; HAND RADIOGRAPHS; ANKYLOSING-SPONDYLITIS; RHEUMATOID-ARTHRITIS; REPRESENTATION; RECOGNITION; SEGMENTATION; ALGORITHM; CONTOURS	In this paper the possibility of classification of X-ray images of the cervical vertebrae is studied. The images should be classified into one of the following classes-the images of healthy vertebrae and the images of vertebrae with syndesmophytes. The vertebra contours, described unambiguously by using the generalized shape language, are the basis of the analysis. As a result, the contour is represented as a chain of sinquads that determine switches. The found switches are the characteristic points of the analyzed contour. In these points additional features of the contour are determined. On the basis of these features two aforementioned classes of images are defined as fuzzy sets. Such an approach allows us to create a hierarchical algorithm of classification based on the syntactic and fuzzy description of the contour.	[Bielecka, Marzena] AGH Univ Sci & Technol, Chair Geoinformat & Appl Comp Sci, Fac Geol Geophys & Environm Protect, Krakow, Poland; [Obuchowicz, Rafal] Jagiellonian Univ, Dept Radiol, Med Coll, Krakow, Poland; [Korkosz, Mariusz] Jagiellonian Univ Hosp, Dept Internal Med & Gerontol, Div Rheumatol, Krakow, Poland	AGH University of Science & Technology; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Bielecka, M (corresponding author), AGH Univ Sci & Technol, Chair Geoinformat & Appl Comp Sci, Fac Geol Geophys & Environm Protect, Krakow, Poland.	bielecka@agh.edu.pl	Bielecka, Marzena/R-8965-2018; Obuchowicz, Rafal/AAA-2715-2022	Obuchowicz, Rafal/0000-0001-5883-5551; Bielecka, Marzena/0000-0002-8472-684X				Antani S, 2004, J VIS COMMUN IMAGE R, V15, P285, DOI 10.1016/j.jvcir.2004.04.005; ANTANI S, 2002, P 3 IND C COMP VIS G, P242; BALLARD DH, 1981, PATTERN RECOGN, V13, P111, DOI 10.1016/0031-3203(81)90009-1; Banerjee S, 2011, IEEE ENG MED BIO, P6196, DOI 10.1109/IEMBS.2011.6091530; Bhisikar S, 2015, INT J SCI ENG TECHNO, V4, P1457; Bielecka M, 2018, APPL SOFT COMPUT, V69, P368, DOI 10.1016/j.asoc.2018.04.038; Bielecka M, 2016, LECT NOTES ARTIF INT, V9692, P531, DOI 10.1007/978-3-319-39378-0_45; Bielecka M, 2016, LECT NOTES COMPUT SC, V9972, P365, DOI 10.1007/978-3-319-46418-3_32; Bielecka M, 2011, LECT NOTES COMPUT SC, V6594, P147, DOI 10.1007/978-3-642-20267-4_16; Bielecka M, 2010, LECT NOTES COMPUT SC, V6374, P11, DOI 10.1007/978-3-642-15910-7_2; Bielecka M, 2009, LECT NOTES COMPUT SC, V5495, P469, DOI 10.1007/978-3-642-04921-7_48; Bielecki A, 2008, PATTERN RECOGN, V41, P3786, DOI 10.1016/j.patcog.2008.05.032; Bielecki A, 2017, INT J ADV ROBOT SYST, V14, DOI 10.1177/1729881416682694; Bielecki A, 2016, LECT NOTES ARTIF INT, V9693, P602, DOI 10.1007/978-3-319-39384-1_53; Bielecki A, 2013, EXPERT SYST APPL, V40, P3623, DOI 10.1016/j.eswa.2012.12.068; Bielecki A, 2012, LECT NOTES COMPUT SC, V7594, P304, DOI 10.1007/978-3-642-33564-8_37; Bielecki A, 2010, LECT NOTES ARTIF INT, V6113, P589, DOI 10.1007/978-3-642-13208-7_73; Bottcher J, 2005, ARTHRITIS RHEUM-US, V52, P3850, DOI 10.1002/art.21606; Choi S, 2011, COMPUT BIOL MED, V41, P987, DOI 10.1016/j.compbiomed.2011.08.008; Creemers MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503; Davis L, 2011, LECT NOTES COMPUT SC, V6936, P92, DOI 10.1007/978-3-642-23878-9_12; DiLascio L, 1996, INT J APPROX REASON, V15, P25, DOI 10.1016/0888-613X(95)00133-2; Elbakri IA, 2002, IEEE T MED IMAGING, V21, P89, DOI 10.1109/42.993128; Flasinski Mariusz, 2016, INTRO ARTIFICIAL INT; Flasiriski M, 2016, HDB PATTERN RECOGNIT, P3; Howe B, 2004, 6th IEEE Southwest Symposium on Image Analysis and Interpretation, P182, DOI 10.1109/IAI.2004.1300970; JAKUBOWSKI R, 1986, INFORM SCIENCES, V39, P129, DOI 10.1016/0020-0255(86)90030-7; JAKUBOWSKI R, 1985, IEEE T SYST MAN CYB, V15, P642, DOI 10.1109/TSMC.1985.6313442; Jakubowski R., 1992, Journal of Design and Manufacturing, V2, P239; JAKUBOWSKI R, 1977, IEEE T COMPUT, V26, P1039, DOI 10.1109/TC.1977.1674743; Long LR, 2000, 13TH IEEE SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS (CBMS 2000), PROCEEDINGS, P255, DOI 10.1109/CBMS.2000.856908; Novikov A. I., 2015, Pattern Recognition and Image Analysis, V25, P73, DOI 10.1134/S1054661815010149; Novikov AI, 2016, J COUPLED SYST MULTI, V4, P251, DOI 10.1166/jcsmd.2016.1112; Nurzynska K, 2017, NEUROINFORMATICS, V15, P365, DOI 10.1007/s12021-017-9340-2; Nurzynska K, 2016, IMAGE ANAL STEREOL, V35, P149, DOI 10.5566/ias.1554; Ogiela MR, 2006, PATTERN RECOGN, V39, P2157, DOI 10.1016/j.patcog.2006.03.014; Piorkowski A, 2016, ADV INTELL SYST, V471, P3, DOI 10.1007/978-3-319-39796-2_1; Sharp JT, 2000, ARTHRITIS RHEUM, V43, P1378, DOI 10.1002/1529-0131(200006)43:6<1378::AID-ANR23>3.0.CO;2-H; Tadeusiewicz R, 2005, INT J AP MAT COM-POL, V15, P305; Tan S, 2015, CURR OPIN RHEUMATOL, V27, P326, DOI 10.1097/BOR.0000000000000179; Tezmol A, 2002, FIFTH IEEE SOUTHWEST SYMPOSIUM ON IMAGE ANALYSIS AND INTERPRETATION, PROCEEDINGS, P224, DOI 10.1109/IAI.2002.999922; Xu XQ, 2008, IEEE T INF TECHNOL B, V12, P100, DOI 10.1109/TITB.2007.904149; Yao W, 2005, IEEE T MED IMAGING, V24, P997, DOI 10.1109/TMI.2005.850541; Zamora G, 2003, PROC SPIE, V5032, P631, DOI 10.1117/12.481400; Zielinski B, 2015, PATTERN RECOGN, V48, P2304, DOI 10.1016/j.patcog.2015.01.018	45	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204546	10.1371/journal.pone.0204546	http://dx.doi.org/10.1371/journal.pone.0204546			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307944	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500019
J	Borson, S; Mobley, P; Fernstrom, K; Bingham, P; Sadak, T; Britt, HR				Borson, Soo; Mobley, Patrick; Fernstrom, Karl; Bingham, Paige; Sadak, Tatiana; Britt, Heather R.			Measuring caregiver activation to identify coaching and support needs: Extending MYLOH to advanced chronic illness	PLOS ONE			English	Article							HEALTH-CARE; LATE-LIFE; DEMENTIA; HOSPITALIZATIONS	Introduction Family and friends of seriously ill patients are key partners in providing support and health care at home, managing relationships with clinicians, and navigating complex health care systems. Becoming a knowledgeable, confident, and effective caregiver is a developmental process we term 'caregiver activation' and could be facilitated by clinicians equipped with suitable tools. Managing Your Loved One's Health (MYLOH) is a new tool to identify gaps in caregivers' knowledge, skills, and access to clinical and personal support. Created in partnership with caregivers and clinicians, MYLOH items reflect the essential dimensions of caregiving and can be used to tailor caregiver coaching to domains of greatest need. In this study, we extend MYLOH's initial focus on dementia care to caregivers of patients with other chronic life-limiting illnesses. Methods MYLOH was completed by primary caregivers (n = 190) of people with a range of advanced chronic illnesses enrolled in the LifeCourse study, an innovative, whole-person approach to health management. Item relevance and responses were compared by group across MYLOH items and domains using z-tests for equality of proportions. Results All MYLOH items were relevant to caregiving for all types of chronic illness; only 13% of caregivers answered "not my responsibility" to any question. MYLOH identified caregiving struggles across patient diagnosis groups with a few, disease-specific `hotspots'. Overall, 64% of caregivers scored low in activation on at least one healthcare management task, especially getting enough help with caregiving, managing everyday caregiving tasks, understanding/managing medications, and knowing how to respond to rapid changes in care recipients' health status. No difficulty was unique to a specific type of care recipient illness. Conclusions MYLOH has potential as a tool for identifying caregiver coaching and support needs in managing a range of serious chronic illnesses. Caregiving difficulties endorsed by over 20% of caregivers should be core components of chronic illness management programs regardless of disease focus, with disease-specific tailoring as required. MYLOH may be useful in evaluating caregiver interventions and health systems' performance in integrating caregivers into the care management of patients with complex life-limiting illness.	[Borson, Soo] Univ Washington, Sch Nursing, Psychiat & Behav Sci, Sch Med & Psychosocial & Community Hlth, Seattle, WA 98195 USA; [Fernstrom, Karl] Minnesota Dept Hlth, Hlth Policy & Hlth Econ, St Paul, MN USA; [Bingham, Paige] Allina Hlth Grp, Minneapolis, MN USA; [Sadak, Tatiana] Univ Washington, Sch Nursing, Psychosocial & Community Hlth, Seattle, WA 98195 USA; [Britt, Heather R.] Minnesota Hosp Assoc, St Paul, MN USA	University of Washington; University of Washington Seattle; Minnesota Department of Health (MHD); University of Washington; University of Washington Seattle	Borson, S (corresponding author), Univ Washington, Sch Nursing, Psychiat & Behav Sci, Sch Med & Psychosocial & Community Hlth, Seattle, WA 98195 USA.	soob@uw.edu			Robina Foundation; Allina Health	Robina Foundation; Allina Health	This work was supported by a grant from the Robina Foundation. The funders had no role in study design, data collections and analysis, decision to publish, or preparation of the manuscript.; This work was conducted when authors PM, KF, PB, and HB were employees of, and SB had a research consulting role with, the Care Delivery Research Division, Allina Health, a non-profit health care system based in Minneapolis, Minnesota, United States of America. The Life-Course approach and study are funded by the Robina Foundation. Allina Health and the Robina Foundation provided support in the form of salaries and research materials for PM, KF, PB, and HB; neither organization played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borson S, 2014, CLIN GERIATR MED, V30, P395, DOI 10.1016/j.cger.2014.05.001; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Gaugler JE, 2014, CLIN GERIATR MED, V30, P493, DOI 10.1016/j.cger.2014.04.003; Lin PJ, 2013, ALZHEIMERS DEMENT, V9, P30, DOI 10.1016/j.jalz.2012.11.002; Phelan EA, 2012, JAMA-J AM MED ASSOC, V307, P165, DOI 10.1001/jama.2011.1964; Rabow MW, 2004, JAMA-J AM MED ASSOC, V291, P483, DOI 10.1001/jama.291.4.483; Reinhard S., 2012, HOME ALONE FAMILY CA; Sadak T, 2018, J APPL GERONTOL, V37, P620, DOI 10.1177/0733464816657472; Sadak T, 2017, INT PSYCHOGERIATR, V29, P1201, DOI 10.1017/S1041610217000217; Sadak T, 2016, RES GERONTOL NURS, V9, P145, DOI 10.3928/19404921-20151019-02; Sadak T, 2015, GERIATR NURS, V36, P284, DOI 10.1016/j.gerinurse.2015.03.003; Schellinger S, 2016, AM J HOSP PALLIAT ME, V33, P561, DOI 10.1177/1049909115574692; Shippee ND, 2018, AM J HOSP PALLIAT ME, V35, P104, DOI 10.1177/1049909117690710; Vitaliano PP, 2011, J AM GERIATR SOC, V59, P900, DOI 10.1111/j.1532-5415.2011.03368.x	14	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205153	10.1371/journal.pone.0205153	http://dx.doi.org/10.1371/journal.pone.0205153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW7TO	30307980	gold, Green Submitted, Green Published			2022-12-26	WOS:000447173500041
J	Colombo, SM; Parrish, CC; Wijekoon, MPA				Colombo, Stefanie M.; Parrish, Christopher C.; Wijekoon, Manju P. A.			Optimizing long chain-polyunsaturated fatty acid synthesis in salmonids by balancing dietary inputs	PLOS ONE			English	Article							FARMED ATLANTIC SALMON; FISH-OIL; CAMELINA OIL; RAPESEED OIL; HUMAN HEALTH; FOOD-WEB; SALAR; REPLACEMENT; METABOLISM; EPA	The increasing use of terrestrial plant lipids to replace of fish oil in commercial aquafeeds requires understanding synthesis and storage of long chain-polyunsaturated fatty acids (LC-PUFA) in farmed fish. Manipulation of dietary fatty acids may maximize tissue storage of LC-PUFA, through increased production and selective utilization. A data synthesis study was conducted to estimate optimal levels of fatty acids that may maximize the production and storage of LC-PUFA in the edible portion of salmonids. Data were compiled from four studies with Atlantic salmon, rainbow trout, and steelhead trout (total n = 180) which were fed diets containing different terrestrial-based oils to replace fish oil. LC-PUFA (%) were linearly correlated between diet and muscle tissue (p < 0.001; r(2) > 44%), indicating proportional storage after consumption. The slope, or retention rate, was highest for docosahexaenoic acid (DHA) at 1.23, indicating that an additional 23% of DHA was stored in the muscle. Dietary saturated fatty acids were positively related to DHA stored in the muscle (p < 0.001; r(2) = 22%), which may involve membrane structural requirements, as well as selective catabolism. DHA was found to be optimally stored with a dietary n-3: n-6 ratio of 1.03: 1. These new results provide a baseline of optimal dietary ratios that can be tested experimentally to determine the efficacy of balancing dietary fatty acids for maximum LC-PUFA storage.	[Colombo, Stefanie M.] Dalhousie Univ, Fac Agr, Dept Anim Sci & Aquaculture, Truro, NS, Canada; [Parrish, Christopher C.] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada; [Wijekoon, Manju P. A.] Canadian Food Inspect Agcy, Meat Hyg Program, Guelph, ON, Canada	Dalhousie University; Memorial University Newfoundland; Canadian Food Inspection Agency	Colombo, SM (corresponding author), Dalhousie Univ, Fac Agr, Dept Anim Sci & Aquaculture, Truro, NS, Canada.	scolombo@dal.ca	Colombo, Stefanie/ABD-4750-2020	Colombo, Stefanie/0000-0003-1828-7145	Natural Sciences and Engineering Research Council of Canada [105379]; Atlantic Canada Opportunities Agency [195298]; Research and Development NL [5404 1349 101]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Atlantic Canada Opportunities Agency; Research and Development NL	The funding was awarded to CP: - Natural Sciences and Engineering Research Council of Canada 105379 - Atlantic Canada Opportunities Agency 195298 - Research and Development NL 5404 1349 101.	[Anonymous], 2007, RMRSGTR189 USDA FOR; Arts MT, 2001, CAN J FISH AQUAT SCI, V58, P122, DOI 10.1139/cjfas-58-1-122; BELL JG, 1993, PROSTAG LEUKOTR ESS, V49, P665, DOI 10.1016/0952-3278(93)90075-8; Betancor MB, 2014, COMP BIOCHEM PHYS B, V172, P74, DOI 10.1016/j.cbpb.2014.04.007; Boselli E, 2012, J AGR FOOD CHEM, V60, P3234, DOI 10.1021/jf205159a; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Budge SM, 2008, OECOLOGIA, V157, P117, DOI 10.1007/s00442-008-1053-7; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Codabaccus BM, 2012, AQUACULTURE, P356; Colombo SM, 2017, ENVIRON REV, V25, P163, DOI 10.1139/er-2016-0062; Emery JA, 2016, LIPIDS, V51, P399, DOI 10.1007/s11745-016-4136-y; Emery JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057463; Farndale BM, 1999, AQUACULTURE, V179, P335, DOI 10.1016/S0044-8486(99)00169-6; Ghioni C, 2002, FISH PHYSIOL BIOCHEM, V27, P81, DOI 10.1023/B:FISH.0000021866.78048.45; Glencross BD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1810-z; Hixson SM, 2017, AQUACULTURE, V467, P76, DOI 10.1016/j.aquaculture.2016.04.011; Hixson SM, 2014, AQUACULTURE, V431, P44, DOI 10.1016/j.aquaculture.2014.04.042; Hixson SM, 2014, FOOD CHEM, V157, P51, DOI 10.1016/j.foodchem.2014.02.026; Hixson SM, 2014, LIPIDS, V49, P97, DOI 10.1007/s11745-013-3862-7; Jin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176216; Kainz M, 2004, LIMNOL OCEANOGR, V49, P1784, DOI 10.4319/lo.2004.49.5.1784; Loef Martin, 2013, Journal of Nutrition in Gerontology and Geriatrics, V32, P1, DOI 10.1080/21551197.2012.752335; Murray DS, 2014, AQUACULTURE, V431, P85, DOI 10.1016/j.aquaculture.2014.03.039; Norambuena F, 2016, AQUACULTURE, V450, P48, DOI 10.1016/j.aquaculture.2015.06.044; Ruyter B, 2000, FISH PHYSIOL BIOCHEM, V23, P151, DOI 10.1023/A:1007893317923; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Sprague M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21892; Stubhaug I, 2005, BIOCHIM BIOPHYS ACTA, V1734, P227; Tacon AGJ, 2015, REV FISH SCI AQUAC, V23, P1, DOI 10.1080/23308249.2014.987209; Thomassen MS, 2012, AQUACULTURE, V360, P78, DOI 10.1016/j.aquaculture.2012.07.001; Tocher DR, 2015, AQUACULTURE, V449, P94, DOI 10.1016/j.aquaculture.2015.01.010; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Trushenski J, 2012, AQUACULTURE, V326, P81, DOI 10.1016/j.aquaculture.2011.11.033; Turchini GM, 2011, AQUACULTURE, V315, P250, DOI 10.1016/j.aquaculture.2011.02.016; Turchini GM, 2007, LIPIDS, V42, P1065, DOI 10.1007/s11745-007-3105-x; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Twining CW, 2016, OIKOS, V125, P749, DOI 10.1111/oik.02910; Wijekoon MPA, 2014, AQUACULTURE, V433, P74, DOI 10.1016/j.aquaculture.2014.05.028; Xue X, 2015, COMP BIOCHEM PHYS D, V14, P1, DOI [10.1016/j.cbd3.2015.01.005, 10.1016/j.cbd.2015.01.005]; Young K, 2009, INT J FOOD SCI NUTR, V60, P203, DOI 10.1080/09637480903140503; Ytrestoyl T, 2015, AQUACULTURE, V448, P365, DOI 10.1016/j.aquaculture.2015.06.023	42	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205347	10.1371/journal.pone.0205347	http://dx.doi.org/10.1371/journal.pone.0205347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304012	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100081
J	de Baptista, CRDA; Nascimento-Elias, A; Lemos, TW; Garcia, B; Calori, PD; Mattiello-Sverzut, AC				de Jesus Alves de Baptista, Cyntia Rogean; Nascimento-Elias, Adriana; Lemos, Tenysson Will; Garcia, Beatriz; Calori, Paula Domingues; Mattiello-Sverzut, Ana Claudia			Characterizing postural oscillation in children and adolescents with hereditary sensorimotor neuropathy	PLOS ONE			English	Article							CHARCOT-MARIE-TOOTH; STATIC STANDING BALANCE; TEST-RETEST RELIABILITY; STABILOMETRIC PARAMETERS; PRESSURE MEASURES; DOWN-SYNDROME; YOUNG-ADULTS; 1A DISEASE; SWAY; AGE	Charcot Marie Tooth disease (CMT) has negative functional impact on postural control of children; however, it has not been widely studied. Stabilometry can provide insights about postural control and guide preventive interventions in immature perceptual and musculoskeletal systems as those seen in children with CMT. This cross-sectional study aimed to identify and interpret stabilometric variables that reflect the postural control of children with CMT. 53 subjects (age 6-17) were assigned to one of the two groups: CMT (15 males and 14 females with CMT) or Control (13 males and 11 females healthy). Quiet standing was tested in different conditions: with open and closed eyes on regular surface (open-regular, closed-regular) and foam surface (open-foam, closed-foam) using a force platform. The minimum of 2 and maximum of 3 trials of 30 seconds for each test condition provided the classical stabilometric variables and Romberg Quotient (RQ(v)). CMT group showed increase of confidence ellipse area, mean velocity, mediolateral and anteroposterior velocities associated with decreased mean body oscillation frequency, as the complexity of tasks increased. CMT postural deficit was identified by greater and faster sway associated with these lower frequencies, when compared to Control.	[de Jesus Alves de Baptista, Cyntia Rogean; Nascimento-Elias, Adriana] Univ Sao Paulo, Ribeirao Preto Med Sch, Grad Program Rehabil & Funct Performance, Sao Paulo, Brazil; [Lemos, Tenysson Will; Mattiello-Sverzut, Ana Claudia] Univ Sao Paulo, Dept Hlth Sci, Ribeirao Preto Med Sch, Sao Paulo, Brazil; [Garcia, Beatriz; Calori, Paula Domingues] Univ Sao Paulo, Phys Therapy Undergrad Course, Ribeirao Preto Med Sch, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Mattiello-Sverzut, AC (corresponding author), Univ Sao Paulo, Dept Hlth Sci, Ribeirao Preto Med Sch, Sao Paulo, Brazil.	acms@fmrp.usp.br	de Lemos, Tenysson Will/P-3706-2018; Mattiello-Sverzut, Ana Cláudia/F-5955-2013	de Lemos, Tenysson Will/0000-0002-9080-6088; Mattiello-Sverzut, Ana Cláudia/0000-0002-4181-0718; Alves de Baptista, Cyntia/0000-0001-5850-9940				Villarroya MA, 2012, RES DEV DISABIL, V33, P1294, DOI 10.1016/j.ridd.2012.02.017; Bair WN, 2011, GAIT POSTURE, V34, P183, DOI 10.1016/j.gaitpost.2011.04.007; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.246; Barozzi S, 2014, EUR ARCH OTO-RHINO-L, V271, P2069, DOI 10.1007/s00405-014-2930-9; Billot M, 2014, J ELECTROMYOGR KINES; Bonnet CT, 2011, J MOTOR BEHAV, V43, P319, DOI 10.1080/00222895.2011.589415; Bucci MP, 2017, INT J DEV NEUROSCI, V61, P51, DOI 10.1016/j.ijdevneu.2017.06.010; Burns J, 2013, TRANSITIONING OUTCOM, V180, P177; Burns J, 2009, NEUROMUSCULAR DISORD, V19, P818, DOI 10.1016/j.nmd.2009.09.007; Carpenter M, 2001, INFLUENCE POSTURAL T, DOI DOI 10.1007/S002210100681; Cattaneo D, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-100; Cherng RJ, 2003, MED ENG PHYS, V25, P509, DOI 10.1016/S1350-4533(03)00049-3; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Chiba R, 2016, NEUROSCI RES, V104, P96, DOI 10.1016/j.neures.2015.12.002; Cuisinier R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019697; Cumberworth VL, 2007, J LARYNGOL OTOL, V121, P449, DOI 10.1017/S0022215106004051; Duarte M, 2010, REVISION POSTUROGRAP, V14; El Mhandi L, 2011, MUSCLE NERVE, V44, P732, DOI 10.1002/mus.22150; Federica D, 2009, GAIT POSTURE, V29, P158, DOI 10.1016/j.gaitpost.2008.08.006; Gouleme N, 2017, RES AUTISM SPECT DIS, V40, P13, DOI 10.1016/j.rasd.2017.05.001; Gouleme N, 2014, INT J DEV NEUROSCI, V38, P169, DOI 10.1016/j.ijdevneu.2014.08.011; Hsu YS, 2009, INT J PEDIATR OTORHI, V73, P737, DOI 10.1016/j.ijporl.2009.01.016; Karakis I, 2013, MUSCLE NERVE, V47, P488, DOI 10.1002/mus.23622; Kaya P, 2015, PEDIATR INT, V57, P92, DOI 10.1111/ped.12428; Kennedy RA, 2019, ARCH DIS CHILD, V104, P535, DOI 10.1136/archdischild-2018-314890; Knak KL, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.794; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Lencioni T, 2014, GAIT POSTURE, V40, P481, DOI 10.1016/j.gaitpost.2014.07.006; Barreto LCLS, 2016, NEUROEPIDEMIOLOGY, V46, P157, DOI 10.1159/000443706; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Matjacic Z, 2006, DISABIL REHABIL, V28, P1455, DOI 10.1080/09638280600646169; Mattiello-Sverzut A, 2015, NEUROMUSCULAR DISORD, V25, pS284, DOI 10.1016/j.nmd.2015.06.352; McKeon PO, 2007, PERCEPT MOTOR SKILL, V104, P56, DOI 10.2466/PMS.104.1.56-66; Menotti F, 2014, PROSTHET ORTHOT INT, V38, P387, DOI 10.1177/0309364613506250; Nardone A, 2006, GAIT POSTURE, V23, P364, DOI 10.1016/j.gaitpost.2005.04.002; Nolan L, 2005, DEV MED CHILD NEUROL, V47, P449, DOI 10.1017/S0012162205000873; OMalley MJ, 1996, J BIOMECH, V29, P619, DOI 10.1016/0021-9290(95)00088-7; Patel M, 2008, GAIT POSTURE, V28, P649, DOI 10.1016/j.gaitpost.2008.04.018; Patel M, 2011, EXP BRAIN RES, V208, P519, DOI 10.1007/s00221-010-2498-6; Pazzaglia C, 2016, J NEUROL, V263, P1434, DOI 10.1007/s00415-016-8157-5; Peterson ML, 2006, GAIT POSTURE, V23, P455, DOI 10.1016/j.gaitpost.2005.05.003; Pinsault N, 2009, MED ENG PHYS, V31, P276, DOI 10.1016/j.medengphy.2008.08.003; Piropo US, 2016, EUR J HUM MOV, V37, P21; Pouwels S, 2014, MUSCLE NERVE, V50, P919, DOI 10.1002/mus.24240; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Ramdharry GM, 2018, PHYSIOTHER RES INT, V23, DOI 10.1002/pri.1702; Ramdharry GM, 2014, J PERIPHER NERV SYST, V19, P328, DOI 10.1111/jns.12100; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Riach C.L., 1994, GAIT POSTURE, V2, P167, DOI [10.1016/0966-6362(94)90004-3, DOI 10.1016/0966-6362(94)90004-3]; RIACH CL, 1993, GAIT POSTURE, V1, P105, DOI 10.1016/0966-6362(93)90021-R; Rigoldi C, 2011, RES DEV DISABIL, V32, P170, DOI 10.1016/j.ridd.2010.09.007; Rival C, 2005, NEUROSCI LETT, V376, P133, DOI 10.1016/j.neulet.2004.11.042; Rocchi L, 2004, MED BIOL ENG COMPUT, V42, P71, DOI 10.1007/BF02351013; Rose KJ, 2015, J FOOT ANKLE RES, V8, DOI 10.1186/s13047-015-0118-1; Rose KJ, 2010, J PHYSIOTHER, V56, P113, DOI 10.1016/S1836-9553(10)70041-2; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Scheffers G, 2012, J FOOT ANKLE RES, V5, pP23, DOI [10.1186/1757-1146-5-S1-P23, DOI 10.1186/1757-1146-5-S1-P23]; Scoppa F, 2012, GAIT POSTURE, V9; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.009; Silva TR, 2014, BRAZ J PHYS THER, V18, P334, DOI 10.1590/bjpt-rbf.2014.0055; Singh NB, 2012, J ELECTROMYOGR KINES, V22, P131, DOI 10.1016/j.jelekin.2011.10.007; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Tozza S, 2016, GAIT POSTURE, V49, P353, DOI 10.1016/j.gaitpost.2016.07.183; Tsai LC, 2006, J ORTHOP SPORT PHYS, V36, P942, DOI 10.2519/jospt.2006.2336; van der Linden MH, 2010, GAIT POSTURE, V31, P483, DOI 10.1016/j.gaitpost.2010.02.005; Verbecque E, 2016, GAIT POSTURE, V49, P402, DOI 10.1016/j.gaitpost.2016.08.003; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; WOOLLACOTT MH, 1990, PHYS THER, V70, P799, DOI 10.1093/ptj/70.12.799	69	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204949	10.1371/journal.pone.0204949	http://dx.doi.org/10.1371/journal.pone.0204949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4VA	30304007	gold, Green Published, Green Submitted			2022-12-26	WOS:000446921100067
J	Fujisawa, M; Moh-Moh-Aung, A; Zeng, Z; Yoshimura, T; Wani, Y; Matsukawa, A				Fujisawa, Masayoshi; Moh-Moh-Aung, Aye; Zeng, Zheng; Yoshimura, Teizo; Wani, Yoji; Matsukawa, Akihiro			Ovarian stromal cells as a source of cancer-associated fibroblasts in human epithelial ovarian cancer: A histopathological study	PLOS ONE			English	Article							MYOFIBROBLASTS CONTRIBUTE; ACTIVATION PROTEIN; TUMOR-GROWTH; FOXL2; EXPRESSION; ENDOMETRIOSIS; METASTASES; EVOLUTION	Fibroblasts are a major component of cancer tissue and known to contribute to cancer progression. However, it remains unknown whether they are derived from local fibroblasts or of other origin. This study was designed to identify the contribution of local stromal cells to cancer stroma in human epithelial ovarian cancer. Seventy-six cases of surgically resected primary ovarian carcinoma (48 cases confined to the ovaries and 28 cases with distant metastases) and 17 cases of secondary ovarian tumor (e.g. colon cancer metastasized to the ovary) were enrolled in this study. The tissues were immunostained for forkhead box protein L2 (FOXL2), a transcription factor crucial for ovarian development and function, and markers for cancer-associated fibroblasts (CAFs) and inflammatory cells. Under normal condition, FOXL2 expression was restricted to ovarian stromal cells and some other types of cells in female genital tracts and never found in other sites of the body. FOXL2-positive cells were found in all primary and secondary tumors in the ovary, and were the dominant stromal cells in most cases. In contrast, only a few FOXL2-positive cells were found in peritoneal seeding sites of four serous carcinoma cases, and all the other tumors at extraovarian sites had no FOXL2-positive cells. FOXL2-positive cells in the ovarian lesion variably expressed CAFs markers, such as alpha-smooth muscle actin and fibroblast activating protein, as determined by double immunostaining. Background inflammation, but not histological subtype or origin of the neoplasm seemed to correlate with the proportion of FOXL2-positive cells. These results suggest that ovarian stromal cells are the main source of cancer stroma in the ovary but do not seem to move to distant sites via circulation together with tumor cells. Our results also support the hypothesis that cancer-associated fibroblasts may originate locally, which was previously demonstrated using animal models.	[Fujisawa, Masayoshi; Moh-Moh-Aung, Aye; Zeng, Zheng; Yoshimura, Teizo; Matsukawa, Akihiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol & Expt Med, Okayama, Japan; [Wani, Yoji] Japanese Red Cross Soc Himeji Hosp, Dept Diagnost Pathol, Himeji, Hyogo, Japan; [Zeng, Zheng] Harbin Med Univ, Systen Ctr, Coll Pharm, Harbin, Heilongjiang, Peoples R China; [Zeng, Zheng] Harbin Med Univ, State Prov Key Labs Biomed Pharmaceut China, Genom Res Ctr, Harbin, Heilongjiang, Peoples R China	Okayama University; Harbin Medical University; Harbin Medical University	Fujisawa, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol & Expt Med, Okayama, Japan.	mfujisawa@okayama-u.ac.jp		Fujisawa, Masayoshi/0000-0003-4794-4837; Matsukawa, Akihiro/0000-0002-5081-6089				Arina A, 2016, P NATL ACAD SCI USA, V113, P7551, DOI 10.1073/pnas.1600363113; Bellessort B, 2015, HUM MOL GENET, V24, P3092, DOI 10.1093/hmg/ddv061; Blanco LZ, 2017, MODERN PATHOL, V30, P563, DOI 10.1038/modpathol.2016.219; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Cocquet J, 2003, CYTOGENET GENOME RES, V101, P206, DOI 10.1159/000074338; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Dionigi A, 2000, AM J CLIN PATHOL, V114, P111, DOI 10.1309/G56H-97A2-JFMT-CD5N; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Egashira N, 2011, MODERN PATHOL, V24, P765, DOI 10.1038/modpathol.2010.169; Eozenou C, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101584; Faddy MJ, 2000, MOL CELL ENDOCRINOL, V163, P43, DOI 10.1016/S0303-7207(99)00238-5; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; Georges A, 2014, J MOL ENDOCRINOL, V52, pR17, DOI 10.1530/JME-13-0159; Gilks B, 2012, HISTOPATHOLOGY PATHO, P1119; Governini L, 2014, REPROD SCI, V21, P1249, DOI 10.1177/1933719114522549; He HY, 2008, AM J SURG PATHOL, V32A, P884, DOI 10.1097/PAS.0b013e3181609d59; Hever A, 2007, P NATL ACAD SCI USA, V104, P12451, DOI 10.1073/pnas.0703451104; Ishii G, 2003, BIOCHEM BIOPH RES CO, V309, P232, DOI 10.1016/S0006-291X(03)01544-4; Kato N, 2013, INT J GYNECOL PATHOL, V32, P556, DOI 10.1097/PGP.0b013e31827c6362; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Kumar V, 2015, PATHOLOGIC BASIS DIS, V9th, P265; Kumar V., 2015, ROBBINS COTRAN PATHO, P69; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; LaRue AC, 2006, EXP HEMATOL, V34, P208, DOI 10.1016/j.exphem.2005.10.009; Mueller L, 2007, AM J PATHOL, V171, P1608, DOI 10.2353/ajpath.2007.060661; Pannetier M, 2003, CYTOGENET GENOME RES, V101, P199, DOI 10.1159/000074337; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; SCULLY RE, 1964, OBSTET GYNECOL, V24, P667; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Shiga K, 2015, CANCERS, V7, P2443, DOI 10.3390/cancers7040902; Slocombe T, 2013, J IMMUNOL, V191, P3128, DOI 10.4049/jimmunol.1301163; Snir OL, 2016, HISTOPATHOLOGY, V69, P383, DOI 10.1111/his.12959; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Westerhoff M, 2014, HUM PATHOL, V45, P1010, DOI 10.1016/j.humpath.2013.12.015	38	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205494	10.1371/journal.pone.0205494	http://dx.doi.org/10.1371/journal.pone.0205494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304016	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100098
J	Toledano, DT; Fernandez-Gallego, MP; Lozano-Diez, A				Toledano, Doroteo T.; Pilar Fernandez-Gallego, Maria; Lozano-Diez, Alicia			Multi-resolution speech analysis for automatic speech recognition using deep neural networks: Experiments on TIMIT	PLOS ONE			English	Article								Speech Analysis for Automatic Speech Recognition (ASR) systems typically starts with a Short-Time Fourier Transform (STFT) that implies selecting a fixed point in the time-frequency resolution trade-off. This approach, combined with a Mel-frequency scaled filterbank and a Discrete Cosine Transform give rise to the Mel-Frequency Cepstral Coefficients (MFCC), which have been the most common speech features in speech processing for the last decades. These features were particularly well suited for the previous Hidden Markov Models/Gaussian Mixture Models (HMM/GMM) state of the art in ASR. In particular they produced highly uncorrelated features of small dimensionality (typically 13 coefficients plus deltas and double deltas), which was very convenient for diagonal covariance GMMs, for dealing with the curse of dimensionality and for the limited computing resources of a decade ago. Currently most ASR systems use Deep Neural Networks (DNN) instead of the GMMs for modeling the acoustic features, which provides more flexibility regarding the definition of the features. In particular, acoustic features can be highly correlated and can be much larger in size because the DNNs are very powerful at processing high-dimensionality inputs. Also, the computing hardware has reached a level of evolution that makes computational cost in speech processing a less relevant issue. In this context we have decided to revisit the problem of the time-frequency resolution in speech analysis, and in particular to check if multiresolution speech analysis (both in time and frequency) can be helpful in improving acoustic modeling using DNNs. Our experiments start with several Kaldi baseline system for the well known TIMIT corpus and modify them by adding multi-resolution speech representations by concatenating different spectra computed using different time-frequency resolutions and different post-processed and speaker-adapted features using different time-frequency resolutions. Our experiments show that using a multi-resolution speech representation tends to improve over results using the baseline single resolution speech representation, which seems to confirm our main hypothesis. However, results combining multi-resolution with the highly post-processed and speaker-adapted features, which provide the best results in Kaldi for TIMIT, yield only very modest improvements.	[Toledano, Doroteo T.; Pilar Fernandez-Gallego, Maria; Lozano-Diez, Alicia] Univ Autonoma Madrid, AuDIaS Audio Data Intelligence & Speech, Madrid, Spain	Autonomous University of Madrid	Toledano, DT (corresponding author), Univ Autonoma Madrid, AuDIaS Audio Data Intelligence & Speech, Madrid, Spain.	doroteo.torre@uam.es	Toledano, Doroteo T/C-7750-2014; Lozano-Diez, Alicia/U-4476-2019; del Pilar Fernandez Gallego, Maria/AAH-7777-2020	Toledano, Doroteo T/0000-0003-1159-6455; Fernandez Gallego, Maria del Pilar/0000-0002-2724-3606	project "DSSL: Redes Profundas y Modelos de Subespacios para Deteccion y Seguimiento de Locutor, Idioma y Enfermedades Degenerativas a partir de la Voz" - Subsecretaria de Estado de Investigacion, Desarrollo e Innovacion, Ministerio de Economia y Competiti [TEC2015-68172-C2-1-P]; FEDER	project "DSSL: Redes Profundas y Modelos de Subespacios para Deteccion y Seguimiento de Locutor, Idioma y Enfermedades Degenerativas a partir de la Voz" - Subsecretaria de Estado de Investigacion, Desarrollo e Innovacion, Ministerio de Economia y Competiti; FEDER(European Commission)	This work has been supported by project "DSSL: Redes Profundas y Modelos de Subespacios para Deteccion y Seguimiento de Locutor, Idioma y Enfermedades Degenerativas a partir de la Voz" (TEC2015-68172-C2-1-P), funded by the Subsecretaria de Estado de Investigacion, Desarrollo e Innovacion, Ministerio de Economia y Competitividad (http://www.mineco.gob.es/), Spain, and FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NIPS 2011 BIGLEARNIN; Bandanau D, 2016, INT CONF ACOUST SPEE, P4945, DOI 10.1109/ICASSP.2016.7472618; Bishop C.M., 1995, NEURAL NETWORKS PATT; Cho K., 2014, EMNLP 2014 2014 C EM, DOI DOI 10.3115/V1/D14-1179; Chollet, 2015, TECH REP, V7, P1; Chorowski J., 2015, ARXIV150607503, DOI DOI 10.1016/0167-739X(94)90007-8; Gales MJF, 1998, COMPUT SPEECH LANG, V12, P75, DOI 10.1006/csla.1998.0043; Gales MJF, 1999, IEEE T SPEECH AUDI P, V7, P272, DOI 10.1109/89.759034; Garofolo JS, 1993, NASA STI RECON TECHN, P1; Graves A, 2005, IEEE IJCNN, P2047; Graves A., 2006, P 23 INT C MACH LEAR; Graves A, 2014, PR MACH LEARN RES, V32, P1764; Graves A, 2013, INT CONF ACOUST SPEE, P6645, DOI 10.1109/ICASSP.2013.6638947; Hannun A., 2014, ARXIV14125567; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; LEE KF, 1989, IEEE T ACOUST SPEECH, V37, P1641, DOI 10.1109/29.46546; Lozano-Diez A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182580; Mikolov T, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P1045; Mikolov T, 2011, INT CONF ACOUST SPEE, P5528; Mnih V., 2014, ADV NEURAL INFORM PR, P2204, DOI [DOI 10.1017/S037346330300239X, DOI 10.48550/ARXIV.1406.6247]; Moon T, 2015, 2015 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING (ASRU), P65, DOI 10.1109/ASRU.2015.7404775; Oppenheim AV, 1990, DISCRETE TIME SIGNAL, V1999; Povey Daniel, 2011, P ASRU BIG ISL HI US; Povey Daniel, 2014, ARXIV14107455; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; The Mathworks Inc, 2016, MATLAB MATHWORKS; Toth Laszlo, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P190, DOI 10.1109/ICASSP.2014.6853584; Young SJ, 2000, CONSTRUCTION, V2009, P384; Zhang XH, 2014, INT CONF ACOUST SPEE	32	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205355	10.1371/journal.pone.0205355	http://dx.doi.org/10.1371/journal.pone.0205355			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304055	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100082
J	Lenz, N; Engler, O; Grandgirard, D; Leib, SL; Ackermann-Gaumann, R				Lenz, Nicole; Engler, Olivier; Grandgirard, Denis; Leib, Stephen L.; Ackermann-Gaumann, Rahel			Evaluation of antivirals against tick-borne encephalitis virus in organotypic brain slices of rat cerebellum	PLOS ONE			English	Article							NUCLEOSIDE ANALOGS	Neurotropic tick borne encephalitis virus (TBEV) causes life-threatening disease, and accounts for most cases of tick-transmitted viral infections in Central and Eastern Europe and Russia. No specific treatment for TBEV infections exists, and vaccination is recommended for people at risk. So far, various nucleoside analogues have been investigated in vitro as potential candidates for treatment of TBEV infections. However, in vitro experiments with more complex cell culture systems, such as organotypic culture slices which model the sophisticated architecture of the target tissue are lacking. Using TBEV as a model, we investigated the suitability of rat organotypic cerebellum slices (OCS) to study the effectiveness of nucleoside analogues with a well-known anti-TBEV activity. In these OCS, 50 mu M of the nucleoside analogues 2'-C-methyladenosine (2'-CMA) and especially 7-deaza-2'-C-methyladenosine (7-deaza-2'-CMA) exhibited strong inhibitory effects on TBEV replication, reducing viral titers to an average of 10(3)-fold and TBEV RNA content 60-90-fold. In contrast, the influence of 2'-C-methylcytidine (2'-CMC) on TBEV replication was very weak, reducing virus titers by 10-fold and TBEV RNA content by 3-fold. In agreement with other studies, there was no noticeable difference in TBEV titers between OCS treated with 50 mu M of Ribavirin and the DMSO treated controls. All tested nucleoside analogues exhibited excellent cytotoxicity profiles at concentrations of 50 mu M. Our findings in OCS were highly comparable to data obtained in cell line culture systems. Therefore, OCS represent an ideal in vitro approach to study antivirals against TBEV and possibly other neurotropic viruses.	[Lenz, Nicole; Grandgirard, Denis; Leib, Stephen L.] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Lenz, Nicole; Engler, Olivier; Ackermann-Gaumann, Rahel] Swiss Fed Off Civil Protect, Spiez Lab, Biol Div, Spiez, Switzerland	University of Bern	Leib, SL (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	Stephen.leib@ifik.unibe.ch	Leib, Stephen/M-3786-2019; Leib, Stephen L/A-7866-2011; Grandgirard, Denis/AAB-8786-2020	Leib, Stephen/0000-0002-1106-6123; Leib, Stephen L/0000-0002-1106-6123; Grandgirard, Denis/0000-0002-4151-5196; Lenz, Nicole/0000-0001-9397-6165	Swiss National Science Foundation [160780]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	NL received funding from the Swiss National Science Foundation grant number 160780 (http://p3.snf.ch/Project-160780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amicizia D, 2013, HUM VACC IMMUNOTHER, V9, P1163, DOI 10.4161/hv.23802; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; De Clercq E, 2011, ANNU REV PHARMACOL, V51, P1, DOI 10.1146/annurev-pharmtox-010510-100228; DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113; Eyer Ludek, 2018, Antiviral Chemistry & Chemotherapy, V26, DOI 10.1177/2040206618761299; Eyer L, 2017, J VIROL, V91, DOI 10.1128/JVI.01028-17; Eyer L, 2016, ANTIVIR RES, V133, P119, DOI 10.1016/j.antiviral.2016.07.018; Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15; Gaumann R, 2011, J MED VIROL, V83, P853, DOI 10.1002/jmv.21993; Gaumann R, 2010, APPL ENVIRON MICROB, V76, P4241, DOI 10.1128/AEM.00391-10; Haviernik J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040184; Kapfhammer JP, 2010, SPRINGER PROTOC HAND, P285, DOI 10.1007/978-1-60761-292-6_17; KOZUCH O, 1975, ACTA VIROL, V19, P498; Lani R, 2014, TICKS TICK-BORNE DIS, V5, P457, DOI 10.1016/j.ttbdis.2014.04.001; LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002; Maffioli C, 2014, J NEUROPATH EXP NEUR, V73, P1107, DOI 10.1097/NEN.0000000000000131; Ortega-Prieto AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071039; Ruzek D, 2010, TRAVEL MED INFECT DI, V8, P223, DOI 10.1016/j.tmaid.2010.06.004	18	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205294	10.1371/journal.pone.0205294	http://dx.doi.org/10.1371/journal.pone.0205294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300398	Green Submitted, gold, Green Published			2022-12-26	WOS:000446897200050
J	Pilacinski, A; Wallscheid, M; Lindner, A				Pilacinski, Artur; Wallscheid, Melanie; Lindner, Axel			Human posterior parietal and dorsal premotor cortex encode the visual properties of an upcoming action	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; HUMAN BRAIN; CORTICAL ACTIVITY; HAND MOVEMENTS; ARM MOVEMENTS; MOTOR IMAGERY; BODY SCHEMA; AREA V6A; REACH; MACAQUE	Behavioral studies show that motor actions are planned by adapting motor programs to produce desired visual consequences. Does this mean that the brain plans these visual consequences independent of the motor actions required to obtain them? Here we addressed this question by investigating planning-related fMRI activity in human posterior parietal (PPC) and dorsal premotor (PMd) cortex. By manipulating visual movement of a virtual end-effector controlled via button presses we could dissociate motor actions from their sensory outcome. A clear representation of the visual consequences was visible in both PPC and PMd activity during early planning stages. Our findings suggest that in both PPC and PMd action plans are initially represented on the basis of the desired sensory outcomes while later activity shifts towards representing motor programs.	[Pilacinski, Artur; Wallscheid, Melanie; Lindner, Axel] Hertie Inst Clin Brain Res, Dept Cognit Neurol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Pilacinski, A (corresponding author), Hertie Inst Clin Brain Res, Dept Cognit Neurol, Tubingen, Germany.	art.pilacinski@gmail.com		Lindner, Axel/0000-0002-8201-788X; Pilacinski, Artur/0000-0002-3816-4372	BMBF [FKZ 01GQ1002]; DFG	BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	This work was supported by grants from BMBF (FKZ 01GQ1002) and DFG (CIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflalo T, 2015, SCIENCE, V348, P906, DOI 10.1126/science.aaa5417; Ames KC, 2014, NEURON, V81, P438, DOI 10.1016/j.neuron.2013.11.003; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Bahcall DO, 1999, NATURE, V400, P864, DOI 10.1038/23693; Beurze SM, 2010, J NEUROPHYSIOL, V104, P1736, DOI 10.1152/jn.01044.2009; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Bosco A., 2016, SCI REP, V6, P1; Buchholz VN, 2013, J NEUROSCI, V33, P3492, DOI 10.1523/JNEUROSCI.3208-12.2013; Cavina-Pratesi C, 2018, CORTEX, V98, P128, DOI 10.1016/j.cortex.2017.05.018; Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; Cisek P, 2002, J NEUROPHYSIOL, V87, P1149, DOI 10.1152/jn.00443.2001; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; COLBY CL, 1988, J COMP NEUROL, V269, P392, DOI 10.1002/cne.902690307; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; CRAMMOND DJ, 1994, J NEUROPHYSIOL, V71, P1281, DOI 10.1152/jn.1994.71.3.1281; Crammond DJ, 1997, TRENDS NEUROSCI, V20, P54, DOI 10.1016/S0166-2236(96)30019-2; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Desmurget M, 2009, TRENDS COGN SCI, V13, P411, DOI 10.1016/j.tics.2009.08.001; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Elsner B, 2002, NEUROIMAGE, V17, P364, DOI 10.1006/nimg.2002.1162; Galletti C, 1999, EUR J NEUROSCI, V11, P575, DOI 10.1046/j.1460-9568.1999.00467.x; Gallivan JP, 2015, CURR OPIN NEUROBIOL, V33, P141, DOI 10.1016/j.conb.2015.03.012; Gallivan JP, 2013, ELIFE, V2, DOI 10.7554/eLife.00425; Hadjidimitrakis K, 2014, CEREB CORTEX, V24, P3209, DOI 10.1093/cercor/bht181; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Hauschild M, 2012, P NATL ACAD SCI USA, V109, P17075, DOI 10.1073/pnas.1215092109; Heed T, 2011, J NEUROSCI, V31, P3066, DOI 10.1523/JNEUROSCI.4370-10.2011; HOCHERMAN S, 1991, EXP BRAIN RES, V83, P285; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hoshi E, 2000, NATURE, V408, P466, DOI 10.1038/35044075; Iriki A, 1996, NEUROREPORT, V7, P2325; Janczyk M, 2014, COGNITION, V132, P30, DOI 10.1016/j.cognition.2014.03.001; KALASKA JF, 1995, CEREB CORTEX, V5, P410, DOI 10.1093/cercor/5.5.410; Kimmig H, 2001, EXP BRAIN RES, V141, P184, DOI 10.1007/s002210100844; Krasovsky A, 2014, J NEUROSCI, V34, P15446, DOI 10.1523/JNEUROSCI.5435-13.2014; Kuang S., 2015, CEREB CORTEX, P1; Kuhn S, 2011, J COGNITIVE NEUROSCI, V23, P214, DOI 10.1162/jocn.2010.21418; Kuhn S, 2010, COGN AFFECT BEHAV NE, V10, P454, DOI 10.3758/CABN.10.4.454; Kuhn S, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00054; Kunde W, 2003, PSYCHOL RES-PSYCH FO, V67, P153, DOI 10.1007/s00426-002-0114-5; Lindner A, 2006, J COGNITIVE NEUROSCI, V18, P1899, DOI 10.1162/jocn.2006.18.11.1899; Lindner A, 2010, J NEUROSCI, V30, P11715, DOI 10.1523/JNEUROSCI.2849-09.2010; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Mechsner F, 2001, NATURE, V414, P69, DOI 10.1038/35102060; Medendorp WP, 2008, CORTEX, V44, P587, DOI 10.1016/j.cortex.2007.06.001; MORASSO P, 1981, EXP BRAIN RES, V42, P223; MOTTER BC, 1981, J NEUROSCI, V1, P3, DOI 10.1523/JNEUROSCI.01-01-00003.1981; Ochiai T, 2002, J NEUROPHYSIOL, V88, P2167, DOI 10.1152/jn.2002.88.4.2167; Pearce TM, 2012, SCIENCE, V337, P984, DOI 10.1126/science.1220642; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Piserchia V, 2017, CEREB CORTEX, V27, P1976, DOI 10.1093/cercor/bhw039; Pitzalis S, 2013, NEUROIMAGE, V82, P517, DOI 10.1016/j.neuroimage.2013.06.026; ROSENBAUM DA, 1980, J EXP PSYCHOL GEN, V109, P444, DOI 10.1037/0096-3445.109.4.444; Schluppeck D., 2005, TOPOGRAPHIC ORG DELA, P1372; Shin YK, 2010, PSYCHOL BULL, V136, P943, DOI 10.1037/a0020541; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Southall, 1866, TREATISE PHYSL OPTIC; Synofzik M, 2006, J NEUROPHYSIOL, V96, P1592, DOI 10.1152/jn.00104.2006; Torres EB, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00039; Tosoni A, 2015, BRAIN STRUCT FUNCT, V220, P3307, DOI 10.1007/s00429-014-0858-x; Westendorff S, 2010, J NEUROSCI, V30, P5426, DOI 10.1523/JNEUROSCI.4628-09.2010; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, EXP BRAIN RES, V103, P460; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	66	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0198051	10.1371/journal.pone.0198051	http://dx.doi.org/10.1371/journal.pone.0198051			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4OW	30300356	Green Published, Green Submitted, gold			2022-12-26	WOS:000446897200003
J	Hattori, H; Ishikawa, Y; Kawashima, N; Akashi, A; Yamaguchi, Y; Harada, Y; Hirano, D; Adachi, Y; Miyao, K; Ushijima, Y; Terakura, S; Nishida, T; Matsushita, T; Kiyoi, H				Hattori, Hikaru; Ishikawa, Yuichi; Kawashima, Naomi; Akashi, Akimi; Yamaguchi, Yohei; Harada, Yasuhiko; Hirano, Daiki; Adachi, Yoshiya; Miyao, Kotaro; Ushijima, Yoko; Terakura, Seitaro; Nishida, Tetsuya; Matsushita, Tadashi; Kiyoi, Hitoshi			Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia	PLOS ONE			English	Article							ARSENIC TRIOXIDE; MISSENSE MUTATIONS; THERAPY; ALPHA; TRANSLOCATION; CELLS; TRIAL; CHEMOTHERAPY; INHIBITOR; T(15-17)	All-trans retinoic acid (ATRA) and arsenic trioxide (ATO) are essential for acute promyelocytic leukemia (APL) treatment. It has been reported that mutations in PML-RARA confer resistance to ATRA and ATO, and are associated with poor prognosis. Although most PML-RARA mutations were point mutations, we identified a novel seven amino acid deletion mutation (p.K227_T233del) in the RARA region of PML-RARA in a refractory APL patient. Here, we analyzed the evolution of the mutated clone and demonstrated the resistance of the mutated clone to retinoic acid (RA). Mutation analysis of PML-RARA was performed using samples from a chemotherapy-and ATRA-resistant APL patient, and the frequencies of mutated PML-RARA transcript were analyzed by targeted deep sequencing. To clarify the biological significance of the identified PML-RARA mutations, we analyzed the ATRA-induced differentiation and PML nuclear body formation in mutant PML-RARA-transduced HL-60 cells. At molecular relapse, the p.K227_T233del deletion and the p.R217S point-mutation in the RARA region of PML-RARA were identified, and their frequencies increased after re-induction therapy with another type of retinoiec acid (RA), tamibarotene. In deletion PML-RARA-transduced cells, the CD11b expression levels and NBT reducing ability were significantly decreased compared with control cells and the formation of PML nuclear bodies was rarely observed after RA treatment. These results indicate that this deletion mutation was closely associated with the disease progression during RA treatment.	[Hattori, Hikaru; Ishikawa, Yuichi; Kawashima, Naomi; Akashi, Akimi; Yamaguchi, Yohei; Harada, Yasuhiko; Hirano, Daiki; Adachi, Yoshiya; Miyao, Kotaro; Ushijima, Yoko; Terakura, Seitaro; Nishida, Tetsuya; Kiyoi, Hitoshi] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi, Japan; [Hattori, Hikaru] Nagoya Univ Hosp, Dept Med Tech, Nagoya, Aichi, Japan; [Matsushita, Tadashi] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University	Ishikawa, Y (corresponding author), Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi, Japan.	yishikaw@med.nagoya-u.ac.jp	Terakura, Seitaro/A-6188-2011	Kawashima, Naomi/0000-0002-9914-739X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17K09921]; Japan Agency for Medical Research and Development, AMED [17ck0106251]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was supported by Grants-in-Aid from the Scientific Research Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (URL: https://www.jsps.go.jp/english/index.html), grant number 17K09921, and from the Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development, AMED (URL: https://www.amed.go.jp/en/index.html), grant number 17ck0106251 for study design, data collection, and analysis.	Beaumont M, 2003, J CLIN ONCOL, V21, P2123, DOI 10.1200/JCO.2003.09.072; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Chen FL, 2016, ONCOTARGET, V7, P47018, DOI 10.18632/oncotarget.10147; Dayyani F, 2011, CANCER-AM CANCER SOC, V117, P110, DOI 10.1002/cncr.25585; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Ding W, 1998, BLOOD, V92, P1172, DOI 10.1182/blood.V92.4.1172.416k02_1172_1183; Elliott MA, 2012, EUR J HAEMATOL, V88, P237, DOI 10.1111/j.1600-0609.2011.01727.x; Gallagher RE, 2006, LEUKEMIA, V20, P556, DOI 10.1038/sj.leu.2404118; Goto E, 2011, BLOOD, V118, P1600, DOI 10.1182/blood-2011-01-329433; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kayser S, 2017, LEUKEMIA, V31, P2347, DOI 10.1038/leu.2017.92; Kitamura K, 1997, LEUKEMIA, V11, P1950, DOI 10.1038/sj.leu.2400837; Kiyoi H, 1997, LEUKEMIA, V11, P1447, DOI 10.1038/sj.leu.2400756; Kudo K, 1998, LEUKEMIA, V12, P1171, DOI 10.1038/sj.leu.2401089; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lo-Coco F, 2010, BLOOD, V116, P3171, DOI 10.1182/blood-2010-03-276196; Lou YJ, 2015, ANN HEMATOL, V94, P1829, DOI 10.1007/s00277-015-2477-x; Ma YF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158760; OHNO R, 1993, LEUKEMIA, V7, P1722; Osumi K, 2002, LEUKEMIA LYMPHOMA, V43, P2291, DOI 10.1080/1042819021000040206; Platzbecker U, 2017, J CLIN ONCOL, V35, P605, DOI 10.1200/JCO.2016.67.1982; Pulsoni A, 2002, BLOOD, V100, P1972, DOI 10.1182/blood-2001-12-0312; Ravandi F, 2011, HAEMATOL-HEMATOL J, V96, P493, DOI 10.3324/haematol.2011.041970; Sanz MA, 2011, J CLIN ONCOL, V29, P495, DOI 10.1200/JCO.2010.32.1067; Schachter-Tokarz E, 2010, LEUKEMIA, V24, P473, DOI 10.1038/leu.2009.220; Shinagawa K, 2014, J CLIN ONCOL, V32, P3729, DOI 10.1200/JCO.2013.53.3570; Shiotsu Y, 2009, BLOOD, V114, P1607, DOI 10.1182/blood-2009-01-199307; Tobita T, 1997, BLOOD, V90, P967, DOI 10.1182/blood.V90.3.967.967_967_973; Tomita A, 2013, INT J HEMATOL, V97, P717, DOI 10.1007/s12185-013-1354-4; Yoshida H, 1996, CANC RES; Zhu HH, 2014, NEW ENGL J MED, V370, P1864, DOI 10.1056/NEJMc1316382	32	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204850	10.1371/journal.pone.0204850	http://dx.doi.org/10.1371/journal.pone.0204850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289902	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500026
J	Im, JH; Lazzaro, BP				Im, Joo Hyun; Lazzaro, Brian P.			Population genetic analysis of autophagy and phagocytosis genes in Drosophila melanogaster and D. simulans	PLOS ONE			English	Article							BALANCING SELECTION; IMMUNE-RESPONSE; SOFT SWEEPS; RNAI SCREEN; EVOLUTION; PROTEIN; POLYMORPHISM; DIVERGENCE; RESISTANCE; ADAPTATION	Autophagy and phagocytosis are cellular immune mechanisms for internalization and elimination of intracellular and extracellular pathogens. Some pathogens have evolved the ability to inhibit or manipulate these processes, raising the prospect of adaptive reciprocal co-evolution by the host. We performed population genetic analyses on phagocytosis and autophagy genes in Drosophila melanogasterand D. simulans to test for molecular evolutionary signatures of immune adaptation. We found that phagocytosis and autophagy genes as a whole exhibited an elevated level of haplotype homozygosity in both species. In addition, we detected signatures of recent selection, notably in the Atg14 and Ykt6 genes in D. melanogasterand a pattern of elevated sequence divergence in the genderblind (gb) gene on the D. simulans lineage. These results suggest that the evolution of the host cellular immune system as a whole may be shaped by a dynamic conflict between Drosophila and its pathogens even without pervasive evidence of strong adaptive evolution at the individual gene level.	[Im, Joo Hyun; Lazzaro, Brian P.] Cornell Univ, Inst Host Microbe Interact & Dis, Ithaca, NY 14853 USA; [Im, Joo Hyun; Lazzaro, Brian P.] Cornell Univ, Grad Field Genet Genom & Dev, Ithaca, NY 14853 USA; [Im, Joo Hyun; Lazzaro, Brian P.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Im, JH (corresponding author), Cornell Univ, Inst Host Microbe Interact & Dis, Ithaca, NY 14853 USA.; Im, JH (corresponding author), Cornell Univ, Grad Field Genet Genom & Dev, Ithaca, NY 14853 USA.; Im, JH (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	ji72@cornell.edu			NIH [AI064950, AI083932]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064950, R56AI083932] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI064950 and AI083932 to BPL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Andres AM, 2009, MOL BIOL EVOL, V26, P2755, DOI 10.1093/molbev/msp190; Augustin H, 2007, J NEUROSCI, V27, P111, DOI 10.1523/JNEUROSCI.4770-06.2007; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cadwell K, 2013, IMMUNITY, V39, P425, DOI 10.1016/j.immuni.2013.08.027; Capy P, 2004, GENETICA, V120, P5, DOI 10.1023/B:GENE.0000017626.41548.97; Casillas S, 2017, GENETICS, V205, P1003, DOI 10.1534/genetics.116.196493; Chaumorcel M, 2012, J VIROL, V86, P2571, DOI 10.1128/JVI.05746-11; CHINA B, 1993, INFECT IMMUN, V61, P3129, DOI 10.1128/IAI.61.8.3129-3136.1993; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Comeron JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002905; Corbett-Detig RB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003056; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P153, DOI 10.1016/0040-5809(72)90024-X; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Fiston-Lavier AS, 2010, GENE, V463, P18, DOI 10.1016/j.gene.2010.04.015; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Garud NR, 2016, GENETICS, V203, P863, DOI 10.1534/genetics.115.184002; Garud NR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005004; Gonzalez EA, 2013, CURR BIOL, V23, P2319, DOI 10.1016/j.cub.2013.09.061; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HART K, 1993, J MOL BIOL, V234, P249, DOI 10.1006/jmbi.1993.1580; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Jiggins FM, 2006, J MOL EVOL, V63, P769, DOI 10.1007/s00239-006-0005-2; Juneja P, 2010, MOL BIOL EVOL, V27, P2284, DOI 10.1093/molbev/msq114; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; Lack JB, 2015, GENETICS, V199, P1229, DOI 10.1534/genetics.115.174664; Langley CH, 2012, GENETICS, V192, P533, DOI 10.1534/genetics.112.142018; Lazzaro BP, 2005, GENETICS, V169, P2023, DOI 10.1534/genetics.104.034249; Leffler EM, 2013, SCIENCE, V339, P1578, DOI 10.1126/science.1234070; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000442; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Moy RH, 2013, J INNATE IMMUN, V5, P444, DOI 10.1159/000350326; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nonaka S, 2013, J BIOL CHEM, V288, P10374, DOI 10.1074/jbc.M113.451427; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Palmer WH, 2018, GENETICS, V208, P1585, DOI 10.1534/genetics.117.300567; Peltan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051831; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Piyankarage SC, 2008, ANAL CHEM, V80, P1201, DOI 10.1021/ac701785z; Pool JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003080; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramarao N, 2000, MOL MICROBIOL, V37, P1389, DOI 10.1046/j.1365-2958.2000.02089.x; Rogers RL, 2014, MOL BIOL EVOL, V31, P1750, DOI 10.1093/molbev/msu124; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Salazar-Jaramillo L, 2014, GENOME BIOL EVOL, V6, P273, DOI 10.1093/gbe/evu012; Sanjuan MA, 2008, AUTOPHAGY, V4, P607, DOI 10.4161/auto.6397; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; Stoletzki N, 2011, MOL BIOL EVOL, V28, P63, DOI 10.1093/molbev/msq249; TAJIMA F, 1989, GENETICS, V123, P585; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Unckless RL, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0291; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; WATTERSON GA, 1977, THEOR POPUL BIOL, V12, P179, DOI 10.1016/0040-5809(77)90041-7; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Webster CL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002210; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Zeng K, 2007, MOL BIOL EVOL, V24, P1562, DOI 10.1093/molbev/msm078; Zeng K, 2007, MOL BIOL EVOL, V24, P1898, DOI 10.1093/molbev/msm119; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zhai WW, 2009, MOL BIOL EVOL, V26, P273, DOI 10.1093/molbev/msn231; Zirin J, 2010, SEMIN IMMUNOPATHOL, V32, P363, DOI 10.1007/s00281-010-0223-y	80	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205024	10.1371/journal.pone.0205024	http://dx.doi.org/10.1371/journal.pone.0205024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281656	gold, Green Published, Green Submitted			2022-12-26	WOS:000446342400076
J	Kha, ML; Hesse, L; Deisinger, F; Sipos, B; Rocken, C; Arlt, A; Sebens, S; Helm, O; Schafer, H				Kha, My-Lan; Hesse, Lisa; Deisinger, Florian; Sipos, Bence; Roecken, Christoph; Arlt, Alexander; Sebens, Susanne; Helm, Ole; Schaefer, Heiner			The antioxidant transcription factor Nrf2 modulates the stress response and phenotype of malignant as well as premalignant pancreatic ductal epithelial cells by inducing expression of the ATF3 splicing variant Delta Zip2	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NUCLEAR FACTOR; GENE ATF3; CANCER; APOPTOSIS; PATHWAY; PROLIFERATION; CARCINOMA; ONCOGENE; GROWTH	Pancreatic ductal adenocarcinoma (PDAC) exhibits one of the worst survival rates of all cancers. While death rates show declining trends in the majority of cancers, PDAC registers rising rates. Based on the recently described crosstalk between TGF-beta 1 and Nrf2 in the PDAC development, the involvement of ATF3 and its splice variant Delta Zip2 in TGF-beta 1- and Nrf2-driven pancreatic tumorigenesis was investigated. As demonstrated here, PDAC (Panc1, T3M4) cells or premalignant H6c7 pancreatic ductal epithelial cells differentially express Delta Zip2- and ATF3, relating to stronger Nrf2 activity seen in Panc1 cells and TGF-beta 1 activity in T3M4 or H6c7 cells, respectively. Treatment with the electrophile/oxidative stress inducer tBHQ or the cytostatic drug gemcitabine strongly elevated Delta Zip2 expression in a Nrf2-dependent fashion. The differential expression of ATF3 and Delta Zip2 in response to Nrf2 and TGF-beta 1 relates to differential ATF3-gene promoter usage, giving rise of distinct splice variants. Nrf2-dependent Delta Zip2 expression confers resistance against gemcitabine-induced apoptosis, only partially relating to interference with ATF3 and its proapoptotic activity, e.g., through CHOP-expression. In fact, Delta Zip2 autonomously activates expression of cIAP anti-apoptotic proteins. Moreover, Delta Zip2 favors and ATF3 suppresses growth and clonal expansion of PDAC cells, again partially independent of each other. Using a Panc1 tumor xenograft model in SCID-beige mice, the opposite activities of ATF3 and Delta Zip2 on tumor-growth and chemoresistance were verified in vivo. Immunohistochemical analyses confirmed Delta Zip2 and Nrf2 coexpression in cancerous and PanIN structures of human PDAC and chronic pancreatitis tissues, respectively, which to some extent was reciprocal to ATF3 expression. It is concluded that depending on selective ATF3-gene promoter usage by Nrf2, the Delta Zip2 expression is induced in response to electrophile/oxidative (here through tBHQ) and xenobiotic (here through gemcitabine) stress, providing apoptosis protection and growth advantages to pancreatic ductal epithelial cells. This condition may substantially add to pancreatic carcinogenesis driven by chronic inflammation.	[Kha, My-Lan; Hesse, Lisa; Deisinger, Florian; Schaefer, Heiner] Univ Kiel, Lab Mol Gastroenterol & Tumor Biol, Inst Expt Canc Res, Campus Kiel,Bldg 17,Arnold Heller Str 3, D-24105 Kiel, Germany; [Kha, My-Lan; Hesse, Lisa; Deisinger, Florian; Sebens, Susanne; Helm, Ole; Schaefer, Heiner] UKSH, Campus Kiel,Bldg 17,Arnold Heller Str 3, D-24105 Kiel, Germany; [Sipos, Bence] Univ Hosp Tubingen, Dept Pathol & Neuropathol, Liebermeisterstr 8, D-72076 Tubingen, Germany; [Roecken, Christoph] Univ Kiel, Inst Pathol, Campus Kiel,Bldg 14,Arnold Heller Str 3, Kiel, Germany; [Roecken, Christoph] UKSH, Campus Kiel,Bldg 14,Arnold Heller Str 3, Kiel, Germany; [Roecken, Christoph; Sebens, Susanne] UKSH, Biomat Bank, Comprehens Canc Ctr Kiel, Campus Kiel,Bldg 17,Arnold Heller Str 3, D-24105 Kiel, Germany; [Arlt, Alexander] UKSH, Lab Gastrointestinal Signal Transduct, Dept Internal Med 1, Campus Kiel,Bldg 6,Arnold Heller Str 3, D-24105 Kiel, Germany; [Sebens, Susanne; Helm, Ole] Univ Kiel, Grp Inflammatory Carcinogenesis, Inst Expt Canc Res, Campus Kiel,Bldg 17,Arnold Heller Str 3, D-24105 Kiel, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Schafer, H (corresponding author), Univ Kiel, Lab Mol Gastroenterol & Tumor Biol, Inst Expt Canc Res, Campus Kiel,Bldg 17,Arnold Heller Str 3, D-24105 Kiel, Germany.; Schafer, H (corresponding author), UKSH, Campus Kiel,Bldg 17,Arnold Heller Str 3, D-24105 Kiel, Germany.	hschaef@1med.uni-kiel.de	Sebens, Susanne/C-1222-2010; Schäfer, Heiner/C-1055-2011; Röcken, Christoph/A-9239-2010; Arlt, Alexander/G-7308-2019	Röcken, Christoph/0000-0002-6989-8002; Arlt, Alexander/0000-0002-6160-1059	Medical Faculty of the CAU Kiel; Cluster of Excellence "Inflammation at Interfaces"	Medical Faculty of the CAU Kiel; Cluster of Excellence "Inflammation at Interfaces"	Financial support by the Medical Faculty of the CAU Kiel (to HS and OH) and the Cluster of Excellence "Inflammation at Interfaces" (to HS, AA, and SS) is greatly acknowledged.	Arfmann-Knubel S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132978; Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bakin AV, 2005, FREE RADICAL BIO MED, V38, P375, DOI 10.1016/j.freeradbiomed.2004.10.033; Brown SL, 2008, CANCER RES, V68, P364, DOI 10.1158/0008-5472.CAN-07-2170; Buganim Y, 2011, CARCINOGENESIS, V32, P1749, DOI 10.1093/carcin/bgr203; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; Distler M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/474905; Dziunycz PJ, 2014, J INVEST DERMATOL, V134, P1998, DOI 10.1038/jid.2014.77; Erkan M, 2013, PANCREATOLOGY, V13, P106, DOI 10.1016/j.pan.2013.01.008; Esakky P, 2015, J MOL CELL BIOL, V7, P73, DOI 10.1093/jmcb/mju049; Evans A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00270; Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-4; Ganan-Gomez I, 2013, FREE RADICAL BIO MED, V65, P750, DOI 10.1016/j.freeradbiomed.2013.06.041; Geismann C, 2014, ONCOTARGETS THER, V7, P1497, DOI 10.2147/OTT.S36624; Geismann C, 2009, CANCER RES, V69, P4517, DOI 10.1158/0008-5472.CAN-08-3493; Genrich G, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2191-7; Hai T, 1999, GENE EXPRESSION, V7, P321; Hashimoto Y, 2002, NUCLEIC ACIDS RES, V30, P2398, DOI 10.1093/nar/30.11.2398; Hawkins KE, 2016, CELL REP, V14, P1883, DOI 10.1016/j.celrep.2016.02.003; Hayes AJ, 2015, INT J BIOCHEM CELL B, V65, P288, DOI 10.1016/j.biocel.2015.06.017; Helm O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094357; Hiss DC, 2009, EXPERT OPIN DRUG DIS, V4, P799, DOI 10.1517/17460440903052559; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Hunt D, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00007; Inman KS, 2014, WORLD J GASTROENTERO, V20, P11160, DOI 10.3748/wjg.v20.i32.11160; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang XJ, 2016, ANTICANCER RES, V36, P509; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim KH, 2010, NUCLEIC ACIDS RES, V38, P48, DOI 10.1093/nar/gkp865; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; La Rosa S, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00041; Liang GS, 1996, J BIOL CHEM, V271, P1695, DOI 10.1074/jbc.271.3.1695; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Lohr M, 2001, CANCER RES, V61, P550; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Miyazaki K, 2009, NUCLEIC ACIDS RES, V37, P1438, DOI 10.1093/nar/gkn1082; Muerkoster SS, 2008, INT J CANCER, V123, P1751, DOI 10.1002/ijc.23703; Murakami S, 2015, FREE RADICAL BIO MED, V88, P168, DOI 10.1016/j.freeradbiomed.2015.06.030; Nilsson M, 1997, CELL GROWTH DIFFER, V8, P913; O'Brien A, 2012, ANTICANCER RES, V32, P2679; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Pandol S, 2009, CLIN GASTROENTEROL H, V7, pS44, DOI 10.1016/j.cgh.2009.07.039; Reichert M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9298535; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sato A, 2014, FEBS J, V281, P1892, DOI 10.1111/febs.12752; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sipos B, 2009, PANCREATOLOGY, V9, P45, DOI 10.1159/000178874; SMIT VTHBM, 1988, NUCLEIC ACIDS RES, V16, P7773, DOI 10.1093/nar/16.16.7773; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Wang A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-268; Weng SY, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0442-3; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Yin X, 2010, J CELL SCI, V123, P3558, DOI 10.1242/jcs.064915	64	8	8	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2019	38	9					1461	1476		10.1038/s41388-018-0518-3	http://dx.doi.org/10.1038/s41388-018-0518-3			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN1KL	30302023				2022-12-26	WOS:000459945800007
J	Zhang, HL; Wang, YL; Dou, JZ; Guo, YM; He, JF; Li, L; Liu, XJ; Chen, R; Deng, R; Huang, J; Xie, RY; Zhao, X; Yu, JX				Zhang, Hailong; Wang, Yanli; Dou, Jinzhuo; Guo, Yanmin; He, Jianfeng; Li, Lian; Liu, Xiaojia; Chen, Ran; Deng, Rong; Huang, Jian; Xie, Ruiyu; Zhao, Xian; Yu, Jianxiu			Acetylation of AGO2 promotes cancer progression by increasing oncogenic miR-19b biogenesis	ONCOGENE			English	Article							RNA-INTERFERENCE; MIR-17-SIMILAR-TO-92 CLUSTER; MICRORNA BIOGENESIS; PHOSPHORYLATION; ARGONAUTE; DICER; COMPLEX; BINDING; METASTASIS; HYPOXIA	Argonaute2 (AGO2) is an effector of small RNA mediated gene silencing. Increasing evidence show that post-translational modifications of AGO2 can change miRNA activity at specific or global levels. Among the six mature miRNAs that are encoded by miR-17-92, miR-19b1 is the most powerful to exert the oncogenic properties of the entire cluster. Here we identify that AGO2 can be acetylated by P300/CBP and deacetylated by HDAC7, and that acetylation occurs at three sites K720, K493, and K355. Mutation of K493R/K720R, but not K355R at AGO2, inhibits miR-19b biogenesis. We demonstrate that acetylation of AGO2 specifically increases its recruiting pre-miR-19b1 to form the miPDC (miRNA precursor deposit complex), thereby to enhance miR-19b maturation. The motif UGUGUG in the terminal-loop of pre-miR-19b1, as a specific processing feature that is recognized and bound by acetylated AGO2, is essential for the assembly of miRISC (miRNA-induced silencing complex) loading complex. Analyses on public clinical data, xenograft mouse models, and IHC and ISH staining of lung cancer tissues, further confirm that the high levels of both AGO2 acetylation and miR-19b correlate with poor prognosis in lung cancer patients. Our finding reveals a novel function of AGO2 acetylation in increasing oncogenic miR-19b biogenesis and suggests that modulation of AGO2 acetylation has potential clinical implications.	[Zhang, Hailong; Wang, Yanli; Dou, Jinzhuo; Guo, Yanmin; He, Jianfeng; Li, Lian; Liu, Xiaojia; Chen, Ran; Deng, Rong; Huang, Jian; Zhao, Xian; Yu, Jianxiu] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200025, Peoples R China; [Yu, Jianxiu] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Sch Med, Shanghai 200025, Peoples R China; [Yu, Jianxiu] Shanghai Jiao Tong Univ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ,Sch Med, Shanghai 200025, Peoples R China; [Xie, Ruiyu] Univ Macau, Fac Hlth Sci, Macau 999078, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Macau	Zhao, X; Yu, JX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200025, Peoples R China.; Yu, JX (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Sch Med, Shanghai 200025, Peoples R China.; Yu, JX (corresponding author), Shanghai Jiao Tong Univ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ,Sch Med, Shanghai 200025, Peoples R China.	Xianzhao1985@sjtu.edu.cn; Jianxiu.Yu@gmail.com	Huang, Jian/ABF-8355-2021	Xie, Ruiyu/0000-0003-0518-2897	National Natural Science Foundation of China [31671345, 81472571, 81630075, 81602251, 81702837, 81702532, 81721004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China [31671345, 81472571, 81630075, 81602251, 81702837, 81702532, 81721004]	Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Bridge KS, 2017, CELL REP, V20, P173, DOI 10.1016/j.celrep.2017.06.027; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9899; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Dahm GM, 2012, JOVE-J VIS EXP, DOI 10.3791/3851; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Fan Y, 2014, RNA, V20, P765, DOI 10.1261/rna.043026.113; Golden RJ, 2017, NATURE, V542, P197, DOI 10.1038/nature21025; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Horman SR, 2013, MOL CELL, V50, P356, DOI 10.1016/j.molcel.2013.03.015; Hu J, 2016, CANCER CELL, V29, P49, DOI 10.1016/j.ccell.2015.12.005; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Huberdeau MQ, 2017, EMBO J, V36, P2088, DOI 10.15252/embj.201696386; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Josa-Prado F, 2015, BIOCHEM BIOPH RES CO, V464, P1066, DOI 10.1016/j.bbrc.2015.07.073; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.458; Liu X, 2012, IMMUNOL LETT, V143, P208, DOI 10.1016/j.imlet.2012.02.014; Liu XH, 2014, MOL CELL, V55, P868, DOI 10.1016/j.molcel.2014.07.017; Liu XH, 2012, MOL CELL, V46, P507, DOI 10.1016/j.molcel.2012.03.010; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Nowak JS, 2017, RNA, V23, P317, DOI 10.1261/rna.059196.116; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Sahin U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102957; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Sun HL, 2016, CANCER CELL, V30, P723, DOI 10.1016/j.ccell.2016.10.001; Tan GS, 2009, NUCLEIC ACIDS RES, V37, P7533, DOI 10.1093/nar/gkp812; Treiber T, 2017, MOL CELL, V66, P270, DOI 10.1016/j.molcel.2017.03.014; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Wu C, 2011, MOL CELL BIOL, V31, P4760, DOI 10.1128/MCB.05776-11; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yoda M, 2013, CELL REP, V5, P715, DOI 10.1016/j.celrep.2013.09.029; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhao X, 2016, ONCOTARGET, V7, P33136, DOI 10.18632/oncotarget.8887	57	39	40	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2019	38	9					1410	1431		10.1038/s41388-018-0530-7	http://dx.doi.org/10.1038/s41388-018-0530-7			22	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN1KL	30305728	hybrid, Green Published			2022-12-26	WOS:000459945800004
J	Arora, K; Sequeira, JM; Alarcon, JM; Wasek, B; Arning, E; Bottiglieri, T; Quadros, EV				Arora, Kaveri; Sequeira, Jeffrey M.; Alarcon, Juan M.; Wasek, Brandi; Arning, Erland; Bottiglieri, Teodoro; Quadros, Edward V.			Neuropathology of vitamin B-12 deficiency in the Cd320(-/-) mouse	FASEB JOURNAL			English	Article						CNS; neuropathy; demyelination; spinal cord	LUMBAR SPINAL-CORD; CELLULAR UPTAKE; PERIPHERAL NEUROPATHY; COMBINED DEGENERATION; S-ADENOSYLMETHIONINE; COBALAMIN; RAT; METABOLISM; RECEPTOR; PROTEIN	In humans, vitamin B-12 deficiency causes peripheral and CNS manifestations. Loss of myelin in the peripheral nerves and the spinal cord (SC) contributes to peripheral neuropathy and motor deficits. The metabolic basis for the demyelination and brain disorder is unknown. The transcobalamin receptor-knockout mouse (Cd320(-/-)) develops cobalamin (Cbl) deficiency in the nervous system, with mild anemia. A decreased S-adenosylmethionine:S-adenosylhomocysteine ratio and increased methionine were seen in the brain with no significant changes in neurotransmitter metabolites. The structural pathology in the SC presented as loss of myelin in the axonal tracts with inflammation. The sciatic nerve (SN) showed increased nonuniform, internodal segments suggesting demyelination, and remyelination in progress. Consistent with these changes, the Cd320(-/-) mouse showed an increased latency to thermal nociception. Further, lower amplitude of compound action potential in the SN suggested that the functional capacity of the heavily myelinated axons were preferentially compromised, leading to loss of peripheral sensation. Although the metabolic basis for the demyelination and the structural and functional alterations of the nervous system in Cbl deficiency remain unresolved, the Cd320(-/-) mouse provides a unique model to investigate the pathologic consequences of vitamin B-12 deficiency. Arora, K., Sequeira, J. M., Alarcon, J. M., Wasek, B., Arning, E., Bottiglieri, T., Quadros, E. V. Neuropathology of vitamin B-12 deficiency in the Cd320(-/-) mouse.	[Arora, Kaveri] Suny Downstate Med Ctr, Sch Grad Studies, Brooklyn, NY 11203 USA; [Sequeira, Jeffrey M.; Quadros, Edward V.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Alarcon, Juan M.] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA; [Wasek, Brandi; Arning, Erland; Bottiglieri, Teodoro] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Baylor Scott & White Health; Baylor University Medical Center	Quadros, EV (corresponding author), Suny Downstate Med Ctr, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	edward.quadros@downstate.edu		Bottiglieri, Teodoro/0000-0002-4199-7551	U.S. National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases [DK064732]; NIH National Institute of Neurological Disorders and Stroke Grant [NS091830]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS091830] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Neurological Disorders and Stroke Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in part, by U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases Grant DK064732 (to E.V.Q.), and NIH National Institute of Neurological Disorders and Stroke Grant NS091830 (to J.M.A.) The authors declare no conflicts of interest.	AGAMANOLIS DP, 1978, J NEUROPATH EXP NEUR, V37, P273, DOI 10.1097/00005072-197805000-00006; Ahmed Z, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12157; [Anonymous], 1998, REP STAND COMM SCI E; Arora K, 2017, FASEB J, V31, P3098, DOI 10.1096/fj.201700025R; Arora K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177156; Baron W, 2010, FEBS LETT, V584, P1760, DOI 10.1016/j.febslet.2009.10.085; Birn H, 2002, AM J PHYSIOL-RENAL, V282, pF408, DOI 10.1152/ajprenal.00206.2000; Cain DM, 2001, J NEUROPHYSIOL, V85, P1561, DOI 10.1152/jn.2001.85.4.1561; CANNATA JJB, 1965, J BIOL CHEM, V240, P3249; CHANARIN I, 1985, BLOOD, V66, P479; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Chung T, 2014, NEUROIMAG CLIN N AM, V24, P49, DOI 10.1016/j.nic.2013.03.023; Fenton Jon, 2011, BMJ Case Rep, V2011, DOI 10.1136/bcr.03.2011.4030; Fernandez-Roig S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-41; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; GARRISON CJ, 1994, EXP NEUROL, V129, P237, DOI 10.1006/exnr.1994.1165; GARRISON CJ, 1991, BRAIN RES, V565, P1, DOI 10.1016/0006-8993(91)91729-K; Gartner L. P., 2001, COLOUR TXB HISTOLOGY; Hannibal L, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00027; HARTE RA, 1953, J NUTR, V49, P669, DOI 10.1093/jn/49.4.669; HEALTON EB, 1991, MEDICINE, V70, P229, DOI 10.1097/00005792-199107000-00001; Hemmer B, 1998, J NEUROL NEUROSUR PS, V65, P822, DOI 10.1136/jnnp.65.6.822; Inoue-Choi M, 2012, INT J MOL EPIDEMIOL, V3, P160; JACOB JJC, 1978, BRIT J PHARMACOL, V64, P91, DOI 10.1111/j.1476-5381.1978.tb08645.x; Kalita J, 2014, NUTR NEUROSCI, V17, P156, DOI 10.1179/1476830513Y.0000000073; KRISTENSSON K, 1986, NATURE, V322, P544, DOI 10.1038/322544a0; KUNZE K, 1976, HDB CLIN NEUROLOGY, V28, P141; Lachner C, 2012, J NEUROPSYCH CLIN N, V24, P5, DOI 10.1176/appi.neuropsych.11020052; Lai SC, 2013, FASEB J, V27, P2468, DOI 10.1096/fj.12-219055; Loughlin AJ, 1997, J NEUROSCI RES, V47, P384; MCCOMBE PA, 1984, J NEUROL SCI, V66, P117, DOI 10.1016/0022-510X(84)90147-3; Ogburn KD, 2006, NEUROBIOL DIS, V22, P294, DOI 10.1016/j.nbd.2005.11.006; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; PANT SS, 1968, ACTA NEUROL SCAND, VS 44, P7; Paul L, 2017, MOL ASPECTS MED, V53, P43, DOI 10.1016/j.mam.2016.11.004; Quadros E. V., 2000, Modern analytical methodologies in fat- and water-soluble vitamins., P313; Quadros EV, 2010, HUM MUTAT, V31, P924, DOI 10.1002/humu.21297; Quadros EV, 2010, BRIT J HAEMATOL, V148, P195, DOI 10.1111/j.1365-2141.2009.07937.x; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Quadros EV, 2005, BIOCHEM BIOPH RES CO, V327, P1006, DOI 10.1016/j.bbrc.2004.12.103; QUADROS EV, 1989, AM J PHYSIOL, V256, pC296, DOI 10.1152/ajpcell.1989.256.2.C296; Rigaud M, 2008, PAIN, V136, P188, DOI 10.1016/j.pain.2008.01.016; ROOS D, 1978, ACTA NEUROL SCAND, V59, P3; Saporta MA, 2009, BRAIN, V132, P3263, DOI 10.1093/brain/awp274; SAVAGE DG, 1995, BAILLIERE CLIN HAEM, V8, P657, DOI 10.1016/S0950-3536(05)80225-2; Scalabrino G, 2009, PROG NEUROBIOL, V88, P203, DOI 10.1016/j.pneurobio.2009.04.004; SCHMALBRUCH H, 1986, ANAT REC, V215, P71, DOI 10.1002/ar.1092150111; SCOTT JSD, 1984, CLIN SCI, V67, P299, DOI 10.1042/cs0670299; Shipton MJ, 2015, CLIN MED, V15, P145, DOI 10.7861/clinmedicine.15-2-145; STAHLBERG KG, 1967, SCAND J HAEMATOL, V4, P312; SUMNER AJ, 1982, ANN NEUROL, V11, P469, DOI 10.1002/ana.410110506; SWETT JE, 1991, EXP NEUROL, V114, P82, DOI 10.1016/0014-4886(91)90087-S; TAYLOR RT, 1967, J BIOL CHEM, V242, P1509; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Wang X, 2015, GLIA, V63, P635, DOI 10.1002/glia.22774; Wasek B, 2018, J NEUROSCI METH, V307, P188, DOI 10.1016/j.jneumeth.2018.05.016; Watkins D, 2011, AM J MED GENET C, V157C, P33, DOI 10.1002/ajmg.c.30288	57	14	15	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2563	2573		10.1096/fj.201800754RR	http://dx.doi.org/10.1096/fj.201800754RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303736	Green Published			2022-12-26	WOS:000457296600082
J	Hu, B; Sun, XW; Yang, YT; Ying, ZM; Meng, JH; Zhou, CH; Jiang, GY; Li, SH; Wu, FF; Zhao, X; Zhu, HX; Wu, HB; Cai, XZ; Shi, ZL; Yan, SG				Hu, Bin; Sun, Xuewu; Yang, Yute; Ying, Zhimin; Meng, Jiahong; Zhou, Chenhe; Jiang, Guangyao; Li, Sihao; Wu, Fengfeng; Zhao, Xiang; Zhu, Hanxiao; Wu, Haobo; Cai, Xunzi; Shi, Zhongli; Yan, Shigui			Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency-induced bone mass loss by modulating TRAF6-mediated signaling	FASEB JOURNAL			English	Article						osteoclast; osteoporosis; NFATc1	NF-KAPPA-B; RECEPTOR ACTIVATOR; INHIBITS OSTEOCLASTOGENESIS; RANK EXPRESSION; CRUCIAL ROLE; DIFFERENTIATION; BISPHOSPHONATES; MECHANISMS; PREVENTION; RESORPTION	Postmenopausal osteoporosis is initiated by estrogen withdrawal and is characterized mainly by overactivated osteoclastic bone resorption. Targeting TNF receptor-associated factor 6 (TRAF6) or its downstream signaling pathways to modulate osteoclast formation and function is an appealing strategy for osteoclast-related disorders. In the present study, we determined the effect of tomatidine, a steroidal alkaloid derived from Solanaceae, on the formation and function of receptor activator of NF-B (RANK) ligand-induced osteoclasts and the underlying mechanism. Tomatidine inhibited osteoclast formation in a dose-dependent manner and decreased the expression of osteoclast marker genes. Actin ring formation and osteoclastic bone resorption were attenuated in the presence of tomatidine in vitro. Eight weeks after ovariectomy, tomatidine prevented estrogen deficiency-induced bone loss and restored the mechanical properties of the femur. At the molecular level, tomatidine abrogated phosphorylation of c-Jun N-terminal kinase (JNK)/p38, NF-B, and protein kinase B (Akt) pathway proteins by suppressing RANK expression, inhibiting the binding of TRAF6 to RANK, and downregulating the osteoclastogenesis marker-related protein expression. In summary, these data demonstrated that tomatidine attenuated osteoclast formation and function by modulating multiple TRAF6-mediated pathways. Therefore, tomatidine could be a novel candidate for the treatment of osteoclast-related disorders, including osteoporosis.Hu, B., Sun, X., Yang, Y., Ying, Z., Meng, J., Zhou, C., Jiang, G., Li, S., Wu, F., Zhao, X., Zhu, H., Wu, H., Cai, X., Shi, Z., Yan, S. Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency-induced bone mass loss by modulating TRAF6-mediated signaling.	[Hu, Bin; Ying, Zhimin; Meng, Jiahong; Zhou, Chenhe; Jiang, Guangyao; Li, Sihao; Zhao, Xiang; Zhu, Hanxiao; Wu, Haobo; Cai, Xunzi; Shi, Zhongli; Yan, Shigui] Zhejiang Univ, Affiliated Hosp 2, Dept Orthoped Surg, Hangzhou, Zhejiang, Peoples R China; [Sun, Xuewu; Yang, Yute] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Orthopaed, Hangzhou, Zhejiang, Peoples R China; [Hu, Bin; Ying, Zhimin; Meng, Jiahong; Zhou, Chenhe; Jiang, Guangyao; Li, Sihao; Zhao, Xiang; Zhu, Hanxiao; Wu, Haobo; Cai, Xunzi; Shi, Zhongli; Yan, Shigui] Zhejiang Univ, Orthoped Res Inst, Hangzhou, Zhejiang, Peoples R China; [Wu, Fengfeng] Zhejiang Univ, Huzhou Hosp, Huzhou Cent Hosp, Dept Orthoped Surg, Huzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Huzhou University; Zhejiang University	Yan, SG (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	zrjwsj@zju.edu.cn	Zhou, Chenhe/AAI-9226-2020	YING, ZHIMIN/0000-0001-5910-5016; Yan, Shigui/0000-0001-9096-2868	National Natural Science Foundation of China [81772360, 81401785]; Natural Science Foundation of Zhejiang Province [LY17H060004, Y17H060027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from the National Natural Science Foundation of China (81772360 and 81401785) and Natural Science Foundation of Zhejiang Province (LY17H060004 and Y17H060027). The authors declare no conflicts of interest.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bai S, 2008, J BIOL CHEM, V283, P30861, DOI 10.1074/jbc.M802525200; Bai ST, 2005, J CLIN INVEST, V115, P2742, DOI 10.1172/JCI24921; Bartell SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4773; Borromeo GL, 2015, J BONE MINER RES, V30, P749, DOI 10.1002/jbmr.2428; Boudot C, 2010, BONE, V46, P1416, DOI 10.1016/j.bone.2010.01.383; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cappuzzo KA, 2004, ANN PHARMACOTHER, V38, P294, DOI 10.1345/aph.1D353; Cardelli P, 2015, ORAL IMPLANTOL ROME, V8, P52; Chen L, 2008, EUR J IMMUNOL, V38, P2845, DOI 10.1002/eji.200838192; Chiu FL, 2008, FEBS LETT, V582, P2407, DOI 10.1016/j.febslet.2008.05.049; D'Amelio P, 2008, BONE, V43, P92, DOI 10.1016/j.bone.2008.02.017; Dyle MC, 2014, J BIOL CHEM, V289, P14913, DOI 10.1074/jbc.M114.556241; Edwards BJ, 2013, J BONE JOINT SURG AM, V95A, P297, DOI 10.2106/JBJS.K.01181; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Friedman M, 2013, J AGR FOOD CHEM, V61, P9534, DOI 10.1021/jf402654e; Ghirardi A, 2014, EUR J CLIN PHARMACOL, V70, P1129, DOI 10.1007/s00228-014-1708-8; Gohda J, 2005, EMBO J, V24, P790, DOI 10.1038/sj.emboj.7600564; Ke K, 2017, J ENDOCRINOL, V235, P85, DOI 10.1530/JOE-16-0591; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Li CH, 2011, J BONE MINER RES, V26, P644, DOI 10.1002/jbmr.242; Loi F, 2016, BONE, V86, P119, DOI 10.1016/j.bone.2016.02.020; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Nakanishi A, 2013, INT J MOL MED, V31, P874, DOI 10.3892/ijmm.2013.1258; Oursler MJ, 2010, J CELL BIOCHEM, V110, P1058, DOI 10.1002/jcb.22640; Silva-Beltran NP, 2015, INT J ANAL CHEM, V2015, DOI 10.1155/2015/284071; Portal-Nunez S, 2012, HISTOL HISTOPATHOL, V27, P559, DOI 10.14670/HH-27.559; Qiu SX, 2007, CHEM BIOL, V14, P860, DOI 10.1016/j.chembiol.2007.06.010; Takahashi N, 2003, METH MOLEC MED, V80, P129; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tan EM, 2017, J BONE MINER RES, V32, P846, DOI 10.1002/jbmr.3031; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weaver MJ, 2010, J AM ACAD ORTHOP SUR, V18, P367, DOI 10.5435/00124635-201006000-00009; Wu XM, 2012, TRANSNATIONAL CORPORATIONS IN CHINA: RESEARCH AND DEVELOPMENT, P1; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yuan FL, 2015, BONE, V75, P128, DOI 10.1016/j.bone.2015.02.017; Zalli D, 2016, J BONE MINER RES, V31, P1701, DOI 10.1002/jbmr.2851; Zhu X, 2016, J BONE MINER RES, V31, P560, DOI 10.1002/jbmr.2710	44	19	19	4	40	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2574	2586		10.1096/fj.201800920R	http://dx.doi.org/10.1096/fj.201800920R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30285579				2022-12-26	WOS:000457296600083
J	Zhou, YQ; Xia, ZC; Cheng, ZK; Xu, G; Yang, XD; Liu, S; Zhu, Y				Zhou, Yaqin; Xia, Zhangchuan; Cheng, Zhikui; Xu, Gang; Yang, Xiaodan; Liu, Shi; Zhu, Ying			Inducible microRNA-590-5p inhibits host antiviral response by targeting the soluble interleukin-6 (IL6) receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); viral replication; cellular immune response; host defense; gene regulation; virus infection	HEPATOCELLULAR-CARCINOMA; VIRUS-INFECTION; PROMOTES; GENE; MIR-590-5P; EXPRESSION; INVASION; PROTEIN; CELLS	MicroRNA (miR)-590-5p has been identified as an important regulator of some signaling pathways such as cell proliferation and tumorigenesis. However, little is known about its role during viral infection. Here, we report that miR-590-5p was significantly induced by various viruses and effectively potentiated virus replication in different viral infection systems. Furthermore, miR-590-5p substantially attenuated the virus-induced expression of type I and type III interferons (IFNs) and inflammatory cytokines, resulting in impaired downstream antiviral signaling. Interleukin-6 receptor (IL6R) was identified as a target of miR-590-5p. Interestingly, the role of miR-590-5p in virus-triggered signaling was abolished in IL6R knockout cells, and this could be rescued by restoring the expression of the soluble IL6R (sIL6R) but not the membrane-bound IL6R (mIL6R), suggesting that sIL6R is indispensable for miR-590-5p in modulating the host antiviral response. Furthermore, miR-590-5p down-regulated endogenous sIL6R and mIL6R expression through a translational repression mechanism. These findings thus uncover a previously uncharacterized role and the underlying mechanism of miR-590-5p in the innate immune response to viral infection.	[Zhou, Yaqin; Xia, Zhangchuan; Cheng, Zhikui; Xu, Gang; Yang, Xiaodan; Liu, Shi; Zhu, Ying] Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Zhu, Y (corresponding author), Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	yingzhu@whu.edu.cn	Xia, Zhangchuan/AAO-3890-2020	Xia, Zhangchuan/0000-0002-1176-0027	National Natural Science Foundation of China [31570870]; Natural Science Foundation of Hubei Province Innovation Group Grant [2017CFA022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province Innovation Group Grant	This work was supported by National Natural Science Foundation of China Grant 31570870 and the Natural Science Foundation of Hubei Province Innovation Group Grant 2017CFA022. The authors declare that they have no conflicts of interest with the contents of this article.	Bakre A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066796; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carroll AP, 2014, WIRES RNA, V5, P361, DOI 10.1002/wrna.1217; Dai Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep22607; Schiavinato JLD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03456-8; Fang JL, 2012, J VIROL, V86, P1010, DOI 10.1128/JVI.06169-11; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He PP, 2014, BIOCHIMIE, V106, P81, DOI 10.1016/j.biochi.2014.08.003; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Jiang XF, 2012, MOL CELLS, V33, P545, DOI 10.1007/s10059-012-2267-4; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kim CW, 2018, CANCER LETT, V416, P31, DOI 10.1016/j.canlet.2017.12.018; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li CJ, 2015, MED SCI MONITOR, V21, P3490, DOI 10.12659/MSM.894987; Li HH, 2015, ONCOTARGET, V6, P14026, DOI 10.18632/oncotarget.4334; Li QS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01954-x; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; Li YK, 2013, J BIOL CHEM, V288, P20927, DOI 10.1074/jbc.M112.440115; Li YK, 2013, PROTEIN CELL, V4, P130, DOI 10.1007/s13238-012-2081-y; Lin XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151930; Long X, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.4; Loveday EK, 2015, J GEN VIROL, V96, P30, DOI 10.1099/vir.0.068585-0; Lukashevich IS, 2003, J VIROL, V77, P1727, DOI 10.1128/JVI.77.3.1727-1737.2003; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Mukhtar MM, 2009, INT J BIOCHEM CELL B, V41, P554, DOI 10.1016/j.biocel.2008.07.001; Musto A, 2015, CELL DEATH DIFFER, V22, P1047, DOI 10.1038/cdd.2014.198; Ou CL, 2017, CANCER LETT, V399, P53, DOI 10.1016/j.canlet.2017.04.011; Ouyang XX, 2016, INT J MED SCI, V13, P195, DOI 10.7150/ijms.13996; Preusse M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00246; Pullamsetti SS, 2018, J CLIN INVEST, V128, P1720, DOI 10.1172/JCI120415; Ramakrishnan Muthannan Andavar, 2016, World J Virol, V5, P85, DOI 10.5501/wjv.v5.i2.85; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Sui JD, 2017, CELL PHYSIOL BIOCHEM, V44, P1188, DOI 10.1159/000485449; Wang J, 2015, CELL MOL IMMUNOL, V12, P633, DOI 10.1038/cmi.2014.80; Wang Q, 2013, J VIROL, V87, P11244, DOI 10.1128/JVI.01248-13; Wang WB, 2018, MICROVASC RES, V120, P21, DOI 10.1016/j.mvr.2018.05.007; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu ZZ, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12483; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang XD, 2016, J IMMUNOL, V197, P2369, DOI 10.4049/jimmunol.1600627; You S, 2018, GENETICS, V208, P1195, DOI 10.1534/genetics.117.300342; Yue X, 2012, J IMMUNOL, V189, P279, DOI 10.4049/jimmunol.1103405; Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047; Zheng QL, 2016, J IMMUNOL, V196, P1317, DOI 10.4049/jimmunol.1502134; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zhu LH, 2010, FEBS J, V277, P3726, DOI 10.1111/j.1742-4658.2010.07773.x	48	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18168	18179		10.1074/jbc.RA118.005057	http://dx.doi.org/10.1074/jbc.RA118.005057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30291142	Green Published, hybrid			2022-12-26	WOS:000451375200012
J	Chawla, S; Pund, A; Vibishan, B; Kulkarni, S; Diwekar-Joshi, M; Watve, M				Chawla, Suraj; Pund, Anagha; Vibishan, B.; Kulkarni, Shubhankar; Diwekar-Joshi, Manawa; Watve, Milind			Inferring causal pathways among three or more variables from steady-state correlations in a homeostatic system	PLOS ONE			English	Article							OB-OB MICE; INSULIN-RESISTANCE; RISK-FACTORS; MALE-RATS; GLUCOSE; HYPERINSULINEMIA; HYPERGLYCEMIA; COEFFICIENTS; ASSOCIATION; SENSITIVITY	Cross-sectional correlations between two variables have limited implications for causality. We examine here whether it is possible to make causal inferences from steady-state data in a homeostatic system with three or more inter-correlated variables. Every putative pathway between three variables makes a set of differential predictions that can be tested with steady state data. For example, among 3 variables, A, B and C, the coefficient of determination, r(AC)(2) is predicted by the product of r(AB)(2) and r(BC)(2) for some pathways, but not for others. Residuals from a regression line are independent of residuals from another regression for some pathways, but positively or negatively correlated for certain other pathways. Different pathways therefore have different prediction signatures, which can be used to accept or reject plausible pathways using appropriate null hypotheses. The type 2 error reduces with sample size but the nature of this relationship is different for different predictions. We apply these principles to test the classical pathway leading to a hyperinsulinemic normoglycemic insulin-resistant, or pre-diabetic, state using four different sets of epidemiological data. Currently, a set of indices called HOMA-IR and HOMA-beta 3 are used to represent insulin resistance and glucose-stimulated insulin response by beta cells respectively. Our analysis shows that if we assume the HOMA indices to be faithful indicators, the classical pathway must in turn be rejected. In effect, among the populations sampled, the classical pathway and faithfulness of the HOMA indices cannot be simultaneously true. The principles and example shows that it is possible to infer causal pathways from cross sectional correlational data on three or more correlated variables.	[Chawla, Suraj; Pund, Anagha; Vibishan, B.; Kulkarni, Shubhankar; Diwekar-Joshi, Manawa; Watve, Milind] Indian Inst Sci Educ & Res, Biol, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Watve, M (corresponding author), Indian Inst Sci Educ & Res, Biol, Pune, Maharashtra, India.	milind@iiserpune.ac.in		Watve, Milind/0000-0003-0730-8393; Kulkarni, Shubhankar/0000-0001-6538-7152	Rajiv Gandhi Science and Technology Commission (RGSTC), Maharashtra State	Rajiv Gandhi Science and Technology Commission (RGSTC), Maharashtra State	This work was supported by Rajiv Gandhi Science and Technology Commission (RGSTC), Maharashtra State.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; Ahlqvist E, 2018, LANCET DIABETES ENDO, V6, P361, DOI 10.1016/S2213-8587(18)30051-2; Alemzadeh R, 2004, ENDOCRINOLOGY, V145, P5476, DOI 10.1210/en.2003-1523; Alemzadeh R, 2008, METABOLISM, V57, P1597, DOI 10.1016/j.metabol.2008.06.017; Bellatorre A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173103; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Cerf ME, 2013, FRONT ENDOCRINOL, V4, DOI [10.3389/fendo.2013.00037/abstract, DOI 10.3389/FENDO.2013.00037/ABSTRACT]; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; CUMMING DC, 1986, MED SCI SPORT EXER, V18, P369, DOI 10.1249/00005768-198608000-00001; DUBUC PU, 1981, J NUTR, V111, P1742, DOI 10.1093/jn/111.10.1742; DUBUC PU, 1976, METABOLISM, V25, P1567, DOI 10.1016/0026-0495(76)90109-8; Eichler M, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0613; Ejima K, 2016, EUR J CLIN INVEST, V46, P985, DOI 10.1111/eci.12681; Fuller WA, 1987, WILEY SERIES PROBABI, DOI [10.1002/9780470316665, DOI 10.1002/9780470316665]; GARVEY WT, 1986, DIABETES, V35, P258, DOI 10.2337/diabetes.35.3.258; Gerber JS, 2009, CLIN INFECT DIS, V48, P456, DOI 10.1086/596476; Gill GV, 1997, POSTGRAD MED J, V73, P640, DOI 10.1136/pgmj.73.864.640; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; GRIGGS RC, 1989, J APPL PHYSIOL, V66, P498, DOI 10.1152/jappl.1989.66.1.498; HALTER JB, 1985, AM J MED, V79, P6, DOI 10.1016/0002-9343(85)90579-0; Han DH, 1998, J GERONTOL A-BIOL, V53, pB19, DOI 10.1093/gerona/53A.1.B19; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HOLMANG A, 1992, ACTA PHYSIOL SCAND, V146, P505, DOI 10.1111/j.1748-1716.1992.tb09452.x; Joshi NP, 2005, AM J OBSTET GYNECOL, V193, P783, DOI 10.1016/j.ajog.2005.01.020; Kadowaki T, 2000, J CLIN INVEST, V106, P459, DOI 10.1172/JCI10830; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; LERNER RL, 1972, J CLIN INVEST, V51, P1624, DOI 10.1172/JCI106963; Lo CM, 2011, DIABETES, V60, P2000, DOI 10.2337/db10-0789; Maianti JP, 2014, NATURE, V511, P94, DOI 10.1038/nature13297; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meehl PE, 2002, PSYCHOL METHODS, V7, P283, DOI 10.1037//1082-989X.7.3.283; Meek TH, 2013, DIABETES, V62, P1512, DOI 10.2337/db12-0837; Neuberg LG, 2003, EC THEORY, V19; Neuberg LG, 2000, CAUSALITY MODELS REA, V19; Niles HE, 1923, GENETICS, V8, P256; Nonogaki K, 2000, DIABETOLOGIA, V43, P533, DOI 10.1007/s001250051341; Parascandola M, 2001, J EPIDEMIOL COMMUN H, V55, P905, DOI 10.1136/jech.55.12.905; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pearl J, 2009, STAT SURV, V3, P96, DOI 10.1214/09-SS057; Peters J, 2011, IEEE T PATTERN ANAL, V33, P2436, DOI 10.1109/TPAMI.2011.71; Polgreen LE, 2012, OBESITY, V20, P2194, DOI 10.1038/oby.2012.108; Pories WJ, 2012, DIABETES CARE, V35, P2438, DOI 10.2337/dc12-0684; Ratzan SC, 2010, J HEALTH COMMUN, V15, P237, DOI 10.1080/10810731003780714; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Tomasi T, 1966, Rev Neuropsychiatr Infant, V14, P315; TURNER RC, 1979, METABOLISM, V28, P1086, DOI 10.1016/0026-0495(79)90146-X; Watve M, 2013, DIPLOMATS DIABETES, DOI [10.1007/978-1-4614-4409-1, DOI 10.1007/978-1-4614-4409-1]; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676; WRIGHT S, 1960, BIOMETRICS, V16, P189, DOI 10.2307/2527551; Yajnik CS, 2008, DIABETOLOGIA, V51, P39, DOI 10.1007/s00125-007-0847-1	54	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204755	10.1371/journal.pone.0204755	http://dx.doi.org/10.1371/journal.pone.0204755			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW7TO	30307959	Green Submitted, gold, Green Published			2022-12-26	WOS:000447173500024
J	Dana, H; Novak, O; Guardado-Montesino, M; Fransen, JW; Hu, A; Borghuis, BG; Guo, C; Kim, DS; Svoboda, K				Dana, Hod; Novak, Ondrej; Guardado-Montesino, Michael; Fransen, James W.; Hu, Amy; Borghuis, Bart G.; Guo, Caiying; Kim, Douglas S.; Svoboda, Karel			Thy1 transgenic mice expressing the red fluorescent calcium indicator jRGECO1 a for neuronal population imaging in vivo	PLOS ONE			English	Article							NEURAL ACTIVITY; CA2+ INDICATOR; MOUSE; PROTEINS; DYNAMICS; SIGNALS; CORTEX; MAP	Calcium imaging is commonly used to measure the neural activity of large groups of neurons in mice. Genetically encoded calcium indicators (GECIs) can be delivered for this purpose using non-invasive genetic methods. Compared to viral gene transfer, transgenic targeting of GECIs provides stable long-term expression and obviates the need for invasive viral injections. Transgenic mice expressing the green GECI GCaMP6 are already widely used. Here we present the generation and characterization of transgenic mice expressing the sensitive red GECI jRGECO1a, driven by the Thy1 promoter. Four transgenic lines with different expression patterns showed sufficiently high expression for cellular in vivo imaging. We used two-photon microscopy to characterize visual responses of individual neurons in the visual cortex in vivo. The signal-to-noise ratio in transgenic mice was comparable to, or better than, mice transduced with adeno-associated virus. In addition, we show that Thy1-jRGECO1 a transgenic mice are useful for transcranial population imaging and functional mapping using widefield fluorescence microscopy. We also demonstrate imaging of visual responses in retinal ganglion cells in vitro. Thy1-jRGECO1a transgenic mice are therefore a useful addition to the toolbox for imaging activity in intact neural networks.	[Dana, Hod; Novak, Ondrej; Guardado-Montesino, Michael; Hu, Amy; Guo, Caiying; Kim, Douglas S.; Svoboda, Karel] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Novak, Ondrej] Acad Sci Czech Republ, Inst Expt Med, Dept Auditory Neurosci, Prague, Czech Republic; [Fransen, James W.; Borghuis, Bart G.] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Dana, Hod] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH USA	Howard Hughes Medical Institute; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; University of Louisville; Cleveland Clinic Foundation	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	NOVAK, Ondrej/F-7031-2014	NOVAK, Ondrej/0000-0003-3452-0154; Dana, Hod/0000-0002-8093-2363; Kim, Douglas/0000-0001-9029-314X	Howard Hughes Medical Institute Janelia Research Campus; National Institute of Health National Eye Institute [R01-EY028188]; NATIONAL EYE INSTITUTE [R01EY028188] Funding Source: NIH RePORTER	Howard Hughes Medical Institute Janelia Research Campus; National Institute of Health National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	HD, ON, MGM, AH, CG, DSK, and KS were supported by the Howard Hughes Medical Institute Janelia Research Campus, as part of their budget to the GENIE Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JWF and BGB were supported by the National Institute of Health National Eye Institute by grant number R01-EY028188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; Atkin SD, 2009, J NEUROSCI METH, V181, P212, DOI 10.1016/j.jneumeth.2009.05.006; Behringer R., 2013, MANIPULATING MOUSE E; Bethge P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179460; Borghuis BG, 2013, J NEUROSCI, V33, P10972, DOI 10.1523/JNEUROSCI.1241-13.2013; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Chen TW, 2017, NEURON, V94, P866, DOI 10.1016/j.neuron.2017.05.005; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; Dana H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108697; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Direnberger S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2035; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Kim TH, 2016, CELL REP, V17, P3385, DOI 10.1016/j.celrep.2016.12.004; Loeb JE, 1999, HUM GENE THER, V10, P2295, DOI 10.1089/10430349950016942; Madisen L, 2017, BIORXIV, DOI [10.1101/224881, DOI 10.1101/224881]; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Peron SP, 2015, NEURON, V86, P783, DOI 10.1016/j.neuron.2015.03.027; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sofroniew NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14472; Sun Y, 2017, NATURE NEUROSCIENCE; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tallini YN, 2007, CIRC RES, V101, P1300, DOI 10.1161/CIRCRESAHA.107.149484; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wekselblatt JB, 2016, J NEUROPHYSIOL, V115, P2852, DOI 10.1152/jn.01056.2015; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhuang J, 2017, ELIFE	40	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205444	10.1371/journal.pone.0205444	http://dx.doi.org/10.1371/journal.pone.0205444			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308007	Green Submitted, gold, Green Published			2022-12-26	WOS:000447173500079
J	Khoddami, A; Chrystal, PV; Selle, PH; Liu, SY				Khoddami, Ali; Chrystal, Peter, V; Selle, Peter H.; Liu, Sonia Yun			Dietary starch to lipid ratios influence growth performance, nutrient utilisation and carcass traits in broiler chickens offered diets with different energy densities	PLOS ONE			English	Article							PROTEIN; MACRONUTRIENTS; METABOLISM; HEALTH	Twelve experimental diets with three levels of energy densities (11.25, 12.38 and 13.50 MJ/kg) and fours levels of starch to lipid ratios (14:1, 12:1, 7:1, 4:1) were offered to 288 male Ross 308 broiler chickens. All the diets were formulated to contain consistent digestible lysine to metabolisable energy ratios (0.87 g digestible lysine/MJ AMEn) and ideal amino acid ratios. Growth performance was monitored from 7 to 27 days post-hatch and parameters of nutrient utilisation (AME, AMEn, AME:GE ratios, N retention) were determined from 24 to 26 days post-hatch. Apparent protein (N) and starch digestibility coefficients, carcass yield and composition were determined at 27 days post-hatch. There were no interactions between energy densities and starch to lipid ratios on growth performance and carcass weights (P > 0.05). Feed intake was reduced with increased energy densities (P < 0.001). Weight gain and FCR were improved with increased dietary energy densities (P < 0.0001). Starch to lipid ratios linearly increased weight gain (r = 0.448, P = 0.001) and feed intake (r = 0.509, P < 0.001) without influencing FCR (P > 0.75). Both nutrient densities and starch to lipid ratios significantly impacted on carcass weight and yield. Heavier carcass weights and higher yields were observed in broiler chickens offered diets with high nutrient density (P <= 0.001). Carcass weight (r = 0.441, P < 0.005) was positively correlated with starch to lipid ratios and this tended to be the case for carcass yield (r = 0.277, P = 0.057) too. However, there were interactions on lipid concentrations in carcass (P < 0.001) as broiler chickens offered diet containing the lowest nutrient density and the highest starch to lipid ratio had the highest lipid carcass concentration of 12.94%. In conclusion, protein and energy need to be considered in tandem in practical diet formulation, especially in diets containing high crystalline amino acid inclusions. The impact of lipid on feed intake and starch on carcass lipid concentrations should also be taken into consideration.	[Khoddami, Ali; Selle, Peter H.; Liu, Sonia Yun] Univ Sydney, Poultry Res Fdn, Sydney Sch Vet Sci, Fac Sci, Camden, NSW, Australia; [Khoddami, Ali] Univ Sydney, Sydney Inst Agr, Fac Sci, Sydney, NSW, Australia; [Chrystal, Peter, V] Baiada Poultry Pty Ltd, Pendle Hill, NSW, Australia; [Liu, Sonia Yun] Univ Sydney, Sch Life & Environm Sci, Fac Sci, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney	Liu, SY (corresponding author), Univ Sydney, Poultry Res Fdn, Sydney Sch Vet Sci, Fac Sci, Camden, NSW, Australia.; Liu, SY (corresponding author), Univ Sydney, Sch Life & Environm Sci, Fac Sci, Sydney, NSW, Australia.	sonia.liu@sydney.edu.au	Khoddami, Ali/E-9535-2016	Khoddami, Ali/0000-0002-1774-0000; Chrystal, Peter/0000-0001-7421-5109	Celestino Baiada Research Fellowship in Poultry Science; Baiada Poultry Pty Limited	Celestino Baiada Research Fellowship in Poultry Science; Baiada Poultry Pty Limited	The present study was funded by the Celestino Baiada Research Fellowship in Poultry Science, a generous donation to The University of Sydney by Baiada Poultry Pty Limited, Sydney, Australia who also provided the operating costs to conduct the present study. As a gift to The University of Sydney, the donor generously agreed to share research outcomes with the public. Baiada Poultry Pty Limited provided support in the form of salaries for authors SL and PVC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mr Peter Chrystal from Baiada Pty Limited contributed to the study design and diet formulation. The specific roles of these authors are articulated in the 'author contributions' section.	CAMPBELL RG, 1983, BRIT J NUTR, V49, P221, DOI 10.1079/BJN19830029; GOLDBERG A, 1962, BIOCHEM J, V83, P129, DOI 10.1042/bj0830129; Gous RM, 2018, BRIT POULTRY SCI, V59, P100, DOI 10.1080/00071668.2017.1390211; Gous R. M., 1973, Agroanimalia, V5, P31; HILL FW, 1958, J NUTR, V64, P587, DOI 10.1093/jn/64.4.587; Keller J, 2006, AM J PHYSIOL-GASTR L, V290, pG704, DOI 10.1152/ajpgi.00411.2005; Kleyn R, 2015, FORMULATING NONLINEA; Leeson S, 1996, POULTRY SCI, V75, P529, DOI 10.3382/ps.0750529; Lewis AJ, 1992, DETERMINATION AMINO; Liu SY, 2015, WORLD POULTRY SCI J, V71, P297, DOI 10.1017/S0043933915000306; Liu SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185480; Liu SY, 2017, BRIT J NUTR, V118, P250, DOI 10.1017/S0007114517002070; Liu SY, 2016, BRIT J NUTR, V116, P2129, DOI 10.1017/S0007114516004190; de Castro MDL, 2010, J CHROMATOGR A, V1217, P2383, DOI 10.1016/j.chroma.2009.11.027; Mahasukhonthachat K, 2010, J CEREAL SCI, V51, P392, DOI 10.1016/j.jcs.2010.02.008; Maljaars PWJ, 2008, PHYSIOL BEHAV, V95, P271, DOI 10.1016/j.physbeh.2008.07.018; MARTINEZ V, 1995, AM J PHYSIOL-REG I, V269, pR445, DOI 10.1152/ajpregu.1995.269.2.R445; MELNICK D, 1946, SCIENCE, V103, P326, DOI 10.1126/science.103.2672.326-a; Ravindran V, 2016, ANIM FEED SCI TECH, V213, P1, DOI 10.1016/j.anifeedsci.2016.01.012; RIESENFELD G, 1980, J NUTR, V110, P117, DOI 10.1093/jn/110.1.117; Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x; SIRIWAN P, 1993, BRIT POULTRY SCI, V34, P939, DOI 10.1080/00071669308417654; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; SUTHAMA N, 1991, Japanese Poultry Science, V28, P1; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0	25	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205272	10.1371/journal.pone.0205272	http://dx.doi.org/10.1371/journal.pone.0205272			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304011	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100074
J	Bouyssou, JM; Liu, CJ; Bustoros, M; Sklavenitis-Pistofidis, R; Aljawai, Y; Manier, S; Yosef, A; Sacco, A; Kokubun, K; Tsukamoto, S; Glen, AP; Huynh, D; Castillo, JJ; Treon, SP; Leblond, V; Hermine, O; Roccaro, AM; Ghobrial, IM; Capelletti, M				Bouyssou, Juliette M.; Liu, Chia-Jen; Bustoros, Mark; Sklavenitis-Pistofidis, Romanos; Aljawai, Yosra; Manier, Salomon; Yosef, Amir; Sacco, Antonio; Kokubun, Katsutoshi; Tsukamoto, Shokichi; Glen, Adriana Perilla; Huynh, Daisy; Castillo, Jorge J.; Treon, Steven P.; Leblond, Veronique; Hermine, Olivier; Roccaro, Aldo M.; Ghobrial, Irene M.; Capelletti, Marzia			Profiling of circulating exosomal miRNAs in patients with Waldenstrom Macroglobulinemia	PLOS ONE			English	Article							TUMOR-DERIVED EXOSOMES; L265P SOMATIC MUTATION; IN-VIVO; MICRORNA SIGNATURES; MULTIPLE-MYELOMA; DRUG-RESISTANCE; CELL-LINE; CANCER; METASTASIS; PROGRESSION	Waldenstrom Macroglobulinemia (WM) is a low-grade B-cell lymphoma characterized by disease progression from IgM MGUS to asymptomatic and then symptomatic disease states. We profiled exosomes from the peripheral blood of patients with WM at different stages (30 smoldering/asymptomatic WM, 44 symptomatic WM samples and 10 healthy controls) to define their role as potential biomarkers of disease progression. In this study, we showed that circulating exosomes and their miRNA content represent unique markers of the tumor and its microenvironment. We observed similar levels of miRNAs in exosomes from patients with asymptomatic (smoldering) and symptomatic WM, suggesting that environmental and clonal changes occur in patients at early stages of disease progression before symptoms occur. Moreover, we identified a small group of miRNAs whose expression correlated directly or inversely with the disease status of patients, notably the known tumor suppressor miRNAs let-7d and the oncogene miR-21 as well as miR-192 and miR-320b. The study of these miRNAs' specific effect in WM cells could help us gain further insights on the mechanisms underlying WM pathogenesis and reveal their potential as novel therapeutic targets for this disease.	[Bouyssou, Juliette M.; Liu, Chia-Jen; Bustoros, Mark; Sklavenitis-Pistofidis, Romanos; Aljawai, Yosra; Manier, Salomon; Yosef, Amir; Sacco, Antonio; Kokubun, Katsutoshi; Tsukamoto, Shokichi; Glen, Adriana Perilla; Huynh, Daisy; Castillo, Jorge J.; Treon, Steven P.; Roccaro, Aldo M.; Ghobrial, Irene M.; Capelletti, Marzia] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bouyssou, Juliette M.] Univ Paris Saclay, Hop Necker Enfants Malad, Paris, France; [Liu, Chia-Jen] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Leblond, Veronique] Hop La Pitie Salpetriere, Dept Hematol, Paris, France; [Hermine, Olivier] INSERM, UMR 1163, Lab Cellular & Mol Mech Hematol Disorders & Thera, Paris, France	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ghobrial, IM; Capelletti, M (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	irene_ghobrial@dfci.harvard.edu; marzia_capelletti@dfci.harvard.edu	Dimopoulos, Meletios Athanasios/AAD-4130-2019; Hermine, Olivier/Q-7072-2018; Sacco, Antonio/AAG-7676-2022; Sacco, Antonio/AFL-7734-2022; Sacco, Antonio/K-4681-2016	Bouyssou, Juliette/0000-0002-2301-0426; Liu, Chia-Jen/0000-0001-7945-9292; Yosef, Amir/0000-0002-9322-1798; Sacco, Antonio/0000-0003-2945-9416	International Waldenstrom's Macroglobulinemia Foundation	International Waldenstrom's Macroglobulinemia Foundation	This work was supported by a grant awarded by the International Waldenstrom's Macroglobulinemia Foundation, https://www.iwmf.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Besse LK, 2015, AM J HEMATOL, V90, pE51, DOI 10.1002/ajh.23910; Bhome R, 2018, CANCER LETT, V420, P228, DOI 10.1016/j.canlet.2018.02.002; Bouyssou JMC, 2014, BBA-REV CANCER, V1845, P255, DOI 10.1016/j.bbcan.2014.02.002; Boyiadzis M, 2017, LEUKEMIA, V31, P1259, DOI 10.1038/leu.2017.91; Braggio E, 2012, HAEMATOL-HEMATOL J, V97, P1281, DOI 10.3324/haematol.2012.068478; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Correa JG, 2017, BRIT J HAEMATOL, V179, P849, DOI 10.1111/bjh.14266; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Hodge LS, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.25; Hodge LS, 2011, BLOOD, V117, pE190, DOI 10.1182/blood-2010-12-326868; Hui LL, 2015, CANCER LETT, V368, P7, DOI 10.1016/j.canlet.2015.07.039; Kapoor P, 2017, JAMA ONCOL, V3, P1257, DOI 10.1001/jamaoncol.2016.5763; Kasi Pashtoon Murtaza, 2015, Clin Adv Hematol Oncol, V13, P56; Leleu X, 2007, BLOOD, V110, P4417, DOI 10.1182/blood-2007-05-092098; Li YQ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006183; Lian JW, 2016, ONCOTARGET, V7, P2672, DOI 10.18632/oncotarget.6603; Lv GY, 2018, ONCOL RES, V26, P837, DOI 10.3727/096504017X14920318811721; Manier S, 2017, LEUKEMIA, V31, P853, DOI 10.1038/leu.2016.296; Manier S, 2017, BLOOD, V129, P2429, DOI 10.1182/blood-2016-09-742296; Matsumura T, 2015, BRIT J CANCER, V113, P275, DOI 10.1038/bjc.2015.201; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Muz B, 2015, MOL CANCER RES, V13, P263, DOI 10.1158/1541-7786.MCR-14-0150; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pfeffer SR, 2015, DRUG DEVELOP RES, V76, P270, DOI 10.1002/ddr.21257; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Rana S, 2013, NEOPLASIA, V15, P281, DOI 10.1593/neo.122010; Roccaro AM, 2014, BLOOD, V123, P4120, DOI 10.1182/blood-2014-03-564583; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Roccaro AM, 2010, BLOOD, V116, P1506, DOI 10.1182/blood-2010-01-265686; Roccaro AM, 2009, BLOOD, V113, P4391, DOI 10.1182/blood-2008-09-178228; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sacco A, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-38; Santos DD, 2007, EXP HEMATOL, V35, P1366, DOI 10.1016/j.exphem.2007.05.022; Sasaki CT, 2016, NEOPLASIA, V18, P329, DOI 10.1016/j.neo.2016.04.007; SATSANGI J, 1994, LANCET, V343, P1509, DOI 10.1016/S0140-6736(94)92622-0; Suchorska WM, 2016, ONCOL REP, V35, P1237, DOI 10.3892/or.2015.4507; Sun JT, 2016, INT J MOL MED, V37, P485, DOI 10.3892/ijmm.2016.2449; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varettoni M, 2013, BLOOD, V121, P2522, DOI 10.1182/blood-2012-09-457101; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang HT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1728-5; Wang JH, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15016892; Wang TZ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0402-5; Wu SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11169; Xu YJ, 2015, CLIN TRANSL ONCOL, V17, P34, DOI 10.1007/s12094-014-1194-6; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zhao L, 2015, CANCER LETT, V356, P339, DOI 10.1016/j.canlet.2014.10.027	57	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204589	10.1371/journal.pone.0204589	http://dx.doi.org/10.1371/journal.pone.0204589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286096	Green Submitted, Green Published, gold			2022-12-26	WOS:000446383500027
J	Dupuis, LJ; Lumens, J; Arts, T; Delhaas, T				Dupuis, Lauren J.; Lumens, Joost; Arts, Theo; Delhaas, Tammo			High tension in sarcomeres hinders myocardial relaxation: A computational study	PLOS ONE			English	Article							RAT CARDIAC TRABECULAE; COOPERATIVE ACTIVATION; DEPENDENT CHANGES; MUSCLE; CALCIUM; TROPONIN; LENGTH; CONTRACTION; FORCE; MODEL	Experiments have shown that the relaxation phase of cardiac sarcomeres during an isometric twitch is prolonged in muscles that reached a higher peak tension. However, the mechanism is not completely understood. We hypothesize that the binding of calcium to troponin is enhanced by the tension in the thin filament, thus contributing to the prolongation of contraction upon higher peak tension generation. To test this hypothesis, we developed a computational model of sarcomere mechanics that incorporates tension-dependence of calcium binding. The model was used to simulate isometric twitch experiments with time dependency in the form of a two-state cross-bridge cycle model and a transient intracellular calcium concentration. In the simulations, peak isometric twitch tension appeared to increase linearly by 51.1 KPa with sarcomere length from 1.9 mu m to 2.2 mu m. Experiments showed an increase of 47.3 KPa over the same range of sarcomere lengths. The duration of the twitch also increased with both sarcomere length and peak intracellular calcium concentration, likely to be induced by the inherently coupled increase of the peak tension in the thin filament. In the model simulations, the time to 50% relaxation (t(R50)) increased over the range of sarcomere lengths from 1.9 mu m to 2.2 mu m by 0.11s, comparable to the increased duration of 0.12s shown in experiments. Model simulated t(R50) increased by 0.12s over the range of peak intracellular calcium concentrations from 0.87 mu M to 1.45 mu M. Our simulation results suggest that the prolongation of contraction at higher tension is a result of the tighter binding of Ca2+ to troponin in areas under higher tension, thus delaying the deactivation of the troponin.	[Dupuis, Lauren J.; Lumens, Joost; Arts, Theo; Delhaas, Tammo] Maastricht Univ, Dept Biomed Engn, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Lumens, Joost] Univ Bordeaux, LIRYC Inst Rythmol & Modelisat Cardiaque, Bordeaux, France	Maastricht University; UDICE-French Research Universities; Universite de Bordeaux	Dupuis, LJ (corresponding author), Maastricht Univ, Dept Biomed Engn, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands.	l.dupuis@maastrichtuniversity.nl		Dupuis, Lauren/0000-0003-2606-3045; Lumens, Joost/0000-0001-8129-7384	Dutch Heart Foundation [2015T082]	Dutch Heart Foundation(Netherlands Heart Foundation)	This work was funded through a personal grant within the Dr. E. Dekker framework of the Dutch Heart Foundation to J. Lumens (grant 2015T082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DG, 1982, J PHYSIOL-LONDON, V327, P79, DOI 10.1113/jphysiol.1982.sp014221; BACKX PH, 1993, AM J PHYSIOL, V264, pH1098, DOI 10.1152/ajpheart.1993.264.4.H1098; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Biesiadecki Brandon J, 2014, Biophys Rev, V6, P273, DOI 10.1007/s12551-014-0143-5; Briston SJ, 2014, CARDIOVASC RES, V104, P347, DOI 10.1093/cvr/cvu201; Campbell SG, 2010, BIOPHYS J, V98, P2254, DOI 10.1016/j.bpj.2010.02.010; Daniel TL, 1998, BIOPHYS J, V74, P1611, DOI 10.1016/S0006-3495(98)77875-0; Desai R, 2015, J BIOL CHEM, V290, P1915, DOI 10.1074/jbc.M114.609743; Dobesh DP, 2002, AM J PHYSIOL-HEART C, V282, pH1055, DOI 10.1152/ajpheart.00667.2001; Dupuis LJ, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005126; Heinzel FR, 2002, CIRC RES, V91, P1023, DOI 10.1161/01.RES.0000045940.67060.DD; IZAKOV VY, 1991, CIRC RES, V69, P1171; JANSSEN PML, 1995, AM J PHYSIOL-HEART C, V269, pH676, DOI 10.1152/ajpheart.1995.269.2.H676; Janssen PML, 2002, AM J PHYSIOL-HEART C, V282, pH499, DOI 10.1152/ajpheart.00595.2001; Kassiri Z, 2000, J PHYSIOL-LONDON, V524, P221, DOI 10.1111/j.1469-7793.2000.t01-3-00221.x; KENTISH JC, 1986, CIRC RES, V58, P755, DOI 10.1161/01.RES.58.6.755; Kurihara S, 1995, J PHYSIOL-LONDON, V489, P617, DOI 10.1113/jphysiol.1995.sp021077; LANDESBERG A, 1994, AM J PHYSIOL, V267, pH779, DOI 10.1152/ajpheart.1994.267.2.H779; Niederer SA, 2006, BIOPHYS J, V90, P1697, DOI 10.1529/biophysj.105.069534; Razumova MV, 2000, BIOPHYS J, V78, P3120, DOI 10.1016/S0006-3495(00)76849-4; Rice JJ, 2008, BIOPHYS J, V95, P2368, DOI 10.1529/biophysj.107.119487; Schonleitner P, 2017, PROG BIOPHYS MOL BIO, V130, P288, DOI 10.1016/j.pbiomolbio.2017.06.013; Solaro J, 2001, HEART PHYSL PATHOPHY, P519; Solaro RJ, 1998, CIRC RES, V83, P471, DOI 10.1161/01.RES.83.5.471; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; ter Keurs HEDJ, 2008, PROG BIOPHYS MOL BIO, V97, P312, DOI 10.1016/j.pbiomolbio.2008.02.013; Wannenburg T, 1997, AM J PHYSIOL-HEART C, V273, pH2428, DOI 10.1152/ajpheart.1997.273.5.H2428; Williams CD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0697	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204642	10.1371/journal.pone.0204642	http://dx.doi.org/10.1371/journal.pone.0204642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286135	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500030
J	Fierro, J; Haynes, DR; Washbourne, P				Fierro, Javier, Jr.; Haynes, Dylan R.; Washbourne, Philip			4.1 Ba is necessary for glutamatergic synapse formation in the sensorimotor circuit of developing zebrafish	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; FUNCTIONAL-CHARACTERIZATION; PROTEIN 4.1B; EXPRESSION; FAMILY; CYTOSKELETAL; ASSOCIATION; EVOLUTION; NEURONS; GENOME	During the process of synapse formation, thousands of proteins assemble at prospective sites of cell-cell communication. Although many of these proteins have been identified, the roles they play in generating functional connections during development remain unknown. 4.1 scaffolding proteins have been implicated in synapse formation and maturation in vitro, but in vivo studies for some family members have suggested these proteins are not important for this role. We examined the role of family member 4.1B because it has been implicated in glutamatergic synaptogenesis, but has not been described in vivo. We identified two 4.1B genes in zebrafish, 4.1Ba and 4.16b, by sequence comparisons and synteny analysis. In situ hybridization shows these genes are differentially expressed, with 4.1Ba expressed primarily in the nervous system and 4.1Bb expressed in the nervous system and muscle, but not the spinal cord. We focused our studies on 4.1Ba in the spinal cord. 4.1Ba knockdown reduced the number of glutamatergic synapses at caudal primary motor neurons and caused an increase in the duration of touch-evoked coiling. These results suggest 4.1Ba is important for the formation of functional glutamatergic synapses in the developing zebrafish spinal cord.	[Fierro, Javier, Jr.; Haynes, Dylan R.; Washbourne, Philip] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Washbourne, P (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	pwash@uoneuro.uoregon.edu			NINDS [R01 NS065795]; NICHD [P01 HD022486]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NINDS: R01 NS065795 and NICHD: P01 HD022486.	An XL, 2006, BIOCHEMISTRY-US, V45, P5725, DOI 10.1021/bi060015v; Baines AJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-85; Baines AJ, 2014, BBA-BIOMEMBRANES, V1838, P605, DOI 10.1016/j.bbamem.2013.05.030; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Easley-Neal C, 2013, CELL REP, V3, P1199, DOI 10.1016/j.celrep.2013.03.031; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Escudero I, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0502-8; Fowler DK, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00024; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Gimm JA, 2002, BIOCHEMISTRY-US, V41, P7275, DOI 10.1021/bi0256330; Hauptmann G, 2000, METH MOL B, V137, P139; Hoy JL, 2009, MOL CELL NEUROSCI, V42, P466, DOI 10.1016/j.mcn.2009.09.010; Ippolito D.M., 2010, J VIS EXP; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; Kutzing M.K., 2010, J VIS EXP; Meyer MP, 2005, J NEUROBIOL, V63, P91, DOI 10.1002/neu.20118; Parra M, 2000, J BIOL CHEM, V275, P3247, DOI 10.1074/jbc.275.5.3247; Pietri T, 2009, DEV NEUROBIOL, V69, P780, DOI 10.1002/dneu.20741; Postlethwait J, 2004, METHOD CELL BIOL, V77, P255; Ryan TJ, 2009, NAT REV NEUROSCI, V10, P701, DOI 10.1038/nrn2717; Saint-Amant L, 2001, NEURON, V31, P1035, DOI 10.1016/S0896-6273(01)00416-0; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Scott C, 2001, EUR J BIOCHEM, V268, P3709, DOI 10.1046/j.1432-1327.2001.02276.x; Scott C, 2001, EUR J BIOCHEM, V268, P1084, DOI 10.1046/j.1432-1327.2001.01968.x; Shen L, 2000, J NEUROSCI, V20, P7932; Subramaniam S, 1998, PROTEINS, V32, P1; Sun CX, 2002, J CELL SCI, V115, P3991, DOI 10.1242/jcs.00094; Terada N, 2007, J HISTOCHEM CYTOCHEM, V55, P1199, DOI 10.1369/jhc.7A7266.2007; Wells S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021559; Welten MCM, 2006, ZEBRAFISH, V3, P465, DOI 10.1089/zeb.2006.3.465; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3; Wozny C, 2009, J CELL SCI, V122, P735, DOI 10.1242/jcs.037382; Yageta M, 2002, CANCER RES, V62, P5129; Yin J, 2016, AUTISM GENETICS OVER; Zelenchuk TA, 2011, GENESIS, V49, P546, DOI 10.1002/dvg.20766	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205255	10.1371/journal.pone.0205255	http://dx.doi.org/10.1371/journal.pone.0205255			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286167	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500103
J	Bayray, A; Meles, KG; Sibhatu, Y				Bayray, Alemayehu; Meles, Kidanu Gebremariam; Sibhatu, Yosef			Magnitude and risk factors for hypertension among public servants in Tigray, Ethiopia: A cross-sectional study	PLOS ONE			English	Article							PREVALENCE	Background Hypertension is a globally recognized threat to social and economic development with premature morbidity and mortality. In middle and low-income countries hypertension appears to be increasing. However, sufficient data on this silent-killer is not available in Ethiopia. Therefore, this study examined the magnitude and risk factors for hypertension among public servants in Tigray, Ethiopia. Methods We used a cross-sectional survey from May-June 2016 among 1525 public servants in Tigray region. Field workers collected data using a pre-tested, standardized questionnaire. A multivariate logistic regression analysis conducted to identify risk factors for hypertension. Statistical significance was declared using a p-value<0.05 and 95% of confidence interval (CI) for an adjusted odds ratio (AOR). Results The overall prevalence of hypertension was 16% (95% CI: 13.10-21.9) and the proportion of awareness (96.7%), treatment (31.3%) and control of hypertension (40.1%) among employees. Being male [AOR = 2.06, 95%CI:1.49, 2.84], ages groups of 30-49 years [AOR = 2.21, 95%CI:1.25, 3.89] and >50years [AOR = 3.61, 95% CI:1.93, 6.69], Body Mass Index(BMI); underweight [AOR = 0.40, 95% CI; 0.20, 0.78], overweight [AOR = 1.70, 95% CI; 1.22, 2.33] and obesity [AOR = 3.20, 95% CI; 1.78, 5.78] were determinants for hypertension. Conclusion The prevalence of hypertension is relatively high in Mekelle city compared with previous reports. This study revealed that male sex, age-group, and BMI were evidenced as risk factors for hypertension. Policy makers need to consider sector wise integrating prevention and control of hypertension. Skilled based information, education and communication strategies should be designed and implemented to avoid unhealthy lifestyles, investing in workforces to eliminate the modifiable risk factors for non-communicable diseases and promote healthy practices.	[Bayray, Alemayehu; Meles, Kidanu Gebremariam; Sibhatu, Yosef] Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia	Mekelle University	Meles, KG (corresponding author), Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia.	kidanumeles2008@gmail.com		Gebremariam, kidanu/0000-0002-7880-6907; Gebregiorgis, Yosef/0000-0003-1329-7782				Abebe SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125210; Angaw K, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0062-9; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Bonsa F, 2014, ETHIOP J HEALTH SCI, V24, P21, DOI 10.4314/ejhs.v24i1.3; Daniel C, 2013, BMC PUBLIC HEALTH, V13, P732; David Bloom, 2011, REDUCING EC IMPACT N; Gebreyes YF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194819; Gebrihet TA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176904; Gudina EK, 2013, INTEGR BLOOD PRESS C, V6, P111, DOI 10.2147/IBPC.S47298; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Kayima J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2146-y; Mengistu MD, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-33; Mion Jr. Decio, 2004, Rev. Hosp. Clin., V59, P329, DOI 10.1590/S0041-87812004000600004; Misganaw A, 2017, POPUL HEALTH METR, V15, P1, DOI [10.1186/s12963, DOI 10.1186/S12963-016-0118-9, 10.1186/s12963-016-0118-9]; Onyango MJ, 2017, PAN AFR MED J, V27, DOI 10.11604/pamj.2017.27.178.13073; Tadesse T, 2014, HYPERTENSION ASS FAC, P2; Tesfaye F, 2007, ASS BODY MASS INDEX, P28; Tran A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/193719; WHO, 2015, NCD FACT SHEET; World Health Organization, NCDS STEPS MAN	21	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204879	10.1371/journal.pone.0204879	http://dx.doi.org/10.1371/journal.pone.0204879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281660	Green Submitted, gold, Green Published			2022-12-26	WOS:000446342400063
J	Kazmierczak, PM; Burton, NC; Keinrath, G; Hirner-Eppeneder, H; Schneider, MJ; Eschbach, RS; Heimer, M; Solyanik, O; Todica, A; Reiser, MF; Ricke, J; Cyran, CC				Kazmierczak, Philipp M.; Burton, Neal C.; Keinrath, Georg; Hirner-Eppeneder, Heidrun; Schneider, Moritz J.; Eschbach, Ralf S.; Heimer, Maurice; Solyanik, Olga; Todica, Andrei; Reiser, Maximilian F.; Ricke, Jens; Cyran, Clemens C.			Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma	PLOS ONE			English	Article							GUIDED SURGERY; BREAST-CANCER; TOMOGRAPHY; FLUORESCENCE; VEMURAFENIB; SURVIVAL; TISSUE; RGD	Purpose To investigate alpha(v)beta(3)-integrin-targeted optoacoustic imaging and MRI for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma. Materials and methods Human BRAF V600E-positive melanoma xenograft (A375)-bearing Balb/c nude mice (n = 10) were imaged before (day 0) and after (day 7) a BRAF/MEK inhibitor combination therapy (encorafenib, 1.3 mg/kg/d; binimetinib, 0.6 mg/kg/d, n = 5) or placebo (n = 5), respectively. Optoacoustic imaging was performed on a preclinical system unenhanced and 5 h after i. v. injection of an alpha(v)beta(3)-integrin-targeted fluorescent probe. The alpha(v)beta(3)-integrin-specific tumor signal was derived by spectral unmixing. For morphology-based tumor response assessments, T2w MRI data sets were acquired on a clinical 3 Tesla scanner. The imaging results were validated by multiparametric immunohistochemistry (beta 3 -integrin expression, CD31 -microvascular density, Ki-67 -proliferation). Results The alpha(v)beta(3)-integrin-specific tumor signal was significantly reduced under therapy, showing a unidirectional decline in all animals (from 7.98 +/- 2.22 to 1.67 +/- 1.30; p = 0.043). No significant signal change was observed in the control group (from 6.60 +/- 6.51 to 3.67 +/- 1.93; p = 0.500). Immunohistochemistry revealed a significantly lower integrin expression (beta(3) : 0.20 +/- 0.02 vs. 0.39 +/- 0.05; p = 0.008) and microvascular density (CD31: 119 +/- 15 vs. 292 +/- 49; p = 0.008) in the therapy group. Tumor volumes increased with no significant intergroup difference (therapy: +107 +/- 42 mm(3); control +112 +/- 44mm(3), p = 0.841). In vivo blocking studies with alpha(v)beta(3-)integrin antagonist cilengitide confirmed the target specificity of the fluorescent probe. Conclusions alpha(v)beta(3)-integrin-targeted optoacoustic imaging allowed for the early non-invasive monitoring of a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma, adding molecular information on tumor receptor status to morphology-based tumor response criteria.	[Kazmierczak, Philipp M.; Keinrath, Georg; Hirner-Eppeneder, Heidrun; Schneider, Moritz J.; Eschbach, Ralf S.; Heimer, Maurice; Solyanik, Olga; Reiser, Maximilian F.; Ricke, Jens; Cyran, Clemens C.] Ludwig Maximilians Univ Munchen, Univ Hosp, Lab Expt Radiol, Dept Radiol, Munich, Germany; [Burton, Neal C.] iThera Med GmbH, Munich, Germany; [Schneider, Moritz J.] German Ctr Lung Res, Comprehens Pneumol Ctr, Munich, Germany; [Todica, Andrei] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany	University of Munich; University of Munich	Kazmierczak, PM (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp, Lab Expt Radiol, Dept Radiol, Munich, Germany.	philipp.kazmierczak@med.lmu.de			FoErderprogramm fur Forschung und Lehre (FoEFoLe), Medizinische FakultaEt, Ludwig-Maximilians-Universitat MuEnchen [907]	FoErderprogramm fur Forschung und Lehre (FoEFoLe), Medizinische FakultaEt, Ludwig-Maximilians-Universitat MuEnchen	This work was supported by FoErderprogramm fur Forschung und Lehre (FoEFoLe), Medizinische FakultaEt, Ludwig-Maximilians-Universitat MuEnchen (FoEFoLe-Reg.Nr. 907); https://www.med.uni-muenchen.de/forschung/foerderprogramme/foefole/index.html (PMK). NCB is an employee of iThera Medical GmbH (Munich, Germany; https://www.itheramedical.com/). The funder provided support in the form of salary for author NCB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Amaral T, 2017, EUR J CANCER, V73, P85, DOI 10.1016/j.ejca.2016.12.010; Arrieta O, 2017, J NUCL MED; Borchmann P, 2017, LANCET; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen HJ, 2016, THERANOSTICS, V6, P78, DOI 10.7150/thno.13242; Cui YF, 2016, INT J NANOMED, V11, P5671, DOI 10.2147/IJN.S115357; Desar IME, 2009, CANCER TREAT REV, V35, P309, DOI 10.1016/j.ctrv.2008.12.001; Dima A, 2016, PHOTOACOUSTICS, V4, P65, DOI 10.1016/j.pacs.2016.05.003; Diot G., 2017, CLIN CANC RES; Gaertner FC, 2010, Q J NUCL MED MOL IM, V54, P309; Georgieva M, 2017, CANC MED; Gibbs SL, 2012, QUANT IMAGING MED SU, V2, P177, DOI 10.3978/j.issn.2223-4292.2012.09.04; Gujrati V, 2017, CHEM COMMUN, V53, P4653, DOI 10.1039/c6cc09421j; Haedicke K, 2017, PHOTOACOUSTICS, V6, P1, DOI 10.1016/j.pacs.2017.03.001; Harlaar NJ, 2016, LANCET GASTROENTEROL, V1, P283, DOI 10.1016/S2468-1253(16)30082-6; Herzog E, 2012, RADIOLOGY, V263, P461, DOI 10.1148/radiol.11111646; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; Hudson SV, 2014, CANCER RES, V74, P6271, DOI 10.1158/0008-5472.CAN-14-1656; Joseph J, 2017, J NUCL MED, V58, P807, DOI 10.2967/jnumed.116.182311; Kazmierczak PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168248; Kazmierczak PM, 2016, INVEST RADIOL, V51, P746, DOI 10.1097/RLI.0000000000000278; Kimbrough CW, 2015, J SURG RES, V193, P246, DOI 10.1016/j.jss.2014.06.045; Knieling F, 2017, NEW ENGL J MED, V376, P1292, DOI 10.1056/NEJMc1612455; Lee JH, 2016, LANCET GASTROENTEROL, V1, P147, DOI 10.1016/S2468-1253(16)30027-9; Mahabeleshwar GH, 2007, SEMIN ONCOL, V34, P555, DOI 10.1053/j.seminoncol.2007.09.009; Manzano JL, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.07; Martelli C, 2016, ONCOTARGET, V7, P48753, DOI 10.18632/oncotarget.9066; Morscher S, 2014, PHOTOACOUSTICS, V2, P103, DOI 10.1016/j.pacs.2014.06.001; Mulgrew K, 2006, MOL CANCER THER, V5, P3122, DOI 10.1158/1535-7163.MCT-06-0356; Riedl CC, 2017, EUR J NUCL MED MOL I, V44, P1428, DOI 10.1007/s00259-017-3703-7; Sarantopoulos A, 2011, MOL IMAGING BIOL, V13, P874, DOI 10.1007/s11307-010-0416-8; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Sourbron S, 2009, MAGN RESON MED, V62, P205, DOI 10.1002/mrm.22005; Stoffels I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad1278; Sullivan RJ, 2013, EUR J CANCER, V49, P1297, DOI 10.1016/j.ejca.2012.11.019; Teng Fei-Fei, 2013, Int J Nanomedicine, V8, P3703, DOI 10.2147/IJN.S51264; Tummers QRJG, 2016, ONCOTARGET, V7, P32144, DOI 10.18632/oncotarget.8282; Tzoumas S, 2014, IEEE T MED IMAGING, V33, P48, DOI 10.1109/TMI.2013.2279994; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Wang DP, 2017, BIOMED OPT EXPRESS, V8, P112, DOI 10.1364/BOE.8.000112; Xie B, 2017, CLIN CANC RES; Yadav V, 2015, PHARMACOL THERAPEUT, V149, P139, DOI 10.1016/j.pharmthera.2014.12.003	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204930	10.1371/journal.pone.0204930	http://dx.doi.org/10.1371/journal.pone.0204930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281669	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400069
J	Yan, XY; Li, Q; Luo, BX; You, TH; Wang, HJ				Yan, Xiao-Ying; Li, Qin; Luo, Bing-Xian; You, Tian-Hui; Wang, Hai-Jun			Trend in the nutritional status of children aged 2-7 years in Luoding city, China: A panel study from 2004 to 2013	PLOS ONE			English	Article							DOUBLE BURDEN; PHYSICAL-ACTIVITY; OVERWEIGHT; UNDERNUTRITION; OVERNUTRITION; OBESITY; GROWTH; INCOME; DIET; CONSEQUENCES	To examine trends in the prevalence of wasting, stunting, overweight, and obesity among children in Luoding, a lower-middle-income city in southern China, we collected height, weight and other information on 65,908 pre-school children aged 2 to 7 years from 23 kindergartens, in which health examinations were conducted annually between 2004 and 2013. We used the growth standards of the World Health Organization (WHO) to calculate Z-scores for height and body mass index (BMI), and used the cut-offs recommended by WHO to define wasting, stunting, overweight, and obesity for each child. From 2004 to 2013, the prevalence of overweight increased from 3.70% to 7.27% and of obesity increased from 1.04% to 2.08%. Meanwhile, the prevalence of wasting decreased from 0.91% to 0.72% and of stunting decreased from 9.29% to 5.22%. These trends suggest there was still a double burden of nutritional status there. The nutritional interventions focusing on pre-school children should be comprehensively elaborated in lower-middle-income areas such as Luoding.	[Yan, Xiao-Ying; You, Tian-Hui] Guangdong Pharmaceut Univ, Sch Nursing, Guangzhou, Guangdong, Peoples R China; [Li, Qin; Wang, Hai-Jun] Peking Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Beijing, Peoples R China; [Luo, Bing-Xian] Luoding City Maternal & Child Hlth Care Hosp, Yunfu, Peoples R China	Guangdong Pharmaceutical University; Peking University	Wang, HJ (corresponding author), Peking Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Beijing, Peoples R China.	whjun1@bjmu.edu.cn	Li, Qin/M-1155-2018; Li, Qin/AAS-9349-2021; Wang, Haijun/AAD-1302-2021	Li, Qin/0000-0002-8633-8859; Li, Qin/0000-0002-8633-8859; Wang, Haijun/0000-0003-0849-2903; You, Tianhui/0000-0002-8499-3809	National Natural Science Foundation of China [81573170]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Data analyses of the present study were supported by a grant from National Natural Science Foundation of China (grant number 81573170) to H-JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2014, OBES REV, V15, P49, DOI 10.1111/obr.12123; Baird J, 2005, BMJ-BRIT MED J, V331, DOI [10.1136/bmj.38586.411273.EO, DOI 10.1136/BMJ.38586.411273.EO]; Nguyen BKL, 2013, BRIT J NUTR, V110, pS45, DOI 10.1017/S0007114513002080; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P142, DOI 10.1017/S1368980011001315; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Li Xiao-Qiang, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P289; Ng SW, 2014, OBES REV, V15, P27, DOI 10.1111/obr.12127; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Olsen EO, 2017, AM J PUBLIC HEALTH, V107, P1116, DOI 10.2105/AJPH.2017.303761; Piernas C, 2015, EUR J CLIN NUTR, V69, P1323, DOI 10.1038/ejcn.2015.106; Skouteris H, 2010, OBES REV, V11, P757, DOI 10.1111/j.1467-789X.2010.00806.x; Song Y, 2012, ZHONGHUA YU FANG YI, V46, P789; Tzioumis E, 2014, FOOD NUTR BULL, V35, P230, DOI 10.1177/156482651403500210; Uauy R., 2004, OBES REV S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; United Nations Children's Fund World Health Organization The World Bank, 2012, UNICEF WHO WORLD BAN; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wang ZH, 2008, ASIA PAC J CLIN NUTR, V17, P123; WHO, 2006, WHO CHILD GROWTH STA; Xiao YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134466; Zhai FY, 2014, OBES REV, V15, P16, DOI 10.1111/obr.12124; Zhang C, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0157000, 10.1371/journal.pone.0162830, 10.1371/journal.pone.0158119]; Zhang Xin, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P781; Zhang YQ, 2017, AM J PHYS ANTHROPOL, V163, P497, DOI 10.1002/ajpa.23224; Zhang YX, 2015, INT J CARDIOL, V184, P380, DOI 10.1016/j.ijcard.2015.02.076; Zong XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046942	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205163	10.1371/journal.pone.0205163	http://dx.doi.org/10.1371/journal.pone.0205163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281659	gold, Green Submitted, Green Published			2022-12-26	WOS:000446342400086
J	Munoz-Galvan, S; Lucena-Cacace, A; Perez, M; Otero-Albiol, D; Gomez-Cambronero, J; Carnero, A				Munoz-Galvan, Sandra; Lucena-Cacace, Antonio; Perez, Marco; Otero-Albiol, Daniel; Gomez-Cambronero, Julian; Carnero, Amancio			Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment	ONCOGENE			English	Article							PHOSPHOLIPASE D2 PLD2; NUCLEOTIDE EXCHANGE; CANCER-CELLS; ACTIVATION; FIBROBLASTS; INVASION; GROWTH; IDENTIFICATION; TRANSFORMATION; TUMORIGENESIS	Cancer cells are in continuous communication with the surrounding microenvironment and this communication can affect tumor evolution. In this work, we show that phospholipase D2 (PLD2) was overexpressed in colon tumors and is secreted by cancer cells, inducing senescence in neighboring fibroblasts. This occurs through its lipase domain. Senescence induced by its product, phosphatidic acid, leads to a senescence-associated secretory phenotype (SASP) able to increase the stem properties of cancer cells. This increase in stemness occurs by Wnt pathway activacion. This closes a feedback loop in which senescence acts as a crosspoint for the generation of CSCs mediated by phospholipid metabolism. We also demonstrate the connexion of both phenomena in mouse models in vivo showing that a high PLD2 expression increased stemness and tumorigenesis. Thus, the patients with colon cancer show high levels of PLD2 and SASP factor genes expression correlating with Wnt pathway activation. Therefore, we demonstrate that tumor cell-secreted PLD2 contributes to tumor development by modifying the microenvironment, making it a possible therapeutic target for cancer treatment. This mechanism may also explain the high levels of Wnt pathway activation in colon cancer.	[Munoz-Galvan, Sandra; Lucena-Cacace, Antonio; Perez, Marco; Otero-Albiol, Daniel; Carnero, Amancio] Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, CSIC,IBIS, Avda Manuel Siurot S-N, Seville 41013, Spain; [Munoz-Galvan, Sandra; Lucena-Cacace, Antonio; Perez, Marco; Otero-Albiol, Daniel; Carnero, Amancio] Inst Salud Carlos III, CIBER CANC, Madrid, Spain; [Gomez-Cambronero, Julian] Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Instituto de Salud Carlos III; University System of Ohio; Wright State University Dayton	Carnero, A (corresponding author), Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, CSIC,IBIS, Avda Manuel Siurot S-N, Seville 41013, Spain.; Carnero, A (corresponding author), Inst Salud Carlos III, CIBER CANC, Madrid, Spain.	acarnero-ibis@us.es	Muñoz-Galván, Sandra/K-5827-2015	Carnero, Amancio/0000-0003-4357-3979; Lucena-Cacace, Antonio/0000-0002-1181-2683; Gomez-Cambronero, Julian/0000-0002-7581-9227; Munoz-Galvan, Sandra/0000-0003-0579-325X	ISCIII-Red de Biobancos [PT13/0010/0056]; ISCIII [CD16/00230]; Spanish Ministry of Economy and Competitivity, Plan Estatal de I + D + I 2013-2016, ISCIII [Fis: PI15/00045]; CIBER de Cancer [CD16/12/00275]; FEDER from Regional Development European Funds (European Union); Consejeria de Ciencia e Innovacion [CTS-1848]; Consejeria de Salud of the Junta de Andalucia [PI-0397-2017]; Fundacion BBVA; AECC Foundation; NIH [HL056653-14]	ISCIII-Red de Biobancos; ISCIII(Instituto de Salud Carlos III); Spanish Ministry of Economy and Competitivity, Plan Estatal de I + D + I 2013-2016, ISCIII; CIBER de Cancer; FEDER from Regional Development European Funds (European Union); Consejeria de Ciencia e Innovacion; Consejeria de Salud of the Junta de Andalucia(Junta de Andalucia); Fundacion BBVA(BBVA Foundation); AECC Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the donors, the HUVR-IBiS Biobank (Andalusian Public Health System Biobank and ISCIII-Red de Biobancos PT13/0010/0056) for the human specimens used in this study, Carolina Castilla for the assistance with IHC assays and Carmen Saez for histological analyses. SM-G was supported by a Sara Borrell grant from ISCIII (CD16/00230). AC lab was supported by grants from the Spanish Ministry of Economy and Competitivity, Plan Estatal de I + D + I 2013-2016, ISCIII (Fis: PI15/00045), and CIBER de Cancer (CD16/12/00275), co-funded by FEDER from Regional Development European Funds (European Union), Consejeria de Ciencia e Innovacion (CTS-1848), and Consejeria de Salud of the Junta de Andalucia (PI-0397-2017). This work was also supported by Fundacion BBVA. Especial thanks to the AECC Foundation for supporting this work. JG-C is supported by Grant HL056653-14 from the NIH.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010; CARNERO A, 1994, J CELL BIOCHEM, V54, P478, DOI 10.1002/jcb.240540415; CARNERO A, 1994, ONCOGENE, V9, P1387; CARNERO A, 1995, MOL CELL BIOL, V15, P1094; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Ferrer I, 2016, ONCOGENE, V35, P2777, DOI 10.1038/onc.2015.341; Foster DA, 2003, MOL CANCER RES, V1, P789; Frankel P, 1999, BIOCHEM BIOPH RES CO, V255, P502, DOI 10.1006/bbrc.1999.0234; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; Gomez-Cambronero J, 2014, J BIOL CHEM, V289, P22557, DOI 10.1074/jbc.R114.574152; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Henkels KM, 2011, J MOL BIOL, V408, P850, DOI 10.1016/j.jmb.2011.03.017; Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225; Jeon H, 2011, CELL SIGNAL, V23, P1320, DOI 10.1016/j.cellsig.2011.03.014; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012109; Kang DW, 2010, CANCER RES, V70, P4233, DOI 10.1158/0008-5472.CAN-09-3470; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Lee YH, 2014, FEBS LETT, V588, P3251, DOI 10.1016/j.febslet.2014.07.009; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; Mahankali M, 2012, J BIOL CHEM, V287, P41417, DOI 10.1074/jbc.M112.383596; Mahankali M, 2011, P NATL ACAD SCI USA, V108, P19617, DOI 10.1073/pnas.1114692108; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nakamura T, 1997, CANCER RES, V57, P3305; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oshimoto H, 2003, ONCOL RES, V14, P31, DOI 10.3727/000000003108748586; Park JB, 2012, NAT REV CANCER, V12, P782, DOI 10.1038/nrc3379; Perez M, 2016, ONCOTARGET, V7, P33111, DOI 10.18632/oncotarget.8880; Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Saito M, 2007, ONCOL REP, V18, P1329; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SONG JG, 1991, MOL CELL BIOL, V11, P4903, DOI 10.1128/MCB.11.10.4903; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Tsuyada A, 2012, CANCER RES, V72, P2768, DOI 10.1158/0008-5472.CAN-11-3567; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; VENABLE ME, 1994, J BIOL CHEM, V269, P26040; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Xu LZ, 2003, MOL CELL BIOL, V23, P645, DOI 10.1128/MCB.23.2.645-654.2003; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	53	24	24	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2019	38	8					1309	1323		10.1038/s41388-018-0527-2	http://dx.doi.org/10.1038/s41388-018-0527-2			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HM1XR	30305726				2022-12-26	WOS:000459249800012
J	Bielsa, B; Hewitt, S; Reyes-Chin-Wo, S; Dhingra, A; Rubio-Cabetas, MJ				Bielsa, Beatriz; Hewitt, Seanna; Reyes-Chin-Wo, Sebastian; Dhingra, Amit; Jose Rubio-Cabetas, Maria			Identification of water use efficiency related genes in 'Garnem' almond-peach rootstock using time-course transcriptome analysis	PLOS ONE			English	Article							REACTIVE OXYGEN-METABOLISM; GENOME-WIDE IDENTIFICATION; ABIOTIC STRESS RESPONSES; DROUGHT STRESS; LEA GENES; RNA-SEQ; EXPRESSION; TOLERANCE; PRUNUS; ARABIDOPSIS	Drought is one of the main abiotic stresses with far-reaching ecological and socioeconomic impacts, especially in perennial food crops such as Prunus. There is an urgent need to identify drought resilient rootstocks that can adapt to changes in water availability. In this study, we tested the hypothesis that PEG-induced water limitation stress will simulate drought conditions and drought-related genes, including transcription factors (TFs), will be differentially expressed in response to this stress. 'Garnem' genotype, an almond x peach hybrid [P. amygdalus Batsch, syn P. dulcis (Mill.) x P. persica (L.) Batsch] was exposed to PEG-6000 solution, and a time-course transcriptome analysis of drought-stressed roots was performed at 0, 2 and 24 h time points post-stress. Transcriptome analysis resulted in the identification of 12,693 unique differentially expressed contigs (DECs) at the 2 h time point, and 7,705 unique DECs at the 24 h time point after initiation of the drought treatment. Interestingly, three drought-induced genes, directly related to water use efficiency (WUE) namely, ERF023 TF; LRR receptor-like serine/threonine-kinase ERECTA; and NF-YB3TF, were found induced under stress. The RNAseq results were validated with quantitative RT-PCR analysis of eighteen randomly selected differentially expressed contigs (DECs). Pathway analysis in the present study provides valuable information regarding metabolic events that occur during stress-induced signalling in 'Garnem' roots. This information is expected to be useful in understanding the potential mechanisms underlying drought stress responses and drought adaptation strategies in Prunus species.	[Bielsa, Beatriz; Jose Rubio-Cabetas, Maria] Agrifood Res & Technol Ctr Aragon CITA, Hortofruticulture Dept, Zaragoza, Spain; [Hewitt, Seanna; Dhingra, Amit] Washington State Univ, Mol Plant Sci, Pullman, WA 99164 USA; [Hewitt, Seanna; Dhingra, Amit] Washington State Univ, Dept Hort, Pullman, WA 99164 USA; [Reyes-Chin-Wo, Sebastian] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	Washington State University; Washington State University; University of California System; University of California Davis	Rubio-Cabetas, MJ (corresponding author), Agrifood Res & Technol Ctr Aragon CITA, Hortofruticulture Dept, Zaragoza, Spain.; Dhingra, A (corresponding author), Washington State Univ, Mol Plant Sci, Pullman, WA 99164 USA.; Dhingra, A (corresponding author), Washington State Univ, Dept Hort, Pullman, WA 99164 USA.	adhingra@wsu.edu; mjrubioc@cita-aragon.es	Bielsa, Beatriz/R-1068-2018; Dhingra, Amit/AAX-9566-2020; Rubio-Cabetas, Maria Jose/R-8120-2018	Bielsa, Beatriz/0000-0002-4614-1592; Dhingra, Amit/0000-0002-4464-2502; Rubio-Cabetas, Maria Jose/0000-0002-3455-0145	Instituto Nacional de Investigacion y Tecnologia Agraria (INIA) [RTA2014-00062]; Research Group of Aragon, Spain; FPI-INIA; Washington State University Agriculture Center Research Hatch Grant [WNP00677]; ARCS Seattle Chapter; National Institutes of Health/National Institute of General Medical Sciences [T32-GM008336]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	Instituto Nacional de Investigacion y Tecnologia Agraria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); Research Group of Aragon, Spain; FPI-INIA; Washington State University Agriculture Center Research Hatch Grant; ARCS Seattle Chapter; National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by RTA2014-00062 from the Instituto Nacional de Investigacion y Tecnologia Agraria (INIA) and by the Research Group A12 of Aragon, Spain. We kindly appreciate the FPI-INIA 2012 grant for B. Bielsa. Work in the Dhingra lab was supported by Washington State University Agriculture Center Research Hatch Grant WNP00677 to AD. SLH acknowledges the support received from ARCS Seattle Chapter and National Institutes of Health/National Institute of General Medical Sciences through an institutional training grant award T32-GM008336. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the NIGMS or NIH.	Alimohammadi A, 2013, SCI HORTIC-AMSTERDAM, V159, P19, DOI 10.1016/j.scienta.2013.04.023; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bassett CL, 2009, PLANTA, V230, P107, DOI 10.1007/s00425-009-0927-1; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Bian YW, 2017, SCI REP-UK, V7, DOI 10.1038/srep46183; Bielsa B, 2014, SCI HORTIC-AMSTERDAM, V168, P108, DOI 10.1016/j.scienta.2014.01.028; Bielsa B, 2016, SCI HORTIC-AMSTERDAM, V213, P260, DOI 10.1016/j.scienta.2016.11.006; Blauer JM, 2013, POSTHARVEST BIOL TEC, V78, P76, DOI 10.1016/j.postharvbio.2012.12.009; Blum A, 2009, FIELD CROP RES, V112, P119, DOI 10.1016/j.fcr.2009.03.009; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Byrne DH, 2012, HANDB PLANT BREED, V8, P505, DOI 10.1007/978-1-4419-0763-9_14; Cao QH, 2016, TROP PLANT BIOL, V9, P63, DOI 10.1007/s12042-016-9162-7; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui FQ, 2016, MOL PLANT, V9, P926, DOI 10.1016/j.molp.2016.04.001; De Almeida Silva M., 2012, PLANT BREEDING ABIOT, P87, DOI [10.1007/978-3-642-30553-5_6, DOI 10.1007/978-3-642-30553-5_]; Dhanyalakshmi KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151323; Du DL, 2013, MOL BIOL REP, V40, P1937, DOI 10.1007/s11033-012-2250-3; Felipe AJ, 2009, HORTSCIENCE, V44, P196, DOI 10.21273/HORTSCI.44.1.196; Fernandez-Bautista N, 2017, PLANT CELL ENVIRON, V40, P1341, DOI 10.1111/pce.12927; Fracasso A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0800-x; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Gong PJ, 2010, J EXP BOT, V61, P3563, DOI 10.1093/jxb/erq167; Guo P, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2064-3; Guo XY, 2017, PLANT CELL TISS ORG, V129, P469, DOI 10.1007/s11240-017-1192-9; Gusberti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078457; Han R, 2018, RUSS J PLANT PHYSL+, V65, P404, DOI 10.1134/S1021443718030123; Han X, 2013, J EXP BOT, V64, P4589, DOI 10.1093/jxb/ert262; Hao PC, 2015, PROTEOMICS, V15, P1544, DOI 10.1002/pmic.201400179; Houston K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00984; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Jiang YZ, 2014, J EXP BOT, V65, P6629, DOI 10.1093/jxb/eru381; Jiao Y, 2017, J PLANT BIOCHEM BIOT, V26, P141, DOI 10.1007/s13562-016-0374-6; Arismendi MJ, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0838-1; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kim S, 2004, PLANT PHYSIOL, V136, P3639, DOI 10.1104/pp.104.049189; Ksouri N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01715; Lackman P, 2011, P NATL ACAD SCI USA, V108, P5891, DOI 10.1073/pnas.1103010108; Lambers H, 2008, PLANT PHYSL ECOLOGY, P154, DOI DOI 10.1007/978-0-387-78341-3; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Layne R. E. C., 1987, ROOTSTOCKS FRUIT CRO, P185; Lecouls AC, 2004, MOL BREEDING, V13, P113, DOI 10.1023/B:MOLB.0000018758.56413.cf; Lee DK, 2017, PLANT SIGNAL BEHAV, V12, DOI 10.1080/15592324.2016.1268311; Lee S, 2001, AM J BOT, V88, P150, DOI 10.2307/2657135; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Li Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01477; Lind C, 2015, CURR BIOL, V25, P928, DOI 10.1016/j.cub.2015.01.067; Liu ZS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0511-8; LOESCHER WH, 1992, PLANT PHYSIOL, V98, P1396, DOI 10.1104/pp.98.4.1396; Lugassi N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01114; Magalhaes AP, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01195; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; MICHEL BE, 1973, PLANT PHYSIOL, V51, P914, DOI 10.1104/pp.51.5.914; Mishra G, 2006, SCIENCE, V312, P264, DOI 10.1126/science.1123769; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakashima K, 2013, PLANT CELL REP, V32, P959, DOI 10.1007/s00299-013-1418-1; Negin B, 2016, PLANT SCI, V251, P82, DOI 10.1016/j.plantsci.2016.05.007; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Noctor G, 2014, PLANT PHYSIOL, V164, P1636, DOI 10.1104/pp.113.233478; Padmalatha KV, 2012, PLANT MOL BIOL, V78, P223, DOI 10.1007/s11103-011-9857-y; Pan L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00519; Park CJ, 2015, PLANT PATHOLOGY J, V31, P323, DOI 10.5423/PPJ.RW.08.2015.0150; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rai GK, 2013, PLANT PHYSIOL BIOCH, V69, P90, DOI 10.1016/j.plaphy.2013.05.002; Rehder A., 1940, MANUAL CULTIVATED TR, V2nd; Roychoudhury A, 2013, PLANT CELL REP, V32, P985, DOI 10.1007/s00299-013-1414-5; Salzman RA, 1999, PLANT MOL BIOL REP, V17, P11, DOI 10.1023/A:1007520314478; SCHOLANDER PF, 1964, P NATL ACAD SCI USA, V52, P119, DOI 10.1073/pnas.52.1.119; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Singh M, 2015, REV ENVIRON SCI BIO, V14, P407, DOI 10.1007/s11157-015-9372-8; Singh M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0404-2; Song LH, 2013, PHYSIOL PLANTARUM, V148, P322, DOI 10.1111/ppl.12013; Tang S, 2015, PLANT MOL BIOL REP, V33, P424, DOI 10.1007/s11105-014-0759-4; Tang S, 2013, PLANT MOL BIOL, V83, P539, DOI 10.1007/s11103-013-0107-3; Tognetti VB, 2012, PLANT CELL ENVIRON, V35, P321, DOI 10.1111/j.1365-3040.2011.02324.x; Tripathi P, 2014, PLANTA, V239, P255, DOI 10.1007/s00425-013-1985-y; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Wang JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124442; Wang X., 2007, ADV MOL BREEDING DRO, P183, DOI [10.1007/978-1-4020-5578-2_8, DOI 10.1007/978-1-4020-5578-2_8]; Wang Y-F, 2016, PLANT CELL, DOI [10.1105/tpc.16.01050, DOI 10.1105/TPC.16.01050]; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watanabe S, 2014, PLANT CELL ENVIRON, V37, P1022, DOI 10.1111/pce.12218; Watanabe S, 2010, FEBS LETT, V584, P1181, DOI 10.1016/j.febslet.2010.02.023; Watkinson JI, 2003, PLANT PHYSIOL, V133, P1702, DOI 10.1104/pp.103.026914; Weidenbach D, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2014.1003752; Xing HT, 2011, PLANTA, V234, P229, DOI 10.1007/s00425-011-1389-9; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang XL, 2015, GENET MOL RES, V14, P8539, DOI 10.4238/2015.July.31.1; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095, DOI 10.1093/oxfordjournals.pcp.a029093; Zeng Ying, 2002, Plant Molecular Biology Reporter, V20, P417, DOI 10.1007/BF02772130; Zhang T, 2015, PLANT PHYSIOL BIOCH, V94, P153, DOI 10.1016/j.plaphy.2015.05.001; Zhao Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005051; Zhou J, 2014, J PLANT RES, V127, P347, DOI 10.1007/s10265-013-0597-8	102	18	19	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205493	10.1371/journal.pone.0205493	http://dx.doi.org/10.1371/journal.pone.0205493			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308016	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500088
J	Abade, L; Cusack, J; Moll, RJ; Strampelli, P; Dickman, AJ; Macdonald, DW; Montgomery, RA				Abade, Leandro; Cusack, Jeremy; Moll, Remington J.; Strampelli, Paolo; Dickman, Amy J.; Macdonald, David W.; Montgomery, Robert A.			Spatial variation in leopard (Panthera pardus) site use across a gradient of anthropogenic pressure in Tanzania's Ruaha landscape	PLOS ONE			English	Article							CARNIVORE CONSERVATION; PROTECTED AREAS; SPACE USE; HABITAT; PREY; MANAGEMENT; CONFLICT; POPULATIONS; LIVESTOCK; SURVIVAL	Understanding large carnivore occurrence patterns in anthropogenic landscapes adjacent to protected areas is central to developing actions for species conservation in an increasingly human-dominated world. Among large carnivores, leopards (Panthera pardus) are the most widely distributed felid. Leopards occupying anthropogenic landscapes frequently come into conflict with humans, which often results in leopard mortality. Leopards' use of anthropogenic landscapes, and their frequent involvement with conflict, make them an insightful species for understanding the determinants of carnivore occurrence across human-dominated habitats. We evaluated the spatial variation in leopard site use across a multiple-use landscape in Tanzania's Ruaha landscape. Our study region encompassed i) Ruaha National Park, where human activities were restricted and sport hunting was prohibited; ii) the Pawaga-Idodi Wildlife Management Area, where wildlife sport hunting, wildlife poaching, and illegal pastoralism all occurred at relatively low levels; and iii) surrounding village lands where carnivores and other wildlife were frequently exposed to human-carnivore conflict related-killings and agricultural habitat conversion and development. We investigated leopard occurrence across the study region via an extensive camera trapping network. We estimated site use as a function of environmental (i.e. habitat and anthropogenic) variables using occupancy models within a Bayesian framework. We observed a steady decline in leopard site use with downgrading protected area status from the national park to the Wildlife Management Area and village lands. Our findings suggest that human-related activities such as increased livestock presence and proximity to human households exerted stronger influence than prey availability on leopard site use, and were the major limiting factors of leopard distribution across the gradient of human pressure, especially in the village lands outside Ruaha National Park. Overall, our study provides valuable information about the determinants of spatial distribution of leopards in human-dominated landscapes that can help inform conservation strategies in the borderlands adjacent to protected areas.	[Abade, Leandro; Strampelli, Paolo; Dickman, Amy J.; Macdonald, David W.; Montgomery, Robert A.] Recanati Kaplan Ctr, Wildlife Conservat Res Unit, Dept Zool, Abingdon, Oxon, England; [Abade, Leandro; Moll, Remington J.; Montgomery, Robert A.] Michigan State Univ, Res Ecol Carnivores & Their Prey Lab, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Cusack, Jeremy] Univ Stirling, Stirling, Scotland	Michigan State University; University of Stirling	Abade, L (corresponding author), Recanati Kaplan Ctr, Wildlife Conservat Res Unit, Dept Zool, Abingdon, Oxon, England.; Abade, L (corresponding author), Michigan State Univ, Res Ecol Carnivores & Their Prey Lab, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	leandrosabade@gmail.com	; Montgomery, Robert A./C-5541-2019	Abade, Leandro/0000-0002-4681-9412; Montgomery, Robert A./0000-0001-5894-0589	CNPq-Brasil [215981/2013-8]; Rufford Foundation; Cleveland Metroparks Zoo/ Cleveland Zoological Society; IdeaWild; Lady Margaret Hall; WildCRU; Ruaha Carnivore Project; UK Natural Environment Research Council; National Science Foundation	CNPq-Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rufford Foundation; Cleveland Metroparks Zoo/ Cleveland Zoological Society; IdeaWild; Lady Margaret Hall; WildCRU; Ruaha Carnivore Project; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Science Foundation(National Science Foundation (NSF))	L.A. was supported by a CNPq-Brasil scholarship (215981/2013-8), and grants by the Rufford Foundation (Rufford Small Grants), Cleveland Metroparks Zoo/ Cleveland Zoological Society, IdeaWild, Lady Margaret Hall, WildCRU, and Ruaha Carnivore Project. J.C. was supported by the UK Natural Environment Research Council, R.J.M. was supported by an National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abade L, 2014, BIOL CONSERV, V180, P241, DOI 10.1016/j.biocon.2014.10.005; Abade L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096261; Alexander JS, 2016, ORYX, V50, P231, DOI 10.1017/S0030605315001027; Allen B.L., 2017, FOOD WEBS, V12, P64, DOI [10.7717/peerj.10738, DOI 10.1016/J.FOOWEB.2017.02.008]; [Anonymous], 2013, QUANTITATIVE FISHERI; [Anonymous], 2005, AFRICAN LEOPARD ECOL; Athreya V, 2016, ORYX, V50, P156, DOI 10.1017/S0030605314000106; Athreya V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142647; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Balme GA, 2013, MAMMAL REV, V43, P221, DOI 10.1111/j.1365-2907.2012.00219.x; Blackburn S, 2016, J APPL ECOL, V53, P1195, DOI 10.1111/1365-2664.12632; Braczkowski AR, 2018, FRONT ECOL ENVIRON, V16, P176, DOI 10.1002/fee.1776; Bruskotter JT, 2014, CONSERV LETT, V7, P158, DOI 10.1111/conl.12072; Burn RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024165; Burton AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038007; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Creel S, 2016, ECOL APPL, V26, P2347, DOI 10.1002/eap.1377; Cusack JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126373; Di Minin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23814; Di Minin E, 2016, TRENDS ECOL EVOL, V31, P99, DOI 10.1016/j.tree.2015.12.006; Dickman AJ., 2015, CONFLICTS CONSERVATI, P30; Dickman AJ, 2014, BIOL CONSERV, V178, P19, DOI 10.1016/j.biocon.2014.07.011; Dolrenry S, 2016, CONSERV BIOL, V30, P467, DOI 10.1111/cobi.12703; Everatt KT, 2015, AFR J WILDL RES, V45, P187, DOI 10.3957/056.045.0187; Fynn RWS, 2016, J APPL ECOL, V53, P388, DOI 10.1111/1365-2664.12591; Gavashelishvili A, 2008, J APPL ECOL, V45, P579, DOI 10.1111/j.1365-2664.2007.01432.x; Gelman A., 2007, DATA ANAL USING REGR; Gese EM, 2001, MONITORING TERRESTRI; Green KE, 2015, J PEASANT STUD, V42, P97, DOI 10.1080/03066150.2014.967686; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hemson G, 2009, BIOL CONSERV, V142, P2718, DOI 10.1016/j.biocon.2009.06.024; Henschel P, 2011, J ZOOL, V285, P11, DOI 10.1111/j.1469-7998.2011.00826.x; Jacobson AP, 2016, PEERJ, V4, DOI 10.7717/peerj.1974; Keane A, 2011, J APPL ECOL, V48, P1164, DOI 10.1111/j.1365-2664.2011.02034.x; Knapp EJ, 2017, CONSERV SOC, V15, P24, DOI 10.4103/0972-4923.201393; Kolowski JM, 2009, J ZOOL, V277, P23, DOI 10.1111/j.1469-7998.2008.00505.x; Kuo L, VARIABLE SELECTION R; LANKFORD BA, 2009, COMPR ASSESS WAT MAN, V8, P171; Lichtenfeld LL, 2015, BIODIVERS CONSERV, V24, P483, DOI 10.1007/s10531-014-0828-x; Lindsey PA, 2017, BIOL CONSERV, V209, P137, DOI 10.1016/j.biocon.2017.01.011; Long RA, 2011, LANDSCAPE ECOL, V26, P327, DOI 10.1007/s10980-010-9547-1; Loveridge AJ, 2017, J APPL ECOL, V54, P815, DOI 10.1111/1365-2664.12794; Loveridge Andrew J., 2010, P283; Macdonald DW, 2016, ANIM BEHAV, V120, P197, DOI 10.1016/j.anbehav.2016.06.013; MacKenzie D. I., 2004, Animal Biodiversity and Conservation, V27, P461; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Moll RJ, 2016, J ZOOL, V300, P177, DOI 10.1111/jzo.12369; NBS, 2013, IR REG SOC EC PROF; Neilson EW, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2092; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Odadi WO, 2017, LAND DEGRAD DEV, V28, P2030, DOI 10.1002/ldr.2725; Oriol-Cotterill A, 2015, ANIM BEHAV, V101, P27, DOI 10.1016/j.anbehav.2014.11.020; Pitman RT, 2014, J ZOOL, V292, P18, DOI 10.1111/jzo.12078; Pitman RT, 2012, J ZOOL, V288, P222, DOI 10.1111/j.1469-7998.2012.00945.x; Pitman RT, 2015, BIODIVERS CONSERV, V24, P1975, DOI 10.1007/s10531-015-0921-9; Plummer M., 2003, P 3 INT WORKSH DISTR, V124, P1; Quinn T.J., 1999, BIOL RES MANAG SER; R Core Team, 2012, R LANG ENV STAT COMP; Ramesh T, 2017, ECOL EVOL, V7, P1964, DOI 10.1002/ece3.2771; Rich LN, 2016, J APPL ECOL, V53, P1225, DOI 10.1111/1365-2664.12650; Ripple WJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160498; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rosenblatt E, 2016, ECOL EVOL, V6, P3772, DOI 10.1002/ece3.2155; Royle J. A., 2008, HIERARCHICAL MODELIN; Seber GA., 1992, REV STAT REV, P129; SOSOVELE H, 2002, SOCIOECONOMIC ROOT C; Stein A, 2016, IUCN RED LIST THREAT; Stewart FEC, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2112; Su Y.-S., 2012, R2JAGS PACKAGE RUNNI; Swanepoel LH, 2013, ANIM CONSERV, V16, P41, DOI 10.1111/j.1469-1795.2012.00566.x; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; TAWIRI, 2007, P 1 TANZ LION LEOP C; TAWIRI, 2009, TANZ CARN CONS ACT P; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; van der Meer E, 2014, ORYX, V48, P285, DOI 10.1017/S0030605312001366; Walsh M, 2000, DEV COMMUNITY WILDLI; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; Wenban-Smith H., 2015, POPULATION GROWTH IN; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Wolf C, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160252; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Woodroffe R, 2015, SCIENCE, V348, P1312, DOI 10.1126/science.aaa8465; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	88	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204370	10.1371/journal.pone.0204370	http://dx.doi.org/10.1371/journal.pone.0204370			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304040	gold, Green Published, Green Submitted			2022-12-26	WOS:000446921100046
J	Bhattacharjee, R; Nwadili, CO; Saski, CA; Paterne, A; Scheffler, BE; Augusto, J; Lopez-Montes, A; Onyeka, JT; Kumar, L; Bandyopadhyay, R				Bhattacharjee, Ranjana; Nwadili, Christian O.; Saski, Christopher A.; Paterne, Agre; Scheffler, Brian E.; Augusto, Joao; Lopez-Montes, Antonio; Onyeka, Joseph T.; Kumar, Lava; Bandyopadhyay, Ranajit			An EST-SSR based genetic linkage map and identification of QTLs for anthracnose disease resistance in water yam (Dioscorea alata L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; COLLETOTRICHUM-GLOEOSPORIOIDES; AFLP MARKERS; CULTIVARS; RICE	Water yam (Dioscorea alata L.) is one of the most important food yams with wide geographical distribution in the tropics. One of the major constraints to water yam production is anthracnose disease caused by a fungus, Colletotrichum gloeosporioides (Penz.). There are no economically feasible solutions as chemical sprays or cultural practices, such as crop rotation are seldom convenient for smallholder farmers for sustainable control of the disease. Breeding for development of durable genetic resistant varieties is known to offer lasting solution to control endemic disease threats to crop production. However, breeding for resistance to anthracnose has been slow considering the biological constraints related to the heterozygous and vegetative propagation of the crop. The development of saturated linkage maps with high marker density, such as SSRs, followed by identification of QTLs can accelerate the speed and precision of resistance breeding in water yam. In a previous study, a total of 1,152 EST-SSRs were developed from >40,000 EST-sequences generated from two D. alata genotypes. A set of 380 EST-SSRs were validated as polymorphic when tested on two diverse parents targeted for anthracnose disease and were used to generate a saturated linkage map. Majority of the SSRs (60.2%) showed Mendelian segregation pattern and had no effect on the construction of linkage map. All 380 EST-SSRs were mapped into 20 linkage groups, and covered a total length of 3229.5 cM. Majority of the markers were mapped on linkage group 1 (LG 1) comprising of 97 EST-SSRs. This is the first genetic linkage map of water yam constructed using EST-SSRs. QTL localization was based on phenotypic data collected over a 3-year period of inoculating the mapping population with the most virulent strain of C. gloeosporioides from West Africa. Based on threshold LOD scores, one QTL was consistently observed on LG 14 in all the three years and average score data. This QTL was found at position interval of 71.1-84.8 cM explaining 68.5% of the total phenotypic variation in the average score data. The high marker density allowed identification of QTLs and association for anthracnose disease, which could be validated in other mapping populations and used in marker-assisted breeding in D. alata improvement programmes.	[Bhattacharjee, Ranjana; Nwadili, Christian O.; Paterne, Agre; Augusto, Joao; Lopez-Montes, Antonio; Kumar, Lava; Bandyopadhyay, Ranajit] IITA, Ibadan, Nigeria; [Nwadili, Christian O.] Michael Okpara Univ Agr, Umudike, Abia State, Nigeria; [Nwadili, Christian O.; Onyeka, Joseph T.] Natl Root Crops Res Inst, Umuahia, Abia State, Nigeria; [Saski, Christopher A.] Clemson Univ, Inst Translat Genom, Genom & Computat Biol Lab, Clemson, SC USA; [Scheffler, Brian E.] USDA ARS, Genom & Bioinformat Res Unit, Stoneville, MS 38776 USA	CGIAR; International Institute of Tropical Agriculture (IITA); Clemson University; United States Department of Agriculture (USDA)	Bhattacharjee, R (corresponding author), IITA, Ibadan, Nigeria.	r.bhattacharjee@cgiar.org	Bhattacharjee, Ranjana/AAN-1979-2020; AGRE, Paterne/ABE-3426-2021	AGRE, Paterne/0000-0003-1231-2530; Scheffler, Brian/0000-0003-1968-8952; Bhattacharjee, Ranjana/0000-0002-5184-5930	USAID-Linkage Grant; CGIAR Research Program - Roots, Tubers and Bananas; USAID-Linkage grant through IITA; CGIAR Research Program on Roots, Tubers and Bananas (CRP-RTB)	USAID-Linkage Grant(United States Agency for International Development (USAID)); CGIAR Research Program - Roots, Tubers and Bananas; USAID-Linkage grant through IITA(United States Agency for International Development (USAID)); CGIAR Research Program on Roots, Tubers and Bananas (CRP-RTB)	This work was supported by USAID-Linkage Grant and CGIAR Research Program - Roots, Tubers and Bananas.; The authors greatly acknowledge the USAID-Linkage grant awarded through IITA to Ranjana Bhattacharjee. Authors would like to acknowledge the CGIAR Research Program on Roots, Tubers and Bananas (CRP-RTB) for additional financial support. Authors would like to acknowledge Drs. Antonio Lopez-Montes and Lava Kumar for providing the mapping population and isolates of C. gloeosporioides for anthracnose disease screening; Christian Nwadili for phenotypic evaluation in the screenhouse; and laboratory personnels from Saski's team for EST-SSR genotyping.	Abang MM, 2005, J PHYTOPATHOL, V153, P137, DOI 10.1111/j.1439-0434.2005.00942.x; Abang MM, 2004, J PHYTOPATHOL, V152, P21, DOI 10.1046/j.1439-0434.2003.00795.x; Abang MM, 2001, P 5 BIENN C AFR CROP, P111; Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; Arnau G, 2009, THEOR APPL GENET, V118, P1239, DOI 10.1007/s00122-009-0977-6; Asiedu R., 1998, FOOD YAMS ADV RES, P63; Beavis W. D., 1994, P 49 ANN CORN SORGH, P250; Bhattacharjee R., 2011, WILD CROP RELATIVES, P71, DOI [10.1007/978-3-642-21102-7_4, DOI 10.1007/978-3-642-21102-7_4]; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chartrain L, 2004, PHYTOPATHOLOGY, V94, P497, DOI 10.1094/PHYTO.2004.94.5.497; Chen H, 2003, P NATL ACAD SCI USA, V100, P2544, DOI 10.1073/pnas.0437898100; Frezal L, 2003, 7 INT C PLANT DIS 3; Frezal L., 2005, THESIS; Green K. R., 2000, Tropical Science, V40, P132; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Jacqua G, 2005, METHODES APPRECIATIO, P139; Kamal Sharma, 2013, African Journal of Biotechnology, V12, P1894; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lashermes P, 2001, GENOME, V44, P589, DOI 10.1139/gen-44-4-589; Li Q, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P402, DOI 10.3115/v1/p14-1038; Mc Donald FD, 1998, TROP AGR, V75, P53; McDonald BA, 2002, EUPHYTICA, V124, P163, DOI 10.1023/A:1015678432355; Mignouna HD, 2002, ANN APPL BIOL, V141, P61, DOI 10.1111/j.1744-7348.2002.tb00195.x; Mignouna HD, 2002, THEOR APPL GENET, V105, P726, DOI 10.1007/s00122-002-0912-6; Narina SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-100; Ngeve, 2001, ROOT CROPS 21 CENTUR, P613; Nwadili CO, 2017, PLANT DIS, V101, P209, DOI 10.1094/PDIS-06-16-0924-RE; Onyeka TJ, 2006, PLANT PATHOL, V55, P671, DOI 10.1111/j.1365-3059.2006.01436.x; Onyeka TJ, 2005, IOBC WPRS B, V28, P51; Petro D, 2011, EUPHYTICA, V179, P405, DOI 10.1007/s10681-010-0338-1; Sartie A., 2014, African Journal of Biotechnology, V13, P2807; SAS Institute, 2011, SAS SYST WIND VERS 9; Saski CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134031; Sharma K, 2009, 15 TRIENN S INT SOC, P104; Siqueira MVBM, 2012, HORTIC BRAS, V30, P653, DOI 10.1590/S0102-05362012000400015; Talukder ZI, 2004, NEW PHYTOL, V162, P197, DOI 10.1111/j.1469-8137.2004.01010.x; Tamiru M, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0419-x; Terauchi R, 1999, GENOME, V42, P752, DOI 10.1139/gen-42-4-752; THOMAS WTB, 1995, THEOR APPL GENET, V91, P1037, DOI 10.1007/BF00223917; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Waldbieser GC, 2003, BIOTECHNIQUES, V35, P976, DOI 10.2144/03355st05; WINCH JE, 1984, PLANT PATHOL, V33, P467, DOI 10.1111/j.1365-3059.1984.tb02870.x	43	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0197717	10.1371/journal.pone.0197717	http://dx.doi.org/10.1371/journal.pone.0197717			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303959	gold, Green Published, Green Submitted			2022-12-26	WOS:000446921100005
J	Rosas-Hernandez, MP; Hernandez-Camacho, CJ; Gonzalez-Rodriguez, E; Aurioles-Gamboa, D				Rosas-Hernandez, Martha P.; Hernandez-Camacho, Claudia J.; Gonzalez-Rodriguez, Eduardo; Aurioles-Gamboa, David			Vibrissa growth rate in California sea lions based on environmental and isotopic oscillations	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; STABLE-ISOTOPES; FORAGING STRATEGIES; PHOCA-VITULINA; FUR SEALS; ECOLOGY; DIET; PATTERNS; TURNOVER; RATIOS	Pinniped vibrissae provide information on changes in diet at seasonal and annual scales; however, species-specific growth patterns must first be determined in order to interpret these data. In this study, a simple linear model was used to estimate the growth rate of vibrissae from adult female California sea lions (Zalophus californianus) from San Esteban Island in the Gulf of California, Mexico. The delta N-15 and delta C-13 values do not display a marked oscillatory pattern that would permit direct determination of the time period contained in each vibrissa; thus, time (age) was calculated in two ways: 1) based on the correlation between the observed number of peaks (Fourier series) in the delta N-15 profile and the length of each vibrissa, and 2) through direct comparison with the observed number of peaks in the delta N-15 profile. Cross-correlation confirmed that the two peaks in the delta N-15 profile reflected the two peaks in the chlorophyll-a concentration recorded annually around the island. The mean growth rate obtained from the correlation was 0.08 +/- 0.01 mm d(-1), while that calculated based on the observed number of peaks was 0.10 +/- 0.05 mm d(-1). Both are consistent with the rates reported for adult females of other otariid species (0.07 to 0.11 mm d(-1)). Vibrissa growth rates vary by individual, age, sex, and species; moreover, small differences in the growth rate can result in significant differences over the time periods represented by the isotopic signal. Thus, it is important to assess this parameter on a species-by-species basis.	[Rosas-Hernandez, Martha P.; Hernandez-Camacho, Claudia J.; Aurioles-Gamboa, David] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Lab Ecol Pinnipedos Burney J Le Boeuf, La Paz, Bcs, Mexico; [Gonzalez-Rodriguez, Eduardo] Ctr Invest Cient & Educ Super Ensenada, Unidad La Paz, La Paz, Bcs, Mexico	Instituto Politecnico Nacional - Mexico; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Hernandez-Camacho, CJ (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Lab Ecol Pinnipedos Burney J Le Boeuf, La Paz, Bcs, Mexico.	cjhernandez78@gmail.com	Camacho, Claudia J. Hernández/Q-8914-2018; Rosas-Hernández, Martha P/F-3566-2019	Camacho, Claudia J. Hernández/0000-0002-6309-9728; Rosas-Hernández, Martha P/0000-0002-9725-0713	Instituto Politecnico Nacional (IPN; National Polytechnic Institute) [SIP 20101451, SIP 20110297, SIP 20110299, SIP 20120069, SIP 20120363]; Consejo Nacional de Ciencia y Tecnologia (CONACyT; National Council of Science and Technology) [132415]; Centro de Investigacion Cientifica y de Educacion Superior de Ensenada, Unidad La Paz (Ensenada Center for Scientific Research and Higher Education, La Paz Unit) [691110]; CONACyT [389196]; Programa Institucional de Formacion de Investigadores del IPN (PIFI; Institutional Research Training Program); Comision de Operacion y Fomento de Actividades Academicas (COFAA; Commission for the Operation and Promotion of Academic Activities)	Instituto Politecnico Nacional (IPN; National Polytechnic Institute); Consejo Nacional de Ciencia y Tecnologia (CONACyT; National Council of Science and Technology)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Centro de Investigacion Cientifica y de Educacion Superior de Ensenada, Unidad La Paz (Ensenada Center for Scientific Research and Higher Education, La Paz Unit); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa Institucional de Formacion de Investigadores del IPN (PIFI; Institutional Research Training Program); Comision de Operacion y Fomento de Actividades Academicas (COFAA; Commission for the Operation and Promotion of Academic Activities)	The authors thank the Instituto Politecnico Nacional (IPN; National Polytechnic Institute) for financial support for projects SIP 20101451 (DAG), SIP 20110297 (DAG), SIP 20110299 (CJHC), SIP 20120069 (CJHC), and SIP 20120363 (DAG). We also thank the Consejo Nacional de Ciencia y Tecnologia (CONACyT; National Council of Science and Technology) and the Centro de Investigacion Cientifica y de Educacion Superior de Ensenada, Unidad La Paz (Ensenada Center for Scientific Research and Higher Education, La Paz Unit) for financial support for projects 132415 (CJHC) and 691110 (EGR) respectively. We thank CONACyT 389196 (MPRH), the Programa Institucional de Formacion de Investigadores del IPN (PIFI; Institutional Research Training Program) (MPRH), and the Comision de Operacion y Fomento de Actividades Academicas (COFAA; Commission for the Operation and Promotion of Academic Activities) for funding to develop this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnau i Gras Jaume, 2001, DISENOS SERIES TEMPO; Baker BM, 2012, P NATL ACAD SCI USA, V109, P14176, DOI 10.1073/pnas.1206962109; Bearhop S, 2004, P ROY SOC B-BIOL SCI, V271, pS215, DOI 10.1098/rsbl.2003.0129; Beltran RS, 2015, MAR ECOL PROG SER, V523, P243, DOI 10.3354/meps11176; Bender DA, 2012, AMINO ACID METABIS; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; Delgadillo-Hinojosa F, 2001, MAR CHEM, V75, P109, DOI 10.1016/S0304-4203(01)00028-7; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Gonzalez-Rodriguez E., 2015, OPEN J SYSTEMS, V5, P604, DOI 10.4236/ojs.2015.56062; Gonzalez-Suarez M, 2009, MOL ECOL, V18, P1088, DOI 10.1111/j.1365-294X.2009.04093.x; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Greaves DK, 2004, MAR MAMMAL SCI, V20, P296, DOI 10.1111/j.1748-7692.2004.tb01158.x; Hall-Aspland SA, 2005, MAR ECOL PROG SER, V305, P249, DOI 10.3354/meps305249; Hernandez-Camacho CJ., 2001, TABLA VIDA LOBO MARI; HEVESY G, 1951, EXPERIENTIA, V7, P144, DOI 10.1007/BF02156152; Hirons AC, 2001, CAN J ZOOL, V79, P1053, DOI 10.1139/z01-055; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; Kernaleguen L, 2016, OECOLOGIA, V180, P657, DOI 10.1007/s00442-015-3407-2; Kernaleguen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032916; Kurle CM, 2001, OECOLOGIA, V126, P254, DOI 10.1007/s004420000518; Lewis R, 2006, P ROY SOC B-BIOL SCI, V273, P2901, DOI 10.1098/rspb.2006.3642; Lluch-Cota SE., 2004, PICES SPECIAL PUBLIC, P194; McHuron EA, 2016, OECOLOGIA, V182, P995, DOI 10.1007/s00442-016-3732-0; McHuron EA, 2016, MAR ECOL PROG SER, V554, P213, DOI 10.3354/meps11793; Melin SR, 2000, MAR MAMMAL SCI, V16, P169, DOI 10.1111/j.1748-7692.2000.tb00911.x; Mote-Herrera S., 2011, O 13C O 15N VIBRISAS; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; O'Reilly CM, 2002, LIMNOL OCEANOGR, V47, P306, DOI 10.4319/lo.2002.47.1.0306; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rea LD, 2015, MAR MAMMAL SCI, V31, P1213, DOI 10.1111/mms.12221; Rigler F., 1975, UNIFYING CONCEPTS EC, P15; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Rogers TL, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1449; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Sadou MC, 2014, AQUAT MAMM, V40, P213, DOI 10.1578/AM.40.2.2014.213; SCHELL DM, 1989, MAR BIOL, V103, P433, DOI 10.1007/BF00399575; Schimel D.S., 1993, THEORY APPL TRACERS; Schramm Y, 2009, MAR BIOL, V156, P1375, DOI 10.1007/s00227-009-1178-1; Sigman DM, 1997, MAR CHEM, V57, P227, DOI 10.1016/S0304-4203(97)00009-1; Szteren D, 2011, CIENC MAR, V37, P349, DOI 10.7773/cm.v37i3.1818; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Villegas-Amtmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023166; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x; Zanden M. Jake Vander, 1999, Ecology (Washington D C), V80, P1395, DOI 10.1890/0012-9658(1999)080[1395:PCCANA]2.0.CO;2; Zhao LY, 2004, MAR ECOL PROG SER, V281, P267, DOI 10.3354/meps281267	52	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204641	10.1371/journal.pone.0204641	http://dx.doi.org/10.1371/journal.pone.0204641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304057	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100060
J	Duthen, S; Rochat, C; Kleiber, D; Violleau, F; Dayde, J; Raynaud, C; Levasseur-Garcia, C				Duthen, Simon; Rochat, Chloe; Kleiber, Didier; Violleau, Frederic; Dayde, Jean; Raynaud, Christine; Levasseur-Garcia, Cecile			Physicochemical characterization and study of molar mass of industrial gelatins by AsFlFFF-UV/MALS and chemometric approach	PLOS ONE			English	Article							FIELD-FLOW FRACTIONATION; SIZE-EXCLUSION CHROMATOGRAPHY; NEAR-INFRARED SPECTROSCOPY; ANGLE LIGHT-SCATTERING; FISH GELATIN; MACROMOLECULES; AGGREGATION; DEGRADATION; TEMPERATURE; SEPARATION	Industrial gelatins have different physicochemical properties that mainly depend of the raw materials origin and the extraction conditions. These properties are closely related to the molar mass distribution of these gelatins. Several methods exist to characterize molar mass distribution of polymer, including the Asymmetrical Flow Field Flow Fractionation method. The goal of this study is to analyze the relationship between physicochemical properties and the gelatins molar mass distribution obtained by Asymmetrical Flow Field Flow Fractionation. In this study, 49 gelatins samples extracted from pig skin are characterized in terms of gel strength and viscosity and their molar mass distribution are analyzed by Asymmetrical Flow Field Flow Fractionation coupled to an Ultraviolet and Multi Angle Light Scattering detector. This analytical method is an interesting tool for studying, simultaneously, the primary chains and the high-molar-mass fraction corresponding to the polymer chains. Correlation analysis between molar mass distribution data from the different fractions highlights the importance of high molar mass polymer chains to explain the gel strength and viscosity of gelatins. These results are confirmed by an additional chemometric approach based on the UV absorbance of gelatin fractograms to predict gel strength (r(2)Cal = 0.85) and viscosity (r(2)Cal = 0.79).	[Duthen, Simon; Rochat, Chloe; Kleiber, Didier; Violleau, Frederic; Dayde, Jean; Levasseur-Garcia, Cecile] Univ Toulouse, INP PURPAN, Lab Physiol Pathol & Genet Vegetales PPGV, Toulouse, France; [Duthen, Simon; Violleau, Frederic; Raynaud, Christine; Levasseur-Garcia, Cecile] Univ Toulouse, INP Purpan, INRA, INPT,LCA, Toulouse, France; [Raynaud, Christine] INPT, Ctr Applicat & Traitement Agroressources CATAR, Toulouse, France	Universite de Toulouse; INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Levasseur-Garcia, C (corresponding author), Univ Toulouse, INP PURPAN, Lab Physiol Pathol & Genet Vegetales PPGV, Toulouse, France.; Levasseur-Garcia, C (corresponding author), Univ Toulouse, INP Purpan, INRA, INPT,LCA, Toulouse, France.	cecile.levasseur@purpan.fr	Raynaud, Christine/Q-7648-2019	Raynaud, Christine/0000-0001-7913-6653	Region Midi-Pyrenees (France) [DESR/12050967]	Region Midi-Pyrenees (France)(Region Occitanie)	This study was supported by Grant no. DESR/12050967 from the Region Midi-Pyrenees (France).	Agelet LE, 2010, CRIT REV ANAL CHEM, V40, P246, DOI 10.1080/10408347.2010.515468; [Anonymous], 2002, 12092 NF EN; Babel W, 2000, ULLMANNS ENCY IND CH; BERTRAND D, 2006, COLLECTION SCI TECHN; Choi SS, 2000, J FOOD SCI, V65, P194, DOI 10.1111/j.1365-2621.2000.tb15978.x; Duconseille A, 2015, FOOD HYDROCOLLOID, V43, P360, DOI 10.1016/j.foodhyd.2014.06.006; Dupont AL, 2002, J CHROMATOGR A, V950, P113, DOI 10.1016/S0021-9673(02)00010-9; El Harfaoui N., 2007, THESIS, V7; Eysturskard J, 2009, FOOD HYDROCOLLOID, V23, P1702, DOI 10.1016/j.foodhyd.2009.01.008; Fraunhofer W, 2004, ANAL CHEM, V76, P1909, DOI 10.1021/ac0353031; Gibot L, 2014, BIOMACROMOLECULES, V15, P1443, DOI 10.1021/bm5000407; GIDDINGS JC, 1977, ANAL BIOCHEM, V81, P395, DOI 10.1016/0003-2697(77)90710-2; Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007; Gudmundsson M, 2002, J FOOD SCI, V67, P2172, DOI 10.1111/j.1365-2621.2002.tb09522.x; Guo L, 2003, MACROMOLECULES, V36, P9999, DOI 10.1021/ma034264s; HARRINGT.WF, 1970, BIOCHEMISTRY-US, V9, P3714, DOI 10.1021/bi00821a010; Haug IJ, 2009, WOODHEAD PUBL FOOD S, P142, DOI 10.1533/9781845695873.142; Jamilah B, 2002, FOOD CHEM, V77, P81, DOI 10.1016/S0308-8146(01)00328-4; Johnston-Banks F. A., 1990, GELATIN FOOD GELS, P233; Liu J, 2006, AAPS J, V8, pE580, DOI 10.1208/aapsj080367; Mewis J., 2012, COLLOIDAL SUSPENSION; Meyer M, 2003, BIOMACROMOLECULES, V4, P1727, DOI 10.1021/bm0341531; Nilsson L, 2013, FOOD HYDROCOLLOID, V30, P1, DOI 10.1016/j.foodhyd.2012.04.007; Rbii K., 2010, THESIS; Rbii K, 2009, FOOD HYDROCOLLOID, V23, P1024, DOI 10.1016/j.foodhyd.2008.08.004; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Schimpf M., 2000, FIELD FLOW FRACTIONA; Schrieber R., 2007, GELATINE HDB THEORY; Segtnan VH, 2003, FOOD HYDROCOLLOID, V17, P585, DOI 10.1016/S0268-005X(02)00099-1; Till U, 2014, ANAL BIOANAL CHEM, V406, P7841, DOI 10.1007/s00216-014-7891-8; Tromp RH, 2002, FOOD HYDROCOLLOID, V16, P235, DOI 10.1016/S0268-005X(01)00093-5; Tuffery S., 2011, DATA MINING STAT DEC; van den Bosch E, 2003, INT J BIOL MACROMOL, V32, P129, DOI 10.1016/S0141-8130(03)00046-1; VanKrevelen DW, 2009, PROPERTIES OF POLYMERS: THEIR CORRELATION WITH CHEMICAL STRUCTURE; THEIR NUMERICAL ESTIMATION AND PREDICTION FROM ADDITIVE GROUP CONTRIBUTIONS, P1; Weng WY, 2014, FOOD HYDROCOLLOID, V41, P19, DOI 10.1016/j.foodhyd.2014.03.026; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yang HS, 2009, FOOD HYDROCOLLOID, V23, P577, DOI 10.1016/j.foodhyd.2008.04.016; ZIMM BH, 1948, J CHEM PHYS, V16, P1099, DOI 10.1063/1.1746740	39	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0203595	10.1371/journal.pone.0203595	http://dx.doi.org/10.1371/journal.pone.0203595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300343	Green Published, gold, Green Submitted			2022-12-26	WOS:000446897200007
J	Fang, Y; Wang, HHX; Liang, MY; Yeung, MS; Leung, C; Chan, CH; Cheung, W; Huang, JLW; Huang, JJ; Sit, RWS; Wong, SYS; Wong, MCS				Fang, Yuan; Wang, Harry H. X.; Liang, Miaoyin; Yeung, Ming Sze; Leung, Colette; Chan, Chun Hei; Cheung, Wilson; Huang, Jason L. W.; Huang, Junjie; Sit, Regina W. S.; Wong, Samuel Y. S.; Wong, Martin C. S.			The adoption of hypertension reference framework: An investigation among primary care physicians of Hong Kong	PLOS ONE			English	Article							EVIDENCE-BASED GUIDELINES; CLINICAL-PRACTICE; ADHERENCE; AWARENESS; RECOMMENDATIONS; MANAGEMENT; BARRIERS; DISEASE; GPS	Background The Hong Kong Government released a Reference Framework (RF-HT) for Hypertension Care for Adults in Primary Care Settings since 2010. No studies have evaluated its adoption by primary care physicians (PCPs) since its release. Aim We aimed to evaluate the level of PCPs' adoption of the RF-HT and the potential barriers of its use in family practice. Design and setting A cross-sectional study was conducted by a self-administered validated survey among all PCPs in Hong Kong through various means. Methods We assessed the level of and factors associated with its adoption by multivariate logistic regression modelling. Result A total of 3,857 invitation episodes were sent to 2,297 PCPs in 2014-2015. We received 383 completed questionnaires. The average score of adoption was 3.43 out of 4.00, and 47.5% of PCPs highly adopted RF-HT in their daily consultations. Male practitioners (adjusted odds ratio [aOR] = 0.524, 95% CI = 0.290-0.948, p = 0.033) and PCPs of public sector (aOR = 0.524, 95% CI = 0.292-0.940, p = 0.030) were significantly less likely to adopt the RF-HT. PCPs with higher training completion or being academic fellow are more likely to adopt RF-HT than those who were "nil to basic training completion" (aOR = 0.479, 95% CI = 0.269-0.853, p = 0.012) or "higher trainee" (aOR = 0.302, 95% CI = 0.093-0.979, p = 0.046). Three most-supported suggestions on RF-HT improvement were simplification of RF-HT, provision of pocket version and promoting in patients. Conclusion Among PCP respondents, the adoption level of the RF-HT was high. These findings also highlighted some factors associated with its adoption that could inform targeted interventions for enhancing its use in clinical practice.	[Fang, Yuan; Liang, Miaoyin; Yeung, Ming Sze; Leung, Colette; Chan, Chun Hei; Cheung, Wilson; Huang, Jason L. W.; Huang, Junjie; Sit, Regina W. S.; Wong, Samuel Y. S.; Wong, Martin C. S.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [Wang, Harry H. X.] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Wang, Harry H. X.] Univ Glasgow, Inst Hlth & Wellbeing, Gen Practice & Primary Care, Glasgow, Lanark, Scotland	Chinese University of Hong Kong; Sun Yat Sen University; University of Glasgow	Wong, MCS (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China.	wong_martin@cuhk.edu.hk	WONG, Samuel Yeung Shan/D-7311-2013; Huang, Junjie/GOV-3795-2022; Wong, Martin/L-4568-2014; Sit, Regina Wing Shan/V-9982-2017; Huang, Junjie/ABB-1807-2020; Wang, Harry H.X./E-9027-2015	WONG, Samuel Yeung Shan/0000-0003-0934-6385; Wong, Martin/0000-0001-7706-9370; Sit, Regina Wing Shan/0000-0002-4717-7773; Huang, Junjie/0000-0003-2382-4443; Wang, Harry H.X./0000-0002-0361-6527; Fang, Yuan/0000-0003-1154-5076	Health and Medical Research Fund of the Food and Health Bureau, HKSAR [12131241]	Health and Medical Research Fund of the Food and Health Bureau, HKSAR	This study is funded by Health and Medical Research Fund of the Food and Health Bureau, HKSAR (Ref. No. 12131241).	Adedeji AR, 2015, AFR J PRIM HEALTH CA, V7, DOI 10.4102/phcfm.v7i1.776; Al-Gelban KS, 2011, SAUDI J KIDNEY DIS T, V22, P941; [Anonymous], APP C HONG KONG CURR; [Anonymous], PROV SURV SERV UNPUB; [Anonymous], 2014, APP 8 STAT CONTR OFF; Ardery Gail, 2007, J Clin Hypertens (Greenwich), V9, P113, DOI 10.1111/j.1524-6175.2007.06112.x; Cabana M., 1998, AM J MANAGED CARE, V4; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Carter Barry L, 2004, J Manag Care Pharm, V10, pS18; Chung N, 2008, INT J CLIN PRACT, V62, P1306, DOI 10.1111/j.1742-1241.2008.01838.x; Cranney M, 2001, FAM PRACT, V18, P359, DOI 10.1093/fampra/18.4.359; Cuspidi C, 2002, J HUM HYPERTENS, V16, P699, DOI 10.1038/sj.jhh.1001468; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Dickson RC, 2013, J AM BOARD FAM MED, V26, P215, DOI 10.3122/jabfm.2013.02.120024; Dorjgochoo T, 2009, J HYPERTENS, V27, P468, DOI 10.1097/HJH.0b013e3283220eb9; Ekesbo R, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-34; Gagliardi AR, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-26; Glasziou Paul, 2005, Evid Based Nurs, V8, P36, DOI 10.1136/ebn.8.2.36; Hagemeister J, 2001, J HYPERTENS, V19, P2079, DOI 10.1097/00004872-200111000-00020; Handler J, 2011, J AM SOC HYPERTENS, V5, P197, DOI 10.1016/j.jash.2011.03.002; Heneghan C, 2007, BRIT J GEN PRACT, V57, P948, DOI 10.3399/096016407782604965; Holmes JS, 2004, MED CARE RES REV, V61, P453, DOI 10.1177/1077558704269501; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lin N D, 2006, AMIA Annu Symp Proc, P494; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Midlov P, 2008, SCAND J PRIM HEALTH, V26, P154, DOI 10.1080/02813430802202111; Milchak JL, 2008, PHARMACOTHERAPY, V28, P843, DOI 10.1592/phco.28.7.843; Milchak JL, 2004, HYPERTENSION, V44, P602, DOI 10.1161/01.HYP.0000144100.29945.5e; Modig S, 2012, SCI WORLD J, DOI 10.1100/2012/767892; Price Morgan, 2005, Can Fam Physician, V51, P1506; Primary Care Office, HONG KONG REF FRAM H; Reiner Z, 2010, ATHEROSCLEROSIS, V213, P598, DOI 10.1016/j.atherosclerosis.2010.09.014; Seroussi B, 2005, INT J MED INFORM, V74, P89, DOI 10.1016/j.ijmedinf.2004.06.004; Tu Karen, 2002, J Contin Educ Health Prof, V22, P11, DOI 10.1002/chp.1340220103; Wang LX, 2004, MED PRIN PRACT, V13, P282, DOI 10.1159/000079528; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10; Wong M C, 2016, MEDICINE, V95	37	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205529	10.1371/journal.pone.0205529	http://dx.doi.org/10.1371/journal.pone.0205529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300397	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000446897200073
J	Gilioli, KC; Kery, M; Guimaraes, M				Gilioli, Karoline C.; Kery, Marc; Guimaraes, Murilo			Unraveling fine-scale habitat use for secretive species: When and where toads are found when not breeding	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; MELANOPHRYNISCUS-RUBRIVENTRIS; ANURA BUFONIDAE; CONSERVATION; AMPHIBIANS; MANAGEMENT; MODELS; FIRE; VEGETATION; DIVERSITY	A good understanding of species-habitat associations, or habitat use, is required to establish conservation strategies for any species. Many amphibian species are elusive and most information concerning amphibian habitat use comes from breeding sites where they are comparatively easy to find and study. Knowledge about retreat sites is extremely limited for most species and for the greater part of the year. For such species, it is especially important to factor in detection probability in habitat analyses, because otherwise distorted views about habitat preferences may result, e.g., when a species is more visible in habitat type B than in A, even though A may be preferred. The South American red-belly toad, Melano-phryniscus pachyrhynus, is a range-restricted species from Southern Brazil and Uruguay that inhabits open areas with rocky outcrops and is usually seen only during explosive breeding events. Here we studied the fine-scale habitat use of the red-belly toad outside of the breeding season to identify retreat sites and test for the importance of accounting for species imperfect detection, using Bayesian occupancy models. We identified shrub density and the number of loose rocks as important predictors of occupancy, while detection probability was highest at intermediate temperatures. Considering the harsh (dry and hot) conditions of rocky outcrops, shrubs and loose rocks may both work as important refuges, besides providing food resources and protecting against predation. Rocky outcrops have been suffering changes in habitat configuration and we identify nonbreeding habitat preferences at a fine scale, which may help to promote population persistence, and highlight the importance of accounting for imperfect detection when studying secretive species.	[Gilioli, Karoline C.; Guimaraes, Murilo] Univ Fed Rio Grande do Sul, Dept Zool, Porto Alegre, RS, Brazil; [Kery, Marc] Swiss Ornithol Inst, Sempach, Switzerland	Universidade Federal do Rio Grande do Sul; Swiss Ornithological Institute	Guimaraes, M (corresponding author), Univ Fed Rio Grande do Sul, Dept Zool, Porto Alegre, RS, Brazil.	mu.guima@gmail.com		Guimaraes, Murilo/0000-0002-0226-1904	PPGBAN; Fundacao de Apoio da Universidade Federal do Rio Grande do Sul; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Master's scholarship; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Postdoctoral scholarship	PPGBAN; Fundacao de Apoio da Universidade Federal do Rio Grande do Sul; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Master's scholarship; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Postdoctoral scholarship	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Master's scholarship (KG) (http://www.capes.gov.br/); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Postdoctoral scholarship (MG) (http://www.capes.gov.br/). We also thank PPGBAN, Laura Verrastro and Fundacao de Apoio da Universidade Federal do Rio Grande do Sul for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Goncalo Ferraz, Larissa Bailey, Marcio Borges-Martins and the reviewers for suggestions. We are grateful to our field crew, especially Priscila Lopes, for helping in data collection, and to the landowners that kindly allowed us access to their land. The Herpetology and Insect Ecology laboratories from Universidade Federal do Rio Grande do Sul provided logistical support during fieldwork. We also thank PPGBAN, Laura Verrastro and Fundacao de Apoio da Universidade Federal do Rio Grande do Sul for financial support. This study was conducted during a time of great political and economic difficulty in Brazil. Beyond their substantial cuts to research budgets, we also feel great dissatisfaction with the manner in which the Brazilian government has been using environmental agencies as an instrument for political manipulation. It is unacceptable to politicize rather than prioritize scientific investigation.	Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; ANDRADE BO, 2016, OECOL AUST, V20, P37, DOI DOI 10.4257/oeco.2016.2002.04; [Anonymous], 2017, RED LIST THREATENED; [Anonymous], 2010, SALAMANDERS US CANAD; [Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; Armstrong DP, 2005, CONSERV BIOL, V19, P1402, DOI 10.1111/j.1523-1739.2005.00117.x; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Baldo D, 2014, BIOL J LINN SOC, V112, P417, DOI 10.1111/bij.12296; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Blevins E, 2011, LANDSCAPE ECOL, V26, P837, DOI 10.1007/s10980-011-9612-4; Bosch J, 2004, BIODIVERS CONSERV, V13, P409, DOI 10.1023/B:BIOC.0000006506.18453.c9; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cairo Samanta L., 2008, South American Journal of Herpetology, V3, P10, DOI 10.2994/1808-9798(2008)3[10:RBOMSF]2.0.CO;2; Cano PD, 2010, EUR J WILDLIFE RES, V56, P411, DOI 10.1007/s10344-009-0335-7; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Chelgren ND, 2011, ECOLOGY, V92, P408, DOI 10.1890/10-0322.1; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; Collins SL, 2012, J VEG SCI, V23, P563, DOI 10.1111/j.1654-1103.2011.01369.x; Correa MM, 2006, NEOTROP ENTOMOL, V35, P724, DOI 10.1590/S1519-566X2006000600002; COTTAM G, 1956, ECOLOGY, V37, P451, DOI 10.2307/1930167; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Dillard LO, 2008, BIODIVERS CONSERV, V17, P1475, DOI 10.1007/s10531-008-9356-x; Encarnacion-Luevano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078290; Fitch H. S., 1956, Publications of the Museum of Natural History University of Kansas, V8, P213; Flesch AD, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1001; FREDERICKSEN NJ, 2003, TROP ECOL, V44, P185; Friedman M, 2016, HERPETOL CONSERV BIO, V11, P476; Frost DR, AMPHIBIAN SPECIES WO; Goldberg FJ, 2006, CAN J ZOOL, V84, P699, DOI 10.1139/Z06-038; Grant T, 2012, CHEMOECOLOGY, V22, P169, DOI 10.1007/s00049-012-0107-9; Guillera-Arroita G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099571; Guimaraes M, 2014, S AM J HERPETOL, V9, P1, DOI 10.2994/SAJH-D-13-00020.1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hasenack H., 2006, MAPEAMENTO COBERTURA; Hazell D, 2004, BIOL CONSERV, V119, P61, DOI 10.1016/j.biocon.2003.10.022; Heyer R.W., 1994, MEASURING MONITORING; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hughes JB, 2000, OECOLOGIA, V123, P375, DOI 10.1007/s004420051024; Kellner K., 2014, JAGSYI RUN JAGS SPEC; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2002, J WILDLIFE MANAGE, V66, P330, DOI 10.2307/3803165; Kery M, 2016, APPL HISERARCHICAL M, V1; Kolbek J.I.R.I., 2008, ACTA U CAROLINAE ENV, V22, P111; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Larson MA, 2004, ECOL MODEL, V180, P103, DOI 10.1016/j.ecolmodel.2003.12.054; Law BS, 1998, BIODIVERS CONSERV, V7, P323, DOI 10.1023/A:1008877611726; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maneyro Raul, 2008, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V1, P95; Marzluff JM, 2002, FOREST SCI, V48, P191; Mazerolle MJ, 2007, J HERPETOL, V41, P672, DOI 10.1670/07-061.1; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; McInerny GJ, 2011, METHODS ECOL EVOL, V2, P248, DOI 10.1111/j.2041-210X.2010.00077.x; Meirelles ST, 1999, ENVIRON CONSERV, V26, P10, DOI 10.1017/S0376892999000041; Navas CA, 1996, J HERPETOL, V30, P488, DOI 10.2307/1565691; Nomura F, 2009, J ETHOL, V27, P195, DOI 10.1007/s10164-008-0112-1; Oseen KL, 2002, OECOLOGIA, V133, P616, DOI 10.1007/s00442-002-1067-5; Ospina OE, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00258.1; PALMER MW, 1990, J VEG SCI, V1, P57, DOI 10.2307/3236053; Pereyra LC, 2011, AMPHIBIA-REPTILIA, V32, P105, DOI 10.1163/017353710X543029; Pillar V.D., 1997, COENOSES, V12, P301, DOI 10.1007/978-3-0348-8722-9_17; Pilliod DS, 2003, FOREST ECOL MANAG, V178, P163, DOI 10.1016/S0378-1127(03)00060-4; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Plummer M., 2003, P 3 INT WORKSH DISTR; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Roche LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035734; Russell KR, 1999, WILDLIFE SOC B, V27, P374; Santos TGD, 2011, HERPETOL B, V116, p15 ; Scherer RD, 2012, POPUL ECOL, V54, P487, DOI 10.1007/s10144-012-0324-7; Sharpe F, 1996, NORTHWEST SCI, V70, P86; Soares C, 2007, BIODIVERS CONSERV, V16, P1087, DOI 10.1007/s10531-006-9070-5; Stebbins R. C., 2021, NATURAL HIST AMPHIBI; Vaira M, 2005, AMPHIBIA-REPTILIA, V26, P193, DOI 10.1163/1568538054253519; Van Sluys Monique, 2011, South American Journal of Herpetology, V6, P43; Vaz-Silva Wilian, 2008, South American Journal of Herpetology, V3, P36, DOI 10.2994/1808-9798(2008)3[36:ROMPMA]2.0.CO;2; Walls SC, 2008, ECOLOGY BEHAV AMPHIB, P94; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wilgers DJ, 2007, SOUTHWEST NAT, V52, P263, DOI 10.1894/0038-4909(2007)52[263:SVIPAO]2.0.CO;2; Withers P. C., 2000, Journal of the Royal Society of Western Australia, V83, P103; Withers P. C., 1997, Journal of the Royal Society of Western Australia, V80, P159; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Zank C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094625	85	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2018	13	10							e0205304	10.1371/journal.pone.0205304	http://dx.doi.org/10.1371/journal.pone.0205304			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW1KF	30296275	Green Published, gold, Green Submitted			2022-12-26	WOS:000446632700030
J	Dally, M; Butler-Dawson, J; Krisher, L; Monaghan, A; Weitzenkamp, D; Sorensen, C; Johnson, RJ; Carlton, EJ; Asensio, C; Tenney, L; Newman, LS				Dally, Miranda; Butler-Dawson, Jaime; Krisher, Lyndsay; Monaghan, Andrew; Weitzenkamp, David; Sorensen, Cecilia; Johnson, Richard J.; Carlton, Elizabeth J.; Asensio, Claudia; Tenney, Liliana; Newman, Lee S.			The impact of heat and impaired kidney function on productivity of Guatemalan sugarcane workers	PLOS ONE			English	Article							CLIMATE-CHANGE; LABOR PRODUCTIVITY; UNITED-STATES; NONLINEAR MODELS; CENTRAL-AMERICA; TEMPERATURE; STRESS; DISEASE; NEPHROPATHY; MORTALITY	Background Climate change has implications for human health and productivity. Models suggest that heat extremes affect worker health, reduce labor capacity, and commodity supply. Chronic health conditions are on the rise internationally. However there is a paucity of direct empirical evidence relating increasing temperatures to both agricultural worker health and productivity. Methods and findings We evaluated the relationship between temperature exposure, kidney function, and two measures of productivity-tons of commodity produced and job attrition, of 4,095 Guatemalan sugarcane cutters over a 6-month harvest. We used distributed lag non-linear models to evaluate associations between wet bulb globe temperature (WBGT) and productivity of workers with normal or impaired kidney function. The cumulative effect of exposure to a max WBGT of 34 degrees C was 1.16 tons (95% CI: -2.87, 0.54) less sugarcane cut over the next five days by workers with impaired kidney function, compared to exposure to 29 degrees C. Impaired kidney function was associated with premature workforce attrition. Workers starting the harvest season with impaired kidney function were more than twice as likely to leave employment (HR: 2.92, 95% CI: 1.88, 4.32). Conclusions Heat extremes may be associated with loss of agricultural worker productivity and employment, especially among those with impaired kidney function. Agricultural workers who develop health conditions, such as kidney disease, are particularly vulnerable in the face of climate change and increasing heat extremes. The resultant loss of employment and productivity has significant implications for global commodity supplies.	[Dally, Miranda; Butler-Dawson, Jaime; Krisher, Lyndsay; Weitzenkamp, David; Tenney, Liliana; Newman, Lee S.] Univ Colorado, Colorado Sch Publ Hlth, Ctr Hlth Work & Environm, Anschutz Med Campus, Aurora, CO 80045 USA; [Dally, Miranda; Butler-Dawson, Jaime; Krisher, Lyndsay; Sorensen, Cecilia; Johnson, Richard J.; Carlton, Elizabeth J.; Tenney, Liliana; Newman, Lee S.] Univ Colorado Denver, Colorado Consortium Climate Change & Human Hlth, Aurora, CO 80204 USA; [Monaghan, Andrew] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA; [Weitzenkamp, David] Univ Colorado, Dept Biostat & Informat, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA; [Sorensen, Cecilia] Univ Colorado, Sch Med, Dept Emergency Med, Anschutz Med Campus, Aurora, CO USA; [Johnson, Richard J.] Univ Colorado, Sch Med, Div Renal Dis & Hypertens, Anschutz Med Campus, Aurora, CO USA; [Carlton, Elizabeth J.; Tenney, Liliana; Newman, Lee S.] Univ Colorado, Dept Environm & Occupat Hlth, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA; [Asensio, Claudia] Pantaleon, Guatemala City, Guatemala; [Newman, Lee S.] Univ Colorado, Div Pulm Sci & Crit Care Med, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Newman, Lee S.] Univ Colorado, Dept Epidemiol, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA	Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Center Atmospheric Research (NCAR) - USA; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Dally, M (corresponding author), Univ Colorado, Colorado Sch Publ Hlth, Ctr Hlth Work & Environm, Anschutz Med Campus, Aurora, CO 80045 USA.; Dally, M (corresponding author), Univ Colorado Denver, Colorado Consortium Climate Change & Human Hlth, Aurora, CO 80204 USA.	miranda.dally@ucdenver.edu	Dally, Miranda/GXV-9250-2022	Carlton, Elizabeth/0000-0002-8664-9606; Monaghan, Andrew/0000-0002-8170-2359	Pantaleon; University of Colorado, Denver - Anschutz; Centers for Disease Control and Prevention [U19 OH01127]; National Institutes of Health [R21 ES028826]; National Science Foundation; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U19OH011227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES028826] Funding Source: NIH RePORTER	Pantaleon; University of Colorado, Denver - Anschutz; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This evaluation was supported in part by Pantaleon; the Chancellor, University of Colorado, Denver - Anschutz; Centers for Disease Control and Prevention (https://www.cdc.gov) (U19 OH01127; LSN) and National Institutes of Health (https://www.nih.gov) (R21 ES028826; LSN). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention, the National Institutes of Health, or the Department of Health and Human Services. The National Center for Atmospheric Research is sponsored by the National Science Foundation. Pantaleon provided the University of Colorado investigators with de-identified productivity data and pre-employment medical screening data, all of which were collected by the company for business purposes prior to the analysis. The funder had no role in data analysis or data interpretation. A co-author employed by the company (CA) participated on the writing team. They provided details regarding work practices, but did not modify the results or conclusions of this report. The corresponding author had full access to all the raw data and had final responsibility for the decision to submit for publication.	Alexandratos N, 2012, 1203 FAO ESA; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 1986, NIOSH PUB, V86-112; Bobb JF, 2014, ENVIRON HEALTH PERSP, V122, P811, DOI 10.1289/ehp.1307392; Chen K, 2016, ENVIRON HEALTH PERSP, V124, P1863, DOI 10.1289/EHP204; Cohen J, 2014, SCIENCE, V344, P143, DOI 10.1126/science.344.6180.143; Correa-Rotter R, 2014, AM J KIDNEY DIS, V63, P506, DOI 10.1053/j.ajkd.2013.10.062; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Dimiceli VE, 2011, LECT NOTES ENG COMP, P591; Dunne JP, 2013, NAT CLIM CHANGE, V3, P563, DOI 10.1038/NCLIMATE1827; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Glaser J, 2016, CLIN J AM SOC NEPHRO, V11, P1472, DOI 10.2215/CJN.13841215; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Janetos A., 2017, RISKS MULTIPLE BREAD; Kiefer M, 2016, REV PANAM SALUD PUBL, V40, P192; Kjellstrom T, 2018, INT J BIOMETEOROL, V62, P291, DOI 10.1007/s00484-017-1407-0; Kjellstrom T, 2009, ARCH ENVIRON OCCUP H, V64, P217, DOI 10.1080/19338240903352776; Krishnamurthy M, 2017, SAF HEALTH WORK-KR, V8, P99, DOI 10.1016/j.shaw.2016.08.005; Laux TS, 2016, REV PANAM SALUD PUBL, V39, P186; Laws RL, 2015, INT J OCCUP ENV HEAL, V21, P241, DOI 10.1179/2049396714Y.0000000102; Lemke B, 2012, IND HEALTH, V50, P267, DOI 10.2486/indhealth.MS1352; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levy BS, 2015, ANN GLOB HEALTH, V81, P310, DOI 10.1016/j.aogh.2015.08.008; Li XD, 2016, BUILD ENVIRON, V95, P42, DOI 10.1016/j.buildenv.2015.09.005; Lundgren K, 2013, IND HEALTH, V51, P3, DOI 10.2486/indhealth.2012-0089; Magrin GO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1499; Occupational Safety and Health Administration (OSHA), 2008, TED0100015 OSHA; Ordunez P, 2014, LANCET GLOB HEALTH, V2, pE440, DOI 10.1016/S2214-109X(14)70217-7; Quiller G, 2017, ARCH ENVIRON OCCUP H, V72, P313, DOI 10.1080/19338244.2017.1288077; Sahu S, 2013, IND HEALTH, V51, P424, DOI 10.2486/indhealth.2013-0006; Stull R, 2011, J APPL METEOROL CLIM, V50, P2267, DOI 10.1175/JAMC-D-11-0143.1; United Nations Development Programme, 2016, CLIM CHANG LAB IMP H; Watts N, 2018, LANCET, V391, P581, DOI 10.1016/S0140-6736(17)32464-9; Weatherly JW, 2017, J APPL METEOROL CLIM, V56, P863, DOI 10.1175/JAMC-D-16-0068.1; Weaver VM, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0105-6; Wegman DH, 2018, SCAND J WORK ENV HEA, V44, P16, DOI 10.5271/sjweh.3659; Wijetunge S, 2013, CEYLON MED J, V58, P142, DOI 10.4038/cmj.v58i4.6304; Zander KK, 2015, NAT CLIM CHANGE, V5, P647, DOI [10.1038/nclimate2623, 10.1038/NCLIMATE2623]	39	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205181	10.1371/journal.pone.0205181	http://dx.doi.org/10.1371/journal.pone.0205181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289894	Green Published, Green Submitted, gold			2022-12-26	WOS:000446545500055
J	Yamamoto, T; Kadoya, N; Morishita, Y; Sato, Y; Matsushita, H; Umezawa, R; Ishikawa, Y; Takahashi, N; Katagiri, Y; Takeda, K; Jingu, K				Yamamoto, Takaya; Kadoya, Noriyuki; Morishita, Yohei; Sato, Yoshinao; Matsushita, Haruo; Umezawa, Rei; Ishikawa, Yojiro; Takahashi, Noriyoshi; Katagiri, Yu; Takeda, Ken; Jingu, Keiichi			Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer	PLOS ONE			English	Article							RISK-FACTORS; THERAPY; PNEUMONITIS; TUMORS; TOXICITY; METAANALYSIS; PATIENT; SBRT	Purpose Radiographic severity of radiation-induced lung injury (RILI) has not been well-studied. The goal of this study was to assess the CT appearance pattern and severity of RILI without consideration of the clinical presentation. Material and methods A total of 49 patients, 41 with primary lung cancer and 8 with metastatic lung cancer, were treated by 4-fraction stereotactic body radiotherapy (SBRT). RILI after SBRT was separately assessed by two observers. The early and late CT appearance patterns and CT-based severity grading were explored. Results The median follow-up period was 39.0 months. In the early CT findings of observers 1 and 2, there was diffuse consolidation in 15 and 8, diffuse ground glass opacity (GGO) in 0 and 0, patchy consolidation and GGO in 17 and 20, patchy GGO in 3 and 3, and no changes in 10 and 14, respectively (kappa = 0.61). In late CT findings of observer 1 and 2, there were modified conventional pattern in 28 and 24, mass-like pattern in 8 and 11, scar-like pattern in 12 and 12, and no changes in 1 and 2, respectively (kappa = 0.63). In the results of the CT-based grading by observers 1 and 2, there were grade 0 in 1 and 2, grade 1 in 10 and 14, grade 2 in 31 and 29, grade 3 in 7 and 4, and none of grade 4 or more, respectively (kappa = 0.66). According to multivariate analyses (MVA), the significant predicting factors of grade 2 or more CT-based RILI were age (p = 0.01), oxygen dependence (p = 0.03) and interstitial shadow (p = 0.03). Conclusions The agreement of the CT appearance and CT-based grading between two observers was good. These indicators may be able to provide us with more objective information and a better understanding of RILI.	[Yamamoto, Takaya; Kadoya, Noriyuki; Matsushita, Haruo; Umezawa, Rei; Ishikawa, Yojiro; Takahashi, Noriyoshi; Katagiri, Yu; Takeda, Ken; Jingu, Keiichi] Tohoku Univ, Grad Sch Med, Dept Radiat Oncol, Sendai, Miyagi, Japan; [Morishita, Yohei; Sato, Yoshinao] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Yamamoto, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Radiat Oncol, Sendai, Miyagi, Japan.	t.yamamoto@rad.med.tohoku.ac.jp	Takahashi, Noriyoshi/GPP-0779-2022; Takeda, Ken/L-1914-2019; Yamamoto, Takaya/AAO-6488-2020	Yamamoto, Takaya/0000-0003-3562-1037				Aoki T, 2004, RADIOLOGY, V230, P101, DOI 10.1148/radiol.2301021226; Avanzo M, 2015, PHYS MEDICA, V31, P1, DOI 10.1016/j.ejmp.2014.10.006; Avanzo M, 2017, PHYS MEDICA, V42, P150, DOI 10.1016/j.ejmp.2017.09.127; Barriger RB, 2012, INT J RADIAT ONCOL, V82, P457, DOI 10.1016/j.ijrobp.2010.08.056; Bernchou U, 2017, RADIOTHER ONCOL, V123, P93, DOI 10.1016/j.radonc.2017.02.001; Cha JH, 2009, AM J ROENTGENOL, V193, pW95, DOI [10.2214/AJR.08.1833, 10.2214/AJR.08.2298]; Dahele M, 2015, ACTA ONCOL, V54, P1237, DOI 10.3109/0284186X.2014.1003961; Dahele M, 2011, J THORAC ONCOL, V6, P1221, DOI 10.1097/JTO.0b013e318219aac5; Deng GD, 2017, ONCOL LETT, V14, P501, DOI 10.3892/ol.2017.6268; Graves PR, 2010, SEMIN RADIAT ONCOL, V20, P201, DOI 10.1016/j.semradonc.2010.01.010; Guckenberger M, 2007, RADIOTHER ONCOL, V85, P435, DOI 10.1016/j.radonc.2007.10.044; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kimura T, 2012, BRIT J RADIOL, V85, P135, DOI 10.1259/bjr/32629867; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Linda A, 2011, EUR J RADIOL, V79, P147, DOI 10.1016/j.ejrad.2009.10.029; Matsuo Y, 2012, INT J RADIAT ONCOL, V83, pE545, DOI 10.1016/j.ijrobp.2012.01.018; Nagata Y, 2009, INT J RADIAT ONCOL, V75, P343, DOI 10.1016/j.ijrobp.2009.02.087; Okubo M, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160508; Palma DA, 2013, INT J RADIAT ONCOL, V85, P444, DOI 10.1016/j.ijrobp.2012.04.043; Pan H, 2011, CANCER-AM CANCER SOC, V117, P4566, DOI 10.1002/cncr.26067; Takeda A, 2008, RADIAT MED, V26, P504, DOI 10.1007/s11604-008-0261-8; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Trovo M, 2010, LUNG CANCER, V69, P77, DOI 10.1016/j.lungcan.2009.09.006; Vogelius IR, 2012, ACTA ONCOL, V51, P975, DOI 10.3109/0284186X.2012.718093; Wang JB, 2013, INT J RADIAT ONCOL, V85, P798, DOI 10.1016/j.ijrobp.2012.06.040; Yamaguchi S, 2013, LUNG CANCER, V82, P260, DOI 10.1016/j.lungcan.2013.08.024; Zhao J, 2016, INT J RADIAT ONCOL, V95, P1357, DOI 10.1016/j.ijrobp.2016.03.024	27	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204734	10.1371/journal.pone.0204734	http://dx.doi.org/10.1371/journal.pone.0204734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286105	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500037
J	Yuda, M				Yuda, Michio			The medical assistance system and inpatient health care provision: Empirical evidence from short-term hospitalizations in Japan	PLOS ONE			English	Article							SUPPLIER-INDUCED DEMAND; INSURANCE EXPERIMENT; RED HERRINGS; COST; EXPENDITURES; POPULATION; MORTALITY; TIMES; VARIABLES; PAYMENTS	This paper uses two nationally representative sets of medical claims data from medical assistance and universal public health insurance systems to examine how medical assistance system assignment affects short-term inpatient health care provision. In Japan, the medical assistance system, which is part of a public assistance system, provides medical care services for its beneficiaries without imposing any financial burdens, such as copayments or advance premium payments. These circumstances can lead to inpatient costs, as physicians may provide more treatments because there is a financial incentive. Because the assignment of public assistance in Japan is not random but is subject to means testing by the local government, I employ the instrumental variable model to control the potential correlation. I find that medical expenditure is significantly higher for medical assistance patients than for universal public health insurance patients, with an arc elasticity of approximately 0.20. This elasticity is slightly greater than that found for inpatient care in the randomized RAND Health Insurance Experiment and recent empirical studies on low-income populations. In addition, the elasticities for patients who receive medication, treatment and surgery are greater.	[Yuda, Michio] Tohoku Univ, Grad Sch Econ & Management, Sendai, Miyagi, Japan	Tohoku University	Yuda, M (corresponding author), Tohoku Univ, Grad Sch Econ & Management, Sendai, Miyagi, Japan.	myuda@tohoku.ac.jp			Japan Society for the Promotion of Science [26780180]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study is financially supported by the Grand-in-Aid for Young Scientists (B) (#26780180) from the Japan Society for the Promotion of Science. http://www.jsps.go.jp/english/e-grants/grants01.html.	Aron-Dine A, 2013, J ECON PERSPECT, V27, P197, DOI 10.1257/jep.27.1.197; Baker LC, 2000, J HUM RESOUR, V35, P480, DOI 10.2307/146389; Card D, 2009, Q J ECON, V124, P597, DOI 10.1162/qjec.2009.124.2.597; Chandra A, 2014, J HEALTH ECON, V33, P57, DOI 10.1016/j.jhealeco.2013.10.008; Choi MK, 2011, J HEALTH ECON, V30, P1020, DOI 10.1016/j.jhealeco.2011.08.002; CURRIE J, 1995, AM ECON REV, V85, P106; Currie J, 2009, J ECON LIT, V47, P87, DOI 10.1257/jel.47.1.87; Felder S, 2000, J HEALTH ECON, V19, P679, DOI 10.1016/S0167-6296(00)00039-4; Felder S, 2010, J HEALTH ECON, V29, P205, DOI 10.1016/j.jhealeco.2009.11.014; Finkelstein A, 2007, Q J ECON, V122, P1, DOI 10.1162/qjec.122.1.1; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Fukushima K, 2016, J HEALTH ECON, V45, P115, DOI 10.1016/j.jhealeco.2015.10.005; Gerdtham UG, 2006, ECON HUM BIOL, V4, P298, DOI 10.1016/j.ehb.2006.04.001; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Granados JAT, 2008, DEMOGRAPHY, V45, P323, DOI 10.1353/dem.0.0008; Gross T, 2011, J PUBLIC ECON, V95, P767, DOI 10.1016/j.jpubeco.2011.01.012; Haaland VF, 2015, J HEALTH ECON, V39, P248, DOI 10.1016/j.jhealeco.2014.08.005; Hashimoto H, 2010, INT J ENV RES PUB HE, V7, P3022, DOI 10.3390/ijerph7083022; Hayashi M., 2012, NEW RISK SOCIAL SECU, P273; Hayashi M, 2011, INT J HEALTH CARE FI, V11, P287, DOI 10.1007/s10754-011-9098-2; HECKMAN JJ, 1978, ECONOMETRICA, V46, P931, DOI 10.2307/1909757; Iizuka T, 2007, RAND J ECON, V38, P844, DOI 10.1111/j.0741-6261.2007.00115.x; Iizuka T, 2012, AM ECON REV, V102, P2826, DOI 10.1257/aer.102.6.2826; Kan M, 2010, JPN WORLD ECON, V22, P1, DOI 10.1016/j.japwor.2009.06.005; Kawaguchi H., 2012, SEIJO EC REV, V196, P59; Keeler EB, 1988, RAND PUBLICATION SER; Kondo A, 2013, J PUBLIC ECON, V99, P1, DOI 10.1016/j.jpubeco.2012.12.004; Kumagai N., 2002, J HLTH CARE SOC, V12, P39, DOI [10.4091/iken1991.12.3_39, DOI 10.4091/IKEN1991.12.3_39]; Lubitz J, 1984, Health Care Financ Rev, V5, P117; LUBITZ J, 1995, NEW ENGL J MED, V332, P999, DOI 10.1056/NEJM199504133321506; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; MANNING WG, 1987, AM ECON REV, V77, P251; National Institute of Population and Social Security Studies, 2014, SOC SEC JAP; NEWEY WK, 1990, J APPL ECONOM, V5, P99, DOI 10.1002/jae.3950050202; Newhouse JP, 1993, FREE ALL LESSONS RAN; Nishikawa M., 2010, AOYAMA J EC, V62, P195; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Ruhm CJ, 2005, J HEALTH ECON, V24, P341, DOI 10.1016/j.jhealeco.2004.09.007; Ruhm CJ, 2003, J HEALTH ECON, V22, P637, DOI 10.1016/S0167-6296(03)00041-9; Sato E, 2009, HEALTH ECON, V18, P843, DOI 10.1002/hec.1410; SCITOVSKY AA, 1984, MILBANK Q, V62, P591, DOI 10.2307/3349838; Shigeoka H, 2014, AM ECON REV, V104, P2152, DOI 10.1257/aer.104.7.2152; Shigeoka H, 2014, J HEALTH ECON, V35, P162, DOI 10.1016/j.jhealeco.2014.03.003; Suzuki W., 2007, J INCOME DISTRIB, V16, P88, DOI [10.25071/1874-6322.7232, DOI 10.25071/1874-6322.7232]; Takaku R, 2016, SOC SCI MED, V151, P46, DOI 10.1016/j.socscimed.2015.12.038; The Fiscal System Council, 2013, POL FISC YEAR 2013 B; The Government Revitalization Unit, 2011, SOC SEC REV PUBL ASS; Travis KM, 1999, ECON INQ, V37, P86, DOI 10.1111/j.1465-7295.1999.tb01418.x; Werblow A, 2007, HEALTH ECON, V16, P1109, DOI 10.1002/hec.1213; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Yuda M, 2013, 9 WORLD C INT HLTH E; Yuda M, 2013, HITOTSUB J ECON, V54, P79, DOI 10.15057/25780; Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4	53	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204798	10.1371/journal.pone.0204798	http://dx.doi.org/10.1371/journal.pone.0204798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286118	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500044
J	Correa, MG; Pires, PR; Ribeiro, FV; Pimentel, SP; Cirano, FR; Napimoga, MH; Casati, MZ; Casarin, RCV				Correa, Monica G.; Pires, Paula Rodrigues; Ribeiro, Fernanda Vieira; Pimentel, Suzana Peres; Cirano, Fabiano Ribeiro; Napimoga, Marcelo Henrique; Casati, Marcio Z.; Viana Casarin, Renato Correa			Systemic treatment with resveratrol reduces the progression of experimental periodontitis and arthritis in rats	PLOS ONE			English	Article							ARGININE DEIMINASE SYSTEM; GINGIVAL CREVICULAR FLUID; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; PORPHYROMONAS-GINGIVALIS; DENDRITIC CELLS; AGGRESSIVE PERIODONTITIS; GENE-THERAPY; TNF-ALPHA; INTERLEUKIN-4	Rheumatoid arthritis and periodontitis are chronic inflammatory diseases which has been closely associated due to the nature of immune-inflammatory imbalance response. Resveratrol is a naturall product with biological proprieties that may promote immunomodulatory effects on host response. This study investigated resveratrol continuous administration effect on experimental periodontitis and arthritis progression in rats. Thirty-five rats were assigned to the following groups: 1-experimental arthritis + experimental periodontitis + placebo (RA+EP +PL) (n = 12); 2 -RA+EP+ ibuprofen (RA+PE+IB) (n =11); 3-RA+EP+ resveratrol (RA+PE+RSV) (n = 11). After euthanasia, the specimens were processed for morphometric analysis of bone loss, and the gingival tissue surrounding the first molar was collected for quantification of inflammatory markers using a Luminex/MAGpix assay and anti-citrullinated protein antibody (ACCPA) levels were measured by ELISA assay. Serum level of rheumatoid factor (RF) was measured by ELISA assay. Paw edema was analyzed using a plethysmometer. Higher bone loss was observed in PL group, when compared to IB and RSV groups. RSV group presented higher IL-4 concentration than PL and IB groups. Resveratrol reduced RF serum levels and both IB and RSV decreased ACCPA gingival levels. Besides, paw swelling level was significantly lower in IB and RSV groups in the 21th day and only in RSV group in the 28th day. Histological analyzes showed smooth articular surface and higher width of the subchondral cortical in RSV group. Resveratrol showed modulatory effect and seems to reduce the inflammatory signs of arthritis and articular damage throughout the time.	[Correa, Monica G.; Pires, Paula Rodrigues; Ribeiro, Fernanda Vieira; Pimentel, Suzana Peres; Cirano, Fabiano Ribeiro; Casati, Marcio Z.; Viana Casarin, Renato Correa] Univ Paulista, Sch Dent, Dent Res Div, Sao Paulo, SP, Brazil; [Napimoga, Marcelo Henrique] Sao Leopoldo Mandic Inst & Res Ctr, Lab Immunol & Mol Biol, Campinas, SP, Brazil	Universidade Paulista; Faculdade Sao Leopoldo Mandic	Correa, MG; Casarin, RCV (corresponding author), Univ Paulista, Sch Dent, Dent Res Div, Sao Paulo, SP, Brazil.	monica.grazieli@hotmail.com; casarinrcv@yahoo.com.br	Cirano, Fabiano R/J-2092-2014; Cirano, Fabiano/ABA-1897-2020; Napimoga, Marcelo/S-2434-2019; CORREA, MONICA GRAZIELI/E-8661-2013; casati, marcio zaffalon/ABA-2670-2020; Ribeiro, Fernanda/I-4030-2012	Cirano, Fabiano R/0000-0002-7331-4612; Cirano, Fabiano/0000-0002-7331-4612; Napimoga, Marcelo/0000-0003-4472-365X; CORREA, MONICA GRAZIELI/0000-0003-1895-3283; casati, marcio zaffalon/0000-0001-9234-0536; Ribeiro, Fernanda/0000-0002-2697-620X; Casarin, Renato/0000-0003-1743-5855	National Counsel of Technological and Scientific Development - (CNPq - Brasilia, Distrito Federal, Brazil) [442275/2014-5]; Research Productivity Fellowship from CNPq	National Counsel of Technological and Scientific Development - (CNPq - Brasilia, Distrito Federal, Brazil); Research Productivity Fellowship from CNPq	This study was partially supported by grant from the National Counsel of Technological and Scientific Development - (CNPq - Brasilia, Distrito Federal, Brazil) (442275/2014-5). This work was also supported by Research Productivity Fellowship to M.H.N, and M.Z.C. from CNPq.	Barrella GE, 2012, BRAZ ORAL RES, V26, P158, DOI 10.1590/S1806-83242012000200012; Bastos MF, 2009, ORAL DIS, V15, P82, DOI 10.1111/j.1601-0825.2008.01491.x; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bello-Gualtero JM, 2016, J PERIODONTOL, V87, P346, DOI 10.1902/jop.2015.150455; Bhatt SR, 2011, EUR J PHARMACOL, V667, P258, DOI 10.1016/j.ejphar.2011.05.026; Breen DM, 2012, ATHEROSCLEROSIS, V222, P375, DOI 10.1016/j.atherosclerosis.2012.03.021; Calderaro DC, 2016, REV BRAS REUMATOL; Candelario-Jalil E, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-25; Carregaro V, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9626427; Casati MZ, 2013, J PERIODONTOL, V84, pE58, DOI 10.1902/jop.2013.120746; CASIANOCOLON A, 1988, APPL ENVIRON MICROB, V54, P1318; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Choi IA, 2016, KOREAN J INTERN MED, V31, P977, DOI 10.3904/kjim.2015.202; Chou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139693; Correa MG, 2017, J PERIODONTAL RES, V52, P201, DOI 10.1111/jre.12382; Correa MG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174442; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Dietrich T, 2008, J RHEUMATOL, V5; Dutzan N, 2009, J CLIN PERIODONTOL, V36, P396, DOI 10.1111/j.1600-051X.2009.01390.x; Elmali N, 2007, INFLAMMATION, V30, P1, DOI 10.1007/s10753-006-9012-0; Filippin LI, 2008, CLIN EXP IMMUNOL, V152, P415, DOI 10.1111/j.1365-2249.2008.03634.x; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fuggle NR, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00080; Gao XZ, 2012, ANN RHEUM DIS, V71, P129, DOI 10.1136/ard.2011.149831; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Ghanim H, 2011, J CLIN ENDOCR METAB, V96, P1409, DOI 10.1210/jc.2010-1812; Giannopoulou C, 2003, J CLIN PERIODONTOL, V30, P145, DOI 10.1034/j.1600-051X.2003.300201.x; HART PH, 1989, P NATL ACAD SCI USA, V86, P3803, DOI 10.1073/pnas.86.10.3803; Havemose-Poulsen A, 2006, J PERIODONTOL, V77, P280, DOI 10.1902/jop.2006.050051; Hecht C, 2015, ANN RHEUM DIS, V74, P2151, DOI 10.1136/annrheumdis-2014-205428; Hitchon CA, 2011, CURR OPIN RHEUMATOL, V23, P352, DOI 10.1097/BOR.0b013e3283477b7b; Jiang CP, 2014, PHYTOMEDICINE, V21, P830, DOI 10.1016/j.phymed.2014.01.009; Joosten LAB, 1999, ARTHRITIS RES, V1, P81, DOI 10.1186/ar14; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kabashima H, 1996, J ORAL PATHOL MED, V25, P449, DOI 10.1111/j.1600-0714.1996.tb00295.x; Kaur Shamsherjit, 2011, Inflammopharmacology, V19, P265, DOI 10.1007/s10787-011-0090-8; Khojah HM, 2018, CLIN RHEUMATOL, V37, P2035, DOI 10.1007/s10067-018-4080-8; Kinane DF, 2011, J CLIN PERIODONTOL, V38, P44, DOI 10.1111/j.1600-051X.2010.01682.x; Li Z, 2012, BRAIN RES, V1450, P116, DOI 10.1016/j.brainres.2012.02.019; Liao F, 2009, MED HYPOTHESES, V72, P732, DOI 10.1016/j.mehy.2008.12.040; Lubberts E, 2000, J CLIN INVEST, V105, P1697, DOI 10.1172/JCI7739; MARQUIS RE, 1987, APPL ENVIRON MICROB, V53, P198, DOI 10.1128/AEM.53.1.198-200.1987; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Mercado F, 2000, J CLIN PERIODONTOL, V27, P267, DOI 10.1034/j.1600-051x.2000.027004267.x; Mercado FB, 2001, J PERIODONTOL, V72, P779, DOI 10.1902/jop.2001.72.6.779; Militaru C, 2013, NUTRITION, V29, P178, DOI 10.1016/j.nut.2012.07.006; Mitani A, 2015, J PERIODONTOL, V86, P301, DOI 10.1902/jop.2014.140293; Morita Y, 2001, J CLIN INVEST, V107, P1275, DOI 10.1172/JCI11490; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; OFFENBACHER S, 1992, J PERIODONTAL RES, V27, P207, DOI 10.1111/j.1600-0765.1992.tb01670.x; Orsu P, 2013, J NEURAL TRANSM, V120, P1217, DOI 10.1007/s00702-013-0982-4; Padua TA, 2014, ARCH PHARM RES, V37, P1487, DOI 10.1007/s12272-014-0345-1; PAUL WE, 1991, BLOOD, V77, P1859; Petersen PE, 2012, PERIODONTOL 2000, V60, P15, DOI 10.1111/j.1600-0757.2011.00425.x; Preshaw PM, 2008, PERIODONTOL 2000, V48, P92, DOI 10.1111/j.1600-0757.2008.00252.x; Queiroz CM, 2012, J CLIN PERIODONTOL, V39, P608, DOI 10.1111/j.1600-051X.2012.01886.x; Ramamurthy HS, 2005, J PERIODONTOL, V76, P229, DOI 10.1902/jop.2005.76.2.229; Reddy Michael S, 2003, Ann Periodontol, V8, P12, DOI 10.1902/annals.2003.8.1.12; Ribeiro FV, 2012, BRAZ J ORAL SCI, V11, P42; Ribeiro J, 2005, J CLIN PERIODONTOL, V32, P412, DOI 10.1111/j.1600-051X.2005.00689.x; Riveiro-Naveira RR, 2016, RHEUMATOLOGY, V55, P1889, DOI 10.1093/rheumatology/kew255; Rotondo S, 1998, BRIT J PHARMACOL, V123, P1691, DOI 10.1038/sj.bjp.0701784; Rutten K, 2014, EUR J PAIN, V18, P204, DOI 10.1002/j.1532-2149.2013.00358.x; Santegoets KCM, 2016, ARTHRITIS RHEUMATOL, V68, P795, DOI 10.1002/art.39514; Sarkar S, 2007, ARTHRITIS RHEUM-US, V56, P89, DOI 10.1002/art.22311; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Shirai H, 2006, PROTEINS, V64, P1010, DOI 10.1002/prot.20863; Silvestre FJ, 2016, MED ORAL PATOL ORAL, V21, pE349, DOI 10.4317/medoral.20974; Silvestre-Rangil J, 2016, CLIN ORAL INVEST, V20, P2575, DOI 10.1007/s00784-016-1745-z; Soufi F G, 2012, Endocr Regul, V46, P83; Tang QQ, 2017, INT J PERIODONT REST, V37, P79, DOI 10.11607/prd.2656; TEVELDE AA, 1990, BLOOD, V76, P1392; Tobon GJ, 2010, J AUTOIMMUN, V35, P10, DOI 10.1016/j.jaut.2009.12.009; Tome-Carneiro J, 2013, PHARMACOL RES, V72, P69, DOI 10.1016/j.phrs.2013.03.011; Trombone AP, 2010, GENES IMMUN, V11, P479, DOI 10.1038/gene.2010.13; Tseng PC, 2011, J BONE MINER RES, V26, P2552, DOI 10.1002/jbmr.460; Vander Cruyssen B, 2005, AUTOIMMUN REV, V4, P468, DOI 10.1016/j.autrev.2005.04.018; Wahba MGF, 2016, PHARM BIOL, V54, P1705, DOI 10.3109/13880209.2015.1125931; Whitlock NC, 2012, NUTR CANCER, V64, P493, DOI 10.1080/01635581.2012.667862; Zhang CF, 2014, J ETHNOPHARMACOL, V153, P793, DOI 10.1016/j.jep.2014.03.046	81	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204414	10.1371/journal.pone.0204414	http://dx.doi.org/10.1371/journal.pone.0204414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281626	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400050
J	Contreras, G; Braun, MS; Schafer, H; Wink, M				Contreras, Gabriela; Braun, Markus Santhosh; Schaefer, Holger; Wink, Michael			Recombinant AfusinC, an anionic fungal CS alpha beta defensin from Aspergillus fumigatus, exhibits antimicrobial activity against gram-positive bacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI CYTOPLASM; PRECURSOR LIPID II; PEPTIDE; PROTEIN; EXPRESSION; PLECTASIN; BINDING; ANTIBIOTICS; PREDICTION; EVOLUTION	Antimicrobial peptides (AMPs) are short and generally positively charged peptides found in a wide variety of organisms. CS alpha beta defensins are a group of AMPs. These defensins are composed of an alpha-helix and a beta-sheet linked by three or four disulphide bridges. In this study, we describe the antimicrobial activity of an anionic CS alpha beta fungal defensin from Aspergillus fumigatus, AfusinC. AfusinC was recombinantly produced as a fusion protein in Escherichia coll. The tag was removed by proteolytic cleavage, and AfusinC was purified by size exclusion chromatography. About 0.8 mg of recombinant AfusinC was obtained from 1 L of culture. Recombinant AfusinC was active against mainly gram-positive bacteria including human pathogens and a multiresistant-strain of A. aureus. Additionally, AfusinC showed bactericidal effect against Micrococcus luteus.	[Contreras, Gabriela; Braun, Markus Santhosh; Schaefer, Holger; Wink, Michael] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Wink, M (corresponding author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany.	wink@uni-heidelberg.de	Wink, Michael/E-3803-2012	Wink, Michael/0000-0002-7875-4510; Contreras, Gabriela/0000-0002-5637-3004	CONICYT/BECAS CHILE scholarship [72150082]	CONICYT/BECAS CHILE scholarship	Gabriela Contreras was funded by a CONICYT/BECAS CHILE scholarship (72150082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminov RI, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00134; Aoki W, 2013, PHARMACEUTICALS-BASE, V6, P1055, DOI 10.3390/ph6081055; Barry AL, 1999, M26A NCCLS; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carvalho AD, 2009, PEPTIDES, V30, P1007, DOI 10.1016/j.peptides.2009.01.018; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Essig A, 2014, J BIOL CHEM, V289, P34953, DOI 10.1074/jbc.M114.599878; Fan XB, 2013, BIOTECHNOL J, V8, P1213, DOI 10.1002/biot.201300121; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Herbel V, 2015, MOLECULES, V20, P14889, DOI 10.3390/molecules200814889; Jungbauer A, 2007, J BIOTECHNOL, V128, P587, DOI 10.1016/j.jbiotec.2006.12.004; Lai R, 2004, BIOCHEM J, V379, P681, DOI 10.1042/BJ20031429; Munch D, 2015, BBA-BIOMEMBRANES, V1848, P3062, DOI 10.1016/j.bbamem.2015.04.014; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Oeemig JS, 2012, J BIOL CHEM, V287, P42361, DOI 10.1074/jbc.M112.382028; Romestand B, 2003, EUR J BIOCHEM, V270, P2805, DOI 10.1046/j.1432-1033.2003.03657.x; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Shafee TMA, 2017, CELL MOL LIFE SCI, V74, P663, DOI 10.1007/s00018-016-2344-5; Silva PM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00097; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wu JJ, 2014, PHARMACEUTICALS-BASE, V7, P866, DOI 10.3390/ph7080866; Wu YC, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160438; Xu XX, 2016, B ENTOMOL RES, V106, P790, DOI 10.1017/S0007485316000596; Zhang J, 2011, PROTEIN EXPRES PURIF, V78, P189, DOI 10.1016/j.pep.2011.04.014; Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354; Zhu SY, 2012, P NATL ACAD SCI USA, V109, P8495, DOI 10.1073/pnas.1201263109	37	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205509	10.1371/journal.pone.0205509	http://dx.doi.org/10.1371/journal.pone.0205509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308015	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500091
J	Lan, YS; Huang, ZY; Jiang, YJ; Zhou, XH; Zhang, JY; Zhang, DY; Wang, B; Hou, GQ				Lan, Yongsheng; Huang, Zhaoyuan; Jiang, Yanjie; Zhou, Xuehua; Zhang, Jingyu; Zhang, Dianyu; Wang, Bo; Hou, Guangqing			Strength exercise weakens aerobic exercise-induced cognitive improvements in rats	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; CELL-PROLIFERATION; PERFORMANCE; METABOLISM; QUALITY	Aerobic exercise improves cognitive function and adult hippocampal neurogenesis. However, the effects of aerobic exercise combined with strength exercise on cognitive function and adult hippocampal neurogenesis are still unknown. In this study, we established exercise paradigms in rats to mimic aerobic exercise combined with low- and high-intensity strength exercise. We found that aerobic exercise improved spatial learning and memory as well as adult hippocampal neurogenesis, whereas strength exercise suppressed aerobic exercise-induced cognitive improvements and adult hippocampal neurogenesis in an intensity-dependent manner. Furthermore, the levels of beta-hydroxybutyrate (beta-HB) and its downstream effector brain-derived neurotrophic factor (BDNF) were increased in the aerobic exercise group, and strength exercise impaired the aerobic exercise-induced increases in beta-HB and BDNF mRNA levels. Taken together, these results demonstrated that strength exercise weakened aerobic exercise-induced cognitive improvements and adult hippocampal neurogenesis in rats.	[Lan, Yongsheng; Huang, Zhaoyuan; Jiang, Yanjie; Zhou, Xuehua; Zhang, Jingyu; Zhang, Dianyu; Hou, Guangqing] Changchun Normal Univ, Coll Phys Educ, Changchun, Jilin, Peoples R China; [Wang, Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Orthopaed, Wuhan, Hubei, Peoples R China	Changchun Normal University; Huazhong University of Science & Technology	Hou, GQ (corresponding author), Changchun Normal Univ, Coll Phys Educ, Changchun, Jilin, Peoples R China.	48516085@qq.com	Zhang, Jing/GWZ-7332-2022		Nature Science Foundation of Changchun Normal University [20202814]; "Thirteen Five" science and technology research project of Jilin Province Education Department [2016-395]	Nature Science Foundation of Changchun Normal University; "Thirteen Five" science and technology research project of Jilin Province Education Department	This work was supported by: (1) 20202814 Nature Science Foundation of Changchun Normal University, the role of the funder was in data collection and analysis; (2) 2016-395 "Thirteen Five" science and technology research project of Jilin Province Education Department, the role of the funder was in preparation of the manuscript.	BOYD AE, 1974, METABOLISM, V23, P531, DOI 10.1016/0026-0495(74)90081-X; Brisswalter J, 2002, SPORTS MED, V32, P555, DOI 10.2165/00007256-200232090-00002; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Carolina N, 2009, PSYCHOSOM MED, V72, P239; Chapman SB, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00075; Choi SH, 2018, SCIENCE, V361, P991, DOI 10.1126/science.aan8821; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Cox PJ, 2016, CELL METAB, V24, P256, DOI 10.1016/j.cmet.2016.07.010; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gano LB, 2014, J LIPID RES, V55, P2211, DOI 10.1194/jlr.R048975; Gasior M, 2006, BEHAV PHARMACOL, V17, P431, DOI 10.1097/00008877-200609000-00009; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; ISSEKUTZ B, 1962, P SOC EXP BIOL MED, V110, P237; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Lee H, 2018, BEHAV BRAIN RES, V345, P59, DOI 10.1016/j.bbr.2018.01.017; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Marosi K, 2016, J NEUROCHEM, V139, P769, DOI 10.1111/jnc.13868; Marston KJ, 2017, J SCI MED SPORT; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mosti MP, 2014, J STRENGTH COND RES, V28, P2935, DOI 10.1519/JSC.0000000000000493; Mustroph ML, 2012, NEUROSCIENCE, V219, P62, DOI 10.1016/j.neuroscience.2012.06.007; Nilsen TS, 2015, ACTA ONCOL, V54, P1805, DOI 10.3109/0284186X.2015.1037008; Nokia MS, 2016, J PHYSIOL-LONDON, V594, P1855, DOI 10.1113/JP271552; Gomes FGN, 2014, PSYCHONEUROENDOCRINO, V50, P106, DOI 10.1016/j.psyneuen.2014.08.009; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; PERSSON B, 1970, SCAND J CLIN LAB INV, V25, P9, DOI 10.3109/00365517009046184; Pinnock SB, 2010, EUROPEAN J NEUROSCIE, V27, P2493; Pinto RS, 2014, AGE, V36, P365, DOI 10.1007/s11357-013-9567-2; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sleiman SF, 2016, ELIFE, V5, DOI 10.7554/eLife.15092; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vilela TC, 2016, MOL NEUROBIOL, V1, DOI [10.1007/s12035-014-8981-5, DOI 10.1007/S12035-014-8981-5]; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012	35	14	14	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205562	10.1371/journal.pone.0205562	http://dx.doi.org/10.1371/journal.pone.0205562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304037	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100001
J	Pan, Q; Law, COK; Yung, MMH; Han, KC; Pon, YL; Lau, TCK				Pan, Qing; Law, Carmen O. K.; Yung, Mingo M. H.; Han, K. C.; Pon, Yuen Lam; Lau, Terrence Chi Kong			Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity	PLOS ONE			English	Article							NUCLEIC-ACID APTAMERS; CARCINOEMBRYONIC ANTIGEN; DNA APTAMERS; QUANTITATIVE SELECTION; EVOLUTION; LIGANDS; CELLS	Gastric cancer is the third most common cause of death from cancer in the world and it remains difficult to cure in Western countries, primarily because most patients present with advanced disease. Currently, CEA, CA50 and CA72-4 are commonly used as tumor markers for gastric cancer by immunoassays. However, the drawback and conundrum of immunoassay are the unceasing problem in standardization of quality of antibodies and time/effort for the intensive production. Therefore, there is an urgent need for the development of a standardized assay to detect gastric cancer at the early stage. Aptamers are DNA or RNA oligonucleotides with structural domain which recognize ligands such as proteins with superior affinity and specificity when compared to antibodies. In this study, SELEX (Systematic Evolution of Ligands by Exponential enrichment) technique was adopted to screen a random 30mer RNA library for aptamers targeting CEA, CA50 and CA72-4 respectively. Combined with high-throughput sequencing, we identified 6 aptamers which specifically target for these three biomarkers of gastrointestinal cancer. Intriguingly, the predicted secondary structures of RNA aptamers from each antigen showed significant structural similarity, suggesting the structural recognition between the aptamers and the antigens. Moreover, we determined the dissociation constants of all the aptamers to their corresponding antigens by fluorescence spectroscopy, which further demonstrated high affinities between the aptamers and the antigens. In addition, immunostaining of gastric adenocarcinoma cell line AGS using CEA Aptamer probe showed positive fluorescent signal which proves the potential of the aptamer as a detection tool for gastric cancer. Furthermore, substantially decreased cell viability and growth were observed when human colorectal cell line LS-174T was transfected with each individual aptamers. Taking together, these novel RNA aptamers targeting gastrointestinal cancer biomarker CEA, CA50 and CA72-4 will aid further development and standardization of clinical diagnostic method with better sensitivity and specificity, and potentially future therapeutics development of gastric cancer.	[Pan, Qing; Law, Carmen O. K.; Yung, Mingo M. H.; Han, K. C.; Pon, Yuen Lam; Lau, Terrence Chi Kong] City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China	City University of Hong Kong	Lau, TCK (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China.	chiklau@cityu.edu.hk	Lau, Terrence/ABB-7900-2021; Pan, Qing/O-1168-2015; YUNG, Mingo Ming Ho/AHB-5775-2022	Lau, Terrence/0000-0002-7505-7306; Pan, Qing/0000-0002-4372-5349; YUNG, Mingo Ming Ho/0000-0003-0903-1164	General Research Fund Early Career Scheme [CityU 189813]; ITF Fund [9440086]; Ivorist Scientific Tech (Hong Kong) Company Limited; Shenzhen New Industries Biomedical Engineering CO., Ltd.	General Research Fund Early Career Scheme; ITF Fund; Ivorist Scientific Tech (Hong Kong) Company Limited; Shenzhen New Industries Biomedical Engineering CO., Ltd.	This work was funded and supported by General Research Fund Early Career Scheme CityU 189813 to TCKL, ITF Fund 9440086 to TCKL, Ivorist Scientific Tech (Hong Kong) Company Limited, and Shenzhen New Industries Biomedical Engineering CO., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezhnoy A, 2012, MOL THERAPY J AM SOC, P6; Blind M, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2014.74; Bunworasate Udomska, 1995, Journal of the Medical Association of Thailand, V78, P255; Cao HY, 2014, ONCOL REP, V32, P2054, DOI 10.3892/or.2014.3411; Cho M, 2013, P NATL ACAD SCI USA, V110, P18460, DOI 10.1073/pnas.1315866110; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; FRYKHOLM G, 1991, IN VITRO CELL DEV B, V27, P900; Hall B., 2009, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB2402588; Huang CJ, 2010, BIOSENS BIOELECTRON, V25, P1761, DOI 10.1016/j.bios.2009.12.029; Huang YZ, 2012, MOL PHARMACOL, V82, P623, DOI 10.1124/mol.112.078220; Hung LY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10326; Jiang YX, 2004, ANAL CHEM, V76, P5230, DOI 10.1021/ac049565u; JOHNSON VG, 1986, CANCER RES, V46, P850; Kong HY, 2013, BIOMOL THER, V21, P423, DOI 10.4062/biomolther.2013.085; Lai HC, 2014, LAB CHIP, V14, P2002, DOI 10.1039/c4lc00187g; Lee YJ, 2012, GASTROENTEROLOGY, P1; Li WM, 2014, BIOMATERIALS, P25; Ma HT, 2015, CHEM SOC REV, V44, P1240, DOI 10.1039/c4cs00357h; Malati T, 2007, INDIAN J CLIN BIOCHE, V22, P17, DOI 10.1007/BF02913308; Musumeci D, 2017, CANCERS, V9, DOI 10.3390/cancers9120174; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Oh SS, 2011, ANAL CHEM, V83, P6883, DOI 10.1021/ac201269f; Orava EW, 2013, MOL ONCOL, V7, P799, DOI 10.1016/j.molonc.2013.03.005; Qian JR, 2009, ANAL CHEM, V81, P5490, DOI 10.1021/ac900759k; Ruhaak LR, 2013, MOL CELL PROTEOMICS, V12, P846, DOI 10.1074/mcp.R112.026799; Schutze T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029604; SHEER DG, 1988, CANCER RES, V48, P6811; SHI ZR, 1983, CANCER RES, V43, P4045; Sturgeon C, 2016, SCAND J CLIN LAB INV, V76, pS94, DOI 10.1080/00365513.2016.1210334; Sun HG, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.32; 't Hoen PAC, 2012, ANAL BIOCHEM, V421, P622, DOI 10.1016/j.ab.2011.11.005; TERRY WD, 1974, TRANSPLANT REV, V20, P100; Thiel KW, 2012, NUCLEIC ACIDS RES, P13; Thiel WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043836; Thomas SN, 2008, J BIOL CHEM, V283, P15647, DOI 10.1074/jbc.M800543200; Ulrich H, 2009, CYTOM PART A, V75A, P727, DOI 10.1002/cyto.a.20766; Yoon S, 2018, ADV DRUGS DELIVERY R, P30167; Zimmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009169; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	39	11	14	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0198980	10.1371/journal.pone.0198980	http://dx.doi.org/10.1371/journal.pone.0198980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303958	gold, Green Submitted, Green Published			2022-12-26	WOS:000446921100006
J	Seifert, R; Kuhlmann, MT; Eligehausen, S; Kiefer, F; Hermann, S; Schafers, M				Seifert, Robert; Kuhlmann, Michael T.; Eligehausen, Sarah; Kiefer, Friedemann; Hermann, Sven; Schafers, Michael			Molecular imaging of MMP activity discriminates unstable from stable plaque phenotypes in shear-stress induced murine atherosclerosis	PLOS ONE			English	Article							STABILITY; LESION	Purpose As atherosclerotic plaque ruptures are the primary cause of ischaemic events, their preventive identification by imaging remains a clinical challenge. Matrix metalloproteinases (MMP) are involved in plaque progression and destabilisation and are therefore promising targets to characterize rupture-prone unstable plaques. This study aims at evaluating MMP imaging to discriminate unstable from stable plaque phenotypes. Methods ApoE deficient mice (ApoE(-/-)) on a high cholesterol diet underwent implantation of a tapered cuff around the right common carotid artery (CCA) inducing a highly inflamed atherosclerotic plaque upstream (US) and a more stable plaque phenotype downstream (DS) of the cuff. 8 weeks after surgery, the MMP inhibitor-based photoprobe Cy5.5-AF443 was administered i.v. 3h prior to in situ and ex vivo fluorescence reflectance imaging of the CCAs. Thereafter, CCAs were analysed regarding plaque size, presence of macrophages, and MMP-2 and MMP-9 concentrations by immunohistochemistry and ELISA. Results We found a significantly higher uptake of Cy5.5-AF443 in US as compared to DS plaques in situ (1.29 vs. 1.06 plaque-to-background ratio; p<0.001), which was confirmed by ex vivo measurements. Immunohistochemistry revealed a higher presence of macrophages, MMP-2 and MMP-9 in US compared to DS plaques. Accordingly, MMP-2 concentrations were significantly higher in US plaques (47.2 +/- 7.6 vs. 29.6 +/- 4.6 ng/mg; p<0.05). Conclusions In the ApoE(-/-) cuff model MMP-2 and MMP-9 activities are significantly higher in upstream low shear stress-induced unstable atherosclerotic plaques as compared to downstream more stable plaque phenotypes. MMP inhibitor-based fluorescence molecular imaging allows visualization of these differences in shear stress-induced atherosclerosis.	[Seifert, Robert; Kuhlmann, Michael T.; Eligehausen, Sarah; Kiefer, Friedemann; Hermann, Sven; Schafers, Michael] Univ Munster, EIMI, Munster, Germany; [Seifert, Robert; Schafers, Michael] Univ Hosp Munster, Dept Nucl Med, Munster, Germany; [Kiefer, Friedemann; Hermann, Sven; Schafers, Michael] Univ Munster, DFG EXC Cluster Excellence Cells Mot 1003, Munster, Germany; [Kiefer, Friedemann] Max Planck Inst Mol Biomed, Munster, Germany	University of Munster; University of Munster; University of Munster; Max Planck Society	Seifert, R (corresponding author), Univ Munster, EIMI, Munster, Germany.; Seifert, R (corresponding author), Univ Hosp Munster, Dept Nucl Med, Munster, Germany.	robert.seifert@uni-muenster.de		Kiefer, Friedemann/0000-0002-3002-8237	Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 656]; Open Access Publication Fund of University of Muenster	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of University of Muenster	The study was funded by the Deutsche Forschungsgemeinschaft (DFG), Sonderforschungsbereich 656 'Cardiovascular Molecular Imaging' projects C06 & C10. We acknowledge support by Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala G, 2016, EUR HEART J-CARD IMG, V17, P1001, DOI 10.1093/ehjci/jev346; Bettenworth D, 2016, CLIN EXP METASTAS, V33, P551, DOI 10.1007/s10585-016-9797-7; Bom MJ, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005973; Cheng C, 2005, BLOOD, V106, P3691, DOI 10.1182/blood-2005-06-2326; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; Debernardi N, 2010, INT J EXP PATHOL, V91, P485, DOI 10.1111/j.1365-2613.2010.00729.x; Faust A, 2008, BIOCONJUGATE CHEM, V19, P1001, DOI 10.1021/bc700409j; Fraga-Silva RA, 2015, VASC PHARMACOL, V74, P103, DOI 10.1016/j.vph.2015.08.014; Gerwien H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8020; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Heo SH, 2011, J CLIN NEUROL, V7, P69, DOI 10.3988/jcn.2011.7.2.69; Hermann S, 2012, J NUCL CARDIOL, V19, P609, DOI 10.1007/s12350-012-9553-6; Hong J, 2016, THROMB RES, V137, P148, DOI 10.1016/j.thromres.2015.11.010; Jager NA, 2016, MOL IMAGING BIOL, V18, P283, DOI 10.1007/s11307-015-0882-0; Khamis RY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21785; Kuhlmann MT, 2012, JOVE-J VIS EXP, DOI 10.3791/3308; Laurberg JM, 2007, ATHEROSCLEROSIS, V192, P275, DOI 10.1016/j.atherosclerosis.2006.07.019; Lebel Rejean, 2014, Contrast Media Mol Imaging, V9, P187, DOI 10.1002/cmmi.1555; Mateo J, 2014, CIRC-CARDIOVASC IMAG, V7, P312, DOI 10.1161/CIRCIMAGING.113.001084; Pan JJ, 2013, INT J CARDIOL, V168, P1691, DOI 10.1016/j.ijcard.2013.03.073; Press MAC, 2017, EUR HEART J-CARD IMG, V18, P510, DOI 10.1093/ehjci/jew228; Roth L, 2016, VASC PHARMACOL, V80, P50, DOI 10.1016/j.vph.2016.01.007; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shalhoub J, 2016, THROMB HAEMOSTASIS, V115, P1064, DOI 10.1160/TH15-08-0650; Stein-Merlob AF, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005813; Steingraber AK, 2013, EXP DERMATOL, V22, P730, DOI 10.1111/exd.12253; Tarkin JM, 2014, NAT REV CARDIOL, V11, P443, DOI 10.1038/nrcardio.2014.80; Toutouzas K, 2015, EUR HEART J, V36, P3147, DOI 10.1093/eurheartj/ehv508; Verhagen SN, 2011, ATHEROSCLEROSIS, V214, P3, DOI 10.1016/j.atherosclerosis.2010.05.034; Wagner S, 2006, CURR MED CHEM, V13, P2819, DOI 10.2174/092986706778522002; Wenning C, 2014, ATHEROSCLEROSIS, V234, P276, DOI 10.1016/j.atherosclerosis.2014.03.008; Wenning C, 2011, CURR CARDIOVASC IMAG, V4, P190, DOI 10.1007/s12410-011-9083-7; Winkel LC, 2015, ATHEROSCLEROSIS, V241, P100, DOI 10.1016/j.atherosclerosis.2015.04.796	34	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204305	10.1371/journal.pone.0204305	http://dx.doi.org/10.1371/journal.pone.0204305			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304051	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100039
J	Zeng, X; Liu, J; Zhao, JF				Zeng, Xu; Liu, Jun; Zhao, Jianfu			Highly efficient degradation of pharmaceutical sludge by catalytic wet oxidation using CuO-CeO2/gamma-Al2O3 as a catalyst	PLOS ONE			English	Article							AIR OXIDATION; WASTE-WATER; SEWAGE-SLUDGE; TECHNOLOGY; PHENOL; ACIDS	Pharmaceutical sludge is considered as a hazardous material with high treatment and disposal costs. In the present study, the catalytic wet oxidation (CWO) of pharmaceutical sludge by CuO-CeO2/gamma-Al2O3 as the catalyst was investigated. The catalyst was prepared by traditional wet impregnation. The catalyst was characterized using X-ray Powder Diffraction (XRD) and Scanning Electron Microscopy (SEM). CWO was performed in an experimental batch reactor. Several parameters that could affect the catalytic degradation efficiency, including catalyst dose, temperature, time, oxygen pressure and pH, were investigated. Under optimum conditions, the highest removal rate of volatile suspended solids (VSS) was 87.3% and was achieved at 260 degrees C for 60 min with an oxygen pressure of 1.0 MPa and 10 g/L of catalyst. At the same time, the chemical oxygen demand (COD) removal rate reached as high as 72.6%. This work implies that catalytic wet oxidation is a promising method for the highly efficient degradation of pharmaceutical sludge.	[Zeng, Xu; Liu, Jun; Zhao, Jianfu] Tongji Univ, Coll Environm Sci & Engn, State Key Lab Pollut Control & Resources Reuse, Shanghai, Peoples R China	Tongji University	Zeng, X (corresponding author), Tongji Univ, Coll Environm Sci & Engn, State Key Lab Pollut Control & Resources Reuse, Shanghai, Peoples R China.	zengxu@tongji.edu.cn						Albuquerque AS, 2012, CERAM INT, V38, P2225, DOI 10.1016/j.ceramint.2011.10.071; Arora PK, 2016, J CHEM-NY, V2016, DOI 10.1155/2016/7589068; Arora PK, 2014, J HAZARD MATER, V266, P42, DOI 10.1016/j.jhazmat.2013.12.011; Arora PK, 2012, APPL MICROBIOL BIOT, V93, P2265, DOI 10.1007/s00253-012-3927-1; Bernardi M, 2010, CATAL TODAY, V157, P420, DOI 10.1016/j.cattod.2010.01.030; Chen YS, 2013, CHEMOSPHERE, V93, P1765, DOI 10.1016/j.chemosphere.2013.06.007; Chung J, 2009, J HAZARD MATER, V162, P10, DOI 10.1016/j.jhazmat.2008.05.038; GASSO S, 1995, WASTE MANAGE RES, V13, P37, DOI 10.1177/0734242X9501300105; Gomes HT, 2002, J MOL CATAL A-CHEM, V182, P47, DOI 10.1016/S1381-1169(01)00475-7; Huang K, 2015, RSC ADV, V5, P32795, DOI 10.1039/c5ra01707f; Jia A, 2012, WATER RES, V46, P387, DOI 10.1016/j.watres.2011.10.055; Kaya Y, 2013, J MEMBRANE SCI, V442, P72, DOI 10.1016/j.memsci.2013.03.059; Lefevre S, 2011, CHEMOSPHERE, V84, P1208, DOI 10.1016/j.chemosphere.2011.05.049; Levec J, 2007, CATAL TODAY, V124, P172, DOI 10.1016/j.cattod.2007.03.035; Luck F, 1999, CATAL TODAY, V53, P81, DOI 10.1016/S0920-5861(99)00112-1; Ma CJ, 2017, RSC ADV, V7, P27079, DOI 10.1039/c7ra04037g; MAYABHATE SP, 1988, WATER AIR SOIL POLL, V38, P189; McClellan K, 2010, WATER RES, V44, P658, DOI 10.1016/j.watres.2009.12.032; Ribeiro RS, 2015, CATAL TODAY, V249, P204, DOI 10.1016/j.cattod.2014.10.004; Serikawa RM, 2007, J HAZARD MATER, V146, P646, DOI 10.1016/j.jhazmat.2007.04.107; Slavik E, 2015, DRY TECHNOL, V33, P1309, DOI 10.1080/07373937.2015.1036282; Stuber F, 2011, APPL CATAL B-ENVIRON, V110, P81, DOI 10.1016/j.apcatb.2011.08.029; Tu YT, 2014, J HAZARD MATER, V276, P88, DOI 10.1016/j.jhazmat.2014.05.024; Wang GW, 2012, J HAZARD MATER, V217, P366, DOI 10.1016/j.jhazmat.2012.03.044; Wei HZ, 2013, J HAZARD MATER, V244, P478, DOI 10.1016/j.jhazmat.2012.10.069; Yang SX, 2010, J HAZARD MATER, V178, P786, DOI 10.1016/j.jhazmat.2010.02.009; Yin FB, 2015, BIORESOURCE TECHNOL, V177, P188, DOI 10.1016/j.biortech.2014.11.091; Zhan W, 2013, WATER SCI TECHNOL, V67, P2281, DOI 10.2166/wst.2013.123; Zhang B, 2016, RSC ADV, V6, P66027, DOI 10.1039/c6ra08576h	29	7	8	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0199520	10.1371/journal.pone.0199520	http://dx.doi.org/10.1371/journal.pone.0199520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30303969	Green Published, gold, Green Submitted			2022-12-26	WOS:000446921100007
J	Kaur, M; Gupta, M; Purayil, VP; Rana, M; Chakrapani, V				Kaur, Manmeet; Gupta, Madhu; Purayil, Vijin Pandara; Rana, Monica; Chakrapani, Venkatesan			Contribution of social factors to maternal deaths in urban India: Use of care pathway and delay models	PLOS ONE			English	Article							MORTALITY; INTERVENTIONS; CHANDIGARH; CHILD	This paper uses care pathway and delay models to better understand the possible social reasons for maternal deaths in a city with good public and private health infrastructure. The findings can inform programmes to reduce maternal mortality. During 2007-15, 136 maternal deaths were reported in Chandigarh, India. Using World Health Organisation's verbal autopsy questionnaire, interviews were conducted with primary caregivers of 68 (50%) of the 136 deceased women, as majority of the families had returned to their native places. We used process-tracing techniques to construct the care pathways and identify delays, and explored open-ended responses using thematic analysis. The mean age of the deceased women was 27 years, 51% resided in slums, 32% were primigravida, 25% had their deliveries assisted by traditional birth attendants, and 23% had Caesarean section. Eight percent died at home, and 54% died in tertiary level facilities. Post-partum haemorrhage (26.5%), and complications of puerperium (25%) and labour/delivery (14.7%) were the reported medical causes. Male child preference and norms for home delivery were identified as the distal socio-cultural causes. Individual and family level factors included: shame on multiple pregnancies; fear of discrimination from providers; past successful deliveries at home leading to overconfidence and not seeking institutional care; and lack of awareness about family planning, antenatal care, and danger signs of pregnancy. Healthcare system factors were: non-availability of senior doctors at the time of consultation in the emergency that delayed initiation of immediate treatment, and lack of availability of life-saving equipment due to patient load. Empirical evidence was found on social causes of maternal deaths, which could have been prevented by appropriate actions at individual, family, societal, institutional and policy levels. This study identified potential preventable causes of primarily social origin, which could help in taking actionable steps at several levels to further reduce maternal deaths in India.	[Gupta, Madhu] Postgrad Inst Med Educ & Res PGIMER, Dept Community Med, Chandigarh, India; Postgrad Inst Med Educ & Res PGIMER, Sch Publ Hlth, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Gupta, M (corresponding author), Postgrad Inst Med Educ & Res PGIMER, Dept Community Med, Chandigarh, India.	madhugupta21@gmail.com	Chakrapani, Venkatesan/P-8056-2014	Chakrapani, Venkatesan/0000-0001-9998-9135; Gupta, Madhu/0000-0003-3877-9956	Health and Family Welfare, Chandigarh Administration [MH-IV-2008/27/3/18]	Health and Family Welfare, Chandigarh Administration	This work was supported by Health and Family Welfare, Chandigarh Administration - no. MH-IV-2008/27/3/18 to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The project was sanctioned to Prof Madhu Gupta (MG).	[Anonymous], 2010, SCI IIOP DISTR LEV H; Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1; Beach Derek., 2019, PROCESS TRACING METH; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Calvello EJ, 2015, B WORLD HEALTH ORGAN, V93, P417, DOI 10.2471/BLT.14.146571; Dhaliwal T., 2015, HINDUSTAN TIMES; Diamond-Smith NG, 2016, FOOD NUTR BULL, V37, P132, DOI 10.1177/0379572116637721; Goldenberg RL, 2012, LANCET, V379, P1178, DOI 10.1016/S0140-6736(12)60474-7; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Gupta M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170175; Gupta M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150537; Gwatkin D R, 2007, Niger J Clin Pract, V10, P272; International Institute for Sciences, 2016, NAT FAM HLTH SURV 4, V4, P2015; Kaur M, 2015, INT J MIGR HEALTH SO, V11, P147, DOI 10.1108/IJMHSC-03-2014-0010; Mathur A, 2014, BJOG-INT J OBSTET GY, V121, P67, DOI 10.1111/1471-0528.13001; *MIN HLTH FAM WELF, 2013, ANN REPORT; Ministry of Health and Family Welfare, 2013, NAT URB HLTH MISS FR; Ministry of Health and Family Welfare (MoHFW), 2013, STRAT APPR REP MAT N; Montgomery AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083331; Office of the Registrar General & Census Commissioner I, 2017, CENS DAT; Rani, 2017, INT J REPROD CONTRAC, V6, P575; Sarker BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146161; Schiffman J, 2010, SEMINARS PERINATOLOG; School of Public Health, 2016, IMPR MON IND REPR CH; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044931; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037037; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Thorsen VC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052090; United Nations, 2017, SUST DEV GOAL 3, V3; Vanhaecht K, 2010, INT J CARE COORD, V14, P117, DOI 10.1258/jicp.2010.010019; WHO, 2014, SUC FACT WOM CHILDR; WHO, INT STAND VERB AUT Q; WHO, 2014, MAT MORT FACT SHEET, V4; World Health Organization, PARTN MAT NEWB CHILD; World Health Organization, ICD 10 VERS 2010 INT	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0203209	10.1371/journal.pone.0203209	http://dx.doi.org/10.1371/journal.pone.0203209			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300352	Green Published, gold, Green Submitted			2022-12-26	WOS:000446897200005
J	Musoke, D; Miiro, G; Ndejjo, R; Karani, G; Morris, K; Kasasa, S; Nakiyingi-Miiro, J; Guwatudde, D; Musoke, MB				Musoke, David; Miiro, George; Ndejjo, Rawlance; Karani, George; Morris, Keith; Kasasa, Simon; Nakiyingi-Miiro, Jessica; Guwatudde, David; Musoke, Miph Boses			Malaria prevention practices and associated environmental risk factors in a rural community in Wakiso district, Uganda	PLOS ONE			English	Article							VECTOR CONTROL; MANAGEMENT; AFRICA; KNOWLEDGE; ETHIOPIA; TRANSMISSION; MOSQUITOS; EXPOSURE; NETS	Background Besides use of insecticide-treated mosquito nets (ITNs) and indoor residual spraying (IRS), other complimentary measures including suitable housing structures, and environmental management that reduce breeding of malaria vectors, can be implemented at households to prevent the disease. However, most studies on malaria prevention have focused mainly on ITNs and IRS. The aim of this study was therefore to assess malaria prevention practices beyond ITNs and IRS, and associated environmental risk factors including housing structure in rural Wakiso district, Uganda. Methods A clustered cross-sectional survey was conducted among 727 households in Wakiso district. Data were collected using an interviewer-administered questionnaire and observational checklist. The questionnaire assessed participants' household practices on malaria prevention, whereas the checklist recorded environmental risk factors for malaria transmission, and structural condition of houses. Poisson regression modeling was used to identify factors associated with use of mosquito nets by households. Results Of the 727 households, 471 (64.8%) owned at least one mosquito net. Use of mosquito nets by households was higher with increasing education level of participants-primary (aPR = 1.27[95% CI: 1.00-1.60]), secondary (ordinary level) (aPR = 1.47[95% CI: 1.16-1.85]) and advanced level/tertiary (aPR = 1.55 [95% CI: 1.19-2.01]), and higher household income (aPR = 1.09 [95% CI: 1.00-1.20]). Additionally, participants who were not employed were less likely to have mosquito nets used in their households (aPR = 0.83 [95% CI: 0.70-0.98]). Houses that had undergone IRS in the previous 12 months were 42 (5.8%), while 220 (43.2%) households closed their windows before 6.00 pm. Environmental risk factors found at households included presence of vessels that could potentially hold water for mosquito breeding 414 (56.9%), and stagnant water in compounds 144 (19.8%). Several structural deficiencies on houses that could promote entry of mosquitoes were found such as lack of screening in ventilators 645 (94.7%), and external doors not fitting perfectly into walls hence potential for mosquito entry 305 (42.0%). Conclusion There is need to increase coverage and utilisation of ITNs and IRS for malaria prevention in Wakiso district, Uganda. In addition, other malaria prevention strategies such as environmental management, and improving structural condition of houses are required to strengthen existing malaria prevention approaches.	[Musoke, David; Ndejjo, Rawlance] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Miiro, George] Uganda Virus Res Inst, Entebbe, Uganda; [Karani, George; Morris, Keith] Cardiff Metropolitan Univ, Cardiff Sch Hlth Sci, Cardiff, S Glam, Wales; [Kasasa, Simon; Guwatudde, David] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Nakiyingi-Miiro, Jessica] Uganda Virus Res Inst, MRC, Entebbe, Uganda; [Musoke, Miph Boses] Nkumba Univ, Sch Sci, Entebbe, Uganda	Makerere University; Uganda Virus Research Institute; Cardiff Metropolitan University; Cardiff University; Makerere University; Uganda Virus Research Institute	Musoke, D (corresponding author), Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Dept Dis Control & Environm Hlth, Kampala, Uganda.	dmusoke@musph.ac.ug		Musoke, David/0000-0003-3262-3918; Ndejjo, Rawlance/0000-0001-9263-557X	Training Health Researchers into Vocational Excellence (THRiVE) in East Africa - Wellcome Trust [087540]; TDR, the Special Programme for Research and Training in Tropical Diseases; UNICEF; UNDP; World Bank; WHO; Africa Research Excellence Fund (AREF) [MUSOKEMRF-157-0013-F-MUSOK]	Training Health Researchers into Vocational Excellence (THRiVE) in East Africa - Wellcome Trust; TDR, the Special Programme for Research and Training in Tropical Diseases; UNICEF; UNDP; World Bank(The World Bank India); WHO(World Health Organization); Africa Research Excellence Fund (AREF)	The work was supported by Training Health Researchers into Vocational Excellence (THRiVE) in East Africa, grant number 087540, funded by Wellcome Trust. This investigation also received financial support from TDR, the Special Programme for Research and Training in Tropical Diseases, co-sponsored by UNICEF, UNDP, the World Bank and WHO. DM received support from the Africa Research Excellence Fund (AREF) grant number MUSOKEMRF-157-0013-F-MUSOK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleme A, 2014, ETHIOP J HEALTH SCI, V24, P75, DOI 10.4314/ejhs.v24i1.10; Animut A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-393; [Anonymous], 2010, UG MAL IND SURV 2009; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], 2007, INS TREAT MOSQ NETS; AULT SK, 1994, AM J TROP MED HYG, V50, P35, DOI 10.4269/ajtmh.1994.50.35; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bonds JAS, 2012, MED VET ENTOMOL, V26, P121, DOI 10.1111/j.1365-2915.2011.00992.x; Bradley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080626; Eisele TP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-36; Eyobo MB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-45; Fokam EB, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4155-5; Govere J, 2000, S AFR MED J, V90, P611; Huho B, 2013, INT J EPIDEMIOL, V42, P235, DOI 10.1093/ije/dys214; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Kaufman MR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-220; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6; Liu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087358; Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57; Massebo F, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-319; Moon TD, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1250-5; Musoke D, 2015, AFR HEALTH SCI, V15, P401, DOI 10.4314/ahs.v15i2.13; Musoke D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122699; Noland GS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-168; Okech BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004050; Parmet S, 2007, MALARIA, V297, P2310; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Raghavendra K, 2011, PARASITOL RES, V108, P757, DOI 10.1007/s00436-010-2232-0; Randell HF, 2010, ECOHEALTH, V7, P507, DOI 10.1007/s10393-010-0343-9; Rhee M, 2005, East Afr Med J, V82, P396; Rodriguez AD, 2006, SALUD PUBLICA MEXICO, V48, P317; Salem OASM, 2013, J VECTOR DIS, V50, P302; SNOW WF, 1987, MED VET ENTOMOL, V1, P9, DOI 10.1111/j.1365-2915.1987.tb00318.x; Uganda Bureau of Statistics (UBOS) and ICF International, 2015, UG MAL IND SURV 2014; Wale M, 2016, J VECTOR DIS, V53, P215; Warrell DA, 2002, ESSENTIAL MALARIOLOG; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; WHO, 2004, WHOCDSCPEPVC200410; WHO, 2015, WORLD MAL REP 2015; World Health Organization, 2017, DEPRESSION; Yeka A, 2012, ACTA TROP, V121, P184, DOI 10.1016/j.actatropica.2011.03.004; Yohannes M, 2005, TROP MED INT HEALTH, V10, P1274, DOI 10.1111/j.1365-3156.2005.01512.x; ZIBA C, 1994, TROP MED PARASITOL, V45, P70; 2013, WORLD MAL REP 2013, P1	47	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205210	10.1371/journal.pone.0205210	http://dx.doi.org/10.1371/journal.pone.0205210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300396	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000446897200046
J	Khoa, DB; Thong, BX; Liem, NV; Hoist, N; Kristensen, M				Dao Bach Khoa; Bui Xuan Thong; Nguyen Van Liem; Hoist, Niels; Kristensen, Michael			Variation in susceptibility of eight insecticides in the brown planthopper Nilaparvata lugens in three regions of Vietnam 2015-2017	PLOS ONE			English	Article							FIELD-EVOLVED RESISTANCE; 2 RICE PLANTHOPPERS; SOGATELLA-FURCIFERA; HEMIPTERA DELPHACIDAE; CHITIN BIOSYNTHESIS; DETOXIFYING ENZYMES; EAST-ASIA; POPULATIONS; STAL; BUPROFEZIN	The brown planthopper (BPH), Nilaparvata lugens, is a serious threat to rice production in Vietnam and insecticides are widely used for its control. Migration of the BPH have one of its roots in tropical Vietnam in the Mekong River Delta and the insecticide resistance status of BPH populations from Vietnam is thus important for East Asia. In the present investigation, we evaluate the susceptibility of BPH populations from nine provinces from the Red River Delta, the Central Coastal region and the Mekong River Delta of eight insecticides during 2015-17. BPH field populations of Vietnam have developed a low to moderate level of resistance to the neonicotinoids dinotefuran, nitenpyram and imidacloprid, the pyrethroid etofenprox, the anticholinesterase fenobucarb, as well as fipronil and pymetrozine, and the growth regulator buprofezin. There was a correlation of in toxicology of fipronil, dinotefuran, etofenprox, buprofezin, which represents four different modes of action. The neonicotinoid nitenpyram, pymetrozine and fenobucarb did not show correlation in toxicology to any of the investigated insecticides. For most insecticides, a gradient of susceptibility was established from the Red River Delta in the north, through the Central Coastal region and to the Mekong River Delta in the south of Vietnam. The most susceptible populations were from the north. Insecticide resistance of the BPH populations in Vietnam is not at an alarming level and they are not the direct origin of high insecticide resistance found in East Asia. The cross-resistance pattern of BPH populations in Vietnam, where insecticides with different modes of action correlated, indicate that insecticides should be used with caution. There could be a buildup of a general metabolic resistance, which alone or in combination with the emergence of target-site resistance mutations will cause control problems. The results will be beneficial for development of resistance management strategies to prevent and delay development of insecticide resistance in BPH not only for Vietnam, but also for more northern Asian regions due the migration of BPH from tropical Vietnam.	[Dao Bach Khoa; Bui Xuan Thong; Nguyen Van Liem] Plant Protect Res Inst, Hanoi, Vietnam; [Hoist, Niels; Kristensen, Michael] Aarhus Univ, Dept Agroecol, Slagelse, Denmark	Aarhus University	Kristensen, M (corresponding author), Aarhus Univ, Dept Agroecol, Slagelse, Denmark.	mikr@agro.au.dk	Kristensen, Michael/F-5536-2016	Kristensen, Michael/0000-0001-7332-3490; Holst, Niels/0000-0002-8414-6773	Denmark's development cooperation DANIDA as part of the Denmark - Vietnam Research Cooperation Programme (RCP) 2013 [14-P01-VIE]	Denmark's development cooperation DANIDA as part of the Denmark - Vietnam Research Cooperation Programme (RCP) 2013	This work was funded by Denmark's development cooperation DANIDA (http://dfcentre.com/research/) as part of the Denmark - Vietnam Research Cooperation Programme (RCP) 2013, Project: 14-P01-VIE.	Catindig J. L., 2009, PLANTHOPPERS NEW THR, P191; Chen C. C., 1981, International Rice Research Newsletter, V6, P13; Cheng J., 2009, PLANTHOPPERS NEW THR, P157; Escalada M. M., 2009, PLANTHOPPERS NEW THR, P447; Garrood WT, 2016, PEST MANAG SCI, V72, P140, DOI 10.1002/ps.3980; Gorman K, 2008, PEST MANAG SCI, V64, P1122, DOI 10.1002/ps.1635; Hemingway J, 1999, INT J PEST MANAGE, V45, P215, DOI 10.1080/096708799227824; Heong K. L., 2015, RICE PLANTHOPPERS, P65, DOI DOI 10.1007/978-94-017-9535; Heong K. L, 2009, PLANTHOPPERS NEW THR, P221; Hibino H., 1979, Review of Plant Protection Research, V12, P98; HOLM S, 1979, SCAND J STAT, V6, P65; Horgan FG, 2015, CROP PROT, V78, P222, DOI 10.1016/j.cropro.2015.09.014; IZAWA Y, 1985, PESTIC BIOCHEM PHYS, V24, P343, DOI 10.1016/0048-3575(85)90145-2; KISIMOTO R, 1976, ECOL ENTOMOL, V1, P95, DOI 10.1111/j.1365-2311.1976.tb01210.x; KRISHNAIAH NV, 1993, CROP PROT, V12, P532, DOI 10.1016/0261-2194(93)90095-Z; Luong Minh Chau, 2007, Omonrice, P185; Malathi VM, 2017, INSECT SCI, V24, P35, DOI 10.1111/1744-7917.12254; Matsumura M., 2009, PLANTHOPPERS NEW THR, P233; Matsumura M, 2008, PEST MANAG SCI, V64, P1115, DOI 10.1002/ps.1641; Matsumura M, 2018, PEST MANAG SCI, V74, P456, DOI 10.1002/ps.4729; Matsumura M, 2014, PEST MANAG SCI, V70, P615, DOI 10.1002/ps.3590; Min S, 2014, J ASIA-PAC ENTOMOL, V17, P711, DOI 10.1016/j.aspen.2014.07.005; Naganagoud A., 1997, Karnataka Journal of Agricultural Sciences, V10, P1200; NAGATA T, 1986, APPL ENTOMOL ZOOL, V21, P357, DOI 10.1303/aez.21.357; Nagata T., 2002, Journal of Asia-Pacific Entomology, V5, P113, DOI 10.1016/S1226-8615(08)60139-9; Nagata T., 2002, Journal of Asia-Pacific Entomology, V5, P103, DOI 10.1016/S1226-8615(08)60138-7; Otuka A, 2008, APPL ENTOMOL ZOOL, V43, P527, DOI 10.1303/aez.2008.527; Otuka A, 2014, APPL ENTOMOL ZOOL, V49, P97, DOI 10.1007/s13355-013-0229-8; Punyawattoe P, 2013, APPL ENTOMOL ZOOL, V48, P205, DOI 10.1007/s13355-013-0174-6; Pymetrozine Harrewijin P, 1997, PEST MANAG SCI, V64, P1122; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Sogawa K, 1993, JPN AGR TECHNOL, V37, P36; Tamashiro M, 1996, SOCIOBIOLOGY, V28, P53; Trisyono YA, 2017, J ASIA-PAC ENTOMOL, V20, P547, DOI 10.1016/j.aspen.2017.03.013; UCHIDA M, 1985, AGR BIOL CHEM TOKYO, V49, P1233, DOI 10.1080/00021369.1985.10866885; Wang YH, 2008, J ECON ENTOMOL, V101, P515, DOI 10.1603/0022-0493(2008)101[515:ISSASR]2.0.CO;2; Wang YH, 2008, PEST MANAG SCI, V64, P1050, DOI 10.1002/ps.1606; Wen YC, 2009, PESTIC BIOCHEM PHYS, V94, P36, DOI 10.1016/j.pestbp.2009.02.009; Wu SF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22906-5; Yang YJ, 2014, J ECON ENTOMOL, V107, P1618, DOI 10.1603/EC13550; Yang YX, 2016, PESTIC BIOCHEM PHYS, V130, P79, DOI 10.1016/j.pestbp.2015.11.007; Zhang Xiao-Lei, 2016, Acta Entomologica Sinica, V59, P1222, DOI 10.16380/j.kcxb.2016.11.010; Zhang XL, 2017, CROP PROT, V94, P106, DOI 10.1016/j.cropro.2016.12.022; Zhang XL, 2016, PESTIC BIOCHEM PHYS, V132, P13, DOI 10.1016/j.pestbp.2015.10.003; Zhang XL, 2014, CROP PROT, V58, P61, DOI 10.1016/j.cropro.2013.12.026	45	18	18	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204962	10.1371/journal.pone.0204962	http://dx.doi.org/10.1371/journal.pone.0204962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289955	Green Published, gold, Green Submitted			2022-12-26	WOS:000446545500033
J	Nabiee, R; Dubois, B; Green, L; Sharma, A; Wong, SF; Aliabadi, HM				Nabiee, Ramina; Dubois, Barent; Green, Laura; Sharma, Ajay; Wong, Siu Fun; Aliabadi, Hamidreza Montazeri			In vitro and ex-vivo evaluation of topical formulations designed to minimize transdermal absorption of Vitamin K1	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; COLORECTAL-CANCER; EGFR INHIBITORS; HUMAN SKIN; PHASE-II; CETUXIMAB; DELIVERY; FOLLICULITIS; PERMEATION; TOXICITIES	Topical application of Vitamin K1 has been demonstrated to effectively treat papulopustular skin rash, a serious and frequently encountered side effect of Epidermal Growth Factor Inhibitors (EGFRIs). Systemic absorption of vitamin K1 from skin and the resultant consequence of antagonizing EGFRIs anticancer effects jeopardizes the clinical acceptability of this rather effective treatment. The purpose of the present study was to rationally formulate and evaluate the release rate and transdermal absorption of a wide range of Vitamin K1 dermal preparations with a variety of physiochemical properties. A library of 33 formulations with were compounded and tested for Vitamin K1 permeation using hydrophobic membranes and porcine skin mounted in a Fran diffusion cells. Our results demonstrate the lowest diffusion for water-in-oil emulsions, which also demonstrated a negligible transdermal absorption. The statistical analysis showed a significant correlation between in vitro and ex vivo results. While viscosity did not have a significant impact on the diffusion or absorption of vitamin K1, an increase in the lipid content was correlated with an increase in transmembrane diffusion (not with transdermal absorption). Overall, formulation design significantly impacts the release rate and transdermal absorption of vitamin K1, and confirms the possibility of minimal systemic distribution of this vitamin for this specific purpose.	[Nabiee, Ramina; Dubois, Barent; Green, Laura; Sharma, Ajay; Aliabadi, Hamidreza Montazeri] Chapman Univ, Dept Biomed & Pharmaceut Sci, Sch Pharm, Harry & Diane Rinker Hlth Sci Campus, Irvine, CA 92618 USA; [Wong, Siu Fun] Chapman Univ, Dept Pharm Practice, Sch Pharm, Harry & Diane Rinker Hlth Sci Campus, Irvine, CA USA; [Aliabadi, Hamidreza Montazeri] Chapman Univ, Ctr Targeted Drug Delivery, Sch Pharm, Harry & Diane Rinker Hlth Sci Campus, Irvine, CA 92618 USA	Chapman University System; Chapman University; Chapman University System; Chapman University; Chapman University System; Chapman University	Aliabadi, HM (corresponding author), Chapman Univ, Dept Biomed & Pharmaceut Sci, Sch Pharm, Harry & Diane Rinker Hlth Sci Campus, Irvine, CA 92618 USA.; Aliabadi, HM (corresponding author), Chapman Univ, Ctr Targeted Drug Delivery, Sch Pharm, Harry & Diane Rinker Hlth Sci Campus, Irvine, CA 92618 USA.	montazer@chapman.edu		Nabiee, Ramina/0000-0001-9806-8481	Hope Foundation [UG1CA189974]; NATIONAL CANCER INSTITUTE [UG1CA189974] Funding Source: NIH RePORTER	Hope Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Hope Foundation, grant Number: UG1CA189974. URL: https://thehopefoundation.org/research-funding/juried-programs/swog-early-exploration-development-seed-fund/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akash MSH, 2015, J CONTROL RELEASE, V209, P120, DOI 10.1016/j.jconrel.2015.04.032; Albanell J, 2002, J CLIN ONCOL, V20, P110, DOI 10.1200/JCO.20.1.110; [Anonymous], 2016, USP NF, DOI DOI 10.31003/USPNF_M20700_01_01; Bachet JB, 2012, ONCOLOGIST, V17, P555, DOI 10.1634/theoncologist.2011-0365; Borowska K, 2012, INT J PHARMACEUT, V436, P764, DOI 10.1016/j.ijpharm.2012.07.067; El-Kattan AF, 2000, INT J PHARMACEUT, V198, P179, DOI 10.1016/S0378-5173(00)00330-6; Eriksen JG, 2017, SUPPORT CARE CANCER, V25, P2179, DOI 10.1007/s00520-017-3623-x; Fan QX, 2004, J CONTROL RELEASE, V98, P355, DOI 10.1016/j.jconrel.2004.05.005; Filipowicz A, 2011, INT J PHARMACEUT, V408, P152, DOI 10.1016/j.ijpharm.2011.01.033; Goindi S, 2016, AAPS PHARMSCITECH, V17, P597, DOI 10.1208/s12249-015-0383-0; Hathout RM, 2013, COLLOID SURFACE B, V110, P254, DOI 10.1016/j.colsurfb.2013.05.007; Holcmann M, 2015, MOL CELL ONCOL, V2, DOI 10.1080/23723556.2015.1004969; Joshi SS, 2010, CANCER-AM CANCER SOC, V116, P3916, DOI 10.1002/cncr.25090; Jung YW, 2013, CURR MED CHEM, V20, P3488, DOI 10.2174/09298673113209990036; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Li TH, 2009, TARGET ONCOL, V4, P107, DOI 10.1007/s11523-009-0114-0; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Ocvirk J, 2008, RADIOL ONCOL, V42, P215, DOI 10.2478/v10019-008-0022-4; Palmer BC, 2016, MOLECULES, V21, DOI 10.3390/molecules21121719; Perez-Soler R, 2005, J CLIN ONCOL, V23, P5235, DOI 10.1200/JCO.2005.00.6916; Perez-Soler R, 2006, J CLIN ONCOL, V24, p129S; Pinta F, 2014, CLIN COLORECTAL CANC, V13, P62, DOI 10.1016/j.clcc.2013.10.001; Robert C, 2005, LANCET ONCOL, V6, P491, DOI 10.1016/S1470-2045(05)70243-6; Roberts MS, 2017, J CONTROL RELEASE, V247, P86, DOI 10.1016/j.jconrel.2016.12.022; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Schmook FP, 2001, INT J PHARM, V215, P51, DOI 10.1016/S0378-5173(00)00665-7; Segaert S, 2005, ANN ONCOL, V16, P1425, DOI 10.1093/annonc/mdi279; Surnmerfield A, 2015, MOL IMMUNOL, V66, P14, DOI 10.1016/j.molimm.2014.10.023; Tomkova H, 2013, J EUR ACAD DERMATOL, V27, P514, DOI 10.1111/j.1468-3083.2011.04324.x	29	1	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204531	10.1371/journal.pone.0204531	http://dx.doi.org/10.1371/journal.pone.0204531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289881	gold, Green Published			2022-12-26	WOS:000446545500018
J	Tetreault, HM; Scully, ED; Gries, T; Palmer, NA; Funnell-Harris, DL; Baird, L; Seravalli, J; Dien, BS; Sarath, G; Clemente, TE; Sattler, SE				Tetreault, Hannah M.; Scully, Erin D.; Gries, Tammy; Palmer, Nathan A.; Funnell-Harris, Deanna L.; Baird, Lisa; Seravalli, Javier; Dien, Bruce S.; Sarath, Gautam; Clemente, Thomas E.; Sattler, Scott E.			Overexpression of the Sorghum bicolor SbCCoAOMT alters cell wall associated hydroxycinnamoyl groups	PLOS ONE			English	Article							COENZYME-A 3-O-METHYLTRANSFERASE; ACID O-METHYLTRANSFERASE; LIGNIN BIOSYNTHESIS; FERULIC ACID; L. MOENCH; MONOLIGNOL BIOSYNTHESIS; SECONDARY METABOLISM; GENETIC-MODIFICATION; DOWN-REGULATION; ALFALFA	Sorghum (Sorghum bicolor) is a drought tolerant crop, which is being developed as a bioenergy feedstock. The monolignol biosynthesis pathway is a major focus for altering the abundance and composition of lignin. Caffeoyl coenzyme-A O-methyltransferase (CCoAOMT) is an S-adenosyl methionine (SAM)-dependent O-methyltransferase that methylates caffeoyl-CoA to generate feruloyl-CoA, an intermediate required for the biosynthesis of both G- and S-lignin. SbCCoAOMT was overexpressed to assess the impact of increasing the amount of this enzyme on biomass composition. SbCCoAOMT overexpression increased both soluble and cell wall-bound (esterified) ferulic and sinapic acids, however lignin concentration and its composition (S/G ratio) remained unaffected. This increased deposition of hydroxycinnamic acids in these lines led to an increase in total energy content of the stover. In stalk and leaf midribs, the increased histochemical staining and autofluorescence in the cell walls of the SbCCoAOMT overexpression lines also indicate increased phenolic deposition within cell walls, which is consistent with the chemical analyses of soluble and wall-bound hydroxycinnamic acids. The growth and development of overexpression lines were similar to wild-type plants. Likewise, RNA-seq and metabolite profiling showed that global gene expression and metabolite levels in overexpression lines were also relatively similar to wild-type plants. Our results demonstrate that SbCCoAOMT overexpression significantly altered cell wall composition through increases in cell wall associated hydroxycinnamic acids without altering lignin concentration or affecting plant growth and development.	[Tetreault, Hannah M.; Scully, Erin D.; Gries, Tammy; Palmer, Nathan A.; Funnell-Harris, Deanna L.; Sarath, Gautam; Sattler, Scott E.] USDA ARS, Wheat Sorghum & Forage Res Unit, Lincoln, NE 68583 USA; [Tetreault, Hannah M.; Scully, Erin D.; Gries, Tammy; Sarath, Gautam; Clemente, Thomas E.; Sattler, Scott E.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; [Funnell-Harris, Deanna L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Baird, Lisa] Univ San Diego, Shiley Ctr Sci & Technol, Dept Biol, San Diego, CA 92110 USA; [Seravalli, Javier] Univ Nebraska, Redox Biol Ctr, Lincoln, NE USA; [Seravalli, Javier] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Dien, Bruce S.] USDA ARS, Natl Ctr Agr Utilizat Res, 1815 N Univ St, Peoria, IL 61604 USA; [Clemente, Thomas E.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA; [Scully, Erin D.] USDA ARS, Stored Prod Insect & Engn Res Unit, Manhattan, KS USA	United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of San Diego; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA)	Sattler, SE (corresponding author), USDA ARS, Wheat Sorghum & Forage Res Unit, Lincoln, NE 68583 USA.; Sattler, SE (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA.	scott.sattler@ars.usda.gov		Sattler, Scott/0000-0002-6814-4073	United States Department of Agriculture - National Institute of Food and Agriculture AFRI [2011-67009-30026]; USDA-ARS, CRIS [3042-21220-032-00D, 3042-21000-030-00D]; National Institute for General Medical Science (NIGMS) [INBRE - P20GM103427-14, COBRE - 1P30GM110768-01]; Fred & Pamela Buffett Cancer Center Support Grant [P30CA036727]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427] Funding Source: NIH RePORTER	United States Department of Agriculture - National Institute of Food and Agriculture AFRI; USDA-ARS, CRIS(United States Department of Agriculture (USDA)); National Institute for General Medical Science (NIGMS); Fred & Pamela Buffett Cancer Center Support Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the United States Department of Agriculture - National Institute of Food and Agriculture AFRI grant number 2011-67009-30026 (SES, TEC, and DLF-H) and additional funding from USDA-ARS, CRIS projects 3042-21220-032-00D (SES and DLF-H) and 3042-21000-030-00D (GS). The University of Nebraska DNA Sequencing Core receives partial support from the National Institute for General Medical Science (NIGMS) INBRE - P20GM103427-14 and COBRE - 1P30GM110768-01 grants as well as The Fred & Pamela Buffett Cancer Center Support Grant - P30CA036727. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudet AM, 2003, TRENDS PLANT SCI, V8, P576, DOI 10.1016/j.tplants.2003.10.001; Bout S, 2003, MOL GENET GENOMICS, V269, P205, DOI 10.1007/s00438-003-0824-4; Brett CT, 1999, J SCI FOOD AGR, V79, P421, DOI 10.1002/(SICI)1097-0010(19990301)79:3&lt;421::AID-JSFA281&gt;3.0.CO;2-0; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; CASTELLUCCIO C, 1995, FEBS LETT, V368, P188, DOI 10.1016/0014-5793(95)00639-Q; Chen HC, 2011, P NATL ACAD SCI USA, V108, P21253, DOI 10.1073/pnas.1116416109; Compton DL, 2000, J AM OIL CHEM SOC, V77, P513, DOI 10.1007/s11746-000-0082-9; de Oliveira DM, 2015, PLANT BIOTECHNOL J, V13, P1224, DOI 10.1111/pbi.12292; Dien BS, 2009, BIOENERG RES, V2, P153, DOI 10.1007/s12155-009-9041-2; Do CT, 2007, PLANTA, V226, P1117, DOI 10.1007/s00425-007-0558-3; Ermawar RA, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0624-0; Ferrer JL, 2005, PLANT PHYSIOL, V137, P1009, DOI 10.1104/pp.104.048751; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Funnell-Harris DL, 2018, PLANT PATHOL, V67, P1474, DOI 10.1111/ppa.12863; Funnell-Harris DL, 2014, PLANT DIS, V98, P1300, DOI 10.1094/PDIS-09-13-0980-RE; Funnell-Harris DL, 2010, PHYTOPATHOLOGY, V100, P671, DOI 10.1094/PHYTO-100-7-0671; GRAF E, 1992, FREE RADICAL BIO MED, V13, P435, DOI 10.1016/0891-5849(92)90184-I; Green AR, 2014, PLANT PHYSIOL, V165, P1440, DOI 10.1104/pp.114.241729; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; HARRIS PJ, 1976, NATURE, V259, P508, DOI 10.1038/259508a0; HARTLEY RD, 1977, PHYTOCHEMISTRY, V16, P1531, DOI 10.1016/0031-9422(77)84017-X; HERRMANN KM, 1995, PLANT PHYSIOL, V107, P7, DOI 10.1104/pp.107.1.7; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ikegawa T, 1996, PHYSIOL MOL PLANT P, V48, P245, DOI 10.1006/pmpp.1996.0021; JACQUET G, 1995, J AGR FOOD CHEM, V43, P2746, DOI 10.1021/jf00058a037; Kumar Naresh, 2014, Biotechnol Rep (Amst), V4, P86, DOI 10.1016/j.btre.2014.09.002; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laszlo JA, 2003, GREEN CHEM, V5, P382, DOI 10.1039/b302384b; Li XY, 2013, GENET MOL BIOL, V36, P540, DOI 10.1590/s1415-47572013005000039; Lu J, 2004, PROG NAT SCI-MATER, V14, P1060, DOI 10.1080/10020070412331344801; Makita Y, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu187; Mathew S, 2004, CRIT REV BIOTECHNOL, V24, P59, DOI 10.1080/07388550490491467; MCKENZIE HA, 1969, DATA BIOCH RES; MILLER FR, 1984, CROP SCI, V24, P1224, DOI 10.2135/cropsci1984.0011183X002400060074x; Nakashima J, 2008, NEW PHYTOL, V179, P738, DOI 10.1111/j.1469-8137.2008.02502.x; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; PAKUSCH AE, 1989, ARCH BIOCHEM BIOPHYS, V271, P488, DOI 10.1016/0003-9861(89)90299-3; PAKUSCH AE, 1991, PLANT PHYSIOL, V95, P137, DOI 10.1104/pp.95.1.137; Palmer NA, 2008, PLANTA, V229, P115, DOI 10.1007/s00425-008-0814-1; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perlack RD, 2011, IEA BIOENERGY; Pincon G, 2001, PHYTOCHEMISTRY, V57, P1167, DOI 10.1016/S0031-9422(01)00098-X; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Rakoczy M, 2018, MOL GENET GENOMICS, V293, P1077, DOI 10.1007/s00438-018-1441-6; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; Saathoff AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016416; Saballos A, 2012, PLANT J, V70, P818, DOI 10.1111/j.1365-313X.2012.04933.x; Saballos A, 2009, GENETICS, V181, P783, DOI 10.1534/genetics.108.098996; Sarath G, 2008, J IND MICROBIOL BIOT, V35, P343, DOI 10.1007/s10295-007-0296-3; Sattler SE, 2010, PLANT SCI, V178, P229, DOI 10.1016/j.plantsci.2010.01.001; Sattler SE, 2009, PLANT PHYSIOL, V150, P584, DOI 10.1104/pp.109.136408; Scully ED, 2016, PLANT J; Scully ED, 2018, NEW PHYTOL, V217, P82, DOI 10.1111/nph.14815; Shaipulah NFM, 2016, PLANT PHYSIOL, V170, P717, DOI 10.1104/pp.15.01646; Sluiter A., 2008, LAB ANAL PROCED, V1617, P1, DOI DOI 10.1007/S00449-014-1243-0; Stewart JJ, 2009, PLANT PHYSIOL, V150, P621, DOI 10.1104/pp.109.137059; Tanger P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00218; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vermerris W, 2015, CURR OPIN BIOTECH, V32, P104, DOI 10.1016/j.copbio.2014.11.024; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Walker AM, 2016, PLANT PHYSL; Weng JK, 2008, CURR OPIN BIOTECH, V19, P166, DOI 10.1016/j.copbio.2008.02.014; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Wu WH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07895-1; Xie SX, 2015, GREEN CHEM, V17, P1657, DOI [10.1039/c4gc01529k, 10.1039/C4GC01529K]; Xu ZY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S3; Yang Q, 2017, NAT GENET; Zhong RQ, 1998, PLANT CELL, V10, P2033, DOI 10.1105/tpc.10.12.2033	72	15	16	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204153	10.1371/journal.pone.0204153	http://dx.doi.org/10.1371/journal.pone.0204153			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289910	Green Published, gold			2022-12-26	WOS:000446545500013
J	Ferretti, R; Moura, EG; dos Santos, VC; Caldeira, EJ; Conte, M; Matsumura, CY; Pertille, A; Mosqueira, M				Ferretti, Renato; Moura, Eliezer Guimaraes; dos Santos, Veridiana Carvalho; Caldeira, Eduardo Jose; Conte, Marcelo; Matsumura, Cintia Yuri; Pertille, Adriana; Mosqueira, Matias			High-fat diet suppresses the positive effect of creatine supplementation on skeletal muscle function by reducing protein expression of IGF-PI3K-AKT-mTOR pathway	PLOS ONE			English	Article							RESISTANCE-EXERCISE; BODY-COMPOSITION; MESSENGER-RNA; OLDER-ADULTS; C2C12 CELLS; HYPERTROPHY; PERFORMANCE; ACTIVATION; DYSTROPHY; AUTOPHAGY	High-fat (HF) diets in combination with sedentary lifestyle represent one of the major public health concerns predisposing to obesity and diabetes leading to skeletal muscle atrophy, decreased fiber diameter and muscle mass with accumulation of fat tissue resulting in loss of muscle strength. One strategy to overcome the maleficent effects of HF diet is resistance training, a strategy used to improve muscle mass, reverting the negative effects on obesity-related changes in skeletal muscle. Together with resistance training, supplementation with creatine monohydrate (CrM) in the diet has been used to improve muscle mass and strength. Creatine is a non-essential amino acid that is directly involved in the cross-bridge cycle providing a phosphate group to ADP during the initiation of muscle contraction. Besides its antioxidant and anti-inflammatory effects CrM also upregulates IGF-1 resulting in hyperthophy with an increase in muscle function. However, it is unknown whether CrM supplementation during resistance training would revert the negative effects of high-fat diet on the muscle performance. During 8 weeks we measured muscle performance to climb a 1.1m and 80 degrees ladder with increasing load on trained rats that had received standard diet or high-fat diet, supplemented or not with CrM. We observed that the CrM supplementation up-regulated IGF-1 and phospho-AKT protein levels, suggesting an activation of the IGF1P13K-Akt/PKB-mTOR pathway. Moreover, despite the CrM supplementation, HF diet downregulated several proteins of the IGF1-PI3K-Akt/PKB-mTOR pathway, suggesting that diet lipid content is crucial to maintain or improve muscle function during resistance training.	[Ferretti, Renato; dos Santos, Veridiana Carvalho; Matsumura, Cintia Yuri] Sao Paulo State Univ UNESP, Inst Biosci Botucatu, Dept Anat, Botucatu, SP, Brazil; [Moura, Eliezer Guimaraes] Ctr Univ Adventista Sao Paulo, Lab Phys Act Metab & Hlth, Sao Paulo, Brazil; [Caldeira, Eduardo Jose] FMJ, Dept Morphol & Basic Pathol, Sao Paulo, Brazil; [Conte, Marcelo] ESEF, Sao Paulo, Brazil; [Pertille, Adriana] Univ Metodista Piracicaba, Lab Neuromuscular Plast, Grad Program Sci Human Movement, Sao Paulo, Brazil; [Mosqueira, Matias] Heidelberg Univ Hosp, Inst Physiol & Pathophysiol, Cardioventilatory Muscle Physiol Lab, Heidelberg, Germany	Universidade Estadual Paulista; Centro Universitario Adventista de Sao Paulo; Universidade Metodista de Piracicaba; Ruprecht Karls University Heidelberg	Ferretti, R (corresponding author), Sao Paulo State Univ UNESP, Inst Biosci Botucatu, Dept Anat, Botucatu, SP, Brazil.; Mosqueira, M (corresponding author), Heidelberg Univ Hosp, Inst Physiol & Pathophysiol, Cardioventilatory Muscle Physiol Lab, Heidelberg, Germany.	r.ferretti@unesp.br; matias@physiologie.uni-heidelberg.de	Mosqueira, Matias/C-5899-2019; Conte, Marcelo/ABE-4445-2021; Ferretti, Renato/AAH-6049-2019; Matsumura, Cintia Yuri/AFQ-5618-2022; Pertille, Adriana/AAE-3285-2021; Moura, Eliézer Guimarães/B-4505-2018	Mosqueira, Matias/0000-0001-7744-9138; Conte, Marcelo/0000-0003-1034-6921; Ferretti, Renato/0000-0003-3944-1906; Moura, Eliezer Guimaraes/0000-0002-2477-8242				Abrigo J, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9047821; Ambery AG, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13363; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6; Blaauw B, 2013, COMPR PHYSIOL, V3, P1645, DOI 10.1002/cphy.c130009; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Burke DG, 2008, INT J SPORT NUTR EXE, V18, P389, DOI 10.1123/ijsnem.18.4.389; Souza MVC, 2014, CLINICS, V69, P265, DOI 10.6061/clinics/2014(04)08; Candow DG, 2012, BIOGERONTOLOGY, V13, P345, DOI 10.1007/s10522-012-9385-4; Cassilhas RC, 2013, MOTRIZ, V19, P178, DOI 10.1590/S1980-65742013000100018; Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015; Chibalin AV, 2000, P NATL ACAD SCI USA, V97, P38, DOI 10.1073/pnas.97.1.38; Chilibeck PD, 2017, OPEN ACCESS J SPORTS, V8, P213, DOI 10.2147/OAJSM.S123529; Choi SJ, 2016, J GERONTOL A-BIOL, V71, P557, DOI 10.1093/gerona/glv169; Clark JF, 1998, NUTRITION, V14, P322, DOI 10.1016/S0899-9007(97)00482-6; Davidson ZE, 2009, J HUM NUTR DIET, V22, P383, DOI 10.1111/j.1365-277X.2009.00979.x; Deldicque L, 2005, EUR J APPL PHYSIOL, V94, P1, DOI 10.1007/s00421-004-1255-6; Deldicque L, 2005, MED SCI SPORT EXER, V37, P731, DOI 10.1249/01.MSS.0000162690.39830.27; Deldicque L, 2007, AM J PHYSIOL-CELL PH, V293, pC1263, DOI 10.1152/ajpcell.00162.2007; Eshima H, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13250; Fujita S, 2007, J PHYSIOL-LONDON, V582, P813, DOI 10.1113/jphysiol.2007.134593; Kirwan JP, 2000, J APPL PHYSIOL, V88, P797, DOI 10.1152/jappl.2000.88.2.797; Kreider RB, 2003, MOL CELL BIOCHEM, V244, P89, DOI 10.1023/A:1022465203458; Kreider RB, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0173-z; Krisan AD, 2004, J APPL PHYSIOL, V96, P1691, DOI 10.1152/japplphysiol.01054.2003; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164; Louis M, 2004, FEBS LETT, V557, P243, DOI 10.1016/S0014-5793(03)01504-7; Ma JT, 2016, OBESITY, V24, P526, DOI 10.1002/oby.21356; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; Moon Ji Hyun, 2015, J Bone Metab, V22, P99, DOI 10.11005/jbm.2015.22.3.99; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Rahimi R, 2011, J STRENGTH COND RES, V25, P3448, DOI 10.1519/JSC.0b013e3182162f2b; Roy B, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00439; Sala D, 2014, J CLIN INVEST, V124, P1914, DOI 10.1172/JCI72327; Santos RVT, 2004, LIFE SCI, V75, P1917, DOI 10.1016/j.lfs.2003.11.036; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; Sishi B, 2011, EXP PHYSIOL, V96, P179, DOI 10.1113/expphysiol.2010.054189; Volek JS, 2004, EUR J APPL PHYSIOL, V91, P628, DOI 10.1007/s00421-003-1031-z; Willoughby DS, 2003, INT J SPORTS MED, V24, P15, DOI 10.1055/s-2003-37197; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yaspelkis BB, 2002, ACTA PHYSIOL SCAND, V175, P315, DOI 10.1046/j.1365-201X.2002.00998.x; Young JF, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-9; Zanou N, 2013, CELL MOL LIFE SCI, V70, P4117, DOI 10.1007/s00018-013-1330-4; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	45	23	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0199728	10.1371/journal.pone.0199728	http://dx.doi.org/10.1371/journal.pone.0199728			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286093	Green Published, gold, Green Submitted			2022-12-26	WOS:000446383500001
J	Kirkpatrick, L; Graham, J; McGregor, S; Munro, L; Scoarize, M; Park, K				Kirkpatrick, Lucinda; Graham, Jennifer; McGregor, Sean; Munro, Lynn; Scoarize, Matheus; Park, Kirsty			Flexible foraging strategies in Pipistrellus pygmaeus in response to abundant but ephemeral prey	PLOS ONE			English	Article							2 PHONIC TYPES; HABITAT SELECTION; HOME-RANGE; INSECTIVOROUS BAT; FOREST; CONSERVATION; BIODIVERSITY; PLANTATIONS; DISTURBANCE; CALLS	There is growing recognition that with sympathetic management, plantation forests may contain more biodiversity than previously thought. However, the extent to which they may support bat populations is contentious. Many studies have demonstrated active avoidance of coniferous plantations and attributed this to the lack of available roost sites and low invertebrate density. In contrast, other work, carried out in plantation dominated landscapes have shown that certain bat species are able to exploit these areas. However, the extent to which bats use plantations for roosting and foraging, or simply move through the plantation matrix to access more favourable sites is unclear. We radio tracked female Pipistrellus pygmaeus over two summers to establish the extent to which individual bats use Sitka Spruce plantations in southern Scotland for foraging and roosting and assess the implications for felling operations on bats. Maternity roosts identified (n = 17) were in all in buildings and most were large (> 500 individuals). We found no evidence of bats roosting in mature Sitka Spruce crop trees, although several bats used roosts in old or dead beech and oak trees as an alternative to their main maternity roost. Home ranges were much larger (mean 9.6 +/- 3.12 km(2)) than those reported from other studies (0.6-1.6 km(2)), and it is likely that roost availability rather than food abundance constrains P. pygmaeus use of Sitka Spruce plantations. At the landscape scale, most individuals selected coniferous habitats over other habitat types, covering large distances to access plantation areas, whilst at a local scale bats used forest tracks to access water, felled stands or patches of broadleaf cover within the plantation. Sitka Spruce plantations support a high abundance of Culicoides impuctatus, the Highland midge which may act as a reliable and plentiful food source for females during lactation, an energetically expensive period. The use of felled stands for foraging by bats has implications for forest management as wind turbines, following small-scale felling operations, are increasingly being installed in plantations; wind turbines have been associated with high bat mortality in some countries. Decisions about siting wind turbines in upland plantations should consider the likelihood of increased bat activity post felling.	[Kirkpatrick, Lucinda; Graham, Jennifer; Munro, Lynn; Park, Kirsty] Univ Stirling, Biol & Ecol Sci, Stirling, Scotland; [Kirkpatrick, Lucinda] Univ Antwerp, EVECO, Antwerp, Belgium; [Graham, Jennifer] Scottish Dolphin Ctr, WDC, Fochabers, Moray, Scotland; [McGregor, Sean] Univ Lausanne, Biophore, Lausanne, Switzerland; [Scoarize, Matheus] Univ Estadual Maringa, PEA, Maringa, Parana, Brazil	University of Stirling; University of Antwerp; University of Lausanne; Universidade Estadual de Maringa	Kirkpatrick, L (corresponding author), Univ Stirling, Biol & Ecol Sci, Stirling, Scotland.; Kirkpatrick, L (corresponding author), Univ Antwerp, EVECO, Antwerp, Belgium.	lucinda.kirkpatrick@uantwerpen.be		Park, Kirsty/0000-0001-6080-7197; Ratz Scoarize, Matheus Maximilian/0000-0003-3234-9808	IMPACT studentship; Forestry Commission; University of Stirling; CNPq; CAPES	IMPACT studentship; Forestry Commission; University of Stirling; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding for Lucinda Kirkpatrick was provided as part of an IMPACT studentship, funded by Forestry Commission and the University of Stirling. We would also like to acknowledge CNPq and CAPES for partial funding support.	Adams MD, 2009, FOREST ECOL MANAG, V258, P2090, DOI 10.1016/j.foreco.2009.08.002; ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Altringham JD, 1996, BATS BIOL BEHAV; [Anonymous], 2015, SCOTTISH NATURAL HER; Arnett EB, IMPACTS WIND ENERGY, P295, DOI [10.1007/978-3-319-25220-9, DOI 10.1007/978-3-319-25220-9]; Arrizabalaga-Escudero A, 2013, MAMM BIOL; August TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112225; Barlow KE, 2015, BIOL CONSERV, V182, P14, DOI 10.1016/j.biocon.2014.11.022; Barlow KE, 1997, J ZOOL, V243, P597, DOI 10.1111/j.1469-7998.1997.tb02804.x; Barlow KE, 1999, Z SAUGETIERKD, V64, P257; Bartonicka T, 2008, ANN ZOOL FENN, V45, P503, DOI 10.5735/086.045.0605; Bender MJ, 2015, FOREST ECOL MANAG, V336, P1, DOI 10.1016/j.foreco.2014.10.004; Blakey RV, 2016, J APPL ECOL, V53, P1694, DOI 10.1111/1365-2664.12691; Bonaccorso FJ, 2015, J MAMMAL, V96, P64, DOI 10.1093/jmammal/gyu003; Borkin KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086163; Borkin KM, 2011, BIODIVERS CONSERV, V20, P3537, DOI 10.1007/s10531-011-0144-7; Borkin KM, 2011, FOREST ECOL MANAG, V262, P845, DOI 10.1016/j.foreco.2011.05.018; Borkin KM, 2010, NEW ZEAL J ZOOL, V37, P35, DOI 10.1080/03014221003602190; Borkin KM, 2010, NEW ZEAL J ZOOL, V37, P13, DOI 10.1080/03014221003602174; Boughey KL, 2011, BIOL CONSERV, V144, P2300, DOI 10.1016/j.biocon.2011.06.008; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Burgar JM, 2015, FOREST ECOL MANAG, V356, P112, DOI 10.1016/j.foreco.2015.07.027; Calenge C, 2006, ECOLOGY, V87, P2349, DOI 10.1890/0012-9658(2006)87[2349:EOSRFA]2.0.CO;2; CARR GM, 1986, ANIM BEHAV, V34, P1540, DOI 10.1016/S0003-3472(86)80223-8; Chambers CL, 2016, LANDSCAPE ECOL, V31, P1299, DOI 10.1007/s10980-016-0343-4; Charbonnier Y, 2016, LANDSCAPE ECOL, V31, P291, DOI 10.1007/s10980-015-0242-0; Christie JE, 2014, ACTA CHIROPTEROL, V16, P369, DOI 10.3161/150811014X687323; Ciechanowski M, 2015, EUR J WILDLIFE RES, V61, P415, DOI 10.1007/s10344-015-0911-y; Cistrone L, 2015, HYSTRIX, V26, P125, DOI 10.4404/hystrix-26.2-11477; Davidson-Watts I, 2006, J ZOOL, V268, P55, DOI 10.1111/j.1469-7998.2005.00016.x; Davidson-Watts I, 2006, BIOL CONSERV, V133, P118, DOI 10.1016/j.biocon.2006.05.027; Dodd LE, 2012, FOREST ECOL MANAG, V267, P262, DOI 10.1016/j.foreco.2011.12.016; Flaquer C, 2006, BIOL CONSERV, V128, P223, DOI 10.1016/j.biocon.2005.09.030; Grindal SD, 1998, J WILDLIFE MANAGE, V62, P996, DOI 10.2307/3802552; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Haupt M, 2006, J MAMMAL, V87, P351, DOI 10.1644/05-MAMM-A-193R1.1; Heer K, 2015, J MAMMAL, V96, P720, DOI 10.1093/jmammal/gyv068; Hein CD, 2008, THESIS; Hill DA, 2005, MAMMAL REV, V35, P116, DOI 10.1111/j.1365-2907.2005.00058.x; Humphrey JW, 2005, FORESTRY, V78, P33, DOI 10.1093/forestry/cpi004; Johnson DDP, 2002, TRENDS ECOL EVOL, V17, P563, DOI 10.1016/S0169-5347(02)02619-8; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones G, 2009, DETERMINING POTENTIA, V11, P12; Jung K, 2012, J APPL ECOL, V49, P523, DOI 10.1111/j.1365-2664.2012.02116.x; Kirkpatrick L., 2017, BAT EXPLOITATION SIT; Kirkpatrick L, 2017, FOREST ECOL MANAG, V395, P1, DOI 10.1016/j.foreco.2017.03.033; Kirkpatrick L, 2017, BIOL CONSERV, V206, P1, DOI 10.1016/j.biocon.2016.11.018; Kunz Thomas H., 1996, P105; Law B, 2015, INSECTIVOROUS BATS S, P105; Lintott PR, 2013, WILDLIFE RES, V40, P675, DOI 10.1071/WR13153; Lopez-Baucells A, 2016, URBAN ECOSYST URBAN, DOI [10.1007/s11252-015-0519-8, DOI 10.1007/S11252-015-0519-8]; Manly BFL., 2007, RESOURCE SELECTION A; Mathews F, 2016, WC0753 DEFRA; Morris AD, 2010, J WILDLIFE MANAGE, V74, P26, DOI 10.2193/2008-471; Mortimer G., 2006, THESIS; Morton D., 2011, 1107 NERC CTR EC HYD; Nicholls B, 2006, BEHAV ECOL SOCIOBIOL, V61, P131, DOI 10.1007/s00265-006-0244-7; Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x; Park KJ, 1998, J ZOOL, V244, P379, DOI 10.1017/S0952836998003094; Patriquin KJ, 2003, J APPL ECOL, V40, P646, DOI 10.1046/j.1365-2664.2003.00831.x; Reiter G, 2013, MAMM BIOL, V78, P283, DOI 10.1016/j.mambio.2012.11.003; Rodriguez-San Pedro A, 2015, EUR J WILDLIFE RES, V61, P177, DOI 10.1007/s10344-014-0871-7; Russ JM, 2002, BIOL CONSERV, V108, P49, DOI 10.1016/S0006-3207(02)00089-7; Russo D, 2016, FRONT ECOL EVOL, V4, DOI [10.3389/fevo.2016.00115, DOI 10.3389/FEVO.2016.00115]; Russo D, 2010, BIODIVERS CONSERV, V19, P2501, DOI 10.1007/s10531-010-9856-3; Rydell J., 2017, DIET PARTI COLOURED, V15, P195; Sattler T, 2007, J APPL ECOL, V44, P1188, DOI 10.1111/j.1365-2664.2007.01328.x; Schnitzler H.-U., 1988, ANIMAL SONAR, P619; Stephens SS, 2007, J FOREST, V105, P307; Verboom B, 1999, CAN J ZOOL, V77, P1393, DOI 10.1139/cjz-77-9-1393; Voigt C. C, 2016, BATS ANTHROPOCENE CO, DOI [10.1007/978-3-319-25220-9, DOI 10.1007/978-3-319-25220-9]; Walsh AL, 1996, J APPL ECOL, V33, P508, DOI 10.2307/2404980; White G.C., 1990, ANAL WILDLIFE RADIO	73	2	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204511	10.1371/journal.pone.0204511	http://dx.doi.org/10.1371/journal.pone.0204511			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286111	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500023
J	Owens, CA; Peterson, CB; Tang, C; Koay, EJ; Yu, W; Mackin, DS; Li, J; Salehpour, MR; Fuentes, DT; Court, LE; Yang, JZ				Owens, Constance A.; Peterson, Christine B.; Tang, Chad; Koay, Eugene J.; Yu, Wen; Mackin, Dennis S.; Li, Jing; Salehpour, Mohammad R.; Fuentes, David T.; Court, Laurence E.; Yang, Jinzhong			Lung tumor segmentation methods: Impact on the uncertainty of radiomics features for non-small cell lung cancer	PLOS ONE			English	Article							CT; REPRODUCIBILITY; RELIABILITY; DELINEATION	Purpose To evaluate the uncertainty of radiomics features from contrast-enhanced breath-hold helical CT scans of non-small cell lung cancer for both manual and semi-automatic segmentation due to intra-observer, inter-observer, and inter-software reliability. Methods Three radiation oncologists manually delineated lung tumors twice from 10 CT scans using two software tools (3D-Slicer and MIM Maestro). Additionally, three observers without formal clinical training were instructed to use two semi-automatic segmentation tools, Lesion Sizing Toolkit (LSTK) and GrowCut, to delineate the same tumor volumes. The accuracy of the semi-automatic contours was assessed by comparison with physician manual contours using Dice similarity coefficients and Hausdorff distances. Eighty-three radiomics features were calculated for each delineated tumor contour. Informative features were identified based on their dynamic range and correlation to other features. Feature reliability was then evaluated using intra-class correlation coefficients (ICC). Feature range was used to evaluate the uncertainty of the segmentation methods. Results From the initial set of 83 features, 40 radiomics features were found to be informative, and these 40 features were used in the subsequent analyses. For both intra-observer and interobserver reliability, LSTK had higher reliability than GrowCut and the two manual segmentation tools. All observers achieved consistently high ICC values when using LSTK, but the ICC value varied greatly for each observer when using GrowCut and the manual segmentation tools. For inter-software reliability, features were not reproducible across the software tools for either manual or semi-automatic segmentation methods. Additionally, no feature category was found to be more reproducible than another feature category. Feature ranges of LSTK contours were smaller than those of manual contours for all features. Conclusion Radiomics features extracted from LSTK contours were highly reliable across and among observers. With semi-automatic segmentation tools, observers without formal clinical training were comparable to physicians in evaluating tumor segmentation.	[Owens, Constance A.; Mackin, Dennis S.; Salehpour, Mohammad R.; Court, Laurence E.; Yang, Jinzhong] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Owens, Constance A.; Peterson, Christine B.; Mackin, Dennis S.; Court, Laurence E.; Yang, Jinzhong] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Peterson, Christine B.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Tang, Chad; Koay, Eugene J.; Li, Jing] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Yu, Wen] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Radiat Oncol, Shanghai, Peoples R China; [Fuentes, David T.; Court, Laurence E.] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center	Owens, CA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA.; Owens, CA (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA.	caowens@mdanderson.org	Mackin, Dennis/Y-1503-2019	Mackin, Dennis/0000-0002-2557-5340; Court, Laurence/0000-0002-3241-6145; Peterson, Christine/0000-0003-3316-0468; Owens, Constance/0000-0001-7208-394X	Cancer Prevention Research Institute of Texas [RP110562]; National Institutes of Health/National Cancer Institute through Cancer Center Support Grant [P30 CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas; National Institutes of Health/National Cancer Institute through Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge financial support from the Cancer Prevention Research Institute of Texas (URL: http://www.cprit.state.tx.us/) grant under award number RP110562. J.Y. and L.C. are the authors that received this fund. The authors acknowledge financial support from the National Institutes of Health/National Cancer Institute (URL: https://cancercenters.cancer.gov/) through Cancer Center Support Grant under award number P30 CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, DECODING TUMOR PHENO, V5, DOI [10.1038/ncomms5006, DOI 10.1038/NCOMMS5006]; Aerts HJWL, 2016, SCI REP-UK, V6, DOI 10.1038/srep33860; Ashraf H, 2010, EUR RADIOL, V20, P1878, DOI 10.1007/s00330-010-1749-z; Balagurunathan Y, 2014, J DIGIT IMAGING, V27, P805, DOI 10.1007/s10278-014-9716-x; Balagurunathan Y, 2014, TRANSL ONCOL, V7, P72, DOI 10.1593/tlo.13844; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; CICCHETTI DV, 1985, APPL PSYCH MEAS, V9, P31, DOI 10.1177/014662168500900103; Court LE, 2016, TRANSL CANCER RES, V5, P340, DOI 10.21037/tcr.2016.06.17; Echegaray S, 2017, J DIGIT IMAGING JOUR, V4, P1, DOI [10.1007/s10278-016-9926-5, DOI 10.1007/S10278-016-9926-5]; Fave X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00665-z; Fave X, 2015, COMPUT MED IMAG GRAP, V44, P54, DOI 10.1016/j.compmedimag.2015.04.006; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gu YH, 2013, PATTERN RECOGN, V46, P692, DOI 10.1016/j.patcog.2012.10.005; Hodkinson DJ, 2013, NEUROIMAGE-CLIN, V3, P301, DOI 10.1016/j.nicl.2013.09.004; Huang YQ, 2016, RADIOLOGY, V281, P947, DOI 10.1148/radiol.2016152234; Hunter LA, 2013, MED PHYS, V40, DOI 10.1118/1.4829514; Jackson SE, 2015, INT J CANCER, V137, P262, DOI 10.1002/ijc.28940; Jameson MG, 2010, J MED IMAG RADIAT ON, V54, P401, DOI 10.1111/j.1754-9485.2010.02192.x; Kalpathy-Cramer J, 2016, TOMOGRAPHY, V2, P430, DOI 10.18383/j.tom.2016.00235; Kalpathy-Cramer J, 2016, J DIGIT IMAGING, V29, P476, DOI 10.1007/s10278-016-9859-z; Kong FM, 2017, JAMA ONCOL, V3, P1358, DOI 10.1001/jamaoncol.2017.0982; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Krishnan K, 2010, OPT EXPRESS, V18, P15256, DOI 10.1364/OE.18.015256; Kumar V, 2013, QIN RADIOMICS PROCES, V30, P1234, DOI [10.1016/j.mri.2012.06.010.QIN, DOI 10.1016/J.MRI.2012.06.010.QIN]; Lee M, 2017, KOREAN J RADIOL, V18, P498, DOI 10.3348/kjr.2017.18.3.498; Liu B, 2015, MED PHYS, V42, P3458, DOI 10.1118/1.4924898; Lu L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166550; Mackin D, 2017, HARMONIZING PIXEL SI, V9, DOI [10.1371/journal.pone.0178524, DOI 10.1371/JOURNAL.PONE.0178524]; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866; Njeh CF, 2008, J MED PHYS, V33, P136, DOI 10.4103/0971-6203.44472; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; Qiu QT, 2017, TRANSL CANCER RES, V6, P940, DOI 10.21037/tcr.2017.09.47; Stewart J, 2012, RTOG 1106 ACRIN 6697; Velazquez ER, 2013, SCI REP-UK, V3, DOI 10.1038/srep03529; Vinod SK, 2016, J MED IMAG RADIAT ON, V60, P393, DOI 10.1111/1754-9485.12462; Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003; Yang JZ, 2016, COMPUT MED IMAG GRAP, V48, P1, DOI 10.1016/j.compmedimag.2015.12.001; Yip SSF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178944; Yip SSF, 2016, PHYS MED BIOL, V61, pR150, DOI 10.1088/0031-9155/61/13/R150; Zhang ZJ, 2018, EUR RADIOL, V28, P2255, DOI 10.1007/s00330-017-5154-8; Zhao BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23428	43	41	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205003	10.1371/journal.pone.0205003	http://dx.doi.org/10.1371/journal.pone.0205003			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286184	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500073
J	Yen, FS; Chen, WS; Wei, JCC; Hsu, CC; Hwu, CM				Yen, Fu-Shun; Chen, Weishan; Wei, James Cheng-Chung; Hsu, Chih-Cheng; Hwu, Chii-Min			Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject design	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RISK; VALIDATION; MELLITUS; CANCER; LUNG; EXACERBATIONS; TAIWAN; COPD; AMPK	Backgrounds Few studies have investigated the therapeutic effects of metformin in patients with type 2 diabetes mellitus (T2DM) and chronic obstructive pulmonary disease (COPD). We compared the risk of all-cause mortality between metformin users and nonusers. Methods We conducted a retrospective cohort study for patients with T2DM and COPD who were enrolled between January 1, 2000 and June 30, 2012. Individuals with exacerbated symptoms who were hospitalized or sent to the emergency department (ED) were identified as having exacerbated COPD; outpatient claims were identified as having stable COPD. A total of 40,597 metformin users and 39,529 nonusers comprised the cohort of stable COPD; 14,001 metformin users and 21,613 nonusers comprised the cohort of exacerbated COPD. Users and nonusers were matched using propensity score (1:1). Our primary outcome was all-cause mortality. Results A total of 19,505 metformin users were matched to 19,505 nonusers in the cohort of diabetes with stable COPD. The mean follow-up time was 3.91 years. All-cause mortality was reported in 1326 and 1609 metformin users and nonusers, respectively. After multivariate adjustment, metformin users had lower risk of mortality (adjusted hazard ratio [aHR] = 0.84, p < 0.0001). Metformin users had significantly lower risk of noncardiovascular death (aHR = 0.86, p = 0.0008). A total of 7721 metformin users were matched to 7721 nonusers in the cohort of diabetes with exacerbated COPD. The mean follow-up time was 3.18 years. Allcause mortality was reported in 1567 and 1865 metformin users and nonusers, respectively. After multivariate adjustment, metformin users had significantly lower risk of mortality (aHR = 0.89, p = 0.002) and cardiovascular death (aHR = 0.70, p = 0.01). Conclusion This large-series, nationwide cohort study demonstrated that metformin use could significantly lower the risk of all-cause mortality in patients with T2DM and either stable or exacerbated COPD.	[Yen, Fu-Shun] Dr Yens Clin, Taoyuan, Taiwan; [Chen, Weishan] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Weishan] China Med Univ, Coll Med, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Hsu, Chih-Cheng] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Hsu, Chih-Cheng] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Hsu, Chih-Cheng] Min Sheng Gen Hosp, Dept Family Med, Taoyuan, Taiwan; [Hwu, Chii-Min] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Hwu, Chii-Min] Taipei Vet Gen Hosp, Sect Endocrinol & Metab, Dept Med, Taipei, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; National Health Research Institutes - Taiwan; China Medical University Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Hsu, CC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan.; Hsu, CC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.; Hsu, CC (corresponding author), Min Sheng Gen Hosp, Dept Family Med, Taoyuan, Taiwan.; Hwu, CM (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan.; Hwu, CM (corresponding author), Taipei Vet Gen Hosp, Sect Endocrinol & Metab, Dept Med, Taipei, Taiwan.	cch@nhri.org.tw; chhwu@vghtpe.gov.tw	Wei, James Cheng-Chung/AAL-8947-2020; Yen, Fu-Shun/K-3854-2019; Hwu, Chii-Min/AAZ-7384-2021; Chen, Wei/GZK-7348-2022	Wei, James Cheng-Chung/0000-0002-1235-0679; YEN, FU-SHUN/0000-0002-4677-2415	Ministry of Health and Welfare, Taiwan [MOHW107-TDU-B-212-123004]; China Medical University Hospital; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 106-2321-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Ministry of Health and Welfare, Taiwan; China Medical University Hospital; Academia Sinica Stroke Biosignature Project; MOST Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This work was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW107-TDU-B-212-123004), China Medical University Hospital, Academia Sinica Stroke Biosignature Project (BM10701010021), MOST Clinical Trial Consortium for Stroke (MOST 106-2321-B-039-005).", Tseng-Lien Lin Foundation, Taichung, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. Foundation, Taichung, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan (WC received the funding). The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding authors had full access to all data in the study and had final responsibility for the decision to submit for publication.	Abbasi A A, 2000, Endocr Pract, V6, P442; Adeloye D, 2015, J GLOB HEALTH, V5, P186, DOI 10.7189/jogh.05.020415; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Burge S, 2003, EUR RESPIR J, V21, p46S, DOI 10.1183/09031936.03.00078002; Caughey GE, 2010, DIABETES RES CLIN PR, V87, P385, DOI 10.1016/j.diabres.2009.10.019; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Garnett JP, 2013, THORAX, V68, P835, DOI 10.1136/thoraxjnl-2012-203178; Glaser S, 2015, RESPIRATION, V89, P253, DOI 10.1159/000369863; Glucophage (metformin hydrochloride) tablets, 2009, GLUC METF HYDR TABL; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Hicks KA, STANDARDIZED DEFINIT; Hitchings AW, 2016, THORAX, V71, P587, DOI 10.1136/thoraxjnl-2015-208035; Hitchings AW, 2015, COPD, V12, P126, DOI [10.3109/15412555.2014.898052, 10.3109/15412555.2015.898052]; Iezzoni LI, 1997, RISK ADJUSTMENT MEAS; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Ito K, 2014, EXP GERONTOL, V59, P21, DOI 10.1016/j.exger.2014.03.014; Kim HJ, 2010, INT J TUBERC LUNG D, V14, P362; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Lowery EM, 2013, CLIN INTERV AGING, V8, P1489, DOI 10.2147/CIA.S51152; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025; Rabe KF, 2017, LANCET, V389, P1931, DOI 10.1016/S0140-6736(17)31222-9; Rana JS, 2004, DIABETES CARE, V27, P2478, DOI 10.2337/diacare.27.10.2478; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; Sexton P, 2014, COPD, V11, P133, DOI 10.3109/15412555.2013.808614; Song P, 2012, FREE RADICAL BIO MED, V52, P1607, DOI 10.1016/j.freeradbiomed.2012.01.025; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Tseng CH, 2019, DIABETES METAB, V45, P184, DOI 10.1016/j.diabet.2018.05.001; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Young BA, 2008, AM J MANAG CARE, V14, P15; Yu YB, 2012, THROMB HAEMOSTASIS, V108, P225, DOI 10.1160/TH12-01-0010; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	41	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204859	10.1371/journal.pone.0204859	http://dx.doi.org/10.1371/journal.pone.0204859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286138	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500052
J	Hollund, HI; Blank, M; Sjogren, KG				Hollund, Hege Ingjerd; Blank, Malou; Sjogren, Karl-Goran			Dead and buried? Variation in post-mortem histories revealed through histotaphonomic characterisation of human bone from megalithic graves in Sweden	PLOS ONE			English	Article							DIAGENETIC ALTERATION; ARCHAEOLOGICAL BONE; MICROBIAL ATTACK; CAVES; MUMMIFICATION; DEGRADATION; MANGANESE; BRITAIN; CARRION	This study investigates possible variation in post-mortem histories during the Neolithic period in southwestern Sweden based on microscopic studies of human bone. Numerous megalithic graves were built in this region and good preservation conditions have left a rich skeletal record. After more than a hundred years of research, it is still a controversy whether or not these skeletal assemblages were the result of primary burials, or ossuaries where skeletonized remains were deposited. In this study we apply histological analysis to obtain insights into post-mortem histories and taphonomic processes affecting the human remains, potentially including funerary rituals. This type of analysis records the condition and traces of degradation found in skeletal material at a microscopic level. Human skeletal material from four different megalithic tombs in the Falbygden area has been sampled and analysed by thin-section light microscopy, and by scanning electron microscopy. The results of the study provide evidence of variation and changes in burial conditions for skeletal remains from the different graves, also for remains from the same grave. Extent of bioerosion varied, from extensive to moderate/arrested, to none. Bone samples from the same graves also differed in the type of staining and mineral inclusions, showing that the non-bioeroded samples relatively early post-mortem must have experienced an anoxic environment, and later a change to an aerated environment. This could be taken as an indication of primary burial somewhere else, but more likely reflect a special micro-environment occurring temporarily in some graves and parts of graves after the tombs were filled with soil and sealed by roof slabs. The study illustrates the usefulness of bone histological analysis in the reconstruction of post-mortem histories, revealing variations not discernible at macro-level that may aid in the interpretations of funerary rituals. However, the results also highlight the issues of equifinality. Based on current data and knowledge, several scenarios are possible. Further histotaphonomic work is advisable, including archaeological remains from megalithic tombs, and bones from taphonomic experiments.	[Hollund, Hege Ingjerd] Univ Stavanger, Museum Archaeol, Stavanger, Norway; [Blank, Malou; Sjogren, Karl-Goran] Univ Gothenburg, Dept Hist Studies, Gothenburg, Sweden	Universitetet i Stavanger; University of Gothenburg	Hollund, HI (corresponding author), Univ Stavanger, Museum Archaeol, Stavanger, Norway.	hege.hollund@uis.no		Sjogren, Karl-Goran/0000-0003-1791-3175; Hollund, Hege Ingjerd/0000-0002-1274-669X	Wilhelm & Martina Lundgrens stiftelser	Wilhelm & Martina Lundgrens stiftelser	Preparation of thin-sections for histological analyses was funded by a grant from Wilhelm & Martina Lundgrens stiftelser (http://www.wmlundgren.se/) (M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom T, 2004, COAST COAST ARRIVAL, V10, P233; Ahlstrom T., 2009, UNDERJORDISKA DODSRI; Algotsson A., 1996, SLM RAPPORT; Anderbjork JE, 1932, V STERG TLANDS FORNM, VIV, P5; Anderson GS, 2011, J FORENSIC SCI, V56, P136, DOI 10.1111/j.1556-4029.2010.01539.x; Anderson GS, 1996, J FORENSIC SCI, V41, P617; [Anonymous], 1995, ANN SOC GEOL POL; BELL LS, 1991, SCANNING, V13, P173, DOI 10.1002/sca.4950130204; Bell LS, 1996, FORENSIC SCI INT, V82, P129, DOI 10.1016/0379-0738(96)01984-6; Bell LS, 2012, Bone Histology: An Anthropological Perspective, P241; Bianucci R., 2012, J ARCHAEOLOGY LOW CO, V4, P37; Blank M., 2016, LUND ARCHAEOL REV, V21, P49; Booth TJ, 2016, ARCHAEOMETRY, V58, P484, DOI 10.1111/arcm.12190; Booth TJ, 2016, J ARCHAEOL SCI, V74, P124, DOI 10.1016/j.jas.2016.08.007; Booth TJ, 2016, J ARCHAEOL SCI, V67, P14, DOI 10.1016/j.jas.2016.01.010; Booth TJ, 2015, ANTIQUITY, V89, P1155, DOI 10.15184/aqy.2015.111; Chambon P, 2003, MORTS SEPILTURES COL; Dal Sasso G, 2014, PALAEOGEOGR PALAEOCL, V416, P30, DOI 10.1016/j.palaeo.2014.06.034; During E., 1986, FAUNA ALVASTRA OSTEO; Fernandez-Jalvo Y, 2010, PALAEOGEOGR PALAEOCL, V288, P62, DOI 10.1016/j.palaeo.2009.12.016; Fischer C., 1985, MUMMIES DIS ANCIENT, P177; Force ER, 1989, MANGANESE CONTENTS S; Fowler C, 2010, DOC PRAEHIST, V37, P1, DOI 10.4312/dp.37.1; Fries M., 1951, POLLENANALYTISKA VIT; Fries M., 1958, VEGETATIONSUTVECKLIN; Garland A. N., 1993, HISTOLOGY ANCIENT HU, DOI [10.1007/978-3-642-77001-2, DOI 10.1007/978-3-642-77001-2]; Garland AN, 1989, APPL GEOCHEM, V4, P215, DOI DOI 10.1016/0883-2927(89)90021-8; Gill-Robinson HC, 2000, BRIT ARCHAEOLOGICAL, V1035, P111; GOFF ML, 1991, J FORENSIC SCI, V36, P748; GREENSLATE J, 1974, SCIENCE, V186, P529, DOI 10.1126/science.186.4163.529; HACKETT CJ, 1981, MED SCI LAW, V21, P243, DOI 10.1177/002580248102100403; Hanson M, 2007, J ARCHAEOL SCI, V34, P1902, DOI 10.1016/j.jas.2007.01.009; HEDGES REM, 1995, J ARCHAEOL SCI, V22, P201, DOI 10.1006/jasc.1995.0022; Hildebrand BE, 1864, ANTIQVARISK TIDSKRIF, VI, P255; HILL C A, 1982, NSS Bulletin, V44, P15; Hollund HI, 2012, INT J OSTEOARCHAEOL, V22, P537, DOI 10.1002/oa.1273; Huisman H, 2017, J ARCHAEOL SCI, V85, P13, DOI 10.1016/j.jas.2017.06.016; Jans MME, 2004, J ARCHAEOL SCI, V31, P87, DOI 10.1016/j.jas.2003.07.007; Jans MME, 2005, HISTOLOGIAL CHARACTE; Karkanas P, 2000, J ARCHAEOL SCI, V27, P915, DOI 10.1006/jasc.1999.0506; Kendall C, 2018, PALAEOGEOGR PALAEOCL, V491, P21, DOI 10.1016/j.palaeo.2017.11.041; Lelong O., 2014, P SOC ANTIQUARIES SC, V144, P65; Liljegren R., 1993, FRAN MAMMUTSTAPP KOH; Lopez-Gonzalez F, 2006, J ARCHAEOL SCI, V33, P707, DOI 10.1016/j.jas.2005.10.006; Lynnerup N, 2007, YEARB PHYS ANTHROPOL, V50, P162, DOI 10.1002/ajpa.20728; McBride M. B., 1994, ENV CHEM SOILS; MIDDELBURG JJ, 1988, MAR CHEM, V23, P353, DOI 10.1016/0304-4203(88)90104-1; Midgley MS, 2008, MEGALITHS NO EUROPE; Montelius, 1873, MBL, V2, P10; Muller K, 2011, PALAEOGEOGR PALAEOCL, V310, P39, DOI 10.1016/j.palaeo.2011.03.023; Nicholson RA, 1998, J ARCHAEOL SCI, V25, P393, DOI 10.1006/jasc.1997.0208; Nielsen-Marsh CM, 2007, J ARCHAEOL SCI, V34, P1523, DOI 10.1016/j.jas.2006.11.012; Northup DE, 2001, GEOMICROBIOL J, V18, P199, DOI 10.1080/01490450152467750; Owocki K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146293; Painter T. J., 1995, BOG BODIES NEW DISCO, P88; Pearson MP, 2007, ANTIQUITY, V81, P617, DOI 10.1017/S0003598X00095624; Pearson MP, 2005, ANTIQUITY, V79, P529; Persson P., 2001, FALBYGDENS GANGGRIFT, V34; Pollard A. M., 2001, HDB ARCHAEOLOGICAL S, P637; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Sahlstrom KE, 1932, GUDHEMS HARADS FORNM; Sahlstrom KE, 1927, UNDERSOKNING BERGA H; Salesse K, 2014, PALAEOGEOGR PALAEOCL, V416, P43, DOI 10.1016/j.palaeo.2014.07.021; Shanks M., 1982, SYMBOLIC STRUCTURAL, P129, DOI DOI 10.1017/CB09780511558252.013; Sjogren K., 2011, EXPLORING TIME MATTE, P103; Sjogren K.G, 2003, MEGALITGRAVAR SAMHAL; Sjogren K. G, 2015, NEOLITHIC DIVERSITIE, P200; Sjogren K- G, 2017, J NEOLITHIC ARCHAEOL, V19, P97, DOI DOI 10.12766/JNA.2017.4; Sjogren K-G, 2008, 62 GOT U; Sjogren KG, 2017, J ARCHAEOL SCI-REP, V12, P295, DOI 10.1016/j.jasrep.2017.01.044; Sjogren KG, 2009, J ANTHROPOL ARCHAEOL, V28, P85, DOI 10.1016/j.jaa.2008.10.001; Sjogren Karl-Goran, 2015, OXFORD HDB NEOLITHIC, P1005; Smith CI, 2007, J ARCHAEOL SCI, V34, P1485, DOI 10.1016/j.jas.2006.11.006; Smith MJ, 2016, J ARCHAEOL SCI-REP, V10, P744, DOI 10.1016/j.jasrep.2016.05.034; Sorensen TF, 2016, J ARCHAEOL METHOD TH, V23, P741, DOI 10.1007/s10816-015-9257-8; Stenskold Eva, 2004, ATT BERATTA SENNEOLI; Stromberg M., 1971, PROBLEMATIK GRABBAUT; Terrell-Nield Chris, 1997, Cave and Karst Science, V24, P53; Tilley C, 1996, ETNOGRAPHY NEOLITHIC; Trueman CN, 2002, ARCHAEOMETRY, V44, P371, DOI 10.1111/1475-4754.t01-1-00070; Trueman CNG, 2004, J ARCHAEOL SCI, V31, P721, DOI 10.1016/j.jas.2003.11.003; Turner-Walker G., 2007, 10 TRIENN M ICOM CC, P659; Turner-Walker G, 2008, PALAEOGEOGR PALAEOCL, V266, P227, DOI 10.1016/j.palaeo.2008.03.024; Turner-Walker G, 2008, PALAEOGEOGR PALAEOCL, V266, P151, DOI 10.1016/j.palaeo.2008.03.027; Ullenius G, 1948, GRAVNINGSBERATTELSE; van der Sluis LG, 2014, PALAEOGEOGR PALAEOCL, V416, P80, DOI 10.1016/j.palaeo.2014.06.003; Weiler E., 1977, FORNLAMNING, V5; Weiler E, STUDIA ARCHAEOLOGICA, V5; White L, 2014, FORENSIC SCI INT, V239, P92, DOI 10.1016/j.forsciint.2014.03.024	89	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204662	10.1371/journal.pone.0204662	http://dx.doi.org/10.1371/journal.pone.0204662			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281639	gold, Green Published, Green Submitted			2022-12-26	WOS:000446342400053
J	Wronska, AK; Bogus, MI; Kaczmarek, A; Kazek, M				Wronska, Anna Katarzyna; Bogus, Mieczyslawa Irena; Kaczmarek, Agata; Kazek, Michalina			Harman and norharman, metabolites of entomopathogenic fungus Conidiobolus coronatus (Entomopthorales), disorganize development of Galleria mellonella (Lepidoptera) and affect serotonin-regulating enzymes	PLOS ONE			English	Article							BETA-CARBOLINE ALKALOIDS; CONIDIOBOLUS-CORONATUS; TOLYPOCLADIUM; METARHIZIUM; DROSOPHILA; GROWTH; INHIBITION; SUBSTANCES; DOPAMINE; INSECTS	Naturally occurring entomopathogenic fungi such as Conidiobolus coronatus are important regulatory factors of insect populations. GC-MS analysis of fungal cell-free filtrates showed that C. coronatus synthesizes two beta-carboline alkaloids: harman and norharman. Significantly higher levels of both alkaloids are produced by C. coronatus in minimal postincubation medium than in rich medium. The beta-carboline alkaloids may have an effect on the nervous system of insects and their behavior. Harman and norharman were applied to Galleria mellonella larvae (a parasite of honeybees) either topically or mixed with food. Larvae received alkaloids in three concentrations: 750, 1000 or 1250 ppm. The effect on the survival and further development of larvae was examined. Both harman and norharman delayed pupation and adult eclosion, and inhibit total monoamine oxidase activity. In addition, they increased the serotonin concentration and decreased the monoamine oxidase A level in the heads of the moths. It is likely that the alkaloids were metabolized by the insects, as their effect wore off 24 hours after topical application. This is the first study to show that C. coronatus produces alkaloids. Its aim was to identify the actions of beta-carboline alkaloids on insect development and serotonin-regulating enzymes. Knowledge of the potential role of harman and norharman in the process of fungal infection might lead to the development of more effective and environmentally-friendly means of controlling insect pests.	[Wronska, Anna Katarzyna; Bogus, Mieczyslawa Irena; Kaczmarek, Agata; Kazek, Michalina] Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland; [Bogus, Mieczyslawa Irena] BIOMIBO, Warsaw, Poland	Polish Academy of Sciences; Witold Stefanski Institute of Parasitology of the Polish Academy of Sciences	Wronska, AK (corresponding author), Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland.	a.wronska@twarda.pan.pl	Wrońska, Anna/HHZ-6185-2022; Kaczmarek, Agata/ABG-3202-2020; Kaczmarek, Agata/ABG-3240-2020; Wrońska, Anna/AAN-8684-2020	Wrońska, Anna/0000-0001-5171-0828; Kaczmarek, Agata/0000-0001-7319-7973; Kaczmarek, Agata/0000-0001-7319-7973; 	Institute of Parasitology PAS in Warsaw; National Science Center Poland [2017/01/X/NZ3/00265]	Institute of Parasitology PAS in Warsaw; National Science Center Poland(National Science Centre, Poland)	The main source of financing were statutory funds from the resources of the Institute of Parasitology PAS in Warsaw. This work was partly supported by National Science Center Poland grant 2017/01/X/NZ3/00265; project manager Dr. Anna Wronska. Biomibo provided support in the form of a salary to MIB and made laboratory equipment available for AKW, MK, and AK. The specific roles of these authors are articulated in the 'author contributions' section. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELL A, 1995, NEUROCHEM RES, V20, P209, DOI 10.1007/BF00970546; Contreras-Cornejo HA, 2018, APPL SOIL ECOL, V124, P45, DOI 10.1016/j.apsoil.2017.10.004; Bandani AR, 2000, MYCOL RES, V104, P537, DOI 10.1017/S0953756299001859; Bania J, 2006, ARCH INSECT BIOCHEM, V62, P186, DOI 10.1002/arch.20134; Beketov MA, 2013, P NATL ACAD SCI USA, V110, P11039, DOI 10.1073/pnas.1305618110; Benny GL, 2001, MYCOTA, V7, P113; Bogus MI, 2017, B ENTOMOL RES, V107, P66, DOI 10.1017/S0007485316000638; Bogus MI, 2002, ACTA PARASITOL, V47, P66; Bortolato M, 2010, HBK BEHAV NEUROSCI, V21, P203, DOI 10.1016/S1569-7339(10)70079-5; Bouayad N, 2012, SAUDI J BIOL SCI, V19, P73, DOI 10.1016/j.sjbs.2010.12.004; Cao RH, 2007, CURR MED CHEM, V14, P479, DOI 10.2174/092986707779940998; CAVIN JC, 1988, J CHEM ECOL, V14, P475, DOI 10.1007/BF01013899; Chang Y, 2015, GENOME BIOL EVOL, V7, P1590, DOI 10.1093/gbe/evv090; Coleman CM, 2005, ARCH INSECT BIOCHEM, V59, P12, DOI 10.1002/arch.20050; Dacks AM, 2003, J INSECT BEHAV, V16, P1, DOI 10.1023/A:1022817610378; Eamvijarn A, 2013, TETRAHEDRON, V69, P8583, DOI 10.1016/j.tet.2013.07.078; French AS, 2014, J INSECT PHYSIOL, V61, P8, DOI 10.1016/j.jinsphys.2013.12.005; Glennon RA, 2000, DRUG ALCOHOL DEPEN, V60, P121, DOI 10.1016/S0376-8716(99)00148-9; Golebiowski M, 2017, CHEM PAP, V71, P1183, DOI 10.1007/s11696-017-0178-8; Harding CR, 2013, JOVE-J VIS EXP, DOI 10.3791/50964; He J, 2005, J NAT PROD, V68, P1397, DOI 10.1021/np058018g; Heinz CA, 1996, ENTOMOL EXP APPL, V80, P443, DOI 10.1007/BF00343467; Herraiz T, 2008, CHEM RES TOXICOL, V21, P2172, DOI 10.1021/tx8002565; Hoge KT, 1996, MYCOLOGIA, V88, P715, DOI 10.2307/3760965; KODAIRA Y, 1961, AGR BIOL CHEM TOKYO, V25, P261, DOI 10.1080/00021369.1961.10857803; Kwadha CA, 2017, INSECTS, V8, DOI 10.3390/insects8020061; Lubeck I, 2008, FUNGAL ECOL, V1, P78, DOI 10.1016/j.funeco.2008.09.002; MAY T, 1991, J NEUROCHEM, V56, P490, DOI 10.1111/j.1471-4159.1991.tb08177.x; Muszewska A, 2014, EUR J CLIN MICROBIOL, V33, P1273, DOI 10.1007/s10096-014-2076-0; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; NOVAK MG, 1994, J MED ENTOMOL, V31, P600, DOI 10.1093/jmedent/31.4.600; Patel K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P660, DOI 10.1016/S2221-1691(12)60116-6; Reino Jose Luis, 2008, Phytochemistry Reviews, V7, P89, DOI 10.1007/s11101-006-9032-2; Roberts D.W., 1981, BIOL CONIDIAL FUNGI, P201; ROMMELSPACHER H, 1994, EUR J PHARMACOL, V252, P51, DOI 10.1016/0014-2999(94)90574-6; Roy HE, 2008, EUR J ENTOMOL, V105, P391, DOI 10.14411/eje.2008.049; SEHNAL F, 1966, Z WISS ZOOL ABT A, V174, P53; Shah FA, 2005, FEMS MICROBIOL LETT, V251, P259, DOI 10.1016/j.femsle.2005.08.010; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Strasser H, 2000, BIOCONTROL SCI TECHN, V10, P717, DOI 10.1080/09583150020011690; Vey A., 2001, Fungi as biocontrol agents: progress, problems and potential, P311, DOI 10.1079/9780851993560.0311; Vikhe A., 2016, INT J PURE APPL BIOS, V4, P97, DOI DOI 10.18782/2320-7051.2303; WARNER HR, 1981, NUCLEIC ACIDS RES, V9, P6083, DOI 10.1093/nar/9.22.6083; WIELOCH W, 2007, ACTA BIOCHIM POL, V54, P79; Wieloch W, 2011, TOXICON, V58, P369, DOI 10.1016/j.toxicon.2011.07.007; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Zhao T, 2012, FOOD CHEM, V134, P1096, DOI 10.1016/j.foodchem.2012.03.024	48	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204828	10.1371/journal.pone.0204828	http://dx.doi.org/10.1371/journal.pone.0204828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281642	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400060
J	McLean, K; Tan, LJ; Bolland, DE; Coffman, LG; Peterson, LF; Talpaz, M; Neamati, N; Buckanovich, RJ				McLean, Karen; Tan, Lijun; Bolland, Danielle E.; Coffman, Lan G.; Peterson, Luke F.; Talpaz, Moshe; Neamati, Nouri; Buckanovich, Ronald J.			Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth	ONCOGENE			English	Article							STEM-CELLS; PROGNOSTIC-SIGNIFICANCE; CARCINOMA; TUMORIGENESIS; METASTASIS; EXPRESSION; RESISTANCE; MODEL; LINE	Ovarian carcinoma-associated mesenchymal stem cells (CA-MSC) produce not only high levels of interleukin-6 (IL6) but also the related cytokine leukemia inhibitory factor (LIF). IL6-mediated activation of STAT3 is implicated as a critical therapeutic target for cancer therapy. Less is known about the role of LIF, which can similarly activate STAT3, in ovarian cancer. We therefore sought to evaluate the tumorigenic effects of CA-MSC paracrine LIF signaling and the redundancy of IL6 and LIF in activating ovarian cancer STAT3 mediated cancer growth. As expected, we found that both IL6 and LIF induce STAT3 phosphorylation in tumor cells. In addition, both IL6 and LIF increased the percentage of ALDH+ ovarian cancer stem-like cells (CSC). Supporting redundancy of function by the two cytokines, CA-MSC induced STAT3 phosphorylation and increased cancer cell "stemness". This effect was not inhibited by LIF or IL6 blocking antibodies alone, but was prevented by dual IL6/LIF blockade or JAK2 inhibition. Similarly, small hairpin RNA (shRNA)-mediated reduction of IL6 or LIF in CA-MSC partially decreased but could not completely abrograte the ability of CA-MSC to induce STAT3 phosphorylation and stemness. Importantly, the in vivo pro-tumorigenic effect of CA-MSC is abrogated by dual blockade with the JAK2 inhibitor ruxolitinib to a much greater extent than treatment with anti-IL6 or anti-LIF antibody alone. Ruxolitinib treatment also improves survival in the immunocompetent ovarian cancer mouse model system with ID8 tumor cells plus MSC. Ruxolitinib-treated tumors in both the immunocompromised and immunocompetent animal models demonstrate decreased phospho-STAT3, indicating on-target activity. In conclusion, CA-MSC activate ovarian cancer cell STAT3 signaling via IL6 and LIF and increase tumor cell stemness. This functional redundancy suggests that therapeutic targeting of a single cytokine may be less effective than strategies such as dual inhibitor therapy or targeting shared downstream factors of the JAK/STAT pathway.	[McLean, Karen; Tan, Lijun; Bolland, Danielle E.] Univ Michigan, Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Ann Arbor, MI 48109 USA; [Coffman, Lan G.; Buckanovich, Ronald J.] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh, PA USA; [Peterson, Luke F.; Talpaz, Moshe] Univ Michigan, Med Ctr, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Neamati, Nouri] Coll Pharm, Dept Med Chem, North Campus Res Complex, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; University of Michigan System; University of Michigan	McLean, K (corresponding author), Univ Michigan, Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Ann Arbor, MI 48109 USA.	karenmcl@umich.edu	Coffman, Lan/AAP-7600-2021	Coffman, Lan/0000-0002-3753-1652; Talpaz, Moshe/0000-0003-3361-3981	Women's Reproductive Health Research (WRHR) Career Development Program Award [K12 HD065257]; Department of Defense Ovarian Cancer Academy Early-Career Investigator Award [DOD W81XWH-15-0194]; Goldberg Family; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD065257] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K08CA211362] Funding Source: NIH RePORTER	Women's Reproductive Health Research (WRHR) Career Development Program Award; Department of Defense Ovarian Cancer Academy Early-Career Investigator Award; Goldberg Family; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank Yusong Gong for her technical assistance in the beginning stages of this project. Funding for this work has been provided in part by the Women's Reproductive Health Research (WRHR) Career Development Program Award to KM (National Institutes of Health, K12 HD065257), the Department of Defense Ovarian Cancer Academy Early-Career Investigator Award to KM (DOD W81XWH-15-0194), and the generous support of the Goldberg Family.	American Cancer Society, SURV RAT OV CANC STA; Anglesio MS, 2011, CLIN CANCER RES, V17, P2538, DOI 10.1158/1078-0432.CCR-10-3314; Burgos-Ojeda D, 2013, CANCER RES, V73, P3555, DOI 10.1158/0008-5472.CAN-12-2845; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Coffman LG, 2016, ONCOTARGET, V7, P6916, DOI 10.18632/oncotarget.6870; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Dijkgraaf EM, 2015, ANN ONCOL, V26, P2141, DOI 10.1093/annonc/mdv309; Ding DC, 2016, J CANCER, V7, P1815, DOI 10.7150/jca.16116; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Gritsina G, 2015, MOL CANCER THER, V14, P1035, DOI 10.1158/1535-7163.MCT-14-0800; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Kenny HA, 2011, CANCER DISCOV, V1, P100, DOI 10.1158/2159-8290.CD-11-0117; Kim B, 2017, CANCER RES TREAT, V49, P338, DOI 10.4143/crt.2016.175; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Lane D, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-210; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Musrap N, 2012, MOL CANCER RES, V10, P1254, DOI 10.1158/1541-7786.MCR-12-0353; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Saini U, 2017, ONCOGENE, V36, P168, DOI 10.1038/onc.2016.197; SCAMBIA G, 1995, BRIT J CANCER, V71, P354, DOI 10.1038/bjc.1995.71; VANDAM M, 1993, J BIOL CHEM, V268, P15285; Wang WM, 2016, CELL, V165, P1092, DOI 10.1016/j.cell.2016.04.009; Xu SL, 2013, MOL CANCER THER, V12, P937, DOI 10.1158/1535-7163.MCT-12-1082; Ye F, 2008, HISTOPATHOLOGY, V53, P224, DOI 10.1111/j.1365-2559.2008.03068.x; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhou T, 2014, LEUKEMIA, V28, P471, DOI 10.1038/leu.2013.299	30	38	39	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2019	38	9					1576	1584		10.1038/s41388-018-0523-6	http://dx.doi.org/10.1038/s41388-018-0523-6			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN1KL	30305729	Green Accepted			2022-12-26	WOS:000459945800015
J	Jang, SY; Hwang, J; Kim, BS; Lee, EY; Oh, BH; Kim, MH				Jang, Song Yee; Hwang, Jungwon; Kim, Byoung Sik; Lee, Eun-Young; Oh, Byung-Ha; Kim, Myung Hee			Structural basis of inactivation of Ras and Rap1 small GTPases by Ras/Rap1-specific endopeptidase from the sepsis-causing pathogen Vibrio vulnificus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						toxin; virulence factor; sepsis; host-pathogen interaction; bacterial pathogenesis; effector; MARTX toxin; Ras; Rap1-specific endopeptidase; Vibrio vulnificus	VI SECRETION SYSTEM; BACTERIAL TOXINS; CROSS-LINKING; FAMILY; ACTIVATION; EFFECTOR; DISTINCT; DOMAIN; RESPONSES; DELIVERY	Multifunctional autoprocessing repeats-in-toxin (MARTX) toxins are secreted by Gram-negative bacteria and function as primary virulence-promoting macromolecules that deliver multiple cytopathic and cytotoxic effector domains into the host cytoplasm. Among these effectors, Ras/Rap1-specific endopeptidase (RRSP) catalyzes the sequence-specific cleavage of the Switch I region of the cellular substrates Ras and Rap1 that are crucial for host innate immune defenses during infection. To dissect the molecular basis underpinning RRSP-mediated substrate inactivation, we determined the crystal structure of an RRSP from the sepsis-causing bacterial pathogen Vibrio vulnificus (VvRRSP). Structural and biochemical analyses revealed that VvRRSP is a metal-independent TIKI family endopeptidase composed of an N-terminal membrane-localization and substrate-recruitment domain (N lobe) connected via an inter-lobe linker to the C-terminal active site-coordinating core -sheet-containing domain (C lobe). Structure-based mutagenesis identified the 2His/2Glu catalytic residues in the core catalytic domain that are shared with other TIKI family enzymes and that are essential for Ras processing. In vitro KRas cleavage assays disclosed that deleting the N lobe in VvRRSP causes complete loss of enzymatic activity. Endogenous Ras cleavage assays combined with confocal microscopy analysis of HEK293T cells indicated that the N lobe functions both in membrane localization via the first -helix and in substrate assimilation by altering the functional conformation of the C lobe to facilitate recruitment of cellular substrates. Collectively, these results indicate that RRSP is a critical virulence factor that robustly inactivates Ras and Rap1 and augments the pathogenicity of invading bacteria via the combined effects of its N and C lobes.	[Jang, Song Yee; Oh, Byung-Ha] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea; [Jang, Song Yee; Hwang, Jungwon; Kim, Byoung Sik; Lee, Eun-Young; Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Infect & Immun Res Lab, Metab Regulat Res Ctr, Daejeon 34141, South Korea; [Kim, Byoung Sik] Ewha Womans Univ, Dept Food Sci & Engn, Seoul 03760, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ewha Womans University	Oh, BH (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea.; Hwang, J; Kim, MH (corresponding author), Korea Res Inst Biosci & Biotechnol, Infect & Immun Res Lab, Daejeon 34141, South Korea.	jwhwang@kribb.re.kr; bhoh@kaist.ac.kr; mhk8n@kribb.re.kr	Kim, Byoungsik/AAE-6239-2021	Kim, Byoung Sik/0000-0001-9820-6071	National Research Foundation of Korea; Korea Research Institute of Bioscience and Biotechnology (KRIBB) Initiative Program; Ministry of Science and ICT of Korea [2017R1A2B3007317]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Research Institute of Bioscience and Biotechnology (KRIBB) Initiative Program; Ministry of Science and ICT of Korea	This work was supported by National Research Foundation of Korea, funded by the Ministry of Science and ICT of Korea Grant 2017R1A2B3007317 (to M.H.K.), and the Korea Research Institute of Bioscience and Biotechnology (KRIBB) Initiative Program. The authors declare that they have no conflicts of interest with the contents of this article.	Ackermann JA, 2011, EMBO J, V30, P1621, DOI 10.1038/emboj.2011.74; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Antic I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8396; Antic I, 2014, PROTEINS, V82, P2643, DOI 10.1002/prot.24628; Bazan JF, 2013, DEV CELL, V25, P225, DOI 10.1016/j.devcel.2013.04.019; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biancucci M, 2017, BIOCHEMISTRY-US, V56, P2747, DOI 10.1021/acs.biochem.7b00246; Boardman BK, 2004, J BACTERIOL, V186, P8137, DOI 10.1128/JB.186.23.8137-8143.2004; Botelho RJ, 2009, J BIOL CHEM, V284, P28522, DOI 10.1074/jbc.M109.009514; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gavin HE, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv092; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Hisao GS, 2017, PROTEIN SCI, V26, P497, DOI 10.1002/pro.3097; Johnson DS, 2012, CURR OPIN PHARMACOL, V12, P458, DOI 10.1016/j.coph.2012.02.003; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Kim BS, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00272-17; Kim BS, 2015, MBIO, V6, DOI 10.1128/mBio.00324-15; Kudryashev M, 2015, CELL, V160, P952, DOI 10.1016/j.cell.2015.01.037; Kwak JS, 2011, P NATL ACAD SCI USA, V108, P1645, DOI 10.1073/pnas.1014339108; Lee BC, 2008, INFECT IMMUN, V76, P1509, DOI 10.1128/IAI.01503-07; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Mitchell D, 2010, MOL IMMUNOL, V47, P2065, DOI 10.1016/j.molimm.2010.04.004; Moest TP, 2013, CURR OPIN MICROBIOL, V16, P38, DOI 10.1016/j.mib.2012.11.006; Morar M, 2012, BIOCHEMISTRY-US, V51, P1740, DOI 10.1021/bi201790u; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagahama M, 2011, INFECT IMMUN, V79, P905, DOI 10.1128/IAI.01019-10; Riese MJ, 2011, J BIOL CHEM, V286, P5254, DOI 10.1074/jbc.M110.171884; Sanchez-Pulido L, 2013, BIOINFORMATICS, V29, P2371, DOI 10.1093/bioinformatics/btt412; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Satchell KJF, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.VE-0002-2014; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Shah S, 2018, RILEM BOOKSER, V15, P3, DOI 10.1007/978-94-024-1194-2_1; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Shin J, 2012, J IMMUNOL, V188, P2111, DOI 10.4049/jimmunol.1102265; So EC, 2015, CAN J MICROBIOL, V61, P617, DOI 10.1139/cjm-2015-0166; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Woida PJ, 2018, MOL MICROBIOL, V107, P133, DOI 10.1111/mmi.13875; Woolery AR, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.601310; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zhang XJ, 2016, J BIOL CHEM, V291, P2435, DOI 10.1074/jbc.M115.677807	52	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18110	18122		10.1074/jbc.RA118.004857	http://dx.doi.org/10.1074/jbc.RA118.004857			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30282804	hybrid, Green Published			2022-12-26	WOS:000451375200008
J	Polineni, D; Piccorelli, AV; Hannah, WB; Dalrymple, SN; Pace, RG; Durie, PR; Ling, SC; Knowles, MR; Stonebraker, JR				Polineni, Deepika; Piccorelli, Annalisa, V; Hannah, William B.; Dalrymple, Sarah N.; Pace, Rhonda G.; Durie, Peter R.; Ling, Simon C.; Knowles, Michael R.; Stonebraker, Jaclyn R.			Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population	PLOS ONE			English	Article							PORTAL-HYPERTENSION; RISK-FACTORS; DELTA-F508	Previous reports of lung function in cystic fibrosis (CF) patients with liver disease have shown worse, similar, or even better forced expiratory volume in 1 second (FEV1), compared to CF patients without liver disease. Varying definitions of CF liver disease likely contribute to these inconsistent relationships reported between CF lung function and liver disease. We retrospectively evaluated spirometric data in 179 subjects (62% male; 58% Phe508del homozygous) with severe CF liver disease (CFLD; defined by presence of portal hypertension due to cirrhosis). FEV1 values were referenced to both a normal population (FEV1 % predicted) and CF population (CF-specific FEV1 percentile). We utilized a linear mixed model with repeated measures to assess changes in lung function (before and after diagnosis of CFLD), relative to both the normal and CF populations. At diagnosis of CFLD, the mean FEV1 was 81% predicted, or at the 53rd percentile referenced to CF patients without CFLD. There was a significant difference in post-CFLD slope compared to pre-CFLD slope (post-pre) using FEV1 % predicted (-1.94, p-value < 0.0001). However, there was insignificant evidence of this difference using the CF-specific FEV1 percentile measure (-0.99, p-value = 0.1268). Although FEV1 % predicted values declined in patients following CFLD diagnosis, there was not significant evidence of lung function decline in CF-specific FEV1 percentiles. Thus, the observed study cohort indicates diagnosis of severe CFLD was not associated with worsened CF lung disease when compared to a large CF reference population.	[Polineni, Deepika; Hannah, William B.; Dalrymple, Sarah N.; Pace, Rhonda G.; Knowles, Michael R.; Stonebraker, Jaclyn R.] Univ North Carolina Chapel Hill, Sch Med, Marsico Lung Inst, UNC Cyst Fibrosis Res Ctr, Chapel Hill, NC 27516 USA; [Polineni, Deepika] Univ Kansas, Dept Pulmonol, Div Pulm & Crit Care Med, Sch Med, Kansas City, KS 66160 USA; [Piccorelli, Annalisa, V] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Piccorelli, Annalisa, V] Univ Wyoming, Dept Math & Stat, Laramie, WY 82071 USA; [Durie, Peter R.] Hosp Sick Children, Res Inst, Physiol & Expt Med, Toronto, ON, Canada; [Durie, Peter R.; Ling, Simon C.] Univ Toronto, Hosp Sick Children, Div Gastroenterol Hepatol & Nutr, Toronto, ON, Canada; [Durie, Peter R.; Ling, Simon C.] Univ Toronto, Dept Paediat, Toronto, ON, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Kansas; University of Kansas Medical Center; Case Western Reserve University; University of Wyoming; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Polineni, D (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Marsico Lung Inst, UNC Cyst Fibrosis Res Ctr, Chapel Hill, NC 27516 USA.; Polineni, D (corresponding author), Univ Kansas, Dept Pulmonol, Div Pulm & Crit Care Med, Sch Med, Kansas City, KS 66160 USA.	dpolineni@kumc.edu		Pace, Rhonda/0000-0001-8606-0327; Stonebraker, Jaclyn/0000-0002-8657-6697	National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases [DK066368]; Cystic Fibrosis Foundation [CFF-KNOWLE00AO]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This study was funded by the Cystic Fibrosis Foundation and the National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases (https://www.niddk.nih.gov/) DK066368 (MRK); Cystic Fibrosis Foundation (https://www.cff.org/) CFF-KNOWLE00AO (MRK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JR, 2009, JAMA-J AM MED ASSOC, V302, P1076, DOI 10.1001/jama.2009.1295; COHN JA, 1993, GASTROENTEROLOGY, V105, P1857, DOI 10.1016/0016-5085(93)91085-V; Collaco JM, 2010, J PEDIATR-US, V157, P802, DOI 10.1016/j.jpeds.2010.05.018; Colombo C, 2002, HEPATOLOGY, V36, P1374, DOI 10.1053/jhep.2002.37136; Corbett K, 2004, J PEDIATR-US, V145, P327, DOI 10.1016/j.jpeds.2004.05.051; DEARCE M, 1992, CLIN GENET, V42, P271; Debray D, 1999, J HEPATOL, V31, P77, DOI 10.1016/S0168-8278(99)80166-4; Foundation CF., 2014, CYST FIBR FDN PAT RE; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; Knowles MR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009548; Knowles MR, 2002, NEW ENGL J MED, V347, P439, DOI 10.1056/NEJMe020070; KNUDSON RJ, 1976, AM REV RESPIR DIS, V113, P587; Kobelska-Dubiel N, 2014, PRZ GASTROENTEROL, V9, P136, DOI 10.5114/pg.2014.43574; Kulich M, 2005, AM J RESP CRIT CARE, V172, P885, DOI 10.1164/rccm.200410-1335OC; Parisi GF, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.11215; Rowland M, 2011, AM J GASTROENTEROL, V106, P104, DOI 10.1038/ajg.2010.316; Slieker MG, 2006, J PEDIATR-US, V149, P144, DOI 10.1016/j.jpeds.2005.12.018; Stonebraker JR, 2016, CLIN GASTROENTEROL H, V14, P1207, DOI 10.1016/j.cgh.2016.03.041; Tabernero da Veiga S., 2004, Nutr. Hosp., V19, P19; VandenBranden SL, 2012, PEDIATR PULM, V47, P135, DOI 10.1002/ppul.21526; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; Wilschanski M, 1999, PEDIATRICS, V103, P52, DOI 10.1542/peds.103.1.52	22	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205257	10.1371/journal.pone.0205257	http://dx.doi.org/10.1371/journal.pone.0205257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30307979	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500053
J	Buczkowska, K; Bakalin, V; Baczkiewicz, A; Aguero, B; Gonera, P; Slipiko, M; Szczecinska, M; Sawicki, J				Buczkowska, Katarzyna; Bakalin, Vadim; Baczkiewicz, Aline; Aguero, Blanka; Gonera, Patrycja; Slipiko, Monika; Szczecinska, Monika; Sawicki, Jakub			Does Calypogeia azurea (Calypogeiaceae, Marchantiophyta) occur outside Europe? Molecular and morphological evidence	PLOS ONE			English	Article							RADDI JUNGERMANNIALES; CHEMICAL-CONSTITUENTS; DNA MARKERS; L. DUMORT.; DELIMITATION; LIVERWORTS; PHYLOGENY; HEPATICAE; HYBRIDIZATION; BIOGEOGRAPHY	Oil bodies are the unique feature of most liverworts. Their shape, color and distribution pattern in leaf and underleaf cells are important taxonomic features of the genus Calypogeia. Most species of the genus Calypogeia have pellucid and colorless oil bodies, whereas colored, including gray to pale brown, purple-brown or blue oil bodies, are rare. To date, C. azurea was the only species with blue oil bodies to have been considered as a species of the Holarctic range. This species has been noted in various parts of the northern hemisphere-from North America, through Europe to the Far East. The aim of this study was to determine the genetic diversity of C. azurea from different parts of its distribution range and to ascertain whether blue oil bodies appeared once or several times in the evolution of the genus Calypogeia. The phylogenetic analyses based on four plastid regions (rbcL, trnG, trnL, trnH-psbA) and one nuclear region (ITS2) revealed that C. azurea is presently a paraphyletic taxon, with other Calypogeia species nested among C. azurea accessions that were clustered into four different clades. Based on the level of genetic divergence (1.03-2.17%) and the observed morphological, ecological and geographical differences, the evaluated clades could be regarded as previously unrecognized species. Four species were identified: C. azurea Stotler & Crotz (a European species corresponding to the holotype), two new species from Pacific Asia-C. orientalis Buczkowska & Bakalin and C. sinensis Bakalin & Buczkowska, and a North American species which, due to the lack of identifiable morphological features, must be regarded as the cryptic species of C. azurea with a provisional name of C. azurea species NA.	[Buczkowska, Katarzyna; Baczkiewicz, Aline; Gonera, Patrycja] Adam Mickiewicz Univ, Fac Biol, Dept Genet, Poznan, Poland; [Bakalin, Vadim] Russian Acad Sci, Bot Garden Inst, Vladivostok, Russia; [Aguero, Blanka] Duke Univ, Dept Biol, Duke Herbarium, Durham, NC USA; [Slipiko, Monika; Szczecinska, Monika; Sawicki, Jakub] Univ Warmia & Mazury, Dept Bot & Nat Protect, Olsztyn, Poland	Adam Mickiewicz University; Russian Academy of Sciences; Botanical Garden Institute of the Far Eastern Branch of the Russian Academy of Sciences; Duke University; University of Warmia & Mazury	Buczkowska, K (corresponding author), Adam Mickiewicz Univ, Fac Biol, Dept Genet, Poznan, Poland.	androsac@amu.edu.pl	Szczecinska, Monika/J-2400-2012; Sawicki, Jakub/H-4432-2012; Bakalin, Vadim A./S-8876-2017	Sawicki, Jakub/0000-0002-4759-8113; Bakalin, Vadim A./0000-0001-7897-4305; Gonera, Patrycja/0000-0002-1645-4088; Slipiko, Monika/0000-0002-7759-2193; Buczkowska, Katarzyna/0000-0003-1491-8157; Szczecinska, Monika/0000-0002-5377-4304	Polish National Science Centre [N303 344235, 2015/19/B/NZ8/03970]; Russian Foundation for Basic Researches [17-04-0018, 12-04-91150]; Vietnam Academy of Science and Technology [BAHT17-002, VAST.HTQT.NGA.02/17-18]; Far Eastern Branch of the Russian Academy of Sciences [BAHT17-002, VAST.HTQT.NGA.02/17-18]; Chinese Foundation for Natural Sciences	Polish National Science Centre; Russian Foundation for Basic Researches(Russian Foundation for Basic Research (RFBR)); Vietnam Academy of Science and Technology; Far Eastern Branch of the Russian Academy of Sciences(Russian Academy of Sciences); Chinese Foundation for Natural Sciences	The work of KB, AB, PG,MS, MS, JS was supported by the Polish National Science Centre (https://www.ncn.gov.pl/), grants no. N303 344235 and 2015/19/B/NZ8/03970. The work of VB was partly supported by the Russian Foundation for Basic Researches no. 17-04-0018 and the collaborative project between the Vietnam Academy of Science and Technology and the Far Eastern Branch of the Russian Academy of Sciences no. BAHT17-002 and VAST.HTQT.NGA.02/17-18. The collection of the material in China was accomplished in the course of joint investigation within collaboration project sponsored by the Russian Foundation for Basic Researches (project no. 12-04-91150) and Chinese Foundation for Natural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda SC, 2014, TAXON, V63, P1008, DOI 10.12705/635.12; ASAKAWA Y, 1982, PROG CH ORG NAT PROD, V42, P1; Asakawa Y, 1995, PROG CH ORG NAT PROD, V65, P1; Asakawa Y., 2013, PROG CHEM ORG NAT PR, V95, P1, DOI [10.1007/978-3-7091-1084-3_1, DOI 10.1007/978-3-7091-1084-3_1]; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baczkiewicz A, 2008, CRYPTOGAMIE BRYOL, V29, P3; Baczkiewicz A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188837; Bakalin VA, 2018, J BRYOL, V40, P68, DOI 10.1080/03736687.2017.1393140; Bakalin Vadim A., 2015, Arctoa, V24, P509, DOI 10.15298/arctoa.24.42; Balachandran K.R.S., 2015, BOT TARGETS THERAPY, V5, P77, DOI DOI 10.2147/BTAT.S61121; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bell D, 2012, MOL ECOL RESOUR, V12, P36, DOI 10.1111/j.1755-0998.2011.03053.x; Boisselier-Dubayle MC, 1998, BOT ACTA, V111, P490; Buch H, 1935, MEM SOC F FL FENN, V11, P197; Buczkowska K, 2004, PLANT SYST EVOL, V247, P187, DOI 10.1007/s00606-003-0156-9; Buczkowska K, 2004, NOVA HEDWIGIA, V78, P147, DOI 10.1127/0029-5035/2004/0078-0147; Buczkowska K, 2004, NOVA HEDWIGIA, V78, P121, DOI 10.1127/0029-5035/2004/0078-0121; Buczkowska K, 2016, BIODIV RES CONSERV, V42, P19, DOI [10.1515/biorc-2016-0010, DOI 10.1515/BIORC-2016-0010]; Buczkowska Katarzyna, 2012, Polish Botanical Journal, V57, P95; Buczkowska K, 2012, PLANT SYST EVOL, V298, P549, DOI 10.1007/s00606-011-0565-5; Buczkowska K, 2011, ACTA SOC BOT POL, V80, P327, DOI 10.5586/asbp.2011.039; Buczkowska K, 2011, J BRYOL, V33, P291, DOI 10.1179/1743282011Y.0000000029; Choi SS, 2013, THESIS; Crandall-Stotler B, 2009, BRYOPHYTE BIOL; Damsholt K, 2002, ILLUSTRATED FLORA NO, P456; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fiedorow P, 2001, GENE, V262, P309, DOI 10.1016/S0378-1119(00)00523-0; FRITSCH R, 1974, Lindbergia, V2, P234; Fritsch R, 1991, BRYOPH BIBL, V40, P19; Fuselier L, 2009, BIOL J LINN SOC, V98, P745, DOI 10.1111/j.1095-8312.2009.01319.x; Goloboff PA, 2004, CLADISTICS, V20, P84; Goloboff P, 2008, CLADISTICS, V24, P91; He XL, 2013, CRIT REV PLANT SCI, V32, P293, DOI 10.1080/07352689.2013.765765; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heinrichs J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082547; Heinrichs J, 2011, AM J BOT, V98, P1252, DOI 10.3732/ajb.1100115; Heinrichs J, 2010, MOL PHYLOGENET EVOL, V56, P1105, DOI 10.1016/j.ympev.2010.05.004; INOUE H, 1975, Bulletin of the National Science Museum Series B (Botany), V1, P135; Inoue H, 1968, B NATN SCI MUS TOKYO, V11, P397; Inoue H, 1966, J JAP BOT, V41, P134; Inoue H., 1974, J JAP BOT, V49, P337; Inoue H, 1968, J JAP BOT, V43, P468; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitagawa N, 1988, NOVA HEDWIGIA S, V90, P163; [Константинова Н.А. Konstantinova N.A.], 2009, [Arctoa, Arctoa], V18, P1; KONSTANTINOVA N.A., 1996, ARCTOA, V6, P125; Kreier HP, 2010, MOL PHYLOGENET EVOL, V57, P1260, DOI 10.1016/j.ympev.2010.10.002; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lorbeer G, 1934, JB WISS BOT, V80, P567; Muller K, 1958, KRYPTOGAMEN FLORA DE, V6, P1161; Myszczynski K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10434-7; NEWTON ME, 1973, J BRYOL, V7, P379, DOI 10.1179/jbr.1973.7.3.379; Pacak A, 2003, J MOL EVOL, V56, P11, DOI 10.1007/s00239-002-2375-4; Paton JA., 1999, LIVERWORT FLORA BRIT, P77; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Potemkin AD, 2017, NOVOSTI SIST NIZSH R, V51, P263; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Renner MAM, 2017, MOL PHYLOGENET EVOL, V107, P576, DOI 10.1016/j.ympev.2016.12.018; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sawicki J, 2010, J SYST EVOL, V48, P183, DOI 10.1111/j.1759-6831.2010.00076.x; Schuster RM, 1969, HEPATICAE ANTHOCEROT, V2, P98; Schuster Rudolf M., 1995, Fragmenta Floristica et Geobotanica, V40, P825; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Stotler RE, 2017, ANN MO BOT GARD, V102, P574, DOI 10.3417/2016027; STOTLER RE, 1983, TAXON, V32, P64, DOI 10.2307/1219851; Szweykowski J, 2005, PLANT SYST EVOL, V253, P133, DOI 10.1007/s00606-005-0301-0; SZWEYKOWSKI J, 1990, NOVA HEDWIGIA, V51, P241; Szweykowski J, 2006, ANNOTATED CHECKLIST, V4, P18; TAKEDA R, 1981, PLANTA, V151, P525, DOI 10.1007/BF00387429; Warmers U, 1999, PHYTOCHEMISTRY, V51, P679, DOI 10.1016/S0031-9422(99)00081-3; Warmers U, 1999, PHYTOCHEMISTRY, V52, P695, DOI 10.1016/S0031-9422(99)00321-0; Yamada K, 2006, J HATTORI BOT LAB, P1; Yang JD, 2009, ENDEMIC SPECIES RES, V11, P93; Yu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0084124, 10.1371/journal.pone.0061967]	79	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204561	10.1371/journal.pone.0204561	http://dx.doi.org/10.1371/journal.pone.0204561			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304042	Green Submitted, Green Published, gold			2022-12-26	WOS:000446921100052
J	Marsh, AD; Rowe, TB				Marsh, Adam D.; Rowe, Timothy B.			Anatomy and systematics of the sauropodomorph Sarahsaurus aurifontanalis from the Early Jurassic Kayenta Formation	PLOS ONE			English	Article							COLORADISAURUS-BREVIS DINOSAURIA; SOUTH-AFRICA EVIDENCE; EARLY EVOLUTION; PHYLOGENETIC-RELATIONSHIPS; POSTCRANIAL ANATOMY; NAVAJO SANDSTONE; BASAL SAUROPOD; THEROPOD; ORIGIN; ARGENTINA	Sarahsaurus aurifontanalis, from the Kayenta Formation of Arizona, is one of only three sauropodomorph dinosaurs known from the Early Jurassic of North America. It joins Anchisaurus polyzelus, from the older Portland Formation of the Hartford Basin, and Seitaad reussi, from the younger Navajo Sandstone of Utah, in representing the oldest North American sauropodomorphs. If it is true that sauropodomorphs were absent from North America during the Late Triassic, the relationship among these three dinosaurs offers a test of the mechanisms that drove recovery in North American biodiversity following the end-Triassic extinction event. Here we provide the first thorough description of Sarahsaurus aurifontanalis based on completed preparation and computed tomographic imaging of the holotype and referred specimens. With new anatomical data, our phylogenetic analysis supports the conclusion that Sarahsaurus aurifontanalis is nested within the primarily Gondwanan Glade Massospondylidae, while agreeing with previous analyses that the three North American sauropodomorphs do not themselves form an exclusive Glade. A revised diagnosis and more thorough understanding of the anatomy of Sarahsaurus aurifontanalis support the view that independent dispersal events were at least partly responsible for the recovery in North American vertebrate diversity following a major extinction event.	[Marsh, Adam D.; Rowe, Timothy B.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Marsh, Adam D.] Petrified Forest Natl Pk, Div Sci & Resource Management, Holbrook, AZ 86028 USA	University of Texas System; University of Texas Austin	Marsh, AD (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.; Marsh, AD (corresponding author), Petrified Forest Natl Pk, Div Sci & Resource Management, Holbrook, AZ 86028 USA.	admarsh@utexas.edu		Marsh, Adam/0000-0002-3223-8940	Jackson School of Geosciences; National Science Foundation (NSF) [EAR 1258878, EAR 1561622, EAR 1160721, EAR 0948842, IIS-0531767]; St. George Dinosaur Discovery Site at Johnson Farm	Jackson School of Geosciences; National Science Foundation (NSF)(National Science Foundation (NSF)); St. George Dinosaur Discovery Site at Johnson Farm	This research was funded by the Jackson School of Geosciences and the National Science Foundation (NSF EAR 1258878, EAR 1561622, EAR 1160721, EAR 0948842, and IIS-0531767) to TBR. Andrew Milner and the St. George Dinosaur Discovery Site at Johnson Farm funded Brian Engh's art of the Kayenta fauna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2008, GEODIVERSITAS, V30, P345; Apaldetti C, 2014, J VERTEBR PALEONTOL, V34, P1113, DOI 10.1080/02724634.2014.859147; Apaldetti C, 2013, PALAEONTOLOGY, V56, P277, DOI 10.1111/j.1475-4983.2012.01198.x; Apaldetti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026964; Archibald JD, 2010, SCIENCE, V328, P973, DOI 10.1126/science.328.5981.973-a; Attridge J., 1985, Journal of Vertebrate Paleontology, V5, P128; Baird D., 1980, P219; Balanoff AM, 2010, AM MUS NOVIT, P1, DOI 10.1206/591.1; Baron MG, 2017, ZOOL J LINN SOC-LOND, V179, P125, DOI 10.1111/zoj.12434; Barrett PM, 2005, J VERTEBR PALEONTOL, V25, P806, DOI 10.1671/0272-4634(2005)025[0806:COOLHY]2.0.CO;2; Bentley M, 2004, TLS-TIMES LIT SUPPL, P7; BENTON MJ, 1987, BIOL REV, V62, P305, DOI 10.1111/j.1469-185X.1987.tb00666.x; Benton MJ, 2000, J VERTEBR PALEONTOL, V20, P77, DOI 10.1671/0272-4634(2000)020[0077:AASOTP]2.0.CO;2; Blackburn TJ, 2013, SCIENCE, V340, P941, DOI 10.1126/science.1234204; BONAPARTE J F, 1978, Ameghiniana, V15, P327; Bonaparte J.F., 1972, OPERA LILLOANA, V22, P1; Bonaparte Jose F., 1995, Ameghiniana, V32, P341; Bonnan MF, 2007, SPEC PAP PALAEONTOL, P157; Brady LF, 1936, AM J SCI, V31, P150; Brady LF, 1935, AM J SCI, V30, P210; Brochu C.A., 1992, THESIS; Bronzati M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11737-5; Broom R, 1913, P ZOOL SOC LOND, V1913, P619; Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Burch SH, 2014, J ANAT, V225, P271, DOI 10.1111/joa.12216; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2013, J VERTEBR PALEONTOL, V33, P224, DOI 10.1080/02724634.2012.710691; Cabreira SF, 2011, NATURWISSENSCHAFTEN, V98, P1035, DOI 10.1007/s00114-011-0858-0; Cabreira SF, 2016, CURR BIOL, V26, P3090, DOI 10.1016/j.cub.2016.09.040; Cai K.-J., 1988, MIDDLE JURASSIC DINO; Chapelle KEJ, 2018, PEERJ, V6, DOI 10.7717/peerj.4224; Chatterjee S, 2002, ZOOL J LINN SOC-LOND, V136, P145, DOI 10.1046/j.1096-3642.2002.00037.x; Chatterjee Sankar, 2010, P105; Colbert E. H., 1970, Am. Mus. Novit., VNo. 2405, P1; Colbert E.H., 1981, Museum of Northern Arizona Bulletin, P1; Colbert E.H., 1973, P395; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; COLBERT EH, 1951, B AM MUS NAT HIST, V97, P143; Cooley ME, 1969, US GEOLOGICAL SURV A, V521A, P1; Cooper M. R, 1981, NATURAL SCI, V6, P689; Crompton A.W., 1980, P193; de Fabregues CP, 2016, PEERJ, V4, DOI 10.7717/peerj.1639; de Fabregues CP, 2015, ZOOL J LINN SOC-LOND, V175, P569, DOI 10.1111/zoj.12290; DODSON P, 1981, J PALEONTOL, V55, P109; DONOGHUE MJ, 1989, ANNU REV ECOL SYST, V20, P431, DOI 10.1146/annurev.es.20.110189.002243; Dzik J, 2003, J VERTEBR PALEONTOL, V23, P556, DOI 10.1671/A1097; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Fabbri M, 2017, NAT ECOL EVOL, V1, P1543, DOI 10.1038/s41559-017-0288-2; Fedak TJ, 2006, THESIS; GALTON P M, 1971, Journal of Paleontology, V45, P781; Galton P.M., 1976, Postilla, VNo. 69, P1; GALTON P M, 1977, Palaeontologische Zeitschrift, V51, P234; Galton P.M., 1998, PALAEONTOGR ABT A, V250, P155; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Galton Peter M., 2000, Palaeontologische Zeitschrift, V74, P393; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gauthier JA., 1984, THESIS; Gilmore C. W., 1936, Memoirs of the Carnegie Museum, V11, P175; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goodwin MB, 2007, PALAEOGEOGR PALAEOCL, V253, P458, DOI 10.1016/j.palaeo.2007.06.017; Griffin CT, 2018, J ANAT, V232, P604, DOI 10.1111/joa.12775; Harshbarger J. W., 1957, US GEOLOGICAL SURVEY; Higgins C.G., 1990, GEOLOGICAL SOC AM SP, V252, P291, DOI DOI 10.1130/SPE252-P291; Hitchcock E., 1858, ICHNOLOGY NEW ENGLAN; Hitchcock E., 1865, SUPPLEMENT ICHNOLOGY, VVol. 385; Hohn Bianca, 2011, P182; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P627; Huene F.von., 1932, MONOGRAPHIEN GEOLOGI, V1, P1; Huene Fv, 1908, GEOL PALAONT AHB S, V1, P1; Hunn CA, 2001, SYST BIOL, V50, P391, DOI 10.1080/713849647; Irmis Randall B., 2007, Historical Biology, V19, P3, DOI 10.1080/08912960600719988; Jain S, 1979, P 4 INT GONDW S CALC, P204; Janensch W., 1935, PALAEONTOGRAPHICA S7, V7, P147; Kent DV, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005407; Knoll F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030060; Langer MC, 2007, SPEC PAP PALAEONTOL, P113; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; Langer Max Cardoso, 2003, Paleobios, V23, P1; Langer MC, 1999, CR ACAD SCI II A, V329, P511, DOI 10.1016/S1251-8050(00)80025-7; Lieberman BS, 1997, GEOLOGY, V25, P1039, DOI 10.1130/0091-7613(1997)025<1039:ECPATH>2.3.CO;2; Long R.A., 1995, NEW MEXICO MUSEUM NA, V4, P1; Maddison, 2018, MESQUITE MODULAR SYS; Mallison H, 2010, PALAEONTOL ELECTRON, V13; Mallison H, 2010, ACTA PALAEONTOL POL, V55, P433, DOI 10.4202/app.2009.0075; Marsh AD, 2014, J VERTEBRATE PAL S2, V34, P178; Marsh O. C., 1891, American Journal of Science (3), Vxlii, P265; Marsh O. C., 1892, American Journal of Science, V(3), P543; Marsh OC, 1896, ANN REP; Marsh OC, 1885, AM J SCI, V29, P169; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Martinez RN, 2009, J VERTEBR PALEONTOL, V29, P142, DOI 10.1671/039.029.0102; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; McPhee BW, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.980504; McPhee BW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13224; McPhee BW, 2014, ZOOL J LINNEAN SOC; McPhee BW, 2017, ZOOL J LINN SOC-LOND, DOI [10.1093/zoolinnean/zlx074, DOI 10.1093/ZOOLINNEAN/ZLX074]; Moser M, 2003, ZITTELIANA B, VB24, P1; Muller RT, 2019, HIST BIOL, V31, P794, DOI 10.1080/08912963.2017.1395421; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; NOVAS FE, 1989, J PALEONTOL, V63, P677, DOI 10.1017/S0022336000041317; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; Olsen P.E., 1986, P321; Osborn HF, 1924, AM MUS NOVIT, V95, P1; Otero A, 2015, ZOOL J LINNEAN SOC; Otero A, 2013, J VERTEBR PALEONTOL, V33, P1138, DOI 10.1080/02724634.2013.769444; Ouyang H., 2002, 1 MAMENCHISAURID SKE, P111; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; PADIAN K, 1989, GEOLOGY, V17, P438, DOI 10.1130/0091-7613(1989)017<0438:POTDSI>2.3.CO;2; Parker WG, 2005, P ROY SOC B-BIOL SCI, V272, P963, DOI 10.1098/rspb.2004.3047; Paul GS, 1987, DINOSAURS PAST PRESE, V2, P4; Piechowski R, 2019, HIST BIOL, V31, P1065, DOI 10.1080/08912963.2017.1418339; Piechowski R, 2010, J VERTEBR PALEONTOL, V30, P1127, DOI 10.1080/02724634.2010.483547; Pol D, 2007, SPEC PAP PALAEONTOL, P223; Pol D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014572; Prieto-Marquez A, 2011, AM MUS NOVIT, P1; Remes K, 2008, THESIS; Rowe T., 1989, Journal of Vertebrate Paleontology, V9, P125; Rowe TB, 2011, P ROY SOC B-BIOL SCI, V278, P1044, DOI 10.1098/rspb.2010.1867; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2082, DOI 10.1139/e93-180; Schaltegger U, 2008, EARTH PLANET SC LETT, V267, P266, DOI 10.1016/j.epsl.2007.11.031; Schweitzer MH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2741; Scotese C. R., 2010, PALEOMAP PROJECT; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P1; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; Sereno PC, 2007, SPEC PAP PALAEONTOL, P261; Sereno PC, 2012, J VERTEBR PALEONTOL, V32, P83, DOI 10.1080/02724634.2013.820113; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sereno PC, 2005, SYST BIOL, V54, P595, DOI 10.1080/106351591007453; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; SERENO PC, 1994, J VERTEBR PALEONTOL, V14, P53, DOI 10.1080/02724634.1994.10011538; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; Sertich JJW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009789; Sobral G, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160072; Sues H.-D., 1986, P279; Sues H.-D., 1985, Journal of Vertebrate Paleontology, V5, P328; SUES HD, 1994, IN THE SHADOW OF THE DINOSAURS, P284; Sues HD, 2004, ANN CARNEGIE MUS, V73, P239; Tang F., 2001, COMPLETE SAUROPOD JI, P128; Tanke DH, 2002, DINOSORES ANNOTATED; Tschopp E, 2013, J ANAT, V222, P321, DOI 10.1111/joa.12012; Turner AH, 2004, P ROY SOC B-BIOL SCI, V271, P2003, DOI 10.1098/rspb.2004.2840; Tykoski R.S, 2005, THESIS; Tykoski RS, 2002, J VERTEBR PALEONTOL, V22, P728, DOI 10.1671/0272-4634(2002)022[0728:AFITCT]2.0.CO;2; Tykoski RS, 2002, J VERTEBR PALEONTOL, V22, P593, DOI 10.1671/0272-4634(2002)022[0593:CVANCF]2.0.CO;2; Tykoski RS, 1998, THESIS; Upchurch P, 2003, J VERTEBR PALEONTOL, V23, P208, DOI 10.1671/0272-4634(2003)23[208:TAATOC]2.0.CO;2; Upchurch P, 2002, P ROY SOC B-BIOL SCI, V269, P613, DOI 10.1098/rspb.2001.1921; Upchurch P, 2002, PALAEONTOLOGY, V45, P1049, DOI 10.1111/1475-4983.00275; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Upchurch P, 2007, SPEC PAP PALAEONTOL, P57; von Huene F., 1926, GEOLOGISCHE PALAONTO, V15, P129; Wang YM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41881; Ward LF, 1901, AM J SCI, V12, P401; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; Whiteside JH, 2015, P NATL ACAD SCI USA, V112, P7909, DOI 10.1073/pnas.1505252112; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Xing LD, 2015, ACTA PALAEONTOL POL, V60, P643, DOI 10.4202/app.00001.2013; Yates Adam M., 2004, Postilla, V230, P1; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 2011, J VERTEBR PALEONTOL, V31, P610, DOI 10.1080/02724634.2011.560626; Yates AM, 2010, PALAEONTOLOGY, V53, P739, DOI 10.1111/j.1475-4983.2010.00952.x; Yates AM, 2010, P ROY SOC B-BIOL SCI, V277, P787, DOI 10.1098/rspb.2009.1440; Yates AM, 2005, J VERTEBR PALEONTOL, V25, P466, DOI 10.1671/0272-4634(2005)025[0466:FCITPD]2.0.CO;2; Yates AM, 2003, PALAEONTOLOGY, V46, P317, DOI 10.1111/j.0031-0239.2003.00301.x; Ye Y, 2001, VERTEBRAT PALASIATIC, V39, P269; Young C, 1972, MEMOIRS I VERTEBRATE, V8, P1; Young C. C., 1942, Bulletin of the Geological Society of China, V22, P63; Young C.C., 1941, ACTA PALAEONTOLOGICA, V7, P1; Zhang Y. H., 1994, NEW COMPLETE OSTEOLO; Zhang YH., 1988, MIDDLE JURASSIC DINO	177	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0204007	10.1371/journal.pone.0204007	http://dx.doi.org/10.1371/journal.pone.0204007			108	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	30304035	gold, Green Published, Green Submitted			2022-12-26	WOS:000446921100027
J	Am, MK; Kolle, K; Fougner, AL; Dirnena-Fusini, I; Bosch, PC; Ellingsen, R; Hjelme, DR; Stavdahl, O; Carlsen, SM; Christiansen, SC				Am, Marte Kierulf; Kolle, Konstanze; Fougner, Anders Lyngvi; Dirnena-Fusini, Ilze; Bosch, Patrick Christian; Ellingsen, Reinold; Hjelme, Dag Roar; Stavdahl, Oyvind; Carlsen, Sven Magnus; Christiansen, Sverre Christian			Effect of sensor location on continuous intraperitoneal glucose sensing in an animal model	PLOS ONE			English	Article							ARTIFICIAL PANCREAS; TIME-LAG; TRANSPORT; IMPLANTATION; KINETICS	Background In diabetes research, the development of the artificial pancreas has been a major topic since continuous glucose monitoring became available in the early 2000's. A prerequisite for an artificial pancreas is fast and reliable glucose sensing. However, subcutaneous continuous glucose monitoring carries the disadvantage of slow dynamics. As an alternative, we explored continuous glucose sensing in the peritoneal space, and investigated potential spatial differences in glucose dynamics within the peritoneal cavity. As a secondary outcome, we compared the glucose dynamics in the peritoneal space to the subcutaneous tissue. Material and methods Eight-hour experiments were conducted on 12 anesthetised non-diabetic pigs. Four commercially available amperometric glucose sensors (FreeStyle Libre, Abbott Diabetes Care Ltd., Witney, UK) were inserted in four different locations of the peritoneal cavity and two sensors were inserted in the subcutaneous tissue. Meals were simulated by intravenous infusions of glucose, and frequent arterial blood and intraperitoneal fluid samples were collected for glucose reference. Results No significant differences were discovered in glucose dynamics between the four quadrants of the peritoneal cavity. The intraperitoneal sensors responded faster to the glucose excursions than the subcutaneous sensors, and the time delay was significantly smaller for the intraperitoneal sensors, but we did not find significant results when comparing the other dynamic parameters.	[Am, Marte Kierulf; Dirnena-Fusini, Ilze; Carlsen, Sven Magnus; Christiansen, Sverre Christian] Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, Fac Med & Hlth Sci, Trondheim, Norway; [Am, Marte Kierulf; Kolle, Konstanze; Carlsen, Sven Magnus; Christiansen, Sverre Christian] St Olavs Hosp, Dept Endocrinol, Trondheim, Norway; [Kolle, Konstanze; Fougner, Anders Lyngvi; Bosch, Patrick Christian; Stavdahl, Oyvind] Norwegian Univ Sci & Technol NTNU, Fac Informat Technol & Elect Engn, Dept Engn Cybernet, Trondheim, Norway; [Ellingsen, Reinold; Hjelme, Dag Roar] Norwegian Univ Sci & Technol NTNU, Fac Informat Technol & Elect Engn, Dept Elect Syst, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Am, MK (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, Fac Med & Hlth Sci, Trondheim, Norway.; Am, MK (corresponding author), St Olavs Hosp, Dept Endocrinol, Trondheim, Norway.	marte.k.am@ntnu.no	Christiansen, Sverre/AAD-5214-2020; Fougner, Anders Lyngvi/J-3284-2013; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Stavdahl, Øyvind/AAC-2875-2019; Carlsen, Sven Magnus/AAI-4635-2020	Fougner, Anders Lyngvi/0000-0001-7583-5027; Am, Marte Kierulf/0000-0001-8245-6893; Christiansen, Sverre Christian/0000-0002-0378-0474; Kolle, Konstanze/0000-0002-6680-5392; Stavdahl, Oyvind/0000-0003-0212-3146	Research Council of Norway(NRC) [248872]; Central Norway Regional Health Authority [2014/23166]; Norwegian Medical Association Johan Selmer Kvanes Endowment	Research Council of Norway(NRC)(Research Council of Norway); Central Norway Regional Health Authority; Norwegian Medical Association Johan Selmer Kvanes Endowment	The Double Intraperitoneal Artificial Pancreas project is part of Centre for Digital Life Norway and supported by the Research Council of Norway(NRC - https://www.forskningsradet.no/en/Home_page/1177315753906), grant number 248872. The study is also supported by a scholarship from the Central Norway Regional Health Authority (https://helse-midt.no/vart-oppdrag/vare-hovedoppgaver/forskning) (grant number 2014/23166). MK A. The study is also supported by a grant from Norwegian Medical Association Johan Selmer Kvanes Endowment. (http://legeforeningen.no/Emner/Andre-emner/Fond-og-legater/Andre-legater/Johan-Selmer-Kvanes-legat-til-forskning-og-bekjempelse-av-sukkersyke/). The funding sources had no role in collection, analysis or interpretation of the data.	Atkins Peter, 2011, PHYS CHEM LIFE SCI, Vsecond; Basu A, 2017, J DIABETES SCI TECHN, DOI [10.1177/1932296817697329, DOI 10.1177/1932296817697329]; Basu Ananda, 2015, J Diabetes Sci Technol, V9, P63, DOI 10.1177/1932296814554797; Basu A, 2013, DIABETES, V62, P4083, DOI 10.2337/db13-1132; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blackburn SC, 2014, SEMIN PEDIATR SURG, V23, P326, DOI 10.1053/j.sempedsurg.2014.06.002; Boesch PC, 2017, ADV TECHNOLOGIES TRE; Burnett DR, 2014, DIABETES, V63, P2498, DOI 10.2337/db13-1649; Cengiz E, 2009, DIABETES TECHNOL THE, V11, pS11, DOI 10.1089/dia.2009.0002; Christiansen SC, 2017, DIABETES THER, V8, P489, DOI 10.1007/s13300-017-0263-6; Clark L C Jr, 1987, ASAIO Trans, V33, P323; CLARK LC, 1988, METHOD ENZYMOL, V137, P68; Cobelli C, 2011, DIABETES, V60, P2672, DOI 10.2337/db11-0654; Dai X, 2018, DIABETES THER, V9, P1269, DOI 10.1007/s13300-018-0436-y; Flessner MF, 2005, AM J PHYSIOL-RENAL, V288, pF433, DOI 10.1152/ajprenal.00313.2004; Flessner MF, 2001, PERITON DIALYSIS INT, V21, pS24; Flessner MF, 2006, AM J PHYSIOL-RENAL, V291, pF1096, DOI 10.1152/ajprenal.00062.2006; Fougner AL, 2016, MODEL IDENT CONTROL, V37, P121, DOI 10.4173/mic.2016.2.4; Fougner AL, 2015, INTRAPERITONEAL GLUC; Fullerton B, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009122.pub2; Hanbidge AE, 2003, RADIOGRAPHICS, V23, P663, DOI 10.1148/rg.233025712; Helton Kristen L, 2011, J Diabetes Sci Technol, V5, P647; Helton Kristen L, 2011, J Diabetes Sci Technol, V5, P632; Hoss U, 2017, DIABETES TECHNOL THE, V19, pS44, DOI 10.1089/dia.2017.0025; Huyett Lauren M, 2016, J Diabetes Sci Technol, V10, P1192, DOI 10.1177/1932296816640542; Klueh Ulrike, 2011, J Diabetes Sci Technol, V5, P583; Kropff J, 2016, DIABETES TECHNOL THE, V18, P53, DOI 10.1089/dia.2015.0345; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lide D.R., 2005, CRC HDB CHEM PHYS IN; MAATHUIS JB, 1978, J ENDOCRINOL, V76, P123, DOI 10.1677/joe.0.0760123; Mensh Brett D, 2013, J Diabetes Sci Technol, V7, P863; Novak MT, 2010, ANAL BIOANAL CHEM, V398, P1695, DOI 10.1007/s00216-010-4097-6; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; Ricotti L, 2013, J ARTIF ORGANS, V16, P9, DOI 10.1007/s10047-012-0660-6; Schaefer B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21344; Schmelzeisen-Redeker Gunther, 2015, J Diabetes Sci Technol, V9, P1006, DOI 10.1177/1932296815590154; SLATER NJ, 1989, J ANAT, V167, P47; Staal OM, 2019, IEEE J BIOMED HEALTH, V23, P218, DOI 10.1109/JBHI.2018.2811706; Stachowska-Pietka J, 2012, AM J PHYSIOL-RENAL, V302, pF1331, DOI 10.1152/ajprenal.00301.2011; Stavdahl O, 2016, IFAC PAPERSONLINE, V49, P765, DOI 10.1016/j.ifacol.2016.07.280; Stout Philip J, 2004, Diabetes Technol Ther, V6, P635, DOI 10.1089/dia.2004.6.635; Thabit H, 2016, DIABETOLOGIA, V59, P1795, DOI 10.1007/s00125-016-4022-4; Twigg SM, 2014, J DIABETES COMPLICAT, V28, P585, DOI 10.1016/j.jdiacomp.2014.04.005; US Food and Drug Administration, 2016, FDA APPR 1 AUT INS D; van Baal JOAM, 2017, TISSUE CELL, V49, P95, DOI 10.1016/j.tice.2016.11.004; VELHO G, 1989, DIABETOLOGIA, V32, P331, DOI 10.1007/BF00277254	46	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205447	10.1371/journal.pone.0205447	http://dx.doi.org/10.1371/journal.pone.0205447			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300416	Green Published, Green Submitted, gold			2022-12-26	WOS:000446897200068
J	Boutchueng-Djidjou, M; Belleau, P; Bilodeau, N; Fortier, S; Bourassa, S; Droit, A; Elowe, S; Faure, RL				Boutchueng-Djidjou, Martial; Belleau, Pascal; Bilodeau, Nicolas; Fortier, Suzanne; Bourassa, Sylvie; Droit, Arnaud; Elowe, Sabine; Faure, Robert L.			A type 2 diabetes disease module with a high collective influence for Cdk2 and PTPLAD1 is localized in endosomes	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; INSULIN-RECEPTOR; NETWORK MEDICINE; PHOSPHORYLATION; DEPHOSPHORYLATION; ASSOCIATION; GENES; PATHWAY; KINASE; RESISTANCE	Despite the identification of many susceptibility genes our knowledge of the underlying mechanisms responsible for complex disease remains limited. Here, we identified a type 2 diabetes disease module in endosomes, and validate it for functional relevance on selected nodes. Using hepatic Golgi/endosomes fractions, we established a proteome of insulin receptor-containing endosomes that allowed the study of physical protein interaction networks on a type 2 diabetes background. The resulting collated network is formed by 313 nodes and 1147 edges with a topology organized around a few major hubs with Cdk2 displaying the highest collective influence. Overall, 88% of the nodes are associated with the type 2 diabetes genetic risk, including 101 new candidates. The Type 2 diabetes module is enriched with cytoskeleton and luminal acidification-dependent processes that are shared with secretion-related mechanisms. We identified new signaling pathways driven by Cdk2 and PTPLAD1 whose expression affects the association of the insulin receptor with TUBA, TUBB, the actin component ACTB and the endosomal sorting markers Rab5c and Rab11a. Therefore, the interactome of internalized insulin receptors reveals the presence of a type 2 diabetes disease module enriched in new layers of feedback loops required for insulin signaling, clearance and islet biology.	[Boutchueng-Djidjou, Martial; Bilodeau, Nicolas; Fortier, Suzanne; Elowe, Sabine; Faure, Robert L.] Univ Laval, Ctr Rech CHU Quebec, Fac Med, Dept Pediat, Quebec City, PQ, Canada; [Belleau, Pascal; Bourassa, Sylvie; Droit, Arnaud] Univ Laval, Plateforme Prote Est Quebec, Quebec City, PQ, Canada; [Boutchueng-Djidjou, Martial] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Belleau, Pascal] Cold Spring Harbor Lab, New York, NY USA	Laval University; Laval University; H Lee Moffitt Cancer Center & Research Institute; Cold Spring Harbor Laboratory	Faure, RL (corresponding author), Univ Laval, Ctr Rech CHU Quebec, Fac Med, Dept Pediat, Quebec City, PQ, Canada.	robert.faure@crchudequebec.ulaval.ca	Droit, Arnaud/AGZ-6283-2022; Belleau, Pascal/AAT-6895-2021	Droit, Arnaud/0000-0001-7922-790X; Boutchueng Djidjou, Martial/0000-0001-6410-347X; Belleau, Pascal/0000-0002-0802-1071; Faure, Robert/0000-0003-1798-4723	National Sciences and Engineering Research Council of Canada (NSERC) [155751]; Fondation du CHU de Quebec; CRCHUQ	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fondation du CHU de Quebec; CRCHUQ	The research program in the R. Faure laboratory was funded by the National Sciences and Engineering Research Council of Canada (NSERC: 155751) and the Fondation du CHU de Quebec. M. B-D acknowledges funding from the Fondation du CHU de Quebec and the CRCHUQ. S. E. holds a FRQS junior investigator salary award. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader M, 2014, OBESITY, V22, P1238, DOI 10.1002/oby.20625; Ahlqvist E, 2018, LANCET DIABETES ENDO, V6, P361, DOI 10.1016/S2213-8587(18)30051-2; Andersen JN, 2005, METHODS, V35, P90, DOI 10.1016/j.ymeth.2004.07.012; Asby DJ, 2015, CHEM BIOL, V22, P838, DOI 10.1016/j.chembiol.2015.06.008; Au CE, 2007, CURR OPIN CELL BIOL, V19, P376, DOI 10.1016/j.ceb.2007.05.004; Balbis A, 2004, J BIOL CHEM, V279, P12777, DOI 10.1074/jbc.M311493200; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barriere C, 2007, MOL ONCOL, V1, P72, DOI 10.1016/j.molonc.2007.03.001; Baumdick M, 2015, ELIFE, V4, DOI 10.7554/eLife.12223; Bergeron JJM, 2016, ANNU REV BIOCHEM, V85, P573, DOI 10.1146/annurev-biochem-060815-014659; Bergeron JJM, 2010, TRENDS CELL BIOL, V20, P337, DOI 10.1016/j.tcb.2010.02.005; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Boutchueng-Djidjou M, 2015, MOL CELL PROTEOMICS, V14, P1079, DOI 10.1074/mcp.M114.047159; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Choi E, 2016, CELL, V166, P567, DOI 10.1016/j.cell.2016.05.074; Courilleau D, 2000, J BIOL CHEM, V275, P17344, DOI 10.1074/jbc.M000887200; De Luca M, 2014, J CELL SCI, V127, P2697, DOI 10.1242/jcs.142604; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; FAURE R, 1992, J BIOL CHEM, V267, P11215; Ferrannini E, 2014, NEW ENGL J MED, V371, P1547, DOI 10.1056/NEJMcibr1409796; Fiset A, 2011, CELL SIGNAL, V23, P911, DOI 10.1016/j.cellsig.2011.01.019; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Gall WE, 2000, CURR BIOL, V10, P1349, DOI 10.1016/S0960-9822(00)00771-5; Gaulin JF, 2000, J BIOL CHEM, V275, P16658, DOI 10.1074/jbc.275.22.16658; Grecco HE, 2011, CELL, V144, P897, DOI 10.1016/j.cell.2011.01.029; Gustafsson M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0082-6; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hannou SA, 2015, TRENDS ENDOCRIN MET, V26, P176, DOI 10.1016/j.tem.2015.01.008; HASHIMOTO N, 1992, J BIOL CHEM, V267, P13811; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Jin MJ, 1996, J BIOL CHEM, V271, P30105, DOI 10.1074/jbc.271.47.30105; KADOWAKI T, 1985, J BIOL CHEM, V260, P4016; Kim SY, 2017, J BIOL CHEM, V292, P3841, DOI 10.1074/jbc.M116.754077; Levy ED, 2010, SCIENCE, V328, P983, DOI 10.1126/science.1190993; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; MOLLER NPH, 1995, J BIOL CHEM, V270, P23126, DOI 10.1074/jbc.270.39.23126; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morone F, 2015, NATURE, V524, P65, DOI 10.1038/nature14604; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Overmeyer JH, 2005, METHOD ENZYMOL, V403, P194, DOI 10.1016/S0076-6879(05)03016-8; Posner BI, 2014, METHOD ENZYMOL, V535, P293, DOI 10.1016/B978-0-12-397925-4.00017-1; Prasad RB, 2015, GENES-BASEL, V6, P87, DOI 10.3390/genes6010087; Progida C, 2007, J CELL SCI, V120, P3729, DOI 10.1242/jcs.017301; RAMACHANDRAN C, 1992, BIOCHEMISTRY-US, V31, P4232, DOI 10.1021/bi00132a012; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rothman JE, 2010, MOL BIOL CELL, V21, P3776, DOI 10.1091/mbc.E10-05-0418; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sawai M, 2017, J BIOL CHEM, V292, P15538, DOI 10.1074/jbc.M117.803171; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Sharma A, 2015, HUM MOL GENET, V24, P3005, DOI 10.1093/hmg/ddv001; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shintani T, 2015, J BIOCHEM, V158, P235, DOI 10.1093/jb/mvv045; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Sousa R, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00026; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; TUOMIKOSKI T, 1989, NATURE, V342, P942, DOI 10.1038/342942a0; van Dam S, 2015, NUCLEIC ACIDS RES, V43, pD1124, DOI 10.1093/nar/gku1042; Villasenor R, 2016, CURR OPIN CELL BIOL, V39, P53, DOI 10.1016/j.ceb.2016.02.002; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; WANDOSELL F, 1987, J BIOL CHEM, V262, P8268; Wang W, 2009, J BIOL CHEM, V284, P3521, DOI 10.1074/jbc.M806707200; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Wood AR, 2017, DIABETES, V66, P2296, DOI 10.2337/db16-1452; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zeigerer A, 2017, EXP CELL RES, V350, P242, DOI 10.1016/j.yexcr.2016.11.027; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014	84	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205180	10.1371/journal.pone.0205180	http://dx.doi.org/10.1371/journal.pone.0205180			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300385	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000446897200044
J	Buffin, A; Sasaki, T; Pratt, SC				Buffin, Aurelie; Sasaki, Takao; Pratt, Stephen C.			Scaling of speed with group size in cooperative transport by the ant Novomessor cockerelli	PLOS ONE			English	Article							DIVISION-OF-LABOR; FOOD-RETRIEVING BEHAVIOR; COLONY SIZE; ARMY ANTS; NEW-WORLD; ORGANIZATION; HYMENOPTERA; RECRUITMENT; FORMICIDAE; TEAMS	Working together allows social animals to accomplish tasks beyond the abilities of solitary individuals, but the benefits of cooperation must be balanced with the costs of coordination. Many ant species form cooperative groups to transport items too large for a single ant. However, transport by groups is often slower and less efficient than that of lone ants, for reasons that remain poorly understood. We tested the hypothesis that groups are slower when porters must encircle the load to carry it, because this arrangement places ants in a variety of postures relative to the load and the direction of travel. Porters may therefore have difficulty maximizing individual forces and aligning them with those of other group members. Experiments on the desert ant Novomessor cockerelli, an adept cooperative transporter, did not support this hypothesis. Groups ranging in size from one to four ants were induced to carry loads such that all porters were aligned with one another. Load weight was adjusted so that all porters pulled the same per capita weight, but lone porters were nonetheless faster than groups of any size. As group size increased, porters persisted in carrying the load for longer periods before letting go. We used simulations to explore a scenario in which ants vary in their intrinsic speed and the group's speed is limited by that of its slowest member. This proposed mechanism is analogous to other social groups where group efficiency is determined by the weakest link. We discuss how interactions among porters, mediated by the load itself, might explain such a constraint.	[Buffin, Aurelie] Mesa Community Coll, Mesa, AZ USA; [Sasaki, Takao] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Pratt, Stephen C.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	University System of Georgia; University of Georgia; Arizona State University; Arizona State University-Tempe	Pratt, SC (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	stephen.pratt@asu.edu		Pratt, Stephen/0000-0002-1086-4019	United States Office of Naval Research [N00014-08-1-0696]; United States National Science Foundation [CCF-1012029]; Wallonie-Bruxelles International; Belgian American Education Foundation	United States Office of Naval Research(Office of Naval Research); United States National Science Foundation(National Science Foundation (NSF)); Wallonie-Bruxelles International; Belgian American Education Foundation	SCP received Award N00014-08-1-0696 from the United States Office of Naval Research (www.onr.navy.mil) and Award CCF-1012029 from the United States National Science Foundation (www.nsf.gov). AB received funding from the Wallonie-Bruxelles International (http://www.wbi.be/fr) and the Belgian American Education Foundation (www.baef.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the United States Office of Naval Research (Award N00014-08-1-0696) and the United States National Science Foundation (Award CCF-1012029). AB was supported by the Wallonie-Bruxelles International and the Belgian American Education Foundation.	Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; Batschelet E, 1981, CIRCULAR STAT BIOL; BECKERS R, 1989, Psyche (Cambridge), V96, P239, DOI 10.1155/1989/94279; Beekman M, 2001, P NATL ACAD SCI USA, V98, P9703, DOI 10.1073/pnas.161285298; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Berman S, 2011, P IEEE, V99, P1470, DOI 10.1109/JPROC.2011.2111450; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Buffin A, 2016, INSECT SOC, V63, P429, DOI 10.1007/s00040-016-0486-y; Cerda X, 2009, BEHAV ECOL SOCIOBIOL, V63, P551, DOI 10.1007/s00265-008-0690-5; Chapman CA, 2015, P NATL ACAD SCI USA, V112, P14751, DOI 10.1073/pnas.1519760112; CHAUVIN R, 1949, BEHAVIOUR, V2, P249; Cook CN, 2013, ANIM BEHAV, V86, P323, DOI 10.1016/j.anbehav.2013.05.021; Creel S, 1997, ANIM BEHAV, V54, P1319, DOI 10.1006/anbe.1997.0481; Czaczkes TJ, 2011, INSECT SOC, V58, P153, DOI 10.1007/s00040-010-0130-1; Czaczkes TJ, 2013, MYRMECOL NEWS, V18, P1; Donaldson-Matasci MC, 2013, ANIM BEHAV, V85, P585, DOI 10.1016/j.anbehav.2012.12.020; Dornhaus A, 2006, BEHAV ECOL, V17, P336, DOI 10.1093/beheco/arj036; Dornhaus A, 2012, ANNU REV ENTOMOL, V57, P123, DOI 10.1146/annurev-ento-120710-100604; Dussutour A, 2005, J EXP BIOL, V208, P2903, DOI 10.1242/jeb.01711; Dussutour A, 2004, NATURE, V428, P70, DOI 10.1038/nature02345; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; Franks NR, 1999, P ROY SOC B-BIOL SCI, V266, P1697, DOI 10.1098/rspb.1999.0834; Franks NR, 2001, ANIM BEHAV, V62, P635, DOI 10.1006/anbe.2001.1794; FRANKS NR, 1986, BEHAV ECOL SOCIOBIOL, V18, P425, DOI 10.1007/BF00300517; FRANKS NR, 1989, AM SCI, V77, P138; Gautrais J, 2002, J THEOR BIOL, V215, P363, DOI 10.1006/jtbi.2001.2506; Gelblum A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8729; Gilbert C, 2006, PHYSIOL BEHAV, V88, P479, DOI 10.1016/j.physbeh.2006.04.024; Giraldeau L.A., 2000, MG BEH ECOL; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Gotwald WH, 1995, ARMY ANTS BIOL SOCIA; Guo SH, 2017, COMPUT ANIMAT VIRT W, V28, DOI 10.1002/cav.1779; HARKINS SG, 1987, J EXP SOC PSYCHOL, V23, P1, DOI 10.1016/0022-1031(87)90022-9; HEINRICH B, 1980, J EXP BIOL, V85, P73; HERBERS JM, 1981, J THEOR BIOL, V89, P175, DOI 10.1016/0022-5193(81)90184-3; HOLLDOBLER B, 1978, BEHAV ECOL SOCIOBIOL, V4, P163, DOI 10.1007/BF00354978; INGHAM AG, 1974, J EXP SOC PSYCHOL, V10, P371, DOI 10.1016/0022-1031(74)90033-X; KARAU SJ, 1993, J PERS SOC PSYCHOL, V65, P681, DOI 10.1037/0022-3514.65.4.681; Karsai I, 1998, P NATL ACAD SCI USA, V95, P8665, DOI 10.1073/pnas.95.15.8665; KARWOWSKI W, 1986, ERGONOMICS, V29, P869, DOI 10.1080/00140138608967199; KRAVITZ DA, 1986, J PERS SOC PSYCHOL, V50, P936, DOI 10.1037/0022-3514.50.5.936; Krieger MJB, 2000, NATURE, V406, P992, DOI 10.1038/35023164; LIMA SL, 1995, ANIM BEHAV, V49, P11, DOI 10.1016/0003-3472(95)80149-9; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; MacNulty DR, 2012, BEHAV ECOL, V23, P75, DOI 10.1093/beheco/arr159; Markham AC, 2015, P NATL ACAD SCI USA, V112, P14882, DOI 10.1073/pnas.1517794112; MARKL H, 1978, BEHAV ECOL SOCIOBIOL, V4, P183, DOI 10.1007/BF00354979; McCreery HF, 2014, INSECT SOC, V61, P99, DOI 10.1007/s00040-013-0333-3; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Moffett MW, 2010, ADVENTURES AMONG ANTS: A GLOBAL SAFARI WITH A CAST OF TRILLIONS, P1; MOFFETT MW, 1988, NATL GEOGR RES, V4, P386; PACKER C, 1988, AM NAT, V132, P159, DOI 10.1086/284844; Phonekeo S, 2016, SOFT MATTER, V12, P4214, DOI 10.1039/c6sm00063k; Pulliam HR, 1984, BEHAV ECOLOGY EVOLUT, P122; Rasband W., 2006, IMAGEJ; Ringelmann M., 1913, ANN I NATL AGRONOMIQ, V2, P1; Ringelmann M., 1907, ANN I NATIONAL AGRON, V6, P243; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; Rubenstein M., 2013, P 2013 INT C AUT AG, P47, DOI DOI 10.5555/2484920.2484932; SUDD J. H., 1960, BEHAVIOUR, V16, P295, DOI 10.1163/156853960X00197; SUDD JH, 1965, BEHAVIOUR, V25, P234, DOI 10.1163/156853965X00156; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Thomas ML, 2003, NATURWISSENSCHAFTEN, V90, P88, DOI 10.1007/s00114-002-0396-x; TRANIELLO JFA, 1991, BEHAV ECOL SOCIOBIOL, V29, P283, DOI 10.1007/BF00163986	64	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205400	10.1371/journal.pone.0205400	http://dx.doi.org/10.1371/journal.pone.0205400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW4OW	30300423	gold, Green Submitted, Green Published			2022-12-26	WOS:000446897200059
J	Hirasen, K; Berhanu, R; Evans, D; Rosen, S; Sanne, I; Long, L				Hirasen, Kamban; Berhanu, Rebecca; Evans, Denise; Rosen, Sydney; Sanne, Ian; Long, Lawrence			High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa	PLOS ONE			English	Article							TUBERCULOSIS; MORTALITY; ANEMIA; KHAYELITSHA; HIV	Introduction Treatment success rates of rifampicin resistant (RR)/multi-drug resistant (MDR) tuberculosis (TB) in South Africa range from 43-48%, falling short of the World Health Organization's target of >= 75%. We present rates and assess predictors of attrition by 12 months on treatment. Methods Prospective observational cohort analysis of adults (>= 18 years) initiating RR/MDR-TB treatment from 01 March 2013 to 30 September 2016. Attrition was defined as a combination of death and loss to follow-up (LTFU; treatment interruption >= 2 months) by 12 months on treatment. Predictors of attrition were identified using Cox Proportional Hazards models to estimate crude (HR) and adjusted hazard ratios (aHR) with corresponding 95% confidence intervals. Results By 12 months on treatment, 75/240 (31.3%) patients had either died (37/240; 15.4%) or been LTFU (38/240; 15.8%). Patients with moderate/severe anaemia (aHR: 2.10; 95% CI 1.00-4.39), and those who were smear positive at baseline (aHR: 2.04; 95% CI 1.01-4.12) were significantly more likely to die or be lost from care. Conclusion At this outpatient DR-TB treatment site, there was a high rate of attrition halfway through the standard treatment course at 12 months of 31%. High rates of attrition by 12 months on treatment may continue during the second-half of therapy.	[Hirasen, Kamban; Berhanu, Rebecca; Evans, Denise; Rosen, Sydney; Sanne, Ian; Long, Lawrence] Univ Witwatersrand, Sch Clin Med, Dept Internal Med, Hlth Econ & Epidemiol Res Off,Fac Hlth Sci, Johannesburg, South Africa; [Berhanu, Rebecca] Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA; [Rosen, Sydney; Long, Lawrence] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Sanne, Ian] Right Care, Johannesburg, South Africa; [Sanne, Ian] Univ Witwatersrand, Sch Clin Med, Dept Internal Med, Clin HIV Res Unit,Fac Hlth Sci, Johannesburg, South Africa	University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill; Boston University; University of Witwatersrand	Hirasen, K (corresponding author), Univ Witwatersrand, Sch Clin Med, Dept Internal Med, Hlth Econ & Epidemiol Res Off,Fac Hlth Sci, Johannesburg, South Africa.	khirasen@heroza.org	Sanne, Ian/ABH-2231-2020	Berhanu, Rebecca/0000-0002-9692-8748; Long, Lawrence/0000-0003-4986-4988	United States Agency for International Development (USAID) [AID-674-A-12-00029]; FOGARTY INTERNATIONAL CENTER [D43TW009340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052074] Funding Source: NIH RePORTER	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the United States Agency for International Development (USAID) under the terms of Cooperative Agreement AID-674-A-12-00029 to the Health Economics and Epidemiology Research Office. The funder had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript. The content of this article is solely the responsibility of the authors and does not necessarily represent the view of the USAID.	[Anonymous], 2015, OUTCOMES SUCCESSES D; [Anonymous], 2012, GLOB TUB REP 2012; Berhanu R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164974; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742; Cox H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002238; Cox HS, 2015, IMPACT DECENTRALIZED; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Isanaka S, 2012, J NUTR, V142, P350, DOI 10.3945/jn.111.144287; Jong E, 2013, PUBLIC HEALTH ACTION, V3, P51, DOI 10.5588/pha.12.0073; Kourbatova EV, 2006, INT J TUBERC LUNG D, V10, P1224; Loveday M, 2015, INT J TUBERC LUNG D, V19, P163, DOI 10.5588/ijtld.14.0369; Mehta J B, 1996, Tenn Med, V89, P369; Minchella PA, 2015, CLIN INFECT DIS, V60, P764, DOI 10.1093/cid/ciu945; Mohr E, 2015, T ROY SOC TROP MED H, V109, P425, DOI 10.1093/trstmh/trv037; Nardell E, 2010, INT J TUBERC LUNG D, V14, P1233; Nunn AJ, 2017, 48 UN WORLD C LUNG H; Republic of South Africa National Department of Health, 2011, MULT RES TUB POL FRA; Republic of South Africa National Department of Health, 2015, NAT CONS GUID PREV M; Saathoff E, 2011, INT J TUBERC LUNG D, V15, P925, DOI 10.5588/ijtld.10.0477; Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126065; Sacks LV, 1998, ARCH INTERN MED, V158, P1916, DOI 10.1001/archinte.158.17.1916; Schnippel K, 2013, SAMJ S AFR MED J, V103, P101, DOI [10.7196/SAMJ.6182, 10.7196/samj.6182]; Schnippel K, 2015, INT J INFECT DIS, V39, P89, DOI 10.1016/j.ijid.2015.09.002; United Nations Programme on HIV/ AIDS, 2018, COUNTR PROF S AFR; WHO, 2017, GLOB TUB REP; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2016, WHO TREATMT GUID DRU	31	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205463	10.1371/journal.pone.0205463	http://dx.doi.org/10.1371/journal.pone.0205463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300403	Green Published, gold, Green Submitted			2022-12-26	WOS:000446897200069
J	Jackowska, J; Klimza, H; Winiarski, P; Piersiala, K; Wierzbicka, M				Jackowska, J.; Klimza, H.; Winiarski, P.; Piersiala, K.; Wierzbicka, M.			The usefulness of narrow band imaging in the assessment of laryngeal papillomatosis	PLOS ONE			English	Article							RECURRENT RESPIRATORY PAPILLOMATOSIS	Objectives/Hypothesis Recurrent respiratory papillomatosis (RRP) is a benign disease caused by human papillomavirus 6 and 11. The characteristic feature of this disease are wart-like lesions covering the respiratory epithelium with a predilection for the larynx. There is no curative treatment for the disease. The goal of the treatment is a total surgical removal of the papillomatous lesions in order to reduce the number of relapses. Therefore, a good visualization method of papillomas is crucial during surgery. The aim of the study was to compare the accuracy of narrow band imaging (NBI) to the use of white light alone in detecting RRP. Methods The study was carried out between April 2013 and November 2015 at Poznan University of Medical Sciences, Department of Otolaryngology, Poland. Rigid endoscopy with conventional white light (WL) and NBI (CV-260SL processor and CLV-260SL light source, Olympus Optical Co. Ltd, Tokyo, Japan) was performed in all patients during direct laryngoscopy. All anatomical sites of the larynx and trachea were assessed using the Dikkers scale and Derkay total site scoring system with WL and NBI. The consensus was reached as to the number of lesions seen in WL compared to NBI. Results During 36 microlaryngoscopies, the number of papillomas detected in the larynx (by Derkay total site score) differed significantly between white light endoscopy and NBI (Wilcoxon test p = 0.000655). In endoscopy with NBI, a mean of 1.3 more papillomas in Derkay total site score was detected in comparison to white light endoscopy NBI showed additional areas of diseased tissue in 15/36 (41.67%) patients. Conclusions NBI as an additional tool during microlaryngoscopy can improve the detection of papillomatous lesions.	[Jackowska, J.; Klimza, H.; Wierzbicka, M.] Poznan Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Poznan, Poland; [Winiarski, P.] Uniwersytet Mikolaja Kopernika, Dept Otolaryngol Otolaryngol Oncol & Maxillofacia, Coll Med, Bydgoszcz, Poland; [Piersiala, K.] Poznan Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Student Res Grp, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences	Klimza, H (corresponding author), Poznan Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Poznan, Poland.	hnogala@wp.pl	Piersiala, Krzysztof/AAC-5351-2021	Piersiala, Krzysztof/0000-0003-3844-5999				Adachi K, 2015, J LARYNGOL OTOL, V129, pS74, DOI 10.1017/S0022215114002436; Armstrong LR, 1999, ARCH OTOLARYNGOL, V125, P743, DOI 10.1001/archotol.125.7.743; Derkay CS, 2008, LARYNGOSCOPE, V118, P1236, DOI 10.1097/MLG.0b013e31816a7135; Derkay CS, 1998, LARYNGOSCOPE, V108, P935, DOI 10.1097/00005537-199806000-00026; Dikkers FG, 2006, EUR ARCH OTO-RHINO-L, V263, P440, DOI 10.1007/s00405-005-1013-3; Dippold S, 2017, EUR ARCH OTO-RHINO-L, V274, P919, DOI 10.1007/s00405-016-4300-2; Dippold S, 2015, ANN OTO RHINOL LARYN, V124, P886, DOI 10.1177/0003489415590656; Gi REATP, 2012, LARYNGOSCOPE, V122, P1826, DOI 10.1002/lary.23344; Hughes OR, 2012, LARYNGOSCOPE, V122, pS63, DOI 10.1002/lary.23805; Imaizumi M, 2012, OTOLARYNG HEAD NECK, V147, P522, DOI 10.1177/0194599812448162; Klimza H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180590; Loizou C, 2014, ACTA OTO-LARYNGOL, V134, P401, DOI 10.3109/00016489.2013.867457; Lukes P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/285486; Ni XG, 2011, J LARYNGOL OTOL, V125, P288, DOI 10.1017/S0022215110002033; Ochsner MC, 2015, J VOICE, V29, P349, DOI 10.1016/j.jvoice.2014.08.002; Piazza C, 2010, EUR ARCH OTO-RHINO-L, V267, P409, DOI 10.1007/s00405-009-1121-6	16	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2018	13	10							e0205554	10.1371/journal.pone.0205554	http://dx.doi.org/10.1371/journal.pone.0205554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4OW	30300415	Green Submitted, gold, Green Published			2022-12-26	WOS:000446897200075
J	Bresin, A; Ragone, G; Cristofoletti, C; Arcelli, D; Bassi, C; Caprini, E; Fiorenza, MT; Citterich, MH; Russo, G; Narducci, MG				Bresin, Antonella; Ragone, Gianluca; Cristofoletti, Cristina; Arcelli, Diego; Bassi, Cristian; Caprini, Elisabetta; Fiorenza, Maria Teresa; Citterich, Mauro Helmer; Russo, Giandomenico; Narducci, Maria Grazia			T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; PROTEIN-KINASE-C; TCL1 EXPRESSION; TRANSGENIC MICE; SELF-RENEWAL; PROTOONCOGENE TCL1; STEM-CELLS; DIFFERENTIATION; AKT; JUN	T Cell Leukemia/Lymphoma 1 A is expressed during B-cell differentiation and, when over-expressed, acts as an oncogene in mouse (Tcl1a) and human (TCL1A) B-cell chronic lymphocytic leukemia (B-CLL) and T-cell prolymphocytic leukemia (T-PLL). Furthermore, in the murine system Tcl1a is expressed in the ovary, testis and in pre-implantation embryos, where it plays an important role in blastomere proliferation and in embryonic stem cell (ESC) proliferation and self-renewal. We have also observed that Tcl1-/- adult mice exhibit alopecia and deep ulcerations. This finding has led us to investigate the role of TCL1 in mouse skin and hair follicles. We have found that TCL1 is expressed in the proliferative structure (i.e. the secondary hair germ) and in the stem cell niche (i.e. the bulge) of the hair follicle during regeneration phase and it is constitutively expressed in the basal layer of epidermis where it is required for the correct proliferative-differentiation program of the keratinocytes (KCs). Taking advantage of the murine models we have generated, including the Tcl1-/- and the K14-TCL1 transgenic mouse, we have analysed the function of TCL1 in mouse KCs and the molecular pathways involved. We provide evidence that in the epidermal compartment TCL1 has a role in the regulation of KC proliferation, differentiation, and apoptosis. In particular, the colony-forming efficiency (CFE) and the insulin-like growth factor 1 (IGF1)-induced proliferation are dramatically impaired, while apoptosis is increased, in KCs from Tcl1-/- mice when compared to WT. Moreover, the expression of differentiation markers such as cytokeratin 6 (KRT6), filaggrin (FLG) and involucrin (IVL) are profoundly altered in mutant mice (Tcl1-/-). Importantly, by over-expressing TCL1A in basal KCs of the K14-TCL1 transgenic mouse model, we observed a significant rescue of cell proliferation, differentiation and apoptosis of the mutant phenotype. Finally, we found TCL1 to act, at least in part, via increasing phospho-ERK1/2 and decreasing phospho-P38 MAPK. Hence, our data demonstrate that regulated levels of Tcl1a are necessary for the correct proliferation and differentiation of the interfollicular KCs.	[Bresin, Antonella; Ragone, Gianluca; Cristofoletti, Cristina; Arcelli, Diego; Caprini, Elisabetta; Citterich, Mauro Helmer; Russo, Giandomenico; Narducci, Maria Grazia] IDI IRCCS, Ist Dermopat Immacolata, Mol Oncol Lab, Rome, Italy; [Bassi, Cristian] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Fiorenza, Maria Teresa] Univ Roma La Sapienza, Dipartimento Psicol, Sez Neurosci, Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Ferrara; Sapienza University Rome	Russo, G (corresponding author), IDI IRCCS, Ist Dermopat Immacolata, Mol Oncol Lab, Rome, Italy.	russo@idi.it	Bassi, Cristian/K-2356-2018; Cristofoletti, Cristina/AAE-5684-2021; Russo, Giandomenico/K-9566-2016; Narducci, Maria Grazia/L-3093-2018; Caprini, Elisabetta/AAG-8523-2020; Fiorenza, Maria Teresa/AAC-2181-2019; bresin, antonella/AAG-7189-2020	Bassi, Cristian/0000-0002-5823-709X; Russo, Giandomenico/0000-0002-7718-9687; Narducci, Maria Grazia/0000-0002-9066-186X; Fiorenza, Maria Teresa/0000-0002-5079-4019; BRESIN, antonella/0000-0003-3954-5481; Narducci, Maria Grazia/0000-0002-8877-4611	Ministero della Salute; AIRC; Associazione Italiana Ricerca sul Cancro	Ministero della Salute(Ministry of Health, Italy); AIRC(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from Ministero della Salute and AIRC to GR.; We thank Dr. Monica Napolitano for critically reviewing the manuscript and Dr. Caterina Cattani for the support in mouse keratinocyte isolation and culture. This work was supported by grants from Associazione Italiana Ricerca sul Cancro and Ministero della salute to GR.	Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Bresin A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.419; Bresin A, 2015, ONCOTARGET, V6, P19807, DOI 10.18632/oncotarget.4415; Cao L, 2010, J APPL TOXICOL, V30, P416, DOI 10.1002/jat.1513; Cianfarani F, 2011, J INVEST DERMATOL, V131, P1821, DOI 10.1038/jid.2011.137; Cursons J, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0187-6; Eckert RL, 2013, J SKIN CANCER, V2013, DOI 10.1155/2013/537028; Eckert RL, 2002, J INVEST DERM SYMP P, V7, P36, DOI 10.1046/j.1523-1747.2002.19634.x; Efanov A, 2010, LEUKEMIA, V24, P970, DOI 10.1038/leu.2010.46; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Enzler T, 2009, BLOOD, V114, P4469, DOI 10.1182/blood-2009-06-230169; Fiorenza MT, 2008, CELL DEATH DIFFER, V15, P420, DOI 10.1038/sj.cdd.4402228; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610; Hager B, 1999, J INVEST DERMATOL, V112, P971, DOI 10.1046/j.1523-1747.1999.00605.x; Herling M, 2006, LEUKEMIA, V20, P280, DOI 10.1038/sj.leu.2404017; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kang SM, 2005, BLOOD, V105, P1288, DOI 10.1182/blood-2004-04-1453; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Laine J, 2002, J BIOL CHEM, V277, P3743, DOI 10.1074/jbc.M107069200; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Miyazaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071645; Narducci MG, 1997, CANCER RES, V57, P5452; Narducci MG, 2002, P NATL ACAD SCI USA, V99, P11712, DOI 10.1073/pnas.182412399; Narducci MG, 2000, CANCER RES, V60, P2095; Nishimura K, 2017, STEM CELL REP, V8, P787, DOI 10.1016/j.stemcr.2017.01.026; Noguchi M, 2007, FASEB J, V21, P2273, DOI 10.1096/fj.06-7684com; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Pekarsky Y, 2008, P NATL ACAD SCI USA, V105, P19643, DOI 10.1073/pnas.0810965105; Ragone G, 2009, ONCOGENE, V28, P1329, DOI 10.1038/onc.2008.489; RUSSO G, 1988, CELL, V53, P137, DOI 10.1016/0092-8674(88)90495-3; Sadagurski M, 2006, MOL CELL BIOL, V26, P2675, DOI 10.1128/MCB.26.7.2675-2687.2006; Saha K, 2014, J BIOL CHEM, V289, P11443, DOI 10.1074/jbc.M113.543165; Santos M, 2002, J BIOL CHEM, V277, P19122, DOI 10.1074/jbc.M201001200; Simon R, 2007, CANCER INFORM, V3, P11; Sivina M, 2012, LEUKEMIA, V26, P1812, DOI 10.1038/leu.2012.63; Stachelscheid H, 2008, EMBO J, V27, P2091, DOI 10.1038/emboj.2008.141; VIRGILIO L, 1994, P NATL ACAD SCI USA, V91, P12530, DOI 10.1073/pnas.91.26.12530; Virgilio L, 1998, P NATL ACAD SCI USA, V95, P3885, DOI 10.1073/pnas.95.7.3885; Zanesi N, 2006, CANCER RES, V66, P915, DOI 10.1158/0008-5472.CAN-05-3426; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhang JY, 2012, AM J CANCER RES, V2, P691	52	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							0204775	10.1371/journal.pone.0204775	http://dx.doi.org/10.1371/journal.pone.0204775			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286151	gold, Green Published, Green Submitted			2022-12-26	WOS:000446383500043
J	Ehrenbrusthoff, K; Ryan, CG; Gruneberg, C; Wand, BM; Martin, DJ				Ehrenbrusthoff, Katja; Ryan, Cormac G.; Grueneberg, Christian; Wand, Benedict M.; Martin, Denis J.			The translation, validity and reliability of the German version of the Fremantle Back Awareness Questionnaire	PLOS ONE			English	Article							TACTILE ACUITY; BODY-IMAGE; 2-POINT DISCRIMINATION; SOMATOSENSORY CORTEX; CLINICAL-PRACTICE; PAIN PATIENTS; REORGANIZATION; DISABILITY; PEOPLE; EFFICACY	Background The Fremantle Back Awareness Questionnaire (FreBAQ) claims to assess disrupted self-perception of the back. The aim of this study was to develop a German version of the FreBAQ (FreBAQ-G) and assess its test-retest reliability, its known-groups validity and its convergent validity with another purported measure of back perception. Methods The FreBaQ-G was translated following international guidelines for the transcultural adaptation of questionnaires. Thirty-five patients with non-specific CLBP and 48 healthy participants were recruited. Assessor one administered the FreBAQ-G to each patient with CLBP on two separate days to quantify intra-observer reliability. Assessor two administered the FreBaQ-G to each patient on day 1. The scores were compared to those obtained by assessor one on day 1 to assess inter-observer reliability. Known-groups validity was quantified by comparing the FreBAQ-G score between patients and healthy controls. To assess convergent validity, patient's FreBAQ-G scores were correlated to their two-point discrimination (TPD) scores. Results Intra- and Inter-observer reliability were both moderate with ICC3.1 = 0.88 (95%CI: 0.77 to 0.94) and 0.89 (95%CI: 0.79 to 0.94), respectively. Intra- and inter-observer limits of agreement (LoA) were 6.2 (95%CI: 5.0-8.1) and 6.0 (4.8-7.8), respectively. The adjusted mean difference between patients and controls was 5.4 (95%CI: 3.0 to 7.8, p<0.01). Patient's FreBAQ-G scores were not associated with TPD thresholds (Pearson's r = -0.05, p = 0.79). Conclusions The FreBAQ-G demonstrated a degree of reliability and known-groups validity. Interpretation of patient level data should be performed with caution because the LoA were substantial. It did not demonstrate convergent validity against TPD. Floor effects of some items of the FreBAQ-G may have influenced the validity and reliability results. The clinimetric properties of the FreBAQ-G require further investigation as a simple measure of disrupted self-perception of the back before firm recommendations on its use can be made.	[Ehrenbrusthoff, Katja; Ryan, Cormac G.; Martin, Denis J.] Teesside Univ, Hlth & Social Care Inst, Middlesbrough, Tees Valley, England; [Ehrenbrusthoff, Katja; Grueneberg, Christian] Hsch Gesundheit, Dept Appl Hlth Sci, Bochum, Germany; [Wand, Benedict M.] Univ Notre Dame Australia, Sch Physiotherapy, Fremantle, WA, Australia	University of Teesside; University of Notre Dame Australia	Ehrenbrusthoff, K (corresponding author), Teesside Univ, Hlth & Social Care Inst, Middlesbrough, Tees Valley, England.; Ehrenbrusthoff, K (corresponding author), Hsch Gesundheit, Dept Appl Hlth Sci, Bochum, Germany.	katja.ehrenbrusthoff@hs-gesundheit.de		Wand, Benedict/0000-0002-0297-0292; Ryan, Cormac/0000-0001-5864-4325				Adamczyk W, 2018, CLIN J PAIN, V34, P82, DOI 10.1097/AJP.0000000000000499; Altman D.G., 1991, PRACTICAL STATISTIC; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Barker KL, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-97; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bot SDM, 2004, ANN RHEUM DIS, V63, P335, DOI 10.1136/ard.2003.007724; Bray H, 2011, BRIT J SPORT MED, V45, P168, DOI 10.1136/bjsm.2009.061978; Bredow J, 2016, ORTHOPADE, V45, P573, DOI 10.1007/s00132-016-3248-7; Catley MJ, 2014, J PAIN, V15, P985, DOI 10.1016/j.jpain.2014.06.009; Catley MJ, 2013, RHEUMATOLOGY, V52, P1454, DOI 10.1093/rheumatology/ket140; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Daffada PJ, 2015, PHYSIOTHERAPY, V101, P25, DOI 10.1016/j.physio.2014.07.002; Vieira EBD, 2014, PAIN MANAG NURS, V15, P593, DOI 10.1016/j.pmn.2013.04.004; de Vet HW, 2011, MEASUREMENT MED PRAC; Deyo RA, 1998, SPINE, V23, P2003, DOI 10.1097/00007632-199809150-00018; Ehrenbrusthoff K, 2016, PHYSIOL MEAS, V37, P1074, DOI 10.1088/0967-3334/37/7/1074; Ehrenbrusthoff K, 2018, MUSCULOSKEL SCI PRAC, V35, P73, DOI 10.1016/j.msksp.2018.02.007; EuroQol G., USE EQ 5D2012; Fahrmeir L, 2016, STAT WEG DATAEANALYS; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Flor H, 2001, LANCET, V357, P1763, DOI 10.1016/S0140-6736(00)04890-X; Grieve G.P., 2015, GRIEVES MODERN MUSCU, V4th ed.; Gutknecht M, 2015, J BODYW MOV THER, V19, P722, DOI 10.1016/j.jbmt.2014.12.003; Haggard P, 2013, CURR BIOL, V23, pR164, DOI 10.1016/j.cub.2013.01.047; Hodges P., 2015, GRIEVES MODERN MUSCU; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Hotz-Boendermaker S, 2016, SPINE, V41, pE667, DOI 10.1097/BRS.0000000000001348; Janssens L, 2017, MUSCULOSKEL SCI PRAC, V32, P84, DOI 10.1016/j.msksp.2017.09.003; Jensen MP, 2001, PAIN, V91, P317, DOI 10.1016/S0304-3959(00)00459-0; Kregel J, 2015, SEMIN ARTHRITIS RHEU, V45, P229, DOI 10.1016/j.semarthrit.2015.05.002; Lauche R, 2012, FORSCH KOMPLEMENTMED, V19, P68, DOI 10.1159/000337688; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Levenig CG, 2016, SCHMERZ, P1, DOI [10.1007/s00482-015-0086-1, DOI 10.1007/S00482-015-0086-1]; Lotze Martin, 2007, Curr Rheumatol Rep, V9, P488; Luomajoki H, 2011, BRIT J SPORT MED, V45, P437, DOI 10.1136/bjsm.2009.060731; Luomajoki H, 2016, C IFOMPT 2016 C UN K, V25, pe93; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Moseley GL, 2008, PAIN, V140, P239, DOI 10.1016/j.pain.2008.08.001; Nishigami T, 2017, PAIN PRACTICE; Nishigami T, 2015, MANUAL THER, V20, P63, DOI 10.1016/j.math.2014.06.010; NOLAN MF, 1985, PHYS THER, V65, P181, DOI 10.1093/ptj/65.2.181; Oesch P, 2011, ASSESSMENTS REHABILI, V2; Portney L, 1993, FDN CLIN RES APPL PR, V2, P427; Radbruch L, 1999, J PAIN SYMPTOM MANAG, V18, P180, DOI 10.1016/S0885-3924(99)00064-0; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Rowe D. A., 2006, MEASUREMENT THEORY P, P9; Ryan C, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-59; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Statista, 2017, MEISTG SPRACH WELTW; Stucki G, 1999, CLIN RHEUMATOL, V18, P101, DOI 10.1007/s100670050065; Vrana A, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00578; Waddell G, 2004, BACK PAIN REVOLUTION; Wand BM, 2010, PHYSIOTHERAPY, V96, P317, DOI 10.1016/j.physio.2010.02.005; Wand BM, 2016, J PAIN, V17, P1001, DOI 10.1016/j.jpain.2016.06.003; Wand BM, 2013, BRIT J SPORT MED, V47, P1085, DOI 10.1136/bjsports-2013-092949; Wand BM, 2017, DISRUPTED BODY IMAGE; Wand BM, 2014, J BACK MUSCULOSKELET, P1, DOI [10.3233/BMR-130409, DOI 10.3233/BMR-130409]; Wenig CM, 2009, EUR J PAIN, V13, P280, DOI 10.1016/j.ejpain.2008.04.005; 2017, J PHYSIOTHER, V63, P186, DOI DOI 10.1016/J.JPHYS.2017.04.005	61	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205244	10.1371/journal.pone.0205244	http://dx.doi.org/10.1371/journal.pone.0205244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286171	Green Published, Green Submitted, gold			2022-12-26	WOS:000446383500101
J	Schupp, JC; Fichtner, UA; Frye, BC; Heyduck-Weides, K; Birring, SS; Windisch, W; Criee, CP; Muller-Quernheim, J; Farin, E				Schupp, Jonas Christian; Fichtner, Urs Alexander; Frye, Bjoern Christian; Heyduck-Weides, Katja; Birring, Surinder S.; Windisch, Wolfram; Criee, Carl-Peter; Mueller-Quernheim, Joachim; Farin, Erik			Psychometric properties of the German version of the Leicester Cough Questionnaire in sarcoidosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; CYSTIC-FIBROSIS; CLINICAL-TRIALS; KOREAN VERSION; RASCH ANALYSIS; DOUBLE-BLIND; FIT INDEXES; RELIABILITY; VALIDATION; VALIDITY	Background Cough is one of the most common symptoms in general and pulmonary medicine with profound negative impact on health-related quality of life (HRQL). The Leicester Cough Questionnaire (LCQ) is a validated HRQL questionnaire, yet a validated German version of the LCQ is not available and it has never been tested in a cohort with sarcoidosis. Objectives To translate the LCQ into German and determine its psychometric properties. Methods The LCQ was translated in a forward-backward approach. Structured interviews in sarcoidosis patients were performed. Subsequently, sarcoidosis patients were asked to answer the German LCQ and comparative questionnaires. Distribution properties, item difficulty, concurrent validity, Rasch model fit and internal consistency of the German LCQ were determined. Results 200 patients with sarcoidosis were included. We provide evidence for reliability, unidimensionality and internal consistency. However, only a moderate correlation with general and respiratory-specific HRQL questionnaires, no Rasch model fit could be shown. Skewed responses caused by floor effects were detected. Conclusion We demonstrate that the German LCQ is valid and reliable and its psychometric properties fulfil the standards required for its use in clinical settings as well as in interventional trials.	[Schupp, Jonas Christian; Frye, Bjoern Christian; Mueller-Quernheim, Joachim] Univ Med Ctr, Dept Pneumol, Fac Med, Freiburg, Germany; [Schupp, Jonas Christian] Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT USA; [Fichtner, Urs Alexander; Heyduck-Weides, Katja; Farin, Erik] Univ Med Ctr, Fac Med, Inst Qual Management & Social Med, Freiburg, Germany; [Birring, Surinder S.] Kings Coll London, Div Asthma Allergy & Lung Biol, London, England; [Windisch, Wolfram] Witten Herdecke Univ Hosp, Kliniken Stadt Koln gGmbH, Cologne Merheim Hosp, Dept Pneumol, Cologne, Germany; [Criee, Carl-Peter] Evangel Hosp Gottingen Weende, Dept Sleep & Resp Med, Bovenden, Germany	University of Freiburg; Yale University; University of Freiburg; University of London; King's College London	Farin, E (corresponding author), Univ Med Ctr, Fac Med, Inst Qual Management & Social Med, Freiburg, Germany.	erik.farin@uniklinik-freiburg.de	Birring, Surinder/GWU-6967-2022; Windisch, Wolfram/ABI-7381-2020; Windisch, Wolfram/AFV-2171-2022	Farin-Glattacker, Erik/0000-0001-6867-0316; Schupp, Jonas/0000-0002-7714-8076	German Research Foundation [SCHU 3147/1]; German Research Foundation (DFG); University of Freiburg in the Open-Access Publishing funding programme	German Research Foundation(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg in the Open-Access Publishing funding programme	This manuscript was partially supported by the German Research Foundation (SCHU 3147/1) to JCS. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the Open-Access Publishing funding programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.This study was made possible by intramural funding.	Acquadro C, 2008, VALUE HEALTH, V11, P509, DOI 10.1111/j.1524-4733.2007.00292.x; AITKEN RCB, 1969, P ROY SOC MED, V62, P989, DOI 10.1177/003591576906201005; Baughman RP, 2012, SARCOIDOSIS VASC DIF, V29, P90; Berkhof FF, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-4; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Chamberlain SAF, 2015, LUNG, V193, P401, DOI 10.1007/s00408-015-9701-2; Chang CC, 2018, ASSESSMENT, V25, P777, DOI 10.1177/1073191116658547; Chang CC, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0213-y; Chang CC, 2015, J CLIN EPIDEMIOL, V68, P674, DOI 10.1016/j.jclinepi.2015.01.018; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Christensen KS, 2017, J PSYCHOSOM RES, V97, P18, DOI 10.1016/j.jpsychores.2017.03.117; Conrad KJ, 2004, MED CARE, V42, P1, DOI 10.1097/01.mlr.0000103527.52821.1c; Coster WJ, 2004, MED CARE, V42, P62, DOI 10.1097/01.mlr.0000103521.84103.21; Cox CE, 2004, CHEST, V125, P997, DOI 10.1378/chest.125.3.997; Dabrowska M, 2016, ADV CLIN EXP MED, V25, P649, DOI 10.17219/acem/59512; del Corral T, 2016, ARCH BRONCONEUMOL, V52, P63, DOI 10.1016/j.arbres.2015.01.016; Drent M, 1998, SARCOIDOSIS VASC DIF, V15, P59; Farin E, 2013, BIOMED CENTRAL, V11, P135, DOI [10.1186/1477-7525-11-135, DOI 10.1186/1477-7525-11-135]; Faruqi S, 2011, RESPIROLOGY, V16, P1150, DOI 10.1111/j.1440-1843.2011.02014.x; Felisbino MB, 2014, J BRAS PNEUMOL, V40, P213, DOI 10.1590/S1806-37132014000300003; Fisseni H.J., 2004, LEHRBUCH PSYCHOLOGIS, V3rd ed.; Gao YH, 2014, INT J TUBERC LUNG D, V18, P1431, DOI 10.5588/ijtld.14.0195; Han JM, 2014, CHRON RESP DIS, V11, P147, DOI 10.1177/1479972314536206; Harrison Nicholas Kim, 2013, Cough, V9, P9, DOI 10.1186/1745-9974-9-9; Hodgson D, 2016, CHEST, V149, P1052, DOI 10.1016/j.chest.2015.12.036; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huisman Arnold N, 2007, Cough, V3, P3, DOI 10.1186/1745-9974-3-3; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Judson MA, 2017, LUNG, V195, P587, DOI 10.1007/s00408-017-0040-3; Kline R.B., 2011, PRINCIPLES PRACTICE; Kwon JW, 2015, ALLERGY ASTHMA IMMUN, V7, P230, DOI 10.4168/aair.2015.7.3.230; Lim L, 2008, BIOMED CENTRAL, V6, P52, DOI [10.1186/1477-7525-6-52, DOI 10.1186/1477-7525-6-52]; Lin CY, 2013, CHILD PSYCHIAT HUM D, V44, P583, DOI 10.1007/s10578-012-0352-8; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Merkyte I, 2016, J LUNG PULM RESP RES, V3, P1; Morice AH, OPIATE THERAPY CHRON, DOI [10.1164/rccm.200607-892OC, DOI 10.1164/RCCM.200607-892OC]; Munoz G, 2016, CHRON RESP DIS, V13, P128, DOI 10.1177/1479972316632005; Murray MP, 2009, EUR RESPIR J, V34, P125, DOI 10.1183/09031936.00160508; Ogawa Haruhiko, 2013, Cough, V9, P1, DOI 10.1186/1745-9974-9-1; Pornsuriyasak P, 2016, ASIAN PAC J ALLERGY, V34, P212, DOI 10.12932/AP0685; Raj A. A., 2009, V187, P311, DOI 10.1007/978-3-540-79842-2_16; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Reychler G, 2015, CHRON RESP DIS, V12, P313, DOI 10.1177/1479972315602618; Schupp JC, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00991-2017; Simpson CB, 2006, OTOLARYNG HEAD NECK, V134, P693, DOI 10.1016/j.otohns.2005.11.014; Sinha A, 2016, EUR RESPIR J, V47, P1461, DOI 10.1183/13993003.01369-2015; Sonnerfors P, 2018, DISABIL REHABIL, V40, P2662, DOI 10.1080/09638288.2017.1353648; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004; Wu TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117592; Yousaf Nadia, 2011, Cough, V7, P4, DOI 10.1186/1745-9974-7-4	56	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205308	10.1371/journal.pone.0205308	http://dx.doi.org/10.1371/journal.pone.0205308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286204	gold, Green Submitted, Green Published			2022-12-26	WOS:000446383500105
J	Garske, LA; Kunarajah, K; Zimmerman, PV; Adams, L; Stewart, IB				Garske, Luke A.; Kunarajah, Kuhan; Zimmerman, Paul, V; Adams, Lewis; Stewart, Ian B.			In patients with unilateral pleural effusion, restricted lung inflation is the principal predictor of increased dyspnoea	PLOS ONE			English	Article							HEMIDIAPHRAGM SECONDARY; PULMONARY MECHANICS; NORMAL VALUES; GAS-EXCHANGE; THORACENTESIS; STANDARDIZATION; SPIROMETRY; PRESSURES; DRAINAGE; SAMPLE	Background and objective The mechanism of dyspnoea associated with pleural effusion is uncertain. A cohort of patients requiring thoracoscopy for unilateral exudative effusion were investigated for associations between dyspnoea and suggested predictors: impaired ipsilateral diaphragm movement, effusion volume and restricted lung inflation. Methods Baseline Dyspnoea Index, respiratory function, and ultrasound assessment of ipsilateral diaphragm movement were assessed prior to thoracoscopy, when effusion volume was measured. Transitional Dyspnoea Index (change from baseline) was assessed 4 and 8 weeks after thoracoscopy. Pearson product moment assessed bivariate correlations and a general linear model examined how well total lung capacity (measuring restricted lung inflation), effusion volume and impaired diaphragm movement predicted Baseline Dyspnoea Index. Un-paired t tests compared the groups with normal and impaired diaphragm movement. Results 19 patients were studied (14 malignant etiology). Total lung capacity was associated with Baseline Dyspnoea Index (r = 0.68, P = 0.003). Effusion volume (r = -0.138, P = 0.60) and diaphragm movement (P = 0.09) were not associated with Baseline Dyspnoea Index. Effusion volume was larger with impaired diaphragm movement compared to normal diaphragm movement (2.16 +/- SD 0.95 vs.1.16 +/- 0.92 L, P = 0.009). Total lung capacity was lower with impaired diaphragm movement compared to normal diaphragm movement (65.4 +/- 10.3 vs 78.2 +/- 8.6% predicted, P = 0.011). The optimal general linear model to predict Baseline Dyspnoea Index used total lung capacity alone (adjusted R-2 = 0.42, P = 0.003). In nine participants with controlled effusion, baseline effusion volume (r = 0.775, P = 0.014) and total lung capacity (r = -0.690, P = 0.040) were associated with Transitional Dyspnoea Index. Conclusions Restricted lung inflation was the principal predictor of increased dyspnoea prior to thoracoscopic drainage of effusion, with no independent additional association with either effusion volume or impaired ipsilateral diaphragm movement. Restricted lung inflation may be an important determinant of the dyspnoea associated with pleural effusion.	[Garske, Luke A.; Stewart, Ian B.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Garske, Luke A.; Zimmerman, Paul, V] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld, Australia; [Kunarajah, Kuhan; Zimmerman, Paul, V] Univ Queensland, Brisbane, Qld, Australia; [Adams, Lewis] Griffith Univ, Allied Hlth Sci & Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia	Queensland University of Technology (QUT); Prince Charles Hospital; University of Queensland; Griffith University	Garske, LA (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.; Garske, LA (corresponding author), Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld, Australia.	luke.garske@connect.qut.edu.au	Stewart, Ian B/I-9927-2012; Garske, Luke/AAV-4965-2021	Stewart, Ian/0000-0003-1741-718X	Australian Postgraduate Award PhD scholarship	Australian Postgraduate Award PhD scholarship	Dr Luke Garske received Australian Postgraduate Award PhD scholarship funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Antony VB, 2000, AM J RESP CRIT CARE, V162, P1987, DOI 10.1164/ajrccm.162.5.ats8-00; Boshuizen RC, 2013, SUPPORT CARE CANCER, V21, P3109, DOI 10.1007/s00520-013-1895-3; BROWN NE, 1978, CHEST, V74, P540, DOI 10.1378/chest.74.5.540; Cartaxo AM, 2011, CHEST, V139, P1424, DOI 10.1378/chest.10-1679; Dresler CM, 2005, CHEST, V127, P909, DOI 10.1378/chest.127.3.909; ESTENNE M, 1983, AM J MED, V74, P813, DOI 10.1016/0002-9343(83)91072-0; Formenti P, 2014, J CRIT CARE, V29, P808, DOI 10.1016/j.jcrc.2014.04.009; GILMARTIN JJ, 1985, THORAX, V40, P60, DOI 10.1136/thx.40.1.60; GOLDMAN HI, 1959, AM REV TUBERC PULM, V79, P457; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; LIGHT RW, 1986, AM REV RESPIR DIS, V133, P658; Light RW, 2001, PLEURAL DIS; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; MAHLER DA, 1987, AM REV RESPIR DIS, V135, P1229; MAREL M, 1993, CHEST, V104, P1486, DOI 10.1378/chest.104.5.1486; MILLER A, 1983, AM REV RESPIR DIS, V127, P270; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mishra EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123798; Mitrouska I, 2004, Can Respir J, V11, P499; MULVEY RB, 1965, RADIOLOGY, V84, P1080, DOI 10.1148/84.6.1080; Norman GR, 2003, PDQ STATISTICS, P67; O'Donnell DE, 2009, RESP PHYSIOL NEUROBI, V167, P116, DOI 10.1016/j.resp.2009.01.010; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Pellegrino R, 2005, EUR RESPIR J, V26, P1104, DOI 10.1183/09031936.05.00026705; Sheel AW, 2011, CURR OPIN PHARMACOL, V11, P195, DOI 10.1016/j.coph.2011.04.004; Thomas R, 2015, CURR OPIN PULM MED, V21, P338, DOI 10.1097/MCP.0000000000000174; Thomas R, 2014, RESPIROLOGY, V19, P809, DOI 10.1111/resp.12328; WANG JS, 1995, CHEST, V107, P1610, DOI 10.1378/chest.107.6.1610; Wang LM, 2007, RESPIROLOGY, V12, P719, DOI 10.1111/j.1440-1843.2007.01124.x; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; WILSON SH, 1984, THORAX, V39, P535, DOI 10.1136/thx.39.7.535	32	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202621	10.1371/journal.pone.0202621	http://dx.doi.org/10.1371/journal.pone.0202621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281613	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400014
J	Tsukada, E; Kitamura, S; Enomoto, M; Moriwaki, A; Kamio, Y; Asada, T; Arai, T; Mishima, K				Tsukada, Eriko; Kitamura, Shingo; Enomoto, Minori; Moriwaki, Aiko; Kamio, Yoko; Asada, Takashi; Arai, Tetsuaki; Mishima, Kazuo			Prevalence of childhood obstructive sleep apnea syndrome and its role in daytime sleepiness	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; CHILDREN; QUESTIONNAIRE; COMMUNITY; DURATION; HABITS; EPIDEMIOLOGY; ASSOCIATION; ADOLESCENTS; PERFORMANCE	Objectives To investigate childhood obstructive sleep apnea syndrome (OSAS) and its role in daytime sleepiness among school-age children. Methods A questionnaire survey was conducted with 25,211 children aged 6-15 (mean, 10.39) years attending 148 elementary and 71 middle schools in 10 prefectures across Japan and their parents. Questions concerned 4 sleep habit items (bedtime, sleep onset latency, wake time after sleep onset, wake-up time) and 4 sleep disorder items (loud snoring, snorts/gasps, breathing pauses, seems very sleepy in the daytime). Total sleep time (TST) was calculated with sleep habits. Severe possible OSAS (p-OSAS) was defined as having loud snoring, snorts and gasps, or breathing pauses "frequently" (>= 5 times per week), and mild p-OSAS was rated as having any of these "sometimes" (2-4 times per week). Severe daytime sleepiness was defined as seeming very sleepy "frequently" and mild daytime sleepiness as seeming very sleepy "sometimes". Results Mean prevalence of mild to severe p-OSAS and severe p-OSAS in children across all grade levels was 9.5% and 1.6%, respectively. p-OSAS was particularly prevalent in children at lower elementary levels, decreasing with advancing grade levels. Prevalence of mild and severe daytime sleepiness was 6.1% and 0.9%, respectively, among all children (7.0%). Prevalence of daytime sleepiness increased with advancing grade levels, particularly in middle-school level. Average TST was 8.4 +/- 2.2 h in both elementary and middle-school levels, and decreased as grades advanced, particularly in middle-school levels. Multivariate logistic regression analysis showed that middle-school level, TST < 8 h, and p-OSAS were independent factors for daytime sleepiness. Strong correlations were found between severe daytime sleepiness and severe p-OSAS or TST < 6 h, and between daytime sleepiness and loud snoring or breathing pauses. Conclusion p-OSAS may be an independent factor influencing daytime sleepiness in school-age children. Loud snoring and breathing pauses could be clinical markers for children with severe daytime sleepiness.	[Tsukada, Eriko; Kitamura, Shingo; Enomoto, Minori; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, Kodaira, Tokyo, Japan; [Tsukada, Eriko; Arai, Tetsuaki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Psychiat, Tsukuba, Ibaraki, Japan; [Tsukada, Eriko] Univ Tsukuba Hosp, Dept Psychiat, Tsukuba, Ibaraki, Japan; [Moriwaki, Aiko] Tokyo Gakugei Univ, Support Room Students Disabil, Koganei, Tokyo, Japan; [Kamio, Yoko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Child & Adolescent Mental Hlth, Kodaira, Tokyo, Japan; [Asada, Takashi] Univ Tokyo Med & Dent Univ, Dept Neuropsychiat, Bunkyo Ku, Tokyo, Japan; [Arai, Tetsuaki] Univ Tsukuba, Fac Med, Dept Psychiat, Tsukuba, Ibaraki, Japan; [Mishima, Kazuo] Akita Univ, Grad Sch Med, Dept Neuropsychiat, Akita, Japan	National Center for Neurology & Psychiatry - Japan; University of Tsukuba; University of Tsukuba; Tokyo Gakugei University; National Center for Neurology & Psychiatry - Japan; University of Tsukuba; Akita University	Mishima, K (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, Kodaira, Tokyo, Japan.; Mishima, K (corresponding author), Akita Univ, Grad Sch Med, Dept Neuropsychiat, Akita, Japan.	mishima@med.akits-u.ac.jp	Kitamura, Shingo/G-6727-2013	Kitamura, Shingo/0000-0001-9607-1812; MISHIMA, KAZUO/0000-0003-1182-1181	Ministry of Health, Labour and Welfare of Japan [H20-KOKORO-004, ID11103316]; Intramural Research Grant for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry [23-1, 29-1]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Intramural Research Grant for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry	This study was supported by research grants from the Ministry of Health, Labour and Welfare of Japan (H20-KOKORO-004 and ID11103316) and an Intramural Research Grant (23-1, 29-1) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry.	Alexopoulos EI, 2013, SLEEP, V36, P1633, DOI 10.5665/sleep.3114; American Academy of Sleep Medicine, 2005, DIAGN COD MAN ICSD 2, V2nd ed.; Archbold KH, 2002, J PEDIATR-US, V140, P97, DOI 10.1067/mpd.2002.119990; Arens R, 2004, SLEEP, V27, P997, DOI 10.1093/sleep/27.5.997; Basner M, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy012; Beebe DW., 2004, NEUROPSYCHOLOGICAL E; Bixler EO, 2009, SLEEP, V32, P731, DOI 10.1093/sleep/32.6.731; BROUILLETTE RT, 1982, J PEDIATR-US, V100, P31, DOI 10.1016/S0022-3476(82)80231-X; Calhoun SL, 2011, SLEEP, V34, P503, DOI 10.1093/sleep/34.4.503; CARROLL JL, 1995, CHEST, V108, P610, DOI 10.1378/chest.108.3.610; Cha J, 2017, J NEUROSCI, V37, P4280, DOI 10.1523/JNEUROSCI.3583-16.2017; Dayyat E, 2007, SLEEP MED CLIN, V2, P433, DOI 10.1016/j.jsmc.2007.05.004; Dollman I, 2007, ACTA PAEDIATR, V96, P1011, DOI 10.1111/j.1651-2227.2007.00278.x; FRANK Y, 1983, PEDIATRICS, V71, P737; Gaina A, 2007, J PEDIATR-US, V151, P518, DOI 10.1016/j.jpeds.2007.04.036; Goodwin JL, 2003, CHEST, V124, P196, DOI 10.1378/chest.124.1.196; Gozal D, 2001, PEDIATRICS, V108, P693, DOI 10.1542/peds.108.3.693; Gozal D, 1998, PEDIATRICS, V102, P616, DOI 10.1542/peds.102.3.616; Hara C, 2004, SLEEP MED, V5, P31, DOI 10.1016/j.sleep.2003.09.009; Hublin C, 1996, J INTERN MED, V239, P417, DOI 10.1046/j.1365-2796.1996.475826000.x; Hunter SJ, 2016, AM J RESP CRIT CARE, V194, P739, DOI 10.1164/rccm.201510-2099OC; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Kaditis AG, 2004, PEDIATR PULM, V37, P499, DOI 10.1002/ppul.20002; Kaneita Y, 2005, J EPIDEMIOL, V15, P1, DOI 10.2188/jea.15.1; Kheirandish L, 2006, DEVELOPMENTAL SCI, V9, P388, DOI 10.1111/j.1467-7687.2006.00504.x; Kohyama J, 2005, SHOUNIKA S, V46; Kuehni CE, 2008, EUR RESPIR J, V31, P326, DOI 10.1183/09031936.00088407; Kuwada A, 2018, SLEEP MED, V41, P69, DOI 10.1016/j.sleep.2017.07.025; Li AM, 2010, THORAX, V65, P991, DOI 10.1136/thx.2010.134858; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083037, 10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604]; Lumeng Julie C, 2008, Proc Am Thorac Soc, V5, P242, DOI 10.1513/pats.200708-135MG; Marcus CL, 2012, PEDIATRICS, V130, pE714, DOI 10.1542/peds.2012-1672; Marcus CL, 1998, AM J RESP CRIT CARE, V157, P1098, DOI 10.1164/ajrccm.157.4.9704080; Matricciani L, 2012, SLEEP MED REV, V16, P203, DOI 10.1016/j.smrv.2011.03.005; Matricciani L, 2011, SLEEP, V34, P651, DOI 10.1093/sleep/34.5.651; Melendres MCS, 2004, PEDIATRICS, V114, P768, DOI 10.1542/peds.2004-0730; Mid RDC, 2006, SLEEP, V29, P495; Mindell JA, 1999, CHILD ADOL PSYCH CL, V8, P695; Mindell Jodi A, 2003, J Pediatr Health Care, V17, P324, DOI 10.1016/S0891-5245(03)00215-3; MOGRASS MA, 1994, AM J RESP CRIT CARE, V150, P1690, DOI 10.1164/ajrccm.150.6.7952634; O'Brien L M, 2004, Minerva Pediatr, V56, P585; O'Brien LM, 2004, PEDIATRICS, V114, P44, DOI 10.1542/peds.114.1.44; O'Brien LM, 2004, J SLEEP RES, V13, P165, DOI 10.1111/j.1365-2869.2004.00395.x; O'Brien LM, 2009, CHILD ADOL PSYCH CL, V18, P813, DOI 10.1016/j.chc.2009.04.008; Ohida T, 2004, SLEEP, V27, P978, DOI 10.1093/sleep/27.5.978; Okada M, 2017, J PHYSIOL ANTHROPOL, V36, DOI 10.1186/s40101-017-0151-9; Owens JA, 2000, SLEEP, V23, P1043; Sadeh A, 2004, PEDIATRICS, V113, pE570, DOI 10.1542/peds.113.6.e570; Shimizu S, 2014, SLEEP MED, V15, P451, DOI 10.1016/j.sleep.2013.05.020; Shinkoda H, 2000, PSYCHIAT CLIN NEUROS, V54, P287, DOI 10.1046/j.1440-1819.2000.00681.x; Spruyt K, 2006, SLEEP MED, V7, P269, DOI 10.1016/j.sleep.2005.08.013; Tauman R, 2004, PEDIATRICS, V113, pE564, DOI 10.1542/peds.113.6.e564; Thorleifsdottir B, 2002, J PSYCHOSOM RES, V53, P529, DOI 10.1016/S0022-3999(02)00444-0; Twenge JM, 2017, SLEEP MED, V39, P47, DOI 10.1016/j.sleep.2017.08.013; Valery PC, 2004, J PAEDIATR CHILD H, V40, P461, DOI 10.1111/j.1440-1754.2004.00428.x; Verhulst SL, 2007, ARCH DIS CHILD, V92, P205, DOI 10.1136/adc.2006.101089; WEBB W, 1969, SLEEP PHYSL PATHOLOG, P53	57	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204409	10.1371/journal.pone.0204409	http://dx.doi.org/10.1371/journal.pone.0204409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281638	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400048
